Citrus Sinensis ID: 039159

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------26
Protein Sequence
MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPGRS
Secondary Structure (PSIPRED)
ccccccccccccHHHHHHHHHHccccccccEEEEEEEEEccEEEEEEEccHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEccccccEEEccccccccccccccccccccEEccccccHHccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccccccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccEccHHHHHHHHHHcccccccEccEEEEEccccEEEEEEEcccEEHHHHHHHcccccccccHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccEEccccccccEEEcccccEEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccccccHHHHcccccHHHHHHHHHHccccHHHcccHHHHHccHHHccccccc
Coil and Loop (DISEMBL)
mmgihntmegvpssMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLkypkdsmngystknfnsysLFTTFLLVEEfsssdssrslsfgtryirrdlkpvnilvdldgktvkvAGFGLAKSLYAykgessaevgthyykapELLLGLLEYstavdiwpvgcifgemvsgkplfpgansLITLgrivgksrkpsfcklslrdhltngfpglepaGIDLISKMLGMDPDKRITAAEALQQEYfkdvpgrs
Flexible Loop (DISEMBL)
mmgihntmegvpsSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEefsssdssrslsfgtryirrdlkpvnilvdldgktVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQqeyfkdvpgrs
Low Complexity Region (SEG)
MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFsssdssrslsFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPGRS
Disordered region (IsUnstruct)
***************IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF********LSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLG*************************
Disordered Region (DISOPRED)
MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLK**********TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD*P***
Disordered Region (DISEMBL)
*********GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE**********SFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPGRS
Disordered Region (DISPRO)
*****NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPGRS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	259	2.2.26 [Sep-21-2011]
P23111	294	Cell division control pro	N/A	no	0.899	0.792	0.403	1e-42
P24100	294	Cyclin-dependent kinase A	yes	no	0.899	0.792	0.415	3e-42
P93101	294	Cell division control pro	N/A	no	0.891	0.785	0.418	4e-42
Q05006	294	Cell division control pro	N/A	no	0.899	0.792	0.399	2e-41
P29618	294	Cyclin-dependent kinase A	yes	no	0.895	0.789	0.401	2e-41
Q38773	280	Cell division control pro	N/A	no	0.891	0.825	0.407	2e-41
P29619	292	Cyclin-dependent kinase A	no	no	0.891	0.791	0.397	6e-41
Q38772	294	Cell division control pro	N/A	no	0.899	0.792	0.399	2e-40
Q26671	298	Cell division control pro	yes	no	0.891	0.775	0.387	3e-40
Q5E9Y0	298	Cyclin-dependent kinase 2	yes	no	0.895	0.778	0.399	4e-40

>sp|P23111|CDC2_MAIZE Cell division control protein 2 homolog OS=Zea mays GN=CDC2 PE=2 SV=1

 Score =  173 bits (438), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 106/263 (40%), Positives = 147/263 (55%), Gaps = 30/263 (11%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLA-YLLKYPKDSMNG 67
           EGVPS+ IRE+S L E+NH NI+RL  V      +Y VFEY   DL  ++   P+ + N 
Sbjct: 42  EGVPSTAIREISLLKEMNHGNIVRLHDVVHSEKRIYLVFEYLDLDLKKFMDSCPEFAKNP 101

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K++        + ++   +   S R L        RDLKP N+L+D     +K+A F
Sbjct: 102 TLIKSY-------LYQILHGVAYCHSHRVL-------HRDLKPQNLLIDRRTNALKLADF 147

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG- 186
           GLA++        + EV T +Y+APE+LLG  +YST VD+W VGCIF EMV+ KPLFPG 
Sbjct: 148 GLARAFGIPVRTFTHEVVTLWYRAPEILLGARQYSTPVDVWSVGCIFAEMVNQKPLFPGD 207

Query: 187 --ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF------------PGLEPAGIDLISKM 232
              + L  + RI+G   + S+  +S        F            P L+PAG+DL+SKM
Sbjct: 208 SEIDELFKIFRILGTPNEQSWPGVSCLPDFKTAFPRWQAQDLATVVPNLDPAGLDLLSKM 267

Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  +P KRITA +AL+ EYFKD+
Sbjct: 268 LRYEPSKRITARQALEHEYFKDL 290

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.
Zea mays (taxid: 4577)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|P24100|CDKA1_ARATH Cyclin-dependent kinase A-1 OS=Arabidopsis thaliana GN=CDKA-1 PE=1 SV=1

 Score =  171 bits (434), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 111/267 (41%), Positives = 146/267 (54%), Gaps = 34/267 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI++L  V      LY VFEY    L   LK   DS   +
Sbjct: 42  EGVPSTAIREISLLKEMQHSNIVKLQDVVHSEKRLYLVFEY----LDLDLKKHMDSTPDF 97

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           S K+ +    +   +L          R +++    R + RDLKP N+L+D    ++K+A 
Sbjct: 98  S-KDLHMIKTYLYQIL----------RGIAYCHSHRVLHRDLKPQNLLIDRRTNSLKLAD 146

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG   YST VDIW VGCIF EM+S KPLFPG
Sbjct: 147 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGSHHYSTPVDIWSVGCIFAEMISQKPLFPG 206

Query: 187 ---ANSLITLGRIVGK-------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
               + L  + RI+G                K +F K    D L    P L+P G+DL+S
Sbjct: 207 DSEIDQLFKIFRIMGTPYEDTWRGVTSLPDYKSAFPKWKPTD-LETFVPNLDPDGVDLLS 265

Query: 231 KMLGMDPDKRITAAEALQQEYFKDVPG 257
           KML MDP KRI A  AL+ EYFKD+ G
Sbjct: 266 KMLLMDPTKRINARAALEHEYFKDLGG 292

Involved in the control of the cell cycle. Essential for both G1/S and G2/M (mitosis) phase transitions. Functions in cell morphogenesis as well as cell proliferation. Required for cell division (entry into mitosis) of the generative cell in male gametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P93101|CDC2_CHERU Cell division control protein 2 homolog OS=Chenopodium rubrum GN=CDC2 PE=2 SV=1

 Score =  171 bits (434), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 111/265 (41%), Positives = 146/265 (55%), Gaps = 34/265 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      LY VFEY    L   LK   DS   +
Sbjct: 42  EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY----LDLDLKKHMDSCPDF 97

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           + K+      F   +L          R +++    R + RDLKP N+L+D     +K+A 
Sbjct: 98  A-KDPRMIKRFLYQIL----------RGIAYCHSHRVLHRDLKPQNLLIDRQTNALKLAD 146

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG   YST VD+W VGCIF EMV+ KPLFPG
Sbjct: 147 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQKPLFPG 206

Query: 187 ---ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
               + L  + R +G                K SF K   +D L+   P L+PAGIDL++
Sbjct: 207 DSEIDELFKIFRTLGTPNEETWPGVTSLPDFKSSFPKWISKD-LSAVVPNLDPAGIDLLN 265

Query: 231 KMLGMDPDKRITAAEALQQEYFKDV 255
           KML +DP KRITA  AL+ EYFKD+
Sbjct: 266 KMLCLDPSKRITARNALEHEYFKDI 290

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Chenopodium rubrum (taxid: 3560)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q05006|CDC22_MEDSA Cell division control protein 2 homolog 2 OS=Medicago sativa GN=CDC2B PE=2 SV=1

 Score =  169 bits (429), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 105/263 (39%), Positives = 140/263 (53%), Gaps = 30/263 (11%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      LY VFEY   DL   +    DS   +
Sbjct: 42  EGVPSTAIREISLLKEMQHRNIVRLQDVVHSEKRLYLVFEYLDLDLKKFM----DSSPEF 97

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
           + K+     +F   +L           +     R + RDLKP N+L+D     VK+A FG
Sbjct: 98  A-KDQRQIKMFLYQILC--------GIAYCHSHRVLHRDLKPQNLLIDRSSNAVKLADFG 148

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG-- 186
           LA++        + EV T +Y+APE+LLG   YST VD+W VGCIF EM++ +PLFPG  
Sbjct: 149 LARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMINQRPLFPGDS 208

Query: 187 -ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
             + L  + RI G                K +F K   +D L    P LEPAG+DL+S  
Sbjct: 209 EIDELFKIFRITGTPNEETWPGVTSLPDFKSAFPKWPAKD-LATQVPNLEPAGLDLLSST 267

Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
             +DP +RITA  AL+ EYFKD+
Sbjct: 268 CRLDPTRRITARGALEHEYFKDI 290

Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P29618|CDKA1_ORYSJ Cyclin-dependent kinase A-1 OS=Oryza sativa subsp. japonica GN=CDKA-1 PE=1 SV=1

 Score =  169 bits (428), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 106/264 (40%), Positives = 148/264 (56%), Gaps = 32/264 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLA-YLLKYPKDSMNG 67
           EGVPS+ IRE+S L E++H NI+RL  V      +Y VFEY   DL  ++   P+ + N 
Sbjct: 42  EGVPSTAIREISLLKEMHHGNIVRLHDVIHSEKRIYLVFEYLDLDLKKFMDSCPEFAKNP 101

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K++    L+     V          +     R + RDLKP N+L+D     +K+A F
Sbjct: 102 TLIKSY----LYQILRGV----------AYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG- 186
           GLA++        + EV T +Y+APE+LLG  +YST VD+W VGCIF EMV+ KPLFPG 
Sbjct: 148 GLARAFGIPVRTFTHEVVTLWYRAPEILLGSRQYSTPVDMWSVGCIFAEMVNQKPLFPGD 207

Query: 187 --ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLISK 231
              + L  + R++G                K +F K   +D L    P L+PAG+DL+SK
Sbjct: 208 SEIDELFKIFRVLGTPNEQSWPGVSSLPDYKSAFPKWQAQD-LATIVPTLDPAGLDLLSK 266

Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           ML  +P+KRITA +AL+ EYFKD+
Sbjct: 267 MLRYEPNKRITARQALEHEYFKDL 290

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q38773|CDC2B_ANTMA Cell division control protein 2 homolog B (Fragment) OS=Antirrhinum majus GN=CDC2B PE=2 SV=1

 Score =  169 bits (428), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 108/265 (40%), Positives = 147/265 (55%), Gaps = 34/265 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E++H NI+ L  V  +   LY VFEY    L   LK   DS   +
Sbjct: 29  EGVPSTAIREISLLKEMHHENIVNLKDVVHREKRLYLVFEY----LDLDLKKHMDSCPEF 84

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           S ++ +   +F   +L          R +++    R + RDLKP N+L+D    T+K+A 
Sbjct: 85  S-QDLHMVKMFLCQIL----------RGVAYCHSHRVLHRDLKPQNLLIDRGSNTIKLAD 133

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG   YST VD+W VGCIF EMV+ KPLFPG
Sbjct: 134 FGLARAFGIPVRTFTHEVVTLWYRAPEVLLGSRHYSTPVDVWSVGCIFAEMVNQKPLFPG 193

Query: 187 ---ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
               + L  + RI+G                K SF K   ++ L    P L   G+DL+ 
Sbjct: 194 DSEIDELHKIFRIIGTPNEDIWPGVTSLPDFKSSFPKWPPKE-LATIVPNLGATGLDLLC 252

Query: 231 KMLGMDPDKRITAAEALQQEYFKDV 255
           KML +DP KRITA +AL+ EYFKD+
Sbjct: 253 KMLQLDPSKRITAKKALEHEYFKDI 277

Plays a key role in the control of the eukaryotic cell cycle.

Antirrhinum majus (taxid: 4151)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P29619|CDKA2_ORYSJ Cyclin-dependent kinase A-2 OS=Oryza sativa subsp. japonica GN=CDKA-2 PE=2 SV=1

 Score =  167 bits (424), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 105/264 (39%), Positives = 150/264 (56%), Gaps = 33/264 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V  +   +Y VFEY   DL       K  M+  
Sbjct: 42  EGVPSTAIREISLLKEMQHRNIVRLQDVVHKEKCIYLVFEYLDLDL-------KKHMD-- 92

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           S+ +F ++ +  +FL           R +++    R + RDLKP N+L+D    ++K+A 
Sbjct: 93  SSPDFKNHRIVKSFLY-------QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNSLKLAD 145

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG   YST VD+W VGCIF EMV+ KPLFPG
Sbjct: 146 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGARHYSTPVDMWSVGCIFAEMVNQKPLFPG 205

Query: 187 ---ANSLITLGRIVGKSRKPSFCKL-SLRDH-----------LTNGFPGLEPAGIDLISK 231
               + L  +  I+G   + ++  + SL D+           L    P L+ +G+DL+SK
Sbjct: 206 DSEIDELFKIFSIMGTPNEETWPGVASLPDYISTFPKWPSVDLATVVPTLDSSGLDLLSK 265

Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           ML +DP KRI A  AL+ EYFKD+
Sbjct: 266 MLRLDPSKRINARAALEHEYFKDL 289

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q38772|CDC2A_ANTMA Cell division control protein 2 homolog A OS=Antirrhinum majus GN=CDC2A PE=2 SV=2

 Score =  166 bits (419), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 105/263 (39%), Positives = 139/263 (52%), Gaps = 30/263 (11%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      LY VFEY   DL       K  M+  
Sbjct: 42  EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDL-------KKHMD-- 92

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
           S   F+         L +         S     R + RDLKP N+L+D     +K+A FG
Sbjct: 93  SCPEFSQDPRLVKMFLYQILRGIAYCHS----HRVLHRDLKPQNLLIDRRTNALKLADFG 148

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG-- 186
           LA++        + EV T +Y+APE+LLG   YST VD+W VGCIF EMV+ +PLFPG  
Sbjct: 149 LARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 208

Query: 187 -ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
             + L  + R++G                K +F K   ++ L    P L+ +G+DL+ KM
Sbjct: 209 EIDELFKIFRVMGTPNEETWPGVTSLPDFKSAFPKWPAKE-LAAVVPNLDASGLDLLDKM 267

Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L +DP KRITA  ALQ EYFKD+
Sbjct: 268 LRLDPSKRITARNALQHEYFKDI 290

Plays a key role in the control of the eukaryotic cell cycle.

Antirrhinum majus (taxid: 4151)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q26671|CDC2H_THEAN Cell division control protein 2 homolog OS=Theileria annulata GN=CRK2 PE=2 SV=1

 Score =  165 bits (418), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 142/263 (53%), Gaps = 32/263 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG+PS+ IRE+S L EL+HPNI+ L  V      L  VFEY   DL  LL      +   
Sbjct: 41  EGIPSTAIREISLLKELHHPNIVWLRDVIHSEKCLTLVFEYLDQDLKKLLDACDGGLEPT 100

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
           + K+F  Y +                 S     R + RDLKP N+L++ +G  +K+A FG
Sbjct: 101 TAKSF-LYQILRGI-------------SYCHDHRILHRDLKPQNLLINREG-VLKLADFG 145

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+AP++L+G  +YSTAVDIW VGCIF EM++G PLFPG +
Sbjct: 146 LARAFAIPVRSYTHEVVTLWYRAPDVLMGSKKYSTAVDIWSVGCIFAEMINGVPLFPGIS 205

Query: 189 SLITLGRIVG----------------KSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
               L RI                   +  P FC    +   ++  P L  +GIDLIS+M
Sbjct: 206 EQDQLKRIFKILGTPNVDSWPQVVNLPAYNPDFCYYE-KQAWSSIVPKLNESGIDLISRM 264

Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L +DP +RI+A EAL+ +YFKD+
Sbjct: 265 LQLDPVQRISAKEALKHDYFKDL 287

Plays a key role in the control of the eukaryotic cell cycle. It is required in higher cells for entry into S-phase and mitosis. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II.

Theileria annulata (taxid: 5874)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q5E9Y0|CDK2_BOVIN Cyclin-dependent kinase 2 OS=Bos taurus GN=CDK2 PE=2 SV=1

 Score =  165 bits (417), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 105/263 (39%), Positives = 144/263 (54%), Gaps = 31/263 (11%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 99

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++  +   S R L        RDLKP N+L++ DG ++K+A FG
Sbjct: 100 PLPLIKSY----LFQLLQGLAFCHSHRVL-------HRDLKPQNLLINADG-SIKLADFG 147

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 266

Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 267 LHYDPNKRISAKAALAHPFFQDV 289

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	259
242060276	293	hypothetical protein SORBIDRAFT_04g00192	0.888	0.784	0.411	1e-41
351726194	294	CDC2 [Glycine max] gi|158198575|gb|ABW23	0.899	0.792	0.422	1e-41
374349346	294	cyclin-dependent kinase A [Persea americ	0.891	0.785	0.426	1e-41
300681320	296	cell division control protein 2 homolog	0.888	0.777	0.411	2e-41
449465537	294	PREDICTED: cell division control protein	0.891	0.785	0.422	2e-41
357145585	293	PREDICTED: cyclin-dependent kinase A-2-l	0.891	0.788	0.409	2e-41
86611379	294	cyclin-dependent kinase type A [Prunus d	0.891	0.785	0.418	2e-41
300681338	293	cell division control protein 2 homolog	0.891	0.788	0.412	2e-41
326422262	294	A-type cyclin dependent kinase 1 [Dendro	0.891	0.785	0.411	2e-41
158519658	294	cell-division-cycle-2 kinase [Saccharum	0.899	0.792	0.399	3e-41

>gi|242060276|ref|XP_002451427.1| hypothetical protein SORBIDRAFT_04g001920 [Sorghum bicolor] gi|241931258|gb|EES04403.1| hypothetical protein SORBIDRAFT_04g001920 [Sorghum bicolor]

 Score =  176 bits (445), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 109/265 (41%), Positives = 148/265 (55%), Gaps = 35/265 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      +Y +FEY   DL       K  M+  
Sbjct: 42  EGVPSTAIREISLLKEMQHRNIVRLQDVVHNDKCIYLIFEYLDLDL-------KKHMD-- 92

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           S+ +F ++ +  ++L           R L++    R + RDLKP N+L+D     +K+A 
Sbjct: 93  SSADFKNHRIVKSYLY-------QILRGLAYCHSHRVLHRDLKPQNLLLDRRNNILKLAD 145

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG   YST VD+W VGCIF EMV+ KPLFPG
Sbjct: 146 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGARHYSTPVDVWSVGCIFAEMVNQKPLFPG 205

Query: 187 ---ANSLITLGRIVGK-------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
               + L  + RI+G                K +F K    D L    P LEPAGIDL+S
Sbjct: 206 DSEIDELFKIFRILGTPTEGTWPGVATLPDYKSTFPKWPSMD-LATVVPTLEPAGIDLLS 264

Query: 231 KMLGMDPDKRITAAEALQQEYFKDV 255
           KM+ +DP KRITA  AL+ EYF+D+
Sbjct: 265 KMVRLDPSKRITARAALEHEYFRDL 289

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351726194|ref|NP_001237630.1| CDC2 [Glycine max] gi|158198575|gb|ABW23441.1| CDC2 [Glycine max]

 Score =  176 bits (445), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 111/263 (42%), Positives = 144/263 (54%), Gaps = 30/263 (11%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      LY VFEY    L   LK   DS   +
Sbjct: 42  EGVPSTAIREISLLKEMQHRNIVRLQDVVHSEKRLYLVFEY----LDLDLKKHMDSSPEF 97

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K+     +F   +L           +     R + RDLKP N+L+D     +K+A FG
Sbjct: 98  -VKDPRQVKMFLYQILC--------GIAYCHSHRVLHRDLKPQNLLIDRSTNALKLADFG 148

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG-- 186
           LA++        + EV T +Y+APE+LLG  +YST VDIW VGCIF EMV+ +PLFPG  
Sbjct: 149 LARAFGIPVRTFTHEVVTLWYRAPEILLGSRQYSTPVDIWSVGCIFAEMVNQRPLFPGDS 208

Query: 187 -ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
             + L  + RI+G                K +F K   +D L N  P LEPAG+DL+S M
Sbjct: 209 EIDELFKIFRIMGTPNEDTWPGVTSLPDFKSAFPKWQPKD-LKNVVPNLEPAGLDLLSSM 267

Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L +DP KRITA  AL+ EYFKD+
Sbjct: 268 LYLDPSKRITARSALEHEYFKDI 290

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|374349346|gb|AEZ35253.1| cyclin-dependent kinase A [Persea americana]

 Score =  175 bits (444), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 113/265 (42%), Positives = 147/265 (55%), Gaps = 34/265 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      LY VFEY    L   LK   DS   +
Sbjct: 42  EGVPSTAIREISLLKEMQHRNIVRLQDVVHSDKRLYLVFEY----LDLDLKKHMDSCPEF 97

Query: 69  STKNFNSYSLFTTFL--LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAG 126
           +        L  TFL  +++  +   S R L        RDLKP N+L+D     +K+A 
Sbjct: 98  A----KDPRLIKTFLYQILKGIAYCHSHRVL-------HRDLKPQNLLIDRRTNALKLAD 146

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG   YST VD+W VGCIF EMV+ KPLFPG
Sbjct: 147 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQKPLFPG 206

Query: 187 ---ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
               + L  + RI+G                K +F K   +D LT   PGLEPAGIDL+ 
Sbjct: 207 DSEIDELFKIFRILGTPNEETWPGVSSLPDFKSAFPKWPPKD-LTTVVPGLEPAGIDLLC 265

Query: 231 KMLGMDPDKRITAAEALQQEYFKDV 255
           KML ++P +RITA  AL+ EYF+D+
Sbjct: 266 KMLCLEPSRRITAKSALEHEYFRDL 290

Source: Persea americana

Species: Persea americana

Genus: Persea

Family: Lauraceae

Order: Laurales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|300681320|emb|CAZ96037.1| cell division control protein 2 homolog 2 [Sorghum bicolor]

 Score =  175 bits (444), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 109/265 (41%), Positives = 148/265 (55%), Gaps = 35/265 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      +Y +FEY   DL       K  M+  
Sbjct: 45  EGVPSTAIREISLLKEMQHRNIVRLQDVVHNDKCIYLIFEYLDLDL-------KKHMD-- 95

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           S+ +F ++ +  ++L           R L++    R + RDLKP N+L+D     +K+A 
Sbjct: 96  SSADFKNHRIVKSYLY-------QILRGLAYCHSHRVLHRDLKPQNLLLDRRNNILKLAD 148

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG   YST VD+W VGCIF EMV+ KPLFPG
Sbjct: 149 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGARHYSTPVDVWSVGCIFAEMVNQKPLFPG 208

Query: 187 ---ANSLITLGRIVGK-------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
               + L  + RI+G                K +F K    D L    P LEPAGIDL+S
Sbjct: 209 DSEIDELFKIFRILGTPTEGTWPGVATLPDYKSTFPKWPSMD-LATVVPTLEPAGIDLLS 267

Query: 231 KMLGMDPDKRITAAEALQQEYFKDV 255
           KM+ +DP KRITA  AL+ EYF+D+
Sbjct: 268 KMVRLDPSKRITARAALEHEYFRDL 292

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449465537|ref|XP_004150484.1| PREDICTED: cell division control protein 2 homolog A-like [Cucumis sativus]

 Score =  175 bits (443), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 112/265 (42%), Positives = 148/265 (55%), Gaps = 34/265 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      LY VFEY    L   LK   DS   +
Sbjct: 42  EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY----LDLDLKKHMDSSPEF 97

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           S K+     +F   +L          R +++    R + RDLKP N+L+D     +K+A 
Sbjct: 98  S-KDPRQVKMFLYQIL----------RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLAD 146

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG   YST VD+W VGCIF EMV+ +PLFPG
Sbjct: 147 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 206

Query: 187 ---ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
               + L  + R++G                K +F K S +D L +  P LE AGIDL+S
Sbjct: 207 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSTFPKWSPKD-LASVVPNLEAAGIDLLS 265

Query: 231 KMLGMDPDKRITAAEALQQEYFKDV 255
           KML +DP KR+TA  AL+ EYFKDV
Sbjct: 266 KMLCLDPTKRVTARNALEHEYFKDV 290

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357145585|ref|XP_003573694.1| PREDICTED: cyclin-dependent kinase A-2-like [Brachypodium distachyon]

 Score =  175 bits (443), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 108/264 (40%), Positives = 151/264 (57%), Gaps = 33/264 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      +Y VFEY   DL       K  M+  
Sbjct: 42  EGVPSTAIREISLLKEMQHRNIVRLQDVVHNDKCIYLVFEYLDLDL-------KKHMD-- 92

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           S+ +F ++ +  +FL           R +++    R + RDLKP N+L+D    ++K+A 
Sbjct: 93  SSPDFKNHHIVKSFLY-------QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNSLKLAD 145

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG  +YST VD+W VGCIF EMV+ KPLFPG
Sbjct: 146 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGARQYSTPVDVWSVGCIFAEMVNQKPLFPG 205

Query: 187 ---ANSLITLGRIVGKSRKPSFCKL-SLRDH-----------LTNGFPGLEPAGIDLISK 231
               + L  + RI+G   + ++  + SL D+           L    P LEP GIDL+SK
Sbjct: 206 DSEIDELFKIFRIMGTPNEETWPGVASLPDYKSAFPRWPSLDLATVVPTLEPLGIDLLSK 265

Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           ML +DP +RI A  AL+ EYFKD+
Sbjct: 266 MLCLDPSRRINARAALEHEYFKDL 289

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|86611379|gb|ABD14373.1| cyclin-dependent kinase type A [Prunus dulcis]

 Score =  175 bits (443), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 111/265 (41%), Positives = 147/265 (55%), Gaps = 34/265 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      LY VFEY    L   LK   DS   +
Sbjct: 42  EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY----LDLDLKKHMDSTPEF 97

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           + K+     +F   +L          R +++    R + RDLKP N+L+D    ++K+A 
Sbjct: 98  A-KDPRQIKMFLYQIL----------RGIAYCHSHRVLHRDLKPQNLLIDRRTNSLKLAD 146

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG   YST VD+W VGCIF EMV+ +PLFPG
Sbjct: 147 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 206

Query: 187 ---ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
               + L  + RI+G                K SF K   +D L    P LE AG+DL+S
Sbjct: 207 DSEIDELFKIFRIMGTPTEDTWPGVNSLPDFKSSFPKWLAKD-LATAVPNLESAGVDLLS 265

Query: 231 KMLGMDPDKRITAAEALQQEYFKDV 255
           KML +DP KRITA  AL+ EYFKD+
Sbjct: 266 KMLCLDPSKRITARTALEHEYFKDI 290

Source: Prunus dulcis

Species: Prunus dulcis

Genus: Prunus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|300681338|emb|CAZ96071.1| cell division control protein 2 homolog 2 [Saccharum hybrid cultivar R570]

 Score =  174 bits (442), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 109/264 (41%), Positives = 150/264 (56%), Gaps = 33/264 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      +Y VFEY   DL       K  M+  
Sbjct: 42  EGVPSTAIREISLLKEMQHRNIVRLQDVVHNDKCIYLVFEYLDLDL-------KKHMD-- 92

Query: 69  STKNFNSYSLFTTFL--LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAG 126
           S+ +F ++ +  ++L  ++   +   S R L        RDLKP N+L+D     +K+A 
Sbjct: 93  SSADFKNHRIVKSYLYQILRGIAYCHSHRVL-------HRDLKPQNLLLDRRNNILKLAD 145

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG   YST VD+W VGCIF EMV+ KPLFPG
Sbjct: 146 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGARHYSTPVDVWSVGCIFAEMVNQKPLFPG 205

Query: 187 ---ANSLITLGRIVGKSRKPSFCKL-SLRDH-----------LTNGFPGLEPAGIDLISK 231
               + L  + RI+G   + ++  + SL D+           L    P LEPAGIDL+SK
Sbjct: 206 DSEIDELFKIFRILGTPTEETWPGVASLPDYKSTFPKWPSVDLATVVPTLEPAGIDLLSK 265

Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           ML +DP KRI A  AL+ EYF+D+
Sbjct: 266 MLRLDPSKRINARAALEHEYFRDL 289

Source: Saccharum hybrid cultivar R570

Species: Saccharum hybrid cultivar

Genus: Saccharum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326422262|gb|ADZ74120.1| A-type cyclin dependent kinase 1 [Dendrobium candidum]

 Score =  174 bits (442), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 109/265 (41%), Positives = 146/265 (55%), Gaps = 34/265 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      +Y VFEY    L   LK   DS   +
Sbjct: 42  EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRIYLVFEY----LDLDLKKHMDSCPDF 97

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           +     + S     L           R +++    R + RDLKP N+L+D     +K+A 
Sbjct: 98  AKDPRLTKSYLYQIL-----------RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLAD 146

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG  +YST VD+W VGCIF EMV+ +PLFPG
Sbjct: 147 FGLARAFGIPVRTFTHEVVTLWYRAPEILLGARQYSTPVDVWSVGCIFAEMVNQRPLFPG 206

Query: 187 ---ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
               + L  + RI+G                K +F K   +D L    P LEPAG+DL+S
Sbjct: 207 DSEIDELFKIFRILGTPTEETWPGVSSLPDFKSAFPKWPSKD-LATVVPNLEPAGVDLLS 265

Query: 231 KMLGMDPDKRITAAEALQQEYFKDV 255
           KML ++P KRITA +ALQ EYFKD+
Sbjct: 266 KMLRLEPSKRITARQALQHEYFKDL 290

Source: Dendrobium candidum

Species: Dendrobium candidum

Genus: Dendrobium

Family: Orchidaceae

Order: Asparagales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|158519658|gb|AAV28534.2| cell-division-cycle-2 kinase [Saccharum hybrid cultivar ROC16]

 Score =  174 bits (441), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 105/263 (39%), Positives = 148/263 (56%), Gaps = 30/263 (11%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLA-YLLKYPKDSMNG 67
           EGVPS+ IRE+S L E+NH NI+RL  V      +Y VFE+   DL  ++   P+ + N 
Sbjct: 42  EGVPSTAIREISLLKEMNHDNIVRLHDVIHSEKRIYLVFEFLDLDLKKFMDSCPEFAKNP 101

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K++    L+     V          +     R++ RDLKP N+L+D    T+K+A F
Sbjct: 102 TLIKSY----LYQILRGV----------AYCHSHRFLHRDLKPQNLLIDRRTNTLKLADF 147

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG- 186
           GL+++        + EV T +Y+APE+LLG  +YST VD+W VGCIF EMV+ KPLFPG 
Sbjct: 148 GLSRAFGIPVRTFTHEVVTLWYRAPEILLGAKQYSTPVDVWSVGCIFAEMVNQKPLFPGD 207

Query: 187 --ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF------------PGLEPAGIDLISKM 232
              + L  + R++G   + S+  +S        F            P LEPAG+DL+SKM
Sbjct: 208 SEIDELFKIFRVLGTPNEQSWPGVSCLPDFKTAFPRWQAQDLATIVPNLEPAGLDLLSKM 267

Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  +P KRITA +AL+ EYFKD+
Sbjct: 268 LRYEPSKRITARQALEHEYFKDL 290

Source: Saccharum hybrid cultivar ROC16

Species: Saccharum hybrid cultivar

Genus: Saccharum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	259
GENEDB_PFALCIPARUM|MAL13P1.279	288	PfPK5 "P. falciparum Protein K	0.586	0.527	0.446	5.1e-39
UNIPROTKB|P61075	288	CRK2 "Cell division control pr	0.586	0.527	0.446	5.1e-39
TAIR|locus:2099478	294	CDC2 "cell division control 2"	0.911	0.802	0.420	4.3e-38
UNIPROTKB|P29618	294	CDKA-1 "Cyclin-dependent kinas	0.903	0.795	0.408	1.9e-37
UNIPROTKB|G4MZ20	320	MGG_01362 "CMGC/CDK/CDC2 prote	0.814	0.659	0.353	1.7e-36
ZFIN|ZDB-GENE-040426-2741	298	cdk2 "cyclin-dependent kinase	0.895	0.778	0.399	1.5e-35
UNIPROTKB|P43450	298	cdk2 "Cyclin-dependent kinase	0.895	0.778	0.399	3.1e-35
UNIPROTKB|Q5E9Y0	298	CDK2 "Cyclin-dependent kinase	0.895	0.778	0.395	5.1e-35
UNIPROTKB|A0MSV8	298	cdk2 "Cyclin-dependent kinase	0.895	0.778	0.395	5.1e-35
UNIPROTKB|F1SPH6	298	CDK2 "Uncharacterized protein"	0.895	0.778	0.391	1.3e-34

GENEDB_PFALCIPARUM|MAL13P1.279 PfPK5 "P. falciparum Protein Kinase 5" [Plasmodium falciparum (taxid:5833)]

 Score = 323 (118.8 bits), Expect = 5.1e-39, Sum P(2) = 5.1e-39
 Identities = 75/168 (44%), Positives = 112/168 (66%)

Query:   102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
             R + RDLKP N+L++ +G+ +K+A FGLA++      + + EV T +Y+AP++L+G  +Y
Sbjct:   120 RVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178

Query:   162 STAVDIWPVGCIFGEMVSGKPLFPG---ANSLITLGRIVG--KSRK-PSFCKLSLRD-HL 214
             ST +DIW VGCIF EMV+G PLFPG   A+ L+ + RI+G   S+  P+  +L   D + 
Sbjct:   179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query:   215 TNGFP--------GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
             T   P        GL+ +GIDL+SKML +DP++RITA +AL+  YFK+
Sbjct:   239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0007049 "cell cycle" evidence=ISS

UNIPROTKB|P61075 CRK2 "Cell division control protein 2 homolog" [Plasmodium falciparum 3D7 (taxid:36329)]

 Score = 323 (118.8 bits), Expect = 5.1e-39, Sum P(2) = 5.1e-39
 Identities = 75/168 (44%), Positives = 112/168 (66%)

Query:   102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
             R + RDLKP N+L++ +G+ +K+A FGLA++      + + EV T +Y+AP++L+G  +Y
Sbjct:   120 RVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178

Query:   162 STAVDIWPVGCIFGEMVSGKPLFPG---ANSLITLGRIVG--KSRK-PSFCKLSLRD-HL 214
             ST +DIW VGCIF EMV+G PLFPG   A+ L+ + RI+G   S+  P+  +L   D + 
Sbjct:   179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query:   215 TNGFP--------GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
             T   P        GL+ +GIDL+SKML +DP++RITA +AL+  YFK+
Sbjct:   239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0007049 "cell cycle" evidence=ISS

TAIR|locus:2099478 CDC2 "cell division control 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 408 (148.7 bits), Expect = 4.3e-38, P = 4.3e-38
 Identities = 111/264 (42%), Positives = 147/264 (55%)

Query:     9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
             EGVPS+ IRE+S L E+ H NI++L  V      LY VFEY   DL   LK   DS   +
Sbjct:    42 EGVPSTAIREISLLKEMQHSNIVKLQDVVHSEKRLYLVFEYL--DLD--LKKHMDSTPDF 97

Query:    69 STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             S K+ +   +  T+L                  R + RDLKP N+L+D    ++K+A FG
Sbjct:    98 S-KDLH---MIKTYLY-----QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNSLKLADFG 148

Query:   129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG-- 186
             LA++        + EV T +Y+APE+LLG   YST VDIW VGCIF EM+S KPLFPG  
Sbjct:   149 LARAFGIPVRTFTHEVVTLWYRAPEILLGSHHYSTPVDIWSVGCIFAEMISQKPLFPGDS 208

Query:   187 -ANSLITLGRIVGKSRKPSFCKL-SLRDH-----------LTNGFPGLEPAGIDLISKML 233
               + L  + RI+G   + ++  + SL D+           L    P L+P G+DL+SKML
Sbjct:   209 EIDQLFKIFRIMGTPYEDTWRGVTSLPDYKSAFPKWKPTDLETFVPNLDPDGVDLLSKML 268

Query:   234 GMDPDKRITAAEALQQEYFKDVPG 257
              MDP KRI A  AL+ EYFKD+ G
Sbjct:   269 LMDPTKRINARAALEHEYFKDLGG 292

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0042023 "DNA endoreduplication" evidence=RCA;IMP

GO:0009555 "pollen development" evidence=IMP

GO:0008284 "positive regulation of cell proliferation" evidence=IMP

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0040020 "regulation of meiosis" evidence=IMP

GO:0048229 "gametophyte development" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=IDA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0010048 "vernalization response" evidence=RCA

GO:0010440 "stomatal lineage progression" evidence=RCA

GO:0045736 "negative regulation of cyclin-dependent protein serine/threonine kinase activity" evidence=RCA

GO:0008356 "asymmetric cell division" evidence=IGI

GO:0000910 "cytokinesis" evidence=IMP

GO:0009409 "response to cold" evidence=IEP

GO:0009574 "preprophase band" evidence=TAS

GO:0010005 "cortical microtubule, transverse to long axis" evidence=IDA

UNIPROTKB|P29618 CDKA-1 "Cyclin-dependent kinase A-1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 402 (146.6 bits), Expect = 1.9e-37, P = 1.9e-37
 Identities = 107/262 (40%), Positives = 149/262 (56%)

Query:     9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
             EGVPS+ IRE+S L E++H NI+RL  V      +Y VFEY   DL   +    DS   +
Sbjct:    42 EGVPSTAIREISLLKEMHHGNIVRLHDVIHSEKRIYLVFEYLDLDLKKFM----DSCPEF 97

Query:    69 STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             + KN    +L  ++L                  R + RDLKP N+L+D     +K+A FG
Sbjct:    98 A-KN---PTLIKSYLY-----QILRGVAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148

Query:   129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG-- 186
             LA++        + EV T +Y+APE+LLG  +YST VD+W VGCIF EMV+ KPLFPG  
Sbjct:   149 LARAFGIPVRTFTHEVVTLWYRAPEILLGSRQYSTPVDMWSVGCIFAEMVNQKPLFPGDS 208

Query:   187 -ANSLITLGRIVGKSRKPSFCKLS-LRDH-----------LTNGFPGLEPAGIDLISKML 233
               + L  + R++G   + S+  +S L D+           L    P L+PAG+DL+SKML
Sbjct:   209 EIDELFKIFRVLGTPNEQSWPGVSSLPDYKSAFPKWQAQDLATIVPTLDPAGLDLLSKML 268

Query:   234 GMDPDKRITAAEALQQEYFKDV 255
               +P+KRITA +AL+ EYFKD+
Sbjct:   269 RYEPNKRITARQALEHEYFKDL 290

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|G4MZ20 MGG_01362 "CMGC/CDK/CDC2 protein kinase" [Magnaporthe oryzae 70-15 (taxid:242507)]

 Score = 307 (113.1 bits), Expect = 1.7e-36, Sum P(2) = 1.7e-36
 Identities = 80/226 (35%), Positives = 125/226 (55%)

Query:     9 EGVPSSMIREVSCLMELNHPNIIRLMRVA-SQGIYLYPVFEYQVNDLA-YLLKYP-KDSM 65
             EGVPS+ IRE+S L E+  PNI+RL  +  + G  LY VFE+   DL  Y+   P  D  
Sbjct:    43 EGVPSTAIREISLLKEMRDPNIVRLFNIVHTDGTKLYLVFEFLDLDLKKYMEALPVADGG 102

Query:    66 NGYSTKNFNSYSLFTTFL---LVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKT 121
              G +        L    L   ++++F            + R + RDLKP N+L+D +G  
Sbjct:   103 RGKALPEGTGPQLSRLGLGDTMIKKFMSQLCDGVRYCHSHRILHRDLKPQNLLIDREGN- 161

Query:   122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             +K+A FGLA++        + EV T +Y+APE+L+G  +YST VD+W VGCIF EM + K
Sbjct:   162 LKLADFGLARAFGVPLRTYTHEVVTLWYRAPEILIGGRQYSTGVDMWSVGCIFAEMCTRK 221

Query:   182 PLFPG---ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPA 224
             PLFPG    + +  + R++G   + ++  ++  +H+   +P  +P+
Sbjct:   222 PLFPGDSEIDEIFKIFRLLGTPTEETWPSVT-DEHI---YPDFKPS 263

GO:0005575 "cellular_component" evidence=ND

ZFIN|ZDB-GENE-040426-2741 cdk2 "cyclin-dependent kinase 2" [Danio rerio (taxid:7955)]

 Score = 384 (140.2 bits), Expect = 1.5e-35, P = 1.5e-35
 Identities = 105/263 (39%), Positives = 145/263 (55%)

Query:     9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
             EGVPS+ IRE+S L ELNHPNI++L  V      LY VFE+   DL   +     S++G 
Sbjct:    42 EGVPSTAIREISLLKELNHPNIVKLRDVIHTENKLYLVFEFLHQDLKRFMD--STSVSGI 99

Query:    69 STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             S     SY     F L++               R + RDLKP N+L++  G+ +K+A FG
Sbjct:   100 SLPLVKSY----LFQLLQGLAFCHSH-------RVLHRDLKPQNLLINAQGE-IKLADFG 147

Query:   129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
             LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EM++ + LFPG +
Sbjct:   148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMITRRALFPGDS 207

Query:   189 SLITLGRI---VGK-------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
              +  L RI   +G                KPSF K + +D L+   P L+  G DL+ +M
Sbjct:   208 EIDQLFRIFRTLGTPDESIWPGVTSMPDYKPSFPKWARQD-LSKVVPPLDEDGRDLLGQM 266

Query:   233 LGMDPDKRITAAEALQQEYFKDV 255
             L  DP+KRI+A  AL   +F+DV
Sbjct:   267 LTYDPNKRISAKNALVHRFFRDV 289

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|P43450 cdk2 "Cyclin-dependent kinase 2" [Carassius auratus (taxid:7957)]

 Score = 381 (139.2 bits), Expect = 3.1e-35, P = 3.1e-35
 Identities = 105/263 (39%), Positives = 144/263 (54%)

Query:     9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
             EGVPS+ IRE+S L ELNHPNI++L  V      LY VFE+   DL   +     ++ G 
Sbjct:    42 EGVPSTAIREISLLKELNHPNIVKLHDVIHTENKLYLVFEFLHQDLKRFMD--SSTVTGI 99

Query:    69 STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             S     SY     F L++               R + RDLKP N+L++  G+ +K+A FG
Sbjct:   100 SLPLVKSY----LFQLLQGLAFCHSH-------RVLHRDLKPQNLLINAQGE-IKLADFG 147

Query:   129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
             LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EM++ K LFPG +
Sbjct:   148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMITRKALFPGDS 207

Query:   189 SLITLGRI---VGK-------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
              +  L RI   +G                KPSF K + +D L+   P L+  G DL+ +M
Sbjct:   208 EIDQLFRIFRTLGTPDESIWPGVTSMPDYKPSFPKWARQD-LSKVVPPLDEDGRDLLGQM 266

Query:   233 LGMDPDKRITAAEALQQEYFKDV 255
             L  DP+KRI+A  AL   +F+DV
Sbjct:   267 LIYDPNKRISAKNALVHRFFRDV 289

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

UNIPROTKB|Q5E9Y0 CDK2 "Cyclin-dependent kinase 2" [Bos taurus (taxid:9913)]

 Score = 379 (138.5 bits), Expect = 5.1e-35, P = 5.1e-35
 Identities = 104/263 (39%), Positives = 144/263 (54%)

Query:     9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
             EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct:    42 EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 99

Query:    69 STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                   SY     F L++               R + RDLKP N+L++ DG ++K+A FG
Sbjct:   100 PLPLIKSY----LFQLLQGLAFCHSH-------RVLHRDLKPQNLLINADG-SIKLADFG 147

Query:   129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
             LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct:   148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

Query:   189 SLITLGRI---VGK-------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
              +  L RI   +G                KPSF K + +D  +   P L+  G  L+S+M
Sbjct:   208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 266

Query:   233 LGMDPDKRITAAEALQQEYFKDV 255
             L  DP+KRI+A  AL   +F+DV
Sbjct:   267 LHYDPNKRISAKAALAHPFFQDV 289

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=ISS

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0007049 "cell cycle" evidence=ISS

GO:0006813 "potassium ion transport" evidence=ISS

GO:0005667 "transcription factor complex" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0015030 "Cajal body" evidence=IEA

GO:0005815 "microtubule organizing center" evidence=IEA

GO:0005768 "endosome" evidence=IEA

GO:0060968 "regulation of gene silencing" evidence=IEA

GO:0035173 "histone kinase activity" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0007265 "Ras protein signal transduction" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0007126 "meiosis" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|A0MSV8 cdk2 "Cyclin-dependent kinase 2" [Capra hircus (taxid:9925)]

 Score = 379 (138.5 bits), Expect = 5.1e-35, P = 5.1e-35
 Identities = 104/263 (39%), Positives = 144/263 (54%)

Query:     9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
             EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct:    42 EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 99

Query:    69 STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                   SY     F L++               R + RDLKP N+L++ DG ++K+A FG
Sbjct:   100 PLPLIKSY----LFQLLQGLAFCHSH-------RVLHRDLKPQNLLINADG-SIKLADFG 147

Query:   129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
             LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct:   148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

Query:   189 SLITLGRI---VGK-------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
              +  L RI   +G                KPSF K + +D  +   P L+  G  L+S+M
Sbjct:   208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 266

Query:   233 LGMDPDKRITAAEALQQEYFKDV 255
             L  DP+KRI+A  AL   +F+DV
Sbjct:   267 LHYDPNKRISAKAALAHPFFQDV 289

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=ISS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005667 "transcription factor complex" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0006813 "potassium ion transport" evidence=ISS

GO:0007049 "cell cycle" evidence=ISS

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=ISS

UNIPROTKB|F1SPH6 CDK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 375 (137.1 bits), Expect = 1.3e-34, P = 1.3e-34
 Identities = 103/263 (39%), Positives = 144/263 (54%)

Query:     9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
             EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct:    42 EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 99

Query:    69 STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                   SY     F L++               R + RDLKP N+L++ +G ++K+A FG
Sbjct:   100 PLPLIKSY----LFQLLQGLAFCHSH-------RVLHRDLKPQNLLINAEG-SIKLADFG 147

Query:   129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
             LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct:   148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

Query:   189 SLITLGRI---VGK-------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
              +  L RI   +G                KPSF K + +D  +   P L+  G  L+S+M
Sbjct:   208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 266

Query:   233 LGMDPDKRITAAEALQQEYFKDV 255
             L  DP+KRI+A  AL   +F+DV
Sbjct:   267 LHYDPNKRISAKAALAHPFFQDV 289

GO:0060968 "regulation of gene silencing" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0035173 "histone kinase activity" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0015030 "Cajal body" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0007265 "Ras protein signal transduction" evidence=IEA

GO:0006813 "potassium ion transport" evidence=IEA

GO:0005768 "endosome" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P61075	CDC2H_PLAF7	2, ., 7, ., 1, 1, ., 2, 3	0.3869	0.8918	0.8020	yes	no
O96821	CDC2H_PLAKH	2, ., 7, ., 1, 1, ., 2, 3	0.3908	0.8918	0.8020	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	259
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-68
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-63
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-58
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-55
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-54
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-54
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-54
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-54
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-52
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-51
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-50
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-50
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-49
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-48
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-47
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-46
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-45
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-45
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-44
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-44
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-43
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-42
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-41
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-41
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-40
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-39
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-39
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-38
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-38
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-38
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-37
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-37
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-37
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-36
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-36
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-35
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-35
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-34
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-34
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-34
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-32
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-32
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	8e-32
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-31
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-31
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-30
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-29
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-29
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-29
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-29
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-29
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-26
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-25
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-25
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-25
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-24
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-24
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-23
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-22
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-20
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-19
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-15
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-15
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-15
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-13
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-13
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-13
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-10
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-07
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-07
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-07
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-07
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-07
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-06
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-06
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-06
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-06
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-05
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-05
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-05
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-05
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-05
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-05
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-04
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-04
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-04
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-04
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-04
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	0.002
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	0.003
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.003

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  211 bits (539), Expect = 6e-68
 Identities = 109/274 (39%), Positives = 143/274 (52%), Gaps = 50/274 (18%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKD 63
           + N  EG+PS+ +RE+S L EL HPNI++L+ V      LY VFEY   DL   L     
Sbjct: 34  LDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPG 93

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
            ++    K+   Y L                R L++    R + RDLKP NIL++ DG  
Sbjct: 94  PLSPNLIKSI-MYQLL---------------RGLAYCHSHRILHRDLKPQNILINRDG-V 136

Query: 122 VKVAGFGLAKS----LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
           +K+A FGLA++    L  Y    + EV T +Y+APE+LLG   YSTAVDIW VGCIF EM
Sbjct: 137 LKLADFGLARAFGIPLRTY----THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEM 192

Query: 178 VSGKPLFPGANSLITLGRI-------------------VGKSRKPSFCKLSLRDHLTNGF 218
           ++GKPLFPG + +  L +I                     K   P F    L        
Sbjct: 193 ITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKV----L 248

Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           P L+P GIDL+SKML  +P KRI+A EAL+  YF
Sbjct: 249 PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  199 bits (507), Expect = 3e-63
 Identities = 108/267 (40%), Positives = 150/267 (56%), Gaps = 45/267 (16%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLA-YLLKYPKDSMNG 67
           EGVPS+ IRE+S L ELNHPNI+RL+ V      LY VFE+   DL  Y+   P   ++ 
Sbjct: 39  EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP 98

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVA 125
              K++  Y L                + +++    R + RDLKP N+L+D +G  +K+A
Sbjct: 99  PLIKSY-LYQLL---------------QGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLA 141

Query: 126 GFGLAKS----LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
            FGLA++    +  Y    + EV T +Y+APE+LLG  +YST VDIW +GCIF EMV+ +
Sbjct: 142 DFGLARAFGVPVRTY----THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Query: 182 PLFPGANSLITLGRIV------------GKSR----KPSFCKLSLRDHLTNGFPGLEPAG 225
           PLFPG + +  L RI             G +     KP+F K + +D L+   P L+  G
Sbjct: 198 PLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQD-LSKVVPNLDEDG 256

Query: 226 IDLISKMLGMDPDKRITAAEALQQEYF 252
           +DL+SKML  DP KRI+A  ALQ  YF
Sbjct: 257 LDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  186 bits (474), Expect = 3e-58
 Identities = 114/266 (42%), Positives = 148/266 (55%), Gaps = 36/266 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L E+ H NI+RL  V      LY VFEY   DL       K  M+  
Sbjct: 42  EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDL-------KKHMD-- 92

Query: 69  STKNFN-SYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVA 125
           S+ +F  +  L  T+L           R +++    R + RDLKP N+L+D     +K+A
Sbjct: 93  SSPDFAKNPRLIKTYLY-------QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLA 145

Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
            FGLA++        + EV T +Y+APE+LLG   YST VDIW VGCIF EMV+ KPLFP
Sbjct: 146 DFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205

Query: 186 G---ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLI 229
           G    + L  + RI+G                K +F K   +D L    P LEPAG+DL+
Sbjct: 206 GDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKD-LATVVPTLEPAGVDLL 264

Query: 230 SKMLGMDPDKRITAAEALQQEYFKDV 255
           SKML +DP KRITA  AL+ EYFKD+
Sbjct: 265 SKMLRLDPSKRITARAALEHEYFKDL 290

Length = 294

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  178 bits (454), Expect = 3e-55
 Identities = 106/262 (40%), Positives = 145/262 (55%), Gaps = 33/262 (12%)

Query: 8   MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS-MN 66
            EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL    K+   S ++
Sbjct: 39  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASPLS 95

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAG 126
           G       SY     F L++  +   S R L        RDLKP N+L++ +G  +K+A 
Sbjct: 96  GIPLPLIKSY----LFQLLQGLAFCHSHRVL-------HRDLKPQNLLINTEGA-IKLAD 143

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG
Sbjct: 144 FGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203

Query: 187 ANSLITLGRI---VG-------------KSRKPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
            + +  L RI   +G                KPSF K + +D  +   P L+  G DL+S
Sbjct: 204 DSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQD-FSKVVPPLDEDGRDLLS 262

Query: 231 KMLGMDPDKRITAAEALQQEYF 252
           +ML  DP+KRI+A  AL   +F
Sbjct: 263 QMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  177 bits (450), Expect = 1e-54
 Identities = 101/262 (38%), Positives = 136/262 (51%), Gaps = 35/262 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG+P + +RE+  L ELNHPNII+L+ V      LY VFE+   DL  L+K   D   G 
Sbjct: 39  EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIK---DRQRGL 95

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
                 SY L+               + L+F      + RDLKP N+L++ +G  +K+A 
Sbjct: 96  PESLIKSY-LYQLL------------QGLAFCHSHGILHRDLKPENLLINTEG-VLKLAD 141

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA+S  +     +  V T +Y+APELLLG   YST VDIW VGCIF E++S +PLFPG
Sbjct: 142 FGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201

Query: 187 ANSLITLGRIVG------KSRKPSFCKLSLRDHLT----NG------FPGLEPAGIDLIS 230
            + +  L +I            P F  L+     +     G      FP   P  +DL+S
Sbjct: 202 KSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLS 261

Query: 231 KMLGMDPDKRITAAEALQQEYF 252
           +ML  DP KRITA +AL   YF
Sbjct: 262 QMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  177 bits (451), Expect = 2e-54
 Identities = 87/268 (32%), Positives = 132/268 (49%), Gaps = 33/268 (12%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
              +G+  + +RE+  L EL HPNII L+ V      +  VFE+   DL  ++K   D  
Sbjct: 40  EAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIK---DKS 96

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF-GTRYI-RRDLKPVNILVDLDGKTVK 123
              +  +  SY L T              R L +  + +I  RDLKP N+L+  DG  +K
Sbjct: 97  IVLTPADIKSYMLMTL-------------RGLEYLHSNWILHRDLKPNNLLIASDG-VLK 142

Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
           +A FGLA+S  +   + + +V T +Y+APELL G   Y   VD+W VGCIF E++   P 
Sbjct: 143 LADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPF 202

Query: 184 FPGANSLITLGRIV------------GKSRKPSFCKLSLRDH--LTNGFPGLEPAGIDLI 229
            PG + +  LG+I             G +  P + +        L   FP      +DL+
Sbjct: 203 LPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLL 262

Query: 230 SKMLGMDPDKRITAAEALQQEYFKDVPG 257
            ++L ++P+KRITA +AL+  YF + P 
Sbjct: 263 QRLLTLNPNKRITARQALEHPYFSNDPA 290

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  175 bits (446), Expect = 5e-54
 Identities = 85/266 (31%), Positives = 129/266 (48%), Gaps = 36/266 (13%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
               G+P+  +RE+  L    HP +++L+ V   G     V EY  +DL+ +L+   D  
Sbjct: 37  RLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLR---DEE 93

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVK 123
                    SY      LL          + +++      + RDLKP N+L+  DG  +K
Sbjct: 94  RPLPEAQVKSYMRM---LL----------KGVAYMHANGIMHRDLKPANLLISADG-VLK 139

Query: 124 VAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           +A FGLA+     +    S +V T +Y+APELL G  +Y   VD+W VGCIF E+++G P
Sbjct: 140 IADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSP 199

Query: 183 LFPGANSLITLGRIV------------GKSRKPSFCKLSLRDH----LTNGFPGLEPAGI 226
           LFPG N +  L  +             G +  P + K++  +     L   FP   P  +
Sbjct: 200 LFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEAL 259

Query: 227 DLISKMLGMDPDKRITAAEALQQEYF 252
           DL+  +L  DP KR++AAEAL+  YF
Sbjct: 260 DLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  175 bits (445), Expect = 9e-54
 Identities = 98/272 (36%), Positives = 139/272 (51%), Gaps = 41/272 (15%)

Query: 4   IHNTMEGVPSSMIREVSCLMEL---NHPNIIRLMRVA-----SQGIYLYPVFEYQVNDLA 55
           +  + EG+P S +RE++ L +L    HPNI+RL+ V       + + L  VFE+   DLA
Sbjct: 34  VPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLA 93

Query: 56  -YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNIL 114
            YL K PK  +   + K+     L        +F  S          R + RDLKP NIL
Sbjct: 94  TYLSKCPKPGLPPETIKDL-MRQLLRGV----DFLHSH---------RIVHRDLKPQNIL 139

Query: 115 VDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIF 174
           V  DG  VK+A FGLA+ +Y+++   ++ V T +Y+APE+LL    Y+T VD+W VGCIF
Sbjct: 140 VTSDG-QVKIADFGLAR-IYSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIF 196

Query: 175 GEMVSGKPLFPGANSLITLGRIVGKSRKP--------------SFCKLSLRDHLTNGFPG 220
            E+   +PLF G +    L +I      P              SF   + R    +  P 
Sbjct: 197 AELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRS-FKSFVPE 255

Query: 221 LEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           +   G+DL+ KML  +P KRI+A EALQ  YF
Sbjct: 256 ICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  171 bits (437), Expect = 5e-52
 Identities = 93/270 (34%), Positives = 128/270 (47%), Gaps = 56/270 (20%)

Query: 17  REVSCLMEL-NHPNIIRLMRV--ASQGIYLYPVFEYQVNDL-----AYLLKYPKDSMNGY 68
           RE+  L EL +HPNI++L+ V  A     +Y VFEY   DL     A +L+     ++  
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILE----DVH-- 108

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
             K +  Y L                ++L +      I RDLKP NIL++ D   VK+A 
Sbjct: 109 --KRYIMYQLL---------------KALKYIHSGNVIHRDLKPSNILLNSDC-RVKLAD 150

Query: 127 FGLAKSLYAYKGESSAEVGTHY-----YKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
           FGLA+SL   +      V T Y     Y+APE+LLG   Y+  VD+W VGCI GEM+ GK
Sbjct: 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Query: 182 PLFPGANSLITLGRIVGKSRKPS-----------------FCKLSLRDHLTNGFPGLEPA 224
           PLFPG ++L  L +I+     PS                       R  L    P     
Sbjct: 211 PLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDD 270

Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFKD 254
            +DL+ K+L  +P+KR+TA EAL+  Y   
Sbjct: 271 ALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  167 bits (424), Expect = 8e-51
 Identities = 101/261 (38%), Positives = 134/261 (51%), Gaps = 32/261 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLA-YLLKYPKDSMNG 67
           EGVPS+ IRE+S L EL HPNI+ L  V  Q   LY +FE+   DL  YL   PK     
Sbjct: 40  EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY-- 97

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              +   SY     + +++      S R L        RDLKP N+L+D  G  +K+A F
Sbjct: 98  MDAELVKSY----LYQILQGILFCHSRRVL-------HRDLKPQNLLIDNKG-VIKLADF 145

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG- 186
           GLA++        + EV T +Y+APE+LLG   YST VDIW +G IF EM + KPLF G 
Sbjct: 146 GLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205

Query: 187 --ANSLITLGRIVG-------------KSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISK 231
              + L  + RI+G                K +F K   +  L +    L+  G+DL+ K
Sbjct: 206 SEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWK-KGSLRSAVKNLDEDGLDLLEK 264

Query: 232 MLGMDPDKRITAAEALQQEYF 252
           ML  DP KRI+A +AL   YF
Sbjct: 265 MLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  165 bits (420), Expect = 4e-50
 Identities = 101/262 (38%), Positives = 146/262 (55%), Gaps = 34/262 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG PS+ IRE+S + EL H NI+RL  V      L  VFEY   DL    KY  D+    
Sbjct: 39  EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLK---KY-MDTHGVR 94

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
              + N+   FT  LL          + ++F    R + RDLKP N+L++  G+ +K+A 
Sbjct: 95  GALDPNTVKSFTYQLL----------KGIAFCHENRVLHRDLKPQNLLINKRGE-LKLAD 143

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        S EV T +Y+AP++LLG   YST++DIW VGCI  EM++G+PLFPG
Sbjct: 144 FGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203

Query: 187 ANS---LITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
            N+   L+ + RI+G                KP+F +   +D L   FP  +P GIDL+ 
Sbjct: 204 TNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQD-LQQLFPHADPLGIDLLH 262

Query: 231 KMLGMDPDKRITAAEALQQEYF 252
           ++L ++P+ RI+A +ALQ  +F
Sbjct: 263 RLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  164 bits (418), Expect = 8e-50
 Identities = 95/281 (33%), Positives = 132/281 (46%), Gaps = 55/281 (19%)

Query: 2   MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYL 57
           + + N  EG P + IRE+  L +L HPNI+RL  +        IY+  VFEY  +DL  L
Sbjct: 32  IRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM--VFEYMDHDLTGL 89

Query: 58  LKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILV 115
           L  P+      +      Y      LL            L +      + RD+K  NIL+
Sbjct: 90  LDSPEVKF---TESQIKCYMKQ---LL----------EGLQYLHSNGILHRDIKGSNILI 133

Query: 116 DLDGKTVKVAGFGLAKSLYAYKGESSAE----VGTHYYKAPELLLGLLEYSTAVDIWPVG 171
           + DG  +K+A FGLA+    Y   +SA+    V T +Y+ PELLLG   Y   VD+W VG
Sbjct: 134 NNDG-VLKLADFGLARP---YTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVG 189

Query: 172 CIFGEMVSGKPLFPGANSLITLGRI------VGKSRKPSFCKL--------------SLR 211
           CI  E+  GKP+F G+  L  L +I            P   KL               LR
Sbjct: 190 CILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLR 249

Query: 212 DHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           +   +      P+ +DL+ K+L +DP KRI+A +ALQ EYF
Sbjct: 250 EFFKHLID---PSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  165 bits (421), Expect = 9e-50
 Identities = 92/279 (32%), Positives = 123/279 (44%), Gaps = 71/279 (25%)

Query: 17  REVSCLMELNHPNIIRLMRV-ASQGIY----LYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           RE+  L  L H NII L+ +           +Y V E    DL  ++K P+   + +   
Sbjct: 48  REIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDH--- 104

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVA 125
                  F   +L               G +Y      I RDLKP NILV+ +   +K+ 
Sbjct: 105 ----IQYFLYQILR--------------GLKYLHSANVIHRDLKPSNILVNSNC-DLKIC 145

Query: 126 GFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
            FGLA+ +      KG  +  V T +Y+APELLL    Y+ A+DIW VGCIF E+++ KP
Sbjct: 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Query: 183 LFPGAN-----SLI--TLG-------------------RIVGKSRKPSFCKLSLRDHLTN 216
           LFPG +     +LI   LG                   + + K  K    KL        
Sbjct: 206 LFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKL-------- 257

Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
            FPG  P  IDL+ KML  DP KRITA EAL   Y   +
Sbjct: 258 -FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  162 bits (412), Expect = 3e-49
 Identities = 87/248 (35%), Positives = 123/248 (49%), Gaps = 33/248 (13%)

Query: 8   MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMN 66
           ++     ++RE+  L +L HPNI+RL  V      LY V EY    DL  LLK  +  ++
Sbjct: 37  IKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLS 95

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKV 124
               + +    +                 +L +      + RDLKP NIL+D DG  VK+
Sbjct: 96  EDEARFY-LRQIL---------------SALEYLHSKGIVHRDLKPENILLDEDG-HVKL 138

Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FGLA+       + +  VGT  Y APE+LLG   Y  AVDIW +G I  E+++GKP F
Sbjct: 139 ADFGLAR-QLDPGEKLTTFVGTPEYMAPEVLLGK-GYGKAVDIWSLGVILYELLTGKPPF 196

Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
           PG + L+ L + +GK + P                 + P   DLI K+L  DP+KR+TA 
Sbjct: 197 PGDDQLLELFKKIGKPKPP----------FPPPEWDISPEAKDLIRKLLVKDPEKRLTAE 246

Query: 245 EALQQEYF 252
           EALQ  +F
Sbjct: 247 EALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  162 bits (411), Expect = 1e-48
 Identities = 90/265 (33%), Positives = 130/265 (49%), Gaps = 32/265 (12%)

Query: 9   EGVPSSMIREVSCLMELNH-PNIIRLMRV-----ASQGIYLYPVFEYQVNDL-AYLLKYP 61
           EG+P + +RE+S L  L+    I+RL+ V      +    LY VFEY  +DL  ++    
Sbjct: 41  EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNG 100

Query: 62  KDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKT 121
           +        K   S+ ++     V                  + RDLKP N+LVD     
Sbjct: 101 RGPGRPLPAKTIKSF-MYQLLKGVAHCHKHG----------VMHRDLKPQNLLVDKQKGL 149

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
           +K+A  GL ++        + E+ T +Y+APE+LLG   YST VDIW VGCIF EM   +
Sbjct: 150 LKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Query: 182 PLFPGAN---SLITLGRIVGKSRKPSFCKLS-LRD----------HLTNGFPGLEPAGID 227
           PLFPG +    L+ + +++G   +  +  +S LRD           L+   P L P G+D
Sbjct: 210 PLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLD 269

Query: 228 LISKMLGMDPDKRITAAEALQQEYF 252
           L+ KML  DP KRI+A  AL   YF
Sbjct: 270 LLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  159 bits (404), Expect = 1e-47
 Identities = 89/283 (31%), Positives = 135/283 (47%), Gaps = 63/283 (22%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVA----SQGIYLYPVFEYQVNDLAYLLK 59
           +    EG P + +RE++ L++L HPNI+ +  V        IY+  V EY  +DL  L++
Sbjct: 40  MEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM--VMEYVEHDLKSLME 97

Query: 60  YPKDSMNGYSTKNFNSYSLFTT----FLLVEEFSSSDSSRSLSFGTRY------IRRDLK 109
             K                F       L+++  S          G  +      + RDLK
Sbjct: 98  TMKQP--------------FLQSEVKCLMLQLLS----------GVAHLHDNWILHRDLK 133

Query: 110 PVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP 169
             N+L++  G  +K+  FGLA+   +     +  V T +Y+APELLLG  EYSTA+D+W 
Sbjct: 134 TSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWS 192

Query: 170 VGCIFGEMVSGKPLFPGANSLITLGRI---VG---KSRKPSFCKLS-------------- 209
           VGCIF E+++ KPLFPG + +  L +I   +G   +   P F +L               
Sbjct: 193 VGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQ 252

Query: 210 LRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           LR         L   G DL++++L  DP KRI+A +AL+  YF
Sbjct: 253 LRKKFPAL--SLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  155 bits (393), Expect = 8e-46
 Identities = 99/280 (35%), Positives = 138/280 (49%), Gaps = 55/280 (19%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVAS----QGIYLYPVFEYQVNDLAYLLKYP 61
           N  +G+P S +RE++ L+ L HPNI+ L  V        I+L  V EY   DLA LL   
Sbjct: 44  NERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL--VMEYCEQDLASLL--- 98

Query: 62  KDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDS---SRSLSFGTRY------IRRDLKPVN 112
            D+M                      FS S        L  G +Y      I RDLK  N
Sbjct: 99  -DNMP-------------------TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSN 138

Query: 113 ILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGC 172
           +L+  D   +K+A FGLA++        + +V T +Y+APELLLG   Y+TA+D+W VGC
Sbjct: 139 LLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGC 197

Query: 173 IFGEMVSGKPLFPGANSLITLGRIV------------GKSRKPSFCKLSLR----DHLTN 216
           I  E+++ KPL PG + +  L  I+            G S  P   K +L     ++L +
Sbjct: 198 ILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKH 257

Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
            FP L  AG+ L++ +L  DP KR TA EAL+  YFK+ P
Sbjct: 258 KFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  154 bits (390), Expect = 1e-45
 Identities = 98/262 (37%), Positives = 132/262 (50%), Gaps = 35/262 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPSS +RE+  L EL H NI+RL  V      L  VFEY   DL    KY  DS NG 
Sbjct: 40  EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLK---KY-FDSCNGD 95

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
              +      F   LL          + L+F      + RDLKP N+L++ +G  +K+A 
Sbjct: 96  I--DPEIVKSFMFQLL----------KGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLAD 142

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV-SGKPLFP 185
           FGLA++        SAEV T +Y+ P++L G   YST++D+W  GCIF E+  +G+PLFP
Sbjct: 143 FGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202

Query: 186 GANSLITLGRIV------------GKSRKPSFCKLSLRD---HLTNGFPGLEPAGIDLIS 230
           G +    L RI             G S+ P +    +      L N  P L   G DL+ 
Sbjct: 203 GNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQ 262

Query: 231 KMLGMDPDKRITAAEALQQEYF 252
            +L  +P +RI+A EALQ  YF
Sbjct: 263 NLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  154 bits (390), Expect = 1e-45
 Identities = 99/266 (37%), Positives = 135/266 (50%), Gaps = 40/266 (15%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLA-YLLKYPKDSMNG 67
           EG P + IRE S L +L H NI+ L  +      L  VFEY   DL  Y+         G
Sbjct: 44  EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCG----GG 99

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVA 125
            S  N     LF   LL          R L++    R + RDLKP N+L+   G+ +K+A
Sbjct: 100 LSMHNVR---LFLFQLL----------RGLAYCHQRRVLHRDLKPQNLLISERGE-LKLA 145

Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
            FGLA++        S EV T +Y+ P++LLG  EYST++D+W VGCIF EM +G+PLFP
Sbjct: 146 DFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205

Query: 186 GA----NSLITLGRIVGK---------SRKPSFCKLSLRDH----LTNGFPGLE--PAGI 226
           G+    + L  + R++G          S  P F   S   +    L N  P L+  P G 
Sbjct: 206 GSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGE 265

Query: 227 DLISKMLGMDPDKRITAAEALQQEYF 252
           +L  K L  +P KRI+AAEA++  YF
Sbjct: 266 ELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  152 bits (385), Expect = 1e-44
 Identities = 88/291 (30%), Positives = 132/291 (45%), Gaps = 64/291 (21%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVA---------SQGIYLYPVFEYQVNDL 54
           +HN  +G P + +RE+  L +L HPN++ L+ +A          +G   Y V  Y  +DL
Sbjct: 43  MHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV-YMVTPYMDHDL 101

Query: 55  AYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDL 108
           + LL+ P   +     K +          L+E             G  Y+       RD+
Sbjct: 102 SGLLENPSVKLTESQIKCY-------MLQLLE-------------GINYLHENHILHRDI 141

Query: 109 KPVNILVDLDGKTVKVAGFGLAKSLYAYK-------GESSAE----VGTHYYKAPELLLG 157
           K  NIL+D  G  +K+A FGLA+             G  + +    V T +Y+ PELLLG
Sbjct: 142 KAANILIDNQG-ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG 200

Query: 158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG 217
              Y+TAVDIW +GC+F EM + +P+  G + +  L  I      P+         L   
Sbjct: 201 ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGC 260

Query: 218 ----------------FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                           F  L P G+DL+SK+L +DP KR+TA++AL+  YF
Sbjct: 261 EGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 6e-44
 Identities = 87/305 (28%), Positives = 126/305 (41%), Gaps = 88/305 (28%)

Query: 7   TMEGVPSSMIREVSCLMELNHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYLLKYPK 62
              G+  S  RE++ L EL H N++ L+ V    A + +YL  +F+Y  +DL  ++K+  
Sbjct: 41  QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL--LFDYAEHDLWQIIKF-- 96

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF----GTRY------IRRDLKPVN 112
                +      S                   +SL +    G  Y      + RDLKP N
Sbjct: 97  -----HRQAKRVSIPPSMV-------------KSLLWQILNGVHYLHSNWVLHRDLKPAN 138

Query: 113 ILVDLDGK---TVKVAGFGLA-------KSLYAYKGESSAEVGTHYYKAPELLLGLLEYS 162
           ILV  +G     VK+   GLA       K L     +    V T +Y+APELLLG   Y+
Sbjct: 139 ILVMGEGPERGVVKIGDLGLARLFNAPLKPLA----DLDPVVVTIWYRAPELLLGARHYT 194

Query: 163 TAVDIWPVGCIFGEMVSGKPLFPGANSLIT---------LGRIVG--------------- 198
            A+DIW +GCIF E+++ +P+F G  + I          L RI                 
Sbjct: 195 KAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKK 254

Query: 199 -----------KSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
                      K++      L+            +  G DL+ K+L  DP KRITA EAL
Sbjct: 255 MPEYDTLMKDFKTKTYPSNSLAKWMEK---HKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311

Query: 248 QQEYF 252
           +  YF
Sbjct: 312 EHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  147 bits (373), Expect = 2e-43
 Identities = 86/255 (33%), Positives = 110/255 (43%), Gaps = 34/255 (13%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKD 63
             +       +  RE+  L  L+HPNI+RL+       +LY V EY              
Sbjct: 34  KRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEY-------------- 79

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDL 117
              G    ++ S           E  +   +  +  G  Y      I RDLKP NIL+D 
Sbjct: 80  -CEGGDLFDYLSRG--GPL---SEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDE 133

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
           +G  VK+A FGLAK L       +  VGT +Y APE+LLG   Y   VD+W +G I  E+
Sbjct: 134 NG-VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYEL 192

Query: 178 VSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
           ++GKP F G N L  L  I      P      L         G E A  DLI K L  DP
Sbjct: 193 LTGKPPFSGENILDQLQLIRRILGPP------LEFDEPKWSSGSEEA-KDLIKKCLNKDP 245

Query: 238 DKRITAAEALQQEYF 252
            KR TA E LQ  +F
Sbjct: 246 SKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  145 bits (369), Expect = 2e-42
 Identities = 84/266 (31%), Positives = 124/266 (46%), Gaps = 40/266 (15%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNG 67
           E V  + +REV  L +L H NI+ L     +   LY VFEY +   L  L   P     G
Sbjct: 41  EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP----GG 96

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY--IRRDLKPVNILVDLDGKTVKVA 125
                  SY     + L+         +++++   +  I RD+KP NILV   G  +K+ 
Sbjct: 97  LPPDAVRSY----IWQLL---------QAIAYCHSHNIIHRDIKPENILVSESG-VLKLC 142

Query: 126 GFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
            FG A++L A       + V T +Y+APELL+G   Y   VD+W +GCI  E++ G+PLF
Sbjct: 143 DFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202

Query: 185 PGANSLITLGRI---VGK---------SRKPSFCKLSL-----RDHLTNGFPG-LEPAGI 226
           PG + +  L  I   +G          S  P F  ++       + L   +PG +    +
Sbjct: 203 PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL 262

Query: 227 DLISKMLGMDPDKRITAAEALQQEYF 252
           D +   L MDP +R+T  E LQ  YF
Sbjct: 263 DFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  144 bits (365), Expect = 2e-41
 Identities = 81/268 (30%), Positives = 125/268 (46%), Gaps = 53/268 (19%)

Query: 17  REVSCLMELNHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
           RE+  L    H NII +  +     +    +Y V +   +DL +++   +     +    
Sbjct: 53  RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHI--R 110

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTVKVAG 126
           +  Y L                     G +YI       RDLKP N+LV+ D   +++  
Sbjct: 111 YFLYQLLR-------------------GLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGD 150

Query: 127 FGLAKSLYA----YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           FG+A+ L +    +K   +  V T +Y+APELLL L EY+TA+D+W VGCIF EM+  + 
Sbjct: 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLS------LRDHLTNG-----------FPGLEPAG 225
           LFPG N +  L  I+     PS   L+      +R ++ N            FP   P  
Sbjct: 211 LFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEA 270

Query: 226 IDLISKMLGMDPDKRITAAEALQQEYFK 253
           +DL+S+ML  DP++RIT  +ALQ  +  
Sbjct: 271 LDLLSQMLQFDPEERITVEQALQHPFLA 298

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  143 bits (363), Expect = 3e-41
 Identities = 90/289 (31%), Positives = 136/289 (47%), Gaps = 61/289 (21%)

Query: 1   MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY 60
           M GIH T        +RE+  + E+ H NI+ L+ V  +G ++  V +   +DL      
Sbjct: 60  MCGIHFTT-------LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLK----- 107

Query: 61  PKDSMNGYSTKNFNSYSLFT----TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVD 116
                     K  +     T      +L++  +  +      F    + RDL P NI ++
Sbjct: 108 ----------KVVDRKIRLTESQVKCILLQILNGLNVLHKWYF----MHRDLSPANIFIN 153

Query: 117 LDGKTVKVAGFGLAKSLYAY---------------KGESSAEVGTHYYKAPELLLGLLEY 161
             G   K+A FGLA+  Y Y               + E +++V T +Y+APELL+G  +Y
Sbjct: 154 SKG-ICKIADFGLARR-YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKY 211

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG------------KSRKPSFCKLS 209
             AVD+W VGCIF E+++GKPLFPG N +  LGRI                + P + + +
Sbjct: 212 HFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFT 271

Query: 210 LRD--HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
            R    L   FP      IDL+  +L ++P +RI+A EAL+ EYFK  P
Sbjct: 272 PRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320

Length = 335

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  140 bits (356), Expect = 1e-40
 Identities = 94/274 (34%), Positives = 121/274 (44%), Gaps = 74/274 (27%)

Query: 17  REVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           REV  L +LN HPNI++L  V  +   LY VFEY               M G      N 
Sbjct: 46  REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY---------------MEG------NL 84

Query: 76  YSLFTTF---LLVEEFSSSDSSRSLSF----GTRYIR------RDLKPVNILVDLDGKTV 122
           Y L              S    RS+ +    G  +I       RDLKP N+LV    + V
Sbjct: 85  YQLMKDRKGKPF-----SESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS-GPEVV 138

Query: 123 KVAGFGLAKSLYAYKGESS----AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           K+A FGLA+ +      S       V T +Y+APE+LL    YS+ VDIW +GCI  E+ 
Sbjct: 139 KIADFGLAREI-----RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELY 193

Query: 179 SGKPLFPGANSLITLGRIV------GKSRKPSFCKL--------------SLRDHLTNGF 218
           + +PLFPG++ +  L +I        K   P   KL              SL   + N  
Sbjct: 194 TLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA- 252

Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               P  IDLI  ML  DP KR TA++ALQ  YF
Sbjct: 253 ---SPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  137 bits (348), Expect = 2e-39
 Identities = 89/258 (34%), Positives = 127/258 (49%), Gaps = 40/258 (15%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVND-LAYLLKYPKDSMNGYSTKNFN 74
           +RE+  L +L H N++ L+ V  +   LY VFE+  +  L  L KYP    NG       
Sbjct: 48  MREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP----NGLDESRVR 103

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRY--IRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
            Y LF               R + F   +  I RD+KP NILV   G  VK+  FG A++
Sbjct: 104 KY-LFQIL------------RGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFART 149

Query: 133 LYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI 191
           L A  GE   + V T +Y+APELL+G  +Y  AVDIW VGC+  EM++G+PLFPG + + 
Sbjct: 150 L-AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID 208

Query: 192 TLGRIVGK------------SRKPSFCKLSL-----RDHLTNGFPGLEPAGIDLISKMLG 234
            L  I+               + P F  + L      + L   FP L    +DL  + L 
Sbjct: 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLR 268

Query: 235 MDPDKRITAAEALQQEYF 252
           +DPD R ++++ L  E+F
Sbjct: 269 IDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  138 bits (350), Expect = 4e-39
 Identities = 84/277 (30%), Positives = 118/277 (42%), Gaps = 77/277 (27%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           RE+  L  ++H N+I L+ V +                      P  S+           
Sbjct: 63  RELRLLKHMDHENVIGLLDVFT----------------------PASSLED--------- 91

Query: 77  SLFTTFLLVEEFSSSDSSRSLSF-----------------GTRYIR------RDLKPVNI 113
             F    LV     +D +  +                   G +YI       RDLKP NI
Sbjct: 92  --FQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI 149

Query: 114 LVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCI 173
            V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+  VDIW VGCI
Sbjct: 150 AVNEDCE-LKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 205

Query: 174 FGEMVSGKPLFPGANSLITLGRI---VGKSRKPSFCKLSL--------------RDHLTN 216
             E+++GK LFPG++ +  L RI   VG   +    K+S               +     
Sbjct: 206 MAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKE 265

Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
            F G  P  IDL+ KML +DPDKRITAAEAL   Y  
Sbjct: 266 VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  136 bits (343), Expect = 1e-38
 Identities = 97/268 (36%), Positives = 141/268 (52%), Gaps = 35/268 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG P + IREVS L +L H NI+ L  +      L  VFEY   DL    +Y  D  N  
Sbjct: 45  EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLK---QYMDDCGNIM 101

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDLDGKTVKVAG 126
           S  N     +F   +L          R L++  R   + RDLKP N+L++  G+ +K+A 
Sbjct: 102 SMHNVK---IFLYQIL----------RGLAYCHRRKVLHRDLKPQNLLINERGE-LKLAD 147

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        S EV T +Y+ P++LLG  EYST +D+W VGCIF EM SG+PLFPG
Sbjct: 148 FGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207

Query: 187 A---NSLITLGRIVGKSRKPSFCKLSLRDH-------------LTNGFPGLEPAGIDLIS 230
           +   + L  + R++G   + ++  +S  D              L N  P L+  GI+L++
Sbjct: 208 STVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLT 267

Query: 231 KMLGMDPDKRITAAEALQQEYFKDVPGR 258
           K L  +  KRI+A EA++  YF+ +  R
Sbjct: 268 KFLQYESKKRISAEEAMKHAYFRSLGTR 295

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  134 bits (338), Expect = 5e-38
 Identities = 93/271 (34%), Positives = 135/271 (49%), Gaps = 39/271 (14%)

Query: 4   IHNTMEGVPSSMIREVSCLMEL---NHPNIIRLMRVAS-----QGIYLYPVFEYQVNDL- 54
           +    +G+P S +REV+ L  L   +HPNI+RLM V +     +   +  VFE+   DL 
Sbjct: 35  VQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLR 94

Query: 55  AYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNIL 114
            YL K P   +   + K+     L   FL   +F  ++           + RDLKP NIL
Sbjct: 95  TYLDKVPPPGLPAETIKD-----LMRQFLRGLDFLHAN---------CIVHRDLKPENIL 140

Query: 115 VDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIF 174
           V   G  VK+A FGLA+ +Y+ +   +  V T +Y+APE+LL    Y+T VD+W VGCIF
Sbjct: 141 VT-SGGQVKLADFGLAR-IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIF 197

Query: 175 GEMVSGKPLFPGANSLITLGRIVGKSRKPSF----CKLSLRDH---------LTNGFPGL 221
            EM   KPLF G +    LG+I      P        ++L            + +  P +
Sbjct: 198 AEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEI 257

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           E +G  L+ +ML  +P KRI+A  ALQ  +F
Sbjct: 258 EESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  134 bits (339), Expect = 5e-38
 Identities = 96/268 (35%), Positives = 140/268 (52%), Gaps = 35/268 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG P + IREVS L +L H NI+ L  +      L  VFEY   DL   L    +S+N +
Sbjct: 45  EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMH 104

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDLDGKTVKVAG 126
           + K      LF   LL          R L++  R   + RDLKP N+L++  G+ +K+A 
Sbjct: 105 NVK------LFLFQLL----------RGLNYCHRRKVLHRDLKPQNLLINERGE-LKLAD 147

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        S EV T +Y+ P++LLG  +YST +D+W VGCIF EM +G+PLFPG
Sbjct: 148 FGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207

Query: 187 AN---SLITLGRIVGKSRKPSFCKLSLR-------------DHLTNGFPGLEPAGIDLIS 230
           +     L  + RI+G   + ++  +                D L N  P L+  G +L+S
Sbjct: 208 STVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLS 267

Query: 231 KMLGMDPDKRITAAEALQQEYFKDVPGR 258
           K+L  +  KRI+A EA++  YF  +  R
Sbjct: 268 KLLQFEGRKRISAEEAMKHPYFHCLGER 295

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  132 bits (334), Expect = 2e-37
 Identities = 94/269 (34%), Positives = 134/269 (49%), Gaps = 40/269 (14%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLA-YLLKYPKDS 64
            T EGVP + IRE S L  L H NI+ L  +      L  VFEY   DLA Y++++P   
Sbjct: 41  KTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHP--- 97

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTV 122
             G    N     LF   LL          R L++  G   + RDLKP N+L+   G+ +
Sbjct: 98  -GGLHPYNVR---LFMFQLL----------RGLAYIHGQHILHRDLKPQNLLISYLGE-L 142

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+A FGLA++        S+EV T +Y+ P++LLG  +YS+A+DIW  GCIF EM+ G+P
Sbjct: 143 KLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202

Query: 183 LFPGANS----LITLGRIVGKSRKPSFCKLS-LRDHLTNGFP--------------GLEP 223
            FPG +     L  +  ++G   + ++  +S L ++    F                  P
Sbjct: 203 AFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPP 262

Query: 224 AGIDLISKMLGMDPDKRITAAEALQQEYF 252
              DL S+ML M P  RI+A +AL   YF
Sbjct: 263 KAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  132 bits (334), Expect = 2e-37
 Identities = 90/262 (34%), Positives = 135/262 (51%), Gaps = 35/262 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG P + IREVS L  L H NI+ L  +      L  VFEY  +DL   L    + M+ +
Sbjct: 44  EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMH 103

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           + K F        F L+         R LS+    + + RDLKP N+L++  G+ +K+A 
Sbjct: 104 NVKIF-------MFQLL---------RGLSYCHKRKILHRDLKPQNLLINEKGE-LKLAD 146

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        S EV T +Y+ P++LLG  EYST +D+W VGCI  EM +G+P+FPG
Sbjct: 147 FGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206

Query: 187 AN---SLITLGRIVGKSRKPSFCKLSLRDH-------------LTNGFPGLEPAGIDLIS 230
           +     L  + R++G   + ++  ++  +              L N  P L+  GIDL+S
Sbjct: 207 STVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLS 266

Query: 231 KMLGMDPDKRITAAEALQQEYF 252
            +L  +   RI+A  AL+  YF
Sbjct: 267 SLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  133 bits (335), Expect = 5e-37
 Identities = 89/261 (34%), Positives = 119/261 (45%), Gaps = 46/261 (17%)

Query: 15  MIREVSCLMELNHPNIIRLMRV---ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
             RE+  L  L H NII L  +     + IY   V E    DL  LL       +    K
Sbjct: 56  TYRELKLLKHLRHENIISLSDIFISPLEDIYF--VTELLGTDLHRLLT------SRPLEK 107

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
            F  Y L+               R L +      + RDLKP NIL++ +   +K+  FGL
Sbjct: 108 QFIQYFLYQIL------------RGLKYVHSAGVVHRDLKPSNILIN-ENCDLKICDFGL 154

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN- 188
           A+       + +  V T YY+APE++L   +Y   VDIW  GCIF EM+ GKPLFPG + 
Sbjct: 155 AR---IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211

Query: 189 ----SLIT--LG--------RIVGKSRKPSFCKLSLRDH--LTNGFPGLEPAGIDLISKM 232
               S+IT  LG         I  ++       L  R+    +  F   +P+ IDL+ KM
Sbjct: 212 VNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKM 271

Query: 233 LGMDPDKRITAAEALQQEYFK 253
           L  DP KRI+AAEAL   Y  
Sbjct: 272 LVFDPQKRISAAEALAHPYLA 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  130 bits (329), Expect = 1e-36
 Identities = 78/255 (30%), Positives = 130/255 (50%), Gaps = 34/255 (13%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLL-KYPKDSMNGYSTKNFN 74
           +RE+  L +L HPN++ L+ V  +   L+ VFEY  + +   L K P+  +  +  K   
Sbjct: 48  LREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKI- 105

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
              ++ T   V  F    +          I RD+KP NIL+   G+ +K+  FG A+ L 
Sbjct: 106 ---IWQTLQAVN-FCHKHNC---------IHRDVKPENILITKQGQ-IKLCDFGFARILT 151

Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS----- 189
               + +  V T +Y+APELL+G  +Y   VD+W +GC+F E+++G+PL+PG +      
Sbjct: 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211

Query: 190 LI--TLGRIVGKSRK-----PSFCKLSL-----RDHLTNGFPGLEPAGIDLISKMLGMDP 237
           LI  TLG ++ + ++       F  LS+     R+ L + FP +    +  +   L MDP
Sbjct: 212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDP 271

Query: 238 DKRITAAEALQQEYF 252
            +R++  E L+  YF
Sbjct: 272 TERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  130 bits (328), Expect = 3e-36
 Identities = 89/274 (32%), Positives = 125/274 (45%), Gaps = 50/274 (18%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGI----------YLYPVFEYQVNDLA 55
           N  EG P + IRE+  L +LNH NI+ L  + +               Y VFEY  +DL 
Sbjct: 44  NEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLM 103

Query: 56  YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNI 113
            LL+      +G    + +    F   LL            L++     ++ RD+K  NI
Sbjct: 104 GLLE------SGLVHFSEDHIKSFMKQLL----------EGLNYCHKKNFLHRDIKCSNI 147

Query: 114 LVDLDGKTVKVAGFGLAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPV 170
           L++  G+ +K+A FGLA+ LY    ES   + +V T +Y+ PELLLG   Y  A+D+W  
Sbjct: 148 LLNNKGQ-IKLADFGLAR-LY-NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 204

Query: 171 GCIFGEMVSGKPLFPGANSLITL---GRIVGKSRK---PSFCKLSL----------RDHL 214
           GCI GE+ + KP+F     L  L    R+ G       P   KL            R  L
Sbjct: 205 GCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRL 264

Query: 215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              F  +    +DL+  ML +DP KR TA EAL 
Sbjct: 265 REEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  129 bits (325), Expect = 2e-35
 Identities = 82/279 (29%), Positives = 125/279 (44%), Gaps = 52/279 (18%)

Query: 4   IHNTMEGVPSSM--IREVSCLMELNHPNIIRL---MRVASQGIY--LYPVFEYQVNDLAY 56
           I N  +    +   +RE+  L  L+H N+I +   M    +  +  +Y V+E    DL  
Sbjct: 38  IANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQ 97

Query: 57  LLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKP 110
           +++  +   + +       Y L+                 L  G +YI       RDLKP
Sbjct: 98  IIRSSQTLSDDHC-----QYFLY----------------QLLRGLKYIHSANVLHRDLKP 136

Query: 111 VNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV 170
            N+L++ +   +K+  FGLA++        +  V T +Y+APELLL   EY+TA+D+W V
Sbjct: 137 SNLLLNANCD-LKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSV 195

Query: 171 GCIFGEMVSGKPLFPG---ANSLITLGRIVGKSRKPSFCKL--------------SLRDH 213
           GCIF E++  KPLFPG    + L  +  ++G   +     +              + R  
Sbjct: 196 GCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQS 255

Query: 214 LTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               FP   P  IDL+ KML  DP KRIT  EAL   Y 
Sbjct: 256 FARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  127 bits (321), Expect = 6e-35
 Identities = 82/276 (29%), Positives = 125/276 (45%), Gaps = 53/276 (19%)

Query: 14  SMIREVSCLMELNHPNIIRLMRV-ASQGIYL-------------YPVFEYQVNDLAYLLK 59
             +RE+  +  L+H NI+++  V    G  L             Y V EY   DLA +L+
Sbjct: 48  HALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE 107

Query: 60  YPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDL 117
               S             LF   LL          R L +      + RDLKP N+ ++ 
Sbjct: 108 QGPLSEE--------HARLFMYQLL----------RGLKYIHSANVLHRDLKPANVFINT 149

Query: 118 DGKTVKVAGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIF 174
           +   +K+  FGLA+ +   Y++KG  S  + T +Y++P LLL    Y+ A+D+W  GCIF
Sbjct: 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 209

Query: 175 GEMVSGKPLFPGANSLITLGRIVGK-------------SRKPSFCKLSL---RDHLTNGF 218
            EM++GKPLF GA+ L  +  I+               +  PSF +      R  L +  
Sbjct: 210 AEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLL 269

Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
           PG+ P  +D + ++L  +P  R+TA EAL   Y   
Sbjct: 270 PGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  125 bits (316), Expect = 2e-34
 Identities = 87/287 (30%), Positives = 124/287 (43%), Gaps = 65/287 (22%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRV----ASQG------IYLYPVFEYQVNDLA 55
           N  EG P + +RE+  L  L H N++ L+ +    A+         YL  VFE+  +DLA
Sbjct: 49  NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL--VFEFCEHDLA 106

Query: 56  YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLK 109
            LL                       F L E        + L  G  YI       RD+K
Sbjct: 107 GLLSNKN-----------------VKFTLSE---IKKVMKMLLNGLYYIHRNKILHRDMK 146

Query: 110 PVNILVDLDGKTVKVAGFGLAKSLYAYKGES----SAEVGTHYYKAPELLLGLLEYSTAV 165
             NIL+  DG  +K+A FGLA++    K       +  V T +Y+ PELLLG  +Y   +
Sbjct: 147 AANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPI 205

Query: 166 DIWPVGCIFGEMVSGKPLFPGAN-----SLIT--LGRIV-----GKSRKPSFCKLSL--- 210
           D+W  GCI  EM +  P+  G       +LI+   G I      G  +   F K+ L   
Sbjct: 206 DMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQG 265

Query: 211 -----RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                ++ L       +P  +DLI K+L +DP KRI A  AL  ++F
Sbjct: 266 QKRKVKERLKPYVK--DPHALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 3e-34
 Identities = 63/176 (35%), Positives = 87/176 (49%), Gaps = 37/176 (21%)

Query: 104 IRRDLKPVNILV----DLDGKTVKVAGFGLAKS---LYAYKGESSAEVGTHYYKAPELLL 156
           + RDLKP N+L+    DL     K+  FGLA+     + + G  +  V T +Y+APE++L
Sbjct: 128 LHRDLKPSNLLLNTNCDL-----KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182

Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG-------------KSRK- 202
               Y+ A+DIW VGCI  EM+S +PLFPG + L  L  I+G              S + 
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242

Query: 203 -------PSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
                  P   K+         FP  +P  +DL+ KML  +P KRIT  EAL   Y
Sbjct: 243 RNYIKSLPFKPKVPWNKL----FPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  124 bits (313), Expect = 9e-34
 Identities = 90/283 (31%), Positives = 135/283 (47%), Gaps = 48/283 (16%)

Query: 4   IHNTMEGVPSS--MIREVSCLMELNHPNII---RLMRVASQGIY--LYPVFEYQVNDLAY 56
           I++  E V  +  ++RE+  L  L HP+I+    +M   S+  +  +Y VFE   +DL  
Sbjct: 33  INDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQ 92

Query: 57  LLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNIL 114
           ++K   D    +       +  F   LL          R+L +        RDLKP NIL
Sbjct: 93  VIKANDDLTPEH-------HQFFLYQLL----------RALKYIHTANVFHRDLKPKNIL 135

Query: 115 VDLDGKTVKVAGFGLAKSLYAYKGES---SAEVGTHYYKAPELLLGLL-EYSTAVDIWPV 170
            + D K +K+  FGLA+  +     +   +  V T +Y+APEL      +Y+ A+DIW +
Sbjct: 136 ANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 194

Query: 171 GCIFGEMVSGKPLFPGAN-----SLIT--LGR----IVGKSR--KPSFCKLSLRDH---- 213
           GCIF E+++GKPLFPG N      LIT  LG      + + R  K      S+R      
Sbjct: 195 GCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP 254

Query: 214 LTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
            +  FP  +P  + L+ ++L  DP  R TA EAL   YFK + 
Sbjct: 255 FSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  120 bits (302), Expect = 1e-32
 Identities = 62/166 (37%), Positives = 86/166 (51%), Gaps = 26/166 (15%)

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV 165
           RD+KP NIL+  D   +K+A FG  + +Y+ K   +  + T +Y+APE LL    Y   +
Sbjct: 124 RDIKPENILIKDD--ILKLADFGSCRGIYS-KPPYTEYISTRWYRAPECLLTDGYYGPKM 180

Query: 166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRI----------VGKSRKPSFCK-------- 207
           DIW VGC+F E++S  PLFPG N L  + +I          V K  + S           
Sbjct: 181 DIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKK 240

Query: 208 -LSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
              LR  L    P     G+DL+ K+L  DPD+RITA +AL+  YF
Sbjct: 241 GTGLRKLL----PNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  118 bits (298), Expect = 4e-32
 Identities = 92/273 (33%), Positives = 133/273 (48%), Gaps = 43/273 (15%)

Query: 4   IHNTMEGVPSSMIREVSCLMELN---HPNIIRLMRVAS-----QGIYLYPVFEYQVNDLA 55
           +    EG+P S IREV+ L  L    HPN++RL  V +     +   L  VFE+   DL 
Sbjct: 37  VQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT 96

Query: 56  -YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVN 112
            YL K P+  +   + K+   + L                R L F    R + RDLKP N
Sbjct: 97  TYLDKVPEPGVPTETIKDM-MFQLL---------------RGLDFLHSHRVVHRDLKPQN 140

Query: 113 ILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGC 172
           ILV   G+ +K+A FGLA+ +Y+++   ++ V T +Y+APE+LL    Y+T VD+W VGC
Sbjct: 141 ILVTSSGQ-IKLADFGLAR-IYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGC 197

Query: 173 IFGEMVSGKPLFPGANSLITLGRIVGKSRKPS-----------FCKLSLR--DHLTNGFP 219
           IF EM   KPLF G++ +  LG+I+     P                  +    +     
Sbjct: 198 IFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT 257

Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
            ++  G DL+ K L  +P KRI+A  AL   YF
Sbjct: 258 DIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  119 bits (299), Expect = 8e-32
 Identities = 86/270 (31%), Positives = 122/270 (45%), Gaps = 66/270 (24%)

Query: 17  REVSCLMELNHPNIIRLMRV-ASQGIY-----LYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           RE++ L  + H N+I L+ V  S          Y V  Y   DL  ++ +P         
Sbjct: 63  RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP--------- 113

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSF----GTRYIR------RDLKPVNILVDLDGK 120
                              S D  + L +    G +YI       RDLKP N+ V+ D +
Sbjct: 114 ------------------LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE 155

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
            +K+  FGLA+   A   E +  V T +Y+APE++L  + Y+  VDIW VGCI  EM++G
Sbjct: 156 -LKILDFGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Query: 181 KPLFPGANSLITLGRIV------------------GKSRKPSFCKLSLRDHLTNGFPGLE 222
           K LF G + L  L +I+                   KS   S  K   +D  +  FP   
Sbjct: 212 KTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKD-FSTLFPKAS 270

Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           P  +DL+ KML +D DKR+TA EAL+  YF
Sbjct: 271 PQAVDLLEKMLELDVDKRLTATEALEHPYF 300

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  117 bits (293), Expect = 3e-31
 Identities = 98/272 (36%), Positives = 128/272 (47%), Gaps = 40/272 (14%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLA-YLLKYPKDSMNG 67
           EG P + IRE S L  L H NI+ L  +      L  VFEY   DL  Y+ K+P     G
Sbjct: 44  EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHP----GG 99

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF-GTRYI-RRDLKPVNILVDLDGKTVKVA 125
              +N     LF   LL          R LS+   RYI  RDLKP N+L+  D   +K+A
Sbjct: 100 LHPENVK---LFLFQLL----------RGLSYIHQRYILHRDLKPQNLLIS-DTGELKLA 145

Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
            FGLA++        S EV T +Y+ P++LLG  EYST +D+W VGCIF EM+ G   FP
Sbjct: 146 DFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205

Query: 186 G----ANSLITLGRIVGKSR-------------KPSFCKLSLRDHLTNGFPGLEPA--GI 226
           G     + L  +  ++G                KP    L    +L   +  L       
Sbjct: 206 GMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAE 265

Query: 227 DLISKMLGMDPDKRITAAEALQQEYFKDVPGR 258
           DL SK+L   P  R++A  AL  EYF D+P R
Sbjct: 266 DLASKLLQCFPKNRLSAQAALSHEYFSDLPPR 297

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  116 bits (293), Expect = 5e-31
 Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 22/169 (13%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE----VGTHYYKAPELLLGLL 159
           + RDLKP N+LV+ D + +K+  FGLA+      GE++      V T +Y+APE++L   
Sbjct: 127 LHRDLKPGNLLVNADCE-LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ 185

Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRI--------------VGKSRKPSF 205
            Y+ A+D+W VGCI  E++  KP+F G + +  L +I              +G  +  ++
Sbjct: 186 SYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNY 245

Query: 206 CKLS---LRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
            +      +    + FP   P  +DL+ K+L  DP KRI+  EAL+  Y
Sbjct: 246 IRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  114 bits (288), Expect = 4e-30
 Identities = 89/279 (31%), Positives = 131/279 (46%), Gaps = 69/279 (24%)

Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKD--SMN 66
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D   M 
Sbjct: 64  RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL--VMELMDANLCQVIQMDLDHERM- 120

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAG 126
                   SY L+     ++   S+            I RDLKP NI+V  D  T+K+  
Sbjct: 121 --------SYLLYQMLCGIKHLHSAG----------IIHRDLKPSNIVVKSDC-TLKILD 161

Query: 127 FGLAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
           FGLA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEM+ G  L
Sbjct: 162 FGLART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVL 216

Query: 184 FPGANSLITLGRIVGKSRKPS---FCKL--SLRDHLTN-------GFPGLEPAGI----- 226
           FPG + +    +I+ +   PS     +L  ++R+++ N        F  L P  +     
Sbjct: 217 FPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDS 276

Query: 227 ------------DLISKMLGMDPDKRITAAEALQQEYFK 253
                       DL+SKML +DP+KRI+  +ALQ  Y  
Sbjct: 277 ESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  113 bits (283), Expect = 2e-29
 Identities = 83/259 (32%), Positives = 125/259 (48%), Gaps = 43/259 (16%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYL------YPVFEYQVNDLAYLLKYPKDSMNGYST 70
           RE+  L  + H N+I L+ V +    L      Y V      DL  ++K  K       T
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LT 118

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
            +   + ++     ++   S+D           I RDLKP N+ V+ D + +K+  FGLA
Sbjct: 119 DDHVQFLIYQILRGLKYIHSAD----------IIHRDLKPSNLAVNEDCE-LKILDFGLA 167

Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA--- 187
           +       E +  V T +Y+APE++L  + Y+  VDIW VGCI  E+++G+ LFPG    
Sbjct: 168 RHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224

Query: 188 NSLITLGRIVGKSRKPSFCKLS---LRDHLT-----------NGFPGLEPAGIDLISKML 233
           + L  + R+VG        K+S    R+++            N F G  P  +DL+ KML
Sbjct: 225 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 284

Query: 234 GMDPDKRITAAEALQQEYF 252
            +D DKRITAA+AL   YF
Sbjct: 285 VLDSDKRITAAQALAHAYF 303

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  113 bits (283), Expect = 2e-29
 Identities = 65/166 (39%), Positives = 89/166 (53%), Gaps = 21/166 (12%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +++  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 140 IHRDLKPSNVAVNEDCE-LRILDFGLARQA---DDEMTGYVATRWYRAPEIMLNWMHYNQ 195

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRI--VGKSRKPSFCKLSLRDH-------- 213
            VDIW VGCI  E++ GK LFPG + +  L RI  V  +  P   K    +H        
Sbjct: 196 TVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSL 255

Query: 214 -------LTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                  L   F G  P  IDL+ KML +D DKRI+A+EAL   YF
Sbjct: 256 PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  114 bits (286), Expect = 3e-29
 Identities = 84/269 (31%), Positives = 136/269 (50%), Gaps = 39/269 (14%)

Query: 12  PSSMIREVSCLMELNHPNIIRL--------MRVASQGIYLYPVFEYQVNDLAYLLKYPKD 63
           P    RE+  +  LNH NII L         +   + I+L  V E+    +   +K+   
Sbjct: 103 PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH--- 159

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF-GTRYI-RRDLKPVNILVDLDGKT 121
               Y+    N+++L     LV+ +S     R+L++  +++I  RDLKP N+L+D +  T
Sbjct: 160 ----YAR---NNHAL--PLFLVKLYSYQ-LCRALAYIHSKFICHRDLKPQNLLIDPNTHT 209

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
           +K+  FG AK+L A +  S + + + +Y+APEL+LG   Y+T +D+W +GCI  EM+ G 
Sbjct: 210 LKLCDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268

Query: 182 PLFPGANSLITLGRIVG----------KSRKPSFCKLSLRD----HLTNGFP-GLEPAGI 226
           P+F G +S+  L RI+           K   P++  +   D     L   FP G     I
Sbjct: 269 PIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAI 328

Query: 227 DLISKMLGMDPDKRITAAEALQQEYFKDV 255
           + IS+ L  +P KR+   EAL   +F D+
Sbjct: 329 NFISQFLKYEPLKRLNPIEALADPFFDDL 357

Length = 440

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  108 bits (273), Expect = 5e-29
 Identities = 73/247 (29%), Positives = 95/247 (38%), Gaps = 64/247 (25%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDS 64
                +   ++RE+  L +LNHPNI++L  V     +LY V EY     L  LLK  +  
Sbjct: 29  EDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK 88

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTV 122
           ++                              L +      I RDLKP NIL+D D   V
Sbjct: 89  LSEDEILRI----------------LLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKV 132

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+A FGL+K L + K      VGT  Y APE+LLG   YS   DIW +G I  E+     
Sbjct: 133 KLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----- 187

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
                                                   P   DLI KML  DP+KR +
Sbjct: 188 ----------------------------------------PELKDLIRKMLQKDPEKRPS 207

Query: 243 AAEALQQ 249
           A E L+ 
Sbjct: 208 AKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  111 bits (280), Expect = 5e-29
 Identities = 82/267 (30%), Positives = 124/267 (46%), Gaps = 55/267 (20%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYL------YPVFEYQVNDLAYLLKYPKDSMNGYST 70
           RE+  L  + H N+I L+ V +  + L      Y V  +   DL  L+K+ K S +    
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR--- 119

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTVKV 124
                      FL+ +             G +YI       RDLKP N+ V+ D + +K+
Sbjct: 120 ---------IQFLVYQMLK----------GLKYIHAAGIIHRDLKPGNLAVNEDCE-LKI 159

Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
             FGLA+       E +  V T +Y+APE++L  + Y+  VDIW VGCI  EM++GKPLF
Sbjct: 160 LDFGLARQT---DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216

Query: 185 PGA---NSLITLGRIVGKSRKPSFCKLSLRD--HLTNGFPGLE------------PAGID 227
            G    + L+ + ++ G   K    KL   D  +     P               P  ++
Sbjct: 217 KGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVN 276

Query: 228 LISKMLGMDPDKRITAAEALQQEYFKD 254
           ++ KML +D + RITAAEAL   YF++
Sbjct: 277 VLEKMLVLDAESRITAAEALAHPYFEE 303

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  109 bits (275), Expect = 4e-28
 Identities = 61/190 (32%), Positives = 90/190 (47%), Gaps = 46/190 (24%)

Query: 100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK------SLYAYKGESSAEVGTHYYKAPE 153
               + RD+KP N+LV+ +   +K+  FGLA+      S +      + EV T YY+APE
Sbjct: 121 SAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHM-----TQEVVTQYYRAPE 174

Query: 154 LLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV---------------- 197
           +L+G   Y++AVDIW VGCIF E++  + LF   + +  L  I                 
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234

Query: 198 --------GKSRKPSFCKL-SLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
                   G  + PS   L +L    T+         + L+ +ML  DPDKRI+AA+AL 
Sbjct: 235 GARAHILRGPHKPPSLPVLYTLSSQATH-------EAVHLLCRMLVFDPDKRISAADALA 287

Query: 249 QEYFKDVPGR 258
             Y  +  GR
Sbjct: 288 HPYLDE--GR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  102 bits (256), Expect = 4e-26
 Identities = 69/252 (27%), Positives = 107/252 (42%), Gaps = 55/252 (21%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFN 74
           + EV  L +LNHPNII+      +   L  V EY    DL+  +K           K   
Sbjct: 47  LNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIK---------KQKKEG 97

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYI------RRDLKPVNILVDLDGKTVKVAGFG 128
               F    +++ F        L    +Y+       RD+KP NI +  +G  VK+  FG
Sbjct: 98  KP--FPEEQILDWFVQ------LCLALKYLHSRKILHRDIKPQNIFLTSNGL-VKLGDFG 148

Query: 129 LAKSLYAYKGESSAE-----VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
           ++K L      S+ +     VGT YY +PEL      Y+   DIW +GC+  E+ + K  
Sbjct: 149 ISKVL-----SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHP 202

Query: 184 FPGANSLITLG-RIVGKSRKPSFCKLS--LRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
           F    +L+ L  +I+     P   + S  LR               +L+S +L  DP++R
Sbjct: 203 F-EGENLLELALKILKGQYPPIPSQYSSELR---------------NLVSSLLQKDPEER 246

Query: 241 ITAAEALQQEYF 252
            + A+ LQ  + 
Sbjct: 247 PSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  104 bits (259), Expect = 5e-26
 Identities = 74/251 (29%), Positives = 108/251 (43%), Gaps = 23/251 (9%)

Query: 14  SMIREVSCLMELNHP-NIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTK 71
             +RE+  L  LNHP NI++L         LY V EY     L  LLK          ++
Sbjct: 43  RFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE 102

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                     F+L +  S+ +   S       I RD+KP NIL+D DG+ VK+  FGLAK
Sbjct: 103 AL--------FILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAK 150

Query: 132 SLYAYKGES------SAEVGTHYYKAPELLLGLLE--YSTAVDIWPVGCIFGEMVSGKPL 183
            L      S      S  VGT  Y APE+LLGL     S++ DIW +G    E+++G P 
Sbjct: 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210

Query: 184 FPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA 243
           F G  +     + +    +             +    +  A  DL+ K+L  DP  R+++
Sbjct: 211 FEGEKNSSATSQTLKIILELPT-PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269

Query: 244 AEALQQEYFKD 254
           +  L  +    
Sbjct: 270 SSDLSHDLLAH 280

Length = 384

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  102 bits (255), Expect = 1e-25
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 53/287 (18%)

Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
           G+  S  RE++ L EL HPN+I L +V    A + ++L  +F+Y  +DL +++K+ + S 
Sbjct: 40  GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL--LFDYAEHDLWHIIKFHRAS- 96

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKT---V 122
                 N     L    +    +   D    L      + RDLKP NILV  +G     V
Sbjct: 97  ----KANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRV 151

Query: 123 KVAGFGLAKSLYAYKGESSAE----VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           K+A  G A+ L+    +  A+    V T +Y+APELLLG   Y+ A+DIW +GCIF E++
Sbjct: 152 KIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Query: 179 SGKPLFPGANSLI---------TLGRI------------------------VGKSRKPSF 205
           + +P+F      I          L RI                        +   R+ ++
Sbjct: 211 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 270

Query: 206 CKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
              SL  ++       +     L+ K+L MDP KRIT+ +A+Q  YF
Sbjct: 271 TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  100 bits (251), Expect = 2e-25
 Identities = 77/241 (31%), Positives = 107/241 (44%), Gaps = 32/241 (13%)

Query: 15  MIREVSCLMELNHPNIIRLMR----VASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYS 69
           ++ EV+ L EL HPNI+R        ++Q +Y+    EY +  DLA L++  K     Y 
Sbjct: 46  LVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV--MEYCEGGDLAQLIQKCK-KERKYI 102

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
            + F  + + T  LL    +  +       G   + RDLKP NI +D     VK+  FGL
Sbjct: 103 EEEF-IWRILTQLLL----ALYECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGL 156

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
           AK L      +   VGT YY +PE L  +  Y    DIW +GC+  E+ +  P F   N 
Sbjct: 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQ 215

Query: 190 LITLGRI-VGK-SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
           L    +I  GK  R P          L             +I  ML +DPDKR +  E L
Sbjct: 216 LQLASKIKEGKFRRIPYR----YSSELNE-----------VIKSMLNVDPDKRPSTEELL 260

Query: 248 Q 248
           Q
Sbjct: 261 Q 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  100 bits (250), Expect = 5e-25
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 53/287 (18%)

Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
           G+  S  RE++ L EL HPN+I L +V    + + ++L  +F+Y  +DL +++K+ + S 
Sbjct: 40  GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL--LFDYAEHDLWHIIKFHRAS- 96

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKT---V 122
                 N     L  + +    +   D    L      + RDLKP NILV  +G     V
Sbjct: 97  ----KANKKPMQLPRSMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRV 151

Query: 123 KVAGFGLAKSLYAYKGESSAE----VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           K+A  G A+ L+    +  A+    V T +Y+APELLLG   Y+ A+DIW +GCIF E++
Sbjct: 152 KIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Query: 179 SGKPLFPGANSLI---------TLGRIVG------------------------KSRKPSF 205
           + +P+F      I          L RI                            R+ ++
Sbjct: 211 TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTY 270

Query: 206 CKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
              SL  ++       +     L+ K+L MDP KRIT+ +ALQ  YF
Sbjct: 271 ANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  100 bits (251), Expect = 7e-25
 Identities = 86/271 (31%), Positives = 127/271 (46%), Gaps = 58/271 (21%)

Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  L  +NH NII L+ V +        Q +YL  V E    +L  ++    D     
Sbjct: 69  RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL--VMELMDANLCQVIHMELDHER-- 124

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++   S+            I RDLKP NI+V  D  T+K+  FG
Sbjct: 125 -----MSYLLYQMLCGIKHLHSAG----------IIHRDLKPSNIVVKSDC-TLKILDFG 168

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        +  V T YY+APE++LG+  Y   VDIW VGCI GE+V G  +F G +
Sbjct: 169 LARTA-CTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTD 226

Query: 189 SLITLGRIVGKSRKPSF-----CKLSLRDHLTN--GFPG-----LEPAGI---------- 226
            +    +++ +   PS       + ++R+++ N   +PG     L P  I          
Sbjct: 227 HIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKL 286

Query: 227 ------DLISKMLGMDPDKRITAAEALQQEY 251
                 DL+SKML +DPDKRI+  EAL+  Y
Sbjct: 287 KTSQARDLLSKMLVIDPDKRISVDEALRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  100 bits (250), Expect = 8e-25
 Identities = 90/274 (32%), Positives = 130/274 (47%), Gaps = 64/274 (23%)

Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL--VMELMDANLCQVIQMELDHER-- 120

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++   S+            I RDLKP NI+V  D  T+K+  FG
Sbjct: 121 -----MSYLLYQMLCGIKHLHSAG----------IIHRDLKPSNIVVKSDC-TLKILDFG 164

Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 165 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 219

Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279

Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEY 251
                    DL+SKML +DP KRI+  EALQ  Y
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 97.9 bits (244), Expect = 2e-24
 Identities = 68/238 (28%), Positives = 99/238 (41%), Gaps = 40/238 (16%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           +E++ L +L HPNI++ +    +   LY   E            P  S+           
Sbjct: 51  QEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL----------VPGGSLA---------- 90

Query: 77  SLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGFGLA 130
            L   +    E      +R +  G  Y      + RD+K  NILVD +G  VK+A FG+A
Sbjct: 91  KLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMA 149

Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
           K +  +    S   G+ Y+ APE++     Y  A DIW +GC   EM +GKP +     +
Sbjct: 150 KQVVEFSFAKSF-KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV 208

Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
             + +I      P      + DH       L     D I K L  DP  R TAAE L+
Sbjct: 209 AAVFKIGRSKELP-----PIPDH-------LSDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 97.6 bits (244), Expect = 3e-24
 Identities = 77/244 (31%), Positives = 99/244 (40%), Gaps = 47/244 (19%)

Query: 17  REVSCLMELNHPNIIRL--MRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           RE+  L  L HPNI+R        +   L    EY               ++G S     
Sbjct: 48  REIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY---------------VSGGSLS--- 89

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGFG 128
             SL   F  + E      +R +  G  Y      + RD+K  NILVD DG  VK+A FG
Sbjct: 90  --SLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFG 146

Query: 129 LAKSL--YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
            AK L        + +  GT Y+ APE++ G  EY  A DIW +GC   EM +GKP +  
Sbjct: 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSE 205

Query: 187 -ANSLITLGRIVGKSRKPSF-CKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
             N +  L +I      P     LS                 D + K L  DP KR TA 
Sbjct: 206 LGNPMAALYKIGSSGEPPEIPEHLS-------------EEAKDFLRKCLRRDPKKRPTAD 252

Query: 245 EALQ 248
           E LQ
Sbjct: 253 ELLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 96.7 bits (240), Expect = 3e-23
 Identities = 88/274 (32%), Positives = 127/274 (46%), Gaps = 64/274 (23%)

Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L  +++   D     
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHER-- 127

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++   S+            I RDLKP NI+V  D  T+K+  FG
Sbjct: 128 -----MSYLLYQMLCGIKHLHSAG----------IIHRDLKPSNIVVKSDC-TLKILDFG 171

Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEM+ G  LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFP 226

Query: 186 GANSLITLGRIVGKSRKP--SFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +   P   F K    ++R ++ N            FP  L PA    
Sbjct: 227 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286

Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEY 251
                    DL+SKML +D  KRI+  EALQ  Y
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 94.5 bits (236), Expect = 3e-23
 Identities = 58/144 (40%), Positives = 75/144 (52%), Gaps = 18/144 (12%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NIL+D DG  +K+  FGLAK L +    ++   GT  Y APE+LLG   Y  
Sbjct: 115 IYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK-GYGK 172

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           AVD W +G +  EM++GKP F   +      +I             L+D L   FP  L 
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI-------------LKDPLR--FPEFLS 217

Query: 223 PAGIDLISKMLGMDPDKRITAAEA 246
           P   DLIS +L  DP KR+ +  A
Sbjct: 218 PEARDLISGLLQKDPTKRLGSGGA 241

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 91.6 bits (227), Expect = 6e-22
 Identities = 78/265 (29%), Positives = 119/265 (44%), Gaps = 39/265 (14%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNG 67
           E V  + +RE+  L  L   NI+ L     +   LY VFEY + N L  L + P    NG
Sbjct: 41  EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP----NG 96

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              +   SY     + L++       +         + RD+KP N+L+  +   +K+  F
Sbjct: 97  VPPEKVRSY----IYQLIKAIHWCHKND-------IVHRDIKPENLLISHN-DVLKLCDF 144

Query: 128 GLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           G A++L      +  E V T +Y++PELLLG   Y  AVD+W VGCI GE+  G+PLFPG
Sbjct: 145 GFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPG 203

Query: 187 A---NSLITLGRIVGKSRKPSFCKLSLRDHLTNG--FPG--------------LEPAGID 227
               + L T+ +++G        KL   +   +G  FP               L    +D
Sbjct: 204 ESEIDQLFTIQKVLG-PLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLD 262

Query: 228 LISKMLGMDPDKRITAAEALQQEYF 252
           L+  +L ++P  R    + L    F
Sbjct: 263 LMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 91.5 bits (228), Expect = 7e-22
 Identities = 69/251 (27%), Positives = 101/251 (40%), Gaps = 50/251 (19%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFN 74
           I E+  + +  HPNI+        G  L+ V EY     L  ++      MN        
Sbjct: 63  INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMN-------- 114

Query: 75  SYSLFTTFLLVEE---FSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
                      E    +   +  + L +      I RD+K  NIL+  DG +VK+A FG 
Sbjct: 115 -----------EPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGF 162

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
           A  L   K + ++ VGT Y+ APE++    +Y   VDIW +G +  EM  G+P +     
Sbjct: 163 AAQLTKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221

Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAG------IDLISKMLGMDPDKRITA 243
           L  L  I                  T G P L+          D ++K L  DP+KR +A
Sbjct: 222 LRALFLIT-----------------TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSA 264

Query: 244 AEALQQEYFKD 254
            E LQ  + K 
Sbjct: 265 EELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 91.1 bits (227), Expect = 7e-22
 Identities = 75/256 (29%), Positives = 103/256 (40%), Gaps = 53/256 (20%)

Query: 16  IREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNF 73
             E   L  LN HP II+L         LY V EY  N +L   ++        Y + + 
Sbjct: 49  KIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-------YGSLDE 101

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
                 T F   E   + +   S       I RDLKP NIL+D D   +K+  FG AK L
Sbjct: 102 K----CTRFYAAEILLALEYLHSKGI----IHRDLKPENILLDKDMH-IKITDFGTAKVL 152

Query: 134 YAYKGESSAE--------------------VGTHYYKAPELLLGLLEYSTAVDIWPVGCI 173
                  S +                    VGT  Y +PELL        + D+W +GCI
Sbjct: 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCI 211

Query: 174 FGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKML 233
             +M++GKP F G+N  +T  +I+    + SF            FP   P   DLI K+L
Sbjct: 212 IYQMLTGKPPFRGSNEYLTFQKIL--KLEYSF---------PPNFP---PDAKDLIEKLL 257

Query: 234 GMDPDKRITAAEALQQ 249
            +DP  R+   E   +
Sbjct: 258 VLDPQDRLGVNEGYDE 273

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 86.9 bits (216), Expect = 2e-20
 Identities = 51/154 (33%), Positives = 72/154 (46%), Gaps = 26/154 (16%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  NIL+  DG+ VK+  FGL+  L   K  ++  VGT Y+ APE++ G   Y  
Sbjct: 120 IHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKARNTM-VGTPYWMAPEVINGK-PYDY 176

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL-E 222
             DIW +G    E+  GKP +     +  L +I                  TNG PGL  
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIA-----------------TNGPPGLRN 219

Query: 223 PAGI-----DLISKMLGMDPDKRITAAEALQQEY 251
           P        D + K L  +P+KR TA + L+  +
Sbjct: 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 2e-19
 Identities = 70/248 (28%), Positives = 106/248 (42%), Gaps = 45/248 (18%)

Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTK 71
            S+++E+  L  L HPNI++ +        LY + EY  N  L  ++K            
Sbjct: 44  KSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK------------ 91

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVA 125
            F  +         E   +    + L  G  Y      I RD+K  NIL   DG  VK+A
Sbjct: 92  KFGPFP--------ESLVAVYVYQVLQ-GLAYLHEQGVIHRDIKAANILTTKDG-VVKLA 141

Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
            FG+A  L     + ++ VGT Y+ APE++  +   STA DIW +GC   E+++G P + 
Sbjct: 142 DFGVATKLNDVSKDDASVVGTPYWMAPEVI-EMSGASTASDIWSLGCTVIELLTGNPPYY 200

Query: 186 GANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRITAA 244
             N +  L RIV     P               P G+ P   D + +    DP+ R TA 
Sbjct: 201 DLNPMAALFRIVQDDHPP--------------LPEGISPELKDFLMQCFQKDPNLRPTAK 246

Query: 245 EALQQEYF 252
           + L+  + 
Sbjct: 247 QLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 83.2 bits (206), Expect = 5e-19
 Identities = 68/244 (27%), Positives = 103/244 (42%), Gaps = 37/244 (15%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFNS 75
            E+  L  L HPN+++   V      +Y   EY     L  LL++ +         + + 
Sbjct: 48  DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR-------ILDEHV 100

Query: 76  YSLFTTFLL--VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
             ++T  LL  +    S             + RD+KP NI +D +G  +K+  FG A  L
Sbjct: 101 IRVYTLQLLEGLAYLHSH----------GIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL 149

Query: 134 ----YAYKGESSAEVGTHYYKAPELLLG--LLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
                    E  +  GT  Y APE++ G     +  A DIW +GC+  EM +GK  +   
Sbjct: 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209

Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
           ++   +   VG   KP      + D L      L P G D + + L  DP KR TA+E L
Sbjct: 210 DNEFQIMFHVGAGHKP-----PIPDSLQ-----LSPEGKDFLDRCLESDPKKRPTASELL 259

Query: 248 QQEY 251
           Q  +
Sbjct: 260 QHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 83.1 bits (206), Expect = 6e-19
 Identities = 58/164 (35%), Positives = 78/164 (47%), Gaps = 27/164 (16%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAK------SLYAYKGESSAE--VGTHYYKAPELL 155
           I RDLKP NIL+D +G  +K+  FGL+K       +     E   +  VGT  Y APE++
Sbjct: 115 IHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 156 LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHL 214
           LG   +S  VD W +GCI  E + G P F G         I+ GK   P   ++S     
Sbjct: 174 LGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVS----- 227

Query: 215 TNGFPGLEPAGIDLISKMLGMDPDKRITAA---EALQQEYFKDV 255
                      IDLISK+L  DP+KR+ A    E     +FK +
Sbjct: 228 --------DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 3e-18
 Identities = 54/188 (28%), Positives = 79/188 (42%), Gaps = 49/188 (26%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---------------------- 139
            +I RD+KP NIL+D DG  +K+A FGL K +   K                        
Sbjct: 121 GFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179

Query: 140 -------SSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT 192
                  +++ VGT  Y APE+L G   Y    D W +G I  EM+ G P F       T
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238

Query: 193 LGRIVGKSRKPSFCKLSLRDHLTNGFP---GLEPAGIDLISKMLGMDPDKRITAAE-ALQ 248
             +I+           + ++ L   FP    + P  IDLI ++L  DP+ R+ + E    
Sbjct: 239 YNKII-----------NWKESLR--FPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKS 284

Query: 249 QEYFKDVP 256
             +FK + 
Sbjct: 285 HPFFKGID 292

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 82.1 bits (203), Expect = 3e-18
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 27/181 (14%)

Query: 82  FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESS 141
           F + E F + D+   L     YI RDLKP N L+D  G  +K+  FGL+K +  Y   ++
Sbjct: 105 FYMAEMFEAVDALHELG----YIHRDLKPENFLIDASGH-IKLTDFGLSKGIVTY---AN 156

Query: 142 AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN---SLITLGRIVG 198
           + VG+  Y APE+L G   Y   VD W +GC+  E + G P F G+    +   L     
Sbjct: 157 SVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE 215

Query: 199 KSRKPSF--CKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE-YFKDV 255
             ++P +   + +L D              DLI+K++  DP +R  + E ++   +FK+V
Sbjct: 216 TLQRPVYDDPRFNLSDEAW-----------DLITKLI-NDPSRRFGSLEDIKNHPFFKEV 263

Query: 256 P 256
            
Sbjct: 264 D 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 5e-18
 Identities = 67/238 (28%), Positives = 97/238 (40%), Gaps = 47/238 (19%)

Query: 28  PNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE 86
           P + +L        YLY V EY    D A L+K       G   +++    +    L VE
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK-----TLGGLPEDWAKQYIAEVVLGVE 111

Query: 87  EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGT 146
           +                I RD+KP N+L+D  G  +K+  FGL+++      E+   VGT
Sbjct: 112 DLH----------QRGIIHRDIKPENLLIDQTGH-LKLTDFGLSRNGL----ENKKFVGT 156

Query: 147 HYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL------ITLGRIVGKS 200
             Y APE +LG+       D W +GC+  E + G P F  A +       I   RI    
Sbjct: 157 PDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPE 214

Query: 201 RKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA---AEALQQEYFKDV 255
               FC                P  +DLI+++L MDP KR+ A    E     +FK +
Sbjct: 215 EVKEFC---------------SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 80.2 bits (198), Expect = 6e-18
 Identities = 65/232 (28%), Positives = 98/232 (42%), Gaps = 27/232 (11%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E+  L  L HPNII            Y  F    N L   ++Y  +    Y         
Sbjct: 49  EIVILSLLQHPNIIAY----------YNHFM-DDNTLLIEMEYA-NGGTLYDKIVRQKGQ 96

Query: 78  LFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
           LF   +++       S+ S       + RD+K +NI +   G  +K+  FG++K L +  
Sbjct: 97  LFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEY 155

Query: 138 GESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV 197
             +   VGT YY +PEL  G+ +Y+   DIW +GC+  E+++ K  F   N L  + +IV
Sbjct: 156 SMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV 214

Query: 198 GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             +  P     S                I L+  +L  DP+KR TA E L Q
Sbjct: 215 QGNYTPVVSVYSS-------------ELISLVHSLLQQDPEKRPTADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.9 bits (197), Expect = 9e-18
 Identities = 68/256 (26%), Positives = 119/256 (46%), Gaps = 42/256 (16%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNG 67
           E V  ++ +E+  +  LNHP+IIR++    +  +     E+     +++LL         
Sbjct: 44  EEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-------- 95

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVA 125
                + ++         E+       R LS+    + I RD+K  N+L+D  G+ +++A
Sbjct: 96  ----KYGAFKEAVIINYTEQLL-----RGLSYLHENQIIHRDVKGANLLIDSTGQRLRIA 146

Query: 126 GFGLAKSLYAYKGESSAE-----VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
            FG A  L A KG  + E     +GT  + APE+L G  +Y  + D+W VGC+  EM + 
Sbjct: 147 DFGAAARLAA-KGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATA 204

Query: 181 KPLFPG---ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
           KP +     +N L  + +I   +  P     S+ +HL+   PGL     D+  + L + P
Sbjct: 205 KPPWNAEKHSNHLALIFKIASATTAP-----SIPEHLS---PGLR----DVTLRCLELQP 252

Query: 238 DKRITAAEALQQEYFK 253
           + R  + E L+   F+
Sbjct: 253 EDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.4 bits (194), Expect = 3e-17
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 33/228 (14%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNS 75
            E   L E NHP I++L R      Y+Y + EY +  +L  +L   +   + Y+ +    
Sbjct: 42  SEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTIL-RDRGLFDEYTAR---- 96

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              F    +V  F     +R +      I RDLKP N+L+D +G  VK+  FG AK L +
Sbjct: 97  ---FYIACVVLAFEYL-HNRGI------IYRDLKPENLLLDSNGY-VKLVDFGFAKKLKS 145

Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS--LITL 193
            +   +   GT  Y APE++L    Y  +VD W +G +  E+++G+P F   +   +   
Sbjct: 146 GQKTWTF-CGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY 203

Query: 194 GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
             I+  + K  F               ++ A  DLI ++L  +P++R+
Sbjct: 204 NDILKGNGKLEFPNY------------IDKAAKDLIKQLLRRNPEERL 239

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 78.3 bits (193), Expect = 4e-17
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 38/253 (15%)

Query: 8   MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
            + +  ++  E+  L +L+H NI++           Y  FE     L+  L+Y      G
Sbjct: 48  QKDMVKALRSEIETLKDLDHLNIVQ-----------YLGFETTEEYLSIFLEYVPGGSIG 96

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKT 121
              + +  +         E+     + + L  G  Y      + RDLK  N+LVD DG  
Sbjct: 97  SCLRTYGRFE--------EQLVRFFTEQVLE-GLAYLHSKGILHRDLKADNLLVDADG-I 146

Query: 122 VKVAGFGLAK-SLYAYKGESSAEV-GTHYYKAPELL-LGLLEYSTAVDIWPVGCIFGEMV 178
            K++ FG++K S   Y  + +  + G+ ++ APE++      YS  VDIW +GC+  EM 
Sbjct: 147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF 206

Query: 179 SGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD 238
           +G+  +    ++  + ++  K   P        D   N    L P  +D ++    ++PD
Sbjct: 207 AGRRPWSDEEAIAAMFKLGNKRSAPPIPP----DVSMN----LSPVALDFLNACFTINPD 258

Query: 239 KRITAAEALQQEY 251
            R TA E LQ  +
Sbjct: 259 NRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 76.8 bits (190), Expect = 2e-16
 Identities = 68/231 (29%), Positives = 96/231 (41%), Gaps = 45/231 (19%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFN 74
           + E   L  + HP ++ L         LY V EY    +L   L+          +  F 
Sbjct: 49  LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR---------KSGRFP 99

Query: 75  SY-SLFTT---FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
              + F      L +E   S D           + RDLKP N+L+D DG  +K+  FG A
Sbjct: 100 EPVARFYAAQVVLALEYLHSLD----------IVYRDLKPENLLLDSDGY-IKITDFGFA 148

Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
           K +   KG +    GT  Y APE++L    Y  AVD W +G +  EM++G P F   N +
Sbjct: 149 KRV---KGRTYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPI 204

Query: 191 ITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
               +I+ GK R PSF     +               DLI  +L +D  KR
Sbjct: 205 QIYEKILEGKVRFPSFFSPDAK---------------DLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.0 bits (187), Expect = 2e-16
 Identities = 70/253 (27%), Positives = 106/253 (41%), Gaps = 51/253 (20%)

Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
            ++ RE++ L EL H NI++ +  +    +L    EY           P  S+       
Sbjct: 51  DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEY----------VPGGSVAAL---- 96

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAG 126
            N+Y  F    LV  F      R +  G  Y      I RD+K  NILVD  G  +K++ 
Sbjct: 97  LNNYGAFEE-TLVRNFV-----RQILKGLNYLHNRGIIHRDIKGANILVDNKGG-IKISD 149

Query: 127 FGLAKSLYA------YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
           FG++K L A        G   +  G+ ++ APE++     Y+   DIW +GC+  EM++G
Sbjct: 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTG 208

Query: 181 KPLFPGANSLITLGRIVGKSRK--PSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD 238
           K  FP    L  + +I   +    PS       D L                K   +D +
Sbjct: 209 KHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFL---------------EKTFEIDHN 253

Query: 239 KRITAAEALQQEY 251
           KR TAAE L+  +
Sbjct: 254 KRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 74.9 bits (184), Expect = 6e-16
 Identities = 70/253 (27%), Positives = 99/253 (39%), Gaps = 41/253 (16%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKD 63
           +    +    +   E   L  L+HPNII       +   L  V EY           P  
Sbjct: 35  VEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA----------PGG 84

Query: 64  SMNGYSTKNFNSY-------SLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVD 116
           ++  Y  K  NS          F   LL      +            + RDLK  NIL+D
Sbjct: 85  TLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---------ILHRDLKTQNILLD 135

Query: 117 LDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGE 176
                VK+  FG++K L + K ++   VGT  Y +PEL  G   Y+   DIW +GC+  E
Sbjct: 136 KHKMVVKIGDFGISKIL-SSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYE 193

Query: 177 MVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD 236
           + S K  F  AN    L  +V K    +F  +S  D  +            LI  ML +D
Sbjct: 194 LASLKRAFEAAN----LPALVLKIMSGTFAPIS--DRYSPDLR-------QLILSMLNLD 240

Query: 237 PDKRITAAEALQQ 249
           P KR   ++ + Q
Sbjct: 241 PSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.6 bits (183), Expect = 1e-15
 Identities = 52/156 (33%), Positives = 74/156 (47%), Gaps = 25/156 (16%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  NIL+ +DG +VK+  FG    +   + + S  VGT Y+ APE++     Y  
Sbjct: 137 IHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKAYGP 194

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE- 222
            VDIW +G +  EMV G+P +   N L  L  I                  TNG P L+ 
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-----------------TNGTPELQN 237

Query: 223 -----PAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
                    D +++ L MD +KR +A E LQ  + K
Sbjct: 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 73.9 bits (182), Expect = 1e-15
 Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 32/230 (13%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKN 72
           +++ E   L ELNHP ++ L         +Y V +  +  DL Y L   K   +    K 
Sbjct: 46  NVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQVK- 103

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
                    F + E   + +   S       I RD+KP NIL+D  G  V +  F +A +
Sbjct: 104 ---------FWICEIVLALEYLHS----KGIIHRDIKPDNILLDEQGH-VHITDFNIA-T 148

Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT 192
                  +++  GT  Y APE+L     YS AVD W +G    E + GK  +        
Sbjct: 149 KVTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYR------- 200

Query: 193 LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP-AGIDLISKMLGMDPDKRI 241
                G SR       + ++     +P       ID I+K+L  DP KR+
Sbjct: 201 -----GHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRL 245

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 73.4 bits (181), Expect = 2e-15
 Identities = 55/147 (37%), Positives = 72/147 (48%), Gaps = 15/147 (10%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+KP N+L++  G+ VK+A FG++K L     + +  VGT  Y +PE + G   YS 
Sbjct: 122 IHRDIKPSNLLINSKGE-VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG-ESYSY 179

Query: 164 AVDIWPVGCIFGEMVSGK-P-LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
           A DIW +G    E   GK P L PG  S   L + +     P     SL     +     
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP-----SLPAEEFS----- 229

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQ 248
            P   D IS  L  DP KR +AAE LQ
Sbjct: 230 -PEFRDFISACLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 73.5 bits (181), Expect = 2e-15
 Identities = 67/270 (24%), Positives = 104/270 (38%), Gaps = 63/270 (23%)

Query: 8   MEGVPSSM---IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           +E   +S+    +EV  + + NHPN+++       G  L+ V  Y               
Sbjct: 36  LEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY--------------- 80

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLD 118
           ++G S  +    S     L  +E   +   + +  G  Y      I RD+K  NIL+  D
Sbjct: 81  LSGGSLLDIMKSSYPRGGL--DEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED 138

Query: 119 GKTVKVAGFGLAKSLYAYKGESSAE----VGTHYYKAPELLLGLLEYSTAVDIWPVGCIF 174
           G +VK+A FG++ SL      +       VGT  + APE++  +  Y    DIW  G   
Sbjct: 139 G-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITA 197

Query: 175 GEMVSGKPLF---PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE--------- 222
            E+ +G   +   P    L+                      L N  P LE         
Sbjct: 198 IELATGAAPYSKYPPMKVLMLT--------------------LQNDPPSLETGADYKKYS 237

Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
            +   +IS  L  DP KR TA E L+ ++F
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 73.7 bits (181), Expect = 2e-15
 Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 21/195 (10%)

Query: 14  SMIREVSCLME-LNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTK 71
            ++ EV+ + E L HPNI+R  +   +   LY V +  +   L       K+    ++ +
Sbjct: 54  DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE 113

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
               +++F   +L        + R L    R + RDL P NI++  D K V +  FGLAK
Sbjct: 114 RI--WNIFVQMVL--------ALRYLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFGLAK 162

Query: 132 SLYAYKGESS---AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
                K   S   + VGT  Y  PE++     Y    D+W  GCI  +M + +P F   N
Sbjct: 163 Q----KQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTN 217

Query: 189 SLITLGRIVGKSRKP 203
            L    +IV    +P
Sbjct: 218 MLSLATKIVEAVYEP 232

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 2e-15
 Identities = 71/247 (28%), Positives = 103/247 (41%), Gaps = 46/247 (18%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY--STKNF-N 74
           E   L E++HP IIRL        +LY + EY           P   +  Y  ++  F N
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY----------VPGGELFSYLRNSGRFSN 100

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           S  LF      E   + +   S       + RDLKP NIL+D +G  +K+  FG AK L 
Sbjct: 101 STGLFYA---SEIVCALEYLHSKEI----VYRDLKPENILLDKEGH-IKLTDFGFAKKL- 151

Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
             +  +    GT  Y APE ++    ++ AVD W +G +  EM+ G P F   N      
Sbjct: 152 --RDRTWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208

Query: 195 RIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAEALQ 248
           +I+ GK   P                 L+    DLI K+L +D  +R+      A +   
Sbjct: 209 KILAGKLEFPR---------------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253

Query: 249 QEYFKDV 255
             +FK V
Sbjct: 254 HRWFKSV 260

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 3e-15
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 17/152 (11%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  NILV   G  VK+  FG+A  L     + S  VGT Y+ APE++     Y T
Sbjct: 123 IHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSL--ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
             DIW +G    EM +G P +   ++   + L   + KS+ P   +L           G 
Sbjct: 182 KADIWSLGITIYEMATGNPPYSDVDAFRAMML---IPKSKPP---RLEDN--------GY 227

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
                + ++  L  +P +R++A E L+ ++ K
Sbjct: 228 SKLLREFVAACLDEEPKERLSAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 73.6 bits (180), Expect = 3e-15
 Identities = 66/245 (26%), Positives = 103/245 (42%), Gaps = 40/245 (16%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +I E+  + EL +PNI+  +     G  L+ V EY               + G S  +  
Sbjct: 63  IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY---------------LAGGSLTDVV 107

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           + +      +         +       + I RD+K  N+L+ +DG +VK+  FG    + 
Sbjct: 108 TETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQIT 166

Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
             + + S  VGT Y+ APE++     Y   VDIW +G +  EMV G+P +   N L  L 
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225

Query: 195 RIVGKSRKPSFCKLSLRDHLTNGFPGLE------PAGIDLISKMLGMDPDKRITAAEALQ 248
            I                  TNG P L+      P   D +++ L MD +KR +A E LQ
Sbjct: 226 LIA-----------------TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268

Query: 249 QEYFK 253
             + K
Sbjct: 269 HPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 72.5 bits (178), Expect = 4e-15
 Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 38/241 (15%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFN 74
           ++E+  L +L+HPN+I+ +    +   L  V E     DL+ ++K+ K        +   
Sbjct: 50  LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-----KRLIP 104

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
             +++  F+ +        S+      R + RD+KP N+ +   G  VK+   GL +   
Sbjct: 105 ERTIWKYFVQLCSALEHMHSK------RIMHRDIKPANVFITATGV-VKLGDLGLGRFFS 157

Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
           +    + + VGT YY +PE +     Y+   DIW +GC+  EM + +  F G        
Sbjct: 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD------- 209

Query: 195 RIVGKSRKPSFCKLSLRDHLTNG-FPGLEPAGI------DLISKMLGMDPDKRITAAEAL 247
               K    S CK      +    +P L PA        DL+S+ +  DP+KR   +  L
Sbjct: 210 ----KMNLYSLCK-----KIEKCDYPPL-PADHYSEELRDLVSRCINPDPEKRPDISYVL 259

Query: 248 Q 248
           Q
Sbjct: 260 Q 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 72.9 bits (179), Expect = 4e-15
 Identities = 50/150 (33%), Positives = 71/150 (47%), Gaps = 13/150 (8%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+  DG  VK++ FG    +        + VGT Y+ APE++   L Y T
Sbjct: 137 IHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPYGT 194

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VDIW +G +  EMV G+P +     L  + RI  +   P   K     +L    P L  
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI--RDNLPPKLK-----NLHKVSPRLR- 246

Query: 224 AGIDLISKMLGMDPDKRITAAEALQQEYFK 253
                + +ML  DP +R TAAE L   +  
Sbjct: 247 ---SFLDRMLVRDPAQRATAAELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 72.2 bits (178), Expect = 5e-15
 Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 43/197 (21%)

Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKD 63
            +  E      +RE   + +L+HPN+++L+ V ++   LY V EY    DL   L+  + 
Sbjct: 38  EDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP 97

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
            +   S  +  S++L               +R + +     +I RDL   N LV  +   
Sbjct: 98  KL---SLSDLLSFAL-------------QIARGMEYLESKNFIHRDLAARNCLVG-ENLV 140

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYK-----------APELLLGLLEYSTAVDIWPV 170
           VK++ FGL++ LY             YY+           APE L    ++++  D+W  
Sbjct: 141 VKISDFGLSRDLYDDD----------YYRKRGGKLPIRWMAPESLK-EGKFTSKSDVWSF 189

Query: 171 GCIFGEMVS-GKPLFPG 186
           G +  E+ + G+  +PG
Sbjct: 190 GVLLWEIFTLGEQPYPG 206

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 72.2 bits (178), Expect = 5e-15
 Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 48/221 (21%)

Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
            +  E      +RE   + +L+HPNI++L+ V ++   L  V EY               
Sbjct: 38  EDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY--------------- 82

Query: 65  MNGYSTKNF---NSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDG 119
           M G    ++   N     +   L+  F+    +R + +     +I RDL   N LV  + 
Sbjct: 83  MPGGDLLDYLRKNRPKELSLSDLLS-FAL-QIARGMEYLESKNFIHRDLAARNCLVG-EN 139

Query: 120 KTVKVAGFGLAKSLYAYKGESSAEVGTHYYK-----------APELLLGLLEYSTAVDIW 168
             VK++ FGL++ LY             YYK           APE L    ++++  D+W
Sbjct: 140 LVVKISDFGLSRDLYDDD----------YYKVKGGKLPIRWMAPESLK-EGKFTSKSDVW 188

Query: 169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSR--KPSFC 206
             G +  E+ + G+  +PG ++   L  +    R  KP  C
Sbjct: 189 SFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC 229

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 72.4 bits (177), Expect = 6e-15
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 25/156 (16%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  NIL+ +DG +VK+  FG    +   + + S  VGT Y+ APE++     Y  
Sbjct: 138 IHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKAYGP 195

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE- 222
            VDIW +G +  EM+ G+P +   N L  L  I                  TNG P L+ 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-----------------TNGTPELQN 238

Query: 223 PAGI-----DLISKMLGMDPDKRITAAEALQQEYFK 253
           P  +     D +++ L MD +KR +A E LQ ++ K
Sbjct: 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 71.8 bits (176), Expect = 7e-15
 Identities = 59/235 (25%), Positives = 85/235 (36%), Gaps = 29/235 (12%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFN 74
           I E   L +L+   IIR          L  V EY  N DL  LLK       G       
Sbjct: 47  IDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLK----MQRGRPLPEDQ 102

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
            +  F   LL      S          + + RD+K +N+ +D     VK+   G+AK L 
Sbjct: 103 VWRFFIQILLGLAHLHSK---------KILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLS 152

Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
                ++  VGT YY +PEL      Y+   D+W +G +  E  +GK  F   N    + 
Sbjct: 153 DNTNFANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL 211

Query: 195 RIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
           +I+     P     S                  LI + L  D  +R    + L+ 
Sbjct: 212 KIIRGVFPPVSQMYS-------------QQLAQLIDQCLTKDYRQRPDTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.1 bits (176), Expect = 1e-14
 Identities = 53/156 (33%), Positives = 76/156 (48%), Gaps = 25/156 (16%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  NIL+ +DG +VK+  FG    +   + + S  VGT Y+ APE++     Y  
Sbjct: 137 IHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKAYGP 194

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE- 222
            VDIW +G +  EMV G+P +   N L  L  I                  TNG P L+ 
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-----------------TNGTPELQN 237

Query: 223 PAGI-----DLISKMLGMDPDKRITAAEALQQEYFK 253
           P  +     D +++ L MD D+R +A E LQ  + K
Sbjct: 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 8e-14
 Identities = 41/154 (26%), Positives = 66/154 (42%), Gaps = 17/154 (11%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGL 158
             + RD+K  NIL D  G  VK+  FG +K L           +  GT Y+ +PE++ G 
Sbjct: 124 MIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
             Y    D+W VGC   EM++ KP  P A     +  I   + +P+  +L          
Sbjct: 183 -GYGRKADVWSVGCTVVEMLTEKP--PWAE-FEAMAAIFKIATQPTNPQLP--------- 229

Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
             + P   + + +    +  KR +A E L+  + 
Sbjct: 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 68.6 bits (168), Expect = 9e-14
 Identities = 61/235 (25%), Positives = 95/235 (40%), Gaps = 31/235 (13%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKN-F 73
           + E+  L  +NHPNII        G  L  V EY    DL+  +            +   
Sbjct: 47  VNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAIS------KRKKKRKLI 100

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
               ++  F+ +     +   + +      + RDLK  NIL+ +    VK+   G++K L
Sbjct: 101 PEQEIWRIFIQLLRGLQALHEQKI------LHRDLKSANILL-VANDLVKIGDLGISKVL 153

Query: 134 YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITL 193
              K  +  ++GT +Y APE+  G   YS   DIW +GC+  EM +  P F  A S+  L
Sbjct: 154 K--KNMAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDL 209

Query: 194 GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              V + + P    +  +D L N            I  ML + P  R    + L 
Sbjct: 210 RYKVQRGKYPPIPPIYSQD-LQN-----------FIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.9 bits (169), Expect = 1e-13
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 23/158 (14%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  N+L+D +G  VK+A FGL K    +   +S   GT  + APE+L     Y+ 
Sbjct: 123 VYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTR 180

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG-KSRKPSFCKLSLRDHLTNGFPGLE 222
           AVD W +G +  EM+ G+  FPG +       IV  + R P F               L 
Sbjct: 181 AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF---------------LS 225

Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
              I ++ ++L  +P++R+      A +  +Q +F+D+
Sbjct: 226 REAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.5 bits (167), Expect = 1e-13
 Identities = 45/149 (30%), Positives = 74/149 (49%), Gaps = 13/149 (8%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+ LDG+ VK++ FG    +     +  + VGT Y+ APE++     Y T
Sbjct: 139 IHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-YGT 196

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VDIW +G +  EMV G+P +   + +  + R+  +   P   K + +         + P
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--RDSPPPKLKNAHK---------ISP 245

Query: 224 AGIDLISKMLGMDPDKRITAAEALQQEYF 252
              D + +ML  +P +R TA E L   + 
Sbjct: 246 VLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 67.6 bits (166), Expect = 3e-13
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 38/210 (18%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKDSMNGYSTKN 72
            ++E   + +L HPN++RL+ V ++   LY V EY    DL  YL K     +     K+
Sbjct: 43  FLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRK--SRPVFPSPEKS 100

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
             S     +F +         ++ + +    +++ RDL   N LV  +   VK++ FGL+
Sbjct: 101 TLSLKDLLSFAI-------QIAKGMEYLASKKFVHRDLAARNCLVG-EDLVVKISDFGLS 152

Query: 131 KSLYAYKGESSAEVGTHYYK-----------APELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           + +Y            +Y K           APE L   + +++  D+W  G +  E+ +
Sbjct: 153 RDVYDDD---------YYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFT 202

Query: 180 -GKPLFPGANSLITLGRIVGKSR--KPSFC 206
            G   +PG ++   L  +    R  KP +C
Sbjct: 203 LGATPYPGLSNEEVLEYLRKGYRLPKPEYC 232

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.9 bits (166), Expect = 3e-13
 Identities = 63/230 (27%), Positives = 91/230 (39%), Gaps = 45/230 (19%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-----NDLAYLLKYPKDSMNGYSTKN 72
           E S LMEL+HP I+ +M        +Y + E+ V       L    ++P D    Y  + 
Sbjct: 68  EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE- 126

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
                     L  E   S D           I RDLKP N+L+D  G  VKV  FG AK 
Sbjct: 127 --------LVLAFEYLHSKD----------IIYRDLKPENLLLDNKGH-VKVTDFGFAKK 167

Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT 192
           +      +    GT  Y APE++     +  AVD W +G +  E ++G P F        
Sbjct: 168 V---PDRTFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223

Query: 193 LGRI-VGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
             +I  G+ + P++     R               DL+  +L  D  KR+
Sbjct: 224 YEKILAGRLKFPNWFDGRAR---------------DLVKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 66.8 bits (164), Expect = 5e-13
 Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 45/180 (25%)

Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAY--LLKYPK 62
               E      + E S + +L+HPNI+RL+ V +QG  LY V EY    +    LL + +
Sbjct: 38  EGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEY----MPGGDLLDFLR 93

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGK 120
                 + K+    +L               ++ + +     ++ RDL   N LV  +  
Sbjct: 94  KHGEKLTLKDLLQMAL-------------QIAKGMEYLESKNFVHRDLAARNCLVT-ENL 139

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APELLLGLLEYSTAVDIW 168
            VK++ FGL++ +Y             YY+            APE L    ++++  D+W
Sbjct: 140 VVKISDFGLSRDIY----------EDDYYRKRGGGKLPIKWMAPESLKD-GKFTSKSDVW 188

Length = 258

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 68.2 bits (166), Expect = 5e-13
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 53/215 (24%)

Query: 13  SSMIREVSCLMELNHPNIIR----LMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           S ++ EV+ + EL H NI+R     +  A+Q +Y+   F     DL+             
Sbjct: 57  SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEF-CDAGDLSR------------ 103

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF-------------GTRYIRRDLKPVNILV 115
                N    +  F  +EE +  D +R L               G R + RDLKP NI +
Sbjct: 104 -----NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158

Query: 116 ---------------DLDGKTV-KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
                          +L+G+ + K+  FGL+K++   +  + + VGT YY +PELLL   
Sbjct: 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI-GIESMAHSCVGTPYYWSPELLLHET 217

Query: 160 E-YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITL 193
           + Y    D+W +GCI  E+ SGK  F  AN+   L
Sbjct: 218 KSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252

Length = 1021

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 66.1 bits (162), Expect = 6e-13
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 25/157 (15%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + I RD+K  NIL++ +G   K+A FG++  L     + +  +GT ++ APE++   + Y
Sbjct: 119 KKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGY 176

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
           +   DIW +G    EM  GKP +   + +  +  I   ++ P               P L
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PNKPP---------------PTL 219

Query: 222 E------PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                  P   D + K L  DP++R +A + LQ  + 
Sbjct: 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (163), Expect = 7e-13
 Identities = 48/139 (34%), Positives = 67/139 (48%), Gaps = 18/139 (12%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NIL+D  G  + +  FGL K       +++   GT  Y APELLLG   Y+ 
Sbjct: 115 IYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH-GYTK 172

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           AVD W +G +  EM++G P F   N                  +  L++ L   FP G +
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENV-------------NEMYRKILQEPLR--FPDGFD 217

Query: 223 PAGIDLISKMLGMDPDKRI 241
               DL+  +L  DP +R+
Sbjct: 218 RDAKDLLIGLLSRDPTRRL 236

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 66.4 bits (162), Expect = 7e-13
 Identities = 51/164 (31%), Positives = 72/164 (43%), Gaps = 28/164 (17%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           R + RDLKP N+L+D  G  V+++  GLA  L   K +     GT  Y APE+L G   Y
Sbjct: 115 RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGK-KIKGRAGTPGYMAPEVLQG-EVY 171

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-- 219
             +VD + +GC   EM++G+  F              + RK    K  L    T      
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF--------------RQRKEKVEKEEL-KRRTLEMAVE 216

Query: 220 ---GLEPAGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
                 P   DL   +L  DP+KR+     +A E  +   FKD+
Sbjct: 217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.7 bits (163), Expect = 7e-13
 Identities = 53/155 (34%), Positives = 74/155 (47%), Gaps = 24/155 (15%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL--GLLEY 161
           I RDLKP NIL+D  G  VK+  FGL K        +    GT  Y APE+L+  G   +
Sbjct: 122 IYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG---H 177

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
             AVD W +G +  +M++G P F   N   T+ +I+         KL+L  +LT      
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK-------GKLNLPPYLT------ 224

Query: 222 EPAGIDLISKMLGMDPDKRITA----AEALQQEYF 252
            P   DL+ K+L  +P  R+ A    A  +Q   F
Sbjct: 225 -PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 64.6 bits (158), Expect = 3e-12
 Identities = 46/156 (29%), Positives = 69/156 (44%), Gaps = 23/156 (14%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+KP NILV+  G  +K+  FG++  L     ++   VGT  Y APE + G  +YS 
Sbjct: 123 IHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAKTF--VGTSSYMAPERIQG-NDYSV 178

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
             DIW +G    E+ +G+  FP          I             L  ++ N  P   P
Sbjct: 179 KSDIWSLGLSLIELATGR--FPYPPENDPPDGI-----------FELLQYIVNEPPPRLP 225

Query: 224 AGI------DLISKMLGMDPDKRITAAEALQQEYFK 253
           +G       D ++  L  DP +R +  E L+  + K
Sbjct: 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 64.6 bits (157), Expect = 3e-12
 Identities = 48/151 (31%), Positives = 66/151 (43%), Gaps = 18/151 (11%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           R + RDLK  NI   L    +K+  FG+++ L      ++   GT YY +PE L     Y
Sbjct: 126 RILHRDLKAKNIF--LKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL-KHQGY 182

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
            +  DIW +GCI  EM      F G N L  + RIV +   PS              P  
Sbjct: 183 DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPS-------------LPET 228

Query: 222 EPAGIDLI-SKMLGMDPDKRITAAEALQQEY 251
               ++ I   ML  DP  R +AAE L+  +
Sbjct: 229 YSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 23/158 (14%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G  +K+A FG+ K        +S   GT  Y APE+L     Y  
Sbjct: 118 IYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ-PYGP 175

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKS-RKPSFCKLSLRDHLTNGFPGLE 222
           AVD W +G +  EM++G+  F G +       I+    R P +               L 
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW---------------LS 220

Query: 223 PAGIDLISKMLGMDPDKRI----TAAEALQQE-YFKDV 255
                ++   L  +P+KR+    T  + ++   +F+++
Sbjct: 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 64.3 bits (156), Expect = 4e-12
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 26/227 (11%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFN 74
           ++E+  L +LNHPN+I+ +    +   L  V E     DL+ ++KY K        +   
Sbjct: 50  VKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
            Y        V+  S+ +   S     R + RD+KP N+ +   G  VK+   GL +   
Sbjct: 110 KY-------FVQLCSAVEHMHS----RRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157

Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITL 193
           +    + + VGT YY +PE  +    Y+   DIW +GC+  EM +   P +    +L +L
Sbjct: 158 SKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216

Query: 194 GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
            + + +   P        +H +           +L+S  +  DPD+R
Sbjct: 217 CQKIEQCDYPPLPT----EHYSEKLR-------ELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 64.1 bits (156), Expect = 6e-12
 Identities = 66/257 (25%), Positives = 101/257 (39%), Gaps = 69/257 (26%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYL-----YPVFEYQVNDLAYLLKYPKDSMNGYS 69
           +I+EV  L +L HPN I       +G YL     + V EY +   + +L+  K  +    
Sbjct: 62  IIKEVRFLQQLRHPNTIEY-----KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQ--- 113

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVK 123
                           E   ++    +L  G  Y      I RD+K  NIL+   G TVK
Sbjct: 114 ----------------EVEIAAICHGALQ-GLAYLHSHERIHRDIKAGNILLTEPG-TVK 155

Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--YSTAVDIWPVG--CIFGEMVS 179
           +A FG A    +    +++ VGT Y+ APE++L + E  Y   VD+W +G  CI  E+  
Sbjct: 156 LADFGSA----SLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAE 209

Query: 180 GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAG-----IDLISKMLG 234
            KP     N++  L  I                   N  P L          + +   L 
Sbjct: 210 RKPPLFNMNAMSALYHIA-----------------QNDSPTLSSNDWSDYFRNFVDSCLQ 252

Query: 235 MDPDKRITAAEALQQEY 251
             P  R ++ E L+  +
Sbjct: 253 KIPQDRPSSEELLKHRF 269

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 6e-12
 Identities = 50/158 (31%), Positives = 71/158 (44%), Gaps = 20/158 (12%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--- 160
           I RDLK  NIL+ LDG  VK+A FG++    +   +    +GT Y+ APE++    E   
Sbjct: 125 IHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV--ACETFK 181

Query: 161 ---YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG 217
              Y    DIW +G    E+   +P     N +  L +I+ KS  P    L      ++ 
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEPP---TLDQPSKWSSS 237

Query: 218 FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           F        D +   L  DPD R TAAE L+  +  D 
Sbjct: 238 FN-------DFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 63.0 bits (153), Expect = 1e-11
 Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 24/169 (14%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           I E   +M+L+H  +++L  V ++   +Y V EY  N    LL Y ++            
Sbjct: 47  IEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN--GCLLNYLREHGKR-------- 96

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
              F    L+E     D    +++    ++I RDL   N LVD  G  VKV+ FGL++  
Sbjct: 97  ---FQPSQLLE--MCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSR-- 148

Query: 134 YAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           Y    E ++ VG+ +   +  PE+LL   ++S+  D+W  G +  E+ S
Sbjct: 149 YVLDDEYTSSVGSKFPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 13/150 (8%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+  DG+ +K++ FG    +     +  + VGT Y+ APE++   L Y T
Sbjct: 140 IHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRLPYGT 197

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VDIW +G +  EM+ G+P +     L  + RI   +  P          +  GF     
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-RDNLPPRVKDSHKVSSVLRGF----- 251

Query: 224 AGIDLISKMLGMDPDKRITAAEALQQEYFK 253
             +DL   ML  +P +R TA E LQ  + K
Sbjct: 252 --LDL---MLVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 62.5 bits (152), Expect = 1e-11
 Identities = 69/259 (26%), Positives = 104/259 (40%), Gaps = 50/259 (19%)

Query: 11  VPSSMIREVSCLME-------LNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYP 61
           +P    R V  L E       L H NI++ +   S+  + + +F  QV    L+ LL+  
Sbjct: 41  IPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF-FKIFMEQVPGGSLSALLR-- 97

Query: 62  KDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILV 115
             S  G    N  +   +T  +L               G +Y      + RD+K  N+LV
Sbjct: 98  --SKWGPLKDNEQTIIFYTKQILE--------------GLKYLHDNQIVHRDIKGDNVLV 141

Query: 116 DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL-LGLLEYSTAVDIWPVGCIF 174
           +     VK++ FG +K L      +    GT  Y APE++  G   Y    DIW +GC  
Sbjct: 142 NTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTI 201

Query: 175 GEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL--SLRDHLTNGFPGLEPAGIDLISKM 232
            EM +GKP F      I LG       K    K+   + + L+           + I + 
Sbjct: 202 VEMATGKPPF------IELGEPQAAMFKVGMFKIHPEIPESLSA-------EAKNFILRC 248

Query: 233 LGMDPDKRITAAEALQQEY 251
              DPDKR +A + LQ  +
Sbjct: 249 FEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+  DG+ VK++ FG    +        + VGT Y+ APEL+   L Y  
Sbjct: 138 IHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPYGP 195

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VDIW +G +  EMV G+P +     L  + +++  +  P    L        GF     
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNLPPKLKNLHKVSPSLKGF----- 249

Query: 224 AGIDLISKMLGMDPDKRITAAEALQQEYF 252
                + ++L  DP +R TAAE L+  + 
Sbjct: 250 -----LDRLLVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.5 bits (152), Expect = 2e-11
 Identities = 45/142 (31%), Positives = 63/142 (44%), Gaps = 16/142 (11%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NIL+D  G  V +  FGL K    +   +S   GT  Y APE+L     Y  
Sbjct: 118 IYRDLKPENILLDSQGHVV-LTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDR 175

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VD W +G +  EM+ G P F   ++      I+ K        L L+       P +  
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-------LRLK-------PNISV 221

Query: 224 AGIDLISKMLGMDPDKRITAAE 245
           +   L+  +L  D  KR+ A +
Sbjct: 222 SARHLLEGLLQKDRTKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.5 bits (152), Expect = 2e-11
 Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 17/153 (11%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D DG  +K+A FG+ K     +G++S   GT  Y APE+L G   Y+ 
Sbjct: 118 IYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNE 175

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           +VD W  G +  EM+ G+  F G +       I   + +P F +             +  
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--LNDRPHFPRW------------ISK 221

Query: 224 AGIDLISKMLGMDPDKRI-TAAEALQQEYFKDV 255
              D +SK+   DP KR+    +  Q  +F+ +
Sbjct: 222 EAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 3e-11
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 14/152 (9%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
             I RD+K  NIL+  +G  VK+A FG++  L +   + +  VGT ++ APE++     Y
Sbjct: 118 GKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS-GY 175

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
               DIW +G    E+  G+P     + +  L  I  K+  P     SL  +        
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPP-----SLEGN------KF 223

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
                D +S  L  DP +R +A E L+ ++ K
Sbjct: 224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 3e-11
 Identities = 65/246 (26%), Positives = 102/246 (41%), Gaps = 43/246 (17%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGYSTKN 72
           +E+S L E  HPNI+       +   L+ V EY     + D+  + + P           
Sbjct: 49  QEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP----------- 97

Query: 73  FNSYSLFTTFLLVEE---FSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGF 127
                      L E    +   ++ + L++   T  I RD+K  NIL+  DG  VK+A F
Sbjct: 98  -----------LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD-VKLADF 145

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--YSTAVDIWPVGCIFGEMVSGKPLFP 185
           G++  L A   +  + +GT Y+ APE+     +  Y    DIW +G    E+   +P   
Sbjct: 146 GVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205

Query: 186 GANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE 245
             + +  L  I   +  P   KL  ++  +  F        D I K L  DP KR TA +
Sbjct: 206 DLHPMRALFLISKSNFPPP--KLKDKEKWSPVF-------HDFIKKCLTKDPKKRPTATK 256

Query: 246 ALQQEY 251
            LQ  +
Sbjct: 257 LLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 60.8 bits (147), Expect = 9e-11
 Identities = 35/83 (42%), Positives = 49/83 (59%), Gaps = 2/83 (2%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  NIL+D DG  +K+A FG+ K       ++    GT  Y APE+LLG  +Y+T
Sbjct: 118 VYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNT 175

Query: 164 AVDIWPVGCIFGEMVSGKPLFPG 186
           +VD W  G +  EM+ G+  F G
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 4/103 (3%)

Query: 88  FSSSDSSRSLSFGTRY--IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG 145
           F +++ + +L F  R+  I RDLK  NIL+D +G   K+A FG+ K        ++   G
Sbjct: 100 FYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCG 158

Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           T  Y APE+L  L EY  +VD W +G +  EM++G+P F   N
Sbjct: 159 TPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.0 bits (145), Expect = 1e-10
 Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 12/169 (7%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFN 74
           ++E+  +  L +PNIIRL+ V      L  + EY  N DL   L   +         N  
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 75  SYSLFTTFLLVEEFSSS-DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
           S S+     +  + +S      SL+F    + RDL   N LV  +  T+K+A FG++++L
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNF----VHRDLATRNCLVG-NHYTIKIADFGMSRNL 179

Query: 134 YA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           Y+   Y+ +  A +   +     +LLG  +++TA D+W  G    EM +
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 60/255 (23%), Positives = 100/255 (39%), Gaps = 52/255 (20%)

Query: 9   EGVPSS--MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVND--LAYLLKYPKDS 64
           EG  S    I E   +M+L+HPN+++L  V ++   ++ V EY  N   L YL +     
Sbjct: 38  EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-- 95

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDLDGKTV 122
                           T  L++    SD   ++ +     +I RDL   N LV  D   V
Sbjct: 96  -------------KLGTEWLLD--MCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VV 139

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           KV+ FGLA+  Y    + ++  GT +   +  PE+      +S+  D+W  G +  E+ S
Sbjct: 140 KVSDFGLAR--YVLDDQYTSSQGTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVLMWEVFS 196

Query: 180 GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF----PGLEPAGI-DLISKMLG 234
                             GK     F    + + ++ G+    P L P  +  ++     
Sbjct: 197 E-----------------GKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWH 239

Query: 235 MDPDKRITAAEALQQ 249
             P+ R    + L Q
Sbjct: 240 EKPEDRPAFKKLLSQ 254

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.5 bits (144), Expect = 2e-10
 Identities = 50/164 (30%), Positives = 73/164 (44%), Gaps = 21/164 (12%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           R I RDLKP N+L+D DG  V+++  GLA  L   + ++    GT  + APELL G  EY
Sbjct: 117 RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEY 174

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG-KSRKPSFCKLSLRDHLTNGFP- 219
             +VD + +G    EM++ +  F          R  G K       +  L D +T  +P 
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF----------RARGEKVENKELKQRILNDSVT--YPD 222

Query: 220 GLEPAGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDVPGR 258
              PA       +L  DP+KR+               F+D+  R
Sbjct: 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 49/149 (32%), Positives = 70/149 (46%), Gaps = 21/149 (14%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLL-GLLEY 161
           I RD+K  NIL+D +G  V +  FGL+K   A + E +    GT  Y APE++  G   +
Sbjct: 127 IYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185

Query: 162 STAVDIWPVGCIFGEMVSGKPLFP---GANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
             AVD W +G +  E+++G   F      NS   + R + KS+ P              F
Sbjct: 186 DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--------------F 231

Query: 219 PG-LEPAGIDLISKMLGMDPDKRITAAEA 246
           P  +     D I K+L  DP KR+ A  A
Sbjct: 232 PKTMSAEARDFIQKLLEKDPKKRLGANGA 260

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 39/109 (35%), Positives = 51/109 (46%), Gaps = 7/109 (6%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEY 161
           Y+ RD+KP N+L+D  G  +K+A FG A  L A K   S   VGT  Y APE+L  +   
Sbjct: 123 YVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181

Query: 162 STAV-----DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF 205
                    D W +G I  EM+ G+  F    S  T   I+   R   F
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKF 230

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.2 bits (143), Expect = 3e-10
 Identities = 34/83 (40%), Positives = 48/83 (57%), Gaps = 2/83 (2%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+++D DG  +K+A FG+ K        +S   GT  Y APE+L G L+Y+ 
Sbjct: 118 IYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG-LKYTF 175

Query: 164 AVDIWPVGCIFGEMVSGKPLFPG 186
           +VD W  G +  EM+ G+  F G
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 58.5 bits (141), Expect = 3e-10
 Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 14/172 (8%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFN 74
           I+E+  L +LNHPN+I+      +   L  V E     DL+ ++K+ K        K   
Sbjct: 50  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
            Y        V+  S+ +   S     R + RD+KP N+ +   G  VK+   GL +   
Sbjct: 110 KY-------FVQLCSALEHMHS----RRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157

Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           +    + + VGT YY +PE  +    Y+   DIW +GC+  EM + +  F G
Sbjct: 158 SKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 5e-10
 Identities = 53/199 (26%), Positives = 77/199 (38%), Gaps = 64/199 (32%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSL----------------------YAYKGES 140
           YI RD+KP N+L+D  G  +K++ FGL   L                      +  K  S
Sbjct: 122 YIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 141 SAE----------------VGTHYYKAPELLL--GLLEYSTAVDIWPVGCIFGEMVSGKP 182
           S                  VGT  Y APE+ L  G   Y+   D W +G I  EM+ G P
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG---YNKECDWWSLGVIMYEMLVGYP 237

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP---GLEPAGIDLISKMLGMDPDK 239
            F   N   T  +I+         K +L+      FP    L P   DLI ++   + ++
Sbjct: 238 PFCSDNPQETYRKIIN-------WKETLQ------FPDEVPLSPEAKDLIKRLC-CEAER 283

Query: 240 RI--TAAEALQQE-YFKDV 255
           R+       ++   +FK V
Sbjct: 284 RLGNNGVNEIKSHPFFKGV 302

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (142), Expect = 6e-10
 Identities = 55/189 (29%), Positives = 75/189 (39%), Gaps = 53/189 (28%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSL-------------------------YAYK 137
            + RDLKP NIL+   G  + ++ F L+K                             + 
Sbjct: 124 IVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 138 GESSAE----VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITL 193
            E S      VGT  Y APE++ G   + +AVD W +G +  EM+ G   F G+N   T 
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241

Query: 194 GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGI---DLISKMLGMDPDKRI----TAAEA 246
             I+ K                  FPG  P      DLI K+L  DP KR+     AAE 
Sbjct: 242 SNILKKEVT---------------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286

Query: 247 LQQEYFKDV 255
            Q  +F+ V
Sbjct: 287 KQHPFFRGV 295

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 58.1 bits (140), Expect = 8e-10
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 21/170 (12%)

Query: 42  YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFG 100
           YLY V +Y V  DL  LL   +D +     +          F + E   +  S   L   
Sbjct: 75  YLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----------FYIAEMVLAIHSIHQL--- 121

Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFG-LAKSLYAYKGESSAEVGTHYYKAPELLL--- 156
             Y+ RD+KP N+L+D++G  +++A FG   K       +SS  VGT  Y +PE+L    
Sbjct: 122 -HYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179

Query: 157 -GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF 205
            G+ +Y    D W +G    EM+ G+  F   + + T G+I+    +  F
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 229

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 57.7 bits (139), Expect = 9e-10
 Identities = 68/252 (26%), Positives = 109/252 (43%), Gaps = 44/252 (17%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYL-----YPVFEYQVNDLAYLLKYPKDSMNGYS 69
           +I+EV  L +L HPN I       +G YL     + V EY +   + LL+  K  +    
Sbjct: 68  IIKEVKFLQQLKHPNTIEY-----KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVE 122

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
                  +L     L         S ++      I RD+K  NIL+   G+ VK+A FG 
Sbjct: 123 IAAITHGALQGLAYL--------HSHNM------IHRDIKAGNILLTEPGQ-VKLADFGS 167

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLE--YSTAVDIWPVGCIFGEMVSGKPLFPGA 187
           A    +    +++ VGT Y+ APE++L + E  Y   VD+W +G    E+   KP     
Sbjct: 168 A----SKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223

Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
           N++  L  I  ++  P+       +  T+ F G        +   L   P +R  +AE L
Sbjct: 224 NAMSALYHI-AQNDSPTL----QSNEWTDSFRG-------FVDYCLQKIPQERPASAELL 271

Query: 248 QQEYF-KDVPGR 258
           + ++  +D P R
Sbjct: 272 RHDFVRRDRPAR 283

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 47/142 (33%), Positives = 66/142 (46%), Gaps = 16/142 (11%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  V +  FGL K    + G +S   GT  Y APE+L     Y  
Sbjct: 118 VYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ-PYDR 175

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VD W +G +  EM+ G P F   N+      I+ K        L L+ ++TN       
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------LQLKPNITN------- 221

Query: 224 AGIDLISKMLGMDPDKRITAAE 245
           +   L+  +L  D  KR+ A +
Sbjct: 222 SARHLLEGLLQKDRTKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 59/243 (24%), Positives = 100/243 (41%), Gaps = 40/243 (16%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFNS 75
           +EV  L ++ HPNI+       +   L+ V EY    DL   +   +  +       F+ 
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVL-------FSE 100

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTVKVAGFGL 129
             + + F+             +S G ++I       RD+K  NI +  +G   K+  FG+
Sbjct: 101 DQILSWFV------------QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGI 148

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
           A+ L      +   VGT YY +PE+      Y+   DIW +GC+  E+ + K  F G N 
Sbjct: 149 ARQLNDSMELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNN- 206

Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
              L ++V K  +  F  +S         P        LIS++  + P  R +    L++
Sbjct: 207 ---LHQLVLKICQGYFAPIS---------PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254

Query: 250 EYF 252
            + 
Sbjct: 255 PFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 53/203 (26%), Positives = 80/203 (39%), Gaps = 17/203 (8%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE-YQVNDLAYLLKYPK 62
           + +          +EV  L  L H ++I L  V S G  +Y + E  +   L   L+ P+
Sbjct: 38  LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTV 122
                   +     SL      V E  +    +        I RDL   NILV  +    
Sbjct: 98  G-------QVLPVASLIDMACQVAEGMAYLEEQ------NSIHRDLAARNILVG-EDLVC 143

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GK 181
           KVA FGLA+ +      SS +   + + APE       +ST  D+W  G +  EM + G+
Sbjct: 144 KVADFGLARLIKEDVYLSSDKKIPYKWTAPE-AASHGTFSTKSDVWSFGILLYEMFTYGQ 202

Query: 182 PLFPGANSLITLGRIVGKSRKPS 204
             +PG N+     +I    R P 
Sbjct: 203 VPYPGMNNHEVYDQITAGYRMPC 225

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 17/158 (10%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYS 162
           + RD+K  NIL+D +G  V +  FGL+K   + + E +    GT  Y APE++ G   + 
Sbjct: 127 VYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185

Query: 163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE 222
            AVD W +G +  E+++G   F       T   +   SR+   C              + 
Sbjct: 186 KAVDWWSLGILIFELLTGASPFTLEGERNTQSEV---SRRILKCDPPFP-------SFIG 235

Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQE-----YFKDV 255
           P   DL+ K+L  DP KR+ A      E     +FK +
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 16/173 (9%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFNS 75
           +EV+ L  + HPNI++      +   LY V +Y +  DL             Y   N   
Sbjct: 48  KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL-------------YKKINAQR 94

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
             LF    +++ F     +       + + RD+K  NI +  DG T+K+  FG+A+ L +
Sbjct: 95  GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNS 153

Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
               +   +GT YY +PE+      Y+   DIW +GC+  EM + K  F   N
Sbjct: 154 TVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.5 bits (136), Expect = 2e-09
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 25/159 (15%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLL-GLLEY 161
           I RD+K  NIL+D +G  V +  FGL+K  +  + E +    GT  Y AP+++  G   +
Sbjct: 127 IYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185

Query: 162 STAVDIWPVGCIFGEMVSGKPLFP---GANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
             AVD W +G +  E+++G   F      NS   + R + KS  P              +
Sbjct: 186 DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--------------Y 231

Query: 219 PG-LEPAGIDLISKMLGMDPDKRI----TAAEALQQEYF 252
           P  +     D+I ++L  DP KR+    + A+ +++  F
Sbjct: 232 PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.7 bits (137), Expect = 2e-09
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 25/159 (15%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  N+++D DG  +K+  FGL K   +         GT  Y APE+L    +Y  
Sbjct: 117 VYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGR 174

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGA--NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
           AVD W +G +  EM+ G+  F       L  L  ++ + R P                 L
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-ILMEEIRFPR---------------TL 218

Query: 222 EPAGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
            P    L++ +L  DP +R+      A E ++  +F  +
Sbjct: 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (136), Expect = 2e-09
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 20/157 (12%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  + +  FGL+K+       ++   GT  Y APE+LL    Y+ 
Sbjct: 118 VYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176

Query: 164 AVDIWPVGCIFGEMVSG-KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE 222
            VD W +G +  EM  G  P +      +      GK R P       ++ L       E
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-------KNVL-----SDE 224

Query: 223 PAGIDLISKMLGMDPDKRITA---AEALQQE-YFKDV 255
             G   +  +L  +P  R+ A   A  L++  +F D+
Sbjct: 225 --GRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 55.8 bits (134), Expect = 3e-09
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 17/174 (9%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFNS 75
           +E   L ++ HPNI+          +LY V EY    DL   +K  +             
Sbjct: 47  KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGK----------- 95

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
             LF    +++ F             R + RD+K  NI +  +GK VK+  FG A+ L +
Sbjct: 96  --LFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK-VKLGDFGSARLLTS 152

Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
               +   VGT YY  PE+   +  Y+   DIW +GCI  E+ + K  F  ANS
Sbjct: 153 PGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQ-ANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 65/246 (26%), Positives = 98/246 (39%), Gaps = 36/246 (14%)

Query: 7   TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMN 66
           TM+  P   + E   + +L HP +I+L  V +    +Y V E        L+KY   S+ 
Sbjct: 42  TMD--PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE--------LMKY--GSLL 89

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAG 126
            Y               L++  +   S  +      YI RDL   N+LV  +    KVA 
Sbjct: 90  EYLQGGAGRALKLPQ--LIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG-ENNICKVAD 146

Query: 127 FGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKP 182
           FGLA+ +   +    A  G  +   + APE  L    +S   D+W  G +  E+V+ G+ 
Sbjct: 147 FGLARVI--KEDIYEAREGAKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRM 203

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            +PG  +   L ++    R P  C            PG      D++      DPD R T
Sbjct: 204 PYPGMTNAEVLQQVDQGYRMP--CP-----------PGCPKELYDIMLDCWKEDPDDRPT 250

Query: 243 AAEALQ 248
             E LQ
Sbjct: 251 -FETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.8 bits (134), Expect = 4e-09
 Identities = 51/169 (30%), Positives = 78/169 (46%), Gaps = 21/169 (12%)

Query: 43  LYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGT 101
           LY V +Y V  DL  LL   +D +     +          F L E   + DS   L    
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----------FYLAEMVIAIDSVHQL---- 121

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFG-LAKSLYAYKGESSAEVGTHYYKAPELLLGLLE 160
            Y+ RD+KP NIL+D++G  +++A FG   K +     +SS  VGT  Y +PE+L  + +
Sbjct: 122 HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 161 ----YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF 205
               Y    D W +G    EM+ G+  F   + + T G+I+    +  F
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 55.0 bits (132), Expect = 6e-09
 Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 21/189 (11%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGY--ST 70
            ++ E + L ++NHP++I+L    SQ   L  + EY +   L   L+  +     Y  S 
Sbjct: 49  DLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSD 108

Query: 71  KNFNSYSLFTTFLLVEEFSSSDS---SRSLSFGTRY------IRRDLKPVNILVDLDGKT 121
            N NS  L          +  D    +  +S G +Y      + RDL   N+LV  +G+ 
Sbjct: 109 GNRNSSYLDNPD--ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRK 165

Query: 122 VKVAGFGLAKSLY---AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           +K++ FGL++ +Y   +Y   S   +   +  A E L   + Y+T  D+W  G +  E+V
Sbjct: 166 MKISDFGLSRDVYEEDSYVKRSKGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 223

Query: 179 S-GKPLFPG 186
           + G   +PG
Sbjct: 224 TLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 55.0 bits (132), Expect = 6e-09
 Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 24/162 (14%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGL-AKSLYAYKGESSAEVGTHYYKAPELLLGLL- 159
           + I RDLK  N+L+ LDG  +K+A FG+ AK++   +   S  +GT Y+ APE+++    
Sbjct: 130 KIIHRDLKAGNVLLTLDGD-IKLADFGVSAKNVKTLQRRDSF-IGTPYWMAPEVVMCETM 187

Query: 160 ---EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF---CKLSLRDH 213
               Y    DIW +G    EM   +P     N +  L +I  KS  P+     K S+   
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSEPPTLSQPSKWSMEFR 246

Query: 214 LTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                        D +   L   P+ R +AA+ L+  +   V
Sbjct: 247 -------------DFLKTALDKHPETRPSAAQLLEHPFVSSV 275

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 54.7 bits (132), Expect = 8e-09
 Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 8/86 (9%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLL 159
           + I RD+KP NIL+   G+ VK+  FG++  L      S A    GT +Y APE + G  
Sbjct: 125 KIIHRDIKPSNILLTRKGQ-VKLCDFGVSGEL----VNSLAGTFTGTSFYMAPERIQG-K 178

Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFP 185
            YS   D+W +G    E+   +  FP
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFP 204

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 54.5 bits (131), Expect = 8e-09
 Identities = 53/235 (22%), Positives = 97/235 (41%), Gaps = 35/235 (14%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           ++E + + E+ HPN+++L+ V ++    Y + E+       LL Y ++           +
Sbjct: 50  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY--GNLLDYLRE----------CN 97

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
                  +L+   +   S+        +I RDL   N LV  +   VKVA FGL++ +  
Sbjct: 98  RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLM-- 154

Query: 136 YKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSL 190
             G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ + G   +PG    
Sbjct: 155 -TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG---- 208

Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE 245
           I L ++     K          +      G  P   +L+      +P  R + AE
Sbjct: 209 IDLSQVYELLEK---------GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAE 254

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.6 bits (131), Expect = 9e-09
 Identities = 34/81 (41%), Positives = 42/81 (51%), Gaps = 2/81 (2%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NIL+D  G  V +  FGL K     +  +S   GT  Y APE+L     Y  
Sbjct: 118 IYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDR 175

Query: 164 AVDIWPVGCIFGEMVSGKPLF 184
            VD W +G +  EM+ G P F
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 54.5 bits (131), Expect = 9e-09
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 4/87 (4%)

Query: 99  FGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL 158
           +  + + RD+KP N+LV+  G+ VK+  FG++  L      +   VGT+ Y APE + G 
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQ-VKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGE 168

Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFP 185
            +Y    D+W +G  F E+  G+  +P
Sbjct: 169 -QYGIHSDVWSLGISFMELALGRFPYP 194

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 54.2 bits (130), Expect = 1e-08
 Identities = 31/81 (38%), Positives = 47/81 (58%), Gaps = 3/81 (3%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  V+++  GLA      K +  A VGTH Y APE+L   + Y +
Sbjct: 119 VYRDLKPANILLDEHGH-VRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDS 175

Query: 164 AVDIWPVGCIFGEMVSGKPLF 184
           + D + +GC+  +++ G   F
Sbjct: 176 SADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 54.1 bits (130), Expect = 1e-08
 Identities = 43/158 (27%), Positives = 67/158 (42%), Gaps = 24/158 (15%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL----- 158
           I RD+KP N+LV+ +G  VK+  FG++ +L A    +   +G   Y APE +        
Sbjct: 125 IHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVA--SLAKTNIGCQSYMAPERIKSGGPNQN 181

Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFP---GANSLITLGRIVGKSRKPSFCKLSLRDHLT 215
             Y+   D+W +G    EM  G+  +P    AN    L  IV     P+           
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV-DGDPPTLP--------- 231

Query: 216 NGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
               G      D ++K L   P++R T A+ L+  +  
Sbjct: 232 ---SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 23/207 (11%)

Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P S + E   + +L H  +++L  V S+   +Y V EY       LL + KD   G + K
Sbjct: 45  PESFLEEAQIMKKLRHDKLVQLYAVVSEEP-IYIVTEYMSK--GSLLDFLKDG-EGRALK 100

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
             N         LV+  +   +  +      YI RDL+  NILV  DG   K+A FGLA+
Sbjct: 101 LPN---------LVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLAR 150

Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+V+ G+  +PG 
Sbjct: 151 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207

Query: 188 NSLITLGRIVGKSRK--PSFCKLSLRD 212
           N+   L ++    R   P  C +SL +
Sbjct: 208 NNREVLEQVERGYRMPCPQDCPISLHE 234

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 46/176 (26%), Positives = 68/176 (38%), Gaps = 32/176 (18%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEY 161
           + RD+KP NILV+  G+ +K+  FG++  L     +S A   VGT  Y +PE L G   Y
Sbjct: 122 MHRDVKPSNILVNSRGE-IKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG-THY 175

Query: 162 STAVDIWPVGCIFGEMVSGK------------PLFPGANSLITLGRIV------GKSRKP 203
           +   DIW +G    EM  G+             +F    S                    
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235

Query: 204 SFCKLSLRDHLTNGFPGLEPAG------IDLISKMLGMDPDKRITAAEALQQEYFK 253
                 L D++ N  P   P+G       D + K L  +P +R    E  +  + K
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 33/84 (39%), Positives = 49/84 (58%), Gaps = 5/84 (5%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLE 160
           R + RDLKP NIL+D D   ++++  GLA  +   +GE+    VGT  Y APE++     
Sbjct: 122 RIVYRDLKPENILLD-DYGHIRISDLGLAVEIP--EGETIRGRVGTVGYMAPEVVKNE-R 177

Query: 161 YSTAVDIWPVGCIFGEMVSGKPLF 184
           Y+ + D W +GC+  EM+ GK  F
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 53.4 bits (128), Expect = 2e-08
 Identities = 66/240 (27%), Positives = 96/240 (40%), Gaps = 36/240 (15%)

Query: 17  REVSCLMELNHPNIIRLMRVASQG--IYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNF 73
           +E   L +L HPNI+   R + +G    LY V  + +  DL + LK  K           
Sbjct: 48  QEAQLLSQLKHPNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK--------- 97

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
               L     +VE F     +         + RDLK  N+ +      +KV   G+A+ L
Sbjct: 98  ----LLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVL 152

Query: 134 YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA--NSLI 191
                 +S  +GT YY +PEL      Y+   D+W +GC   EM + K  F     NSL+
Sbjct: 153 ENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV 211

Query: 192 TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
              RI+     P     S             P   +LI+ ML   P+KR +    L+Q Y
Sbjct: 212 Y--RIIEGKLPPMPKDYS-------------PELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.4 bits (128), Expect = 2e-08
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 17/174 (9%)

Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKDSMNGYST 70
           +  ++E+  +  L  PNIIRL+ V      L  + EY  N DL  +L ++        + 
Sbjct: 64  NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK--TVKVAGFG 128
               SYS    F+  +  S      SL+F    + RDL   N LV   GK  T+K+A FG
Sbjct: 124 VVTISYSTL-IFMATQIASGMKYLSSLNF----VHRDLATRNCLV---GKNYTIKIADFG 175

Query: 129 LAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           ++++LY+   Y+ +  A +   +     +LLG  +++TA D+W  G    E+++
Sbjct: 176 MSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 16/155 (10%)

Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE 160
            + I RDLK  NIL  LDG  +K+A FG++           + +GT Y+ APE+++    
Sbjct: 122 NKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 161 ----YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
               Y    D+W +G    EM   +P     N +  L +I  KS  P+  + S       
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSEPPTLAQPS------- 232

Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
                     D + K L  + D R T  + LQ  +
Sbjct: 233 ---RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 53.6 bits (128), Expect = 2e-08
 Identities = 63/244 (25%), Positives = 100/244 (40%), Gaps = 43/244 (17%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYL-----YPVFEYQVNDLAYLLKYPKDSMNGYS 69
           +I+EV  L  + HPN I       +G YL     + V EY +   + LL+  K  +    
Sbjct: 72  IIKEVKFLQRIKHPNSIEY-----KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE 126

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
                  +L     L         S ++      I RD+K  NIL+   G+ VK+A FG 
Sbjct: 127 IAAITHGALQGLAYL--------HSHNM------IHRDIKAGNILLTEPGQ-VKLADFGS 171

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLE--YSTAVDIWPVGCIFGEMVSGKPLFPGA 187
           A    +    +++ VGT Y+ APE++L + E  Y   VD+W +G    E+   KP     
Sbjct: 172 A----SIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227

Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
           N++  L  I  ++  P+       D+  N            +   L   P  R T+ E L
Sbjct: 228 NAMSALYHI-AQNESPTLQSNEWSDYFRN-----------FVDSCLQKIPQDRPTSEELL 275

Query: 248 QQEY 251
           +  +
Sbjct: 276 KHMF 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 31/81 (38%), Positives = 46/81 (56%), Gaps = 3/81 (3%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  V+++  GLA      K +  A VGTH Y APE+L     Y +
Sbjct: 119 VYRDLKPANILLDEHGH-VRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGTAYDS 175

Query: 164 AVDIWPVGCIFGEMVSGKPLF 184
           + D + +GC+  +++ G   F
Sbjct: 176 SADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 53.0 bits (127), Expect = 2e-08
 Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 16/156 (10%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+L+D  G   +++  GLA  L   K   +   GT+ Y APE+L     YS 
Sbjct: 117 VYRDMKPENVLLDDQGN-CRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEP-YSY 173

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VD + +GC   EMV+G+  F              K  K    + +L D +         
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKE---------KVAKEELKRRTLEDEVKFEHQNFTE 224

Query: 224 AGIDLISKMLGMDPDKRITAAEA----LQQEYFKDV 255
              D+    L   P+ R+ + E      + E+FK +
Sbjct: 225 ESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 31/84 (36%), Positives = 51/84 (60%), Gaps = 5/84 (5%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLE 160
           R + RDLKP NIL+D  G  ++++  GLA  ++  +G++    VGT  Y APE++     
Sbjct: 122 RIVYRDLKPENILLDDHGH-IRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKN-ER 177

Query: 161 YSTAVDIWPVGCIFGEMVSGKPLF 184
           Y+ + D W +GC+  EM++G+  F
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 61/244 (25%), Positives = 98/244 (40%), Gaps = 59/244 (24%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E   + + +HP+I++L+ V ++     PV  + V +LA     P   +  Y   N  S  
Sbjct: 57  EAYIMRQFDHPHIVKLIGVITEN----PV--WIVMELA-----PLGELRSYLQVNKYSLD 105

Query: 78  LFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
           L +  L      S   S +L++    R++ RD+   N+LV      VK+  FGL++    
Sbjct: 106 LASLILY-----SYQLSTALAYLESKRFVHRDIAARNVLV-SSPDCVKLGDFGLSR---- 155

Query: 136 YKGESSAEVGTHYYKA-----------PELLLGLLEYSTAVDIWPVG-CIFGEMVSGKPL 183
           Y  + S      YYKA           PE  +    +++A D+W  G C++  ++ G   
Sbjct: 156 YLEDES------YYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Query: 184 FPGANSLITLGRIVGKSR--KPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
           F G  +   +GRI    R   P  C                P    L++K    DP KR 
Sbjct: 209 FQGVKNNDVIGRIENGERLPMPPNCP---------------PTLYSLMTKCWAYDPSKRP 253

Query: 242 TAAE 245
              E
Sbjct: 254 RFTE 257

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 4e-08
 Identities = 54/169 (31%), Positives = 76/169 (44%), Gaps = 33/169 (19%)

Query: 41  IYLYPVFEYQVN-DLAYLL-----KYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS 94
             LY V +Y V  DL  LL     + P+D                  F L E   + DS 
Sbjct: 74  NNLYLVMDYYVGGDLLTLLSKFEDRLPED---------------MARFYLAEMVLAIDSV 118

Query: 95  RSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPE 153
             L     Y+ RD+KP N+L+D +G  +++A FG    L A    +S+  VGT  Y +PE
Sbjct: 119 HQL----GYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 154 LLL----GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI-TLGRIV 197
           +L     G   Y    D W +G    EM+ G+  F  A SL+ T G+I+
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIM 221

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 44/129 (34%), Positives = 67/129 (51%), Gaps = 13/129 (10%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D DG  +K+  +G+ K        +S   GT  Y APE+L G  EY  
Sbjct: 118 IYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGF 175

Query: 164 AVDIWPVGCIFGEMVSGKPLF------PGANSLITLGRIVGKS--RKPSFCKLSLR-DHL 214
           +VD W +G +  EM++G+  F      P  N+   L +++ +   R P F  LS++  H+
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHV 233

Query: 215 TNGFPGLEP 223
             GF   +P
Sbjct: 234 LKGFLNKDP 242

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 15/150 (10%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + I RD+K  N+L+   G  VK+A FG+A  L   + + +  VGT ++ APE ++    Y
Sbjct: 121 KKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAY 178

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
            +  DIW +G    E+  G+P     + +  L  I      P     +L    +  F   
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------PKNNPPTLTGEFSKPFK-- 230

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEY 251
                + I   L  DP  R TA E L+ ++
Sbjct: 231 -----EFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 50/185 (27%), Positives = 78/185 (42%), Gaps = 29/185 (15%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLL-----KYPKDSMNGYSTKN 72
           E   L  +NHP  + L        YLY V E+ +    +       ++P D    Y+ + 
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ- 139

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
                     +L+ E+  S            + RDLKP N+L+D DG  +K+  FG AK 
Sbjct: 140 ---------IVLIFEYLQS---------LNIVYRDLKPENLLLDKDG-FIKMTDFGFAKV 180

Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT 192
           +      +    GT  Y APE+LL  + +  A D W +G    E++ G P F     L+ 
Sbjct: 181 V---DTRTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236

Query: 193 LGRIV 197
             +I+
Sbjct: 237 YQKIL 241

Length = 340

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 52.3 bits (125), Expect = 5e-08
 Identities = 34/84 (40%), Positives = 49/84 (58%), Gaps = 5/84 (5%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLEYS 162
           + RDLKP NIL+D  G  ++++  GLA  +   +GES    VGT  Y APE+L     Y+
Sbjct: 124 VYRDLKPENILLDDYGH-IRISDLGLAVKIP--EGESIRGRVGTVGYMAPEVLNNQ-RYT 179

Query: 163 TAVDIWPVGCIFGEMVSGKPLFPG 186
            + D W +GC+  EM+ G+  F G
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 52.5 bits (126), Expect = 5e-08
 Identities = 66/263 (25%), Positives = 109/263 (41%), Gaps = 59/263 (22%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
           N  + V   + RE+  L ++NHPN+++   +           E QV     LL++    M
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN------GEIQV-----LLEF----M 154

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDG 119
           +G S +  +         + +E   +D +R +  G  Y      + RD+KP N+L++   
Sbjct: 155 DGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN-SA 204

Query: 120 KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST----AVDIWPVGCIFG 175
           K VK+A FG+++ L       ++ VGT  Y +PE +   L +      A DIW +G    
Sbjct: 205 KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264

Query: 176 EMVSGKPLFPGANSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGI-----DL 228
           E   G+  FP           VG+    +   C + +        P   PA         
Sbjct: 265 EFYLGR--FPFG---------VGRQGDWASLMCAICMSQ------PPEAPATASREFRHF 307

Query: 229 ISKMLGMDPDKRITAAEALQQEY 251
           IS  L  +P KR +A + LQ  +
Sbjct: 308 ISCCLQREPAKRWSAMQLLQHPF 330

Length = 353

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 52.2 bits (125), Expect = 5e-08
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 27/186 (14%)

Query: 7   TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMN 66
           +M   P + + E + + +L HP ++RL  V +Q   +Y + EY  N    L+ + K    
Sbjct: 42  SMS--PEAFLAEANLMKQLQHPRLVRLYAVVTQEP-IYIITEYMEN--GSLVDFLKTP-- 94

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDLDGKTVKV 124
                      L           ++  +  ++F  R  YI RDL+  NILV  +    K+
Sbjct: 95  --EGIKLTINKLIDM--------AAQIAEGMAFIERKNYIHRDLRAANILVS-ETLCCKI 143

Query: 125 AGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-G 180
           A FGLA+ +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G
Sbjct: 144 ADFGLARLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTYG 200

Query: 181 KPLFPG 186
           +  +PG
Sbjct: 201 RIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 52.2 bits (125), Expect = 6e-08
 Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 2/85 (2%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G   K+A FG+ K        +S   GT  Y APE+L  +L Y  
Sbjct: 118 IYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGP 175

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGAN 188
           +VD W +G +  EM+ G   F   N
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAEN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 52.1 bits (125), Expect = 6e-08
 Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 32/194 (16%)

Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           V + M R++  L E+NHP I++L             + +Q     YL+    D + G   
Sbjct: 43  VRTKMERDI--LAEVNHPFIVKLH------------YAFQTEGKLYLIL---DFLRGGDL 85

Query: 71  KNFNSYS---LFT----TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVK 123
             F   S   +FT     F L E   + D   SL      I RDLKP NIL+D +G  +K
Sbjct: 86  --FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI----IYRDLKPENILLDEEGH-IK 138

Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
           +  FGL+K    ++ ++ +  GT  Y APE ++    ++ + D W  G +  EM++G   
Sbjct: 139 LTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Query: 184 FPGANSLITLGRIV 197
           F G +   T+  I+
Sbjct: 198 FQGKDRKETMTMIL 211

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 52.0 bits (125), Expect = 6e-08
 Identities = 38/154 (24%), Positives = 63/154 (40%), Gaps = 15/154 (9%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL---LGLLE 160
           I RD+KP NIL+D  G  VK+  FG++  L   K ++ +  G   Y APE +       +
Sbjct: 137 IHRDVKPSNILLDASG-NVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPERIDPPDPNPK 194

Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG 220
           Y    D+W +G    E+ +G+  +    +   +   + +   PS   L   +  +  F  
Sbjct: 195 YDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS---LPPNEGFSPDF-- 249

Query: 221 LEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
                   +   L  D  KR    E LQ  + + 
Sbjct: 250 -----CSFVDLCLTKDHRKRPKYRELLQHPFIRR 278

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.1 bits (125), Expect = 7e-08
 Identities = 30/83 (36%), Positives = 45/83 (54%), Gaps = 2/83 (2%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+++D +G  +K+A FG+ K        +    GT  Y APE++     Y  
Sbjct: 123 IYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA-YQPYGK 180

Query: 164 AVDIWPVGCIFGEMVSGKPLFPG 186
           +VD W  G +  EM++G+P F G
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.1 bits (125), Expect = 7e-08
 Identities = 54/202 (26%), Positives = 73/202 (36%), Gaps = 65/202 (32%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLA-------KSLYAYKGESSAE------------ 143
           +I RD+KP NIL+D DG  +K+  FGL         S Y  KG+   +            
Sbjct: 122 FIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 144 ------------------------VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
                                   VGT  Y APE+LL    Y+   D W VG I  EM+ 
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLV 239

Query: 180 GKPLFPGANSLITLGRIVGKS---RKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD 236
           G+P F       T  +++        PS  KLS                 DLI + L   
Sbjct: 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLS-------------REASDLILR-LCCG 285

Query: 237 PDKRI---TAAEALQQEYFKDV 255
            + R+    A E     +FK +
Sbjct: 286 AEDRLGKNGADEIKAHPFFKGI 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 51.6 bits (123), Expect = 8e-08
 Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 15/150 (10%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           R I RD+K  N+L+   G  VK+A FG+A  L   + + +  VGT ++ APE ++    Y
Sbjct: 121 RKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAY 178

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
               DIW +G    E+  G+P     + +  L  ++ K+  P     +L    +  F   
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVL-FLIPKNSPP-----TLEGQYSKPFK-- 230

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEY 251
                + +   L  DP  R TA E L+ ++
Sbjct: 231 -----EFVEACLNKDPRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 45/181 (24%), Positives = 81/181 (44%), Gaps = 28/181 (15%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFNS 75
           RE + + E +HPNI++L+ V + G  +  +FEY    DL   L++        S +   S
Sbjct: 57  REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRH-------RSPRAQCS 109

Query: 76  YSLFTTFLLVEEFSSSD--------SSRSLSFGT------RYIRRDLKPVNILVDLDGKT 121
            S  T+       +            ++ ++ G       +++ RDL   N LV  +   
Sbjct: 110 LSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN-MV 168

Query: 122 VKVAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           VK+A FGL++++Y+   YK   +  +   +   PE +     Y+T  D+W  G +  E+ 
Sbjct: 169 VKIADFGLSRNIYSADYYKASENDAIPIRWM-PPESIF-YNRYTTESDVWAYGVVLWEIF 226

Query: 179 S 179
           S
Sbjct: 227 S 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 46/161 (28%), Positives = 67/161 (41%), Gaps = 21/161 (13%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLL 159
           R + RD+KP NILV+  G+ +K+  FG++  L      S A+  VGT  Y +PE + G  
Sbjct: 124 RIMHRDIKPSNILVNSRGQ-IKLCDFGVSGELI----NSIADTFVGTSTYMSPERIQG-G 177

Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
           +Y+   D+W +G    E+  GK  FP A S I                L L   +    P
Sbjct: 178 KYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDD-----PMGILDLLQQIVQEPP 230

Query: 220 GLEPAG------IDLISKMLGMDPDKRITAAEALQQEYFKD 254
              P+        D +   L  DP +R T  +      F  
Sbjct: 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 55/179 (30%), Positives = 77/179 (43%), Gaps = 26/179 (14%)

Query: 26  NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL 84
           N   I++L        YLY V EY    DL  L+             N++    +  F  
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS------------NYDIPEKWARFYT 148

Query: 85  VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSA 142
            E   + D+  S+ F    I RD+KP N+L+D  G  +K+A FG    + A  G      
Sbjct: 149 AEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGH-LKLADFGTCMKMDA-NGMVRCDT 202

Query: 143 EVGTHYYKAPELLL---GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI-TLGRIV 197
            VGT  Y +PE+L    G   Y    D W VG    EM+ G   F  A+SL+ T  +I+
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 51.1 bits (122), Expect = 1e-07
 Identities = 32/84 (38%), Positives = 50/84 (59%), Gaps = 5/84 (5%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLE 160
           R + RDLKP NIL+D D   ++++  GLA  +   +GE+    VGT  Y APE++    +
Sbjct: 122 RIVYRDLKPENILLD-DRGHIRISDLGLAVQI--PEGETVRGRVGTVGYMAPEVINN-EK 177

Query: 161 YSTAVDIWPVGCIFGEMVSGKPLF 184
           Y+ + D W +GC+  EM+ G+  F
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 29/219 (13%)

Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDL-AYLLKYPKDSMNGYST 70
              ++E   +   NHPNI++L+ V       Y + E  +  DL +YL     +       
Sbjct: 44  KEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGP--- 100

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDG----KTVKV 124
                  L T   L++     D ++   +     +I RDL   N LV   G    + VK+
Sbjct: 101 ------PLLTLKELLD--ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152

Query: 125 AGFGLAKSLYA---YKGESSAEVGTHYYKAPELLL-GLLEYSTAVDIWPVGCIFGEMVS- 179
             FGLA+ +Y    Y+ E    +   +  APE LL G   ++T  D+W  G +  E+++ 
Sbjct: 153 GDFGLARDIYKSDYYRKEGEGLLPVRWM-APESLLDGK--FTTQSDVWSFGVLMWEILTL 209

Query: 180 GKPLFPGANSLITLGRIV--GKSRKPSFCKLSLRDHLTN 216
           G+  +P  N+   L  +   G+ +KP  C   +   +TN
Sbjct: 210 GQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTN 248

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)

Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K         
Sbjct: 45  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYM--SKGSLLDFLK--------- 92

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDLDGKTVKVAGFGL 129
                  +     + + ++  +S  +++  R  Y+ RDL+  NILV  +    KVA FGL
Sbjct: 93  --GEMGKYLRLPQLVDMAAQIAS-GMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGL 148

Query: 130 AKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFP 185
           A+ +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +P
Sbjct: 149 ARLI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYP 205

Query: 186 GANSLITLGRIVGKSRK--PSFCKLSLRDHLTN 216
           G  +   L ++    R   P  C  SL D +  
Sbjct: 206 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 30/81 (37%), Positives = 46/81 (56%), Gaps = 2/81 (2%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G  +K+  +G+ K        +S   GT  Y APE+L G  +Y  
Sbjct: 118 IYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE-DYGF 175

Query: 164 AVDIWPVGCIFGEMVSGKPLF 184
           +VD W +G +  EM++G+  F
Sbjct: 176 SVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 53/191 (27%), Positives = 82/191 (42%), Gaps = 35/191 (18%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYL-----YPVFEYQVNDLAYLLKYPKDSMNGYS 69
           +I+EV  L +L HPN I+      +G YL     + V EY +   + LL+  K  +    
Sbjct: 62  IIKEVRFLQKLRHPNTIQY-----RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE 116

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGF 127
                  +L                + L++      I RD+K  NIL+   G  VK+  F
Sbjct: 117 IAAVTHGAL----------------QGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDF 159

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--YSTAVDIWPVGCIFGEMVSGKPLFP 185
           G A  +      ++  VGT Y+ APE++L + E  Y   VD+W +G    E+   KP   
Sbjct: 160 GSASIM----APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Query: 186 GANSLITLGRI 196
             N++  L  I
Sbjct: 216 NMNAMSALYHI 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 49/186 (26%), Positives = 80/186 (43%), Gaps = 47/186 (25%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFN 74
           ++EV  L  L+ PNI RL+ V +    L  + EY  N DL   L+      +G       
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG------- 119

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGT------------RY------IRRDLKPVNILVD 116
                           + +S+SLSF T            RY      + RDL   N LV 
Sbjct: 120 ---------------LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164

Query: 117 LDGKTVKVAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCI 173
               T+K+A FG++++LY+   Y+ +  A +   +     +LLG  +++T  D+W  G  
Sbjct: 165 -KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVT 221

Query: 174 FGEMVS 179
             E+++
Sbjct: 222 LWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 24/183 (13%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
             +       +RE S + +L+HP I+RL+ V  +G  L  V E  +  L  LLKY K   
Sbjct: 34  EHIAAGKKEFLREASVMAQLDHPCIVRLIGV-CKGEPLMLVME--LAPLGPLLKYLKK-- 88

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVA 125
                             L E         +      ++ RDL   N+L+ ++    K++
Sbjct: 89  ----------RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL-VNRHQAKIS 137

Query: 126 GFGLAKSLYA----YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-- 179
            FG++++L A    Y+  ++      +Y APE +    ++S+  D+W  G    E  S  
Sbjct: 138 DFGMSRALGAGSDYYRATTAGRWPLKWY-APECI-NYGKFSSKSDVWSYGVTLWEAFSYG 195

Query: 180 GKP 182
            KP
Sbjct: 196 AKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 26/213 (12%)

Query: 7   TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMN 66
           TM   P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K    
Sbjct: 42  TMS--PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK--GSLLDFLKSG-- 95

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAG 126
               K      L      + E  +   SR       YI RDL   NILV  +    K+A 
Sbjct: 96  --EGKKLRLPQLVDMAAQIAEGMAYLESR------NYIHRDLAARNILVG-ENLVCKIAD 146

Query: 127 FGLAKSLYAYKGESSAEVGTHY---YKAPE-LLLGLLEYSTAVDIWPVGCIFGEMVS-GK 181
           FGLA+ +     E +A  G  +   + APE    G   ++   D+W  G +  E+V+ G+
Sbjct: 147 FGLARLI--EDDEYTAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGR 202

Query: 182 PLFPGANSLITLGRIVGKSR--KPSFCKLSLRD 212
             +PG  +   L ++    R  +P  C   L D
Sbjct: 203 VPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 44/142 (30%), Positives = 62/142 (43%), Gaps = 16/142 (11%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  V +  FGL K   A    ++   GT  Y APE++     Y  
Sbjct: 118 VYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDN 175

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VD W +G +  EM+ G P F   +       I+ K        L LR       PG   
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-------PLVLR-------PGASL 221

Query: 224 AGIDLISKMLGMDPDKRITAAE 245
               ++ ++L  D  +R+ A E
Sbjct: 222 TAWSILEELLEKDRQRRLGAKE 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 31/86 (36%), Positives = 49/86 (56%), Gaps = 4/86 (4%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYS 162
           I RDLK  N+++D +G  +K+A FG+ K  +   G ++    GT  Y APE++     Y 
Sbjct: 123 IYRDLKLDNVMLDSEGH-IKIADFGMCKE-HMVDGVTTRTFCGTPDYIAPEII-AYQPYG 179

Query: 163 TAVDIWPVGCIFGEMVSGKPLFPGAN 188
            +VD W  G +  EM++G+P F G +
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 49.9 bits (119), Expect = 3e-07
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 21/155 (13%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-------GTHYYKAPELLL 156
           + RD+K  N+++  +G  +K+  FG A+ L A+ G             GT Y+ APE++ 
Sbjct: 124 VHRDIKGNNVMLMPNG-IIKLIDFGCARRL-AWVGLHGTHSNMLKSMHGTPYWMAPEVI- 180

Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
               Y    DIW +GC   EM +GKP     + L  +  I G  R        L D  + 
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-GAHRGLM---PRLPDSFSA 236

Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
                  A ID ++  L  D  +R +A + L+ ++
Sbjct: 237 -------AAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 5/103 (4%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA--YKGESSAEV-GTHYYKAPELLLGLLE 160
           + RD+K  NIL D  G  VK+  FG +K L      G     V GT Y+ +PE++ G   
Sbjct: 128 VHRDIKGANILRDSVG-NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-G 185

Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP 203
           Y    DIW VGC   EM++ KP +    ++  + +I  +   P
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 228

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.7 bits (119), Expect = 3e-07
 Identities = 62/203 (30%), Positives = 87/203 (42%), Gaps = 26/203 (12%)

Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVA--SQGIYLYPVFEYQVNDLAYLLKYPK 62
           H+  E   S   RE+  L  L+H NI++   V     G  L  + EY           P 
Sbjct: 43  HSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY----------LPS 92

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGT-RYIRRDLKPVNILVDLDGKT 121
            S+  Y  ++ +  +L    L    FSS         G+ RYI RDL   NILV+ +   
Sbjct: 93  GSLRDYLQRHRDQINLKRLLL----FSSQICKGMDYLGSQRYIHRDLAARNILVESE-DL 147

Query: 122 VKVAGFGLAKSLYA----YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
           VK++ FGLAK L      Y  +   E    +Y APE L    ++S+A D+W  G    E+
Sbjct: 148 VKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLR-TSKFSSASDVWSFGVTLYEL 205

Query: 178 VS-GKP-LFPGANSLITLGRIVG 198
            + G P   P A  L  +G   G
Sbjct: 206 FTYGDPSQSPPAEFLRMIGIAQG 228

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 23/158 (14%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  N+++D DG  +K+  FGL K             GT  Y APE+L    +Y  
Sbjct: 118 VYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGR 175

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           AVD W +G +  EM+ G+  F   +                  +L L + +   FP  L 
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQD-------------HEKLFELILMEEIR--FPRTLS 220

Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
           P    L+S +L  DP +R+      A E +Q ++F  +
Sbjct: 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.3 bits (117), Expect = 4e-07
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 5/103 (4%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAK---SLYAYKGESSAEVGTHYYKAPELLLGLLE 160
           + RD+K  NIL D  G  VK+  FG +K   ++        +  GT Y+ +PE++ G   
Sbjct: 128 VHRDIKGANILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-G 185

Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP 203
           Y    D+W V C   EM++ KP +    ++  + +I  +  KP
Sbjct: 186 YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKP 228

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 49.3 bits (117), Expect = 5e-07
 Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 5/107 (4%)

Query: 100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA--YKGESSAEV-GTHYYKAPELLL 156
               + RD+K  NIL D  G  VK+  FG +K L      G     V GT Y+ +PE++ 
Sbjct: 124 SNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP 203
           G   Y    D+W +GC   EM++ KP +    ++  + +I  +   P
Sbjct: 183 GE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP 228

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.5 bits (118), Expect = 5e-07
 Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 19/179 (10%)

Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKDSMNGYST 70
           +  ++EV  L  L  PNIIRL+ V      L  + EY  N DL  +L  +  D       
Sbjct: 64  NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDD----KE 119

Query: 71  KNFNSYSLFTTFLLVEEFSSSDS-SRSLSFGTRY------IRRDLKPVNILVDLDGKTVK 123
           +N N        L    +SS    +  ++ G +Y      + RDL   N LV  +  T+K
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG-ENLTIK 178

Query: 124 VAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           +A FG++++LYA   Y+ +  A +   +     +L+G  +++TA D+W  G    E++ 
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 49.3 bits (117), Expect = 6e-07
 Identities = 35/100 (35%), Positives = 51/100 (51%), Gaps = 12/100 (12%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G  +K+  +G+ K        +S   GT  Y APE+L G  +Y  
Sbjct: 118 IYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGF 175

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP 203
           +VD W +G +  EM++G+  F           IVG S  P
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD----------IVGSSDNP 205

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 49.2 bits (117), Expect = 6e-07
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 27/212 (12%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKDSM---NGYSTK 71
           RE   L  L H +I++   V   G  L  VFEY  + DL  +L  +  D+M   +G   +
Sbjct: 56  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                 L     +  + +S     +      ++ RDL   N LV      VK+  FG+++
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVG-ANLLVKIGDFGMSR 171

Query: 132 SLYAYKGESSAEVGTHY-----YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GK-PLF 184
            +Y+        VG H      +  PE ++   +++T  D+W  G I  E+ + GK P F
Sbjct: 172 DVYS---TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWF 227

Query: 185 PGANSL----ITLGRIVGKSRKPSFCKLSLRD 212
             +N+     IT GR++    +P  C   + D
Sbjct: 228 QLSNTEVIECITQGRVL---ERPRVCPKEVYD 256

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 49.2 bits (117), Expect = 7e-07
 Identities = 52/180 (28%), Positives = 68/180 (37%), Gaps = 65/180 (36%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLA-------KSLYAYKG----ESSAE-------- 143
           +I RD+KP NIL+DLDG  +K+  FGL         S Y  KG    + S E        
Sbjct: 122 FIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 144 ----------------------------VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFG 175
                                       VGT  Y APE+LL    Y+   D W VG I  
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILF 239

Query: 176 EMVSGKPLFPGANSLITLGRIVGKSRK---PSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
           EM+ G+P F       T  +++        P   KLS             P  +DLI+K+
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLS-------------PEAVDLITKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 49.3 bits (117), Expect = 7e-07
 Identities = 50/184 (27%), Positives = 77/184 (41%), Gaps = 36/184 (19%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + + RD+KP NILV+  G+ +K+  FG++  L      S   VGT  Y +PE L G   Y
Sbjct: 124 KIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THY 179

Query: 162 STAVDIWPVGCIFGEMVSGK-PLFPGANSLITL----------------------GRIV- 197
           S   DIW +G    EM  G+ P+ P     + L                      GR + 
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239

Query: 198 --GKSRKPSFCKLSLRDHLTNGFPGLEPAGI------DLISKMLGMDPDKRITAAEALQQ 249
             G   +P      L D++ N  P   P+G+      D ++K L  +P +R    + +  
Sbjct: 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299

Query: 250 EYFK 253
            + K
Sbjct: 300 AFIK 303

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 49.0 bits (117), Expect = 7e-07
 Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 40/208 (19%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNG----YSTK 71
           RE   L    H NI++   V ++G     VFEY  + DL   L+      +G    +   
Sbjct: 57  REAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLR-----SHGPDAAFLKS 111

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
             +     T   L++      S         ++ RDL   N LV  D   VK+  FG+++
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD-LVVKIGDFGMSR 170

Query: 132 SLYAYKGESSAEVGTHYYK------------APELLLGLLEYSTAVDIWPVGCIFGEMVS 179
            +Y           T YY+             PE ++   +++T  D+W  G +  E+ +
Sbjct: 171 DVYT----------TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFT 219

Query: 180 -GK-PLFPGANS----LITLGRIVGKSR 201
            GK P +  +N      IT GR++ + R
Sbjct: 220 YGKQPWYGLSNEEVIECITQGRLLQRPR 247

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 48.8 bits (116), Expect = 8e-07
 Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 14/172 (8%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPK-DSMNGYSTKNFN 74
           EV C +  +HPNII L+       YLY   EY    N L +L K    ++   ++  N  
Sbjct: 59  EVLCKLG-HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 117

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGT--RYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
           + +L +  LL     ++D +R + + +  ++I RDL   NILV  +    K+A FGL++ 
Sbjct: 118 ASTLSSQQLLH---FAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRG 173

Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKP 182
              Y  ++   +   +     L   +  Y+T  D+W  G +  E+VS  G P
Sbjct: 174 QEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.6 bits (116), Expect = 8e-07
 Identities = 48/170 (28%), Positives = 69/170 (40%), Gaps = 31/170 (18%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAK--------SLYAYKGESSAE-------VGTHY 148
           + RDLKP N+L+   G  +K+  FGL+K        +LY    E            GT  
Sbjct: 123 VHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 149 YKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL 208
           Y APE++L    Y   VD W +G I  E + G   F G       G+++           
Sbjct: 182 YIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI----------- 229

Query: 209 SLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI---TAAEALQQEYFKDV 255
           S       G   L     DLIS++L  +P +R+    A E  Q  +F  +
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.8 bits (116), Expect = 9e-07
 Identities = 47/169 (27%), Positives = 73/169 (43%), Gaps = 8/169 (4%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPKDSMNGYSTKNFNS 75
           EV C +  +HPNII L+       YLY   EY    N L +L K      +    K   +
Sbjct: 54  EVLCKLG-HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT 112

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
            S  T+  L++  S   +        ++I RDL   N+LV  +    K+A FGL++    
Sbjct: 113 ASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG-ENLASKIADFGLSRGEEV 171

Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKP 182
           Y  ++   +   +     L   +  Y+T  D+W  G +  E+VS  G P
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 48.5 bits (116), Expect = 9e-07
 Identities = 47/194 (24%), Positives = 70/194 (36%), Gaps = 56/194 (28%)

Query: 8   MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYP----VFEYQVNDLAYLLKYPKD 63
           +  +    ++E + +  L+H N+IRL      G+ L      V E  +  L  LL   + 
Sbjct: 36  LSDIMDDFLKEAAIMHSLDHENLIRLY-----GVVLTHPLMMVTE--LAPLGSLLDRLRK 88

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDL 117
              G+          F    L       D +  ++ G RY      I RDL   NIL+  
Sbjct: 89  DALGH----------FLISTL------CDYAVQIANGMRYLESKRFIHRDLAARNILLAS 132

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APELLLGLLEYSTAV 165
           D   VK+  FGL ++L              +Y             APE  L    +S A 
Sbjct: 133 D-DKVKIGDFGLMRAL---------PQNEDHYVMEEHLKVPFAWCAPE-SLRTRTFSHAS 181

Query: 166 DIWPVGCIFGEMVS 179
           D+W  G    EM +
Sbjct: 182 DVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 10/169 (5%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKY-PKDSMNGYSTKNF 73
           +E   + +L HPNI+ L+ V ++      +FEY  + DL  +L++  P   +   S    
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
              SL  +  L      +     LS    ++ RDL   N LV  +G TVK++ FGL++ +
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLS-SHHFVHRDLAARNCLVG-EGLTVKISDFGLSRDI 174

Query: 134 YA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           Y+   Y+ +S + +   +     +L G  +++T  DIW  G +  E+ S
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 16/152 (10%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--- 160
           + RD+K  NIL+  D   VK+A FG++  + A   +  + +GT Y+ APE  +  +E   
Sbjct: 128 MHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE--VAAVERKG 184

Query: 161 -YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            Y+   DIW VG    E+   +P     + +  L  +   + +P   KL  +   +N F 
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--KLKDKMKWSNSFH 242

Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
                    +   L  +P KR TA + LQ  +
Sbjct: 243 -------HFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.5 bits (115), Expect = 1e-06
 Identities = 56/206 (27%), Positives = 75/206 (36%), Gaps = 69/206 (33%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAK-------SLYAYKGE---------------- 139
           +I RD+KP NIL+D DG  +K+  FGL         S Y   G+                
Sbjct: 122 FIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 140 ------------------------SSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFG 175
                                   + + VGT  Y APE+LL    Y+   D W VG I  
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILY 239

Query: 176 EMVSGKPLFPGANSLITLGRIVGKSRK---PSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
           EM+ G+P F     L T  +++        P   KLS             P   DLI K 
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLS-------------PEASDLIIK- 285

Query: 233 LGMDPDKRI---TAAEALQQEYFKDV 255
           L   P+ R+    A E     +FK +
Sbjct: 286 LCRGPEDRLGKNGADEIKAHPFFKTI 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 2/85 (2%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+++D +G  +K+A FG+ K        +    GT  Y APE++     Y  
Sbjct: 123 IYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-AYQPYGK 180

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGAN 188
           +VD W  G +  EM++G+  F G +
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.8 bits (113), Expect = 2e-06
 Identities = 46/160 (28%), Positives = 69/160 (43%), Gaps = 23/160 (14%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + + RDLK  N+++D DG  +K+  FGL K             GT  Y APE+L    +Y
Sbjct: 115 KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN-DY 172

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-G 220
             AVD W +G +  EM+ G+  F   +       I+ +  K               FP  
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK---------------FPRT 217

Query: 221 LEPAGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
           L      L+S +L  DP+KR+      A E ++  +F  V
Sbjct: 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 16/154 (10%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE- 160
           + I RD+K  NIL+  +G  VK+  FG++  L + +   +  VGT ++ APE++    + 
Sbjct: 144 KTIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202

Query: 161 ---YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG 217
              Y    D+W +G    E+  G P     + +  L +I    R P    L   +  +N 
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI---PRNPP-PTLHQPELWSNE 258

Query: 218 FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
           F        D I K L  D +KR T ++ LQ  +
Sbjct: 259 FN-------DFIRKCLTKDYEKRPTVSDLLQHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 23/158 (14%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+K  N+++D DG  +K+  FGL K   +         GT  Y APE+L    +Y  
Sbjct: 117 VYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGR 174

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           AVD W +G +  EM+ G+  F   +       I+ +  +               FP  L 
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR---------------FPRTLS 219

Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
           P    L++ +L  DP +R+      A E ++  +F  +
Sbjct: 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 47.0 bits (111), Expect = 3e-06
 Identities = 28/81 (34%), Positives = 46/81 (56%), Gaps = 2/81 (2%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + I RD+K  N+L+   G+ VK+A FG+A  L   + + +  VGT ++ APE ++    Y
Sbjct: 121 KKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAY 178

Query: 162 STAVDIWPVGCIFGEMVSGKP 182
            +  DIW +G    E+  G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 23/159 (14%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-----GTHYYKAPELLL 156
           + + RDLK  NI +   G  +K+  FG +K    Y    S +V     GT YY APEL  
Sbjct: 189 KMMHRDLKSANIFLMPTG-IIKLGDFGFSKQ---YSDSVSLDVASSFCGTPYYLAPELW- 243

Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
               YS   D+W +G I  E+++    F G +    + +++     P  C +S       
Sbjct: 244 ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVS------- 296

Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
              G++     L+  +L  +P  R T  + L  E+ K V
Sbjct: 297 --SGMKA----LLDPLLSKNPALRPTTQQLLHTEFLKYV 329

Length = 478

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 51/186 (27%), Positives = 69/186 (37%), Gaps = 57/186 (30%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY---------------QVNDLAYLL 58
           + + E S +  L HPN+++L+ V  QG  LY V EY                V  LA  L
Sbjct: 46  AFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQL 105

Query: 59  KYPKDSMNGY---STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILV 115
            +  D   G      KNF                              + RDL   N+LV
Sbjct: 106 GFALDVCEGMEYLEEKNF------------------------------VHRDLAARNVLV 135

Query: 116 DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK--APELLLGLLEYSTAVDIWPVGCI 173
             D    KV+ FGLAK     +     + G    K  APE  L   ++ST  D+W  G +
Sbjct: 136 SEDL-VAKVSDFGLAK-----EASQGQDSGKLPVKWTAPE-ALREKKFSTKSDVWSFGIL 188

Query: 174 FGEMVS 179
             E+ S
Sbjct: 189 LWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 47.0 bits (111), Expect = 3e-06
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 12/171 (7%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPKDSMNGYSTKNFNS 75
           EV C +  +HPNII L+       YLY   EY    N L +L K      +       ++
Sbjct: 47  EVLCKLG-HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 105

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGT--RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
            S  ++  L+    ++D +R + + +  ++I RDL   NILV  +    K+A FGL++  
Sbjct: 106 ASTLSSQQLLH--FAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQ 162

Query: 134 YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKP 182
             Y  ++   +   +     L   +  Y+T  D+W  G +  E+VS  G P
Sbjct: 163 EVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 46/184 (25%), Positives = 83/184 (45%), Gaps = 24/184 (13%)

Query: 2   MGIHNTMEGVPSS--MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVND-LAYLL 58
           + I    EG  S    I E   +M+L+HP +++L  V ++   +  VFE+  +  L+  L
Sbjct: 31  VAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL 90

Query: 59  KYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLD 118
           +  +          F+  +L    L V E  +   S +       I RDL   N LV  +
Sbjct: 91  RAQRGK--------FSQETLLGMCLDVCEGMAYLESSN------VIHRDLAARNCLVG-E 135

Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFG 175
            + VKV+ FG+ +  +    + ++  GT +   + +PE +    +YS+  D+W  G +  
Sbjct: 136 NQVVKVSDFGMTR--FVLDDQYTSSTGTKFPVKWSSPE-VFSFSKYSSKSDVWSFGVLMW 192

Query: 176 EMVS 179
           E+ S
Sbjct: 193 EVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 50/200 (25%), Positives = 80/200 (40%), Gaps = 36/200 (18%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFN 74
           ++E   L + +HPNI++L+ V  Q   +Y V E      L   L+  K+ +         
Sbjct: 40  LQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRL--------- 90

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGFG 128
                T   L++       S   + G  Y      I RDL   N LV  +   +K++ FG
Sbjct: 91  -----TVKKLLQ------MSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFG 138

Query: 129 LAKSLYAYKGESSAEVGTHY----YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPL 183
           +++      G  +   G       + APE L     Y++  D+W  G +  E  S G   
Sbjct: 139 MSRE--EEGGIYTVSDGLKQIPIKWTAPEAL-NYGRYTSESDVWSYGILLWETFSLGDTP 195

Query: 184 FPGANSLITLGRIVGKSRKP 203
           +PG ++  T  RI    R P
Sbjct: 196 YPGMSNQQTRERIESGYRMP 215

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 46.9 bits (112), Expect = 3e-06
 Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 37/176 (21%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           + E S + + +HPNIIRL  V ++   +  + EY  N           S++ +  +N   
Sbjct: 53  LTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENG----------SLDKFLRENDGK 102

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGFGL 129
              FT   LV         R ++ G +Y      + RDL   NILV+ +    KV+ FGL
Sbjct: 103 ---FTVGQLVGML------RGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGL 152

Query: 130 AKSLYAYKGESSAEVGTHYYK------APELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           ++ L     +S A   T   K      APE  +   ++++A D+W  G +  E++S
Sbjct: 153 SRRL----EDSEATYTTKGGKIPIRWTAPE-AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 46.6 bits (110), Expect = 4e-06
 Identities = 32/83 (38%), Positives = 45/83 (54%), Gaps = 5/83 (6%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP NILV+  G+ +K+  FG++  L      S   VGT  Y +PE L G   YS 
Sbjct: 126 MHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THYSV 181

Query: 164 AVDIWPVGCIFGEMVSGK-PLFP 185
             DIW +G    E+  G+ P+ P
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 66/275 (24%), Positives = 105/275 (38%), Gaps = 60/275 (21%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLK-------YPKDSMNG 67
           +RE     +L HP I+ +  + S G  +Y    Y +   L  LLK         K+    
Sbjct: 50  LREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEK 109

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            S   F   S+F       E+  S            + RDLKP NIL+ L G+ V +  +
Sbjct: 110 TSVGAF--LSIFHKICATIEYVHSKG---------VLHRDLKPDNILLGLFGEVV-ILDW 157

Query: 128 GLAKSLYAYKGESSAE------------------VGTHYYKAPELLLGLLEYSTAVDIWP 169
           G A      + +                      VGT  Y APE LLG +  S + DI+ 
Sbjct: 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYA 216

Query: 170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN-----GFPGLEPA 224
           +G I  +M++    FP               R+    K+S RD + +      +  + P 
Sbjct: 217 LGVILYQMLTLS--FP--------------YRRKKGRKISYRDVILSPIEVAPYREIPPF 260

Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFKDVPGRS 259
              +  K L +DP +R ++ + L+Q+    + G  
Sbjct: 261 LSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295

Length = 932

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.1 bits (109), Expect = 5e-06
 Identities = 40/171 (23%), Positives = 77/171 (45%), Gaps = 26/171 (15%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKDSMNGYSTKNFNS 75
           +E+  L  L H NI++   + ++            N +  ++++ P  S+  Y  +N N 
Sbjct: 55  KEIEILRNLYHENIVKYKGICTED---------GGNGIKLIMEFLPSGSLKEYLPRNKNK 105

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTR-YIRRDLKPVNILVDLDGKTVKVAGFGLAKSL- 133
            +L        +++          G+R Y+ RDL   N+LV+ +   VK+  FGL K++ 
Sbjct: 106 INLKQQL----KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIE 160

Query: 134 -----YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
                Y  K +  + V   ++ APE L+   ++  A D+W  G    E+++
Sbjct: 161 TDKEYYTVKDDLDSPV---FWYAPECLIQ-SKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.2 bits (109), Expect = 6e-06
 Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 38/195 (19%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGI----YLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           + E  C+ E +HPN++RL+ V  Q +    Y  PV          +L + K         
Sbjct: 48  LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV---------ILPFMKHG------- 91

Query: 72  NFNSYSLFT----------TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKT 121
           + +S+ L++          T +LV+  +   S         +I RDL   N +++ +   
Sbjct: 92  DLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN-ENMN 150

Query: 122 VKVAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           V VA FGL+K +Y    Y+    A++   +  A E L   + Y+T  D+W  G    E+ 
Sbjct: 151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWI-AIESLADRV-YTTKSDVWSFGVTMWEIA 208

Query: 179 S-GKPLFPGA-NSLI 191
           + G+  +PG  NS I
Sbjct: 209 TRGQTPYPGVENSEI 223

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 45.8 bits (109), Expect = 7e-06
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 10/92 (10%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSA---EVGTHYYKAPELLL--GL 158
           I RD+KP NIL+D +G  +K+  FG++  L     +S A   + G   Y APE +     
Sbjct: 130 IHRDVKPSNILLDRNG-NIKLCDFGISGQLV----DSIAKTRDAGCRPYMAPERIDPSAR 184

Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
             Y    D+W +G    E+ +GK  +P  NS+
Sbjct: 185 DGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.2 bits (109), Expect = 7e-06
 Identities = 55/187 (29%), Positives = 80/187 (42%), Gaps = 26/187 (13%)

Query: 26  NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL 84
           N P +++L        YLY V EY    DL  L+             N++    +  F  
Sbjct: 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS------------NYDVPEKWARFYT 148

Query: 85  VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSA 142
            E   + D+  S+ F    I RD+KP N+L+D  G  +K+A FG    +   +G      
Sbjct: 149 AEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDT 202

Query: 143 EVGTHYYKAPELLL---GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI-TLGRIVG 198
            VGT  Y +PE+L    G   Y    D W VG    EM+ G   F  A+SL+ T  +I+ 
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMN 261

Query: 199 KSRKPSF 205
                +F
Sbjct: 262 HKNSLTF 268

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 45.7 bits (108), Expect = 8e-06
 Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 40/233 (17%)

Query: 14  SMIREVSCLMELNHPNIIRLMRV-ASQGIYLYPVFEYQVND--LAYLLKYPKDSMNGYST 70
           + + E S + +L H N+++L+ V   +   LY V EY      + YL    +  + G   
Sbjct: 45  AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 104

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             F                S D   ++ +     ++ RDL   N+LV  D    KV+ FG
Sbjct: 105 LKF----------------SLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFG 147

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
           L K   + +      V    + APE L     +ST  D+W  G +  E+ S G+  +P  
Sbjct: 148 LTKEASSTQDTGKLPVK---WTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYP-- 201

Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
              I L  +V +  K    K+   D       G  P   D++ +   +D   R
Sbjct: 202 --RIPLKDVVPRVEKGY--KMDAPD-------GCPPVVYDVMKQCWHLDAATR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 32/213 (15%)

Query: 13  SSMIREVSCL-MELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPKDSMNGYS 69
           S +I E+  + M   H NII L+   +Q   LY + EY    N   YL       M    
Sbjct: 68  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM---- 123

Query: 70  TKNFNSYSLFTTFLLVEEFSSSD---SSRSLSFGTRY------IRRDLKPVNILVDLDGK 120
                 Y    T +  E+ S  D    +  ++ G  Y      I RDL   N+LV  D  
Sbjct: 124 -----EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-N 177

Query: 121 TVKVAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
            +K+A FGLA+ ++    YK  ++  +   +  APE L   + Y+   D+W  G +  E+
Sbjct: 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEI 235

Query: 178 VS--GKPLFPGA--NSLITLGRIVGKSRKPSFC 206
            +  G P +PG     L  L +   +  KPS C
Sbjct: 236 FTLGGSP-YPGVPVEELFKLLKEGHRMDKPSNC 267

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 18/210 (8%)

Query: 13  SSMIREVSCL-MELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           S ++ E+  + M   H NII L+   +Q   LY + EY    +L   L+  +     YS 
Sbjct: 62  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS- 120

Query: 71  KNFNSYSLFTTFLLVEEFSSS--DSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
             F++  L    L  ++  S     +R + +    + I RDL   N+LV  D   +K+A 
Sbjct: 121 --FDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED-NVMKIAD 177

Query: 127 FGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKP 182
           FGLA+ ++    YK  ++  +   +  APE L   + Y+   D+W  G +  E+ + G  
Sbjct: 178 FGLARDVHNIDYYKKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLLWEIFTLGGS 235

Query: 183 LFPG--ANSLITLGRIVGKSRKPSFCKLSL 210
            +PG     L  L +   +  KP+ C   L
Sbjct: 236 PYPGIPVEELFKLLKEGHRMDKPANCTHEL 265

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 8/107 (7%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           R I RD+K  NIL+  +G  VK+  FG++  L + +   +  VGT ++ APE++    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 162 STA----VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS 204
             +     D+W +G    E+  G P     + + TL +I    R P 
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI---PRNPP 250

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 24/170 (14%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           + E S + + +HPNII L  V ++   +  V EY  N           S++ +  K+   
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMEN----------GSLDAFLRKHDGQ 102

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              FT   LV       S         Y+ RDL   NILV+      KV+ FGL++ L  
Sbjct: 103 ---FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN-SNLVCKVSDFGLSRVL-- 156

Query: 136 YKGESSAEVGTH------YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
            + +  A   T        + APE  +   ++++A D+W  G +  E++S
Sbjct: 157 -EDDPEAAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 46/156 (29%), Positives = 66/156 (42%), Gaps = 28/156 (17%)

Query: 104 IRRDLKPVNILVDL--DGKTVKVAGFGLAKSLYAYKGESSAE-------VGTHYYKAPEL 154
           + RDLKP NI+V         KV  FG+   L   +    A        +GT  Y APE 
Sbjct: 101 VHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQ 160

Query: 155 LLGLLEYSTA-VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL--SLR 211
           L G  E  T   D++  G IF E ++G+ +  GA    ++  I+ +   P    L   + 
Sbjct: 161 LRG--EPVTPNSDLYAWGLIFLECLTGQRVVQGA----SVAEILYQQLSPVDVSLPPWIA 214

Query: 212 DHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
            H         P G  ++ K L  DP +R  +A AL
Sbjct: 215 GH---------PLG-QVLRKALNKDPRQRAASAPAL 240

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 47/175 (26%), Positives = 73/175 (41%), Gaps = 28/175 (16%)

Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVNDLAYLLKY-PKDSMNGYS 69
           S   +E++ L  L H NI++     S+  G  L  + EY    L  L  Y PK       
Sbjct: 51  SGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV--PLGSLRDYLPK------- 101

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
               +  +L    L  ++        +      YI RDL   N+L+D D + VK+  FGL
Sbjct: 102 ----HKLNLAQLLLFAQQICEG---MAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGL 153

Query: 130 AKS-----LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           AK+      Y Y+     +    +Y A E  L   ++S A D+W  G    E+++
Sbjct: 154 AKAVPEGHEY-YRVREDGDSPVFWY-AVE-CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 52/206 (25%), Positives = 79/206 (38%), Gaps = 69/206 (33%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY-----AY-----KGESS----------- 141
           +I RD+KP NIL+D  G  +K++ FGL+   +     AY     +G+S+           
Sbjct: 122 FIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 142 --------------------------AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFG 175
                                     + VGT  Y APE+ L    Y    D W +G I  
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMF 239

Query: 176 EMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG---LEPAGIDLISKM 232
           E + G P F   NS  T  +I+           + R+ L   FP    L     DLI ++
Sbjct: 240 ECLIGWPPFCSENSHETYRKII-----------NWRETLY--FPDDIHLSVEAEDLIRRL 286

Query: 233 LGMDPDKRI---TAAEALQQEYFKDV 255
           +  + + R+    A E     +F+ V
Sbjct: 287 I-TNAENRLGRGGAHEIKSHPFFRGV 311

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 44.5 bits (105), Expect = 2e-05
 Identities = 48/175 (27%), Positives = 74/175 (42%), Gaps = 25/175 (14%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           I E   +M+L+HP +++L  V +Q   LY V E+  N    LL Y +      S     S
Sbjct: 47  IEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN--GCLLNYLRQRQGKLSKDMLLS 104

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
                           D    + +  R  +I RDL   N LV   G  VKV+ FG+ +  
Sbjct: 105 MCQ-------------DVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTR-- 148

Query: 134 YAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLF 184
           Y    E ++  G  +   +  PE+     +YS+  D+W  G +  E+ + GK  F
Sbjct: 149 YVLDDEYTSSSGAKFPVKWSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 27/175 (15%)

Query: 27  HPNIIRLMRVASQGIYLYPVFEY--QVNDLAYL-LKYPKDSMNGYS-----TKNFNSYSL 78
           H NII L+ V +Q   LY V EY    N   +L  + P              +      L
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 79  FTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA- 135
            +    V        +R + F    + I RDL   N+LV  +   +K+A FGLA+ ++  
Sbjct: 135 VSFAYQV--------ARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLARDIHHI 185

Query: 136 --YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLFPG 186
             Y+  ++  +   +  APE L   + Y+   D+W  G +  E+ +  G P +PG
Sbjct: 186 DYYRKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSP-YPG 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 16/152 (10%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--- 160
           + RD+K  NIL+  D   VK+A FG+A  + A   +  + +GT Y+ APE  +  +E   
Sbjct: 128 MHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE--VAAVEKNG 184

Query: 161 -YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            Y+   DIW VG    E+   +P     + +    R +    K +F    L+D       
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPM----RALFLMSKSNFQPPKLKDKTK---- 236

Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
                  + +   L  +P KR TA   L   +
Sbjct: 237 -WSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 33/190 (17%)

Query: 9   EGVPSSM----IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKD 63
           E +P  +    + E   L + +HPNI++L+ V +Q   +Y V E     D    L+  KD
Sbjct: 29  EDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD 88

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
            +    TK    ++L             D++  +++      I RDL   N LV  +   
Sbjct: 89  ELK---TKQLVKFAL-------------DAAAGMAYLESKNCIHRDLAARNCLVG-ENNV 131

Query: 122 VKVAGFGLAKS----LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
           +K++ FG+++     +Y+  G     +    + APE  L    YS+  D+W  G +  E 
Sbjct: 132 LKISDFGMSRQEDDGIYSSSGLKQIPIK---WTAPE-ALNYGRYSSESDVWSYGILLWET 187

Query: 178 VS-GKPLFPG 186
            S G   +PG
Sbjct: 188 FSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 26/64 (40%), Positives = 40/64 (62%), Gaps = 10/64 (15%)

Query: 141 SAEVGTHYYKAPELLLGL-LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL-------IT 192
           +A V T +Y++PE++LGL   YST  D+W +GCI  E+ +GK L+   ++L        T
Sbjct: 303 TAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360

Query: 193 LGRI 196
           LGR+
Sbjct: 361 LGRL 364

Length = 467

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 31/204 (15%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNS 75
           RE   L  L H +I+R   V ++G  L  VFEY  + DL   L+         +     +
Sbjct: 56  REAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA 115

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
               T   ++   S   S         ++ RDL   N LV   G  VK+  FG+++ +Y+
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYS 174

Query: 136 YKGESSAEVGTHYYKA------------PELLLGLLEYSTAVDIWPVGCIFGEMVS-GK- 181
                     T YY+             PE +L   +++T  DIW  G +  E+ + GK 
Sbjct: 175 ----------TDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQ 223

Query: 182 PLFPGANS----LITLGRIVGKSR 201
           P +  +N+     IT GR + + R
Sbjct: 224 PWYQLSNTEAIECITQGRELERPR 247

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 46/178 (25%), Positives = 72/178 (40%), Gaps = 36/178 (20%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLK--YPKDSMNGYSTKNFN 74
           E S + E N  +++RL+ V S G     V E     DL   L+   P+   N        
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNP----GLG 114

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
             +L     +  E +  D    L+   +++ RDL   N +V  D  TVK+  FG+ + +Y
Sbjct: 115 PPTLQKFIQMAAEIA--DGMAYLA-AKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIY 170

Query: 135 AYKGESSAEVGTHYYK------------APELLL-GLLEYSTAVDIWPVGCIFGEMVS 179
                      T YY+            APE L  G+  ++T  D+W  G +  EM +
Sbjct: 171 E----------TDYYRKGGKGLLPVRWMAPESLKDGV--FTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 43.6 bits (103), Expect = 4e-05
 Identities = 52/175 (29%), Positives = 75/175 (42%), Gaps = 34/175 (19%)

Query: 17  REVSCLMELNHPNIIRLMRVA-SQG-IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           RE+  L  L H NI++   V  S G   L  V EY           P  S+  Y  K+  
Sbjct: 54  REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY----------LPYGSLRDYLQKH-- 101

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
              L    LL+    +S   + + +    RY+ RDL   NILV+ + + VK+  FGL K 
Sbjct: 102 RERLDHRKLLL---YASQICKGMEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKV 157

Query: 133 LYAYK--------GESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           L   K        GES       ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 158 LPQDKEYYKVREPGESPI-----FWYAPESLTE-SKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 43.6 bits (103), Expect = 4e-05
 Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 25/168 (14%)

Query: 26  NHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL 84
           NH NI+ L+   + G  +  + EY    DL   L+  ++S          SY +      
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM-- 154

Query: 85  VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK-----SLYAYKGE 139
              F +S +          I RDL   N+L+   GK VK+  FGLA+     S Y  KG 
Sbjct: 155 --AFLASKNC---------IHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGN 202

Query: 140 SSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           +   V    + APE +   + Y+   D+W  G +  E+ S G   +PG
Sbjct: 203 ARLPVK---WMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.8 bits (103), Expect = 4e-05
 Identities = 71/280 (25%), Positives = 98/280 (35%), Gaps = 70/280 (25%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E   L  +NHP+II+L      G + Y  F          L  P+     Y T  +   +
Sbjct: 133 EAHILRAINHPSIIQLK-----GTFTYNKFT--------CLILPR-----YKTDLYCYLA 174

Query: 78  LFTTFLLVEEFSSSDSS-RSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
                 + +  +   S  R++ +    R I RD+K  NI ++  G  V +  FG A    
Sbjct: 175 AKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD-VCLGDFGAA---- 229

Query: 135 AYKGESSAE-----VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL------ 183
            +  + +A       GT    APELL     Y  AVDIW  G +  EM +          
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288

Query: 184 ------------------------FPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
                                   FP  ++   L  I     K S  K   R   TN   
Sbjct: 289 LDGDCDSDRQIKLIIRRSGTHPNEFP-IDAQANLDEIYIGLAKKSSRKPGSRPLWTN--- 344

Query: 220 GLEPAGID---LISKMLGMDPDKRITAAEALQQEYFKDVP 256
            L    ID   LI KML  D   R +A   L    F+D+P
Sbjct: 345 -LYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383

Length = 391

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 43.4 bits (102), Expect = 5e-05
 Identities = 54/239 (22%), Positives = 108/239 (45%), Gaps = 40/239 (16%)

Query: 16  IREVSCLMELNHPNIIRLMRVA----SQG-----IYLYPVFEYQVNDL-AYLLKYPKDSM 65
           +RE +C+ E +HPN+I+L+ V+    ++G     + + P  ++   DL  +LL      M
Sbjct: 49  LREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKH--GDLHTFLL------M 100

Query: 66  NGYSTKNFN-SYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTV 122
           +    + F         F++       D +  + +     +I RDL   N +++ +  TV
Sbjct: 101 SRIGEEPFTLPLQTLVRFMI-------DIASGMEYLSSKNFIHRDLAARNCMLNEN-MTV 152

Query: 123 KVAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
            VA FGL+K +Y+   Y+   ++++   +     L   +  Y+T  D+W  G    E+++
Sbjct: 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV--YTTHSDVWAFGVTMWEIMT 210

Query: 180 -GKPLFPGA-NSLITLGRIVG-KSRKPSFCKLSLRDHLTNGF---PGLEPAGIDLISKM 232
            G+  + G  NS I    I G + ++P  C   + + +   +   P   P+   L  ++
Sbjct: 211 RGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 5e-05
 Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 31/198 (15%)

Query: 27  HPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL 84
           H NII L+   +Q   LY + EY  + N   YL       M          YS     + 
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM---------EYSYDIARVP 130

Query: 85  VEEFSSSD---SSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
            E+ +  D    +  ++ G  Y      I RDL   N+LV  +   +K+A FGLA+ +  
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNN 189

Query: 136 ---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLFPG--AN 188
              YK  ++  +   +  APE L   + Y+   D+W  G +  E+ +  G P +PG    
Sbjct: 190 IDYYKKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVE 246

Query: 189 SLITLGRIVGKSRKPSFC 206
            L  L +   +  KP+ C
Sbjct: 247 ELFKLLKEGHRMDKPANC 264

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 23/151 (15%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG-----THYYKAPELLL 156
             I RD+K  NIL+  +G  VK+  FG +K    Y    S +VG     T YY APE+  
Sbjct: 163 HMIHRDIKSANILLCSNG-LVKLGDFGFSK---MYAATVSDDVGRTFCGTPYYVAPEIWR 218

Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
               YS   D++ +G +  E+++ K  F G N    +  ++ K+    +  L        
Sbjct: 219 -RKPYSKKADMFSLGVLLYELLTLKRPFDGEN----MEEVMHKTLAGRYDPLP------- 266

Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
             P + P   ++++ +L  DP +R ++++ L
Sbjct: 267 --PSISPEMQEIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 43.0 bits (102), Expect = 6e-05
 Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 28/155 (18%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--- 160
           I RD+K  NIL+  + + VK+  FG++  L +  G  +  +GT Y+ APE++    +   
Sbjct: 135 IHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDA 193

Query: 161 -YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            Y    D+W +G    E+  GKP     + +  L +I    R P               P
Sbjct: 194 SYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP---RNPP--------------P 236

Query: 220 GLEPAG------IDLISKMLGMDPDKRITAAEALQ 248
            L+          D IS+ L  + ++R    E L+
Sbjct: 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 7e-05
 Identities = 59/287 (20%), Positives = 95/287 (33%), Gaps = 74/287 (25%)

Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
            +++I E   L  +NHP++IR+      G     V  +  +DL   L           TK
Sbjct: 102 GTTLI-EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYL-----------TK 149

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
                 +    ++ ++         L +    R I RD+K  NI ++ D   V +   G 
Sbjct: 150 RSRPLPIDQALIIEKQIL-----EGLRYLHAQRIIHRDVKTENIFIN-DVDQVCIGDLGA 203

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV----------- 178
           A+             GT    APE+L    +Y++  DIW  G +  EM+           
Sbjct: 204 AQFPVVAPAFLGL-AGTVETNAPEVL-ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261

Query: 179 --------SGK-----------------PLFPGANSLITLGRIVGKSRKP-----SFCKL 208
                   S                   P  PG+  +          R+P      F ++
Sbjct: 262 STPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRV 321

Query: 209 SLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +L   +   F         L+ KML  D   R +A E L    F  +
Sbjct: 322 NL--PIDGEF---------LVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 42.7 bits (100), Expect = 8e-05
 Identities = 43/172 (25%), Positives = 82/172 (47%), Gaps = 15/172 (8%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLL--KYPKDSMNGYSTKNF 73
           +E S + EL+HPNI+ L+ V +Q   +  +FEY    DL   L  + P   +   S ++ 
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115

Query: 74  NSYSLFT--TFL-LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
              S      FL +  + ++     S  F   ++ +DL   NIL+  +   VK++  GL+
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIG-EQLHVKISDLGLS 171

Query: 131 KSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           + +Y+   Y+ +  + +   +     ++ G  ++S+  DIW  G +  E+ S
Sbjct: 172 REIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 42.7 bits (100), Expect = 8e-05
 Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 8/88 (9%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLL 159
           YI RDL+  NILV  D    K+A FGLA+ +     E +A  G  +   + APE  L   
Sbjct: 123 YIHRDLRAANILVG-DNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAAL-YG 178

Query: 160 EYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
            ++   D+W  G +  E+V+ G+  +PG
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 42.7 bits (100), Expect = 8e-05
 Identities = 54/187 (28%), Positives = 77/187 (41%), Gaps = 26/187 (13%)

Query: 26  NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL 84
           N P +++L        YLY V EY    DL  L+             N++    +  F  
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS------------NYDVPEKWAKFYT 148

Query: 85  VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL-YAYKGESSAE 143
            E   + D+  S+      I RD+KP N+L+D  G  +K+A FG    +           
Sbjct: 149 AEVVLALDAIHSMGL----IHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTA 203

Query: 144 VGTHYYKAPELLL---GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI-TLGRIVGK 199
           VGT  Y +PE+L    G   Y    D W VG    EM+ G   F  A+SL+ T  +I+  
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY-ADSLVGTYSKIM-- 260

Query: 200 SRKPSFC 206
             K S  
Sbjct: 261 DHKNSLN 267

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 34/181 (18%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
             +   ++RE + + +L++P I+R++ +     ++       V +LA L       +N +
Sbjct: 37  PALKDELLREANVMQQLDNPYIVRMIGICEAESWML------VMELAEL-----GPLNKF 85

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTV 122
             KN +          V E + ++    +S G +Y      + RDL   N+L+ +     
Sbjct: 86  LQKNKH----------VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL-VTQHYA 134

Query: 123 KVAGFGLAKSLYA----YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           K++ FGL+K+L A    YK ++  +    +Y APE  +   ++S+  D+W  G +  E  
Sbjct: 135 KISDFGLSKALGADENYYKAKTHGKWPVKWY-APE-CMNYYKFSSKSDVWSFGVLMWEAF 192

Query: 179 S 179
           S
Sbjct: 193 S 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 52/217 (23%), Positives = 88/217 (40%), Gaps = 38/217 (17%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFNS 75
           RE+    +L+H N++RL+ +  +    Y + EY  + DL   L+  K           ++
Sbjct: 57  RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 76  ---YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
               +L T   L  +  S+          R++ RDL   N LV    + VKV+   L+K 
Sbjct: 117 KQKVALCTQIALGMDHLSN---------ARFVHRDLAARNCLVSSQRE-VKVSLLSLSKD 166

Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLL----------EYSTAVDIWPVGCIFGEMVS-GK 181
           +Y      ++E    YYK    L+ L           ++ST  D+W  G +  E+ + G+
Sbjct: 167 VY------NSE----YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216

Query: 182 PLFPGANSLITLGRIVGKSRK---PSFCKLSLRDHLT 215
             F G +    L R+     +   P  C   L   +T
Sbjct: 217 LPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMT 253

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 39/140 (27%), Positives = 58/140 (41%), Gaps = 41/140 (29%)

Query: 80  TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL------ 133
           T F + E   + D+   L F    I RD+KP N+L+D  G  VK++ FGL   L      
Sbjct: 103 TQFYIAETVLAIDAIHQLGF----IHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRT 157

Query: 134 -------------YAYKGESS----------------AEVGTHYYKAPELLLGLLEYSTA 164
                        ++++  +S                + VGT  Y APE+ +    Y+  
Sbjct: 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKL 216

Query: 165 VDIWPVGCIFGEMVSGKPLF 184
            D W +G I  EM+ G P F
Sbjct: 217 CDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 40/140 (28%), Positives = 57/140 (40%), Gaps = 41/140 (29%)

Query: 80  TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL------ 133
           T F + E   + DS   L F    I RD+KP N+L+D  G  VK++ FGL   L      
Sbjct: 103 TQFYIAETVLAIDSIHQLGF----IHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRT 157

Query: 134 -------------YAYKGESS----------------AEVGTHYYKAPELLLGLLEYSTA 164
                        + ++  +S                + VGT  Y APE+ +    Y+  
Sbjct: 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKL 216

Query: 165 VDIWPVGCIFGEMVSGKPLF 184
            D W +G I  EM+ G P F
Sbjct: 217 CDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 41/187 (21%), Positives = 76/187 (40%), Gaps = 33/187 (17%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQG---------IYLYPVFEYQVNDL-AYLLKYPKDSM 65
           + E +C+ + +HPN+++L+ V  +          + + P  ++   DL ++LL     S 
Sbjct: 49  LSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKH--GDLHSFLLY----SR 102

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVA 125
            G   +     +L    + +       S+R       +I RDL   N ++  +  TV VA
Sbjct: 103 LGGLPEKLPLQTLLKFMVDIALGMEYLSNR------NFIHRDLAARNCMLR-EDMTVCVA 155

Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE-----YSTAVDIWPVGCIFGE-MVS 179
            FGL+K +Y+              K P   + +       Y++  D+W  G    E    
Sbjct: 156 DFGLSKKIYS----GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Query: 180 GKPLFPG 186
           G+  +PG
Sbjct: 212 GQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 37/203 (18%)

Query: 2   MGIHNTMEGV------PSSM-----IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ 50
           MG +N    V      P +M     + E + +  L H  ++RL  V ++   +Y + EY 
Sbjct: 24  MGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83

Query: 51  VNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS-SSDSSRSLSFGTR--YIRRD 107
                 LL + K    G               LL +    S+  +  +++  R  YI RD
Sbjct: 84  AK--GSLLDFLKSDEGG-------------KVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128

Query: 108 LKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTA 164
           L+  N+LV  +    K+A FGLA+ +     E +A  G  +   + APE  +    ++  
Sbjct: 129 LRAANVLVS-ESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPE-AINFGSFTIK 184

Query: 165 VDIWPVGCIFGEMVS-GKPLFPG 186
            D+W  G +  E+V+ GK  +PG
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 11/89 (12%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAK-----SLYAYKGESSAEVGTHYYKAPELLLGL 158
           I RD+   N+L+  DG+  K+  FGLA+     S Y  KG +   V    + APE +   
Sbjct: 234 IHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFDC 289

Query: 159 LEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + Y+   D+W  G +  E+ S GK  +PG
Sbjct: 290 V-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 73/279 (26%), Positives = 97/279 (34%), Gaps = 78/279 (27%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E+  L  LNH NI+++     + I       Y +       KY           +F+ YS
Sbjct: 213 EILALGRLNHENILKI-----EEILRSEANTYMITQ-----KY-----------DFDLYS 251

Query: 78  LFTTFLLVEEFSSSDSS---------RSLSFGTRY------IRRDLKPVNILVDLDGKTV 122
               F+  E F   D           + L     Y      I RD+K  NI ++ DGK V
Sbjct: 252 ----FMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV 307

Query: 123 KVAGFGLAKSLYAYKGESSAE----VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
            +  FG A     ++ E  A     VGT    +PE+L G   Y    DIW  G I  +M+
Sbjct: 308 -LGDFGTAMP---FEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDML 362

Query: 179 SGKPLFP----GANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGID------- 227
           S     P    G      L +I+      S C     D     F  ++ A ID       
Sbjct: 363 S-HDFCPIGDGGGKPGKQLLKII---DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVP 418

Query: 228 -LIS-------------KMLGMDPDKRITAAEALQQEYF 252
            LI              KML  D   R  AAE L    F
Sbjct: 419 PLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457

Length = 501

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 5/85 (5%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL----G 157
           + I RD+K  N+L+  +   VK+  FG++  L    G  +  +GT Y+ APE++      
Sbjct: 131 KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 189

Query: 158 LLEYSTAVDIWPVGCIFGEMVSGKP 182
              Y    D+W +G    EM  G P
Sbjct: 190 DATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 40/178 (22%), Positives = 69/178 (38%), Gaps = 36/178 (20%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSY 76
           E   + + NH NI+RL+ V+ + +  + + E     DL   L+  +              
Sbjct: 59  EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE-------RPS 111

Query: 77  SLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLY 134
           SL    LL      +   + L     +I RD+   N L+   G  +  K+A FG+A+ +Y
Sbjct: 112 SLTMKDLLFCARDVAKGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY 170

Query: 135 AYKGESSAEVGTHYYK------------APELLL-GLLEYSTAVDIWPVGCIFGEMVS 179
                        YY+             PE  L G+  +++  D+W  G +  E+ S
Sbjct: 171 ----------RASYYRKGGRAMLPIKWMPPEAFLDGI--FTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 5/83 (6%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL----GLL 159
           I RD+K  N+L+  +   VK+  FG++  L    G  +  +GT Y+ APE++        
Sbjct: 143 IHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 201

Query: 160 EYSTAVDIWPVGCIFGEMVSGKP 182
            Y    DIW +G    EM  G P
Sbjct: 202 TYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 40.7 bits (95), Expect = 3e-04
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 18/165 (10%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +H NIIRL  V ++      + EY  N    L KY +D  +G          
Sbjct: 56  EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMEN--GALDKYLRDH-DGE--------- 103

Query: 78  LFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            F+++ LV       +         Y+ RDL   NILV+      KV+ FGL++ L    
Sbjct: 104 -FSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDP 161

Query: 138 GESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +    G      + APE  +   ++++A D+W  G +  E++S
Sbjct: 162 EGTYTTSGGKIPIRWTAPE-AIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.2 bits (96), Expect = 3e-04
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 11/89 (12%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLLGL 158
           + RDL   N+L+   GK VK+  FGLA+ +     Y  KG +   V    + APE +   
Sbjct: 259 VHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK---WMAPESIFDN 314

Query: 159 LEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           L Y+T  D+W  G +  E+ S G   +PG
Sbjct: 315 L-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 8/91 (8%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLL 159
           YI RDL+  NILV       K+A FGLA+ +     E +A  G  +   + APE  +   
Sbjct: 123 YIHRDLRAANILVS-ASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPE-AINFG 178

Query: 160 EYSTAVDIWPVGCIFGEMVS-GKPLFPGANS 189
            ++   D+W  G +  E+V+ G+  +PG ++
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 39/142 (27%), Positives = 69/142 (48%), Gaps = 14/142 (9%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL--- 158
           +++ RDL   N ++D +  TVKVA FGLA+ +Y  +  S         K P   + L   
Sbjct: 118 KFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHN--HTGAKLPVKWMALESL 174

Query: 159 --LEYSTAVDIWPVGCIFGE-MVSGKPLFPGANSL-ITLGRIVGKS-RKPSFCKLSLRDH 213
              +++T  D+W  G +  E M  G P +P  +S  IT+  + G+   +P +C   L + 
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234

Query: 214 LT---NGFPGLEPAGIDLISKM 232
           +    +  P + P   +L+S++
Sbjct: 235 MLSCWHPKPEMRPTFSELVSRI 256

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 40.5 bits (95), Expect = 4e-04
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 13/91 (14%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSA---EVGTHYYKAPELLLGLLE 160
           I RD+KP N+L++ +G+ VK+  FG++  L     +S A   + G   Y APE +   L 
Sbjct: 126 IHRDVKPSNVLINRNGQ-VKLCDFGISGYLV----DSVAKTIDAGCKPYMAPERINPELN 180

Query: 161 ---YSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
              Y    D+W +G    E+ +G+  FP  +
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGR--FPYDS 209

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 7/87 (8%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLE 160
           I RDL   NIL+  +   VK+  FGLA+ +Y    Y  + SA +   +  APE +   + 
Sbjct: 196 IHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APESIFDKV- 252

Query: 161 YSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           Y+T  D+W  G +  E+ S G   +PG
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.4 bits (94), Expect = 5e-04
 Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 15/119 (12%)

Query: 78  LFTTFLLVEEF--SSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
           L+   L +E+    S   ++ + F    + I RDL   NIL+  +   VK+  FGLA+ +
Sbjct: 171 LYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDI 229

Query: 134 -----YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
                Y  KG++   +    + APE +   + Y+   D+W  G +  E+ S G   +PG
Sbjct: 230 YKDPDYVRKGDARLPLK---WMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 39.4 bits (92), Expect = 8e-04
 Identities = 37/141 (26%), Positives = 62/141 (43%), Gaps = 23/141 (16%)

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV 165
           RDL P NIL+D  G  +++  F         +     E   + Y APE+  G+ E + A 
Sbjct: 109 RDLNPNNILLDDRGH-IQLTYFS---RWSEVEDSCDGEAVENMYCAPEVG-GISEETEAC 163

Query: 166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAG 225
           D W +G I  E+++GK L     S I            +   L++ + ++      E A 
Sbjct: 164 DWWSLGAILFELLTGKTLVECHPSGIN-----------THTTLNIPEWVS------EEAR 206

Query: 226 IDLISKMLGMDPDKRITAAEA 246
             L+ ++L  +P +R+ A  A
Sbjct: 207 -SLLQQLLQFNPTERLGAGVA 226

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 39.8 bits (93), Expect = 8e-04
 Identities = 30/84 (35%), Positives = 36/84 (42%), Gaps = 5/84 (5%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA--YKGESSAEVGTHYYKAPELLLGLLEY 161
           I RD+K  NI +D     V +  FG A  L A     +     GT    +PELL  L  Y
Sbjct: 207 IHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL-ALDPY 264

Query: 162 STAVDIWPVGCIFGEM-VSGKPLF 184
               DIW  G +  EM V    LF
Sbjct: 265 CAKTDIWSAGLVLFEMSVKNVTLF 288

Length = 392

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.8 bits (93), Expect = 8e-04
 Identities = 29/89 (32%), Positives = 44/89 (49%), Gaps = 7/89 (7%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLE 160
           I RDL   NIL+  +   VK+  FGLA+ +Y    Y  +  A +   +  APE +   + 
Sbjct: 195 IHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APESIFDKV- 251

Query: 161 YSTAVDIWPVGCIFGEMVS-GKPLFPGAN 188
           Y+T  D+W  G +  E+ S G   +PG  
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 38.4 bits (89), Expect = 0.002
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 21/174 (12%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVA-SQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
           + + E + + +L+H N++RL+ V    G+Y+      + N + +L    +  ++      
Sbjct: 45  AFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ 104

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
           F+        L V E      S+ L      + RDL   NILV  DG   KV+ FGLA+ 
Sbjct: 105 FS--------LDVAEGMEYLESKKL------VHRDLAARNILVSEDG-VAKVSDFGLARV 149

Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFP 185
                G  ++++    + APE L    ++S+  D+W  G +  E+ S G+  +P
Sbjct: 150 --GSMGVDNSKLPVK-WTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 37.9 bits (88), Expect = 0.003
 Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 22/168 (13%)

Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNII L  V ++   +  + E+  N           +++ +  +N     
Sbjct: 55  EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMEN----------GALDSFLRQNDGQ-- 102

Query: 78  LFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY--- 134
            FT   LV       +         Y+ RDL   NILV+      KV+ FGL++ L    
Sbjct: 103 -FTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDT 160

Query: 135 ---AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
               Y      ++    + APE  +   ++++A D+W  G +  E++S
Sbjct: 161 SDPTYTSSLGGKIPIR-WTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 37.9 bits (89), Expect = 0.003
 Identities = 25/80 (31%), Positives = 37/80 (46%), Gaps = 5/80 (6%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
             I  D+K  N+L D     + +  +GL K      G  S   GT  Y +PE + G   Y
Sbjct: 129 NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI----IGTPSCYDGTLDYFSPEKIKGHN-Y 183

Query: 162 STAVDIWPVGCIFGEMVSGK 181
             + D W VG +  E+++GK
Sbjct: 184 DVSFDWWAVGVLTYELLTGK 203

Length = 267

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	259
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
PRK09188	365	serine/threonine protein kinase; Provisional	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.78
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.75
PRK10345	210	hypothetical protein; Provisional	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.65
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.62
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
PRK14879	211	serine/threonine protein kinase; Provisional	99.55
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.54
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.52
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.51
KOG1243	690	consensus Protein kinase [General function predict	99.49
smart00090	237	RIO RIO-like kinase.	99.45
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.45
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.39
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.32
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.3
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.17
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.14
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.09
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.06
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.05
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.04
KOG3087	229	consensus Serine/threonine protein kinase [General	98.96
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.88
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.84
COG4248	637	Uncharacterized protein with protein kinase and he	98.84
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.8
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.69
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.61
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.57
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.53
PRK09902	216	hypothetical protein; Provisional	98.35
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.24
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.92
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.8
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.61
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.57
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.53
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.27
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.26
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.25
PLN02876	822	acyl-CoA dehydrogenase	97.12
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.1
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.94
COG0661	517	AarF Predicted unusual protein kinase [General fun	96.72
PLN02236	344	choline kinase	96.62
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.9
KOG1235	538	consensus Predicted unusual protein kinase [Genera	95.84
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.48
PRK10593	297	hypothetical protein; Provisional	95.31
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.16
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	94.86
PRK05231	319	homoserine kinase; Provisional	94.5
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	94.38
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.37
PF01636	239	APH: Phosphotransferase enzyme family This family	94.24
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	94.02
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	93.83
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	93.59
PTZ00384	383	choline kinase; Provisional	93.35
PRK10271	188	thiK thiamine kinase; Provisional	93.25
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.74
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	92.6
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	92.59
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	92.23
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	92.09
KOG4720	391	consensus Ethanolamine kinase [Lipid transport and	91.97
COG2334	331	Putative homoserine kinase type II (protein kinase	91.63
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.29
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	91.24
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	91.02
KOG2270	520	consensus Serine/threonine protein kinase involved	90.73
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	88.88
PRK06148	1013	hypothetical protein; Provisional	87.74
PHA03111	444	Ser/Thr kinase; Provisional	86.96
PRK09550	401	mtnK methylthioribose kinase; Reviewed	85.85
PRK06149	972	hypothetical protein; Provisional	85.58

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-54  Score=345.07  Aligned_cols=217  Identities=30%  Similarity=0.389  Sum_probs=181.8

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .++.+|+++|++|+|||||+++++|+..+..|+||||+.| .|.+.+-..               ..+.+..-..++.|+
T Consensus       221 ~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n---------------k~l~ed~~K~~f~Ql  285 (475)
T KOG0615|consen  221 RDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN---------------KYLREDLGKLLFKQL  285 (475)
T ss_pred             hhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhc---------------cccccchhHHHHHHH
Confidence            4467999999999999999999999999999999999996 888887432               333444557889999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCC---CCeEEEeeccccccccccCCCCcCCccCccccCcccccCc--cCCCcccc
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLD---GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL--LEYSTAVD  166 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~---~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~D  166 (259)
                      +.|+.|||+.||+||||||+|||++.+   . .+||+|||+|+... ...-..+.+|||.|.|||++.+.  ..++.++|
T Consensus       286 l~avkYLH~~GI~HRDiKPeNILl~~~~e~~-llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVD  363 (475)
T KOG0615|consen  286 LTAVKYLHSQGIIHRDIKPENILLSNDAEDC-LLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVD  363 (475)
T ss_pred             HHHHHHHHHcCcccccCCcceEEeccCCcce-EEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchhe
Confidence            999999999999999999999999876   4 79999999998653 23346778999999999999752  33456899


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHH-HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLI-TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +||+||++|-+++|.+||.+..... ...+|..+...          ..+..|..+|++.++||..||.+||++||+++|
T Consensus       364 iWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~----------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~e  433 (475)
T KOG0615|consen  364 IWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA----------FGPLQWDRISEEALDLINWMLVVDPENRPSADE  433 (475)
T ss_pred             eeeccceEEEEeccCCCcccccCCccHHHHHhcCccc----------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHH
Confidence            9999999999999999999877666 55555544322          223456789999999999999999999999999


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +|+||||+..+
T Consensus       434 aL~hpW~~~~~  444 (475)
T KOG0615|consen  434 ALNHPWFKDAP  444 (475)
T ss_pred             HhcChhhhccc
Confidence            99999999765

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-53  Score=336.13  Aligned_cols=218  Identities=26%  Similarity=0.358  Sum_probs=190.6

Q ss_pred             CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc-eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159            7 TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGI-YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ..+...+++.+|++++++.+||+||.+||+|+.+. .++++||||.| +|..++...               ..++...+
T Consensus       116 ~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~---------------g~i~E~~L  180 (364)
T KOG0581|consen  116 IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV---------------GRIPEPVL  180 (364)
T ss_pred             CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc---------------CCCCHHHH
Confidence            34567788999999999999999999999999988 59999999995 899988643               44677888


Q ss_pred             HHHHhhcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCc
Q 039159           85 VEEFSSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      ..++.++++||.|||+ ++|+||||||+|+|++..| .|||+|||.+..+.+.  ...++.||..|||||.+.+ ..|+.
T Consensus       181 ~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g-~~Ys~  256 (364)
T KOG0581|consen  181 GKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVNS--IANTFVGTSAYMSPERISG-ESYSV  256 (364)
T ss_pred             HHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhhh--hcccccccccccChhhhcC-CcCCc
Confidence            9999999999999995 9999999999999999998 8999999999988665  5677899999999999998 68999


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGA-----NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      ++||||||++++|+++|+.||...     ...+.+..|..+. .|..+.           ..+|+++++||..||++||.
T Consensus       257 ~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-pP~lP~-----------~~fS~ef~~FV~~CL~Kdp~  324 (364)
T KOG0581|consen  257 KSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-PPRLPE-----------GEFSPEFRSFVSCCLRKDPS  324 (364)
T ss_pred             ccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC-CCCCCc-----------ccCCHHHHHHHHHHhcCCcc
Confidence            999999999999999999999874     5667777776543 222221           13899999999999999999


Q ss_pred             CccCHHHHhcCccccCC
Q 039159          239 KRITAAEALQQEYFKDV  255 (259)
Q Consensus       239 ~Rp~~~~~l~h~~f~~~  255 (259)
                      +||++.++++|||++.-
T Consensus       325 ~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  325 ERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             cCCCHHHHhcCHHHhhc
Confidence            99999999999999854

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-51  Score=343.27  Aligned_cols=215  Identities=27%  Similarity=0.349  Sum_probs=194.6

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +....+++.+||+|++.|+|||||+++++|++++++|+|+|+|.. +|-.+++..               ..+++.....
T Consensus        58 k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krr---------------k~ltEpEary  122 (592)
T KOG0575|consen   58 KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRR---------------KPLTEPEARY  122 (592)
T ss_pred             CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhc---------------CCCCcHHHHH
Confidence            456678999999999999999999999999999999999999995 888888621               5677889999


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +++||+.|+.|||+++|+|||||..|++++.+. .|||+|||+|..+........+.+|||-|.|||++.. ...+..+|
T Consensus       123 ~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvD  200 (592)
T KOG0575|consen  123 FLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVD  200 (592)
T ss_pred             HHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeeeecCcccccceecCCCcccChhHhcc-CCCCCchh
Confidence            999999999999999999999999999999887 8999999999998877677788899999999999986 67899999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||+||+||.+++|+|||...+-.+.+..|........              ..+|.++++||.+||+.||.+|||+++|
T Consensus       201 iWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P--------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~v  266 (592)
T KOG0575|consen  201 IWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP--------------SHLSAEAKDLIRKLLRPNPSERPSLDEV  266 (592)
T ss_pred             hhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc--------------cccCHHHHHHHHHHhcCCcccCCCHHHH
Confidence            99999999999999999999998889988865443211              3689999999999999999999999999


Q ss_pred             hcCcccc
Q 039159          247 LQQEYFK  253 (259)
Q Consensus       247 l~h~~f~  253 (259)
                      |.|+||.
T Consensus       267 L~h~Ff~  273 (592)
T KOG0575|consen  267 LDHPFFK  273 (592)
T ss_pred             hcCHhhh
Confidence            9999994

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.3e-52  Score=322.74  Aligned_cols=232  Identities=31%  Similarity=0.507  Sum_probs=198.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+-+++||++|++|+|||+|.++.+|.....++||+|||..+..+.+....              ..+....+..++
T Consensus        42 ~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p--------------~G~~~~~vk~~l  107 (396)
T KOG0593|consen   42 PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYP--------------NGVPSELVKKYL  107 (396)
T ss_pred             HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhcc--------------CCCCHHHHHHHH
Confidence            356777889999999999999999999999999999999999998777775421              456667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +|++.|++|+|+++++||||||+||+++.+| .+||||||+|+.+...+..-...+.|.+|+|||.+.+...|+..+|||
T Consensus       108 ~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiW  186 (396)
T KOG0593|consen  108 YQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIW  186 (396)
T ss_pred             HHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccch
Confidence            9999999999999999999999999999999 999999999998875555555567899999999999878899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCC--CC---------------CccccccccccccCCCCCCCHHHHHHHHh
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKS--RK---------------PSFCKLSLRDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~--~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~  231 (259)
                      |+||++.||++|.+.|++.++..+...|....  ..               ...|..+-.++++..+++++.-+.||+++
T Consensus       187 AiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~  266 (396)
T KOG0593|consen  187 AIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKK  266 (396)
T ss_pred             hhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHH
Confidence            99999999999999999999888877762211  11               22233334456777788899999999999


Q ss_pred             hcCcCCCCccCHHHHhcCccccCC
Q 039159          232 MLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ||..||++|++.+++|.||||.+.
T Consensus       267 cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  267 CLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             HhcCCccccccHHHHhcChHHHHH
Confidence            999999999999999999999653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-51  Score=338.90  Aligned_cols=225  Identities=26%  Similarity=0.400  Sum_probs=200.3

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |++....+.-.+=+++|+.+|+..+|+|||++++.|..++.+|+||||+.| +|.+++..                ..+.
T Consensus       304 K~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~----------------~~~~  367 (550)
T KOG0578|consen  304 KRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK----------------TRMT  367 (550)
T ss_pred             EEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc----------------cccc
Confidence            444455566677889999999999999999999999999999999999996 88888854                5588


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccC
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      +.++..++..+++||+|||..||+|||||.+|||++.+| .+||+|||++..+........+.+|||+|||||++.. ..
T Consensus       368 E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr-k~  445 (550)
T KOG0578|consen  368 EGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR-KP  445 (550)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeeeeeccccccCccccccCCCCccchhhhhh-cc
Confidence            899999999999999999999999999999999999999 8999999999988776667788899999999999977 68


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      |+.+.||||||++.+||..|++||...++......|.......-           .....+|+.+++|+.+||++|+.+|
T Consensus       446 YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l-----------k~~~klS~~~kdFL~~cL~~dv~~R  514 (550)
T KOG0578|consen  446 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL-----------KNPEKLSPELKDFLDRCLVVDVEQR  514 (550)
T ss_pred             cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc-----------CCccccCHHHHHHHHHHhhcchhcC
Confidence            99999999999999999999999999999999988876553321           1134689999999999999999999


Q ss_pred             cCHHHHhcCccccCC
Q 039159          241 ITAAEALQQEYFKDV  255 (259)
Q Consensus       241 p~~~~~l~h~~f~~~  255 (259)
                      +++.|+|+||||+..
T Consensus       515 asA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  515 ASAKELLEHPFLKMA  529 (550)
T ss_pred             CCHHHHhcChhhhhc
Confidence            999999999999643

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=322.24  Aligned_cols=224  Identities=36%  Similarity=0.542  Sum_probs=190.4

Q ss_pred             HHHHHHHhhCC-CCCeeEEEEEEEeCc-eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhccc
Q 039159           16 IREVSCLMELN-HPNIIRLMRVASQGI-YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDS   93 (259)
Q Consensus        16 ~~Ei~~l~~l~-H~niv~~~~~~~~~~-~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (259)
                      .|||+.|++|+ |||||++..++.+.+ .+|+|||||+..|+++++...              ..++...+..+++|+++
T Consensus        56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~--------------r~fse~~irnim~Qilq  121 (538)
T KOG0661|consen   56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRN--------------RLFSESDIRNIMYQILQ  121 (538)
T ss_pred             HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcC--------------CcCCHHHHHHHHHHHHH
Confidence            48999999999 999999999999888 999999999999999997531              66888999999999999


Q ss_pred             ccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHHHH
Q 039159           94 SRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCI  173 (259)
Q Consensus        94 ~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~  173 (259)
                      ||+|+|++|+.|||+||+|||+.... .+||+|||+|+.+... +.-...+.|.+|+|||+++....|+...|+||+||+
T Consensus       122 GL~hiHk~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI  199 (538)
T KOG0661|consen  122 GLAHIHKHGFFHRDLKPENILISGND-VIKIADFGLAREVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCI  199 (538)
T ss_pred             HHHHHHhcCcccccCChhheEecccc-eeEecccccccccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHH
Confidence            99999999999999999999999666 8999999999987553 344456789999999999987889999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccc----------------ccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          174 FGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLS----------------LRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       174 l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      ++|+++-++.|+|.+...++.+|..-.-.|......                ....+....++.++++.++|.+|+.+||
T Consensus       200 ~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP  279 (538)
T KOG0661|consen  200 MAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDP  279 (538)
T ss_pred             HHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCC
Confidence            999999999999999888887774332222211111                1113334456789999999999999999


Q ss_pred             CCccCHHHHhcCccccCC
Q 039159          238 DKRITAAEALQQEYFKDV  255 (259)
Q Consensus       238 ~~Rp~~~~~l~h~~f~~~  255 (259)
                      ++||||.++|+||||+.-
T Consensus       280 ~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  280 DKRPTASQALQHPFFQVG  297 (538)
T ss_pred             ccCccHHHHhcCcccccc
Confidence            999999999999999853

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.4e-49  Score=296.28  Aligned_cols=236  Identities=36%  Similarity=0.613  Sum_probs=203.1

Q ss_pred             CCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159            6 NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus         6 ~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      +.++.+...+.+||+.|+.++|+||+.++|+|.....+.+|+||++-+|+.+++...              ..+...++.
T Consensus        39 ~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~--------------i~l~pa~iK  104 (318)
T KOG0659|consen   39 NAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKN--------------IILSPADIK  104 (318)
T ss_pred             ccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccccHHHHhcccc--------------cccCHHHHH
Confidence            456778889999999999999999999999999999999999999999999997532              567778899


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.+.++|++|||.+.|.||||||.|+|++.+| .+||+|||+++.+..........+-|.+|+|||.+.|...|+...
T Consensus       105 ~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~V  183 (318)
T KOG0659|consen  105 SYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGV  183 (318)
T ss_pred             HHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcc
Confidence            9999999999999999999999999999999999 899999999998765544444446789999999999988999999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccc--------------ccccccCCCCCCCHHHHHHHHh
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLS--------------LRDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~  231 (259)
                      |+||.||++.|++.|.+.|++.++.++...|....-.|.-...+              ........++..++++.||+.+
T Consensus       184 DmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~  263 (318)
T KOG0659|consen  184 DMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSK  263 (318)
T ss_pred             hhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHh
Confidence            99999999999999999999999999888885544333222211              1122334567788999999999


Q ss_pred             hcCcCCCCccCHHHHhcCccccCCC
Q 039159          232 MLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |+..||.+|+++.++|+|+||++-+
T Consensus       264 m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  264 MLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             hhccCchhcccHHHHhcchhhhcCC
Confidence            9999999999999999999999754

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-49  Score=328.71  Aligned_cols=218  Identities=27%  Similarity=0.402  Sum_probs=196.1

Q ss_pred             CCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159            6 NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus         6 ~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      +.++..+..+.+||-||+.+.||||+.+|+++++..++|+|+||++| .|++.+...               +.+.....
T Consensus        50 ~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~k---------------G~l~e~ea  114 (786)
T KOG0588|consen   50 ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRK---------------GPLPEREA  114 (786)
T ss_pred             ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhh---------------CCCCCHHH
Confidence            44677889999999999999999999999999999999999999995 888888543               55677889


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      +..|.||+.|+.|||..+|+||||||+|+|++..+ .+||+|||+|.. ...+....+-+|+|.|.|||.+.|....+.+
T Consensus       115 a~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-nIKIADFGMAsL-e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~  192 (786)
T KOG0588|consen  115 AHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-NIKIADFGMASL-EVPGKLLETSCGSPHYAAPEIVSGRPYDGRP  192 (786)
T ss_pred             HHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-CEeeeccceeec-ccCCccccccCCCcccCCchhhcCCCCCCCc
Confidence            99999999999999999999999999999999998 699999999974 4556678888999999999999997777999


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCC-CCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSR-KPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +||||+||+||.++||+.||.+.+....+.++..+.. .|               .++|+++++||.+||.+||.+|.|.
T Consensus       193 sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP---------------s~Is~eaQdLLr~ml~VDp~~RiT~  257 (786)
T KOG0588|consen  193 SDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP---------------SNISSEAQDLLRRMLDVDPSTRITT  257 (786)
T ss_pred             cccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC---------------CcCCHHHHHHHHHHhccCccccccH
Confidence            9999999999999999999999999988888865532 22               4689999999999999999999999


Q ss_pred             HHHhcCccccCC
Q 039159          244 AEALQQEYFKDV  255 (259)
Q Consensus       244 ~~~l~h~~f~~~  255 (259)
                      ++|++|||+..-
T Consensus       258 ~eI~kHP~l~g~  269 (786)
T KOG0588|consen  258 EEILKHPFLSGY  269 (786)
T ss_pred             HHHhhCchhhcC
Confidence            999999998754

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-48  Score=316.95  Aligned_cols=237  Identities=37%  Similarity=0.590  Sum_probs=199.9

Q ss_pred             CCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159            4 IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus         4 ~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      +.++.++.+.-+.+||.||++|+||||+++.++..+.  ..+|||||||+.+|.-++....              ..++.
T Consensus       152 ~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~--------------vkft~  217 (560)
T KOG0600|consen  152 FDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPG--------------VKFTE  217 (560)
T ss_pred             cccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCC--------------cccCh
Confidence            3445578888889999999999999999999998776  6899999999999999886532              56888


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccCccC
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      .++..++.|++.||+|||++||.|||||.+|||||.+| .+||+|||+|+........ ....+-|++|+|||.++|...
T Consensus       218 ~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~  296 (560)
T KOG0600|consen  218 PQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATS  296 (560)
T ss_pred             HHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcc
Confidence            99999999999999999999999999999999999888 8999999999876544322 444567999999999999889


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc---------------cccccccCCCCCCCHHH
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL---------------SLRDHLTNGFPGLEPAG  225 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~  225 (259)
                      |+.+.|+||+||+|.||++|++.|.+....+++..|+..+-.|...-.               .....+...+..+++.+
T Consensus       297 Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~  376 (560)
T KOG0600|consen  297 YGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASA  376 (560)
T ss_pred             cccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHH
Confidence            999999999999999999999999999999988888554433222111               11222333456789999


Q ss_pred             HHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          226 IDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       226 ~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      .+|+..||..||++|.|+.++|+++||...
T Consensus       377 l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  377 LDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             HHHHHHHhccCccccccHHHHhcCcccccC
Confidence            999999999999999999999999999544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-48  Score=306.96  Aligned_cols=217  Identities=29%  Similarity=0.406  Sum_probs=193.1

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+...+|..+|.+++||.||+++..|++.+.+|+|+||+.| .|...++..               ..+......-++
T Consensus        67 ~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~e---------------g~F~E~~arfYl  131 (357)
T KOG0598|consen   67 KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQRE---------------GRFSEDRARFYL  131 (357)
T ss_pred             hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhc---------------CCcchhHHHHHH
Confidence            4567889999999999999999999999999999999999997 899988653               456666777888


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ..++.||.|||++||+||||||+|||+|.+| +++|+|||+++..........+.+||+.|+|||.+.+ ..++..+|.|
T Consensus       132 aEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWW  209 (357)
T KOG0598|consen  132 AEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG-KGYDKAVDWW  209 (357)
T ss_pred             HHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhcccCCCccccccCCccccChHHHhc-CCCCcccchH
Confidence            8999999999999999999999999999999 9999999999977666667788899999999999998 5899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc----CHH
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI----TAA  244 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----~~~  244 (259)
                      |+|+++|+|++|.+||.+.+......++.......             ...-++++++++++++|..||.+|.    ++.
T Consensus       210 sLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~-------------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~  276 (357)
T KOG0598|consen  210 SLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL-------------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAE  276 (357)
T ss_pred             hHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC-------------CCccCCHHHHHHHHHHhccCHHHhcCCCCChH
Confidence            99999999999999999999999998887665111             0123889999999999999999996    699


Q ss_pred             HHhcCccccCCC
Q 039159          245 EALQQEYFKDVP  256 (259)
Q Consensus       245 ~~l~h~~f~~~~  256 (259)
                      ++-+||||.++.
T Consensus       277 ~ik~HpfF~~in  288 (357)
T KOG0598|consen  277 EIKRHPFFKGIN  288 (357)
T ss_pred             HhhcCcccccCC
Confidence            999999999874

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-48  Score=306.63  Aligned_cols=228  Identities=25%  Similarity=0.401  Sum_probs=192.1

Q ss_pred             CCCCCCC--CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcc
Q 039159            1 MMGIHNT--MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYS   77 (259)
Q Consensus         1 ~~~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~   77 (259)
                      ||.|.+.  ..+..+.+..||.+|+.++|||||.++++++.++.+|+|||||.| +|..+++..               .
T Consensus        40 IK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~---------------~  104 (429)
T KOG0595|consen   40 IKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR---------------G  104 (429)
T ss_pred             eeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc---------------C
Confidence            3455555  456778899999999999999999999999999999999999995 999999753               3


Q ss_pred             hhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCC--C---CeEEEeeccccccccccCCCCcCCccCccccCc
Q 039159           78 LFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLD--G---KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAP  152 (259)
Q Consensus        78 ~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~--~---~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aP  152 (259)
                      .+........+.|++.|+++||+++||||||||+|||++..  +   ..+||+|||+|+.+. .+....+.+|+|.||||
T Consensus       105 ~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~-~~~~a~tlcGSplYMAP  183 (429)
T KOG0595|consen  105 RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ-PGSMAETLCGSPLYMAP  183 (429)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC-chhHHHHhhCCccccCH
Confidence            45667788889999999999999999999999999999864  1   368999999999875 34456778999999999


Q ss_pred             ccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhh
Q 039159          153 ELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                      |++.. ..|+.++|+||+|+++|++++|++||...+..+....+..........           ....++...+++...
T Consensus       184 EV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~-----------~~~~s~~~~~Ll~~l  251 (429)
T KOG0595|consen  184 EVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVL-----------PAELSNPLRELLISL  251 (429)
T ss_pred             HHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCch-----------hhhccCchhhhhhHH
Confidence            99976 689999999999999999999999999999888887664443332221           134677778999999


Q ss_pred             cCcCCCCccCHHHHhcCccccCCC
Q 039159          233 LGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      +..++..|.+..+-+.|++.+.-+
T Consensus       252 l~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  252 LQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             HhcCccccCchHHhhhhhhcccCc
Confidence            999999999999999999887543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-49  Score=301.91  Aligned_cols=213  Identities=27%  Similarity=0.385  Sum_probs=183.7

Q ss_pred             CCCCCCCchhHHHHHHHhhCCCCCeeEEEE-EEEeCce-EEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            6 NTMEGVPSSMIREVSCLMELNHPNIIRLMR-VASQGIY-LYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         6 ~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~-~~~~~~~-~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      ..++....+...|+.+|++|+|||||++++ .+.+++. +++|||+|. |+|.+.++..+...           ..++..
T Consensus        56 ~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qk-----------r~ipE~  124 (375)
T KOG0591|consen   56 MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQK-----------RLIPEK  124 (375)
T ss_pred             hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhcc-----------ccCchH
Confidence            344556678899999999999999999999 5666655 899999999 69999998765432           567778


Q ss_pred             HHHHHHhhcccccccccC--CC--ceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc
Q 039159           83 LLVEEFSSSDSSRSLSFG--TR--YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~--~~--i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (259)
                      .+++++.|++.||..+|.  ..  ++||||||.||+++.+| .|||+|||+++.+.....-....+|||.||+||.+.+ 
T Consensus       125 ~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~-  202 (375)
T KOG0591|consen  125 TVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE-  202 (375)
T ss_pred             HHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc-
Confidence            899999999999999998  45  89999999999999998 8999999999988766656677899999999999988 


Q ss_pred             cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      ..|+.++||||+||++|||+.-++||.+.+-.+...+|.++ ..|..+.           ..+|.++..+|..|+.+||.
T Consensus       203 ~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~-----------~~YS~~l~~li~~ci~vd~~  270 (375)
T KOG0591|consen  203 SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPD-----------EHYSTDLRELINMCIAVDPE  270 (375)
T ss_pred             CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcH-----------HHhhhHHHHHHHHHccCCcc
Confidence            78999999999999999999999999999888777777655 3444332           35889999999999999999


Q ss_pred             CccCH
Q 039159          239 KRITA  243 (259)
Q Consensus       239 ~Rp~~  243 (259)
                      .||+.
T Consensus       271 ~RP~t  275 (375)
T KOG0591|consen  271 QRPDT  275 (375)
T ss_pred             cCCCc
Confidence            99985

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-47  Score=285.82  Aligned_cols=219  Identities=27%  Similarity=0.375  Sum_probs=188.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...-+++.+|++|.+.|+||||+++.+.+.+....|+|+|++.| +|...+-.               ...++....-..
T Consensus        51 ~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~---------------R~~ySEa~aSH~  115 (355)
T KOG0033|consen   51 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA---------------REFYSEADASHC  115 (355)
T ss_pred             cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH---------------HHHHHHHHHHHH
Confidence            34567899999999999999999999999999999999999997 67665521               056777888899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCC--CCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~--~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      ..|++.+|+|+|.++|+|||+||+|+++...  +-.+||+|||++..+. ....-....|||.|+|||++.. -.++..+
T Consensus       116 ~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrk-dpy~kpv  193 (355)
T KOG0033|consen  116 IQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKK-DPYSKPV  193 (355)
T ss_pred             HHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhc-CCCCCcc
Confidence            9999999999999999999999999998542  2259999999998775 3444556789999999999987 5788999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||+.|++||-++.|.+||.+.+....+..|..+...-          -.+.|+++++++++|+++||..||.+|.|+.|
T Consensus       194 DiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~----------~~~~w~~is~~Ak~LvrrML~~dP~kRIta~E  263 (355)
T KOG0033|consen  194 DIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY----------PSPEWDTVTPEAKSLIRRMLTVNPKKRITADE  263 (355)
T ss_pred             hhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC----------CCcccCcCCHHHHHHHHHHhccChhhhccHHH
Confidence            99999999999999999999999888888887654332          22457899999999999999999999999999


Q ss_pred             HhcCccccC
Q 039159          246 ALQQEYFKD  254 (259)
Q Consensus       246 ~l~h~~f~~  254 (259)
                      +|+|||+.+
T Consensus       264 AL~HpWi~~  272 (355)
T KOG0033|consen  264 ALKHPWICN  272 (355)
T ss_pred             HhCCchhcc
Confidence            999999975

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-47  Score=312.07  Aligned_cols=216  Identities=32%  Similarity=0.452  Sum_probs=188.4

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .-...+..|-.+|.+| .||.|++++-.|.+...+|.|+||++ |+|..++...               +.+.+.....+
T Consensus       115 ~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~---------------Gsfde~caR~Y  179 (604)
T KOG0592|consen  115 KKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY---------------GSFDETCARFY  179 (604)
T ss_pred             cccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh---------------CcchHHHHHHH
Confidence            3445677888899999 79999999999999999999999999 5899999653               56777888889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-------------CcCCccCccccCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-------------SSAEVGTHYYKAPEL  154 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-------------~~~~~~~~~~~aPE~  154 (259)
                      +.+|+.|++|||++|||||||||+|||++.++ +++|+|||.|+.+......             ...++||-.|.+||+
T Consensus       180 AAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPEl  258 (604)
T KOG0592|consen  180 AAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPEL  258 (604)
T ss_pred             HHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHH
Confidence            99999999999999999999999999999999 9999999999876432211             144789999999999


Q ss_pred             ccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcC
Q 039159          155 LLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                      +.. ...+..+|+|+|||++|+|+.|++||.+.+..-.+.+|.......              .+++++.+.|||.+.|.
T Consensus       259 L~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f--------------p~~fp~~a~dLv~KLLv  323 (604)
T KOG0592|consen  259 LND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF--------------PEGFPEDARDLIKKLLV  323 (604)
T ss_pred             hcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC--------------CCCCCHHHHHHHHHHHc
Confidence            987 678899999999999999999999999999998888886543221              24678999999999999


Q ss_pred             cCCCCccCHHHHhcCccccCCC
Q 039159          235 MDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .||.+|+|++++.+||||.++.
T Consensus       324 ~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  324 RDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             cCccccccHHHHhhCcccccCC
Confidence            9999999999999999999874

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=307.89  Aligned_cols=233  Identities=25%  Similarity=0.316  Sum_probs=192.1

Q ss_pred             CCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159            6 NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus         6 ~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ++.++ .+.+.+|++.++.++||||++++-.|..+..+|+||.||.+ ++.+++...-.             ..+....+
T Consensus        63 kc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~-------------~Gl~E~~I  128 (516)
T KOG0582|consen   63 KCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYP-------------DGLEEASI  128 (516)
T ss_pred             hhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcc-------------ccccHHHH
Confidence            34444 67899999999999999999999999999999999999994 99999864211             34778889


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC----cCCccCccccCccccc-Ccc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES----SAEVGTHYYKAPELLL-GLL  159 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~----~~~~~~~~~~aPE~~~-~~~  159 (259)
                      ..++.++++||.|||.+|.||||||+.|||++.+| .|||+|||.+..+...+...    .+..||++|+|||+++ ...
T Consensus       129 a~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~  207 (516)
T KOG0582|consen  129 ATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLH  207 (516)
T ss_pred             HHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhccc
Confidence            99999999999999999999999999999999999 89999999988776544332    4558999999999954 456


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      .|+.++||||||++..|+++|..||....+...+..-+++...  .+.....+  ......++..++.++..||+.||.+
T Consensus       208 GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp--~~~t~~~~--~d~~k~~~ksf~e~i~~CL~kDP~k  283 (516)
T KOG0582|consen  208 GYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP--TLLTSGLD--KDEDKKFSKSFREMIALCLVKDPSK  283 (516)
T ss_pred             CccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC--CcccccCC--hHHhhhhcHHHHHHHHHHhhcCccc
Confidence            7999999999999999999999999998888777665544322  11111111  1112346779999999999999999


Q ss_pred             ccCHHHHhcCccccCCCC
Q 039159          240 RITAAEALQQEYFKDVPG  257 (259)
Q Consensus       240 Rp~~~~~l~h~~f~~~~~  257 (259)
                      |||++++|+|+||++...
T Consensus       284 RptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  284 RPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             CCCHHHHhccHHHhhccc
Confidence            999999999999998764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-47  Score=313.22  Aligned_cols=215  Identities=32%  Similarity=0.418  Sum_probs=187.8

Q ss_pred             CCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...+.+.+|+.++++++ ||||++++.++.....+|+||||+.| +|++.+.. +              ..+....+..+
T Consensus        61 ~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~--------------g~l~E~~ar~~  125 (370)
T KOG0583|consen   61 KLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-K--------------GRLKEDEARKY  125 (370)
T ss_pred             ccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-c--------------CCCChHHHHHH
Confidence            45667779999999999 99999999999999999999999996 89999975 2              44555788999


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCC-CCeEEEeeccccccccccCCCCcCCccCccccCcccccCcc-CCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLD-GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL-EYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~-~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~  165 (259)
                      |.|+++|++|||++||+||||||+|++++.+ + .+||+|||++...........+.+||+.|+|||++.+.. ..+.++
T Consensus       126 F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~-~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~a  204 (370)
T KOG0583|consen  126 FRQLISAVAYCHSRGIVHRDLKPENILLDGNEG-NLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAA  204 (370)
T ss_pred             HHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC-CEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchh
Confidence            9999999999999999999999999999998 6 899999999987643445678889999999999999855 446899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCC-CHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL-EPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      ||||+|++||.|++|+.||...+.......+.......              ...+ |+++.+|+.+||..||.+|+++.
T Consensus       205 DvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~--------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~  270 (370)
T KOG0583|consen  205 DVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI--------------PSYLLSPEARSLIEKMLVPDPSTRITLL  270 (370)
T ss_pred             hhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC--------------CCCcCCHHHHHHHHHHcCCCcccCCCHH
Confidence            99999999999999999999988887777765443211              1234 99999999999999999999999


Q ss_pred             HHhcCccccC
Q 039159          245 EALQQEYFKD  254 (259)
Q Consensus       245 ~~l~h~~f~~  254 (259)
                      ++++||||+.
T Consensus       271 ~i~~h~w~~~  280 (370)
T KOG0583|consen  271 EILEHPWFQK  280 (370)
T ss_pred             HHhhChhhcc
Confidence            9999999996

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-48  Score=307.66  Aligned_cols=218  Identities=30%  Similarity=0.396  Sum_probs=180.0

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCc--eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGI--YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .+.+.+|+++|++|+|||||+++|......  .++++|||++| +|.+++....              ..++...+..+.
T Consensus        58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g--------------~~l~E~~v~~yt  123 (313)
T KOG0198|consen   58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYG--------------GKLPEPLVRRYT  123 (313)
T ss_pred             HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcC--------------CCCCHHHHHHHH
Confidence            556899999999999999999999754444  68999999995 9999997532              136678889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcC-CCCeEEEeeccccccccccC---CCCcCCccCccccCcccccCccCCCcc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDL-DGKTVKVAGFGLAKSLYAYK---GESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~-~~~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      .|+++||+|||++|++|+||||+|||++. ++ .+||+|||.++......   .......||+.|||||++.........
T Consensus       124 r~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~  202 (313)
T KOG0198|consen  124 RQILEGLAYLHSKGIVHCDIKPANILLDPSNG-DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRE  202 (313)
T ss_pred             HHHHHHHHHHHhCCEeccCcccceEEEeCCCC-eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCcc
Confidence            99999999999999999999999999998 46 89999999998765311   123456799999999999852334469


Q ss_pred             cchHhHHHHHHHHHhCCCCCCC-CChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPG-ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +|||||||++.||+||++||.+ .........+......|..+            ..+|+++++|+.+|+..||.+||||
T Consensus       203 sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip------------~~ls~~a~~Fl~~C~~~~p~~Rpta  270 (313)
T KOG0198|consen  203 SDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIP------------DSLSDEAKDFLRKCFKRDPEKRPTA  270 (313)
T ss_pred             chhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCC------------cccCHHHHHHHHHHhhcCcccCcCH
Confidence            9999999999999999999988 45555555555444444332            4689999999999999999999999


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      +++|+|||..+..
T Consensus       271 ~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  271 EELLEHPFLKQNS  283 (313)
T ss_pred             HHHhhChhhhccc
Confidence            9999999997643

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-46  Score=296.97  Aligned_cols=240  Identities=38%  Similarity=0.605  Sum_probs=199.2

Q ss_pred             CCCCCCchhHHHHHHHhhCCCCC-eeEEEEEEEeCc------eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchh
Q 039159            7 TMEGVPSSMIREVSCLMELNHPN-IIRLMRVASQGI------YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLF   79 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~H~n-iv~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~   79 (259)
                      +.+.++....+|+.+++.|+|+| |+.+++++..++      .+++||||..-+|..++.......           ...
T Consensus        49 ~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~-----------~g~  117 (323)
T KOG0594|consen   49 EEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKP-----------QGL  117 (323)
T ss_pred             cccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccc-----------cCC
Confidence            34579999999999999999999 999999998877      899999999999999997643211           123


Q ss_pred             HHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCcc
Q 039159           80 TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        80 ~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      +...+..++.|++.|++|||+++|+||||||+||+++++| .+||+|||+|+...-........++|.+|+|||++.+..
T Consensus       118 ~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~  196 (323)
T KOG0594|consen  118 PPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGST  196 (323)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCC
Confidence            3367889999999999999999999999999999999988 899999999986554444456668899999999999977


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccc----------------cccccCCCCCCCH
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSL----------------RDHLTNGFPGLEP  223 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~  223 (259)
                      .|+...||||+||++.||+++++.|.+.+...+..+|......|.....+.                ...+....+..++
T Consensus       197 ~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~  276 (323)
T KOG0594|consen  197 SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDP  276 (323)
T ss_pred             cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCc
Confidence            899999999999999999999999999999888888855444433222211                1112222344567


Q ss_pred             HHHHHHHhhcCcCCCCccCHHHHhcCccccCCCCC
Q 039159          224 AGIDLISKMLGMDPDKRITAAEALQQEYFKDVPGR  258 (259)
Q Consensus       224 ~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~~~  258 (259)
                      +..+++.+||+.+|.+|.+++.+|.||||...+.+
T Consensus       277 ~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  277 DGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             cHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            99999999999999999999999999999988654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=309.22  Aligned_cols=212  Identities=27%  Similarity=0.369  Sum_probs=183.8

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCc-eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGI-YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .++|.+|+.+|++++|||||+++|++.+.. .+++||||+++ +|..++....             ...+....++.++.
T Consensus        83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~-------------~~~l~~~~~l~~al  149 (362)
T KOG0192|consen   83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKR-------------KRKLPLKVRLRIAL  149 (362)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcc-------------cCCCCHHHHHHHHH
Confidence            568999999999999999999999999887 79999999995 9999996530             15677888999999


Q ss_pred             hcccccccccCCC-ceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC-ccCCCcccch
Q 039159           90 SSDSSRSLSFGTR-YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG-LLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~-i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di  167 (259)
                      +++.|+.|||+++ ||||||||+|+|++.++..+||+|||+++.............||+.|||||++.+ ...++.++||
T Consensus       150 diArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~Dv  229 (362)
T KOG0192|consen  150 DIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDV  229 (362)
T ss_pred             HHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchh
Confidence            9999999999999 9999999999999988558999999999865443334444689999999999985 2679999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||+++||++||+.||.+.........+......|..+.            ..++.+..+|..||..||.+||++.+++
T Consensus       230 ySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~------------~~~~~l~~l~~~CW~~dp~~RP~f~ei~  297 (362)
T KOG0192|consen  230 YSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK------------ECPPHLSSLMERCWLVDPSRRPSFLEIV  297 (362)
T ss_pred             hhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc------------cCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence            9999999999999999999988777777776666655432            4789999999999999999999999887


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      .
T Consensus       298 ~  298 (362)
T KOG0192|consen  298 S  298 (362)
T ss_pred             H
Confidence            4

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=301.61  Aligned_cols=239  Identities=37%  Similarity=0.536  Sum_probs=196.6

Q ss_pred             CCCCCC--CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEe-----CceEEEEeeeecCCHHHHhhcCCCCCCCcccccC
Q 039159            1 MMGIHN--TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQ-----GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF   73 (259)
Q Consensus         1 ~~~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~   73 (259)
                      +|||.+  .+...-++..+|+++|+.++|+||+.+.+++..     -+.+|+|+|+|+-+|.++++..            
T Consensus        52 IKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~------------  119 (359)
T KOG0660|consen   52 IKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQ------------  119 (359)
T ss_pred             hhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcC------------
Confidence            355653  344556788999999999999999999999976     2478999999988999999752            


Q ss_pred             CCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccccc--CCCCcCCccCccccC
Q 039159           74 NSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY--KGESSAEVGTHYYKA  151 (259)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~--~~~~~~~~~~~~~~a  151 (259)
                         ..++.......++|++.||+|+|+.+++||||||.|++++.+. .+||+|||+|+.....  ....+..+.|.+|+|
T Consensus       120 ---~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRA  195 (359)
T KOG0660|consen  120 ---QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-DLKICDFGLARYLDKFFEDGFMTEYVATRWYRA  195 (359)
T ss_pred             ---ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-CEEeccccceeeccccCcccchhcceeeeeecC
Confidence               2255667778889999999999999999999999999999998 7999999999876432  122345578999999


Q ss_pred             cccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc-----------------cccccc
Q 039159          152 PELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL-----------------SLRDHL  214 (259)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-----------------~~~~~~  214 (259)
                      ||.+.....|+.+.||||+||++.||++|++.|++.+...+...|......|.-...                 ....+.
T Consensus       196 PElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f  275 (359)
T KOG0660|consen  196 PELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPF  275 (359)
T ss_pred             HHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCH
Confidence            999998889999999999999999999999999999988888777554443321110                 111234


Q ss_pred             cCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       215 ~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ...+++.++.+.+|+.+||..||++|+|++|+|+|||+...
T Consensus       276 ~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  276 SSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             HHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence            45568899999999999999999999999999999999754

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-47  Score=290.85  Aligned_cols=218  Identities=28%  Similarity=0.389  Sum_probs=190.4

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +..+.-.+|+.||+++ .||||+++.|+|+.+..+++|+|.|+ |.|.+++...               ..++......+
T Consensus        64 ~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~---------------VtlSEK~tR~i  128 (411)
T KOG0599|consen   64 EMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK---------------VTLSEKETRRI  128 (411)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh---------------eeecHHHHHHH
Confidence            3456677899999999 59999999999999999999999999 7899999542               56777888999


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCccccc-----CccCCC
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL-----GLLEYS  162 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~  162 (259)
                      +.|+..|+.|||..+|+||||||+|||++++- .++|+|||++..+.. +......+|||+|.|||.+.     +.+.|+
T Consensus       129 MrqlfegVeylHa~~IVHRDLKpENILlddn~-~i~isDFGFa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs  206 (411)
T KOG0599|consen  129 MRQLFEGVEYLHARNIVHRDLKPENILLDDNM-NIKISDFGFACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYS  206 (411)
T ss_pred             HHHHHHHHHHHHHhhhhhcccChhheeecccc-ceEEeccceeeccCC-chhHHHhcCCCcccChhheeeecccCCCCcc
Confidence            99999999999999999999999999999877 899999999987654 44566779999999999885     345688


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ..+|+||+|+++|.++.|.+||....+.-.+..|..+......          +.|.++|.+.+|||++||++||.+|.|
T Consensus       207 ~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s----------peWadis~~~KdLIsrlLqVdp~~Rit  276 (411)
T KOG0599|consen  207 KEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS----------PEWADISATVKDLISRLLQVDPTKRIT  276 (411)
T ss_pred             chhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC----------cchhhccccHHHHHHHHHeeCchhccc
Confidence            9999999999999999999999988887777777766554333          346789999999999999999999999


Q ss_pred             HHHHhcCccccC
Q 039159          243 AAEALQQEYFKD  254 (259)
Q Consensus       243 ~~~~l~h~~f~~  254 (259)
                      ++|+|.||||..
T Consensus       277 ake~LaHpff~q  288 (411)
T KOG0599|consen  277 AKEALAHPFFIQ  288 (411)
T ss_pred             HHHHhcChHHHH
Confidence            999999999953

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-45  Score=300.56  Aligned_cols=228  Identities=36%  Similarity=0.561  Sum_probs=181.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .....+.+|++++++++||||+++++++..++..++||||+.++|.+.+....              ..+....+..++.
T Consensus        45 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--------------~~~~~~~~~~~~~  110 (288)
T cd07871          45 GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCG--------------NLMSMHNVKIFMF  110 (288)
T ss_pred             CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhcC--------------CCCCHHHHHHHHH
Confidence            34557889999999999999999999999999999999999999988885421              2345567788899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||++||+||||||+||+++.++ .+||+|||+++.............+++.|+|||.+.+...++.++||||
T Consensus       111 qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  189 (288)
T cd07871         111 QLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWG  189 (288)
T ss_pred             HHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHH
Confidence            999999999999999999999999999888 8999999999765433333445578999999999876566889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc---cccc----c---------cccccCCCCCCCHHHHHHHHhhc
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF---CKLS----L---------RDHLTNGFPGLEPAGIDLISKML  233 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~----~---------~~~~~~~~~~~~~~~~~li~~~l  233 (259)
                      +||++|+|++|++||.+.+..+....+......+..   +...    .         ........+..++++.+|+.+||
T Consensus       190 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL  269 (288)
T cd07871         190 VGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLL  269 (288)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhc
Confidence            999999999999999987766665554322111110   0000    0         00111122457889999999999


Q ss_pred             CcCCCCccCHHHHhcCccc
Q 039159          234 GMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h~~f  252 (259)
                      ..||.+|||++++++||||
T Consensus       270 ~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         270 LYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CcCcccCCCHHHHhcCCCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.5e-47  Score=298.75  Aligned_cols=229  Identities=32%  Similarity=0.534  Sum_probs=187.7

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCc-----eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGI-----YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      -.+|+++|++++|||||++..+|....     +..+||||++.+|++++++.....           ..++...+..+.+
T Consensus        64 knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~-----------~~mp~~~iKLYt~  132 (364)
T KOG0658|consen   64 KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRAN-----------QRMPLLEIKLYTY  132 (364)
T ss_pred             CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcC-----------CCCceeeeHHHHH
Confidence            458999999999999999999986432     567999999999999998632221           4456667788899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |+.+|++|||+.||+||||||+|+|+|.+.+.+||||||.|+.+....+. .....|-.|+|||.+.|...|+.+.||||
T Consensus       133 Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWS  211 (364)
T KOG0658|consen  133 QLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWS  211 (364)
T ss_pred             HHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhh
Confidence            99999999999999999999999999999779999999999988664443 45577999999999999889999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccc---cc-----------ccccC-CCCCCCHHHHHHHHhhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLS---LR-----------DHLTN-GFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---~~-----------~~~~~-~~~~~~~~~~~li~~~l~  234 (259)
                      .|||+.||+.|++.|++.+...+...|..-...|...+..   ..           ..+.. .....+++..+|+.++|.
T Consensus       212 aGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~  291 (364)
T KOG0658|consen  212 AGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQ  291 (364)
T ss_pred             hhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhc
Confidence            9999999999999999998887777774444333322211   00           01111 235678999999999999


Q ss_pred             cCCCCccCHHHHhcCccccCC
Q 039159          235 MDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ++|.+|.++.+++.||||...
T Consensus       292 Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  292 YSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             cChhhcCCHHHHhcchhhHHh
Confidence            999999999999999999854

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.1e-47  Score=312.61  Aligned_cols=215  Identities=28%  Similarity=0.443  Sum_probs=192.3

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +.....+.+|++|++.|+|||||.+++.|+.+..+|+|.|||.|+|.+++.+.               ..++..+...+.
T Consensus        42 ~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g~L~~il~~d---------------~~lpEe~v~~~a  106 (808)
T KOG0597|consen   42 EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVGDLFTILEQD---------------GKLPEEQVRAIA  106 (808)
T ss_pred             hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhhhHHHHHHhc---------------cCCCHHHHHHHH
Confidence            34456799999999999999999999999999999999999999999999764               567778889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .++.+||.|||+.+|.|||+||.||++++.+ .+|++|||+++-.....--....-|||.|||||.+.+ ..|+..+|+|
T Consensus       107 ~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlW  184 (808)
T KOG0597|consen  107 YDLVSALYYLHSNRILHRDMKPQNILLEKGG-TLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLW  184 (808)
T ss_pred             HHHHHHHHHHHhcCcccccCCcceeeecCCC-ceeechhhhhhhcccCceeeeeccCcccccCHHHHcC-CCccchhhHH
Confidence            9999999999999999999999999999888 8999999999876543334455579999999999997 7899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |+||++||+++|++||...+..+....|......+.              ...|..+.+|+...|..||.+|.++.+++.
T Consensus       185 slGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p--------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  185 SLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP--------------STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc--------------ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            999999999999999999988888888876654432              368999999999999999999999999999


Q ss_pred             CccccC
Q 039159          249 QEYFKD  254 (259)
Q Consensus       249 h~~f~~  254 (259)
                      |||.++
T Consensus       251 HpF~k~  256 (808)
T KOG0597|consen  251 HPFWKG  256 (808)
T ss_pred             ChHHhh
Confidence            999874

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-45  Score=287.13  Aligned_cols=238  Identities=36%  Similarity=0.578  Sum_probs=196.3

Q ss_pred             CCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159            4 IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus         4 ~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      ...+++..+---.+||.+|.+++|||||.+-.+..-+  +.+|+|||||+.+|..++..-+              ..+..
T Consensus       111 mekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~--------------q~F~~  176 (419)
T KOG0663|consen  111 MEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMK--------------QPFLP  176 (419)
T ss_pred             cccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhcc--------------CCCch
Confidence            3445667777889999999999999999999998754  5799999999999999997643              23445


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      .+...+..|+++|++|||.+.|+|||||++|+|++..| .+||+|||+|+............+-|.+|+|||.+.+...|
T Consensus       177 ~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~ty  255 (419)
T KOG0663|consen  177 GEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTY  255 (419)
T ss_pred             HHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCccc
Confidence            56677788999999999999999999999999999998 89999999999876655555566779999999999998889


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccc----------------cccccCCCCC--CCH
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSL----------------RDHLTNGFPG--LEP  223 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----------------~~~~~~~~~~--~~~  223 (259)
                      +.+.|+||+||++.|++++++.|++.....+...|....-.|.....+-                ...+...|..  +++
T Consensus       256 st~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse  335 (419)
T KOG0663|consen  256 STAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSE  335 (419)
T ss_pred             CcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccch
Confidence            9999999999999999999999999999888888855443333222110                0122233333  458


Q ss_pred             HHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          224 AGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       224 ~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ...+|+..+|.+||.+|.|+++.|+|+||+..+
T Consensus       336 ~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  336 QGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             hHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            899999999999999999999999999999754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-46  Score=283.99  Aligned_cols=211  Identities=28%  Similarity=0.409  Sum_probs=187.5

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+...+|..+|+.+.||.++++++.+.+...+|+||||.+| .|...++..               ..++.....-++.+
T Consensus        88 veH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~---------------~rF~e~~arFYAAe  152 (355)
T KOG0616|consen   88 VEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS---------------GRFSEPHARFYAAE  152 (355)
T ss_pred             HHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc---------------CCCCchhHHHHHHH
Confidence            35678999999999999999999999999999999999996 899998754               34555667788889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||+++|++|||||+|||+|++| .+||+|||+|+.+.   +..-+.+|||.|+|||.+.. ..++.++|-|||
T Consensus       153 ivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~---~rT~TlCGTPeYLAPEii~s-k~ynkavDWWal  227 (355)
T KOG0616|consen  153 IVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVS---GRTWTLCGTPEYLAPEIIQS-KGYNKAVDWWAL  227 (355)
T ss_pred             HHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEec---CcEEEecCCccccChHHhhc-CCCCcchhHHHH
Confidence            99999999999999999999999999999 99999999999873   34667799999999999988 679999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CHHH
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAE  245 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~  245 (259)
                      |+++|||+.|.+||...+....+.+|........              +-+++++++|++.+|++|-.+|.     ...+
T Consensus       228 GVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP--------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~d  293 (355)
T KOG0616|consen  228 GVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP--------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVED  293 (355)
T ss_pred             HHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC--------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccc
Confidence            9999999999999999999999999987653321              35789999999999999999994     5789


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +..||||+++.
T Consensus       294 Ik~H~wF~~v~  304 (355)
T KOG0616|consen  294 IKNHPWFKGVD  304 (355)
T ss_pred             cccCccccccc
Confidence            99999999874

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.3e-45  Score=299.11  Aligned_cols=233  Identities=34%  Similarity=0.489  Sum_probs=177.7

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .....+.+|+.+++.++||||+++++++.+++..++||||+.++|.+.+....              ..+....+..++.
T Consensus        45 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~  110 (303)
T cd07869          45 GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHP--------------GGLHPENVKLFLF  110 (303)
T ss_pred             ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCC--------------CCCCHHHHHHHHH
Confidence            33456889999999999999999999999999999999999999888875421              2244566778899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||+++|+||||||+||+++.++ .+||+|||++..............+++.|+|||.+.+...++.++||||
T Consensus       111 qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  189 (303)
T cd07869         111 QLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWG  189 (303)
T ss_pred             HHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHH
Confidence            999999999999999999999999999888 8999999998754332333344578999999999876556788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChH-HHHHHHhCCCCCCc---ccc---------ccc----cccccCCC--CCCCHHHHHHHH
Q 039159          170 VGCIFGEMVSGKPLFPGANSL-ITLGRIVGKSRKPS---FCK---------LSL----RDHLTNGF--PGLEPAGIDLIS  230 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~-~~~~~i~~~~~~~~---~~~---------~~~----~~~~~~~~--~~~~~~~~~li~  230 (259)
                      +||++|+|++|..||.+.... .....+......+.   .+.         ...    ...+...+  ...++.+.+|+.
T Consensus       190 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~  269 (303)
T cd07869         190 VGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLAS  269 (303)
T ss_pred             HHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHH
Confidence            999999999999999875433 22222211110100   000         000    00000001  125678999999


Q ss_pred             hhcCcCCCCccCHHHHhcCccccCCCC
Q 039159          231 KMLGMDPDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       231 ~~l~~dp~~Rp~~~~~l~h~~f~~~~~  257 (259)
                      +||+.||++|||+.++++||||++++.
T Consensus       270 ~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         270 KLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             HHhccCchhccCHHHHhcCcccccCCh
Confidence            999999999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.3e-45  Score=301.03  Aligned_cols=214  Identities=25%  Similarity=0.335  Sum_probs=180.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.++++++||||+++++++..++..|+||||+.| +|...+...               ..+....+..++.|
T Consensus        39 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~q  103 (323)
T cd05571          39 VAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE---------------RVFSEDRARFYGAE  103 (323)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            35678899999999999999999999999999999999996 888777532               33456677788899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.||+|||++||+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|||||
T Consensus       104 i~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl  181 (323)
T cd05571         104 IVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGL  181 (323)
T ss_pred             HHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCCcccceecCccccChhhhcC-CCCCccccCccc
Confidence            99999999999999999999999999888 8999999998754333334445679999999999987 578899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CHHH
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAE  245 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~  245 (259)
                      ||++|+|++|..||.+.+.......+......              ....+++++.++|.+||..||++||     ++.+
T Consensus       182 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~--------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~  247 (323)
T cd05571         182 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE  247 (323)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence            99999999999999887766666555433211              1135789999999999999999999     8999


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +++||||.++.
T Consensus       248 ll~h~~f~~~~  258 (323)
T cd05571         248 IMEHRFFASIN  258 (323)
T ss_pred             HHcCCCcCCCC
Confidence            99999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.6e-45  Score=299.40  Aligned_cols=219  Identities=31%  Similarity=0.460  Sum_probs=187.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +-.+.+..|-.+|...++|+||++|..|.+.+++||||||++| +..+++...               ..++...+.-++
T Consensus       183 ~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~---------------~~L~e~~arfYi  247 (550)
T KOG0605|consen  183 NQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRK---------------DTLTEDWARFYI  247 (550)
T ss_pred             hhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhc---------------CcCchHHHHHHH
Confidence            4456788899999999999999999999999999999999996 888888653               456667777888


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccccc-------------------CC---C-----C-
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY-------------------KG---E-----S-  140 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~-------------------~~---~-----~-  140 (259)
                      ...+.|+..+|+.|+|||||||+|+|||..| ++||+|||++..+...                   .+   .     . 
T Consensus       248 aE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (550)
T KOG0605|consen  248 AETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRS  326 (550)
T ss_pred             HHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccc
Confidence            8888899999999999999999999999999 9999999998643210                   00   0     0 


Q ss_pred             -------------------cCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCC
Q 039159          141 -------------------SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSR  201 (259)
Q Consensus       141 -------------------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~  201 (259)
                                         ...+|||-|+|||++++ ..|+..+|.|||||++|||+.|.+||.+.++.+.+.+|.+...
T Consensus       327 ~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~  405 (550)
T KOG0605|consen  327 TMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE  405 (550)
T ss_pred             hhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh
Confidence                               12259999999999999 5699999999999999999999999999999999999987765


Q ss_pred             CCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC---HHHHhcCccccCCC
Q 039159          202 KPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT---AAEALQQEYFKDVP  256 (259)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~~l~h~~f~~~~  256 (259)
                      ...+|.          ....+++++|||.+||. ||++|..   ++||-+||||+.+.
T Consensus       406 ~l~fP~----------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  406 TLKFPE----------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             hccCCC----------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence            555443          13577999999999999 9999985   99999999999874

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=297.32  Aligned_cols=210  Identities=25%  Similarity=0.353  Sum_probs=181.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      -..++|.+|+++|++|+|+|||+++|+|..++.+||||||+. |+|.++++...+             ..+...+.+.++
T Consensus       243 m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~-------------~~l~~~~Ll~~a  309 (468)
T KOG0197|consen  243 MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREG-------------GLLNLPQLLDFA  309 (468)
T ss_pred             cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCC-------------CccchHHHHHHH
Confidence            345789999999999999999999999999889999999998 799999976222             567778899999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .|||+|++||.++++|||||.+.|||++.+. .|||+|||+|+......  ...+. --...|.|||.+.. ..++.+||
T Consensus       310 ~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~~Y~~~~~~-kfPIkWtAPEa~~~-~~FS~kSD  386 (468)
T KOG0197|consen  310 AQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLARLIGDDEYTASEGG-KFPIKWTAPEALNY-GKFSSKSD  386 (468)
T ss_pred             HHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEcccccccccCCCceeecCCC-CCCceecCHHHHhh-CCcccccc
Confidence            9999999999999999999999999999998 99999999999432211  11111 12457999999987 68999999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||++|||+.| |+.||.+....+....+..+.+.|.             +.++++++-++|..||..+|++|||++.
T Consensus       387 VWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~-------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~  453 (468)
T KOG0197|consen  387 VWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR-------------PEGCPDEVYELMKSCWHEDPEDRPTFET  453 (468)
T ss_pred             eeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-------------CCCCCHHHHHHHHHHhhCCcccCCCHHH
Confidence            9999999999998 8999999999999999988877654             2578999999999999999999999997


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +..
T Consensus       454 L~~  456 (468)
T KOG0197|consen  454 LRE  456 (468)
T ss_pred             HHH
Confidence            763

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-45  Score=300.69  Aligned_cols=221  Identities=31%  Similarity=0.388  Sum_probs=198.0

Q ss_pred             CCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCce-EEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            5 HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIY-LYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         5 ~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      .+.++..+..+.+|+.++++++|||||.+++.|+.++. +++||+||+| ++.+.+...++             ..+...
T Consensus        40 ~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~-------------~~f~E~  106 (426)
T KOG0589|consen   40 EKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKG-------------VLFPEE  106 (426)
T ss_pred             cccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhh-------------ccccHH
Confidence            34567777889999999999999999999999999887 9999999997 89999976542             567788


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .+..++.|++.|+.|||+++|.|||||+.||++++++ .|+|+|||+|+.+.....-..+..|||.|++||.+.+ .+|+
T Consensus       107 ~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d-~pYn  184 (426)
T KOG0589|consen  107 RILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD-IPYN  184 (426)
T ss_pred             HHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC-CCCC
Confidence            9999999999999999999999999999999999999 7899999999988665556777899999999999998 7899


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      .++|||||||++|||++-+++|.+.+......++......             +....++.+++.+|+.||..+|..||+
T Consensus       185 ~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~-------------Plp~~ys~el~~lv~~~l~~~P~~RPs  251 (426)
T KOG0589|consen  185 EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS-------------PLPSMYSSELRSLVKSMLRKNPEHRPS  251 (426)
T ss_pred             ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC-------------CCCccccHHHHHHHHHHhhcCCccCCC
Confidence            9999999999999999999999999999999888765422             223578999999999999999999999


Q ss_pred             HHHHhcCcccc
Q 039159          243 AAEALQQEYFK  253 (259)
Q Consensus       243 ~~~~l~h~~f~  253 (259)
                      +.++|.+|...
T Consensus       252 a~~LL~~P~l~  262 (426)
T KOG0589|consen  252 ALELLRRPHLL  262 (426)
T ss_pred             HHHHhhChhhh
Confidence            99999998654

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-44  Score=294.50  Aligned_cols=214  Identities=28%  Similarity=0.373  Sum_probs=180.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|+.++++++||||+++++++..++..++||||+.| +|...+...               ..+.......++.
T Consensus        36 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~~~  100 (312)
T cd05585          36 EVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE---------------GRFDLSRARFYTA  100 (312)
T ss_pred             HHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            345678999999999999999999999999999999999996 888888532               2345566778889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||+++|+||||||+||+++.++ .++|+|||+++.............||+.|+|||.+.+ ..++.++||||
T Consensus       101 qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws  178 (312)
T cd05585         101 ELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAVDWWT  178 (312)
T ss_pred             HHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccCCcccCCHHHHcC-CCCCCccceec
Confidence            999999999999999999999999999888 8999999999754333333445679999999999987 57889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc---CHHHH
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI---TAAEA  246 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~~  246 (259)
                      |||++|+|++|..||.+.........+......              ....+++.+.+++.+||..||.+||   ++.++
T Consensus       179 lGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~  244 (312)
T cd05585         179 LGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--------------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEI  244 (312)
T ss_pred             hhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC--------------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence            999999999999999987776666655433211              1235789999999999999999997   58999


Q ss_pred             hcCccccCC
Q 039159          247 LQQEYFKDV  255 (259)
Q Consensus       247 l~h~~f~~~  255 (259)
                      +.||||...
T Consensus       245 l~hp~~~~~  253 (312)
T cd05585         245 KNHPFFSQL  253 (312)
T ss_pred             HcCCCcCCC
Confidence            999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.2e-44  Score=294.03  Aligned_cols=233  Identities=36%  Similarity=0.555  Sum_probs=182.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .....+.+|++++++++||||+++++++..++..++||||+.++|.+.+....              ..+....+..++.
T Consensus        46 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~  111 (309)
T cd07872          46 GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCG--------------NIMSMHNVKIFLY  111 (309)
T ss_pred             CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCCCHHHHHHhcC--------------CCCCHHHHHHHHH
Confidence            33456889999999999999999999999999999999999998888775421              2345566778889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||++||+||||||+||+++.++ .++|+|||.+..............+++.|+|||.+.+...++.++||||
T Consensus       112 qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws  190 (309)
T cd07872         112 QILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWG  190 (309)
T ss_pred             HHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHH
Confidence            999999999999999999999999999888 8999999998754333333344567899999999876556888999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc---cc---------cc----ccccccCCCCCCCHHHHHHHHhhc
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF---CK---------LS----LRDHLTNGFPGLEPAGIDLISKML  233 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~---~~---------~~----~~~~~~~~~~~~~~~~~~li~~~l  233 (259)
                      |||++|+|++|++||.+.+.......+......+..   +.         ..    .........+.+++++.+||.+||
T Consensus       191 lG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  270 (309)
T cd07872         191 VGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFL  270 (309)
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhc
Confidence            999999999999999887655444443221111100   00         00    000111223467899999999999


Q ss_pred             CcCCCCccCHHHHhcCccccCCCC
Q 039159          234 GMDPDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h~~f~~~~~  257 (259)
                      ..||.+|||++++++||||+....
T Consensus       271 ~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         271 QYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             cCChhhCCCHHHHhcChhhhhccc
Confidence            999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=293.18  Aligned_cols=216  Identities=26%  Similarity=0.358  Sum_probs=179.8

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcch-hHHHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSL-FTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~   88 (259)
                      .++..+||.+|++|.|||||+++.+..+.  +.+|||+|||..+-....               +.-.. +...+...++
T Consensus       152 ~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---------------p~d~~els~~~Ar~yl  216 (576)
T KOG0585|consen  152 IEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---------------PPDKPELSEQQARKYL  216 (576)
T ss_pred             HHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC---------------CCCcccccHHHHHHHH
Confidence            46899999999999999999999999765  589999999984211111               00022 6778899999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccccc-----CCCCcCCccCccccCcccccC---ccC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY-----KGESSAEVGTHYYKAPELLLG---LLE  160 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~---~~~  160 (259)
                      ..+..||.|||..||+||||||+|+|++.+| +|||+|||.+......     ........|||.|+|||.+.+   ...
T Consensus       217 rDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~  295 (576)
T KOG0585|consen  217 RDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSY  295 (576)
T ss_pred             HHHHHHHHHHHhcCeeccccchhheEEcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccc
Confidence            9999999999999999999999999999998 9999999999765222     122344689999999999987   334


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      .+.+.||||+||+||.++.|+.||.+......+.+|.+......            ..+.+.+.++|||.+||.+||.+|
T Consensus       296 ~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP------------~~pe~~e~~kDli~~lL~KdP~~R  363 (576)
T KOG0585|consen  296 SGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFP------------ENPEINEDLKDLIKRLLEKDPEQR  363 (576)
T ss_pred             cchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCC------------CcccccHHHHHHHHHHhhcChhhe
Confidence            57899999999999999999999999999999999987653321            123578999999999999999999


Q ss_pred             cCHHHHhcCccccCC
Q 039159          241 ITAAEALQQEYFKDV  255 (259)
Q Consensus       241 p~~~~~l~h~~f~~~  255 (259)
                      .++.++-.|||....
T Consensus       364 i~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  364 ITLPDIKLHPWVTRD  378 (576)
T ss_pred             eehhhheecceeccC
Confidence            999999999998754

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.6e-44  Score=297.63  Aligned_cols=212  Identities=26%  Similarity=0.347  Sum_probs=180.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+++++.++||||+++++++.+++.+|+||||+.| +|.+.+...               ..+.......++.
T Consensus        74 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~---------------~~~~~~~~~~~~~  138 (340)
T PTZ00426         74 QVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN---------------KRFPNDVGCFYAA  138 (340)
T ss_pred             hHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            345688999999999999999999999999999999999985 888888542               2345566778899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||+.+|+||||||+||+++.++ .++|+|||+++....   ......||+.|+|||.+.+ ..++.++|+||
T Consensus       139 qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS  213 (340)
T PTZ00426        139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAKVVDT---RTYTLCGTPEYIAPEILLN-VGHGKAADWWT  213 (340)
T ss_pred             HHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCeecCC---CcceecCChhhcCHHHHhC-CCCCccccccc
Confidence            999999999999999999999999999888 899999999976422   2334578999999999987 56789999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CHH
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAA  244 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~  244 (259)
                      |||++|+|++|..||.+.+.......+......              ....+++.+.+++++||+.||.+|+     +++
T Consensus       214 lGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~  279 (340)
T PTZ00426        214 LGIFIYEILVGCPPFYANEPLLIYQKILEGIIY--------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQ  279 (340)
T ss_pred             hhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHH
Confidence            999999999999999988877666666543211              1135788999999999999999995     899


Q ss_pred             HHhcCccccCCC
Q 039159          245 EALQQEYFKDVP  256 (259)
Q Consensus       245 ~~l~h~~f~~~~  256 (259)
                      ++++||||+++.
T Consensus       280 ~~~~hp~f~~~~  291 (340)
T PTZ00426        280 NVKEHPWFGNID  291 (340)
T ss_pred             HHHcCCCcCCCC
Confidence            999999999764

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.4e-44  Score=295.69  Aligned_cols=211  Identities=28%  Similarity=0.391  Sum_probs=177.8

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|++++++++||||+++++++.+++..|+||||+.| +|.+.+...               ..+.......++.
T Consensus        61 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~  125 (329)
T PTZ00263         61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA---------------GRFPNDVAKFYHA  125 (329)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            345688999999999999999999999999999999999986 888888542               2234456667888


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||+++|+||||||+||+++.++ .+||+|||+++....   ......||+.|+|||.+.+ ..++.++||||
T Consensus       126 qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws  200 (329)
T PTZ00263        126 ELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPD---RTFTLCGTPEYLAPEVIQS-KGHGKAVDWWT  200 (329)
T ss_pred             HHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCC---CcceecCChhhcCHHHHcC-CCCCCcceeec
Confidence            999999999999999999999999999888 899999999976532   2234578999999999987 56789999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HH
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AA  244 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~  244 (259)
                      |||++|+|++|..||.+.........+.....  ..            ...+++.+++|+.+||+.||.+|++     ++
T Consensus       201 lG~il~elltg~~pf~~~~~~~~~~~i~~~~~--~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~  266 (329)
T PTZ00263        201 MGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL--KF------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVA  266 (329)
T ss_pred             hHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc--CC------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHH
Confidence            99999999999999998877766666654321  11            1247889999999999999999997     79


Q ss_pred             HHhcCccccCC
Q 039159          245 EALQQEYFKDV  255 (259)
Q Consensus       245 ~~l~h~~f~~~  255 (259)
                      +++.||||.+.
T Consensus       267 ~ll~hp~f~~~  277 (329)
T PTZ00263        267 DVKNHPYFHGA  277 (329)
T ss_pred             HHhcCCccCCC
Confidence            99999999874

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-44  Score=292.20  Aligned_cols=211  Identities=30%  Similarity=0.414  Sum_probs=178.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+.++++++||||+++++++.+++..++||||+.+ +|.+.+...               ..+.......++.|
T Consensus        45 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~q  109 (291)
T cd05612          45 EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS---------------GRFSNSTGLFYASE  109 (291)
T ss_pred             HHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            45688999999999999999999999999999999999986 898888542               23455667788899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||++|++||||||+||+++.++ .+||+|||++.....   ......|++.|+|||.+.+ ..++.++|||||
T Consensus       110 i~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl  184 (291)
T cd05612         110 IVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVIQS-KGHNKAVDWWAL  184 (291)
T ss_pred             HHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccC---CcccccCChhhcCHHHHcC-CCCCchhhHHHH
Confidence            99999999999999999999999999888 899999999976532   2234568999999999977 567899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HHH
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AAE  245 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~~  245 (259)
                      ||++|+|++|+.||.+.........+......              ....+++.+++++.+||+.||.+||+     +++
T Consensus       185 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~  250 (291)
T cd05612         185 GILIYEMLVGYPPFFDDNPFGIYEKILAGKLE--------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADD  250 (291)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC--------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHH
Confidence            99999999999999988777766666543211              11346889999999999999999995     999


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +++||||+.+.
T Consensus       251 ~l~h~~~~~~~  261 (291)
T cd05612         251 VKNHRWFKSVD  261 (291)
T ss_pred             HhcCccccCCC
Confidence            99999998753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.8e-44  Score=294.00  Aligned_cols=214  Identities=25%  Similarity=0.336  Sum_probs=179.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+++++.++||||+++++++..++.+|+||||+.| +|...+...               ..+....+..++.|
T Consensus        39 ~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~q  103 (323)
T cd05595          39 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---------------RVFTEERARFYGAE  103 (323)
T ss_pred             HHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            45677899999999999999999999999999999999996 887777432               23556777888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.||+|||++|++||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|||||
T Consensus       104 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl  181 (323)
T cd05595         104 IVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGL  181 (323)
T ss_pred             HHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCCccccccCCcCcCCcccccC-CCCCchhchhhh
Confidence            99999999999999999999999999888 8999999998754333333445679999999999977 568899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CHHH
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAE  245 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~  245 (259)
                      ||++|++++|+.||...+.......+......              ....+++++.++|.+||+.||++|+     ++.+
T Consensus       182 Gvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~--------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~  247 (323)
T cd05595         182 GVVMYEMMCGRLPFYNQDHERLFELILMEEIR--------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE  247 (323)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence            99999999999999887776666555433211              1135789999999999999999998     8999


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +++||||.+..
T Consensus       248 ~l~h~~~~~~~  258 (323)
T cd05595         248 VMEHRFFLSIN  258 (323)
T ss_pred             HHcCCCcCCCC
Confidence            99999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.2e-44  Score=294.74  Aligned_cols=214  Identities=26%  Similarity=0.323  Sum_probs=179.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|+++++.++||||+++++++..++..|+||||+.+ +|...+...               ..+....+..++.
T Consensus        38 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---------------~~l~~~~~~~~~~  102 (328)
T cd05593          38 EVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE---------------RVFSEDRTRFYGA  102 (328)
T ss_pred             HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            345788999999999999999999999999999999999986 787776432               2355677788899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||+++|+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++||||
T Consensus       103 qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws  180 (328)
T cd05593         103 EIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVDWWG  180 (328)
T ss_pred             HHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcccccccccCCcCccChhhhcC-CCCCccCCccc
Confidence            999999999999999999999999999888 8999999998754333333445579999999999977 56889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CHH
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAA  244 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~  244 (259)
                      |||++|++++|+.||.+.+.......+.....  .            ....+++++.+++.+||..||++|+     ++.
T Consensus       181 lGvil~elltG~~Pf~~~~~~~~~~~~~~~~~--~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~  246 (328)
T cd05593         181 LGVVMYEMMCGRLPFYNQDHEKLFELILMEDI--K------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAK  246 (328)
T ss_pred             cchHHHHHhhCCCCCCCCCHHHHHHHhccCCc--c------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHH
Confidence            99999999999999988776665555433221  1            1135789999999999999999997     899


Q ss_pred             HHhcCccccCC
Q 039159          245 EALQQEYFKDV  255 (259)
Q Consensus       245 ~~l~h~~f~~~  255 (259)
                      ++++||||.+.
T Consensus       247 ~il~h~~~~~~  257 (328)
T cd05593         247 EIMRHSFFTGV  257 (328)
T ss_pred             HHhcCCCcCCC
Confidence            99999999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-43  Score=288.96  Aligned_cols=227  Identities=37%  Similarity=0.543  Sum_probs=178.0

Q ss_pred             CCCchhHHHHHHHhhC---CCCCeeEEEEEEEe-----CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159           10 GVPSSMIREVSCLMEL---NHPNIIRLMRVASQ-----GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l---~H~niv~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      .....+.+|+.+++.+   +||||+++++++..     ...+++||||+.++|.+.+.....             ..++.
T Consensus        43 ~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-------------~~~~~  109 (290)
T cd07862          43 GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-------------PGVPT  109 (290)
T ss_pred             CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCC-------------CCCCH
Confidence            3445677888888776   69999999999852     346899999999999888854211             23556


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      ..+..++.|++.||+|||+.+++||||||+||+++.++ .++|+|||.+...... .......|++.|+|||.+.+ ..+
T Consensus       110 ~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~  186 (290)
T cd07862         110 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQ-SSY  186 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccceEeccCC-cccccccccccccChHHHhC-CCC
Confidence            77888999999999999999999999999999999888 8999999999764322 23345578999999999977 568


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc-------------cccccccCCCCCCCHHHHHH
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL-------------SLRDHLTNGFPGLEPAGIDL  228 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~l  228 (259)
                      +.++|||||||++|+|++|.+||.+.........+......+.....             ..........+.+++.+.++
T Consensus       187 ~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (290)
T cd07862         187 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL  266 (290)
T ss_pred             CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHH
Confidence            88999999999999999999999988877776666433221111000             00011112234678899999


Q ss_pred             HHhhcCcCCCCccCHHHHhcCccc
Q 039159          229 ISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      +.+||+.||++|||+.++|+||||
T Consensus       267 i~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         267 LLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHhccCchhcCCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=293.03  Aligned_cols=217  Identities=29%  Similarity=0.411  Sum_probs=191.1

Q ss_pred             CCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+.+|+++|+++. |||||+++++|++...+++|||++.| .|.+.+...                .++......++
T Consensus        78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~----------------~~sE~da~~~~  141 (382)
T KOG0032|consen   78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK----------------HYSERDAAGII  141 (382)
T ss_pred             cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc----------------cCCHHHHHHHH
Confidence            3468999999999998 99999999999999999999999996 888888531                16778889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCC---CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDG---KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~---~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .|++.+++|||+.|++||||||+|+++....   ..++++|||++..... .......+||+.|+|||++.. ..++..+
T Consensus       142 ~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~-~~y~~~~  219 (382)
T KOG0032|consen  142 RQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGG-RPYGDEV  219 (382)
T ss_pred             HHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcC-CCCCccc
Confidence            9999999999999999999999999996542   2799999999987755 445677899999999999986 5799999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||+|+++|.|+.|.+||.+.........+......          ...+.|+.+|..+.++++.||..||.+|+++.+
T Consensus       220 DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~----------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~  289 (382)
T KOG0032|consen  220 DVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFD----------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQ  289 (382)
T ss_pred             chhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCC----------CCCCCccccCHHHHHHHHHhcccCcccCCCHHH
Confidence            9999999999999999999999988888887665442          223446789999999999999999999999999


Q ss_pred             HhcCccccCC
Q 039159          246 ALQQEYFKDV  255 (259)
Q Consensus       246 ~l~h~~f~~~  255 (259)
                      +|+|||+++.
T Consensus       290 ~L~HpWi~~~  299 (382)
T KOG0032|consen  290 ALQHPWIKSI  299 (382)
T ss_pred             HhcCccccCC
Confidence            9999999975

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7e-44  Score=289.69  Aligned_cols=228  Identities=29%  Similarity=0.468  Sum_probs=176.0

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +...+.+.+|+++++.++||||+++++++..++..++||||+.+++...+....              ..+....+..++
T Consensus        41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--------------~~~~~~~~~~~~  106 (287)
T cd07848          41 EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP--------------NGVPPEKVRSYI  106 (287)
T ss_pred             ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcC--------------CCCCHHHHHHHH
Confidence            445677889999999999999999999999999999999999986666553211              235556778889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .|++.||+|||+.+++||||||+||+++.++ .+||+|||++........ ......|++.|+|||.+.+ ..++.++|+
T Consensus       107 ~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  184 (287)
T cd07848         107 YQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAVDM  184 (287)
T ss_pred             HHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCcccccccccccccccccccccCCcHHHcC-CCCCCchhH
Confidence            9999999999999999999999999999888 899999999976533221 2234568999999999987 568899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCC------------Ccccccc-----ccc-cccCCCCCCCHHHHHHH
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRK------------PSFCKLS-----LRD-HLTNGFPGLEPAGIDLI  229 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~------------~~~~~~~-----~~~-~~~~~~~~~~~~~~~li  229 (259)
                      |||||++|+|++|++||.+.+.......+......            +......     ... ........+|+++.+|+
T Consensus       185 wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll  264 (287)
T cd07848         185 WSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLM  264 (287)
T ss_pred             HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHH
Confidence            99999999999999999887655443333211100            0000000     000 00111234788999999


Q ss_pred             HhhcCcCCCCccCHHHHhcCccc
Q 039159          230 SKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       230 ~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      .+||+.||++|||++++|+||||
T Consensus       265 ~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         265 KNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             HHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.8e-44  Score=296.63  Aligned_cols=229  Identities=32%  Similarity=0.532  Sum_probs=175.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeC-----ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQG-----IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ..++.+|++++++++||||+++++++...     ...|+||||+.++|.+.+...               ..+.......
T Consensus        43 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------------~~~~~~~~~~  107 (338)
T cd07859          43 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN---------------DDLTPEHHQF  107 (338)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhc---------------ccCCHHHHHH
Confidence            45688999999999999999999998643     258999999998998888532               2355677788


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCc-cCCC
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGL-LEYS  162 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~  162 (259)
                      ++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++........   .....|++.|+|||.+.+. ..++
T Consensus       108 i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  186 (338)
T cd07859         108 FLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT  186 (338)
T ss_pred             HHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccC
Confidence            999999999999999999999999999999888 8999999999754322211   1334689999999998652 4678


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc-----------------cccccccccCCCCCCCHHH
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC-----------------KLSLRDHLTNGFPGLEPAG  225 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~  225 (259)
                      .++|||||||++|+|++|++||.+.+.......+......+...                 ...........+++.++.+
T Consensus       187 ~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (338)
T cd07859         187 PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLA  266 (338)
T ss_pred             chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHH
Confidence            89999999999999999999998766544332221111000000                 0000011222345678899


Q ss_pred             HHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          226 IDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       226 ~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .+++.+||+.||++||+++++++||||+...
T Consensus       267 ~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         267 LRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             HHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence            9999999999999999999999999998764

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.9e-44  Score=305.03  Aligned_cols=231  Identities=31%  Similarity=0.456  Sum_probs=176.6

Q ss_pred             hhHHHHHHHhhCCCCCeeEEEEEEEeC--------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           14 SMIREVSCLMELNHPNIIRLMRVASQG--------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H~niv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ...+|+.+++.++||||+++++++...        ..+++||||+++++..++.......           ..++...+.
T Consensus       105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~-----------~~l~~~~~~  173 (440)
T PTZ00036        105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNN-----------HALPLFLVK  173 (440)
T ss_pred             hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcC-----------CCCCHHHHH
Confidence            456899999999999999999987532        2577999999999888775421110           345566778


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.|++.||+|||+.+|+||||||+||+++.++..+||+|||+++..... .......||+.|+|||.+.+...++.++
T Consensus       174 ~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~  252 (440)
T PTZ00036        174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHI  252 (440)
T ss_pred             HHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHH
Confidence            888999999999999999999999999999977647999999999865432 2233457899999999987755689999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc---------------ccccccccccCCCCCCCHHHHHHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF---------------CKLSLRDHLTNGFPGLEPAGIDLIS  230 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~  230 (259)
                      |||||||++|+|++|.+||.+.........+......|..               +.....+.........++++.+||.
T Consensus       253 DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~  332 (440)
T PTZ00036        253 DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFIS  332 (440)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHH
Confidence            9999999999999999999988776665555332211111               0000000000111346789999999


Q ss_pred             hhcCcCCCCccCHHHHhcCccccCCC
Q 039159          231 KMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       231 ~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      +||+.||.+|||+.++|+||||....
T Consensus       333 ~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        333 QFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHCCCChhHCcCHHHHhCChhHHhhh
Confidence            99999999999999999999998653

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=303.13  Aligned_cols=230  Identities=23%  Similarity=0.319  Sum_probs=199.5

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHH-HHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLA-YLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |.|...+++..++++-||.||..++||+||++++.|+-++.+|++.|||.|+-. .++-...              ..++
T Consensus        63 KvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~--------------r~Lt  128 (1187)
T KOG0579|consen   63 KVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG--------------RVLT  128 (1187)
T ss_pred             hhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhc--------------cccc
Confidence            557778888899999999999999999999999999999999999999998544 4443221              5677


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC---
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG---  157 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---  157 (259)
                      ..++.-++++.+.||.|||+.+|||||||.-|||++.+| .++|+|||.+..........+.++|||+|||||++..   
T Consensus       129 E~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~  207 (1187)
T KOG0579|consen  129 EDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETF  207 (1187)
T ss_pred             hHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccccccchhHHhhhccccCCcccccchheeeccc
Confidence            788999999999999999999999999999999999999 8999999999877666677889999999999998752   


Q ss_pred             -ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          158 -LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       158 -~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                       ..+|+.++||||||++|.||+.+.+|-...++...+.+|....+ |..          ...+..+..+.|++++||..|
T Consensus       208 KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP-PTL----------lqPS~Ws~~F~DfLk~cL~Kn  276 (1187)
T KOG0579|consen  208 KDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PTL----------LQPSHWSRSFSDFLKRCLVKN  276 (1187)
T ss_pred             cCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC-Ccc----------cCcchhhhHHHHHHHHHHhcC
Confidence             25789999999999999999999999999999998888754432 221          112467889999999999999


Q ss_pred             CCCccCHHHHhcCccccCCCC
Q 039159          237 PDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       237 p~~Rp~~~~~l~h~~f~~~~~  257 (259)
                      |..||++.++|+||||.+++.
T Consensus       277 p~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  277 PRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             CccCCCHHHHhhCcccccCCc
Confidence            999999999999999998864

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-43  Score=291.63  Aligned_cols=213  Identities=31%  Similarity=0.439  Sum_probs=178.2

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.+++.++||||+++++++..++..|+||||+.| +|...+...               ..+.......++.|
T Consensus        44 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~q  108 (323)
T cd05584          44 TAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE---------------GIFMEDTACFYLSE  108 (323)
T ss_pred             HHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            34567899999999999999999999999999999999996 888887532               22344566677889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.||+|||+++|+||||||+||+++.++ .+||+|||+++.............|++.|+|||.+.+ ..++.++|||||
T Consensus       109 i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diwsl  186 (323)
T cd05584         109 ISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR-SGHGKAVDWWSL  186 (323)
T ss_pred             HHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCCcccccCCCccccChhhccC-CCCCCcceeccc
Confidence            99999999999999999999999999888 8999999998754333333445579999999999977 567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CHHH
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAE  245 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~  245 (259)
                      ||++|+|++|+.||.+.+.......+.....              ...+.+++++.++|.+||..||.+||     ++++
T Consensus       187 G~il~ell~G~~pf~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~  252 (323)
T cd05584         187 GALMYDMLTGAPPFTAENRKKTIDKILKGKL--------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAE  252 (323)
T ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHH
Confidence            9999999999999998877666666543321              11235789999999999999999999     8999


Q ss_pred             HhcCccccCC
Q 039159          246 ALQQEYFKDV  255 (259)
Q Consensus       246 ~l~h~~f~~~  255 (259)
                      +++||||+..
T Consensus       253 l~~h~~~~~~  262 (323)
T cd05584         253 VQSHPFFRHV  262 (323)
T ss_pred             HhcCCCcCCC
Confidence            9999999864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=297.13  Aligned_cols=219  Identities=26%  Similarity=0.387  Sum_probs=187.1

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .++..+++.+|+.+|..++++||.++|+.|..+..+|++||||.| ++..+++..               ..+....+..
T Consensus        51 ~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~---------------~~~~E~~i~~  115 (467)
T KOG0201|consen   51 AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSG---------------NILDEFEIAV  115 (467)
T ss_pred             cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccC---------------CCCccceeee
Confidence            456678999999999999999999999999999999999999996 888888542               2224556667


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +++.++.|+.|||..+.+|||||+.||++..+| .|||+|||.+..+........+++|||.|||||++.+ ..|+.++|
T Consensus       116 ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KAD  193 (467)
T KOG0201|consen  116 ILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKAD  193 (467)
T ss_pred             ehHHHHHHhhhhhhcceecccccccceeEeccC-cEEEEecceeeeeechhhccccccccccccchhhhcc-ccccchhh
Confidence            778889999999999999999999999999997 8999999999888777666788999999999999996 68999999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++.+||++|.+|+....+......|-... .|.         +.   ..+|+.+++||..||+.||+.||+|.++
T Consensus       194 IWSLGITaiEla~GePP~s~~hPmrvlflIpk~~-PP~---------L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~L  260 (467)
T KOG0201|consen  194 IWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA-PPR---------LD---GDFSPPFKEFVEACLDKNPEFRPSAKEL  260 (467)
T ss_pred             hhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC-CCc---------cc---cccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence            9999999999999999999887754443332211 111         11   2688999999999999999999999999


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      |+|+|++..+
T Consensus       261 LKh~FIk~a~  270 (467)
T KOG0201|consen  261 LKHKFIKRAK  270 (467)
T ss_pred             hhhHHHHhcC
Confidence            9999999754

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3e-43  Score=287.91  Aligned_cols=232  Identities=35%  Similarity=0.527  Sum_probs=181.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ....+.+|+++++.++||||+++++++..++..++||||+.++|...+....              ..+....+..++.+
T Consensus        47 ~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--------------~~~~~~~~~~~~~q  112 (301)
T cd07873          47 APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG--------------NSINMHNVKLFLFQ  112 (301)
T ss_pred             chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccccCHHHHHHhcC--------------CCCCHHHHHHHHHH
Confidence            3456889999999999999999999999999999999999999888875321              23455677888899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||+.+++||||||+||+++.++ .++|+|||.+..............+++.|+|||.+.+...++.++|||||
T Consensus       113 i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl  191 (301)
T cd07873         113 LLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGV  191 (301)
T ss_pred             HHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHH
Confidence            99999999999999999999999999888 89999999997543333333445678899999998765567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc------------c----ccccccCCCCCCCHHHHHHHHhhcC
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL------------S----LRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------~----~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                      ||++|+|++|++||...+.......+......+.....            .    ..+......+.+++.+.+||.+||.
T Consensus       192 G~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~  271 (301)
T cd07873         192 GCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQ  271 (301)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhc
Confidence            99999999999999887665444333221111100000            0    0001112224678899999999999


Q ss_pred             cCCCCccCHHHHhcCccccCCCC
Q 039159          235 MDPDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~h~~f~~~~~  257 (259)
                      .||.+|||++++++||||.....
T Consensus       272 ~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         272 FEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             CCcccCcCHHHHhcCcccccccc
Confidence            99999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=300.95  Aligned_cols=213  Identities=25%  Similarity=0.341  Sum_probs=189.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      -.++++||++|++|+|||+|.+.|+|..+...|||||||-|+-.+++...+              .++....+..+.++.
T Consensus        70 WqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhk--------------KplqEvEIAAi~~ga  135 (948)
T KOG0577|consen   70 WQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK--------------KPLQEVEIAAITHGA  135 (948)
T ss_pred             HHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhccHHHHHHHHh--------------ccchHHHHHHHHHHH
Confidence            458999999999999999999999999999999999999998888886644              567778999999999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCccccc--CccCCCcccchHh
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL--GLLEYSTAVDIWP  169 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Diws  169 (259)
                      +.||+|||+++.||||||.-|||++..| .|||+|||.+....    ....++|||+|||||++.  ..+.|+-++||||
T Consensus       136 L~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWS  210 (948)
T KOG0577|consen  136 LQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS  210 (948)
T ss_pred             HHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhcC----chhcccCCccccchhHheeccccccCCccceee
Confidence            9999999999999999999999999998 99999999998653    345689999999999996  3467999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      ||+++.|++.+++|+.+.+....++.|..+. .|..+           .+..|..+..|+..||+.-|.+|||.+++|+|
T Consensus       211 LGITCIELAERkPPlFnMNAMSALYHIAQNe-sPtLq-----------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  211 LGITCIELAERKPPLFNMNAMSALYHIAQNE-SPTLQ-----------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCCCC-----------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            9999999999999999999999999987653 23322           24678999999999999999999999999999


Q ss_pred             ccccCC
Q 039159          250 EYFKDV  255 (259)
Q Consensus       250 ~~f~~~  255 (259)
                      +|+.-.
T Consensus       279 ~fv~R~  284 (948)
T KOG0577|consen  279 RFVLRE  284 (948)
T ss_pred             chhccC
Confidence            998754

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.1e-43  Score=284.99  Aligned_cols=218  Identities=22%  Similarity=0.289  Sum_probs=175.1

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ..+.+|++++++++|+||+++++++.+++..++||||+.+ +|...+.....             ..+.......++.|+
T Consensus        45 ~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~-------------~~~~~~~~~~~~~qi  111 (285)
T cd05631          45 AMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-------------PGFDEQRAIFYAAEL  111 (285)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCC-------------CCCCHHHHHHHHHHH
Confidence            4678999999999999999999999999999999999996 78776643211             235566778889999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      +.|++|||+.+|+||||||+||+++.++ .++|+|||++...... .......|++.|+|||.+.+ ..++.++||||||
T Consensus       112 ~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG  188 (285)
T cd05631         112 CCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLG  188 (285)
T ss_pred             HHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCC-CeecCCCCCCCccCHhhhcC-CCCCcccCchhHH
Confidence            9999999999999999999999999888 8999999999764321 22234578999999999987 5788999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HHHH
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AAEA  246 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~~~  246 (259)
                      |++|+|++|+.||.+.........+......          ........+++++.+|+.+||+.||++||+     ++++
T Consensus       189 vil~el~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~  258 (285)
T cd05631         189 CLIYEMIQGQSPFRKRKERVKREEVDRRVKE----------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV  258 (285)
T ss_pred             HHHHHHHhCCCCCCCCCcchhHHHHHHHhhc----------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH
Confidence            9999999999999876543222222111100          111122468899999999999999999997     9999


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      ++||||.++.
T Consensus       259 ~~h~~~~~~~  268 (285)
T cd05631         259 KQHPIFKNIN  268 (285)
T ss_pred             hcCHhhcCCC
Confidence            9999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-44  Score=268.84  Aligned_cols=217  Identities=25%  Similarity=0.355  Sum_probs=189.4

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ...+..++.+|++|.+.|+||||+++|++|-++...||++||.. |++++.++....             ..+.......
T Consensus        62 ~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~-------------~~f~e~~~a~  128 (281)
T KOG0580|consen   62 KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRM-------------KRFDEQRAAT  128 (281)
T ss_pred             HhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhccc-------------ccccccchhH
Confidence            34677889999999999999999999999999999999999998 599999974222             3455566788


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +..|++.|+.|+|.++++||||||+|+|++..+ .+|++|||-+..-  ......+.+||.-|.+||++.+ ...+..+|
T Consensus       129 Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~--p~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd  204 (281)
T KOG0580|consen  129 YIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHA--PSNKRKTLCGTLDYLPPEMVEG-RGHDKFVD  204 (281)
T ss_pred             HHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCceeec--CCCCceeeecccccCCHhhcCC-CCccchhh
Confidence            889999999999999999999999999999999 8999999999643  2456678899999999999998 67889999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      +|++|++.||++.|.+||...+..+.+..|.......              .+.++.+++|+|.+|+..+|.+|....++
T Consensus       205 ~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~--------------p~~is~~a~dlI~~ll~~~p~~r~~l~~v  270 (281)
T KOG0580|consen  205 LWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKF--------------PSTISGGAADLISRLLVKNPIERLALTEV  270 (281)
T ss_pred             HHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccC--------------CcccChhHHHHHHHHhccCccccccHHHH
Confidence            9999999999999999999988888888775433211              14689999999999999999999999999


Q ss_pred             hcCccccCC
Q 039159          247 LQQEYFKDV  255 (259)
Q Consensus       247 l~h~~f~~~  255 (259)
                      +.|||+...
T Consensus       271 ~~hpwI~a~  279 (281)
T KOG0580|consen  271 MDHPWIVAN  279 (281)
T ss_pred             hhhHHHHhc
Confidence            999999754

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3e-43  Score=290.19  Aligned_cols=216  Identities=25%  Similarity=0.331  Sum_probs=180.1

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...+.+.+|+.+++.+ +||||+++++++..++.+|+||||+.| +|...+...               ..+.......+
T Consensus        37 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~---------------~~l~~~~~~~~  101 (320)
T cd05590          37 DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS---------------RRFDEARARFY  101 (320)
T ss_pred             cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc---------------CCCCHHHHHHH
Confidence            3445677899999877 699999999999999999999999996 888777532               23455677788


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||+++++||||||+||+++.++ .++|+|||+++.............||+.|+|||.+.+ ..++.++|+
T Consensus       102 ~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  179 (320)
T cd05590         102 AAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPSVDW  179 (320)
T ss_pred             HHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC-CCCCCccch
Confidence            89999999999999999999999999999888 8999999998754333333445579999999999977 567889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH----
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA----  243 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~----  243 (259)
                      |||||++|+|++|+.||.+.+.......+......              ....+++++.+++.+||+.||++||++    
T Consensus       180 wslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~--------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~  245 (320)
T cd05590         180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLG  245 (320)
T ss_pred             hhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC--------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCC
Confidence            99999999999999999988877776666543211              113478999999999999999999998    


Q ss_pred             --HHHhcCccccCCC
Q 039159          244 --AEALQQEYFKDVP  256 (259)
Q Consensus       244 --~~~l~h~~f~~~~  256 (259)
                        +++++||||..+.
T Consensus       246 ~~~~~~~h~~f~~~~  260 (320)
T cd05590         246 GEEAILRHPFFKELD  260 (320)
T ss_pred             CHHHHHcCCCcCCCC
Confidence              9999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.1e-43  Score=283.40  Aligned_cols=231  Identities=40%  Similarity=0.591  Sum_probs=179.4

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +.....+.+|+.++++++||||+++++++.+++..++||||+.++|.+.+......            ..+....+..++
T Consensus        40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~------------~~~~~~~~~~~~  107 (285)
T cd07861          40 EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKG------------QYMDAELVKSYL  107 (285)
T ss_pred             CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCCC------------CcCCHHHHHHHH
Confidence            34456788999999999999999999999999999999999999988888543211            345667788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.||+|||+.+++||||+|+||+++.++ .++|+|||++..............+++.|+|||.+.+...++.++|+|
T Consensus       108 ~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~  186 (285)
T cd07861         108 YQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIW  186 (285)
T ss_pred             HHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHH
Confidence            9999999999999999999999999999888 899999999875433222233446788999999987655678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCc---------ccc------ccccccccCCCCCCCHHHHHHHHhhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS---------FCK------LSLRDHLTNGFPGLEPAGIDLISKML  233 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~---------~~~------~~~~~~~~~~~~~~~~~~~~li~~~l  233 (259)
                      ||||++|++++|++||.+.........+......+.         ...      .............+++++.++|.+||
T Consensus       187 slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  266 (285)
T cd07861         187 SIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKML  266 (285)
T ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHh
Confidence            999999999999999987665444333221111000         000      00000111123457899999999999


Q ss_pred             CcCCCCccCHHHHhcCccc
Q 039159          234 GMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h~~f  252 (259)
                      ..||++|||+.++++||||
T Consensus       267 ~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         267 IYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             cCChhhCCCHHHHhcCCCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-43  Score=291.27  Aligned_cols=218  Identities=25%  Similarity=0.377  Sum_probs=181.3

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.+++.++||||+++++++..++..|+||||++| +|.+++...               ..+.......++.|
T Consensus        45 ~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---------------~~l~~~~~~~~~~q  109 (333)
T cd05600          45 VRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL---------------GVLSEDHARFYMAE  109 (333)
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            45688999999999999999999999999999999999986 899988532               23456677788899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.||+|||+.+|+||||||+||+++.++ .+||+|||++.....   ......||+.|+|||.+.+ ..++.++|||||
T Consensus       110 i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvwsl  184 (333)
T cd05600         110 MFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSL  184 (333)
T ss_pred             HHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc---ccCCcccCccccChhHhcC-CCCCCccceecc
Confidence            99999999999999999999999999888 899999999975432   3345578999999999987 578899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      ||++|+|++|..||.+.+.......+.........+.      .......+++++.+++.+||..+|++||+++++++||
T Consensus       185 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~  258 (333)
T cd05600         185 GCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP  258 (333)
T ss_pred             hHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCC------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence            9999999999999998877776666543322211111      0001135789999999999999999999999999999


Q ss_pred             cccCC
Q 039159          251 YFKDV  255 (259)
Q Consensus       251 ~f~~~  255 (259)
                      ||..+
T Consensus       259 ~~~~~  263 (333)
T cd05600         259 FFKEV  263 (333)
T ss_pred             ccCCC
Confidence            99975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.8e-43  Score=292.17  Aligned_cols=215  Identities=27%  Similarity=0.349  Sum_probs=179.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|+++++.++||||+++++++..++..|+||||+.| +|...+...               ..+....+..++.
T Consensus        38 ~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~---------------~~l~~~~~~~~~~  102 (325)
T cd05594          38 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE---------------RVFSEDRARFYGA  102 (325)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            345678899999999999999999999999999999999996 787776432               3355677788899


Q ss_pred             hcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      |++.||+|||+ .+|+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|||
T Consensus       103 qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw  180 (325)
T cd05594         103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWW  180 (325)
T ss_pred             HHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc-CCCCCccccc
Confidence            99999999997 7999999999999999888 8999999998754333333445579999999999977 5788999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CH
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TA  243 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~  243 (259)
                      ||||++|+|++|..||.+.........+......  .            ...+++++.+++.+||+.||++|+     ++
T Consensus       181 slG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~--~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  246 (325)
T cd05594         181 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--F------------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDA  246 (325)
T ss_pred             cccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC--C------------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCH
Confidence            9999999999999999887766665555432211  1            135789999999999999999997     99


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      .++++||||.++.
T Consensus       247 ~~il~h~~~~~~~  259 (325)
T cd05594         247 KEIMQHKFFAGIV  259 (325)
T ss_pred             HHHhcCCCcCCCC
Confidence            9999999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=298.14  Aligned_cols=218  Identities=26%  Similarity=0.372  Sum_probs=191.8

Q ss_pred             CCCCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .++..+....|-+|+...+ ||.+++++.+|...+++|.||||+.|+.  ++...+             ...+....+.-
T Consensus       408 ~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggd--m~~~~~-------------~~~F~e~rarf  472 (694)
T KOG0694|consen  408 QRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGD--LMHHIH-------------TDVFSEPRARF  472 (694)
T ss_pred             ccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCc--EEEEEe-------------cccccHHHHHH
Confidence            3566788899999999985 9999999999999999999999999844  222111             15567778888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++..++.||.|||++|||+||||.+|||+|.+| ++||+|||+++.........++++|||-|+|||.+.+ ..|+.++|
T Consensus       473 yaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVD  550 (694)
T KOG0694|consen  473 YAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVD  550 (694)
T ss_pred             HHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEecccccccccCCCCCccccccCChhhcChhhhcc-Ccccchhh
Confidence            899999999999999999999999999999999 9999999999988777778999999999999999988 68999999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC----
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT----  242 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----  242 (259)
                      -|||||++|||+.|++||.+.+..+.+..|......-              ...+|.++.++++++|..+|.+|..    
T Consensus       551 WW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y--------------P~~ls~ea~~il~~ll~k~p~kRLG~~e~  616 (694)
T KOG0694|consen  551 WWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY--------------PRFLSKEAIAIMRRLLRKNPEKRLGSGER  616 (694)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC--------------CCcccHHHHHHHHHHhccCcccccCCCCC
Confidence            9999999999999999999999999999997654221              1358999999999999999999996    


Q ss_pred             -HHHHhcCccccCCC
Q 039159          243 -AAEALQQEYFKDVP  256 (259)
Q Consensus       243 -~~~~l~h~~f~~~~  256 (259)
                       +++|.+||||+++.
T Consensus       617 d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  617 DAEDIKKHPFFRSID  631 (694)
T ss_pred             CchhhhhCCccccCC
Confidence             58999999999874

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.2e-43  Score=288.86  Aligned_cols=213  Identities=27%  Similarity=0.410  Sum_probs=177.5

Q ss_pred             CchhHHHHHHH---hhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           12 PSSMIREVSCL---MELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        12 ~~~~~~Ei~~l---~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+.+.+|++++   +.++||||+++++++..++..|+||||+.| +|...+..                ..+.......+
T Consensus        43 ~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~----------------~~l~~~~~~~~  106 (324)
T cd05589          43 VESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT----------------DVFSEPRAVFY  106 (324)
T ss_pred             HHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc----------------CCCCHHHHHHH
Confidence            45677777665   566799999999999999999999999996 77766642                33566778889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.|++|||+.+++||||||+||+++.++ .+||+|||+++.............|++.|+|||.+.+ ..++.++|+
T Consensus       107 ~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di  184 (324)
T cd05589         107 AACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDW  184 (324)
T ss_pred             HHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCCCCcccccccCccccCHhHhcC-CCCCcccch
Confidence            99999999999999999999999999999988 8999999998754333334455679999999999987 568889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----C
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----T  242 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~  242 (259)
                      |||||++|+|++|+.||.+.+.......+......              ....+++.+.++|.+||..||++||     +
T Consensus       185 wslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~  250 (324)
T cd05589         185 WGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--------------YPRFLSREAISIMRRLLRRNPERRLGSGEKD  250 (324)
T ss_pred             hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence            99999999999999999988777666666543221              1135789999999999999999999     7


Q ss_pred             HHHHhcCccccCCC
Q 039159          243 AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ~~~~l~h~~f~~~~  256 (259)
                      +.++++||||+++.
T Consensus       251 ~~~l~~~~~f~~~~  264 (324)
T cd05589         251 AEDVKKQPFFRDIN  264 (324)
T ss_pred             HHHHhhCCCcCCCC
Confidence            99999999998753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5e-43  Score=289.06  Aligned_cols=214  Identities=26%  Similarity=0.338  Sum_probs=179.7

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+..|+++++.+ +||||+++++++..++..|+||||+.| +|...+...               ..+.......++
T Consensus        38 ~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~---------------~~~~~~~~~~~~  102 (321)
T cd05591          38 DVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---------------RKFDEPRSRFYA  102 (321)
T ss_pred             HHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHHH
Confidence            345677899999876 799999999999999999999999996 888777532               234456677888


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.||+|||+++|+||||||+||+++.++ .++|+|||++..............||+.|+|||.+.+ ..++.++|||
T Consensus       103 ~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvw  180 (321)
T cd05591         103 AEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWW  180 (321)
T ss_pred             HHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCccccccccCccccCHHHHcC-CCCCCcccee
Confidence            9999999999999999999999999999888 8999999998764433333445578999999999977 5788999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-------
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-------  241 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-------  241 (259)
                      ||||++|+|++|+.||...+.......+.......              ...+++++.+++.+||..||++||       
T Consensus       181 slG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~--------------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~  246 (321)
T cd05591         181 ALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY--------------PVWLSKEAVSILKAFMTKNPNKRLGCVASQG  246 (321)
T ss_pred             chhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCC
Confidence            99999999999999999888777777665433211              124689999999999999999999       


Q ss_pred             CHHHHhcCccccCC
Q 039159          242 TAAEALQQEYFKDV  255 (259)
Q Consensus       242 ~~~~~l~h~~f~~~  255 (259)
                      +++++++||||.++
T Consensus       247 ~~~~~~~hp~~~~~  260 (321)
T cd05591         247 GEDAIKQHPFFKEI  260 (321)
T ss_pred             CHHHHhcCCccCCC
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.7e-43  Score=282.36  Aligned_cols=221  Identities=24%  Similarity=0.299  Sum_probs=176.0

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      +.+..|++++++++||||+++.+++..++..++||||+.| +|...+......           ...++...++.++.|+
T Consensus        38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~-----------~~~l~~~~~~~~~~qi  106 (280)
T cd05608          38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE-----------NPGFPEPRACFYTAQI  106 (280)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhcccc-----------CCCCCHHHHHHHHHHH
Confidence            5677899999999999999999999999999999999986 887776432111           1345667788899999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      +.|++|||+++|+||||||+||+++.++ .++|+|||.+..............|++.|+|||.+.+ ..++.++|+||||
T Consensus       107 ~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG  184 (280)
T cd05608         107 ISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALG  184 (280)
T ss_pred             HHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCccccccCCCcCccCHHHhcC-CCCCccccHHHHH
Confidence            9999999999999999999999999888 8999999999765443333445578999999999987 5788999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CHHHH
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAEA  246 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~~  246 (259)
                      |++|+|++|+.||...........+.......          .......+++++.+++.+||+.||++||     +++++
T Consensus       185 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~  254 (280)
T cd05608         185 VTLYEMIAARGPFRARGEKVENKELKQRILND----------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL  254 (280)
T ss_pred             HHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence            99999999999998654322111111110000          0011235789999999999999999999     88999


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      ++||||+...
T Consensus       255 l~h~~~~~~~  264 (280)
T cd05608         255 RTHPLFRDLN  264 (280)
T ss_pred             hcChhhhcCC
Confidence            9999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-42  Score=292.22  Aligned_cols=217  Identities=25%  Similarity=0.306  Sum_probs=178.8

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.+++.++||||+++++++.+++..|+||||++| +|..++..                ..++......++.+
T Consensus        87 ~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~----------------~~l~~~~~~~~~~q  150 (370)
T cd05596          87 SAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN----------------YDIPEKWARFYTAE  150 (370)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh----------------cCCCHHHHHHHHHH
Confidence            34577899999999999999999999999999999999986 89888853                12344556677889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCc---cCCCcccc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGL---LEYSTAVD  166 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~---~~~~~~~D  166 (259)
                      ++.||+|||+++|+||||||+||+++.++ .+||+|||.+........ ......||+.|+|||.+.+.   ..++.++|
T Consensus       151 i~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~D  229 (370)
T cd05596         151 VVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD  229 (370)
T ss_pred             HHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCcee
Confidence            99999999999999999999999999888 899999999976533221 23455799999999998652   23678999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC--ccCHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK--RITAA  244 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rp~~~  244 (259)
                      +|||||++|+|++|+.||.+.+.......+.........+          ....+|.++.+||.+||+.+|++  |++++
T Consensus       230 iwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~  299 (370)
T cd05596         230 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP----------DDIEISKQAKDLICAFLTDREVRLGRNGVD  299 (370)
T ss_pred             eeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC----------CcCCCCHHHHHHHHHHccChhhccCCCCHH
Confidence            9999999999999999999888777777765543222221          12357899999999999999988  99999


Q ss_pred             HHhcCccccCC
Q 039159          245 EALQQEYFKDV  255 (259)
Q Consensus       245 ~~l~h~~f~~~  255 (259)
                      ++++||||++.
T Consensus       300 ell~h~~~~~~  310 (370)
T cd05596         300 EIKSHPFFKND  310 (370)
T ss_pred             HHhcCcccCCC
Confidence            99999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-43  Score=296.22  Aligned_cols=227  Identities=26%  Similarity=0.295  Sum_probs=172.0

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      ..+.+|++++++|+||||+++++++..+...++|+|++.++|...+...               ..+....++.++.|++
T Consensus       128 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------------~~l~~~~~~~i~~qi~  192 (391)
T PHA03212        128 GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK---------------RNIAICDILAIERSVL  192 (391)
T ss_pred             hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHH
Confidence            4578999999999999999999999999999999999998888877532               2345567788999999


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-CCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      .||+|||+++|+||||||+||+++.++ .++|+|||+++...... .......||+.|+|||.+.+ ..++.++||||||
T Consensus       193 ~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG  270 (391)
T PHA03212        193 RAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAG  270 (391)
T ss_pred             HHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCcccccccccccccccccCccCCCChhhhcC-CCCCcHHHHHHHH
Confidence            999999999999999999999999888 89999999996532211 22334579999999999977 5689999999999


Q ss_pred             HHHHHHHhCCCCCCCCC-------hHHHHHHHhCC-CCCC-cccc---ccc-------------c---ccccCCCCCCCH
Q 039159          172 CIFGEMVSGKPLFPGAN-------SLITLGRIVGK-SRKP-SFCK---LSL-------------R---DHLTNGFPGLEP  223 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~-------~~~~~~~i~~~-~~~~-~~~~---~~~-------------~---~~~~~~~~~~~~  223 (259)
                      |++|+|++|..||.+..       .......+... ...| ..+.   ...             .   .+.......++.
T Consensus       271 vil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (391)
T PHA03212        271 IVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPI  350 (391)
T ss_pred             HHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhh
Confidence            99999999998775432       11111112110 0000 0000   000             0   000001123567


Q ss_pred             HHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          224 AGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       224 ~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ++.+||.+||..||.+|||++|+|+||||+.++
T Consensus       351 ~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        351 DLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             hHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence            899999999999999999999999999999864

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.5e-42  Score=290.84  Aligned_cols=217  Identities=23%  Similarity=0.312  Sum_probs=176.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.++++++||||+++++.+.++..+|+||||++| +|.+.+...               ..+....+..++.|
T Consensus        45 ~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~l~~~~~~~~~~q  109 (363)
T cd05628          45 VGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK---------------DTLTEEETQFYIAE  109 (363)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            35678899999999999999999999999999999999986 888888542               33556777888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--------------------------------
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--------------------------------  138 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--------------------------------  138 (259)
                      ++.||+|||++||+||||||+||+++.++ .+||+|||+++.......                                
T Consensus       110 i~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (363)
T cd05628         110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN  188 (363)
T ss_pred             HHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhc
Confidence            99999999999999999999999999888 899999999875422100                                


Q ss_pred             ---CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccccccccc
Q 039159          139 ---ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLT  215 (259)
Q Consensus       139 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  215 (259)
                         ......||+.|+|||.+.+ ..++.++|+|||||++|||++|+.||.+.........+.........+.        
T Consensus       189 ~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~--------  259 (363)
T cd05628         189 RRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPP--------  259 (363)
T ss_pred             cccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCC--------
Confidence               0123479999999999987 5688999999999999999999999998887777777765332222211        


Q ss_pred             CCCCCCCHHHHHHHHhhcCcCCC---CccCHHHHhcCccccCCC
Q 039159          216 NGFPGLEPAGIDLISKMLGMDPD---KRITAAEALQQEYFKDVP  256 (259)
Q Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~---~Rp~~~~~l~h~~f~~~~  256 (259)
                        ...+++++.+++.+|+. +|.   .||+++++++||||+++.
T Consensus       260 --~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~  300 (363)
T cd05628         260 --EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD  300 (363)
T ss_pred             --cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence              12478999999998765 444   468999999999998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.6e-43  Score=302.53  Aligned_cols=217  Identities=24%  Similarity=0.322  Sum_probs=180.3

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.+++.++||||+++++++..++..|+||||+.| +|.+.+......           ...+.......++.|
T Consensus       109 ~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~-----------~~~l~~~~~~~i~~q  177 (478)
T PTZ00267        109 AAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE-----------HLPFQEYEVGLLFYQ  177 (478)
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhc-----------cCCCCHHHHHHHHHH
Confidence            45677899999999999999999999999999999999985 898877532111           034566778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++.||+|||+++|+||||||+||+++.++ .+||+|||+++.......  ......||+.|+|||.+.+ ..++.++|||
T Consensus       178 i~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~  255 (478)
T PTZ00267        178 IVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMW  255 (478)
T ss_pred             HHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHH
Confidence            99999999999999999999999999888 899999999986543221  2344569999999999977 5788999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||||++|+|++|..||.+.........+......+             ....+++++.++|.+||..||++||++++++.
T Consensus       256 slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        256 SLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            99999999999999999887776666655432211             11357899999999999999999999999999


Q ss_pred             CccccC
Q 039159          249 QEYFKD  254 (259)
Q Consensus       249 h~~f~~  254 (259)
                      |+|++.
T Consensus       323 ~~~~~~  328 (478)
T PTZ00267        323 TEFLKY  328 (478)
T ss_pred             CHHHHH
Confidence            999864

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-42  Score=285.94  Aligned_cols=235  Identities=32%  Similarity=0.490  Sum_probs=171.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEe--CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ....+.+|++++++++||||+++++++..  +...|++|||+.++|..++........      ......++...+..++
T Consensus        41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~------~~~~~~l~~~~~~~i~  114 (317)
T cd07868          41 ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKA------NKKPVQLPRGMVKSLL  114 (317)
T ss_pred             CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccc------cCCcccCCHHHHHHHH
Confidence            34568899999999999999999999864  457899999999999888864322111      0111345667788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEc----CCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVD----LDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~----~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      .|++.||+|||+.+|+||||||+||+++    .++ .+||+|||+++.......   ......||+.|+|||.+.+...+
T Consensus       115 ~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  193 (317)
T cd07868         115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY  193 (317)
T ss_pred             HHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcC-cEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCc
Confidence            9999999999999999999999999993    344 799999999976533221   22345789999999999875568


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHhCCCCCCccccc------------------------
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANS---------LITLGRIVGKSRKPSFCKL------------------------  208 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~------------------------  208 (259)
                      +.++||||+||++|+|++|++||.....         ......+......+.....                        
T Consensus       194 ~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (317)
T cd07868         194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC  273 (317)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcc
Confidence            8999999999999999999999975332         1111122111110000000                        


Q ss_pred             cccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccc
Q 039159          209 SLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      .............++++.+||.+||..||.+|||++++|+||||
T Consensus       274 ~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         274 SLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00000111112346678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=302.20  Aligned_cols=232  Identities=22%  Similarity=0.280  Sum_probs=195.8

Q ss_pred             CCCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchh
Q 039159            1 MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLF   79 (259)
Q Consensus         1 ~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~   79 (259)
                      ||-|+........-+..||...+.|+|.|||+++|.+.+++.+-+.||-.+| +|..+++..++...            -
T Consensus       605 IKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlK------------D  672 (1226)
T KOG4279|consen  605 IKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLK------------D  672 (1226)
T ss_pred             eeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCc------------c
Confidence            4566776777777789999999999999999999999999999999999996 99999998877643            2


Q ss_pred             HHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC-c
Q 039159           80 TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG-L  158 (259)
Q Consensus        80 ~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~  158 (259)
                      ....+.-+-.||++||.|||+..|||||||-+|++++-..+.+||+|||-++.+..-+++..++-||..|||||++.. .
T Consensus       673 NEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~  752 (1226)
T KOG4279|consen  673 NESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGP  752 (1226)
T ss_pred             chhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCC
Confidence            334556677899999999999999999999999999887669999999999999888889999999999999999964 4


Q ss_pred             cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHH-HHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT-LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      ..|+.++|||||||++.||+||++||.+.-..+. ..++-.-..-|.            ....+|.++++||.+|+..||
T Consensus       753 RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~------------iPeelsaeak~FilrcFepd~  820 (1226)
T KOG4279|consen  753 RGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPP------------IPEELSAEAKNFILRCFEPDP  820 (1226)
T ss_pred             cCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCC------------CcHHHHHHHHHHHHHHcCCCc
Confidence            5689999999999999999999999987543333 323211111222            234788999999999999999


Q ss_pred             CCccCHHHHhcCccccCCC
Q 039159          238 DKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       238 ~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .+||++.++|+.||++.-.
T Consensus       821 ~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  821 CDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             ccCccHHHhccCcccccCC
Confidence            9999999999999998653

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-44  Score=294.71  Aligned_cols=205  Identities=25%  Similarity=0.301  Sum_probs=170.9

Q ss_pred             HHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccc
Q 039159           16 IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS   94 (259)
Q Consensus        16 ~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (259)
                      ..+|+-|++|+|||||+|.|+|.....+|+|||||. |.|+++++..               ..++...++.+..+|+.|
T Consensus       160 ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~---------------~~itp~llv~Wsk~IA~G  224 (904)
T KOG4721|consen  160 ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG---------------RPITPSLLVDWSKGIAGG  224 (904)
T ss_pred             hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc---------------CccCHHHHHHHHHHhhhh
Confidence            458899999999999999999999999999999998 7999999653               445566778889999999


Q ss_pred             cccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHHHHH
Q 039159           95 RSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIF  174 (259)
Q Consensus        95 l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l  174 (259)
                      +.|||.++|||||||.-||||+.+. .|||+|||-++....- ...=.++||..|||||++.+ ..++.++|||||||||
T Consensus       225 M~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVL  301 (904)
T KOG4721|consen  225 MNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVL  301 (904)
T ss_pred             hHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHH
Confidence            9999999999999999999999888 8999999999876432 22234689999999999998 6899999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          175 GEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       175 ~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      |||+||..||.+-+...++.-+-......            +-....++.++-||++||+-.|..||++.++|.|-
T Consensus       302 WEmLT~EiPYkdVdssAIIwGVGsNsL~L------------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  302 WEMLTGEIPYKDVDSSAIIWGVGSNSLHL------------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HHHHhcCCCccccchheeEEeccCCcccc------------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            99999999998765544433321111111            11245778888999999999999999999999983

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.7e-43  Score=283.47  Aligned_cols=230  Identities=35%  Similarity=0.515  Sum_probs=177.7

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+.....+.+|++++++++||||+++++++.+++..++++||+.++|.+.+....              ..++...+..+
T Consensus        39 ~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~~~~~~~~~~  104 (284)
T cd07839          39 DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCN--------------GDIDPEIVKSF  104 (284)
T ss_pred             cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCCCHHHHHHhcC--------------CCCCHHHHHHH
Confidence            3445577889999999999999999999999999999999999998888775321              33567788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||.|||+.+++||||||+||+++.++ .++|+|||.+..............+++.|+|||.+.+...++.++||
T Consensus       105 ~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  183 (284)
T cd07839         105 MFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM  183 (284)
T ss_pred             HHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHH
Confidence            99999999999999999999999999999888 89999999997653333333445678899999998775557889999


Q ss_pred             HhHHHHHHHHHhCCCCCC-CCChHHHHHHHhCCCCCC---------------ccccccccccccCCCCCCCHHHHHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFP-GANSLITLGRIVGKSRKP---------------SFCKLSLRDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~-~~~~~~~~~~i~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~  231 (259)
                      |||||++|+|++|..||. +.+.......+......+               ..+............+.+++++.++|.+
T Consensus       184 wslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  263 (284)
T cd07839         184 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQN  263 (284)
T ss_pred             HHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHH
Confidence            999999999999987754 444333333322111000               0000000011122235678999999999


Q ss_pred             hcCcCCCCccCHHHHhcCccc
Q 039159          232 MLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      ||+.||.+|||++++++||||
T Consensus       264 ~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         264 LLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             HhcCChhhcCCHHHHhcCCCC
Confidence            999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-43  Score=280.70  Aligned_cols=213  Identities=25%  Similarity=0.349  Sum_probs=186.3

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +.....+.+||+|++.|+||||+++|.+|+..+..++||||..+ .|++++...               ..++......+
T Consensus        94 eqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer---------------~~LsErEaRhf  158 (668)
T KOG0611|consen   94 EQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER---------------GSLSEREARHF  158 (668)
T ss_pred             HHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh---------------ccccHHHHHHH
Confidence            33445678999999999999999999999999999999999985 899999653               45677889999


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      |+||.+|+.|||+++++|||||.+|||+|.++ .+||+|||++... ....-..+++|+|.|.+||.+.|.+.-++.+|.
T Consensus       159 FRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGLSNly-~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDs  236 (668)
T KOG0611|consen  159 FRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGLSNLY-ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDS  236 (668)
T ss_pred             HHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccchhhhh-ccccHHHHhcCCcccCCccccCCCCCCCCccch
Confidence            99999999999999999999999999999998 8999999999764 334456788999999999999997777899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++||.+..|..||.+.+......+|..+-...               +..+.++.-||+.||.++|++|.|++++-
T Consensus       237 WsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---------------P~~PSdA~gLIRwmLmVNP~RRATieDiA  301 (668)
T KOG0611|consen  237 WSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---------------PETPSDASGLIRWMLMVNPERRATIEDIA  301 (668)
T ss_pred             hhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---------------CCCCchHHHHHHHHHhcCcccchhHHHHh
Confidence            999999999999999999999888888886654221               34567778899999999999999999998


Q ss_pred             cCcccc
Q 039159          248 QQEYFK  253 (259)
Q Consensus       248 ~h~~f~  253 (259)
                      .|=|+.
T Consensus       302 sHWWvN  307 (668)
T KOG0611|consen  302 SHWWVN  307 (668)
T ss_pred             hhheee
Confidence            876654

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-42  Score=286.11  Aligned_cols=215  Identities=24%  Similarity=0.339  Sum_probs=179.9

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +....+.+|+.+++.+ +||||+++++++...+.+|+||||+.| +|...+...               ..++..++..+
T Consensus        37 ~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~l~~~~~~~~  101 (318)
T cd05570          37 DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS---------------GRFDEPRARFY  101 (318)
T ss_pred             hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc---------------CCCCHHHHHHH
Confidence            3345677899999988 699999999999999999999999986 887777532               23556778888


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||+.+++||||||+||+++.++ .++|+|||++..............|++.|+|||.+.+ ..++.++|+
T Consensus       102 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di  179 (318)
T cd05570         102 AAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY-QPYGPAVDW  179 (318)
T ss_pred             HHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCcccceecCccccCHHHhcC-CCCCcchhh
Confidence            99999999999999999999999999999988 8999999998754333333445578999999999987 578899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH----
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA----  243 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~----  243 (259)
                      |||||++|++++|+.||.+.+.......+......  .            ...+++.+.++|.+||..||++||++    
T Consensus       180 wslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~--~------------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~  245 (318)
T cd05570         180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR--Y------------PRWLSKEAKSILKSFLTKNPEKRLGCLPTG  245 (318)
T ss_pred             hhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC--C------------CCcCCHHHHHHHHHHccCCHHHcCCCCCCC
Confidence            99999999999999999988777666665443211  1            13478999999999999999999999    


Q ss_pred             -HHHhcCccccCC
Q 039159          244 -AEALQQEYFKDV  255 (259)
Q Consensus       244 -~~~l~h~~f~~~  255 (259)
                       .++++||||+++
T Consensus       246 ~~~ll~~~~~~~~  258 (318)
T cd05570         246 EQDIKGHPFFREI  258 (318)
T ss_pred             HHHHhcCCCcCCC
Confidence             999999999875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.7e-43  Score=288.91  Aligned_cols=213  Identities=25%  Similarity=0.339  Sum_probs=179.5

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|++++++++||||+++++++..++.+|+||||+.| +|.+.+...               ..+....+..++.|
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~~q  106 (318)
T cd05582          42 RVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE---------------VMFTEEDVKFYLAE  106 (318)
T ss_pred             HHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            34577899999999999999999999999999999999985 888877431               33566778888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.||+|||+++|+||||||+||+++.++ .++|+|||++..............|++.|+|||.+.+ ..++.++|||||
T Consensus       107 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diwsl  184 (318)
T cd05582         107 LALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSF  184 (318)
T ss_pred             HHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC-CCCCCccceecc
Confidence            99999999999999999999999999888 8999999998765443333445578999999999977 567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HHH
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AAE  245 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~~  245 (259)
                      ||++|+|++|+.||...........+......              ....+++.+.+++.+||+.||.+||+     +++
T Consensus       185 G~il~el~tg~~p~~~~~~~~~~~~i~~~~~~--------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~  250 (318)
T cd05582         185 GVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEE  250 (318)
T ss_pred             ceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC--------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence            99999999999999988776666665433211              11357899999999999999999999     788


Q ss_pred             HhcCccccCC
Q 039159          246 ALQQEYFKDV  255 (259)
Q Consensus       246 ~l~h~~f~~~  255 (259)
                      ++.||||.++
T Consensus       251 ~~~~~~~~~~  260 (318)
T cd05582         251 IKRHPFFSTI  260 (318)
T ss_pred             HhCCCCcCCC
Confidence            9999999865

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-42  Score=284.54  Aligned_cols=215  Identities=25%  Similarity=0.369  Sum_probs=176.5

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+..|..++..+ +||||+++++++.+++..|+||||+.| +|...+...               ..+.......++
T Consensus        38 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~---------------~~~~~~~~~~~~  102 (316)
T cd05620          38 DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK---------------GRFDLYRATFYA  102 (316)
T ss_pred             hHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc---------------CCCCHHHHHHHH
Confidence            345677788888765 899999999999999999999999996 888877532               234556777888


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.|++|||++||+||||||+||+++.++ .++|+|||++..............||+.|+|||.+.+ ..++.++|||
T Consensus       103 ~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw  180 (316)
T cd05620         103 AEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG-LKYTFSVDWW  180 (316)
T ss_pred             HHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC-CCCCcccchh
Confidence            9999999999999999999999999999888 8999999998753322333445678999999999987 5788999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH-HHHh
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA-AEAL  247 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-~~~l  247 (259)
                      ||||++|+|++|+.||.+.+.......+....  +..            ...++.++.+++.+||..||++||++ ++++
T Consensus       181 slGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~~~------------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         181 SFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--PHY------------PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             hhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCC------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            99999999999999999877766665553321  111            12478899999999999999999997 5888


Q ss_pred             cCccccCCC
Q 039159          248 QQEYFKDVP  256 (259)
Q Consensus       248 ~h~~f~~~~  256 (259)
                      +||||..+.
T Consensus       247 ~h~~f~~~~  255 (316)
T cd05620         247 GHPFFKTIN  255 (316)
T ss_pred             cCCCcCCCC
Confidence            999998763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.9e-42  Score=284.26  Aligned_cols=226  Identities=23%  Similarity=0.304  Sum_probs=175.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++..++..++||||+.| +|.+++...               ..+....+..++.
T Consensus        46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~  110 (331)
T cd06649          46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA---------------KRIPEEILGKVSI  110 (331)
T ss_pred             HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            346799999999999999999999999999999999999996 899888542               2244566778889


Q ss_pred             hcccccccccCC-CceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGT-RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~-~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.|++|||+. +|+||||||+||+++.++ .++|+|||++.....  .......|++.|+|||.+.+ ..++.++|||
T Consensus       111 ~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Diw  186 (331)
T cd06649         111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQG-THYSVQSDIW  186 (331)
T ss_pred             HHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcccccccc--cccccCCCCcCcCCHhHhcC-CCCCchHhHH
Confidence            999999999985 699999999999999888 899999999875532  22344578999999999987 5688999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCC------C-----cc---------------ccc---cc-----cc-c
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRK------P-----SF---------------CKL---SL-----RD-H  213 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~------~-----~~---------------~~~---~~-----~~-~  213 (259)
                      ||||++|++++|+.||......+....+ .....      +     ..               +..   ..     .. .
T Consensus       187 slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (331)
T cd06649         187 SMGLSLVELAIGRYPIPPPDAKELEAIF-GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP  265 (331)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHh-cccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCC
Confidence            9999999999999999876554432221 11000      0     00               000   00     00 0


Q ss_pred             ccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          214 LTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       214 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .......+++++++||.+||+.||++|||++++++||||+...
T Consensus       266 ~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         266 PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence            0000124688999999999999999999999999999998653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=290.35  Aligned_cols=216  Identities=29%  Similarity=0.422  Sum_probs=178.1

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+++++.++||||+++++++.+++..|+||||+.| +|.+++...               ..++...+..++.|
T Consensus        45 ~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~---------------~~l~~~~~~~~~~q  109 (364)
T cd05599          45 VAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK---------------DTFTEEETRFYIAE  109 (364)
T ss_pred             HHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            35577899999999999999999999999999999999986 888887532               33566778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--------------------------------
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--------------------------------  138 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--------------------------------  138 (259)
                      ++.||+|||+++|+||||||+||+++.++ .++|+|||++..+.....                                
T Consensus       110 i~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (364)
T cd05599         110 TILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETW  188 (364)
T ss_pred             HHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceeccccccccccccccccccccccccccccccccccccch
Confidence            99999999999999999999999999988 899999999875422110                                


Q ss_pred             ------CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccc
Q 039159          139 ------ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRD  212 (259)
Q Consensus       139 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  212 (259)
                            ......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.........+.     
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-----  262 (364)
T cd05599         189 KRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPD-----  262 (364)
T ss_pred             hhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCC-----
Confidence                  0112468999999999977 5688999999999999999999999998887777666654332221111     


Q ss_pred             cccCCCCCCCHHHHHHHHhhcCcCCCCccC---HHHHhcCccccCC
Q 039159          213 HLTNGFPGLEPAGIDLISKMLGMDPDKRIT---AAEALQQEYFKDV  255 (259)
Q Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~~l~h~~f~~~  255 (259)
                           ...+++++.++|.+|+. +|.+|++   ++++++||||+..
T Consensus       263 -----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         263 -----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             -----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence                 12578999999999997 8999998   9999999999865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.9e-42  Score=285.78  Aligned_cols=213  Identities=27%  Similarity=0.367  Sum_probs=176.4

Q ss_pred             chhHHHHH-HHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           13 SSMIREVS-CLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        13 ~~~~~Ei~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .++.+|.. +++.++||||+++++++.+++..|+||||+.| +|...+...               ..+.......++.|
T Consensus        40 ~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~~~q  104 (323)
T cd05575          40 KHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE---------------RSFPEPRARFYAAE  104 (323)
T ss_pred             HHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            44555655 56789999999999999999999999999996 888777532               23455667788899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.||+|||++||+||||||+||+++.++ .+||+|||++..............||+.|+|||.+.+ ..++.++|||||
T Consensus       105 i~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvwsl  182 (323)
T cd05575         105 IASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCL  182 (323)
T ss_pred             HHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCccccccCChhhcChhhhcC-CCCCcccccccc
Confidence            99999999999999999999999999888 8999999998764433334445679999999999987 568899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH----HHH
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA----AEA  246 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~----~~~  246 (259)
                      ||++|+|++|..||...+.......+......              ..+.+++.+.++|.+||+.||.+||++    .++
T Consensus       183 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (323)
T cd05575         183 GAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR--------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEI  248 (323)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC--------------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHH
Confidence            99999999999999988777666666543211              124578999999999999999999987    699


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      ++||||.++.
T Consensus       249 l~~~~~~~~~  258 (323)
T cd05575         249 KNHVFFSSIN  258 (323)
T ss_pred             HcCCCcCCCC
Confidence            9999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-42  Score=291.06  Aligned_cols=217  Identities=24%  Similarity=0.300  Sum_probs=177.2

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.+++.++||||+++++++.+++.+|+||||++| +|.+++..                ..+.......++.|
T Consensus        87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~----------------~~~~~~~~~~~~~q  150 (370)
T cd05621          87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN----------------YDVPEKWAKFYTAE  150 (370)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh----------------cCCCHHHHHHHHHH
Confidence            34577999999999999999999999999999999999986 89988853                22344567788899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCc---cCCCcccc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGL---LEYSTAVD  166 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~---~~~~~~~D  166 (259)
                      ++.||+|||+++|+||||||+||+++.++ .+||+|||++........ ......||+.|+|||.+.+.   ..++.++|
T Consensus       151 il~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~D  229 (370)
T cd05621         151 VVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD  229 (370)
T ss_pred             HHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccC
Confidence            99999999999999999999999999888 899999999976532221 23456799999999999752   23678999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC--ccCHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK--RITAA  244 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rp~~~  244 (259)
                      +||+||++|+|++|..||.+.+.......+.........+.          ...+++.+++++..||..++.+  |++++
T Consensus       230 iwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~  299 (370)
T cd05621         230 WWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVE  299 (370)
T ss_pred             EEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHH
Confidence            99999999999999999998887777777654432222211          1357899999999999865544  88999


Q ss_pred             HHhcCccccCC
Q 039159          245 EALQQEYFKDV  255 (259)
Q Consensus       245 ~~l~h~~f~~~  255 (259)
                      ++++||||+..
T Consensus       300 e~l~hp~~~~~  310 (370)
T cd05621         300 EIKQHPFFKND  310 (370)
T ss_pred             HHhcCcccCCC
Confidence            99999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-42  Score=292.15  Aligned_cols=228  Identities=29%  Similarity=0.454  Sum_probs=179.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCc-----eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGI-----YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ..++.+|+.+++.++||||+++++++...+     ..|+|+||+.++|...+...               ..+....+..
T Consensus        43 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---------------~~l~~~~~~~  107 (372)
T cd07853          43 CKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSP---------------QPLSSDHVKV  107 (372)
T ss_pred             HHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcC---------------CCCCHHHHHH
Confidence            457889999999999999999999998776     78999999998888877432               3355677888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      ++.|++.||+|||+.+++||||||+||+++.++ .+||+|||++........ ......+++.|+|||.+.+...++.++
T Consensus       108 ~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  186 (372)
T cd07853         108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAV  186 (372)
T ss_pred             HHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHH
Confidence            899999999999999999999999999999888 899999999975433221 223346789999999998755678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc------------------cccccccCCCCCCCHHHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL------------------SLRDHLTNGFPGLEPAGID  227 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~  227 (259)
                      ||||+||++|+|++|+.||.+.+.......+......+.....                  .............++++.+
T Consensus       187 DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (372)
T cd07853         187 DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVH  266 (372)
T ss_pred             HHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHH
Confidence            9999999999999999999988776665554332111111000                  0000011122456889999


Q ss_pred             HHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          228 LISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       228 li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ||.+||+.||.+|||++++|+||||+..
T Consensus       267 li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         267 LLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.9e-42  Score=290.97  Aligned_cols=216  Identities=29%  Similarity=0.408  Sum_probs=175.1

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.++++++||||+++++++.+++.+|+||||+.| +|.+.+...               ..+....+..++.|
T Consensus        45 ~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~e~~~~~~~~q  109 (382)
T cd05625          45 VAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---------------GIFPEDLARFYIAE  109 (382)
T ss_pred             HHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            45688999999999999999999999999999999999986 888887532               22445566778889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC---------------------------------
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK---------------------------------  137 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~---------------------------------  137 (259)
                      ++.||+|||+.+|+||||||+||+++.++ .+||+|||++.......                                 
T Consensus       110 i~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (382)
T cd05625         110 LTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDR  188 (382)
T ss_pred             HHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCcccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999888 89999999975321000                                 


Q ss_pred             --------------CCCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC
Q 039159          138 --------------GESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP  203 (259)
Q Consensus       138 --------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~  203 (259)
                                    .......||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.......+.......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  267 (382)
T cd05625         189 LKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL  267 (382)
T ss_pred             ccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc
Confidence                          00112468999999999987 568899999999999999999999999887776666665433222


Q ss_pred             ccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC---HHHHhcCccccCC
Q 039159          204 SFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT---AAEALQQEYFKDV  255 (259)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~~l~h~~f~~~  255 (259)
                      ..+          ....+++++.++|.+|+ .+|.+|++   ++++++||||+.+
T Consensus       268 ~~p----------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         268 HIP----------PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             CCC----------CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            211          12357899999999976 59999997   9999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.1e-42  Score=283.11  Aligned_cols=235  Identities=32%  Similarity=0.499  Sum_probs=170.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEe--CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ....+.+|++++++++||||+++++++..  +...++||||+.++|.+++........      ......+....+..++
T Consensus        41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~------~~~~~~l~~~~~~~i~  114 (317)
T cd07867          41 ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKA------NKKPMQLPRSMVKSLL  114 (317)
T ss_pred             CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhcccc------CCCCccCCHHHHHHHH
Confidence            34568899999999999999999999854  457899999999999888864322111      0111345667788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEE----cCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILV----DLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili----~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      .|++.||+|||+.+++||||||+||++    +.++ .+||+|||+++.......   ......||+.|+|||.+.+...+
T Consensus       115 ~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  193 (317)
T cd07867         115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHY  193 (317)
T ss_pred             HHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCC-cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCcc
Confidence            999999999999999999999999999    3445 899999999976543221   12344689999999999775567


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChH---------HHHHHHhCCCCCCc------------ccc------------c
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSL---------ITLGRIVGKSRKPS------------FCK------------L  208 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~---------~~~~~i~~~~~~~~------------~~~------------~  208 (259)
                      +.++|||||||++|+|+||.+||......         .....+......+.            .+.            .
T Consensus       194 ~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (317)
T cd07867         194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANS  273 (317)
T ss_pred             CcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCc
Confidence            89999999999999999999999753321         11111111000000            000            0


Q ss_pred             cccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccc
Q 039159          209 SLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      .............+..+.+|+.+||+.||.+|||+.++|+||||
T Consensus       274 ~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         274 SLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00000111112346778899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.2e-42  Score=283.54  Aligned_cols=215  Identities=26%  Similarity=0.368  Sum_probs=176.8

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+..|..+++.+ +||||+++++++.+++.+++||||++| +|...+...               ..+.......++
T Consensus        38 ~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---------------~~~~~~~~~~~~  102 (316)
T cd05619          38 DVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC---------------HKFDLPRATFYA  102 (316)
T ss_pred             hHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHHH
Confidence            345677888888865 899999999999999999999999986 898888532               234456677788


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.|++|||+.+++||||||+||+++.++ .++|+|||++..............||+.|+|||++.+ ..++.++|+|
T Consensus       103 ~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvw  180 (316)
T cd05619         103 AEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWW  180 (316)
T ss_pred             HHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceeeecCCccccCHHHHcC-CCCCchhhhh
Confidence            9999999999999999999999999999888 8999999998754332333345578999999999987 5688999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH-HHh
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA-EAL  247 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~-~~l  247 (259)
                      ||||++|+|++|+.||.+.+.......+.....  ..            ...++.++.+++.+||+.||++||++. +++
T Consensus       181 slG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--~~------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         181 SFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP--CY------------PRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             hHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CC------------CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            999999999999999998777666655532211  11            124788999999999999999999996 899


Q ss_pred             cCccccCCC
Q 039159          248 QQEYFKDVP  256 (259)
Q Consensus       248 ~h~~f~~~~  256 (259)
                      +||||+.+.
T Consensus       247 ~h~~~~~~~  255 (316)
T cd05619         247 QHPFFREID  255 (316)
T ss_pred             cCcccCCCC
Confidence            999998763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=290.53  Aligned_cols=218  Identities=31%  Similarity=0.447  Sum_probs=181.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|+++++.++||||+++++++.+++..|+||||+.| +|.+.+...               ..+....+..++
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~  107 (350)
T cd05573          43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK---------------DVFPEETARFYI  107 (350)
T ss_pred             cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc---------------CCCCHHHHHHHH
Confidence            3446788999999999999999999999999999999999986 898888542               234556777888


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-----------------------------CC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-----------------------------GE  139 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-----------------------------~~  139 (259)
                      .|++.||+|||++||+||||||+||+++.++ .++|+|||++.......                             ..
T Consensus       108 ~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (350)
T cd05573         108 AELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR  186 (350)
T ss_pred             HHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCccccccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999988 89999999997654332                             12


Q ss_pred             CcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCC
Q 039159          140 SSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP  219 (259)
Q Consensus       140 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  219 (259)
                      .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.........+          ...
T Consensus       187 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p----------~~~  255 (350)
T cd05573         187 ANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFP----------PDP  255 (350)
T ss_pred             ccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCC----------CCC
Confidence            234568999999999987 578999999999999999999999999888776666665422221111          112


Q ss_pred             CCCHHHHHHHHhhcCcCCCCccC-HHHHhcCccccCC
Q 039159          220 GLEPAGIDLISKMLGMDPDKRIT-AAEALQQEYFKDV  255 (259)
Q Consensus       220 ~~~~~~~~li~~~l~~dp~~Rp~-~~~~l~h~~f~~~  255 (259)
                      .+++++.++|.+||. ||.+||+ ++++++||||.++
T Consensus       256 ~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         256 PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            378999999999997 9999999 9999999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.9e-42  Score=283.08  Aligned_cols=213  Identities=28%  Similarity=0.410  Sum_probs=175.9

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+..|..++..+ +||||+++++++..++..++||||+.| +|...+...               ..+....+..++.
T Consensus        39 ~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~---------------~~~~~~~~~~~~~  103 (316)
T cd05592          39 VECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS---------------GRFDEARARFYAA  103 (316)
T ss_pred             HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            44566777777765 899999999999999999999999986 888877532               2345566778889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.|++|||+.+|+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++||||
T Consensus       104 qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws  181 (316)
T cd05592         104 EIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWS  181 (316)
T ss_pred             HHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCccccccCCccccCHHHHcC-CCCCCcccchh
Confidence            999999999999999999999999999888 8999999999764433334445679999999999987 56889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH-HHHhc
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA-AEALQ  248 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-~~~l~  248 (259)
                      |||++|+|++|+.||.+.+.......+....  +..            ...++.++.+++.+||+.||++||++ +++++
T Consensus       182 lG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~------------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         182 FGVLLYEMLIGQSPFHGEDEDELFDSILNDR--PHF------------PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCC------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            9999999999999999887776666654322  111            13478899999999999999999986 58889


Q ss_pred             CccccCC
Q 039159          249 QEYFKDV  255 (259)
Q Consensus       249 h~~f~~~  255 (259)
                      ||||+.+
T Consensus       248 h~~~~~~  254 (316)
T cd05592         248 HPFFRGI  254 (316)
T ss_pred             CcccCCC
Confidence            9999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.3e-42  Score=277.59  Aligned_cols=222  Identities=22%  Similarity=0.298  Sum_probs=179.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+++++.++||||+++++++..++..++|+||+.+ +|...+....              ..+....+..++
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--------------~~l~~~~~~~~~  109 (282)
T cd06643          44 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--------------RPLTEPQIRVVC  109 (282)
T ss_pred             HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC--------------CCCCHHHHHHHH
Confidence            3346788999999999999999999999999999999999996 7777664311              335567788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC----ccCCCcc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG----LLEYSTA  164 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~  164 (259)
                      .+++.||+|||+.|++||||||+||+++.++ .++++|||++..............+++.|+|||.+..    ...++.+
T Consensus       110 ~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~  188 (282)
T cd06643         110 KQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK  188 (282)
T ss_pred             HHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCcc
Confidence            9999999999999999999999999999888 8999999998765433333445578999999999842    2446789


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      +|+|||||++|++++|++||...+.......+...... ..          .....++.++.+++.+||+.||.+||+++
T Consensus       189 ~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  257 (282)
T cd06643         189 ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TL----------AQPSRWSSEFKDFLKKCLEKNVDARWTTT  257 (282)
T ss_pred             chhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC-CC----------CCccccCHHHHHHHHHHccCChhhCcCHH
Confidence            99999999999999999999887766655555332211 10          11134678999999999999999999999


Q ss_pred             HHhcCccccCCCC
Q 039159          245 EALQQEYFKDVPG  257 (259)
Q Consensus       245 ~~l~h~~f~~~~~  257 (259)
                      ++++||||+....
T Consensus       258 ~il~~~~~~~~~~  270 (282)
T cd06643         258 QLLQHPFVTVNSN  270 (282)
T ss_pred             HHhcCCCEeccCC
Confidence            9999999996543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.5e-42  Score=279.29  Aligned_cols=230  Identities=41%  Similarity=0.633  Sum_probs=179.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +.....+.+|++++++++||||+++++++.+++..++||||+.++|...+.....             ..+.......++
T Consensus        40 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~-------------~~l~~~~~~~~~  106 (284)
T cd07860          40 EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPL-------------SGIPLPLIKSYL  106 (284)
T ss_pred             cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccccCHHHHHHhCCC-------------CCCCHHHHHHHH
Confidence            3445678999999999999999999999999999999999998888888754221             335667788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||+.+++||||+|+||+++.++ .++|+|||.+..............+++.|+|||.+.+...++.++|+|
T Consensus       107 ~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~  185 (284)
T cd07860         107 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW  185 (284)
T ss_pred             HHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHH
Confidence            9999999999999999999999999999888 899999999876533333333445788999999987645568889999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc---------------ccccccccCCCCCCCHHHHHHHHhhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK---------------LSLRDHLTNGFPGLEPAGIDLISKML  233 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~~l  233 (259)
                      |||+++|+++||+.||.+.+.......+......+....               ...........+.+++++.++|.+||
T Consensus       186 slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  265 (284)
T cd07860         186 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQML  265 (284)
T ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhc
Confidence            999999999999999988766554444332211111000               00001111223457889999999999


Q ss_pred             CcCCCCccCHHHHhcCccc
Q 039159          234 GMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h~~f  252 (259)
                      +.||++|||++++++||||
T Consensus       266 ~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         266 HYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             CCCcccCCCHHHHhcCCCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.7e-42  Score=286.92  Aligned_cols=226  Identities=32%  Similarity=0.490  Sum_probs=172.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc------eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGI------YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      .....++.+|+.+++.++||||+++++++....      ..|+||||+.++|...+..                 .+...
T Consensus        61 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----------------~~~~~  123 (359)
T cd07876          61 QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM-----------------ELDHE  123 (359)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc-----------------cCCHH
Confidence            344567889999999999999999999986543      5799999999988877632                 23445


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++..... ........||+.|+|||.+.+ ..++
T Consensus       124 ~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~  200 (359)
T cd07876         124 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACT-NFMMTPYVVTRYYRAPEVILG-MGYK  200 (359)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCcccccc-CccCCCCcccCCCCCchhccC-CCCC
Confidence            6677889999999999999999999999999999988 899999999975422 222334578999999999987 5788


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCc--------------------ccccccccc--------c
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS--------------------FCKLSLRDH--------L  214 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~--------------------~~~~~~~~~--------~  214 (259)
                      .++|||||||++|+|++|+.||.+.+.......+......+.                    .+.....+.        .
T Consensus       201 ~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (359)
T cd07876         201 ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSE  280 (359)
T ss_pred             cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccc
Confidence            999999999999999999999988765544443322211111                    000000000        0


Q ss_pred             cCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccC
Q 039159          215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       215 ~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      .......++.+++||.+||..||++|||++|+|+||||..
T Consensus       281 ~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         281 SERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             cccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence            0111234678999999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.2e-42  Score=288.23  Aligned_cols=226  Identities=32%  Similarity=0.465  Sum_probs=175.1

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      +....++.+|+.+++.++||||+++++++...      ...|+||||+.++|...+..                 .+...
T Consensus        64 ~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----------------~~~~~  126 (364)
T cd07875          64 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----------------ELDHE  126 (364)
T ss_pred             chhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh-----------------cCCHH
Confidence            34456788999999999999999999988643      35799999999988887742                 23445


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++.... ........||+.|+|||.+.+ ..++
T Consensus       127 ~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~  203 (364)
T cd07875         127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYK  203 (364)
T ss_pred             HHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCccccCC-CCcccCCcccCCcCCHHHHhC-CCCC
Confidence            6678889999999999999999999999999999888 899999999975432 222334578999999999987 5788


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc--------------------ccccccc--------cc
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF--------------------CKLSLRD--------HL  214 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~--------------------~~~~~~~--------~~  214 (259)
                      .++|||||||++|+|++|+.||.+.+.......+......+..                    .......        ..
T Consensus       204 ~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (364)
T cd07875         204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPAD  283 (364)
T ss_pred             chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccccc
Confidence            9999999999999999999999988776666655432221110                    0000000        00


Q ss_pred             cCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccC
Q 039159          215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       215 ~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      .......+..+++||.+||+.||++|||++++|+||||..
T Consensus       284 ~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         284 SEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             ccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            0011123568899999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.8e-42  Score=288.51  Aligned_cols=218  Identities=28%  Similarity=0.378  Sum_probs=173.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+.++++++||||+++++++.+++.+|+||||++| +|.+.+...               ..+.......++.|
T Consensus        45 ~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~e~~~~~~~~q  109 (381)
T cd05626          45 VAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---------------EVFPEVLARFYIAE  109 (381)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            45688999999999999999999999999999999999986 888887532               22445566778889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--------------------------------
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--------------------------------  138 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--------------------------------  138 (259)
                      ++.||+|||+.||+||||||+||+++.++ .++|+|||++........                                
T Consensus       110 i~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (381)
T cd05626         110 LTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDR  188 (381)
T ss_pred             HHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccc
Confidence            99999999999999999999999999888 899999998753210000                                


Q ss_pred             ---------------CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC
Q 039159          139 ---------------ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP  203 (259)
Q Consensus       139 ---------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~  203 (259)
                                     ......||+.|+|||.+.+ ..++.++|||||||++|||++|..||...........+.......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~  267 (381)
T cd05626         189 LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL  267 (381)
T ss_pred             cchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc
Confidence                           0123469999999999977 568899999999999999999999999877766665554332222


Q ss_pred             ccccccccccccCCCCCCCHHHHHHHHhhcC--cCCCCccCHHHHhcCccccCCC
Q 039159          204 SFCKLSLRDHLTNGFPGLEPAGIDLISKMLG--MDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~--~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ..+          ....+++++.+||.+|+.  .++..|+++++++.||||..+.
T Consensus       268 ~~~----------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         268 HIP----------PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             CCC----------CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence            111          123578999999999654  4555699999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=290.18  Aligned_cols=216  Identities=27%  Similarity=0.383  Sum_probs=173.9

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|++++++++||||+++++++.+++..|+||||++| +|.+.+...               ..+....+..++.|
T Consensus        45 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~~~~~~~~~~q  109 (377)
T cd05629          45 LAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY---------------DTFSEDVTRFYMAE  109 (377)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            45678899999999999999999999999999999999985 898888532               23445566778889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC------------C-------------------
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG------------E-------------------  139 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~------------~-------------------  139 (259)
                      ++.||+|||+.||+||||||+||+++.++ .++|+|||+++.......            .                   
T Consensus       110 l~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (377)
T cd05629         110 CVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTM  188 (377)
T ss_pred             HHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeecccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999888 899999999863211000            0                   


Q ss_pred             ----------------CcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC
Q 039159          140 ----------------SSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP  203 (259)
Q Consensus       140 ----------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~  203 (259)
                                      .....||+.|+|||.+.+ ..++.++|||||||++|||++|.+||.+.........+.......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  267 (377)
T cd05629         189 SSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL  267 (377)
T ss_pred             cchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc
Confidence                            012468999999999977 568899999999999999999999999887776666665432222


Q ss_pred             ccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc---cCHHHHhcCccccCC
Q 039159          204 SFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR---ITAAEALQQEYFKDV  255 (259)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---p~~~~~l~h~~f~~~  255 (259)
                      ..+          ....+++++.+||.+||. +|.+|   +++.++++||||+++
T Consensus       268 ~~p----------~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         268 YFP----------DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             CCC----------CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            111          123578999999999998 66665   599999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.5e-42  Score=288.71  Aligned_cols=226  Identities=33%  Similarity=0.462  Sum_probs=173.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeC------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ....++.+|+.+++.++||||+++++++...      ...|+||||+.+++.+.+..                 .+....
T Consensus        58 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----------------~l~~~~  120 (355)
T cd07874          58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM-----------------ELDHER  120 (355)
T ss_pred             HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh-----------------cCCHHH
Confidence            3456788999999999999999999998644      35799999999988877742                 234556


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCc
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      +..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++.... ........||+.|+|||.+.+ ..++.
T Consensus       121 ~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~  197 (355)
T cd07874         121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKE  197 (355)
T ss_pred             HHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCcccccCCC-ccccCCccccCCccCHHHHcC-CCCCc
Confidence            778889999999999999999999999999999888 899999999975422 222334578999999999987 56889


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC--------------------cccc--------cccccccc
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP--------------------SFCK--------LSLRDHLT  215 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~--------------------~~~~--------~~~~~~~~  215 (259)
                      ++|||||||++|+|++|+.||.+.+.......+......+                    ....        ........
T Consensus       198 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (355)
T cd07874         198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS  277 (355)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccccccc
Confidence            9999999999999999999998876555544432211110                    0000        00000001


Q ss_pred             CCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          216 NGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ......+..+.+||.+||+.||.+|||++++|+||||...
T Consensus       278 ~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         278 EHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             ccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            1112346788999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.5e-42  Score=288.43  Aligned_cols=214  Identities=22%  Similarity=0.268  Sum_probs=168.7

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+++++.++|+||+++++++..++.+++||||+.+ +|...                   .......+..++
T Consensus       114 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-------------------~~~~~~~~~~i~  174 (353)
T PLN00034        114 TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-------------------HIADEQFLADVA  174 (353)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc-------------------ccCCHHHHHHHH
Confidence            3456788999999999999999999999999999999999996 55321                   112334566788


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC----ccCCCcc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG----LLEYSTA  164 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~  164 (259)
                      .|++.||+|||+++|+||||||+||+++.++ .+||+|||+++.............||..|+|||.+..    ....+.+
T Consensus       175 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  253 (353)
T PLN00034        175 RQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYA  253 (353)
T ss_pred             HHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceecccccccccccccCccccCccccccccccCcCCCcc
Confidence            9999999999999999999999999999888 8999999999865443333345679999999998743    1234568


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHH---HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLI---TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      +|||||||++|+|++|+.||.......   ....+.... .            ......+++++.+||.+||..||++||
T Consensus       254 ~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~l~~li~~~l~~~P~~Rp  320 (353)
T PLN00034        254 GDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-P------------PEAPATASREFRHFISCCLQREPAKRW  320 (353)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-C------------CCCCCccCHHHHHHHHHHccCChhhCc
Confidence            999999999999999999997432211   111111111 1            111245789999999999999999999


Q ss_pred             CHHHHhcCccccCCC
Q 039159          242 TAAEALQQEYFKDVP  256 (259)
Q Consensus       242 ~~~~~l~h~~f~~~~  256 (259)
                      +++++++||||.+..
T Consensus       321 t~~ell~hp~~~~~~  335 (353)
T PLN00034        321 SAMQLLQHPFILRAQ  335 (353)
T ss_pred             CHHHHhcCcccccCC
Confidence            999999999999763

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.6e-42  Score=278.98  Aligned_cols=219  Identities=27%  Similarity=0.423  Sum_probs=178.5

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ....+.+.+|+.+++.++||||+++++.+..+...|+||||+.| +|..++..                ..+...++..+
T Consensus        58 ~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~i  121 (296)
T cd06654          58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------------TCMDEGQIAAV  121 (296)
T ss_pred             cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh----------------cCCCHHHHHHH
Confidence            34456788999999999999999999999999999999999986 89888753                22445677889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.|++|||+.+++||||||+||+++.++ .++|+|||.+..............+++.|+|||.+.+ ..++.++|+
T Consensus       122 ~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  199 (296)
T cd06654         122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI  199 (296)
T ss_pred             HHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhccccccccCcccCCccccCHHHHcC-CCCCccchH
Confidence            99999999999999999999999999999888 8999999998765433333344578899999999977 567889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||||++|++++|+.||...........+.... .+..          .....+++.+.+++.+||..||++||++++++
T Consensus       200 ~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil  268 (296)
T cd06654         200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPEL----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL  268 (296)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCC----------CCccccCHHHHHHHHHHCcCCcccCcCHHHHh
Confidence            999999999999999998766544433332211 1110          11235778999999999999999999999999


Q ss_pred             cCccccCCC
Q 039159          248 QQEYFKDVP  256 (259)
Q Consensus       248 ~h~~f~~~~  256 (259)
                      +||||....
T Consensus       269 ~~~~~~~~~  277 (296)
T cd06654         269 QHQFLKIAK  277 (296)
T ss_pred             hChhhhccC
Confidence            999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.2e-42  Score=284.41  Aligned_cols=213  Identities=23%  Similarity=0.318  Sum_probs=172.4

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...+.+|+.+++++ +||||+++++++.+++.+|+||||++| +|...+...               ..++...+..++.
T Consensus        39 ~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~---------------~~l~~~~~~~~~~  103 (329)
T cd05588          39 IDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ---------------RKLPEEHARFYSA  103 (329)
T ss_pred             HHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            45578899999998 799999999999999999999999996 887776431               3356677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.|++|||++|++||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|+||
T Consensus       104 qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws  181 (329)
T cd05588         104 EISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWA  181 (329)
T ss_pred             HHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCCCccccccCCccccCHHHHcC-CCCCCccceec
Confidence            999999999999999999999999999888 8999999998754333334445679999999999987 56888999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC--------hHH-HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          170 VGCIFGEMVSGKPLFPGAN--------SLI-TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~--------~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      |||++|++++|+.||....        ... ....+....  .            .....+++.+.+++.+||+.||.+|
T Consensus       182 lG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~------------~~p~~~~~~~~~li~~~L~~dP~~R  247 (329)
T cd05588         182 LGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--I------------RIPRSLSVKASSVLKGFLNKDPKER  247 (329)
T ss_pred             hHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--C------------CCCCCCCHHHHHHHHHHhccCHHHc
Confidence            9999999999999996311        111 111222111  0            1123578999999999999999999


Q ss_pred             cC------HHHHhcCccccCC
Q 039159          241 IT------AAEALQQEYFKDV  255 (259)
Q Consensus       241 p~------~~~~l~h~~f~~~  255 (259)
                      ++      ++++++||||.++
T Consensus       248 ~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         248 LGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             CCCCCCCCHHHHhcCCCCCCC
Confidence            87      7999999999865

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2e-42  Score=298.28  Aligned_cols=231  Identities=23%  Similarity=0.313  Sum_probs=193.8

Q ss_pred             CCCCCCCCCC-CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcch
Q 039159            1 MMGIHNTMEG-VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus         1 ~~~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      ||.++..++. ...+|.+|+++++.|+|||||+++|+|.+++..|+|+|||. |+|-++++-...- .............
T Consensus       521 VK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~-a~~~~~g~~~~~~  599 (774)
T KOG1026|consen  521 VKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPK-ADKLASGQDTPPP  599 (774)
T ss_pred             HhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCc-cccccCCCCCCCC
Confidence            5677777776 88999999999999999999999999999999999999999 7999999754321 1122121122456


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCccccc
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLL  156 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  156 (259)
                      +...+.+.++.||+.|+.||-++.+|||||-.+|+||+.+- .|||+|||+++..+...-.  .+...-...|||||.++
T Consensus       600 L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl  678 (774)
T KOG1026|consen  600 LSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL  678 (774)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh
Confidence            88899999999999999999999999999999999999887 9999999999876553211  22223467899999998


Q ss_pred             CccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          157 GLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      . .+++.+||||||||+|||+.+ |+-||.+..+.+....+..+...             +...+.+.++-+||..||+.
T Consensus       679 y-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL-------------~~Pe~CP~~vY~LM~~CW~~  744 (774)
T KOG1026|consen  679 Y-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLL-------------SCPENCPTEVYSLMLECWNE  744 (774)
T ss_pred             c-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcc-------------cCCCCCCHHHHHHHHHHhhc
Confidence            7 789999999999999999997 89999999999999888766542             23357999999999999999


Q ss_pred             CCCCccCHHHHh
Q 039159          236 DPDKRITAAEAL  247 (259)
Q Consensus       236 dp~~Rp~~~~~l  247 (259)
                      +|++||++.+|-
T Consensus       745 ~P~~RPsF~eI~  756 (774)
T KOG1026|consen  745 NPKRRPSFKEIH  756 (774)
T ss_pred             CcccCCCHHHHH
Confidence            999999999874

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.3e-42  Score=282.85  Aligned_cols=215  Identities=24%  Similarity=0.328  Sum_probs=178.2

Q ss_pred             CCCchhHHHHHHHhhCCC-CCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNH-PNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...+.+..|+++++.++| ++|+++++++...+.+|+||||+.| +|...+...               ..+.......+
T Consensus        42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~---------------~~~~~~~~~~~  106 (324)
T cd05587          42 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV---------------GKFKEPHAVFY  106 (324)
T ss_pred             hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc---------------CCCCHHHHHHH
Confidence            345678899999999976 5688999999999999999999986 888877532               23455677888


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||+++|+||||||+||+++.++ .++|+|||++..............||+.|+|||++.+ ..++.++|+
T Consensus       107 ~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  184 (324)
T cd05587         107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYGKSVDW  184 (324)
T ss_pred             HHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCCCceeeecCCccccChhhhcC-CCCCcccch
Confidence            99999999999999999999999999999888 8999999998754322333445578999999999987 568899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH----
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA----  243 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~----  243 (259)
                      ||+||++|+|++|+.||.+.........+......              ....+++++.+++.+||..||.+|++.    
T Consensus       185 wslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~  250 (324)
T cd05587         185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTG  250 (324)
T ss_pred             hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCC
Confidence            99999999999999999988877777666543211              113578999999999999999999976    


Q ss_pred             -HHHhcCccccCC
Q 039159          244 -AEALQQEYFKDV  255 (259)
Q Consensus       244 -~~~l~h~~f~~~  255 (259)
                       +++++||||+.+
T Consensus       251 ~~~~~~hp~~~~~  263 (324)
T cd05587         251 ERDIREHAFFRRI  263 (324)
T ss_pred             HHHHhcCCCcCCC
Confidence             899999999875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.2e-42  Score=278.74  Aligned_cols=224  Identities=28%  Similarity=0.439  Sum_probs=182.8

Q ss_pred             CCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            4 IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         4 ~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      +........+.+.+|+.+++.++||||+++++++..++..++|+||+.+ +|...+..                ..++..
T Consensus        52 ~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~l~~~  115 (296)
T cd06655          52 INLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE----------------TCMDEA  115 (296)
T ss_pred             EecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh----------------cCCCHH
Confidence            3333444557788999999999999999999999999999999999986 88887743                234567


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      ++..++.+++.|++|||+.+++||||+|+||+++.++ .++|+|||++..............+++.|+|||.+.+ ..++
T Consensus       116 ~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  193 (296)
T cd06655         116 QIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYG  193 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhcccccccCCCcCCCccccCcchhcC-CCCC
Confidence            8888999999999999999999999999999999888 8999999998765433333344568889999999976 5678


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      .++|+|||||++|++++|+.||...+.......+.... .+..          .....+++.+.+++.+||..||.+||+
T Consensus       194 ~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rpt  262 (296)
T cd06655         194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPEL----------QNPEKLSPIFRDFLNRCLEMDVEKRGS  262 (296)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Cccc----------CCcccCCHHHHHHHHHHhhcChhhCCC
Confidence            89999999999999999999998877655544443221 1111          112457889999999999999999999


Q ss_pred             HHHHhcCccccCCC
Q 039159          243 AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ~~~~l~h~~f~~~~  256 (259)
                      +.++++||||+...
T Consensus       263 ~~~il~~~~~~~~~  276 (296)
T cd06655         263 AKELLQHPFLKLAK  276 (296)
T ss_pred             HHHHhhChHhhhcc
Confidence            99999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.5e-42  Score=276.85  Aligned_cols=206  Identities=18%  Similarity=0.157  Sum_probs=169.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEe----CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQ----GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .+.+.+|+.++++++||||++++|++.+    ...+++||||+.| +|.+++...               ..+.....+.
T Consensus        62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---------------~~~~~~~~~~  126 (283)
T PHA02988         62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---------------KDLSFKTKLD  126 (283)
T ss_pred             HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC---------------CCCChhHHHH
Confidence            4677799999999999999999999877    3478999999996 899988642               2234556778


Q ss_pred             HHhhcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC-ccCCCcc
Q 039159           87 EFSSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG-LLEYSTA  164 (259)
Q Consensus        87 ~~~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~  164 (259)
                      ++.+++.|++|||+ .+++||||||+||+++.++ .+||+|||+++....   ......|++.|+|||.+.+ ...++.+
T Consensus       127 i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~k  202 (283)
T PHA02988        127 MAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSS---PPFKNVNFMVYFSYKMLNDIFSEYTIK  202 (283)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcc---ccccccCcccccCHHHhhhccccccch
Confidence            89999999999997 4999999999999999988 899999999875432   1223467899999999865 2468899


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      +|||||||++|||++|+.||.+.+..+....+......+..+            ...++.+.+++.+||+.||++|||++
T Consensus       203 ~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------~~~~~~l~~li~~cl~~dp~~Rps~~  270 (283)
T PHA02988        203 DDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP------------LDCPLEIKCIVEACTSHDSIKRPNIK  270 (283)
T ss_pred             hhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC------------CcCcHHHHHHHHHHhcCCcccCcCHH
Confidence            999999999999999999999887777666665443332221            25788999999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++++
T Consensus       271 ell~  274 (283)
T PHA02988        271 EILY  274 (283)
T ss_pred             HHHH
Confidence            9985

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.9e-42  Score=277.43  Aligned_cols=227  Identities=37%  Similarity=0.546  Sum_probs=175.5

Q ss_pred             CCCchhHHHHHHHhhC---CCCCeeEEEEEEEeC-----ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159           10 GVPSSMIREVSCLMEL---NHPNIIRLMRVASQG-----IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l---~H~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      .....+.+|+.+++.+   +||||+++++++...     ...+++|||+.++|.+++.....             ..++.
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-------------~~~~~  107 (288)
T cd07863          41 GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPP-------------PGLPA  107 (288)
T ss_pred             CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCC-------------CCCCH
Confidence            3445677888888776   699999999998642     45899999999999888854211             23567


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      ..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++...... .......|++.|+|||.+.+ ..+
T Consensus       108 ~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~  184 (288)
T cd07863         108 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVLLQ-STY  184 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCccccccCc-ccCCCccccccccCchHhhC-CCC
Confidence            78889999999999999999999999999999999888 8999999999765322 22234467899999999977 568


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC---cccc----------ccccccccCCCCCCCHHHHHH
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP---SFCK----------LSLRDHLTNGFPGLEPAGIDL  228 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~---~~~~----------~~~~~~~~~~~~~~~~~~~~l  228 (259)
                      +.++||||+||++|+|++|.+||.+.........+......+   ..+.          ...........+.+++.+.++
T Consensus       185 ~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  264 (288)
T cd07863         185 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQL  264 (288)
T ss_pred             CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHH
Confidence            899999999999999999999998876665554443211110   0000          000111222335678899999


Q ss_pred             HHhhcCcCCCCccCHHHHhcCccc
Q 039159          229 ISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      +.+||+.||++|||+.+++.||||
T Consensus       265 i~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         265 LLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHHHhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.3e-42  Score=290.07  Aligned_cols=217  Identities=27%  Similarity=0.378  Sum_probs=175.0

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|++++++++||||+++++.+.+++.+|+||||++| +|.+++...               ..+....+..++.|
T Consensus        45 ~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~---------------~~~~~~~~~~~~~q  109 (376)
T cd05598          45 AAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL---------------GIFEEDLARFYIAE  109 (376)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            45678999999999999999999999999999999999986 899988542               23445566778889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC---------------------------------
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK---------------------------------  137 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~---------------------------------  137 (259)
                      ++.||+|||+++|+||||||+||+++.++ .++|+|||++..+....                                 
T Consensus       110 i~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (376)
T cd05598         110 LTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPL  188 (376)
T ss_pred             HHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCccccccccccccccccccccccccccccccccccccccch
Confidence            99999999999999999999999999888 89999999975321000                                 


Q ss_pred             ----------CCCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc
Q 039159          138 ----------GESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK  207 (259)
Q Consensus       138 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  207 (259)
                                .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.........  
T Consensus       189 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--  265 (376)
T cd05598         189 ERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHI--  265 (376)
T ss_pred             hhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccC--
Confidence                      00113469999999999977 56889999999999999999999999988776665555433222111  


Q ss_pred             ccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc---CHHHHhcCccccCCC
Q 039159          208 LSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI---TAAEALQQEYFKDVP  256 (259)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~~l~h~~f~~~~  256 (259)
                              +....+++++.++|.+|+ .+|.+|+   ++.++++||||+.+.
T Consensus       266 --------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         266 --------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             --------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence                    112357899999999976 5999999   999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.6e-41  Score=276.59  Aligned_cols=222  Identities=23%  Similarity=0.314  Sum_probs=178.5

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+..+++.+|+++++.++||||+++++++..++.+++||||+.| +|...+....              ..+....+..+
T Consensus        50 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--------------~~l~~~~~~~~  115 (292)
T cd06644          50 EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD--------------RGLTEPQIQVI  115 (292)
T ss_pred             HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc--------------CCCCHHHHHHH
Confidence            34456788999999999999999999999999999999999997 6766664321              23556778889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC----ccCCCc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG----LLEYST  163 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~  163 (259)
                      +.|++.+++|||+.+++||||||+||+++.++ .++|+|||.+..............+++.|+|||.+.+    ...++.
T Consensus       116 ~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~  194 (292)
T cd06644         116 CRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY  194 (292)
T ss_pred             HHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCc
Confidence            99999999999999999999999999999887 8999999998754333333344568889999999853    234677


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      ++|+|||||++|++++|..||...+.......+..... +..          .....++.++.+++.+||..||++||++
T Consensus       195 ~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~  263 (292)
T cd06644         195 KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PTL----------SQPSKWSMEFRDFLKTALDKHPETRPSA  263 (292)
T ss_pred             hhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC-ccC----------CCCcccCHHHHHHHHHHhcCCcccCcCH
Confidence            89999999999999999999987766555544432221 111          1123577899999999999999999999


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      +++++||||+++.
T Consensus       264 ~~il~~~~~~~~~  276 (292)
T cd06644         264 AQLLEHPFVSSVT  276 (292)
T ss_pred             HHHhcCccccccc
Confidence            9999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.3e-42  Score=284.27  Aligned_cols=213  Identities=24%  Similarity=0.333  Sum_probs=171.0

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...+.+|+.++.++ +||||+++++++..++..++||||+.+ +|...+...               ..+.......++.
T Consensus        39 ~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~---------------~~l~~~~~~~i~~  103 (329)
T cd05618          39 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ---------------RKLPEEHARFYSA  103 (329)
T ss_pred             HHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            34577899988877 799999999999999999999999996 787766432               3355667788899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|++|||+++|+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|+||
T Consensus       104 qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws  181 (329)
T cd05618         104 EISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWA  181 (329)
T ss_pred             HHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCccccccCCccccCHHHHcC-CCCCCccceec
Confidence            999999999999999999999999999988 8999999998754333333445679999999999987 57888999999


Q ss_pred             HHHHHHHHHhCCCCCCCC--------ChHH-HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          170 VGCIFGEMVSGKPLFPGA--------NSLI-TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~--------~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      |||++|+|++|+.||...        .... ....+.....              .....++..+.+++.+||+.||++|
T Consensus       182 lG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------------~~p~~~~~~~~~ll~~~L~~dP~~R  247 (329)
T cd05618         182 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------------RIPRSLSVKAASVLKSFLNKDPKER  247 (329)
T ss_pred             ccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--------------CCCCCCCHHHHHHHHHHhcCCHHHc
Confidence            999999999999999521        1111 1112221110              1123578899999999999999999


Q ss_pred             cC------HHHHhcCccccCC
Q 039159          241 IT------AAEALQQEYFKDV  255 (259)
Q Consensus       241 p~------~~~~l~h~~f~~~  255 (259)
                      |+      +.++++||||++.
T Consensus       248 ~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         248 LGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             CCCCCCCCHHHHhcCCCCCCC
Confidence            98      5899999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-42  Score=286.91  Aligned_cols=220  Identities=30%  Similarity=0.341  Sum_probs=180.6

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+.+++.++||||+++++++.+++..++||||++| +|.+++....              ..++...+..++.
T Consensus        44 ~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~l~~~~~~~~~~  109 (330)
T cd05601          44 TVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE--------------DQFDEDMAQFYLA  109 (330)
T ss_pred             HHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc--------------CCCCHHHHHHHHH
Confidence            456688999999999999999999999999999999999986 8999886421              2345566777889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccC-----ccCCCc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLG-----LLEYST  163 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~-----~~~~~~  163 (259)
                      |++.||+|||+.+|+||||||+||+++.++ .+||+|||++......... .....||+.|+|||.+..     ...++.
T Consensus       110 qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  188 (330)
T cd05601         110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGV  188 (330)
T ss_pred             HHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCC
Confidence            999999999999999999999999999888 8999999999765432222 233468999999999863     245778


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      ++|||||||++|+|++|+.||...........+.........+          ..+.+++++.+|+.+||. +|++||++
T Consensus       189 ~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----------~~~~~~~~~~~li~~ll~-~p~~R~t~  257 (330)
T cd05601         189 ECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP----------EDPKVSSDFLDLIQSLLC-GQKERLGY  257 (330)
T ss_pred             cceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC----------CCCCCCHHHHHHHHHHcc-ChhhCCCH
Confidence            9999999999999999999999887777766665443222211          123578999999999998 99999999


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      +++++||||..+.
T Consensus       258 ~~l~~h~~~~~~~  270 (330)
T cd05601         258 EGLCCHPFFSKID  270 (330)
T ss_pred             HHHhCCCCcCCCC
Confidence            9999999998753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=272.26  Aligned_cols=221  Identities=32%  Similarity=0.376  Sum_probs=184.7

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+...++..|-+||+.++||.++.+|..|+.++..|++||||+| +|..+.+...+             ..++...+.-+
T Consensus       118 rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~-------------~~fse~~aRFY  184 (459)
T KOG0610|consen  118 RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPG-------------KRFSESAARFY  184 (459)
T ss_pred             hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCC-------------CccchhhHHHH
Confidence            34556788999999999999999999999999999999999997 66666654222             45666677778


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccc--------------------------------
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA--------------------------------  135 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~--------------------------------  135 (259)
                      +..++-||+|||-.|||.|||||+|||+-.+| ++.|+||.++.....                                
T Consensus       185 aAEvl~ALEYLHmlGivYRDLKPENILvredG-HIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~  263 (459)
T KOG0610|consen  185 AAEVLLALEYLHMLGIVYRDLKPENILVREDG-HIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCL  263 (459)
T ss_pred             HHHHHHHHHHHHhhceeeccCCcceeEEecCC-cEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchh
Confidence            88888999999999999999999999999999 999999999742100                                


Q ss_pred             -c-C----------------------CCCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHH
Q 039159          136 -Y-K----------------------GESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI  191 (259)
Q Consensus       136 -~-~----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~  191 (259)
                       . .                      .....++||..|.|||++.| ...+.++|.|+||+++|||+.|..||.+.+..+
T Consensus       264 ~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~  342 (459)
T KOG0610|consen  264 SSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE  342 (459)
T ss_pred             ccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh
Confidence             0 0                      00112369999999999998 678899999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC----HHHHhcCccccCCC
Q 039159          192 TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT----AAEALQQEYFKDVP  256 (259)
Q Consensus       192 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~~l~h~~f~~~~  256 (259)
                      .+.+|..+.....  .          .+.++..++|||+++|.+||.+|..    +.||-+||||+++.
T Consensus       343 Tl~NIv~~~l~Fp--~----------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  343 TLRNIVGQPLKFP--E----------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN  399 (459)
T ss_pred             hHHHHhcCCCcCC--C----------CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence            9999876643221  1          1367899999999999999999998    99999999999873

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.8e-42  Score=282.35  Aligned_cols=233  Identities=18%  Similarity=0.191  Sum_probs=174.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+++++.++||||+++++++..++..++||||+.+ +|.+++.....             ..++...++.++
T Consensus        41 ~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-------------~~l~~~~~~~i~  107 (327)
T cd08227          41 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM-------------DGMSELAIAYIL  107 (327)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhcc-------------CCCCHHHHHHHH
Confidence            3345677899999999999999999999999999999999995 88888853211             234567788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-------CcCCccCccccCcccccCc-cC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-------SSAEVGTHYYKAPELLLGL-LE  160 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~-~~  160 (259)
                      .|++.||+|||+++++||||||+||+++.++ .++++||+...........       .....++..|+|||.+.+. ..
T Consensus       108 ~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  186 (327)
T cd08227         108 QGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQG  186 (327)
T ss_pred             HHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhccccccccccccccccccccceecccChHHhhcccCC
Confidence            9999999999999999999999999999888 8999999876543221111       1223467789999999753 35


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc-----cc---------------------------c
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF-----CK---------------------------L  208 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~-----~~---------------------------~  208 (259)
                      ++.++|||||||++|++++|+.||.....................     +.                           .
T Consensus       187 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (327)
T cd08227         187 YDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPS  266 (327)
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCcc
Confidence            788999999999999999999999876544433333221110000     00                           0


Q ss_pred             cccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          209 SLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .......+....+++.+.+|+.+||+.||++|||++++++||||+.+.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         267 NGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             ccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            000001111234678999999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.7e-41  Score=276.60  Aligned_cols=235  Identities=43%  Similarity=0.636  Sum_probs=181.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...+.+.+|++++++++||||+++++++.+++..++||||+.++|...+.....             .......+..++.
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~  109 (294)
T PLN00009         43 GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPD-------------FAKNPRLIKTYLY  109 (294)
T ss_pred             cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccccHHHHHHhCCC-------------CCcCHHHHHHHHH
Confidence            445678899999999999999999999999999999999998888887743211             2234566677888


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.||+|||+++++||||+|+||+++.++..+||+|||++..............+++.|+|||.+.+...++.++|+||
T Consensus       110 qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~s  189 (294)
T PLN00009        110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWS  189 (294)
T ss_pred             HHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHH
Confidence            99999999999999999999999999876558999999999754332222334467889999999876456788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc---------ccc------ccccccCCCCCCCHHHHHHHHhhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC---------KLS------LRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~---------~~~------~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                      +|+++|+++||.+||...........+......+...         ...      .........+++++.+.+++.+||+
T Consensus       190 lG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  269 (294)
T PLN00009        190 VGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLR  269 (294)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHcc
Confidence            9999999999999998776665555543221111100         000      0000111124678999999999999


Q ss_pred             cCCCCccCHHHHhcCccccCCCC
Q 039159          235 MDPDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~h~~f~~~~~  257 (259)
                      .+|++||+++++++||||++++.
T Consensus       270 ~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        270 LDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             CChhhCcCHHHHhcCchHhHHhc
Confidence            99999999999999999998753

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-41  Score=282.58  Aligned_cols=215  Identities=24%  Similarity=0.302  Sum_probs=173.2

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+.+|+++++++ +||||+++++++..++.+++||||+.| +|...+...               ..+....+..++
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~~  111 (332)
T cd05614          47 TVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR---------------DNFSEDEVRFYS  111 (332)
T ss_pred             HHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHHH
Confidence            345678899999999 499999999999999999999999996 888887532               234566778889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .|++.||+|||+++|+||||||+||+++.++ .++|+|||+++....... ......||+.|+|||.+.+...++.++||
T Consensus       112 ~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  190 (332)
T cd05614         112 GEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDW  190 (332)
T ss_pred             HHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCcccc
Confidence            9999999999999999999999999999888 899999999876433222 23345789999999999874457889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCC---hHH-HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc--
Q 039159          168 WPVGCIFGEMVSGKPLFPGAN---SLI-TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI--  241 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~---~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp--  241 (259)
                      |||||++|+|++|..||....   ... ....+....  +            .....+++.+.+++.+||..||++||  
T Consensus       191 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~  256 (332)
T cd05614         191 WSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--P------------PFPSFIGPEAQDLLHKLLRKDPKKRLGA  256 (332)
T ss_pred             ccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--C------------CCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence            999999999999999996432   122 222222111  1            11235789999999999999999999  


Q ss_pred             ---CHHHHhcCccccCC
Q 039159          242 ---TAAEALQQEYFKDV  255 (259)
Q Consensus       242 ---~~~~~l~h~~f~~~  255 (259)
                         +++++++||||+..
T Consensus       257 ~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         257 GPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCCCHHHHHcCCCcCCC
Confidence               89999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=275.92  Aligned_cols=220  Identities=26%  Similarity=0.336  Sum_probs=180.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++..+...++||||+.+ +|..++....              ..++...+..++.
T Consensus        45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~l~~~~~~~~~~  110 (280)
T cd06611          45 ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE--------------RGLTEPQIRYVCR  110 (280)
T ss_pred             HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc--------------CCCCHHHHHHHHH
Confidence            345788999999999999999999999999999999999997 8888875421              2355677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC----ccCCCccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG----LLEYSTAV  165 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~  165 (259)
                      +++.|+.|||+.+++||||+|+||+++.++ .++|+|||.+..............+++.|+|||.+..    ...++.++
T Consensus       111 ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~s  189 (280)
T cd06611         111 QMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA  189 (280)
T ss_pred             HHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccc
Confidence            999999999999999999999999999888 8999999998765443334445578999999999852    23467789


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |+||||+++|++++|..||.+.........+..... +..          .....++.++.+++.+||..+|++||++++
T Consensus       190 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  258 (280)
T cd06611         190 DIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-PTL----------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAE  258 (280)
T ss_pred             cHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC-CCc----------CCcccCCHHHHHHHHHHhccChhhCcCHHH
Confidence            999999999999999999988776665555543221 111          112357889999999999999999999999


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +++||||.+..
T Consensus       259 il~~~~~~~~~  269 (280)
T cd06611         259 LLKHPFVSDQS  269 (280)
T ss_pred             HhcChhhcccc
Confidence            99999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3e-41  Score=273.97  Aligned_cols=227  Identities=31%  Similarity=0.558  Sum_probs=176.9

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCC-HHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVND-LAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|++++++++||||+++++++..+...++||||++++ |.......               ..+....++.++
T Consensus        42 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~  106 (286)
T cd07847          42 VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP---------------RGVPEHLIKKII  106 (286)
T ss_pred             cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCC---------------CCCCHHHHHHHH
Confidence            34566889999999999999999999999999999999999984 44443221               235667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.|++|||+.+++||||||+||+++.++ .++|+|||++..............++..|+|||.+.+...++.++|+|
T Consensus       107 ~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~  185 (286)
T cd07847         107 WQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVW  185 (286)
T ss_pred             HHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhH
Confidence            9999999999999999999999999999888 899999999986644333334456788999999987645678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCC--C---------------CccccccccccccCCCCCCCHHHHHHHHh
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSR--K---------------PSFCKLSLRDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~--~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~  231 (259)
                      |||+++|+|++|++||.+.........+.....  .               ...+...........++.++..+.+|+.+
T Consensus       186 slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  265 (286)
T cd07847         186 AIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKG  265 (286)
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHH
Confidence            999999999999999988766544433321100  0               00000001111222245678999999999


Q ss_pred             hcCcCCCCccCHHHHhcCccc
Q 039159          232 MLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      ||+.||++||++.+++.||||
T Consensus       266 ~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         266 CLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             HhcCCccccCCHHHHhcCCCC
Confidence            999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.1e-42  Score=286.42  Aligned_cols=219  Identities=24%  Similarity=0.342  Sum_probs=178.3

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +....+.+|+.++..++||||+++++.+.+++.+|+||||++| +|.+.+...               ..+....+..++
T Consensus        43 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~l~~~~~~~~~  107 (360)
T cd05627          43 EQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK---------------DTLSEEATQFYI  107 (360)
T ss_pred             hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhc---------------CCCCHHHHHHHH
Confidence            3456788899999999999999999999999999999999996 898888542               234566777889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC------------------------------
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG------------------------------  138 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~------------------------------  138 (259)
                      .|++.||+|||+.||+||||||+||+++.++ .++|+|||++..+.....                              
T Consensus       108 ~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (360)
T cd05627         108 AETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK  186 (360)
T ss_pred             HHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCcccccccccccccccccCCccccccccccccccccccc
Confidence            9999999999999999999999999999888 899999999864421100                              


Q ss_pred             -----CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccccccc
Q 039159          139 -----ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDH  213 (259)
Q Consensus       139 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  213 (259)
                           ......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.........+.........+.      
T Consensus       187 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~------  259 (360)
T cd05627         187 KNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPP------  259 (360)
T ss_pred             ccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCC------
Confidence                 0113469999999999987 5788999999999999999999999998887777766654322221111      


Q ss_pred             ccCCCCCCCHHHHHHHHhhcCcCCCCcc---CHHHHhcCccccCCC
Q 039159          214 LTNGFPGLEPAGIDLISKMLGMDPDKRI---TAAEALQQEYFKDVP  256 (259)
Q Consensus       214 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~~l~h~~f~~~~  256 (259)
                          ...+++++.+++.+|+ .||.+|+   +++++++||||.++.
T Consensus       260 ----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         260 ----EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             ----CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCC
Confidence                1247899999999977 4999998   489999999998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-41  Score=270.18  Aligned_cols=211  Identities=23%  Similarity=0.370  Sum_probs=174.1

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ..+.+|++++++++||||+++++++..++.+++++||++| +|.+.+...               ..++......++.++
T Consensus        49 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~~~l  113 (263)
T cd06625          49 NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY---------------GALTETVTRKYTRQI  113 (263)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh---------------CCCCHHHHHHHHHHH
Confidence            5688999999999999999999999999999999999986 888887532               224456677888999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC---cCCccCccccCcccccCccCCCcccchH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +.|++|||+.+++||||+|+||+++.++ .++|+|||.++.........   ....+++.|+|||.+.+ ..++.++|+|
T Consensus       114 ~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  191 (263)
T cd06625         114 LEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVW  191 (263)
T ss_pred             HHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceeccccccccccccCCCcCccccCcceecc-CCCCchhhhH
Confidence            9999999999999999999999999888 89999999987543221111   23457889999999987 5688999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|++++|+.||...........+......+..            ...+++.+.+++.+||..+|++|||+.++++
T Consensus       192 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         192 SVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQL------------PSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             HHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCC------------CccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence            9999999999999999877665555444333222111            2357889999999999999999999999999


Q ss_pred             Cccc
Q 039159          249 QEYF  252 (259)
Q Consensus       249 h~~f  252 (259)
                      ||||
T Consensus       260 ~~~~  263 (263)
T cd06625         260 HFFV  263 (263)
T ss_pred             CCCC
Confidence            9998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.6e-41  Score=277.44  Aligned_cols=231  Identities=37%  Similarity=0.572  Sum_probs=181.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .....+.+|+.++++++|+||+++++++...  +..++||||+.++|.+++....              ..+....+..+
T Consensus        48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--------------~~l~~~~~~~~  113 (309)
T cd07845          48 GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMP--------------TPFSESQVKCL  113 (309)
T ss_pred             CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcc--------------cCCCHHHHHHH
Confidence            3445677899999999999999999999765  4689999999999988886422              33566778889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.|++|||+.+++||||||+||+++.++ .++|+|||.+..............+++.|+|||.+.+...++.++|+
T Consensus       114 ~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv  192 (309)
T cd07845         114 MLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDM  192 (309)
T ss_pred             HHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHH
Confidence            99999999999999999999999999999888 89999999997654332233333467889999998765567899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc------------cc----cccccCCCCCCCHHHHHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL------------SL----RDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------~~----~~~~~~~~~~~~~~~~~li~~  231 (259)
                      ||+||++|++++|.+||.+.+.......+......+.....            ..    .......+...++.+.++|.+
T Consensus       193 wslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  272 (309)
T cd07845         193 WAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNF  272 (309)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHH
Confidence            99999999999999999988877776665443221111000            00    001111223468899999999


Q ss_pred             hcCcCCCCccCHHHHhcCccccCC
Q 039159          232 MLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ||+.||++|||++++++||||+..
T Consensus       273 ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         273 LLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             HhcCChhhCcCHHHHhcChhhccC
Confidence            999999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-42  Score=284.71  Aligned_cols=224  Identities=34%  Similarity=0.536  Sum_probs=175.1

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeC------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      .+.+.+|++++++++||||+++++++...      ...|++++++.++|.+.+..                ..++...+.
T Consensus        58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----------------~~l~~~~~~  121 (343)
T cd07878          58 ARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC----------------QKLSDEHVQ  121 (343)
T ss_pred             HHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhc----------------CCCCHHHHH
Confidence            35677999999999999999999988643      35799999998888887743                335567788


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++....   ......||+.|+|||.+.+...++.++
T Consensus       122 ~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~  197 (343)
T cd07878         122 FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTV  197 (343)
T ss_pred             HHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccceecCC---CcCCccccccccCchHhcCCccCCchh
Confidence            8999999999999999999999999999999888 899999999976432   233457899999999997755688999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc--c---------------ccccccccCCCCCCCHHHHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC--K---------------LSLRDHLTNGFPGLEPAGIDL  228 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~--~---------------~~~~~~~~~~~~~~~~~~~~l  228 (259)
                      |||||||++|+|++|+.||.+.+.......+......+...  .               ..........+.+.++.+.+|
T Consensus       198 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  277 (343)
T cd07878         198 DIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDL  277 (343)
T ss_pred             hhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHH
Confidence            99999999999999999998776555444432211110000  0               000001112234567889999


Q ss_pred             HHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          229 ISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      +.+||..||++|||+.++|+||||...
T Consensus       278 i~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         278 LEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             HHHHcCCChhhCCCHHHHhcCcchhcc
Confidence            999999999999999999999999865

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-41  Score=288.05  Aligned_cols=228  Identities=24%  Similarity=0.218  Sum_probs=175.0

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      ..+.+|++++++++||||+++++++......|++||++.++|...+...               ..+....++.++.|++
T Consensus       131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---------------~~l~~~~~~~i~~ql~  195 (392)
T PHA03207        131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS---------------GPLPLEQAITIQRRLL  195 (392)
T ss_pred             ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCCCHHHHHHhc---------------CCCCHHHHHHHHHHHH
Confidence            3457899999999999999999999999999999999999988888321               3456678889999999


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      .||+|||+.+|+||||||+||+++.++ .++|+|||++........  ......||+.|+|||++.+ ..++.++|||||
T Consensus       196 ~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvwsl  273 (392)
T PHA03207        196 EALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSA  273 (392)
T ss_pred             HHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccCcccccccccccccccCccCHhHhcC-CCCCchhhHHHH
Confidence            999999999999999999999999888 899999999976543222  2234578999999999977 568899999999


Q ss_pred             HHHHHHHHhCCCCCCCCCh---HHHHHHHhCCCC--CCccccc---c-----------cc--ccccCC--CCCCCHHHHH
Q 039159          171 GCIFGEMVSGKPLFPGANS---LITLGRIVGKSR--KPSFCKL---S-----------LR--DHLTNG--FPGLEPAGID  227 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~---~~~~~~i~~~~~--~~~~~~~---~-----------~~--~~~~~~--~~~~~~~~~~  227 (259)
                      ||++|+|++|+.||.+...   ......+.....  ....+..   .           ..  ......  ...++.++.+
T Consensus       274 Gvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (392)
T PHA03207        274 GLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEY  353 (392)
T ss_pred             HHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHH
Confidence            9999999999999976432   122222211100  0000000   0           00  000000  1245778999


Q ss_pred             HHHhhcCcCCCCccCHHHHhcCccccCCCC
Q 039159          228 LISKMLGMDPDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       228 li~~~l~~dp~~Rp~~~~~l~h~~f~~~~~  257 (259)
                      +|.+||..||++||++.++|.||||+..+.
T Consensus       354 li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        354 LIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             HHHHHhccChhhCCCHHHHhhCchhhccch
Confidence            999999999999999999999999998754

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.5e-41  Score=283.79  Aligned_cols=217  Identities=24%  Similarity=0.309  Sum_probs=176.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.+++.++||||+++++++.+++..|+||||++| +|..++..                ..+.......++.|
T Consensus        87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~----------------~~~~~~~~~~~~~q  150 (371)
T cd05622          87 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN----------------YDVPEKWARFYTAE  150 (371)
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh----------------cCCCHHHHHHHHHH
Confidence            34577899999999999999999999999999999999986 89888853                22344566778889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCc---cCCCcccc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGL---LEYSTAVD  166 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~---~~~~~~~D  166 (259)
                      ++.|++|||+++|+||||||+||+++.++ .+||+|||++........ ......||+.|+|||.+.+.   ..++.++|
T Consensus       151 i~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~D  229 (371)
T cd05622         151 VVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD  229 (371)
T ss_pred             HHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccc
Confidence            99999999999999999999999999888 899999999976533221 23455799999999998752   23678999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC--ccCHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK--RITAA  244 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rp~~~  244 (259)
                      ||||||++|+|++|..||...+.......+.........+          ....+++.+++++..||..++.+  |++++
T Consensus       230 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~  299 (371)
T cd05622         230 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVE  299 (371)
T ss_pred             eeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC----------CcCCCCHHHHHHHHHHcCChhhhcCCCCHH
Confidence            9999999999999999999888777777776543322221          12368899999999999844433  78999


Q ss_pred             HHhcCccccCC
Q 039159          245 EALQQEYFKDV  255 (259)
Q Consensus       245 ~~l~h~~f~~~  255 (259)
                      ++++||||++.
T Consensus       300 ei~~h~~~~~~  310 (371)
T cd05622         300 EIKRHLFFKND  310 (371)
T ss_pred             HHhcCcccCCC
Confidence            99999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.5e-42  Score=280.42  Aligned_cols=221  Identities=25%  Similarity=0.366  Sum_probs=179.8

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .....+.+.+|+.++++++||||+++++.+..++..++||||+++ +|..++..                ..+.......
T Consensus        59 ~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~l~~~~~~~  122 (292)
T cd06658          59 KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH----------------TRMNEEQIAT  122 (292)
T ss_pred             hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc----------------CCCCHHHHHH
Confidence            334456788999999999999999999999999999999999997 77777642                2244567788


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.+++.|++|||+++++||||||+||+++.++ .++|+|||++..............|++.|+|||.+.+ ..++.++|
T Consensus       123 ~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  200 (292)
T cd06658         123 VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR-LPYGTEVD  200 (292)
T ss_pred             HHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccccccCceeecCccccCHHHHcc-CCCCchhh
Confidence            899999999999999999999999999999888 8999999998765433333344568899999999976 56788999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      +||||+++|++++|+.||...........+..... +..          ......++.+.+++.+||..||.+|||++++
T Consensus       201 v~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i  269 (292)
T cd06658         201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRV----------KDSHKVSSVLRGFLDLMLVREPSQRATAQEL  269 (292)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-Ccc----------ccccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence            99999999999999999988766555444332111 110          1123478899999999999999999999999


Q ss_pred             hcCccccCCCC
Q 039159          247 LQQEYFKDVPG  257 (259)
Q Consensus       247 l~h~~f~~~~~  257 (259)
                      ++||||+....
T Consensus       270 l~~~~~~~~~~  280 (292)
T cd06658         270 LQHPFLKLAGP  280 (292)
T ss_pred             hhChhhhccCC
Confidence            99999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.4e-42  Score=282.56  Aligned_cols=212  Identities=25%  Similarity=0.362  Sum_probs=175.1

Q ss_pred             chhHHHHH-HHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           13 SSMIREVS-CLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        13 ~~~~~Ei~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..+.+|.. +++.++||||+++++++..++..|+||||+.| +|...+...               ..+.......++.|
T Consensus        40 ~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~q  104 (325)
T cd05604          40 KHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE---------------RSFPEPRARFYAAE  104 (325)
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            45566655 56779999999999999999999999999996 787776431               33556677888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.||+|||+.||+||||||+||+++.++ .++|+|||+++.............|++.|+|||.+.+ ..++.++|||||
T Consensus       105 i~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvwsl  182 (325)
T cd05604         105 IASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCL  182 (325)
T ss_pred             HHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC-CCCCCcCccccc
Confidence            99999999999999999999999999988 8999999998754333333445579999999999987 567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH----HHH
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA----AEA  246 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~----~~~  246 (259)
                      ||++|+|++|..||...+.......+......              ..+..+..+.+++.+||..||.+||++    .++
T Consensus       183 G~il~el~~G~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         183 GAVLYEMLYGLPPFYCRDVAEMYDNILHKPLV--------------LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             cceehhhhcCCCCCCCCCHHHHHHHHHcCCcc--------------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence            99999999999999988777666665443211              123578899999999999999999976    599


Q ss_pred             hcCccccCC
Q 039159          247 LQQEYFKDV  255 (259)
Q Consensus       247 l~h~~f~~~  255 (259)
                      ++||||.+.
T Consensus       249 ~~h~~f~~~  257 (325)
T cd05604         249 QEHPFFESL  257 (325)
T ss_pred             hcCCCcCCC
Confidence            999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-41  Score=281.84  Aligned_cols=225  Identities=23%  Similarity=0.305  Sum_probs=172.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++.+++..++||||+.| +|.+++...               ..+.......++.
T Consensus        46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~  110 (333)
T cd06650          46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---------------GRIPEQILGKVSI  110 (333)
T ss_pred             HHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            346789999999999999999999999999999999999986 899888542               2234556678888


Q ss_pred             hcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.|++|||+ .+++||||||+||+++.++ .+||+|||++.....  .......|++.|+|||.+.+ ..++.++|+|
T Consensus       111 ~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvw  186 (333)
T cd06650         111 AVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQG-THYSVQSDIW  186 (333)
T ss_pred             HHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhh--hccccCCCCccccCHHHhcC-CCCCcHHHHH
Confidence            99999999997 4799999999999999888 899999999875422  22334568999999999977 5688899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCC---C------------------------cccccc-----ccccccC
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRK---P------------------------SFCKLS-----LRDHLTN  216 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~---~------------------------~~~~~~-----~~~~~~~  216 (259)
                      ||||++|++++|+.||......... .+......   .                        ......     .......
T Consensus       187 slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (333)
T cd06650         187 SMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPK  265 (333)
T ss_pred             HHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCcc
Confidence            9999999999999999865543322 11110000   0                        000000     0000000


Q ss_pred             C-CCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          217 G-FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       217 ~-~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      . ...++.++++|+.+||+.||++|||++++++||||+..
T Consensus       266 ~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         266 LPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             CCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence            0 01357889999999999999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.9e-41  Score=274.39  Aligned_cols=229  Identities=37%  Similarity=0.594  Sum_probs=179.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +.....+.+|+.++++++||||+++++++..+  +..|+|+||+.++|.+++....              ..+....++.
T Consensus        45 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~--------------~~l~~~~~~~  110 (293)
T cd07843          45 EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMK--------------QPFLQSEVKC  110 (293)
T ss_pred             ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhcc--------------CCCCHHHHHH
Confidence            34445678999999999999999999999877  7999999999999988885421              2356778889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.|++.||+|||+.+++||||||+||+++.++ .++|+|||.+..............+++.|+|||.+.+....+.++|
T Consensus       111 i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  189 (293)
T cd07843         111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAID  189 (293)
T ss_pred             HHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhh
Confidence            999999999999999999999999999999888 8999999999865443333344567889999999876455688999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc------------c----cccccccccCCCCC--CCHHHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF------------C----KLSLRDHLTNGFPG--LEPAGIDL  228 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~------------~----~~~~~~~~~~~~~~--~~~~~~~l  228 (259)
                      +||||+++|+|++|.+||...........+......+..            .    .......+...++.  +++.+.++
T Consensus       190 i~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  269 (293)
T cd07843         190 MWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDL  269 (293)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHH
Confidence            999999999999999999887766555444322111100            0    00000111222333  48899999


Q ss_pred             HHhhcCcCCCCccCHHHHhcCccc
Q 039159          229 ISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      |.+||+.||++|||++++++||||
T Consensus       270 i~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         270 LNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             HHHHhccCccccCCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-42  Score=284.19  Aligned_cols=214  Identities=25%  Similarity=0.333  Sum_probs=175.9

Q ss_pred             chhHHHHHHHhhC---CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           13 SSMIREVSCLMEL---NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        13 ~~~~~Ei~~l~~l---~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+|..++..+   +||||+++++++..++..|+||||+.| +|...+...               ..+....+..++
T Consensus        38 ~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~~  102 (330)
T cd05586          38 AHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE---------------GRFSEDRAKFYI  102 (330)
T ss_pred             HHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhc---------------CCCCHHHHHHHH
Confidence            3455677777665   699999999999999999999999986 888777532               335567778889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.|++|||+++|+||||||+||+++.++ .++|+|||++..............||+.|+|||.+.+...++.++|||
T Consensus       103 ~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvw  181 (330)
T cd05586         103 AELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFW  181 (330)
T ss_pred             HHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCcccee
Confidence            9999999999999999999999999999888 899999999875433333344567999999999997645578999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc----CHH
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI----TAA  244 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----~~~  244 (259)
                      ||||++|+|++|+.||.+....+....+.......  +           ...+++++.+++.+||+.||++||    +++
T Consensus       182 slGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  248 (330)
T cd05586         182 SLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF--P-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAV  248 (330)
T ss_pred             ccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC--C-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHH
Confidence            99999999999999999887776666664432111  1           124789999999999999999998    799


Q ss_pred             HHhcCccccCC
Q 039159          245 EALQQEYFKDV  255 (259)
Q Consensus       245 ~~l~h~~f~~~  255 (259)
                      ++++||||++.
T Consensus       249 ~ll~h~~~~~~  259 (330)
T cd05586         249 ELKEHPFFADI  259 (330)
T ss_pred             HHhcCccccCC
Confidence            99999999865

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-42  Score=287.30  Aligned_cols=216  Identities=23%  Similarity=0.269  Sum_probs=180.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc--eEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGI--YLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +..++|..|+.+|+.|+||||+++|+++.+..  .+.+|+|.+. |+|..++...               ..+....+..
T Consensus        83 ~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~---------------~~vn~kaik~  147 (632)
T KOG0584|consen   83 EELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH---------------RRVNIKAIKS  147 (632)
T ss_pred             HHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh---------------ccCCHHHHHH
Confidence            34489999999999999999999999998765  4889999998 6999998654               3445568889


Q ss_pred             HHhhcccccccccCC--CceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           87 EFSSSDSSRSLSFGT--RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~--~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      |++||+.||.|||++  .|+|||||.+||+|+.+-+.|||+|+|+|........  ...+|||.|||||++..  .|+..
T Consensus       148 W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a--ksvIGTPEFMAPEmYEE--~YnE~  223 (632)
T KOG0584|consen  148 WCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA--KSVIGTPEFMAPEMYEE--NYNEL  223 (632)
T ss_pred             HHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc--ceeccCccccChHHHhh--hcchh
Confidence            999999999999976  8999999999999998877999999999987654322  23689999999999974  69999


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGAN-SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +||||||+.++||+|+..||.... ..+++.++..+.....+.            .--++++++||.+||.. ..+||++
T Consensus       224 VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~------------kV~dPevr~fIekCl~~-~~~R~sa  290 (632)
T KOG0584|consen  224 VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS------------KVKDPEVREFIEKCLAT-KSERLSA  290 (632)
T ss_pred             hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh------------ccCCHHHHHHHHHHhcC-chhccCH
Confidence            999999999999999999998754 455555555544332221            12368999999999999 9999999


Q ss_pred             HHHhcCccccCCCC
Q 039159          244 AEALQQEYFKDVPG  257 (259)
Q Consensus       244 ~~~l~h~~f~~~~~  257 (259)
                      .|+|+||||....|
T Consensus       291 ~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  291 KELLKDPFFDEDGG  304 (632)
T ss_pred             HHHhhChhhccccc
Confidence            99999999997643

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-41  Score=278.10  Aligned_cols=220  Identities=28%  Similarity=0.414  Sum_probs=177.6

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .....+.+.+|+.+++.++||||+++++++..++..++||||++| +|..++..                ..+...++..
T Consensus        56 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~  119 (297)
T cd06656          56 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------------TCMDEGQIAA  119 (297)
T ss_pred             ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh----------------CCCCHHHHHH
Confidence            334456788999999999999999999999999999999999986 88888753                2245567788


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.+++.|+.|||+.+++||||||+||+++.++ .++|+|||.+..............+++.|+|||.+.+ ..++.++|
T Consensus       120 ~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  197 (297)
T cd06656         120 VCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVD  197 (297)
T ss_pred             HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCccCcCcccCCccccCHHHHcC-CCCCcHHH
Confidence            899999999999999999999999999999888 8999999998765433333344578899999999977 56788999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      +|||||++|++++|..||...+.......+.... .+.          ......+++.+.+++.+||..+|++||+++++
T Consensus       198 i~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  266 (297)
T cd06656         198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPE----------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL  266 (297)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCC----------CCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999999999999999997755433222221111 111          01123577889999999999999999999999


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      ++||||+...
T Consensus       267 l~~~~~~~~~  276 (297)
T cd06656         267 LQHPFLKLAK  276 (297)
T ss_pred             hcCchhcccc
Confidence            9999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.1e-41  Score=279.59  Aligned_cols=214  Identities=22%  Similarity=0.307  Sum_probs=178.3

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+..|..++..+ +||+|+++++++..++.+|+||||+.| +|.+.+...               ..+....+..++.
T Consensus        44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~---------------~~~~~~~~~~~~~  108 (323)
T cd05616          44 VECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV---------------GRFKEPHAVFYAA  108 (323)
T ss_pred             HHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            34567788888887 589999999999999999999999985 888877532               2345567788999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||+++|+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|+||
T Consensus       109 qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS  186 (323)
T cd05616         109 EIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWA  186 (323)
T ss_pred             HHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhc
Confidence            999999999999999999999999999988 8999999998754333333445578999999999987 57889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HH
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AA  244 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~  244 (259)
                      |||++|+|++|+.||.+.+.......+......              ....+++++.+++.+||+.||.+|++     ..
T Consensus       187 lGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~  252 (323)
T cd05616         187 FGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGER  252 (323)
T ss_pred             hhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHH
Confidence            999999999999999988877777666543211              11357899999999999999999997     58


Q ss_pred             HHhcCccccCCC
Q 039159          245 EALQQEYFKDVP  256 (259)
Q Consensus       245 ~~l~h~~f~~~~  256 (259)
                      ++++||||+.+.
T Consensus       253 ~i~~h~~~~~~~  264 (323)
T cd05616         253 DIKEHAFFRYID  264 (323)
T ss_pred             HHhcCCCcCCCC
Confidence            999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-41  Score=273.59  Aligned_cols=219  Identities=22%  Similarity=0.323  Sum_probs=171.4

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ..+..|++++++++||||+++++++..+...++||||+.| +|...+.....             .......+..++.|+
T Consensus        38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~-------------~~~~~~~~~~~~~qi  104 (277)
T cd05607          38 KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-------------RGLEMERVIHYSAQI  104 (277)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccc-------------cCCCHHHHHHHHHHH
Confidence            3456799999999999999999999999999999999986 88777743211             234566777888999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      +.|++|||+.+++||||||+||+++.++ .++|+|||++...... .......|++.|+|||.+.+ ..++.++|+||+|
T Consensus       105 ~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG  181 (277)
T cd05607         105 TCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDG-KTITQRAGTNGYMAPEILKE-EPYSYPVDWFAMG  181 (277)
T ss_pred             HHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCC-ceeeccCCCCCccCHHHHcc-CCCCCchhHHHHH
Confidence            9999999999999999999999999888 8999999998765332 22233468899999999987 4588999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH----HHHh
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA----AEAL  247 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~----~~~l  247 (259)
                      |++|+|++|..||...........+.......         ........+++++.+++.+||+.||.+||++    ++++
T Consensus       182 v~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         182 CSIYEMVAGRTPFKDHKEKVAKEELKRRTLED---------EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             HHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc---------ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            99999999999997643221111111110000         0111123578999999999999999999999    7788


Q ss_pred             cCccccCCC
Q 039159          248 QQEYFKDVP  256 (259)
Q Consensus       248 ~h~~f~~~~  256 (259)
                      .||||+.+.
T Consensus       253 ~h~~f~~~~  261 (277)
T cd05607         253 KHEFFKTIN  261 (277)
T ss_pred             cChhhcCCC
Confidence            999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.7e-41  Score=279.94  Aligned_cols=213  Identities=28%  Similarity=0.355  Sum_probs=173.8

Q ss_pred             CchhHHHHH-HHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVS-CLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..++.+|+. +++.++||||+++++++.+++..|+||||+.| +|...+...               ..+....+..++.
T Consensus        39 ~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~  103 (321)
T cd05603          39 QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE---------------RCFLEPRARFYAA  103 (321)
T ss_pred             HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            344566655 67889999999999999999999999999996 887776432               2344556677889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||+.+|+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++||||
T Consensus       104 qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws  181 (321)
T cd05603         104 EVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWC  181 (321)
T ss_pred             HHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC-CCCCCcCcccc
Confidence            999999999999999999999999999988 8999999998754333333445578999999999977 56888999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH----HH
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA----AE  245 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~----~~  245 (259)
                      |||++|+|++|..||.+.+.......+.....  .            .....+..+.+++.+||+.||.+||++    .+
T Consensus       182 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (321)
T cd05603         182 LGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL--Q------------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLE  247 (321)
T ss_pred             cchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC--C------------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHH
Confidence            99999999999999998877666666543321  1            113578899999999999999999875    59


Q ss_pred             HhcCccccCC
Q 039159          246 ALQQEYFKDV  255 (259)
Q Consensus       246 ~l~h~~f~~~  255 (259)
                      +++|+||..+
T Consensus       248 ~~~~~~~~~~  257 (321)
T cd05603         248 IKNHVFFSPI  257 (321)
T ss_pred             HhCCCCcCCC
Confidence            9999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.7e-41  Score=269.13  Aligned_cols=216  Identities=25%  Similarity=0.299  Sum_probs=180.2

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +....++.+|+++++.++||||+++++++.+++..++||||++| +|.+++....+             ..+.......+
T Consensus        40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~i  106 (256)
T cd08529          40 RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG-------------RPLPEDQVWRF  106 (256)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcC-------------CCCCHHHHHHH
Confidence            44567888999999999999999999999999999999999986 99998864211             34556677888


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.|+.|||+.+++||||+|+||+++.++ .++|+|||.++.............|++.|+|||++.+ ..++.++|+
T Consensus       107 ~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  184 (256)
T cd08529         107 FIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED-KPYNEKSDV  184 (256)
T ss_pred             HHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccchhhccccCccccCHHHhcC-CCCCCccch
Confidence            89999999999999999999999999999888 8999999998866544333445578899999999987 567889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||+++|++++|+.||...........+..... +.            ....+++++.+++.+||+.+|++||++.+++
T Consensus       185 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll  251 (256)
T cd08529         185 WALGVVLYECCTGKHPFDANNQGALILKIIRGVF-PP------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLL  251 (256)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CC------------CccccCHHHHHHHHHHccCCcccCcCHHHHh
Confidence            9999999999999999988776665555543321 11            1125778999999999999999999999999


Q ss_pred             cCccc
Q 039159          248 QQEYF  252 (259)
Q Consensus       248 ~h~~f  252 (259)
                      +|||+
T Consensus       252 ~~~~~  256 (256)
T cd08529         252 RNPSL  256 (256)
T ss_pred             hCCCC
Confidence            99985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.9e-41  Score=280.09  Aligned_cols=211  Identities=28%  Similarity=0.385  Sum_probs=173.9

Q ss_pred             hhHHHHH-HHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           14 SMIREVS-CLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        14 ~~~~Ei~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .+.+|.. +++.++||||+++++++..++..|+||||+.| +|...+...               ..+.......++.|+
T Consensus        41 ~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~qi  105 (325)
T cd05602          41 HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE---------------RCFLEPRARFYAAEI  105 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc---------------CCCCHHHHHHHHHHH
Confidence            4455554 56788999999999999999999999999996 888887532               223445666788999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      +.||+|||++||+||||||+||+++.++ .++|+|||+++.............||+.|+|||++.+ ..++.++||||||
T Consensus       106 ~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG  183 (325)
T cd05602         106 ASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLG  183 (325)
T ss_pred             HHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCcccccCCccccCHHHHcC-CCCCCcccccccc
Confidence            9999999999999999999999999888 8999999998754333334455679999999999987 5788999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH----HHh
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA----EAL  247 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~----~~l  247 (259)
                      |++|+|++|.+||.+.+.......+.....              ...+.+++.+.+++.+||+.||.+|+++.    +++
T Consensus       184 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~  249 (325)
T cd05602         184 AVLYEMLYGLPPFYSRNTAEMYDNILNKPL--------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK  249 (325)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence            999999999999998877766666543321              11246889999999999999999999865    899


Q ss_pred             cCccccCC
Q 039159          248 QQEYFKDV  255 (259)
Q Consensus       248 ~h~~f~~~  255 (259)
                      +|+||...
T Consensus       250 ~~~~~~~~  257 (325)
T cd05602         250 NHIFFSPI  257 (325)
T ss_pred             cCcccCCC
Confidence            99999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.9e-41  Score=279.13  Aligned_cols=216  Identities=23%  Similarity=0.293  Sum_probs=173.6

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+.+|+.++.++ +||||+++++++...+.+|+||||+.| +|...+...               ..++...+..++
T Consensus        38 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~l~~~~~~~~~  102 (327)
T cd05617          38 DIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ---------------RKLPEEHARFYA  102 (327)
T ss_pred             HHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHHH
Confidence            345678999999988 699999999999999999999999986 887776432               335667788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.|++|||+++++||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|+|
T Consensus       103 ~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw  180 (327)
T cd05617         103 AEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWW  180 (327)
T ss_pred             HHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceecccCCcccCCHHHHCC-CCCCchheee
Confidence            9999999999999999999999999999888 8999999998754333334445679999999999987 5788999999


Q ss_pred             hHHHHHHHHHhCCCCCCCC------ChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          169 PVGCIFGEMVSGKPLFPGA------NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ||||++|+|++|..||...      .............. .            .....++..+.+++.+||+.||++|++
T Consensus       181 slGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~------------~~p~~~~~~~~~li~~~L~~dP~~R~~  247 (327)
T cd05617         181 ALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-I------------RIPRFLSVKASHVLKGFLNKDPKERLG  247 (327)
T ss_pred             hhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-C------------CCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence            9999999999999999532      11122222211111 0            112357899999999999999999997


Q ss_pred             ------HHHHhcCccccCCC
Q 039159          243 ------AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ------~~~~l~h~~f~~~~  256 (259)
                            +++++.||||+++.
T Consensus       248 ~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         248 CQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             CCCCCCHHHHHcCCCCCCCC
Confidence                  57999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-41  Score=273.48  Aligned_cols=219  Identities=22%  Similarity=0.297  Sum_probs=175.2

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+++++.++||||+++++++..++.+++||||+.| +|...+.....             ..++......++.|
T Consensus        44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~q  110 (285)
T cd05605          44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN-------------PGFDEERAVFYAAE  110 (285)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCc-------------CCCCHHHHHHHHHH
Confidence            34577899999999999999999999999999999999986 78777643211             23556777888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|+.|||+.+++||||||+||+++.++ .++|+|||++...... .......|++.|+|||.+.+ ..++.++|+||+
T Consensus       111 i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~  187 (285)
T cd05605         111 ITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGL  187 (285)
T ss_pred             HHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCC-CccccccCCCCccCcHHhcC-CCCCccccchhH
Confidence            99999999999999999999999999888 8999999998764322 22234478999999999977 568889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CHHH
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAE  245 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~  245 (259)
                      ||++|++++|+.||.+.........+......          ........+++.+.+++.+||+.||++||     ++++
T Consensus       188 G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~  257 (285)
T cd05605         188 GCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEE  257 (285)
T ss_pred             HHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHH
Confidence            99999999999999876544333222111000          00111235789999999999999999999     9999


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +++||||+...
T Consensus       258 l~~~~~~~~~~  268 (285)
T cd05605         258 VKAHPFFRTAN  268 (285)
T ss_pred             HhcCcCccCCC
Confidence            99999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-41  Score=287.75  Aligned_cols=226  Identities=24%  Similarity=0.251  Sum_probs=171.1

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      ..+.+|++++++|+||||+++++++..++..++|||++.++|...+....              ..+.+.+++.++.|++
T Consensus       205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--------------~~l~~~~~~~i~~qi~  270 (461)
T PHA03211        205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARL--------------RPLGLAQVTAVARQLL  270 (461)
T ss_pred             cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHH
Confidence            45679999999999999999999999999999999999988888875321              2466778889999999


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      .||+|||++||+||||||+||+++.++ .++|+|||+++.......  ......||+.|+|||++.+ ..++.++|||||
T Consensus       271 ~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSl  348 (461)
T PHA03211        271 SAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSA  348 (461)
T ss_pred             HHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceecccccccccccccCCCcCCcCHHHHcC-CCCCchHHHHHH
Confidence            999999999999999999999999888 899999999976533211  1223468999999999987 568899999999


Q ss_pred             HHHHHHHHhCCCCCCCCC-------hHHHHHHHhCCCC--CCccccc---cc------------c----ccccCCCCCCC
Q 039159          171 GCIFGEMVSGKPLFPGAN-------SLITLGRIVGKSR--KPSFCKL---SL------------R----DHLTNGFPGLE  222 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~-------~~~~~~~i~~~~~--~~~~~~~---~~------------~----~~~~~~~~~~~  222 (259)
                      ||++|||++|..++....       .......+.....  ....+..   .+            .    ......+..++
T Consensus       349 GviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  428 (461)
T PHA03211        349 GLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLD  428 (461)
T ss_pred             HHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhcccc
Confidence            999999999876553321       1122222221111  0001000   00            0    00001112467


Q ss_pred             HHHHHHHHhhcCcCCCCccCHHHHhcCccccC
Q 039159          223 PAGIDLISKMLGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       223 ~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      +++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       429 ~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        429 LDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            78999999999999999999999999999975

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.8e-41  Score=273.15  Aligned_cols=235  Identities=36%  Similarity=0.551  Sum_probs=180.1

Q ss_pred             CCCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCce-----EEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            9 EGVPSSMIREVSCLMELN-HPNIIRLMRVASQGIY-----LYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~-----~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      +.....+.+|+.+++++. ||||+++++++...+.     .|+||||+.++|.+.+.......          ...+...
T Consensus        41 ~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~----------~~~~~~~  110 (295)
T cd07837          41 EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGP----------GRPLPAK  110 (295)
T ss_pred             cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccC----------CCCCCHH
Confidence            345567899999999995 6999999999987655     89999999999888886432210          0345667


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .+..++.|++.||.|||+.+++||||+|+||+++.+++.++|+|||.+..............+++.|+|||.+.+...++
T Consensus       111 ~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  190 (295)
T cd07837         111 TIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYS  190 (295)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCC
Confidence            88889999999999999999999999999999998333899999999876533322333345688899999987645678


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccc--------------ccccccCCCCCCCHHHHHH
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLS--------------LRDHLTNGFPGLEPAGIDL  228 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~l  228 (259)
                      .++|+||||+++|+|++|..||.+.........+......+......              .........+.+++++.++
T Consensus       191 ~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (295)
T cd07837         191 TPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDL  270 (295)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHH
Confidence            89999999999999999999999877666655543322111110000              0001112234688999999


Q ss_pred             HHhhcCcCCCCccCHHHHhcCcccc
Q 039159          229 ISKMLGMDPDKRITAAEALQQEYFK  253 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~h~~f~  253 (259)
                      |.+||..||.+||++++++.||||+
T Consensus       271 i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         271 LQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HHHHccCChhhcCCHHHHhcCCCcC
Confidence            9999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.5e-41  Score=275.98  Aligned_cols=220  Identities=24%  Similarity=0.406  Sum_probs=180.9

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .....+.+.+|+.+++.++||||+++++.+..++..++++||+++ +|...+..                ..+....+..
T Consensus        58 ~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~----------------~~~~~~~~~~  121 (297)
T cd06659          58 KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----------------TRLNEEQIAT  121 (297)
T ss_pred             ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh----------------cCCCHHHHHH
Confidence            344456788999999999999999999999999999999999996 78776642                2345667888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.+++.|++|||+.+++||||+|+||+++.++ .++|+|||++..............|+..|+|||.+.+ ..++.++|
T Consensus       122 ~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  199 (297)
T cd06659         122 VCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-TPYGTEVD  199 (297)
T ss_pred             HHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhcccccccccceecCccccCHHHHcc-CCCCchhh
Confidence            999999999999999999999999999999888 8999999998755433333344568899999999977 56789999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      +|||||++|++++|+.||...........+.... .+.          ......+++.+.+++.+||+.+|++||+++++
T Consensus       200 v~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~----------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~l  268 (297)
T cd06659         200 IWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPK----------LKNAHKISPVLRDFLERMLTREPQERATAQEL  268 (297)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCC----------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            9999999999999999998777666555443221 111          11123578899999999999999999999999


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      ++||||.+..
T Consensus       269 l~~~~~~~~~  278 (297)
T cd06659         269 LDHPFLLQTG  278 (297)
T ss_pred             hhChhhccCC
Confidence            9999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.5e-41  Score=269.48  Aligned_cols=215  Identities=20%  Similarity=0.246  Sum_probs=172.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.+++.++||||+++++++..++..+++|||+++ +|.+++...               ..++..+.+.++.+
T Consensus        50 ~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~~  114 (267)
T cd06645          50 FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT---------------GPLSESQIAYVSRE  114 (267)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            45678899999999999999999999999999999999996 888887532               33556778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC--ccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG--LLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Diw  168 (259)
                      ++.|++|||+.|++|+||||+||+++.++ .++|+|||.+..............|++.|+|||.+..  ...++.++|+|
T Consensus       115 i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dvw  193 (267)
T cd06645         115 TLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIW  193 (267)
T ss_pred             HHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhH
Confidence            99999999999999999999999999888 8999999998765443333445578999999999742  24577899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||||++|++++|..||..................+..         ......++..+.+++.+||..+|++||+++++++
T Consensus       194 SlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         194 AVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK---------LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCc---------ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            9999999999999999765544333332221111110         0111246788999999999999999999999999


Q ss_pred             Ccc
Q 039159          249 QEY  251 (259)
Q Consensus       249 h~~  251 (259)
                      |||
T Consensus       265 ~~~  267 (267)
T cd06645         265 HPF  267 (267)
T ss_pred             CCC
Confidence            998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-41  Score=284.84  Aligned_cols=226  Identities=23%  Similarity=0.232  Sum_probs=168.6

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      .....|+.++++++||||+++++++..++..++|||++.++|..++....              ..+....+..++.|++
T Consensus       102 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--------------~~~~~~~~~~i~~qi~  167 (357)
T PHA03209        102 GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS--------------RPLPIDQALIIEKQIL  167 (357)
T ss_pred             cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcHHHHHHhcc--------------CCCCHHHHHHHHHHHH
Confidence            34567999999999999999999999999999999999999988885421              3356677888999999


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHHH
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGC  172 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~  172 (259)
                      .||.|||+++|+||||||+||+++.++ .++|+|||.++.... ........||+.|+|||++.+ ..++.++|||||||
T Consensus       168 ~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGv  244 (357)
T PHA03209        168 EGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVV-APAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGI  244 (357)
T ss_pred             HHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCcccccccc-CcccccccccccccCCeecCC-CCCCchhhHHHHHH
Confidence            999999999999999999999999888 899999999974322 122234568999999999987 56889999999999


Q ss_pred             HHHHHHhCCCCC-CCCChH---------HHHHHHhCC-C-CCCccc---ccccc-----------ccc----cCCCCCCC
Q 039159          173 IFGEMVSGKPLF-PGANSL---------ITLGRIVGK-S-RKPSFC---KLSLR-----------DHL----TNGFPGLE  222 (259)
Q Consensus       173 ~l~e~~tg~~pf-~~~~~~---------~~~~~i~~~-~-~~~~~~---~~~~~-----------~~~----~~~~~~~~  222 (259)
                      ++|||+++..++ ......         .....+... . .....+   .....           .+.    .....+++
T Consensus       245 vl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (357)
T PHA03209        245 VLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLP  324 (357)
T ss_pred             HHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCC
Confidence            999999865444 321110         111111110 0 000000   00000           000    00112467


Q ss_pred             HHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          223 PAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       223 ~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      .+..+||.+||+.||.+|||++++|+||||+++
T Consensus       325 ~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        325 IDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             chHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            788899999999999999999999999999874

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.7e-41  Score=269.69  Aligned_cols=217  Identities=20%  Similarity=0.252  Sum_probs=173.6

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeC------ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQG------IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~------~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      .....+.+|+.+++++ +||||+++++++...      ...|++|||+.+ +|.+.+.....             ..+..
T Consensus        44 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~-------------~~l~~  110 (272)
T cd06637          44 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------------NTLKE  110 (272)
T ss_pred             ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC-------------CCCCH
Confidence            3456789999999999 699999999998753      468999999986 89888864221             23456


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC----
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG----  157 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----  157 (259)
                      ..+..++.|++.|++|||+++++||||||+||+++.++ .++|+|||++..............|++.|+|||.+.+    
T Consensus       111 ~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~  189 (272)
T cd06637         111 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP  189 (272)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCceecccccccCCcccccccccCHhHhccccCc
Confidence            66778899999999999999999999999999999888 8999999999765443334455678999999999863    


Q ss_pred             ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      ...++.++|+|||||++|++++|+.||...........+...... .           .....++..+.+|+.+||..||
T Consensus       190 ~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~-----------~~~~~~~~~~~~li~~~l~~~p  257 (272)
T cd06637         190 DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP-R-----------LKSKKWSKKFQSFIESCLVKNH  257 (272)
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCC-C-----------CCCCCcCHHHHHHHHHHcCCCh
Confidence            134678999999999999999999999876655444433221100 0           1113467899999999999999


Q ss_pred             CCccCHHHHhcCccc
Q 039159          238 DKRITAAEALQQEYF  252 (259)
Q Consensus       238 ~~Rp~~~~~l~h~~f  252 (259)
                      .+|||++++++||||
T Consensus       258 ~~Rpt~~~il~~~~~  272 (272)
T cd06637         258 SQRPTTEQLMKHPFI  272 (272)
T ss_pred             hhCCCHHHHhhCCCC
Confidence            999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.2e-41  Score=274.80  Aligned_cols=231  Identities=34%  Similarity=0.572  Sum_probs=181.7

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ....+.+|++++++++|+||+++++++.+++..++||||+.++|.+++....              ..+....+..++.|
T Consensus        45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~~~~--------------~~~~~~~~~~~~~q  110 (298)
T cd07841          45 INFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKS--------------IVLTPADIKSYMLM  110 (298)
T ss_pred             hhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcccCCCHHHHHhccC--------------CCCCHHHHHHHHHH
Confidence            4456778999999999999999999999999999999999669999885421              13556778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      +++||+|||+++++||||+|+||+++.++ .++|+|||++..............+++.|+|||.+.+...++.++|+|||
T Consensus       111 i~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  189 (298)
T cd07841         111 TLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSV  189 (298)
T ss_pred             HHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHH
Confidence            99999999999999999999999999888 89999999997664433333444678889999998765567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc--------------ccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK--------------LSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                      ||++|++++|.++|.+.........+......+....              ..........+...+..+.++|.+||+.|
T Consensus       190 G~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  269 (298)
T cd07841         190 GCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLN  269 (298)
T ss_pred             HHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCC
Confidence            9999999999888887666555444432211110000              00001112223456889999999999999


Q ss_pred             CCCccCHHHHhcCccccCCC
Q 039159          237 PDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       237 p~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |++|||+.++++||||++..
T Consensus       270 P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         270 PNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             cccCcCHHHHhhCccccCCC
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6e-41  Score=272.16  Aligned_cols=230  Identities=34%  Similarity=0.598  Sum_probs=181.6

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +...+.+.+|+.++++++||||+++++++..+...++|+||+.++|.+.+....              ..+...++..++
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~--------------~~~~~~~~~~~~  105 (286)
T cd07832          40 GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEE--------------RPLPEAQVKSYM  105 (286)
T ss_pred             chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecccCCCHHHHHHhcC--------------CCCCHHHHHHHH
Confidence            445678999999999999999999999999999999999999559999885422              235667788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.||+|||+.+++|+||||+||+++.++ .++++|||.+........ ......++..|+|||.+.+...++.++||
T Consensus       106 ~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  184 (286)
T cd07832         106 RMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDL  184 (286)
T ss_pred             HHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHH
Confidence            9999999999999999999999999999888 899999999876543321 13345688999999998765557889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc----------------ccccccccCCCCCCCHHHHHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK----------------LSLRDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~li~~  231 (259)
                      ||+|+++|++++|.++|.+.........+......+....                ......+...+++.+.++.+++.+
T Consensus       185 ~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  264 (286)
T cd07832         185 WAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKG  264 (286)
T ss_pred             HHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHH
Confidence            9999999999999999987776655555433221111100                000001122335678999999999


Q ss_pred             hcCcCCCCccCHHHHhcCcccc
Q 039159          232 MLGMDPDKRITAAEALQQEYFK  253 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~h~~f~  253 (259)
                      ||+.||.+||+++++++||||.
T Consensus       265 ~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         265 LLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             HhccChhhCCCHHHHhhCcCcC
Confidence            9999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.1e-41  Score=268.29  Aligned_cols=214  Identities=25%  Similarity=0.402  Sum_probs=176.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+++.+|++++++++||||+++++++..+...|+++||+.+ +|.+.+....              ..++...+..++.+
T Consensus        42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--------------~~l~~~~~~~~~~~  107 (256)
T cd06612          42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN--------------KTLTEEEIAAILYQ  107 (256)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc--------------cCCCHHHHHHHHHH
Confidence            56899999999999999999999999999999999999996 8888885321              34566788889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||+.+++||||+|+||+++.++ .++|+|||.+..............++..|+|||.+.+ ..++.++|||||
T Consensus       108 l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~  185 (256)
T cd06612         108 TLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSL  185 (256)
T ss_pred             HHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCccccccccCCccccCHHHHhc-CCCCchhhHHHH
Confidence            99999999999999999999999999888 8999999999876544333444567889999999877 567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      |+++|+|++|+.||...........+..... +.          ......+++++.+++.+||+.||++||++.++++||
T Consensus       186 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~  254 (256)
T cd06612         186 GITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-PT----------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP  254 (256)
T ss_pred             HHHHHHHHhCCCCCCCcchhhhhhhhccCCC-CC----------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCC
Confidence            9999999999999987665544333221110 00          011134678999999999999999999999999999


Q ss_pred             cc
Q 039159          251 YF  252 (259)
Q Consensus       251 ~f  252 (259)
                      ||
T Consensus       255 ~~  256 (256)
T cd06612         255 FI  256 (256)
T ss_pred             CC
Confidence            97

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=269.26  Aligned_cols=217  Identities=24%  Similarity=0.334  Sum_probs=180.2

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+++++.++||||+++++++.++...++|+||+++ +|.+.+..                ..+.......++.|
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~~q  106 (274)
T cd06609          43 IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP----------------GKLDETYIAFILRE  106 (274)
T ss_pred             HHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh----------------cCCCHHHHHHHHHH
Confidence            45688999999999999999999999999999999999986 88888853                23456778888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|+.|||+.+++||||+|+||+++.++ .++++|||.+..............+++.|+|||.+.+ ..++.++|+|||
T Consensus       107 l~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~sDv~sl  184 (274)
T cd06609         107 VLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSL  184 (274)
T ss_pred             HHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEcccccceeecccccccccccCCccccChhhhcc-CCCCchhhHHHH
Confidence            99999999999999999999999999988 8999999999876544334445578889999999987 458899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      |+++|++++|+.||...+.......+.... .+...           ...+++++.+++.+||..+|++||+++++++||
T Consensus       185 G~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~-----------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~  252 (274)
T cd06609         185 GITAIELAKGEPPLSDLHPMRVLFLIPKNN-PPSLE-----------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHK  252 (274)
T ss_pred             HHHHHHHHhCCCCcccCchHHHHHHhhhcC-CCCCc-----------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence            999999999999998766544443332221 11111           012788999999999999999999999999999


Q ss_pred             cccCCCCC
Q 039159          251 YFKDVPGR  258 (259)
Q Consensus       251 ~f~~~~~~  258 (259)
                      ||+....+
T Consensus       253 ~~~~~~~~  260 (274)
T cd06609         253 FIKKAKKT  260 (274)
T ss_pred             hhcCCCcc
Confidence            99987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=270.64  Aligned_cols=226  Identities=37%  Similarity=0.540  Sum_probs=171.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ...+.+|++++++++||||+++++++.+++..++||||+.++|.+.+....              ..+.......++.|+
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~ql  112 (291)
T cd07844          47 PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCG--------------GGLSMHNVRLFLFQL  112 (291)
T ss_pred             chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCCCHHHHHHhCC--------------CCCCHHHHHHHHHHH
Confidence            455778999999999999999999999999999999999999988875321              234556778888999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      +.||.|||+.+++||||||+||+++.++ .++|+|||.+..............+++.|+|||.+.+...++.++|+||+|
T Consensus       113 ~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG  191 (291)
T cd07844         113 LRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVG  191 (291)
T ss_pred             HHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHH
Confidence            9999999999999999999999999888 899999999865432222223335688899999987645678899999999


Q ss_pred             HHHHHHHhCCCCCCCCC-hHHHHHHHhCCCCCCccccc----------------cccccccCCCCCCC--HHHHHHHHhh
Q 039159          172 CIFGEMVSGKPLFPGAN-SLITLGRIVGKSRKPSFCKL----------------SLRDHLTNGFPGLE--PAGIDLISKM  232 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~----------------~~~~~~~~~~~~~~--~~~~~li~~~  232 (259)
                      +++|+|++|..||.+.. .......+......+.....                .....+....+.++  +++.+++.+|
T Consensus       192 ~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  271 (291)
T cd07844         192 CIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKF  271 (291)
T ss_pred             HHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHH
Confidence            99999999999997655 22222222111100000000                00011111222344  8889999999


Q ss_pred             cCcCCCCccCHHHHhcCccc
Q 039159          233 LGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      |..+|++||++.++++||||
T Consensus       272 L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         272 LQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hccCcccccCHHHHhcCCCC
Confidence            99999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=275.66  Aligned_cols=219  Identities=28%  Similarity=0.383  Sum_probs=190.7

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +-....+++|+++|+.++|||||++|.+......+|||+|+-.| +|++++..-.              ..+......++
T Consensus        58 ~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe--------------~Gl~E~La~kY  123 (864)
T KOG4717|consen   58 TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHE--------------EGLNEDLAKKY  123 (864)
T ss_pred             hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhh--------------ccccHHHHHHH
Confidence            34456789999999999999999999999988999999999885 9999985421              45566777899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      |.||..|+.|||+..+|||||||+|+.+-..-+-|||.|||++..+. .+....+.+|++.|-|||.++|....-+++||
T Consensus       124 F~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDi  202 (864)
T KOG4717|consen  124 FAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDI  202 (864)
T ss_pred             HHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-CcchhhcccchhhccCchhhhcCccCCcchhh
Confidence            99999999999999999999999999765443389999999998764 35677888999999999999997777889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++||-+..|++||...++.+.+..|........              ..+|.++++||..||..||++|.+.+++.
T Consensus       203 WSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP--------------shvS~eCrdLI~sMLvRdPkkRAslEeI~  268 (864)
T KOG4717|consen  203 WSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP--------------SHVSKECRDLIQSMLVRDPKKRASLEEIV  268 (864)
T ss_pred             hHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc--------------hhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence            9999999999999999999999999888876554322              36889999999999999999999999999


Q ss_pred             cCccccCCC
Q 039159          248 QQEYFKDVP  256 (259)
Q Consensus       248 ~h~~f~~~~  256 (259)
                      .|+|++.+.
T Consensus       269 s~~Wlq~~D  277 (864)
T KOG4717|consen  269 STSWLQAGD  277 (864)
T ss_pred             ccccccCCC
Confidence            999999774

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-41  Score=271.16  Aligned_cols=230  Identities=43%  Similarity=0.656  Sum_probs=180.5

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +...+.+.+|+++++.++|||++++++++.+++..+++|||+.++|.+++.....             ..+.....+.++
T Consensus        39 ~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~  105 (283)
T cd07835          39 EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPL-------------TGLDPPLIKSYL  105 (283)
T ss_pred             ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccCcCHHHHHhhCCC-------------CCCCHHHHHHHH
Confidence            3445678899999999999999999999999999999999998899888854221             245667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.||+|||+.+++||||+|+||+++.++ .++|+|||.+..............+++.|+|||.+.+...++.++|+|
T Consensus       106 ~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~  184 (283)
T cd07835         106 YQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIW  184 (283)
T ss_pred             HHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHH
Confidence            9999999999999999999999999999887 899999999875433222233345688999999887645578899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc---------------ccccccccCCCCCCCHHHHHHHHhhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK---------------LSLRDHLTNGFPGLEPAGIDLISKML  233 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~~l  233 (259)
                      |||+++|++++|++||...........+......+....               ...........+.+++.+.+++.+||
T Consensus       185 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  264 (283)
T cd07835         185 SIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKML  264 (283)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHh
Confidence            999999999999999987766555444432211111000               00001122234568899999999999


Q ss_pred             CcCCCCccCHHHHhcCccc
Q 039159          234 GMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h~~f  252 (259)
                      +.||.+||+++++++||||
T Consensus       265 ~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         265 VYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cCChhhCcCHHHHhcCCCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-42  Score=263.41  Aligned_cols=219  Identities=26%  Similarity=0.356  Sum_probs=179.0

Q ss_pred             chhHHHHHHHhhCC-CCCeeEEEEEEEeC----ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           13 SSMIREVSCLMELN-HPNIIRLMRVASQG----IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~-H~niv~~~~~~~~~----~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .++.+|++...... |||||.++++|++.    ..+.+|||.++| .|+.-++....             ..++..+..+
T Consensus        99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~-------------~afTErea~e  165 (400)
T KOG0604|consen   99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD-------------QAFTEREASE  165 (400)
T ss_pred             HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc-------------ccchHHHHHH
Confidence            45789999988885 99999999999764    468899999997 78888864321             5688899999


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      +..+|+.|+.|||+.+|.||||||+|+|....+  -.+||+|||+|+.-.. .....+++.||+|.|||++-. ..|+.+
T Consensus       166 I~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~-eKydks  243 (400)
T KOG0604|consen  166 IMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGP-EKYDKS  243 (400)
T ss_pred             HHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC-CccccCCcccccccCHHHhCc-hhcCCC
Confidence            999999999999999999999999999996432  2689999999986432 445667788999999999965 679999


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChH----HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSL----ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      +|+||+||++|-++.|.+||+.....    ....+|..+...          ...+.|..+|++.+|+|+++|..+|.+|
T Consensus       244 cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~----------FP~pEWs~VSe~aKdlIR~LLkt~PteR  313 (400)
T KOG0604|consen  244 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE----------FPEPEWSCVSEAAKDLIRKLLKTEPTER  313 (400)
T ss_pred             CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc----------CCChhHhHHHHHHHHHHHHHhcCCchhh
Confidence            99999999999999999999865432    222333333222          2234467899999999999999999999


Q ss_pred             cCHHHHhcCccccCCC
Q 039159          241 ITAAEALQQEYFKDVP  256 (259)
Q Consensus       241 p~~~~~l~h~~f~~~~  256 (259)
                      .|+.+++.|||+.+..
T Consensus       314 lTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  314 LTIEEVMDHPWINQYE  329 (400)
T ss_pred             eeHHHhhcCchhcccc
Confidence            9999999999998653

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-41  Score=294.94  Aligned_cols=234  Identities=22%  Similarity=0.193  Sum_probs=172.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ....+.+|+.++++++||||+++++++...+..|++++++.++|..++........          ..........++.|
T Consensus       206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~----------~~~~~~~~~~i~~q  275 (501)
T PHA03210        206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK----------DRPLLKQTRAIMKQ  275 (501)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhcccccc----------ccccHHHHHHHHHH
Confidence            34567899999999999999999999999999999999999888887743211100          11223456678999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccchHh
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      ++.||+|||+++|+||||||+||+++.++ .+||+|||+++....... ......||+.|+|||.+.+ ..++.++||||
T Consensus       276 l~~aL~yLH~~gIiHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS  353 (501)
T PHA03210        276 LLCAVEYIHDKKLIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWS  353 (501)
T ss_pred             HHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHH
Confidence            99999999999999999999999999888 899999999976543222 2234579999999999987 56889999999


Q ss_pred             HHHHHHHHHhCCC-CCCCC--ChHHHHHHHhCCCCCC--ccccc--ccc------------ccccCC--CCCCCHHHHHH
Q 039159          170 VGCIFGEMVSGKP-LFPGA--NSLITLGRIVGKSRKP--SFCKL--SLR------------DHLTNG--FPGLEPAGIDL  228 (259)
Q Consensus       170 lG~~l~e~~tg~~-pf~~~--~~~~~~~~i~~~~~~~--~~~~~--~~~------------~~~~~~--~~~~~~~~~~l  228 (259)
                      |||++|||++|.. |+...  ........+......+  .++..  ...            ..+...  ...++.++.++
T Consensus       354 lGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~l  433 (501)
T PHA03210        354 CGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP  433 (501)
T ss_pred             HHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHH
Confidence            9999999999875 44322  2223333322211100  00000  000            000000  12356788899


Q ss_pred             HHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          229 ISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      +.+||+.||++||++.|+|.||||.+..
T Consensus       434 i~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        434 LVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HHHHhccCcccCcCHHHHhhChhhhcCC
Confidence            9999999999999999999999998764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-40  Score=276.15  Aligned_cols=223  Identities=21%  Similarity=0.303  Sum_probs=168.6

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeC-ceEEEEeeeecC-CHHHHhhcCCCCCCCccc------------------
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKDSMNGYST------------------   70 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~------------------   70 (259)
                      ...+.+|+.+++++ +||||+++++++... +.++++|||+++ +|.+++............                  
T Consensus        54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  133 (338)
T cd05102          54 HKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV  133 (338)
T ss_pred             HHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcc
Confidence            45788999999999 899999999998764 468999999995 999988753221100000                  


Q ss_pred             -----------------------------ccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCe
Q 039159           71 -----------------------------KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKT  121 (259)
Q Consensus        71 -----------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~  121 (259)
                                                   ....+...+....++.++.|++.||+|||+.+|+||||||+||+++.++ .
T Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~  212 (338)
T cd05102         134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-V  212 (338)
T ss_pred             ccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-c
Confidence                                         0000113466677888999999999999999999999999999999888 8


Q ss_pred             EEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhC
Q 039159          122 VKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVG  198 (259)
Q Consensus       122 vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~  198 (259)
                      +||+|||+++.......  ......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+............
T Consensus       213 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~  291 (338)
T cd05102         213 VKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK  291 (338)
T ss_pred             EEEeecccccccccCcchhcccCCCCCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh
Confidence            99999999976432211  1223345678999999977 568899999999999999997 9999987554333333322


Q ss_pred             CCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          199 KSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ....+..            ....++++.+++.+||+.||++||++.++++
T Consensus       292 ~~~~~~~------------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         292 DGTRMRA------------PENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             cCCCCCC------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2211111            1357889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.5e-41  Score=270.29  Aligned_cols=211  Identities=21%  Similarity=0.334  Sum_probs=168.2

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|++++++++||||+++++.+..++..++||||+++ +|...                   ..++...+..++.+
T Consensus        43 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~-------------------~~~~~~~~~~~~~q  103 (279)
T cd06619          43 QKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-------------------RKIPEHVLGRIAVA  103 (279)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh-------------------hcCCHHHHHHHHHH
Confidence            45688999999999999999999999999999999999997 55322                   12334556788899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||+.+++|+||||+||+++.++ .++|+|||++.....  .......|+..|+|||.+.+ ..++.++|+|||
T Consensus       104 i~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvwsl  179 (279)
T cd06619         104 VVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN--SIAKTYVGTNAYMAPERISG-EQYGIHSDVWSL  179 (279)
T ss_pred             HHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc--ccccCCCCChhhcCceeecC-CCCCCcchHHHH
Confidence            99999999999999999999999999988 899999999975432  23344578999999999987 568899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChH-------HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          171 GCIFGEMVSGKPLFPGANSL-------ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      |+++|+|++|+.||......       .....+.... .+.           ......++++.+++.+||+.||++||++
T Consensus       180 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~-----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~  247 (279)
T cd06619         180 GISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPV-----------LPVGQFSEKFVHFITQCMRKQPKERPAP  247 (279)
T ss_pred             HHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-CCC-----------CCCCcCCHHHHHHHHHHhhCChhhCCCH
Confidence            99999999999999653211       1111111110 000           0113477899999999999999999999


Q ss_pred             HHHhcCccccCCCC
Q 039159          244 AEALQQEYFKDVPG  257 (259)
Q Consensus       244 ~~~l~h~~f~~~~~  257 (259)
                      +++++||||+....
T Consensus       248 ~eil~~~~~~~~~~  261 (279)
T cd06619         248 ENLMDHPFIVQYND  261 (279)
T ss_pred             HHHhcCcccccccC
Confidence            99999999997643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.6e-40  Score=269.79  Aligned_cols=218  Identities=27%  Similarity=0.421  Sum_probs=179.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+.+++.++||||+++++++..++..++++||+.| +|.+.+..                ..+....+..++
T Consensus        58 ~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~  121 (285)
T cd06648          58 QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH----------------TRMNEEQIATVC  121 (285)
T ss_pred             hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh----------------CCCCHHHHHHHH
Confidence            3345688999999999999999999999999999999999986 88888754                224456777889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||+++++||||+|+||+++.++ .++++|||.+..............|++.|+|||.+.+ ..++.++|+|
T Consensus       122 ~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~  199 (285)
T cd06648         122 LAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR-LPYGTEVDIW  199 (285)
T ss_pred             HHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCcccccccCCccccCHHHhcC-CCCCCcccHH
Confidence            9999999999999999999999999999888 8999999988755433333344568999999999877 5688899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|++++|+.||...+.......+.... .+..          .....+++.+.+++.+||..+|++||++.++++
T Consensus       200 slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         200 SLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPKL----------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCCC----------cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            99999999999999998877665555444321 1111          011237789999999999999999999999999


Q ss_pred             CccccCCC
Q 039159          249 QEYFKDVP  256 (259)
Q Consensus       249 h~~f~~~~  256 (259)
                      ||||++..
T Consensus       269 ~~~~~~~~  276 (285)
T cd06648         269 HPFLAKAG  276 (285)
T ss_pred             CcccccCC
Confidence            99998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.5e-40  Score=264.56  Aligned_cols=215  Identities=28%  Similarity=0.377  Sum_probs=176.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEe-CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...+.+.+|++++++++|||++++++.+.. +..++++|||+++ +|.+.+.....             ..++..++..+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-------------~~l~~~~~~~~  107 (257)
T cd08223          41 RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG-------------KLLPENQVVEW  107 (257)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcC-------------CCCCHHHHHHH
Confidence            344578899999999999999999998864 4478999999986 88888854211             23556778889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.|+++||+.+++||||||+||+++.++ .++|+|||.+..............+++.|+|||.+.+ ..++.++|+
T Consensus       108 ~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  185 (257)
T cd08223         108 FVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDV  185 (257)
T ss_pred             HHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccCCccccccCCcCccChhHhcC-CCCCchhhh
Confidence            99999999999999999999999999999888 8999999999866443334445578899999999977 567889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++++++++|+.||...+.......+..... +.            ....+++.+.+++.+||+.||++||++.+++
T Consensus       186 ~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l  252 (257)
T cd08223         186 WALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PP------------MPKDYSPELGELIATMLSKRPEKRPSVKSIL  252 (257)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CC------------CccccCHHHHHHHHHHhccCcccCCCHHHHh
Confidence            9999999999999999987766555444433221 11            1235789999999999999999999999999


Q ss_pred             cCccc
Q 039159          248 QQEYF  252 (259)
Q Consensus       248 ~h~~f  252 (259)
                      +||||
T Consensus       253 ~~~~~  257 (257)
T cd08223         253 RQPYI  257 (257)
T ss_pred             cCCCC
Confidence            99997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-40  Score=269.44  Aligned_cols=230  Identities=37%  Similarity=0.600  Sum_probs=180.1

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...+.+.+|++++++++||||+++++++.+++..++||||+.++|..++......            ..+....+..++.
T Consensus        40 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~------------~~~~~~~~~~~~~  107 (284)
T cd07836          40 GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVR------------GALDPNTVKSFTY  107 (284)
T ss_pred             cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCC------------CCcCHHHHHHHHH
Confidence            3456788999999999999999999999999999999999999988887542210            3466778889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|++|||+.+++||||+|+||+++.++ .++++|||.+..............+++.|++||.+.+...++.++|+||
T Consensus       108 qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~s  186 (284)
T cd07836         108 QLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWS  186 (284)
T ss_pred             HHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHH
Confidence            999999999999999999999999999888 8999999999755332222334457889999999876556788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccc---------------ccccccCCCCCCCHHHHHHHHhhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLS---------------LRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                      ||+++|++++|+.||.+.+.......+......+.....+               .........+..++.+.+++.+||+
T Consensus       187 lG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  266 (284)
T cd07836         187 VGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQ  266 (284)
T ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhc
Confidence            9999999999999998877665555443222111110000               0000111123467899999999999


Q ss_pred             cCCCCccCHHHHhcCccc
Q 039159          235 MDPDKRITAAEALQQEYF  252 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~h~~f  252 (259)
                      .||.+||++.++++||||
T Consensus       267 ~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         267 LNPELRISAHDALQHPWF  284 (284)
T ss_pred             CCcccCCCHHHHhcCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.4e-40  Score=274.59  Aligned_cols=214  Identities=23%  Similarity=0.335  Sum_probs=177.8

Q ss_pred             CchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+..|+.+++.+. |++|+++++++..++.+|+||||++| +|.+.+...               ..++......++.
T Consensus        44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~---------------~~l~~~~~~~i~~  108 (323)
T cd05615          44 VECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV---------------GKFKEPQAVFYAA  108 (323)
T ss_pred             HHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            456788999999886 67888999999999999999999986 888877432               3355677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|++|||+++++||||||+||+++.++ .++|+|||+++.............||+.|+|||.+.+ ..++.++|+||
T Consensus       109 qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws  186 (323)
T cd05615         109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWA  186 (323)
T ss_pred             HHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCccccCccCCccccCHHHHcC-CCCCCccchhh
Confidence            999999999999999999999999999888 8999999998754333333445568999999999977 56889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HH
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AA  244 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~  244 (259)
                      +||++|+|++|..||.+.........+......              ....+++++.+++.+||..+|.+|++     .+
T Consensus       187 lGvil~elltG~~pf~~~~~~~~~~~i~~~~~~--------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  252 (323)
T cd05615         187 YGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS--------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGER  252 (323)
T ss_pred             hHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHH
Confidence            999999999999999988777666666543211              11357889999999999999999997     58


Q ss_pred             HHhcCccccCCC
Q 039159          245 EALQQEYFKDVP  256 (259)
Q Consensus       245 ~~l~h~~f~~~~  256 (259)
                      ++++||||+.+.
T Consensus       253 ~i~~h~~f~~~~  264 (323)
T cd05615         253 DIREHAFFRRID  264 (323)
T ss_pred             HHhcCcccCCCC
Confidence            999999999764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=266.83  Aligned_cols=217  Identities=27%  Similarity=0.326  Sum_probs=176.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|++++++++||||+++++++.+++.+|++|||+.+ +|.+++....              ..++...+..++.
T Consensus        43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~--------------~~l~~~~~~~~~~  108 (262)
T cd06613          43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--------------GPLSELQIAYVCR  108 (262)
T ss_pred             hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc--------------cCCCHHHHHHHHH
Confidence            457789999999999999999999999999999999999996 8888775421              2345667788999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc--cCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL--LEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di  167 (259)
                      |++.|++|||+.+++||||+|+||+++.++ .++|+|||.+..............++..|+|||.+.+.  ..++.++|+
T Consensus       109 ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di  187 (262)
T cd06613         109 ETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI  187 (262)
T ss_pred             HHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhh
Confidence            999999999999999999999999999888 89999999987654433334455788899999998762  267789999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||+++|+|++|.+||.+.........+......+...         ......+.++.+++.+||..+|.+||++.+++
T Consensus       188 ~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  258 (262)
T cd06613         188 WALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKL---------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLL  258 (262)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccc---------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            999999999999999998876555544433221111110         01134678899999999999999999999999


Q ss_pred             cCcc
Q 039159          248 QQEY  251 (259)
Q Consensus       248 ~h~~  251 (259)
                      .|+|
T Consensus       259 ~~~~  262 (262)
T cd06613         259 QHPF  262 (262)
T ss_pred             cCCC
Confidence            9998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-40  Score=265.55  Aligned_cols=210  Identities=30%  Similarity=0.467  Sum_probs=172.7

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      +.+.+|+.++++++||||+++++++.+++..++++||+++ +|...+...               ..+....+..++.++
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~~~l  115 (267)
T cd06628          51 DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY---------------GAFEETLVRNFVRQI  115 (267)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc---------------cCccHHHHHHHHHHH
Confidence            5688999999999999999999999999999999999986 888888532               234456677889999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC------CCcCCccCccccCcccccCccCCCccc
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG------ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.|++|||+.+++||||+|+||+++.++ .++|+|||.++.......      ......|+..|+|||.+.+ ..++.++
T Consensus       116 ~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~  193 (267)
T cd06628         116 LKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKA  193 (267)
T ss_pred             HHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc-CCCCchh
Confidence            9999999999999999999999999888 899999999876542111      1123357889999999977 5678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |+||||+++|++++|..||...........+.... .+.            ....++..+.+++.+||+.||++||++.+
T Consensus       194 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  260 (267)
T cd06628         194 DIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-SPE------------IPSNISSEAIDFLEKTFEIDHNKRPTAAE  260 (267)
T ss_pred             hhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC-CCc------------CCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence            99999999999999999998766554444433211 111            12357899999999999999999999999


Q ss_pred             HhcCccc
Q 039159          246 ALQQEYF  252 (259)
Q Consensus       246 ~l~h~~f  252 (259)
                      +++||||
T Consensus       261 il~~~~~  267 (267)
T cd06628         261 LLKHPFL  267 (267)
T ss_pred             HhhCCCC
Confidence            9999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.9e-40  Score=274.82  Aligned_cols=220  Identities=24%  Similarity=0.358  Sum_probs=178.0

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ..+.+|+.++..++|+||+++++++.+++.+|+||||+.| +|.+++....              ..+.......++.|+
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--------------~~l~~~~~~~~~~qi  111 (332)
T cd05623          46 ACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE--------------DRLPEDMARFYLAEM  111 (332)
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhc--------------CCCCHHHHHHHHHHH
Confidence            4578899999999999999999999999999999999985 8999886421              224455677788999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccC----ccCCCcccc
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLG----LLEYSTAVD  166 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~D  166 (259)
                      +.|++|||+.+|+||||||+||+++.++ .++|+|||++........ ......||+.|+|||.+.+    ...++.++|
T Consensus       112 ~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D  190 (332)
T cd05623         112 VIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECD  190 (332)
T ss_pred             HHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCC
Confidence            9999999999999999999999999888 899999999875433222 2234579999999999863    245788999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC--ccCHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK--RITAA  244 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rp~~~  244 (259)
                      +|||||++|+|++|+.||...+.......+.........         ......+++++.+|+.+||..++++  |++++
T Consensus       191 vwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~  261 (332)
T cd05623         191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF---------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIE  261 (332)
T ss_pred             EEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC---------CCccccCCHHHHHHHHHHccChhhhcCCCCHH
Confidence            999999999999999999988877777777554322211         1223467899999999999765554  68999


Q ss_pred             HHhcCccccCCC
Q 039159          245 EALQQEYFKDVP  256 (259)
Q Consensus       245 ~~l~h~~f~~~~  256 (259)
                      ++++||||.++.
T Consensus       262 ~~~~h~~f~~~~  273 (332)
T cd05623         262 DFKQHPFFTGID  273 (332)
T ss_pred             HHhCCCCcCCCC
Confidence            999999998753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-40  Score=267.40  Aligned_cols=218  Identities=23%  Similarity=0.294  Sum_probs=170.7

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+.++++++|+||+++++++..++..++++||+++ +|...+......            .......++.++.
T Consensus        48 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~  115 (268)
T cd06624          48 YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGP------------LKDNEQTIIFYTK  115 (268)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhccc------------CCCcHHHHHHHHH
Confidence            445788999999999999999999999999999999999986 899988642111            1114556677888


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc-cCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL-LEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Diw  168 (259)
                      +++.|++|||+.+|+||||||+||+++.+...++|+|||.+..............|++.|+|||.+.+. ..++.++|+|
T Consensus       116 qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~  195 (268)
T cd06624         116 QILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIW  195 (268)
T ss_pred             HHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhH
Confidence            999999999999999999999999998744489999999987654333333444678999999998652 3477899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHH-HHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITL-GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|++++|..||......... .........+            .....+++++.+++.+||+.+|++||++.+++
T Consensus       196 slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll  263 (268)
T cd06624         196 SLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP------------EIPESLSAEAKNFILRCFEPDPDKRASAHDLL  263 (268)
T ss_pred             HHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCC------------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence            9999999999999999764332221 1111011111            11235788999999999999999999999999


Q ss_pred             cCccc
Q 039159          248 QQEYF  252 (259)
Q Consensus       248 ~h~~f  252 (259)
                      +||||
T Consensus       264 ~~~~~  268 (268)
T cd06624         264 QDPFL  268 (268)
T ss_pred             hCCCC
Confidence            99997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-41  Score=274.79  Aligned_cols=232  Identities=34%  Similarity=0.553  Sum_probs=174.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +...+.+.+|+.++++++||||+++++++.+.  +.+++||||+.+++..++........          ..+....+..
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~----------~~~~~~~~~~  112 (316)
T cd07842          43 TGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKR----------VSIPPSMVKS  112 (316)
T ss_pred             cCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCC----------cCcCHHHHHH
Confidence            45567889999999999999999999999988  78999999999988887754322111          3456677888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcC----CCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCcc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDL----DGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~----~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      ++.|++.|++|||+.+++||||||+||+++.    ++ .+||+|||++........   ......+++.|+|||.+.+..
T Consensus       113 i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  191 (316)
T cd07842         113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR  191 (316)
T ss_pred             HHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc-eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCC
Confidence            9999999999999999999999999999998    77 899999999876533222   123346788999999987755


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCChHH---------HHHHHhCCCCC------------------------Cccc
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI---------TLGRIVGKSRK------------------------PSFC  206 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~---------~~~~i~~~~~~------------------------~~~~  206 (259)
                      .++.++|+|||||++|+|++|++||.+.....         ....+......                        ...+
T Consensus       192 ~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (316)
T cd07842         192 HYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYP  271 (316)
T ss_pred             CCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCC
Confidence            67889999999999999999999997644321         11111100000                        0000


Q ss_pred             cccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccc
Q 039159          207 KLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      ..... .....+...+.++.+++.+||+.||++|||+.++++||||
T Consensus       272 ~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         272 SNSLA-KWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             CccHH-HHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00000 0001112577889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-40  Score=274.02  Aligned_cols=220  Identities=24%  Similarity=0.346  Sum_probs=176.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+.+++.++||||+++++++.+++.+|+||||+.| +|.+++....              ..+....+..++.|
T Consensus        45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~~~~~q  110 (331)
T cd05597          45 TACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE--------------DRLPEDMARFYLAE  110 (331)
T ss_pred             HHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc--------------CCCCHHHHHHHHHH
Confidence            45578899999999999999999999999999999999986 8988885421              23455667788899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccC----ccCCCccc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLG----LLEYSTAV  165 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~  165 (259)
                      ++.||+|||+++|+||||||+||+++.++ .++|+|||++........ ......||+.|+|||++.+    ...++.++
T Consensus       111 i~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  189 (331)
T cd05597         111 MVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPEC  189 (331)
T ss_pred             HHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcc
Confidence            99999999999999999999999999888 899999999876543222 2233468999999999863    23467899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC--ccCH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK--RITA  243 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rp~~  243 (259)
                      |||||||++|+|++|+.||.+.+..+....+.........         ......+++.+++++.+||..++++  |+++
T Consensus       190 DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~  260 (331)
T cd05597         190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF---------PPDVTDVSEEAKDLIRRLICSPETRLGRNGL  260 (331)
T ss_pred             eeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccC---------CCccCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            9999999999999999999988777776666543222111         1222458899999999988765444  7899


Q ss_pred             HHHhcCccccCC
Q 039159          244 AEALQQEYFKDV  255 (259)
Q Consensus       244 ~~~l~h~~f~~~  255 (259)
                      +++++||||.+.
T Consensus       261 ~~~l~hp~~~~~  272 (331)
T cd05597         261 QDFKDHPFFEGI  272 (331)
T ss_pred             HHHhcCCCCCCC
Confidence            999999999865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-40  Score=268.01  Aligned_cols=217  Identities=22%  Similarity=0.251  Sum_probs=171.8

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|+.++++++||||+++++++..++..++||||+.+ +|.+.+...               ..++......++
T Consensus        48 ~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~  112 (267)
T cd06646          48 DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT---------------GPLSELQIAYVC  112 (267)
T ss_pred             chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc---------------CCCCHHHHHHHH
Confidence            3345678999999999999999999999999999999999996 888887531               234566778889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC--ccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG--LLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D  166 (259)
                      .|++.|++|||+.+|+||||+|+||+++.++ .++|+|||.+..............|++.|+|||.+.+  ...++.++|
T Consensus       113 ~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~D  191 (267)
T cd06646         113 RETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD  191 (267)
T ss_pred             HHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhh
Confidence            9999999999999999999999999999888 7999999999865433333345568899999998853  234678999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      +|||||++|+|++|+.||...........+......+.         .......++..+.+++.+||..+|++||+++++
T Consensus       192 vws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  262 (267)
T cd06646         192 IWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP---------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL  262 (267)
T ss_pred             HHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC---------CCccccccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence            99999999999999999976544333222211111111         011123578899999999999999999999999


Q ss_pred             hcCcc
Q 039159          247 LQQEY  251 (259)
Q Consensus       247 l~h~~  251 (259)
                      ++|+|
T Consensus       263 l~~l~  267 (267)
T cd06646         263 LTHLF  267 (267)
T ss_pred             hcCCC
Confidence            99987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.9e-41  Score=272.29  Aligned_cols=226  Identities=35%  Similarity=0.557  Sum_probs=176.7

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+++++.++||||+++++++..++..++|+||+.+ +|.......               ..+....+..++.
T Consensus        43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~~  107 (286)
T cd07846          43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP---------------NGLDESRVRKYLF  107 (286)
T ss_pred             hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhcc---------------CCCCHHHHHHHHH
Confidence            456788999999999999999999999999999999999997 455444321               2356678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|++|||+.+++||||+|+||+++.++ .++|+|||++..............++..|+|||.+.+...++.++||||
T Consensus       108 ~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s  186 (286)
T cd07846         108 QILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWA  186 (286)
T ss_pred             HHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHH
Confidence            999999999999999999999999999888 8999999998765443333344567889999999876455778999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC-----------------ccccccccccccCCCCCCCHHHHHHHHhh
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP-----------------SFCKLSLRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                      ||+++|++++|.+||...........+.......                 ..+............++++..+.+++.+|
T Consensus       187 lG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  266 (286)
T cd07846         187 VGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQC  266 (286)
T ss_pred             HHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHH
Confidence            9999999999999998766554443332110000                 00000011112223457889999999999


Q ss_pred             cCcCCCCccCHHHHhcCccc
Q 039159          233 LGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      |+.+|++||++.++++||||
T Consensus       267 l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         267 LRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hcCCcccchhHHHHhcCCCC
Confidence            99999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.6e-40  Score=262.39  Aligned_cols=216  Identities=30%  Similarity=0.414  Sum_probs=181.2

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +....++.+|++++++++|+||+++++++.+.+..+++|||+++ +|.+.+.....             ..++..++..+
T Consensus        40 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~  106 (256)
T cd08221          40 EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG-------------QLFEEEMVLWY  106 (256)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccc-------------cCCCHHHHHHH
Confidence            44456788999999999999999999999999999999999986 99998864211             33566778889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.+++|||+.+++||||+|+||+++.++ .+||+|||.+..............+++.|.|||.+.+ ..++.++|+
T Consensus       107 ~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~-~~~~~~~Dv  184 (256)
T cd08221         107 LFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG-VKYNFKSDI  184 (256)
T ss_pred             HHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccccccccCCCccccCHhhcCC-CCCCCcchh
Confidence            99999999999999999999999999999888 8999999999765443333345578999999999977 457889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||+++|+|++|..||......+....+......+             ....++.++.+++.+||..+|++||++++++
T Consensus       185 ~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll  251 (256)
T cd08221         185 WALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-------------VVSVYSSELISLVHSLLQQDPEKRPTADEVL  251 (256)
T ss_pred             HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-------------CccccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence            999999999999999998877776666654332211             1145789999999999999999999999999


Q ss_pred             cCccc
Q 039159          248 QQEYF  252 (259)
Q Consensus       248 ~h~~f  252 (259)
                      +|||+
T Consensus       252 ~~~~l  256 (256)
T cd08221         252 DQPLL  256 (256)
T ss_pred             hCcCC
Confidence            99986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=267.96  Aligned_cols=230  Identities=25%  Similarity=0.335  Sum_probs=186.7

Q ss_pred             CCCCCCCCCCCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcch
Q 039159            1 MMGIHNTMEGVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus         1 ~~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      ||-|.+.......++++|++++...+ |+||++++++|+++..+|||||-+.| +|..-+...               ..
T Consensus       108 VKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~---------------~~  172 (463)
T KOG0607|consen  108 VKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR---------------KH  172 (463)
T ss_pred             hhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh---------------hh
Confidence            46677777788899999999999996 99999999999999999999999996 777777542               56


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCC--eEEEeeccccccccccC-------CCCcCCccCccc
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK--TVKVAGFGLAKSLYAYK-------GESSAEVGTHYY  149 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~--~vkl~dfg~~~~~~~~~-------~~~~~~~~~~~~  149 (259)
                      ++......+...+++||+|||.+||.||||||+|||-...+.  -|||+||.+.......+       +...+++|+-.|
T Consensus       173 F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEf  252 (463)
T KOG0607|consen  173 FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEF  252 (463)
T ss_pred             ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhh
Confidence            777888889999999999999999999999999999876542  48999999986543222       234466788899


Q ss_pred             cCcccccC----ccCCCcccchHhHHHHHHHHHhCCCCCCCCChH---------------HHHHHHhCCCCCCccccccc
Q 039159          150 KAPELLLG----LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL---------------ITLGRIVGKSRKPSFCKLSL  210 (259)
Q Consensus       150 ~aPE~~~~----~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~  210 (259)
                      ||||++.-    ...|+.++|.||||+++|-|+.|++||.+....               ..+..|..+          .
T Consensus       253 MAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG----------k  322 (463)
T KOG0607|consen  253 MAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG----------K  322 (463)
T ss_pred             cchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc----------C
Confidence            99998742    245889999999999999999999999875432               112222222          2


Q ss_pred             cccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          211 RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       211 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      .+.....|..+|.+.+++++.+|..|+.+|.++..+++|||++..
T Consensus       323 YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  323 YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence            223344567899999999999999999999999999999999865

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-40  Score=270.51  Aligned_cols=222  Identities=25%  Similarity=0.390  Sum_probs=179.4

Q ss_pred             CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159            7 TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      .+......+.+|+.+++.++|+||+++++.+..++..+++|||+++ +|.+.+..                ..+......
T Consensus        56 ~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~  119 (292)
T cd06657          56 RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH----------------TRMNEEQIA  119 (292)
T ss_pred             cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc----------------CCCCHHHHH
Confidence            3344456788999999999999999999999999999999999997 77776642                224556677


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.+++.|++|||+.|++||||+|+||+++.++ .++|+|||.+..............|++.|+|||.+.+ ..++.++
T Consensus       120 ~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~  197 (292)
T cd06657         120 AVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEV  197 (292)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceecccccccccccccCccccCHHHhcC-CCCCchh
Confidence            8889999999999999999999999999999888 8999999998755433323344568899999999876 5678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |+||+|+++|++++|..||.+.........+..... +..          ......++.+.+++.+||+.||.+||++.+
T Consensus       198 Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~----------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~  266 (292)
T cd06657         198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKL----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAE  266 (292)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-ccc----------CCcccCCHHHHHHHHHHHhCCcccCcCHHH
Confidence            999999999999999999987765554444322111 110          112357889999999999999999999999


Q ss_pred             HhcCccccCCCC
Q 039159          246 ALQQEYFKDVPG  257 (259)
Q Consensus       246 ~l~h~~f~~~~~  257 (259)
                      +++||||.....
T Consensus       267 ll~~~~~~~~~~  278 (292)
T cd06657         267 LLKHPFLAKAGP  278 (292)
T ss_pred             HhcChHHhccCC
Confidence            999999997754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=255.06  Aligned_cols=227  Identities=22%  Similarity=0.263  Sum_probs=176.2

Q ss_pred             CCCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc-----eEEEEeeeec-CCHHHHhhcCCCCCCCcccccCC
Q 039159            1 MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGI-----YLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFN   74 (259)
Q Consensus         1 ~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~   74 (259)
                      +|||...+.+..+...+||+..++++||||+++++....+.     ..|++++|+. |||.+.++..+..          
T Consensus        51 lKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~k----------  120 (302)
T KOG2345|consen   51 LKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIK----------  120 (302)
T ss_pred             hheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhc----------
Confidence            57888888888999999999999999999999999875543     4899999988 7999999765432          


Q ss_pred             CcchhHHHHHHHHHhhcccccccccCCC--ceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---------CcCC
Q 039159           75 SYSLFTTFLLVEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---------SSAE  143 (259)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~--i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---------~~~~  143 (259)
                       ...++..+++.++.++++||.+||+..  ++||||||.||+++.++ .++++|||.+....-....         -...
T Consensus       121 -g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e  198 (302)
T KOG2345|consen  121 -GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPVLMDLGSATQAPIQIEGSRQALRLQEWAEE  198 (302)
T ss_pred             -CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceEEEeccCccccceEeechHHHHHHHHHHHH
Confidence             156888999999999999999999987  99999999999999888 8999999998754221111         1122


Q ss_pred             ccCccccCcccccC--ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCC
Q 039159          144 VGTHYYKAPELLLG--LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL  221 (259)
Q Consensus       144 ~~~~~~~aPE~~~~--~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  221 (259)
                      ..|..|+|||.+.-  ....+.++|||||||+||+|+.|..||.-.         .+..........+....++. .+.+
T Consensus       199 ~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~GgSlaLAv~n~q~s~P~-~~~y  268 (302)
T KOG2345|consen  199 RCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQGGSLALAVQNAQISIPN-SSRY  268 (302)
T ss_pred             hCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcCCeEEEeeeccccccCC-CCCc
Confidence            47889999999852  345688999999999999999999999521         11111111111111111111 1348


Q ss_pred             CHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          222 EPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       222 ~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      |+.+.++|+.||++||.+||++.+++.+
T Consensus       269 se~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  269 SEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             cHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            9999999999999999999999999863

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.3e-40  Score=267.00  Aligned_cols=228  Identities=36%  Similarity=0.522  Sum_probs=170.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .....+.+|+.+++.++|+||+++++++..++..|+||||+.+++.+.+....              ..+....+..++.
T Consensus        45 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~  110 (291)
T cd07870          45 GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHP--------------GGLHPYNVRLFMF  110 (291)
T ss_pred             CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecccCCHHHHHHhCC--------------CCCCHHHHHHHHH
Confidence            34457789999999999999999999999999999999999888877764321              2233455667888


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||+.+++||||||+||+++.++ .++|+|||.++.............+++.|+|||.+.+...++.++|+||
T Consensus       111 qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s  189 (291)
T cd07870         111 QLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWG  189 (291)
T ss_pred             HHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHH
Confidence            999999999999999999999999999888 8999999998754333333344467889999999876455788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChH-HHHHHHhCCCCCC------------cccc----ccccccccCCCC--CCCHHHHHHHH
Q 039159          170 VGCIFGEMVSGKPLFPGANSL-ITLGRIVGKSRKP------------SFCK----LSLRDHLTNGFP--GLEPAGIDLIS  230 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~-~~~~~i~~~~~~~------------~~~~----~~~~~~~~~~~~--~~~~~~~~li~  230 (259)
                      ||+++|++++|..||...... +....+......|            ....    ..........+.  ..++++.+++.
T Consensus       190 lG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  269 (291)
T cd07870         190 AGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLAS  269 (291)
T ss_pred             HHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHH
Confidence            999999999999999765432 2222221100000            0000    000000000011  13678899999


Q ss_pred             hhcCcCCCCccCHHHHhcCccc
Q 039159          231 KMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       231 ~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      +|+..||.+|||+++++.||||
T Consensus       270 ~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         270 QMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             HHhCcCcccCcCHHHHhcCCCC
Confidence            9999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-40  Score=273.95  Aligned_cols=234  Identities=19%  Similarity=0.179  Sum_probs=175.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+....+.+|+++++.++||||+++++++.+++..+++|||+.+ +|.+++.....             ..+....+..+
T Consensus        40 ~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~  106 (314)
T cd08216          40 KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP-------------EGLPELAIAFI  106 (314)
T ss_pred             hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc-------------cCCCHHHHHHH
Confidence            44557899999999999999999999999999999999999995 88888864221             23455667788


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-------CCcCCccCccccCcccccCc-c
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-------ESSAEVGTHYYKAPELLLGL-L  159 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~-~  159 (259)
                      +.+++.|++|||+++|+||||||+||+++.++ .++++|||.+........       ......++..|+|||.+.+. .
T Consensus       107 ~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  185 (314)
T cd08216         107 LKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ  185 (314)
T ss_pred             HHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCC
Confidence            99999999999999999999999999999888 899999998865432211       12233567789999998652 3


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc-----ccc---------------cccccccCCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF-----CKL---------------SLRDHLTNGFP  219 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~-----~~~---------------~~~~~~~~~~~  219 (259)
                      .++.++|+|||||++|+|++|..||.....................     +..               ...........
T Consensus       186 ~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (314)
T cd08216         186 GYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTR  265 (314)
T ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhh
Confidence            4788999999999999999999999876544433322211110000     000               00000001112


Q ss_pred             CCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       220 ~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .+++++.+++.+||+.||++|||++++|+||||+.+.
T Consensus       266 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         266 TFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             HHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence            3457888999999999999999999999999999774

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.5e-40  Score=265.40  Aligned_cols=217  Identities=29%  Similarity=0.477  Sum_probs=178.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+++++.++||||+++++.+.++..+++++||+++ +|.+.+...               ..++...+..++
T Consensus        35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~   99 (262)
T cd05572          35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR---------------GLFDEYTARFYI   99 (262)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc---------------CCCCHHHHHHHH
Confidence            3456799999999999999999999999999999999999986 899888542               224566778888


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .++++|++|||+++++|+||+|+||+++.++ .++|+|||.+....... ......+++.|++||.+.+ ..++.++|+|
T Consensus       100 ~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~  176 (262)
T cd05572         100 ACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILN-KGYDFSVDYW  176 (262)
T ss_pred             HHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccc-ccccccCCcCccChhHhcC-CCCCChhhhh
Confidence            9999999999999999999999999999888 89999999997654322 2233467889999999876 5678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCC--hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC----
Q 039159          169 PVGCIFGEMVSGKPLFPGAN--SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT----  242 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----  242 (259)
                      |+|+++|++++|..||....  .......+......+..+            ...++++.++|.+||..+|++||+    
T Consensus       177 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~  244 (262)
T cd05572         177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP------------NYIDKAAKDLIKQLLRRNPEERLGNLKG  244 (262)
T ss_pred             hhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC------------cccCHHHHHHHHHHccCChhhCcCCccc
Confidence            99999999999999998766  444444444222222111            234789999999999999999999    


Q ss_pred             -HHHHhcCccccCCC
Q 039159          243 -AAEALQQEYFKDVP  256 (259)
Q Consensus       243 -~~~~l~h~~f~~~~  256 (259)
                       ++++++||||++..
T Consensus       245 ~~~~l~~~~~~~~~~  259 (262)
T cd05572         245 GIKDIKKHKWFNGFD  259 (262)
T ss_pred             CHHHHhcChhhhCCC
Confidence             99999999999763

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.2e-40  Score=263.17  Aligned_cols=214  Identities=25%  Similarity=0.404  Sum_probs=177.8

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++.+|+.++++++||||+++++++..++..++|+||+.+ +|.+.+.....             ...+..+.+.++.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~  108 (256)
T cd08218          42 EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRG-------------VLFPEDQILDWFV  108 (256)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccC-------------CCCCHHHHHHHHH
Confidence            345789999999999999999999999999999999999986 89888854211             2345567788889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|++|||+++++|+||+|+||+++.++ .++++|||.+..............|++.|+|||.+.+ ...+.++|+||
T Consensus       109 ~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~s  186 (256)
T cd08218         109 QICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN-RPYNNKSDIWA  186 (256)
T ss_pred             HHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchhhhhhccCCccccCHHHhCC-CCCCCccchhH
Confidence            999999999999999999999999999888 8999999999765433222334467889999999877 56788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      |||+++++++|+.||...........+......+             ....++.++.+++.+||+.+|++||+++++++|
T Consensus       187 lG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         187 LGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP-------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC-------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            9999999999999998877766666654433211             123578899999999999999999999999999


Q ss_pred             ccc
Q 039159          250 EYF  252 (259)
Q Consensus       250 ~~f  252 (259)
                      |||
T Consensus       254 ~~~  256 (256)
T cd08218         254 NFI  256 (256)
T ss_pred             cCC
Confidence            998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=266.65  Aligned_cols=219  Identities=26%  Similarity=0.386  Sum_probs=178.2

Q ss_pred             CCCchhHHHHHHHhhCC---CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           10 GVPSSMIREVSCLMELN---HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ...+++.+|+.++++++   |||++++++++.++...+++|||+.| +|.++++.                ..++....+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~l~~~~~~  104 (277)
T cd06917          41 DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA----------------GPIAEKYIS  104 (277)
T ss_pred             hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc----------------cCCCHHHHH
Confidence            34467889999999997   99999999999999999999999986 88887743                234556777


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.+++.|++|||+.+++||||+|+||+++.++ .++++|||.+..............|+..|+|||.+.+...++.++
T Consensus       105 ~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  183 (277)
T cd06917         105 VIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA  183 (277)
T ss_pred             HHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccch
Confidence            8889999999999999999999999999999888 899999999987654444444557889999999987645678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |+||||+++|+|++|..||.+.........+... ..+..+           ....+.++.+++.+||+.||++||++.+
T Consensus       184 Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~-----------~~~~~~~~~~~i~~~l~~~p~~R~~~~~  251 (277)
T cd06917         184 DIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLE-----------DNGYSKLLREFVAACLDEEPKERLSAEE  251 (277)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCC-----------cccCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            9999999999999999999876654433322111 111110           1136789999999999999999999999


Q ss_pred             HhcCccccCCCC
Q 039159          246 ALQQEYFKDVPG  257 (259)
Q Consensus       246 ~l~h~~f~~~~~  257 (259)
                      ++.||||+....
T Consensus       252 il~~~~~~~~~~  263 (277)
T cd06917         252 LLKSKWIKAHSK  263 (277)
T ss_pred             HhhChHhhcccc
Confidence            999999987653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.9e-40  Score=267.60  Aligned_cols=223  Identities=34%  Similarity=0.506  Sum_probs=173.1

Q ss_pred             chhHHHHHHHhhCC-CCCeeEEEEEEEeC--ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           13 SSMIREVSCLMELN-HPNIIRLMRVASQG--IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~-H~niv~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+|+.+++++. |||++++++++.++  +.+++||||+.+++.+.+....              ..++...+..++.
T Consensus        42 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--------------~~~~~~~~~~~~~  107 (282)
T cd07831          42 VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK--------------RPLPEKRVKSYMY  107 (282)
T ss_pred             hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhcc--------------CCCCHHHHHHHHH
Confidence            34568999999995 99999999999987  8899999999998888875421              2356678888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.||+|||+.+++||||+|+||+++. + .++|+|||.+....... ......+++.|+|||.+.+...++.++|+||
T Consensus       108 qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s  184 (282)
T cd07831         108 QLLKSLDHMHRNGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYSKP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWA  184 (282)
T ss_pred             HHHHHHHHHHHCCceecccCHHHEEEcC-C-CeEEEecccccccccCC-CcCCCCCCcccCChhHhhcCCCCCcchhHHH
Confidence            9999999999999999999999999998 6 89999999997654322 2233467889999998765455788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc-----------cc----ccccccccCCCCCCCHHHHHHHHhhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF-----------CK----LSLRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~-----------~~----~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                      +||++|+|++|.+||.+.+.......+......+..           ..    ......+....+.++..+.++|.+||+
T Consensus       185 lGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  264 (282)
T cd07831         185 VGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLA  264 (282)
T ss_pred             HHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhc
Confidence            999999999999999887665544433221110000           00    000001112234578999999999999


Q ss_pred             cCCCCccCHHHHhcCccc
Q 039159          235 MDPDKRITAAEALQQEYF  252 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~h~~f  252 (259)
                      .+|++||+++++++||||
T Consensus       265 ~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         265 YDPDERITAKQALRHPYF  282 (282)
T ss_pred             cCcccccCHHHHhhCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.2e-40  Score=268.53  Aligned_cols=217  Identities=22%  Similarity=0.263  Sum_probs=171.5

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEe------CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQ------GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~------~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      ....++..|+.+++++ +||||+++++++..      +...|++|||+.+ +|.+++.....             .....
T Consensus        54 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-------------~~~~~  120 (282)
T cd06636          54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-------------NALKE  120 (282)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-------------CCCCH
Confidence            3446788999999999 69999999999853      4578999999986 89888864321             22445


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC----
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG----  157 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----  157 (259)
                      ..+..++.|++.|++|||+.+++||||+|+||+++.++ .++|+|||.+..............|++.|+|||.+..    
T Consensus       121 ~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~  199 (282)
T cd06636         121 DWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP  199 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCc
Confidence            66778889999999999999999999999999999888 8999999998765433333445578999999999853    


Q ss_pred             ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      ...++.++|+|||||++|++++|..||...........+.... .+.           .....++..+.++|.+||+.||
T Consensus       200 ~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~-----------~~~~~~~~~~~~li~~cl~~~p  267 (282)
T cd06636         200 DATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPK-----------LKSKKWSKKFIDFIEGCLVKNY  267 (282)
T ss_pred             CcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC-CCC-----------CcccccCHHHHHHHHHHhCCCh
Confidence            2457789999999999999999999998765544433322111 000           1113578899999999999999


Q ss_pred             CCccCHHHHhcCccc
Q 039159          238 DKRITAAEALQQEYF  252 (259)
Q Consensus       238 ~~Rp~~~~~l~h~~f  252 (259)
                      .+||++.++++||||
T Consensus       268 ~~Rp~~~ell~~~~~  282 (282)
T cd06636         268 LSRPSTEQLLKHPFI  282 (282)
T ss_pred             hhCcCHHHHhcCCCC
Confidence            999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-40  Score=276.93  Aligned_cols=236  Identities=29%  Similarity=0.463  Sum_probs=178.4

Q ss_pred             CCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--------------ceEEEEeeeecCCHHHHhhcCCCCCCCcc
Q 039159            4 IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG--------------IYLYPVFEYQVNDLAYLLKYPKDSMNGYS   69 (259)
Q Consensus         4 ~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~   69 (259)
                      +........+.+.+|++++++++||||+++++++...              ...|+||||+.++|.+.+..         
T Consensus        38 i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---------  108 (342)
T cd07854          38 IVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ---------  108 (342)
T ss_pred             EecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHc---------
Confidence            3333444556788999999999999999999877654              35799999999888887743         


Q ss_pred             cccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccC
Q 039159           70 TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGT  146 (259)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~  146 (259)
                             ..+.......++.|+++|+.|||+.|++||||||+||+++.++..++++|||.+........   ......++
T Consensus       109 -------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  181 (342)
T cd07854         109 -------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT  181 (342)
T ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccccccc
Confidence                   23455677888999999999999999999999999999986655799999999976532211   11223578


Q ss_pred             ccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc----------------cccc
Q 039159          147 HYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC----------------KLSL  210 (259)
Q Consensus       147 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~----------------~~~~  210 (259)
                      ..|+|||.+.+...++.++|||||||++|++++|+.||...+.......+......+...                ....
T Consensus       182 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (342)
T cd07854         182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEP  261 (342)
T ss_pred             ccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhccccc
Confidence            899999987654567889999999999999999999998777665555443322111000                0000


Q ss_pred             cccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          211 RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       211 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ........+.++.++.+|+.+||+.||.+|||++++++||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         262 RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             CCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            011112234688999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4e-40  Score=273.33  Aligned_cols=227  Identities=35%  Similarity=0.584  Sum_probs=179.2

Q ss_pred             hhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhccc
Q 039159           14 SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDS   93 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (259)
                      .+.+|+++++.++||||+++++++..++..+++|||+.|+|.+.+...               ..++......++.|++.
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---------------~~~~~~~~~~~~~ql~~  130 (335)
T PTZ00024         66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRK---------------IRLTESQVKCILLQILN  130 (335)
T ss_pred             hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccccCHHHHHHhc---------------CCCCHHHHHHHHHHHHH
Confidence            578999999999999999999999999999999999999998888531               33556778889999999


Q ss_pred             ccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccc--------------cCCCCcCCccCccccCcccccCcc
Q 039159           94 SRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA--------------YKGESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        94 ~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~--------------~~~~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      |++|||+.+++||||+|+||+++.++ .++|+|||.+.....              .........+++.|+|||.+.+..
T Consensus       131 aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  209 (335)
T PTZ00024        131 GLNVLHKWYFMHRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE  209 (335)
T ss_pred             HHHHHHhCCeecccccHHHeEECCCC-CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC
Confidence            99999999999999999999999888 899999999875531              111122335688899999997755


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc---cccc-----------ccccccCCCCCCCHHH
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF---CKLS-----------LRDHLTNGFPGLEPAG  225 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~-----------~~~~~~~~~~~~~~~~  225 (259)
                      .++.++|+|||||++|++++|.+||.+.........+......+..   +...           ............++.+
T Consensus       210 ~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (335)
T PTZ00024        210 KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDA  289 (335)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHH
Confidence            5788999999999999999999999988776655554332211111   1000           0001111234568899


Q ss_pred             HHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          226 IDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       226 ~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .+++.+||+.+|++||++++++.||||++..
T Consensus       290 ~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        290 IDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999764

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.2e-40  Score=270.18  Aligned_cols=226  Identities=22%  Similarity=0.287  Sum_probs=173.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++.+|++++++++||||+++++++..++..++||||+.| +|.+.+...               ..+.......++.
T Consensus        42 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~---------------~~~~~~~~~~~~~  106 (308)
T cd06615          42 IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---------------GRIPENILGKISI  106 (308)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            345688999999999999999999999999999999999986 898888542               2244566778899


Q ss_pred             hcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++++|++|||+ .+++||||||+||+++.++ .++|+|||.+.....  .......|++.|+|||.+.+ ..++.++|+|
T Consensus       107 ~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Diw  182 (308)
T cd06615         107 AVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQG-THYTVQSDIW  182 (308)
T ss_pred             HHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCcccccc--cccccCCCCcCccChhHhcC-CCCCccchHH
Confidence            99999999997 6999999999999999888 899999999865422  22344578899999999876 5678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc------c----------------ccccccCC--CCCCCHH
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL------S----------------LRDHLTNG--FPGLEPA  224 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~------~----------------~~~~~~~~--~~~~~~~  224 (259)
                      |||+++|++++|+.||...+....................      .                ......+.  ...++.+
T Consensus       183 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (308)
T cd06615         183 SLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDE  262 (308)
T ss_pred             HHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHH
Confidence            9999999999999999765533322222111000000000      0                00000000  1136788


Q ss_pred             HHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          225 GIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       225 ~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      +.+++.+||..||++||+++++++||||...
T Consensus       263 ~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         263 FQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            9999999999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.3e-40  Score=267.01  Aligned_cols=221  Identities=23%  Similarity=0.294  Sum_probs=173.9

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeC-----ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQG-----IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~-----~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      .....+.+|+.+++++ +|||++++++++...     ...++||||+.| +|.++++.....           ...+...
T Consensus        60 ~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-----------~~~~~~~  128 (291)
T cd06639          60 DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-----------GQRLDEA  128 (291)
T ss_pred             cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhc-----------CCCCCHH
Confidence            3446778999999999 799999999998754     368999999986 888887532111           0335567


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCcc---
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL---  159 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---  159 (259)
                      .+..++.+++.|++|||+.+++||||||+||+++.++ .++|+|||.+..............|+..|+|||.+....   
T Consensus       129 ~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  207 (291)
T cd06639         129 MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYD  207 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcc
Confidence            7888999999999999999999999999999999888 799999999876543333334456888999999986422   


Q ss_pred             -CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          160 -EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       160 -~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                       .++.++|+|||||++|++++|++||...........+..... +..          ......+..+.+++.+||+.+|+
T Consensus       208 ~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~----------~~~~~~~~~l~~li~~~l~~~p~  276 (291)
T cd06639         208 YSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP-PTL----------LHPEKWCRSFNHFISQCLIKDFE  276 (291)
T ss_pred             cccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC-CCC----------CcccccCHHHHHHHHHHhhcChh
Confidence             357899999999999999999999988766555554432211 110          01124667899999999999999


Q ss_pred             CccCHHHHhcCcccc
Q 039159          239 KRITAAEALQQEYFK  253 (259)
Q Consensus       239 ~Rp~~~~~l~h~~f~  253 (259)
                      +||++.++++||||+
T Consensus       277 ~Rps~~~il~~~~~~  291 (291)
T cd06639         277 ARPSVTHLLEHPFIK  291 (291)
T ss_pred             hCcCHHHHhcCcccC
Confidence            999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.6e-40  Score=267.08  Aligned_cols=214  Identities=25%  Similarity=0.339  Sum_probs=172.0

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ..+.+|+.++++++|+||+++++.+.+++..++||||+.| +|...+.....             ..+....++.++.|+
T Consensus        45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-------------~~l~~~~~~~~~~qi  111 (285)
T cd05630          45 SMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGE-------------AGFEEGRAVFYAAEI  111 (285)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcc-------------cCCCHHHHHHHHHHH
Confidence            4577899999999999999999999999999999999986 88887743211             235566778889999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      +.|+.|||+.+++||||||+||+++.++ .++|+|||++...... .......|++.|+|||.+.+ ..++.++|+||+|
T Consensus       112 ~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG  188 (285)
T cd05630         112 CCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALG  188 (285)
T ss_pred             HHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCC-ccccCCCCCccccChHHHcC-CCCCCccccHHHH
Confidence            9999999999999999999999999888 8999999998754322 12233478999999999987 5688999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHH---HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----H
Q 039159          172 CIFGEMVSGKPLFPGANSLI---TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----A  243 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~  243 (259)
                      +++|+|++|+.||.......   ......... .            ......+++++.+|+.+||+.||.+||+     +
T Consensus       189 ~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  255 (285)
T cd05630         189 CLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-Q------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGA  255 (285)
T ss_pred             HHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-h------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCch
Confidence            99999999999998654321   111111100 0            0112357889999999999999999999     9


Q ss_pred             HHHhcCccccCC
Q 039159          244 AEALQQEYFKDV  255 (259)
Q Consensus       244 ~~~l~h~~f~~~  255 (259)
                      +++++||||+..
T Consensus       256 ~~~~~h~~~~~~  267 (285)
T cd05630         256 REVKEHPLFKQI  267 (285)
T ss_pred             HHHHcChhhhcc
Confidence            999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.6e-40  Score=262.62  Aligned_cols=212  Identities=23%  Similarity=0.349  Sum_probs=168.9

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEe--CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .+.+.+|+.++++++||||+++++++..  +..+++++||+.+ +|.+.+...               ..+.....+.++
T Consensus        48 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~  112 (266)
T cd06651          48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY---------------GALTESVTRKYT  112 (266)
T ss_pred             HHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHHH
Confidence            3468899999999999999999999875  3678999999986 898888532               223455667788


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC---CCCcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK---GESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .+++.|++|||+.+++||||+|+||+++.++ .++|+|||++.......   .......++..|+|||.+.+ ..++.++
T Consensus       113 ~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~  190 (266)
T cd06651         113 RQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKA  190 (266)
T ss_pred             HHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCccccccccccCCccccCCccccccCHHHhCC-CCCCchh
Confidence            9999999999999999999999999999888 89999999987543211   11223457889999999977 5678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |+|||||++|++++|+.||...........+......+..            ...+++.+.+++ .||..+|++||++++
T Consensus       191 Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~li-~~~~~~p~~Rp~~~e  257 (266)
T cd06651         191 DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL------------PSHISEHARDFL-GCIFVEARHRPSAEE  257 (266)
T ss_pred             hhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCC------------chhcCHHHHHHH-HHhcCChhhCcCHHH
Confidence            9999999999999999999876655544444332222221            124678888998 577789999999999


Q ss_pred             HhcCcccc
Q 039159          246 ALQQEYFK  253 (259)
Q Consensus       246 ~l~h~~f~  253 (259)
                      +++||||+
T Consensus       258 il~hp~~~  265 (266)
T cd06651         258 LLRHPFAQ  265 (266)
T ss_pred             HhcCcccc
Confidence            99999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=238.37  Aligned_cols=239  Identities=35%  Similarity=0.547  Sum_probs=195.9

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            3 GIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         3 ~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      ++...++.++....+||-+|+.|+|.|||+++++.-.++.+.+|+|||..+|..+.....              ..+...
T Consensus        36 rlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdqdlkkyfdsln--------------g~~d~~  101 (292)
T KOG0662|consen   36 RLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLN--------------GDLDPE  101 (292)
T ss_pred             eccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcC--------------CcCCHH
Confidence            455677899999999999999999999999999999999999999999999988886554              334556


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .....+.|+++||.|+|++++.|||+||+|.+|+.+| .+|++|||+++-+.-...+-+...-|.+|++|+++.+..-|+
T Consensus       102 ~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-elkladfglarafgipvrcysaevvtlwyrppdvlfgakly~  180 (292)
T KOG0662|consen  102 IVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS  180 (292)
T ss_pred             HHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhc
Confidence            6677888999999999999999999999999999999 899999999987644444556667799999999999877799


Q ss_pred             cccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCcccccccccc---------------ccCCCCCCCHHHH
Q 039159          163 TAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDH---------------LTNGFPGLEPAGI  226 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~  226 (259)
                      .+-|+||-||++.|+.. |++.|++.+-..+..+|....-.|.-...+....               +....+.+...-+
T Consensus       181 tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~gr  260 (292)
T KOG0662|consen  181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGR  260 (292)
T ss_pred             cchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhH
Confidence            99999999999999986 7899999988888877744332222211111111               1111244566778


Q ss_pred             HHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          227 DLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       227 ~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |++.+.|.-+|.+|.+++++|+||||...+
T Consensus       261 dllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  261 DLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             HHHHHHhccCcccccCHHHHhcCccccccC
Confidence            999999999999999999999999998764

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=267.48  Aligned_cols=222  Identities=23%  Similarity=0.361  Sum_probs=189.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+||.++.+++.|+||++||.|.....+|+|||||. |+..+.++-..              ..+....+..++.
T Consensus        71 DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~--------------K~L~E~EIs~iL~  136 (502)
T KOG0574|consen   71 DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR--------------KPLSEQEISAVLR  136 (502)
T ss_pred             hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhc--------------CCccHHHHHHHHH
Confidence            34668899999999999999999999998899999999998 79999986532              5677788899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      .-+.||.|||...-+|||||.-|||++-+| ..||+|||.+-.+...-....+.+|||.|+|||++.. ..|+..+||||
T Consensus       137 ~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWS  214 (502)
T KOG0574|consen  137 DTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEE-IGYDTKADIWS  214 (502)
T ss_pred             HHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHHhhCccccCcccccHHHHHH-hccchhhhHhh
Confidence            999999999999999999999999999999 9999999999877665556778899999999999987 56899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      ||++..||+.|++||.+-.+.....-|- ....|.+.          .....|.++-||+++||..+|++|-|+-++++|
T Consensus       215 LGITaIEMAEG~PPYsDIHPMRAIFMIP-T~PPPTF~----------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  215 LGITAIEMAEGRPPYSDIHPMRAIFMIP-TKPPPTFK----------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hcchhhhhhcCCCCcccccccceeEecc-CCCCCCCC----------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            9999999999999998876655443321 11122221          123578899999999999999999999999999


Q ss_pred             ccccCCCCCC
Q 039159          250 EYFKDVPGRS  259 (259)
Q Consensus       250 ~~f~~~~~~~  259 (259)
                      ||+++.+|-|
T Consensus       284 ~FiknA~g~~  293 (502)
T KOG0574|consen  284 TFIKNAPGCD  293 (502)
T ss_pred             hhhcCCCccc
Confidence            9999988753

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.5e-41  Score=258.87  Aligned_cols=243  Identities=33%  Similarity=0.517  Sum_probs=189.2

Q ss_pred             CCCCCCC--CCCCchhHHHHHHHhhCCCCCeeEEEEEEEe-CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcch
Q 039159            2 MGIHNTM--EGVPSSMIREVSCLMELNHPNIIRLMRVASQ-GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus         2 ~~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      |+++.++  +.+...+.+|+..++.|+||||+.+..+|.. +..+++++||++.+|.++++.-+....          ..
T Consensus        59 Kkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~----------~~  128 (438)
T KOG0666|consen   59 KKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKA----------KQ  128 (438)
T ss_pred             HHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchh----------cc
Confidence            4444443  4788889999999999999999999999987 779999999999999999987554322          34


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCC----CCeEEEeeccccccccccCCC---CcCCccCccccC
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLD----GKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKA  151 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~----~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~a  151 (259)
                      ++......++.|++.|++|||++=|+||||||.||++..+    | +|||+|+|+++.+.+....   .+..+-|.+|+|
T Consensus       129 lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG-~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRA  207 (438)
T KOG0666|consen  129 LPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERG-RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRA  207 (438)
T ss_pred             CCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccC-eeEeecccHHHHhhccccccccCCceEEEEEecC
Confidence            4556678899999999999999999999999999999877    6 8999999999987655432   345567999999


Q ss_pred             cccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCC---------hHHHHHHHhCCCCCCcccccccccccc-------
Q 039159          152 PELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN---------SLITLGRIVGKSRKPSFCKLSLRDHLT-------  215 (259)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~-------  215 (259)
                      ||.+.|...|+.+.|+||.||++.|++|-++.|.+..         ......+|..-.-.|...+.+.....+       
T Consensus       208 PELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls  287 (438)
T KOG0666|consen  208 PELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLS  287 (438)
T ss_pred             hHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHH
Confidence            9999998899999999999999999999999887532         123333443322222222211111110       


Q ss_pred             ----CCC------------CCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          216 ----NGF------------PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       216 ----~~~------------~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                          ...            ..-++...+|+.+||.+||.+|.|++++|+|+||...
T Consensus       288 ~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  288 DFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             HhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence                111            1235568899999999999999999999999999976

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.8e-40  Score=264.37  Aligned_cols=215  Identities=24%  Similarity=0.353  Sum_probs=176.3

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|++++++++||||+++++++.+++..++||||+.| +|.+.++.                ..+...+...++.+
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~----------------~~l~~~~~~~~~~~  109 (277)
T cd06640          46 IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA----------------GPFDEFQIATMLKE  109 (277)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc----------------CCCCHHHHHHHHHH
Confidence            45788999999999999999999999999999999999986 88888753                22344566778889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||+.+++|+||+|+||+++.++ .++++|||.+..............++..|+|||.+.+ ...+.++|+|||
T Consensus       110 l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~sl  187 (277)
T cd06640         110 ILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSL  187 (277)
T ss_pred             HHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCccccccccCcccccCHhHhcc-CCCccHHHHHHH
Confidence            99999999999999999999999999888 8999999999765443333344567889999999877 567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      |+++|+|++|..||...........+.... .+            ......+..+.+++.+||+.+|++||+++++++||
T Consensus       188 G~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         188 GITAIELAKGEPPNSDMHPMRVLFLIPKNN-PP------------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             HHHHHHHHHCCCCCCCcChHhHhhhhhcCC-CC------------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence            999999999999998766554443332111 11            11234678899999999999999999999999999


Q ss_pred             cccCCCC
Q 039159          251 YFKDVPG  257 (259)
Q Consensus       251 ~f~~~~~  257 (259)
                      ||.....
T Consensus       255 ~~~~~~~  261 (277)
T cd06640         255 FIVKNAK  261 (277)
T ss_pred             Hhhhcch
Confidence            9987643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.6e-40  Score=269.53  Aligned_cols=220  Identities=28%  Similarity=0.422  Sum_probs=177.6

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .....+.+.+|+.++++++||||+++++++..++..|+|+||+++ +|...+..                ..+....+..
T Consensus        56 ~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~l~~~~~~~  119 (293)
T cd06647          56 QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------------TCMDEGQIAA  119 (293)
T ss_pred             cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh----------------cCCCHHHHHH
Confidence            334456789999999999999999999999999999999999986 88888753                2234556778


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.+++.|++|||+.+++||||+|+||+++.++ .++|+|||++..............+++.|++||.+.+ ..++.++|
T Consensus       120 i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~D  197 (293)
T cd06647         120 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVD  197 (293)
T ss_pred             HHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceecccccccccccccCChhhcCchhhcc-CCCCchhh
Confidence            899999999999999999999999999999888 8999999998765443333444568889999999876 56788999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      +||||+++|++++|+.||...+.......+.... .+..          .....++..+.+++.+||..+|++||+++++
T Consensus       198 v~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i  266 (293)
T cd06647         198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPEL----------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKEL  266 (293)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCC----------CCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999999999999999998765543332221111 1111          1123467889999999999999999999999


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      +.|+||++..
T Consensus       267 l~h~~~~~~~  276 (293)
T cd06647         267 LQHPFLKIAK  276 (293)
T ss_pred             hcCHHHhcCc
Confidence            9999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.5e-40  Score=265.85  Aligned_cols=220  Identities=23%  Similarity=0.319  Sum_probs=171.6

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEE-----eCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVAS-----QGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~-----~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      .....+.+|+.+++++ +||||+++++++.     .++.+++||||++| +|.+++......           ...+...
T Consensus        56 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~  124 (286)
T cd06638          56 DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-----------GERMEEP  124 (286)
T ss_pred             chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-----------CccccHH
Confidence            3346788999999999 6999999999884     34578999999986 888877532110           1335566


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC----c
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG----L  158 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~  158 (259)
                      .+..++.+++.|+.|||+.+++||||||+||+++.++ .++|+|||.+..............|++.|+|||.+..    .
T Consensus       125 ~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (286)
T cd06638         125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLD  203 (286)
T ss_pred             HHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhcc
Confidence            7788899999999999999999999999999999988 7999999998765433333344568999999998853    1


Q ss_pred             cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      ..++.++|+||+||++|++++|+.||...........+.... .+..          ......+..+.+++.+||+.||+
T Consensus       204 ~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~li~~~l~~~p~  272 (286)
T cd06638         204 STYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP-PPTL----------HQPELWSNEFNDFIRKCLTKDYE  272 (286)
T ss_pred             ccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-CCcc----------cCCCCcCHHHHHHHHHHccCCcc
Confidence            346789999999999999999999998766544443322111 1110          01123578899999999999999


Q ss_pred             CccCHHHHhcCccc
Q 039159          239 KRITAAEALQQEYF  252 (259)
Q Consensus       239 ~Rp~~~~~l~h~~f  252 (259)
                      +||++.++++|+||
T Consensus       273 ~Rps~~ell~~~~~  286 (286)
T cd06638         273 KRPTVSDLLQHVFI  286 (286)
T ss_pred             cCCCHHHHhhcccC
Confidence            99999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-40  Score=274.89  Aligned_cols=232  Identities=38%  Similarity=0.554  Sum_probs=185.2

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc-----eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGI-----YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ....+.+.+|+.+++.++||||+++++++...+     .+|++|||+.++|.+.+...               ..++...
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---------------~~l~~~~  104 (330)
T cd07834          40 LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSP---------------QPLTDDH  104 (330)
T ss_pred             chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCC---------------CCCCHHH
Confidence            344568999999999999999999999998775     78999999998888888532               2456677


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC---CCCcCCccCccccCcccccCccC
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK---GESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      ...++.+++.|++|||+.|++||||||+||+++.++ .++|+|||.+.......   .......+++.|+|||.+.+...
T Consensus       105 ~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  183 (330)
T cd07834         105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR  183 (330)
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccCceEeecccccccccccccccccCcCCceeeecccC
Confidence            788999999999999999999999999999999887 89999999998764432   12344567889999999987447


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc-----------------cccccccCCCCCCCH
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL-----------------SLRDHLTNGFPGLEP  223 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~  223 (259)
                      ++.++|+||+|+++|+|++|.+||.+.+.......+......+.....                 ..........+++++
T Consensus       184 ~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T cd07834         184 YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASP  263 (330)
T ss_pred             CCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCH
Confidence            889999999999999999999999988776666555432222111000                 000111222345789


Q ss_pred             HHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          224 AGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       224 ~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .+.+++.+||+.+|++||+++++++||||++..
T Consensus       264 ~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         264 EAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            999999999999999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-39  Score=261.68  Aligned_cols=221  Identities=25%  Similarity=0.356  Sum_probs=179.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|+++++.++|+||+++++.+..++..++++|++.| +|.+.++.....            ..+.......++.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~------------~~~~~~~~~~~~~  109 (267)
T cd06610          42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPR------------GGLDEAIIATVLK  109 (267)
T ss_pred             HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhccc------------CCCCHHHHHHHHH
Confidence            456788999999999999999999999999999999999986 898888642110            2355667778899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC----CcCCccCccccCcccccCccCCCccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE----SSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +++.|++|||+.|++||||+|+||+++.++ .++|+|||.+.........    .....|+..|+|||.+.....++.++
T Consensus       110 ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~  188 (267)
T cd06610         110 EVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKA  188 (267)
T ss_pred             HHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCccc
Confidence            999999999999999999999999999887 8999999998766543222    13346888999999987744678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |+||||+++|+|++|+.||...+............. +...       .......+++.+.+++.+||..||++||++++
T Consensus       189 Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  260 (267)
T cd06610         189 DIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-PSLE-------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEE  260 (267)
T ss_pred             chHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC-CCcC-------CccccccccHHHHHHHHHHcCCChhhCcCHHH
Confidence            999999999999999999988766655555443311 1110       00112367899999999999999999999999


Q ss_pred             HhcCccc
Q 039159          246 ALQQEYF  252 (259)
Q Consensus       246 ~l~h~~f  252 (259)
                      +++||||
T Consensus       261 ll~~p~~  267 (267)
T cd06610         261 LLKHKFF  267 (267)
T ss_pred             HhhCCCC
Confidence            9999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.1e-40  Score=278.74  Aligned_cols=228  Identities=31%  Similarity=0.456  Sum_probs=182.9

Q ss_pred             CCCchhHHHHHHHhhCC------CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           10 GVPSSMIREVSCLMELN------HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~------H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ..-.+...||.+|..|+      --|+|+++++|.-.+++|||+|.+.-+|+++++..+.             ..++...
T Consensus       224 ~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f-------------~Glsl~~  290 (586)
T KOG0667|consen  224 RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKF-------------RGLSLPL  290 (586)
T ss_pred             HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhhhHHHHHHhcCC-------------CCCCHHH
Confidence            33456778999999997      3589999999999999999999999999999986433             5577888


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCC-CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG-KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~-~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      +..++.|++.||.+||+.+|||.||||||||+-..+ ..|||+|||.+....+   ...+.+.+..|+|||+++| ..|+
T Consensus       291 ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q---~vytYiQSRfYRAPEVILG-lpY~  366 (586)
T KOG0667|consen  291 VRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ---RVYTYIQSRFYRAPEVILG-LPYD  366 (586)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC---cceeeeeccccccchhhcc-CCCC
Confidence            899999999999999999999999999999996533 2699999999987533   3347788999999999999 6899


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCC----------------------Cccccccc----------
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRK----------------------PSFCKLSL----------  210 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~----------------------~~~~~~~~----------  210 (259)
                      .+.|||||||++.||.+|.+.|++.+...++..|.+..-.                      +..+....          
T Consensus       367 ~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~  446 (586)
T KOG0667|consen  367 TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEV  446 (586)
T ss_pred             CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhh
Confidence            9999999999999999999999999998888887332221                      11111100          


Q ss_pred             --------cc--------cccCCCC-CCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccC
Q 039159          211 --------RD--------HLTNGFP-GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       211 --------~~--------~~~~~~~-~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                              .+        .+..... .-...+.|||.+||.+||.+|+|+.++|+||||..
T Consensus       447 ~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  447 RKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG  507 (586)
T ss_pred             hhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence                    00        0111111 12346689999999999999999999999999984

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.7e-40  Score=261.97  Aligned_cols=216  Identities=25%  Similarity=0.383  Sum_probs=178.1

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|++++++++|+||+++++.+..+...++|+||+++ +|.+.+.....             ..+.....+.++
T Consensus        41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~  107 (257)
T cd08225          41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG-------------VLFSEDQILSWF  107 (257)
T ss_pred             hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccC-------------CCCCHHHHHHHH
Confidence            3456788999999999999999999999999999999999986 89888854221             234567788889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||+.+++|+||||+||+++.++..++++|||.+..............|++.|+|||.+.+ ..++.++|+|
T Consensus       108 ~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~  186 (257)
T cd08225         108 VQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN-RPYNNKTDIW  186 (257)
T ss_pred             HHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcC-CCCCchhhHH
Confidence            999999999999999999999999999988656899999999766443333344568899999999876 4678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|++++|..||...........+......             ...+..+..+.+++.+||..+|++|||+.++++
T Consensus       187 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         187 SLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-------------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             HHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC-------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            9999999999999999877665555444432211             112457789999999999999999999999999


Q ss_pred             Cccc
Q 039159          249 QEYF  252 (259)
Q Consensus       249 h~~f  252 (259)
                      ||||
T Consensus       254 ~~~~  257 (257)
T cd08225         254 RPFL  257 (257)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-40  Score=270.01  Aligned_cols=219  Identities=30%  Similarity=0.391  Sum_probs=178.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|+++++.++||||+++++.+..++..|+||||+.| +|.+++....+             ..++......++.
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~l~~~~~~~~~~  110 (316)
T cd05574          44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG-------------KCLSEEVARFYAA  110 (316)
T ss_pred             HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCC-------------CccCHHHHHHHHH
Confidence            345688999999999999999999999999999999999986 89888853211             2345567777889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-----------------------------CC
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-----------------------------ES  140 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-----------------------------~~  140 (259)
                      |++.|++|||+.+++||||||+||+++.++ .++|+|||++........                             ..
T Consensus       111 qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (316)
T cd05574         111 EVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRS  189 (316)
T ss_pred             HHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCC
Confidence            999999999999999999999999999888 899999999865422111                             11


Q ss_pred             cCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCC
Q 039159          141 SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG  220 (259)
Q Consensus       141 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  220 (259)
                      ....|+..|+|||.+.+ ..++.++||||||+++|++++|..||.+.+.......+......  .+          ....
T Consensus       190 ~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~----------~~~~  256 (316)
T cd05574         190 NSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVT--FP----------GSPP  256 (316)
T ss_pred             CCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCcc--CC----------Cccc
Confidence            13367889999999987 56788999999999999999999999887776666555432211  10          1123


Q ss_pred             CCHHHHHHHHhhcCcCCCCccC----HHHHhcCccccCCC
Q 039159          221 LEPAGIDLISKMLGMDPDKRIT----AAEALQQEYFKDVP  256 (259)
Q Consensus       221 ~~~~~~~li~~~l~~dp~~Rp~----~~~~l~h~~f~~~~  256 (259)
                      .++.+.+++.+||..||++||+    +++++.||||++..
T Consensus       257 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         257 VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             cCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            7899999999999999999999    99999999998763

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.7e-40  Score=285.40  Aligned_cols=220  Identities=24%  Similarity=0.329  Sum_probs=179.0

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc--------eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchh
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGI--------YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLF   79 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--------~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~   79 (259)
                      +.....+.+|+.++..++|+|++++++.+...+        .+++||||+.+ +|.+.+......           ...+
T Consensus        72 ~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----------~~~l  140 (496)
T PTZ00283         72 EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-----------NRTF  140 (496)
T ss_pred             HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-----------CCCC
Confidence            334567889999999999999999998775432        36899999995 899888542211           1345


Q ss_pred             HHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccccc--CCCCcCCccCccccCcccccC
Q 039159           80 TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY--KGESSAEVGTHYYKAPELLLG  157 (259)
Q Consensus        80 ~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~  157 (259)
                      ....+..++.|++.||+|||+.+|+||||||+||+++.++ .+||+|||+++.....  ........||+.|+|||.+.+
T Consensus       141 ~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~  219 (496)
T PTZ00283        141 REHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR  219 (496)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEEEecccCeeccccccccccccccCCcceeCHHHhCC
Confidence            6677888999999999999999999999999999999888 8999999999765332  122345579999999999987


Q ss_pred             ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                       ..++.++|||||||++|++++|+.||.+.+.......+......+             ..+.+++++.+++.+||..||
T Consensus       220 -~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~L~~dP  285 (496)
T PTZ00283        220 -KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP-------------LPPSISPEMQEIVTALLSSDP  285 (496)
T ss_pred             -CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC-------------CCCCCCHHHHHHHHHHcccCh
Confidence             568899999999999999999999999887766666654432211             124678999999999999999


Q ss_pred             CCccCHHHHhcCccccC
Q 039159          238 DKRITAAEALQQEYFKD  254 (259)
Q Consensus       238 ~~Rp~~~~~l~h~~f~~  254 (259)
                      ++||++.++++|||++.
T Consensus       286 ~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        286 KRRPSSSKLLNMPICKL  302 (496)
T ss_pred             hhCcCHHHHHhCHHHHH
Confidence            99999999999999864

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.7e-40  Score=265.76  Aligned_cols=219  Identities=22%  Similarity=0.293  Sum_probs=177.0

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|++++++++|+||+++++++..++..+++|||+.+ +|...+.....             ..++...+..++.|
T Consensus        44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~q  110 (285)
T cd05632          44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-------------PGFEEERALFYAAE  110 (285)
T ss_pred             HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcC-------------CCCCHHHHHHHHHH
Confidence            34578899999999999999999999999999999999996 78777643211             24667788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|+.|||+.+|+||||||+||+++.++ .++|+|||++...... .......|++.|+|||.+.+ ..++.++|+|||
T Consensus       111 l~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~sl  187 (285)
T cd05632         111 ILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGL  187 (285)
T ss_pred             HHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCC-CcccCCCCCcCccChHHhcC-CCCCcccchHHH
Confidence            99999999999999999999999999888 8999999998654321 22234468999999999977 568899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HHH
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AAE  245 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~~  245 (259)
                      |+++|++++|..||.+.........+.......          .......+++++.+|+..||+.||++||+     +++
T Consensus       188 G~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~  257 (285)
T cd05632         188 GCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET----------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGE  257 (285)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc----------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHH
Confidence            999999999999998766554433332211110          01112457889999999999999999999     899


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      ++.|+||++..
T Consensus       258 l~~~~~~~~~~  268 (285)
T cd05632         258 VKRHPFFRNMN  268 (285)
T ss_pred             HHcChhhhcCC
Confidence            99999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.3e-39  Score=265.10  Aligned_cols=213  Identities=27%  Similarity=0.391  Sum_probs=178.1

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +..+++.+|++++++++||||+++++++.+++..++||||+.+ +|.+.+...               ..++......++
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---------------~~l~~~~~~~~~  107 (290)
T cd05580          43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS---------------GRFPEPVARFYA  107 (290)
T ss_pred             hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc---------------CCCCHHHHHHHH
Confidence            3456788999999999999999999999999999999999975 898888542               234566777888


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||+.+++||||+|+||+++.++ .++|+|||++......   .....+++.|+|||.+.+ ...+.++|+|
T Consensus       108 ~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  182 (290)
T cd05580         108 AQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILS-KGYGKAVDWW  182 (290)
T ss_pred             HHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC---CCCCCCCccccChhhhcC-CCCCccccHH
Confidence            9999999999999999999999999999888 8999999998765332   334468899999999977 4678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CH
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TA  243 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~  243 (259)
                      |||+++|+|++|+.||...........+.....  .            ....+++.+.+++.+||..||.+|+     ++
T Consensus       183 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~  248 (290)
T cd05580         183 ALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV--R------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGV  248 (290)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc--c------------CCccCCHHHHHHHHHHccCCHHHccCcccCCH
Confidence            999999999999999988775555555442211  1            1134689999999999999999999     99


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      +++++||||..+.
T Consensus       249 ~~l~~~~~~~~~~  261 (290)
T cd05580         249 NDIKNHPWFAGID  261 (290)
T ss_pred             HHHHcCcccccCC
Confidence            9999999998765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=264.57  Aligned_cols=219  Identities=22%  Similarity=0.301  Sum_probs=174.1

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCc------eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGI------YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~------~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      ..+++.+|+.+++++ +||||+++++++....      ..++||||+.+ +|.+++......           ...+...
T Consensus        45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-----------~~~~~~~  113 (275)
T cd06608          45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK-----------GKRLKEE  113 (275)
T ss_pred             hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhc-----------CCCCCHH
Confidence            456789999999999 6999999999997543      58999999996 888887542210           0345567


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc----
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL----  158 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----  158 (259)
                      .+..++.|++.|++|||+.+++||||+|+||+++.++ .++|+|||.+..............|++.|+|||.+...    
T Consensus       114 ~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  192 (275)
T cd06608         114 WIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPD  192 (275)
T ss_pred             HHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCCccceecccchhhhcCccccccccCHhHhccccccc
Confidence            7888999999999999999999999999999999888 89999999987654433344456789999999987531    


Q ss_pred             cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      ..++.++||||||+++|++++|..||...........+..... +..          .....+++++.+++.+||..||+
T Consensus       193 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~----------~~~~~~~~~~~~li~~~l~~dp~  261 (275)
T cd06608         193 ASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP-PTL----------KSPENWSKKFNDFISECLIKNYE  261 (275)
T ss_pred             CCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC-CCC----------CchhhcCHHHHHHHHHHhhcChh
Confidence            3467789999999999999999999987665555554433211 110          00123678999999999999999


Q ss_pred             CccCHHHHhcCccc
Q 039159          239 KRITAAEALQQEYF  252 (259)
Q Consensus       239 ~Rp~~~~~l~h~~f  252 (259)
                      +|||++++++|||+
T Consensus       262 ~Rpt~~~ll~~~~~  275 (275)
T cd06608         262 QRPFMEELLEHPFI  275 (275)
T ss_pred             hCcCHHHHhcCCCC
Confidence            99999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2e-40  Score=268.11  Aligned_cols=215  Identities=25%  Similarity=0.326  Sum_probs=175.1

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|++++++++||||+++++++..++..++||||+++ +|...+..                ..+....+..++
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~  107 (277)
T cd06642          44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP----------------GPLEETYIATIL  107 (277)
T ss_pred             HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc----------------CCCCHHHHHHHH
Confidence            3445788999999999999999999999999999999999996 88777742                224456677888


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|+.|||+.+++|+||+|+||+++.++ .++++|||++..............++..|+|||.+.+ ..++.++|+|
T Consensus       108 ~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~  185 (277)
T cd06642         108 REILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDFKADIW  185 (277)
T ss_pred             HHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcchhhhcccCcccccCHHHhCc-CCCchhhhHH
Confidence            9999999999999999999999999999888 8999999999765443333344568889999999977 5678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|++++|+.||...........+.... .+            ......+.++.+++.+||+.+|++||++.++++
T Consensus       186 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         186 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PP------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             HHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-CC------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999997655444333322111 11            111246788999999999999999999999999


Q ss_pred             CccccCC
Q 039159          249 QEYFKDV  255 (259)
Q Consensus       249 h~~f~~~  255 (259)
                      ||||...
T Consensus       253 ~~~~~~~  259 (277)
T cd06642         253 HKFITRY  259 (277)
T ss_pred             hHHHHHH
Confidence            9999854

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.9e-39  Score=262.67  Aligned_cols=222  Identities=21%  Similarity=0.278  Sum_probs=176.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++.+|++++++++||||+++++++..+...+++|||++| +|.+.++.......... ........+....+..++.
T Consensus        51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~  129 (280)
T cd05049          51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLK-SPDSPMGELTLSQLLQIAV  129 (280)
T ss_pred             HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhc-ccccccccccHHHHHHHHH
Confidence            346889999999999999999999999999999999999996 99999865432111110 0111224567788889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +++.|++|||+++++||||||+||+++.++ .++|+|||.+........  ......+++.|+|||.+.+ ..++.++||
T Consensus       130 ~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  207 (280)
T cd05049         130 QIASGMVYLASQHFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDV  207 (280)
T ss_pred             HHHHHHHHHhhCCeeccccccceEEEcCCC-eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhH
Confidence            999999999999999999999999999988 899999999875432211  1233345788999999987 568899999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++|+|++ |..||...........+......+             .....+..+.+++.+||+.||++||+++|+
T Consensus       208 ~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei  274 (280)
T cd05049         208 WSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ-------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDI  274 (280)
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            999999999998 999998877776666655332111             113578899999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       275 l~  276 (280)
T cd05049         275 HE  276 (280)
T ss_pred             HH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.2e-40  Score=273.12  Aligned_cols=232  Identities=22%  Similarity=0.261  Sum_probs=174.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+.+++.++||||+++++++..++..++|+||+.+ ++..++.....             ..++...+..++.
T Consensus        42 ~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~-------------~~~~~~~~~~~~~  108 (328)
T cd08226          42 HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP-------------EGMSEALIGNILF  108 (328)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcc-------------cCCCHHHHHHHHH
Confidence            346788999999999999999999999999999999999996 88888865321             2355667788999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC-------cCCccCccccCcccccCc-cCC
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES-------SAEVGTHYYKAPELLLGL-LEY  161 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~-~~~  161 (259)
                      |++.||+|||+.+++||||||+||+++.++ .++++||+.+..........       ....++..|+|||.+.+. ..+
T Consensus       109 qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  187 (328)
T cd08226         109 GALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY  187 (328)
T ss_pred             HHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCC
Confidence            999999999999999999999999999888 89999998654332211111       112345679999999753 346


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc---------------------------------c
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK---------------------------------L  208 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~---------------------------------~  208 (259)
                      +.++|||||||++|++++|+.||.+.....................                                 .
T Consensus       188 ~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (328)
T cd08226         188 NVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTM  267 (328)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccccc
Confidence            8899999999999999999999987765555444433221100000                                 0


Q ss_pred             cccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          209 SLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .......+.....++.+.+|+++||+.||++|||++++++||||+.+.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         268 TSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence            000000111224677899999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.9e-39  Score=259.24  Aligned_cols=215  Identities=29%  Similarity=0.354  Sum_probs=177.7

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|+++++.++||||+++++.+..++..++||||++| +|.+++.....             ..++...+..++
T Consensus        41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~  107 (256)
T cd08220          41 DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCN-------------SLLDEDTILHFF  107 (256)
T ss_pred             HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcc-------------cCCCHHHHHHHH
Confidence            3456789999999999999999999999999999999999986 89998864221             335566778889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.+++|||+++++||||+|+||+++.++..++++|||.+...... .......++..|+|||.+.+ ...+.++|+|
T Consensus       108 ~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~  185 (256)
T cd08220         108 VQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTVVGTPCYISPELCEG-KPYNQKSDIW  185 (256)
T ss_pred             HHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-ccccccccCCcccCchhccC-CCCCcccchH
Confidence            999999999999999999999999999876657899999999765332 22334568889999999977 5678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|++++|..||.+.+.......+...... .            .....++++.+++.+||..+|++|||++++++
T Consensus       186 slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         186 ALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-P------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-C------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            9999999999999999887766555555432211 1            11347889999999999999999999999999


Q ss_pred             Cccc
Q 039159          249 QEYF  252 (259)
Q Consensus       249 h~~f  252 (259)
                      ||||
T Consensus       253 ~p~~  256 (256)
T cd08220         253 QPIC  256 (256)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.4e-39  Score=265.61  Aligned_cols=213  Identities=25%  Similarity=0.358  Sum_probs=175.5

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      .++.+|+.+++.++||||+++++++.+++..++|+||+.|++.+.+....              ..+....+..++.|++
T Consensus        60 ~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~--------------~~l~~~~~~~~~~ql~  125 (307)
T cd06607          60 QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK--------------KPLQEVEIAAICHGAL  125 (307)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHcc--------------cCCCHHHHHHHHHHHH
Confidence            46889999999999999999999999999999999999998888775321              2345667788899999


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC--ccCCCcccchHhH
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG--LLEYSTAVDIWPV  170 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Diwsl  170 (259)
                      .|+.|||+.+++||||+|+||+++.++ .++|+|||.+....    ......+++.|+|||.+.+  ...++.++|||||
T Consensus       126 ~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~  200 (307)
T cd06607         126 QGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  200 (307)
T ss_pred             HHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecC----CCCCccCCccccCceeeeccCCCCCCcccchHHH
Confidence            999999999999999999999999888 89999999986542    2234567889999998852  2457889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      |+++|++++|++||.+.+.......+..... +...           ....++.+.+++.+||..||++||++.+++.||
T Consensus       201 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         201 GITCIELAERKPPLFNMNAMSALYHIAQNDS-PTLS-----------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             HHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-CCCC-----------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            9999999999999988776665555433211 1111           123678899999999999999999999999999


Q ss_pred             cccCCC
Q 039159          251 YFKDVP  256 (259)
Q Consensus       251 ~f~~~~  256 (259)
                      ||....
T Consensus       269 ~~~~~~  274 (307)
T cd06607         269 FVLRER  274 (307)
T ss_pred             hhcccC
Confidence            998653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-39  Score=264.68  Aligned_cols=221  Identities=29%  Similarity=0.391  Sum_probs=182.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+++++.++|+|++++++++..++..++++||+.| +|.+++....              ..++...+..++.
T Consensus        58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~l~~~~~~~i~~  123 (286)
T cd06614          58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--------------VRMNEPQIAYVCR  123 (286)
T ss_pred             hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc--------------cCCCHHHHHHHHH
Confidence            356789999999999999999999999999999999999995 9999986521              1456677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|++|||+.|++|+||+|+||+++.++ .++|+|||.+..............+++.|+|||.+.+ ..++.++|+||
T Consensus       124 ~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~s  201 (286)
T cd06614         124 EVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWS  201 (286)
T ss_pred             HHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccchhhhccccCCcccCCHhHhcC-CCCCCccccHH
Confidence            999999999999999999999999999888 8999999998755433333344567889999999876 56789999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      ||+++|++++|..||...........+...... ..          .....++..+.+++.+||+.+|.+||++.++++|
T Consensus       202 lGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         202 LGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PL----------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CC----------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            999999999999999887766555544332211 11          0113477899999999999999999999999999


Q ss_pred             ccccCCCCC
Q 039159          250 EYFKDVPGR  258 (259)
Q Consensus       250 ~~f~~~~~~  258 (259)
                      |||.....+
T Consensus       271 ~~~~~~~~~  279 (286)
T cd06614         271 PFLKKACPK  279 (286)
T ss_pred             hHhhccCch
Confidence            999986554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.2e-39  Score=260.35  Aligned_cols=211  Identities=22%  Similarity=0.349  Sum_probs=172.2

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ..+.+|++++++++|+||+++++++.+++..++++||+.| +|.+++...               ..+....+..++.++
T Consensus        47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~qi  111 (265)
T cd06631          47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF---------------GPLPEPVFCKYTKQI  111 (265)
T ss_pred             HHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc---------------CCCCHHHHHHHHHHH
Confidence            5688999999999999999999999999999999999986 888888532               224456667788999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccccc------CCCCcCCccCccccCcccccCccCCCccc
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY------KGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.|++|||+.+++|+||+|+||+++.++ .++|+|||.+......      ........|+..|+|||.+.+ ..++.++
T Consensus       112 ~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~  189 (265)
T cd06631         112 LDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKS  189 (265)
T ss_pred             HHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC-CCCcchh
Confidence            9999999999999999999999999888 8999999998754211      111223468889999999977 5678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCC-CCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGK-SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |+||||+++|++++|..||...+.......+... ...+            .....++.++.+++.+||..+|++||++.
T Consensus       190 Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~  257 (265)
T cd06631         190 DIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP------------RLPDSFSAAAIDFVTSCLTRDQHERPSAL  257 (265)
T ss_pred             hHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC------------CCCCCCCHHHHHHHHHHhcCCcccCCCHH
Confidence            9999999999999999999876655444333222 1111            11235789999999999999999999999


Q ss_pred             HHhcCccc
Q 039159          245 EALQQEYF  252 (259)
Q Consensus       245 ~~l~h~~f  252 (259)
                      ++++||||
T Consensus       258 ~~l~~~~~  265 (265)
T cd06631         258 QLLRHDFL  265 (265)
T ss_pred             HHhcCCCC
Confidence            99999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.8e-40  Score=273.10  Aligned_cols=224  Identities=33%  Similarity=0.492  Sum_probs=172.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeC------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ...++.+|+.++++++||||+++++++...      ...|+||||+.++|.+.+..                 .+....+
T Consensus        58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----------------~l~~~~~  120 (353)
T cd07850          58 HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM-----------------DLDHERM  120 (353)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhh-----------------cCCHHHH
Confidence            345678999999999999999999998644      35799999999998887742                 1445566


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||.++.... ........+++.|+|||.+.+ ..++.+
T Consensus       121 ~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~  197 (353)
T cd07850         121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKEN  197 (353)
T ss_pred             HHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccceeCCC-CCCCCCCcccccccCHHHHhC-CCCCCc
Confidence            77889999999999999999999999999999988 899999999976432 222334467889999999987 578899


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc--------------------ccccccccc---------c
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF--------------------CKLSLRDHL---------T  215 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~--------------------~~~~~~~~~---------~  215 (259)
                      +|||||||++|+|++|+.||...+.......+......+..                    .........         .
T Consensus       198 ~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (353)
T cd07850         198 VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSE  277 (353)
T ss_pred             hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccc
Confidence            99999999999999999999877665554444322211100                    000000000         0


Q ss_pred             CCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccC
Q 039159          216 NGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      ......++.++++|.+||+.||++|||+.++|+||||+.
T Consensus       278 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         278 SHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             cccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence            001234667899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=263.85  Aligned_cols=229  Identities=34%  Similarity=0.556  Sum_probs=176.7

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ....+.+.+|++++++++|+||+++++++..++..+++|||+.+++...+....              ..+....+..++
T Consensus        41 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~--------------~~~~~~~~~~~~  106 (288)
T cd07833          41 EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP--------------GGLPPDAVRSYI  106 (288)
T ss_pred             ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC--------------CCCCHHHHHHHH
Confidence            445678999999999999999999999999999999999999986665543211              234567788889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.|++|||+.+++||||+|+||+++.++ .++|+|||.+........ ......++..|+|||.+.+...++.++|+
T Consensus       107 ~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv  185 (288)
T cd07833         107 WQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDV  185 (288)
T ss_pred             HHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhH
Confidence            9999999999999999999999999999888 899999999876644332 23345678899999999874478899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCC--CC---------------ccccccccccccCCCC-CCCHHHHHHH
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSR--KP---------------SFCKLSLRDHLTNGFP-GLEPAGIDLI  229 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~--~~---------------~~~~~~~~~~~~~~~~-~~~~~~~~li  229 (259)
                      ||||+++|++++|.+||.+.........+.....  .+               ..+...........++ .+++++.+++
T Consensus       186 ~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  265 (288)
T cd07833         186 WAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFL  265 (288)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHH
Confidence            9999999999999999987665544333221100  00               0000000001111122 2488999999


Q ss_pred             HhhcCcCCCCccCHHHHhcCccc
Q 039159          230 SKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       230 ~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      .+||..+|++||+++++++||||
T Consensus       266 ~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         266 KACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             HHHhccCchhcccHHHHhcCCCC
Confidence            99999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-40  Score=273.18  Aligned_cols=230  Identities=33%  Similarity=0.521  Sum_probs=176.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeC-----ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQG-----IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ...++.+|+.+++.++||||+++++++...     ...|+++||+.++|.+.+...               ..+......
T Consensus        47 ~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---------------~~l~~~~~~  111 (337)
T cd07858          47 DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS---------------QTLSDDHCQ  111 (337)
T ss_pred             hhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcC---------------CCCCHHHHH
Confidence            345678999999999999999999988654     247999999998988887532               335567788


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.|++.|+.|||+++++||||||+||+++.++ .++|+|||++..............++..|+|||.+.+...++.++
T Consensus       112 ~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  190 (337)
T cd07858         112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAI  190 (337)
T ss_pred             HHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcc
Confidence            8999999999999999999999999999999888 899999999976543322334456788999999987544588899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc-----------------cccccccCCCCCCCHHHHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL-----------------SLRDHLTNGFPGLEPAGIDL  228 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l  228 (259)
                      |+|||||++|++++|++||.+.+.......+......+.....                 ..........+.+++.+.++
T Consensus       191 DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  270 (337)
T cd07858         191 DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDL  270 (337)
T ss_pred             cHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHH
Confidence            9999999999999999999876544333322111000000000                 00001112235688999999


Q ss_pred             HHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          229 ISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      +.+||+.+|.+||+++++++||||..+.
T Consensus       271 i~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         271 LEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            9999999999999999999999998764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.7e-39  Score=264.20  Aligned_cols=217  Identities=26%  Similarity=0.335  Sum_probs=174.5

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.+++.++||||+++++.+..++.+++||||++| +|..++...               ..+.......++.+
T Consensus        45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---------------~~~~~~~~~~~~~~  109 (305)
T cd05609          45 IQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI---------------GALPVDMARMYFAE  109 (305)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            45678999999999999999999999999999999999996 888888542               22455666778889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC---------------CCCcCCccCccccCcccc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK---------------GESSAEVGTHYYKAPELL  155 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~  155 (259)
                      ++.|++|||+.+++||||||+||+++.++ .++++|||.++......               .......++..|+|||.+
T Consensus       110 i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  188 (305)
T cd05609         110 TVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI  188 (305)
T ss_pred             HHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhc
Confidence            99999999999999999999999999888 89999999986321100               011123578889999998


Q ss_pred             cCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          156 LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      .+ ..++.++|+|||||++|++++|..||.+.........+........           .....+++.+.++|.+||+.
T Consensus       189 ~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~  256 (305)
T cd05609         189 LR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-----------EGDEALPADAQDLISRLLRQ  256 (305)
T ss_pred             cC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-----------CccccCCHHHHHHHHHHhcc
Confidence            77 5688999999999999999999999988776665555443321100           01125788999999999999


Q ss_pred             CCCCccC---HHHHhcCccccCCC
Q 039159          236 DPDKRIT---AAEALQQEYFKDVP  256 (259)
Q Consensus       236 dp~~Rp~---~~~~l~h~~f~~~~  256 (259)
                      ||++||+   +.++++||||.+.+
T Consensus       257 ~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         257 NPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             ChhhccCccCHHHHHhCccccCCC
Confidence            9999998   79999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.7e-39  Score=269.11  Aligned_cols=220  Identities=23%  Similarity=0.371  Sum_probs=176.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.+++.++|+||+++++++.+++..|+||||+.| +|.+++....              ..+.......++.|
T Consensus        45 ~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~--------------~~l~~~~~~~~~~q  110 (331)
T cd05624          45 TACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE--------------DRLPEDMARFYIAE  110 (331)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhc--------------CCCCHHHHHHHHHH
Confidence            34577899999999999999999999999999999999986 8999886421              22345566778899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCc----cCCCccc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGL----LEYSTAV  165 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~----~~~~~~~  165 (259)
                      ++.||+|||+++|+||||||+||+++.++ .+||+|||++........ ......|++.|+|||.+.+.    ..++.++
T Consensus       111 i~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  189 (331)
T cd05624         111 MVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC  189 (331)
T ss_pred             HHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcc
Confidence            99999999999999999999999999888 899999999976533222 22345699999999998642    3467899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC--ccCH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK--RITA  243 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rp~~  243 (259)
                      |+|||||++|+|++|+.||...+.......+.........         ......+++++++++.+||..++++  |+++
T Consensus       190 DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~  260 (331)
T cd05624         190 DWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF---------PSHITDVSEEAKDLIQRLICSRERRLGQNGI  260 (331)
T ss_pred             cEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC---------CCccccCCHHHHHHHHHHccCchhhcCCCCH
Confidence            9999999999999999999988777776666543322111         1223457899999999999876654  5689


Q ss_pred             HHHhcCccccCC
Q 039159          244 AEALQQEYFKDV  255 (259)
Q Consensus       244 ~~~l~h~~f~~~  255 (259)
                      +++++||||..+
T Consensus       261 ~~~~~h~~f~~~  272 (331)
T cd05624         261 EDFKKHAFFEGI  272 (331)
T ss_pred             HHHhcCCCcCCC
Confidence            999999999865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-40  Score=272.42  Aligned_cols=229  Identities=32%  Similarity=0.521  Sum_probs=174.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc-----eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGI-----YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ....++.+|+.++++++||||+++++++....     ..++++||+.+++...+..                ..+....+
T Consensus        45 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----------------~~l~~~~~  108 (336)
T cd07849          45 TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT----------------QHLSNDHI  108 (336)
T ss_pred             hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHhc----------------CCCCHHHH
Confidence            34566889999999999999999999876543     5799999999988887743                23555677


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCC
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      ..++.|++.||+|||+.+++||||||+||+++.++ .++|+|||++.........   .....|++.|+|||.+.+...+
T Consensus       109 ~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  187 (336)
T cd07849         109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGY  187 (336)
T ss_pred             HHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCC
Confidence            88899999999999999999999999999999888 8999999998765332211   1234678999999988664567


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc-----------------ccccccccCCCCCCCHH
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK-----------------LSLRDHLTNGFPGLEPA  224 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~  224 (259)
                      +.++|+||+||++|+|++|++||.+.+.......+......+....                 ...........+..+++
T Consensus       188 ~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (336)
T cd07849         188 TKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPK  267 (336)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcH
Confidence            8899999999999999999999987655443333221111110000                 00000111122456889


Q ss_pred             HHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          225 GIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       225 ~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      +.++|.+||+.||.+|||+.++++||||+..
T Consensus       268 ~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         268 ALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            9999999999999999999999999999865

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-40  Score=266.53  Aligned_cols=227  Identities=40%  Similarity=0.621  Sum_probs=180.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...++.+|++++++++||||+++++++..++..++|+||+.+++...+....              ..++...+..++.+
T Consensus        41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~--------------~~~~~~~~~~~~~~  106 (283)
T cd05118          41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ--------------RGLPESLIKSYLYQ  106 (283)
T ss_pred             hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCCCHHHHHHhhc--------------ccCCHHHHHHHHHH
Confidence            4568889999999999999999999999999999999999999888886421              23556778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||+.+++|+||+|+||+++.++ .++|+|||.+..............++..|+|||.+.+...++.++|+|||
T Consensus       107 i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~sl  185 (283)
T cd05118         107 LLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSV  185 (283)
T ss_pred             HHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHH
Confidence            99999999999999999999999999888 89999999997664433233345678889999999874468899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc----------------cccccccCCCCCCCHHHHHHHHhhcC
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL----------------SLRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                      |+++|++++|+.||...+.......+......+.....                ..........+.++.++.++|.+||.
T Consensus       186 G~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  265 (283)
T cd05118         186 GCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLH  265 (283)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhc
Confidence            99999999999999887766555444322111100000                00001112234578899999999999


Q ss_pred             cCCCCccCHHHHhcCccc
Q 039159          235 MDPDKRITAAEALQQEYF  252 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~h~~f  252 (259)
                      .||.+||++.+++.||||
T Consensus       266 ~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         266 YDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cCcccCcCHHHHhhCCCC
Confidence            999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.2e-39  Score=262.56  Aligned_cols=225  Identities=20%  Similarity=0.252  Sum_probs=176.1

Q ss_pred             CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159            7 TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      .++.....+.+|++++++++||||+++++++..++..++||||+.+ +|.+++.........  .........++...++
T Consensus        46 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~--~~~~~~~~~l~~~~~~  123 (288)
T cd05093          46 ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVL--MAEGNRPAELTQSQML  123 (288)
T ss_pred             cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCcccc--ccccCCCCCCCHHHHH
Confidence            3334456789999999999999999999999999999999999985 999988643211110  0011111347778889


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      .++.+++.|++|||++|++||||||+||+++.++ .++|+|||.++.......  ......+++.|+|||.+.+ ..++.
T Consensus       124 ~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  201 (288)
T cd05093         124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTT  201 (288)
T ss_pred             HHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCc
Confidence            9999999999999999999999999999999888 899999999975432211  1223345778999999977 56888


Q ss_pred             ccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          164 AVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       164 ~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ++|+|||||++|+|++ |.+||...........+......+             .....++++.+++.+||+.||.+|||
T Consensus       202 ~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rpt  268 (288)
T cd05093         202 ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ-------------RPRTCPKEVYDLMLGCWQREPHMRLN  268 (288)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHccCChhhCCC
Confidence            9999999999999998 899998877666665554432111             11347789999999999999999999


Q ss_pred             HHHHhc
Q 039159          243 AAEALQ  248 (259)
Q Consensus       243 ~~~~l~  248 (259)
                      +.+++.
T Consensus       269 ~~~v~~  274 (288)
T cd05093         269 IKEIHS  274 (288)
T ss_pred             HHHHHH
Confidence            999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.1e-40  Score=271.72  Aligned_cols=232  Identities=32%  Similarity=0.506  Sum_probs=178.9

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEe----CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQ----GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ....++.+|+.++++++||||+++++++..    ....++||||+.++|.+++...               ..++.....
T Consensus        46 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---------------~~~~~~~~~  110 (334)
T cd07855          46 TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD---------------QPLTEEHIR  110 (334)
T ss_pred             cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhccC---------------CCCCHHHHH
Confidence            445678899999999999999999998863    3478999999998888887531               335667788


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC----CcCCccCccccCcccccCccCC
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE----SSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      .++.+++.||+|||+++++||||||+||+++.++ .+||+|||.+.........    .....|+..|+|||.+.+...+
T Consensus       111 ~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  189 (334)
T cd07855         111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEY  189 (334)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceeecccCcCCCcccccccccccccChHHhcCCccc
Confidence            8999999999999999999999999999999988 8999999999765432221    1234688899999998664567


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc-----------------ccccccccCCCCCCCHH
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK-----------------LSLRDHLTNGFPGLEPA  224 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~  224 (259)
                      +.++|+|||||++|+|++|++||.+.+.......+......+....                 ...........+..+++
T Consensus       190 ~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (334)
T cd07855         190 TTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPE  269 (334)
T ss_pred             ccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHH
Confidence            8999999999999999999999987765544433322111110000                 00000111123457899


Q ss_pred             HHHHHHhhcCcCCCCccCHHHHhcCccccCCCC
Q 039159          225 GIDLISKMLGMDPDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       225 ~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~~  257 (259)
                      +.++|.+||+.+|++||++++++.||||.....
T Consensus       270 ~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         270 ALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence            999999999999999999999999999986643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2e-39  Score=269.39  Aligned_cols=228  Identities=37%  Similarity=0.605  Sum_probs=175.7

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeC--ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQG--IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+|+.+++++ +||||+++++++...  ..+++||||+.++|...+..                ..+.......++
T Consensus        50 ~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----------------~~~~~~~~~~i~  113 (337)
T cd07852          50 AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA----------------NILEDVHKRYIM  113 (337)
T ss_pred             hhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccccCHHHHHhc----------------CCCCHHHHHHHH
Confidence            45677899999999 999999999998653  46899999999999888753                123345666788


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-----CCCcCCccCccccCcccccCccCCCc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-----GESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      .+++.|++|||++|++||||||+||+++.++ .++|+|||.+.......     .......|++.|+|||.+.+...++.
T Consensus       114 ~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  192 (337)
T cd07852         114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTK  192 (337)
T ss_pred             HHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccc
Confidence            9999999999999999999999999999988 89999999997654322     12233468889999999876556788


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc-----------------cccccccccCCCCCCCHHHH
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC-----------------KLSLRDHLTNGFPGLEPAGI  226 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~  226 (259)
                      ++|+||||+++|++++|++||.+.........+......+...                 ............+.++.++.
T Consensus       193 ~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  272 (337)
T cd07852         193 GVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDAL  272 (337)
T ss_pred             cchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHH
Confidence            9999999999999999999998766554444332221111000                 00000112222345789999


Q ss_pred             HHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          227 DLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       227 ~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      +++.+||+.||++|||+.++++||||+...
T Consensus       273 ~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         273 DLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             HHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence            999999999999999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-39  Score=273.29  Aligned_cols=223  Identities=20%  Similarity=0.286  Sum_probs=170.0

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc--------------------
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS--------------------   69 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~--------------------   69 (259)
                      .+.+.+|+++++.+ +||||+++++++..++..++||||+.+ +|.++++..........                    
T Consensus        85 ~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (374)
T cd05106          85 REALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEK  164 (374)
T ss_pred             HHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhc
Confidence            45688999999999 899999999999999999999999995 99998865321100000                    


Q ss_pred             -----------------------------------cccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEE
Q 039159           70 -----------------------------------TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNIL  114 (259)
Q Consensus        70 -----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nil  114 (259)
                                                         .........+....++.++.+++.||+|||+++++||||||+||+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil  244 (374)
T cd05106         165 KYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVL  244 (374)
T ss_pred             ccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEE
Confidence                                               000001124667788899999999999999999999999999999


Q ss_pred             EcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHH
Q 039159          115 VDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLI  191 (259)
Q Consensus       115 i~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~  191 (259)
                      ++.++ .++|+|||+++.......  ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |+.||.......
T Consensus       245 ~~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~  322 (374)
T cd05106         245 LTDGR-VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS  322 (374)
T ss_pred             EeCCC-eEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence            99887 899999999976433211  1122235567999999976 568999999999999999997 999998765444


Q ss_pred             HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          192 TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       192 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ...........+..            ....++++.+++.+||+.||++||++.++++
T Consensus       323 ~~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         323 KFYKMVKRGYQMSR------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHcccCccC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            44343322211111            1236799999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-40  Score=269.53  Aligned_cols=218  Identities=28%  Similarity=0.399  Sum_probs=172.7

Q ss_pred             CCCCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ++.+...+.+||..|.+|+ |.+||+++|+-..++.+|+||||-..+|...++..++....              ..+..
T Consensus       399 D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~--------------~~lk~  464 (677)
T KOG0596|consen  399 DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKSIDPD--------------WFLKF  464 (677)
T ss_pred             CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccccHHHHHHhccCCCch--------------HHHHH
Confidence            4456677999999999995 99999999999999999999999888999999876554321              14556


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCc------
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGL------  158 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~------  158 (259)
                      +..|++.++.+.|.+||||-||||.|+++- .| .+||+|||+|+-+......  ....+||+-||+||.+...      
T Consensus       465 ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG-~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~  542 (677)
T KOG0596|consen  465 YWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KG-RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSREN  542 (677)
T ss_pred             HHHHHHHHHHHHHHhceeecCCCcccEEEE-ee-eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccC
Confidence            667788889999999999999999999997 55 7999999999876554332  4567899999999998631      


Q ss_pred             ----cCCCcccchHhHHHHHHHHHhCCCCCCCCChHH-HHHHHhCCCCCCccccccccccccCCCCCCCH--HHHHHHHh
Q 039159          159 ----LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI-TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP--AGIDLISK  231 (259)
Q Consensus       159 ----~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~li~~  231 (259)
                          ...+.++|||||||+||+|+.|++||....... .+..|..-.....++             .+++  ++.++++.
T Consensus       543 ~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp-------------~~~~~~~li~~mK~  609 (677)
T KOG0596|consen  543 GKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP-------------DIPENDELIDVMKC  609 (677)
T ss_pred             CCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc-------------CCCCchHHHHHHHH
Confidence                125789999999999999999999998654332 233333222222222             2222  38999999


Q ss_pred             hcCcCCCCccCHHHHhcCccccC
Q 039159          232 MLGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      ||..||++||++.++|+|||..-
T Consensus       610 CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  610 CLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             HHhcCcccCCCcHHHhcCccccc
Confidence            99999999999999999999876

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-39  Score=293.20  Aligned_cols=222  Identities=28%  Similarity=0.397  Sum_probs=174.4

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEe--CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      +.....+.+|+.++++|+||||++++++|..  ...+|+||||+.+ +|..++......           ...++...++
T Consensus        53 e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~-----------~g~L~E~~Il  121 (1021)
T PTZ00266         53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM-----------FGKIEEHAIV  121 (1021)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhc-----------cCCCCHHHHH
Confidence            3445678899999999999999999999864  3578999999995 999988642211           1346677888


Q ss_pred             HHHhhcccccccccCC-------CceeccCCCCcEEEcCCC----------------CeEEEeeccccccccccCCCCcC
Q 039159           86 EEFSSSDSSRSLSFGT-------RYIRRDLKPVNILVDLDG----------------KTVKVAGFGLAKSLYAYKGESSA  142 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~-------~i~H~dlkp~Nili~~~~----------------~~vkl~dfg~~~~~~~~~~~~~~  142 (259)
                      .++.|++.||+|||+.       +|+||||||+|||++...                ..+||+|||++...... .....
T Consensus       122 ~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s  200 (1021)
T PTZ00266        122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHS  200 (1021)
T ss_pred             HHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc-ccccc
Confidence            9999999999999984       599999999999996421                14899999999754322 22334


Q ss_pred             CccCccccCcccccCc-cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCC
Q 039159          143 EVGTHYYKAPELLLGL-LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL  221 (259)
Q Consensus       143 ~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  221 (259)
                      ..||+.|+|||++.+. ..++.++|||||||++|+|++|..||..................  .+           ....
T Consensus       201 ~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~--lp-----------i~~~  267 (1021)
T PTZ00266        201 CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPD--LP-----------IKGK  267 (1021)
T ss_pred             cCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCC--CC-----------cCCC
Confidence            5789999999998642 35788999999999999999999999876655544443322211  10           1346


Q ss_pred             CHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       222 ~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ++++.+||..||..+|.+||++.++|.||||..+
T Consensus       268 S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        268 SKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            8999999999999999999999999999999865

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.6e-39  Score=262.05  Aligned_cols=228  Identities=21%  Similarity=0.273  Sum_probs=176.7

Q ss_pred             CCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159            6 NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus         6 ~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ..++....++.+|+++++.++||||+++++++..+...+++|||+.+ +|.+++....................+....+
T Consensus        45 ~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~  124 (280)
T cd05092          45 EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM  124 (280)
T ss_pred             cCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHH
Confidence            33344456799999999999999999999999999999999999985 89998865432111111111112234677888


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCC
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      +.++.|++.|++|||+.+++||||||+||+++.++ .++|+|||++........  ......+++.|+|||.+.+ ..++
T Consensus       125 ~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  202 (280)
T cd05092         125 LAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFT  202 (280)
T ss_pred             HHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcC
Confidence            89999999999999999999999999999999888 899999999875432211  1223345678999999977 5688


Q ss_pred             cccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          163 TAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      .++|||||||++|++++ |.+||...........+...... .            ....+++.+.+++.+||..||.+||
T Consensus       203 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~li~~cl~~~P~~Rp  269 (280)
T cd05092         203 TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL-E------------RPRTCPPEVYAIMQGCWQREPQQRM  269 (280)
T ss_pred             chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccC-C------------CCCCCCHHHHHHHHHHccCChhhCC
Confidence            99999999999999998 89999877766665555433211 1            1135789999999999999999999


Q ss_pred             CHHHHhc
Q 039159          242 TAAEALQ  248 (259)
Q Consensus       242 ~~~~~l~  248 (259)
                      +++++++
T Consensus       270 ~~~~l~~  276 (280)
T cd05092         270 VIKDIHS  276 (280)
T ss_pred             CHHHHHH
Confidence            9999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7e-39  Score=258.35  Aligned_cols=216  Identities=25%  Similarity=0.437  Sum_probs=173.4

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      +.+.+|+.+++.++|||++++++++...+..++||||+.| +|.+.++..               ..+....+..++.++
T Consensus        53 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~~qi  117 (272)
T cd06629          53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY---------------GRFEEQLVRFFTEQV  117 (272)
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc---------------cCCCHHHHHHHHHHH
Confidence            4678899999999999999999999999999999999986 898888542               234455677788999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCcc-CCCcccchH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLL-EYSTAVDIW  168 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~~Diw  168 (259)
                      +.|+.|||+.+++||||+|+||+++.++ .++++|||.+........  ......|+..|+|||.+.... .++.++|+|
T Consensus       118 ~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~  196 (272)
T cd06629         118 LEGLAYLHSKGILHRDLKADNLLVDADG-ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIW  196 (272)
T ss_pred             HHHHHHHhhCCeeecCCChhhEEEcCCC-eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhH
Confidence            9999999999999999999999999888 899999999875432211  122345788999999987633 478899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|++++|..||...........+......+..+.        .....++..+.+++.+||..+|++||+++++++
T Consensus       197 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         197 SLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP--------DVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc--------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            999999999999999976665554444433222222111        122457899999999999999999999999999


Q ss_pred             Cccc
Q 039159          249 QEYF  252 (259)
Q Consensus       249 h~~f  252 (259)
                      ||||
T Consensus       269 ~~~~  272 (272)
T cd06629         269 HPFI  272 (272)
T ss_pred             CCCC
Confidence            9997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.7e-40  Score=282.38  Aligned_cols=225  Identities=21%  Similarity=0.264  Sum_probs=166.2

Q ss_pred             CchhHHHHHHHhhCCCC------CeeEEEEEEEeC-ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           12 PSSMIREVSCLMELNHP------NIIRLMRVASQG-IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~------niv~~~~~~~~~-~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ...+..|+++++.++|.      +++++++++..+ ...|+|||++.++|.+.+...               ..+....+
T Consensus       169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~---------------~~l~~~~~  233 (467)
T PTZ00284        169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH---------------GPFSHRHL  233 (467)
T ss_pred             HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEeccCCCHHHHHHHc---------------CCCCHHHH
Confidence            34566788888887654      589999998764 578999999988888887532               23555677


Q ss_pred             HHHHhhcccccccccC-CCceeccCCCCcEEEcCCCC---------------eEEEeeccccccccccCCCCcCCccCcc
Q 039159           85 VEEFSSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGK---------------TVKVAGFGLAKSLYAYKGESSAEVGTHY  148 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~---------------~vkl~dfg~~~~~~~~~~~~~~~~~~~~  148 (259)
                      ..++.|++.||+|||+ .||+||||||+|||++.++.               .+||+|||.+...   ........||+.
T Consensus       234 ~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~---~~~~~~~~gt~~  310 (467)
T PTZ00284        234 AQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE---RHSRTAIVSTRH  310 (467)
T ss_pred             HHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccC---ccccccccCCcc
Confidence            8889999999999997 69999999999999986652               4999999987532   223345679999


Q ss_pred             ccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCC-CCccc---------------------
Q 039159          149 YKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSR-KPSFC---------------------  206 (259)
Q Consensus       149 ~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~-~~~~~---------------------  206 (259)
                      |+|||.+.+ ..++.++|||||||++|||++|++||.+.+.......+..... .|...                     
T Consensus       311 Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  389 (467)
T PTZ00284        311 YRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRP  389 (467)
T ss_pred             ccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccc
Confidence            999999987 5789999999999999999999999988776554443322110 00000                     


Q ss_pred             ---cccccccccC---CCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          207 ---KLSLRDHLTN---GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       207 ---~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                         ..........   .....++.+.+||.+||++||++|||++|+|+||||.+.
T Consensus       390 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        390 CTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             cCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence               0000000000   000124667899999999999999999999999999975

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-39  Score=258.34  Aligned_cols=213  Identities=30%  Similarity=0.420  Sum_probs=174.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+++++.++||||+++++++.++..+++++||+++ +|.+.+...               ..++......++.
T Consensus        45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~  109 (258)
T cd06632          45 AVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY---------------GSFPEPVIRLYTR  109 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            456789999999999999999999999999999999999986 898888532               2244566777888


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|++|||+.+++|+||+|+||+++.++ .+||+|||.+....... ......|++.|++||.+.....++.++|+||
T Consensus       110 ~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~s  187 (258)
T cd06632         110 QILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWS  187 (258)
T ss_pred             HHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHH
Confidence            999999999999999999999999999888 89999999987653322 2344568899999999876333788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      ||+++|++++|+.||...........+......+.            ....+++++.+++.+||+.+|++||+++++++|
T Consensus       188 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         188 LGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP------------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             HHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCC------------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            99999999999999987665444444332111111            123578999999999999999999999999999


Q ss_pred             ccc
Q 039159          250 EYF  252 (259)
Q Consensus       250 ~~f  252 (259)
                      ||+
T Consensus       256 ~~~  258 (258)
T cd06632         256 PFV  258 (258)
T ss_pred             CCC
Confidence            996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=263.43  Aligned_cols=229  Identities=38%  Similarity=0.640  Sum_probs=179.2

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +.....+.+|++++++++|||++++++++..+  +..++|+||+.++|..++....              ..+....+..
T Consensus        39 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~~~~~~~~~  104 (287)
T cd07840          39 EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE--------------VKFTESQIKC  104 (287)
T ss_pred             ccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccC--------------CCCCHHHHHH
Confidence            44556788999999999999999999999887  7999999999999888885421              2456678889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      ++.+++.|++|||+.+++|+||+|+||+++.++ .++|+|||.+........ ......++..|+|||.+.+...++.++
T Consensus       105 i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~  183 (287)
T cd07840         105 YMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEV  183 (287)
T ss_pred             HHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHH
Confidence            999999999999999999999999999999988 899999999976544321 123345678899999887645678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc----------------cccccccCCCCC-CCHHHHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL----------------SLRDHLTNGFPG-LEPAGIDL  228 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------------~~~~~~~~~~~~-~~~~~~~l  228 (259)
                      ||||||+++|++++|+.||...........+......+.....                .....+...... .++.+.++
T Consensus       184 Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (287)
T cd07840         184 DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDL  263 (287)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHH
Confidence            9999999999999999999887766555544332211111000                000011112223 38899999


Q ss_pred             HHhhcCcCCCCccCHHHHhcCccc
Q 039159          229 ISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      +.+||+.+|.+||++.++++||||
T Consensus       264 i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         264 LDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             HHHHcCCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-40  Score=264.62  Aligned_cols=229  Identities=44%  Similarity=0.678  Sum_probs=181.4

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +...+.+.+|+.++++++|+|++++++++.+++..++|+||+.++|.+++....              ..++......++
T Consensus        39 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~~--------------~~~~~~~~~~~~  104 (282)
T cd07829          39 EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRP--------------GPLSPNLIKSIM  104 (282)
T ss_pred             ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCcCHHHHHHhhc--------------cCCCHHHHHHHH
Confidence            455677889999999999999999999999999999999999999999986421              235667788889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||+.+++||||+|+||+++.++ .++|+|||.+..............++..|+|||.+.+...++.++|+|
T Consensus       105 ~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~  183 (282)
T cd07829         105 YQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIW  183 (282)
T ss_pred             HHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHH
Confidence            9999999999999999999999999999888 899999999976544333333445678899999987744788899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc---------------ccccccccCCCCCCCHHHHHHHHhhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK---------------LSLRDHLTNGFPGLEPAGIDLISKML  233 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~~l  233 (259)
                      |||+++|++++|.+||...........+......+....               ..........++..+..+.+++.+||
T Consensus       184 slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  263 (282)
T cd07829         184 SVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKML  263 (282)
T ss_pred             HHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhh
Confidence            999999999999999988776555544432211110000               00000111223456889999999999


Q ss_pred             CcCCCCccCHHHHhcCccc
Q 039159          234 GMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h~~f  252 (259)
                      ..||++||++++++.||||
T Consensus       264 ~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         264 QYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCcccCCCHHHHhhCcCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.8e-39  Score=261.42  Aligned_cols=220  Identities=25%  Similarity=0.332  Sum_probs=174.8

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|++++++++||||+++++++..++..|+||||+.| +|.+.+.....             ..+....+..++.
T Consensus        36 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~  102 (277)
T cd05577          36 GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE-------------PGFPEARAIFYAA  102 (277)
T ss_pred             hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCc-------------CCCCHHHHHHHHH
Confidence            345678899999999999999999999999999999999996 89888854221             2356677788889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|+.|||+++++||||+|+||+++.++ .++|+|||.+..... ........++..|+|||.+.+ ..++.++|+||
T Consensus       103 ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s  179 (277)
T cd05577         103 QIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKG-GKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFA  179 (277)
T ss_pred             HHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhcc-CCccccccCCCCcCCHHHhcC-CCCCchhhhHH
Confidence            999999999999999999999999999888 899999999875433 222334467889999999977 45888999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CHH
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAA  244 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~  244 (259)
                      ||+++|++++|+.||...........+......          ........+++.+.+++.+||+.||.+||     +++
T Consensus       180 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  249 (277)
T cd05577         180 LGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE----------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSAD  249 (277)
T ss_pred             HHHHHHHHhhCCCCCCCCcccccHHHHHhcccc----------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHH
Confidence            999999999999999765432222222111100          00111235789999999999999999999     999


Q ss_pred             HHhcCccccCCC
Q 039159          245 EALQQEYFKDVP  256 (259)
Q Consensus       245 ~~l~h~~f~~~~  256 (259)
                      ++++||||+...
T Consensus       250 ~ll~h~~~~~~~  261 (277)
T cd05577         250 EVREHPLFKDLN  261 (277)
T ss_pred             HHHhChhhhcCC
Confidence            999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.5e-39  Score=263.23  Aligned_cols=229  Identities=34%  Similarity=0.559  Sum_probs=177.0

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc----------eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcch
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGI----------YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~----------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      +.....+.+|++++++++||||+++++++.+..          .+++|+||+.+++...+....              ..
T Consensus        47 ~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--------------~~  112 (302)
T cd07864          47 EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL--------------VH  112 (302)
T ss_pred             cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCC--------------CC
Confidence            344567789999999999999999999987654          789999999998888775321              34


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccC
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLG  157 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~  157 (259)
                      +....+..++.+++.||+|||+.+|+||||+|+||+++.++ .+||+|||.+........ ......++..|+|||.+.+
T Consensus       113 ~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  191 (302)
T cd07864         113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG  191 (302)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCcccccccccCCcccccccceeccCccChHHhcC
Confidence            56678889999999999999999999999999999999888 899999999976543221 1222346778999999876


Q ss_pred             ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC---cccccc-------------ccccccCCCCCC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP---SFCKLS-------------LRDHLTNGFPGL  221 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~-------------~~~~~~~~~~~~  221 (259)
                      ....+.++|||||||++|++++|++||...+.......+......+   ..+...             ........+..+
T Consensus       192 ~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (302)
T cd07864         192 EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI  271 (302)
T ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCC
Confidence            4557889999999999999999999998776655544443221111   111000             001111223457


Q ss_pred             CHHHHHHHHhhcCcCCCCccCHHHHhcCccc
Q 039159          222 EPAGIDLISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       222 ~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      +..+.+++.+||+.||.+||++++++.||||
T Consensus       272 ~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         272 PTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-39  Score=260.99  Aligned_cols=215  Identities=27%  Similarity=0.433  Sum_probs=172.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++.+++..++|+||+.| +|.+++...               ..+.......++.
T Consensus        46 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~  110 (268)
T cd06630          46 VVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY---------------GAFKEAVIINYTE  110 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh---------------CCCCHHHHHHHHH
Confidence            346789999999999999999999999999999999999996 898888532               2344567788899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC----CCcCCccCccccCcccccCccCCCccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG----ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      |++.|++|||++|++||||+|+||+++.++..++|+|||.+........    ......++..|+|||.+.+ ..++.++
T Consensus       111 ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~  189 (268)
T cd06630         111 QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSC  189 (268)
T ss_pred             HHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCccc
Confidence            9999999999999999999999999987765799999999876543211    1223467889999999876 5678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHH---hCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRI---VGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      |+||+|++++++++|..||...........+   ......+            .....+++++.+++.+||..+|++||+
T Consensus       190 Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~~p~~R~~  257 (268)
T cd06630         190 DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP------------SIPEHLSPGLRDVTLRCLELQPEDRPP  257 (268)
T ss_pred             chHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC------------CCchhhCHHHHHHHHHHcCCCcccCcC
Confidence            9999999999999999999754322211111   1111111            111357889999999999999999999


Q ss_pred             HHHHhcCcccc
Q 039159          243 AAEALQQEYFK  253 (259)
Q Consensus       243 ~~~~l~h~~f~  253 (259)
                      +.++++||||+
T Consensus       258 ~~~ll~~~~~~  268 (268)
T cd06630         258 SRELLKHPVFR  268 (268)
T ss_pred             HHHHhcCcccC
Confidence            99999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.1e-39  Score=263.74  Aligned_cols=228  Identities=32%  Similarity=0.514  Sum_probs=171.3

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc--------eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGI--------YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      .....+.+|++++++++||||+++++++....        ..++||||+.++|...+....              ..++.
T Consensus        53 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--------------~~~~~  118 (310)
T cd07865          53 GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKN--------------VKFTL  118 (310)
T ss_pred             CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcc--------------cCCCH
Confidence            33456678999999999999999999987653        459999999998888875321              24567


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC----CCcCCccCccccCcccccC
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG----ESSAEVGTHYYKAPELLLG  157 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~  157 (259)
                      ..+..++.|++.|++|||+++++|+||||+||+++.++ .++|+|||.+........    ......++..|+|||.+.+
T Consensus       119 ~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  197 (310)
T cd07865         119 SEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG  197 (310)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcC
Confidence            78889999999999999999999999999999999888 899999999976533221    1223457888999999876


Q ss_pred             ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhC---CCCCCccccc---ccc------c----ccc--CCCC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG---KSRKPSFCKL---SLR------D----HLT--NGFP  219 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~---~~~~~~~~~~---~~~------~----~~~--~~~~  219 (259)
                      ...++.++|+||||+++|++++|.+||.+.+.......+..   .......+..   ...      .    ...  -...
T Consensus       198 ~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  277 (310)
T cd07865         198 ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY  277 (310)
T ss_pred             CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccc
Confidence            55578899999999999999999999987765544333221   1111000000   000      0    000  0001


Q ss_pred             CCCHHHHHHHHhhcCcCCCCccCHHHHhcCccc
Q 039159          220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       220 ~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      ..++.+.++|.+||..||.+|||++++++||||
T Consensus       278 ~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         278 VKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            236788899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.7e-39  Score=260.32  Aligned_cols=224  Identities=21%  Similarity=0.245  Sum_probs=175.8

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCccc-ccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST-KNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   88 (259)
                      ...++.+|++++++++||||+++++++..++..+++|||+.+ +|.+++............ ........+....+..++
T Consensus        51 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  130 (283)
T cd05048          51 VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA  130 (283)
T ss_pred             HHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHH
Confidence            345688999999999999999999999988899999999985 899888653221110000 001111346677888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .+++.|++|||+.+++||||||+||+++.++ .++|+|||++........  ......+++.|+|||.+.+ ..++.++|
T Consensus       131 ~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sD  208 (283)
T cd05048         131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESD  208 (283)
T ss_pred             HHHHHHHHHHHhCCeeccccccceEEEcCCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhh
Confidence            9999999999999999999999999999888 899999999875432211  1233456788999999877 56889999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +|||||++||+++ |..||.+....+....+......             .....+++++.+++.+||+.||++||++.+
T Consensus       209 v~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~-------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~  275 (283)
T cd05048         209 IWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL-------------PCPEDCPARVYALMIECWNEIPARRPRFKD  275 (283)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-------------CCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999998 99999987776666555433211             112467899999999999999999999999


Q ss_pred             HhcC
Q 039159          246 ALQQ  249 (259)
Q Consensus       246 ~l~h  249 (259)
                      ++++
T Consensus       276 i~~~  279 (283)
T cd05048         276 IHTR  279 (283)
T ss_pred             HHHH
Confidence            9864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.1e-39  Score=263.90  Aligned_cols=216  Identities=25%  Similarity=0.303  Sum_probs=177.5

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...++.+|++++++++|||++++++++.+++..++||||+.|++.+.+....              ..+...++..++.+
T Consensus        68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~--------------~~l~~~~~~~i~~~  133 (317)
T cd06635          68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK--------------KPLQEVEIAAITHG  133 (317)
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhc--------------CCCCHHHHHHHHHH
Confidence            3457889999999999999999999999999999999999998887774321              33556778888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC--ccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG--LLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Diw  168 (259)
                      ++.|+.|||+.+++||||+|+||+++.++ .++|+|||.+....    ......|++.|+|||.+.+  ...++.++|+|
T Consensus       134 i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~  208 (317)
T cd06635         134 ALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIAS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVW  208 (317)
T ss_pred             HHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccC----CcccccCCccccChhhhhcCCCCCCCccccHH
Confidence            99999999999999999999999999888 89999999986432    2334568889999999842  24578899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||||++|+|++|..||...........+......+.            .....++.+.+++.+||+.+|.+||++.++++
T Consensus       209 slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  276 (317)
T cd06635         209 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK  276 (317)
T ss_pred             HHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC------------CCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence            999999999999999988766665555543322111            11346788999999999999999999999999


Q ss_pred             CccccCCCC
Q 039159          249 QEYFKDVPG  257 (259)
Q Consensus       249 h~~f~~~~~  257 (259)
                      |+|+.....
T Consensus       277 ~~~~~~~~~  285 (317)
T cd06635         277 HMFVLRERP  285 (317)
T ss_pred             ChhhhccCc
Confidence            999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.8e-39  Score=258.51  Aligned_cols=217  Identities=29%  Similarity=0.362  Sum_probs=179.7

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|++++++++|||++++++++..++..++++||+.+ +|.+.+...               ..++....+.++
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~  105 (264)
T cd06623          41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV---------------GKIPEPVLAYIA  105 (264)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc---------------CCCCHHHHHHHH
Confidence            3467899999999999999999999999999999999999995 999988642               335567788899


Q ss_pred             hhcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.|++|||+ .+++||||+|+||+++.++ .++|+|||.+..............++..|+|||.+.+ ..++.++|+
T Consensus       106 ~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv  183 (264)
T cd06623         106 RQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG-ESYSYAADI  183 (264)
T ss_pred             HHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCCCcccceeecccccCHhhhCC-CCCCchhhH
Confidence            999999999999 9999999999999999888 8999999999876544433335567889999999877 578889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCC---hHHHHHHHhCCCCCCccccccccccccCCCCC-CCHHHHHHHHhhcCcCCCCccCH
Q 039159          168 WPVGCIFGEMVSGKPLFPGAN---SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG-LEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      ||||+++|++++|..||....   .......+.... .+.            .... ++..+.+++.+||..+|++||++
T Consensus       184 ~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~~~l~~li~~~l~~~p~~R~~~  250 (264)
T cd06623         184 WSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP-PPS------------LPAEEFSPEFRDFISACLQKDPKKRPSA  250 (264)
T ss_pred             HHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC-CCC------------CCcccCCHHHHHHHHHHccCChhhCCCH
Confidence            999999999999999998763   233333333211 111            1123 78999999999999999999999


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      .++++||||+...
T Consensus       251 ~~ll~~~~~~~~~  263 (264)
T cd06623         251 AELLQHPFIKKAD  263 (264)
T ss_pred             HHHHhCHHHHhcc
Confidence            9999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.8e-39  Score=262.02  Aligned_cols=225  Identities=23%  Similarity=0.333  Sum_probs=173.0

Q ss_pred             CCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++.+|+.++.++. ||||+++++++..++..+++|||+.+++.++........          ...+.......++.
T Consensus        45 ~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~----------~~~l~~~~~~~i~~  114 (288)
T cd06616          45 EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL----------KSVIPEEILGKIAV  114 (288)
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhh----------cCCCCHHHHHHHHH
Confidence            3457889999999996 999999999999989999999999887766553211100          03355667888999


Q ss_pred             hcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc--cCCCcccc
Q 039159           90 SSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL--LEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~D  166 (259)
                      +++.|++|||+ .+++||||||+||+++.++ .++|+|||++....... ......|++.|+|||.+.+.  ..++.++|
T Consensus       115 ~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~D  192 (288)
T cd06616         115 ATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSD  192 (288)
T ss_pred             HHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHhccCC-ccccccCccCccCHHHhccccccCCcchhh
Confidence            99999999997 5999999999999999888 89999999987654322 22334678899999999764  36788999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChH-HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSL-ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +|||||++|++++|+.||...... .....+.. ...+..+        ......+++++.+|+.+||+.||++||++++
T Consensus       193 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  263 (288)
T cd06616         193 VWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILS--------NSEEREFSPSFVNFINLCLIKDESKRPKYKE  263 (288)
T ss_pred             hhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCC--------CcCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence            999999999999999999765421 22222211 1111111        0111357899999999999999999999999


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +++||||+...
T Consensus       264 i~~~~~~~~~~  274 (288)
T cd06616         264 LLEHPFIKDYE  274 (288)
T ss_pred             HhcChhhhchh
Confidence            99999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.9e-39  Score=256.20  Aligned_cols=210  Identities=24%  Similarity=0.292  Sum_probs=171.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ....++.+|+.++++++||||+++++++..++..++||||++| +|.+.+....              ..++...+..++
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~  106 (256)
T cd05114          41 MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ--------------GKLSKDMLLSMC  106 (256)
T ss_pred             ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCc--------------cCCCHHHHHHHH
Confidence            3456899999999999999999999999999999999999985 8988875321              224556778899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.|++|||+++++||||||+||+++.++ .++++|||.+......... .....++..|+|||.+.+ ..++.++|+
T Consensus       107 ~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  184 (256)
T cd05114         107 QDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDV  184 (256)
T ss_pred             HHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-Cccchhhhh
Confidence            9999999999999999999999999999888 8999999998754322111 122234567999999976 568889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|++++ |+.||...+.......+....... .            ....+..+.+++.+||+.+|++||+++++
T Consensus       185 ~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-~------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l  251 (256)
T cd05114         185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY-R------------PKLASMTVYEVMYSCWHEKPEGRPTFAEL  251 (256)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC-C------------CCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence            999999999999 899998888777777665543211 1            12356789999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       252 ~~  253 (256)
T cd05114         252 LR  253 (256)
T ss_pred             HH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-39  Score=261.44  Aligned_cols=216  Identities=26%  Similarity=0.381  Sum_probs=173.6

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ....++.+|++++++++||||+++++++..++.+++++||+.+ +|.+++....              ..++......++
T Consensus        41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~  106 (265)
T cd06605          41 AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ--------------GRIPERILGKIA  106 (265)
T ss_pred             HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc--------------CCCCHHHHHHHH
Confidence            4456789999999999999999999999999999999999995 9999886421              234456667889


Q ss_pred             hhcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.|++|||+ .+++||||||+||+++.++ .++|+|||.+.......  .....++..|+|||.+.+ ..++.++|+
T Consensus       107 ~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~--~~~~~~~~~y~~PE~~~~-~~~~~~~Dv  182 (265)
T cd06605         107 VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQG-NDYSVKSDI  182 (265)
T ss_pred             HHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHH--hhcccCChhccCHHHHcC-CCCCchhhH
Confidence            999999999999 9999999999999999988 89999999987653321  122678889999999977 578899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          168 WPVGCIFGEMVSGKPLFPGAN-----SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ||||+++|++++|..||....     .......+... ..+..+.           ..+++++.++|.+||..||++|||
T Consensus       183 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rpt  250 (265)
T cd06605         183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-PPPRLPS-----------GKFSPDFQDFVNLCLIKDPRERPS  250 (265)
T ss_pred             HHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-CCCCCCh-----------hhcCHHHHHHHHHHcCCCchhCcC
Confidence            999999999999999997542     22222222221 1111110           127889999999999999999999


Q ss_pred             HHHHhcCccccCC
Q 039159          243 AAEALQQEYFKDV  255 (259)
Q Consensus       243 ~~~~l~h~~f~~~  255 (259)
                      +.+++.||||+.-
T Consensus       251 ~~~ll~~~~~~~~  263 (265)
T cd06605         251 YKELLEHPFIKKY  263 (265)
T ss_pred             HHHHhhCchhhcc
Confidence            9999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-39  Score=263.85  Aligned_cols=218  Identities=22%  Similarity=0.301  Sum_probs=174.0

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|++++++++||||+++++++..++..++||||++| +|..++.....            ...++...+..++.+
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~------------~~~~~~~~~~~~~~~  110 (286)
T cd06622          43 FNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVA------------TEGIPEDVLRRITYA  110 (286)
T ss_pred             HHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccc------------cCCCCHHHHHHHHHH
Confidence            45788999999999999999999999999999999999997 88887753210            034667788899999


Q ss_pred             cccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc-----cCCCcc
Q 039159           91 SDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL-----LEYSTA  164 (259)
Q Consensus        91 ~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~  164 (259)
                      ++.|+.|||+ .+++||||||+||+++.++ .++|+|||.+.....  .......+++.|+|||.+.+.     ..++.+
T Consensus       111 i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~  187 (286)
T cd06622         111 VVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVA--SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQ  187 (286)
T ss_pred             HHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccC--CccccCCCccCccCcchhcCCCCCccCCCCcc
Confidence            9999999996 6999999999999999887 899999999875432  223344678899999998542     234779


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhC--CCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG--KSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      +|+|||||++|++++|..||...........+..  ....+            ...+.+++++.+++.+||+.+|++||+
T Consensus       188 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~  255 (286)
T cd06622         188 SDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP------------TLPSGYSDDAQDFVAKCLNKIPNRRPT  255 (286)
T ss_pred             cchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC------------CCCcccCHHHHHHHHHHcccCcccCCC
Confidence            9999999999999999999976544333322211  11111            112357899999999999999999999


Q ss_pred             HHHHhcCccccCCC
Q 039159          243 AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ~~~~l~h~~f~~~~  256 (259)
                      +++++.||||....
T Consensus       256 ~~~l~~~~~~~~~~  269 (286)
T cd06622         256 YAQLLEHPWLVKYK  269 (286)
T ss_pred             HHHHhcChhhhhcc
Confidence            99999999998653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.3e-38  Score=261.95  Aligned_cols=213  Identities=26%  Similarity=0.366  Sum_probs=175.8

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      ..+.+|+++++.++|||++++++++.+++..|+||||+.|++...+....              ..+....++.++.+++
T Consensus        66 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--------------~~l~~~~~~~~~~qi~  131 (313)
T cd06633          66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK--------------KPLQEVEIAAITHGAL  131 (313)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999999998888875422              2345677788899999


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC--ccCCCcccchHhH
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG--LLEYSTAVDIWPV  170 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Diwsl  170 (259)
                      .|++|||+.|++||||+|+||+++.++ .++|+|||.+...    .......|+..|+|||.+.+  ...++.++|+|||
T Consensus       132 ~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~sl  206 (313)
T cd06633         132 QGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKS----SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  206 (313)
T ss_pred             HHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCccc----CCCCCccccccccChhhccccCCCCCCchhhHHHH
Confidence            999999999999999999999999888 8999999998642    22334568889999999853  2457889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      |+++|+|++|..||...+.......+..... +..           ....++..+.+++.+||+.+|.+||++.++++||
T Consensus       207 Gvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~-----------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~  274 (313)
T cd06633         207 GITCIELAERKPPLFNMNAMSALYHIAQNDS-PTL-----------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHD  274 (313)
T ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            9999999999999988776665555543221 111           1134678899999999999999999999999999


Q ss_pred             cccCCC
Q 039159          251 YFKDVP  256 (259)
Q Consensus       251 ~f~~~~  256 (259)
                      ||+..+
T Consensus       275 ~~~~~~  280 (313)
T cd06633         275 FVRRDR  280 (313)
T ss_pred             ccCCCc
Confidence            998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.9e-39  Score=270.97  Aligned_cols=225  Identities=23%  Similarity=0.254  Sum_probs=170.9

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCc--------------------
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGY--------------------   68 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~--------------------   68 (259)
                      ..+.+.+|+++++.+ +||||+++++++..++..++||||++| +|.++++.........                    
T Consensus        81 ~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (375)
T cd05104          81 EREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREM  160 (375)
T ss_pred             HHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcc
Confidence            345788999999999 899999999999999999999999995 9999987543211000                    


Q ss_pred             ---ccc-------------------------------------cCCCcchhHHHHHHHHHhhcccccccccCCCceeccC
Q 039159           69 ---STK-------------------------------------NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDL  108 (259)
Q Consensus        69 ---~~~-------------------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dl  108 (259)
                         ...                                     .......+....+..++.+++.|++|||+++++||||
T Consensus       161 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  240 (375)
T cd05104         161 SCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDL  240 (375)
T ss_pred             cchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence               000                                     0000123566778899999999999999999999999


Q ss_pred             CCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHh-CCCCCC
Q 039159          109 KPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFP  185 (259)
Q Consensus       109 kp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~t-g~~pf~  185 (259)
                      ||+||+++.++ .+||+|||+++.......  ..+...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus       241 kp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~  318 (375)
T cd05104         241 AARNILLTHGR-ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYP  318 (375)
T ss_pred             chhhEEEECCC-cEEEecCccceeccCcccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            99999999877 899999999976533221  1122334567999999977 578899999999999999998 889998


Q ss_pred             CCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          186 GANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       186 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      .................+..            ....+.++.+++.+||+.||++||++.++++.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         319 GMPVDSKFYKMIKEGYRMLS------------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCCchHHHHHHHHhCccCCC------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            76544444443332211111            12457899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.7e-39  Score=258.56  Aligned_cols=213  Identities=22%  Similarity=0.317  Sum_probs=176.5

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.++++++||||+++++.+..++..++||||+.+ +|...+..                ..+.......++.+
T Consensus        46 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~----------------~~~~~~~~~~~~~~  109 (277)
T cd06641          46 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP----------------GPLDETQIATILRE  109 (277)
T ss_pred             HHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc----------------CCCCHHHHHHHHHH
Confidence            35688999999999999999999999999999999999996 88887742                23456777888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.++.|||+.+++|+||+|+||+++.++ .++++|||.+..............++..|+|||.+.+ ...+.++|+|||
T Consensus       110 l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~sl  187 (277)
T cd06641         110 ILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSL  187 (277)
T ss_pred             HHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccchhhhccccCCccccChhhhcc-CCCCchhhHHHH
Confidence            99999999999999999999999999888 8999999998765443333344568889999999876 567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      ||++|++++|..||...........+.... .+.            ....++.++.+++.+||+.+|.+||++.++++||
T Consensus       188 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~  254 (277)
T cd06641         188 GITAIELAKGEPPHSELHPMKVLFLIPKNN-PPT------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  254 (277)
T ss_pred             HHHHHHHHcCCCCCCccchHHHHHHHhcCC-CCC------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence            999999999999998766554444432221 111            1135788999999999999999999999999999


Q ss_pred             cccCC
Q 039159          251 YFKDV  255 (259)
Q Consensus       251 ~f~~~  255 (259)
                      ||+..
T Consensus       255 ~~~~~  259 (277)
T cd06641         255 FIVRF  259 (277)
T ss_pred             HHhhh
Confidence            99864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.4e-39  Score=264.25  Aligned_cols=228  Identities=35%  Similarity=0.576  Sum_probs=174.9

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQG--------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      .....+.+|++++++++||||+++++++.+.        ..+++|+||+.+++...+....              ..++.
T Consensus        49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~--------------~~~~~  114 (311)
T cd07866          49 GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS--------------VKLTE  114 (311)
T ss_pred             CcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccc--------------cCCCH
Confidence            3445778999999999999999999987543        3579999999988888775321              34667


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-----------CcCCccCcccc
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-----------SSAEVGTHYYK  150 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-----------~~~~~~~~~~~  150 (259)
                      ..+..++.++++||+|||+.+++||||||+||+++.++ .++|+|||++.........           .....+++.|+
T Consensus       115 ~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  193 (311)
T cd07866         115 SQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR  193 (311)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCccchhccCCCcccccCCcccccccccceeccCcC
Confidence            78889999999999999999999999999999999888 8999999998754322111           11224678899


Q ss_pred             CcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc----------------cccccccc
Q 039159          151 APELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC----------------KLSLRDHL  214 (259)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~----------------~~~~~~~~  214 (259)
                      |||.+.+...++.++|||||||++|+|++|++||.+.+.......+......+...                ........
T Consensus       194 aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (311)
T cd07866         194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL  273 (311)
T ss_pred             ChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccH
Confidence            99998764567889999999999999999999998877665554443221111000                00011112


Q ss_pred             cCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccc
Q 039159          215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       215 ~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      ...+...++.+.+++.+||..||.+|||+.+++.||||
T Consensus       274 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         274 EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            22334567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.9e-39  Score=258.56  Aligned_cols=209  Identities=19%  Similarity=0.226  Sum_probs=169.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|+.++++++||||++++|++..++..++||||+++ +|.+++....              ..++...++.++.
T Consensus        49 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~l~~~~~~~~~~  114 (266)
T cd05064          49 QRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE--------------GQLVAGQLMGMLP  114 (266)
T ss_pred             HHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC--------------CCCCHHHHHHHHH
Confidence            345788999999999999999999999999999999999996 7888775321              2355677889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.|++|||+.+++||||||+||+++.++ .++++|||.+......... .....++..|+|||.+.+ ..++.++|||
T Consensus       115 ~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  192 (266)
T cd05064         115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVW  192 (266)
T ss_pred             HHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHH
Confidence            999999999999999999999999999888 8999999987643221111 112234678999999877 5788999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++|++++ |..||.+.........+......+             ....++..+.+++.+||+.+|.+||++++++
T Consensus       193 slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~  259 (266)
T cd05064         193 SFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP-------------APRNCPNLLHQLMLDCWQKERGERPRFSQIH  259 (266)
T ss_pred             HHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence            99999999775 999999877766665554332221             1245788999999999999999999999987


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       260 ~  260 (266)
T cd05064         260 S  260 (266)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.3e-39  Score=263.70  Aligned_cols=228  Identities=21%  Similarity=0.206  Sum_probs=169.3

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCccc----ccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST----KNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~   86 (259)
                      ..++.+|++++++++||||+++++++.+.+..++||||+.+ +|.+++............    ........+.......
T Consensus        63 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (304)
T cd05096          63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLH  142 (304)
T ss_pred             HHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHH
Confidence            45688999999999999999999999999999999999986 899888543211110000    0011123456678889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ++.+++.|++|||+++++||||||+||+++.++ .+||+|||+++.......  ..+...++..|+|||.+.+ ..++.+
T Consensus       143 i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  220 (304)
T cd05096         143 VALQIASGMKYLSSLNFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTA  220 (304)
T ss_pred             HHHHHHHHHHHHHHCCccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCch
Confidence            999999999999999999999999999999888 899999999975533211  1223345778999999876 568899


Q ss_pred             cchHhHHHHHHHHHh--CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          165 VDIWPVGCIFGEMVS--GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       165 ~DiwslG~~l~e~~t--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      +||||||+++|+|++  +..||.+.........+..........      ......+..++.+.+++.+||..||++|||
T Consensus       221 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs  294 (304)
T cd05096         221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPS  294 (304)
T ss_pred             hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence            999999999999987  567887766555444332111000000      001112457789999999999999999999


Q ss_pred             HHHHh
Q 039159          243 AAEAL  247 (259)
Q Consensus       243 ~~~~l  247 (259)
                      ++++.
T Consensus       295 ~~~i~  299 (304)
T cd05096         295 FSDIH  299 (304)
T ss_pred             HHHHH
Confidence            99995

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.7e-39  Score=260.45  Aligned_cols=218  Identities=31%  Similarity=0.431  Sum_probs=179.6

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|++++++++||||+++++.+..+...|+++||+.| +|.+++...               ..+....+..++
T Consensus        35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~   99 (265)
T cd05579          35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV---------------GSLDEDVARIYI   99 (265)
T ss_pred             hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc---------------CCCCHHHHHHHH
Confidence            3456788999999999999999999999999999999999986 898888532               235566788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--------CCcCCccCccccCcccccCccC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--------ESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      .|++.||+|||+.+++||||+|+||+++.++ .++|+|||++........        ......++..|++||...+ ..
T Consensus       100 ~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~  177 (265)
T cd05579         100 AEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QG  177 (265)
T ss_pred             HHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcC-CC
Confidence            9999999999999999999999999999988 899999999875433211        2233467889999999977 45


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      .+.++|+||||+++|++++|..||...........+......+  +.          ....++.+.+++.+||+.+|++|
T Consensus       178 ~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~----------~~~~~~~~~~~i~~~l~~~p~~R  245 (265)
T cd05579         178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW--PE----------DVEVSDEAIDLISKLLVPDPEKR  245 (265)
T ss_pred             CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCC--Cc----------cccCCHHHHHHHHHHhcCCHhhc
Confidence            7889999999999999999999998877766665554422111  00          11258999999999999999999


Q ss_pred             cCH---HHHhcCccccCCC
Q 039159          241 ITA---AEALQQEYFKDVP  256 (259)
Q Consensus       241 p~~---~~~l~h~~f~~~~  256 (259)
                      ||+   .++|+||||+++.
T Consensus       246 pt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         246 LGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             CCCccHHHHhcCccccCCC
Confidence            999   9999999999763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.6e-39  Score=261.47  Aligned_cols=222  Identities=20%  Similarity=0.262  Sum_probs=173.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc-cccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS-TKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...+.+|++++++++||||+++++++..++..++||||+++ +|.+++........... .........++...++.++.
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  130 (291)
T cd05094          51 RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS  130 (291)
T ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHH
Confidence            45788999999999999999999999999999999999985 99999865321100000 00001113466788899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +++.|++|||+++++||||||+||+++.++ .++|+|||.+.......  .......+++.|+|||.+.+ ..++.++||
T Consensus       131 ~i~~al~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  208 (291)
T cd05094         131 QIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDV  208 (291)
T ss_pred             HHHHHHHHHHhCCeeecccCcceEEEccCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhH
Confidence            999999999999999999999999999888 89999999987543221  11233456788999999977 567889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|+|++ |..||...+.......+...... .            .....+..+.+++.+||+.||++||+++++
T Consensus       209 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v  275 (291)
T cd05094         209 WSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL-E------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEI  275 (291)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC-C------------CCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence            999999999999 99999887766655554332211 1            113467899999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       276 ~~  277 (291)
T cd05094         276 YK  277 (291)
T ss_pred             HH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.5e-39  Score=256.18  Aligned_cols=212  Identities=27%  Similarity=0.377  Sum_probs=174.8

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|+.+++.++||||+++++.+..++.+|++|||+++ +|.+.+.....             ..++....+.++
T Consensus        40 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~  106 (255)
T cd08219          40 SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRG-------------KLFPEDTILQWF  106 (255)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccC-------------CCCCHHHHHHHH
Confidence            3456788999999999999999999999999999999999985 88888754221             234566778889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|+.|||+++++|+||||+||+++.++ .++++|||.+..............|++.|+|||.+.+ ..++.++|+|
T Consensus       107 ~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~  184 (255)
T cd08219         107 VQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN-MPYNNKSDIW  184 (255)
T ss_pred             HHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeecccccccccccCCccccCHHHHcc-CCcCchhhhh
Confidence            9999999999999999999999999999888 8999999999766443333344568899999999977 5688899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|+|++|..||...+.......+......+             ....++..+.+++.+||+.||++||++.+++.
T Consensus       185 slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  251 (255)
T cd08219         185 SLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILS  251 (255)
T ss_pred             hhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC-------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence            99999999999999998877665555554332211             11346788999999999999999999999986


Q ss_pred             C
Q 039159          249 Q  249 (259)
Q Consensus       249 h  249 (259)
                      -
T Consensus       252 ~  252 (255)
T cd08219         252 R  252 (255)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.6e-39  Score=257.50  Aligned_cols=217  Identities=31%  Similarity=0.429  Sum_probs=176.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEe--CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ...+++.+|++++++++||||+++++++..  +...+++|||+.+ +|.+++......           ...++....+.
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~-----------~~~l~~~~~~~  109 (265)
T cd08217          41 KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE-----------RKYIEEEFIWR  109 (265)
T ss_pred             HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhc-----------ccCCCHHHHHH
Confidence            344678899999999999999999998764  4578999999986 899888643211           13456677889


Q ss_pred             HHhhccccccccc-----CCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           87 EFSSSDSSRSLSF-----GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        87 ~~~~~~~~l~~lh-----~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      ++.+++.|++|||     +.+++||||+|+||+++.++ .++++|||.+..............+++.|+|||.+.+ ..+
T Consensus       110 ~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~  187 (265)
T cd08217         110 ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH-MSY  187 (265)
T ss_pred             HHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEecccccccccCCcccccccccCCCccChhhhcC-CCC
Confidence            9999999999999     89999999999999999888 8999999999876543332445578999999999977 567


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      +.++|+||||+++|+|++|..||...+.......+.... .+            ......+..+.+++.+||+.+|++||
T Consensus       188 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~~l~~~~l~~~p~~Rp  254 (265)
T cd08217         188 DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-FR------------RIPYRYSSELNEVIKSMLNVDPDKRP  254 (265)
T ss_pred             CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC-CC------------CCccccCHHHHHHHHHHccCCcccCC
Confidence            889999999999999999999998876554444443221 11            11235789999999999999999999


Q ss_pred             CHHHHhcCccc
Q 039159          242 TAAEALQQEYF  252 (259)
Q Consensus       242 ~~~~~l~h~~f  252 (259)
                      +++++++|||+
T Consensus       255 ~~~~il~~~~~  265 (265)
T cd08217         255 STEELLQLPLI  265 (265)
T ss_pred             CHHHHhhCCCC
Confidence            99999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-38  Score=256.22  Aligned_cols=211  Identities=24%  Similarity=0.339  Sum_probs=168.9

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      +.+.+|++++++++||||+++++++.++  ..++++|||++| +|.+.+...               ..+.....+.++.
T Consensus        49 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~  113 (265)
T cd06652          49 NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY---------------GALTENVTRKYTR  113 (265)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            4678899999999999999999998764  478899999986 898887532               2234456678889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +++.|++|||+.+++|+||+|+||+++.++ .++|+|||.+........   ......|+..|+|||.+.+ ..++.++|
T Consensus       114 ~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  191 (265)
T cd06652         114 QILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKAD  191 (265)
T ss_pred             HHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCccccccccccccccccccCCCCccccChhhhcC-CCCCcchh
Confidence            999999999999999999999999999888 899999999875432111   1223457889999999977 56789999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      +|||||++|++++|+.||...........+......+..            ....+..+.+++.+|+. +|++||+++++
T Consensus       192 v~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~i~~~l~-~p~~Rp~~~~i  258 (265)
T cd06652         192 IWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVL------------PPHVSDHCRDFLKRIFV-EAKLRPSADEL  258 (265)
T ss_pred             HHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCC------------chhhCHHHHHHHHHHhc-ChhhCCCHHHH
Confidence            999999999999999999876555554444332222111            23567889999999995 99999999999


Q ss_pred             hcCcccc
Q 039159          247 LQQEYFK  253 (259)
Q Consensus       247 l~h~~f~  253 (259)
                      ++|||++
T Consensus       259 l~~~~~~  265 (265)
T cd06652         259 LRHTFVH  265 (265)
T ss_pred             hcCcccC
Confidence            9999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=299.65  Aligned_cols=224  Identities=28%  Similarity=0.408  Sum_probs=186.0

Q ss_pred             CCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            4 IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         4 ~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      |+.........+-+|..++..++|||+|++||+-...+..++.||||.| +|.++++..               ......
T Consensus      1270 iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~g---------------ri~dE~ 1334 (1509)
T KOG4645|consen 1270 IQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHG---------------RIEDEM 1334 (1509)
T ss_pred             cCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhc---------------chhhhh
Confidence            3444456667788999999999999999999999999999999999995 999999752               334555


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC----CCcCCccCccccCcccccCc
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG----ESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~  158 (259)
                      ....+..|++.|++|||++|||||||||.||+++.+| .+|++|||.|..+.+...    ......||+.|||||++.+.
T Consensus      1335 vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t 1413 (1509)
T KOG4645|consen 1335 VTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGT 1413 (1509)
T ss_pred             HHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhccc
Confidence            6667778999999999999999999999999999998 899999999988765532    23445799999999999863


Q ss_pred             --cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          159 --LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       159 --~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                        .....++||||+|||..||+||+.||...+...+..-.......|+.|.            .+|++.+|||..||..|
T Consensus      1414 ~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~------------~ls~~g~dFle~Cl~~d 1481 (1509)
T KOG4645|consen 1414 KGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE------------RLSSEGRDFLEHCLEQD 1481 (1509)
T ss_pred             ccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch------------hhhHhHHHHHHHHHhcC
Confidence              2356789999999999999999999998655544444444555565543            58999999999999999


Q ss_pred             CCCccCHHHHhcCccccCC
Q 039159          237 PDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       237 p~~Rp~~~~~l~h~~f~~~  255 (259)
                      |++|.++.++++|-|-++-
T Consensus      1482 P~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1482 PKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             chhhhHHHHHHHhhccccc
Confidence            9999999999999987754

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-39  Score=268.93  Aligned_cols=228  Identities=33%  Similarity=0.536  Sum_probs=175.8

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc------eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGI------YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      +.....+.+|++++++++||||+++++++....      ..++|+||+.++|.....                 ..+...
T Consensus        55 ~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-----------------~~~~~~  117 (342)
T cd07879          55 EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG-----------------HPLSED  117 (342)
T ss_pred             ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHHHc-----------------CCCCHH
Confidence            334566889999999999999999999987543      469999999877666542                 234456


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .+..++.+++.|++|||+.+++||||||+||+++.++ .++|+|||+++...   .......+++.|+|||.+.+...++
T Consensus       118 ~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~  193 (342)
T cd07879         118 KVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHAD---AEMTGYVVTRWYRAPEVILNWMHYN  193 (342)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCcCCC---CCCCCceeeecccChhhhcCccccC
Confidence            6778889999999999999999999999999999988 89999999987532   1223446788999999987645678


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc--cc---------------ccccccccCCCCCCCHHH
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF--CK---------------LSLRDHLTNGFPGLEPAG  225 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~--~~---------------~~~~~~~~~~~~~~~~~~  225 (259)
                      .++|+|||||++|++++|+.||.+.+.......+......+..  ..               ..........++..++.+
T Consensus       194 ~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (342)
T cd07879         194 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQA  273 (342)
T ss_pred             chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHH
Confidence            8999999999999999999999987765555444332211110  00               000011122234678899


Q ss_pred             HHHHHhhcCcCCCCccCHHHHhcCccccCCCC
Q 039159          226 IDLISKMLGMDPDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       226 ~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~~  257 (259)
                      .++|.+||+.||.+||++++++.||||.....
T Consensus       274 ~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         274 VDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            99999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.1e-39  Score=259.47  Aligned_cols=212  Identities=32%  Similarity=0.442  Sum_probs=171.3

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhccc
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDS   93 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (259)
                      ..+|+.++++++||||+++++++.++...+++||++.+ +|.+++...               ..+....+..++.+++.
T Consensus        45 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~qi~~  109 (260)
T PF00069_consen   45 NIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKN---------------KPLSEEEILKIAYQILE  109 (260)
T ss_dssp             HHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHH---------------SSBBHHHHHHHHHHHHH
T ss_pred             hhhhhhcccccccccccccccccccccccccccccccccccccccccc---------------ccccccccccccccccc
Confidence            34599999999999999999999999999999999998 999988611               44567888999999999


Q ss_pred             ccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHHHH
Q 039159           94 SRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCI  173 (259)
Q Consensus        94 ~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~  173 (259)
                      ||++||+++++|+||||+||+++.++ .++|+|||.+..............+++.|+|||.+......+.++|+||+|++
T Consensus       110 ~L~~Lh~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i  188 (260)
T PF00069_consen  110 ALAYLHSKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGII  188 (260)
T ss_dssp             HHHHHHHTTEEESSBSGGGEEESTTS-EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999887 89999999997542333344556789999999999833678999999999999


Q ss_pred             HHHHHhCCCCCCCCChH---HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          174 FGEMVSGKPLFPGANSL---ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       174 l~e~~tg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      +|+|++|..||......   ...............          ......++.+.+++.+||+.||++||++.++++||
T Consensus       189 l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~  258 (260)
T PF00069_consen  189 LYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS----------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHP  258 (260)
T ss_dssp             HHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT----------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred             cccccccccccccccchhhhhhhhhcccccccccc----------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence            99999999999987322   222222111000000          00011238999999999999999999999999999


Q ss_pred             cc
Q 039159          251 YF  252 (259)
Q Consensus       251 ~f  252 (259)
                      ||
T Consensus       259 ~~  260 (260)
T PF00069_consen  259 WF  260 (260)
T ss_dssp             GG
T ss_pred             CC
Confidence            98

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.9e-39  Score=260.14  Aligned_cols=221  Identities=19%  Similarity=0.277  Sum_probs=172.5

Q ss_pred             CchhHHHHHH-HhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSC-LMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~-l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++..|+.+ ++.++||||+++++++..++..|++|||+.|+|.++++......           ..++...+..++.|
T Consensus        43 ~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~-----------~~~~~~~~~~~~~q  111 (283)
T cd06617          43 QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKG-----------LTIPEDILGKIAVS  111 (283)
T ss_pred             HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcccHHHHHHHhccCC-----------CCCCHHHHHHHHHH
Confidence            3466677775 66678999999999999999999999999999988886432110           34667888899999


Q ss_pred             cccccccccCC-CceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc---cCCCcccc
Q 039159           91 SDSSRSLSFGT-RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL---LEYSTAVD  166 (259)
Q Consensus        91 ~~~~l~~lh~~-~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~D  166 (259)
                      ++.|++|||++ +++||||||+||+++.++ .+||+|||.+...... .......++..|+|||.+.+.   ..++.++|
T Consensus       112 i~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~D  189 (283)
T cd06617         112 IVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSD  189 (283)
T ss_pred             HHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecccccccccc-cccccccCCccccChhhcCCcccccccCcccc
Confidence            99999999987 999999999999999888 8999999998754321 122234678899999988642   34578999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGA-NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +|||||++|+|++|+.||... ........+... ..+..+           ...+++++.+++.+||..+|++||++++
T Consensus       190 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~  257 (283)
T cd06617         190 VWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-PSPQLP-----------AEKFSPEFQDFVNKCLKKNYKERPNYPE  257 (283)
T ss_pred             chhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-CCCCCC-----------ccccCHHHHHHHHHHccCChhhCcCHHH
Confidence            999999999999999999753 223333333221 111111           1247889999999999999999999999


Q ss_pred             HhcCccccCCCC
Q 039159          246 ALQQEYFKDVPG  257 (259)
Q Consensus       246 ~l~h~~f~~~~~  257 (259)
                      +++||||+....
T Consensus       258 il~~~~~~~~~~  269 (283)
T cd06617         258 LLQHPFFELHLS  269 (283)
T ss_pred             HhcCchhhhccc
Confidence            999999997653

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-40  Score=248.36  Aligned_cols=237  Identities=32%  Similarity=0.524  Sum_probs=189.8

Q ss_pred             CCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCc
Q 039159            5 HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG--------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY   76 (259)
Q Consensus         5 ~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~   76 (259)
                      +++++..+....+|+++|..|+|+|++.++.+|...        ..+|+||.+|+.+|.-++....              
T Consensus        53 eneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~--------------  118 (376)
T KOG0669|consen   53 ENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRK--------------  118 (376)
T ss_pred             hccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCcc--------------
Confidence            567888999999999999999999999999888543        2589999999999999886532              


Q ss_pred             chhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC----CcCCccCccccCc
Q 039159           77 SLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE----SSAEVGTHYYKAP  152 (259)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~----~~~~~~~~~~~aP  152 (259)
                      ..++...+..++.++.+||.|+|...|+|||+|+.|++|++++ .++|+|||+++.+......    -...+-|.+|++|
T Consensus       119 vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGlar~fs~~~n~~kprytnrvvTLwYrpp  197 (376)
T KOG0669|consen  119 VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPP  197 (376)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeeccccccceecccccCCCCcccceeeeecCCH
Confidence            4566678888999999999999999999999999999999999 9999999999765443221    1223458999999


Q ss_pred             ccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCC--CC----Cccccccccccc--cCC-------
Q 039159          153 ELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKS--RK----PSFCKLSLRDHL--TNG-------  217 (259)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~--~~----~~~~~~~~~~~~--~~~-------  217 (259)
                      |.+.|...++++.|||+.||++.||+||++.|.+.........|...+  ..    |.....++...+  ++.       
T Consensus       198 EllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rk  277 (376)
T KOG0669|consen  198 ELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRK  277 (376)
T ss_pred             HHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhh
Confidence            999999999999999999999999999999999988887776663322  11    111122222222  110       


Q ss_pred             ----C--CCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          218 ----F--PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       218 ----~--~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                          .  -.-++++.+|+.++|..||.+|++++++|.|.||++.+
T Consensus       278 v~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  278 VKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             hhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence                0  11256888999999999999999999999999999764

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.5e-39  Score=256.34  Aligned_cols=208  Identities=16%  Similarity=0.170  Sum_probs=162.5

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ++....+.+|+.+++.++||||+++++++..+...+++|||+.+ +|..++....              ..+.......+
T Consensus        45 ~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--------------~~~~~~~~~~i  110 (262)
T cd05077          45 RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--------------DVLTTPWKFKV  110 (262)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcC--------------CCCCHHHHHHH
Confidence            44456788999999999999999999999998899999999996 6766664311              23556677889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCC------eEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK------TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~------~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      +.|++.|++|||+.+++||||||+||+++.++.      .++++|||.+.....    .....++..|+|||.+.....+
T Consensus       111 ~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~  186 (262)
T cd05077         111 AKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNL  186 (262)
T ss_pred             HHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC----cccccccccccChhhhcCCCCC
Confidence            999999999999999999999999999986551      289999999865422    2234578889999998754668


Q ss_pred             CcccchHhHHHHHHHHH-hCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          162 STAVDIWPVGCIFGEMV-SGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      +.++|||||||++|+|+ +|..||......+... ......              ......++++.+++.+||+.||.+|
T Consensus       187 ~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~--------------~~~~~~~~~~~~li~~cl~~dp~~R  251 (262)
T cd05077         187 SIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC--------------MLVTPSCKELADLMTHCMNYDPNQR  251 (262)
T ss_pred             CchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCc--------------cCCCCChHHHHHHHHHHcCCChhhC
Confidence            88999999999999998 5888887654433222 111110              0112345788999999999999999


Q ss_pred             cCHHHHhcC
Q 039159          241 ITAAEALQQ  249 (259)
Q Consensus       241 p~~~~~l~h  249 (259)
                      |++.+++++
T Consensus       252 p~~~~il~~  260 (262)
T cd05077         252 PFFRAIMRD  260 (262)
T ss_pred             cCHHHHHHh
Confidence            999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-38  Score=255.55  Aligned_cols=214  Identities=25%  Similarity=0.293  Sum_probs=174.8

Q ss_pred             CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159            7 TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ........+.+|+++++.++||||+++++++..++..++||||+++ +|.+++....+             ..+....+.
T Consensus        41 ~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~  107 (261)
T cd05148          41 DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG-------------QVLPVASLI  107 (261)
T ss_pred             cchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCC-------------CCCCHHHHH
Confidence            3333567899999999999999999999999999999999999986 99999864321             234567788


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.+++.|++|||+.+++||||+|+||+++.++ .++|+|||.+..............++..|+|||.+.+ ..++.++
T Consensus       108 ~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~  185 (261)
T cd05148         108 DMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKS  185 (261)
T ss_pred             HHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCccccccCCCCceEecCHHHHcc-CCCCchh
Confidence            8999999999999999999999999999999888 8999999999765332222233345678999999876 5678899


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |+||||+++|++++ |..||...+.......+......+             .....++.+.+++.+||+.||++|||++
T Consensus       186 DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~  252 (261)
T cd05148         186 DVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP-------------CPAKCPQEIYKIMLECWAAEPEDRPSFK  252 (261)
T ss_pred             hHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC-------------CCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            99999999999998 899998877666666555332211             1235789999999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++++
T Consensus       253 ~l~~  256 (261)
T cd05148         253 ALRE  256 (261)
T ss_pred             HHHH
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-38  Score=258.27  Aligned_cols=226  Identities=24%  Similarity=0.320  Sum_probs=173.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...++.+|++++++++||||+++++++.+.  +.+++||||++| +|.+++......           ...+.......+
T Consensus        42 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~l~~~~~~~i  110 (287)
T cd06621          42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR-----------GGRIGEKVLGKI  110 (287)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhc-----------CCCCCHHHHHHH
Confidence            456789999999999999999999998653  478999999986 888876532110           133556678889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.|++|||+.+++|+||+|+||+++.++ .++|+|||++......  ......++..|+|||.+.+ ..++.++|+
T Consensus       111 ~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~--~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv  186 (287)
T cd06621         111 AESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNS--LAGTFTGTSFYMAPERIQG-KPYSITSDV  186 (287)
T ss_pred             HHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeecccccccccc--ccccccCCccccCHHHhcC-CCCCchhhH
Confidence            99999999999999999999999999999888 8999999998754322  2223457888999999976 568889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          168 WPVGCIFGEMVSGKPLFPGAN-----SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      |||||++|+|++|..||....     .......+... ..+....     . ...-...++.+.+++.+||..+|.+|||
T Consensus       187 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt  259 (287)
T cd06621         187 WSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPELKD-----E-PGNGIKWSEEFKDFIKQCLEKDPTRRPT  259 (287)
T ss_pred             HHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-Cchhhcc-----C-CCCCCchHHHHHHHHHHHcCCCcccCCC
Confidence            999999999999999998652     22222222221 1111110     0 0000135678999999999999999999


Q ss_pred             HHHHhcCccccCCCCC
Q 039159          243 AAEALQQEYFKDVPGR  258 (259)
Q Consensus       243 ~~~~l~h~~f~~~~~~  258 (259)
                      +.++++||||++...|
T Consensus       260 ~~eil~~~~~~~~~~~  275 (287)
T cd06621         260 PWDMLEHPWIKAQMKK  275 (287)
T ss_pred             HHHHHhCccccccccc
Confidence            9999999999877654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=265.46  Aligned_cols=216  Identities=23%  Similarity=0.292  Sum_probs=163.1

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCc-eEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGI-YLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+|.+|+.++.+++|||+|+++|+|.+++ ..+||+||++ |+|.+.+.....             ..++|..+++++.
T Consensus       115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~-------------~~L~W~~R~kIa~  181 (361)
T KOG1187|consen  115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKG-------------EPLDWETRLKIAL  181 (361)
T ss_pred             hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCC-------------CCCCHHHHHHHHH
Confidence            345999999999999999999999999988 5999999999 599999865321             1568999999999


Q ss_pred             hcccccccccCC---CceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCC-ccCccccCcccccCccCCCccc
Q 039159           90 SSDSSRSLSFGT---RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        90 ~~~~~l~~lh~~---~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      ++++||+|||+.   .|+||||||+|||+|.+. .+||+|||+|+..........+. .||.+|++||++.. ...+.++
T Consensus       182 g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~Ks  259 (361)
T KOG1187|consen  182 GAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKS  259 (361)
T ss_pred             HHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCccc
Confidence            999999999974   499999999999999888 89999999996543211111222 79999999999987 5789999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCC---h--HHHH-HHHhCCCCCCccccccccccccCCCCCCC-----HHHHHHHHhhcC
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGAN---S--LITL-GRIVGKSRKPSFCKLSLRDHLTNGFPGLE-----PAGIDLISKMLG  234 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~---~--~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~li~~~l~  234 (259)
                      ||||||+++.|++||+.+.....   .  ...+ .............+.    .+..  ...+     ..+..+...|++
T Consensus       260 DVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~----~l~~--~~~~~~~~~~~~~~~a~~C~~  333 (361)
T KOG1187|consen  260 DVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP----RLKE--GEYPDEKEVKKLAELALRCLR  333 (361)
T ss_pred             ccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC----CccC--CCCChHHHHHHHHHHHHHHcC
Confidence            99999999999999998877432   1  1111 111222222221111    1110  1222     235567889999


Q ss_pred             cCCCCccCHHHHhc
Q 039159          235 MDPDKRITAAEALQ  248 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~  248 (259)
                      .+|.+||++.+|++
T Consensus       334 ~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  334 PDPKERPTMSQVVK  347 (361)
T ss_pred             cCCCcCcCHHHHHH
Confidence            99999999999864

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-38  Score=255.67  Aligned_cols=209  Identities=23%  Similarity=0.325  Sum_probs=169.1

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+++++.++||||+++++++..++.++++|||+++ +|.+.+.....             ..+....++.++.|
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~l~~~~~~~~~~q  112 (263)
T cd05052          46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------------QEVNAVVLLYMATQ  112 (263)
T ss_pred             HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCC-------------CCCCHHHHHHHHHH
Confidence            45788999999999999999999999999999999999985 89888854211             23456677888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccCccCCCcccchHh
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      ++.|++|||+.+++||||||+||+++.++ .++|+|||.+......... .....++..|+|||.+.+ ..++.++||||
T Consensus       113 l~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s  190 (263)
T cd05052         113 ISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWA  190 (263)
T ss_pred             HHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCccccccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHH
Confidence            99999999999999999999999999888 8999999999765432211 112233567999999876 56788999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          170 VGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||++|+|++ |..||.+.........+..... +.            .....++++.+++.+||+.||++||++.++++
T Consensus       191 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         191 FGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR-ME------------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-CC------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            9999999998 8999988776655555433221 11            12357899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-39  Score=260.98  Aligned_cols=210  Identities=26%  Similarity=0.363  Sum_probs=167.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|++.+++++||||++++|++...+..++|+||++ |+|.+++.....             ..++...+..++.
T Consensus        44 ~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~-------------~~~~~~~~~~i~~  110 (259)
T PF07714_consen   44 EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNK-------------EPLSEQQRLSIAI  110 (259)
T ss_dssp             HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCT-------------TTSBHHHHHHHHH
T ss_pred             cceeeeeccccccccccccccccccccccccccccccccccccccccccccccc-------------ccccccccccccc
Confidence            36789999999999999999999999998888999999998 599999976411             4466778899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      |++.||+|||+.+++||||+++||+++.++ .+||+|||++........  ......+...|+|||.+.+ ..++.++||
T Consensus       111 ~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDV  188 (259)
T PF07714_consen  111 QIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDV  188 (259)
T ss_dssp             HHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH-SEESHHHHH
T ss_pred             cccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            999999999999999999999999999988 999999999976522111  1233346778999999977 458999999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++||+++ |+.||.+.........+......+ .            ...++..+.++|.+||..||++||++.++
T Consensus       189 ysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~li~~C~~~~p~~RPs~~~i  255 (259)
T PF07714_consen  189 YSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP-I------------PDNCPKDIYSLIQQCWSHDPEKRPSFQEI  255 (259)
T ss_dssp             HHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT-S------------BTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred             cccccccccccccccccccccccccccccccccccce-e------------ccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence            999999999999 689999887777666664443221 1            13578999999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       256 ~~  257 (259)
T PF07714_consen  256 LQ  257 (259)
T ss_dssp             HH
T ss_pred             Hh
Confidence            75

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=270.43  Aligned_cols=204  Identities=26%  Similarity=0.358  Sum_probs=167.6

Q ss_pred             chhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           13 SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        13 ~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+..+|+.++... +||||+++++++.++...|+|||.+.| -+.+-+...               .... ..+..++.+
T Consensus       360 ~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~---------------~~~~-~e~~~w~~~  423 (612)
T KOG0603|consen  360 DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK---------------PEFC-SEASQWAAE  423 (612)
T ss_pred             cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhc---------------chhH-HHHHHHHHH
Confidence            3455688877777 699999999999999999999999997 444444321               1222 566789999


Q ss_pred             cccccccccCCCceeccCCCCcEEE-cCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILV-DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili-~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      ++.|+.|||++|++||||||+|||+ +..+ +++|+|||.++.....   ..+.+-|..|.|||+... ..++.++|+||
T Consensus       424 lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~-~~yt~acD~WS  498 (612)
T KOG0603|consen  424 LVSAVDYLHEQGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAI-QEYTEACDWWS  498 (612)
T ss_pred             HHHHHHHHHhcCeeecCCChhheeecCCCC-cEEEEEechhhhCchh---hcccchhhcccChhhhcc-CCCCcchhhHH
Confidence            9999999999999999999999999 5666 8999999999876443   445566888999999985 78999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChH-HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          170 VGCIFGEMVSGKPLFPGANSL-ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||++||+|++|+.||...... +....+...    .+            ...+|.++++|+.+||++||.+||++++++.
T Consensus       499 LGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~----~~------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  499 LGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP----KF------------SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHHHHHHHhCCCccccCCchHHHHHhhcCC----cc------------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            999999999999999987766 333333211    11            0468999999999999999999999999999


Q ss_pred             Ccccc
Q 039159          249 QEYFK  253 (259)
Q Consensus       249 h~~f~  253 (259)
                      ||||.
T Consensus       563 h~w~~  567 (612)
T KOG0603|consen  563 HPWFL  567 (612)
T ss_pred             Ccchh
Confidence            99993

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-40  Score=272.82  Aligned_cols=216  Identities=19%  Similarity=0.200  Sum_probs=177.8

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +++..+.|.+|+.++++-+|.||+-|+|++..+.. .+|+.+|+| +|+..++...              ..+.+..++.
T Consensus       428 t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e--------------tkfdm~~~id  492 (678)
T KOG0193|consen  428 TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE--------------TKFDMNTTID  492 (678)
T ss_pred             CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchh--------------hhhhHHHHHH
Confidence            34456789999999999999999999999988777 899999999 9999997643              5678889999


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccc--cccCCCCcCCccCccccCcccccC--ccCCC
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL--YAYKGESSAEVGTHYYKAPELLLG--LLEYS  162 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~--~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~  162 (259)
                      ++.|+++|+.|||.++|||||||..||++..++ +|||+|||++..-  ...........|+..|+|||++..  ..+|+
T Consensus       493 IAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS  571 (678)
T KOG0193|consen  493 IAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFS  571 (678)
T ss_pred             HHHHHHHhhhhhhhhhhhhhhccccceEEccCC-cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCC
Confidence            999999999999999999999999999999887 8999999998632  222334455678899999999974  25688


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ..+||||||+|+|||++|..||...+..+++..+-.+...+...         ....+.+.++++|+..||..++++||.
T Consensus       572 ~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s---------~~~s~~pk~mk~Ll~~C~~~~~~eRP~  642 (678)
T KOG0193|consen  572 FQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS---------KIRSNCPKAMKRLLSDCWKFDREERPL  642 (678)
T ss_pred             cccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch---------hhhccCHHHHHHHHHHHHhcCcccCcc
Confidence            99999999999999999999999666555554443332222221         112456789999999999999999999


Q ss_pred             HHHHhc
Q 039159          243 AAEALQ  248 (259)
Q Consensus       243 ~~~~l~  248 (259)
                      +.++|.
T Consensus       643 F~~il~  648 (678)
T KOG0193|consen  643 FPQLLS  648 (678)
T ss_pred             HHHHHH
Confidence            998885

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.3e-39  Score=257.17  Aligned_cols=215  Identities=27%  Similarity=0.403  Sum_probs=169.7

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +...++.+|+++++.++||||+++++++...+..++++||+++ +|.+++.......           ..++......++
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~-----------~~~~~~~~~~~~  112 (267)
T cd08228          44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK-----------RLIPERTVWKYF  112 (267)
T ss_pred             HHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhcc-----------CCCCHHHHHHHH
Confidence            3345688999999999999999999999999999999999996 8888885422110           335567778899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||+++++||||||+||+++.++ .++|+|||.+..............|++.|+|||.+.+ ..++.++|+|
T Consensus       113 ~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~  190 (267)
T cd08228         113 VQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIW  190 (267)
T ss_pred             HHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceeccchhHHHhcCCCCccccChhhhcc-CCCCchhhHH
Confidence            9999999999999999999999999999888 8999999998765433333334568889999999977 5678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCh-HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVSGKPLFPGANS-LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|++++|..||..... .............+..+           ....+..+.+++.+||..+|++||++.+++
T Consensus       191 slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl  259 (267)
T cd08228         191 SLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLP-----------TEHYSEKLRELVSMCIYPDPDQRPDIGYVH  259 (267)
T ss_pred             HHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCC-----------hhhcCHHHHHHHHHHCCCCcccCcCHHHHH
Confidence            999999999999999875432 12222222221111111           124678899999999999999999999999


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       260 ~  260 (267)
T cd08228         260 Q  260 (267)
T ss_pred             H
Confidence            6

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-38  Score=255.39  Aligned_cols=215  Identities=27%  Similarity=0.418  Sum_probs=172.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|+++++.++|+||+++++.+...+..++|+||+.+ +|.+.+...               ..........++.
T Consensus        42 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~i~~  106 (264)
T cd06626          42 TIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG---------------RILDEHVIRVYTL  106 (264)
T ss_pred             HHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc---------------CCCChHHHHHHHH
Confidence            567889999999999999999999999999999999999996 898888532               2234566778889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCc----CCccCccccCcccccCcc--CCCc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESS----AEVGTHYYKAPELLLGLL--EYST  163 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~--~~~~  163 (259)
                      +++.|++|||+.+++|+||+|+||+++.++ .++|+|||.+...........    ...+++.|+|||.+.+..  ..+.
T Consensus       107 ~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~  185 (264)
T cd06626         107 QLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGR  185 (264)
T ss_pred             HHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCc
Confidence            999999999999999999999999999887 899999999876543322211    346788999999997632  3788


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChH-HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSL-ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ++|+||||+++|++++|+.||...... .....+.. ...+..+          .....++.+.+++.+||+.+|.+||+
T Consensus       186 ~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~~  254 (264)
T cd06626         186 AADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIP----------DSLQLSPEGKDFLDRCLESDPKKRPT  254 (264)
T ss_pred             ccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCC----------cccccCHHHHHHHHHHccCCcccCCC
Confidence            999999999999999999999765333 22222222 2222211          12345889999999999999999999


Q ss_pred             HHHHhcCccc
Q 039159          243 AAEALQQEYF  252 (259)
Q Consensus       243 ~~~~l~h~~f  252 (259)
                      +++++.|||+
T Consensus       255 ~~~i~~~~~~  264 (264)
T cd06626         255 ASELLQHPFV  264 (264)
T ss_pred             HHHHhcCCCC
Confidence            9999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=286.89  Aligned_cols=224  Identities=21%  Similarity=0.278  Sum_probs=188.0

Q ss_pred             CCCCC-CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchh
Q 039159            2 MGIHN-TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLF   79 (259)
Q Consensus         2 ~~~~~-~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~   79 (259)
                      |++.+ .++...++|.+|..+|++++|||||+++|++.+....++++|||.| +|..+++..+-...        ....+
T Consensus       728 K~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~--------~~~~L  799 (1025)
T KOG1095|consen  728 KSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPF--------QPSNL  799 (1025)
T ss_pred             EeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccC--------CCCCC
Confidence            44444 3456678999999999999999999999999999999999999995 99999987533211        12678


Q ss_pred             HHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcC-CccCccccCcccccC
Q 039159           80 TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSA-EVGTHYYKAPELLLG  157 (259)
Q Consensus        80 ~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~-~~~~~~~~aPE~~~~  157 (259)
                      .+.+++.++.++++|..||+++++|||||..+|+|++... .|||+|||+|+......-. .+. -.-...|||||.+..
T Consensus       800 ~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d  878 (1025)
T KOG1095|consen  800 SMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD  878 (1025)
T ss_pred             CHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-cEEEcccchhHhhhhchheeccCccccceecCCHHHHhh
Confidence            8899999999999999999999999999999999999987 8999999999854332111 111 123468999999997


Q ss_pred             ccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                       ..++.++|||||||++||++| |..||.+.++.+....+..+.+.+.             .+.++..+-++|.+||..+
T Consensus       879 -~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~-------------P~~CP~~ly~lM~~CW~~~  944 (1025)
T KOG1095|consen  879 -GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP-------------PSYCPEKLYQLMLQCWKHD  944 (1025)
T ss_pred             -cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC-------------CCCCChHHHHHHHHHccCC
Confidence             689999999999999999998 7899999999999987777764432             2568899999999999999


Q ss_pred             CCCccCHHHHhc
Q 039159          237 PDKRITAAEALQ  248 (259)
Q Consensus       237 p~~Rp~~~~~l~  248 (259)
                      |++||++..+++
T Consensus       945 pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  945 PEDRPSFRTIVE  956 (1025)
T ss_pred             hhhCccHHHHHh
Confidence            999999999986

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-38  Score=258.18  Aligned_cols=212  Identities=24%  Similarity=0.311  Sum_probs=166.1

Q ss_pred             hhHHHHHHHhh---CCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           14 SMIREVSCLME---LNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        14 ~~~~Ei~~l~~---l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+|..+++.   .+||||+.+++++..++..++||||+.| +|...+...               ..+....+..++.
T Consensus        40 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~---------------~~l~~~~~~~i~~  104 (279)
T cd05633          40 LALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH---------------GVFSEKEMRFYAT  104 (279)
T ss_pred             HHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            34556554444   4799999999999998999999999996 888777431               3356677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.|++|||+.+++||||||+||+++.++ .++++|||++......  ......|++.|+|||.+.+...++.++|+||
T Consensus       105 qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s  181 (279)
T cd05633         105 EIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFS  181 (279)
T ss_pred             HHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHH
Confidence            999999999999999999999999999888 8999999998654322  2233468999999999875456788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCh--HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----C
Q 039159          170 VGCIFGEMVSGKPLFPGANS--LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----T  242 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~  242 (259)
                      +||++|++++|..||.....  ........... .+            .....+++++.+++.+||+.||++||     +
T Consensus       182 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  248 (279)
T cd05633         182 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV-NV------------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRG  248 (279)
T ss_pred             HHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcC-Cc------------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCC
Confidence            99999999999999975432  11121111110 00            11235789999999999999999999     6


Q ss_pred             HHHHhcCccccCCC
Q 039159          243 AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ~~~~l~h~~f~~~~  256 (259)
                      +.++++||||+.+.
T Consensus       249 ~~~~~~h~~~~~~~  262 (279)
T cd05633         249 AQEVKEHVFFKGID  262 (279)
T ss_pred             HHHHHhCccccCCC
Confidence            99999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.8e-38  Score=256.24  Aligned_cols=224  Identities=20%  Similarity=0.276  Sum_probs=176.0

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .++.+|+.+++.++||||+++++++.+++..++||||+.+ +|.+.++........     ...........+..++.++
T Consensus        54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l  128 (288)
T cd05061          54 IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN-----NPGRPPPTLQEMIQMAAEI  128 (288)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhcccccc-----CCCCCCCCHHHHHHHHHHH
Confidence            4578899999999999999999999998999999999985 999999653221110     0011233456678889999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchHh
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +.|++|||+++++||||||+||+++.++ .++|+|||+++.......  ......++..|+|||.+.+ ..++.++|+||
T Consensus       129 ~~~l~~lH~~~i~H~dikp~nili~~~~-~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dvws  206 (288)
T cd05061         129 ADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWS  206 (288)
T ss_pred             HHHHHHHHhCCCcCCCCChheEEEcCCC-cEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHH
Confidence            9999999999999999999999999888 899999999875432221  1222345678999999876 56788999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          170 VGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||++|++++ |..||.+.........+...... ..            ....++.+.+++.+||+.||++||++.++++
T Consensus       207 lG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  273 (288)
T cd05061         207 FGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL-DQ------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVN  273 (288)
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999998 78899887766655554433211 11            1245789999999999999999999999987


Q ss_pred             ------CccccCCC
Q 039159          249 ------QEYFKDVP  256 (259)
Q Consensus       249 ------h~~f~~~~  256 (259)
                            ||||++++
T Consensus       274 ~l~~~~~~~~~~~~  287 (288)
T cd05061         274 LLKDDLHPSFPEVS  287 (288)
T ss_pred             HHHhhcCCCCCCCC
Confidence                  99999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=248.00  Aligned_cols=218  Identities=21%  Similarity=0.323  Sum_probs=175.1

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +.-++++..+.++.+- +-|.||+.+|+|..+..+++.||.|.--+..+++.-+              ..++...+.++.
T Consensus       132 ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik--------------~piPE~ilGk~t  197 (391)
T KOG0983|consen  132 EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIK--------------GPIPERILGKMT  197 (391)
T ss_pred             HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhc--------------CCchHHhhhhhH
Confidence            4456788888866665 4899999999999999999999998754555554322              345566667777


Q ss_pred             hhcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC--ccCCCccc
Q 039159           89 SSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG--LLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~  165 (259)
                      ..+.+||.||.+ ++|+|||+||+|||+|..| .+|++|||++-.+... ...+...|.+.|||||.+.-  ...|+.++
T Consensus       198 va~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGrlvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRa  275 (391)
T KOG0983|consen  198 VAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGRLVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRA  275 (391)
T ss_pred             HHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccceeecc-cccccccCCccccCccccCCCCCCccchhh
Confidence            888899999995 6999999999999999999 8999999999766543 23344578999999999863  36788999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGAN-SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      ||||||++++|++||+.||.+.+ ..+....+.+... |..+          .-.++|+.+++|+..||..|+.+||...
T Consensus       276 DVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~  344 (391)
T KOG0983|consen  276 DVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLP----------GHMGFSPDFQSFVKDCLTKDHRKRPKYN  344 (391)
T ss_pred             hhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCC----------cccCcCHHHHHHHHHHhhcCcccCcchH
Confidence            99999999999999999999854 4566666666332 3332          1235899999999999999999999999


Q ss_pred             HHhcCccccC
Q 039159          245 EALQQEYFKD  254 (259)
Q Consensus       245 ~~l~h~~f~~  254 (259)
                      ++|+|||++.
T Consensus       345 ~Ll~h~Fi~~  354 (391)
T KOG0983|consen  345 KLLEHPFIKR  354 (391)
T ss_pred             HHhcCcceee
Confidence            9999999874

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2e-38  Score=260.22  Aligned_cols=213  Identities=25%  Similarity=0.333  Sum_probs=174.3

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ..++.+|+++++.++|+|++++++++..++..++||||+.|++...+....              ..+....+..++.++
T Consensus        59 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~l~~~~~~~~~~~l  124 (308)
T cd06634          59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--------------KPLQEVEIAAVTHGA  124 (308)
T ss_pred             HHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcC--------------CCCCHHHHHHHHHHH
Confidence            456789999999999999999999999999999999999998887775321              234567778888999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC--ccCCCcccchHh
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG--LLEYSTAVDIWP  169 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Diws  169 (259)
                      +.|+.|||+.+++||||+|+||+++.++ .++++|||.+.....    .....+++.|+|||.+.+  ....+.++||||
T Consensus       125 ~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~s  199 (308)
T cd06634         125 LQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWS  199 (308)
T ss_pred             HHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecC----cccccCCccccCHHHHhhcccCCCCcccchHH
Confidence            9999999999999999999999999888 899999999875422    234467889999999853  235678999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      |||++|++++|..||...........+..... +..           .....+..+.++|.+||..+|++||+++++++|
T Consensus       200 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~-----------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         200 LGITCIELAERKPPLFNMNAMSALYHIAQNES-PAL-----------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-CCc-----------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            99999999999999987665555544433221 111           013577889999999999999999999999999


Q ss_pred             ccccCC
Q 039159          250 EYFKDV  255 (259)
Q Consensus       250 ~~f~~~  255 (259)
                      ||+...
T Consensus       268 ~~~~~~  273 (308)
T cd06634         268 RFVLRE  273 (308)
T ss_pred             cccccc
Confidence            999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.3e-38  Score=255.87  Aligned_cols=222  Identities=20%  Similarity=0.279  Sum_probs=171.7

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCC-Ccc-cccCCCcchhHHHHHHHHHh
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMN-GYS-TKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .++.+|+.++++++||||+++++++..++..|++|||+.+ +|.+++........ ... .........++..+.+.++.
T Consensus        52 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  131 (283)
T cd05090          52 GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI  131 (283)
T ss_pred             HHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHH
Confidence            5688999999999999999999999999999999999985 89888853211100 000 00001113456677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +++.|++|||+++++||||||+||+++.++ .+||+|||+++......  .......++..|+|||.+.+ ..++.++|+
T Consensus       132 ~i~~al~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  209 (283)
T cd05090         132 QIAAGMEYLSSHFFVHKDLAARNILIGEQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDI  209 (283)
T ss_pred             HHHHHHHHHHhcCeehhccccceEEEcCCC-cEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhh
Confidence            999999999999999999999999999888 89999999997653221  11233345677999999976 568899999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|+|++ |..||.+.........+......             +....+++.+.+++.+||+.||.+||+++++
T Consensus       210 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  276 (283)
T cd05090         210 WSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL-------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDI  276 (283)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence            999999999998 99999887665555444332211             1124578999999999999999999999999


Q ss_pred             hcC
Q 039159          247 LQQ  249 (259)
Q Consensus       247 l~h  249 (259)
                      +++
T Consensus       277 ~~~  279 (283)
T cd05090         277 HTR  279 (283)
T ss_pred             HHH
Confidence            864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2e-38  Score=253.55  Aligned_cols=209  Identities=24%  Similarity=0.299  Sum_probs=170.3

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+.++++++||||+++++++.....++++|||+.+ +|.+.+....              ..+....++.++.+
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~--------------~~~~~~~~~~~~~~  108 (256)
T cd05113          43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG--------------KRFQPSQLLEMCKD  108 (256)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcC--------------CCCCHHHHHHHHHH
Confidence            46789999999999999999999999988899999999985 8888885321              23456778899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccCccCCCcccchHh
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      ++.|++|||+.+++|+||||+||+++.++ .+||+|||.++........ .....++..|+|||.+.+ ..++.++|+||
T Consensus       109 i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~s  186 (256)
T cd05113         109 VCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWA  186 (256)
T ss_pred             HHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCCceeecCCCccChhhCCHHHHhc-CcccchhHHHH
Confidence            99999999999999999999999999888 8999999998755332111 112235667999999976 46888999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          170 VGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||+++|+|++ |..||...........+......+.             ....++.+.+++.+||+.||.+||++.+++.
T Consensus       187 lG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~  253 (256)
T cd05113         187 FGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR-------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLS  253 (256)
T ss_pred             HHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999998 9999987776666655544332211             1236789999999999999999999999986


Q ss_pred             C
Q 039159          249 Q  249 (259)
Q Consensus       249 h  249 (259)
                      +
T Consensus       254 ~  254 (256)
T cd05113         254 S  254 (256)
T ss_pred             h
Confidence            4

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=257.64  Aligned_cols=228  Identities=38%  Similarity=0.561  Sum_probs=176.5

Q ss_pred             CCCCchhHHHHHHHhhC---CCCCeeEEEEEEEeCce-----EEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            9 EGVPSSMIREVSCLMEL---NHPNIIRLMRVASQGIY-----LYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l---~H~niv~~~~~~~~~~~-----~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      +.....+.+|+.+++++   +|||++++++++...+.     .+++|||+.++|.+.+.....             ..++
T Consensus        39 ~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~-------------~~l~  105 (287)
T cd07838          39 EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK-------------PGLP  105 (287)
T ss_pred             chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccC-------------CCCC
Confidence            34456677898888776   59999999999988776     999999999988888754221             2355


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccC
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      ...++.++.+++.|++|||+.+++|+||+|+||+++.++ .++|+|||.+....... ......++..|+|||.+.+ ..
T Consensus       106 ~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~  182 (287)
T cd07838         106 PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYSFEM-ALTSVVVTLWYRAPEVLLQ-SS  182 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-CEEEeccCcceeccCCc-ccccccccccccChHHhcc-CC
Confidence            678888999999999999999999999999999999997 89999999987653322 2223357888999999987 56


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc-------------ccccccccCCCCCCCHHHHH
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK-------------LSLRDHLTNGFPGLEPAGID  227 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~  227 (259)
                      ++.++|+|||||++|+|++|.+||.+.........+......+....             ...........+.+++.+.+
T Consensus       183 ~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (287)
T cd07838         183 YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLD  262 (287)
T ss_pred             CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHH
Confidence            78899999999999999999999998777666665543221111000             00000111122346788899


Q ss_pred             HHHhhcCcCCCCccCHHHHhcCccc
Q 039159          228 LISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       228 li~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      ++.+||+.||++||+++++++||||
T Consensus       263 li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         263 LLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HHHHHhccCCccCCCHHHHhcCcCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.9e-38  Score=254.30  Aligned_cols=210  Identities=21%  Similarity=0.287  Sum_probs=171.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+.+++.++||||+++++++..++..+++|||+.+ +|.+++.....             .......++.++.
T Consensus        44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~  110 (261)
T cd05072          44 SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG-------------GKVLLPKLIDFSA  110 (261)
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcC-------------CCCCHHHHHHHHH
Confidence            356889999999999999999999999999999999999985 89988854211             2345567788889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.|++|||+.+++||||||+||+++.++ .++|+|||.+......... .....++..|+|||.+.+ ..++.++|+|
T Consensus       111 ~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  188 (261)
T cd05072         111 QIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVW  188 (261)
T ss_pred             HHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhh
Confidence            999999999999999999999999999888 8999999999765332211 122335678999999876 5678899999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++|++++ |..||...........+......+             ....++.++.+++.+||..+|++||++++++
T Consensus       189 slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  255 (261)
T cd05072         189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP-------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQ  255 (261)
T ss_pred             hhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence            99999999998 999998877766666655433221             1235788999999999999999999999987


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       256 ~  256 (261)
T cd05072         256 S  256 (261)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-38  Score=252.69  Aligned_cols=210  Identities=24%  Similarity=0.292  Sum_probs=170.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++.+|+.++++++||||+++++++...+..++||||++| +|.+.+....              ..++......++.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~  107 (256)
T cd05059          42 SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK--------------GKLGTEWLLDMCS  107 (256)
T ss_pred             CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc--------------cCCCHHHHHHHHH
Confidence            345788999999999999999999999998999999999986 8988885321              2355677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.|++|||+.+++||||||+||+++.++ .+||+|||.++....... ......++..|+|||.+.+ ..++.++|+|
T Consensus       108 qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~  185 (256)
T cd05059         108 DVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVW  185 (256)
T ss_pred             HHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceecccccccccCCCCCCccccCHHHhcc-CCCCchhhHH
Confidence            999999999999999999999999999888 899999999875432211 1112223457999999987 5688899999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|++++ |..||...........+......+             .....++++.+++.+||..+|++|||+.+++
T Consensus       186 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l  252 (256)
T cd05059         186 SFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY-------------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLL  252 (256)
T ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            99999999999 799998777666665554332111             1134788999999999999999999999998


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      +.
T Consensus       253 ~~  254 (256)
T cd05059         253 SQ  254 (256)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-39  Score=270.97  Aligned_cols=211  Identities=28%  Similarity=0.381  Sum_probs=181.8

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ..+.+|+++++.|+|||||+++.+.+....+|+||||+.| .+++.+...               ..+........|.|+
T Consensus       100 ~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~---------------gr~~e~~ar~~F~q~  164 (596)
T KOG0586|consen  100 QKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKH---------------GRMKEKEARAKFRQI  164 (596)
T ss_pred             HHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhc---------------ccchhhhhhhhhHHH
Confidence            4588999999999999999999999999999999999986 788777543               334446677888999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      .+|++|||+++|+|||||.+|++++.+. .+||+|||++..+. ......+++|++.|.|||.+.+....++.+|+||+|
T Consensus       165 vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslg  242 (596)
T KOG0586|consen  165 VSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLG  242 (596)
T ss_pred             HHHHHHHhhcceeccccchhhccccccc-ceeeeccccceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhh
Confidence            9999999999999999999999999887 79999999998775 455677889999999999999977778999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCcc
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY  251 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~  251 (259)
                      +++|.++.|..||.+.+..+....++.......              .-++.++.++|+++|..+|.+|++.++++.|+|
T Consensus       243 vvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp--------------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  243 VVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP--------------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             hhheeeeecccccCCcccccccchheeeeeccc--------------ceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            999999999999998776655555443322211              247899999999999999999999999999999


Q ss_pred             ccC
Q 039159          252 FKD  254 (259)
Q Consensus       252 f~~  254 (259)
                      ...
T Consensus       309 ~n~  311 (596)
T KOG0586|consen  309 RND  311 (596)
T ss_pred             cch
Confidence            864

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4e-38  Score=252.05  Aligned_cols=217  Identities=23%  Similarity=0.337  Sum_probs=177.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+++++.++|+||+++++++..+...+++|||+++ +|.+.+.......      .......++......++.+
T Consensus        40 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~~~~  113 (262)
T cd00192          40 RKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVF------PSPEKSTLSLKDLLSFAIQ  113 (262)
T ss_pred             HHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccc------cccccccCCHHHHHHHHHH
Confidence            57889999999999999999999999999999999999975 9999986532110      0011145677888999999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++.|++|||+++++||||+|+||+++.++ .++|+|||.+.......  .......+++.|+|||.+.+ ..++.++|+|
T Consensus       114 l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  191 (262)
T cd00192         114 IAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVW  191 (262)
T ss_pred             HHHHHHHHHcCCcccCccCcceEEECCCC-cEEEcccccccccccccccccccCCCcCccccCHHHhcc-CCcchhhccH
Confidence            99999999999999999999999999888 89999999998764432  22334457889999999977 4688999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|++++ |..||...........+......             .....+++++.+++.+||..+|++||++.+++
T Consensus       192 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~  258 (262)
T cd00192         192 SFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL-------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELV  258 (262)
T ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------CCCccCChHHHHHHHHHccCCcccCcCHHHHH
Confidence            99999999999 69999988777666666542211             11235689999999999999999999999998


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      ++
T Consensus       259 ~~  260 (262)
T cd00192         259 ER  260 (262)
T ss_pred             Hh
Confidence            64

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-39  Score=267.62  Aligned_cols=226  Identities=35%  Similarity=0.546  Sum_probs=178.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCce------EEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIY------LYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~------~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ....+.+|+.++++++|||++++++++..++.      .++|+||+.++|.+++..                ..+....+
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----------------~~l~~~~~  120 (343)
T cd07851          57 HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC----------------QKLSDDHI  120 (343)
T ss_pred             HHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc----------------CCCCHHHH
Confidence            34667889999999999999999998876654      899999998899888853                33566778


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ..++.+++.|++|||+.|++||||+|+||+++.++ .++|+|||.+.....   ......+++.|+|||.+.+...++.+
T Consensus       121 ~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~  196 (343)
T cd07851         121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQT  196 (343)
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEccccccccccc---cccCCcccccccCHHHHhCCCCCCch
Confidence            88999999999999999999999999999999888 899999999975432   23344678899999998764467889


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc--c---------------ccccccccCCCCCCCHHHHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC--K---------------LSLRDHLTNGFPGLEPAGID  227 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~--~---------------~~~~~~~~~~~~~~~~~~~~  227 (259)
                      +|+||||+++|++++|+.||.+.........+......+...  .               ..........+...++.+.+
T Consensus       197 ~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~d  276 (343)
T cd07851         197 VDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAID  276 (343)
T ss_pred             HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHH
Confidence            999999999999999999998877666555544332211100  0               00000111122356899999


Q ss_pred             HHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          228 LISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       228 li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ++.+||+.||++|||+.++++||||+...
T Consensus       277 li~~~l~~~P~~Rpt~~ell~h~~~~~~~  305 (343)
T cd07851         277 LLEKMLVLDPDKRITAAEALAHPYLAEYH  305 (343)
T ss_pred             HHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence            99999999999999999999999998764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-38  Score=251.63  Aligned_cols=211  Identities=26%  Similarity=0.330  Sum_probs=171.1

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|++++++++||||+++++++..++.++++|||+.+ +|.+.+....+             ..+....+..++
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~  109 (261)
T cd05068          43 MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG-------------RALKLPQLIDMA  109 (261)
T ss_pred             ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCC-------------CCCCHHHHHHHH
Confidence            3456789999999999999999999999999999999999975 89998864321             235667788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.|+.|||+.+++||||||+||+++.++ .++|+|||+++........ ......+..|+|||.+.+ ..++.++|+
T Consensus       110 ~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  187 (261)
T cd05068         110 AQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDV  187 (261)
T ss_pred             HHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhH
Confidence            9999999999999999999999999999888 8999999999765422111 111123457999999876 568889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|++++ |+.||.+.........+......+             .....+..+.+++.+||+.+|++||+++++
T Consensus       188 ~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l  254 (261)
T cd05068         188 WSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP-------------CPPGCPKELYDIMLDCWKEDPDDRPTFETL  254 (261)
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            999999999999 999998877766666654432211             113567899999999999999999999998


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       255 ~~  256 (261)
T cd05068         255 QW  256 (261)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=269.31  Aligned_cols=212  Identities=22%  Similarity=0.288  Sum_probs=176.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+....|.+|++++++++|||||++||++.....+++|||+|.| +|.+.++...              ..++..+.+..
T Consensus       202 ~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~--------------~~v~~~ek~~~  267 (474)
T KOG0194|consen  202 KEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK--------------KSLPTLEKLRF  267 (474)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC--------------CCCCHHHHHHH
Confidence            45677899999999999999999999999999999999999996 9999997542              23667888999


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.|++|||+++++||||-.+|+|++.++ .+||+|||++.............--...|+|||.+.. ..++.++||
T Consensus       268 ~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV  345 (474)
T KOG0194|consen  268 CYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDV  345 (474)
T ss_pred             HHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEeCccccccCCcceeeccccccCcceecChhhhcc-Cccccccch
Confidence            99999999999999999999999999999887 7899999998754321111111123568999999988 489999999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++||+.+ |..||.+....+....+.........+            ...+..+..++.+||..||++||++.++
T Consensus       346 ~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i  413 (474)
T KOG0194|consen  346 WSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP------------SKTPKELAKVMKQCWKKDPEDRPTMSTI  413 (474)
T ss_pred             hheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC------------CCCHHHHHHHHHHhccCChhhccCHHHH
Confidence            999999999998 788999999999988884433222211            2567888899999999999999999988


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      .+
T Consensus       414 ~~  415 (474)
T KOG0194|consen  414 KK  415 (474)
T ss_pred             HH
Confidence            74

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.3e-38  Score=251.99  Aligned_cols=217  Identities=29%  Similarity=0.420  Sum_probs=180.3

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|+++++.++|||++++++.+..+...++++||+++ +|.+.+.....           ....++...+..++
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~  109 (258)
T cd08215          41 KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKK-----------EGKPFPEEQILDWF  109 (258)
T ss_pred             HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhc-----------cCCCcCHHHHHHHH
Confidence            4456788999999999999999999999999999999999996 89988865321           01446677888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||+.+++|+||+|+||+++.++ .++|+|||.+..............|++.|+|||...+ ...+.++|+|
T Consensus       110 ~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~  187 (258)
T cd08215         110 VQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIW  187 (258)
T ss_pred             HHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccCcceecceeeeecccChhHhcc-CCCCccccHH
Confidence            9999999999999999999999999999887 8999999999765443333445578899999999877 5678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |+|++++++++|..||................ .+            ......+..+.+++.+||..+|++||++.++|+
T Consensus       188 slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         188 SLGCVLYELCTLKHPFEGENLLELALKILKGQ-YP------------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            99999999999999998877665555543322 11            112357889999999999999999999999999


Q ss_pred             Cccc
Q 039159          249 QEYF  252 (259)
Q Consensus       249 h~~f  252 (259)
                      ||||
T Consensus       255 ~~~~  258 (258)
T cd08215         255 SPFI  258 (258)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.7e-38  Score=255.66  Aligned_cols=218  Identities=19%  Similarity=0.266  Sum_probs=171.2

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|+.+++.++||||+++++++.++...++||||+.+ +|.+++...+......     ..........+..++.+
T Consensus        53 ~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  127 (277)
T cd05062          53 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN-----PVQAPPSLKKMIQMAGE  127 (277)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCcccccc-----ccccCCCHHHHHHHHHH
Confidence            34688999999999999999999999998999999999985 8998886533221100     11133456677888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++.|++|||+.+++||||||+||+++.++ .++|+|||+++.......  ......+++.|+|||.+.+ ..++.++|+|
T Consensus       128 l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  205 (277)
T cd05062         128 IADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVW  205 (277)
T ss_pred             HHHHHHHHHHCCcccCCcchheEEEcCCC-CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHH
Confidence            99999999999999999999999999888 899999999875432211  1122345778999999977 5688999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++|++++ |..||.+.........+..... +..            ....++.+.+++.+||+.||++||++.+++
T Consensus       206 slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l  272 (277)
T cd05062         206 SFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL-LDK------------PDNCPDMLFELMRMCWQYNPKMRPSFLEII  272 (277)
T ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            99999999999 6899988776655555443321 111            134678899999999999999999999998


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      ++
T Consensus       273 ~~  274 (277)
T cd05062         273 SS  274 (277)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.8e-38  Score=249.20  Aligned_cols=213  Identities=28%  Similarity=0.403  Sum_probs=174.5

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|++++++++|||++++++++..+...++++||+.| +|.+++....              ..++...+..++.
T Consensus        40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~  105 (253)
T cd05122          40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN--------------QTLTESQIAYVCK  105 (253)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC--------------CCCCHHHHHHHHH
Confidence            457899999999999999999999999999999999999995 8988885421              2356677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|+++||+.+++||||+|+||+++.++ .++|+|||.+........ .....++..|+|||.+.+ ...+.++|+||
T Consensus       106 ~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~s  182 (253)
T cd05122         106 ELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVING-KPYDYKADIWS  182 (253)
T ss_pred             HHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEeecccccccccccc-ccceecCCcccCHHHHcC-CCCCccccHHH
Confidence            999999999999999999999999999888 899999999876543221 345568889999999977 45788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      ||+++|++++|+.||...+........... ..+..+          ....++..+.+++.+||+.||++|||+.++++|
T Consensus       183 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         183 LGITAIELAEGKPPYSELPPMKALFKIATN-GPPGLR----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCCcC----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            999999999999999877554444443321 111111          011247899999999999999999999999999


Q ss_pred             cc
Q 039159          250 EY  251 (259)
Q Consensus       250 ~~  251 (259)
                      ||
T Consensus       252 ~~  253 (253)
T cd05122         252 PF  253 (253)
T ss_pred             CC
Confidence            98

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-38  Score=255.29  Aligned_cols=216  Identities=24%  Similarity=0.322  Sum_probs=171.7

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +...+.+.+|+++++.++||||+++++++...+..++||||+++ +|...+...               ..+.......+
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~  108 (284)
T cd06620          44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG---------------GPIPVEILGKI  108 (284)
T ss_pred             chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc---------------cCCCHHHHHHH
Confidence            34567889999999999999999999999999999999999996 787777431               23455667788


Q ss_pred             HhhcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           88 FSSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        88 ~~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +.+++.++.|||+ ++++||||+|+||+++.++ .++|+|||++.....  .......|+..|+|||.+.+ ..++.++|
T Consensus       109 ~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~D  184 (284)
T cd06620         109 AVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELIN--SIADTFVGTSTYMSPERIQG-GKYTVKSD  184 (284)
T ss_pred             HHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhh--hccCccccCcccCCHHHHcc-CCCCccch
Confidence            8999999999996 6999999999999999888 899999999865422  22234578999999999876 47788999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChH-----------HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSL-----------ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      +|||||++|++++|..||......           .....+.... .+..+           ...++..+.+|+.+||+.
T Consensus       185 i~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-----------~~~~~~~~~~li~~~l~~  252 (284)
T cd06620         185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPRLP-----------SSDFPEDLRDFVDACLLK  252 (284)
T ss_pred             HHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCCCC-----------chhcCHHHHHHHHHHhcC
Confidence            999999999999999999865432           1111221111 11110           123678899999999999


Q ss_pred             CCCCccCHHHHhcCccccCC
Q 039159          236 DPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       236 dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ||++||+++++++||||..-
T Consensus       253 dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         253 DPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             CcccCcCHHHHhcCcccccc
Confidence            99999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.6e-38  Score=253.02  Aligned_cols=198  Identities=21%  Similarity=0.281  Sum_probs=160.2

Q ss_pred             CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccccccccCCCce
Q 039159           26 NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYI  104 (259)
Q Consensus        26 ~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~  104 (259)
                      +||||+++++.+..++..|+||||++| +|.+.+...               ..+....+..++.|+++|++|||+.+++
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~  131 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE---------------GKLSEAEVKKIIRQLVEALNDLHKHNII  131 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            699999999999999999999999985 999988542               2456678889999999999999999999


Q ss_pred             eccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCC
Q 039159          105 RRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF  184 (259)
Q Consensus       105 H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf  184 (259)
                      ||||||+||+++.++..++++|||.+.....    .....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||
T Consensus       132 H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~  206 (267)
T PHA03390        132 HNDIKLENVLYDRAKDRIYLCDYGLCKIIGT----PSCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPF  206 (267)
T ss_pred             eCCCCHHHEEEeCCCCeEEEecCccceecCC----CccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            9999999999998775799999999875432    233467889999999977 56788999999999999999999999


Q ss_pred             CCCChHHHH-HHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-HHHHhcCccccC
Q 039159          185 PGANSLITL-GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-AAEALQQEYFKD  254 (259)
Q Consensus       185 ~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-~~~~l~h~~f~~  254 (259)
                      ......... ....... .          .........++.+.++|.+||+.+|.+||+ ++++|+||||++
T Consensus       207 ~~~~~~~~~~~~~~~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        207 KEDEDEELDLESLLKRQ-Q----------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             CCCCcchhhHHHHHHhh-c----------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            754332211 1111110 0          011122368899999999999999999996 699999999975

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.6e-38  Score=257.98  Aligned_cols=210  Identities=22%  Similarity=0.321  Sum_probs=169.0

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+.+|+.+++++ +||||+++++++...+..+++|||+.+ +|.++++....             ..++..+.+.++.
T Consensus        82 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-------------~~l~~~~~~~i~~  148 (302)
T cd05055          82 REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE-------------SFLTLEDLLSFSY  148 (302)
T ss_pred             HHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCC-------------CCCCHHHHHHHHH
Confidence            35688999999999 799999999999999999999999985 89988854221             2256778888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +++.|++|||+.+++|+||||+||+++.++ .++++|||.++.......  ......+++.|+|||.+.+ ..++.++||
T Consensus       149 ~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  226 (302)
T cd05055         149 QVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDV  226 (302)
T ss_pred             HHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHH
Confidence            999999999999999999999999999887 899999999975533221  1223345778999999977 567889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||+||++|++++ |..||..................+.            .....++.+.+++.+||+.+|++||++.++
T Consensus       227 wslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~el  294 (302)
T cd05055         227 WSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQI  294 (302)
T ss_pred             HHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            999999999998 9999987665544444332221111            113467899999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       295 l~  296 (302)
T cd05055         295 VQ  296 (302)
T ss_pred             HH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-38  Score=251.57  Aligned_cols=212  Identities=27%  Similarity=0.399  Sum_probs=170.3

Q ss_pred             hhHHHHHHH-hhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           14 SMIREVSCL-MELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        14 ~~~~Ei~~l-~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .+..|..++ +..+|||++++++++..++..|+|+||+.| +|..++...               ..++...+..++.|+
T Consensus        42 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~qi  106 (260)
T cd05611          42 NVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL---------------GGLPEDWAKQYIAEV  106 (260)
T ss_pred             HHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc---------------CCCCHHHHHHHHHHH
Confidence            345555544 445899999999999999999999999986 899888542               234566777889999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      +.||.|||+.+++||||+|+||+++.++ .++|+|||.+.....    .....+++.|+|||.+.+ ..++.++|+||||
T Consensus       107 ~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG  180 (260)
T cd05611         107 VLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILG-VGDDKMSDWWSLG  180 (260)
T ss_pred             HHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc----cccCCCCcCccChhhhcC-CCCcchhhhHHHH
Confidence            9999999999999999999999999888 899999999875422    334467889999999987 4578999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc---CHHHHhc
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI---TAAEALQ  248 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~~l~  248 (259)
                      +++|++++|..||...+.......+........          ......+++.+.+++.+||+.||++||   ++++++.
T Consensus       181 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         181 CVIFEFLFGYPPFHAETPDAVFDNILSRRINWP----------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             HHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC----------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            999999999999988776665555433221110          011235789999999999999999999   4579999


Q ss_pred             CccccCCC
Q 039159          249 QEYFKDVP  256 (259)
Q Consensus       249 h~~f~~~~  256 (259)
                      ||||+++.
T Consensus       251 ~~~~~~~~  258 (260)
T cd05611         251 HPFFKSIN  258 (260)
T ss_pred             ChHhhcCC
Confidence            99998753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-38  Score=253.22  Aligned_cols=207  Identities=17%  Similarity=0.153  Sum_probs=163.3

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+.+++.++||||+++++++..++..++||||+.+ +|..+++...              ..++....+.++
T Consensus        41 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~~  106 (258)
T cd05078          41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK--------------NLINISWKLEVA  106 (258)
T ss_pred             HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCC--------------CCCCHHHHHHHH
Confidence            3346788999999999999999999999998999999999986 8888886422              234556678889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCC-------eEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK-------TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~-------~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      .|++.|++|||+++|+||||||+||+++.++.       .++++|||.+....    ......+++.|+|||.+.+...+
T Consensus       107 ~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~  182 (258)
T cd05078         107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL----PKEILLERIPWVPPECIENPQNL  182 (258)
T ss_pred             HHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC----CchhccccCCccCchhccCCCCC
Confidence            99999999999999999999999999987662       27999999986542    22334678889999999764557


Q ss_pred             CcccchHhHHHHHHHHHhCC-CCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          162 STAVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      +.++|+||||+++|++++|. +||................   .            .....++++.+++.+||+.||++|
T Consensus       183 ~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~---~------------~~~~~~~~~~~li~~~l~~~p~~R  247 (258)
T cd05078         183 SLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRH---Q------------LPAPKWTELANLINQCMDYEPDFR  247 (258)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccc---c------------CCCCCcHHHHHHHHHHhccChhhC
Confidence            88999999999999999984 6666554443322211111   1            112456789999999999999999


Q ss_pred             cCHHHHhcC
Q 039159          241 ITAAEALQQ  249 (259)
Q Consensus       241 p~~~~~l~h  249 (259)
                      ||++++++.
T Consensus       248 ps~~~il~~  256 (258)
T cd05078         248 PSFRAIIRD  256 (258)
T ss_pred             CCHHHHHHh
Confidence            999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.7e-38  Score=259.13  Aligned_cols=228  Identities=34%  Similarity=0.522  Sum_probs=174.3

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEe-CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQ-GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +...+.+.+|++++++++||||+++++++.. ++..++++||+.++|...+..                ..+.......+
T Consensus        50 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----------------~~~~~~~~~~~  113 (328)
T cd07856          50 PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTS----------------RPLEKQFIQYF  113 (328)
T ss_pred             cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhccCHHHHHhc----------------CCCCHHHHHHH
Confidence            3456778899999999999999999999875 567899999998888888753                22334455677


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.++++|++|||+.+++||||+|+||+++.++ .++|+|||.+....   .......+++.|+|||.+.+...++.++|+
T Consensus       114 ~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv  189 (328)
T cd07856         114 LYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLARIQD---PQMTGYVSTRYYRAPEIMLTWQKYDVEVDI  189 (328)
T ss_pred             HHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccccccC---CCcCCCcccccccCceeeeccCCcCcHHHH
Confidence            88999999999999999999999999999888 89999999987532   222344678889999988664568899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC--------------cc-cccc--ccccccCCCCCCCHHHHHHHH
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP--------------SF-CKLS--LRDHLTNGFPGLEPAGIDLIS  230 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~--------------~~-~~~~--~~~~~~~~~~~~~~~~~~li~  230 (259)
                      ||||+++|++++|++||...........+......+              .. ....  ...+.....+..++.+.++|.
T Consensus       190 ~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  269 (328)
T cd07856         190 WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLE  269 (328)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHH
Confidence            999999999999999998766543332221110000              00 0000  001112223467899999999


Q ss_pred             hhcCcCCCCccCHHHHhcCccccCCC
Q 039159          231 KMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       231 ~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      +||+.+|++||++++++.||||....
T Consensus       270 ~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         270 KMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             HHcCCChhhCCCHHHHhcCCcccccc
Confidence            99999999999999999999997654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-38  Score=250.43  Aligned_cols=212  Identities=31%  Similarity=0.477  Sum_probs=177.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|++++++++|||++++++++.+++..+++|||+++ +|.+.+...               ..++......++.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---------------~~l~~~~~~~~~~  106 (254)
T cd06627          42 ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF---------------GPFPESLVAVYVY  106 (254)
T ss_pred             HHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc---------------cCCCHHHHHHHHH
Confidence            456789999999999999999999999999999999999986 888887532               2355677788899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|++|||+.|++||||+|+||+++.++ .++|+|||.+..............++..|+|||...+ ...+.++|+||
T Consensus       107 ~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~  184 (254)
T cd06627         107 QVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-SGASTASDIWS  184 (254)
T ss_pred             HHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCcccccccccchhhcCHhhhcC-CCCCcchhHHH
Confidence            999999999999999999999999999887 8999999999876544433445578899999999876 44788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      +|+++|++++|..||................ .+            .....+++.+.+++.+||..+|++||++.+++.|
T Consensus       185 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         185 LGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HP------------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             HHHHHHHHHhCCCCCCCccHHHHHHHHhccC-CC------------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            9999999999999998766555444443211 11            1123578899999999999999999999999999


Q ss_pred             ccc
Q 039159          250 EYF  252 (259)
Q Consensus       250 ~~f  252 (259)
                      |||
T Consensus       252 ~~~  254 (254)
T cd06627         252 PWI  254 (254)
T ss_pred             CCC
Confidence            997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-38  Score=254.92  Aligned_cols=205  Identities=19%  Similarity=0.155  Sum_probs=161.0

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.+++.++||||+++++++.++...++||||+++ +|...+....              ..+.....+.++.|
T Consensus        60 ~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~q  125 (274)
T cd05076          60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--------------GRVPVAWKITVAQQ  125 (274)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--------------CCCCHHHHHHHHHH
Confidence            45788999999999999999999999999999999999996 7877775321              23445667889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCC------CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDG------KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~------~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ++.|++|||+.+++||||||+||++++.+      ..++++|||.+.....    .....++..|+|||.+.+...++.+
T Consensus       126 i~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~----~~~~~~~~~~~aPe~~~~~~~~~~~  201 (274)
T cd05076         126 LASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS----REERVERIPWIAPECVPGGNSLSTA  201 (274)
T ss_pred             HHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccccccc----ccccccCCcccCchhhcCCCCCCcH
Confidence            99999999999999999999999997543      1489999998754321    1223567889999998764567899


Q ss_pred             cchHhHHHHHHHHH-hCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMV-SGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +|+||||+++||++ +|..||..................               ....++.+.+++.+||+.+|++||++
T Consensus       202 ~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~cl~~~p~~Rps~  266 (274)
T cd05076         202 ADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRL---------------PEPSCKELATLISQCLTYEPTQRPSF  266 (274)
T ss_pred             HHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccCC---------------CCCCChHHHHHHHHHcccChhhCcCH
Confidence            99999999999995 689999876544432221111110               12345789999999999999999999


Q ss_pred             HHHhcC
Q 039159          244 AEALQQ  249 (259)
Q Consensus       244 ~~~l~h  249 (259)
                      ++++++
T Consensus       267 ~~il~~  272 (274)
T cd05076         267 RTILRD  272 (274)
T ss_pred             HHHHHh
Confidence            999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.1e-38  Score=252.94  Aligned_cols=217  Identities=21%  Similarity=0.252  Sum_probs=166.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+++++.++||||+++++.+..+...++||||+.+ +|.+++........          .......++.++.|
T Consensus        39 ~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------~~~~~~~~~~~~~q  108 (269)
T cd05042          39 QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVA----------QMAQKDVLQRMACE  108 (269)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhcccccc----------ccccHHHHHHHHHH
Confidence            45688999999999999999999999999999999999985 99998865332111          22345567788999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccC------ccCCC
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLG------LLEYS  162 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~------~~~~~  162 (259)
                      ++.|++|||+.+|+||||||+||+++.++ .+||+|||.+.......  .......+++.|+|||.+..      ...++
T Consensus       109 i~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~  187 (269)
T cd05042         109 VASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQT  187 (269)
T ss_pred             HHHHHHHHHhcCEecccccHhheEecCCC-cEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccc
Confidence            99999999999999999999999999988 89999999986532211  11233345677999998743      13467


Q ss_pred             cccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          163 TAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      .++|||||||++|++++ |..||................... .+.       ......+++...+++..|| .||++||
T Consensus       188 ~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~~-~dp~~Rp  258 (269)
T cd05042         188 KKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK-LPK-------PQLDLKYSDRWYEVMQFCW-LDPETRP  258 (269)
T ss_pred             hhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc-CCC-------CcccccCCHHHHHHHHHHh-cCccccc
Confidence            89999999999999999 788998877666555544332211 110       1112357788899999998 5999999


Q ss_pred             CHHHHhc
Q 039159          242 TAAEALQ  248 (259)
Q Consensus       242 ~~~~~l~  248 (259)
                      ++++|++
T Consensus       259 t~~~v~~  265 (269)
T cd05042         259 TAEEVHE  265 (269)
T ss_pred             CHHHHHH
Confidence            9999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.5e-38  Score=250.12  Aligned_cols=207  Identities=23%  Similarity=0.257  Sum_probs=166.3

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+.++++++||||+++++++. .+..++||||+++ +|.+++....              ..++...++.++.+
T Consensus        39 ~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~  103 (257)
T cd05115          39 RDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKK--------------DEITVSNVVELMHQ  103 (257)
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCC--------------CCCCHHHHHHHHHH
Confidence            456889999999999999999999986 4578999999986 8888875321              34566788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCCCcccch
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      ++.|++|||+++++||||||+||+++.++ .+||+|||.+.........   .....+++.|+|||.+.+ ..++.++|+
T Consensus       104 i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  181 (257)
T cd05115         104 VSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-RKFSSRSDV  181 (257)
T ss_pred             HHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc-CCCCchhhH
Confidence            99999999999999999999999999888 8999999998754322111   111123568999999876 567889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|++++ |..||...........+..... +..            ....++++.+++.+||..||++||+++++
T Consensus       182 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i  248 (257)
T cd05115         182 WSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-LDC------------PAECPPEMYALMKDCWIYKWEDRPNFAKV  248 (257)
T ss_pred             HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            999999999996 9999988777666555543322 111            13568999999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      .+
T Consensus       249 ~~  250 (257)
T cd05115         249 EE  250 (257)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.6e-38  Score=254.55  Aligned_cols=214  Identities=28%  Similarity=0.359  Sum_probs=174.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|+.+++.++||||+++++++.+....++|+||+++ +|...+......           ...++...++.++.+
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-----------~~~~~~~~~~~~~~~  114 (260)
T cd08222          46 TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHT-----------GKTLSENQVCEWFIQ  114 (260)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhc-----------ccccCHHHHHHHHHH
Confidence            34677899999999999999999999988899999999996 888887542111           134667788889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||+.+++|+||+|+||+++. + .++|+|||.+..............|++.|+|||.+.+ ..++.++|+|||
T Consensus       115 l~~~l~~lH~~~i~h~~l~~~nili~~-~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~sl  191 (260)
T cd08222         115 LLLGVHYMHQRRILHRDLKAKNIFLKN-N-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSL  191 (260)
T ss_pred             HHHHHHHHHHcCccccCCChhheEeec-C-CEeecccCceeecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHH
Confidence            999999999999999999999999974 4 6999999998765443333445568889999999876 567788999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      |+++|++++|..||...........+.... .+.            ....++.++.++|.+||..+|++||++.++++||
T Consensus       192 G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  258 (260)
T cd08222         192 GCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPS------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNP  258 (260)
T ss_pred             HHHHHHHHhCCCCCCCccHHHHHHHHHcCC-CCC------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCC
Confidence            999999999999998766555554443321 111            1135788999999999999999999999999999


Q ss_pred             cc
Q 039159          251 YF  252 (259)
Q Consensus       251 ~f  252 (259)
                      ||
T Consensus       259 ~~  260 (260)
T cd08222         259 FI  260 (260)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-38  Score=252.50  Aligned_cols=210  Identities=24%  Similarity=0.312  Sum_probs=172.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++.+|+.++++++||||+++++.+..++..+++|||+.+ +|.+++....              ..++...+..++.
T Consensus        48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~  113 (266)
T cd05033          48 QRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND--------------GKFTVGQLVGMLR  113 (266)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhcc--------------CCCCHHHHHHHHH
Confidence            345788999999999999999999999999999999999986 8998885421              2355677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +++.|++|||+++++||||||+||+++.++ .++|+|||.++........  .....+++.|+|||.+.+ ..++.++|+
T Consensus       114 ~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv  191 (266)
T cd05033         114 GIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDV  191 (266)
T ss_pred             HHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhcccccccceeccCCCCCccccChhhhcc-CCCccccch
Confidence            999999999999999999999999999888 8999999999876422221  112234578999999876 568889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|++++ |..||...........+......+.             ....++.+.+++.+||+.+|++||+++++
T Consensus       192 ~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei  258 (266)
T cd05033         192 WSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP-------------PMDCPSALYQLMLDCWQKDRNERPTFSQI  258 (266)
T ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            999999999998 9999987776666655544322221             13578899999999999999999999999


Q ss_pred             hcC
Q 039159          247 LQQ  249 (259)
Q Consensus       247 l~h  249 (259)
                      +++
T Consensus       259 ~~~  261 (266)
T cd05033         259 VST  261 (266)
T ss_pred             HHH
Confidence            864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-38  Score=263.33  Aligned_cols=225  Identities=34%  Similarity=0.534  Sum_probs=172.8

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeC------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      .+.+.+|+.++++++||||+++++++...      ...|++++++.++|.+.+..                ..+....+.
T Consensus        60 ~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~----------------~~l~~~~~~  123 (345)
T cd07877          60 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----------------QKLTDDHVQ  123 (345)
T ss_pred             HHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhc----------------CCCCHHHHH
Confidence            46788999999999999999999998643      34788999887788887743                224556678


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.|++.|++|||+.+++||||||+||+++.++ .++|+|||++....   .......+++.|+|||.+.+...++.++
T Consensus       124 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~  199 (345)
T cd07877         124 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTV  199 (345)
T ss_pred             HHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEeccccccccc---ccccccccCCCccCHHHHhCccCCCchh
Confidence            8899999999999999999999999999999988 89999999987542   2233446788999999987645678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC--cccc---------------ccccccccCCCCCCCHHHHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP--SFCK---------------LSLRDHLTNGFPGLEPAGIDL  228 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~--~~~~---------------~~~~~~~~~~~~~~~~~~~~l  228 (259)
                      |+|||||++|++++|++||...........+......+  ....               ..............++.+.++
T Consensus       200 DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  279 (345)
T cd07877         200 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL  279 (345)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHH
Confidence            99999999999999999998766554444332211100  0000               000001111223568899999


Q ss_pred             HHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          229 ISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |.+||+.||.+||++.++++||||++..
T Consensus       280 i~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         280 LEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             HHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence            9999999999999999999999998653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.8e-38  Score=261.97  Aligned_cols=229  Identities=29%  Similarity=0.469  Sum_probs=175.2

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeC----ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQG----IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ..++.+|+.+++++ +||||+++++.+...    ...+++++|+.++|...+...               ..+....+..
T Consensus        45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~---------------~~~~~~~~~~  109 (332)
T cd07857          45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG---------------QPLTDAHFQS  109 (332)
T ss_pred             HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHhcC---------------CCCCHHHHHH
Confidence            45788999999999 599999999975432    457899999988988888532               3355677888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC----CCcCCccCccccCcccccCccCCC
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG----ESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      ++.|++.||+|||+.|++||||||+||+++.++ .++|+|||.++.......    ......|++.|+|||.+.+...++
T Consensus       110 ~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  188 (332)
T cd07857         110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYT  188 (332)
T ss_pred             HHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCC
Confidence            999999999999999999999999999999888 899999999976533221    123346899999999987645678


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc-----------------ccccccccCCCCCCCHHH
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK-----------------LSLRDHLTNGFPGLEPAG  225 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~  225 (259)
                      .++|+||+|+++|++++|.+||.+.+.......+......+....                 ...........+..+..+
T Consensus       189 ~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (332)
T cd07857         189 KAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLA  268 (332)
T ss_pred             cHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHH
Confidence            999999999999999999999987765544443322111110000                 000011222234568899


Q ss_pred             HHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          226 IDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       226 ~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .+++.+||+.||.+|||++++++||||++..
T Consensus       269 ~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         269 LDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             HHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence            9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=251.79  Aligned_cols=213  Identities=29%  Similarity=0.379  Sum_probs=187.0

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ..-..|-++|+..+||.+..+...|...+.+|.||||+.| .|+..+...               ..++.....-+...|
T Consensus       213 AHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsre---------------r~FsE~RtRFYGaEI  277 (516)
T KOG0690|consen  213 AHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRE---------------RVFSEDRTRFYGAEI  277 (516)
T ss_pred             hhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhh---------------hcccchhhhhhhHHH
Confidence            4456788999999999999999999999999999999996 676666442               345555666677788


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      .+||.|||+.+|+.||+|.+|.++|++| ++||.|||+++..........+++|||.|.|||++.. ..|+.++|-|.+|
T Consensus       278 vsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~G  355 (516)
T KOG0690|consen  278 VSALGYLHSRNIVYRDLKLENLLLDKDG-HIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVG  355 (516)
T ss_pred             HHHhhhhhhCCeeeeechhhhheeccCC-ceEeeecccchhcccccceeccccCChhhcCchhhcc-ccccceeehhhhh
Confidence            8999999999999999999999999999 9999999999987777778889999999999999988 7899999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CHHHH
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAEA  246 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~~  246 (259)
                      +++|||+.|+.||.+.+....+..|........              ..++++++.|+..+|..||++|.     .+.|+
T Consensus       356 VVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP--------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi  421 (516)
T KOG0690|consen  356 VVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP--------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEI  421 (516)
T ss_pred             HHHHHHHhccCcccccchhHHHHHHHhhhccCC--------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHH
Confidence            999999999999999998888888765543221              36899999999999999999998     49999


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      .+|+||.++.
T Consensus       422 ~~h~FF~~v~  431 (516)
T KOG0690|consen  422 MRHRFFASVD  431 (516)
T ss_pred             HhhhhhccCC
Confidence            9999999874

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.6e-38  Score=260.91  Aligned_cols=223  Identities=22%  Similarity=0.324  Sum_probs=169.0

Q ss_pred             chhHHHHHHHhhC-CCCCeeEEEEEEEe-CceEEEEeeeecC-CHHHHhhcCCCCCCCccccc-----------------
Q 039159           13 SSMIREVSCLMEL-NHPNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKN-----------------   72 (259)
Q Consensus        13 ~~~~~Ei~~l~~l-~H~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~-----------------   72 (259)
                      ..+.+|+.+++++ +||||+++++++.. +..++++|||+.+ +|.+.+..............                 
T Consensus        55 ~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (337)
T cd05054          55 KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD  134 (337)
T ss_pred             HHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccc
Confidence            4677899999999 89999999998864 4578899999996 89888865332111000000                 


Q ss_pred             -----------------------------CCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEE
Q 039159           73 -----------------------------FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVK  123 (259)
Q Consensus        73 -----------------------------~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vk  123 (259)
                                                   ......++...+..++.+++.||+|||+++|+||||||+||+++.++ .++
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vk  213 (337)
T cd05054         135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVK  213 (337)
T ss_pred             cCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEE
Confidence                                         00012467788899999999999999999999999999999999888 899


Q ss_pred             EeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCC
Q 039159          124 VAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKS  200 (259)
Q Consensus       124 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~  200 (259)
                      |+|||++..+.....  ..+...++..|+|||++.+ ..++.++|||||||++|++++ |..||.+....+.........
T Consensus       214 L~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~  292 (337)
T cd05054         214 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG  292 (337)
T ss_pred             EeccccchhcccCcchhhccCCCCCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc
Confidence            999999986533221  1233455678999999987 578899999999999999998 999998754433333333222


Q ss_pred             CCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          201 RKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      ..+..            ....++++.+++.+||+.+|++||+++++++|
T Consensus       293 ~~~~~------------~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         293 TRMRA------------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CCCCC------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            21111            13467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.5e-38  Score=253.89  Aligned_cols=216  Identities=21%  Similarity=0.325  Sum_probs=171.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.++++++|+||+++++++.+.+..++||||+.| +|.+++........        ....+.+..++.++.+
T Consensus        53 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~--------~~~~~~~~~~~~~~~q  124 (277)
T cd05036          53 ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE--------RPSSLTMKDLLFCARD  124 (277)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCC--------CCCCCCHHHHHHHHHH
Confidence            35689999999999999999999999988899999999986 99998865432110        1134677888899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.|++|||+++++||||||+||+++.++  ..++|+|||.++.......  .......+..|+|||.+.+ ..++.++|
T Consensus       125 i~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  203 (277)
T cd05036         125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTD  203 (277)
T ss_pred             HHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhH
Confidence            99999999999999999999999998653  2589999999976532211  1222334567999999977 56899999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||||++|++++ |..||.+.........+...... .            ....+++.+.+++.+||+.+|++||++.+
T Consensus       204 iwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~  270 (277)
T cd05036         204 VWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL-D------------PPKGCPGPVYRIMTDCWQHTPEDRPNFAT  270 (277)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-C------------CCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            9999999999997 99999887766555444332211 1            12357889999999999999999999999


Q ss_pred             HhcC
Q 039159          246 ALQQ  249 (259)
Q Consensus       246 ~l~h  249 (259)
                      +++|
T Consensus       271 vl~~  274 (277)
T cd05036         271 ILER  274 (277)
T ss_pred             HHHH
Confidence            9976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.9e-38  Score=249.80  Aligned_cols=209  Identities=22%  Similarity=0.275  Sum_probs=166.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|++++++++||||+++++++..+...++||||+.+ +|.+.+....              ..+.....+.++.
T Consensus        36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~  101 (252)
T cd05084          36 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--------------PRLKVKELIQMVE  101 (252)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC--------------CCCCHHHHHHHHH
Confidence            346789999999999999999999999999999999999986 8888885321              2345667888899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      |++.||.|||+.+++||||||+||+++.++ .++|+|||.+.........  .....++..|+|||.+.+ ..++.++|+
T Consensus       102 qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  179 (252)
T cd05084         102 NAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY-GRYSSESDV  179 (252)
T ss_pred             HHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccccccCCCCCCceeecCchhhcC-CCCChHHHH
Confidence            999999999999999999999999999888 8999999998754321111  111123456999999977 567889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|++++ |..||...........+...... .            .....+..+.+++.+||+.+|++||++.++
T Consensus       180 ~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  246 (252)
T cd05084         180 WSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-P------------CPELCPDAVYRLMERCWEYDPGQRPSFSTV  246 (252)
T ss_pred             HHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC-C------------CcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            999999999998 88999776655544444322111 1            113467899999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       247 ~~  248 (252)
T cd05084         247 HQ  248 (252)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.9e-38  Score=250.26  Aligned_cols=207  Identities=21%  Similarity=0.255  Sum_probs=166.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+.+++.++||||+++++++. ++..++||||+.+ +|.+++...               ..++......++.
T Consensus        39 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~  102 (257)
T cd05116          39 LKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKN---------------KHVTEKNITELVH  102 (257)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            3457889999999999999999999885 4577899999995 898888532               2345567788999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      |++.|++|||+++++||||||+||+++.++ .++|+|||.+.........   .....+++.|+|||.+.+ ..++.++|
T Consensus       103 qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  180 (257)
T cd05116         103 QVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSD  180 (257)
T ss_pred             HHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhH
Confidence            999999999999999999999999999887 8999999999765332211   112234578999999866 56788999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +|||||++||+++ |..||...........+..... +..            ....++++.++|.+||+.||++||++++
T Consensus       181 i~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~~------------~~~~~~~l~~li~~~~~~~p~~Rp~~~~  247 (257)
T cd05116         181 VWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-MEC------------PQRCPPEMYDLMKLCWTYGVDERPGFAV  247 (257)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CCC------------CCCCCHHHHHHHHHHhccCchhCcCHHH
Confidence            9999999999998 9999987766655555543221 111            2357899999999999999999999999


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      |.+
T Consensus       248 i~~  250 (257)
T cd05116         248 VEL  250 (257)
T ss_pred             HHH
Confidence            875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1e-37  Score=249.55  Aligned_cols=211  Identities=23%  Similarity=0.268  Sum_probs=170.9

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|++++++++||||+++++++.. ...++++||+.+ +|.+.+.....             ..+.......++
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~  103 (257)
T cd05040          38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-------------GHFLISTLCDYA  103 (257)
T ss_pred             HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-------------ccCcHHHHHHHH
Confidence            345678899999999999999999999988 889999999985 99998864211             235667788889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .+++.||+|||+.+++||||+|+||+++.++ .+||+|||.+........   ......++..|+|||.+.+ ..++.++
T Consensus       104 ~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~  181 (257)
T cd05040         104 VQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHAS  181 (257)
T ss_pred             HHHHHHHHHHHhCCccccccCcccEEEecCC-EEEeccccccccccccccceecccCCCCCceecCHHHhcc-cCcCchh
Confidence            9999999999999999999999999999988 899999999976543221   1223356778999999876 5688899


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|+|++ |..||...+.......+........            .....+..+.+++.+||+.+|++||++.
T Consensus       182 Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~  249 (257)
T cd05040         182 DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE------------RPEACPQDIYNVMLQCWAHNPADRPTFA  249 (257)
T ss_pred             hhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC------------CCccCCHHHHHHHHHHCCCCcccCCCHH
Confidence            99999999999998 9999987776666555543211111            1134678999999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++++
T Consensus       250 ~~~~  253 (257)
T cd05040         250 ALRE  253 (257)
T ss_pred             HHHH
Confidence            9985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.6e-38  Score=254.36  Aligned_cols=212  Identities=27%  Similarity=0.362  Sum_probs=173.9

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|++++++++||||+++++++.++...++|+||+.| +|...+...               ..+....+..++
T Consensus        42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~  106 (258)
T cd05578          42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---------------VKFSEEQVKFWI  106 (258)
T ss_pred             hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc---------------CCcCHHHHHHHH
Confidence            3456889999999999999999999999999999999999987 888888542               234566788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|+.|||+.+++|+||+|+||+++.++ .++|+|||.+....... ......|+..|+|||.+.+ ..++.++|+|
T Consensus       107 ~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~  183 (258)
T cd05578         107 CEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCR-QGYSVAVDWW  183 (258)
T ss_pred             HHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCc-cccccCCChhhcCHHHHcc-cCCCCcccch
Confidence            9999999999999999999999999999888 89999999987653321 3344568889999999977 4578999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCh--HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH--H
Q 039159          169 PVGCIFGEMVSGKPLFPGANS--LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA--A  244 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~--~  244 (259)
                      |||+++|++++|..||.....  .......... ..+            ...+..++.+.++|.+||+.||++||++  +
T Consensus       184 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~  250 (258)
T cd05578         184 SLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADV------------LYPATWSTEAIDAINKLLERDPQKRLGDNLK  250 (258)
T ss_pred             hhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccc------------cCcccCcHHHHHHHHHHccCChhHcCCccHH
Confidence            999999999999999987663  2222222111 111            1123567999999999999999999999  9


Q ss_pred             HHhcCccc
Q 039159          245 EALQQEYF  252 (259)
Q Consensus       245 ~~l~h~~f  252 (259)
                      ++++||||
T Consensus       251 ~l~~~~~~  258 (258)
T cd05578         251 DLKNHPYF  258 (258)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-37  Score=250.19  Aligned_cols=214  Identities=26%  Similarity=0.388  Sum_probs=170.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ....++.+|++++++++|+|++++++++.+++..+++|||+++ +|..++......           ...+.......++
T Consensus        44 ~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~~  112 (267)
T cd08224          44 KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-----------KRLIPERTIWKYF  112 (267)
T ss_pred             hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhccc-----------CCCcCHHHHHHHH
Confidence            3466889999999999999999999999999999999999996 999888642211           0335667788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||+.|++||||+|+||+++.++ .++++|||.+..............+++.|+|||.+.+ ..++.++|+|
T Consensus       113 ~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~  190 (267)
T cd08224         113 VQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIW  190 (267)
T ss_pred             HHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeeccCCCcccceecCCccccCHHHhcc-CCCCchhcHH
Confidence            9999999999999999999999999999888 8999999998765443333444568889999999976 5688899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCh--HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          169 PVGCIFGEMVSGKPLFPGANS--LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||+++|++++|+.||.....  ......+... ..+..+           ....+..+.+++.+||..+|++||++.++
T Consensus       191 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~-----------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~i  258 (267)
T cd08224         191 SLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYPPLP-----------ADHYSEELRDLVSRCINPDPEKRPDISYV  258 (267)
T ss_pred             HHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC-CCCCCC-----------hhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            999999999999999965432  1122222111 111110           12567899999999999999999999998


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       259 l~  260 (267)
T cd08224         259 LQ  260 (267)
T ss_pred             HH
Confidence            75

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.7e-38  Score=264.65  Aligned_cols=224  Identities=21%  Similarity=0.287  Sum_probs=169.9

Q ss_pred             CCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCccc------------------
Q 039159           11 VPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST------------------   70 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~------------------   70 (259)
                      ..+.+.+|++++++++ ||||+++++++.+.+..|+||||+.+ +|.+++............                  
T Consensus        83 ~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (400)
T cd05105          83 EKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADES  162 (400)
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccccc
Confidence            3467899999999996 99999999999999999999999995 999888653211000000                  


Q ss_pred             ------------------cc---------------------------------------------CCCcchhHHHHHHHH
Q 039159           71 ------------------KN---------------------------------------------FNSYSLFTTFLLVEE   87 (259)
Q Consensus        71 ------------------~~---------------------------------------------~~~~~~~~~~~~~~~   87 (259)
                                        +.                                             ......++...++.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~  242 (400)
T cd05105         163 TRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSF  242 (400)
T ss_pred             ccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHH
Confidence                              00                                             000123556777889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.|++.|++|||+.+++||||||+||+++.++ .++|+|||+++.......  ......+++.|+|||.+.+ ..++.++
T Consensus       243 ~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~  320 (400)
T cd05105         243 TYQVARGMEFLASKNCVHRDLAARNVLLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLS  320 (400)
T ss_pred             HHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchh
Confidence            99999999999999999999999999999888 899999999976533222  2233456788999999977 5678999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|+|++ |..||..................+.            ....+++++.+++.+||+.||++||++.
T Consensus       321 DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~RPt~~  388 (400)
T cd05105         321 DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA------------KPDHATQEVYDIMVKCWNSEPEKRPSFL  388 (400)
T ss_pred             hHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC------------CCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence            99999999999997 8899987544433333322221111            1135788999999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++.+
T Consensus       389 ~l~~  392 (400)
T cd05105         389 HLSD  392 (400)
T ss_pred             HHHH
Confidence            8875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-37  Score=248.84  Aligned_cols=211  Identities=25%  Similarity=0.322  Sum_probs=168.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ....+++.+|+++++.++|||++++++++. ++..+++|||+.+ +|.+.+.....             .......+..+
T Consensus        42 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~  107 (260)
T cd05069          42 TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDG-------------KYLKLPQLVDM  107 (260)
T ss_pred             CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCC-------------CCCCHHHHHHH
Confidence            344567899999999999999999999885 4568899999986 89998854211             23456677888


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +.+++.|++|||+.+++||||||+||+++.++ .++|+|||.+........ ......++..|+|||...+ ...+.++|
T Consensus       108 ~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~D  185 (260)
T cd05069         108 AAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSD  185 (260)
T ss_pred             HHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHH
Confidence            99999999999999999999999999999888 899999999976532211 1122345678999998876 56888999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +||||+++|++++ |..||.+.........+......+             .....+..+.+++.+||..||++||++++
T Consensus       186 i~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  252 (260)
T cd05069         186 VWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP-------------CPQGCPESLHELMKLCWKKDPDERPTFEY  252 (260)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------CCcccCHHHHHHHHHHccCCcccCcCHHH
Confidence            9999999999999 899998877666665554432211             12357789999999999999999999999


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +++
T Consensus       253 i~~  255 (260)
T cd05069         253 IQS  255 (260)
T ss_pred             HHH
Confidence            984

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=279.45  Aligned_cols=217  Identities=24%  Similarity=0.331  Sum_probs=169.7

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCC-CCCeeEEEEE-EEe--C----ceEEEEeeeecC-CHHHHhhcCCCCCCCccccc
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELN-HPNIIRLMRV-ASQ--G----IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKN   72 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~-~~~--~----~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~   72 (259)
                      |++-..++.-.+.+.+||.+|++|. |+|||.|+|. ...  +    -.++|+||||+| +|.+++.....         
T Consensus        68 Krm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq---------  138 (738)
T KOG1989|consen   68 KRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ---------  138 (738)
T ss_pred             eeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHh---------
Confidence            3444445666678889999999997 9999999993 221  1    257899999995 99999974211         


Q ss_pred             CCCcchhHHHHHHHHHhhcccccccccCCC--ceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC---------c
Q 039159           73 FNSYSLFTTFLLVEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES---------S  141 (259)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~--i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~---------~  141 (259)
                          ..++..+++++++++++|+++||..+  |||||||-||||++.+| ..||||||.+..-.......         -
T Consensus       139 ----~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI  213 (738)
T KOG1989|consen  139 ----TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-NYKLCDFGSATTKILSPTSAQEVNYVEEEI  213 (738)
T ss_pred             ----ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-CEEeCcccccccccCCCccHHHHHHHHHHH
Confidence                44788999999999999999999875  99999999999999998 89999999986432221110         0


Q ss_pred             CCccCccccCcccccCc--cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCC-CCCccccccccccccCCC
Q 039159          142 AEVGTHYYKAPELLLGL--LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKS-RKPSFCKLSLRDHLTNGF  218 (259)
Q Consensus       142 ~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~  218 (259)
                      ....|+.|+|||++.-+  ...+.++|||||||+||.++....||.+.-..    .|+... ..|.             +
T Consensus       214 ~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng~Y~~P~-------------~  276 (738)
T KOG1989|consen  214 EKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNGNYSFPP-------------F  276 (738)
T ss_pred             HhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEeccccCCC-------------C
Confidence            11479999999998532  45689999999999999999999999865322    222222 1222             3


Q ss_pred             CCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       219 ~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      +.++..+.+||+.||+.||++||++-+++.+
T Consensus       277 p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  277 PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            5789999999999999999999999999863

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-38  Score=262.35  Aligned_cols=225  Identities=33%  Similarity=0.532  Sum_probs=174.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCc------eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGI------YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ..+.+.+|++++++++||||+++++++..+.      ..++||||+.++|..++..                ..++...+
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----------------~~l~~~~~  120 (343)
T cd07880          57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH----------------EKLSEDRI  120 (343)
T ss_pred             HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc----------------CCCCHHHH
Confidence            3456889999999999999999999997654      4589999997788877742                23455677


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ..++.|++.|++|||+.||+||||||+||+++.++ .++++|||.+.....   ......+++.|+|||.+.+...++.+
T Consensus       121 ~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~  196 (343)
T cd07880         121 QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQTDS---EMTGYVVTRWYRAPEVILNWMHYTQT  196 (343)
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeccccccccc---CccccccCCcccCHHHHhCCCCCCcH
Confidence            88999999999999999999999999999999888 899999999875422   22334678899999999764457889


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCc-----------ccc------ccccccccCCCCCCCHHHHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS-----------FCK------LSLRDHLTNGFPGLEPAGID  227 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~-----------~~~------~~~~~~~~~~~~~~~~~~~~  227 (259)
                      +|+||+|+++|++++|..||.+.........+......+.           ...      ...........+..++.+.+
T Consensus       197 ~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (343)
T cd07880         197 VDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVN  276 (343)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHH
Confidence            9999999999999999999987765544444322111100           000      00000111223467889999


Q ss_pred             HHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          228 LISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       228 li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ++.+||..||++|||+.++++||||+..
T Consensus       277 li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         277 VLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            9999999999999999999999999875

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=256.05  Aligned_cols=224  Identities=38%  Similarity=0.568  Sum_probs=174.5

Q ss_pred             hhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           14 SMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        14 ~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      ...+|+..+++++ ||||+++++++.+++..++||||+.|+|.+.+.....             ..+....++.++.+++
T Consensus        43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~l~  109 (283)
T cd07830          43 MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKG-------------KPFSESVIRSIIYQIL  109 (283)
T ss_pred             HHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecCCCCHHHHHHhccc-------------ccCCHHHHHHHHHHHH
Confidence            4567999999999 9999999999999999999999998899888864321             3456778889999999


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHHH
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGC  172 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~  172 (259)
                      .++.|||+++++|+||+|+||+++.++ .++|+|||.+...... .......++..|+|||.+.+...++.++|+||||+
T Consensus       110 ~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~  187 (283)
T cd07830         110 QGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSR-PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGC  187 (283)
T ss_pred             HHHHHHHHCCcccCCCChhhEEEcCCC-CEEEeecccceeccCC-CCcCCCCCcccccCceeeecCcCcCCccchhhHHH
Confidence            999999999999999999999999888 8999999999765332 22233467889999999866456788999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc----------------ccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          173 IFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK----------------LSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       173 ~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                      +++++++|++||...........+......+....                ...........+..++++.+++.+||+.|
T Consensus       188 ~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  267 (283)
T cd07830         188 IMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWD  267 (283)
T ss_pred             HHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccC
Confidence            99999999999987765554443322111110000                00000111122345789999999999999


Q ss_pred             CCCccCHHHHhcCccc
Q 039159          237 PDKRITAAEALQQEYF  252 (259)
Q Consensus       237 p~~Rp~~~~~l~h~~f  252 (259)
                      |++||++++++.||||
T Consensus       268 p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         268 PKKRPTASQALQHPYF  283 (283)
T ss_pred             cccCCCHHHHhhCCCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.9e-37  Score=251.42  Aligned_cols=223  Identities=19%  Similarity=0.215  Sum_probs=173.5

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCC-cccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNG-YSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+.+|+.+++.++||||+++++++......++++||+.+ +|.+++......... ...........+....+..++.
T Consensus        52 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  131 (283)
T cd05091          52 REEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT  131 (283)
T ss_pred             HHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence            45688999999999999999999999999999999999985 888887432111000 0001111113466677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      |++.|++|+|+++++||||||+||+++.++ .+||+|||+++.......  ......+++.|+|||.+.+ ..++.++||
T Consensus       132 ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  209 (283)
T cd05091         132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDI  209 (283)
T ss_pred             HHHHHHHHHHHcCccccccchhheEecCCC-ceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhH
Confidence            999999999999999999999999999888 799999999876533221  1233456788999999976 568889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++|||++ |..||.+.........+......+             .....++.+.+++.+||+.+|++||+++++
T Consensus       210 ~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i  276 (283)
T cd05091         210 WSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP-------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDI  276 (283)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence            999999999998 888998877766666655433221             123578899999999999999999999999


Q ss_pred             hcC
Q 039159          247 LQQ  249 (259)
Q Consensus       247 l~h  249 (259)
                      +..
T Consensus       277 ~~~  279 (283)
T cd05091         277 HSR  279 (283)
T ss_pred             HHH
Confidence            863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-37  Score=251.41  Aligned_cols=211  Identities=23%  Similarity=0.316  Sum_probs=166.1

Q ss_pred             hHHHHHH---HhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           15 MIREVSC---LMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        15 ~~~Ei~~---l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      +..|..+   ++..+||||+++++++..++..++||||+.| +|...+...               ..++...+..++.|
T Consensus        41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~---------------~~l~~~~~~~~~~q  105 (278)
T cd05606          41 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---------------GVFSEAEMRFYAAE  105 (278)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            4445444   4445799999999999999999999999996 787766431               34667788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||+.+++||||||+||+++.++ .++|+|||.+......  ......|+..|+|||.+.+...++.++|+||+
T Consensus       106 l~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~  182 (278)
T cd05606         106 IILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSL  182 (278)
T ss_pred             HHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhH
Confidence            99999999999999999999999999888 8999999998754322  22344689999999999764567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChH--HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CH
Q 039159          171 GCIFGEMVSGKPLFPGANSL--ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TA  243 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~  243 (259)
                      |+++|+|++|..||.+....  .......... .+.            .....++++.+++.+||..+|.+||     ++
T Consensus       183 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~------------~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~  249 (278)
T cd05606         183 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVE------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA  249 (278)
T ss_pred             HHHHHHHHhCCCCCCCCCccchHHHHHHhhcc-CCC------------CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCH
Confidence            99999999999999865321  1111111110 111            1134689999999999999999999     99


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      +++++||||+...
T Consensus       250 ~~ll~~~~~~~~~  262 (278)
T cd05606         250 QEVKEHPFFRSLD  262 (278)
T ss_pred             HHHHhCccccCCC
Confidence            9999999998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-37  Score=251.30  Aligned_cols=216  Identities=23%  Similarity=0.313  Sum_probs=169.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeC------ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      ...+.+.+|+++++.++||||+++++++...      ...+++|||+.+ +|...+........         ...++..
T Consensus        42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~---------~~~~~~~  112 (272)
T cd05075          42 SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC---------PQYLPTQ  112 (272)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCC---------cccCCHH
Confidence            3356788999999999999999999987532      256899999985 88887743211100         1345677


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      ....++.+++.|++|||+++|+||||||+||+++.++ .++|+|||+++.......  ......+++.|++||...+ ..
T Consensus       113 ~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~  190 (272)
T cd05075         113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RV  190 (272)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CC
Confidence            7888999999999999999999999999999999888 899999999986533221  1223345678999999977 56


Q ss_pred             CCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          161 YSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      ++.++|+||||+++|++++ |+.||.+.........+......+             ..+..++.+.+++.+||..||++
T Consensus       191 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~  257 (272)
T cd05075         191 YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK-------------QPPDCLDGLYSLMSSCWLLNPKD  257 (272)
T ss_pred             cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcCCCccc
Confidence            8899999999999999999 789998877666655554432211             12357788999999999999999


Q ss_pred             ccCHHHHhcC
Q 039159          240 RITAAEALQQ  249 (259)
Q Consensus       240 Rp~~~~~l~h  249 (259)
                      |||+++++++
T Consensus       258 Rps~~~l~~~  267 (272)
T cd05075         258 RPSFETLRCE  267 (272)
T ss_pred             CcCHHHHHHH
Confidence            9999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=250.73  Aligned_cols=216  Identities=21%  Similarity=0.297  Sum_probs=172.4

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ..+.+|+++++.++||||+++++++..+...++||||+.+ +|.+.+........     .........+..++.++.++
T Consensus        54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i  128 (277)
T cd05032          54 IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAE-----NNPGLGPPTLQKFIQMAAEI  128 (277)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchh-----hccCCCCCCHHHHHHHHHHH
Confidence            4688999999999999999999999999999999999984 99999864321110     00111345667788899999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchHh
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +.|++|||+.+++||||||+||+++.++ .++|+|||.++.......  ......++..|+|||.+.+ ..++.++||||
T Consensus       129 ~~~l~~lH~~~i~H~di~p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s  206 (277)
T cd05032         129 ADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWS  206 (277)
T ss_pred             HHHHHHHHhCCccccccChheEEEcCCC-CEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHH
Confidence            9999999999999999999999999988 899999999876543221  2334456788999999976 46888999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          170 VGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||++|++++ |..||.+.........+.... .+..            ....+.++.+++.+||+.+|++|||+.+++.
T Consensus       207 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         207 FGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG-HLDL------------PENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHHHHHHhhccCCCCCccCCHHHHHHHHhcCC-CCCC------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9999999998 899998877666665554222 1111            1345789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-37  Score=249.80  Aligned_cols=217  Identities=17%  Similarity=0.175  Sum_probs=163.8

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.++++++||||+++++++.+....++||||+++ +|.+++........          .......+..++.|
T Consensus        39 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------~~~~~~~~~~~~~q  108 (269)
T cd05087          39 QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAEL----------MTPDPTTLQRMACE  108 (269)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhccc----------ccccHHHHHHHHHH
Confidence            34788999999999999999999999988899999999995 89888864321110          22344566678889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCc------cCCC
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGL------LEYS  162 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~  162 (259)
                      ++.|++|||+.+++||||||+||+++.++ .++|+|||.++.......  ......+++.|+|||.+.+.      ..++
T Consensus       109 i~~al~~lH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~  187 (269)
T cd05087         109 IALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQT  187 (269)
T ss_pred             HHHHHHHHHHCCEeccccCcceEEEcCCC-cEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCC
Confidence            99999999999999999999999999887 899999999865322211  12234567889999998642      1357


Q ss_pred             cccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          163 TAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      .++|+||||+++|++++ |..||......+........... ..+       ........++.+.+++.+|+ .+|++||
T Consensus       188 ~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rp  258 (269)
T cd05087         188 KESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRP  258 (269)
T ss_pred             ccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-CCC-------CCccCCCCChHHHHHHHHHh-cCcccCC
Confidence            79999999999999996 99999876655544333222111 000       00111246788899999998 6899999


Q ss_pred             CHHHHhc
Q 039159          242 TAAEALQ  248 (259)
Q Consensus       242 ~~~~~l~  248 (259)
                      |+++|+.
T Consensus       259 t~~~l~~  265 (269)
T cd05087         259 SAEEVHL  265 (269)
T ss_pred             CHHHHHH
Confidence            9999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.8e-38  Score=252.73  Aligned_cols=212  Identities=25%  Similarity=0.372  Sum_probs=168.5

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|+.+++.++||||+++++++..++..+++|||+.| +|.+++......           ...++......++.+
T Consensus        46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~~~~  114 (267)
T cd08229          46 RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ-----------KRLIPEKTVWKYFVQ  114 (267)
T ss_pred             HHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhcc-----------CCCCCHHHHHHHHHH
Confidence            45788999999999999999999999999999999999996 898888532111           134566778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||+.|++|+||||+||+++.++ .++++|||.+..............+++.|+|||.+.+ ..++.++|+|||
T Consensus       115 i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~sl  192 (267)
T cd08229         115 LCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSL  192 (267)
T ss_pred             HHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhccccCCcccccccCCcCccCHHHhcC-CCccchhhHHHH
Confidence            99999999999999999999999999888 8999999998765433333344568899999999976 567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChH--HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          171 GCIFGEMVSGKPLFPGANSL--ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |+++|++++|..||.+....  .....+. ....+..           .....++.+.+++.+||..||++|||+.++++
T Consensus       193 G~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         193 GCLLYEMAALQSPFYGDKMNLYSLCKKIE-QCDYPPL-----------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhCCCCcccccchHHHHhhhhh-cCCCCCC-----------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            99999999999999754322  1111111 1111111           11347889999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-37  Score=252.57  Aligned_cols=222  Identities=23%  Similarity=0.284  Sum_probs=173.4

Q ss_pred             chhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCccc-ccCCCcchhHHHHHHHHHh
Q 039159           13 SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST-KNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        13 ~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   89 (259)
                      .++.+|+.+++++ +||||+++++++..+..++++|||+.+ +|..+++........... ........++...++.++.
T Consensus        60 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  139 (293)
T cd05053          60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY  139 (293)
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence            4688999999999 799999999999999999999999985 999998653211110000 0112224577788899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      |++.|++|||+.+++||||||+||+++.++ .++|+|||.++.......  ......++..|+|||.+.+ ..++.++||
T Consensus       140 qi~~al~~LH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  217 (293)
T cd05053         140 QVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDV  217 (293)
T ss_pred             HHHHHHHHHHHCCccccccceeeEEEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccce
Confidence            999999999999999999999999999888 899999999976543221  1122234567999999876 568899999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++|++++ |..||.+.........+...... .            .....++.+.+++.+||..||++|||++++
T Consensus       218 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ei  284 (293)
T cd05053         218 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRM-E------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQL  284 (293)
T ss_pred             eehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC-C------------CCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence            999999999997 89999887766665554433211 1            123567899999999999999999999999


Q ss_pred             hcC
Q 039159          247 LQQ  249 (259)
Q Consensus       247 l~h  249 (259)
                      +++
T Consensus       285 l~~  287 (293)
T cd05053         285 VED  287 (293)
T ss_pred             HHH
Confidence            864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-37  Score=247.67  Aligned_cols=210  Identities=25%  Similarity=0.325  Sum_probs=168.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|+.++++++|||++++++++.+ ...+++|||+.+ +|.+.+.....             ..++......++
T Consensus        43 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~  108 (260)
T cd05070          43 MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEG-------------RALKLPNLVDMA  108 (260)
T ss_pred             CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCC-------------CCCCHHHHHHHH
Confidence            345679999999999999999999998854 567899999986 89998854211             235667788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.|++|||+.+++||||||+||+++.++ .++|+|||.+........ ......++..|+|||...+ ..++.++|+
T Consensus       109 ~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  186 (260)
T cd05070         109 AQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDV  186 (260)
T ss_pred             HHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-CCCcchhhh
Confidence            9999999999999999999999999999887 899999999976433211 1112234567999999876 567889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|++++ |.+||.+....+....+......+             .....+..+.+++.+||..+|++|||++++
T Consensus       187 ~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  253 (260)
T cd05070         187 WSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP-------------CPQDCPISLHELMLQCWKKDPEERPTFEYL  253 (260)
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------CCCcCCHHHHHHHHHHcccCcccCcCHHHH
Confidence            999999999999 899998877766666654332211             123577899999999999999999999998


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      .+
T Consensus       254 ~~  255 (260)
T cd05070         254 QS  255 (260)
T ss_pred             HH
Confidence            73

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.9e-37  Score=251.22  Aligned_cols=222  Identities=23%  Similarity=0.289  Sum_probs=172.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc------c---ccCCCcchhHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS------T---KNFNSYSLFTT   81 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~------~---~~~~~~~~~~~   81 (259)
                      ..++.+|+.+++.++||||+++++.+..++..++++||+.+ +|.+++...........      .   ........+..
T Consensus        47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  126 (290)
T cd05045          47 LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM  126 (290)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCH
Confidence            35688999999999999999999999999999999999995 89988865322111000      0   00111234677


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCcc
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      ..++.++.+++.|++|||+++++||||||+||+++.++ .++|+|||+++.......  ......++..|+|||.+.+ .
T Consensus       127 ~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~  204 (290)
T cd05045         127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-H  204 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc-C
Confidence            88899999999999999999999999999999999887 899999999875433221  1223345678999999876 5


Q ss_pred             CCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      .++.++||||||+++|+|++ |..||.+.........+...... .            ....++.++.+++..||+.+|+
T Consensus       205 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~~i~~cl~~~P~  271 (290)
T cd05045         205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM-E------------RPENCSEEMYNLMLTCWKQEPD  271 (290)
T ss_pred             CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-C------------CCCCCCHHHHHHHHHHccCCcc
Confidence            68899999999999999998 99999887766555444322111 1            1135788999999999999999


Q ss_pred             CccCHHHHhc
Q 039159          239 KRITAAEALQ  248 (259)
Q Consensus       239 ~Rp~~~~~l~  248 (259)
                      +||+++++++
T Consensus       272 ~Rp~~~~i~~  281 (290)
T cd05045         272 KRPTFADISK  281 (290)
T ss_pred             cCCCHHHHHH
Confidence            9999999984

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=248.10  Aligned_cols=210  Identities=24%  Similarity=0.354  Sum_probs=170.3

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+|++++++++||||+++++++.+.  +.+++++||+++ +|.+.+...               ..+.......++.
T Consensus        49 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---------------~~l~~~~~~~~~~  113 (264)
T cd06653          49 NALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY---------------GALTENVTRRYTR  113 (264)
T ss_pred             HHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            4788999999999999999999998764  468899999986 888887532               2244566778889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC---CCCcCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK---GESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +++.|+.|||+.+++|+||||+||+++.++ .++|+|||.++......   .......++..|+|||.+.+ ...+.++|
T Consensus       114 ~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  191 (264)
T cd06653         114 QILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKAD  191 (264)
T ss_pred             HHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECccccccccccccccCccccccCCcccccCHhhhcC-CCCCcccc
Confidence            999999999999999999999999999888 89999999997653211   11223468889999999987 56788999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      +|||||++|++++|..||.+........++......+..            ...+++.+.+++.+||+ +|++||++.++
T Consensus       192 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~  258 (264)
T cd06653         192 VWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML------------PDGVSDACRDFLKQIFV-EEKRRPTAEFL  258 (264)
T ss_pred             HHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCC------------CcccCHHHHHHHHHHhc-CcccCccHHHH
Confidence            999999999999999999877666555555433222222            24688999999999999 57999999999


Q ss_pred             hcCccc
Q 039159          247 LQQEYF  252 (259)
Q Consensus       247 l~h~~f  252 (259)
                      +.|||+
T Consensus       259 ~~~~~~  264 (264)
T cd06653         259 LRHPFV  264 (264)
T ss_pred             hcCCCC
Confidence            999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.7e-37  Score=254.17  Aligned_cols=222  Identities=23%  Similarity=0.283  Sum_probs=170.5

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccc-cCCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTK-NFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+|+.++.++ +||||+++++++..++..++||||+++ +|.+++............. .......++...++.++
T Consensus        51 ~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  130 (303)
T cd05088          51 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA  130 (303)
T ss_pred             HHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHH
Confidence            35678899999999 899999999999999999999999985 8999986543211100000 01111356778889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||++|++||||||+||+++.++ .++|+|||++...... .......++..|+|||.+.+ ..++.++|||
T Consensus       131 ~qi~~al~~LH~~gi~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  207 (303)
T cd05088         131 ADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVW  207 (303)
T ss_pred             HHHHHHHHHHHhCCccccccchheEEecCCC-cEEeCccccCcccchh-hhcccCCCcccccCHHHHhc-cCCcccccch
Confidence            9999999999999999999999999999888 8999999998643211 11122234567999998876 5678899999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++|+++| |..||......+....+......             ......++++.+++.+||+.+|++||++++++
T Consensus       208 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il  274 (303)
T cd05088         208 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQIL  274 (303)
T ss_pred             hhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcC-------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            99999999998 99999876665555444222111             11134678999999999999999999999998


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      ++
T Consensus       275 ~~  276 (303)
T cd05088         275 VS  276 (303)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=247.42  Aligned_cols=207  Identities=22%  Similarity=0.231  Sum_probs=167.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|+++++.++||||+++++++. ++..++||||+.+ +|.+++...               ..+....++.++.
T Consensus        39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~  102 (257)
T cd05060          39 GKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKR---------------REIPVSDLKELAH  102 (257)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhC---------------CCCCHHHHHHHHH
Confidence            4567889999999999999999999876 4568999999985 899988542               2345677889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC---cCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      |++.|++|||+.+++||||||+||+++.++ .++|+|||.++.........   ....++..|+|||.+.+ ..++.++|
T Consensus       103 qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  180 (257)
T cd05060         103 QVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSD  180 (257)
T ss_pred             HHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccccccCccccccccCHHHhcC-CCCCccch
Confidence            999999999999999999999999999888 89999999997653322211   11123467999999976 56888999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +||||+++|++++ |.+||...........+......             ......++.+.+++.+||..+|++||++.+
T Consensus       181 i~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~  247 (257)
T cd05060         181 VWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-------------PRPEECPQEIYSIMLSCWKYRPEDRPTFSE  247 (257)
T ss_pred             HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence            9999999999998 99999887766555555433221             112357889999999999999999999999


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +++
T Consensus       248 l~~  250 (257)
T cd05060         248 LES  250 (257)
T ss_pred             HHH
Confidence            984

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-37  Score=252.64  Aligned_cols=223  Identities=22%  Similarity=0.259  Sum_probs=174.3

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCccccc-CCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKN-FNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   88 (259)
                      ..++.+|+.+++.+ +||||+++++++......+++|||+.+ +|.+++.............. ......++...++.++
T Consensus        64 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (304)
T cd05101          64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCT  143 (304)
T ss_pred             HHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHH
Confidence            45788999999999 899999999999999999999999985 99999875432111111000 0112356677888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .|++.|+.|||++|++||||||+||+++.++ .++|+|||.++........  .....+++.|+|||.+.+ ..++.++|
T Consensus       144 ~qi~~al~~LH~~givH~dlkp~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  221 (304)
T cd05101         144 YQVARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSD  221 (304)
T ss_pred             HHHHHHHHHHHHCCeeecccccceEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhh
Confidence            9999999999999999999999999999888 8999999999765332211  222345678999999977 56889999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||+++|++++ |..||.+.........+...... .            .....+..+.+++.+||..+|++||++.+
T Consensus       222 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e  288 (304)
T cd05101         222 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM-D------------KPANCTNELYMMMRDCWHAIPSHRPTFKQ  288 (304)
T ss_pred             HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-C------------CCCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence            9999999999998 78899877766665555433211 1            12357899999999999999999999999


Q ss_pred             HhcC
Q 039159          246 ALQQ  249 (259)
Q Consensus       246 ~l~h  249 (259)
                      +++.
T Consensus       289 ~l~~  292 (304)
T cd05101         289 LVED  292 (304)
T ss_pred             HHHH
Confidence            9863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-37  Score=248.03  Aligned_cols=222  Identities=23%  Similarity=0.275  Sum_probs=170.5

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCc-ccccCCCcchhHHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGY-STKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   87 (259)
                      ..+.+.+|+++++++ +||||+++++++..++..+++|||+++ +|.+++.......... ..........++...+..+
T Consensus        38 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  117 (270)
T cd05047          38 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF  117 (270)
T ss_pred             HHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHH
Confidence            345788999999999 799999999999999999999999985 9999986533211100 0011111234667888999


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.|++|||+++++||||||+||+++.++ .++++|||++...... ........+..|+|||.+.+ ..++.++|+
T Consensus       118 ~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~dfgl~~~~~~~-~~~~~~~~~~~y~apE~~~~-~~~~~~~Di  194 (270)
T cd05047         118 AADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDV  194 (270)
T ss_pred             HHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECCCCCccccchh-hhccCCCCccccCChHHHcc-CCCCchhhH
Confidence            99999999999999999999999999999888 8999999998632211 11112233567999999876 568889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|+|++ |..||.+.+.......+......             ......+.++.+++.+||..||.+||++.++
T Consensus       195 ~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  261 (270)
T cd05047         195 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQI  261 (270)
T ss_pred             HHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC-------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence            999999999997 99999877665555544332111             0113467899999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       262 l~  263 (270)
T cd05047         262 LV  263 (270)
T ss_pred             HH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.9e-37  Score=249.40  Aligned_cols=209  Identities=24%  Similarity=0.303  Sum_probs=170.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+.++++++||||+++++++..++..++||||+++ +|.+.+....              ..+....+..++.
T Consensus        48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~  113 (267)
T cd05066          48 QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD--------------GQFTVIQLVGMLR  113 (267)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcC--------------CCCCHHHHHHHHH
Confidence            346789999999999999999999999999999999999986 8888885321              2345567788899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC---cCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +++.|++|||+.+++||||||+||+++.++ .++++|||.+..........   ....++..|+|||.+.+ ..++.++|
T Consensus       114 ~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~D  191 (267)
T cd05066         114 GIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASD  191 (267)
T ss_pred             HHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc-CccCchhh
Confidence            999999999999999999999999999888 89999999997654322111   11223567999999977 56889999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +||||+++|++++ |..||.+....+....+......+.             ....++.+.+++.+||+.+|.+||++.+
T Consensus       192 v~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~  258 (267)
T cd05066         192 VWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-------------PMDCPAALHQLMLDCWQKDRNERPKFEQ  258 (267)
T ss_pred             hHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC-------------CCCCCHHHHHHHHHHcccCchhCCCHHH
Confidence            9999999999886 9999988776666655554322211             2356889999999999999999999999


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +++
T Consensus       259 i~~  261 (267)
T cd05066         259 IVS  261 (267)
T ss_pred             HHH
Confidence            985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-37  Score=256.41  Aligned_cols=210  Identities=20%  Similarity=0.225  Sum_probs=165.6

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|+.+++.++||||++++|++..+ ..++++||+.+ +|.+.+....              ..+....++.++
T Consensus        51 ~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~--------------~~~~~~~~~~~~  115 (316)
T cd05108          51 KANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK--------------DNIGSQYLLNWC  115 (316)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhcc--------------ccCCHHHHHHHH
Confidence            3456788999999999999999999999765 56789999885 8988886421              224456677888


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .+++.||+|||+.+++||||||+||+++.++ .+||+|||+++........  .....++..|+|||.+.+ ..++.++|
T Consensus       116 ~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~D  193 (316)
T cd05108         116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSD  193 (316)
T ss_pred             HHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEccccccccccCCCcceeccCCccceeecChHHhcc-CCCCchhh
Confidence            9999999999999999999999999999888 8999999999865433221  112234667999999977 56889999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||+++||+++ |..||.+....... .+......+..            .+..+.++.+++.+||..||++||++.+
T Consensus       194 i~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rps~~~  260 (316)
T cd05108         194 VWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ------------PPICTIDVYMIMVKCWMIDADSRPKFRE  260 (316)
T ss_pred             hHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCC------------CCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999997 99999876655443 33322211111            1346788999999999999999999999


Q ss_pred             HhcC
Q 039159          246 ALQQ  249 (259)
Q Consensus       246 ~l~h  249 (259)
                      ++.+
T Consensus       261 l~~~  264 (316)
T cd05108         261 LIIE  264 (316)
T ss_pred             HHHH
Confidence            9975

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-37  Score=247.24  Aligned_cols=213  Identities=33%  Similarity=0.459  Sum_probs=174.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ..+.+.+|+.++++++||||+++++.+..+  ...++++||+.+ +|.+.+...               ..+....+..+
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~  106 (260)
T cd06606          42 ELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF---------------GKLPEPVIRKY  106 (260)
T ss_pred             HHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHc---------------CCCCHHHHHHH
Confidence            356789999999999999999999999988  899999999975 888888542               24556777888


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.+++.|++|||+.+++|+||+|+||+++.++ .++|+|||.+........  ......++..|.|||.+.+ ...+.++
T Consensus       107 ~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~  184 (260)
T cd06606         107 TRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-EEYGRAA  184 (260)
T ss_pred             HHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEecccccccccccCCCCCccccCHhhhcC-CCCCchh
Confidence            99999999999999999999999999999887 899999999976544332  1344568889999999977 4588999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGAN-SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |+||||++++++++|..||.... .......+......+.            .....++.+.+++.+||..||++||++.
T Consensus       185 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~  252 (260)
T cd06606         185 DIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE------------IPEHLSEEAKDFLRKCLRRDPKKRPTAD  252 (260)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcC------------CCcccCHHHHHHHHHhCcCChhhCCCHH
Confidence            99999999999999999998765 2222222221111111            1234588999999999999999999999


Q ss_pred             HHhcCccc
Q 039159          245 EALQQEYF  252 (259)
Q Consensus       245 ~~l~h~~f  252 (259)
                      ++++||||
T Consensus       253 ~ll~~~~~  260 (260)
T cd06606         253 ELLQHPFL  260 (260)
T ss_pred             HHhhCCCC
Confidence            99999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.1e-37  Score=247.20  Aligned_cols=210  Identities=24%  Similarity=0.340  Sum_probs=168.6

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|+.++++++||||+++++++. ++..+++|||+.+ +|.+.+....+             ..+...+...++
T Consensus        43 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~i~  108 (260)
T cd05067          43 MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEG-------------IKLTINKLIDMA  108 (260)
T ss_pred             CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCC-------------CCCCHHHHHHHH
Confidence            33568999999999999999999999874 4578999999985 89888754321             235566778889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.|++|||+.+++||||||+||+++.++ .++|+|||.+........ ......++..|+|||.+.+ ..++.++|+
T Consensus       109 ~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di  186 (260)
T cd05067         109 AQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDV  186 (260)
T ss_pred             HHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccch
Confidence            9999999999999999999999999999888 899999999976542211 1223345678999999876 567889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|++++ |+.||.+.+.......+......+             .....+.++.+++.+||+.+|++||+++++
T Consensus       187 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l  253 (260)
T cd05067         187 WSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP-------------RPDNCPEELYELMRLCWKEKPEERPTFEYL  253 (260)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            999999999999 999998877666655543332211             123467899999999999999999999998


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      +.
T Consensus       254 ~~  255 (260)
T cd05067         254 RS  255 (260)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=247.67  Aligned_cols=211  Identities=33%  Similarity=0.431  Sum_probs=176.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|++++++++||||+++++.+..++..+++|||+.+ +|.+.+...               ..++......++.
T Consensus        36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~~  100 (250)
T cd05123          36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE---------------GRFSEERARFYAA  100 (250)
T ss_pred             HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            345789999999999999999999999999999999999964 898888542               2345677788899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.|+.|+|+.+++|+||+|+||+++.++ .++|+|||.+..............++..|+|||...+ ...+.++|+||
T Consensus       101 qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~s  178 (250)
T cd05123         101 EIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWS  178 (250)
T ss_pred             HHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcCCccccChHHhCC-CCCCchhhHHH
Confidence            999999999999999999999999999888 8999999999765443334455678889999999977 45788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH---HHH
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA---AEA  246 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~---~~~  246 (259)
                      ||+++|++++|..||...........+....  ..            .....+..+.+++.+||..||++||++   +++
T Consensus       179 lG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l  244 (250)
T cd05123         179 LGVLLYEMLTGKPPFYAEDRKEIYEKILKDP--LR------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEI  244 (250)
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--CC------------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHH
Confidence            9999999999999998777655555544311  11            112357899999999999999999999   999


Q ss_pred             hcCccc
Q 039159          247 LQQEYF  252 (259)
Q Consensus       247 l~h~~f  252 (259)
                      ++||||
T Consensus       245 ~~~~~f  250 (250)
T cd05123         245 KAHPFF  250 (250)
T ss_pred             HhCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-37  Score=246.98  Aligned_cols=207  Identities=26%  Similarity=0.332  Sum_probs=169.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|+.+++.++|+||+++++++..++..++||||+++ +|.+++.....             ..+.......++.
T Consensus        43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~  109 (256)
T cd05039          43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-------------AVITLAQQLGFAL  109 (256)
T ss_pred             HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCC-------------CCCCHHHHHHHHH
Confidence            356899999999999999999999999988999999999995 99998864221             2456778889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.|+.|||+++++||||||+||+++.++ .++|+|||.++......   ....++..|+|||.+.+ ..++.++|+||
T Consensus       110 qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~~---~~~~~~~~~~ape~~~~-~~~~~~~Di~s  184 (256)
T cd05039         110 DVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ---DSGKLPVKWTAPEALRE-KKFSTKSDVWS  184 (256)
T ss_pred             HHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEccccccccccccc---ccCCCcccccCchhhcC-CcCCcHHHHHH
Confidence            999999999999999999999999999888 89999999998653221   12334567999999876 56788999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          170 VGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||+++|++++ |..||...........+..... +.            .....++.+.+++.+||..+|++||+++++++
T Consensus       185 lG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         185 FGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-ME------------APEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CC------------CccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            9999999997 9999987766655544433211 11            11346899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-37  Score=249.25  Aligned_cols=208  Identities=23%  Similarity=0.292  Sum_probs=168.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|++++++++|||++++.+++...+..++||||+.+ +|..++....              ..++..+...++.+
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~  115 (268)
T cd05063          50 RQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD--------------GEFSSYQLVGMLRG  115 (268)
T ss_pred             HHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHH
Confidence            45688999999999999999999999999999999999996 8888875321              23455677888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCc---CCccCccccCcccccCccCCCcccch
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESS---AEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      ++.|++|||+.+++||||||+||+++.++ .++++|||++...........   ....++.|+|||.+.+ ..++.++|+
T Consensus       116 l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv  193 (268)
T cd05063         116 IAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDV  193 (268)
T ss_pred             HHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCccceecccccccceeccCCCcCceecCHHHhhc-CCcChHhHH
Confidence            99999999999999999999999999888 899999999876533221111   1123457999999976 567899999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++|++++ |..||...+.......+......+.             ....+.++.+++.+||..+|++||++.++
T Consensus       194 ~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i  260 (268)
T cd05063         194 WSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-------------PMDCPSAVYQLMLQCWQQDRARRPRFVDI  260 (268)
T ss_pred             HHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            999999999997 9999988776666666654322221             12467899999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       261 ~~  262 (268)
T cd05063         261 VN  262 (268)
T ss_pred             HH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.4e-37  Score=251.00  Aligned_cols=222  Identities=24%  Similarity=0.282  Sum_probs=170.6

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCc-ccccCCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGY-STKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .+++.+|+++++++ +||||+++++++...+..++++||+++ +|.+++.......... ..........+....+..++
T Consensus        46 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  125 (297)
T cd05089          46 HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA  125 (297)
T ss_pred             HHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHH
Confidence            35688999999999 799999999999998899999999985 9999986532211100 00011112346778888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.|++|||+++++||||||+||+++.++ .+||+|||++...... ........+..|+|||.+.+ ..++.++|||
T Consensus       126 ~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvw  202 (297)
T cd05089         126 SDVATGMQYLSEKQFIHRDLAARNVLVGENL-ASKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNY-SVYTTKSDVW  202 (297)
T ss_pred             HHHHHHHHHHHHCCcccCcCCcceEEECCCC-eEEECCcCCCccccce-eccCCCCcCccccCchhhcc-CCCCchhhHH
Confidence            9999999999999999999999999999887 8999999998643211 11111223456999999876 5678899999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++|+|++ |..||...........+......             .....+++.+.+++.+||+.+|.+||++++++
T Consensus       203 SlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  269 (297)
T cd05089         203 SFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM-------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQIS  269 (297)
T ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            99999999997 99999887766655554332111             11135789999999999999999999999997


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      +.
T Consensus       270 ~~  271 (297)
T cd05089         270 VQ  271 (297)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-37  Score=245.28  Aligned_cols=209  Identities=24%  Similarity=0.316  Sum_probs=166.8

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|++++++++||||+++++++.+....++||||+.| +|.+.+....              ........+.++.
T Consensus        35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~--------------~~~~~~~~~~~~~  100 (251)
T cd05041          35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK--------------NRLTVKKLLQMSL  100 (251)
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC--------------CCCCHHHHHHHHH
Confidence            345789999999999999999999999999999999999986 8888875421              2244566778888


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +++.+++|||+++++||||+|+||+++.++ .++|+|||.+.........  .....++..|+|||.+.+ ..++.++|+
T Consensus       101 ~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di  178 (251)
T cd05041         101 DAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY-GRYTSESDV  178 (251)
T ss_pred             HHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceeccccCcceeccCChHhhcc-CCCCcchhH
Confidence            999999999999999999999999999888 8999999998754321111  112233566999999876 568899999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|++++ |..||...........+......+             .....+..+.+++.+||..+|++||+++++
T Consensus       179 ~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~el  245 (251)
T cd05041         179 WSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP-------------APQLCPEEIYRLMLQCWAYDPENRPSFSEI  245 (251)
T ss_pred             HHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC-------------CCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            999999999999 788998776555444443321111             113467899999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       246 l~  247 (251)
T cd05041         246 YN  247 (251)
T ss_pred             HH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.8e-37  Score=247.83  Aligned_cols=217  Identities=19%  Similarity=0.242  Sum_probs=166.5

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+.+++.++||||+++++.+.+....++||||+.+ +|.+++......           ........+..++.
T Consensus        38 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~~~  106 (268)
T cd05086          38 EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWH-----------RRNSQLLLLQRMAC  106 (268)
T ss_pred             HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcc-----------cccccHHHHHHHHH
Confidence            456899999999999999999999999999999999999995 999888643211           02234456678889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCc------cCC
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGL------LEY  161 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~  161 (259)
                      +++.||+|||+.+++||||||+||+++.++ .++|+|||++.......  .......++..|+|||.+...      ..+
T Consensus       107 ~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~  185 (268)
T cd05086         107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQ  185 (268)
T ss_pred             HHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCC
Confidence            999999999999999999999999999888 89999999986432211  122345678899999987531      235


Q ss_pred             CcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          162 STAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      +.++||||||+++|+|++ |..||...........+....... ...       ......+++.+.+++..|| .+|++|
T Consensus       186 ~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~l~~~c~-~~P~~R  256 (268)
T cd05086         186 TKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK-LFK-------PQLELPYSERWYEVLQFCW-LSPEKR  256 (268)
T ss_pred             CCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc-cCC-------CccCCCCcHHHHHHHHHHh-hCcccC
Confidence            678999999999999997 567888777666665544332211 000       1112347889999999999 689999


Q ss_pred             cCHHHHhc
Q 039159          241 ITAAEALQ  248 (259)
Q Consensus       241 p~~~~~l~  248 (259)
                      |+++++++
T Consensus       257 p~~~~i~~  264 (268)
T cd05086         257 ATAEEVHR  264 (268)
T ss_pred             CCHHHHHH
Confidence            99999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.6e-37  Score=250.70  Aligned_cols=226  Identities=21%  Similarity=0.231  Sum_probs=173.6

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|++++++++||||+++++++..++..+++||++.+ +|.+++..........    ......+....+..++.
T Consensus        62 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~  137 (296)
T cd05051          62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL----ACNSKSLSFSTLLYMAT  137 (296)
T ss_pred             HHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc----cccCCCCCHHHHHHHHH
Confidence            346788999999999999999999999999999999999985 8999886543211100    11123567788899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +++.|++|||+++++||||||+||+++.++ .++|+|||.+.......  .......+++.|+|||.+.+ ..++.++||
T Consensus       138 ~i~~al~~LH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  215 (296)
T cd05051         138 QIASGMRYLESLNFVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDV  215 (296)
T ss_pred             HHHHHHHHHHHcCccccccchhceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchh
Confidence            999999999999999999999999999888 89999999987543221  11233456778999999876 568899999


Q ss_pred             HhHHHHHHHHHh--CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          168 WPVGCIFGEMVS--GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       168 wslG~~l~e~~t--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||++|++++  +..||......................      .........+.++.+++.+||+.||.+|||+.+
T Consensus       216 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e  289 (296)
T cd05051         216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE  289 (296)
T ss_pred             hhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHH
Confidence            999999999998  678887766665555443221111100      001112356789999999999999999999999


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +++
T Consensus       290 l~~  292 (296)
T cd05051         290 IHL  292 (296)
T ss_pred             HHH
Confidence            974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.6e-37  Score=244.75  Aligned_cols=207  Identities=23%  Similarity=0.314  Sum_probs=166.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEE-eCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVAS-QGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~-~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+.+|+.++++++|+|++++++++. .++..++++||+++ +|.+.+.....             ........+.++
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~  108 (256)
T cd05082          42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------------SVLGGDCLLKFS  108 (256)
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCC-------------CCCCHHHHHHHH
Confidence            3457899999999999999999999764 45678999999985 99998864221             234556778888


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||++|++||||||+||+++.++ .+||+|||++......   .....++..|+|||.+.+ ..++.++|||
T Consensus       109 ~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~  183 (256)
T cd05082         109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST---QDTGKLPVKWTAPEALRE-KKFSTKSDVW  183 (256)
T ss_pred             HHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceecccc---CCCCccceeecCHHHHcc-CCCCchhhhH
Confidence            9999999999999999999999999999888 8999999998754322   123344567999999876 5678899999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++|+|++ |+.||...........+..... +.            ....+++.+.+++.+||..+|++|||+.+++
T Consensus       184 slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  250 (256)
T cd05082         184 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-MD------------APDGCPPVVYDVMKQCWHLDAATRPSFLQLR  250 (256)
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CC------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            99999999997 9999987766555554433211 11            1235789999999999999999999999997


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       251 ~  251 (256)
T cd05082         251 E  251 (256)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.8e-37  Score=243.39  Aligned_cols=208  Identities=23%  Similarity=0.282  Sum_probs=167.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|++++++++||||+++++++...+..++||||+++ +|.+.+....              ..+.....+.++.+
T Consensus        36 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~  101 (250)
T cd05085          36 KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK--------------DELKTKQLVKFALD  101 (250)
T ss_pred             HHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC--------------CCCCHHHHHHHHHH
Confidence            34688999999999999999999999999999999999985 8888775321              22456677888899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccCccCCCcccchHh
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      ++.++.|+|+++++||||+|+||+++.++ .++|+|||++......... .....+++.|+|||.+.+ ..++.++|+||
T Consensus       102 i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s  179 (250)
T cd05085         102 AAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVWS  179 (250)
T ss_pred             HHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceeccccccccCCCCCCcccccCHHHhcc-CCCCchhHHHH
Confidence            99999999999999999999999999888 8999999998654322111 112234567999999976 56788999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          170 VGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||+++|++++ |..||.+.........+......             ......+..+.+++.+||..+|++||++.++++
T Consensus       180 lG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         180 YGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM-------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             HHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC-------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            9999999998 99999887666555554432211             112357899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-37  Score=247.56  Aligned_cols=214  Identities=21%  Similarity=0.288  Sum_probs=168.9

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCce------EEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIY------LYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~------~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      .+.+.+|+.+++.++||||+++++++.....      .++++||+.+ +|...+........         ...++....
T Consensus        45 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~---------~~~~~~~~~  115 (273)
T cd05035          45 IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL---------PEKLPLQTL  115 (273)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCC---------cccCCHHHH
Confidence            3578899999999999999999998866544      7999999995 88888754221100         134566778


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCC
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      ..++.|++.||+|||+.+++||||||+||+++.++ .+||+|||.++.......  ......++..|+|||.+.+ ..++
T Consensus       116 ~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~  193 (273)
T cd05035         116 LKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYT  193 (273)
T ss_pred             HHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECCccceeeccccccccccccccCCccccCHhhccc-CCCC
Confidence            88999999999999999999999999999999888 899999999976543221  1122234668999999876 5688


Q ss_pred             cccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          163 TAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      .++|||||||++|||++ |..||.+.........+...... .            .....++.+.+++.+||+.||++||
T Consensus       194 ~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~li~~~l~~~p~~Rp  260 (273)
T cd05035         194 SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL-K------------QPEDCLDELYDLMYSCWRADPKDRP  260 (273)
T ss_pred             cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C------------CCcCCCHHHHHHHHHHcCCChhhCc
Confidence            99999999999999999 88999887766665555433211 1            1235788999999999999999999


Q ss_pred             CHHHHhcC
Q 039159          242 TAAEALQQ  249 (259)
Q Consensus       242 ~~~~~l~h  249 (259)
                      ++.+++++
T Consensus       261 ~~~e~~~~  268 (273)
T cd05035         261 TFTKLREV  268 (273)
T ss_pred             CHHHHHHH
Confidence            99999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.2e-37  Score=246.26  Aligned_cols=209  Identities=25%  Similarity=0.344  Sum_probs=167.5

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++.+.+ ...++||||+++ +|.+.+.....             ..++...++.++.
T Consensus        44 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~  109 (262)
T cd05071          44 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG-------------KYLRLPQLVDMAA  109 (262)
T ss_pred             CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccc-------------cCCCHHHHHHHHH
Confidence            34678999999999999999999998854 568999999996 99988853211             2345677788999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.||+|+|+.+++||||||+||+++.++ .++|+|||.+........ ......++..|+|||...+ ..++.++|+|
T Consensus       110 ~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dvw  187 (262)
T cd05071         110 QIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVW  187 (262)
T ss_pred             HHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeeccccccccccCCcccceecCHhHhcc-CCCCchhhHH
Confidence            999999999999999999999999999888 899999999975533221 1123345678999998876 5678999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|++++ |..||.+.........+......+             .....+..+.+++.+||..||++||++++++
T Consensus       188 slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~  254 (262)
T cd05071         188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQ  254 (262)
T ss_pred             HHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC-------------CccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            99999999999 888998877666655554332111             1135788999999999999999999999987


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       255 ~  255 (262)
T cd05071         255 A  255 (262)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-37  Score=246.44  Aligned_cols=211  Identities=25%  Similarity=0.328  Sum_probs=171.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|+.++++++||||+++++++..+...+++|||+.+ +|.+.+....+             ..+.......++
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~-------------~~~~~~~~~~~~  109 (261)
T cd05034          43 MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG-------------KKLRLPQLVDMA  109 (261)
T ss_pred             cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcccc-------------CCCCHHHHHHHH
Confidence            3456799999999999999999999999988899999999986 89988854211             235567788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.|++|||+++++|+||||+||+++.++ .++++|||.+........ ......++..|+|||.+.+ ...+.++|+
T Consensus       110 ~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di  187 (261)
T cd05034         110 AQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDV  187 (261)
T ss_pred             HHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceeccchhhhhhhccCCCccccCHHHhcc-CCcCchhHH
Confidence            9999999999999999999999999999888 899999999876532111 1122234567999999986 567889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||+|+++|++++ |+.||.+.........+......+.             ....+.++.+++.+||..+|++||+++++
T Consensus       188 ~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l  254 (261)
T cd05034         188 WSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR-------------PPNCPEELYDLMLQCWDKDPEERPTFEYL  254 (261)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence            999999999998 9999988777666666654322111             13457899999999999999999999998


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      .+
T Consensus       255 ~~  256 (261)
T cd05034         255 QS  256 (261)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.7e-37  Score=247.90  Aligned_cols=215  Identities=26%  Similarity=0.338  Sum_probs=176.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|+++++.++||||+++++++..+...++|+||+++ +|...+......           ...+....+..++
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-----------~~~~~~~~~~~~~  109 (256)
T cd08530          41 KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKK-----------RKLIPEQEIWRIF  109 (256)
T ss_pred             HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhh-----------cCCCCHHHHHHHH
Confidence            3455788999999999999999999999999999999999986 898888542110           1335667788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||+.|++||||+|+||+++.++ .++++|||.+......  ......+++.|+|||.+.+ ..++.++|+|
T Consensus       110 ~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~  185 (256)
T cd08530         110 IQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKG-RPYSYKSDIW  185 (256)
T ss_pred             HHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC--CcccccCCccccCHHHHCC-CCCCchhhHH
Confidence            9999999999999999999999999999887 8999999999765433  3334567889999999977 5678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |+|+++|++++|+.||...+.......+.... .+.            .....+.++.+++.+||..+|++||++.++++
T Consensus       186 slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         186 SLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPP------------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCC------------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            99999999999999998877655544443221 111            11357789999999999999999999999999


Q ss_pred             Cccc
Q 039159          249 QEYF  252 (259)
Q Consensus       249 h~~f  252 (259)
                      ||++
T Consensus       253 ~p~~  256 (256)
T cd08530         253 SPAV  256 (256)
T ss_pred             CCCC
Confidence            9984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-37  Score=250.18  Aligned_cols=220  Identities=20%  Similarity=0.159  Sum_probs=162.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ..+.+.+|++++++++||||+++++++...  ..++++|||+.+ +|.+.+..                ..++..++..+
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------------~~l~~~~~~~i  112 (283)
T cd05080          49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK----------------HKLNLAQLLLF  112 (283)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH----------------cCCCHHHHHHH
Confidence            456788999999999999999999988653  468999999996 88888853                23567788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCCCcc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      +.+++.|++|||+++++||||||+||+++.++ .++|+|||+++........   .....++..|+|||.+.+ ..++.+
T Consensus       113 ~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~  190 (283)
T cd05080         113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYA  190 (283)
T ss_pred             HHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcc
Confidence            99999999999999999999999999999888 8999999999765332111   112235667999999876 567899


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHH-HHHHhCCCC-CCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLIT-LGRIVGKSR-KPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~-~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      +||||||+++|++++|..||........ ......... .......-......+.....+..+.+++.+||..+|++||+
T Consensus       191 ~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps  270 (283)
T cd05080         191 SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPT  270 (283)
T ss_pred             cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCC
Confidence            9999999999999999999865332110 000000000 00000000000011123457889999999999999999999


Q ss_pred             HHHHhc
Q 039159          243 AAEALQ  248 (259)
Q Consensus       243 ~~~~l~  248 (259)
                      ++++++
T Consensus       271 ~~~i~~  276 (283)
T cd05080         271 FRSLIP  276 (283)
T ss_pred             HHHHHH
Confidence            999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.3e-37  Score=250.96  Aligned_cols=225  Identities=20%  Similarity=0.199  Sum_probs=169.1

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|++++++++||||+++++++..++..+++|||+.+ +|.+++........    ........+....+..++.+
T Consensus        63 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  138 (296)
T cd05095          63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA----AEKADVVTISYSTLIFMATQ  138 (296)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccc----cccccccccCHHHHHHHHHH
Confidence            45788999999999999999999999999999999999985 99988865321111    11112234667788999999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++.|++|||+.+++||||||+||+++.++ .++|+|||.++.......  ..+...+++.|++||...+ ..++.++|+|
T Consensus       139 i~~al~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Diw  216 (296)
T cd05095         139 IASGMKYLSSLNFVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVW  216 (296)
T ss_pred             HHHHHHHHHHCCeecccCChheEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhh
Confidence            99999999999999999999999999888 899999999875433211  1222344678999998876 5688999999


Q ss_pred             hHHHHHHHHHh--CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          169 PVGCIFGEMVS--GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       169 slG~~l~e~~t--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||++|||++  |..||.................. ...     ....+.....++.+.+++.+||+.||++||++.++
T Consensus       217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  290 (296)
T cd05095         217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRD-QGR-----QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI  290 (296)
T ss_pred             HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhh-ccc-----cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            99999999998  67888766554443322110000 000     00011123467899999999999999999999998


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       291 ~~  292 (296)
T cd05095         291 HA  292 (296)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.5e-37  Score=247.50  Aligned_cols=207  Identities=21%  Similarity=0.211  Sum_probs=164.1

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++..|+.++++++||||+++++++. +...++++||++ |+|.+.+....              ..++......++.|
T Consensus        53 ~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~q  117 (279)
T cd05111          53 FQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHR--------------DSLDPQRLLNWCVQ  117 (279)
T ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcc--------------cCCCHHHHHHHHHH
Confidence            356778888999999999999999885 456788999998 59999986422              23556778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++.|++|||+.+++||||||+||+++.++ .+||+|||.++.......  ......++..|+|||.+.+ ..++.++|||
T Consensus       118 i~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~  195 (279)
T cd05111         118 IAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVW  195 (279)
T ss_pred             HHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHH
Confidence            99999999999999999999999999887 899999999976533221  1223356778999999977 5688999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++||+++ |..||.+.........+. ....+..            ....+.++.+++.+||..||++|||+.+++
T Consensus       196 slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~  262 (279)
T cd05111         196 SYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQ------------PQICTIDVYMVMVKCWMIDENVRPTFKELA  262 (279)
T ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            99999999998 999998776554433332 2222211            123567889999999999999999999998


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       263 ~  263 (279)
T cd05111         263 N  263 (279)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.9e-37  Score=246.77  Aligned_cols=208  Identities=20%  Similarity=0.261  Sum_probs=162.0

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEE-eCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVAS-QGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~-~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+.+|+.+++.++||||+++++++. .++..+++|||+.+ +|.+++....              ........+.++.
T Consensus        40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~  105 (262)
T cd05058          40 VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSET--------------HNPTVKDLIGFGL  105 (262)
T ss_pred             HHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcC--------------CCCCHHHHHHHHH
Confidence            457889999999999999999999875 45568899999985 9999886421              1123345677888


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC----CCCcCCccCccccCcccccCccCCCccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK----GESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      ++++|++|||+.+++||||||+||+++.++ .+||+|||.++......    .......++..|+|||.+.+ ..++.++
T Consensus       106 ~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~  183 (262)
T cd05058         106 QVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKS  183 (262)
T ss_pred             HHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcceeecccccCcCCccccChhHhcc-CccchHH
Confidence            999999999999999999999999999888 89999999987543211    11122345678999999876 5688899


Q ss_pred             chHhHHHHHHHHHhC-CCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVSG-KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      ||||||+++|||++| .+||...+.......+...... ..            ....++.+.+++.+||..+|++||++.
T Consensus       184 Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~li~~cl~~~p~~Rp~~~  250 (262)
T cd05058         184 DVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL-LQ------------PEYCPDPLYEVMLSCWHPKPEMRPTFS  250 (262)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-CC------------CCcCCHHHHHHHHHHcCCChhhCCCHH
Confidence            999999999999995 6777766655554444332211 11            124578899999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++++
T Consensus       251 ~il~  254 (262)
T cd05058         251 ELVS  254 (262)
T ss_pred             HHHH
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.4e-37  Score=248.59  Aligned_cols=222  Identities=21%  Similarity=0.256  Sum_probs=173.0

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCccc-------ccCCCcchhHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST-------KNFNSYSLFTTFL   83 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~   83 (259)
                      ..++.+|+.++++++||||+++++++..+...+++|||+.+ +|.+++............       +.......+....
T Consensus        52 ~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  131 (288)
T cd05050          52 QADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE  131 (288)
T ss_pred             HHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHH
Confidence            45688999999999999999999999999999999999995 999998753321111110       0111123466778


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCC
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      ++.++.+++.||+|||+.+++||||||+||+++.++ .++|+|||.+........  ......++..|+|||.+.+ ..+
T Consensus       132 ~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~  209 (288)
T cd05050         132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRY  209 (288)
T ss_pred             HHHHHHHHHHHHHHHHhCCeecccccHhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCC
Confidence            889999999999999999999999999999999888 899999999875433221  1222344667999999876 568


Q ss_pred             CcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          162 STAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      +.++|+|||||++|+|++ |..||.+....+....+......             ......+.++.+++.+||+.||++|
T Consensus       210 ~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~R  276 (288)
T cd05050         210 TTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL-------------SCPDNCPLELYNLMRLCWSKLPSDR  276 (288)
T ss_pred             CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-------------CCCCCCCHHHHHHHHHHcccCcccC
Confidence            899999999999999997 88899877766655554432211             1123567899999999999999999


Q ss_pred             cCHHHHhc
Q 039159          241 ITAAEALQ  248 (259)
Q Consensus       241 p~~~~~l~  248 (259)
                      |+++|+++
T Consensus       277 pt~~el~~  284 (288)
T cd05050         277 PSFASINR  284 (288)
T ss_pred             CCHHHHHH
Confidence            99999975

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1e-36  Score=250.74  Aligned_cols=222  Identities=23%  Similarity=0.273  Sum_probs=171.5

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCccccc-CCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKN-FNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+|+.+++++ +||||+++++++..+...+++|||+.+ +|.+++.............. ......+....++.++
T Consensus        61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  140 (314)
T cd05099          61 LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA  140 (314)
T ss_pred             HHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHH
Confidence            34688999999999 699999999999988899999999985 99999865332111110000 0111346777888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .|++.|++|||++|++||||||+||+++.++ .+||+|||.++........  .....++..|+|||.+.+ ..++.++|
T Consensus       141 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  218 (314)
T cd05099         141 YQVARGMEYLESRRCIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSD  218 (314)
T ss_pred             HHHHHHHHHHHHCCeeeccccceeEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccch
Confidence            9999999999999999999999999999888 8999999999765322111  122234467999999977 56888999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +||||+++|++++ |..||.+.........+..... .            ......+.++.+++.+||..||++||++.+
T Consensus       219 iwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~  285 (314)
T cd05099         219 VWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR-M------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQ  285 (314)
T ss_pred             hhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            9999999999999 8899987766655555443211 1            112356789999999999999999999999


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +++
T Consensus       286 ll~  288 (314)
T cd05099         286 LVE  288 (314)
T ss_pred             HHH
Confidence            985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-37  Score=250.75  Aligned_cols=226  Identities=22%  Similarity=0.222  Sum_probs=168.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+++.+|++++++++|||++++++++..++..++||||+.+ +|.+++........   ..............++.++.+
T Consensus        61 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~  137 (295)
T cd05097          61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST---FTHANNIPSVSIANLLYMAVQ  137 (295)
T ss_pred             HHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhcccccc---ccccccCCcccHHHHHHHHHH
Confidence            34688999999999999999999999999999999999996 89998854211000   000011123566778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++.|++|||+.+++||||||+||+++.++ .+||+|||++........  ......+++.|+|||.+.+ ..++.++|+|
T Consensus       138 i~~al~~lH~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dvw  215 (295)
T cd05097         138 IASGMKYLASLNFVHRDLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVW  215 (295)
T ss_pred             HHHHHHHHHhcCeeccccChhhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHH
Confidence            99999999999999999999999999887 899999999875432211  1223345678999999876 5688999999


Q ss_pred             hHHHHHHHHHh--CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          169 PVGCIFGEMVS--GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       169 slG~~l~e~~t--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||++|+|++  +..||...........+..........      ......+..++.+.+++.+||+.||++||+++++
T Consensus       216 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i  289 (295)
T cd05097         216 AFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI  289 (295)
T ss_pred             HHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            99999999998  567887766554443332111000000      0001123467899999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       290 ~~  291 (295)
T cd05097         290 HH  291 (295)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.6e-37  Score=251.55  Aligned_cols=223  Identities=21%  Similarity=0.254  Sum_probs=170.9

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCC-cccccCCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNG-YSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+|+.+++++ +||||+++++++..++..|+||||+.+ +|.+++......... ...........+....++.++
T Consensus        67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  146 (307)
T cd05098          67 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCA  146 (307)
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence            34688899999999 799999999999999999999999985 999998653221100 000000111346677889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .+++.|++|||++|++||||||+||+++.++ .++|+|||.+.........  .....+++.|+|||.+.+ ..++.++|
T Consensus       147 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  224 (307)
T cd05098         147 YQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSD  224 (307)
T ss_pred             HHHHHHHHHHHHCCcccccccHHheEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHH
Confidence            9999999999999999999999999999888 8999999998754322111  112234568999999977 56789999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +|||||++|+|++ |..||.+.........+.... .+            ......+.++.+++.+||..+|++||++.+
T Consensus       225 vwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  291 (307)
T cd05098         225 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-RM------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQ  291 (307)
T ss_pred             HHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC-CC------------CCCCcCCHHHHHHHHHHcccChhhCcCHHH
Confidence            9999999999998 888997766554444443221 11            112357889999999999999999999999


Q ss_pred             HhcC
Q 039159          246 ALQQ  249 (259)
Q Consensus       246 ~l~h  249 (259)
                      ++++
T Consensus       292 vl~~  295 (307)
T cd05098         292 LVED  295 (307)
T ss_pred             HHHH
Confidence            9864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.9e-37  Score=276.28  Aligned_cols=221  Identities=25%  Similarity=0.295  Sum_probs=167.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++.+++..+++|||++| +|.+++........ .. .  ..........++.++.
T Consensus        45 ~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~-l~-e--~~~~~lsv~~iL~I~~  120 (932)
T PRK13184         45 LKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKES-LS-K--ELAEKTSVGAFLSIFH  120 (932)
T ss_pred             HHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccc-cc-h--hhhcccCHHHHHHHHH
Confidence            346789999999999999999999999999999999999996 99998864321110 00 0  0012344567788999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC------------------CCCcCCccCccccC
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK------------------GESSAEVGTHYYKA  151 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~------------------~~~~~~~~~~~~~a  151 (259)
                      +++.||+|||+.||+||||||+||+++.++ .++|+|||++.......                  .......||+.|+|
T Consensus       121 QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmA  199 (932)
T PRK13184        121 KICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMA  199 (932)
T ss_pred             HHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCC
Confidence            999999999999999999999999999888 89999999997652110                  01123468999999


Q ss_pred             cccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHh
Q 039159          152 PELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  231 (259)
                      ||.+.+ ..++.++|||||||++|+|+||..||...............  .+..         ......+++.+.+++.+
T Consensus       200 PE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~--~P~~---------~~p~~~iP~~L~~LI~r  267 (932)
T PRK13184        200 PERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVIL--SPIE---------VAPYREIPPFLSQIAMK  267 (932)
T ss_pred             HHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhcc--Chhh---------ccccccCCHHHHHHHHH
Confidence            999987 56789999999999999999999999875433222211100  0000         01124678999999999


Q ss_pred             hcCcCCCCccCHHHHhc
Q 039159          232 MLGMDPDKRITAAEALQ  248 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~  248 (259)
                      ||..||++|++..+.+.
T Consensus       268 cL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        268 ALAVDPAERYSSVQELK  284 (932)
T ss_pred             HccCChhhCcCHHHHHH
Confidence            99999999987655553

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3e-37  Score=251.90  Aligned_cols=219  Identities=22%  Similarity=0.316  Sum_probs=170.4

Q ss_pred             CchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.++.+.. ||||+++++++.++...|++|||+.+++.+++....              ..++......++.+
T Consensus        57 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~--------------~~l~~~~~~~i~~~  122 (296)
T cd06618          57 NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQ--------------GPIPEDILGKMTVA  122 (296)
T ss_pred             HHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCcCHHHHHHHhc--------------CCCCHHHHHHHHHH
Confidence            455677887777764 999999999999999999999999888777775421              23455677789999


Q ss_pred             cccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc---cCCCcccc
Q 039159           91 SDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL---LEYSTAVD  166 (259)
Q Consensus        91 ~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~D  166 (259)
                      ++.|++|||+ .+++||||+|+||+++.++ .++|+|||.+....... ......+++.|+|||.+.+.   ..++.++|
T Consensus       123 i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~D  200 (296)
T cd06618         123 IVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGRLVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRAD  200 (296)
T ss_pred             HHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchhccCCC-cccCCCCCccccCHhhcCCCCCccccccchh
Confidence            9999999997 6999999999999999888 89999999987543222 22233578889999998753   23678999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANS-LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +||||+++|+|++|+.||..... .+....+.... .+..+          ....+++++.+|+.+||..||++||++++
T Consensus       201 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~  269 (296)
T cd06618         201 VWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRE  269 (296)
T ss_pred             HHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            99999999999999999976433 23333333221 11110          11246789999999999999999999999


Q ss_pred             HhcCccccCCCC
Q 039159          246 ALQQEYFKDVPG  257 (259)
Q Consensus       246 ~l~h~~f~~~~~  257 (259)
                      +++||||+....
T Consensus       270 il~~~~~~~~~~  281 (296)
T cd06618         270 LLQHPFIRRYET  281 (296)
T ss_pred             HhcChhhhccch
Confidence            999999997654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.7e-37  Score=247.47  Aligned_cols=208  Identities=25%  Similarity=0.331  Sum_probs=168.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|++++++++||||+++++++.+ +..++||||+++ +|.+++....              ..+....++.++.
T Consensus        50 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~  114 (270)
T cd05056          50 VREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNK--------------YSLDLASLILYSY  114 (270)
T ss_pred             HHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCC--------------CCCCHHHHHHHHH
Confidence            34578999999999999999999999875 567899999985 8999885421              2356677888899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.|++|||+.+++||||||+||+++.++ .++++|||+++........ .....+++.|+|||.+.+ ..++.++|+|
T Consensus       115 ~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  192 (270)
T cd05056         115 QLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVW  192 (270)
T ss_pred             HHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhH
Confidence            999999999999999999999999999888 8999999998765433211 112234567999999876 5678999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|++++ |..||......+....+......+             .....++.+.+++.+|+..+|++|||+.+++
T Consensus       193 slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~  259 (270)
T cd05056         193 MFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP-------------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELK  259 (270)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            99999999986 999998887766665554433221             1245788999999999999999999999988


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      .
T Consensus       260 ~  260 (270)
T cd05056         260 A  260 (270)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.9e-37  Score=247.09  Aligned_cols=219  Identities=22%  Similarity=0.298  Sum_probs=172.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|++++++++||||+++++++.+.+..++||||+++ +|.+++.........      .....+.......++.
T Consensus        51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~------~~~~~l~~~~~~~~~~  124 (275)
T cd05046          51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEK------LKPPPLSTKQKVALCT  124 (275)
T ss_pred             HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhccccccc------ccccCCCHHHHHHHHH
Confidence            346789999999999999999999999988899999999985 999988653211100      1112467788899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.||+|||+.+++||||||+||+++.++ .++++|||.+........ ......++..|+|||.+.+ ...+.++|||
T Consensus       125 ~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~  202 (275)
T cd05046         125 QIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVW  202 (275)
T ss_pred             HHHHHHHHhhhcCcccCcCccceEEEeCCC-cEEEcccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHH
Confidence            999999999999999999999999999988 899999999865432211 1223356778999999876 4578899999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|++++ |..||...........+........            ....++..+.+++.+||+.+|.+||++.+++
T Consensus       203 slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l  270 (275)
T cd05046         203 SFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP------------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELV  270 (275)
T ss_pred             HHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence            99999999998 7889987666555555432221110            1235778999999999999999999999998


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      ..
T Consensus       271 ~~  272 (275)
T cd05046         271 SA  272 (275)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.4e-37  Score=247.50  Aligned_cols=209  Identities=23%  Similarity=0.310  Sum_probs=168.5

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...+|.+|+.+++.++||||+++++++.++...++||||+.+ +|..++....              ..+...+++.++.
T Consensus        48 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~  113 (269)
T cd05065          48 QRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND--------------GQFTVIQLVGMLR  113 (269)
T ss_pred             HHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC--------------CCCCHHHHHHHHH
Confidence            456789999999999999999999999999999999999986 8888885421              2345677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCc---cCccccCcccccCccCCCcc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEV---GTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~---~~~~~~aPE~~~~~~~~~~~  164 (259)
                      +++.|++|||++|++||||||+||+++.++ .++++|||.+.........  .....   .+..|+|||.+.+ ..++.+
T Consensus       114 ~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~  191 (269)
T cd05065         114 GIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSA  191 (269)
T ss_pred             HHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCccccccccCccccccccccCCCcceeecCHhHhcc-Ccccch
Confidence            999999999999999999999999999887 8999999998754332111  01111   1346999999976 567889


Q ss_pred             cchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +|+|||||++||+++ |..||...+.......+......+.             ....+..+.+++.+||..+|++||++
T Consensus       192 ~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~  258 (269)
T cd05065         192 SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP-------------PMDCPTALHQLMLDCWQKDRNARPKF  258 (269)
T ss_pred             hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC-------------cccCCHHHHHHHHHHcCCChhhCcCH
Confidence            999999999999886 9999988776666655543322211             13567899999999999999999999


Q ss_pred             HHHhc
Q 039159          244 AEALQ  248 (259)
Q Consensus       244 ~~~l~  248 (259)
                      ++++.
T Consensus       259 ~~i~~  263 (269)
T cd05065         259 GQIVS  263 (269)
T ss_pred             HHHHH
Confidence            99985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=278.93  Aligned_cols=221  Identities=26%  Similarity=0.343  Sum_probs=187.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .....-|..|-.+|..-+.+.|++++.+|.++.++|+||||++| +|.+++...               ..++.....-+
T Consensus       116 r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~---------------~~~pE~~ArFY  180 (1317)
T KOG0612|consen  116 RAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKF---------------DRLPEDWARFY  180 (1317)
T ss_pred             chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhc---------------CCChHHHHHHH
Confidence            44445567788888888999999999999999999999999996 899999653               23555566677


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccccc-CCCCcCCccCccccCcccccC---c-cCCC
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY-KGESSAEVGTHYYKAPELLLG---L-LEYS  162 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~---~-~~~~  162 (259)
                      +..+.-||+-+|+.|+|||||||+|||+|.+| ++||+|||.+-.+... ....+..+|||-|.+||++..   . +.|+
T Consensus       181 ~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG  259 (1317)
T KOG0612|consen  181 TAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYG  259 (1317)
T ss_pred             HHHHHHHHHHHHhccceeccCCcceeEecccC-cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccC
Confidence            77888899999999999999999999999999 9999999999877643 335677799999999999963   2 5789


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ..+|.||+||++|||+.|..||+..+..+.+.+|.+......+|+.          ..+|+++++||.+.+. +|..|..
T Consensus       260 ~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLg  328 (1317)
T KOG0612|consen  260 RECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLG  328 (1317)
T ss_pred             CccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc----------cccCHHHHHHHHHHhc-Chhhhcc
Confidence            9999999999999999999999999999999999887655555421          2489999999998765 5889998


Q ss_pred             ---HHHHhcCccccCCC
Q 039159          243 ---AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ---~~~~l~h~~f~~~~  256 (259)
                         ++++-.||||.++.
T Consensus       329 rngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  329 RNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             cccHHHHHhCccccCCC
Confidence               99999999999874

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-36  Score=243.33  Aligned_cols=209  Identities=22%  Similarity=0.289  Sum_probs=167.9

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|++++++++|||++++++++......+++|||+.+ +|.+.+....              ..+....+..++.+
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~  108 (256)
T cd05112          43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR--------------GKFSQETLLGMCLD  108 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc--------------cCCCHHHHHHHHHH
Confidence            46789999999999999999999999998999999999986 8888875322              22445667788889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccchHh
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      ++.+++|||+.+++||||||+||+++.++ .++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||
T Consensus       109 l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~s  186 (256)
T cd05112         109 VCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWS  186 (256)
T ss_pred             HHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceeecccCcccccCCCccchhhcCHhHhcc-CCcChHHHHHH
Confidence            99999999999999999999999999887 899999999875432211 1122234568999999976 56788999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          170 VGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||+++|++++ |..||...........+....... .            ....++.+.+++.+||..+|++||+++++++
T Consensus       187 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~  253 (256)
T cd05112         187 FGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY-K------------PRLASQSVYELMQHCWKERPEDRPSFSLLLH  253 (256)
T ss_pred             HHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC-C------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            9999999998 899998777666555553322111 0            1235789999999999999999999999986


Q ss_pred             C
Q 039159          249 Q  249 (259)
Q Consensus       249 h  249 (259)
                      .
T Consensus       254 ~  254 (256)
T cd05112         254 Q  254 (256)
T ss_pred             h
Confidence            3

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.2e-36  Score=256.92  Aligned_cols=224  Identities=19%  Similarity=0.260  Sum_probs=171.6

Q ss_pred             CchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc--------------------
Q 039159           12 PSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS--------------------   69 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~--------------------   69 (259)
                      ...+.+|++++.++. ||||+++++++...+..++||||+.+ +|.++++..........                    
T Consensus        84 ~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (401)
T cd05107          84 KQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQ  163 (401)
T ss_pred             HHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccc
Confidence            346889999999997 99999999999998999999999995 99999875432100000                    


Q ss_pred             ---------------------------------------------------------------cccCCCcchhHHHHHHH
Q 039159           70 ---------------------------------------------------------------TKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        70 ---------------------------------------------------------------~~~~~~~~~~~~~~~~~   86 (259)
                                                                                     .........+....++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  243 (401)
T cd05107         164 RKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVG  243 (401)
T ss_pred             cccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHH
Confidence                                                                           00001112355677888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ++.+++.||+|||+.+++||||||+||+++.++ .++|+|||+++.......  ......+++.|+|||.+.+ ..++.+
T Consensus       244 ~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  321 (401)
T cd05107         244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTL  321 (401)
T ss_pred             HHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcH
Confidence            999999999999999999999999999999887 899999999975432211  1233456788999999977 567889


Q ss_pred             cchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +|+||||+++|||++ |..||..................+.            ....++.++.+++.+||..+|.+||++
T Consensus       322 ~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~------------~p~~~~~~l~~li~~cl~~~P~~RPs~  389 (401)
T cd05107         322 SDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA------------KPAHASDEIYEIMQKCWEEKFEIRPDF  389 (401)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC------------CCCCCCHHHHHHHHHHcCCChhHCcCH
Confidence            999999999999998 8899987655544444332221111            123578999999999999999999999


Q ss_pred             HHHhcC
Q 039159          244 AEALQQ  249 (259)
Q Consensus       244 ~~~l~h  249 (259)
                      +++++.
T Consensus       390 ~ell~~  395 (401)
T cd05107         390 SQLVHL  395 (401)
T ss_pred             HHHHHH
Confidence            999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-36  Score=244.50  Aligned_cols=217  Identities=24%  Similarity=0.343  Sum_probs=171.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|+++++.++||||+++++++..++..+++|||+++ +|.+.+........        ....+....++.++
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~--------~~~~~~~~~~~~~~  112 (269)
T cd05044          41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERF--------GPPLLTLKELLDIC  112 (269)
T ss_pred             hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhccc--------CCccccHHHHHHHH
Confidence            4456789999999999999999999999998999999999985 99988864321100        11335667888899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCC----CeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDG----KTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~----~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .+++.|++|||+.+++|+||||+||+++.++    ..++++|||++........  ......++..|+|||.+.+ ..++
T Consensus       113 ~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  191 (269)
T cd05044         113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFT  191 (269)
T ss_pred             HHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc-CCcc
Confidence            9999999999999999999999999998754    2699999999875432211  1223345678999999977 5688


Q ss_pred             cccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          163 TAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      .++|||||||++|+|++ |..||...........+......             ......++.+.+++.+||..+|++||
T Consensus       192 ~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rp  258 (269)
T cd05044         192 TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL-------------QKPENCPDKIYQLMTNCWAQDPSERP  258 (269)
T ss_pred             cchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc-------------CCcccchHHHHHHHHHHcCCCcccCC
Confidence            99999999999999998 99999877766655544332211             11235778999999999999999999


Q ss_pred             CHHHHhc
Q 039159          242 TAAEALQ  248 (259)
Q Consensus       242 ~~~~~l~  248 (259)
                      +++++++
T Consensus       259 ~~~~i~~  265 (269)
T cd05044         259 TFDRIQE  265 (269)
T ss_pred             CHHHHHH
Confidence            9999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-36  Score=243.55  Aligned_cols=208  Identities=21%  Similarity=0.292  Sum_probs=167.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|++++++++|+||+++++++.. ...+++|||+++ +|.+++.....             .......++.++.+
T Consensus        45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~~~~~  110 (260)
T cd05073          45 VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-------------SKQPLPKLIDFSAQ  110 (260)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCc-------------cccCHHHHHHHHHH
Confidence            4678999999999999999999999987 778999999985 99998864221             23455667888899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccchHh
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      ++.|++|||+.+++||||||+||+++.++ .++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||
T Consensus       111 l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s  188 (260)
T cd05073         111 IAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWS  188 (260)
T ss_pred             HHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccchH
Confidence            99999999999999999999999999888 899999999875532211 1222345567999999976 56788999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          170 VGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||+++|++++ |..||.+.+.......+......+             .....+.++.+++.+||+.+|++||+++++++
T Consensus       189 lG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         189 FGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC-------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999 899998877666655554332211             11357789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.8e-36  Score=242.17  Aligned_cols=210  Identities=25%  Similarity=0.349  Sum_probs=172.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+++++.++|+||+++++++.+++..+++|||+.+ +|.+.+.....             ..+.......++.
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~  110 (258)
T smart00219       44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRP-------------KELSLSDLLSFAL  110 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhh-------------ccCCHHHHHHHHH
Confidence            456889999999999999999999999999999999999986 89888864211             1166778889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCc-CCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.|++|||+.+++||||+|+||+++.++ .++|+|||.+........... ...+++.|+|||.+.+ ..++.++|+|
T Consensus       111 ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~  188 (258)
T smart00219      111 QIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVW  188 (258)
T ss_pred             HHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceecccccccccccCCCcccccChHHhcc-CCCCcchhHH
Confidence            999999999999999999999999999888 899999999976543311111 2236788999999865 5688999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |+|++++++++ |.+||...........+......+             .....+.++.+++.+||..||++|||+.+++
T Consensus       189 slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll  255 (258)
T smart00219      189 SFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP-------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELV  255 (258)
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHH
Confidence            99999999998 789998776666665554433211             1134789999999999999999999999998


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       256 ~  256 (258)
T smart00219      256 E  256 (258)
T ss_pred             h
Confidence            5

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-37  Score=250.65  Aligned_cols=210  Identities=32%  Similarity=0.450  Sum_probs=174.8

Q ss_pred             CchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...+.+|++++++++ ||||+++++++..++..+++||++.+ +|.+.+...               ..+.......++.
T Consensus        45 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~~  109 (280)
T cd05581          45 VKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY---------------GSLDEKCTRFYAA  109 (280)
T ss_pred             HHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            467889999999998 99999999999999999999999975 999888542               2466778888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--------------------CCcCCccCccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--------------------ESSAEVGTHYY  149 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--------------------~~~~~~~~~~~  149 (259)
                      +++.|++|||+++++|+||+|+||+++.++ .++++|||.+........                    ......++..|
T Consensus       110 ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (280)
T cd05581         110 EILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY  188 (280)
T ss_pred             HHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccc
Confidence            999999999999999999999999999888 899999999876533221                    12234578899


Q ss_pred             cCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHH
Q 039159          150 KAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLI  229 (259)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  229 (259)
                      +|||...+ ...+.++|+||||++++++++|+.||...........+.....              .....+++.+.+++
T Consensus       189 ~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~li  253 (280)
T cd05581         189 VSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY--------------SFPPNFPPDAKDLI  253 (280)
T ss_pred             cCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC--------------CCCCccCHHHHHHH
Confidence            99999876 5678899999999999999999999998776555544432111              11135688999999


Q ss_pred             HhhcCcCCCCccCH----HHHhcCccc
Q 039159          230 SKMLGMDPDKRITA----AEALQQEYF  252 (259)
Q Consensus       230 ~~~l~~dp~~Rp~~----~~~l~h~~f  252 (259)
                      .+||+.+|++||++    +++++||||
T Consensus       254 ~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         254 EKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            99999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.8e-37  Score=245.33  Aligned_cols=200  Identities=21%  Similarity=0.220  Sum_probs=159.9

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhccc
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDS   93 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (259)
                      +.+|...+....||||+++++++.+++..+++|||+.| +|.+.+...               ..++...+..++.++++
T Consensus        32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~~ql~~   96 (237)
T cd05576          32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF---------------LNIPEECVKRWAAEMVV   96 (237)
T ss_pred             hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh---------------cCCCHHHHHHHHHHHHH
Confidence            44566666667899999999999999999999999996 888887532               23566778889999999


Q ss_pred             ccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHHHH
Q 039159           94 SRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCI  173 (259)
Q Consensus        94 ~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~  173 (259)
                      |++|||+.+++||||||+||+++.++ .++++|||.+.....   ......++..|+|||.+.+ ..++.++|+||+|++
T Consensus        97 ~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~i  171 (237)
T cd05576          97 ALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVED---SCDGEAVENMYCAPEVGGI-SEETEACDWWSLGAI  171 (237)
T ss_pred             HHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhcccc---ccccCCcCccccCCcccCC-CCCCchhhHHHHHHH
Confidence            99999999999999999999999988 899999998765432   2233455778999999866 567889999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH-----HHHhc
Q 039159          174 FGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA-----AEALQ  248 (259)
Q Consensus       174 l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~-----~~~l~  248 (259)
                      +|++++|..|+......     + .....            ......+++.+.+++.+||+.||++||++     ++++.
T Consensus       172 l~el~~g~~~~~~~~~~-----~-~~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  233 (237)
T cd05576         172 LFELLTGKTLVECHPSG-----I-NTHTT------------LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKS  233 (237)
T ss_pred             HHHHHHCcchhhcCchh-----c-ccccc------------cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHc
Confidence            99999999887543211     0 00000            01123578899999999999999999985     99999


Q ss_pred             Cccc
Q 039159          249 QEYF  252 (259)
Q Consensus       249 h~~f  252 (259)
                      ||||
T Consensus       234 h~~~  237 (237)
T cd05576         234 HPFF  237 (237)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.2e-36  Score=244.72  Aligned_cols=208  Identities=19%  Similarity=0.203  Sum_probs=165.6

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+.+++.++||||+++++++.. ...++++||+++ +|.+.+....              ..+.....+.++.
T Consensus        52 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~--------------~~~~~~~~~~~~~  116 (279)
T cd05109          52 ANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENK--------------DRIGSQDLLNWCV  116 (279)
T ss_pred             HHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhcc--------------CCCCHHHHHHHHH
Confidence            34578899999999999999999999975 457789999985 8988885421              2355677888899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      |++.|++|||+.+++||||||+||+++.++ .+||+|||+++........  .....+++.|+|||.+.+ ..++.++||
T Consensus       117 qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di  194 (279)
T cd05109         117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDV  194 (279)
T ss_pred             HHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCceeecccccceeecCCCccchhhCCHHHhcc-CCCCchhHH
Confidence            999999999999999999999999999888 8999999999865432221  112234678999999977 568889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++||+++ |..||...........+......+             .....+.++.+++.+||..||++||++.++
T Consensus       195 ~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l  261 (279)
T cd05109         195 WSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP-------------QPPICTIDVYMIMVKCWMIDSECRPRFREL  261 (279)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC-------------CCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            999999999998 899998766555444443322111             123578899999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       262 ~~  263 (279)
T cd05109         262 VD  263 (279)
T ss_pred             HH
Confidence            84

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-36  Score=246.41  Aligned_cols=222  Identities=18%  Similarity=0.262  Sum_probs=162.7

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ...+++.+|+++++.++||||+++++++...  ...++||||++| +|.+++....              ..+.......
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~~  113 (284)
T cd05079          48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK--------------NKINLKQQLK  113 (284)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc--------------CCCCHHHHHH
Confidence            3446789999999999999999999999875  578999999986 8988874311              2356677788


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      ++.+++.||+|||+.|++||||||+||+++.++ .++|+|||.+........   ......++..|+|||.+.+ ..++.
T Consensus       114 i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~  191 (284)
T cd05079         114 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYI  191 (284)
T ss_pred             HHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCccccccccCccceeecCCCCCCccccCHHHhcc-CCCCc
Confidence            999999999999999999999999999999888 899999999876533221   1223456778999999877 56888


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC---c-cccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP---S-FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      ++||||||+++|+++++..|+.....  ............   . ...........+....+++.+.+|+.+||+.||++
T Consensus       192 ~~Di~slG~il~ellt~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  269 (284)
T cd05079         192 ASDVWSFGVTLYELLTYCDSESSPMT--LFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSK  269 (284)
T ss_pred             cccchhhhhhhhhhhcCCCCCccccc--hhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCccc
Confidence            99999999999999998765432111  000000000000   0 00000000011123457899999999999999999


Q ss_pred             ccCHHHHhcC
Q 039159          240 RITAAEALQQ  249 (259)
Q Consensus       240 Rp~~~~~l~h  249 (259)
                      ||+++++++.
T Consensus       270 Rpt~~~il~~  279 (284)
T cd05079         270 RTTFQNLIEG  279 (284)
T ss_pred             CcCHHHHHHH
Confidence            9999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.8e-36  Score=240.08  Aligned_cols=205  Identities=23%  Similarity=0.319  Sum_probs=165.3

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+.++++++|||++++++++..+ ..+++|||+.+ +|.+.+.....             ........+.++.+
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~q  108 (254)
T cd05083          43 AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGR-------------ALVSVIQLLQFSLD  108 (254)
T ss_pred             HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCc-------------CCCCHHHHHHHHHH
Confidence            46789999999999999999999998754 57899999985 99999864321             23456677788899


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||+.|++||||||+||+++.++ .++|+|||.++.....   ......+..|+|||.+.+ ..++.++|+|||
T Consensus       109 i~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~sl  183 (254)
T cd05083         109 VAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKH-KKFSSKSDVWSY  183 (254)
T ss_pred             HHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceecccc---CCCCCCCceecCHHHhcc-CCcCchhhHHHH
Confidence            99999999999999999999999999888 8999999998754221   122334567999999876 568889999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          171 GCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       171 G~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |+++|++++ |..||...........+...... .            ....+++.+.+++.+||+.+|++||+++++++
T Consensus       184 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         184 GVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM-E------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC-C------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999997 99999887766555444332211 1            01357889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.6e-36  Score=246.79  Aligned_cols=216  Identities=24%  Similarity=0.302  Sum_probs=169.6

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+.+|+++++++ +|+||+++++++..+..+++|+||+.+ +|.+.+...               ..+....+..++.
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~~  112 (290)
T cd05613          48 TEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR---------------ERFKEQEVQIYSG  112 (290)
T ss_pred             HHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            46678899999999 599999999999999999999999996 888887532               2244566777888


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCc-cCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGL-LEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di  167 (259)
                      +++.|++|||+.+++||||+|+||+++.++ .++|+|||++........ ......|+..|+|||.+.+. ..++.++|+
T Consensus       113 qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv  191 (290)
T cd05613         113 EIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDW  191 (290)
T ss_pred             HHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccH
Confidence            999999999999999999999999999888 899999999875432211 12234688899999998652 246788999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChH---HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc---
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSL---ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI---  241 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---  241 (259)
                      ||||+++|++++|..||......   ........... +            +....+++.+.+++.+||+.||++||   
T Consensus       192 ~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~  258 (290)
T cd05613         192 WSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-P------------PYPQEMSALAKDIIQRLLMKDPKKRLGCG  258 (290)
T ss_pred             HHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-C------------CCCccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence            99999999999999999643221   11111111110 0            11234788999999999999999997   


Q ss_pred             --CHHHHhcCccccCCC
Q 039159          242 --TAAEALQQEYFKDVP  256 (259)
Q Consensus       242 --~~~~~l~h~~f~~~~  256 (259)
                        ++++++.||||....
T Consensus       259 ~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         259 PSDADEIKKHPFFQKIN  275 (290)
T ss_pred             CCCHHHHHcCcccccCC
Confidence              899999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.1e-36  Score=249.22  Aligned_cols=223  Identities=22%  Similarity=0.271  Sum_probs=172.7

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc-cccCCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS-TKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+|+++++++ +||||+++++++..++..++++||+.+ +|.+++........... .........+....++.++
T Consensus        61 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  140 (334)
T cd05100          61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCA  140 (334)
T ss_pred             HHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence            45788999999999 799999999999999999999999985 99998865321100000 0000112346677888899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .|++.|++|||+++++||||||+||+++.++ .++|+|||.++........  .....++..|+|||.+.+ ..++.++|
T Consensus       141 ~qi~~al~~LH~~givH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  218 (334)
T cd05100         141 YQVARGMEYLASQKCIHRDLAARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSD  218 (334)
T ss_pred             HHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhh
Confidence            9999999999999999999999999999888 8999999998765332211  122234567999999977 56888999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||+++|+|++ |..||.+.........+......             ......+.++.+++.+||+.+|.+||++.+
T Consensus       219 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~e  285 (334)
T cd05100         219 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRM-------------DKPANCTHELYMIMRECWHAVPSQRPTFKQ  285 (334)
T ss_pred             hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------CCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence            9999999999998 88999887766665555432211             112356789999999999999999999999


Q ss_pred             HhcC
Q 039159          246 ALQQ  249 (259)
Q Consensus       246 ~l~h  249 (259)
                      ++++
T Consensus       286 ll~~  289 (334)
T cd05100         286 LVED  289 (334)
T ss_pred             HHHH
Confidence            9975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=258.38  Aligned_cols=210  Identities=27%  Similarity=0.332  Sum_probs=175.4

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +.+..+.|..|+.++++++|||||+++|+|.+ ...|+|||+++ |.|..+++..+              ..+....+..
T Consensus       431 t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk--------------~sL~l~tL~l  495 (974)
T KOG4257|consen  431 TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNK--------------DSLPLRTLTL  495 (974)
T ss_pred             ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhcc--------------ccchHHHHHH
Confidence            34557899999999999999999999999965 58899999999 79999997654              3455677889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC-cCCccCccccCcccccCccCCCccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +++|++.||+|||+.++|||||...|||+.... +|||+|||+++.+....-.. +...-...|||||.+.- ..++.++
T Consensus       496 y~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtAS  573 (974)
T KOG4257|consen  496 YCYQICTALAYLESKRFVHRDIAARNILVSSPQ-CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF-RRFTTAS  573 (974)
T ss_pred             HHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-eeeecccchhhhccccchhhccccccceeecCccccch-hcccchh
Confidence            999999999999999999999999999999887 89999999999876543322 22233567999999965 7899999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||-||+.+||++. |..||.+-........+-++.+.|             ..+++++.+-.|+.+||.+||.+||++.
T Consensus       574 DVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP-------------~P~nCPp~LYslmskcWayeP~kRPrft  640 (974)
T KOG4257|consen  574 DVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP-------------CPPNCPPALYSLMSKCWAYEPSKRPRFT  640 (974)
T ss_pred             hHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC-------------CCCCCChHHHHHHHHHhccCcccCCcHH
Confidence            99999999999985 899999876666665555444433             2367899999999999999999999987


Q ss_pred             HHh
Q 039159          245 EAL  247 (259)
Q Consensus       245 ~~l  247 (259)
                      ++.
T Consensus       641 ei~  643 (974)
T KOG4257|consen  641 EIK  643 (974)
T ss_pred             HHH
Confidence            765

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.3e-36  Score=242.41  Aligned_cols=212  Identities=26%  Similarity=0.365  Sum_probs=170.4

Q ss_pred             CCchhHHHHHHHhh-CCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLME-LNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~-l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...++.+|+.++++ ++||||+++++++..++..+++|||+.| +|.+.+......           ...+.....+.++
T Consensus        51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~-----------~~~~~~~~~~~~~  119 (269)
T cd08528          51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK-----------KQRFTEERIWNIF  119 (269)
T ss_pred             HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhc-----------cCCCCHHHHHHHH
Confidence            34567889998875 7999999999999999999999999996 888887532111           0335567788889


Q ss_pred             hhcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.++.|||+ .+++||||+|+||+++.++ .++|+|||.+....... ......|+..|++||.+.+ ..++.++|+
T Consensus       120 ~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv  196 (269)
T cd08528         120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKN-EPYGEKADV  196 (269)
T ss_pred             HHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEecccceeeccccc-ccccccCcccCcChhhhcC-CCCchHHHH
Confidence            999999999996 7899999999999999888 89999999997653322 3345568889999999987 567899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||+++|++++|++||...........+......+.            ....+++.+.+++.+||+.||++||++.++.
T Consensus       197 ~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~  264 (269)
T cd08528         197 WAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVS  264 (269)
T ss_pred             HHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHH
Confidence            9999999999999999987776655555543322111            0124678999999999999999999999987


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      .
T Consensus       265 ~  265 (269)
T cd08528         265 A  265 (269)
T ss_pred             H
Confidence            5

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-36  Score=242.02  Aligned_cols=203  Identities=20%  Similarity=0.193  Sum_probs=160.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.++++++||||+++++++.. ...++||||+++ +|.+++....              ..+....++.++.+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~  109 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREK--------------NNVSLHWKLDVAKQ  109 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhc--------------cCCCHHHHHHHHHH
Confidence            6789999999999999999999999988 778999999996 8888885421              13556677888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCC------eEEEeeccccccccccCCCCcCCccCccccCcccccCc-cCCCc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGK------TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL-LEYST  163 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~------~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~  163 (259)
                      ++.||+|||+.+++||||||+||+++.++.      .++++|||.+.....    .....++..|+|||.+.+. ..++.
T Consensus       110 i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~  185 (259)
T cd05037         110 LASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTI  185 (259)
T ss_pred             HHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcch
Confidence            999999999999999999999999987652      499999999976432    2334567789999999763 36788


Q ss_pred             ccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          164 AVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       164 ~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ++|+||||+++|++++ |..||..................+               ......+.+++.+||..+|.+||+
T Consensus       186 ~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~li~~~l~~~p~~Rpt  250 (259)
T cd05037         186 AADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP---------------MPDCAELANLINQCWTYDPTKRPS  250 (259)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCC---------------CCCchHHHHHHHHHhccChhhCCC
Confidence            9999999999999999 577887654332222221111000               112378899999999999999999


Q ss_pred             HHHHhc
Q 039159          243 AAEALQ  248 (259)
Q Consensus       243 ~~~~l~  248 (259)
                      +.++++
T Consensus       251 ~~~il~  256 (259)
T cd05037         251 FRAILR  256 (259)
T ss_pred             HHHHHH
Confidence            999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-37  Score=263.96  Aligned_cols=227  Identities=22%  Similarity=0.304  Sum_probs=197.0

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhC-CCCCeeEEEEEEEe-----CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCC
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQ-----GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFN   74 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~-----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~   74 (259)
                      .||....++..+.+..|..||+.+ +|||++.++|+|.-     ++++|||||||.| |.-+++.+..+           
T Consensus        49 ~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g-----------  117 (953)
T KOG0587|consen   49 IKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKG-----------  117 (953)
T ss_pred             eEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcc-----------
Confidence            478888888899999999999999 59999999999863     4689999999995 89999977653           


Q ss_pred             CcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCccc
Q 039159           75 SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPEL  154 (259)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~  154 (259)
                        ..+.+..+..+++.++.|+.+||.+.++|||||-.|||++.++ .|||.|||.+..+........+.+|||.|||||+
T Consensus       118 --~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEV  194 (953)
T KOG0587|consen  118 --NRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEV  194 (953)
T ss_pred             --cchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEEeeeeeeeeeecccccccCcCCCccccccee
Confidence              5677888999999999999999999999999999999999999 8999999999988887778889999999999999


Q ss_pred             ccC----ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHH
Q 039159          155 LLG----LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLIS  230 (259)
Q Consensus       155 ~~~----~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  230 (259)
                      +..    ...|+..+|+||||++-.||..|.+|+.+..+...+..|-...+ |.          ...+...++.+.++|.
T Consensus       195 iac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP-Pk----------Lkrp~kWs~~FndFIs  263 (953)
T KOG0587|consen  195 IACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP-PK----------LKRPKKWSKKFNDFIS  263 (953)
T ss_pred             eecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC-cc----------ccchhhHHHHHHHHHH
Confidence            853    24577899999999999999999999999888877766533321 11          1123467899999999


Q ss_pred             hhcCcCCCCccCHHHHhcCcccc
Q 039159          231 KMLGMDPDKRITAAEALQQEYFK  253 (259)
Q Consensus       231 ~~l~~dp~~Rp~~~~~l~h~~f~  253 (259)
                      .||..|..+||+..++|+|||+.
T Consensus       264 ~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  264 TCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             HHHhhccccCcchhhhccCCccc
Confidence            99999999999999999999997

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.5e-37  Score=230.12  Aligned_cols=225  Identities=28%  Similarity=0.479  Sum_probs=175.2

Q ss_pred             CchhHHHHHHHhhCC-CCCeeEEEEEEEeCc--eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           12 PSSMIREVSCLMELN-HPNIIRLMRVASQGI--YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+.+.+|+.||..|+ ||||++++++..+..  ...||+||..+ +...+.                  ..++...+..+
T Consensus        76 kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly------------------~tl~d~dIryY  137 (338)
T KOG0668|consen   76 KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY------------------PTLTDYDIRYY  137 (338)
T ss_pred             HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh------------------hhhchhhHHHH
Confidence            467889999999997 999999999998754  67899999998 444444                  55667788999


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.||.|||+.||.|||+||.|++|+.....++|+|+|+|.. ...+..-.....+..|.-||.+.....++.+-|+
T Consensus       138 ~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF-YHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~  216 (338)
T KOG0668|consen  138 IYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDM  216 (338)
T ss_pred             HHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh-cCCCceeeeeeehhhcCCchheeechhccccHHH
Confidence            999999999999999999999999999998777899999999965 3445555566778889999999988889999999


Q ss_pred             HhHHHHHHHHHhCCCCC-CCCChHHHHHHHhCCC---------------CCCcccc---cccc----ccccCCCC-CCCH
Q 039159          168 WPVGCIFGEMVSGKPLF-PGANSLITLGRIVGKS---------------RKPSFCK---LSLR----DHLTNGFP-GLEP  223 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf-~~~~~~~~~~~i~~~~---------------~~~~~~~---~~~~----~~~~~~~~-~~~~  223 (259)
                      |||||++..|+..+-|| .+.+...++.+|..-.               ..|....   ....    ..+.+... -.++
T Consensus       217 WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~p  296 (338)
T KOG0668|consen  217 WSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSP  296 (338)
T ss_pred             HHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCCh
Confidence            99999999999987665 4565555554441111               0111111   0000    01111111 2579


Q ss_pred             HHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          224 AGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       224 ~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ++.||+.+.|..|-.+|+|++|++.||||..+
T Consensus       297 eaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  297 EAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             HHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            99999999999999999999999999999865

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=266.02  Aligned_cols=221  Identities=30%  Similarity=0.404  Sum_probs=170.7

Q ss_pred             CCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +....+.+||+.|+.-+ |||||++|+.-.+....|+..|.|..+|.+++... +...          ...........+
T Consensus       544 e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~-~~d~----------~~~~~i~~~~~l  612 (903)
T KOG1027|consen  544 EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLIESS-GLDV----------EMQSDIDPISVL  612 (903)
T ss_pred             HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHHhcc-ccch----------hhcccccHHHHH
Confidence            34456789999999985 99999999999999999999999999999999763 1100          000013456777


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcC---CC-CeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDL---DG-KTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~---~~-~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      .|+++||++||+.+|+||||||.||||+.   ++ .+++|+|||+++.+......   ..+..||-+|+|||++.. ...
T Consensus       613 ~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~  691 (903)
T KOG1027|consen  613 SQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE-DRK  691 (903)
T ss_pred             HHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc-ccc
Confidence            89999999999999999999999999987   23 36899999999987544322   455679999999999987 345


Q ss_pred             CcccchHhHHHHHHHHHhC-CCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          162 STAVDIWPVGCIFGEMVSG-KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      +.++||+|+||++|+.++| ..||.....  ...+|..+.....        .+.   +.-..++.+||.+|++.+|..|
T Consensus       692 ~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~--------~L~---~~~d~eA~dLI~~ml~~dP~~R  758 (903)
T KOG1027|consen  692 TQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLV--------HLE---PLPDCEAKDLISRMLNPDPQLR  758 (903)
T ss_pred             CcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCcccee--------eec---cCchHHHHHHHHHhcCCCcccC
Confidence            6799999999999999986 899965433  3333433322111        111   1222388999999999999999


Q ss_pred             cCHHHHhcCccccCC
Q 039159          241 ITAAEALQQEYFKDV  255 (259)
Q Consensus       241 p~~~~~l~h~~f~~~  255 (259)
                      |+|.+||.||||++.
T Consensus       759 Psa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  759 PSATDVLNHPLFWDS  773 (903)
T ss_pred             CCHHHHhCCCccCCh
Confidence            999999999999975

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-36  Score=245.06  Aligned_cols=225  Identities=22%  Similarity=0.250  Sum_probs=161.5

Q ss_pred             CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEe--CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159            7 TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      .+....+.+.+|++++++++||||+++++++..  +...++||||+++ +|.+++....              ..+....
T Consensus        44 ~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~l~~~~  109 (284)
T cd05081          44 STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--------------ERLDHRK  109 (284)
T ss_pred             CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC--------------cCCCHHH
Confidence            333334578899999999999999999998754  3478999999985 9999885321              2345667


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccC
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      +..++.+++.||+|||++|++||||||+||+++.++ .++|+|||++.........   .....++..|+|||.+.+ ..
T Consensus       110 ~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  187 (284)
T cd05081         110 LLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SK  187 (284)
T ss_pred             HHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc-CC
Confidence            788899999999999999999999999999999888 8999999999865332211   111223456999999976 56


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc----cccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC----KLSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                      ++.++|+||||+++||+++|..++...... ....+......+...    ..-......+....++.++.+++.+||..+
T Consensus       188 ~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  266 (284)
T cd05081         188 FSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNND  266 (284)
T ss_pred             cChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCC
Confidence            888999999999999999987765432211 111110000000000    000000011122457889999999999999


Q ss_pred             CCCccCHHHHhc
Q 039159          237 PDKRITAAEALQ  248 (259)
Q Consensus       237 p~~Rp~~~~~l~  248 (259)
                      |++|||+.++++
T Consensus       267 p~~Rpt~~ei~~  278 (284)
T cd05081         267 PSQRPSFSELAL  278 (284)
T ss_pred             hhhCCCHHHHHH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.1e-36  Score=243.22  Aligned_cols=217  Identities=19%  Similarity=0.260  Sum_probs=170.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEe-CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...+.+.+|+.++++++||||+++++++.. +...++++||+.+ +|..++........       .....++....+.+
T Consensus        50 ~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~-------~~~~~l~~~~~~~i  122 (280)
T cd05043          50 IQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEA-------NNPQALSTQQLVHM  122 (280)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhcccccc-------ccccCCCHHHHHHH
Confidence            335668899999999999999999998776 4678999999984 89888865322110       01134667788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.+++.|++|||+++++||||||+||+++.++ .+|++|||+++.+.....  ......++..|+|||.+.+ ..++.++
T Consensus       123 ~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~  200 (280)
T cd05043         123 AIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSAS  200 (280)
T ss_pred             HHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchh
Confidence            99999999999999999999999999999888 899999999975532211  1122345677999999977 5688999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|++++ |+.||...+.......+......+             .....++++.+++.+||..||++|||+.
T Consensus       201 Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~  267 (280)
T cd05043         201 DVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA-------------QPINCPDELFAVMACCWALDPEERPSFS  267 (280)
T ss_pred             hHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC-------------CCCcCCHHHHHHHHHHcCCChhhCCCHH
Confidence            99999999999999 999998877666555444332111             1134678999999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++++
T Consensus       268 ~~~~  271 (280)
T cd05043         268 QLVQ  271 (280)
T ss_pred             HHHH
Confidence            9985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-36  Score=241.45  Aligned_cols=207  Identities=21%  Similarity=0.246  Sum_probs=166.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.++++++||||+++++++.. ...+++|||+.+ +|.+.+....              ..++...++.++.|
T Consensus        53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~~~q  117 (279)
T cd05057          53 NKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHK--------------DNIGSQYLLNWCVQ  117 (279)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhcc--------------CCCCHHHHHHHHHH
Confidence            3578899999999999999999999987 788999999985 8998886432              23556778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC--cCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES--SAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++.|++|||+.+++||||||+||+++.++ .++|+|||.++.........  ....++..|+|||.+.. ..++.++|+|
T Consensus       118 i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~  195 (279)
T cd05057         118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVW  195 (279)
T ss_pred             HHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHH
Confidence            99999999999999999999999999888 89999999998654322211  11223567999999876 5678899999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|++++ |..||.+....+....+......+.             ....+.++.+++.+||..||++||++.+++
T Consensus       196 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~  262 (279)
T cd05057         196 SYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ-------------PPICTIDVYMVLVKCWMIDAESRPTFKELI  262 (279)
T ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC-------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            99999999998 9999988776665555443221111             124668899999999999999999999987


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       263 ~  263 (279)
T cd05057         263 N  263 (279)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=239.74  Aligned_cols=225  Identities=32%  Similarity=0.500  Sum_probs=177.0

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      .....+..+|..+++.++|+||++++.+|.-.      ..+|+|||++.++|.+++..                 -..=.
T Consensus        56 ~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~-----------------elDH~  118 (369)
T KOG0665|consen   56 QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILM-----------------ELDHE  118 (369)
T ss_pred             CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHH-----------------hcchH
Confidence            34567899999999999999999999999654      25799999999999998862                 12224


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .+..++.|.+.|+++||+.||+||||||+||++..++ .+||.|||+++.-.. .-..+..+.|-.|+|||.+.+. .+.
T Consensus       119 tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e~~-~~~mtpyVvtRyyrapevil~~-~~k  195 (369)
T KOG0665|consen  119 TISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-TLKILDFGLARTEDT-DFMMTPYVVTRYYRAPEVILGM-GYK  195 (369)
T ss_pred             HHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-heeeccchhhcccCc-ccccCchhheeeccCchheecc-CCc
Confidence            5678889999999999999999999999999999998 899999999975322 2244555778899999999984 489


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc--------------------cccccccccC-CC---
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC--------------------KLSLRDHLTN-GF---  218 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~--------------------~~~~~~~~~~-~~---  218 (259)
                      ..+||||+||++.||++|...|.+......+.++......|...                    ..+..+..+. .|   
T Consensus       196 e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~  275 (369)
T KOG0665|consen  196 ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVV  275 (369)
T ss_pred             ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccccccc
Confidence            99999999999999999999999988887777775443331110                    0000000000 01   


Q ss_pred             ----CCCCHHHHHHHHhhcCcCCCCccCHHHHhcCcccc
Q 039159          219 ----PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK  253 (259)
Q Consensus       219 ----~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~  253 (259)
                          +--+.-+++++.+||..||++|.+++++|+||||+
T Consensus       276 ~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  276 LEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             ccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                11234678899999999999999999999999997

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-38  Score=257.06  Aligned_cols=225  Identities=25%  Similarity=0.380  Sum_probs=192.8

Q ss_pred             CCCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchh
Q 039159            1 MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLF   79 (259)
Q Consensus         1 ~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~   79 (259)
                      ++|.+-.++.-++.+..|-.+|..++.|.||++|..|.++.++|++||-|-| .+-+.++..               ..+
T Consensus       453 lkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR---------------g~F  517 (732)
T KOG0614|consen  453 LKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR---------------GSF  517 (732)
T ss_pred             HhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc---------------CCc
Confidence            3566777788889999999999999999999999999999999999999986 677777542               223


Q ss_pred             HHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCcc
Q 039159           80 TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        80 ~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      ......-+..++..|++|||.+|||.|||||+|++++.+| .+||.|||+|+.+.. +...-+++|||.|.|||.+++ .
T Consensus       518 dd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-y~KLVDFGFAKki~~-g~KTwTFcGTpEYVAPEIILn-K  594 (732)
T KOG0614|consen  518 DDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-YLKLVDFGFAKKIGS-GRKTWTFCGTPEYVAPEIILN-K  594 (732)
T ss_pred             ccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-ceEEeehhhHHHhcc-CCceeeecCCcccccchhhhc-c
Confidence            3334445566778888999999999999999999999999 799999999998754 445667899999999999998 5


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      ..+.++|.||||+++||+++|.+||.+.++...++.|+.+-....+|            ..++..+.+||+++...+|.+
T Consensus       595 GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P------------r~I~k~a~~Lik~LCr~~P~E  662 (732)
T KOG0614|consen  595 GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP------------RRITKTATDLIKKLCRDNPTE  662 (732)
T ss_pred             CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc------------cccchhHHHHHHHHHhcCcHh
Confidence            67899999999999999999999999999999999998765544443            257788899999999999999


Q ss_pred             ccC-----HHHHhcCccccCC
Q 039159          240 RIT-----AAEALQQEYFKDV  255 (259)
Q Consensus       240 Rp~-----~~~~l~h~~f~~~  255 (259)
                      |..     +.++-+|.||.+.
T Consensus       663 RLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  663 RLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             hhccccCChHHHHhhhhhhcC
Confidence            996     9999999999865

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-37  Score=255.76  Aligned_cols=210  Identities=25%  Similarity=0.354  Sum_probs=174.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.|+.|+.+|+.++|||+|+++|+|.....+|+|+|||. |.|.++++.+.+             .-.+...++..+.
T Consensus       306 eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr-------------~ev~avvLlyMAt  372 (1157)
T KOG4278|consen  306 EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNR-------------SEVPAVVLLYMAT  372 (1157)
T ss_pred             hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhch-------------hhcchhHHHHHHH
Confidence            35679999999999999999999999999999999999988 699999987654             3345566778889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCC-ccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ||++|+.||..+++|||||...|+|++.+. .||++|||+++.+....-....- --...|.|||.+.- ..++.++|||
T Consensus       373 QIsSaMeYLEkknFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVW  450 (1157)
T KOG4278|consen  373 QISSAMEYLEKKNFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVW  450 (1157)
T ss_pred             HHHHHHHHHHHhhhhhhhhhhhhccccccc-eEEeeccchhhhhcCCceecccCccCcccccCcccccc-cccccchhhH
Confidence            999999999999999999999999999988 89999999998775432211110 12457999999865 6789999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      +||++|||++| |..||++-+..+.+..+-.+.+.             ....++++.+-+||+.||+++|.+||++.|+-
T Consensus       451 AFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM-------------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  451 AFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM-------------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc-------------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence            99999999998 78999998877777665444332             12357889999999999999999999999885


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       518 q  518 (1157)
T KOG4278|consen  518 Q  518 (1157)
T ss_pred             H
Confidence            4

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.4e-36  Score=249.84  Aligned_cols=224  Identities=21%  Similarity=0.306  Sum_probs=166.3

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEe-CceEEEEeeeecC-CHHHHhhcCCCCCCCcccc-----------------
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTK-----------------   71 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~-----------------   71 (259)
                      ...+.+|+.++.++ +||||+++++++.. +..++++|||+.+ +|.+++.............                 
T Consensus        54 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  133 (343)
T cd05103          54 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISED  133 (343)
T ss_pred             HHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhh
Confidence            34688999999999 68999999998865 4578999999995 9999886533211100000                 


Q ss_pred             -----------------------------------cCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEc
Q 039159           72 -----------------------------------NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVD  116 (259)
Q Consensus        72 -----------------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~  116 (259)
                                                         .......++...+..++.++++|++|||+++++||||||+||+++
T Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~  213 (343)
T cd05103         134 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  213 (343)
T ss_pred             hhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc
Confidence                                               000012356677888999999999999999999999999999999


Q ss_pred             CCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHH
Q 039159          117 LDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITL  193 (259)
Q Consensus       117 ~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~  193 (259)
                      .++ .++|+|||++........  ......+++.|+|||.+.+ ..++.++|+||||+++|++++ |..||.........
T Consensus       214 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  291 (343)
T cd05103         214 ENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  291 (343)
T ss_pred             CCC-cEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH
Confidence            888 899999999876432211  1222345677999999877 568889999999999999997 89999875443333


Q ss_pred             HHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          194 GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       194 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      .........+..            ....++++.+++..||+.||++||++.++++|
T Consensus       292 ~~~~~~~~~~~~------------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         292 CRRLKEGTRMRA------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHhccCCCCC------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            332222111111            12367889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.5e-36  Score=245.44  Aligned_cols=216  Identities=25%  Similarity=0.295  Sum_probs=169.2

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+++.+|+++++++ +||||+++++.+..+...++||||+.+ +|...+...               ..+....+..++
T Consensus        47 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~  111 (288)
T cd05583          47 TAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR---------------EHFTESEVRVYI  111 (288)
T ss_pred             HHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc---------------CCcCHHHHHHHH
Confidence            345688999999999 599999999999999999999999986 888877431               224456677788


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCcc-CCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLL-EYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~~D  166 (259)
                      .|++.+++|||+.+++||||+|+||+++.++ .++++|||++........ ......|++.|+|||.+.+.. ..+.++|
T Consensus       112 ~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D  190 (288)
T cd05583         112 AEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVD  190 (288)
T ss_pred             HHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhh
Confidence            8999999999999999999999999999888 899999999876533221 122345788999999986632 3678999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChH----HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSL----ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      +||||+++|+|++|..||......    .....+....              .+....+++.+.+++.+||+.||++|||
T Consensus       191 v~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~R~t  256 (288)
T cd05583         191 WWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--------------PPFPKTMSAEARDFIQKLLEKDPKKRLG  256 (288)
T ss_pred             hHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--------------CCCCcccCHHHHHHHHHHhcCCHhhccC
Confidence            999999999999999999643221    1111121111              1112347789999999999999999998


Q ss_pred             ---HHHHhcCccccCCC
Q 039159          243 ---AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ---~~~~l~h~~f~~~~  256 (259)
                         +.++|+||||+++.
T Consensus       257 ~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         257 ANGADEIKNHPFFQGID  273 (288)
T ss_pred             cchHHHHhcCcccccCC
Confidence               56779999999763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=244.76  Aligned_cols=218  Identities=24%  Similarity=0.313  Sum_probs=177.7

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .-..+|-+||.+++.+.||.+-.+|+..+.+|+|+..|.| +|...+-+ .+.            ..+....++-++.+|
T Consensus       230 ~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn-~g~------------~gF~e~ra~FYAAEi  296 (591)
T KOG0986|consen  230 TMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYN-HGN------------PGFDEQRARFYAAEI  296 (591)
T ss_pred             HHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeec-cCC------------CCCchHHHHHHHHHH
Confidence            4567899999999999999999999999999999999997 55554432 222            567888889999999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      +-||.+||..+||.||+||+|||+|..| +|+|+|+|+|..+.. .......+||.+|||||++.+ ..|+.++|-||+|
T Consensus       297 ~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRISDLGLAvei~~-g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lG  373 (591)
T KOG0986|consen  297 ICGLEHLHRRRIVYRDLKPENILLDDHG-HVRISDLGLAVEIPE-GKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLG  373 (591)
T ss_pred             HhhHHHHHhcceeeccCChhheeeccCC-CeEeeccceEEecCC-CCccccccCcccccCHHHHcC-CcccCCccHHHHH
Confidence            9999999999999999999999999999 999999999987644 333444589999999999998 4599999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CHHHH
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAEA  246 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~~  246 (259)
                      |++|||+.|..||...........+-..-.  .        -.......+|++++++.+..|..||.+|.     .++++
T Consensus       374 CllYemi~G~sPFr~~KeKvk~eEvdrr~~--~--------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~ev  443 (591)
T KOG0986|consen  374 CLLYEMIAGHSPFRQRKEKVKREEVDRRTL--E--------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEV  443 (591)
T ss_pred             hHHHHHHcccCchhhhhhhhhHHHHHHHHh--c--------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchh
Confidence            999999999999986544333222211000  0        00112246899999999999999999998     47899


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      -+||||+++.
T Consensus       444 k~HpfFk~ln  453 (591)
T KOG0986|consen  444 KEHPFFKDLN  453 (591)
T ss_pred             hhCcccccCC
Confidence            9999999874

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=264.50  Aligned_cols=212  Identities=25%  Similarity=0.336  Sum_probs=186.0

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ++.-..+|+.|+.||.+++||||+.+-|+......+.+|+|||+ |+|..+++...              ..+.+.|++.
T Consensus       670 tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--------------GqftviQLVg  735 (996)
T KOG0196|consen  670 TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--------------GQFTVIQLVG  735 (996)
T ss_pred             cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--------------CceEeehHHH
Confidence            45677899999999999999999999999999999999999999 59999998654              4577789999


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCc-c--CccccCcccccCccCCCc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-G--THYYKAPELLLGLLEYST  163 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~-~--~~~~~aPE~~~~~~~~~~  163 (259)
                      .++.|++|++||.+.++|||||...|||++.+= .+|++|||+++.+++......+.. |  ...|.|||.+.. .+++.
T Consensus       736 MLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL-vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTs  813 (996)
T KOG0196|consen  736 MLRGIASGMKYLSDMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTS  813 (996)
T ss_pred             HHHHHHHHhHHHhhcCchhhhhhhhheeeccce-EEEeccccceeecccCCCccccccCCccceeecChhHhhh-cccCc
Confidence            999999999999999999999999999999887 899999999998765542222212 1  357999999977 78999


Q ss_pred             ccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          164 AVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       164 ~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ++||||+|+++||+++ |..||.+.++.+....|-.+.+.|.-             .+.+..+..||..||++|-.+||+
T Consensus       814 ASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-------------mDCP~aL~qLMldCWqkdR~~RP~  880 (996)
T KOG0196|consen  814 ASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-------------MDCPAALYQLMLDCWQKDRNRRPK  880 (996)
T ss_pred             hhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-------------CCCcHHHHHHHHHHHHHHhhcCCC
Confidence            9999999999999875 99999999999999999888777653             358899999999999999999999


Q ss_pred             HHHHhc
Q 039159          243 AAEALQ  248 (259)
Q Consensus       243 ~~~~l~  248 (259)
                      +.+++.
T Consensus       881 F~qiV~  886 (996)
T KOG0196|consen  881 FAQIVS  886 (996)
T ss_pred             HHHHHH
Confidence            999875

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=252.54  Aligned_cols=227  Identities=21%  Similarity=0.217  Sum_probs=178.5

Q ss_pred             CCCCCCCCCCCC-chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcch
Q 039159            1 MMGIHNTMEGVP-SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus         1 ~~~~~~~~~~~~-~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      ||+++..++... .+|.+||++|.+|+||||+.++|+|..++.+++|+||++ |+|.+++....-             ..
T Consensus       567 VK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahea-------------pt  633 (807)
T KOG1094|consen  567 VKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHEL-------------PT  633 (807)
T ss_pred             EeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccC-------------cc
Confidence            355666665444 899999999999999999999999999999999999999 599999964211             11


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCccccc
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLL  156 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~  156 (259)
                      ......+.++.||++|++||.+.+++|||+.+.|+|++.++ .+||+|||.++-++...-  ..+...-...|+|||.+.
T Consensus       634 ~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsil  712 (807)
T KOG1094|consen  634 AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESIL  712 (807)
T ss_pred             cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCcccccccccCCceeeecceeeeeeehhHHHHH
Confidence            23345567999999999999999999999999999999998 999999999986644221  122334567899999998


Q ss_pred             CccCCCcccchHhHHHHHHHHHh--CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcC
Q 039159          157 GLLEYSTAVDIWPVGCIFGEMVS--GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~e~~t--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                      . .+++.++|+|+||+++||+++  .+.||......+...+.-.-...+...      ......+-++..+-++|..||+
T Consensus       713 l-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~------~~l~~P~~cp~~lyelml~Cw~  785 (807)
T KOG1094|consen  713 L-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ------VVLSRPPACPQGLYELMLRCWR  785 (807)
T ss_pred             h-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc------eeccCCCcCcHHHHHHHHHHhc
Confidence            7 689999999999999999976  678998877766665543322221111      1112234577899999999999


Q ss_pred             cCCCCccCHHHHhc
Q 039159          235 MDPDKRITAAEALQ  248 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~  248 (259)
                      .|..+||+++++..
T Consensus       786 ~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  786 RESEQRPSFEQLHL  799 (807)
T ss_pred             hhhhcCCCHHHHHH
Confidence            99999999999864

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.9e-35  Score=242.01  Aligned_cols=206  Identities=20%  Similarity=0.230  Sum_probs=162.3

Q ss_pred             hhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           14 SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      .+.+|+.+++.++||||+++++++..+ ..++++||++ |+|.+.+....              ..+....+..++.+++
T Consensus        55 ~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~--------------~~~~~~~~~~~~~qi~  119 (303)
T cd05110          55 EFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHK--------------DNIGSQLLLNWCVQIA  119 (303)
T ss_pred             HHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcc--------------cCCCHHHHHHHHHHHH
Confidence            678999999999999999999998754 5678999998 48888875321              2345567788899999


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcccchHhH
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      .|++|||+++++||||||+||+++.++ .+||+|||+++........  .....++..|+|||.+.+ ..++.++|||||
T Consensus       120 ~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Diwsl  197 (303)
T cd05110         120 KGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSY  197 (303)
T ss_pred             HHHHHHhhcCeeccccccceeeecCCC-ceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHH
Confidence            999999999999999999999999888 8999999999865432221  122345678999999876 568899999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          171 GCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       171 G~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      |+++|++++ |..||.+.........+......+             ..+..+..+.+++..||..+|++||+++++++.
T Consensus       198 G~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         198 GVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP-------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999997 889998765544433332221111             113467889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=239.67  Aligned_cols=233  Identities=19%  Similarity=0.228  Sum_probs=179.1

Q ss_pred             CCCCCCCCC-CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcch
Q 039159            1 MMGIHNTME-GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus         1 ~~~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      ||+|..... ..+.++..|.....+= +-||||++||++-..+..|+.||+|.-|+..+.........          ..
T Consensus        94 VKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~----------~~  163 (361)
T KOG1006|consen   94 VKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQK----------SR  163 (361)
T ss_pred             EEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHh----------cc
Confidence            467776554 6778899999966655 68999999999888889999999999877766654222211          33


Q ss_pred             hHHHHHHHHHhhcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG  157 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (259)
                      ++...+..+......||.||.+ .+|+|||+||+|||++..| .+||||||++-.+..+. ..+...|...|+|||.+..
T Consensus       164 ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv~Si-AkT~daGCrpYmAPERi~p  241 (361)
T KOG1006|consen  164 IPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLVDSI-AKTVDAGCRPYMAPERIDP  241 (361)
T ss_pred             CcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHHHHH-HhhhccCCccccChhccCC
Confidence            4444555666667788999985 5999999999999999999 89999999996554321 2334468889999999975


Q ss_pred             ccC-CCcccchHhHHHHHHHHHhCCCCCCC-CChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          158 LLE-YSTAVDIWPVGCIFGEMVSGKPLFPG-ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       158 ~~~-~~~~~DiwslG~~l~e~~tg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      ... |+.++|+||||++|||++||..|+.. .+..++...+..+....-..+        ....+++..+..+|..||..
T Consensus       242 ~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~--------~~~~~~s~~~~~fintCl~K  313 (361)
T KOG1006|consen  242 SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD--------KECVHYSFSMVRFINTCLIK  313 (361)
T ss_pred             ccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc--------ccccccCHHHHHHHHHHhhc
Confidence            433 88999999999999999999999986 445556666554432211111        11235889999999999999


Q ss_pred             CCCCccCHHHHhcCcccc
Q 039159          236 DPDKRITAAEALQQEYFK  253 (259)
Q Consensus       236 dp~~Rp~~~~~l~h~~f~  253 (259)
                      |-..||..++++++||++
T Consensus       314 d~~~Rpky~~Lk~~~fyr  331 (361)
T KOG1006|consen  314 DRSDRPKYDDLKKFPFYR  331 (361)
T ss_pred             ccccCcchhhhhcCchhh
Confidence            999999999999999987

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-37  Score=242.27  Aligned_cols=228  Identities=29%  Similarity=0.382  Sum_probs=173.4

Q ss_pred             CCCchhHHHHHHHhhCC-C-C----CeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           10 GVPSSMIREVSCLMELN-H-P----NIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~-H-~----niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ...++..-|+++|.+++ + |    -++++.++|.-.+..|+|+|.+.-++++++....             +..++...
T Consensus       127 kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~-------------y~~fpi~~  193 (415)
T KOG0671|consen  127 KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENN-------------YIPFPIDH  193 (415)
T ss_pred             HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCC-------------ccccchHH
Confidence            44567788999999994 2 2    2677778898889999999999889999996533             26678889


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCC-------------------CCeEEEeeccccccccccCCCCcCCc
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLD-------------------GKTVKVAGFGLAKSLYAYKGESSAEV  144 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~-------------------~~~vkl~dfg~~~~~~~~~~~~~~~~  144 (259)
                      +..+..|++++++|||+.+++|-||||+||++..+                   ...++++|||.|......   -++.+
T Consensus       194 ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iV  270 (415)
T KOG0671|consen  194 IRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIV  270 (415)
T ss_pred             HHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC---cceee
Confidence            99999999999999999999999999999998311                   125799999999764332   35567


Q ss_pred             cCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHH---HHHhCCCCCCccccccc-----------
Q 039159          145 GTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITL---GRIVGKSRKPSFCKLSL-----------  210 (259)
Q Consensus       145 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~-----------  210 (259)
                      .|..|+|||++++ -.++..+||||+||+|+|++||...|+++++.+.+   ..+.+  +.|.......           
T Consensus       271 sTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG--p~P~~mi~r~~~~Kyf~~~rl  347 (415)
T KOG0671|consen  271 STRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG--PIPSRMIKKTRKEKYFRRGRL  347 (415)
T ss_pred             eccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC--CCcHHHhhhhhhHhhhhcccc
Confidence            8999999999999 57899999999999999999999999988766633   33332  1111111110           


Q ss_pred             -------c----------ccccCCCCCCC---HHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          211 -------R----------DHLTNGFPGLE---PAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       211 -------~----------~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                             .          .++.......+   ..+.|||.+||..||.+|+|+.|+|.||||....
T Consensus       348 dw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  348 DWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             cCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence                   0          00111111112   2567899999999999999999999999998653

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-35  Score=240.30  Aligned_cols=210  Identities=25%  Similarity=0.309  Sum_probs=163.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEe--CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ..+.+.+|+++++.++||||+++++++..  +...+++|||+.+ +|.+++....              ..+....+..+
T Consensus        49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~--------------~~~~~~~~~~~  114 (284)
T cd05038          49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--------------DQINLKRLLLF  114 (284)
T ss_pred             HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCc--------------cccCHHHHHHH
Confidence            45689999999999999999999999877  5578999999985 8998885421              23566778889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCCCcc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      +.+++.||+|||+.+++||||||+||+++.++ .++|+|||.+.........   .....++..|++||.+.+ ..++.+
T Consensus       115 ~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~  192 (284)
T cd05038         115 SSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSA  192 (284)
T ss_pred             HHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc-CCCCcc
Confidence            99999999999999999999999999999888 8999999999765422111   112234567999999876 567889


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHH--------------HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLI--------------TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLIS  230 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~--------------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  230 (259)
                      +|+||||+++|+|++|..|+.......              ...........            .+.....+.++.+++.
T Consensus       193 ~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~li~  260 (284)
T cd05038         193 SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER------------LPRPPSCPDEVYDLMK  260 (284)
T ss_pred             cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc------------CCCCccCCHHHHHHHH
Confidence            999999999999999998886532211              11111111100            0112346688999999


Q ss_pred             hhcCcCCCCccCHHHHhc
Q 039159          231 KMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       231 ~~l~~dp~~Rp~~~~~l~  248 (259)
                      +||+.+|++||++.++++
T Consensus       261 ~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         261 LCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHhccChhhCCCHHHHHH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.7e-35  Score=236.12  Aligned_cols=214  Identities=22%  Similarity=0.314  Sum_probs=164.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCc------eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGI------YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      .+++.+|++++++++||||+++++++....      ..++++||+.+ +|...+........         ...++....
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~---------~~~l~~~~~  115 (273)
T cd05074          45 IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEE---------PFTLPLQTL  115 (273)
T ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCC---------CCCCCHHHH
Confidence            456889999999999999999999886532      34788999885 88777643211100         023556777


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCC
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      +.++.+++.|++|||+.+++||||||+||+++.++ .++++|||.++.......  ......+++.|++||.+.+ ..++
T Consensus       116 ~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~  193 (273)
T cd05074         116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYT  193 (273)
T ss_pred             HHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-Cccc
Confidence            88999999999999999999999999999999887 899999999876532211  1222345678999999876 5678


Q ss_pred             cccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          163 TAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      .++|||||||++|++++ |.+||.+.........+.......             ..+..++.+.+++.+||+.+|++||
T Consensus       194 ~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~~~l~~~p~~Rp  260 (273)
T cd05074         194 THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK-------------QPPDCLEDVYELMCQCWSPEPKCRP  260 (273)
T ss_pred             hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHcCCChhhCc
Confidence            89999999999999999 889998777665555544332111             1135678999999999999999999


Q ss_pred             CHHHHhcC
Q 039159          242 TAAEALQQ  249 (259)
Q Consensus       242 ~~~~~l~h  249 (259)
                      ++.++++.
T Consensus       261 s~~~~~~~  268 (273)
T cd05074         261 SFQHLRDQ  268 (273)
T ss_pred             CHHHHHHH
Confidence            99999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4e-35  Score=262.02  Aligned_cols=104  Identities=28%  Similarity=0.385  Sum_probs=92.0

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+.+++.++||||+++++++...+.+|+||||+.| +|..++...               ..+....++.++.+
T Consensus        48 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~---------------~~l~~~~~~~i~~q  112 (669)
T cd05610          48 VHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY---------------GYFDEEMAVKYISE  112 (669)
T ss_pred             HHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            46788999999999999999999999999999999999986 899888532               22344567888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      ++.||+|||.++|+||||||+|||++.++ .++|+|||+++
T Consensus       113 il~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610         113 VALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             HHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            99999999999999999999999999888 89999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.2e-35  Score=231.12  Aligned_cols=213  Identities=42%  Similarity=0.574  Sum_probs=173.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|++.+++++|+||+++++.+..+...++++|++.+ +|..++....               ..+......++.+
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~   95 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG---------------RLSEDEARFYARQ   95 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc---------------CCCHHHHHHHHHH
Confidence            57899999999999999999999999999999999999997 9999885421               1556678888999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.++++||+.+++|+||+|+||+++.++ .++++|||.+....... ......++..|++||...+ ...+.++|+|||
T Consensus        96 l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~sl  172 (244)
T smart00220       96 ILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSL  172 (244)
T ss_pred             HHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeecccc-ccccccCCcCCCCHHHHcc-CCCCchhhHHHH
Confidence            99999999999999999999999999887 89999999997654322 3344567888999999976 567889999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      |++++++++|..||.....................          .....++.++.+++.+||..+|++||++.++++||
T Consensus       173 G~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~  242 (244)
T smart00220      173 GVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP----------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHP  242 (244)
T ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc----------cccccCCHHHHHHHHHHccCCchhccCHHHHhhCC
Confidence            99999999999999874333333333322211111          00112778999999999999999999999999999


Q ss_pred             cc
Q 039159          251 YF  252 (259)
Q Consensus       251 ~f  252 (259)
                      ||
T Consensus       243 ~~  244 (244)
T smart00220      243 FF  244 (244)
T ss_pred             CC
Confidence            97

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-35  Score=245.53  Aligned_cols=215  Identities=27%  Similarity=0.374  Sum_probs=176.7

Q ss_pred             hhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           14 SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      .+..|-.||..-+++.||++|..|.+++.+|.||+|.+| ++-.++-..               ..+......-++..+.
T Consensus       675 HVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm---------------gIFeE~LARFYIAElt  739 (1034)
T KOG0608|consen  675 HVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---------------GIFEEDLARFYIAELT  739 (1034)
T ss_pred             hhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHh---------------ccCHHHHHHHHHHHHH
Confidence            455788899999999999999999999999999999996 777766432               5666677777788888


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccc--------ccCC------------------C-------
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY--------AYKG------------------E-------  139 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~--------~~~~------------------~-------  139 (259)
                      .|+++.|+.|+|||||||+|||||.+| ++||.|||++..+.        +.+.                  +       
T Consensus       740 cAiesVHkmGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~r  818 (1034)
T KOG0608|consen  740 CAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERR  818 (1034)
T ss_pred             HHHHHHHhccceecccCccceEEccCC-ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHH
Confidence            999999999999999999999999999 99999999986431        0000                  0       


Q ss_pred             ---------CcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccc
Q 039159          140 ---------SSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSL  210 (259)
Q Consensus       140 ---------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  210 (259)
                               ....+||+-|+|||++.. ..++..+|.||.||+||||+.|++||....+.+...++.+......++.   
T Consensus       819 a~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~---  894 (1034)
T KOG0608|consen  819 AMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPY---  894 (1034)
T ss_pred             HHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhcccccc---
Confidence                     022369999999999987 6789999999999999999999999999888877777776655444321   


Q ss_pred             cccccCCCCCCCHHHHHHHHhhcCcCCCCccC---HHHHhcCccccCCC
Q 039159          211 RDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT---AAEALQQEYFKDVP  256 (259)
Q Consensus       211 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~~l~h~~f~~~~  256 (259)
                             ..++|+++.++|.++ ..+++.|..   +++|-.||||+.+.
T Consensus       895 -------~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  895 -------QGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             -------ccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccc
Confidence                   357899999999875 556888884   78899999999875

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=246.58  Aligned_cols=216  Identities=25%  Similarity=0.343  Sum_probs=174.9

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCC-HHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVND-LAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+.||.+++||.||.+--.|+..+..++|||-+.|+ |.-.+...+              ..++.....-.+.|
T Consensus       607 esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEk--------------gRL~er~TkFlvtQ  672 (888)
T KOG4236|consen  607 ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEK--------------GRLPERITKFLVTQ  672 (888)
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhc--------------ccchHHHHHHHHHH
Confidence            478899999999999999999999999999999999999995 555554433              34455556667789


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCC--CCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~--~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      |+.||+|||.++|+|.||||+|+|+...  ..++||+|||+|++.... .-.....|||.|.|||++.. ..|+.+-|+|
T Consensus       673 IL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsVVGTPAYLaPEVLrn-kGyNrSLDMW  750 (888)
T KOG4236|consen  673 ILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSVVGTPAYLAPEVLRN-KGYNRSLDMW  750 (888)
T ss_pred             HHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhhcCCccccCHHHHhh-ccccccccce
Confidence            9999999999999999999999999753  458999999999875321 12345689999999999988 6789999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |+|+++|-.++|..||.+..+-  ..+|.+..-  .        ....-|.++|+++.|||..+|++.-.+|.+++..|.
T Consensus       751 SVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaF--M--------yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  751 SVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAF--M--------YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             eeeEEEEEEecccccCCCccch--hHHhhcccc--c--------cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            9999999999999999865432  222221110  0        111225689999999999999999999999999999


Q ss_pred             CccccCC
Q 039159          249 QEYFKDV  255 (259)
Q Consensus       249 h~~f~~~  255 (259)
                      |||+++-
T Consensus       819 h~Wlq~y  825 (888)
T KOG4236|consen  819 HPWLQDY  825 (888)
T ss_pred             chhhhcc
Confidence            9999864

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-34  Score=235.63  Aligned_cols=207  Identities=14%  Similarity=0.094  Sum_probs=151.3

Q ss_pred             HHHHHhhCCCCCeeEEEEEEEeCc----eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhccc
Q 039159           18 EVSCLMELNHPNIIRLMRVASQGI----YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDS   93 (259)
Q Consensus        18 Ei~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (259)
                      +...+..++|+|++++++++....    ..+++++++..++.+.+...               ...+...+..++.|++.
T Consensus        73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~i~~qi~~  137 (294)
T PHA02882         73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI---------------KCKNKKLIKNIMKDMLT  137 (294)
T ss_pred             HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh---------------ccCCHHHHHHHHHHHHH
Confidence            334556678999999999876543    44788888777776666432               11234556788999999


Q ss_pred             ccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-------CCCcCCccCccccCcccccCccCCCcccc
Q 039159           94 SRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-------GESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        94 ~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      |++|||+.+++||||||+||+++.++ .++|+|||+++......       .......||+.|+|||...+ ..++.++|
T Consensus       138 ~l~~lH~~~iiHrDiKp~Nill~~~~-~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~D  215 (294)
T PHA02882        138 TLEYIHEHGISHGDIKPENIMVDGNN-RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGD  215 (294)
T ss_pred             HHHHHHhCCeecCCCCHHHEEEcCCC-cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHH
Confidence            99999999999999999999999888 89999999997653221       11223469999999999887 56899999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANS-LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||||++|++++|+.||.+... ........... .....      ......++.++.+.+++..|+..+|++||++++
T Consensus       216 iwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~  288 (294)
T PHA02882        216 LESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDF-IKRLH------EGKIKIKNANKFIYDFIECVTKLSYEEKPDYDA  288 (294)
T ss_pred             HHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHH-HHHhh------hhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHH
Confidence            99999999999999999987632 21111110000 00000      000112456789999999999999999999999


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +++
T Consensus       289 l~~  291 (294)
T PHA02882        289 LIK  291 (294)
T ss_pred             HHH
Confidence            975

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4e-34  Score=254.16  Aligned_cols=160  Identities=31%  Similarity=0.419  Sum_probs=121.0

Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccc----c----------c----CCCCcC
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY----A----------Y----KGESSA  142 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~----~----------~----~~~~~~  142 (259)
                      ......+|++|+.||+|+|+.|||||||||.||+++.++ .|||+|||++....    .          .    .+..+.
T Consensus       696 ~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts  774 (1351)
T KOG1035|consen  696 RDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTS  774 (1351)
T ss_pred             hHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCccccc
Confidence            456778999999999999999999999999999999888 89999999997621    0          0    011234


Q ss_pred             CccCccccCcccccCcc--CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCC
Q 039159          143 EVGTHYYKAPELLLGLL--EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG  220 (259)
Q Consensus       143 ~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  220 (259)
                      .+||-.|.|||.+.+..  .|+.++|+||||++|+||+.   ||...........   ..+.+..+.     . ...+.+
T Consensus       775 ~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~---~LR~g~iP~-----~-~~f~~~  842 (1351)
T KOG1035|consen  775 QVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILT---NLRKGSIPE-----P-ADFFDP  842 (1351)
T ss_pred             ccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHH---hcccCCCCC-----C-cccccc
Confidence            57999999999998754  69999999999999999975   4665433322222   222222221     1 111223


Q ss_pred             CCHHHHHHHHhhcCcCCCCccCHHHHhcCcccc
Q 039159          221 LEPAGIDLISKMLGMDPDKRITAAEALQQEYFK  253 (259)
Q Consensus       221 ~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~  253 (259)
                      .-+.-..+|..|++.||.+||||.|+|++.||.
T Consensus       843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  843 EHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             cchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            345667899999999999999999999999987

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=230.31  Aligned_cols=213  Identities=24%  Similarity=0.342  Sum_probs=182.0

Q ss_pred             chhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           13 SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        13 ~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      +--+.|-++|... +-|.+++++.+|...+.+|.||||+.| +|-.-+++.               ..+.....+-++..
T Consensus       394 ectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~---------------GkFKEp~AvFYAaE  458 (683)
T KOG0696|consen  394 ECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV---------------GKFKEPVAVFYAAE  458 (683)
T ss_pred             cceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh---------------cccCCchhhhhhHH
Confidence            3445677777777 588999999999999999999999996 777777553               44455566677778


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++-||=|||++||+.||||.+||+++.+| ++||+|||+++.-.-......+++|||-|+|||.+.- .+|+.++|.||+
T Consensus       459 iaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~  536 (683)
T KOG0696|consen  459 IAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAF  536 (683)
T ss_pred             HHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeecccccccccCCcceeeecCCCcccccceEEe-cccccchhHHHH
Confidence            88899999999999999999999999999 9999999999876555667788899999999999976 689999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HHH
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AAE  245 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~~  245 (259)
                      |++||||+.|++||.+.+..+.+..|......              ....+|.++.++.+..|...|.+|..     -.+
T Consensus       537 GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs--------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~d  602 (683)
T KOG0696|consen  537 GVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS--------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERD  602 (683)
T ss_pred             HHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc--------------CcccccHHHHHHHHHHhhcCCccccCCCCccccc
Confidence            99999999999999999999999998764321              22468999999999999999999985     467


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +-.||||+.+.
T Consensus       603 i~~H~FFR~iD  613 (683)
T KOG0696|consen  603 IREHPFFRRID  613 (683)
T ss_pred             hhhCcchhhcc
Confidence            88999999774

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=244.20  Aligned_cols=219  Identities=25%  Similarity=0.323  Sum_probs=163.8

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc------eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGI------YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      ...++..+|+++|++|+|||||+++|+-+...      ..+++||||.| +|...++.+...            .+++..
T Consensus        53 r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~------------~GLpE~  120 (732)
T KOG4250|consen   53 RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENA------------YGLPES  120 (732)
T ss_pred             chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccc------------cCCCHH
Confidence            44567789999999999999999999877654      46899999996 999999765433            678888


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcC--CCC-eEEEeeccccccccccCCCCcCCccCccccCcccccCcc
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDL--DGK-TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~--~~~-~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      .++.++.+++.|+.|||++||+||||||.||++-.  +|. .-||+|||.|+.+.+.. ......||+.|.+||++....
T Consensus       121 e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~  199 (732)
T KOG4250|consen  121 EFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQK  199 (732)
T ss_pred             HHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC-eeeeecCchhhcChHHHhhcc
Confidence            99999999999999999999999999999998743  332 35899999999876544 455668999999999998546


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCC----hHHHHHHHhCCCCCCcccccccccc-------ccCCCCCCCH----H
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGAN----SLITLGRIVGKSRKPSFCKLSLRDH-------LTNGFPGLEP----A  224 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~-------~~~~~~~~~~----~  224 (259)
                      .|+..+|.|||||++|+.+||..||....    ..+....+...............+.       .-+.....++    .
T Consensus       200 ~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~  279 (732)
T KOG4250|consen  200 KYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATR  279 (732)
T ss_pred             CcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhh
Confidence            89999999999999999999999996432    2234444433332211111000000       0011122333    3


Q ss_pred             HHHHHHhhcCcCCCCcc
Q 039159          225 GIDLISKMLGMDPDKRI  241 (259)
Q Consensus       225 ~~~li~~~l~~dp~~Rp  241 (259)
                      +-.++..+|..+|.+|.
T Consensus       280 ~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  280 LTKWLASMLEWNPRKRG  296 (732)
T ss_pred             hhHHHHHHHhhhHHHhC
Confidence            34578889999999998

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=238.91  Aligned_cols=209  Identities=24%  Similarity=0.310  Sum_probs=175.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .-.+|.+|+.+|.+|+|||+|++||+..+ ..+.+|||+++ |+|.+-++...+             ..+.+..+..++.
T Consensus       154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~-------------~~llv~~Lcdya~  219 (1039)
T KOG0199|consen  154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKK-------------AILLVSRLCDYAM  219 (1039)
T ss_pred             hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccc-------------cceeHHHHHHHHH
Confidence            56789999999999999999999999986 78889999999 599998876322             5566778889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC---cCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      |++.|+.||..+++|||||-..|+++.... .|||+|||+.+.+....+.-   ...--...|.|||.+.. ..++.++|
T Consensus       220 QiA~aM~YLeskrlvHRDLAARNlllaspr-tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSD  297 (1039)
T KOG0199|consen  220 QIAKAMQYLESKRLVHRDLAARNLLLASPR-TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASD  297 (1039)
T ss_pred             HHHHHHHHHhhhhhhhhhhhhhhheecccc-eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc-ccccccch
Confidence            999999999999999999999999998776 89999999998764433211   11112346999999988 78999999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      +|+|||++|||.| |+-||.+.....++.++-.+.+.+.             .+.+++++-++++.||..+|.+|||+..
T Consensus       298 vWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR-------------Pk~csedIY~imk~cWah~paDRptFsa  364 (1039)
T KOG0199|consen  298 VWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR-------------PKYCSEDIYQIMKNCWAHNPADRPTFSA  364 (1039)
T ss_pred             hhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC-------------CCCChHHHHHHHHHhccCCccccccHHH
Confidence            9999999999997 7899999999888887764433322             2468899999999999999999999988


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +-+
T Consensus       365 ir~  367 (1039)
T KOG0199|consen  365 IRE  367 (1039)
T ss_pred             HHH
Confidence            854

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-33  Score=244.72  Aligned_cols=223  Identities=23%  Similarity=0.321  Sum_probs=173.8

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCc--chhHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSY--SLFTTFLLV   85 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~   85 (259)
                      ...+.+..|+++++.+ +||||+.++|++..+...++|+||+. |+|..+++..+....-.... ....  ..+...+.+
T Consensus       343 ~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~-~~~~~~~~L~~~dLl  421 (609)
T KOG0200|consen  343 SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSG-VFPNERDALTTKDLL  421 (609)
T ss_pred             HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccC-CCccccCCcCHHHHH
Confidence            4567899999999999 59999999999999999999999999 69999998876100000000 0111  247788999


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC-cCCc--cCccccCcccccCccCCC
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES-SAEV--GTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~-~~~~--~~~~~~aPE~~~~~~~~~  162 (259)
                      .+..|++.|++||++.+++||||-..||++..+. .+|++|||+++......... ....  -...|||||.+.. ..++
T Consensus       422 sfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft  499 (609)
T KOG0200|consen  422 SFAYQIANGMEYLASVPCVHRDLAARNVLITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFT  499 (609)
T ss_pred             HHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-Cccc
Confidence            9999999999999999999999999999999887 89999999998543322211 1111  2345999999988 7899


Q ss_pred             cccchHhHHHHHHHHHh-CCCCCCCCC-hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          163 TAVDIWPVGCIFGEMVS-GKPLFPGAN-SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~t-g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      .++||||||++|||+.| |..||.+-. .......+..+.+. ..            ....++++-++|+.||+.+|++|
T Consensus       500 ~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~-~~------------P~~c~~eiY~iM~~CW~~~p~~R  566 (609)
T KOG0200|consen  500 SKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRM-EQ------------PEHCSDEIYDLMKSCWNADPEDR  566 (609)
T ss_pred             ccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCC-CC------------CCCCCHHHHHHHHHHhCCCcccC
Confidence            99999999999999998 789999854 34443334333322 21            23568999999999999999999


Q ss_pred             cCHHHHhc
Q 039159          241 ITAAEALQ  248 (259)
Q Consensus       241 p~~~~~l~  248 (259)
                      |++.++.+
T Consensus       567 P~F~~~~~  574 (609)
T KOG0200|consen  567 PTFSECVE  574 (609)
T ss_pred             CCHHHHHH
Confidence            99988873

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=3.3e-34  Score=261.53  Aligned_cols=206  Identities=15%  Similarity=0.166  Sum_probs=150.1

Q ss_pred             HHHhhCCC-CCeeEEEEEE-------EeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           20 SCLMELNH-PNIIRLMRVA-------SQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        20 ~~l~~l~H-~niv~~~~~~-------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .-.+.++| +||++++|+|       ..+..++.++|++.++|.+++....              ..++...++.++.|+
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~qi   89 (793)
T PLN00181         24 DGSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD--------------RSVDAFECFHVFRQI   89 (793)
T ss_pred             CccchhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc--------------ccccHHHHHHHHHHH
Confidence            34566778 7999999988       3345788899999889999996321              346677889999999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCC------------------CeEEEeeccccccccccC--------C-------
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDG------------------KTVKVAGFGLAKSLYAYK--------G-------  138 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~------------------~~vkl~dfg~~~~~~~~~--------~-------  138 (259)
                      ++||+|||++||+||||||+|||++..+                  ..+|++|||+++......        .       
T Consensus        90 ~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~  169 (793)
T PLN00181         90 VEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFP  169 (793)
T ss_pred             HHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCc
Confidence            9999999999999999999999996433                  145666666664321100        0       


Q ss_pred             -CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCC
Q 039159          139 -ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG  217 (259)
Q Consensus       139 -~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  217 (259)
                       ......||+.|+|||.+.+ ..++.++|||||||++|||++|.+|+.....  ....+.... .+.            .
T Consensus       170 ~~~~~~~gt~~Y~APE~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~------------~  233 (793)
T PLN00181        170 MKQILAMEMSWYTSPEEDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPP------------Q  233 (793)
T ss_pred             ccccccCCCcceEChhhhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cCh------------h
Confidence             0112357899999999987 5689999999999999999999888764321  111111111 110            0


Q ss_pred             CCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          218 FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       218 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      .....+...+++..||..+|.+||++.++++||||...
T Consensus       234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            01124566789999999999999999999999999753

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-32  Score=235.59  Aligned_cols=240  Identities=16%  Similarity=0.146  Sum_probs=157.0

Q ss_pred             hhHHHHHHHhhCCCCCe-----eEEEEEEEe--------CceEEEEeeeecC-CHHHHhhcCCCCCCCcc---------c
Q 039159           14 SMIREVSCLMELNHPNI-----IRLMRVASQ--------GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS---------T   70 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H~ni-----v~~~~~~~~--------~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~---------~   70 (259)
                      ....|+.++.+++|.++     ++++++|..        .+..++|+||+.+ +|.++++...+......         .
T Consensus       218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l  297 (507)
T PLN03224        218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI  297 (507)
T ss_pred             hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence            34457788888877655     677777653        3467999999996 99999875332211100         0


Q ss_pred             ccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccc
Q 039159           71 KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYY  149 (259)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~  149 (259)
                      ..........+..+..++.+++.+++|||+.+|+||||||+||+++.++ .++|+|||++........ ......+++.|
T Consensus       298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y  376 (507)
T PLN03224        298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRY  376 (507)
T ss_pred             hhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcce
Confidence            0001112344567788899999999999999999999999999999888 899999999965432211 11122347899


Q ss_pred             cCcccccCcc---------------------CCCcccchHhHHHHHHHHHhCCC-CCCCCChHHHHHHHhCCCCCCcccc
Q 039159          150 KAPELLLGLL---------------------EYSTAVDIWPVGCIFGEMVSGKP-LFPGANSLITLGRIVGKSRKPSFCK  207 (259)
Q Consensus       150 ~aPE~~~~~~---------------------~~~~~~DiwslG~~l~e~~tg~~-pf~~~~~~~~~~~i~~~~~~~~~~~  207 (259)
                      +|||.+....                     ....+.|+||+||++++|+++.. ||.+................. ...
T Consensus       377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~-~r~  455 (507)
T PLN03224        377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR-WRM  455 (507)
T ss_pred             eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH-HHh
Confidence            9999885311                     01234799999999999999874 775432211111110000000 000


Q ss_pred             ccccccccCCCCCCCHHHHHHHHhhcCcCC---CCccCHHHHhcCccccCC
Q 039159          208 LSLRDHLTNGFPGLEPAGIDLISKMLGMDP---DKRITAAEALQQEYFKDV  255 (259)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rp~~~~~l~h~~f~~~  255 (259)
                      ......--+.+...++..+||+.+||..+|   .+|+|++++|+||||..+
T Consensus       456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            000000011234578999999999999866   689999999999999753

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.4e-32  Score=255.06  Aligned_cols=205  Identities=18%  Similarity=0.226  Sum_probs=149.7

Q ss_pred             HHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccc
Q 039159           16 IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS   94 (259)
Q Consensus        16 ~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (259)
                      .+|++++++++||||++++|++.+++..++||||+++ +|.++++.                  +.+.....++.+++.|
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------------------l~~~~~~~i~~~ia~~  792 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------------------LSWERRRKIAIGIAKA  792 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------------------CCHHHHHHHHHHHHHH
Confidence            4679999999999999999999999999999999995 89988842                  3456678889999999


Q ss_pred             ccccc---CCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           95 RSLSF---GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        95 l~~lh---~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      ++|||   +.+++||||||+||+++.++ .+++. ++......    ......+++.|+|||.+.+ ..++.++||||||
T Consensus       793 L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~G  865 (968)
T PLN00113        793 LRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLC----TDTKCFISSAYVAPETRET-KDITEKSDIYGFG  865 (968)
T ss_pred             HHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-eccccccc----cCCCccccccccCcccccC-CCCCcccchhhHH
Confidence            99999   66999999999999999877 56664 55543321    1123367899999999977 5789999999999


Q ss_pred             HHHHHHHhCCCCCCCCCh----HHHHHHH-hCCCCCCccccccccccccCCC---CCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          172 CIFGEMVSGKPLFPGANS----LITLGRI-VGKSRKPSFCKLSLRDHLTNGF---PGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~----~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      |++|||+||+.||.....    ....... ..........+    ..+....   .....++.+++.+||+.||++||++
T Consensus       866 vvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~  941 (968)
T PLN00113        866 LILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID----PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA  941 (968)
T ss_pred             HHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC----ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH
Confidence            999999999999853211    1111111 11100000000    0000000   1122356789999999999999999


Q ss_pred             HHHhcC
Q 039159          244 AEALQQ  249 (259)
Q Consensus       244 ~~~l~h  249 (259)
                      +++++.
T Consensus       942 ~evl~~  947 (968)
T PLN00113        942 NDVLKT  947 (968)
T ss_pred             HHHHHH
Confidence            999863

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=4e-32  Score=237.60  Aligned_cols=217  Identities=21%  Similarity=0.216  Sum_probs=138.9

Q ss_pred             EeCceEEEEeeeecC-CHHHHhhcCCCCCC--Ccc---cccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCC
Q 039159           38 SQGIYLYPVFEYQVN-DLAYLLKYPKDSMN--GYS---TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPV  111 (259)
Q Consensus        38 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~  111 (259)
                      ..+...++|+||+.+ +|.+++........  ...   ..............+..++.|++.||+|||+.+|+||||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            345688999999996 89988864321000  000   000111112223445678999999999999999999999999


Q ss_pred             cEEEcCCCCeEEEeeccccccccccC-CCCcCCccCccccCcccccCcc---------------------CCCcccchHh
Q 039159          112 NILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGLL---------------------EYSTAVDIWP  169 (259)
Q Consensus       112 Nili~~~~~~vkl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~Diws  169 (259)
                      |||++.+...+||+|||+++.+.... .......+++.|+|||.+....                     .++.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            99998654389999999997653322 2234567899999999764211                     2344679999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC--ccccc---ccccccc---CCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP--SFCKL---SLRDHLT---NGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~--~~~~~---~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      |||++|||+++..++.  .....+..........  .....   .......   ......+....+||.+||+.||.+||
T Consensus       365 lGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~  442 (566)
T PLN03225        365 AGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI  442 (566)
T ss_pred             HHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence            9999999999765543  2222222222111100  00000   0000000   01112234567999999999999999


Q ss_pred             CHHHHhcCccccCCC
Q 039159          242 TAAEALQQEYFKDVP  256 (259)
Q Consensus       242 ~~~~~l~h~~f~~~~  256 (259)
                      |++++|+||||+...
T Consensus       443 ta~e~L~Hpff~~~~  457 (566)
T PLN03225        443 SAKAALAHPYFDREG  457 (566)
T ss_pred             CHHHHhCCcCcCCCC
Confidence            999999999998754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.5e-32  Score=220.18  Aligned_cols=223  Identities=24%  Similarity=0.287  Sum_probs=172.4

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC-ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +..-+.+.+|-+|.+.|+||.||++|++|.-+ +.+|-|+|||+| +|.-++.+.               ..++......
T Consensus       508 eNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh---------------klmSEKEARS  572 (775)
T KOG1151|consen  508 ENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH---------------KLMSEKEARS  572 (775)
T ss_pred             hhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhh---------------hhhhHHHHHH
Confidence            44456778999999999999999999999754 689999999998 666666542               5677788899


Q ss_pred             HHhhcccccccccCC--CceeccCCCCcEEEcCC--CCeEEEeeccccccccccCCC-------CcCCccCccccCcccc
Q 039159           87 EFSSSDSSRSLSFGT--RYIRRDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGE-------SSAEVGTHYYKAPELL  155 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~--~i~H~dlkp~Nili~~~--~~~vkl~dfg~~~~~~~~~~~-------~~~~~~~~~~~aPE~~  155 (259)
                      ++.|++.||.||.+.  .|||-||||.|||+-..  .+.+||.|||+++++......       .+-..||.+|++||.+
T Consensus       573 IiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcF  652 (775)
T KOG1151|consen  573 IIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECF  652 (775)
T ss_pred             HHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCccee
Confidence            999999999999964  89999999999999532  127999999999987554321       3344799999999988


Q ss_pred             cC---ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhh
Q 039159          156 LG---LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       156 ~~---~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                      .-   -+..+.++||||+||++|+.+.|+.||...-..+....   .........     -.-+..+-+++++++||++|
T Consensus       653 vVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq---eNTIlkAtE-----VqFP~KPvVsseAkaFIRRC  724 (775)
T KOG1151|consen  653 VVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ---ENTILKATE-----VQFPPKPVVSSEAKAFIRRC  724 (775)
T ss_pred             ecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh---hhchhccee-----ccCCCCCccCHHHHHHHHHH
Confidence            53   24568899999999999999999999976543322211   111110000     00011246899999999999


Q ss_pred             cCcCCCCccCHHHHhcCccccC
Q 039159          233 LGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      |.+.-.+|...-++-.||+|..
T Consensus       725 LaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  725 LAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HHhhhhhhhhHHHHccCccccc
Confidence            9999999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-33  Score=215.16  Aligned_cols=226  Identities=31%  Similarity=0.479  Sum_probs=171.3

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCc-----eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGI-----YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      -+++++|+++|..++|.||+..+++....+     .+|+++|.+..+|-..+-.               ...++...+.-
T Consensus        96 ~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVS---------------PQ~Ls~DHvKV  160 (449)
T KOG0664|consen   96 CKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVS---------------PQALTPDHVKV  160 (449)
T ss_pred             HHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheecc---------------CCCCCcchhhh
Confidence            468899999999999999999999987553     4588888887766665522               23344455667


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++||++||+|||+.+|.||||||-|.+++.+. .+||+|||+++.-..... ......-|.+|+|||.++|...|+.+.
T Consensus       161 FlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~Av  239 (449)
T KOG0664|consen  161 FVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAV  239 (449)
T ss_pred             hHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCcc
Confidence            789999999999999999999999999999888 899999999985433211 122234578999999999988999999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc---------------------cccccccCCCCCCCHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL---------------------SLRDHLTNGFPGLEPA  224 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~  224 (259)
                      ||||+||++.|++.++..|...++.+....|.+..-.|.....                     .....+. ....-..+
T Consensus       240 DiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtls-S~~~~~he  318 (449)
T KOG0664|consen  240 DIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIA-SPDDKNHE  318 (449)
T ss_pred             ceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeec-CCcccchH
Confidence            9999999999999999999988887777666443333222111                     0000000 00122336


Q ss_pred             HHHHHHhhcCcCCCCccCHHHHhcCccccC
Q 039159          225 GIDLISKMLGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       225 ~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      ..+++.+++..||++|.+.++.+.|++...
T Consensus       319 av~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  319 AVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             HHHHHHHHhCCCCcccccHhhhcccccccc
Confidence            667888999999999999999999998754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=231.79  Aligned_cols=229  Identities=21%  Similarity=0.257  Sum_probs=193.8

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |-++-+..++..-+.+||-+++..+||||+.++|.|...+.+|+.||||.| +|.+..+.-               ..+.
T Consensus        46 kvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~T---------------gpls  110 (829)
T KOG0576|consen   46 KVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVT---------------GPLS  110 (829)
T ss_pred             eeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeec---------------ccch
Confidence            445556667778889999999999999999999999999999999999996 777766431               6788


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCccccc--Cc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL--GL  158 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~  158 (259)
                      ..++...++..+.|++|||+.|-+|||||-.||+++..| .+|+.|||.+............++||++|||||+..  ..
T Consensus       111 elqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-DvklaDfgvsaqitati~KrksfiGtpywmapEvaaverk  189 (829)
T KOG0576|consen  111 ELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK  189 (829)
T ss_pred             hHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-ceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhc
Confidence            899999999999999999999999999999999999998 899999999987766666667789999999999874  23


Q ss_pred             cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      ..|+..+|||++|+...|+..-++|.....+.+...........|..-         ......++.+.+|++.+|..+|+
T Consensus       190 ggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l---------kDk~kws~~fh~fvK~altknpK  260 (829)
T KOG0576|consen  190 GGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL---------KDKTKWSEFFHNFVKGALTKNPK  260 (829)
T ss_pred             ccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc---------cCCccchHHHHHHHHHHhcCCCc
Confidence            568999999999999999999999998888887777665444332211         11234788999999999999999


Q ss_pred             CccCHHHHhcCccccCC
Q 039159          239 KRITAAEALQQEYFKDV  255 (259)
Q Consensus       239 ~Rp~~~~~l~h~~f~~~  255 (259)
                      +||+++.+|+|||+...
T Consensus       261 kRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  261 KRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             cCCChhhheeceeeccc
Confidence            99999999999998754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1.1e-33  Score=232.34  Aligned_cols=233  Identities=29%  Similarity=0.417  Sum_probs=174.6

Q ss_pred             CCCCCCchhHHHHHHHhhCC------CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            7 TMEGVPSSMIREVSCLMELN------HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~------H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      -++...+.=.+|++||++|+      --|.+.++..|...+++|||||.+.-.|..++......            ..+.
T Consensus       467 nNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~n------------vGL~  534 (752)
T KOG0670|consen  467 NNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRN------------VGLH  534 (752)
T ss_pred             cchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcc------------ccee
Confidence            34455556678999999995      45899999999999999999999998999999765443            4455


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccC
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      ......+..|+.-||..|..+||+|.||||+|||++.....+||||||.|.....  .....++-+-.|.|||.+.| ..
T Consensus       535 ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e--neitPYLVSRFYRaPEIiLG-~~  611 (752)
T KOG0670|consen  535 IKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE--NEITPYLVSRFYRAPEIILG-LP  611 (752)
T ss_pred             ehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc--ccccHHHHHHhccCcceeec-Cc
Confidence            5666777888888999999999999999999999998766899999999976532  23333445678999999999 67


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCC-CCCc------------c-cccc-----------------
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKS-RKPS------------F-CKLS-----------------  209 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~-~~~~------------~-~~~~-----------------  209 (259)
                      |+..-|+||+||.|||++||+..|++...-+.+....... ..|.            + .+.+                 
T Consensus       612 yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~v  691 (752)
T KOG0670|consen  612 YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTV  691 (752)
T ss_pred             ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEE
Confidence            8999999999999999999999999876544443321110 1000            0 0000                 


Q ss_pred             ---c---cc---c------ccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccC
Q 039159          210 ---L---RD---H------LTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       210 ---~---~~---~------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                         .   .+   -      ++...+..-..+++|+.+||..||.+|.|..++|+||||..
T Consensus       692 m~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  692 MVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             ecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence               0   00   0      00001112346789999999999999999999999999964

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=207.35  Aligned_cols=214  Identities=23%  Similarity=0.320  Sum_probs=171.1

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..=...|-.+..+- +||.+|-++.+|.....++.|.||..| +|--.++..               ..++.....-+..
T Consensus       294 idwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq---------------rklpeeharfys~  358 (593)
T KOG0695|consen  294 IDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ---------------RKLPEEHARFYSA  358 (593)
T ss_pred             chhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh---------------hcCcHHHhhhhhH
Confidence            44455666666665 799999999999999999999999997 554444321               3345555666667


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      .++.||.|||+.||+.||||.+|++++..| ++||.|+|.++..-......++++|||-|.|||.+.+ ..|+.++|.|+
T Consensus       359 ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdygmcke~l~~gd~tstfcgtpnyiapeilrg-eeygfsvdwwa  436 (593)
T KOG0695|consen  359 EICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWA  436 (593)
T ss_pred             HHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccchhhcCCCCCcccccccCCCcccchhhhcc-cccCceehHHH
Confidence            788899999999999999999999999999 9999999999987777778899999999999999998 78999999999


Q ss_pred             HHHHHHHHHhCCCCCCC-------CChHHHHHHH-hCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          170 VGCIFGEMVSGKPLFPG-------ANSLITLGRI-VGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~-------~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      ||++++||+.|+.||.-       .+....+.++ +.....              ....+|-.+..+++.-|+.||++|.
T Consensus       437 lgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--------------iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  437 LGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--------------IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------------ccceeehhhHHHHHHhhcCCcHHhc
Confidence            99999999999999962       2222333333 222111              1134677777899999999999997


Q ss_pred             C------HHHHhcCccccCCC
Q 039159          242 T------AAEALQQEYFKDVP  256 (259)
Q Consensus       242 ~------~~~~l~h~~f~~~~  256 (259)
                      .      ..++-.|+||+++.
T Consensus       503 gc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  503 GCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             CCCcccchhhhhcchhhhhCC
Confidence            4      78899999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=1.2e-31  Score=215.28  Aligned_cols=229  Identities=26%  Similarity=0.366  Sum_probs=171.9

Q ss_pred             CCCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .+.+.++.+|+++|..+. +.||+++.+++...++..+|+||++. +..+++                  ..+...++..
T Consensus        75 ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~------------------~~l~~~~i~~  136 (418)
T KOG1167|consen   75 TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLY------------------RSLSLAEIRW  136 (418)
T ss_pred             ccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHH------------------hcCCHHHHHH
Confidence            456788999999999995 99999999999999999999999996 666666                  3345678899


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--------------C--------------
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--------------G--------------  138 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--------------~--------------  138 (259)
                      +++.+..||+++|..|||||||||.|++.+...++-.|.|||++.......              +              
T Consensus       137 Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~  216 (418)
T KOG1167|consen  137 YLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATA  216 (418)
T ss_pred             HHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccc
Confidence            999999999999999999999999999999887678999999986210000              0              


Q ss_pred             --C--------------CcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCC-hHHHHHHH-----
Q 039159          139 --E--------------SSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN-SLITLGRI-----  196 (259)
Q Consensus       139 --~--------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~-~~~~~~~i-----  196 (259)
                        .              .....||++|+|||++...+..+.+.||||.|+++.-++++..||.... +......+     
T Consensus       217 ~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG  296 (418)
T KOG1167|consen  217 SKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFG  296 (418)
T ss_pred             cCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhC
Confidence              0              0122599999999999887788999999999999999999999986322 22111111     


Q ss_pred             ----------hCC------CCCCcccc-------------ccccc---cccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          197 ----------VGK------SRKPSFCK-------------LSLRD---HLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       197 ----------~~~------~~~~~~~~-------------~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                                .+.      ...+....             .+...   .........+..+.+|+.+||..||.+|.|++
T Consensus       297 ~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAE  376 (418)
T KOG1167|consen  297 SAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAE  376 (418)
T ss_pred             hHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHH
Confidence                      111      00000000             00000   11111123455888999999999999999999


Q ss_pred             HHhcCccccCC
Q 039159          245 EALQQEYFKDV  255 (259)
Q Consensus       245 ~~l~h~~f~~~  255 (259)
                      ++|+||||...
T Consensus       377 eALkHpFF~~~  387 (418)
T KOG1167|consen  377 DALKHPFFDEA  387 (418)
T ss_pred             HHhcCcCCcch
Confidence            99999999854

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-32  Score=231.74  Aligned_cols=212  Identities=23%  Similarity=0.236  Sum_probs=177.7

Q ss_pred             CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159            7 TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      .+.+....+..|+-+|.+|+|||+++++|++..+. +-||++|++ |+|.++++..+              ..+....++
T Consensus       737 t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr--------------~~igsq~lL  801 (1177)
T KOG1025|consen  737 TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR--------------DNIGSQDLL  801 (1177)
T ss_pred             CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhh--------------ccccHHHHH
Confidence            33444678999999999999999999999998765 889999999 59999998754              334567889


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCcc--CccccCcccccCccCCCc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG--THYYKAPELLLGLLEYST  163 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~--~~~~~aPE~~~~~~~~~~  163 (259)
                      .++.||++|+.|||+++++||||-..|+|+..-+ .+|+.|||+++.+...........|  .+.|+|-|.+.. ..++.
T Consensus       802 nw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~th  879 (1177)
T KOG1025|consen  802 NWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTH  879 (1177)
T ss_pred             HHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cCCCc
Confidence            9999999999999999999999999999999888 9999999999987665554443333  467889898877 78999


Q ss_pred             ccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          164 AVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       164 ~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ++|||||||++||++| |..|+.+....++-..+-...+.+             ..+..+-++.-+|.+||..|++.||+
T Consensus       880 qSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs-------------qPpiCtiDVy~~mvkCwmid~~~rp~  946 (1177)
T KOG1025|consen  880 QSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS-------------QPPICTIDVYMVMVKCWMIDADSRPT  946 (1177)
T ss_pred             hhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC-------------CCCCccHHHHHHHHHHhccCcccCcc
Confidence            9999999999999998 899999988777766554444322             23567889999999999999999999


Q ss_pred             HHHHhc
Q 039159          243 AAEALQ  248 (259)
Q Consensus       243 ~~~~l~  248 (259)
                      ++++..
T Consensus       947 fkel~~  952 (1177)
T KOG1025|consen  947 FKELAE  952 (1177)
T ss_pred             HHHHHH
Confidence            998864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=216.61  Aligned_cols=101  Identities=20%  Similarity=0.280  Sum_probs=87.9

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCC-C-------CCeeEEEEEEEe----CceEEEEeeeecCCHHHHhhcCCCCCCCcc
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELN-H-------PNIIRLMRVASQ----GIYLYPVFEYQVNDLAYLLKYPKDSMNGYS   69 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~-H-------~niv~~~~~~~~----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~   69 (259)
                      +||.+..+...+..+.||++|++++ +       .+||++++.|..    +.++|+|+|++...|..++.+..       
T Consensus       108 lKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~-------  180 (590)
T KOG1290|consen  108 LKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSN-------  180 (590)
T ss_pred             EEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhC-------
Confidence            4677888888899999999999984 2       479999999975    45899999999989999997643       


Q ss_pred             cccCCCcchhHHHHHHHHHhhccccccccc-CCCceeccCCCCcEEE
Q 039159           70 TKNFNSYSLFTTFLLVEEFSSSDSSRSLSF-GTRYIRRDLKPVNILV  115 (259)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh-~~~i~H~dlkp~Nili  115 (259)
                            +..++......++.|++.||.||| ++||||-||||+|||+
T Consensus       181 ------YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  181 ------YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             ------CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence                  367888889999999999999999 4799999999999999

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=194.63  Aligned_cols=178  Identities=20%  Similarity=0.281  Sum_probs=143.9

Q ss_pred             CCCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .....+..+|+.+..+. .-|.+|.|||.+.+....|+.||.|.-||..+.++.-.           ....++...+.++
T Consensus        85 ~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~-----------~g~~ipE~vlGkI  153 (282)
T KOG0984|consen   85 SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLK-----------KGGTIPEDVLGKI  153 (282)
T ss_pred             hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHh-----------cCCcCchHHhhHh
Confidence            34566788888876665 68999999999999999999999999888887754211           1145666778899


Q ss_pred             HhhcccccccccCC-CceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC---ccCCCc
Q 039159           88 FSSSDSSRSLSFGT-RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG---LLEYST  163 (259)
Q Consensus        88 ~~~~~~~l~~lh~~-~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~  163 (259)
                      +.++..||.|||++ .++|||+||+|||++.+| +||+||||++-.+.++- ..+...|.-.|+|||.+..   ...|+.
T Consensus       154 a~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~v  231 (282)
T KOG0984|consen  154 AVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSV  231 (282)
T ss_pred             HHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeehhhh-HHHHhcCCCccCChhhcCcccCccccee
Confidence            99999999999975 999999999999999999 99999999997765432 2233467788999999863   236889


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCC-CChHHHHHHHhCC
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPG-ANSLITLGRIVGK  199 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~-~~~~~~~~~i~~~  199 (259)
                      ++||||||+++.||++++.||.. ..+.+++.++...
T Consensus       232 ksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  232 KSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             ehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            99999999999999999999985 5666667666544

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3e-30  Score=208.43  Aligned_cols=218  Identities=24%  Similarity=0.302  Sum_probs=158.9

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhC--CCCCeeEEEEEEEeC----ceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCC
Q 039159            3 GIHNTMEGVPSSMIREVSCLMEL--NHPNIIRLMRVASQG----IYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNS   75 (259)
Q Consensus         3 ~~~~~~~~~~~~~~~Ei~~l~~l--~H~niv~~~~~~~~~----~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~   75 (259)
                      ||....++  ...++|.+|+...  +|+||+.|++.=..+    .++|||++|.+ |||++++..               
T Consensus       240 KiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---------------  302 (513)
T KOG2052|consen  240 KIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---------------  302 (513)
T ss_pred             EEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh---------------
Confidence            34444444  7788999988874  999999999875444    37899999998 799999964               


Q ss_pred             cchhHHHHHHHHHhhccccccccc--------CCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC----CcCC
Q 039159           76 YSLFTTFLLVEEFSSSDSSRSLSF--------GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE----SSAE  143 (259)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~l~~lh--------~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~----~~~~  143 (259)
                       ..++...+++.++++++||++||        +..|.|||||+.|||+.+++ .+-|+|+|+|-.-......    ....
T Consensus       303 -~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~r  380 (513)
T KOG2052|consen  303 -NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPR  380 (513)
T ss_pred             -ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeeceeeEEecccCCcccCCCCCc
Confidence             55677888999999999999999        34799999999999999999 8999999999654443332    3455


Q ss_pred             ccCccccCcccccCccC-----CCcccchHhHHHHHHHHHh----------CCCCCCC----CChHHHHHHHhCCCCCCc
Q 039159          144 VGTHYYKAPELLLGLLE-----YSTAVDIWPVGCIFGEMVS----------GKPLFPG----ANSLITLGRIVGKSRKPS  204 (259)
Q Consensus       144 ~~~~~~~aPE~~~~~~~-----~~~~~DiwslG~~l~e~~t----------g~~pf~~----~~~~~~~~~i~~~~~~~~  204 (259)
                      +||-.|||||++...-.     .-..+||||||.++||++-          -++||.+    +...+...++.       
T Consensus       381 VGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV-------  453 (513)
T KOG2052|consen  381 VGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVV-------  453 (513)
T ss_pred             cceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcce-------
Confidence            79999999999864211     1236999999999999986          2457754    22233333321       


Q ss_pred             cccccccccccCCCCCCCH--HHHHHHHhhcCcCCCCccCHHHHh
Q 039159          205 FCKLSLRDHLTNGFPGLEP--AGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~--~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                       +.....+.+++.|...+.  .+.++|+.||..+|..|.|+-.+-
T Consensus       454 -Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  454 -CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             -eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence             111122233333332222  556789999999999999976553

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=200.86  Aligned_cols=215  Identities=17%  Similarity=0.217  Sum_probs=178.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeC-ceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...+..|.-.+..+.|||++++.+++.++ ...++++.+.. |.|..+++.+++.....       ....+..+++..+.
T Consensus       331 v~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~-------aqtvtt~qlV~mas  403 (563)
T KOG1024|consen  331 VNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSY-------AQTVTTIQLVLMAS  403 (563)
T ss_pred             HHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCcc-------ccchhHHHHHHHHH
Confidence            34567888888888999999999998655 57788899988 69999998776433211       13466678899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      |++.|++|||+++++|.||...|++|++.- +|||+|=.+++.+....-  ..+.......||+||.+.+ ..|+.++|+
T Consensus       404 Qla~am~hlh~~~ViHkDiAaRNCvIdd~L-qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDv  481 (563)
T KOG1024|consen  404 QLAMAMEHLHNHGVIHKDIAARNCVIDDQL-QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDV  481 (563)
T ss_pred             HHHHHHHHHHhcCcccchhhhhcceehhhe-eEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhh
Confidence            999999999999999999999999999887 899999999886644321  2344455778999999988 689999999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++||++| |+.|+.+-++.+...-+..+.+..+             ..++++++..+|..||..+|++||+.+++
T Consensus       482 WsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ-------------P~NCPDeLf~vMacCWallpeeRPsf~Ql  548 (563)
T KOG1024|consen  482 WSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ-------------PFNCPDELFTVMACCWALLPEERPSFSQL  548 (563)
T ss_pred             HHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC-------------CCCCcHHHHHHHHHHHhcCcccCCCHHHH
Confidence            999999999998 8999999999998888877765422             35789999999999999999999999998


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ..
T Consensus       549 v~  550 (563)
T KOG1024|consen  549 VI  550 (563)
T ss_pred             HH
Confidence            64

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.6e-30  Score=207.87  Aligned_cols=214  Identities=24%  Similarity=0.274  Sum_probs=162.9

Q ss_pred             CCCchhHHHHHHHhhC--CCCCeeEEEEEEEeCc----eEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159           10 GVPSSMIREVSCLMEL--NHPNIIRLMRVASQGI----YLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l--~H~niv~~~~~~~~~~----~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      .....|.+|-.|++..  +|+||++|+++-+.+.    ..+||++|.+ |+|.+++..                ...++.
T Consensus       244 ~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~----------------ntisw~  307 (534)
T KOG3653|consen  244 QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA----------------NTISWN  307 (534)
T ss_pred             HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh----------------ccccHH
Confidence            3456788888887775  7999999999987766    7899999988 799999975                678889


Q ss_pred             HHHHHHhhcccccccccC---------CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccC
Q 039159           83 LLVEEFSSSDSSRSLSFG---------TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKA  151 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~---------~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~a  151 (259)
                      ...+++..+++||+|||+         ..|+|||||..|||+..|. .+-|+|||+|..+......  ....+||..|||
T Consensus       308 ~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMA  386 (534)
T KOG3653|consen  308 SLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMA  386 (534)
T ss_pred             HHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccceeEEecCCCCCcchhhhhhhhhhcC
Confidence            999999999999999993         3799999999999999888 8999999999887654332  334689999999


Q ss_pred             cccccCccCCC-----cccchHhHHHHHHHHHhCCC------------CCC---C--CChHHHHHHHhCCCCCCcccccc
Q 039159          152 PELLLGLLEYS-----TAVDIWPVGCIFGEMVSGKP------------LFP---G--ANSLITLGRIVGKSRKPSFCKLS  209 (259)
Q Consensus       152 PE~~~~~~~~~-----~~~DiwslG~~l~e~~tg~~------------pf~---~--~~~~~~~~~i~~~~~~~~~~~~~  209 (259)
                      ||++.+.....     .+.||||+|.|+|||+++-.            ||.   +  ....+....+......|.+++  
T Consensus       387 PEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~--  464 (534)
T KOG3653|consen  387 PEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPD--  464 (534)
T ss_pred             HHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChh--
Confidence            99998744443     36899999999999998532            222   0  112233334454554554443  


Q ss_pred             ccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          210 LRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                         .+..  .....-+.+.+..||+.||+.|.|+.-+-
T Consensus       465 ---~W~~--h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  465 ---AWRK--HAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             ---hhhc--CccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence               1111  02334667899999999999999977554

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=5.1e-30  Score=193.59  Aligned_cols=156  Identities=16%  Similarity=0.121  Sum_probs=117.8

Q ss_pred             chhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCccccc
Q 039159           77 SLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL  156 (259)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (259)
                      ..+++..+..++.|++.||+|||+.+      ||+||+++.++ .+++  ||.+......     ...|++.|+|||.+.
T Consensus        12 ~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~-----~~~g~~~y~aPE~~~   77 (176)
T smart00750       12 RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPE-----QSRVDPYFMAPEVIQ   77 (176)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeeccc-----cCCCcccccChHHhc
Confidence            34677889999999999999999988      99999999888 7888  9998754321     226889999999998


Q ss_pred             CccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHH-HHHHhCCCCCCccccccccccccCCCCCCCH--HHHHHHHhhc
Q 039159          157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT-LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP--AGIDLISKML  233 (259)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~li~~~l  233 (259)
                      + ..++.++|||||||++|||++|+.||........ ...+..... +..+.      .......++.  .+.+++.+||
T Consensus        78 ~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~i~~cl  149 (176)
T smart00750       78 G-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP-ADDPR------DRSNLESVSAARSFADFMRVCA  149 (176)
T ss_pred             C-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc-cCCcc------ccccHHHHHhhhhHHHHHHHHH
Confidence            7 5788999999999999999999999976543322 222221111 11000      0000112333  6899999999


Q ss_pred             CcCCCCccCHHHHhcCccccC
Q 039159          234 GMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      ..||++||++.++++|+|+..
T Consensus       150 ~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      150 SRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             hcccccccCHHHHHHHHHHHH
Confidence            999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=2e-28  Score=189.05  Aligned_cols=179  Identities=40%  Similarity=0.539  Sum_probs=153.0

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|++.++.++|++|+++++++......++++|++.| +|..++....              ..........++.+
T Consensus        35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~~  100 (215)
T cd00180          35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE--------------GKLSEDEILRILLQ  100 (215)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc--------------CCCCHHHHHHHHHH
Confidence            46799999999999999999999999998999999999995 9999886421              23456778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcC-CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDL-DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~-~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++++++||+.+++|+||+|.||+++. ++ .++++|||.+..............+...|.+||.+......+.++|+|+
T Consensus       101 l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~  179 (215)
T cd00180         101 ILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS  179 (215)
T ss_pred             HHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHH
Confidence            999999999999999999999999998 66 8999999999765433222344567888999999876336788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      +|++++++                                             ..+.+++..|+..+|++||++.+++++
T Consensus       180 lg~~~~~l---------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         180 LGVILYEL---------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHH---------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            99999999                                             456689999999999999999999987


Q ss_pred             c
Q 039159          250 E  250 (259)
Q Consensus       250 ~  250 (259)
                      +
T Consensus       215 ~  215 (215)
T cd00180         215 L  215 (215)
T ss_pred             C
Confidence            5

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=209.35  Aligned_cols=154  Identities=27%  Similarity=0.347  Sum_probs=136.8

Q ss_pred             hHHHHHHHhhCC---CCCeeEEEEEEEeCceEEEEeeeec-C-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           15 MIREVSCLMELN---HPNIIRLMRVASQGIYLYPVFEYQV-N-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        15 ~~~Ei~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~-~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      +-.||+||..|+   |+||++++++|++++++||+||-.. | +|++++...               ..+.......++.
T Consensus       613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k---------------p~m~E~eAk~IFk  677 (772)
T KOG1152|consen  613 VPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK---------------PRMDEPEAKLIFK  677 (772)
T ss_pred             cchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc---------------CccchHHHHHHHH
Confidence            346999999998   9999999999999999999999976 6 899999754               4566778889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |+..|++.||+.||+|||||-+|+.++.+| .+||+|||.+....  .+.-+.+.||..|.|||++.|...-+...|||+
T Consensus       678 QV~agi~hlh~~~ivhrdikdenvivd~~g-~~klidfgsaa~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwa  754 (772)
T KOG1152|consen  678 QVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKLIDFGSAAYTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWA  754 (772)
T ss_pred             HHHhccccccccCceecccccccEEEecCC-eEEEeeccchhhhc--CCCcceeeeeccccchhhhCCCccCCCcchhhh
Confidence            999999999999999999999999999999 89999999997543  345677899999999999988655677899999


Q ss_pred             HHHHHHHHHhCCCCCCC
Q 039159          170 VGCIFGEMVSGKPLFPG  186 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~  186 (259)
                      +|++||.+.....||++
T Consensus       755 lgillytivykenpyyn  771 (772)
T KOG1152|consen  755 LGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhheeeEEEeccCCCcC
Confidence            99999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-28  Score=187.77  Aligned_cols=207  Identities=24%  Similarity=0.241  Sum_probs=153.6

Q ss_pred             CCCCCchhHHHHHHHhhC-CCCCeeEEEEE-EEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159            8 MEGVPSSMIREVSCLMEL-NHPNIIRLMRV-ASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~-~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ......+|.+|..---.| -|.||+.-|++ |+..+..+.++||++ |+|..-+.-                .++.....
T Consensus        60 p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~----------------~GigE~~~  123 (378)
T KOG1345|consen   60 PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA----------------AGIGEANT  123 (378)
T ss_pred             chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc----------------ccccHHHH
Confidence            344567888887765556 49999999975 777788889999999 688877632                55666778


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcC-CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc----c
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDL-DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL----L  159 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~-~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~  159 (259)
                      ..++.|+++|+.|+|++++||||||.+||||-. +..+|||+|||.++.....   ....--+..|.+||.+...    -
T Consensus       124 K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t---V~~~~~~~~y~~pe~~~~~~ne~~  200 (378)
T KOG1345|consen  124 KKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT---VKYLEYVNNYHAPELCDTVVNEKL  200 (378)
T ss_pred             HHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce---ehhhhhhcccCCcHHHhhccccce
Confidence            889999999999999999999999999999843 4458999999999754221   1112234568899887531    2


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCChH----HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSL----ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      ..++.+|+|.||+++|.++||.+||......    ..+.. ..+...+         ..+..|..+|+.+..+.++-|..
T Consensus       201 ~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~-w~~rk~~---------~~P~~F~~fs~~a~r~Fkk~lt~  270 (378)
T KOG1345|consen  201 VVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ-WLKRKNP---------ALPKKFNPFSEKALRLFKKSLTP  270 (378)
T ss_pred             EecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH-HhcccCc---------cCchhhcccCHHHHHHHHHhcCC
Confidence            3578899999999999999999999743211    11111 1122222         34456778999999999999999


Q ss_pred             CCCCccCH
Q 039159          236 DPDKRITA  243 (259)
Q Consensus       236 dp~~Rp~~  243 (259)
                      ++++|..+
T Consensus       271 ~~~drcki  278 (378)
T KOG1345|consen  271 RFKDRCKI  278 (378)
T ss_pred             cccccchh
Confidence            99999443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=6.4e-29  Score=217.16  Aligned_cols=219  Identities=26%  Similarity=0.293  Sum_probs=170.3

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccc
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS   94 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (259)
                      +..|.-+-..|.|||++.....+.+.....-.||||+++|+.++...               ..+....+-..+.|+..|
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~---------------~~~~~~e~~c~fKqL~~G  432 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPYDLFSLVMSN---------------GKLTPLEADCFFKQLLRG  432 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccHHHHHHHhcc---------------cccchhhhhHHHHHHHHH
Confidence            45577777889999999988888776655556999999888888542               356667778888999999


Q ss_pred             cccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC----CCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           95 RSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG----ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        95 l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++|+|+.||.|||+|++|+++..++ .+|++|||.+..+.....    ......|+..|.|||.+.+........||||.
T Consensus       433 v~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~  511 (601)
T KOG0590|consen  433 VKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSC  511 (601)
T ss_pred             HHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhc
Confidence            9999999999999999999999998 899999999976533322    24556799999999999885556678999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHH--HHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITL--GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |+++..|.+|+.||.-.......  .......       .+...........++.+.+.+|.+||++||.+|.|++++++
T Consensus       512 ~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  512 GIIYICMILGRFPWKVAKKSDNSFKTNNYSDQ-------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cceEEEEecCCCccccccccccchhhhccccc-------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            99999999999999754332221  1111000       01111222233457788999999999999999999999999


Q ss_pred             CccccCCC
Q 039159          249 QEYFKDVP  256 (259)
Q Consensus       249 h~~f~~~~  256 (259)
                      .+||+++.
T Consensus       585 d~W~~~i~  592 (601)
T KOG0590|consen  585 DEWIRSIE  592 (601)
T ss_pred             ChHhhhcc
Confidence            99999885

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=1.3e-26  Score=181.28  Aligned_cols=174  Identities=32%  Similarity=0.419  Sum_probs=142.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|++.+++++|+|++++++.+..+...++++|++.+ +|.+.+.....              .........++.
T Consensus        40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~  105 (225)
T smart00221       40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGG--------------KLSEEEARFYLR  105 (225)
T ss_pred             HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhccc--------------CCCHHHHHHHHH
Confidence            467889999999999999999999999988999999999997 99998864211              045567788889


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-CCCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.++.+||+.+++|+|++|+||+++.++ .++|+|||.+....... +......++..|++||.+.+...++.++|+|
T Consensus       106 ~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~  184 (225)
T smart00221      106 QILEALEYLHSLGIVHRDLKPENILLGMDG-LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIW  184 (225)
T ss_pred             HHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHH
Confidence            999999999999999999999999999887 89999999987654322 1234456788899999984335677799999


Q ss_pred             hHHHHHHHHHhCCCCCCC-CChH-HHHHHHhCC
Q 039159          169 PVGCIFGEMVSGKPLFPG-ANSL-ITLGRIVGK  199 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~-~~~~-~~~~~i~~~  199 (259)
                      +||++++++++|+.||.. .+.. .....+...
T Consensus       185 ~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~  217 (225)
T smart00221      185 SLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG  217 (225)
T ss_pred             HHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence            999999999999999987 4544 444444443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.2e-27  Score=180.08  Aligned_cols=215  Identities=16%  Similarity=0.181  Sum_probs=172.7

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      .+.+..+.....+|..|.-.|+.+.||||+.++|.|.....+.++..|++ |+|+++++....             ....
T Consensus       221 l~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~-------------vvvd  287 (448)
T KOG0195|consen  221 LNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTS-------------VVVD  287 (448)
T ss_pred             hhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCcc-------------EEEe
Confidence            45667788889999999999999999999999999999999999999999 699999976432             4455


Q ss_pred             HHHHHHHHhhcccccccccCC-C-ceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGT-R-YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~-~-i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (259)
                      ..+.+..+..+++|++|||+. . |..--|++..+++|.+- ..+|+- +-++...+    ......+|.|++||.++..
T Consensus       288 ~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarism-ad~kfsfq----e~gr~y~pawmspealqrk  361 (448)
T KOG0195|consen  288 HSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISM-ADTKFSFQ----EVGRAYSPAWMSPEALQRK  361 (448)
T ss_pred             cchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheec-ccceeeee----ccccccCcccCCHHHHhcC
Confidence            567888999999999999975 3 44446889999999876 555542 22222211    1223457889999999764


Q ss_pred             cCC--CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          159 LEY--STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       159 ~~~--~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                      +..  -.++|+|||++++||+.|+..||.+.++.+...++.-+...+..+            ++++..+..|+.-|++.|
T Consensus       362 ped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip------------pgis~hm~klm~icmned  429 (448)
T KOG0195|consen  362 PEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP------------PGISRHMNKLMNICMNED  429 (448)
T ss_pred             chhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC------------CCccHHHHHHHHHHhcCC
Confidence            433  347999999999999999999999999999998887666554443            689999999999999999


Q ss_pred             CCCccCHHHHh
Q 039159          237 PDKRITAAEAL  247 (259)
Q Consensus       237 p~~Rp~~~~~l  247 (259)
                      |.+||.++.+.
T Consensus       430 pgkrpkfdmiv  440 (448)
T KOG0195|consen  430 PGKRPKFDMIV  440 (448)
T ss_pred             CCcCCCcceeh
Confidence            99999988765

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=6.6e-23  Score=164.62  Aligned_cols=190  Identities=23%  Similarity=0.242  Sum_probs=136.4

Q ss_pred             CCCCeeEEEEEEEeC---------------------------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcch
Q 039159           26 NHPNIIRLMRVASQG---------------------------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus        26 ~H~niv~~~~~~~~~---------------------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      +|||||.+.++|.++                           ..+|+||.-+..+|..++.....               
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~---------------  338 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHR---------------  338 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCC---------------
Confidence            699999999988652                           35799999999999998864322               


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCC---CeEEEeeccccccccccCCCC---cCC---ccCccc
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG---KTVKVAGFGLAKSLYAYKGES---SAE---VGTHYY  149 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~---~~vkl~dfg~~~~~~~~~~~~---~~~---~~~~~~  149 (259)
                       +.....-++.|+++|+.|||.+|+.|||+|++||++.-+.   ..+.++|||.+--.....-..   +..   -|.-..
T Consensus       339 -s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~l  417 (598)
T KOG4158|consen  339 -SYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKL  417 (598)
T ss_pred             -chHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCccee
Confidence             1223445667889999999999999999999999995432   357899999985332211111   111   256678


Q ss_pred             cCcccccCccC-----CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHH
Q 039159          150 KAPELLLGLLE-----YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPA  224 (259)
Q Consensus       150 ~aPE~~~~~~~-----~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (259)
                      ||||.....+.     .-.++|.|+.|.+-||+++...||+..-.......-+++...|            .....+++.
T Consensus       418 mAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP------------alp~~vpp~  485 (598)
T KOG4158|consen  418 MAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP------------ALPSRVPPV  485 (598)
T ss_pred             cchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC------------CCcccCChH
Confidence            99999864221     1248999999999999999999998743332222223333222            333568899


Q ss_pred             HHHHHHhhcCcCCCCccCH
Q 039159          225 GIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       225 ~~~li~~~l~~dp~~Rp~~  243 (259)
                      +++++...|+.||.+|++.
T Consensus       486 ~rqlV~~lL~r~pskRvsp  504 (598)
T KOG4158|consen  486 ARQLVFDLLKRDPSKRVSP  504 (598)
T ss_pred             HHHHHHHHhcCCccccCCc
Confidence            9999999999999999983

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=1.6e-22  Score=170.17  Aligned_cols=204  Identities=21%  Similarity=0.250  Sum_probs=154.1

Q ss_pred             HhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccccccccC
Q 039159           22 LMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFG  100 (259)
Q Consensus        22 l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~  100 (259)
                      |+.+.|.|+.+++|.+.++...++|.+||. |+|.+.+....              ..+.........+.++.|++|+|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--------------~~~d~~F~~s~~rdi~~Gl~ylh~   66 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--------------IKLDYFFILSFIRDISKGLAYLHN   66 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--------------cCccHHHHHHHHHHHHHHHHHHhc
Confidence            467899999999999999999999999999 69999996521              445566677778888999999998


Q ss_pred             CCc-eeccCCCCcEEEcCCCCeEEEeecccccccccc--CCCCcCCccCccccCcccccCc---c---CCCcccchHhHH
Q 039159          101 TRY-IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY--KGESSAEVGTHYYKAPELLLGL---L---EYSTAVDIWPVG  171 (259)
Q Consensus       101 ~~i-~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~---~---~~~~~~DiwslG  171 (259)
                      ..| .|+.+++.|++++... .+|++|||+.......  ........-...|.|||.+.+.   .   ..+.+.|+||||
T Consensus        67 s~i~~hg~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~  145 (484)
T KOG1023|consen   67 SPIGYHGALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFG  145 (484)
T ss_pred             CcceeeeeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHH
Confidence            866 9999999999999877 9999999999766321  0111111235579999999762   1   146789999999


Q ss_pred             HHHHHHHhCCCCCCCCC----hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          172 CIFGEMVSGKPLFPGAN----SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ++++|+++++.||....    ..+....+......+..|.....       ....++...++..||..+|.+||+++.+-
T Consensus       146 ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~-------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  146 IIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELL-------NELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             HHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhh-------hhcchHHHHHHHHhcccChhhCccHHHHH
Confidence            99999999999998632    23444444442333333321111       13455888999999999999999998874

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=2.2e-21  Score=159.60  Aligned_cols=226  Identities=34%  Similarity=0.459  Sum_probs=169.2

Q ss_pred             CCchhHHHHHHHhhCCCC-CeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHP-NIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~-niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ....+.+|+++++.+.|+ +++++.+.+......+++++++.+ ++..++......            ..+.......++
T Consensus        40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~------------~~~~~~~~~~~~  107 (384)
T COG0515          40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK------------GPLSESEALFIL  107 (384)
T ss_pred             HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc------------cCCCHHHHHHHH
Confidence            467899999999999988 799999999777778999999997 777566432110            245566778888


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC------CCcCCccCccccCcccccCc--cC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG------ESSAEVGTHYYKAPELLLGL--LE  160 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~--~~  160 (259)
                      .+++.++.|+|+.+++|||+||+||+++..+..++++|||.+........      ......|+..|++||.+.+.  ..
T Consensus       108 ~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~  187 (384)
T COG0515         108 AQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY  187 (384)
T ss_pred             HHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCC
Confidence            89999999999999999999999999998764599999999975543322      23566899999999999873  46


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCCh----HHHHHHHhCCCCCC-ccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANS----LITLGRIVGKSRKP-SFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~----~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      .....|+||+|++++++++|..||.....    ......+.... .+ ......  ....   ........+++..++..
T Consensus       188 ~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~  261 (384)
T COG0515         188 ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP-TPSLASPLS--PSNP---ELISKAASDLLKKLLAK  261 (384)
T ss_pred             CCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC-CcccccccC--cccc---chhhHHHHHHHHHHHhc
Confidence            78899999999999999999999877653    23333332222 11 000000  0000   12235788999999999


Q ss_pred             CCCCccCHHHHhcCccccC
Q 039159          236 DPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       236 dp~~Rp~~~~~l~h~~f~~  254 (259)
                      +|..|.+..+...+++...
T Consensus       262 ~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         262 DPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             CchhcCCHHHHhhchHhhC
Confidence            9999999999888765543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.4e-22  Score=170.96  Aligned_cols=202  Identities=24%  Similarity=0.343  Sum_probs=162.8

Q ss_pred             hhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           14 SMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        14 ~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .-..|-.++...+ ||.+++++..++.+...++++++..| .+..-+...               ..+.......+...+
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~---------------~~f~~~~~~~~~ael  106 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKE---------------VMFDELDVAFYLAEL  106 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccC---------------CchHHHHHHHHHHHH
Confidence            5567888888887 99999999999999999999999986 555544321               334444555566677


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      +-+++.+|+.++++||+|++||+++.+| ++++.|||.++.......    .+||..|||||.+.+   ...++|.||||
T Consensus       107 aLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~~----~cgt~eymApEI~~g---h~~a~D~ws~g  178 (612)
T KOG0603|consen  107 ALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKI----ACGTYEYRAPEIING---HLSAADWWSFG  178 (612)
T ss_pred             HHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhhh----cccchhhhhhHhhhc---cCCcccchhhh
Confidence            7889999999999999999999999999 999999999987643322    288999999999973   56789999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HHHH
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AAEA  246 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~~~  246 (259)
                      ++.++++||..||.+    +....|......              ....++..+++++..++..+|..|.-     +.++
T Consensus       179 vl~felltg~~pf~~----~~~~~Il~~~~~--------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~ei  240 (612)
T KOG0603|consen  179 VLAFELLTGTLPFGG----DTMKRILKAELE--------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEI  240 (612)
T ss_pred             hhHHHHhhCCCCCch----HHHHHHhhhccC--------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHH
Confidence            999999999999988    344444332111              11357889999999999999999985     6899


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      ++|+||+++.
T Consensus       241 k~h~f~~~i~  250 (612)
T KOG0603|consen  241 KQHEFFQSID  250 (612)
T ss_pred             hccchheeee
Confidence            9999999874

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=6.2e-23  Score=182.09  Aligned_cols=204  Identities=22%  Similarity=0.260  Sum_probs=149.9

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccc
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS   94 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (259)
                      -..|++ .+..+|||.+++.-+.+.+...|||=+|...+|++-+.-               ...+...+...++.|++.|
T Consensus        69 rL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkhnLyDRlST---------------RPFL~~iEKkWiaFQLL~a  132 (1431)
T KOG1240|consen   69 RLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKHNLYDRLST---------------RPFLVLIEKKWIAFQLLKA  132 (1431)
T ss_pred             HHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhhhhhhhhcc---------------chHHHHHHHHHHHHHHHHH
Confidence            344555 555689999999999888889999999999999998843               1566777778888999999


Q ss_pred             cccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC-------cCCccCccccCcccccCc---------
Q 039159           95 RSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES-------SAEVGTHYYKAPELLLGL---------  158 (259)
Q Consensus        95 l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~---------  158 (259)
                      +.-+|..||+|||||.+|||++..+ -+.|+||..-+..+-..+..       ++-..-.+|.|||.+...         
T Consensus       133 l~qcH~~gVcHGDIKsENILiTSWN-W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~  211 (1431)
T KOG1240|consen  133 LSQCHKLGVCHGDIKSENILITSWN-WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQD  211 (1431)
T ss_pred             HHHHHHcCccccccccceEEEeeec-hhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCc
Confidence            9999999999999999999999988 59999998887654432221       111234589999988531         


Q ss_pred             -cCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCC-CCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          159 -LEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGK-SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       159 -~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                       ...+++.||+|+||++.|+++ |+++|.-.    ++.....+ ...+..       .++.   --+...++||..|++.
T Consensus       212 ~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~~~~e~-------~Le~---Ied~~~Rnlil~Mi~r  277 (1431)
T KOG1240|consen  212 APLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNADDPEQ-------LLEK---IEDVSLRNLILSMIQR  277 (1431)
T ss_pred             ccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCccCHHH-------HHHh---CcCccHHHHHHHHHcc
Confidence             114678999999999999987 68888521    11111111 111110       0000   1234788999999999


Q ss_pred             CCCCccCHHHHhcC
Q 039159          236 DPDKRITAAEALQQ  249 (259)
Q Consensus       236 dp~~Rp~~~~~l~h  249 (259)
                      ||.+|.++++.|+.
T Consensus       278 dPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  278 DPSKRLSAEDYLQK  291 (1431)
T ss_pred             CchhccCHHHHHHh
Confidence            99999999999975

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=3.5e-20  Score=152.79  Aligned_cols=212  Identities=17%  Similarity=0.144  Sum_probs=158.5

Q ss_pred             hhHHHHHHHhhCCC----CCeeEEEEEE-EeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           14 SMIREVSCLMELNH----PNIIRLMRVA-SQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H----~niv~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .+..|+.+++.+..    +++..+++.. ..+...|+||+.+..+|.++.....             ...++....+.++
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~G~sL~dl~~~~~-------------~~~fs~~T~l~ia  128 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLLGPSLEDLRKRNP-------------PGRFSRKTVLRIA  128 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEeccCccHHHHHHhCC-------------CCCcCHhHHHHHH
Confidence            68899999999973    6999999999 4777899999998889999885432             1556777888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCC----CeEEEeeccccc--cccccCC-----C---CcCCccCccccCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDG----KTVKVAGFGLAK--SLYAYKG-----E---SSAEVGTHYYKAPEL  154 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~----~~vkl~dfg~~~--~~~~~~~-----~---~~~~~~~~~~~aPE~  154 (259)
                      .|.+.+|.++|+.|++||||||+|++++...    ..+++.|||+++  .......     .   .....||..|.++..
T Consensus       129 ~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~  208 (322)
T KOG1164|consen  129 IQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINV  208 (322)
T ss_pred             HHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHH
Confidence            9999999999999999999999999998653    369999999998  3211111     1   234459999999998


Q ss_pred             ccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcC
Q 039159          155 LLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                      ..+ ...+.+.|+||++-++.++..|..||......................         ......+..+.++...+-.
T Consensus       209 H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~  278 (322)
T KOG1164|consen  209 HLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD---------RFGDLKPEEFAKILEYIDS  278 (322)
T ss_pred             hCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc---------cccCCChHHHHHHHHHhhc
Confidence            887 678999999999999999999999997655332222221111110000         0122345677777777777


Q ss_pred             cCCCCccCHHHHhc
Q 039159          235 MDPDKRITAAEALQ  248 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~  248 (259)
                      .+...+|....+..
T Consensus       279 ~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  279 LDYEDKPDYEKLAE  292 (322)
T ss_pred             cCCcCCCCHHHHHH
Confidence            89999998776643

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2e-20  Score=155.23  Aligned_cols=178  Identities=28%  Similarity=0.419  Sum_probs=130.7

Q ss_pred             eEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCC
Q 039159           42 YLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK  120 (259)
Q Consensus        42 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~  120 (259)
                      ++|+.|++|. ++|.+.+......            .--.+..++.++.|++.|+.|   ++.+|||+||.||+...+. 
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~------------e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-  393 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG------------EERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-  393 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc------------cccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-
Confidence            5899999999 5999999753332            223345678889999999999   9999999999999999888 


Q ss_pred             eEEEeeccccccccccCC------CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHH
Q 039159          121 TVKVAGFGLAKSLYAYKG------ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITL  193 (259)
Q Consensus       121 ~vkl~dfg~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~  193 (259)
                      ++||+|||+.........      ......||.+|++||.+.+ ..|+.++||||||++++|++. -...|...   ...
T Consensus       394 q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~  469 (516)
T KOG1033|consen  394 QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFERI---ATL  469 (516)
T ss_pred             hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHHH---Hhh
Confidence            899999999876544331      2234479999999999998 689999999999999999987 33333211   111


Q ss_pred             HHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccc
Q 039159          194 GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF  252 (259)
Q Consensus       194 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f  252 (259)
                      ..+-.+...|.+             -.--+.-.+|+.+|+...|.+||++.+.-.|.|.
T Consensus       470 ~d~r~g~ip~~~-------------~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  470 TDIRDGIIPPEF-------------LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhhhcCCCChHH-------------hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            122212111111             1122444589999999999999988888777764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=5.1e-19  Score=139.27  Aligned_cols=207  Identities=18%  Similarity=0.174  Sum_probs=165.3

Q ss_pred             hhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           14 SMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        14 ~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      ++..|.+.++.|. -++|.++|.+..++.+..||+|++.-+|.+++..+.+              .++....+.++.|++
T Consensus        69 QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~CgR--------------~FSvKTV~miA~Qmi  134 (449)
T KOG1165|consen   69 QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGPSLEDLFDLCGR--------------RFSVKTVAMIAKQMI  134 (449)
T ss_pred             hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCcCHHHHHHHhcC--------------cccHHhHHHHHHHHH
Confidence            4788999999995 7999999999999999999999998899999988753              456666777778888


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCC----CeEEEeeccccccccccCCCCcC-------CccCccccCcccccCccCC
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDG----KTVKVAGFGLAKSLYAYKGESSA-------EVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~----~~vkl~dfg~~~~~~~~~~~~~~-------~~~~~~~~aPE~~~~~~~~  161 (259)
                      .-++|+|++.+|.|||||+|+||+..+    ..+.++|||+|+...+.......       .-||-.||+--...+ .+.
T Consensus       135 ~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQ  213 (449)
T KOG1165|consen  135 TRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQ  213 (449)
T ss_pred             HHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecccc-chh
Confidence            889999999999999999999997643    26899999999987655443332       358999999988888 678


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCC---ChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGA---NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      +.+.|+=|+|=+++..+-|..||.+.   +..+.+.+|-+..+.-         ++.....+++.++...+...-+.+-.
T Consensus       214 SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T---------~i~~Lc~g~P~efa~Yl~yvR~L~F~  284 (449)
T KOG1165|consen  214 SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST---------PIEVLCEGFPEEFATYLRYVRRLDFF  284 (449)
T ss_pred             hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC---------CHHHHHhcCHHHHHHHHHHHHhcCcc
Confidence            89999999999999999999999874   4455555554333221         23334457788888888888888888


Q ss_pred             CccCHH
Q 039159          239 KRITAA  244 (259)
Q Consensus       239 ~Rp~~~  244 (259)
                      +-|.-+
T Consensus       285 E~PDYd  290 (449)
T KOG1165|consen  285 ETPDYD  290 (449)
T ss_pred             cCCCHH
Confidence            888744

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.79  E-value=1e-19  Score=161.42  Aligned_cols=153  Identities=28%  Similarity=0.409  Sum_probs=124.8

Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---------------CCcCCccCccccCccccc
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---------------ESSAEVGTHYYKAPELLL  156 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---------------~~~~~~~~~~~~aPE~~~  156 (259)
                      +.+++|+|+.+|+|||+||+|.+|..-| ++|+.|||+++..-....               .....+|||.|.|||++.
T Consensus       153 vla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil  231 (1205)
T KOG0606|consen  153 VLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL  231 (1205)
T ss_pred             hHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence            4678999999999999999999999998 999999999875321110               012337999999999998


Q ss_pred             CccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                      . ..|+..+|.|++|+++|+.+.|..||.+..+.+.+..++.......           +.-....+++++++.++|+.+
T Consensus       232 r-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp-----------E~dea~p~Ea~dli~~LL~qn  299 (1205)
T KOG0606|consen  232 R-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-----------EEDEALPPEAQDLIEQLLRQN  299 (1205)
T ss_pred             h-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc-----------ccCcCCCHHHHHHHHHHHHhC
Confidence            7 5688999999999999999999999999999988888755432211           112457899999999999999


Q ss_pred             CCCcc---CHHHHhcCccccCCCC
Q 039159          237 PDKRI---TAAEALQQEYFKDVPG  257 (259)
Q Consensus       237 p~~Rp---~~~~~l~h~~f~~~~~  257 (259)
                      |..|.   .+-++.+|+||+...-
T Consensus       300 p~~Rlgt~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  300 PLCRLGTGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             hHhhcccchhhhhhhccceeeccc
Confidence            99996   5778889999997653

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=3.2e-19  Score=134.96  Aligned_cols=147  Identities=18%  Similarity=0.023  Sum_probs=105.2

Q ss_pred             hhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           14 SMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        14 ~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .+.+|+++|++|. |+++++++++    +..+++|||+.| +|......                .      ...++.++
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~----------------~------~~~~~~qi  100 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR----------------G------DLAYFRAA  100 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh----------------h------hHHHHHHH
Confidence            4789999999995 6889999886    346899999998 56433210                0      12355677


Q ss_pred             ccccccccCCCceeccC-CCCcEEEcCCCCeEEEeeccccccccccCCC-------------CcCCccCccccCcccccC
Q 039159           92 DSSRSLSFGTRYIRRDL-KPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-------------SSAEVGTHYYKAPELLLG  157 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dl-kp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~  157 (259)
                      +.++.++|..||+|||| ||+||+++.++ .++|+|||++.........             ......++.+++|+.-.-
T Consensus       101 ~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~  179 (218)
T PRK12274        101 RRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRV  179 (218)
T ss_pred             HHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhh
Confidence            78899999999999999 79999999888 8999999999754322210             001124666777765433


Q ss_pred             ccCCC-cccchHhHHHHHHHHHhCCCCCCCC
Q 039159          158 LLEYS-TAVDIWPVGCIFGEMVSGKPLFPGA  187 (259)
Q Consensus       158 ~~~~~-~~~DiwslG~~l~e~~tg~~pf~~~  187 (259)
                      ....+ ...+.++.|.-+|.+.|+..++.+.
T Consensus       180 l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        180 LKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             hccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            22333 3455558899999999999877654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=1.6e-19  Score=149.11  Aligned_cols=118  Identities=21%  Similarity=0.162  Sum_probs=89.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeE-EEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELNHPNIIR-LMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~-~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.|.+|+++|++++|+|+++ +++.    +..|+||||+.| +|. .+. .   .           .      ...++.
T Consensus        65 ~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~-~~~-~---~-----------~------~~~~~~  118 (365)
T PRK09188         65 RHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLH-LAR-P---H-----------G------DPAWFR  118 (365)
T ss_pred             HHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHH-HhC-c---c-----------c------hHHHHH
Confidence            456899999999999999985 4432    457999999997 564 221 0   0           0      024567


Q ss_pred             hcccccccccCCCceeccC-CCCcEEEcCCCCeEEEeeccccccccccCCC--------CcCCccCccccCccccc
Q 039159           90 SSDSSRSLSFGTRYIRRDL-KPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--------SSAEVGTHYYKAPELLL  156 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dl-kp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~  156 (259)
                      +++++|+|||+.||+|||| ||+||+++.++ .++|+|||+++........        .....+++.|.|||.+.
T Consensus       119 ~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        119 SAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             HHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            7889999999999999999 99999998887 8999999999865432211        12335777889999885

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=5.7e-20  Score=145.87  Aligned_cols=168  Identities=17%  Similarity=0.143  Sum_probs=106.8

Q ss_pred             EEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeE
Q 039159           43 LYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTV  122 (259)
Q Consensus        43 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~v  122 (259)
                      .+++|+-+.++|..++.........        .........+.+-.|+.+.+++||..|++|+||+|+|++++.+| .+
T Consensus       114 ~~~l~P~~~~dL~~~~~~l~~~~~~--------~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G-~v  184 (288)
T PF14531_consen  114 RFLLMPRAQGDLQDLVEALFSRAQT--------HSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDG-GV  184 (288)
T ss_dssp             EEEEEE--SEEHHHHHHHHHHHTTT--------SHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS--E
T ss_pred             hhhccchhhhcHHHHHHHHhhcccc--------cchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCC-CE
Confidence            3678888888998887542221110        13344444555667888889999999999999999999999999 89


Q ss_pred             EEeeccccccccccCCCCcCCccCccccCcccccCc-------cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 039159          123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL-------LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGR  195 (259)
Q Consensus       123 kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~  195 (259)
                      .|+||+.......   .......+..|.+||.....       ..++.+.|.|+||+++|.++.+..||...........
T Consensus       185 ~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~  261 (288)
T PF14531_consen  185 FLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW  261 (288)
T ss_dssp             EE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG
T ss_pred             EEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc
Confidence            9999987654211   11112334668899876431       2467899999999999999999999975432211110


Q ss_pred             HhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          196 IVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       196 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                                       ....+. ++++.++.||.++|+.||.+|
T Consensus       262 -----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  262 -----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             -----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence                             122223 789999999999999999987

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=5.8e-19  Score=133.29  Aligned_cols=208  Identities=19%  Similarity=0.200  Sum_probs=159.2

Q ss_pred             chhHHHHHHHhhCCC-CCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNH-PNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      -.+..|.++.+.|++ ..|..+..+..+..+-.+||+...-||.+++..+.              ..+++...+-.+-|+
T Consensus        55 pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLLGPsLEdLfnfC~--------------R~ftmkTvLMLaDQm  120 (341)
T KOG1163|consen   55 PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLLGPSLEDLFNFCS--------------RRFTMKTVLMLADQM  120 (341)
T ss_pred             cchhHHHHHHHHhccCCCCchhhhhccccccceeeeeccCccHHHHHHHHh--------------hhhhHHhHHHHHHHH
Confidence            357889999999975 56666777777888999999999889999997664              335566667777788


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCC--CCeEEEeeccccccccccCCCC-------cCCccCccccCcccccCccCCC
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGES-------SAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~--~~~vkl~dfg~~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      +.-++|+|.++++||||||+|+|.+-.  ..++.++|||+++.........       ....||..|.+--...+ ...+
T Consensus       121 l~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqS  199 (341)
T KOG1163|consen  121 LSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQS  199 (341)
T ss_pred             HHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhh-hhhh
Confidence            888999999999999999999998753  2378999999999875543322       23368889988777666 5677


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANS---LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      .+.|+=|+|-++..+--|..||.+...   .+.+..|.+..         +..+++..+.+++.++.-.+..|-..--++
T Consensus       200 RRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK---------~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E  270 (341)
T KOG1163|consen  200 RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK---------MSTPIEVLCKGFPAEFAMYLNYCRGLGFEE  270 (341)
T ss_pred             hhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh---------cCCCHHHHhCCCcHHHHHHHHHHhhcCCCC
Confidence            889999999999999999999997543   33344443332         122444556788899988999998888888


Q ss_pred             ccCHH
Q 039159          240 RITAA  244 (259)
Q Consensus       240 Rp~~~  244 (259)
                      -|.-.
T Consensus       271 ~Pdy~  275 (341)
T KOG1163|consen  271 KPDYM  275 (341)
T ss_pred             CCcHH
Confidence            88643

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.75  E-value=3.6e-19  Score=137.35  Aligned_cols=125  Identities=13%  Similarity=0.074  Sum_probs=94.1

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeC--------ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQG--------IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~--------~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      +.+|++.+.+++||+|..+.+++...        ...+++|||++| +|.+....                .       .
T Consensus        82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~----------------~-------~  138 (232)
T PRK10359         82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEI----------------S-------E  138 (232)
T ss_pred             HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhhc----------------c-------H
Confidence            67999999999999999999986643        357999999998 77665310                0       1


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcc-cccCccCCCcc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPE-LLLGLLEYSTA  164 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE-~~~~~~~~~~~  164 (259)
                      ..+.+++.+++.+|..|++|||++|.||+++.++  ++++|||.........             |-+ .++. ..++.+
T Consensus       139 ~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liDfg~~~~~~e~~-------------a~d~~vle-r~y~~~  202 (232)
T PRK10359        139 DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIIDLSGKRCTAQRK-------------AKDRIDLE-RHYGIK  202 (232)
T ss_pred             HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEECCCcccccchh-------------hHHHHHHH-hHhccc
Confidence            1244677788999999999999999999999776  9999999886432110             111 2222 456689


Q ss_pred             cchHhHHHHHHHHH
Q 039159          165 VDIWPVGCIFGEMV  178 (259)
Q Consensus       165 ~DiwslG~~l~e~~  178 (259)
                      +|+||||+++....
T Consensus       203 ~di~~lg~~~~~~~  216 (232)
T PRK10359        203 NEIKDLGYYLLIYK  216 (232)
T ss_pred             ccccceeEeehHHH
Confidence            99999998877543

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=3.5e-18  Score=131.31  Aligned_cols=112  Identities=15%  Similarity=0.126  Sum_probs=82.6

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhC-----CCCCeeEEEEEEEeCc---e-EEEEeee--ec-CCHHHHhhcCCCCCCCcc
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMEL-----NHPNIIRLMRVASQGI---Y-LYPVFEY--QV-NDLAYLLKYPKDSMNGYS   69 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~~~~~~~~~~---~-~~lv~e~--~~-~~l~~~~~~~~~~~~~~~   69 (259)
                      |.+...+....+.+.+|+++++.+     +||||++++|+++++.   . +.+|+||  +. ++|.+++....       
T Consensus        30 Kv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~-------  102 (210)
T PRK10345         30 KIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR-------  102 (210)
T ss_pred             EEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc-------
Confidence            333444344567899999999999     6799999999999873   4 3478999  44 49999995411       


Q ss_pred             cccCCCcchhHHHHHHHHHhhccccc-ccccCCCceeccCCCCcEEEcCC---CCeEEEeeccccc
Q 039159           70 TKNFNSYSLFTTFLLVEEFSSSDSSR-SLSFGTRYIRRDLKPVNILVDLD---GKTVKVAGFGLAK  131 (259)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~l-~~lh~~~i~H~dlkp~Nili~~~---~~~vkl~dfg~~~  131 (259)
                               +...  ...+.+++.++ +|||+++|+||||||+||++++.   +..++|+|++.+.
T Consensus       103 ---------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345        103 ---------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             ---------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence                     1111  24456666666 99999999999999999999753   2269999955553

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=1.2e-18  Score=152.93  Aligned_cols=224  Identities=20%  Similarity=0.274  Sum_probs=171.9

Q ss_pred             CCCCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      +....+++..|..+-+.+. |+|++.+++...+.+..+++++|..| ++...+....             .........-
T Consensus        60 ~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~-------------~~~~~~~~~~  126 (601)
T KOG0590|consen   60 SEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPD-------------STGTSSSSAS  126 (601)
T ss_pred             ccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCC-------------ccCCCCcchh
Confidence            3566677777999989997 99999999999999999999999876 6666552110             0133344556


Q ss_pred             HHHhhccccccccc-CCCceeccCCCCcEEEcCCCCeEEEeeccccccccc-cCC--CCcCCcc-CccccCcccccCccC
Q 039159           86 EEFSSSDSSRSLSF-GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA-YKG--ESSAEVG-THYYKAPELLLGLLE  160 (259)
Q Consensus        86 ~~~~~~~~~l~~lh-~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~-~~~--~~~~~~~-~~~~~aPE~~~~~~~  160 (259)
                      ..+.++..++.|+| +.++.|||+||+|.+++.++...++.|||++..... .+.  .....+| ++.|.|||...+...
T Consensus       127 ~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~  206 (601)
T KOG0590|consen  127 RYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY  206 (601)
T ss_pred             hhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhh
Confidence            78889999999999 999999999999999998764689999999987655 221  2334467 999999999987546


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHH-HhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGR-IVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      .....|+||.|+++..+++|..|+........... ......          ..-..-+..++....+++.+++..+|..
T Consensus       207 ~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~k~l~~~~~~  276 (601)
T KOG0590|consen  207 RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG----------RFTQLPWNSISDQAHDLLHKILKENPSN  276 (601)
T ss_pred             cCCCcccccccccccccccCCCCccccccccccceeeccccc----------ccccCccccCChhhhhcccccccCCchh
Confidence            67889999999999999999999875433221111 111100          0112234678899999999999999999


Q ss_pred             ccCHHHHhcCccccC
Q 039159          240 RITAAEALQQEYFKD  254 (259)
Q Consensus       240 Rp~~~~~l~h~~f~~  254 (259)
                      |.+.+++-.+||+..
T Consensus       277 r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  277 RLSIEELKLDNWLSS  291 (601)
T ss_pred             ccccccccccccccc
Confidence            999999999999987

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.65  E-value=1.1e-16  Score=121.83  Aligned_cols=99  Identities=16%  Similarity=0.085  Sum_probs=74.0

Q ss_pred             HHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCC-HHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccc
Q 039159           16 IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVND-LAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS   94 (259)
Q Consensus        16 ~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (259)
                      .+|++++.++.++++.....+...  ..++||||+.|+ +.......               ..++......++.+++.+
T Consensus        67 ~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---------------~~~~~~~~~~i~~qi~~~  129 (190)
T cd05147          67 EKEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---------------APLSESKARELYLQVIQI  129 (190)
T ss_pred             HHHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc---------------CCCCHHHHHHHHHHHHHH
Confidence            359999999988877443332222  238999999973 33222110               234567788899999999


Q ss_pred             cccc-cCCCceeccCCCCcEEEcCCCCeEEEeeccccccc
Q 039159           95 RSLS-FGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL  133 (259)
Q Consensus        95 l~~l-h~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~  133 (259)
                      ++++ |+.||+||||||+||+++ ++ .++|+|||++...
T Consensus       130 L~~l~H~~giiHrDlkP~NIli~-~~-~v~LiDFG~a~~~  167 (190)
T cd05147         130 MRILYQDCRLVHADLSEYNLLYH-DG-KLYIIDVSQSVEH  167 (190)
T ss_pred             HHHHHHhCCcccCCCCHHHEEEE-CC-cEEEEEccccccC
Confidence            9999 699999999999999998 45 7999999999643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.62  E-value=7.2e-16  Score=117.61  Aligned_cols=99  Identities=18%  Similarity=0.110  Sum_probs=76.3

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCC-HHHH-hhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVND-LAYL-LKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~-l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      +.+|++.+.++.|+++.....+....  .++||||++|. +... +..                ...+......++.+++
T Consensus        66 ~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----------------~~~~~~~~~~i~~~l~  127 (190)
T cd05145          66 AEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----------------VPLEEEEAEELYEQVV  127 (190)
T ss_pred             HHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh----------------ccCCHHHHHHHHHHHH
Confidence            46899999999999885444443332  47999999973 3222 211                2234556778889999


Q ss_pred             cccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccc
Q 039159           93 SSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL  133 (259)
Q Consensus        93 ~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~  133 (259)
                      .++.++|+ .||+||||||+||+++ ++ .++|+|||++...
T Consensus       128 ~~l~~lH~~~givHrDlkP~NIll~-~~-~~~liDFG~a~~~  167 (190)
T cd05145         128 EQMRRLYQEAGLVHGDLSEYNILYH-DG-KPYIIDVSQAVEL  167 (190)
T ss_pred             HHHHHHHHhCCEecCCCChhhEEEE-CC-CEEEEEcccceec
Confidence            99999999 9999999999999998 66 8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=1.4e-15  Score=120.01  Aligned_cols=204  Identities=20%  Similarity=0.166  Sum_probs=138.6

Q ss_pred             HHhhCCCCCeeEEEEEEEeCc-----eEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccc
Q 039159           21 CLMELNHPNIIRLMRVASQGI-----YLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS   94 (259)
Q Consensus        21 ~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (259)
                      -|-.+.|.|+|+++.++.+..     ....+.||+. |++..+++.-+...           ..+....+.+++.|+.+|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-----------~a~~~~~wkkw~tqIlsa  188 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-----------KALFQKAWKKWCTQILSA  188 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-----------hhhhHHHHHHHHHHHHhh
Confidence            344557999999999986654     4678999998 79999998755432           455667888999999999


Q ss_pred             cccccCC--CceeccCCCCcEEEcCCCCeEEEeeccccc--ccccc--CCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           95 RSLSFGT--RYIRRDLKPVNILVDLDGKTVKVAGFGLAK--SLYAY--KGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        95 l~~lh~~--~i~H~dlkp~Nili~~~~~~vkl~dfg~~~--~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      |.|||+.  .|+|+++..+-|++..+| -+|++--....  .....  ....+...+-++|.+||.-.. ...+..+|||
T Consensus       189 l~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy  266 (458)
T KOG1266|consen  189 LSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIY  266 (458)
T ss_pred             hhhhhccCCccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhh
Confidence            9999975  899999999999999777 67765211111  00000  011223346778899987654 3456789999


Q ss_pred             hHHHHHHHHHhCCCC-CCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCH-HHHHHHHhhcCcCCCCccCHHHH
Q 039159          169 PVGCIFGEMVSGKPL-FPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP-AGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       169 slG~~l~e~~tg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      +||.-..+|..+..- -.+.+.......+.+.                  .-+.+. .-++++.+|++-.|..||++.++
T Consensus       267 ~fgmcAlemailEiq~tnseS~~~~ee~ia~~------------------i~~len~lqr~~i~kcl~~eP~~rp~ar~l  328 (458)
T KOG1266|consen  267 KFGMCALEMAILEIQSTNSESKVEVEENIANV------------------IIGLENGLQRGSITKCLEGEPNGRPDARLL  328 (458)
T ss_pred             hhhHHHHHHHHheeccCCCcceeehhhhhhhh------------------eeeccCccccCcCcccccCCCCCCcchhhh
Confidence            999988999877532 2222211111111100                  001111 12358899999999999999999


Q ss_pred             hcCccccCC
Q 039159          247 LQQEYFKDV  255 (259)
Q Consensus       247 l~h~~f~~~  255 (259)
                      |.||..-.+
T Consensus       329 lfHpllfeV  337 (458)
T KOG1266|consen  329 LFHPLLFEV  337 (458)
T ss_pred             hcCceeeec
Confidence            999965544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.55  E-value=7.6e-15  Score=113.89  Aligned_cols=99  Identities=17%  Similarity=0.139  Sum_probs=83.7

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .++.+|++++..++|+|+.....++...+..+++|||++| +|.+.+...               .   . ....++.++
T Consensus        44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~---------------~---~-~~~~i~~~i  104 (211)
T PRK14879         44 ERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN---------------G---M-EELELSREI  104 (211)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc---------------c---H-HHHHHHHHH
Confidence            4678999999999999988777777777788999999997 888887421               1   1 566777888


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      +.+++++|+.+++|||++|.||+++ ++ .++++|||.+..
T Consensus       105 ~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879        105 GRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            8999999999999999999999998 55 799999999864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=1.6e-14  Score=122.34  Aligned_cols=215  Identities=23%  Similarity=0.190  Sum_probs=159.7

Q ss_pred             CCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      -...+=.+|+...++++ |+|.++.+..++.++..++-+|++..+|........              ..+........+
T Consensus       159 ~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~--------------~~~p~~~l~~~~  224 (524)
T KOG0601|consen  159 LDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCGESLQSYCHTPC--------------NFLPDNLLWNSL  224 (524)
T ss_pred             cccccccchhhcccccCccccccccCcccccCCcceeeeccccchhHHhhhccc--------------ccCCchhhhhHH
Confidence            34455567888888886 999999999999999999999999988777775422              112333444555


Q ss_pred             hhccc----ccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCC-----ccCccccCcccccCcc
Q 039159           89 SSSDS----SRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE-----VGTHYYKAPELLLGLL  159 (259)
Q Consensus        89 ~~~~~----~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~-----~~~~~~~aPE~~~~~~  159 (259)
                      .+..+    ||..+|..+++|-|+||+|++...+...++++|||....+..........     .|...|++||...+  
T Consensus       225 ~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--  302 (524)
T KOG0601|consen  225 RDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--  302 (524)
T ss_pred             hhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--
Confidence            55555    99999999999999999999999984489999999987654433221111     56778999999976  


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCC--ChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGA--NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      .++..+|++++|.++.+..++..+....  .........+               -....+.+.+.+....+.+|++.+|
T Consensus       303 l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---------------ip~e~~~~~s~~l~~~~~~~~d~~~  367 (524)
T KOG0601|consen  303 LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---------------IPLEFCEGGSSSLRSVTSQMLDEDP  367 (524)
T ss_pred             ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---------------CchhhhcCcchhhhhHHHHhcCcch
Confidence            4788999999999999999987665443  2222111111               0111234566777779999999999


Q ss_pred             CCccCHHHHhcCccccCC
Q 039159          238 DKRITAAEALQQEYFKDV  255 (259)
Q Consensus       238 ~~Rp~~~~~l~h~~f~~~  255 (259)
                      ..|+++..++.|+++.+.
T Consensus       368 ~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  368 RLRLTAQILTALNVIHSK  385 (524)
T ss_pred             hhhhHHHHHhccccccch
Confidence            999999999999998754

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.54  E-value=1.1e-14  Score=128.00  Aligned_cols=95  Identities=20%  Similarity=0.139  Sum_probs=82.0

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      +++.+|+++++.++|+|++....++......++||||++| +|.+.+.                       ....++.++
T Consensus       381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------------------~~~~~~~~i  437 (535)
T PRK09605        381 ERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------------------GNPELVRKV  437 (535)
T ss_pred             HHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------------------HHHHHHHHH
Confidence            5688999999999999999888777777788999999997 7877763                       235677788


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      +.++.+||+.+++|||+||+||+++ ++ .++|+|||+++.
T Consensus       438 ~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla~~  476 (535)
T PRK09605        438 GEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKY  476 (535)
T ss_pred             HHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCccccc
Confidence            9999999999999999999999994 55 799999999965

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=1.6e-14  Score=113.87  Aligned_cols=100  Identities=19%  Similarity=0.168  Sum_probs=77.1

Q ss_pred             CchhHHHHHHHhhCCCCCe--eEEEEEEEeC-c---eEEEEeeeecC--CHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           12 PSSMIREVSCLMELNHPNI--IRLMRVASQG-I---YLYPVFEYQVN--DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~ni--v~~~~~~~~~-~---~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ..++.+|++++.+|+|++|  ++.+++.... .   ..++|||+++|  +|.+++...                .+..  
T Consensus        84 ~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~----------------~l~~--  145 (239)
T PRK01723         84 RTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA----------------PLSE--  145 (239)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC----------------CCCH--
Confidence            4678899999999998885  7777765433 2   23599999996  787776431                0111  


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                        ..+.+++.++++||++||+||||||.|||++.++ .++|+|||.+..
T Consensus       146 --~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~~~~  191 (239)
T PRK01723        146 --EQWQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDRGEL  191 (239)
T ss_pred             --HHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCCccc
Confidence              1245678889999999999999999999999887 899999999864

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=6.4e-15  Score=132.94  Aligned_cols=150  Identities=18%  Similarity=0.196  Sum_probs=115.3

Q ss_pred             HHHHHHHhhCC---CCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           16 IREVSCLMELN---HPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        16 ~~Ei~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .=-.+++.+|+   -+.|..+..++.-.+.-+||+||.+ |||.+++...               ..+.+...+.+..++
T Consensus       739 YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~---------------~~m~e~lv~~~~~qm  803 (974)
T KOG1166|consen  739 YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTN---------------KVMDEYLVMFFSCQM  803 (974)
T ss_pred             eehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccC---------------CCCCchhhhHHHHHH
Confidence            33446667776   3456666666666677789999998 7999999632               445555566677778


Q ss_pred             ccccccccCCCceeccCCCCcEEEcC------CCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCc
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDL------DGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~------~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      +..++.||..+||||||||+|+++..      +...++|+|||.+-.+....  ..-...++|-.+.++|+..| +.++.
T Consensus       804 l~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtY  882 (974)
T KOG1166|consen  804 LRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTY  882 (974)
T ss_pred             HHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCch
Confidence            88889999999999999999999942      23358999999996543322  22334467889999999998 78999


Q ss_pred             ccchHhHHHHHHHHHhCC
Q 039159          164 AVDIWPVGCIFGEMVSGK  181 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~  181 (259)
                      ..|.|.++.+++-|+.|+
T Consensus       883 q~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  883 QIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             hhhhHHHHHHHHHHHHHH
Confidence            999999999999999986

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.51  E-value=3e-14  Score=109.55  Aligned_cols=96  Identities=18%  Similarity=0.128  Sum_probs=77.3

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      +++.+|+++++.++|+++.....++...+..+++|||++| +|.+.+...               . .      .++.++
T Consensus        42 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~---------------~-~------~~~~~i   99 (199)
T TIGR03724        42 ERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEG---------------N-D------ELLREI   99 (199)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhc---------------H-H------HHHHHH
Confidence            5677899999999988765555455566677899999997 787766321               0 0      567788


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      +.+++++|+.+++|||++|.||+++ ++ .++++|||.+..
T Consensus       100 ~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724       100 GRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             HHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            8999999999999999999999998 55 899999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.49  E-value=7.4e-14  Score=119.79  Aligned_cols=148  Identities=20%  Similarity=0.278  Sum_probs=113.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      +..+.+.+-++-|+.++||||+++++.++.++.+|+|+|-+.- |...+.                  ..........++
T Consensus        51 ~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk------------------~l~~~~v~~Gl~  111 (690)
T KOG1243|consen   51 EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP-LETVLK------------------ELGKEEVCLGLF  111 (690)
T ss_pred             hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc-HHHHHH------------------HhHHHHHHHHHH
Confidence            4456677888999999999999999999999999999997542 233332                  122455677889


Q ss_pred             hccccccccc-CCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSF-GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh-~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ||+.||.||| +++++|+||.-+.++++..| ..||++|..+......+...........|..|+.+..   -....|.|
T Consensus       112 qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~  187 (690)
T KOG1243|consen  112 QILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP---SEWSIDSW  187 (690)
T ss_pred             HHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCc---cccchhhh
Confidence            9999999997 68999999999999999999 8999999998665443322222223334666765532   12467999


Q ss_pred             hHHHHHHHHHhC
Q 039159          169 PVGCIFGEMVSG  180 (259)
Q Consensus       169 slG~~l~e~~tg  180 (259)
                      .|||+++++..|
T Consensus       188 ~Lg~li~el~ng  199 (690)
T KOG1243|consen  188 GLGCLIEELFNG  199 (690)
T ss_pred             hHHHHHHHHhCc
Confidence            999999999998

>smart00090 RIO RIO-like kinase

Probab=99.45  E-value=7.2e-14  Score=109.89  Aligned_cols=98  Identities=16%  Similarity=0.059  Sum_probs=72.8

Q ss_pred             hhHHHHHHHhhCCCC--CeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           14 SMIREVSCLMELNHP--NIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H~--niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+|+++++++.+.  .+.++++.   . ..++||||+.| ++.......               ..........++.+
T Consensus        96 ~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~---------------~~~~~~~~~~i~~q  156 (237)
T smart00090       96 WAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD---------------VEPEEEEEFELYDD  156 (237)
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc---------------CCcchHHHHHHHHH
Confidence            467899999999753  34444442   2 34799999998 544432110               11223445678889


Q ss_pred             cccccccccCCC-ceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159           91 SDSSRSLSFGTR-YIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus        91 ~~~~l~~lh~~~-i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ++.++++||+.| ++||||||+||+++ ++ .++++|||.+..
T Consensus       157 i~~~l~~LH~~g~iiH~Dikp~NIli~-~~-~i~LiDFg~a~~  197 (237)
T smart00090      157 ILEEMRKLYKEGELVHGDLSEYNILVH-DG-KVVIIDVSQSVE  197 (237)
T ss_pred             HHHHHHHHHhcCCEEeCCCChhhEEEE-CC-CEEEEEChhhhc
Confidence            999999999999 99999999999998 66 799999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.45  E-value=5.4e-14  Score=125.69  Aligned_cols=204  Identities=25%  Similarity=0.313  Sum_probs=151.9

Q ss_pred             CCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccccccccCCCc
Q 039159           25 LNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY  103 (259)
Q Consensus        25 l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i  103 (259)
                      ..||-++.....+......+|+++|+.| +|...++....               ....-.......+..++.+||...+
T Consensus       861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~---------------~saepaRs~i~~~vqs~e~L~s~~r  925 (1205)
T KOG0606|consen  861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC---------------LSAEPARSPILERVQSLESLHSSLR  925 (1205)
T ss_pred             CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC---------------cccccccchhHHHHhhhhccccchh
Confidence            3456666665555556788999999986 88888765321               1111122233445567799999999


Q ss_pred             eeccCCCCcEEEcCCCCeEEEeeccccccccccC-------------------------------CCCcCCccCccccCc
Q 039159          104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-------------------------------GESSAEVGTHYYKAP  152 (259)
Q Consensus       104 ~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-------------------------------~~~~~~~~~~~~~aP  152 (259)
                      .|+|++|.|.++..++ +.++.+|+.........                               .......||+.|.+|
T Consensus       926 ~h~~~~p~~~l~~~~g-h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laP 1004 (1205)
T KOG0606|consen  926 KHRDLKPDSLLIAYDG-HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAP 1004 (1205)
T ss_pred             hcccccccchhhcccC-CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCC
Confidence            9999999999999888 89999998432210000                               001223589999999


Q ss_pred             ccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhh
Q 039159          153 ELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       153 E~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                      |...+ ......+|.|++|+.+++.++|.+||........+..+.....           ++.......++++++++...
T Consensus      1005 e~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~-----------~~p~g~~~~s~~aq~~~~~l 1072 (1205)
T KOG0606|consen 1005 EILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDI-----------PWPEGPEEGSYEAQDLINRL 1072 (1205)
T ss_pred             ccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCC-----------CCCCCccccChhhhhhhhhh
Confidence            99988 5677889999999999999999999999988888877755432           23333456889999999999


Q ss_pred             cCcCCCCccCHH---HHhcCccccCCC
Q 039159          233 LGMDPDKRITAA---EALQQEYFKDVP  256 (259)
Q Consensus       233 l~~dp~~Rp~~~---~~l~h~~f~~~~  256 (259)
                      +..+|.+|..+.   ++-.||||+.+.
T Consensus      1073 l~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1073 LTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             hccCchhccCcccccccccCCccCCCC
Confidence            999999999887   888999999764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.39  E-value=3.5e-13  Score=103.50  Aligned_cols=95  Identities=19%  Similarity=0.102  Sum_probs=72.9

Q ss_pred             chhHHHHHHHhhCCCC--CeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           13 SSMIREVSCLMELNHP--NIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~--niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+|+.++.++.|+  .+++.++    ....++||||+.| +|......                     .....++.
T Consensus        78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------------~~~~~~~~  132 (198)
T cd05144          78 LAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------------------EDPEEVLD  132 (198)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------------------ccHHHHHH
Confidence            3477899999999887  4455444    2345899999998 65543310                     12345667


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL  133 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~  133 (259)
                      +++.++.++|+.+++||||+|+||+++.++ .++|+|||.+...
T Consensus       133 ~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         133 EILEEIVKAYKHGIIHGDLSEFNILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             HHHHHHHHHHHCCCCcCCCCcccEEEcCCC-cEEEEECCccccC
Confidence            788889999999999999999999999887 8999999999644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=1.1e-12  Score=113.20  Aligned_cols=163  Identities=18%  Similarity=0.235  Sum_probs=117.6

Q ss_pred             HHHHHHHhhcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--C-------CcCCccCccccC
Q 039159           82 FLLVEEFSSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--E-------SSAEVGTHYYKA  151 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~-------~~~~~~~~~~~a  151 (259)
                      .+...-+.+.+.|+.|+|. .++||++|.|++|.++..+ ..|++.|+++........  .       ........-|.|
T Consensus        99 e~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a  177 (700)
T KOG2137|consen   99 EDGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA  177 (700)
T ss_pred             cHhhhhhhcccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence            3444556677799999995 5999999999999999998 899999999865432111  0       001124557999


Q ss_pred             cccccCccCCCcccchHhHHHHHHHHH-hCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHH
Q 039159          152 PELLLGLLEYSTAVDIWPVGCIFGEMV-SGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLIS  230 (259)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~e~~-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  230 (259)
                      ||.+.+ ...+.++|++|+|+.+|.+. .|+..+........+...........+          ....++++++++=+.
T Consensus       178 pE~~~~-~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~----------~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  178 PEYLLG-TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAF----------GYSNNLPSELRESLK  246 (700)
T ss_pred             chhhcc-ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccc----------cccccCcHHHHHHHH
Confidence            999987 67789999999999999998 456555543322222222111111111          112578899999999


Q ss_pred             hhcCcCCCCccCHHHHhcCccccCCC
Q 039159          231 KMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       231 ~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      +++..++..||++..++..|||.+.+
T Consensus       247 k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             HHhcCCcccCcchhhhhcccccCCch
Confidence            99999999999999999999998865

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.30  E-value=4.4e-12  Score=92.69  Aligned_cols=97  Identities=18%  Similarity=0.132  Sum_probs=78.6

Q ss_pred             CchhHHHHHHHhhCCC--CCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMELNH--PNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..++.+|+.+++.++|  .++++++++...++..+++|||+.| .+..+                      ........+
T Consensus        35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------------------~~~~~~~~~   92 (155)
T cd05120          35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------------------SEEEKEDIA   92 (155)
T ss_pred             hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----------------------CHHHHHHHH
Confidence            4679999999999976  5999999998888889999999987 22221                      123345556


Q ss_pred             hhcccccccccCC---CceeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159           89 SSSDSSRSLSFGT---RYIRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus        89 ~~~~~~l~~lh~~---~i~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      .+++++++.+|..   +++|+|++|.||+++..+ .++++|||.+.
T Consensus        93 ~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~  137 (155)
T cd05120          93 EQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAG  137 (155)
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEeccccc
Confidence            6777888888874   799999999999999866 89999999885

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.17  E-value=5.5e-10  Score=93.86  Aligned_cols=198  Identities=14%  Similarity=0.089  Sum_probs=136.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEe----CceEEEEeeeecC--CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQ----GIYLYPVFEYQVN--DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ......-+++++++.|+|||++.++|..    +..+++|++|+++  +|++..-...............+...++...++
T Consensus       317 ~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW  396 (655)
T KOG3741|consen  317 TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLW  396 (655)
T ss_pred             cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHH
Confidence            3344556899999999999999999873    3578999999985  788776433222211111112233567778899


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.|+..||.++|+.|+..+-|.|.+|+++.+- +++|+..|..-.+....       +       +.+.    -..+-
T Consensus       397 ~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d~-------~-------~~le----~~Qq~  457 (655)
T KOG3741|consen  397 SYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQEDP-------T-------EPLE----SQQQN  457 (655)
T ss_pred             HHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeecCCC-------C-------cchh----HHhhh
Confidence            9999999999999999999999999999998665 78887666654332111       0       1111    23456


Q ss_pred             chHhHHHHHHHHHhCCCC-CCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVSGKPL-FPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |.=.||.++..++||.-- +......+.                    .+......+|.+++++|......++++ -++.
T Consensus       458 D~~~lG~ll~aLAt~~~ns~~~d~~~~s--------------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~  516 (655)
T KOG3741|consen  458 DLRDLGLLLLALATGTENSNRTDSTQSS--------------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQ  516 (655)
T ss_pred             hHHHHHHHHHHHhhcccccccccchHHH--------------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHH
Confidence            888999999999998532 222222211                    111222468889999999888888876 6777


Q ss_pred             HHhcC
Q 039159          245 EALQQ  249 (259)
Q Consensus       245 ~~l~h  249 (259)
                      +++.+
T Consensus       517 ~llp~  521 (655)
T KOG3741|consen  517 DLLPM  521 (655)
T ss_pred             HHHHH
Confidence            77764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.14  E-value=2e-11  Score=103.75  Aligned_cols=208  Identities=21%  Similarity=0.167  Sum_probs=146.8

Q ss_pred             hHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           15 MIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        15 ~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      -..|+.+...+. |.+++.++..+......|+=.|||.+ ++.....- .              ..+.....+....+++
T Consensus       312 sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~-~--------------~~~d~~~~~~~~~q~~  376 (524)
T KOG0601|consen  312 SLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT-S--------------QMLDEDPRLRLTAQIL  376 (524)
T ss_pred             chhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH-H--------------HhcCcchhhhhHHHHH
Confidence            457888888875 99999999988888888899999986 44333310 0              3344456678888999


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccC-cccccCccCCCcccchHhHH
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKA-PELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~a-PE~~~~~~~~~~~~DiwslG  171 (259)
                      .++.++|+..++|+|++|+||++..++...+++|||....+.   .......+.-++.| .|.+.....+..++|++|||
T Consensus       377 ~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~---~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~  453 (524)
T KOG0601|consen  377 TALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA---FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLG  453 (524)
T ss_pred             hccccccchhhhcccccccceeeccchhhhhccccccccccc---eecccccccccccccchhhcccccccccccccccc
Confidence            999999999999999999999998764468899999986431   12222333444553 55555546778899999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCcc
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY  251 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~  251 (259)
                      ..+.+.+++.+.-.....   ...+ .....+.             .++.....+.+...++..++..||.+.++..|.=
T Consensus       454 ~~~~e~~~~~~ls~~~~~---~~~i-~~~~~p~-------------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  454 LSVDEAITGSPLSESGVQ---SLTI-RSGDTPN-------------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ccccccccCcccCccccc---ceee-ecccccC-------------CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            999999998753322111   1111 1111111             2344467778899999999999999999999876


Q ss_pred             ccCCCC
Q 039159          252 FKDVPG  257 (259)
Q Consensus       252 f~~~~~  257 (259)
                      |-...+
T Consensus       517 ~~~~~~  522 (524)
T KOG0601|consen  517 FYRDSR  522 (524)
T ss_pred             hhhhcc
Confidence            654443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.09  E-value=1.3e-10  Score=88.41  Aligned_cols=95  Identities=20%  Similarity=0.139  Sum_probs=67.6

Q ss_pred             HHHHHHHhhCCCC--CeeEEEEEEEeCceEEEEeeeecC-CHH-HHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           16 IREVSCLMELNHP--NIIRLMRVASQGIYLYPVFEYQVN-DLA-YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        16 ~~Ei~~l~~l~H~--niv~~~~~~~~~~~~~lv~e~~~~-~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ..|.+.+.++.+.  .+.+.+++.    ..+++|||++| ++. ..+..                . ........++.++
T Consensus        65 ~~e~~~l~~l~~~~~~~~~~~~~~----~~~lv~e~~~g~~~~~~~l~~----------------~-~~~~~~~~~~~~~  123 (187)
T cd05119          65 EKEFRNLKRLYEAGVPVPKPIDLN----RHVLVMEFIGGDGIPAPRLKD----------------V-RLLEDPEELYDQI  123 (187)
T ss_pred             HHHHHHHHHHHHcCCCCCceEecC----CCEEEEEEeCCCCccChhhhh----------------h-hhcccHHHHHHHH
Confidence            4667777777543  355555532    35899999997 321 11110                0 0004566778889


Q ss_pred             ccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccc
Q 039159           92 DSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL  133 (259)
Q Consensus        92 ~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~  133 (259)
                      +.++.++|. .+++||||||+||+++ ++ .++++|||.+...
T Consensus       124 ~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-~~~liDfg~a~~~  164 (187)
T cd05119         124 LELMRKLYREAGLVHGDLSEYNILVD-DG-KVYIIDVPQAVEI  164 (187)
T ss_pred             HHHHHHHhhccCcCcCCCChhhEEEE-CC-cEEEEECcccccc
Confidence            999999999 9999999999999999 66 7999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.06  E-value=2.8e-10  Score=86.23  Aligned_cols=96  Identities=15%  Similarity=0.076  Sum_probs=69.2

Q ss_pred             HHHHHHHhhCC--CCCeeEEEEEEEeCceEEEEeeeecCC-HHH-HhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           16 IREVSCLMELN--HPNIIRLMRVASQGIYLYPVFEYQVND-LAY-LLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        16 ~~Ei~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~~-l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .+|++.|+++.  .-++.+.+++    ..-++||||..++ +.. .+..                ......+...++.++
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----------------~~~~~~~~~~i~~~i  133 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----------------AKLNDEEMKNAYYQV  133 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----------------cccCHHHHHHHHHHH
Confidence            38999999995  4577788765    3567899999863 211 1111                111123345566788


Q ss_pred             ccccccc-cCCCceeccCCCCcEEEcCCCCeEEEeeccccccc
Q 039159           92 DSSRSLS-FGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL  133 (259)
Q Consensus        92 ~~~l~~l-h~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~  133 (259)
                      +.++..+ |+.|++||||++.||+++ ++ .+.++|||-+...
T Consensus       134 ~~~l~~l~H~~glVHGDLs~~NIL~~-~~-~v~iIDF~qav~~  174 (197)
T cd05146         134 LSMMKQLYKECNLVHADLSEYNMLWH-DG-KVWFIDVSQSVEP  174 (197)
T ss_pred             HHHHHHHHHhCCeecCCCCHHHEEEE-CC-cEEEEECCCceeC
Confidence            8888888 899999999999999997 45 6999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=3.6e-10  Score=83.22  Aligned_cols=96  Identities=16%  Similarity=0.083  Sum_probs=69.3

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      ++..+|++++++++--.|.--.=+..+.+...++|||.+| .|.+.+...                      ....+..+
T Consensus        44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------------------~~~~~r~v  101 (204)
T COG3642          44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------------------RPDLLREV  101 (204)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------------------chHHHHHH
Confidence            5677999999998644433333333455677899999999 555566431                      12333444


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ...+.-||..||+|+||.++||+++..+  +.++|||++..
T Consensus       102 G~~vg~lH~~givHGDLTtsNiIl~~~~--i~~IDfGLg~~  140 (204)
T COG3642         102 GRLVGKLHKAGIVHGDLTTSNIILSGGR--IYFIDFGLGEF  140 (204)
T ss_pred             HHHHHHHHhcCeecCCCccceEEEeCCc--EEEEECCcccc
Confidence            4556889999999999999999998654  99999999964

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.04  E-value=2.4e-10  Score=85.39  Aligned_cols=93  Identities=17%  Similarity=0.081  Sum_probs=66.2

Q ss_pred             CchhHHHHHHHhhCCCCCe-eEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELNHPNI-IRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..++.+|+.+++.+.+.++ .++++...  ...++||||++| ++...-                       ......+.
T Consensus        36 ~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~-----------------------~~~~~~~~   90 (170)
T cd05151          36 LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED-----------------------FSDPENLE   90 (170)
T ss_pred             ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc-----------------------ccCHHHHH
Confidence            4567899999999965454 45555432  345799999998 433210                       00122345


Q ss_pred             hcccccccccCCCc-----eeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159           90 SSDSSRSLSFGTRY-----IRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus        90 ~~~~~l~~lh~~~i-----~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      +++.+++.||..++     +|+|++|.||+++ ++ .++++||+.+.
T Consensus        91 ~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          91 KIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            66777889998875     9999999999998 55 79999999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.96  E-value=1.3e-09  Score=80.18  Aligned_cols=109  Identities=16%  Similarity=0.054  Sum_probs=78.2

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC--CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN--DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+..+|++.|.++.--.|.--.=++.+...-.++|||..|  ++.+++...-..             ..........+.
T Consensus        54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~-------------~~~d~~~~~~~~  120 (229)
T KOG3087|consen   54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMED-------------ESEDEGLAELAR  120 (229)
T ss_pred             HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccC-------------cccchhHHHHHH
Confidence            45678999999998744444433445555666788999998  777777542111             111122256666


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeE--EEeeccccccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTV--KVAGFGLAKSL  133 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~v--kl~dfg~~~~~  133 (259)
                      .+.+.+.-||..+|+|+||..+||++.+++.++  .++|||++...
T Consensus       121 ~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  121 RIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            777778999999999999999999998776554  89999999653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.88  E-value=2e-09  Score=92.19  Aligned_cols=103  Identities=17%  Similarity=0.153  Sum_probs=68.2

Q ss_pred             hhHHHHHHHhhCC----CCCeeEEEEEEEe-CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           14 SMIREVSCLMELN----HPNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        14 ~~~~Ei~~l~~l~----H~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ++.+|++.+.+++    |.+-+.+..++.+ ....++||||+.| +|.+........              ....   .+
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--------------~~~~---~i  261 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--------------LDRK---AL  261 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--------------CCHH---HH
Confidence            5778888777763    4445555555532 3457899999998 776665321100              0011   11


Q ss_pred             Hhhccc-ccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccc
Q 039159           88 FSSSDS-SRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY  134 (259)
Q Consensus        88 ~~~~~~-~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~  134 (259)
                      ...++. .+..+|..|++|+|++|.||+++.++ .++++|||++..+.
T Consensus       262 a~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       262 AENLARSFLNQVLRDGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHhCCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            111111 24667889999999999999999888 89999999997653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.84  E-value=6.8e-09  Score=78.37  Aligned_cols=99  Identities=20%  Similarity=0.120  Sum_probs=60.6

Q ss_pred             CchhHHHHHHHhhCCCC--CeeEEEEEEEeCceEEEEeeeec--C-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHP--NIIRLMRVASQGIYLYPVFEYQV--N-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~--niv~~~~~~~~~~~~~lv~e~~~--~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .....+|.+.|.++..-  ++.+.+++-    .-++||||.+  | .+..+....                 +.......
T Consensus        52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~-----------------~~~~~~~~  110 (188)
T PF01163_consen   52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD-----------------LSPEEPKE  110 (188)
T ss_dssp             HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG-----------------GGGSTHHH
T ss_pred             HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc-----------------ccchhHHH
Confidence            45678999999999755  577777553    2468999998  7 343333211                 00112233


Q ss_pred             HHhhcccc-cccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccc
Q 039159           87 EFSSSDSS-RSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL  133 (259)
Q Consensus        87 ~~~~~~~~-l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~  133 (259)
                      ++.+++.. ...+|..||+||||++.||+++.+  .+.++|||.+...
T Consensus       111 ~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~qav~~  156 (188)
T PF01163_consen  111 LLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFGQAVDS  156 (188)
T ss_dssp             HHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GTTEEET
T ss_pred             HHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecCcceec
Confidence            33344442 345679999999999999999866  5999999988643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.84  E-value=3.5e-08  Score=81.48  Aligned_cols=168  Identities=15%  Similarity=0.053  Sum_probs=113.1

Q ss_pred             cchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccc
Q 039159           76 YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL  155 (259)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~  155 (259)
                      +..+.+...+...+.++.+.+-||++|.+=+|++++|+|+++++ .|.|.|-..-..- .....-.+..|.+.|.+||.-
T Consensus       111 ~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~-~ng~~~~cpVg~~eftPPElQ  188 (637)
T COG4248         111 YPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQIN-ANGTLHLCPVGVSEFTPPELQ  188 (637)
T ss_pred             CCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccceeec-cCCceEecccCccccCCHHHh
Confidence            35677788899999999999999999999999999999999988 8999986554332 112223456789999999986


Q ss_pred             c-C---ccCCCcccchHhHHHHHHHHHhC-CCCCCCCCh-----HHHHHHHhCCCC--CCccccccccccccCCCCCCCH
Q 039159          156 L-G---LLEYSTAVDIWPVGCIFGEMVSG-KPLFPGANS-----LITLGRIVGKSR--KPSFCKLSLRDHLTNGFPGLEP  223 (259)
Q Consensus       156 ~-~---~~~~~~~~DiwslG~~l~e~~tg-~~pf~~~~~-----~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~  223 (259)
                      . +   ....+...|.+.||+++++++.| ++||.+-..     ......|....-  .+.....-...+...-++-+++
T Consensus       189 ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp  268 (637)
T COG4248         189 TLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPP  268 (637)
T ss_pred             ccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCH
Confidence            5 1   13456789999999999999986 899975321     001111111000  0000000000122222456788


Q ss_pred             HHHHHHHhhcCcC--CCCccCHHH
Q 039159          224 AGIDLISKMLGMD--PDKRITAAE  245 (259)
Q Consensus       224 ~~~~li~~~l~~d--p~~Rp~~~~  245 (259)
                      +++.|..+|+...  +.-||+++.
T Consensus       269 ~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         269 DVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             HHHHHHHHHhcccCCCCCCCCHHH
Confidence            9999999998763  568998653

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.80  E-value=1.8e-08  Score=80.48  Aligned_cols=105  Identities=11%  Similarity=-0.028  Sum_probs=75.0

Q ss_pred             hhHHHHHHHhhCC--CCCeeEEEEEEEe-----CceEEEEeeeecC--CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           14 SMIREVSCLMELN--HPNIIRLMRVASQ-----GIYLYPVFEYQVN--DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        14 ~~~~Ei~~l~~l~--H~niv~~~~~~~~-----~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      .+.+|.+.+.+|.  .=.+++.+++.+.     ....++|+|++++  +|.+++.....             ........
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~-------------~~~~~~~~  140 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWAT-------------NPPDPRLK  140 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcc-------------cCCCHHHH
Confidence            5889999999984  3334445555543     2357899999997  68887742110             11122344


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCC------CCeEEEeeccccc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLD------GKTVKVAGFGLAK  131 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~------~~~vkl~dfg~~~  131 (259)
                      ..++.+++..++-||..||+|+|+++.||+++.+      ...+.++||+.+.
T Consensus       141 ~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        141 RMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            5667778888899999999999999999999752      2379999999885

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.69  E-value=7.3e-08  Score=74.41  Aligned_cols=106  Identities=20%  Similarity=0.093  Sum_probs=78.7

Q ss_pred             CchhHHHHHHHhhCC--CCCeeEEEEEEEeCc----eEEEEeeeecC--CHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           12 PSSMIREVSCLMELN--HPNIIRLMRVASQGI----YLYPVFEYQVN--DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~--H~niv~~~~~~~~~~----~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ..++.+|...+..|.  .=.+.+.+++.+...    ..++|+|+.+|  +|.+++.....               .....
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------------~~~~~  119 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------------LDPSQ  119 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------------cchhh
Confidence            457889999888885  334566666665532    45899999987  68888853111               22234


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCC--CeEEEeecccccc
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKS  132 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~  132 (259)
                      ...++.+++..++-||..|++|+|+++.|||++.++  ..+.++||+.++.
T Consensus       120 ~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  120 RRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            456667778888999999999999999999998764  3688999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.61  E-value=8.7e-08  Score=74.67  Aligned_cols=47  Identities=15%  Similarity=0.072  Sum_probs=35.7

Q ss_pred             CCchhHHHHHHHhhCCC--CCeeEEEEEEEeC---ceEEEEeeeecC-CHHHH
Q 039159           11 VPSSMIREVSCLMELNH--PNIIRLMRVASQG---IYLYPVFEYQVN-DLAYL   57 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H--~niv~~~~~~~~~---~~~~lv~e~~~~-~l~~~   57 (259)
                      ...++.+|+++++.+.+  .++.+++.+....   +..++||||++| ++...
T Consensus        38 ~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~   90 (223)
T cd05154          38 SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDR   90 (223)
T ss_pred             ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCC
Confidence            46789999999999975  4467788777654   256899999987 55543

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.57  E-value=1.8e-07  Score=81.61  Aligned_cols=104  Identities=17%  Similarity=0.198  Sum_probs=68.0

Q ss_pred             hhHHHHHHHhhCC----CCCeeEEEEEEEe-CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           14 SMIREVSCLMELN----HPNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        14 ~~~~Ei~~l~~l~----H~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ++.+|+..+.+++    +.+.+.+..++.+ ...-++||||+.| .+.++-......         .....+.......+
T Consensus       202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---------~d~~~la~~~v~~~  272 (537)
T PRK04750        202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---------TDMKLLAERGVEVF  272 (537)
T ss_pred             CHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---------CCHHHHHHHHHHHH
Confidence            4667777666663    5666666676654 3567899999998 776532110000         00022333344444


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCC---CeEEEeeccccccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG---KTVKVAGFGLAKSL  133 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~---~~vkl~dfg~~~~~  133 (259)
                      +.|+.       ..|++|+|++|.||+++.++   ++++++|||+...+
T Consensus       273 ~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        273 FTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             HHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            54543       47999999999999998765   37999999998765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.53  E-value=7.4e-08  Score=83.32  Aligned_cols=210  Identities=18%  Similarity=0.143  Sum_probs=142.1

Q ss_pred             chhHHHHHHHhhCCCCC-eeEEEEEEEeCceEEEEeeeecCC--HHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           13 SSMIREVSCLMELNHPN-IIRLMRVASQGIYLYPVFEYQVND--LAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....-++++|.+++||| .+..++-+..+...++.++++.+.  .....              ..+...+...++...++
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~--------------~~se~~~~~~~~~~~~r  343 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM--------------TVSEIALEQYQFAYPLR  343 (829)
T ss_pred             hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC--------------ChhhHhhhhhhhhhhhh
Confidence            44567889999999999 777777676677889999998853  11111              11114455677788888


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      ....+++++|+..=+|+|    ||+... + ..+..+|+....+...- ...+..+++.++|||.... ..+....|.|+
T Consensus       344 ~et~~l~~l~~~~~~~~d----~~l~s~-~-~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~  415 (829)
T KOG0576|consen  344 KETRPLAELHSSYKVHRD----NILGSE-E-EVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGS  415 (829)
T ss_pred             hhcccccccccccccCcc----cccccc-c-ccccccccCCcccCccc-ccccCCCCCCCCCchhhcc-cccccCCCccC
Confidence            889999999988778888    777764 4 68999999987664332 3556689999999998877 56788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      +|.--.++..|.+|-...  ......+   ...+..+.....    ..+.  ...-.++...|+.-.|..|+....++-|
T Consensus       416 ~~~~~~~~ap~~pPr~~P--~~~~~~~---g~~p~s~~L~~~----~aw~--~~~~~~~~~~~~~g~P~~pkv~mgacfs  484 (829)
T KOG0576|consen  416 LAVSAIQMAPGLPPRSSP--PAVLPMI---GNGPNSPMLTDK----SAWS--PVFHRDFPAPCLNGLPPTPKVHMGACFS  484 (829)
T ss_pred             CCcchhhcCCCCCCCCCC--ccccCCC---CCCCCccccchh----hhcC--cccccCCcccccCCCCCCCcchhhHHHH
Confidence            998888888887776431  1000001   001111100000    1111  1112257788899999999999999888


Q ss_pred             ccccCC
Q 039159          250 EYFKDV  255 (259)
Q Consensus       250 ~~f~~~  255 (259)
                      .+|..-
T Consensus       485 KvfngC  490 (829)
T KOG0576|consen  485 KVFNGC  490 (829)
T ss_pred             HHhccC
Confidence            888754

>PRK09902 hypothetical protein; Provisional

Probab=98.35  E-value=1.6e-06  Score=66.15  Aligned_cols=106  Identities=11%  Similarity=0.037  Sum_probs=75.9

Q ss_pred             chhHHHHHHHhhCC--CCCeeEEEEEEEe--C--ceEEEEeeeecC--CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           13 SSMIREVSCLMELN--HPNIIRLMRVASQ--G--IYLYPVFEYQVN--DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~--H~niv~~~~~~~~--~--~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ..|.+|+..+.+|.  .-.+.+....-..  +  -..+||+|-..|  +|.+.+.....             ...+....
T Consensus        64 ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~-------------~~~~~~~k  130 (216)
T PRK09902         64 PTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAV-------------SPYSDEVR  130 (216)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCc-------------CCcchHHH
Confidence            46889999999995  3335555522211  1  257899998885  78887743111             22233445


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCe--EEEeecccccc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKT--VKVAGFGLAKS  132 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~--vkl~dfg~~~~  132 (259)
                      ..++..++..++-||..|+.|+|+.+.||+++.++ .  +.++||..++.
T Consensus       131 ~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~  179 (216)
T PRK09902        131 QAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR  179 (216)
T ss_pred             HHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence            56777888889999999999999999999998666 5  99999988764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.24  E-value=2.4e-06  Score=78.84  Aligned_cols=200  Identities=18%  Similarity=0.176  Sum_probs=127.9

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCc----eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGI----YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..-|...+.+..|+|++.++.+..+..    ...+..+++.. ++...+...               ........+.+..
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---------------~~i~~~~~r~~~~  293 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---------------GSIPLETLRILHQ  293 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---------------cccCHHHHHHHHH
Confidence            345666788889999999999876543    22345566665 666666432               4445566667777


Q ss_pred             hcccccccccCCCceeccCCCC---cEEEcCCCCeEEEe--eccccccccccCCCCcCCccCccccCcccccC-ccCCCc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPV---NILVDLDGKTVKVA--GFGLAKSLYAYKGESSAEVGTHYYKAPELLLG-LLEYST  163 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~---Nili~~~~~~vkl~--dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~  163 (259)
                      ++..|++++|+....|.-+..+   +-..+..+ .+..+  ||+..+.+... ........+..+.++|.... ......
T Consensus       294 ~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~-~~~~~~~~~~~~~~~e~~~~~~~~~~r  371 (1351)
T KOG1035|consen  294 KLLEGLAYLHSLSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDN-EKSFSDLLAEIRNADEDLKENTAKKSR  371 (1351)
T ss_pred             HHhhhHHHHHHhccceeEEecccccccccCccc-eeecchhhhcccccCCCc-ccchhhcCccccccccccccccchhhh
Confidence            8889999999886666555444   33334444 45555  78777654322 22233344556677776654 122344


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCC-HHHHHHHHhhcCcCCCCccC
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE-PAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ..|+|.+|.....+..|..+-.-.....   ..                     ....+ ....+.+.+|+..++++|++
T Consensus       372 ~~dL~~lgll~~~~~~~~~i~~~~~~~~---~~---------------------l~~~~~~~~~d~~~~~~~~~~~~Rl~  427 (1351)
T KOG1035|consen  372 LTDLWCLGLLLLQLSQGEDISEKSAVPV---SL---------------------LDVLSTSELLDALPKCLDEDSEERLS  427 (1351)
T ss_pred             hhHHHHHHHHHhhhhhcCcccccccchh---hh---------------------hccccchhhhhhhhhhcchhhhhccc
Confidence            5799999999999988764332111000   00                     01111 15668899999999999999


Q ss_pred             HHHHhcCccccCC
Q 039159          243 AAEALQQEYFKDV  255 (259)
Q Consensus       243 ~~~~l~h~~f~~~  255 (259)
                      +.+++.|+|.+..
T Consensus       428 ~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  428 ALELLTHPFLRFP  440 (1351)
T ss_pred             hhhhhhchhcccc
Confidence            9999999998743

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.99  E-value=4.1e-05  Score=58.83  Aligned_cols=37  Identities=14%  Similarity=0.162  Sum_probs=31.7

Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      +++.-+|+.|+.|+|..|.|++++.+  .++++|++..+
T Consensus       146 ~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~k~  182 (229)
T PF06176_consen  146 EAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQGKR  182 (229)
T ss_pred             HHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECcccc
Confidence            44688899999999999999999855  49999997765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.92  E-value=6.4e-06  Score=64.77  Aligned_cols=95  Identities=21%  Similarity=0.142  Sum_probs=62.4

Q ss_pred             CCchhHHHHHHHhhCCCC--CeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHP--NIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~--niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ....+.+|.++|.+|...  .|.+.++.    +.-.+|||+..| .|..+--                    .....-.+
T Consensus       152 sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------------------~~en~~~i  207 (304)
T COG0478         152 SRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL--------------------DVENPDEI  207 (304)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC--------------------cccCHHHH
Confidence            345688999999999754  66666553    345689999998 3333221                    01111222


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA  130 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~  130 (259)
                      +..++..+.-.-..|++|+|+++=||+++.+| .+.++||--+
T Consensus       208 l~~il~~~~~~~~~GiVHGDlSefNIlV~~dg-~~~vIDwPQ~  249 (304)
T COG0478         208 LDKILEEVRKAYRRGIVHGDLSEFNILVTEDG-DIVVIDWPQA  249 (304)
T ss_pred             HHHHHHHHHHHHHcCccccCCchheEEEecCC-CEEEEeCccc
Confidence            22222222333367999999999999999998 7999998444

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.80  E-value=4.5e-05  Score=65.24  Aligned_cols=172  Identities=17%  Similarity=0.146  Sum_probs=104.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeC-ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++....++++.+.|+|.-+++++-... ....+|+|++.-+|++.+.... .               ...       
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~-l---------------~~~-------   81 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN-L---------------KDE-------   81 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc-c---------------chh-------
Confidence            345678889999999999999999988754 4688999999999998885421 0               000       


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                            .++ .+++.|     .|        ..+.+|-    ....    ...                 ...+++||||
T Consensus        82 ------s~~-~~~~~~-----~~--------~~~~td~----~~t~----~~~-----------------~~~pKsdVws  116 (725)
T KOG1093|consen   82 ------SLL-AHGVLH-----LN--------IIYITDH----FLTK----YPS-----------------PIGPKSDVWS  116 (725)
T ss_pred             ------hhc-ccccce-----eh--------hhhcccc----cccc----CCC-----------------CCCcchhhhh
Confidence                  000 122222     11        2233331    0000    011                 1124899999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc-ccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK-LSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      +|.++.++..|..-+......+....+..-...+..-. .... .  ...-.++....++..+|+...|..||...++.+
T Consensus       117 l~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e-~--~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  117 LGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAME-H--LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHH-H--HHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            99999999999877765444433333321111110000 0000 0  001235677788999999999999999999988


Q ss_pred             Ccccc
Q 039159          249 QEYFK  253 (259)
Q Consensus       249 h~~f~  253 (259)
                      ++-|.
T Consensus       194 ~~i~~  198 (725)
T KOG1093|consen  194 RCSFT  198 (725)
T ss_pred             CccHH
Confidence            87664

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.61  E-value=0.00037  Score=55.23  Aligned_cols=46  Identities=15%  Similarity=0.023  Sum_probs=35.4

Q ss_pred             CchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHH
Q 039159           12 PSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYL   57 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~   57 (259)
                      ..++.+|+++++.+. +--+.+++++...++..++|||+.+| ++...
T Consensus        35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150          35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            356889999999994 45577888887766678899999998 55533

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.57  E-value=0.00015  Score=55.01  Aligned_cols=101  Identities=15%  Similarity=0.010  Sum_probs=74.4

Q ss_pred             HHHHHHHhhCCC-CCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhccc
Q 039159           16 IREVSCLMELNH-PNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDS   93 (259)
Q Consensus        16 ~~Ei~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (259)
                      .+|.-+++.|.+ +++++++|+|-+    +++.||... ++....            .........++..+++++.++++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~------------~~l~~~~~~~w~~R~~iA~~lL~   70 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIY------------RPLSQFLQSPWEQRAKIALQLLE   70 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccc------------cccccccccCHHHHHHHHHHHHH
Confidence            468889999975 799999999942    458898773 443210            00011134566778888888888


Q ss_pred             ccccccC---CCceeccCCCCcEEEcCCCCeEEEeeccccccc
Q 039159           94 SRSLSFG---TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL  133 (259)
Q Consensus        94 ~l~~lh~---~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~  133 (259)
                      .+.+++.   ..+.-.|++++|+-++.++ .+|++|.......
T Consensus        71 ~l~~l~~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~  112 (188)
T PF12260_consen   71 LLEELDHGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE  112 (188)
T ss_pred             HHHHHhcCCCCcEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence            8888886   3567789999999999888 8999999887543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.53  E-value=0.00031  Score=55.01  Aligned_cols=41  Identities=15%  Similarity=0.132  Sum_probs=33.6

Q ss_pred             CchhHHHHHHHhhCCCCC--eeEEEEEEEeCceEEEEeeeecC
Q 039159           12 PSSMIREVSCLMELNHPN--IIRLMRVASQGIYLYPVFEYQVN   52 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~   52 (259)
                      ..++.+|.++++.+..-+  +.+.+++...++...+|||++.|
T Consensus        36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172        36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            456899999999996433  57888888888888899999998

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.27  E-value=0.0021  Score=50.59  Aligned_cols=30  Identities=23%  Similarity=0.323  Sum_probs=26.1

Q ss_pred             CCceeccCCCCcEEEcC-CCCeEEEeeccccc
Q 039159          101 TRYIRRDLKPVNILVDL-DGKTVKVAGFGLAK  131 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~-~~~~vkl~dfg~~~  131 (259)
                      ..++|+|+.+.||+++. ++ .+.++||..+.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~-~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKN-SVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCC-CEEEEEcccCC
Confidence            47899999999999997 35 79999998874

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.26  E-value=0.00068  Score=52.99  Aligned_cols=98  Identities=15%  Similarity=0.089  Sum_probs=60.2

Q ss_pred             hHHHHHHHhhCC--CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           15 MIREVSCLMELN--HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        15 ~~~Ei~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      ..+|++-|+++.  +=.+.+-+++.    ...|||||....         +...+ ..+..   . ........++.++.
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~---------g~pAP-~LkDv---~-~e~~e~~~~~~~~v  176 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDD---------GLPAP-RLKDV---P-LELEEAEGLYEDVV  176 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCC---------CCCCC-CcccC---C-cCchhHHHHHHHHH
Confidence            347888888885  44555555544    357899997742         00000 11111   0 11113334444455


Q ss_pred             cccccccC-CCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159           93 SSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus        93 ~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ..+.-|-. .++||+||+.=|||+. ++ .+.++|++-+..
T Consensus       177 ~~~~~l~~~a~LVHgDLSEyNiL~~-~~-~p~iID~~QaV~  215 (268)
T COG1718         177 EYMRRLYKEAGLVHGDLSEYNILVH-DG-EPYIIDVSQAVT  215 (268)
T ss_pred             HHHHHHHHhcCcccccchhhheEEE-CC-eEEEEECccccc
Confidence            55555555 7999999999999999 55 799999988854

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.25  E-value=0.0018  Score=51.07  Aligned_cols=32  Identities=28%  Similarity=0.341  Sum_probs=26.2

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ...++|+|+.+.|++++..+ ..-++||+.+..
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~~  194 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGR-LSAVIDFGCLGV  194 (235)
T ss_pred             CceEEeCCCCCCcEEEECCC-EEEEEeCcccCc
Confidence            44689999999999998654 567999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=97.12  E-value=0.0012  Score=61.71  Aligned_cols=41  Identities=17%  Similarity=0.303  Sum_probs=32.9

Q ss_pred             chhHHHHHHHhhCC-CCCe--eEEEEEEEeC---ceEEEEeeeecCC
Q 039159           13 SSMIREVSCLMELN-HPNI--IRLMRVASQG---IYLYPVFEYQVND   53 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~-H~ni--v~~~~~~~~~---~~~~lv~e~~~~~   53 (259)
                      ..+.+|+++++.+. |+++  .+++.++.+.   +..|+||||++|.
T Consensus        83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~  129 (822)
T PLN02876         83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGR  129 (822)
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCc
Confidence            46889999999995 7765  8888887654   3678999999983

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.10  E-value=0.004  Score=47.61  Aligned_cols=96  Identities=21%  Similarity=0.192  Sum_probs=65.0

Q ss_pred             CCchhHHHHHHHhhCC------CCCeeEEEEEEEeCceEEEEeeeec---C----CHHHHhhcCCCCCCCcccccCCCcc
Q 039159           11 VPSSMIREVSCLMELN------HPNIIRLMRVASQGIYLYPVFEYQV---N----DLAYLLKYPKDSMNGYSTKNFNSYS   77 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~------H~niv~~~~~~~~~~~~~lv~e~~~---~----~l~~~~~~~~~~~~~~~~~~~~~~~   77 (259)
                      ......+|+.....+.      +.+|.+++|+.+.+--.-+|+|...   |    ||.+++...                
T Consensus        54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----------------  117 (199)
T PF10707_consen   54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----------------  117 (199)
T ss_pred             hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----------------
Confidence            3567788888877776      8999999999999988888888743   2    466666321                


Q ss_pred             hhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCC--C-eEEEee
Q 039159           78 LFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG--K-TVKVAG  126 (259)
Q Consensus        78 ~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~-~vkl~d  126 (259)
                      .++. .....+...   ..||-+++|+.+|++|.||++...+  . .+.|+|
T Consensus       118 ~~~~-~~~~~L~~f---~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  118 GLTE-ELRQALDEF---KRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CccH-HHHHHHHHH---HHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence            1111 122222111   3666788999999999999997543  2 455665

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.94  E-value=3.4e-05  Score=73.63  Aligned_cols=165  Identities=15%  Similarity=0.038  Sum_probs=108.0

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ++...+-...|...++...|+++...+.=....  ...+..++++. |.+.+.+.......    .....+ ......+ 
T Consensus      1269 sePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~----~~ld~~-~v~~~~k- 1342 (2724)
T KOG1826|consen 1269 SEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES----PDLDRS-PVHLRHK- 1342 (2724)
T ss_pred             hhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC----Ccchhc-hHHHHHH-
Confidence            344455556677777778999998887765433  35688999988 47888875421111    111111 1111111 


Q ss_pred             HHHHhhccccccccc-----CCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCcc
Q 039159           85 VEEFSSSDSSRSLSF-----GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh-----~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (259)
                           +...+..-+|     ++--+|+++|+-|.+|..+. .++++++|+.+.........+...+++.|++|+.... -
T Consensus      1343 -----vsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-i 1415 (2724)
T KOG1826|consen 1343 -----VSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-I 1415 (2724)
T ss_pred             -----HHHhccchhhhcccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-H
Confidence                 1122333333     12357999999999998777 7999999999854333334455678888888887755 5


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFP  185 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~  185 (259)
                      .++.++|+|+.|+.+|....|..+|.
T Consensus      1416 k~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1416 KFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             hhhhHHHHHHHHHHHHHHhcccHHHH
Confidence            67777999999999999988877764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=96.72  E-value=0.0053  Score=53.78  Aligned_cols=104  Identities=15%  Similarity=0.178  Sum_probs=66.3

Q ss_pred             chhHHHHHHHhhC----CCCCeeEEEEEEEe-CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           13 SSMIREVSCLMEL----NHPNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        13 ~~~~~Ei~~l~~l----~H~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      -++.+|+..+.++    .+.--+.+-.+|.+ ...-+|+|||+.| .+.+.........         ....+...-...
T Consensus       206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~---------d~k~ia~~~~~~  276 (517)
T COG0661         206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGI---------DRKELAELLVRA  276 (517)
T ss_pred             hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCC---------CHHHHHHHHHHH
Confidence            3566777777776    34455666666654 3566899999999 6666532211110         001222222222


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL  133 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~  133 (259)
                      .+.|+.       ..|+.|.|..|-||+++.+| ++-+.|||....+
T Consensus       277 f~~q~~-------~dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l  315 (517)
T COG0661         277 FLRQLL-------RDGFFHADPHPGNILVRSDG-RIVLLDFGIVGRL  315 (517)
T ss_pred             HHHHHH-------hcCccccCCCccceEEecCC-cEEEEcCcceecC
Confidence            332322       36999999999999999998 8999999998654

>PLN02236 choline kinase

Probab=96.62  E-value=0.009  Score=49.94  Aligned_cols=33  Identities=18%  Similarity=0.378  Sum_probs=27.1

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ...++|+|+++.||+++..+..+.++||..+..
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            447899999999999986433799999988853

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.90  E-value=0.018  Score=44.56  Aligned_cols=96  Identities=13%  Similarity=0.043  Sum_probs=58.7

Q ss_pred             CCCCCCCCC-CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEG-VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |||++..-. ...-+.++.+++.++.  .|+++..=  +....-+++|.|..-                       ....
T Consensus        91 KKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-----------------------~i~~  143 (308)
T PF07387_consen   91 KKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-----------------------KINF  143 (308)
T ss_pred             hhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc-----------------------ccch
Confidence            556554433 4455677887877764  57777631  222455888887531                       0000


Q ss_pred             HHHHHHHHhhccccccccc--CCCceeccCCCCcEEEcCCCCeEEEeeccc
Q 039159           81 TFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGL  129 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh--~~~i~H~dlkp~Nili~~~~~~vkl~dfg~  129 (259)
                      .    ......+++|.-.|  +.+.+|||..|+||+-|+.| .+||.|=+.
T Consensus       144 ~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G-~lKlVDP~~  189 (308)
T PF07387_consen  144 S----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFG-YLKLVDPVC  189 (308)
T ss_pred             h----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCC-CEEecChhh
Confidence            0    11111123445556  34899999999999999999 799998654

The function of this family is unknown.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.84  E-value=0.02  Score=50.19  Aligned_cols=105  Identities=15%  Similarity=0.142  Sum_probs=59.9

Q ss_pred             chhHHHHHHHhhC----CCCC---eeEEEEEEEeC-ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           13 SSMIREVSCLMEL----NHPN---IIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        13 ~~~~~Ei~~l~~l----~H~n---iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      -+|.+|++-..++    .|-+   =|.+..++.+- ..-+|+|||++| .+.++-.-.+              ..+....
T Consensus       239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--------------~gi~~~~  304 (538)
T KOG1235|consen  239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--------------RGISPHD  304 (538)
T ss_pred             cchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--------------cCCCHHH
Confidence            4566777655554    5666   34455555443 356899999998 3333211110              1111112


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCC---CCeEEEeeccccccc
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLD---GKTVKVAGFGLAKSL  133 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~---~~~vkl~dfg~~~~~  133 (259)
                      +...+.+...  .-+-..|++|.|-.|-||++.++   +..+.+.|||+....
T Consensus       305 i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  305 ILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            2221111111  11224689999999999999942   337899999998754

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.48  E-value=0.012  Score=48.85  Aligned_cols=31  Identities=16%  Similarity=0.264  Sum_probs=25.9

Q ss_pred             CceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       102 ~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      .+.|+|+.+.||+++.++..++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4689999999999976543799999999853

>PRK10593 hypothetical protein; Provisional

Probab=95.31  E-value=0.19  Score=41.10  Aligned_cols=41  Identities=15%  Similarity=-0.004  Sum_probs=32.9

Q ss_pred             CchhHHHHHHHhhCCC---CCeeEEEEEEEeC---ceEEEEeeeecC
Q 039159           12 PSSMIREVSCLMELNH---PNIIRLMRVASQG---IYLYPVFEYQVN   52 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H---~niv~~~~~~~~~---~~~~lv~e~~~~   52 (259)
                      ...+.+|...|+.|.-   -.|.++++++..+   +..++|||+..|
T Consensus        51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            4688999999999953   3688888887543   568999999887

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.16  E-value=0.023  Score=46.57  Aligned_cols=92  Identities=15%  Similarity=0.051  Sum_probs=59.0

Q ss_pred             chhHHHHHHHhhCC-CCC-eeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           13 SSMIREVSCLMELN-HPN-IIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~-H~n-iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      -++.+|...|+.|. |.. |.+.+++    +.-++|||+..| .|.++-+...              .......++.++ 
T Consensus       155 laa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d--------------~~~ly~~lm~~I-  215 (465)
T KOG2268|consen  155 LAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVED--------------PPTLYDDLMGLI-  215 (465)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecCC--------------hHHHHHHHHHHH-
Confidence            35678999999985 322 3344333    355789999887 6665543211              111112222222 


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA  130 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~  130 (259)
                            --|..+|+||+|.+-=||++..++ .+.++||=-.
T Consensus       216 ------v~la~~GlIHgDFNEFNimv~dd~-~i~vIDFPQm  249 (465)
T KOG2268|consen  216 ------VRLANHGLIHGDFNEFNIMVKDDD-KIVVIDFPQM  249 (465)
T ss_pred             ------HHHHHcCceecccchheeEEecCC-CEEEeechHh
Confidence                  233468999999999999999887 7999998543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=94.86  E-value=0.057  Score=41.28  Aligned_cols=87  Identities=14%  Similarity=0.158  Sum_probs=56.9

Q ss_pred             CCchhHHHHHHHhhCC---CCCe--eEEEEEEEeCc------------------eEEEEeeeecCCHHHHhhcCCCCCCC
Q 039159           11 VPSSMIREVSCLMELN---HPNI--IRLMRVASQGI------------------YLYPVFEYQVNDLAYLLKYPKDSMNG   67 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~---H~ni--v~~~~~~~~~~------------------~~~lv~e~~~~~l~~~~~~~~~~~~~   67 (259)
                      ...-|..|-+...+|+   +.++  ++++|+..=..                  ..-+|.||.+..              
T Consensus        97 y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~--------------  162 (207)
T PF13095_consen   97 YADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDD--------------  162 (207)
T ss_pred             hcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCc--------------
Confidence            3457889999999885   4466  99999873210                  123444443321              


Q ss_pred             cccccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccc
Q 039159           68 YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA  130 (259)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~  130 (259)
                               ...    ....+.++.+-+..+|..||+-+|+++.|..   +|   +|+|||.+
T Consensus       163 ---------~~~----~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~G---~lvDfs~~  206 (207)
T PF13095_consen  163 ---------PPL----QIRDIPQMLRDLKILHKLGIVPRDVKPRNYR---GG---KLVDFSSS  206 (207)
T ss_pred             ---------ccc----chhHHHHHHHHHHHHHHCCeeeccCcccccc---CC---EEEecccC
Confidence                     111    2233344445558899999999999999988   33   89999864

>PRK05231 homoserine kinase; Provisional

Probab=94.50  E-value=0.034  Score=45.90  Aligned_cols=32  Identities=25%  Similarity=0.171  Sum_probs=26.4

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ..+++|+|+.|.||+++.+. ..-++||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDR-LSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence            34899999999999998554 457999998853

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=94.38  E-value=0.089  Score=39.30  Aligned_cols=96  Identities=16%  Similarity=0.083  Sum_probs=59.0

Q ss_pred             CCCCchhHHHHHHHhhCCCCCee-EEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNII-RLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv-~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +.-...+..|+++|..+.--++- ++|.+-++    ++.|||..| .|...-...                  .    .+
T Consensus        56 ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~------------------~----rk  109 (201)
T COG2112          56 DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG------------------D----RK  109 (201)
T ss_pred             CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc------------------c----HH
Confidence            44467899999999999866654 44444432    234999998 666655321                  0    01


Q ss_pred             HHhhcccccccccCCCceeccCCC--CcEEEcCCCCeEEEeecccccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKP--VNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp--~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      .+..++...--|-..||-|+.+.-  .|++++ ++ .+.|+||..|+.
T Consensus       110 ~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~  155 (201)
T COG2112         110 HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATF  155 (201)
T ss_pred             HHHHHHHHHHHHHHhccchhhhcCCceeEEec-CC-cEEEEEccchhh
Confidence            111122222233345888888864  366665 54 699999999973

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.37  E-value=0.095  Score=43.77  Aligned_cols=84  Identities=21%  Similarity=0.231  Sum_probs=54.0

Q ss_pred             hHHHHHHHHHhhcccccccccCC-CceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGT-RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG  157 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~-~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (259)
                      ....+.+.++.+-++.++-+... ..-|||+.-+||+|+ .| .|-|+||-+++.....+.     +.....--|..+.|
T Consensus       318 ~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDfklsRl~~~q~~-----isy~rldhp~lF~G  390 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDFKLSRLSYSQGI-----ISYNRLDHPDLFNG  390 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEeeeeecccCCce-----eeccccCchhhhcC
Confidence            33456666666666555555533 778999999999999 77 799999999984322111     11122345666655


Q ss_pred             ccCCCcccchHhHH
Q 039159          158 LLEYSTAVDIWPVG  171 (259)
Q Consensus       158 ~~~~~~~~DiwslG  171 (259)
                        ..+..-+||-+-
T Consensus       391 --~dd~QFeIYrlM  402 (488)
T COG5072         391 --VDDYQFEIYRLM  402 (488)
T ss_pred             --ccceeeeHHHHH
Confidence              235667777763

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.24  E-value=0.033  Score=43.33  Aligned_cols=32  Identities=34%  Similarity=0.402  Sum_probs=21.4

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      ...++|+|+.|.||+++.+++.+.++||+.+.
T Consensus       165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             CcEEEEeccccccceeeeccceeEEEecccce
Confidence            45799999999999999433367899998874

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=94.02  E-value=0.047  Score=44.72  Aligned_cols=30  Identities=23%  Similarity=0.269  Sum_probs=26.2

Q ss_pred             CCceeccCCCCcEEEcCC----CCeEEEeeccccc
Q 039159          101 TRYIRRDLKPVNILVDLD----GKTVKVAGFGLAK  131 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~----~~~vkl~dfg~~~  131 (259)
                      ..++|+|+.+.||+++.+    + .+.++||..+.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~-~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETK-KLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCC-cEEEEeeCCCC
Confidence            478999999999999874    5 79999998884

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=93.83  E-value=0.053  Score=44.55  Aligned_cols=31  Identities=35%  Similarity=0.336  Sum_probs=27.2

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      ..+++|+|+.+.|++++.++ .+.++||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence            36899999999999999876 67899999885

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=93.59  E-value=0.06  Score=43.87  Aligned_cols=30  Identities=33%  Similarity=0.251  Sum_probs=26.2

Q ss_pred             CCceeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159          101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      .+++|+|+.|.|++++.++ .+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            4799999999999999766 67899998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PTZ00384 choline kinase; Provisional

Probab=93.35  E-value=0.17  Score=43.01  Aligned_cols=29  Identities=24%  Similarity=0.189  Sum_probs=24.4

Q ss_pred             CCceeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159          101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      ....|.|+-+.||+.+.+  .++++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence            467899999999998644  59999998885

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.25  E-value=0.085  Score=39.86  Aligned_cols=29  Identities=14%  Similarity=0.290  Sum_probs=24.9

Q ss_pred             CceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       102 ~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ..+|+|+.|.|++++.++  ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            568999999999998665  88999999864

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.74  E-value=0.079  Score=40.92  Aligned_cols=47  Identities=15%  Similarity=-0.014  Sum_probs=30.6

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN   52 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~   52 (259)
                      .||....++..-+-.+|..+++.+. +..-.++++.+..+    .|.+|..|
T Consensus         7 ~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g   54 (211)
T PF01633_consen    7 VRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEG   54 (211)
T ss_dssp             EEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SS
T ss_pred             EEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecc
Confidence            3455556666677889999999995 56667788776443    45687765

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02721 ycfN_thiK thiamine kinase

Probab=92.60  E-value=0.095  Score=41.80  Aligned_cols=29  Identities=21%  Similarity=0.383  Sum_probs=25.3

Q ss_pred             CceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       102 ~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      .++|+|+.|.||+++.++  +.++||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC--CEEEeccccCc
Confidence            689999999999999765  78999998854

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=92.59  E-value=0.12  Score=41.82  Aligned_cols=33  Identities=30%  Similarity=0.423  Sum_probs=26.6

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ...++|+|+.|.||+++.++...-|+||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            346899999999999997553467999999854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=92.23  E-value=0.13  Score=42.29  Aligned_cols=29  Identities=24%  Similarity=0.303  Sum_probs=25.3

Q ss_pred             CCceeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159          101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      .+++|||+.+.|++++. + .+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            58899999999999986 4 58999998774

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=92.09  E-value=0.13  Score=41.34  Aligned_cols=30  Identities=23%  Similarity=0.274  Sum_probs=26.8

Q ss_pred             CceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       102 ~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      -++|+|+.|+|++.+..+ .++|+||..|..
T Consensus       154 v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~  183 (269)
T COG0510         154 VPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL  183 (269)
T ss_pred             eeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence            578999999999999867 799999999853

>KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism]

Probab=91.97  E-value=0.23  Score=40.21  Aligned_cols=123  Identities=14%  Similarity=-0.004  Sum_probs=70.4

Q ss_pred             CCCCCCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCC-------Cccccc--CC
Q 039159            6 NTMEGVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMN-------GYSTKN--FN   74 (259)
Q Consensus         6 ~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~-------~~~~~~--~~   74 (259)
                      -.+++..-+-.+|+...+.|. |..-.++++.|..+    ||+||+.| +|..---.......       ..-...  ..
T Consensus       116 g~~te~vIdre~Ev~afk~L~a~G~ap~Ly~tF~NG----Lvyefi~g~tL~p~~mr~pki~~lIAr~mak~H~~~~~g~  191 (391)
T KOG4720|consen  116 GHNTELVIDRENEVIAFKLLAAYGFAPKLYGTFNNG----LVYEFIQGKTLEPEHMREPKIFRLIARRMAKIHSIVATGG  191 (391)
T ss_pred             cCCCceeeccHHHHHHHHHHHHcCcChhhhheecCc----eEEeeecCcccChhhccChHHHHHHHHHHHHhheeccCCC
Confidence            344555555678999999995 99999999999876    89999998 65432111000000       000000  00


Q ss_pred             CcchhHHHHHHHHHhhccccc-----------------------------ccccCC-CceeccCCCCcEEEcCCCCeEEE
Q 039159           75 SYSLFTTFLLVEEFSSSDSSR-----------------------------SLSFGT-RYIRRDLKPVNILVDLDGKTVKV  124 (259)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~l-----------------------------~~lh~~-~i~H~dlkp~Nili~~~~~~vkl  124 (259)
                      .....-+..+...+..+-...                             .-|.+. -+.|.||=..||+.+..-+.+..
T Consensus       192 ~pkp~lw~km~~f~~lv~~~f~de~~kq~~~~~~~~~~L~~Ei~~l~E~l~~L~sPVVFcHNDLL~~Niiy~~~~~~v~f  271 (391)
T KOG4720|consen  192 NPKPPLWEKMRKFLQLVPTSFEDEINKQNLFDEPSPEDLGEEISKLKEMLSMLKSPVVFCHNDLLCGNIIYDSEKGSVEF  271 (391)
T ss_pred             CCCCcHHHHHHHHHHhcCchhhcccchhhcccCCCHHHHHHHHHHHHHHHHhhCCCeEEeecchhhcceeeccccCcEEE
Confidence            112222333333332222210                             111111 24699999999999987668999


Q ss_pred             eecccccc
Q 039159          125 AGFGLAKS  132 (259)
Q Consensus       125 ~dfg~~~~  132 (259)
                      +||..+..
T Consensus       272 IDYEYa~y  279 (391)
T KOG4720|consen  272 IDYEYAGY  279 (391)
T ss_pred             Eeeccccc
Confidence            99988753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=91.63  E-value=0.29  Score=40.66  Aligned_cols=29  Identities=34%  Similarity=0.397  Sum_probs=25.2

Q ss_pred             ceeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159          103 YIRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus       103 i~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      ++|+|+.|.||+++.++..+.++||+.+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            99999999999999876337899999884

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.29  E-value=0.22  Score=38.06  Aligned_cols=33  Identities=24%  Similarity=0.229  Sum_probs=26.4

Q ss_pred             cCCCceeccCCCCcEEEcCCCC----eEEEeeccccc
Q 039159           99 FGTRYIRRDLKPVNILVDLDGK----TVKVAGFGLAK  131 (259)
Q Consensus        99 h~~~i~H~dlkp~Nili~~~~~----~vkl~dfg~~~  131 (259)
                      +...++|||+.+.|+++..++.    .+.++||..+.
T Consensus       118 ~~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      118 EFNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             CceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            3468899999999999975431    48899998875

subfamily of choline kinases

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=91.24  E-value=0.16  Score=42.09  Aligned_cols=19  Identities=42%  Similarity=0.557  Sum_probs=15.7

Q ss_pred             CCceeccCCCCcEEEcCCC
Q 039159          101 TRYIRRDLKPVNILVDLDG  119 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~~  119 (259)
                      .+.+|-||||+|||+-++.
T Consensus       298 ~nF~H~DLKPdNILiFds~  316 (434)
T PF05445_consen  298 TNFLHVDLKPDNILIFDSK  316 (434)
T ss_pred             ceeeecccCcCcEEEecCC
Confidence            4789999999999995443

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=91.02  E-value=0.14  Score=42.15  Aligned_cols=31  Identities=19%  Similarity=0.083  Sum_probs=27.1

Q ss_pred             CCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      .+++|+|+.+.|++++.++ .+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETR-GGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence            3799999999999998887 789999988853

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=90.73  E-value=0.44  Score=40.08  Aligned_cols=96  Identities=20%  Similarity=0.168  Sum_probs=52.7

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-C-HHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-D-LAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      +.+|++-|++++.-.|. +..-..- ..-+|||+|+.. + -.-.+            +.    ..++...+.....+.+
T Consensus       213 AEKE~RNLkRl~~aGIP-~PePIlL-k~hVLVM~FlGrdgw~aPkL------------Kd----~~ls~~ka~~~Y~~~v  274 (520)
T KOG2270|consen  213 AEKEMRNLKRLNNAGIP-CPEPILL-KNHVLVMEFLGRDGWAAPKL------------KD----ASLSTSKARELYQQCV  274 (520)
T ss_pred             HHHHHHHHHHHHhcCCC-CCCceee-ecceEeeeeccCCCCcCccc------------cc----ccCChHHHHHHHHHHH
Confidence            45788999998876643 2221111 134689999874 1 11111            10    0111111222222222


Q ss_pred             ccccccc-CCCceeccCCCCcEEEcCCCCeEEEeecccc
Q 039159           93 SSRSLSF-GTRYIRRDLKPVNILVDLDGKTVKVAGFGLA  130 (259)
Q Consensus        93 ~~l~~lh-~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~  130 (259)
                      ..+.-|. .+++||.||+-=|+|+- +| +++++|-+-+
T Consensus       275 ~~MR~lY~~c~LVHADLSEfN~Lyh-dG-~lyiIDVSQS  311 (520)
T KOG2270|consen  275 RIMRRLYQKCRLVHADLSEFNLLYH-DG-KLYIIDVSQS  311 (520)
T ss_pred             HHHHHHHHHhceeccchhhhhheEE-CC-EEEEEEcccc
Confidence            2222222 46899999999999996 55 8999997655

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=88.88  E-value=0.48  Score=39.10  Aligned_cols=33  Identities=21%  Similarity=0.286  Sum_probs=28.6

Q ss_pred             cCCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159           99 FGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus        99 h~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      +...++|+|+.+.|++++..+ -+-+.||+.+..
T Consensus       196 ~~~~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         196 GPPVLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             CCceeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            345789999999999999888 588999999864

>PRK06148 hypothetical protein; Provisional

Probab=87.74  E-value=0.52  Score=45.43  Aligned_cols=33  Identities=33%  Similarity=0.420  Sum_probs=26.5

Q ss_pred             CCCceeccCCCCcEEEcCCC--CeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~  132 (259)
                      ..++||+|+.+.||+++.++  ...-|+|||.+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            35799999999999998764  2345999999854

>PHA03111 Ser/Thr kinase; Provisional

Probab=86.96  E-value=0.6  Score=38.64  Aligned_cols=19  Identities=37%  Similarity=0.534  Sum_probs=16.1

Q ss_pred             CCceeccCCCCcEEEcCCC
Q 039159          101 TRYIRRDLKPVNILVDLDG  119 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~~  119 (259)
                      .+.+|-||||+|||+-++.
T Consensus       302 ~nF~H~DLKPdNILiFds~  320 (444)
T PHA03111        302 DNFLHVDLKPDNILIFDSD  320 (444)
T ss_pred             ceeeeccCCCCcEEEecCC
Confidence            4789999999999996554

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=85.85  E-value=0.74  Score=39.33  Aligned_cols=40  Identities=10%  Similarity=-0.049  Sum_probs=29.9

Q ss_pred             CCchhHHHHHHHhhCC---CCCeeEEEEEEEeCceEEEEeeeecC
Q 039159           11 VPSSMIREVSCLMELN---HPNIIRLMRVASQGIYLYPVFEYQVN   52 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~   52 (259)
                      ..+++..|.+.|+.+.   -.++++++.+-  .+..++|||++++
T Consensus        73 ~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lVME~L~~  115 (401)
T PRK09550         73 TLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTVMEDLSD  115 (401)
T ss_pred             cHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEEEecCCC
Confidence            4567888999999873   35678887773  3557899999875

>PRK06149 hypothetical protein; Provisional

Probab=85.58  E-value=0.69  Score=44.43  Aligned_cols=33  Identities=18%  Similarity=0.180  Sum_probs=26.2

Q ss_pred             CCCceeccCCCCcEEEcCCC----CeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDG----KTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~----~~vkl~dfg~~~~  132 (259)
                      ..++||+|+.+.||+++.+.    ...-|+|||.+..
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~  243 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR  243 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence            46899999999999998652    1246999999853

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	259
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-40
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-40
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-40
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-39
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-39
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-39
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-39
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-39
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-39
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-39
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-39
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-39
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-39
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-39
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-39
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-39
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-39
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-39
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-39
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-39
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-39
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-39
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-39
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-39
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-39
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-39
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-39
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-39
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-39
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-39
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-39
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-39
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-39
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-39
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-39
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-39
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-39
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-38
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-38
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-38
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-31
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-31
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-30
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-29
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-29
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-28
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-28
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-28
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-28
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-28
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-28
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-28
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-27
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-27
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-26
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-26
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-26
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-26
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-25
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-25
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-25
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-25
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-25
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-25
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-25
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-25
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-25
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-25
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-25
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-25
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-25
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-25
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-25
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-25
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-25
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-25
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-25
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-25
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-25
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-25
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-25
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-25
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-25
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-25
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-25
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-25
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-25
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-25
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-25
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-25
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-25
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-25
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-25
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-25
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-25
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-25
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-25
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-25
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-25
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-25
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-25
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-25
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-25
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-25
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-25
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-25
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-25
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-25
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-25
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-25
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-25
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-25
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-24
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-24
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-24
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-24
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-24
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-24
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		7e-24
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-23
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-23
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-23
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-23
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-23
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-23
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-22
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-22
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-22
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-22
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-22
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-22
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-22
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-22
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-22
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-22
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-22
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-22
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-22
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-22
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-22
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-22
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-22
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-22
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-22
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-22
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-22
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-22
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-22
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-22
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-22
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-22
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-21
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-21
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-21
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-21
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-21
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-21
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-21
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-21
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-21
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-21
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-21
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-21
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-21
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-21
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-21
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-21
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-21
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-21
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-21
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-21
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-21
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-21
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-21
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-21
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-21
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-21
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-21
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-21
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-21
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-21
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-21
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-21
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-21
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-21
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-21
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-21
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-21
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-21
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-21
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-21
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-21
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-21
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-21
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-21
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-20
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-20
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-20
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-20
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-20
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-20
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-20
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-20
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-20
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-20
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-20
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-20
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-19
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-19
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-19
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-19
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-19
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-19
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-19
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-18
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-17
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-17
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-17
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-17
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		5e-17
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		5e-17
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-17
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-17
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-17
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		6e-17
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		7e-17
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-16
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-16
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-15
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-15
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		6e-15
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		6e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-15
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-15
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		6e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-15
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		6e-15
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		6e-15
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		6e-15
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		6e-15
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-15
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		7e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-15
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		7e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-15
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-15
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		9e-15
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		9e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-13
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-13
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-13
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-12
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-12
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-12
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-12
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-12
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-12
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-12
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-12
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-12
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-12
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-12
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-12
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-12
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-12
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-12
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-12
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-12
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-12
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-12
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-12
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-12
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-12
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-12
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-12
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-12
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-12
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-12
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-12
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-12
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-12
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-12
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-12
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		9e-12
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-11
3soa_A	444	Full-Length Human Camkii Length = 444		2e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-11
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-08
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		5e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-08
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-08
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		5e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-06
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-06
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-06
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-06
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-05
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-05
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-05
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-05
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-05
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-05
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-05
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-05
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-05
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-05
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-05
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-05
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-05
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-05
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-05
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-05
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-05
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-05
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-05
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-05
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-05
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-05
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-05
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-05
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-05
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-05
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-05
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-05
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-05
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-05
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-05
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-05
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-05
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-05
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-05
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-05
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-04
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-04
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-04
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-04
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-04
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-04
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-04
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-04
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-04
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-04
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-04
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-04
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-04
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-04
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-04
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-04
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-04
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-04
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-04
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-04
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-04
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-04
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-04
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-04
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-04
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-04
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-04
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-04
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-04
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-04
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-04
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-04
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-04
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-04
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-04
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-04
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-04
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		9e-04

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 146/261 (55%), Gaps = 30/261 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG+PS+ IRE+S L EL H NI++L  V      L  VFE+   DL  LL   +  +   
Sbjct: 41  EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
           + K+F                            R + RDLKP N+L++ +G+ +K+A FG
Sbjct: 101 TAKSF--------------LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFG 145
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG-- 186
           LA++      + + EV T +Y+AP++L+G  +YST +DIW VGCIF EMV+G PLFPG  
Sbjct: 146 LARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
Query: 187 -ANSLITLGRIVGKSRK---PSFCKLSLRD-HLTNGFP--------GLEPAGIDLISKML 233
            A+ L+ + RI+G       P+  +L   D + T   P        GL+ +GIDL+SKML
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265
Query: 234 GMDPDKRITAAEALQQEYFKD 254
            +DP++RITA +AL+  YFK+
Sbjct: 266 KLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 146/261 (55%), Gaps = 30/261 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG+PS+ IRE+S L EL H NI++L  V      L  VFE+   DL  LL   +  +   
Sbjct: 41  EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
           + K+F                            R + RDLKP N+L++ +G+ +K+A FG
Sbjct: 101 TAKSF--------------LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFG 145
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG-- 186
           LA++      + + EV T +Y+AP++L+G  +YST +DIW VGCIF EMV+G PLFPG  
Sbjct: 146 LARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVS 205
Query: 187 -ANSLITLGRIVGKSRK---PSFCKLSLRD-HLTNGFP--------GLEPAGIDLISKML 233
            A+ L+ + RI+G       P+  +L   D + T   P        GL+ +GIDL+SKML
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265
Query: 234 GMDPDKRITAAEALQQEYFKD 254
            +DP++RITA +AL+  YFK+
Sbjct: 266 KLDPNQRITAKQALEHAYFKE 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  160 bits (404), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 99/261 (37%), Positives = 146/261 (55%), Gaps = 30/261 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG+PS+ IRE+S L EL H NI++L  V      L  VFE+   DL  LL   +  +   
Sbjct: 41  EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
           + K+F                            R + RDLKP N+L++ +G+ +K+A FG
Sbjct: 101 TAKSF--------------LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFG 145
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG-- 186
           LA++      + + E+ T +Y+AP++L+G  +YST +DIW VGCIF EMV+G PLFPG  
Sbjct: 146 LARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
Query: 187 -ANSLITLGRIVGKSRK---PSFCKLSLRD-HLTNGFP--------GLEPAGIDLISKML 233
            A+ L+ + RI+G       P+  +L   D + T   P        GL+ +GIDL+SKML
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265
Query: 234 GMDPDKRITAAEALQQEYFKD 254
            +DP++RITA +AL+  YFK+
Sbjct: 266 KLDPNQRITAKQALEHAYFKE 286

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 101 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 148
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 267
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 268 LHYDPNKRISAKAALAHPFFQDV 290

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 101 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 148
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 267
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 268 LHYDPNKRISAKAALAHPFFQDV 290

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 99
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 100 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 147
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 266
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 267 LHYDPNKRISAKAALAHPFFQDV 289

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 101 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 148
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 267
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 268 LHYDPNKRISAKAALAHPFFQDV 290

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 99
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 100 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 147
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 266
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 267 LHYDPNKRISAKAALAHPFFQDV 289

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 101 PLPLIKSY----LFQLLQGLSFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 148
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 267
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 268 LHYDPNKRISAKAALAHPFFQDV 290

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 101
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 102 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 149
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 150 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 268
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 269 LHYDPNKRISAKAALAHPFFQDV 291

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 99
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 100 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 147
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 266
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 267 LHYDPNKRISAKAALAHPFFQDV 289

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMD--ASALTGI 99
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 100 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 147
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 266
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 267 LHYDPNKRISAKAALAHPFFQDV 289

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 101 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 148
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 149 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 267
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 268 LHYDPNKRISAKAALAHPFFQDV 290

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 47  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 104
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 105 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 152
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 153 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 213 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 271
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 272 LHYDPNKRISAKAALAHPFFQDV 294

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 50  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 107
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 108 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 155
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 156 LARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 215
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 216 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 274
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 275 LHYDPNKRISAKAALAHPFFQDV 297

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 141/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 50  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 107
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 108 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 155
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 156 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 215
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 216 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 274
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 275 LHYDPNKRISAKAALAHPFFQDV 297

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  158 bits (399), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 99
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 100 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 147
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 148 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 266
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 267 LHYDPNKRISAKAALAHPFFQDV 289

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  158 bits (399), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 101 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 148
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 267
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 268 LHYDPNKRISAKAALAHPFFQDV 290

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  158 bits (399), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 101 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 148
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 267
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 268 LHYDPNKRISAKAALAHPFFQDV 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 99
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 100 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 147
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 148 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 266
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 267 LHYDPNKRISAKAALAHPFFQDV 289

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 101
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 102 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 149
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 268
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 269 LHYDPNKRISAKAALAHPFFQDV 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 101 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 148
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 267
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 268 LHYDPNKRISAKAALAHPFFQDV 290

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 103
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 104 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 151
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 270
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 271 LHYDPNKRISAKAALAHPFFQDV 293

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 45  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 102
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 103 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 150
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 269
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 270 LHYDPNKRISAKAALAHPFFQDV 292

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMD--ASALTGI 103
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 104 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 151
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 270
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 271 LHYDPNKRISAKAALAHPFFQDV 293

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 101
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 102 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 149
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 268
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 269 LHYDPNKRISAKAALAHPFFQDV 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 103
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 104 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 151
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 270
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 271 LHYDPNKRISAKAALAHPFFQDV 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 47  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 104
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 105 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 152
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 153 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 213 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 271
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 272 LHYDPNKRISAKAALAHPFFQDV 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 45  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 102
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 103 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 150
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 269
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 270 LHYDPNKRISAKAALAHPFFQDV 292

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  157 bits (397), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 45  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 102
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 103 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPENLLINTEG-AIKLADFG 150
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 269
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 270 LHYDPNKRISAKAALAHPFFQDV 292

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  157 bits (397), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 101
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 102 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPENLLINTEG-AIKLADFG 149
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 268
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 269 LHYDPNKRISAKAALAHPFFQDV 291

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  157 bits (397), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMD--ASALTGI 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 101 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPENLLINTEG-AIKLADFG 148
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 267
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 268 LHYDPNKRISAKAALAHPFFQDV 290

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  157 bits (397), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMD--ASALTGI 103
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 104 PLPLIKSY----LFQLLQGLAFC-------HSHRVLHRDLKPQNLLINTEG-AIKLADFG 151
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 270
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 271 LHYDPNKRISAKAALAHPFFQDV 293

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  157 bits (396), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMD--ASALTGI 101
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 102 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPENLLINTEG-AIKLADFG 149
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 150 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 209
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 210 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 268
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 269 LHYDPNKRISAKAALAHPFFQDV 291

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  157 bits (396), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMD--ASALTGI 103
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 104 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPENLLINTEG-AIKLADFG 151
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 270
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 271 LHYDPNKRISAKAALAHPFFQDV 293

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  156 bits (395), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 45  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMD--ASALTGI 102
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 103 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 150
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 151 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 210
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 211 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 269
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 270 LHYDPNKRISAKAALAHPFFQDV 292

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  156 bits (395), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 102/263 (38%), Positives = 140/263 (53%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMD--ASALTGI 103
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 104 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 151
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 152 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 211
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 212 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 270
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A  AL   +F+DV
Sbjct: 271 LHYDPNKRISAKAALAHPFFQDV 293

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 98/263 (37%), Positives = 137/263 (52%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG+PS+ IRE+S L EL+HPNI+ L+ V      L  VFE+   DL  +L   K  +   
Sbjct: 60  EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS 119
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K +  Y L        +              R + RDLKP N+L++ DG  +K+A FG
Sbjct: 120 QIKIY-LYQLLRGVAHCHQH-------------RILHRDLKPQNLLINSDG-ALKLADFG 164
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+AP++L+G  +YST+VDIW +GCIF EM++GKPLFPG  
Sbjct: 165 LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224
Query: 189 SLITLGRIV------GKSRKPSFCKLSLRDHLT----------NGFPGLEPAGIDLISKM 232
               L +I            P   +L L    T          +  PG    GIDL+S M
Sbjct: 225 DDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNM 284
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A +A+   YFKD+
Sbjct: 285 LCFDPNKRISARDAMNHPYFKDL 307

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 98/263 (37%), Positives = 137/263 (52%), Gaps = 31/263 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG+PS+ IRE+S L EL+HPNI+ L+ V      L  VFE+   DL  +L   K  +   
Sbjct: 60  EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS 119
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K +  Y L        +              R + RDLKP N+L++ DG  +K+A FG
Sbjct: 120 QIKIY-LYQLLRGVAHCHQH-------------RILHRDLKPQNLLINSDG-ALKLADFG 164
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+AP++L+G  +YST+VDIW +GCIF EM++GKPLFPG  
Sbjct: 165 LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224
Query: 189 SLITLGRIV------GKSRKPSFCKLSLRDHLT----------NGFPGLEPAGIDLISKM 232
               L +I            P   +L L    T          +  PG    GIDL+S M
Sbjct: 225 DDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNM 284
Query: 233 LGMDPDKRITAAEALQQEYFKDV 255
           L  DP+KRI+A +A+   YFKD+
Sbjct: 285 LCFDPNKRISARDAMNHPYFKDL 307

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/262 (38%), Positives = 139/262 (53%), Gaps = 31/262 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY     F L++               R + RDLKP N+L++ +G  +K+A FG
Sbjct: 101 PLPLIKSY----LFQLLQGLAFCH-------SHRVLHRDLKPQNLLINTEG-AIKLADFG 148
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 149 LARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 208
Query: 189 SLITLGRIVGK----------------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + +D  +   P L+  G  L+S+M
Sbjct: 209 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD-FSKVVPPLDEDGRSLLSQM 267
Query: 233 LGMDPDKRITAAEALQQEYFKD 254
           L  DP+KRI+A  AL   +F+D
Sbjct: 268 LHYDPNKRISAKAALAHPFFQD 289

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 130/263 (49%), Gaps = 33/263 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPSS +RE+  L EL H NI+RL  V      L  VFE+   DL        DS NG 
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGD 97
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYI-RRDLKPVNILVDLDGKTVKVAGF 127
                          +V+ F            +R +  RDLKP N+L++ +G+ +K+A F
Sbjct: 98  LDPE-----------IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANF 145
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV-SGKPLFPG 186
           GLA++        SAEV T +Y+ P++L G   YST++D+W  GCIF E+  +G+PLFPG
Sbjct: 146 GLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205
Query: 187 ANSLITLGRIV------GKSRKPSFCKL---------SLRDHLTNGFPGLEPAGIDLISK 231
            +    L RI        + + PS  KL              L N  P L   G DL+  
Sbjct: 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265
Query: 232 MLGMDPDKRITAAEALQQEYFKD 254
           +L  +P +RI+A EALQ  YF D
Sbjct: 266 LLKCNPVQRISAEEALQHPYFSD 288

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  130 bits (328), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 94/263 (35%), Positives = 129/263 (49%), Gaps = 33/263 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPSS +RE+  L EL H NI+RL  V      L  VFE+   DL        DS NG 
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGD 97
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYI-RRDLKPVNILVDLDGKTVKVAGF 127
                          +V+ F            +R +  RDLKP N+L++ +G+ +K+A F
Sbjct: 98  LDPE-----------IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLADF 145
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV-SGKPLFPG 186
           GLA++        SAEV T +Y+ P++L G   YST++D+W  GCIF E+  + +PLFPG
Sbjct: 146 GLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPG 205
Query: 187 ANSLITLGRIV------GKSRKPSFCKL---------SLRDHLTNGFPGLEPAGIDLISK 231
            +    L RI        + + PS  KL              L N  P L   G DL+  
Sbjct: 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265
Query: 232 MLGMDPDKRITAAEALQQEYFKD 254
           +L  +P +RI+A EALQ  YF D
Sbjct: 266 LLKCNPVQRISAEEALQHPYFSD 288

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  127 bits (318), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 132/271 (48%), Gaps = 34/271 (12%)
Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
           ++ EG PS+ IRE+S + EL H NI+RL  V      L  VFE+  NDL    KY     
Sbjct: 41  DSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLK---KYMDSRT 97
Query: 66  NGYSTK--NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVK 123
            G + +    N    F   LL                 + + RDLKP N+L++  G+ +K
Sbjct: 98  VGNTPRGLELNLVKYFQWQLL--------QGLAFCHENKILHRDLKPQNLLINKRGQ-LK 148
Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
           +  FGLA++        S+EV T +Y+AP++L+G   YST++DIW  GCI  EM++GKPL
Sbjct: 149 LGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPL 208
Query: 184 FPGANSLITLGRIV------GKSRKPSFCKLSLRDHLTNGFPG------LEPAG------ 225
           FPG N    L  I        +S  PS  KL   +      P       L+P        
Sbjct: 209 FPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDG 268
Query: 226 --IDLISKMLGMDPDKRITAAEALQQEYFKD 254
             +D +  +L ++PD R++A +AL   +F +
Sbjct: 269 NLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 90/265 (33%), Positives = 134/265 (50%), Gaps = 33/265 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           +G+  + +RE+  L EL+HPNII L+        +  VF++   DL  ++K   D+    
Sbjct: 53  DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVL 109
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
           +  +  +Y L T   L  E+               + RDLKP N+L+D +G  +K+A FG
Sbjct: 110 TPSHIKAYMLMTLQGL--EYLHQHW---------ILHRDLKPNNLLLDENG-VLKLADFG 157
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LAKS  +       +V T +Y+APELL G   Y   VD+W VGCI  E++   P  PG +
Sbjct: 158 LAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217
Query: 189 SLITLGRIV------GKSRKPSFCKLSLRDHLT-NGFPGL------EPAGIDLISKMLGM 235
            L  L RI        + + P  C  SL D++T   FPG+        AG DL+  + G+
Sbjct: 218 DLDQLTRIFETLGTPTEEQWPDMC--SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGL 275
Query: 236 ---DPDKRITAAEALQQEYFKDVPG 257
              +P  RITA +AL+ +YF + PG
Sbjct: 276 FLFNPCARITATQALKMKYFSNRPG 300

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 89/265 (33%), Positives = 126/265 (47%), Gaps = 37/265 (13%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLA-YLLKYPKDSMNG 67
           EGVP + IREVS L EL H NII L  V      L+ +FEY  NDL  Y+ K P  SM  
Sbjct: 74  EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMR- 132
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKT----VK 123
              K+F  Y L                       R + RDLKP N+L+ +   +    +K
Sbjct: 133 -VIKSF-LYQLINGVNFCH-------------SRRCLHRDLKPQNLLLSVSDASETPVLK 177
Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
           +  FGLA++      + + E+ T +Y+ PE+LLG   YST+VDIW + CI+ EM+   PL
Sbjct: 178 IGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPL 237
Query: 184 FPGANSLITLGRI---VGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLI----------- 229
           FPG + +  L +I   +G     ++  ++        FP      +  +           
Sbjct: 238 FPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLD 297
Query: 230 --SKMLGMDPDKRITAAEALQQEYF 252
             + ML MDP KRI+A  AL+  YF
Sbjct: 298 LLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 98/271 (36%), Positives = 132/271 (48%), Gaps = 39/271 (14%)
Query: 4   IHNTMEGVPSSMIREVSCLMELN---HPNIIRLMRVAS-----QGIYLYPVFEYQVNDL- 54
           + N  EG+P S +REV+ L  L    HPN++RLM V +     + I +  VFE+   DL 
Sbjct: 39  VPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLR 98
Query: 55  AYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL 114
            YL K P   +   + K+     L   FL   +F               + RDLKP NIL
Sbjct: 99  TYLDKAPPPGLPAETIKD-----LMRQFLRGLDFL---------HANCIVHRDLKPENIL 144
Query: 115 VDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIF 174
           V   G TVK+A FGLA+ +Y+Y+   +  V T +Y+APE+LL    Y+T VD+W VGCIF
Sbjct: 145 V-TSGGTVKLADFGLAR-IYSYQMALAPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIF 201
Query: 175 GEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG-------------FPGL 221
            EM   KPLF G +    LG+I      P          L  G              P +
Sbjct: 202 AEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEM 261
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           E +G  L+ +ML  +P KRI+A  ALQ  Y 
Sbjct: 262 EESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 98/271 (36%), Positives = 131/271 (48%), Gaps = 39/271 (14%)
Query: 4   IHNTMEGVPSSMIREVSCLMELN---HPNIIRLMRVAS-----QGIYLYPVFEYQVNDL- 54
           + N  EG+P S +REV+ L  L    HPN++RLM V +     + I +  VFE+   DL 
Sbjct: 39  VPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLR 98
Query: 55  AYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL 114
            YL K P   +   + K+     L   FL   +F               + RDLKP NIL
Sbjct: 99  TYLDKAPPPGLPAETIKD-----LMRQFLRGLDFL---------HANCIVHRDLKPENIL 144
Query: 115 VDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIF 174
           V   G TVK+A FGLA+ +Y+Y+      V T +Y+APE+LL    Y+T VD+W VGCIF
Sbjct: 145 V-TSGGTVKLADFGLAR-IYSYQMALDPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIF 201
Query: 175 GEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG-------------FPGL 221
            EM   KPLF G +    LG+I      P          L  G              P +
Sbjct: 202 AEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEM 261
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           E +G  L+ +ML  +P KRI+A  ALQ  Y 
Sbjct: 262 EESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 126/261 (48%), Gaps = 34/261 (13%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLK-YPKDSMNGYS 69
           V    +RE+  L +L H N++ L+ V  +    Y VFE+  + +   L+ +P    NG  
Sbjct: 67  VKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP----NGLD 122
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
            +    Y LF                        I RD+KP NILV   G  VK+  FG 
Sbjct: 123 YQVVQKY-LFQII----------NGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGF 170
Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
           A++L A       EV T +Y+APELL+G ++Y  AVD+W +GC+  EM  G+PLFPG + 
Sbjct: 171 ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230
Query: 190 -------LITLGRIVGK-----SRKPSFCKLSL-----RDHLTNGFPGLEPAGIDLISKM 232
                  ++ LG ++ +     ++ P F  + L     R+ L   +P L    IDL  K 
Sbjct: 231 IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKC 290
Query: 233 LGMDPDKRITAAEALQQEYFK 253
           L +DPDKR   AE L  ++F+
Sbjct: 291 LHIDPDKRPFCAELLHHDFFQ 311

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 95/269 (35%), Positives = 138/269 (51%), Gaps = 39/269 (14%)
Query: 9   EGVPSSMIREVSCLMELN---HPNIIRLMRVAS-----QGIYLYPVFEYQVNDLA-YLLK 59
           EG+P S IREV+ L  L    HPN++RL  V +     +   L  VFE+   DL  YL K
Sbjct: 52  EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK 111
Query: 60  YPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDG 119
            P+  +   + K+         F L+                R + RDLKP NILV   G
Sbjct: 112 VPEPGVPTETIKDM-------MFQLLRGLDFL-------HSHRVVHRDLKPQNILVTSSG 157
Query: 120 KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           + +K+A FGLA+ +Y+++   ++ V T +Y+APE+LL    Y+T VD+W VGCIF EM  
Sbjct: 158 Q-IKLADFGLAR-IYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFR 214
Query: 180 GKPLFPGANSLITLGRIV------GKSRKPSFCKLSLRD-HLTNGFP------GLEPAGI 226
            KPLF G++ +  LG+I+      G+   P    L  +  H  +  P       ++  G 
Sbjct: 215 RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK 274
Query: 227 DLISKMLGMDPDKRITAAEALQQEYFKDV 255
           DL+ K L  +P KRI+A  AL   YF+D+
Sbjct: 275 DLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  122 bits (305), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 94/274 (34%), Positives = 139/274 (50%), Gaps = 39/274 (14%)
Query: 4   IHNTMEGVPSSMIREVSCLMELN---HPNIIRLMRVAS-----QGIYLYPVFEYQVNDLA 55
           +    EG+P S IREV+ L  L    HPN++RL  V +     +   L  VFE+   DL 
Sbjct: 47  VQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT 106
Query: 56  -YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL 114
            YL K P+  +   + K+   + L      +                R + RDLKP NIL
Sbjct: 107 TYLDKVPEPGVPTETIKDM-MFQLLRGLDFLH-------------SHRVVHRDLKPQNIL 152
Query: 115 VDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIF 174
           V   G+ +K+A FGLA+ +Y+++   ++ V T +Y+APE+LL    Y+T VD+W VGCIF
Sbjct: 153 VTSSGQ-IKLADFGLAR-IYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIF 209
Query: 175 GEMVSGKPLFPGANSLITLGRIV------GKSRKPSFCKLSLRD-HLTNGFP------GL 221
            EM   KPLF G++ +  LG+I+      G+   P    L  +  H  +  P       +
Sbjct: 210 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 269
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  G DL+ K L  +P KRI+A  AL   YF+D+
Sbjct: 270 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 98/271 (36%), Positives = 131/271 (48%), Gaps = 39/271 (14%)
Query: 4   IHNTMEGVPSSMIREVSCLMELN---HPNIIRLMRVAS-----QGIYLYPVFEYQVNDL- 54
           + N  EG+P S +REV+ L  L    HPN++RLM V +     + I +  VFE+   DL 
Sbjct: 39  VPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLR 98
Query: 55  AYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL 114
            YL K P   +   + K+     L   FL   +F               + RDLKP NIL
Sbjct: 99  TYLDKAPPPGLPAETIKD-----LMRQFLRGLDFL---------HANCIVHRDLKPENIL 144
Query: 115 VDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIF 174
           V   G TVK+A FGLA+ +Y+Y+      V T +Y+APE+LL    Y+T VD+W VGCIF
Sbjct: 145 V-TSGGTVKLADFGLAR-IYSYQMALFPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIF 201
Query: 175 GEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG-------------FPGL 221
            EM   KPLF G +    LG+I      P          L  G              P +
Sbjct: 202 AEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEM 261
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           E +G  L+ +ML  +P KRI+A  ALQ  Y 
Sbjct: 262 EESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 131/260 (50%), Gaps = 31/260 (11%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG P + IREVS L +L H NI+ L  +      L  VFEY   DL    +Y  D  N  
Sbjct: 41  EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLK---QYLDDCGN-- 95
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
              N ++  LF   LL                 + + RDLKP N+L++  G+ +K+A FG
Sbjct: 96  -IINMHNVKLFLFQLL--------RGLAYCHRQKVLHRDLKPQNLLINERGE-LKLADFG 145
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++          EV T +Y+ P++LLG  +YST +D+W VGCIF EM +G+PLFPG+ 
Sbjct: 146 LARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205
Query: 189 ---SLITLGRIVGKSRKPSFCKLSLRDH-------------LTNGFPGLEPAGIDLISKM 232
               L  + RI+G   + ++  +   +              L +  P L+  G DL++K+
Sbjct: 206 VEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKL 265
Query: 233 LGMDPDKRITAAEALQQEYF 252
           L  +   RI+A +A++  +F
Sbjct: 266 LQFEGRNRISAEDAMKHPFF 285

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 137/272 (50%), Gaps = 39/272 (14%)
Query: 4   IHNTMEGVPSSMIREVSCLMELN---HPNIIRLMRVAS-----QGIYLYPVFEYQVNDLA 55
           +    EG+P S IREV+ L  L    HPN++RL  V +     +   L  VFE+   DL 
Sbjct: 47  VQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT 106
Query: 56  -YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL 114
            YL K P+  +   + K+   + L      +                R + RDLKP NIL
Sbjct: 107 TYLDKVPEPGVPTETIKDM-MFQLLRGLDFLH-------------SHRVVHRDLKPQNIL 152
Query: 115 VDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIF 174
           V   G+ +K+A FGLA+ +Y+++   ++ V T +Y+APE+LL    Y+T VD+W VGCIF
Sbjct: 153 VTSSGQ-IKLADFGLAR-IYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIF 209
Query: 175 GEMVSGKPLFPGANSLITLGRIV------GKSRKPSFCKLSLRD-HLTNGFP------GL 221
            EM   KPLF G++ +  LG+I+      G+   P    L  +  H  +  P       +
Sbjct: 210 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 269
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           +  G DL+ K L  +P KRI+A  AL   YF+
Sbjct: 270 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 95/264 (35%), Positives = 128/264 (48%), Gaps = 39/264 (14%)
Query: 11  VPSSMIREVSCLMELN---HPNIIRLMRVAS-----QGIYLYPVFEYQVNDL-AYLLKYP 61
           +P S +REV+ L  L    HPN++RLM V +     + I +  VFE+   DL  YL K P
Sbjct: 54  LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP 113
Query: 62  KDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKT 121
              +   + K+     L   FL   +F               + RDLKP NILV   G T
Sbjct: 114 PPGLPAETIKD-----LMRQFLRGLDFL---------HANCIVHRDLKPENILVT-SGGT 158
Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
           VK+A FGLA+ +Y+Y+   +  V T +Y+APE+LL    Y+T VD+W VGCIF EM   K
Sbjct: 159 VKLADFGLAR-IYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRK 216
Query: 182 PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG-------------FPGLEPAGIDL 228
           PLF G +    LG+I      P          L  G              P +E +G  L
Sbjct: 217 PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQL 276
Query: 229 ISKMLGMDPDKRITAAEALQQEYF 252
           + +ML  +P KRI+A  ALQ  Y 
Sbjct: 277 LLEMLTFNPHKRISAFRALQHSYL 300

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 66/166 (39%), Positives = 94/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+ GFGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILGFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  114 bits (284), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 153 IHRDLKPSNLAVNEDSE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 268
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 269 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 149 IHRDLKPSNLAVNEDSE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 264
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 265 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGXVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 153 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 268
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 269 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDXE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 153 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 268
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 269 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 153 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 268
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 269 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 152 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 267
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 268 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 152 IHRDLKPSNLAVNEDXE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 267
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 268 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 152 IHRDLKPSNLAVNEDXE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 267
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 268 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 158 IHRDLKPSNLAVNEDXE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 213
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 214 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 273
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 274 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 154 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---ADEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 92/166 (55%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 176 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNM 231
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGA---NSLITLGRIVGK------SRKPSFCKLSL---- 210
            VDIW VGCI  E+++G+ LFPG    N L  + R+ G       SR PS    +     
Sbjct: 232 TVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSL 291
Query: 211 ----RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               + +  + F G  P  +DL+ KML +D DKRITA+EAL   YF
Sbjct: 292 PQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYF 337

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 154 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 152 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 267
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 268 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 146 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 201
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 202 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 261
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 262 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 307

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 154 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---ADEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 157 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 212
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 213 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 272
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 273 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 318

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 154 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---ADEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 149 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 264
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 265 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/166 (37%), Positives = 92/166 (55%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +++  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 153 IHRDLKPSNVAVNEDSE-LRILDFGLARQA---DEEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRI---VGKSRKPSFCKLSL---------- 210
            VDIW VGCI  E++ GK LFPG++ +  L RI   VG        K+S           
Sbjct: 209 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSL 268
Query: 211 ----RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               +  L++ F G  P  IDL+ +ML +D D+R++AAEAL   YF
Sbjct: 269 PPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/166 (37%), Positives = 92/166 (55%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +++  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 153 IHRDLKPSNVAVNEDSE-LRILDFGLARQA---DEEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRI---VGKSRKPSFCKLSL---------- 210
            VDIW VGCI  E++ GK LFPG++ +  L RI   VG        K+S           
Sbjct: 209 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSL 268
Query: 211 ----RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               +  L++ F G  P  IDL+ +ML +D D+R++AAEAL   YF
Sbjct: 269 PPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 143 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 259 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 143 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 259 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 149 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 264
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 265 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 144 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 199
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 200 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 259
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 260 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 144 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 199
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 200 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 259
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 260 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 159 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 214
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 215 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 274
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 275 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 159 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 214
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 215 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 274
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 275 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 143 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 259 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 159 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 214
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 215 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 274
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 275 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNAMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 158 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 213
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 214 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 273
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 274 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 145 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 200
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 201 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 260
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 261 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 306

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 149 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 264
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 265 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 170 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 225
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 226 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 285
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 286 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 166 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 221
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 222 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 281
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 282 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 167 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 222
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 282
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 283 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 167 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 222
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 282
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 283 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 166 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 221
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 222 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 281
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 282 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 92/166 (55%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E    V T +Y+APE++L  + Y+ 
Sbjct: 167 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMXGXVATRWYRAPEIMLNWMHYNQ 222
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 282
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 283 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMAGFVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMAGFVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 143 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMAGFVATRWYRAPEIMLNWMHYNQ 198
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 259 AQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 65/166 (39%), Positives = 92/166 (55%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGLA+       E    V T +Y+APE++L  + Y+ 
Sbjct: 170 IHRDLKPSNLAVNEDCE-LKILDFGLARHT---DDEMXGYVATRWYRAPEIMLNWMHYNQ 225
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 226 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 285
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 286 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 63/166 (37%), Positives = 92/166 (55%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +++  FGLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 145 IHRDLKPSNVAVNEDCE-LRILDFGLARQA---DEEMTGYVATRWYRAPEIMLNWMHYNQ 200
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRI---VGKSRKPSFCKLSL---------- 210
            VDIW VGCI  E++ GK LFPG++ +  L RI   VG        K+S           
Sbjct: 201 TVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSL 260
Query: 211 ----RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               +  L++ F G  P  IDL+ +ML +D D+R++AAEAL   YF
Sbjct: 261 PPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 306

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 64/166 (38%), Positives = 92/166 (55%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  FGL +       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDSE-LKILDFGLCRHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 64/166 (38%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  +GLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDYGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 121/266 (45%), Gaps = 55/266 (20%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYL------YPVFEYQVNDLAYLLKYPKDSMNGYST 70
           RE+  L  + H N+I L+ V +    L      Y V  +   DL  L+K+ K    G   
Sbjct: 73  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDR 129
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
             F  Y +                     G RYI       RDLKP N+ V+ D + +K+
Sbjct: 130 IQFLVYQMLK-------------------GLRYIHAAGIIHRDLKPGNLAVNEDCE-LKI 169
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
             FGLA+       E    V T +Y+APE++L  + Y+  VDIW VGCI  EM++GK LF
Sbjct: 170 LDFGLARQA---DSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
Query: 185 PGANSLITLGRIVGKSRKP--SFCKLSLRDHLTN---GFPGLE------------PAGID 227
            G++ L  L  I+  +  P   F +    D   N   G P LE            P  ++
Sbjct: 227 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVN 286
Query: 228 LISKMLGMDPDKRITAAEALQQEYFK 253
           L+ KML +D ++R+TA EAL   YF+
Sbjct: 287 LLEKMLVLDAEQRVTAGEALAHPYFE 312

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/166 (38%), Positives = 92/166 (55%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+  F LA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDFYLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/166 (38%), Positives = 92/166 (55%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+   GLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDAGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 64/166 (38%), Positives = 92/166 (55%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+   GLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDRGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 64/166 (38%), Positives = 92/166 (55%), Gaps = 21/166 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+ V+ D + +K+   GLA+       E +  V T +Y+APE++L  + Y+ 
Sbjct: 147 IHRDLKPSNLAVNEDCE-LKILDGGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLG---RIVGKSRKPSFCKL---SLRDHL--- 214
            VDIW VGCI  E+++G+ LFPG + +  L    R+VG        K+   S R+++   
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 262
Query: 215 --------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                    N F G  P  +DL+ KML +D DKRITAA+AL   YF
Sbjct: 263 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 36/259 (13%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           +RE+  L +L HPN++ L+ V  +   L+ VFEY  + + + L   +  +  +  K+   
Sbjct: 50  LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW 109
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRY--IRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
            +L                    F  ++  I RD+KP NIL+      +K+  FG A+ L
Sbjct: 110 QTL----------------QAVNFCHKHNCIHRDVKPENILI-TKHSVIKLCDFGFARLL 152
Query: 134 YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL--- 190
                    EV T +Y++PELL+G  +Y   VD+W +GC+F E++SG PL+PG + +   
Sbjct: 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212
Query: 191 ----ITLGRIVGKSRK-----PSFCKLSLRD-----HLTNGFPGLEPAGIDLISKMLGMD 236
                TLG ++ + ++       F  + + D      L   FP +    + L+   L MD
Sbjct: 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMD 272
Query: 237 PDKRITAAEALQQEYFKDV 255
           P +R+T  + L   YF+++
Sbjct: 273 PTERLTCEQLLHHPYFENI 291

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 60/166 (36%), Positives = 89/166 (53%), Gaps = 22/166 (13%)
Query: 105 RRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA 164
            RD+KP N+LV+    T+K+  FG AK L   +  S A + + +Y+APEL+LG  EY+ +
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAXICSRFYRAPELMLGATEYTPS 222
Query: 165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG------------------KSRKPSFC 206
           +D+W +GC+FGE++ GKPLF G  S+  L RI+                   + R P+  
Sbjct: 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282
Query: 207 KLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               R  L  G P L    IDL+ ++L  +PD RI   EA+   +F
Sbjct: 283 AKDWRKILPEGTPSL---AIDLLEQILRYEPDLRINPYEAMAHPFF 325

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 64/167 (38%), Positives = 91/167 (54%), Gaps = 21/167 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP N+ V+ D + +K+  FGLA+   A   E +  V T +Y+APE++L  + Y+ 
Sbjct: 148 VHRDLKPGNLAVNEDCE-LKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQ 203
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV---------------GKSRKPSFCKL 208
            VDIW VGCI  EM++GK LF G + L  L +I+                K+ K     L
Sbjct: 204 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 263
Query: 209 --SLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
             + R   T  FP   P   DL+ KML +D DKR+TAA+AL   +F+
Sbjct: 264 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/167 (38%), Positives = 91/167 (54%), Gaps = 21/167 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP N+ V+ D + +K+  FGLA+   A   E +  V T +Y+APE++L  + Y+ 
Sbjct: 166 VHRDLKPGNLAVNEDCE-LKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQ 221
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV---------------GKSRKPSFCKL 208
            VDIW VGCI  EM++GK LF G + L  L +I+                K+ K     L
Sbjct: 222 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 281
Query: 209 --SLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
             + R   T  FP   P   DL+ KML +D DKR+TAA+AL   +F+
Sbjct: 282 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 53/291 (18%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
           G+  S  RE++ L EL HPN+I L +V    A + ++L  +F+Y  +DL +++K+ + S 
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL--LFDYAEHDLWHIIKFHRAS- 116
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYI-RRDLKPVNILVDLDGKT--- 121
                   N   +     +V+                ++  RDLKP NILV  +G     
Sbjct: 117 ------KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170
Query: 122 VKVAGFGLAK---SLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           VK+A  G A+   S      +    V T +Y+APELLLG   Y+ A+DIW +GCIF E++
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230
Query: 179 SGKPLFPGANSLI---------TLGRI------------------------VGKSRKPSF 205
           + +P+F      I          L RI                        +   R+ ++
Sbjct: 231 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 290
Query: 206 CKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
              SL  ++       +     L+ K+L MDP KRIT+ +A+Q  YF + P
Sbjct: 291 TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 122/271 (45%), Gaps = 50/271 (18%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIY-----LYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L    H NII +  +     +     +Y + E    DL  ++     S    S 
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSD 111
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
            +   Y ++ T   V+             G+  I RDLKP N+L++ +   +KV  FGLA
Sbjct: 112 DHIQ-YFIYQTLRAVK----------VLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLA 159
Query: 131 KSLYAYKGESSAEVG----------THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
           + +     ++S   G          T +Y+APE++L   +YS A+D+W  GCI  E+   
Sbjct: 160 RIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
Query: 181 KPLFPGAN---SLITLGRIVG--KSRKPSFCKLSLRDH-------------LTNGFPGLE 222
           +P+FPG +    L+ +  I+G   S     C  S R               L   FP + 
Sbjct: 220 RPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVN 279
Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           P GIDL+ +ML  DP KRITA EAL+  Y +
Sbjct: 280 PKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 121/271 (44%), Gaps = 50/271 (18%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIY-----LYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L    H NII +  +     +     +Y + E    DL  ++           +
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS------TQMLS 110
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
            +   Y ++ T   V+             G+  I RDLKP N+L++ +   +KV  FGLA
Sbjct: 111 DDHIQYFIYQTLRAVK----------VLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLA 159
Query: 131 KSLYAYKGESSAEVG----------THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
           + +     ++S   G          T +Y+APE++L   +YS A+D+W  GCI  E+   
Sbjct: 160 RIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
Query: 181 KPLFPGAN---SLITLGRIVG--KSRKPSFCKLSLRDH-------------LTNGFPGLE 222
           +P+FPG +    L+ +  I+G   S     C  S R               L   FP + 
Sbjct: 220 RPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVN 279
Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           P GIDL+ +ML  DP KRITA EAL+  Y +
Sbjct: 280 PKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 121/271 (44%), Gaps = 50/271 (18%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIY-----LYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L    H NII +  +     +     +Y + E    DL  ++           +
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS------TQMLS 110
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
            +   Y ++ T   V+             G+  I RDLKP N+L++ +   +KV  FGLA
Sbjct: 111 DDHIQYFIYQTLRAVK----------VLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLA 159
Query: 131 KSLYAYKGESSAEVG----------THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
           + +     ++S   G          T +Y+APE++L   +YS A+D+W  GCI  E+   
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
Query: 181 KPLFPGAN---SLITLGRIVG--KSRKPSFCKLSLRDH-------------LTNGFPGLE 222
           +P+FPG +    L+ +  I+G   S     C  S R               L   FP + 
Sbjct: 220 RPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVN 279
Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           P GIDL+ +ML  DP KRITA EAL+  Y +
Sbjct: 280 PKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 58/271 (21%)
Query: 16  IREVSCLMELNHPNIIRLMRV-------ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           +RE+  L+   H N+I +  +       A + +Y+  V +    DL  LLK         
Sbjct: 89  LREIQILLRFRHENVIGIRDILRASTLEAMRDVYI--VQDLMETDLYKLLK--------- 137
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTV 122
           S +  N +  +  + ++              G +YI       RDLKP N+L++     +
Sbjct: 138 SQQLSNDHICYFLYQILR-------------GLKYIHSANVLHRDLKPSNLLINTTCD-L 183
Query: 123 KVAGFGLAK---SLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S
Sbjct: 184 KICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243
Query: 180 GKPLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHLTN-----------GFPGLE 222
            +P+FPG + L  L  I+G    PS         +  R++L +            FP  +
Sbjct: 244 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSD 303
Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
              +DL+ +ML  +P+KRIT  EAL   Y +
Sbjct: 304 SKALDLLDRMLTFNPNKRITVEEALAHPYLE 334

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 58/166 (34%), Positives = 91/166 (54%), Gaps = 18/166 (10%)
Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTA 164
           RD+KP N+L+D     +K+  FG AK L A  GE + + + + YY+APEL+ G   Y+T 
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIA--GEPNVSXICSRYYRAPELIFGATNYTTN 222
Query: 165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLR--DHLTNGFPGLE 222
           +DIW  GC+  E++ G+PLFPG + +  L  I+     PS  ++     +++ + FP + 
Sbjct: 223 IDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIR 282
Query: 223 PA-------------GIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           P               IDLIS++L   P  R+TA EAL   +F ++
Sbjct: 283 PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDX-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 227 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 122
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 123 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNT-TXDLKI 165
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 166 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 226 PIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSK 285
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 286 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 122
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 123 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNT-TXDLKI 165
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 166 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 226 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 285
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 286 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 126
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 127 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNT-TXDLKI 169
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 289
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 290 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 126
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 127 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNT-TXDLKI 169
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 289
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 290 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 61/174 (35%), Positives = 93/174 (53%), Gaps = 22/174 (12%)
Query: 100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES----SAEVGTHYYKAPELL 155
             + I RDLKP N+LV+ +   +K+  FG+A+ L     E     +  V T +Y+APEL+
Sbjct: 176 SAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 156 LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRI--------------VGKSR 201
           L L EY+ A+D+W VGCIFGEM++ + LFPG N +  L  I              VG  R
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 294
Query: 202 KPSFCK-LSLRDHL--TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
             ++ + L  R  +     +PG +   + L+ +ML  +P  RI+AA AL+  + 
Sbjct: 295 VRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLXQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDX-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 227 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLXQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLXGIKHL----------HSAGIIHRDLKPSNIVVKSDX-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 227 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 122
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 123 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 165
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 166 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 226 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 285
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 286 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 122
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 123 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNT-TXDLKI 165
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 166 XDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 226 PIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSK 285
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 286 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 126
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 127 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 169
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 289
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 290 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  100 bits (249), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 88/170 (51%), Gaps = 21/170 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLE 160
           + RDLKP N+L++     +K+  FGLA+     + + G  +  V T +Y+APE++L    
Sbjct: 166 LHRDLKPSNLLLNT-TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL 214
           Y+ ++DIW VGCI  EM+S +P+FPG + L  L  I+G    PS         L  R++L
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 284
Query: 215 -----------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
                         FP  +   +DL+ KML  +P KRI   +AL   Y +
Sbjct: 285 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 71  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 124
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 125 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 167
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 168 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 228 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 287
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 288 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 316

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 74  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 127
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 128 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 170
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 171 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 231 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 290
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 291 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 75  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 128
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 129 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 171
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 172 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 232 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 291
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 292 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 320

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 66  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 119
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 120 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 162
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 163 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 223 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 282
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 283 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 311

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 126
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 127 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 169
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 289
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 290 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 77  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 130
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 131 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 173
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 174 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 234 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 293
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 294 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 322

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 122
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 123 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 165
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 166 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 226 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 285
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 286 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 314

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 67  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 120
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 121 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 163
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 164 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 224 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 283
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 284 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 61/174 (35%), Positives = 93/174 (53%), Gaps = 22/174 (12%)
Query: 100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES----SAEVGTHYYKAPELL 155
             + I RDLKP N+LV+ +   +K+  FG+A+ L     E     +  V T +Y+APEL+
Sbjct: 177 SAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 156 LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRI--------------VGKSR 201
           L L EY+ A+D+W VGCIFGEM++ + LFPG N +  L  I              VG  R
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 295
Query: 202 KPSFCK-LSLRDHL--TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
             ++ + L  R  +     +PG +   + L+ +ML  +P  RI+AA AL+  + 
Sbjct: 296 VRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 349

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 89  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 142
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 143 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 185
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 186 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 246 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 305
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 306 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 334

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 120/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 126
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 127 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTC-DLKI 169
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G     V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 170 CDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 289
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 290 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 120/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 74  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 127
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 128 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTC-DLKI 170
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G     V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 171 CDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    PS         L  R++L              FP  +  
Sbjct: 231 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 290
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 291 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 319

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 88/170 (51%), Gaps = 21/170 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLE 160
           + RDLKP N+L++     +K+  FGLA+     + + G  +  V T +Y+APE++L    
Sbjct: 150 LHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL 214
           Y+ ++DIW VGCI  EM+S +P+FPG + L  L  I+G    PS         L  R++L
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 215 -----------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
                         FP  +   +DL+ KML  +P KRI   +AL   Y +
Sbjct: 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 59/169 (34%), Positives = 90/169 (53%), Gaps = 21/169 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLE 160
           + RDLKP N+L++     +K+  FGLA+     + + G  +  V T +Y+APE++L    
Sbjct: 148 LHRDLKPSNLLLNTTSD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS----FCKLSL--RDHL 214
           Y+ ++DIW VGCI  EM+S +P+FPG + L  L  I+G    PS     C ++L  R++L
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYL 266
Query: 215 -----------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                         FP  +   +DL+ KML  +P KRI   +AL   Y 
Sbjct: 267 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 127/264 (48%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPV 121
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 122 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 128 GLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 168 GSAKQLV--RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKLS---LRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ + +   ++ H  T  F P   P  I L S+
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 286 LLEYTPTARLTPLEACAHSFFDEL 309

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 87/169 (51%), Gaps = 21/169 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLE 160
           + RDLKP N+L++     +K+  FGLA+     + + G  +  V T +Y+APE++L    
Sbjct: 148 LHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL 214
           Y+ ++DIW VGCI  EM+S +P+FPG + L  L  I+G    PS         L  R++L
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 266
Query: 215 -----------TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                         FP  +   +DL+ KML  +P KRI   +AL   Y 
Sbjct: 267 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 71  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDHERM- 127
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 128 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 170
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 171 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 225
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 226 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 285
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 286 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDHERM- 121
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 122 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 164
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 165 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 219
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 73  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDHERM- 129
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 130 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 172
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 173 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 227
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 228 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 287
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 288 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 126/259 (48%), Gaps = 35/259 (13%)
Query: 22  LMELNHPNIIRLMRVASQGIYLYPVFEYQVND--LAYLLKYPKDSMNGYSTKNFNSYSLF 79
           L  L+HPNI++L        Y Y + E    D  L  +++Y  D+++    +N+    + 
Sbjct: 73  LAVLHHPNIVQLQS------YFYTLGERDRRDIYLNVVMEYVPDTLHR-CCRNYYRRQVA 125
Query: 80  TTFLLVEEFXXXXXXXXXXF---GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY 136
              +L++ F                    RD+KP N+LV+    T+K+  FG AK L   
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185
Query: 137 KGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS---LITL 193
           +  + A + + YY+APEL+ G   Y+TAVDIW VGCIF EM+ G+P+F G NS   L  +
Sbjct: 186 E-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244
Query: 194 GRIVG-------KSRKPSFCKLSLRDHLTNGFP--------GLEPA--GIDLISKMLGMD 236
            R++G       +   PS   + L +  + G P         L+ A    DL+S +L   
Sbjct: 245 VRVLGCPSREVLRKLNPSHTDVDLYN--SKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 237 PDKRITAAEALQQEYFKDV 255
           P++R+   EAL   YF ++
Sbjct: 303 PEERMKPYEALCHPYFDEL 321

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 227 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 66  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDHERM- 122
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 123 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 165
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 166 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 220
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 221 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 280
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 281 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 66  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDHERM- 122
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 123 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 165
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 166 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 220
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 221 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 280
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 281 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 227 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 122 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 128 GLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE +   + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 168 GSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKLS---LRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ + +   ++ H  T  F P   P  I L S+
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 286 LLEYTPTARLTPLEACAHSFFDEL 309

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 73  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDHERM- 129
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 130 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 172
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 173 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 227
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 228 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 287
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 288 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDHERM- 166
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 167 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 209
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 210 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 264
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 265 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLXQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLXGIKHL----------HSAGIIHRDLKPSNIVVKSDX-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 227 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 286
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDHERM- 166
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 167 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 209
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 210 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 264
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 265 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLXQVIQMELDHERM- 121
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 122 ------SYLLYQMLXGIKHL----------HSAGIIHRDLKPSNIVVKSD-XTLKILDFG 164
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 165 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFP 219
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTN-------GFPGLEPAGI------- 226
           G + +    +++ +  +  P F K    ++R+++ N        FP L P  +       
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 227 ---------DLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +DP KRI+  +ALQ  Y 
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 61/276 (22%)
Query: 16  IREVSCLMELNHPNIIRLMRVA--------------SQGIYLYPVFEYQVNDLAYLLKYP 61
           +RE+  +  L+H NI+++  +               ++   +Y V EY   DLA +L+  
Sbjct: 56  LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG 115
Query: 62  KDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILV 115
                                 L+EE            G +YI       RDLKP N+ +
Sbjct: 116 P---------------------LLEEHARLFMYQLLR-GLKYIHSANVLHRDLKPANLFI 153
Query: 116 DLDGKTVKVAGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGC 172
           + +   +K+  FGLA+ +   Y++KG  S  + T +Y++P LLL    Y+ A+D+W  GC
Sbjct: 154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 213
Query: 173 IFGEMVSGKPLFPGANSLITLGRIV---------GKSRKPSFCKLSLRDH-------LTN 216
           IF EM++GK LF GA+ L  +  I+          +    S   + +R+        LT 
Sbjct: 214 IFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQ 273
Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
             PG+    +D + ++L   P  R+TA EAL   Y 
Sbjct: 274 LLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 63  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 122
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 123 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 168
Query: 128 GLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 169 GSAKQLV--RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 226
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 227 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 286
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 287 LLEYTPTARLTPLEACAHSFFDEL 310

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 81  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 140
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 141 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 186
Query: 128 GLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 187 GSAKQLV--RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 244
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 245 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 304
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 305 LLEYTPTARLTPLEACAHSFFDEL 328

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 122 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 128 GLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 168 GSAKQLV--RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 286 LLEYTPTARLTPLEACAHSFFDEL 309

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 74  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 133
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 134 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 179
Query: 128 GLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 180 GSAKQLV--RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 237
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 238 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 297
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 298 LLEYTPTARLTPLEACAHSFFDEL 321

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 122 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 128 GLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE +   + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 168 GSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 286 LLEYTPTARLTPLEACAHSFFDEL 309

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 70  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 129
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 130 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 175
Query: 128 GLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 176 GSAKQLV--RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 233
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 234 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 293
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 294 LLEYTPTARLTPLEACAHSFFDEL 317

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 66  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 125
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 126 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 171
Query: 128 GLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 172 GSAKQLV--RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 229
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 230 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 289
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 290 LLEYTPTARLTPLEACAHSFFDEL 313

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 74  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 133
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 134 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 179
Query: 128 GLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 180 GSAKQLV--RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 237
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 238 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 297
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 298 LLEYTPTARLTPLEACAHSFFDEL 321

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 122 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 128 GLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 168 GSAKQLV--RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 286 LLEYTPTARLTPLEACAHSFFDEL 309

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 122 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 128 GLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE +   + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 168 GSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 286 LLEYTPTARLTPLEACAHSFFDEL 309

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 128/264 (48%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV-ASQG-----IYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL     S G     +YL  V +Y    V  +A      K ++  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 122 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 128 GLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 168 GSAKQLV--RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 286 LLEYTPTARLTPLEACAHSFFDEL 309

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 67  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 126
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 127 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 172
Query: 128 GLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE +   + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 173 GSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 230
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 231 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 290
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 291 LLEYTPTARLTPLEACAHSFFDEL 314

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 75  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 134
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 135 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 180
Query: 128 GLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE +   + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 181 GSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 238
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 239 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 298
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 299 LLEYTPTARLTPLEACAHSFFDEL 322

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 90  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 149
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 150 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 195
Query: 128 GLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE +   + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 196 GSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 253
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 254 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 313
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 314 LLEYTPTARLTPLEACAHSFFDEL 337

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 131/292 (44%), Gaps = 74/292 (25%)
Query: 17  REVSCLMELN-HPNIIRLMRV--ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
           RE+  L EL+ H NI+ L+ V  A     +Y VF+Y   DL  +++    ++     K +
Sbjct: 57  REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA---NILEPVHKQY 113
Query: 74  NSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
             Y L      +                  + RD+KP NIL++ +   VKVA FGL++S 
Sbjct: 114 VVYQLIKVIKYLH-------------SGGLLHRDMKPSNILLNAECH-VKVADFGLSRSF 159
Query: 134 YAYK----------GESSAE-----------VGTHYYKAPELLLGLLEYSTAVDIWPVGC 172
              +           E++             V T +Y+APE+LLG  +Y+  +D+W +GC
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219
Query: 173 IFGEMVSGKPLFPGANSLITLGRIVGKSRKPS----------FCKLSL------------ 210
           I GE++ GKP+FPG++++  L RI+G    PS          F K  +            
Sbjct: 220 ILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQS 279
Query: 211 --RDHLT---------NGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
             RD  T         N         +DL+ K+L  +P+KRI+A +AL+  +
Sbjct: 280 NKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF 331

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 156 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 201
Query: 128 GLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 202 GSAKQLV--RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 319
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 320 LLEYTPTARLTPLEACAHSFFDEL 343

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 120/269 (44%), Gaps = 54/269 (20%)
Query: 16  IREVSCLMELNHPNII---RLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +RE+  L+   H NII    ++R  +  Q   +Y V +    DL  LLK        + +
Sbjct: 67  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK------TQHLS 120
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVKV 124
            +   Y L+                    G +YI       RDLKP N+L++     +K+
Sbjct: 121 NDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LKI 163
Query: 125 AGFGLAKSL---YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FGLA+     + + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +
Sbjct: 164 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223
Query: 182 PLFPGANSLITLGRIVGKSRKPS------FCKLSLRDHL-----------TNGFPGLEPA 224
           P+FPG + L  L  I+G    P          L  R++L              FP  +  
Sbjct: 224 PIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 283
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
            +DL+ KML  +P KRI   +AL   Y +
Sbjct: 284 ALDLLDKMLTFNPHKRIEVEQALAHPYLE 312

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 156 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 201
Query: 128 GLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE +   + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 202 GSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 319
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 320 LLEYTPTARLTPLEACAHSFFDEL 343

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 141 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 200
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 201 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 246
Query: 128 GLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE +   + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 247 GSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 304
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 305 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 364
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 365 LLEYTPTARLTPLEACAHSFFDEL 388

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 98  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 157
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 158 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 203
Query: 128 GLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE +   + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 204 GSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 261
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 262 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 321
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 322 LLEYTPTARLTPLEACAHSFFDEL 345

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 41/264 (15%)
Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEY---QVNDLAYLLKYPKDSMNG 67
           RE+  + +L+H NI+RL             +YL  V +Y    V  +A      K ++  
Sbjct: 100 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 159
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              K +  Y LF +   +  F                 RD+KP N+L+D D   +K+  F
Sbjct: 160 IYVKLY-MYQLFRSLAYIHSFGI-------------CHRDIKPQNLLLDPDTAVLKLCDF 205
Query: 128 GLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP- 185
           G AK L   +GE +   + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FP 
Sbjct: 206 GSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 263
Query: 186 --GANSLITLGRIVG-------KSRKPSFCKL---SLRDH-LTNGF-PGLEPAGIDLISK 231
             G + L+ + +++G       +   P++ +     ++ H  T  F P   P  I L S+
Sbjct: 264 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 323
Query: 232 MLGMDPDKRITAAEALQQEYFKDV 255
           +L   P  R+T  EA    +F ++
Sbjct: 324 LLEYTPTARLTPLEACAHSFFDEL 347

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 116/264 (43%), Gaps = 43/264 (16%)
Query: 15  MIREVSCLMELNHPNIIRLMRV-------ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
           ++RE+  L   +HPNI+ L  +       A   +YL  V E    DLA ++   +  ++ 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIHDQRIVISP 133
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              + F  + L    +L E                 + RDL P NIL+  D   + +  F
Sbjct: 134 QHIQYFMYHILLGLHVLHE--------------AGVVHRDLHPGNILL-ADNNDITICDF 178
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            LA+   A     +  V   +Y+APEL++    ++  VD+W  GC+  EM + K LF G+
Sbjct: 179 NLAREDTA-DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 188 NSLITLGRIVGKSRKPS------FCKLSLRDHLTNGF------------PGLEPAGIDLI 229
                L +IV     P       F   S RD+L N              P  +P  +DLI
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI 297
Query: 230 SKMLGMDPDKRITAAEALQQEYFK 253
           +KML  +P +RI+  +AL+  YF+
Sbjct: 298 AKMLEFNPQRRISTEQALRHPYFE 321

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 126/272 (46%), Gaps = 58/272 (21%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  L  +NH NII L+ V +        Q +YL  V E    +L  ++    D     
Sbjct: 70  RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIHMELDHERM- 126
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 127 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 169
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++  +     +  V T YY+APE++LG+  Y   VDIW VGCI GE+V G  +F G +
Sbjct: 170 LARTA-STNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTD 227
Query: 189 SLITLGRIVGKSRKPS-----FCKLSLRDHLTN--GFPGLE-----PAGI---------- 226
            +    +++ +   PS       + ++R+++ N   +PG+      P  I          
Sbjct: 228 HIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKI 287
Query: 227 ------DLISKMLGMDPDKRITAAEALQQEYF 252
                 DL+SKML +DPDKRI+  EAL+  Y 
Sbjct: 288 KTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 116/264 (43%), Gaps = 43/264 (16%)
Query: 15  MIREVSCLMELNHPNIIRLMRV-------ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
           ++RE+  L   +HPNI+ L  +       A   +YL  V E    DLA ++   +  ++ 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIHDQRIVISP 133
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
              + F  + L    +L E                 + RDL P NIL+  D   + +  F
Sbjct: 134 QHIQYFMYHILLGLHVLHE--------------AGVVHRDLHPGNILL-ADNNDITICDF 178
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            LA+   A     +  V   +Y+APEL++    ++  VD+W  GC+  EM + K LF G+
Sbjct: 179 NLAREDTA-DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 188 NSLITLGRIVGKSRKPS------FCKLSLRDHLTNGF------------PGLEPAGIDLI 229
                L +IV     P       F   S RD+L N              P  +P  +DLI
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI 297
Query: 230 SKMLGMDPDKRITAAEALQQEYFK 253
           +KML  +P +RI+  +AL+  YF+
Sbjct: 298 AKMLEFNPQRRISTEQALRHPYFE 321

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 127/272 (46%), Gaps = 58/272 (21%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  L  +NH NII L+ V +        Q +YL  V E    +L  ++    D     
Sbjct: 72  RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIHMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 171
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        +  V T YY+APE++LG+  Y+  VDIW VGCI GE+V G  +F G +
Sbjct: 172 LARTA-CTNFMMTPYVVTRYYRAPEVILGM-GYAANVDIWSVGCIMGELVKGCVIFQGTD 229
Query: 189 SLITLGRIVGKSRKPS-----FCKLSLRDHLTN--GFPGLE-----PAGI---------- 226
            +    +++ +   PS       + ++R+++ N   +PG++     P  I          
Sbjct: 230 HIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKI 289
Query: 227 ------DLISKMLGMDPDKRITAAEALQQEYF 252
                 DL+SKML +DPDKRI+  EAL+  Y 
Sbjct: 290 KTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L+ +++   D     
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+   + ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLVGIKHL----------HSAGIIHRDLKPSNIVVKSDA-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEM+ G  LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 227 GTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 128/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L  +++   D     
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S     EV T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFP
Sbjct: 172 LART----AGTSFMMEPEVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVCHKILFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P+F K    ++R+++ N            FP  L PA    
Sbjct: 227 GRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 127/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L  +++   D     
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   + EV T YY+APE++LG+  Y   VDIW VGCI GEM+ G  LFP
Sbjct: 172 LART----AGTSFMMTPEVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 227 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 287 NALKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 127/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L+ +++   D     
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDA-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEM+ G  LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 227 GTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 127/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L+ +++   D     
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDA-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEM+ G  LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 227 GTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 94.4 bits (233), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 127/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L+ +++   D     
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEM+ G  LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 227 GTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 126/275 (45%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L  +++   D     
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEM+ G  LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 227 GTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/180 (38%), Positives = 94/180 (52%), Gaps = 37/180 (20%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES---SAEVGTHYYKAPELLLGLLE 160
           I RDLKP NI+V  D  T+K+  FGLA++     G S     EV T YY+APE++LG+  
Sbjct: 148 IHRDLKPSNIVVKSDC-TLKILDFGLART----AGTSFMMEPEVVTRYYRAPEVILGM-G 201
Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGK--SRKPSFCKL---SLRDHLT 215
           Y   VD+W VGCI GEMV  K LFPG + +    +++ +  +  P F K    ++R ++ 
Sbjct: 202 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 216 NG-----------FPG-LEPA-----------GIDLISKMLGMDPDKRITAAEALQQEYF 252
           N            FP  L PA             DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 51/286 (17%)
Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIY--------LYPVFEYQVNDLA 55
           + N  EG P + +RE+  L  L H N++ L+ +              +Y VF++  +DLA
Sbjct: 53  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 112
Query: 56  YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV 115
            LL               N    FT   +                 + + RD+K  N+L+
Sbjct: 113 GLLS--------------NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 158
Query: 116 DLDGKTVKVAGFGLAKSLYAYKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIWPVG 171
             DG  +K+A FGLA++    K          V T +Y+ PELLLG  +Y   +D+W  G
Sbjct: 159 TRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAG 217
Query: 172 CIFGEMVSGKPLFPG---ANSLITLGRIVGKSRKPSFC------------------KLSL 210
           CI  EM +  P+  G    + L  + ++ G S  P                     K  +
Sbjct: 218 CIMAEMWTRSPIMQGNTEQHQLALISQLCG-SITPEVWPNVDNYELYEKLELVKGQKRKV 276
Query: 211 RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
           +D L       +P  +DLI K+L +DP +RI + +AL  ++F   P
Sbjct: 277 KDRLKAYV--RDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 320

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 51/286 (17%)
Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIY--------LYPVFEYQVNDLA 55
           + N  EG P + +RE+  L  L H N++ L+ +              +Y VF++  +DLA
Sbjct: 52  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 111
Query: 56  YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV 115
            LL               N    FT   +                 + + RD+K  N+L+
Sbjct: 112 GLLS--------------NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 157
Query: 116 DLDGKTVKVAGFGLAKSLYAYKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIWPVG 171
             DG  +K+A FGLA++    K          V T +Y+ PELLLG  +Y   +D+W  G
Sbjct: 158 TRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216
Query: 172 CIFGEMVSGKPLFPG---ANSLITLGRIVGKSRKPSFC------------------KLSL 210
           CI  EM +  P+  G    + L  + ++ G S  P                     K  +
Sbjct: 217 CIMAEMWTRSPIMQGNTEQHQLALISQLCG-SITPEVWPNVDNYELYEKLELVKGQKRKV 275
Query: 211 RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
           +D L       +P  +DLI K+L +DP +RI + +AL  ++F   P
Sbjct: 276 KDRLKAYVR--DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 51/286 (17%)
Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIY--------LYPVFEYQVNDLA 55
           + N  EG P + +RE+  L  L H N++ L+ +              +Y VF++  +DLA
Sbjct: 53  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 112
Query: 56  YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV 115
            LL               N    FT   +                 + + RD+K  N+L+
Sbjct: 113 GLLS--------------NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 158
Query: 116 DLDGKTVKVAGFGLAKSLYAYKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIWPVG 171
             DG  +K+A FGLA++    K          V T +Y+ PELLLG  +Y   +D+W  G
Sbjct: 159 TRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAG 217
Query: 172 CIFGEMVSGKPLFPG---ANSLITLGRIVGKSRKPSFC------------------KLSL 210
           CI  EM +  P+  G    + L  + ++ G S  P                     K  +
Sbjct: 218 CIMAEMWTRSPIMQGNTEQHQLALISQLCG-SITPEVWPNVDNYELYEKLELVKGQKRKV 276
Query: 211 RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
           +D L       +P  +DLI K+L +DP +RI + +AL  ++F   P
Sbjct: 277 KDRLKAYVR--DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 320

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 51/286 (17%)
Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIY--------LYPVFEYQVNDLA 55
           + N  EG P + +RE+  L  L H N++ L+ +              +Y VF++  +DLA
Sbjct: 53  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLA 112
Query: 56  YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV 115
            LL               N    FT   +                 + + RD+K  N+L+
Sbjct: 113 GLLS--------------NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 158
Query: 116 DLDGKTVKVAGFGLAKSLYAYKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIWPVG 171
             DG  +K+A FGLA++    K          V T +Y+ PELLLG  +Y   +D+W  G
Sbjct: 159 TRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAG 217
Query: 172 CIFGEMVSGKPLFPG---ANSLITLGRIVGKSRKPSFC------------------KLSL 210
           CI  EM +  P+  G    + L  + ++ G S  P                     K  +
Sbjct: 218 CIMAEMWTRSPIMQGNTEQHQLALISQLCG-SITPEVWPNVDNYELYEKLELVKGQKRKV 276
Query: 211 RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
           +D L       +P  +DLI K+L +DP +RI + +AL  ++F   P
Sbjct: 277 KDRLKAYVR--DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 320

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 127/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L+ +++   D     
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+   + ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLVGIKHL----------HSAGIIHRDLKPSNIVVKSDA-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VG I GEM+ G  LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGVIMGEMIKGGVLFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 227 GTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 126/275 (45%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L  +++   D     
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEM+ G  LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 227 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 126/275 (45%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L  +++   D     
Sbjct: 73  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHERM- 129
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 130 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 172
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VGCI GEM+ G  LFP
Sbjct: 173 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFP 227
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 228 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 287
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 288 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 127/275 (46%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L+ +++   D     
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERM- 128
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+   + ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 129 ------SYLLYQMLVGIKHL----------HSAGIIHRDLKPSNIVVKSDA-TLKILDFG 171
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VDIW VG I GEM+ G  LFP
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGVIMGEMIKGGVLFP 226
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 227 GTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 286
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 125/275 (45%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L  +++   D     
Sbjct: 74  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHERM- 130
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 131 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 173
Query: 129 LAKSLYAYKGESSAEVG---THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   V    T YY+APE++LG+  Y   VDIW VGCI GEM+ G  LFP
Sbjct: 174 LART----AGTSFMMVPFVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFP 228
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 229 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 288
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 289 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 323

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/180 (38%), Positives = 94/180 (52%), Gaps = 37/180 (20%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES---SAEVGTHYYKAPELLLGLLE 160
           I RDLKP NI+V  D  T+K+  FGLA++     G S   +  V T YY+APE++LG+  
Sbjct: 142 IHRDLKPSNIVVKSDC-TLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGK--SRKPSFCKL---SLRDHLT 215
           Y   VD+W VGCI GEMV  K LFPG + +    +++ +  +  P F K    ++R ++ 
Sbjct: 196 YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 255
Query: 216 NG-----------FPG-LEPA-----------GIDLISKMLGMDPDKRITAAEALQQEYF 252
           N            FP  L PA             DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 256 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 315

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 126/275 (45%), Gaps = 64/275 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +Y+  V E    +L  +++   D     
Sbjct: 77  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHERM- 133
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++                 I RDLKP NI+V  D  T+K+  FG
Sbjct: 134 ------SYLLYQMLCGIKHL----------HSAGIIHRDLKPSNIVVKSDC-TLKILDFG 176
Query: 129 LAKSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
           LA++     G S   +  V T YY+APE++LG+  Y   VD+W VGCI GEMV  K LFP
Sbjct: 177 LART----AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDLWSVGCIMGEMVCHKILFP 231
Query: 186 GANSLITLGRIVGK--SRKPSFCKL---SLRDHLTNG-----------FPG-LEPA---- 224
           G + +    +++ +  +  P F K    ++R ++ N            FP  L PA    
Sbjct: 232 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 291
Query: 225 -------GIDLISKMLGMDPDKRITAAEALQQEYF 252
                    DL+SKML +D  KRI+  EALQ  Y 
Sbjct: 292 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 326

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 90/313 (28%), Positives = 130/313 (41%), Gaps = 88/313 (28%)
Query: 15  MIREVSCLMELNHPNIIRLMRVAS-----QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYS 69
           ++RE++ L  L    IIRL  +       +   LY V E   +DL  L K P      + 
Sbjct: 72  ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-----IFL 126
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
           T+      L+   LL E F            +  I RDLKP N L++ D  +VKV  FGL
Sbjct: 127 TEEHIKTILYN-LLLGENFI---------HESGIIHRDLKPANCLLNQDC-SVKVCDFGL 175
Query: 130 AKSLYAYKG-------ESSAEVGTH---------------YYKAPELLLGLLEYSTAVDI 167
           A+++ + K        E + E G H               +Y+APEL+L    Y+ ++DI
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235
Query: 168 WPVGCIFGEMV-----------SGKPLFPGA--------------------NSLITLGRI 196
           W  GCIF E++           +  PLFPG+                    + L  +  I
Sbjct: 236 WSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNI 295
Query: 197 VGKS--------RKPSFCK-LSLRDH-----LTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
           +G           KP   K + L  H     L   +P +   GI+L+  ML  +P+KRIT
Sbjct: 296 IGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT 355
Query: 243 AAEALQQEYFKDV 255
             +AL   Y KDV
Sbjct: 356 IDQALDHPYLKDV 368

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/327 (24%), Positives = 124/327 (37%), Gaps = 108/327 (33%)
Query: 15  MIREVSCLMELNHPNIIRLMRVA-----SQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYS 69
           ++RE++ L  LNH ++++++ +       +   LY V E   +D                
Sbjct: 99  ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFK-------------- 144
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIR------RDLKPVNILVDLDGKTVK 123
                   LF T + + E            G +Y+       RDLKP N LV+ D  +VK
Sbjct: 145 -------KLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVK 196
Query: 124 VAGFGLAKSL-YAYKGES--------------------------SAEVGTHYYKAPELLL 156
           V  FGLA+++ Y   G S                          +  V T +Y+APEL+L
Sbjct: 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256
Query: 157 GLLEYSTAVDIWPVGCIFGEMVS-----------GKPLFPGA------------------ 187
               Y+ A+D+W +GCIF E+++             PLFPG+                  
Sbjct: 257 LQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFH 316
Query: 188 -----NSLITLGRIVGKSRKPSFCKLSLRD--------------HLTNGFPGLEPAGIDL 228
                + L  +  I+G   +     L   D               L   FP      I L
Sbjct: 317 TRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHL 376
Query: 229 ISKMLGMDPDKRITAAEALQQEYFKDV 255
           + +ML  +P+KRIT  E L   +FK+V
Sbjct: 377 LKRMLVFNPNKRITINECLAHPFFKEV 403

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 56/260 (21%)
Query: 28  PNIIRLMRVASQGIYLYP--VFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV 85
           PNI++L+ +        P  +FEY VN+  + + YP  ++  Y  + +  Y L       
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEY-VNNTDFKVLYP--TLTDYDIRYY-IYELLKAL--- 138
Query: 86  EEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG 145
                             + RD+KP N+++D + + +++  +GLA+  Y    E +  V 
Sbjct: 139 ----------DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 187
Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVG--- 198
           + Y+K PELL+ L +Y  ++D+W +GC+F  M+  K P F G ++   L+ + +++G   
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 199 ----------------------KSRKPSFCKLSLRD-HLTNGFPGLEPAGIDLISKMLGM 235
                                  SRKP    ++  + HL +      P  ID + K+L  
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRY 301
Query: 236 DPDKRITAAEALQQEYFKDV 255
           D  +R+TA EA+   YF+ V
Sbjct: 302 DHQERLTALEAMTHPYFQQV 321

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 56/260 (21%)
Query: 28  PNIIRLMRVASQGIYLYP--VFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV 85
           PNI++L+ +        P  +FEY VN+  + + YP  ++  Y  + +  Y L       
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEY-VNNTDFKVLYP--TLTDYDIRYY-IYELLKAL--- 138
Query: 86  EEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG 145
                             + RD+KP N+++D + + +++  +GLA+  Y    E +  V 
Sbjct: 139 ----------DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 187
Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVG--- 198
           + Y+K PELL+ L +Y  ++D+W +GC+F  M+  K P F G ++   L+ + +++G   
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 199 ----------------------KSRKPSFCKLSLRD-HLTNGFPGLEPAGIDLISKMLGM 235
                                  SRKP    ++  + HL +      P  ID + K+L  
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRY 301
Query: 236 DPDKRITAAEALQQEYFKDV 255
           D  +R+TA EA+   YF+ V
Sbjct: 302 DHQERLTALEAMTHPYFQQV 321

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 56/260 (21%)
Query: 28  PNIIRLMRVASQGIYLYP--VFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV 85
           PNI++L+ +        P  +FEY VN+  + + YP  ++  Y  + +  Y L       
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEY-VNNTDFKVLYP--TLTDYDIRYY-IYELLKAL--- 139
Query: 86  EEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG 145
                             + RD+KP N+++D + + +++  +GLA+  Y    E +  V 
Sbjct: 140 ----------DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 188
Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVG--- 198
           + Y+K PELL+ L +Y  ++D+W +GC+F  M+  K P F G ++   L+ + +++G   
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 248
Query: 199 ----------------------KSRKPSFCKLSLRD-HLTNGFPGLEPAGIDLISKMLGM 235
                                  SRKP    ++  + HL +      P  ID + K+L  
Sbjct: 249 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRY 302
Query: 236 DPDKRITAAEALQQEYFKDV 255
           D  +R+TA EA+   YF+ V
Sbjct: 303 DHQERLTALEAMTHPYFQQV 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 56/260 (21%)
Query: 28  PNIIRLMRVASQGIYLYP--VFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV 85
           PNI++L+ +        P  +FEY VN+  + + YP  ++  Y  + +  Y L       
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEY-VNNTDFKVLYP--TLTDYDIRYY-IYELLKAL--- 138
Query: 86  EEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG 145
                             + RD+KP N+++D + + +++  +GLA+  Y    E +  V 
Sbjct: 139 ----------DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 187
Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVG--- 198
           + Y+K PELL+ L +Y  ++D+W +GC+F  M+  K P F G ++   L+ + +++G   
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 199 ----------------------KSRKPSFCKLSLRD-HLTNGFPGLEPAGIDLISKMLGM 235
                                  SRKP    ++  + HL +      P  ID + K+L  
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRY 301
Query: 236 DPDKRITAAEALQQEYFKDV 255
           D  +R+TA EA+   YF+ V
Sbjct: 302 DHQERLTALEAMTHPYFQQV 321

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 56/260 (21%)
Query: 28  PNIIRLMRVASQGIYLYP--VFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV 85
           PNI++L+ +        P  +FEY VN+  + + YP  ++  Y  + +  Y L       
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEY-VNNTDFKVLYP--TLTDYDIRYY-IYELLKAL--- 138
Query: 86  EEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG 145
                             + RD+KP N+++D + + +++  +GLA+  Y    E +  V 
Sbjct: 139 ----------DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 187
Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVG--- 198
           + Y+K PELL+ L +Y  ++D+W +GC+F  M+  K P F G ++   L+ + +++G   
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 199 ----------------------KSRKPSFCKLSLRD-HLTNGFPGLEPAGIDLISKMLGM 235
                                  SRKP    ++  + HL +      P  ID + K+L  
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRY 301
Query: 236 DPDKRITAAEALQQEYFKDV 255
           D  +R+TA EA+   YF+ V
Sbjct: 302 DHQERLTALEAMTHPYFQQV 321

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 56/260 (21%)
Query: 28  PNIIRLMRVASQGIYLYP--VFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV 85
           PNI++L+ +        P  +FEY VN+  + + YP  ++  Y  + +  Y L       
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEY-VNNTDFKVLYP--TLTDYDIRYY-IYELLKAL--- 138
Query: 86  EEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG 145
                             + RD+KP N+++D + + +++  +GLA+  Y    E +  V 
Sbjct: 139 ----------DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 187
Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVG--- 198
           + Y+K PELL+ L +Y  ++D+W +GC+F  M+  K P F G ++   L+ + +++G   
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 199 ----------------------KSRKPSFCKLSLRD-HLTNGFPGLEPAGIDLISKMLGM 235
                                  SRKP    ++  + HL +      P  ID + K+L  
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRY 301
Query: 236 DPDKRITAAEALQQEYFKDV 255
           D  +R+TA EA+   YF+ V
Sbjct: 302 DHQERLTALEAMTHPYFQQV 321

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 56/260 (21%)
Query: 28  PNIIRLMRVASQGIYLYP--VFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV 85
           PNI++L+ +        P  +FEY VN+  + + YP  ++  Y  + +  Y L       
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEY-VNNTDFKVLYP--TLTDYDIRYY-IYELLKALDYC 143
Query: 86  EEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG 145
                             + RD+KP N+++D + + +++  +GLA+  Y    E +  V 
Sbjct: 144 H-------------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 189
Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVG--- 198
           + Y+K PELL+ L +Y  ++D+W +GC+F  M+  K P F G ++   L+ + +++G   
Sbjct: 190 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 249
Query: 199 ----------------------KSRKPSFCKLSLRD-HLTNGFPGLEPAGIDLISKMLGM 235
                                  SRKP    ++  + HL +      P  ID + K+L  
Sbjct: 250 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRY 303
Query: 236 DPDKRITAAEALQQEYFKDV 255
           D  +R+TA EA+   YF+ V
Sbjct: 304 DHQERLTALEAMTHPYFQQV 323

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 56/260 (21%)
Query: 28  PNIIRLMRVASQGIYLYP--VFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV 85
           PNI++L+ +        P  +FEY VN+  + + YP  ++  Y  + +  Y L       
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEY-VNNTDFKVLYP--TLTDYDIRYY-IYELLKAL--- 139
Query: 86  EEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG 145
                             + RD+KP N+++D + + +++  +GLA+  Y    E +  V 
Sbjct: 140 ----------DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 188
Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVG--- 198
           + Y+K PELL+ L +Y  ++D+W +GC+F  M+  K P F G ++   L+ + +++G   
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 248
Query: 199 ----------------------KSRKPSFCKLSLRD-HLTNGFPGLEPAGIDLISKMLGM 235
                                  SRKP    ++  + HL +      P  ID + K+L  
Sbjct: 249 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRY 302
Query: 236 DPDKRITAAEALQQEYFKDV 255
           D  +R+TA EA+   YF+ V
Sbjct: 303 DHQERLTALEAMTHPYFQQV 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 56/260 (21%)
Query: 28  PNIIRLMRVASQGIYLYP--VFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV 85
           PNI++L+ +        P  +FEY VN+  + + YP  ++  Y  + +  Y L       
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEY-VNNTDFKVLYP--TLTDYDIRYY-IYELLKAL--- 138
Query: 86  EEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG 145
                             + RD+KP N+++D + + +++  +GLA+  Y    E +  V 
Sbjct: 139 ----------DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 187
Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVG--- 198
           + Y+K PELL+ L +Y  ++D+W +GC+F  M+  K P F G ++   L+ + +++G   
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 199 ----------------------KSRKPSFCKLSLRD-HLTNGFPGLEPAGIDLISKMLGM 235
                                  SRKP    ++  + HL +      P  ID + K+L  
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRY 301
Query: 236 DPDKRITAAEALQQEYFKDV 255
           D  +R+TA EA+   YF+ V
Sbjct: 302 DHQERLTALEAMTHPYFQQV 321

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 56/260 (21%)
Query: 28  PNIIRLMRVASQGIYLYP--VFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV 85
           PNI++L+ +        P  +FEY VN+  + + YP  ++  Y  + +  Y L       
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEY-VNNTDFKVLYP--TLTDYDIRYY-IYELLKALDYC 162
Query: 86  EEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG 145
                             + RD+KP N+++D + + +++  +GLA+  Y    E +  V 
Sbjct: 163 H-------------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 208
Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVG--- 198
           + Y+K PELL+ L +Y  ++D+W +GC+F  M+  K P F G ++   L+ + +++G   
Sbjct: 209 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 268
Query: 199 ----------------------KSRKPSFCKLSLRD-HLTNGFPGLEPAGIDLISKMLGM 235
                                  SRKP    ++  + HL +      P  ID + K+L  
Sbjct: 269 LNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVS------PEAIDFLDKLLRY 322
Query: 236 DPDKRITAAEALQQEYFKDV 255
           D  +R+TA EA+   YF+ V
Sbjct: 323 DHQERLTALEAMTHPYFQQV 342

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/316 (26%), Positives = 131/316 (41%), Gaps = 91/316 (28%)
Query: 15  MIREVSCLMELNHPNIIRLMR-VASQGIY----LYPVFEYQVNDLAYLLKYPKDSMNGYS 69
           ++RE++ L  L    IIRL   +  + +     LY V E   +DL  L K P      + 
Sbjct: 74  ILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTP-----IFL 128
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
           T+  +  ++    LL E+F            +  I RDLKP N L++ D  +VK+  FGL
Sbjct: 129 TEQ-HVKTILYNLLLGEKFI---------HESGIIHRDLKPANCLLNQDC-SVKICDFGL 177
Query: 130 AKSLYA-------------------------YKGESSAEVGTHYYKAPELLLGLLEYSTA 164
           A+++ +                          K + ++ V T +Y+APEL+L    Y+ +
Sbjct: 178 ARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNS 237
Query: 165 VDIWPVGCIFGEMVSGK-----------PLFPGA--------------------NSLITL 193
           +DIW  GCIF E+++             PLFPG+                    + L  +
Sbjct: 238 IDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNII 297
Query: 194 GRIVG-----------KSRKPSFCKL-SLRD--HLTNGFPGLEPAGIDLISKMLGMDPDK 239
             ++G           K     + KL   RD   L+  +  +   GIDL+  ML  +  K
Sbjct: 298 FNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQK 357
Query: 240 RITAAEALQQEYFKDV 255
           RIT  +AL   Y KDV
Sbjct: 358 RITIDKALSHPYLKDV 373

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 103/247 (41%), Gaps = 35/247 (14%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
             S++REV  L +L+HPNI++L        Y Y V E                  G    
Sbjct: 70  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG--------------GELFD 115
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK--TVKVAGFGL 129
              S   F+                     + + RDLKP N+L++   K   +++  FGL
Sbjct: 116 EIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175
Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
           +    A K +   ++GT YY APE+L G   Y    D+W  G I   ++SG P F GAN 
Sbjct: 176 STHFEASK-KMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANE 232
Query: 190 LITLGRI-VGKS--RKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA 246
              L ++  GK     P + K+S              +  DLI KML   P  RI+A +A
Sbjct: 233 YDILKKVEKGKYTFELPQWKKVS-------------ESAKDLIRKMLTYVPSMRISARDA 279
Query: 247 LQQEYFK 253
           L  E+ +
Sbjct: 280 LDHEWIQ 286

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
           S++REV  L +L+HPNI++L        Y Y V E                  G      
Sbjct: 95  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG--------------GELFDEI 140
Query: 74  NSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK--TVKVAGFGLAK 131
            S   F+                     + + RDLKP N+L++   K   +++  FGL+ 
Sbjct: 141 ISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 200
Query: 132 SLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI 191
              A K +   ++GT YY APE+L G   Y    D+W  G I   ++SG P F GAN   
Sbjct: 201 HFEASK-KMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYD 257
Query: 192 TLGRI-VGKS--RKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
            L ++  GK     P + K+S              +  DLI KML   P  RI+A +AL 
Sbjct: 258 ILKKVEKGKYTFELPQWKKVS-------------ESAKDLIRKMLTYVPSMRISARDALD 304
Query: 249 QEYFK 253
            E+ +
Sbjct: 305 HEWIQ 309

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 86/173 (49%), Gaps = 25/173 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D   K +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 154 MHRDVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQMYDY 212
Query: 164 AVDIWPVGCIFGEMV-SGKPLFPGANS---LITLGRIVGKSRKPSFCK---LSLRDHLTN 216
           ++D+W +GC+   M+   +P F G ++   L+ + +++G      + K   + L  H  +
Sbjct: 213 SLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFND 272
Query: 217 -----------GFPGLE------PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                       F   E      P  +DL+ K+L  D  +R+TA EA++  YF
Sbjct: 273 ILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 86/173 (49%), Gaps = 25/173 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D   K +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 159 MHRDVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQMYDY 217
Query: 164 AVDIWPVGCIFGEMV-SGKPLFPGANS---LITLGRIVGKSRKPSFCK---LSLRDHLTN 216
           ++D+W +GC+   M+   +P F G ++   L+ + +++G      + K   + L  H  +
Sbjct: 218 SLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFND 277
Query: 217 -----------GFPGLE------PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                       F   E      P  +DL+ K+L  D  +R+TA EA++  YF
Sbjct: 278 ILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 103/245 (42%), Gaps = 35/245 (14%)
Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
           S++REV  L +L+HPNI++L        Y Y V E                  G      
Sbjct: 96  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG--------------GELFDEI 141
Query: 74  NSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK--TVKVAGFGLAK 131
            S   F+                     + + RDLKP N+L++   K   +++  FGL+ 
Sbjct: 142 ISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 201
Query: 132 SLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI 191
              A K +   ++GT YY APE+L G   Y    D+W  G I   ++SG P F GAN   
Sbjct: 202 HFEASK-KMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYD 258
Query: 192 TLGRI-VGKS--RKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
            L ++  GK     P + K+S              +  DLI KML   P  RI+A +AL 
Sbjct: 259 ILKKVEKGKYTFELPQWKKVS-------------ESAKDLIRKMLTYVPSMRISARDALD 305
Query: 249 QEYFK 253
            E+ +
Sbjct: 306 HEWIQ 310

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 105/246 (42%), Gaps = 35/246 (14%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
            S++REV  L +L+HPNI++L          Y  FE    D  Y     +    G     
Sbjct: 77  ESLLREVQLLKQLDHPNIMKL----------YEFFE----DKGYFYLVGEVYTGGELFDE 122
Query: 73  FNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK--TVKVAGFGLA 130
             S   F+                     + + RDLKP N+L++   K   +++  FGL+
Sbjct: 123 IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 182
Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
               A K +   ++GT YY APE+L G   Y    D+W  G I   ++SG P F GAN  
Sbjct: 183 THFEASK-KMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEY 239
Query: 191 ITLGRI-VGKS--RKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
             L ++  GK     P + K+S              +  DLI KML   P  RI+A +AL
Sbjct: 240 DILKKVEKGKYTFELPQWKKVS-------------ESAKDLIRKMLTYVPSMRISARDAL 286
Query: 248 QQEYFK 253
             E+ +
Sbjct: 287 DHEWIQ 292

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
           S++REV  L +L+HPNI +L        Y Y V E                  G      
Sbjct: 72  SLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTG--------------GELFDEI 117
Query: 74  NSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK--TVKVAGFGLAK 131
            S   F+                     + + RDLKP N+L++   K   +++  FGL+ 
Sbjct: 118 ISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 132 SLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI 191
              A K +   ++GT YY APE+L G   Y    D+W  G I   ++SG P F GAN   
Sbjct: 178 HFEASK-KXKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYD 234
Query: 192 TLGRI-VGKS--RKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
            L ++  GK     P + K+S              +  DLI K L   P  RI+A +AL 
Sbjct: 235 ILKKVEKGKYTFELPQWKKVS-------------ESAKDLIRKXLTYVPSXRISARDALD 281
Query: 249 QEYFK 253
            E+ +
Sbjct: 282 HEWIQ 286

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 107/249 (42%), Gaps = 42/249 (16%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L ++ +  
Sbjct: 54  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQR 113
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+  +G+ +K+
Sbjct: 114 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSNGE-LKI 153
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + G P F
Sbjct: 154 ADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGMPPF 210
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +  +R+T A
Sbjct: 211 EAHTYQETYRRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNASQRLTLA 256
Query: 245 EALQQEYFK 253
           E L+  + K
Sbjct: 257 EVLEHPWIK 265

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+L+D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 153 MHRDVKPHNVLIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF  V
Sbjct: 272 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 111/252 (44%), Gaps = 37/252 (14%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE-YQVNDL-AYLLKYPKDSMNGYST 70
           S+++REV  L +L+HPNI++L  +       Y V E Y   +L   ++K  + S +  + 
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR 125
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKT--VKVAGFG 128
                +S  T                       + RDLKP NIL++   K   +K+  FG
Sbjct: 126 IIKQVFSGITYM----------------HKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           L+ + +    +    +GT YY APE+L G   Y    D+W  G I   ++SG P F G N
Sbjct: 170 LS-TCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKN 226
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
               L R+  ++ K +F     R         +     DLI KML   P  RITA + L+
Sbjct: 227 EYDILKRV--ETGKYAFDLPQWR--------TISDDAKDLIRKMLTFHPSLRITATQCLE 276
Query: 249 ----QEYFKDVP 256
               Q+Y  + P
Sbjct: 277 HPWIQKYSSETP 288

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF  V
Sbjct: 272 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF  V
Sbjct: 272 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 105/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 110 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 149
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +A  GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 150 ADFGW--SVHAPSSRRAALCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 206
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 207 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 252
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 253 EVLEHPW 259

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF  V
Sbjct: 272 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF  V
Sbjct: 270 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 106/249 (42%), Gaps = 42/249 (16%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L ++ +  
Sbjct: 54  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQR 113
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+  +G+ +K+
Sbjct: 114 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSNGE-LKI 153
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A         GT  Y  PE++ G + +   VD+W +G +  E + G P F
Sbjct: 154 ADFGW--SVHAPSSRRDTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGMPPF 210
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +  +R+T A
Sbjct: 211 EAHTYQETYRRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNASQRLTLA 256
Query: 245 EALQQEYFK 253
           E L+  + K
Sbjct: 257 EVLEHPWIK 265

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF  V
Sbjct: 272 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 27/174 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF
Sbjct: 272 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 210
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 270
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF  V
Sbjct: 271 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF  V
Sbjct: 272 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF  V
Sbjct: 272 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 210
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 270
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF  V
Sbjct: 271 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 106/243 (43%), Gaps = 29/243 (11%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
           S+++REV  L +L+HPNI++L  +       Y V E       +      D +     K 
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF------DEI--IKRKR 117
Query: 73  FNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKT--VKVAGFGLA 130
           F+ +      ++ + F               + RDLKP NIL++   K   +K+  FGL+
Sbjct: 118 FSEHD--AARIIKQVFSGITYMHKHNI----VHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
            + +    +    +GT YY APE+L G   Y    D+W  G I   ++SG P F G N  
Sbjct: 172 -TCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228
Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE 250
             L R+  ++ K +F     R         +     DLI KML   P  RITA + L+  
Sbjct: 229 DILKRV--ETGKYAFDLPQWR--------TISDDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 251 YFK 253
           + +
Sbjct: 279 WIQ 281

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 27/174 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF
Sbjct: 272 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 105/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 113 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 152
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +A  GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 153 ADFGW--SVHAPSSRRAALCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 209
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 210 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 255
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 256 EVLEHPW 262

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 106/243 (43%), Gaps = 29/243 (11%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
           S+++REV  L +L+HPNI++L  +       Y V E       +      D +     K 
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF------DEI--IKRKR 117
Query: 73  FNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKT--VKVAGFGLA 130
           F+ +      ++ + F               + RDLKP NIL++   K   +K+  FGL+
Sbjct: 118 FSEHD--AARIIKQVFSGITYMHKHNI----VHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
            + +    +    +GT YY APE+L G   Y    D+W  G I   ++SG P F G N  
Sbjct: 172 -TCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228
Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE 250
             L R+  ++ K +F     R         +     DLI KML   P  RITA + L+  
Sbjct: 229 DILKRV--ETGKYAFDLPQWR--------TISDDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 251 YFK 253
           + +
Sbjct: 279 WIQ 281

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 27/174 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF
Sbjct: 272 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 27/174 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF
Sbjct: 272 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+KP N+++D + + +++  +GLA+  Y    E +  V + Y+K PELL+    Y  
Sbjct: 158 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDYQMYDY 216
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANS---LITLGRIVGKSR------------KPSFCK 207
           ++D+W +GC+   M+  K P F G ++   L+ + +++G                P F  
Sbjct: 217 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 276
Query: 208 LSLRD---------HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +  R          H  N    + P  +D + K+L  D   R+TA EA++  YF  V
Sbjct: 277 ILGRHSRKRWERFVHSENQHL-VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 332

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 113 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 152
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 153 ANFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 209
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 210 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 255
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 256 EVLEHPW 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 52  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 111
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 112 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 151
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 152 ANFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 208
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 209 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 254
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 255 EVLEHPW 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 113 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 152
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 153 ADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 209
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 210 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 255
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 256 EVLEHPW 262

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 47  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 106
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 107 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 146
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 147 ADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 203
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 204 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 249
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 250 EVLEHPW 256

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 113 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 152
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 153 ADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 209
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 210 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 255
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 256 EVLEHPW 262

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 49  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 108
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 109 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 148
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 149 ADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 205
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 206 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 251
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 252 EVLEHPW 258

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 114
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 115 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 154
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 155 ADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 211
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 212 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 257
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 258 EVLEHPW 264

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 67  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 126
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 127 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 166
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 167 ADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 223
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 224 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 269
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 270 EVLEHPW 276

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQR 114
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 115 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 154
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 155 ADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 211
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 212 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 257
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 258 EVLEHPW 264

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 104/248 (41%), Gaps = 42/248 (16%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 76  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 135
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 136 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 175
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 176 ADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 232
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 233 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 278
Query: 245 EALQQEYF 252
           E L+  + 
Sbjct: 279 EVLEHPWI 286

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 110 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 149
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 150 ADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 206
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 207 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 252
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 253 EVLEHPW 259

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 54  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 113
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 114 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 153
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 154 ADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 210
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 211 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 256
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 257 EVLEHPW 263

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 110 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 149
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 150 ADFGW--SVHAPSSRRTELCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 206
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 207 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 252
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 253 EVLEHPW 259

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 105/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    + I RD+KP N+L+   G+ +K+
Sbjct: 110 TATYITELANALSYCHS-------------------KKVIHRDIKPENLLLGSAGE-LKI 149
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +A  GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 150 ADFGW--SVHAPSSRRAALCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 206
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 207 EANTYQDTYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 252
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 253 EVLEHPW 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 110 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 149
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 150 ADFGW--SVHAPSSRRTXLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 206
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 207 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 252
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 253 EVLEHPW 259

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 110 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 149
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 150 ADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 206
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 207 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 252
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 253 EVLEHPW 259

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 114
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 115 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 154
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 155 ADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 211
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 212 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 257
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 258 EVLEHPW 264

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 51  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 110
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 111 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 150
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A         GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 151 ADFGW--SVHAPSSRRDTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 207
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 208 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 253
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 254 EVLEHPW 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 51  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 110
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 111 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 150
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 151 ADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 207
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 208 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 253
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 254 EVLEHPW 260

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 110 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 149
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 150 ADFGW--SVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 206
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 207 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 252
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 253 EVLEHPW 259

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 110 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 149
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A         GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 150 ADFGW--SVHAPSSRRXXLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 206
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 207 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 252
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 253 EVLEHPW 259

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 113 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 152
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A         GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 153 ADFGW--SVHAPSSRRXXLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 209
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 210 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 255
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 256 EVLEHPW 262

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 52  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 111
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 112 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 151
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A         GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 152 ADFGW--SVHAPSSRRXXLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 208
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 209 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 254
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 255 EVLEHPW 261

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 51  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 110
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 111 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 150
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S +A     +   GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 151 ADFGW--SCHAPSSRRTTLSGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 207
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 208 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 253
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 254 EVLEHPW 260

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 76  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 135
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 136 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 175
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A         GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 176 ADFGW--SVHAPSSRRDDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 232
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 233 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 278
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 279 EVLEHPW 285

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 113 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 152
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A         GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 153 ADFGW--SVHAPSSRRDDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 209
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 210 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 255
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 256 EVLEHPW 262

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQR 114
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 115 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 154
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A         GT  Y  PE++ G + +   VD+W +G +  E + GKP F
Sbjct: 155 ADFGW--SVHAPSSRRXXLXGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPF 211
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 212 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPMLR 257
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 258 EVLEHPW 264

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 105/252 (41%), Gaps = 31/252 (12%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE-YQVNDLAYLLKYPKD 63
           +  +E     +  E+S L  L+HPNII+L  V     Y Y V E Y+  +L   +     
Sbjct: 83  NKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI----- 137
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK--T 121
            +N +     ++ ++    L                    + RD+KP NIL++       
Sbjct: 138 -INRHKFDECDAANIMKQIL---------SGICYLHKHNIVHRDIKPENILLENKNSLLN 187
Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
           +K+  FGL+ S ++   +    +GT YY APE+L    +Y+   D+W  G I   ++ G 
Sbjct: 188 IKIVDFGLS-SFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGY 244
Query: 182 PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
           P F G N    + ++        F          N +  +     +LI  ML  D +KR 
Sbjct: 245 PPFGGQNDQDIIKKVEKGKYYFDF----------NDWKNISDEAKELIKLMLTYDYNKRC 294
Query: 242 TAAEALQQEYFK 253
           TA EAL   + K
Sbjct: 295 TAEEALNSRWIK 306

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 105/246 (42%), Gaps = 30/246 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMR--VASQGIYLYPVFEY-QVNDLAYLLKYPKDSM 65
           E     ++ EV+ L EL HPNI+R     +      LY V EY +  DLA ++       
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI------T 99
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK-TVKV 124
            G   + +         +                G   + RDLKP N+   LDGK  VK+
Sbjct: 100 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF--LDGKQNVKL 157
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
             FGLA+ L      + A VGT YY +PE  +  + Y+   DIW +GC+  E+ +  P F
Sbjct: 158 GDFGLARILNHDTSFAKAFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLR--DHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
               +  +   + GK R+  F ++  R  D L            ++I++ML +    R +
Sbjct: 217 ----TAFSQKELAGKIREGKFRRIPYRYSDELN-----------EIITRMLNLKDYHRPS 261
Query: 243 AAEALQ 248
             E L+
Sbjct: 262 VEEILE 267

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 103/245 (42%), Gaps = 40/245 (16%)
Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +I E+  + E  +PNI+  +     G  L+ V EY               + G S  +  
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY---------------LAGGSLTDVV 108
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           + +      +                 + I RD+K  NIL+ +DG +VK+  FG    + 
Sbjct: 109 TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT 167
Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
             + + S  VGT Y+ APE++     Y   VDIW +G +  EM+ G+P +   N L  L 
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 195 RIVGKSRKPSFCKLSLRDHLTNGFPGLE-PAGI-----DLISKMLGMDPDKRITAAEALQ 248
            I                  TNG P L+ P  +     D +++ L MD +KR +A E LQ
Sbjct: 227 LIA-----------------TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
Query: 249 QEYFK 253
            ++ K
Sbjct: 270 HQFLK 274

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 102/247 (41%), Gaps = 42/247 (17%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYLLKYPKDS 64
           GV   + REV     L HPNI+RL         +Y + EY        +L  L K+ +  
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 114
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
              Y T+  N+ S   +                    R I RD+KP N+L+   G+ +K+
Sbjct: 115 TATYITELANALSYCHS-------------------KRVIHRDIKPENLLLGSAGE-LKI 154
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           A FG   S++A     +   GT  Y  PE + G   +   VD+W +G +  E + GKP F
Sbjct: 155 ADFGW--SVHAPSSRRTTLCGTLDYLPPEXIEGRX-HDEKVDLWSLGVLCYEFLVGKPPF 211
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T  RI       S  + +  D +T G         DLIS++L  +P +R    
Sbjct: 212 EANTYQETYKRI-------SRVEFTFPDFVTEG-------ARDLISRLLKHNPSQRPXLR 257
Query: 245 EALQQEY 251
           E L+  +
Sbjct: 258 EVLEHPW 264

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 103/245 (42%), Gaps = 40/245 (16%)
Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +I E+  + E  +PNI+  +     G  L+ V EY               + G S  +  
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY---------------LAGGSLTDVV 108
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           + +      +                 + I RD+K  NIL+ +DG +VK+  FG    + 
Sbjct: 109 TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT 167
Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
             + + S  VGT Y+ APE++     Y   VDIW +G +  EM+ G+P +   N L  L 
Sbjct: 168 PEQSKRSEMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 195 RIVGKSRKPSFCKLSLRDHLTNGFPGLE-PAGI-----DLISKMLGMDPDKRITAAEALQ 248
            I                  TNG P L+ P  +     D +++ L MD +KR +A E LQ
Sbjct: 227 LIA-----------------TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
Query: 249 QEYFK 253
            ++ K
Sbjct: 270 HQFLK 274

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 103/245 (42%), Gaps = 40/245 (16%)
Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +I E+  + E  +PNI+  +     G  L+ V EY               + G S  +  
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY---------------LAGGSLTDVV 108
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           + +      +                 + I RD+K  NIL+ +DG +VK+  FG    + 
Sbjct: 109 TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT 167
Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
             + + S  VGT Y+ APE++     Y   VDIW +G +  EM+ G+P +   N L  L 
Sbjct: 168 PEQSKRSXMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 195 RIVGKSRKPSFCKLSLRDHLTNGFPGLE-PAGI-----DLISKMLGMDPDKRITAAEALQ 248
            I                  TNG P L+ P  +     D +++ L MD +KR +A E LQ
Sbjct: 227 LIA-----------------TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269
Query: 249 QEYFK 253
            ++ K
Sbjct: 270 HQFLK 274

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 36/243 (14%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDL-AYLLKYPKDSMNGYSTKNFNS 75
           RE+S L  L HP+II+L  V      +  V EY  N+L  Y+++  +D M+    + F  
Sbjct: 63  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRF-- 118
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              F   +   E+             + + RDLKP N+L+D +   VK+A FGL+ ++  
Sbjct: 119 ---FQQIISAVEYCHRH---------KIVHRDLKPENLLLD-EHLNVKIADFGLS-NIMT 164
Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGR 195
                    G+  Y APE++ G L     VD+W  G I   M+  +  F   +  +    
Sbjct: 165 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKN 224
Query: 196 IV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK- 253
           I  G    P F               L P    LI +ML ++P  RI+  E +Q ++FK 
Sbjct: 225 ISNGVYTLPKF---------------LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 269
Query: 254 DVP 256
           D+P
Sbjct: 270 DLP 272

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 36/243 (14%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDL-AYLLKYPKDSMNGYSTKNFNS 75
           RE+S L  L HP+II+L  V      +  V EY  N+L  Y+++  +D M+    + F  
Sbjct: 62  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRF-- 117
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              F   +   E+             + + RDLKP N+L+D +   VK+A FGL+ ++  
Sbjct: 118 ---FQQIISAVEYCHRH---------KIVHRDLKPENLLLD-EHLNVKIADFGLS-NIMT 163
Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGR 195
                    G+  Y APE++ G L     VD+W  G I   M+  +  F   +  +    
Sbjct: 164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKN 223
Query: 196 IV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK- 253
           I  G    P F               L P    LI +ML ++P  RI+  E +Q ++FK 
Sbjct: 224 ISNGVYTLPKF---------------LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268
Query: 254 DVP 256
           D+P
Sbjct: 269 DLP 271

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 36/243 (14%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDL-AYLLKYPKDSMNGYSTKNFNS 75
           RE+S L  L HP+II+L  V      +  V EY  N+L  Y+++  +D M+    + F  
Sbjct: 57  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRF-- 112
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              F   +   E+             + + RDLKP N+L+D +   VK+A FGL+ ++  
Sbjct: 113 ---FQQIISAVEYCHRH---------KIVHRDLKPENLLLD-EHLNVKIADFGLS-NIMT 158
Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGR 195
                    G+  Y APE++ G L     VD+W  G I   M+  +  F   +  +    
Sbjct: 159 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKN 218
Query: 196 IV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK- 253
           I  G    P F               L P    LI +ML ++P  RI+  E +Q ++FK 
Sbjct: 219 ISNGVYTLPKF---------------LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 263
Query: 254 DVP 256
           D+P
Sbjct: 264 DLP 266

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 36/243 (14%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDL-AYLLKYPKDSMNGYSTKNFNS 75
           RE+S L  L HP+II+L  V      +  V EY  N+L  Y+++  +D M+    + F  
Sbjct: 53  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRF-- 108
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              F   +   E+             + + RDLKP N+L+D +   VK+A FGL+ ++  
Sbjct: 109 ---FQQIISAVEYCHRH---------KIVHRDLKPENLLLD-EHLNVKIADFGLS-NIMT 154
Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGR 195
                    G+  Y APE++ G L     VD+W  G I   M+  +  F   +  +    
Sbjct: 155 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKN 214
Query: 196 IV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK- 253
           I  G    P F               L P    LI +ML ++P  RI+  E +Q ++FK 
Sbjct: 215 ISNGVYTLPKF---------------LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 259
Query: 254 DVP 256
           D+P
Sbjct: 260 DLP 262

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 105/246 (42%), Gaps = 30/246 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMR--VASQGIYLYPVFEY-QVNDLAYLLKYPKDSM 65
           E     ++ EV+ L EL HPNI+R     +      LY V EY +  DLA ++       
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI------T 99
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK-TVKV 124
            G   + +         +                G   + RDLKP N+   LDGK  VK+
Sbjct: 100 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF--LDGKQNVKL 157
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
             FGLA+ L   +  +   VGT YY +PE  +  + Y+   DIW +GC+  E+ +  P F
Sbjct: 158 GDFGLARILNHDEDFAKEFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLR--DHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
               +  +   + GK R+  F ++  R  D L            ++I++ML +    R +
Sbjct: 217 ----TAFSQKELAGKIREGKFRRIPYRYSDELN-----------EIITRMLNLKDYHRPS 261
Query: 243 AAEALQ 248
             E L+
Sbjct: 262 VEEILE 267

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 114/247 (46%), Gaps = 44/247 (17%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E+S + +L+H N+I+L          Y  FE + ND+  +++Y  D    +      SY+
Sbjct: 136 EISVMNQLDHANLIQL----------YDAFESK-NDIVLVMEYV-DGGELFDRIIDESYN 183
Query: 78  L--FTTFLLVEEFXXXXXXXXXXFGTRYIRR------DLKPVNIL-VDLDGKTVKVAGFG 128
           L    T L +++            G R++ +      DLKP NIL V+ D K +K+  FG
Sbjct: 184 LTELDTILFMKQICE---------GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFG 234
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELL-LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
           LA+  Y  + +     GT  + APE++    + + T  D+W VG I   ++SG   F G 
Sbjct: 235 LARR-YKPREKLKVNFGTPEFLAPEVVNYDFVSFPT--DMWSVGVIAYMLLSGLSPFLGD 291
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
           N   TL  I+        C+  L D     F  +     + ISK+L  +   RI+A+EAL
Sbjct: 292 NDAETLNNILA-------CRWDLEDE---EFQDISEEAKEFISKLLIKEKSWRISASEAL 341
Query: 248 QQEYFKD 254
           +  +  D
Sbjct: 342 KHPWLSD 348

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 30/246 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMR--VASQGIYLYPVFEY-QVNDLAYLLKYPKDSM 65
           E     ++ EV+ L EL HPNI+R     +      LY V EY +  DLA ++       
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI------T 99
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK-TVKV 124
            G   + +         +                G   + RDLKP N+   LDGK  VK+
Sbjct: 100 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF--LDGKQNVKL 157
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
             FGLA+ L      +   VGT YY +PE  +  + Y+   DIW +GC+  E+ +  P F
Sbjct: 158 GDFGLARILNHDTSFAKTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLR--DHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
               +  +   + GK R+  F ++  R  D L            ++I++ML +    R +
Sbjct: 217 ----TAFSQKELAGKIREGKFRRIPYRYSDELN-----------EIITRMLNLKDYHRPS 261
Query: 243 AAEALQ 248
             E L+
Sbjct: 262 VEEILE 267

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 112/253 (44%), Gaps = 34/253 (13%)
Query: 8   MEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMN 66
           +E V  +  RE   L ++  HP+II L+       +++ VF+       +     K +++
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS 198
Query: 67  GYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAG 126
              T+     S+  + L    F               + RDLKP NIL+D D   ++++ 
Sbjct: 199 EKETR-----SIMRSLLEAVSFL---------HANNIVHRDLKPENILLD-DNMQIRLSD 243
Query: 127 FGLAKSLYAYKGESSAEV-GTHYYKAPELLLGLLE-----YSTAVDIWPVGCIFGEMVSG 180
           FG   S +   GE   E+ GT  Y APE+L   ++     Y   VD+W  G I   +++G
Sbjct: 244 FGF--SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
Query: 181 KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
            P F     ++ L  I+    + S  +   R               DLIS++L +DP+ R
Sbjct: 302 SPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVK----------DLISRLLQVDPEAR 351
Query: 241 ITAAEALQQEYFK 253
           +TA +ALQ  +F+
Sbjct: 352 LTAEQALQHPFFE 364

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 103/245 (42%), Gaps = 40/245 (16%)
Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +I E+  + E  +PNI+  +     G  L+ V EY               + G S  +  
Sbjct: 65  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY---------------LAGGSLTDVV 109
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           + +      +                 + I RD+K  NIL+ +DG +VK+  FG    + 
Sbjct: 110 TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT 168
Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
             + + S  VGT Y+ APE++     Y   VDIW +G +  EM+ G+P +   N L  L 
Sbjct: 169 PEQSKRSXMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 227
Query: 195 RIVGKSRKPSFCKLSLRDHLTNGFPGLE-PAGI-----DLISKMLGMDPDKRITAAEALQ 248
            I                  TNG P L+ P  +     D +++ L MD +KR +A E +Q
Sbjct: 228 LIA-----------------TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQ 270
Query: 249 QEYFK 253
            ++ K
Sbjct: 271 HQFLK 275

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 102/241 (42%), Gaps = 26/241 (10%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNS 75
           RE S    L HP+I+ L+   S    LY VFE+    DL + +    D+   YS    + 
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLDGKTVKVAGFGLAKSL 133
           Y                           I RD+KP N+L+    +   VK+  FG+A  L
Sbjct: 135 Y-----------MRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL 183
Query: 134 YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITL 193
                 +   VGT ++ APE++     Y   VD+W  G I   ++SG   F G    +  
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE 242
Query: 194 GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           G I GK       K++ R      +  +  +  DL+ +ML +DP +RIT  EAL   + K
Sbjct: 243 GIIKGKY------KMNPRQ-----WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291
Query: 254 D 254
           +
Sbjct: 292 E 292

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 102/241 (42%), Gaps = 26/241 (10%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNS 75
           RE S    L HP+I+ L+   S    LY VFE+    DL + +    D+   YS    + 
Sbjct: 77  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 136
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLDGKTVKVAGFGLAKSL 133
           Y                           I RD+KP  +L+    +   VK+ GFG+A  L
Sbjct: 137 Y-----------MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 185
Query: 134 YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITL 193
                 +   VGT ++ APE++     Y   VD+W  G I   ++SG   F G    +  
Sbjct: 186 GESGLVAGGRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE 244
Query: 194 GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           G I GK       K++ R      +  +  +  DL+ +ML +DP +RIT  EAL   + K
Sbjct: 245 GIIKGKY------KMNPRQ-----WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 293
Query: 254 D 254
           +
Sbjct: 294 E 294

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 102/241 (42%), Gaps = 26/241 (10%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNS 75
           RE S    L HP+I+ L+   S    LY VFE+    DL + +    D+   YS    + 
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLDGKTVKVAGFGLAKSL 133
           Y                           I RD+KP  +L+    +   VK+ GFG+A  L
Sbjct: 135 Y-----------MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 134 YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITL 193
                 +   VGT ++ APE++     Y   VD+W  G I   ++SG   F G    +  
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE 242
Query: 194 GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           G I GK       K++ R      +  +  +  DL+ +ML +DP +RIT  EAL   + K
Sbjct: 243 GIIKGKY------KMNPRQ-----WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291
Query: 254 D 254
           +
Sbjct: 292 E 292

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 111/254 (43%), Gaps = 41/254 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
           S ++ EV+ L  L+HPNI++L          Y  FE + N   YL+      M  Y  K 
Sbjct: 81  SKLLEEVAVLKLLDHPNIMKL----------YDFFEDKRN--YYLV------MECY--KG 120
Query: 73  FNSYSLFTTFLLVEEFXXXXXXXXXXFGTRY------IRRDLKPVNILVDLDGKT--VKV 124
              +      +   E            G  Y      + RDLKP N+L++   K   +K+
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKI 180
Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
             FGL+ +++  + +    +GT YY APE+L    +Y    D+W +G I   +++G P F
Sbjct: 181 VDFGLS-AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPF 237
Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
            G     T   I+ K  K  +   S        +  +     DLI +ML  D  +RI+A 
Sbjct: 238 GGQ----TDQEILRKVEKGKYTFDSPE------WKNVSEGAKDLIKQMLQFDSQRRISAQ 287
Query: 245 EALQQEYFKDVPGR 258
           +AL+  + K++  +
Sbjct: 288 QALEHPWIKEMCSK 301

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 87/205 (42%), Gaps = 63/205 (30%)
Query: 104 IRRDLKPVNILV-DLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGL 158
           I  DLKP NIL+ +     +K+  FG    L + +Y         + + +Y++PE+LLG+
Sbjct: 181 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-------XIQSRFYRSPEVLLGM 233
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG--------------KSRK-- 202
             Y  A+D+W +GCI  EM +G+PLF GAN +  + +IV               K+RK  
Sbjct: 234 -PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFF 292
Query: 203 ----------------------PSFCKLSLRDHLTNGFPGLEPAG------------IDL 228
                                 P   KL     +  G PG   AG             DL
Sbjct: 293 EKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352
Query: 229 ISKMLGMDPDKRITAAEALQQEYFK 253
           I +ML  DP  RI    ALQ  +FK
Sbjct: 353 ILRMLDYDPKTRIQPYYALQHSFFK 377

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/114 (42%), Positives = 62/114 (54%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  +KVA FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/114 (42%), Positives = 62/114 (54%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  +KVA FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLLIDQQG-YIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 87/205 (42%), Gaps = 63/205 (30%)
Query: 104 IRRDLKPVNILV-DLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGL 158
           I  DLKP NIL+ +     +K+  FG    L + +Y         + + +Y++PE+LLG+
Sbjct: 181 IHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQ-------XIQSRFYRSPEVLLGM 233
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG--------------KSRK-- 202
             Y  A+D+W +GCI  EM +G+PLF GAN +  + +IV               K+RK  
Sbjct: 234 -PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFF 292
Query: 203 ----------------------PSFCKLSLRDHLTNGFPGLEPAG------------IDL 228
                                 P   KL     +  G PG   AG             DL
Sbjct: 293 EKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352
Query: 229 ISKMLGMDPDKRITAAEALQQEYFK 253
           I +ML  DP  RI    ALQ  +FK
Sbjct: 353 ILRMLDYDPKTRIQPYYALQHSFFK 377

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 87/205 (42%), Gaps = 63/205 (30%)
Query: 104 IRRDLKPVNILV-DLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGL 158
           I  DLKP NIL+ +     +K+  FG    L + +Y         + + +Y++PE+LLG+
Sbjct: 162 IHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-------XIQSRFYRSPEVLLGM 214
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG--------------KSRK-- 202
             Y  A+D+W +GCI  EM +G+PLF GAN +  + +IV               K+RK  
Sbjct: 215 -PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFF 273
Query: 203 ----------------------PSFCKLSLRDHLTNGFPGLEPAG------------IDL 228
                                 P   KL     +  G PG   AG             DL
Sbjct: 274 EKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 333
Query: 229 ISKMLGMDPDKRITAAEALQQEYFK 253
           I +ML  DP  RI    ALQ  +FK
Sbjct: 334 ILRMLDYDPKTRIQPYYALQHSFFK 358

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/114 (42%), Positives = 62/114 (54%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  +KVA FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/114 (42%), Positives = 62/114 (54%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  +KVA FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIKVADFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 40/245 (16%)
Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +I E+  + E  +PNI+  +     G  L+ V EY               + G S  +  
Sbjct: 65  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY---------------LAGGSLTDVV 109
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           + +      +                 + I R++K  NIL+ +DG +VK+  FG    + 
Sbjct: 110 TETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDG-SVKLTDFGFCAQIT 168
Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
             + + S  VGT Y+ APE++     Y   VDIW +G +  EM+ G+P +   N L  L 
Sbjct: 169 PEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 227
Query: 195 RIVGKSRKPSFCKLSLRDHLTNGFPGLE-PAGI-----DLISKMLGMDPDKRITAAEALQ 248
            I                  TNG P L+ P  +     D +++ L MD +KR +A E +Q
Sbjct: 228 LIA-----------------TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQ 270
Query: 249 QEYFK 253
            ++ K
Sbjct: 271 HQFLK 275

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 102/245 (41%), Gaps = 40/245 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
             + REV  +  LNHPNI++L  V      LY + EY    +V D  YL+ + +      
Sbjct: 59  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD--YLVAHGR------ 110
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K   + S F   +   ++             R + RDLK  N+L+D D   +K+A FG
Sbjct: 111 -MKEKEARSKFRQIVSAVQYCHQ---------KRIVHRDLKAENLLLDAD-MNIKIADFG 159
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
            +   +   G+  A  G   Y APEL  G       VD+W +G I   +VSG   F G N
Sbjct: 160 FSNE-FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218
Query: 189 SLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
                 R++ GK R P +                     +L+ + L ++P KR T  + +
Sbjct: 219 LKELRERVLRGKYRIPFYMSTDCE---------------NLLKRFLVLNPIKRGTLEQIM 263
Query: 248 QQEYF 252
           +  + 
Sbjct: 264 KDRWI 268

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/114 (41%), Positives = 62/114 (54%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+++D  G  +KV  FGLAK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLMIDQQG-YIKVTDFGLAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 69  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GCLLKY---- 122
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 123 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQI 173
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL      S + D+W +GCI  ++V+G P
Sbjct: 174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SASKSSDLWALGCIIYQLVAGLP 232
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 233 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 277
Query: 242 TAAE 245
              E
Sbjct: 278 GCEE 281

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 110/246 (44%), Gaps = 34/246 (13%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGV   + RE+     L+HPNI+RL         +Y + EY           P+  +   
Sbjct: 64  EGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYA----------PRGELYKE 113
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K+  ++    T  ++EE            G + I RD+KP N+L+ L    +K+A FG
Sbjct: 114 LQKSC-TFDEQRTATIMEELADALMYC---HGKKVIHRDIKPENLLLGL-KGELKIADFG 168
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
              S++A         GT  Y  PE++ G + ++  VD+W +G +  E++ G P F  A+
Sbjct: 169 W--SVHAPSLRRKTMCGTLDYLPPEMIEGRM-HNEKVDLWCIGVLCYELLVGNPPFESAS 225
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGI-DLISKMLGMDPDKRITAAEAL 247
              T  RIV         K+ L+      FP   P G  DLISK+L  +P +R+  A+  
Sbjct: 226 HNETYRRIV---------KVDLK------FPASVPTGAQDLISKLLRHNPSERLPLAQVS 270
Query: 248 QQEYFK 253
              + +
Sbjct: 271 AHPWVR 276

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 102/245 (41%), Gaps = 40/245 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
             + REV  +  LNHPNI++L  V      LY + EY    +V D  YL+ + +      
Sbjct: 56  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD--YLVAHGR------ 107
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K   + S F   +   ++             R + RDLK  N+L+D D   +K+A FG
Sbjct: 108 -MKEKEARSKFRQIVSAVQYCHQ---------KRIVHRDLKAENLLLDAD-MNIKIADFG 156
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
            +   +   G+     G+  Y APEL  G       VD+W +G I   +VSG   F G N
Sbjct: 157 FSNE-FTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215
Query: 189 SLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
                 R++ GK R P +                     +L+ + L ++P KR T  + +
Sbjct: 216 LKELRERVLRGKYRIPFYMSTDCE---------------NLLKRFLVLNPIKRGTLEQIM 260
Query: 248 QQEYF 252
           +  + 
Sbjct: 261 KDRWI 265

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 98/244 (40%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 67  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 120
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 121 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQI 171
Query: 125 AGFGLAKSLY--AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L   + +  ++A VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 172 TDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 230
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 231 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 275
Query: 242 TAAE 245
              E
Sbjct: 276 GCEE 279

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 101/236 (42%), Gaps = 37/236 (15%)
Query: 26  NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLK----YPKDSMNGYSTKNFNSYSLFTT 81
            HPNII L  V   G Y+Y V E        L+K      K     + ++   S  LFT 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTE--------LMKGGELLDKILRQKFFSEREASAVLFTI 125
Query: 82  FLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL-VDLDG--KTVKVAGFGLAKSLYAYKG 138
              VE                 + RDLKP NIL VD  G  +++++  FG AK L A  G
Sbjct: 126 TKTVEYL----------HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 139 ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG-KPLFPGANSLITLGRIV 197
                  T  + APE+L     Y  A DIW +G +   M++G  P   G +   T   I+
Sbjct: 176 LLMTPCYTANFVAPEVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEIL 232
Query: 198 GKSRKPSFCKLSLRDHLTNGF-PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
            +     F        L+ G+   +     DL+SKML +DP +R+TAA  L+  + 
Sbjct: 233 ARIGSGKFS-------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 62/114 (54%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+++D  G  ++V  FGLAK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLMIDQQG-YIQVTDFGLAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+++D  G  +KV  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLMIDQQG-YIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 47/250 (18%)
Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
           +++ EV+ L +L+HPNI++          LY  FE + N   YL+            + +
Sbjct: 67  ALLDEVAVLKQLDHPNIMK----------LYEFFEDKRN--YYLV-----------MEVY 103
Query: 74  NSYSLFTTFLLVEEFXXXXXX---XXXXFGTRY------IRRDLKPVNILVDLDGKT--V 122
               LF   +L ++F              GT Y      + RDLKP N+L++   +   +
Sbjct: 104 RGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALI 163
Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+  FGL+ + +   G+    +GT YY APE+L    +Y    D+W  G I   ++ G P
Sbjct: 164 KIVDFGLS-AHFEVGGKMKERLGTAYYIAPEVLRK--KYDEKCDVWSCGVILYILLCGYP 220
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F G      L R+  +  K SF            +  +      L+  ML  +P KRI+
Sbjct: 221 PFGGQTDQEILKRV--EKGKFSFD--------PPDWTQVSDEAKQLVKLMLTYEPSKRIS 270
Query: 243 AAEALQQEYF 252
           A EAL   + 
Sbjct: 271 AEEALNHPWI 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+++D  G  +KV  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLMIDQQG-YIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 72  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 125
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 126 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQI 176
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 177 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 235
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 236 PFRAGNEYLIFQKII---------------KLEYDFPAAFFPKARDLVEKLLVLDATKRL 280
Query: 242 TAAE 245
              E
Sbjct: 281 GCEE 284

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+++D  G  +KV  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLMIDQQG-YIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+++D  G  +KV  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLMIDQQG-YIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 47/250 (18%)
Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
           +++ EV+ L +L+HPNI++          LY  FE + N   YL+            + +
Sbjct: 50  ALLDEVAVLKQLDHPNIMK----------LYEFFEDKRN--YYLV-----------MEVY 86
Query: 74  NSYSLFTTFLLVEEFXXXXXX---XXXXFGTRY------IRRDLKPVNILVDLDGKT--V 122
               LF   +L ++F              GT Y      + RDLKP N+L++   +   +
Sbjct: 87  RGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALI 146
Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+  FGL+ + +   G+    +GT YY APE+L    +Y    D+W  G I   ++ G P
Sbjct: 147 KIVDFGLS-AHFEVGGKMKERLGTAYYIAPEVLRK--KYDEKCDVWSCGVILYILLCGYP 203
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F G      L R+  +  K SF            +  +      L+  ML  +P KRI+
Sbjct: 204 PFGGQTDQEILKRV--EKGKFSFD--------PPDWTQVSDEAKQLVKLMLTYEPSKRIS 253
Query: 243 AAEALQQEYF 252
           A EAL   + 
Sbjct: 254 AEEALNHPWI 263

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+++D  G  +KV  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLMIDQQG-YIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 149 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWTLCGTPEYLAPEIILSK-GYNK 203
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 204 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 257

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+++D  G  +KV  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLMIDQQG-YIKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+ LDG+ VK++ FG    +     +    VGT Y+ APE++   L Y+T
Sbjct: 163 IHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSL-YAT 220
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VDIW +G +  EMV G+P +   + +  + R+  +   P   K S +         + P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--RDSPPPKLKNSHK---------VSP 269
Query: 224 AGIDLISKMLGMDPDKRITAAEALQQEYF 252
              D + +ML  DP +R TA E L   + 
Sbjct: 270 VLRDFLERMLVRDPQERATAQELLDHPFL 298

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 46  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 99
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 100 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH-IQI 150
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 151 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 209
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 210 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 254
Query: 242 TAAE 245
              E
Sbjct: 255 GCEE 258

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 45  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 98
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 99  -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH-IQI 149
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 150 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 208
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 209 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 253
Query: 242 TAAE 245
              E
Sbjct: 254 GCEE 257

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 44  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 97
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 98  -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH-IQI 148
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 149 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 207
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 208 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 252
Query: 242 TAAE 245
              E
Sbjct: 253 GCEE 256

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWTLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLAGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 47  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 100
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 101 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH-IQI 151
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 152 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 210
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 211 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 255
Query: 242 TAAE 245
              E
Sbjct: 256 GCEE 259

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 74  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKN--GELLKY---- 127
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 128 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQI 178
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 179 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 237
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 238 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 282
Query: 242 TAAE 245
              E
Sbjct: 283 GCEE 286

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 51  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 104
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 105 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH-IQI 155
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 156 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 214
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 215 PFRAGNEYLIFQKIIK---------------LEYDFPEKFFPKARDLVEKLLVLDATKRL 259
Query: 242 TAAE 245
              E
Sbjct: 260 GCEE 263

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 104/245 (42%), Gaps = 41/245 (16%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGYSTKN 72
           RE      L HPNI+RL    S+  + Y +F+     ++ +     +Y  ++   +  + 
Sbjct: 70  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ 129
Query: 73  FNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLDGKTVKVAGFGLA 130
                L    + V                  + RDLKP N+L+   L G  VK+A FGLA
Sbjct: 130 ILEAVLHCHQMGV------------------VHRDLKPENLLLASKLKGAAVKLADFGLA 171
Query: 131 KSLYAYKGESSAE---VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
             +   +GE  A     GT  Y +PE+L     Y   VD+W  G I   ++ G P F   
Sbjct: 172 IEV---EGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDE 227
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
           +      +I          K    D  +  +  + P   DLI+KML ++P KRITAAEAL
Sbjct: 228 DQHRLYQQI----------KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 277
Query: 248 QQEYF 252
           +  + 
Sbjct: 278 KHPWI 282

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
             + REV  +  LNHPNI++L  V      LY V EY    +V D  YL+ + +      
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD--YLVAHGR------ 109
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K   + + F   +   ++               + RDLK  N+L+D D   +K+A FG
Sbjct: 110 -MKEKEARAKFRQIVSAVQYCHQKFI---------VHRDLKAENLLLDAD-MNIKIADFG 158
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
            +   + +  +  A  G   Y APEL  G       VD+W +G I   +VSG   F G N
Sbjct: 159 FSNE-FTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217
Query: 189 SLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
                 R++ GK R P +                     +L+ K L ++P KR T  + +
Sbjct: 218 LKELRERVLRGKYRIPFYMSTDCE---------------NLLKKFLILNPSKRGTLEQIM 262
Query: 248 QQEY 251
           +  +
Sbjct: 263 KDRW 266

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 156 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 210
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 211 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 264

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 69  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 122
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 123 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH-IQI 173
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 174 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 232
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 233 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 277
Query: 242 TAAE 245
              E
Sbjct: 278 GCEE 281

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 67  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 120
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 121 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH-IQI 171
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 172 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 230
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 231 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 275
Query: 242 TAAE 245
              E
Sbjct: 276 GCEE 279

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 156 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 210
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 211 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 264

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 69  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 122
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 123 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQI 173
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 174 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 232
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 233 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 277
Query: 242 TAAE 245
              E
Sbjct: 278 GCEE 281

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 104 IRRDLKPVNILVDLDGKT--VKVAGFGLAKSLYAYKGESS---AEVGTHYYKAPELLL-- 156
           I RDLKP N+L+    +   +K+  FG +K L    GE+S      GT  Y APE+L+  
Sbjct: 275 IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEVLVSV 330
Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
           G   Y+ AVD W +G I    +SG P F    +                 ++SL+D +T+
Sbjct: 331 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-----------------QVSLKDQITS 373
Query: 217 G--------FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
           G        +  +    +DL+ K+L +DP  R T  EAL+  + +D
Sbjct: 374 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 158 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 212
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 213 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 266

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 67  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 120
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 121 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQI 171
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 172 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 230
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 231 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 275
Query: 242 TAAE 245
              E
Sbjct: 276 GCEE 279

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 66  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 119
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 120 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH-IQI 170
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 171 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 229
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 230 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 274
Query: 242 TAAE 245
              E
Sbjct: 275 GCEE 278

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 66  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 119
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 120 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH-IQI 170
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 171 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 229
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 230 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 274
Query: 242 TAAE 245
              E
Sbjct: 275 GCEE 278

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 69  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 122
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 123 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQI 173
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 174 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 232
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 233 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 277
Query: 242 TAAE 245
              E
Sbjct: 278 GCEE 281

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 70  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 123
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 124 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQI 174
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 175 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 233
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 234 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 278
Query: 242 TAAE 245
              E
Sbjct: 279 GCEE 282

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 70  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 123
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 124 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQI 174
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 175 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 233
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 234 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 278
Query: 242 TAAE 245
              E
Sbjct: 279 GCEE 282

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 67  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 120
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 121 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQI 171
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 172 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 230
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 231 PFRAGNEYLIFQKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 275
Query: 242 TAAE 245
              E
Sbjct: 276 GCEE 279

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 164 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 94/234 (40%), Gaps = 34/234 (14%)
Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           + RE   +  L+HP  ++L         LY    Y  N    LLKY          +   
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---------IRKIG 127
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           S+    T     E            G   I RDLKP NIL++ D   +++  FG AK L 
Sbjct: 128 SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQITDFGTAKVLS 183
Query: 135 AYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT 192
               ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P F   N  + 
Sbjct: 184 PESKQARANXFVGTAQYVSPELLTEKSAXKSS-DLWALGCIIYQLVAGLPPFRAGNEGLI 242
Query: 193 LGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRITAAE 245
             +I+                L   FP    P   DL+ K+L +D  KR+   E
Sbjct: 243 FAKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEE 281

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLXGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 104 IRRDLKPVNILVDLDGKT--VKVAGFGLAKSLYAYKGESS---AEVGTHYYKAPELLL-- 156
           I RDLKP N+L+    +   +K+  FG +K L    GE+S      GT  Y APE+L+  
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEVLVSV 316
Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
           G   Y+ AVD W +G I    +SG P F    +                 ++SL+D +T+
Sbjct: 317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-----------------QVSLKDQITS 359
Query: 217 G--------FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
           G        +  +    +DL+ K+L +DP  R T  EAL+  + +D
Sbjct: 360 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 96/244 (39%), Gaps = 34/244 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           H   E     + RE   +  L+HP  ++L         LY    Y  N    LLKY    
Sbjct: 69  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--GELLKY---- 122
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                 +   S+    T     E            G   I RDLKP NIL++ D   +++
Sbjct: 123 -----IRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED-MHIQI 173
Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
             FG AK L     ++ A   VGT  Y +PELL       ++ D+W +GCI  ++V+G P
Sbjct: 174 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLP 232
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLEPAGIDLISKMLGMDPDKRI 241
            F   N  +   +I+                L   FP    P   DL+ K+L +D  KR+
Sbjct: 233 PFRAGNEGLIFAKII---------------KLEYDFPEKFFPKARDLVEKLLVLDATKRL 277
Query: 242 TAAE 245
              E
Sbjct: 278 GCEE 281

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 104 IRRDLKPVNILVDLDGKT--VKVAGFGLAKSLYAYKGESS---AEVGTHYYKAPELLL-- 156
           I RDLKP N+L+    +   +K+  FG +K L    GE+S      GT  Y APE+L+  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEVLVSV 191
Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
           G   Y+ AVD W +G I    +SG P F    +                 ++SL+D +T+
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-----------------QVSLKDQITS 234
Query: 217 G--------FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
           G        +  +    +DL+ K+L +DP  R T  EAL+  + +D
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 104 IRRDLKPVNILVDLDGKT--VKVAGFGLAKSLYAYKGESS---AEVGTHYYKAPELLL-- 156
           I RDLKP N+L+    +   +K+  FG +K L    GE+S      GT  Y APE+L+  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEVLVSV 191
Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
           G   Y+ AVD W +G I    +SG P F    +                 ++SL+D +T+
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-----------------QVSLKDQITS 234
Query: 217 G--------FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
           G        +  +    +DL+ K+L +DP  R T  EAL+  + +D
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 184 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 238
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 292

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 104 IRRDLKPVNILVDLDGKT--VKVAGFGLAKSLYAYKGESS---AEVGTHYYKAPELLL-- 156
           I RDLKP N+L+    +   +K+  FG +K L    GE+S      GT  Y APE+L+  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEVLVSV 191
Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
           G   Y+ AVD W +G I    +SG P F    +                 ++SL+D +T+
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-----------------QVSLKDQITS 234
Query: 217 G--------FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
           G        +  +    +DL+ K+L +DP  R T  EAL+  + +D
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 150 IYRDLKPENLLIDEQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 204
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 205 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 258

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 50/236 (21%)
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKT-V 122
           SMN Y     N +  F+  L+ +               R I  DLKP NIL+   G++ +
Sbjct: 182 SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI 241
Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           KV  FG   S Y ++      + + +Y+APE++LG   Y   +D+W +GCI  E+++G P
Sbjct: 242 KVIDFG--SSCYEHQ-RVYTXIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYP 297
Query: 183 LFPGANSLITLG-----------RIVGKSRK----------PSFCKL------------- 208
           L PG +    L            +++  S++          P +C +             
Sbjct: 298 LLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGG 357
Query: 209 -SLRDHLT---------NGFPGL-EPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
            S R  L          N   G  +P  +D + + L  DP  R+T  +AL+  + +
Sbjct: 358 RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 104 IRRDLKPVNILVDLDGKT--VKVAGFGLAKSLYAYKGESS---AEVGTHYYKAPELLL-- 156
           I RDLKP N+L+    +   +K+  FG +K L    GE+S      GT  Y APE+L+  
Sbjct: 135 IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEVLVSV 190
Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
           G   Y+ AVD W +G I    +SG P F    +                 ++SL+D +T+
Sbjct: 191 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-----------------QVSLKDQITS 233
Query: 217 G--------FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
           G        +  +    +DL+ K+L +DP  R T  EAL+  + +D
Sbjct: 234 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 184 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 238
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 292

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGLL 159
            R I RDLK  N+ ++ D + VK+  FGLA  +  Y GE    + GT  Y APE+L    
Sbjct: 136 NRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKV-EYDGERKKTLCGTPNYIAPEVL-SKK 192
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +S  VD+W +GCI   ++ GKP F  +    T  RI          + S+  H+     
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------EYSIPKHIN---- 241
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD--VPGR 258
              P    LI KML  DP  R T  E L  E+F    +P R
Sbjct: 242 ---PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 279

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGLL 159
            R I RDLK  N+ ++ D + VK+  FGLA  +  Y GE    + GT  Y APE+L    
Sbjct: 136 NRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKV-EYDGERKKTLCGTPNYIAPEVL-SKK 192
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +S  VD+W +GCI   ++ GKP F  +    T  RI          + S+  H+     
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------EYSIPKHIN---- 241
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD--VPGR 258
              P    LI KML  DP  R T  E L  E+F    +P R
Sbjct: 242 ---PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 279

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 64/127 (50%), Gaps = 5/127 (3%)
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKT-V 122
           SMN Y     N +  F+  L+ +               R I  DLKP NIL+   G++ +
Sbjct: 182 SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI 241
Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           KV  FG   S Y ++      + + +Y+APE++LG   Y   +D+W +GCI  E+++G P
Sbjct: 242 KVIDFG--SSCYEHQ-RVYTXIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYP 297
Query: 183 LFPGANS 189
           L PG + 
Sbjct: 298 LLPGEDE 304

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 103/237 (43%), Gaps = 33/237 (13%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDL-AYLLKYPKDSMNGYSTKNFNS 75
           RE+S L  L HP+II+L  V +    +  V EY   +L  Y+++  K  M     + F  
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE--KKRMTEDEGRRF-- 113
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              F   +   E+             + + RDLKP N+L+D D   VK+A FGL+ ++  
Sbjct: 114 ---FQQIICAIEYCHRH---------KIVHRDLKPENLLLD-DNLNVKIADFGLS-NIMT 159
Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGR 195
                    G+  Y APE++ G L     VD+W  G +   M+ G+   P  +  I    
Sbjct: 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR--LPFDDEFIP--- 214
Query: 196 IVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                +K + C   + D L+       P    LI +M+  DP +RIT  E  +  +F
Sbjct: 215 --NLFKKVNSCVYVMPDFLS-------PGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 36/166 (21%)
Query: 104 IRRDLKPVNILVDLDGKT--VKVAGFGLAKSLYAYKGESS---AEVGTHYYKAPELLL-- 156
           I RDLKP N+L+    +   +K+  FG +K L    GE+S      GT  Y APE+L+  
Sbjct: 142 IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEVLVSV 197
Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
           G   Y+ AVD W +G I    +SG P F    +                 ++SL+D +T+
Sbjct: 198 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-----------------QVSLKDQITS 240
Query: 217 G--------FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
           G        +  +    +DL+ K+L +DP  R T  EAL+  + +D
Sbjct: 241 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 85/195 (43%), Gaps = 54/195 (27%)
Query: 107 DLKPVNIL-------------VDLDGKT-----VKVAGFGLAKSLYAYKGES-SAEVGTH 147
           DLKP NIL             +  D +T     +KV  FG A     Y  E  S  V T 
Sbjct: 143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA----TYDDEHHSTLVSTR 198
Query: 148 YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS---LITLGRIVG------ 198
           +Y+APE++L L  +S   D+W +GCI  E   G  +FP  +S   L  + RI+G      
Sbjct: 199 HYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHM 257
Query: 199 --KSRKPSFC---KLSLRDHLTNG---FPGLEPAG-------------IDLISKMLGMDP 237
             K+RK  +    +L   +H + G       +P                DLI KML  DP
Sbjct: 258 IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317
Query: 238 DKRITAAEALQQEYF 252
            KRIT  EAL+  +F
Sbjct: 318 AKRITLREALKHPFF 332

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/114 (40%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 184 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGATWTLCGTPEYLAPEIILSK-GYNK 238
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 292

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGLL 159
            R I RDLK  N+ ++ D + VK+  FGLA  +  Y GE    + GT  Y APE+L    
Sbjct: 140 NRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKV-EYDGERKKTLCGTPNYIAPEVL-SKK 196
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +S  VD+W +GCI   ++ GKP F  +    T  RI          + S+  H+     
Sbjct: 197 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------EYSIPKHIN---- 245
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD--VPGR 258
              P    LI KML  DP  R T  E L  E+F    +P R
Sbjct: 246 ---PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 283

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 45/114 (39%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+++D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLMIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 50/236 (21%)
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKT-V 122
           SMN Y     N +  F+  L+ +               R I  DLKP NIL+   G++ +
Sbjct: 182 SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGI 241
Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           KV  FG   S Y ++      + + +Y+APE++LG   Y   +D+W +GCI  E+++G P
Sbjct: 242 KVIDFG--SSCYEHQ-RVYXXIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYP 297
Query: 183 LFPGANSLITLG-----------RIVGKSRK----------PSFCKL------------- 208
           L PG +    L            +++  S++          P +C +             
Sbjct: 298 LLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGG 357
Query: 209 -SLRDHLT---------NGFPGL-EPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
            S R  L          N   G  +P  +D + + L  DP  R+T  +AL+  + +
Sbjct: 358 RSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 109/261 (41%), Gaps = 43/261 (16%)
Query: 4   IHNTMEGVPSSMIR-EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ-----VNDLAYL 57
           I+     VP   I  E+  L  L+HPNII++  V      +Y V E       +  +   
Sbjct: 55  INKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSA 114
Query: 58  LKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYI-RRDLKPVNILVD 116
               K    GY                V E           F ++++  +DLKP NIL  
Sbjct: 115 QARGKALSEGY----------------VAELMKQMMNALAYFHSQHVVHKDLKPENILFQ 158
Query: 117 LDG--KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIF 174
                  +K+  FGLA+ L+     S+   GT  Y APE+    + +    DIW  G + 
Sbjct: 159 DTSPHSPIKIIDFGLAE-LFKSDEHSTNAAGTALYMAPEVFKRDVTFK--CDIWSAGVVM 215
Query: 175 GEMVSGKPLFPGANSLITLGRIVGKS--RKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
             +++G   F G     +L  +  K+  ++P++  +  R         L P  +DL+ +M
Sbjct: 216 YFLLTGCLPFTGT----SLEEVQQKATYKEPNYA-VECR--------PLTPQAVDLLKQM 262
Query: 233 LGMDPDKRITAAEALQQEYFK 253
           L  DP++R +AA+ L  E+FK
Sbjct: 263 LTKDPERRPSAAQVLHHEWFK 283

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
             + REV  +  LNHPNI++L  V      LY V EY    +V D  YL+ + +      
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD--YLVAHGR------ 109
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K   + + F   +   ++               + RDLK  N+L+D D   +K+A FG
Sbjct: 110 -MKEKEARAKFRQIVSAVQYCHQKFI---------VHRDLKAENLLLDAD-MNIKIADFG 158
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
            +   + +  +     G+  Y APEL  G       VD+W +G I   +VSG   F G N
Sbjct: 159 FSNE-FTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217
Query: 189 SLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
                 R++ GK R P +                     +L+ K L ++P KR T  + +
Sbjct: 218 LKELRERVLRGKYRIPFYMSTDCE---------------NLLKKFLILNPSKRGTLEQIM 262
Query: 248 QQEY 251
           +  +
Sbjct: 263 KDRW 266

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
             + REV  +  LNHPNI++L  V      LY V EY    +V D  YL+ + +      
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD--YLVAHGR------ 109
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K   + + F   +   ++               + RDLK  N+L+D D   +K+A FG
Sbjct: 110 -MKEKEARAKFRQIVSAVQYCHQKFI---------VHRDLKAENLLLDAD-MNIKIADFG 158
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
            +   + +  +     G+  Y APEL  G       VD+W +G I   +VSG   F G N
Sbjct: 159 FSNE-FTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217
Query: 189 SLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
                 R++ GK R P +                     +L+ K L ++P KR T  + +
Sbjct: 218 LKELRERVLRGKYRIPFYMSTDCE---------------NLLKKFLILNPSKRGTLEQIM 262
Query: 248 QQEY 251
           +  +
Sbjct: 263 KDRW 266

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
             + REV  +  LNHPNI++L  V      LY V EY    +V D  YL+ + +      
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD--YLVAHGR------ 109
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K   + + F   +   ++               + RDLK  N+L+D D   +K+A FG
Sbjct: 110 -MKEKEARAKFRQIVSAVQYCHQKFI---------VHRDLKAENLLLDAD-MNIKIADFG 158
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
            +   + +  +     G+  Y APEL  G       VD+W +G I   +VSG   F G N
Sbjct: 159 FSNE-FTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217
Query: 189 SLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
                 R++ GK R P +                     +L+ K L ++P KR T  + +
Sbjct: 218 LKELRERVLRGKYRIPFYMSTDCE---------------NLLKKFLILNPSKRGTLEQIM 262
Query: 248 QQEY 251
           +  +
Sbjct: 263 KDRW 266

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGLL 159
            R I RDLK  N+ ++ D + VK+  FGLA  +  Y GE    + GT  Y APE+L    
Sbjct: 134 NRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVL-SKK 190
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +S  VD+W +GCI   ++ GKP F  +    T  RI    +K  +   S+  H+     
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----KKNEY---SIPKHIN---- 239
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD--VPGR 258
              P    LI KML  DP  R T  E L  E+F    +P R
Sbjct: 240 ---PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 277

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
             + REV  +  LNHPNI++L  V      LY V EY    +V D  YL+ + +      
Sbjct: 58  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD--YLVAHGR------ 109
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K   + + F   +   ++               + RDLK  N+L+D D   +K+A FG
Sbjct: 110 -MKEKEARAKFRQIVSAVQYCHQKFI---------VHRDLKAENLLLDAD-MNIKIADFG 158
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
            +   + +  +     G+  Y APEL  G       VD+W +G I   +VSG   F G N
Sbjct: 159 FSNE-FTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217
Query: 189 SLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
                 R++ GK R P +                     +L+ K L ++P KR T  + +
Sbjct: 218 LKELRERVLRGKYRIPFYMSTDCE---------------NLLKKFLILNPSKRGTLEQIM 262
Query: 248 QQEY 251
           +  +
Sbjct: 263 KDRW 266

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/114 (39%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  +M +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGLL 159
            R I RDLK  N+ ++ D + VK+  FGLA  +  Y GE    + GT  Y APE+L    
Sbjct: 158 NRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVL-SKK 214
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +S  VD+W +GCI   ++ GKP F  +    T  RI          + S+  H+     
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------EYSIPKHIN---- 263
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD--VPGR 258
              P    LI KML  DP  R T  E L  E+F    +P R
Sbjct: 264 ---PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 301

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGLL 159
            R I RDLK  N+ ++ D + VK+  FGLA  +  Y GE    + GT  Y APE+L    
Sbjct: 160 NRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVL-SKK 216
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +S  VD+W +GCI   ++ GKP F  +    T  RI          + S+  H+     
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------EYSIPKHIN---- 265
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD--VPGR 258
              P    LI KML  DP  R T  E L  E+F    +P R
Sbjct: 266 ---PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 303

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 40/244 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
             + REV  +  LNHPNI++L  V      LY V EY    +V D  YL+ +      G+
Sbjct: 51  QKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD--YLVAH------GW 102
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K   + + F   +   ++               + RDLK  N+L+D D   +K+A FG
Sbjct: 103 -MKEKEARAKFRQIVSAVQYCHQKFI---------VHRDLKAENLLLDAD-MNIKIADFG 151
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
            +   + +  +     G+  Y APEL  G       VD+W +G I   +VSG   F G N
Sbjct: 152 FSNE-FTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210
Query: 189 SLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
                 R++ GK R P +                     +L+ K L ++P KR T  + +
Sbjct: 211 LKELRERVLRGKYRIPFYMSTDCE---------------NLLKKFLILNPSKRGTLEQIM 255
Query: 248 QQEY 251
           +  +
Sbjct: 256 KDRW 259

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 104/245 (42%), Gaps = 41/245 (16%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGYSTKN 72
           RE      L HPNI+RL    S+  + Y +F+     ++ +     +Y  ++   +  + 
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ 118
Query: 73  FNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLDGKTVKVAGFGLA 130
                L    + V                  + R+LKP N+L+   L G  VK+A FGLA
Sbjct: 119 ILEAVLHCHQMGV------------------VHRNLKPENLLLASKLKGAAVKLADFGLA 160
Query: 131 KSLYAYKGESSAE---VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
             +   +GE  A     GT  Y +PE+L     Y   VD+W  G I   ++ G P F   
Sbjct: 161 IEV---EGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDE 216
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
           +      +I          K    D  +  +  + P   DLI+KML ++P KRITAAEAL
Sbjct: 217 DQHRLYQQI----------KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266
Query: 248 QQEYF 252
           +  + 
Sbjct: 267 KHPWI 271

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 113/252 (44%), Gaps = 36/252 (14%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
             +I+E+S + + + P++++      +   L+ V EY     V+D+  L        N  
Sbjct: 69  QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL-------RNKT 121
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
            T++  +  L +T   +E               R I RD+K  NIL++ +G   K+A FG
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFM----------RKIHRDIKAGNILLNTEGHA-KLADFG 170
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           +A  L     + +  +GT ++ APE++   + Y+   DIW +G    EM  GKP +   +
Sbjct: 171 VAGQLTDXMAKRNXVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIH 229
Query: 189 SLITLGRIVGKSRKPSFCKLSL-RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
            +  +  ++  +  P+F K  L  D+ T           D + + L   P++R TA + L
Sbjct: 230 PMRAIF-MIPTNPPPTFRKPELWSDNFT-----------DFVKQCLVKSPEQRATATQLL 277
Query: 248 QQEYFKDVPGRS 259
           Q  + +   G S
Sbjct: 278 QHPFVRSAKGVS 289

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/114 (38%), Positives = 61/114 (53%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+++D  G  ++V  FG AK +   KG +    GT  Y APE+++    Y+ 
Sbjct: 163 IYRDLKPENLIIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIISK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 30/250 (12%)
Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
             +EG   SM  E++ L ++ HPNI+ L  +   G +LY +   Q+     L  + +   
Sbjct: 54  EALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM--QLVSGGEL--FDRIVE 109
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL---VDLDGKTV 122
            G+ T+   S  +F     V+                 + RDLKP N+L   +D D K +
Sbjct: 110 KGFYTERDASRLIFQVLDAVKYLHDLGI----------VHRDLKPENLLYYSLDEDSK-I 158
Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
            ++ FGL+K        S+A  GT  Y APE+L     YS AVD W +G I   ++ G P
Sbjct: 159 MISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYP 216
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F   N      +I+    +            +  +  +  +  D I  ++  DP+KR T
Sbjct: 217 PFYDENDAKLFEQILKAEYEFD----------SPYWDDISDSAKDFIRHLMEKDPEKRFT 266
Query: 243 AAEALQQEYF 252
             +ALQ  + 
Sbjct: 267 CEQALQHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 107/249 (42%), Gaps = 30/249 (12%)
Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
             +EG   SM  E++ L ++ HPNI+ L  +   G +LY +   Q+     L  + +   
Sbjct: 54  EALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM--QLVSGGEL--FDRIVE 109
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL---VDLDGKTV 122
            G+ T+   S  +F     V+                 + RDLKP N+L   +D D K +
Sbjct: 110 KGFYTERDASRLIFQVLDAVKYLHDLGI----------VHRDLKPENLLYYSLDEDSK-I 158
Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
            ++ FGL+K        S+A  GT  Y APE+L     YS AVD W +G I   ++ G P
Sbjct: 159 MISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYP 216
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F   N      +I+    +            +  +  +  +  D I  ++  DP+KR T
Sbjct: 217 PFYDENDAKLFEQILKAEYEFD----------SPYWDDISDSAKDFIRHLMEKDPEKRFT 266
Query: 243 AAEALQQEY 251
             +ALQ  +
Sbjct: 267 CEQALQHPW 275

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 99/244 (40%), Gaps = 40/244 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
             + REV     LNHPNI++L  V      LY V EY    +V D  YL+ + +      
Sbjct: 58  QKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFD--YLVAHGR------ 109
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K   + + F   +   ++               + RDLK  N+L+D D   +K+A FG
Sbjct: 110 -XKEKEARAKFRQIVSAVQYCHQKFI---------VHRDLKAENLLLDAD-XNIKIADFG 158
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
            +   + +  +  A  G   Y APEL  G       VD+W +G I   +VSG   F G N
Sbjct: 159 FSNE-FTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217
Query: 189 SLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
                 R++ GK R P +                     +L+ K L ++P KR T  +  
Sbjct: 218 LKELRERVLRGKYRIPFYXSTDCE---------------NLLKKFLILNPSKRGTLEQIX 262
Query: 248 QQEY 251
           +  +
Sbjct: 263 KDRW 266

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 30/250 (12%)
Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
             +EG   SM  E++ L ++ HPNI+ L  +   G +LY +   Q+     L  + +   
Sbjct: 54  EALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM--QLVSGGEL--FDRIVE 109
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL---VDLDGKTV 122
            G+ T+   S  +F     V+                 + RDLKP N+L   +D D K +
Sbjct: 110 KGFYTERDASRLIFQVLDAVKYLHDLGI----------VHRDLKPENLLYYSLDEDSK-I 158
Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
            ++ FGL+K        S+A  GT  Y APE+L     YS AVD W +G I   ++ G P
Sbjct: 159 MISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYP 216
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F   N      +I+    +            +  +  +  +  D I  ++  DP+KR T
Sbjct: 217 PFYDENDAKLFEQILKAEYEFD----------SPYWDDISDSAKDFIRHLMEKDPEKRFT 266
Query: 243 AAEALQQEYF 252
             +ALQ  + 
Sbjct: 267 CEQALQHPWI 276

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/114 (39%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT  Y AP ++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEYLAPAIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 30/250 (12%)
Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
             +EG   SM  E++ L ++ HPNI+ L  +   G +LY +   Q+     L  + +   
Sbjct: 54  KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM--QLVSGGEL--FDRIVE 109
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL---VDLDGKTV 122
            G+ T+   S  +F     V+                 + RDLKP N+L   +D D K +
Sbjct: 110 KGFYTERDASRLIFQVLDAVKYLHDLGI----------VHRDLKPENLLYYSLDEDSK-I 158
Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
            ++ FGL+K        S+A  GT  Y APE+L     YS AVD W +G I   ++ G P
Sbjct: 159 MISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYP 216
Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F   N      +I+    +            +  +  +  +  D I  ++  DP+KR T
Sbjct: 217 PFYDENDAKLFEQILKAEYEFD----------SPYWDDISDSAKDFIRHLMEKDPEKRFT 266
Query: 243 AAEALQQEYF 252
             +ALQ  + 
Sbjct: 267 CEQALQHPWI 276

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 83/188 (44%), Gaps = 16/188 (8%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKNFNS 75
           REV+ L  + HPNI++      +   LY V +Y +  DL             +   N   
Sbjct: 72  REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL-------------FKRINAQK 118
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
             LF    +++ F             + + RD+K  NI +  DG TV++  FG+A+ L +
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNS 177
Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGR 195
               + A +GT YY +PE+      Y+   DIW +GC+  E+ + K  F   +    + +
Sbjct: 178 TVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK 236
Query: 196 IVGKSRKP 203
           I+  S  P
Sbjct: 237 IISGSFPP 244

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 84/195 (43%), Gaps = 54/195 (27%)
Query: 107 DLKPVNIL-------------VDLDGKT-----VKVAGFGLAKSLYAYKGES-SAEVGTH 147
           DLKP NIL             +  D +T     +KV  FG A     Y  E  S  V   
Sbjct: 143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA----TYDDEHHSTLVXXR 198
Query: 148 YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS---LITLGRIVG------ 198
           +Y+APE++L L  +S   D+W +GCI  E   G  +FP  +S   L  + RI+G      
Sbjct: 199 HYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHM 257
Query: 199 --KSRKPSFC---KLSLRDHLTNG---FPGLEPAG-------------IDLISKMLGMDP 237
             K+RK  +    +L   +H + G       +P                DLI KML  DP
Sbjct: 258 IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317
Query: 238 DKRITAAEALQQEYF 252
            KRIT  EAL+  +F
Sbjct: 318 AKRITLREALKHPFF 332

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 73/154 (47%), Gaps = 18/154 (11%)
Query: 100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGL 158
             R I RDLK  N+ ++ D   VK+  FGLA  +  + GE   ++ GT  Y APE+L   
Sbjct: 144 NNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAPEVLCKK 201
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
             +S  VDIW +GCI   ++ GKP F  +    T  RI          + S+  H+    
Sbjct: 202 -GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKN-------EYSVPRHIN--- 250
Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               P    LI +ML  DP  R + AE L  E+F
Sbjct: 251 ----PVASALIRRMLHADPTLRPSVAELLTDEFF 280

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 39/245 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVND--LAYLLKYPKDSMNGYSTKNFN 74
           RE+  L    HP+II+L +V S    ++ V EY        Y+ K      NG   +   
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK------NGRLDEK-E 117
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           S  LF   L   ++               + RDLKP N+L+D      K+A FGL+  + 
Sbjct: 118 SRRLFQQILSGVDYCHRHMV---------VHRDLKPENVLLDA-HMNAKIADFGLSNMMS 167
Query: 135 AYKGES-SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITL 193
              GE      G+  Y APE++ G L     VDIW  G I   ++ G   F   +     
Sbjct: 168 --DGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF 225
Query: 194 GRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
            +I  G    P +               L P+ I L+  ML +DP KR T  +  + E+F
Sbjct: 226 KKICDGIFYTPQY---------------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270
Query: 253 K-DVP 256
           K D+P
Sbjct: 271 KQDLP 275

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 73/154 (47%), Gaps = 18/154 (11%)
Query: 100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGL 158
             R I RDLK  N+ ++ D   VK+  FGLA  +  + GE   ++ GT  Y APE+L   
Sbjct: 160 NNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAPEVLCKK 217
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
             +S  VDIW +GCI   ++ GKP F  +    T  RI          + S+  H+    
Sbjct: 218 -GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKN-------EYSVPRHIN--- 266
Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               P    LI +ML  DP  R + AE L  E+F
Sbjct: 267 ----PVASALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/114 (39%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT    APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQG-YIQVTDFGFAKRV---KGRTWXLCGTPEALAPEIILSK-GYNK 217
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTN 216
           AVD W +G +  EM +G P F     +    +IV GK R PS     L+D L N
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 99/234 (42%), Gaps = 33/234 (14%)
Query: 26  NHPNIIRLMRVASQGIYLYPVFEYQVND--LAYLLKYPKDSMNGYSTKNFNSYSLFTTFL 83
            HPNII L  V   G Y+Y V E       L  +L+        + ++   S  LFT   
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILR------QKFFSEREASAVLFTITK 127
Query: 84  LVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL-VDLDG--KTVKVAGFGLAKSLYAYKGES 140
            VE                 + RDLKP NIL VD  G  +++++  FG AK L A  G  
Sbjct: 128 TVEYL----------HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 141 SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG-KPLFPGANSLITLGRIVGK 199
                T  + APE+L     Y  A DIW +G +    ++G  P   G +   T   I+ +
Sbjct: 178 XTPCYTANFVAPEVL-ERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDD--TPEEILAR 234
Query: 200 SRKPSFCKLSLRDHLTNGF-PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                F        L+ G+   +     DL+SK L +DP +R+TAA  L+  + 
Sbjct: 235 IGSGKFS-------LSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 98/254 (38%), Gaps = 59/254 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFE----------------YQVNDLAYLLKY 60
           RE      L HPNI+RL    S+  + Y VF+                Y   D ++ ++ 
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQ 111
Query: 61  PKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLD 118
             +S+N                                     + RDLKP N+L+     
Sbjct: 112 ILESVNHCHLNGI------------------------------VHRDLKPENLLLASKSK 141
Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           G  VK+A FGLA  +   +       GT  Y +PE+L     Y   VD+W  G I   ++
Sbjct: 142 GAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDMWACGVILYILL 200
Query: 179 SGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD 238
            G P F   +      +I          K    D  +  +  + P   DLI+KML ++P 
Sbjct: 201 VGYPPFWDEDQHRLYQQI----------KAGAYDFPSPEWDTVTPEAKDLINKMLTINPA 250
Query: 239 KRITAAEALQQEYF 252
           KRITA+EAL+  + 
Sbjct: 251 KRITASEALKHPWI 264

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 105 RRDLKPVNILVDLDGK-TVKVAGFGLAKSLYAYK-GE---SSAEVGTHYYKAPELLLGLL 159
            RD+KP N L   +    +K+  FGL+K  Y    GE    + + GT Y+ APE+L    
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250
Query: 160 E-YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
           E Y    D W  G +   ++ G   FPG N   T+ +++ K       KL   +     +
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK-------KLCFEN---PNY 300
Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
             L P   DL+S +L  + D+R  A  ALQ  +
Sbjct: 301 NVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 98/254 (38%), Gaps = 59/254 (23%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFE----------------YQVNDLAYLLKY 60
           RE      L HPNI+RL    S+  + Y VF+                Y   D ++ ++ 
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQ 111
Query: 61  PKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLD 118
             +S+N                                     + RDLKP N+L+     
Sbjct: 112 ILESVNHCHLNGI------------------------------VHRDLKPENLLLASKSK 141
Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           G  VK+A FGLA  +   +       GT  Y +PE+L     Y   VD+W  G I   ++
Sbjct: 142 GAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDMWACGVILYILL 200
Query: 179 SGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD 238
            G P F   +      +I          K    D  +  +  + P   DLI+KML ++P 
Sbjct: 201 VGYPPFWDEDQHRLYQQI----------KAGAYDFPSPEWDTVTPEAKDLINKMLTINPA 250
Query: 239 KRITAAEALQQEYF 252
           KRITA+EAL+  + 
Sbjct: 251 KRITASEALKHPWI 264

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+  DG+ +K++ FG    +     +    VGT Y+ APE++   L Y T
Sbjct: 163 IHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVI-SRLPYGT 220
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VDIW +G +  EM+ G+P +     L  + RI   S  P    L     +  GF     
Sbjct: 221 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-RDSLPPRVKDLHKVSSVLRGF----- 274
Query: 224 AGIDLISKMLGMDPDKRITAAEALQQEYFK 253
             +DL   ML  +P +R TA E L   + K
Sbjct: 275 --LDL---MLVREPSQRATAQELLGHPFLK 299

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E + L E+ HP I+ L+     G  LY + EY ++     ++  ++ +    T       
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEY-LSGGELFMQLEREGIFMEDT------- 122
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
               F L E                 I RDLKP NI+++  G  VK+  FGL K      
Sbjct: 123 --ACFYLAE----ISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDG 175
Query: 138 GESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV 197
             +    GT  Y APE+L+    ++ AVD W +G +  +M++G P F G N   T+ +I+
Sbjct: 176 TVTHTFCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
Query: 198 GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                   CKL+L  +LT           DL+ K+L  +   R+ A 
Sbjct: 235 K-------CKLNLPPYLTQ-------EARDLLKKLLKRNAASRLGAG 267

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGL 158
             R I RDLK  N+ ++ D   VK+  FGLA  +  + GE    + GT  Y APE+L   
Sbjct: 160 NNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKI-EFDGERKKTLCGTPNYIAPEVLCKK 217
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
             +S  VDIW +GCI   ++ GKP F  +    T  RI          + S+  H+    
Sbjct: 218 -GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKN-------EYSVPRHIN--- 266
Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               P    LI +ML  DP  R + AE L  E+F
Sbjct: 267 ----PVASALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGL 158
             R I RDLK  N+ ++ D   VK+  FGLA  +  + GE    + GT  Y APE+L   
Sbjct: 160 NNRVIHRDLKLGNLFLN-DDMDVKIGDFGLATKI-EFDGERKKXLCGTPNYIAPEVLCKK 217
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
             +S  VDIW +GCI   ++ GKP F  +    T  RI          + S+  H+    
Sbjct: 218 -GHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKN-------EYSVPRHIN--- 266
Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               P    LI +ML  DP  R + AE L  E+F
Sbjct: 267 ----PVASALIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 103/248 (41%), Gaps = 34/248 (13%)
Query: 13  SSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
            + ++EV  L +++ HPNII+L        + + VF+       +     K +++   T+
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                 L     L                   + RDLKP NIL+D D   +K+  FG + 
Sbjct: 128 KIMRALLEVICAL--------------HKLNIVHRDLKPENILLD-DDMNIKLTDFGFSC 172
Query: 132 SLYAYKGESSAEV-GTHYYKAPELLLGLLE-----YSTAVDIWPVGCIFGEMVSGKPLFP 185
            L    GE   EV GT  Y APE++   +      Y   VD+W  G I   +++G P F 
Sbjct: 173 QLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230
Query: 186 GANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE 245
               ++ L  I+  + +  F      D+             DL+S+ L + P KR TA E
Sbjct: 231 HRKQMLMLRMIMSGNYQ--FGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 246 ALQQEYFK 253
           AL   +F+
Sbjct: 281 ALAHPFFQ 288

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 34/248 (13%)
Query: 13  SSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
            + ++EV  L +++ HPNII+L        + + VF+       +     K +++   T+
Sbjct: 55  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 114
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                +L      + +                + RDLKP NIL+D D   +K+  FG + 
Sbjct: 115 KIMR-ALLEVICALHKL-------------NIVHRDLKPENILLD-DDMNIKLTDFGFSC 159
Query: 132 SLYAYKGESSAEV-GTHYYKAPELLLGLLE-----YSTAVDIWPVGCIFGEMVSGKPLFP 185
            L    GE   EV GT  Y APE++   +      Y   VD+W  G I   +++G P F 
Sbjct: 160 QLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 217
Query: 186 GANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE 245
               ++ L  I+  + +  F      D+             DL+S+ L + P KR TA E
Sbjct: 218 HRKQMLMLRMIMSGNYQ--FGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEE 267
Query: 246 ALQQEYFK 253
           AL   +F+
Sbjct: 268 ALAHPFFQ 275

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E + L E+ HP I+ L+     G  LY + EY ++     ++  ++ +    T       
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEY-LSGGELFMQLEREGIFMEDT------- 122
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
               F L E                 I RDLKP NI+++  G  VK+  FGL K      
Sbjct: 123 --ACFYLAE----ISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDG 175
Query: 138 GESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV 197
             +    GT  Y APE+L+    ++ AVD W +G +  +M++G P F G N   T+ +I+
Sbjct: 176 TVTHXFCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
Query: 198 GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                   CKL+L  +LT           DL+ K+L  +   R+ A 
Sbjct: 235 K-------CKLNLPPYLTQ-------EARDLLKKLLKRNAASRLGAG 267

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM-NGYSTKNFNS 75
           RE      L HPNI+RL    S+  + Y VF     DL    +  +D +   Y ++   S
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVF-----DLVTGGELFEDIVAREYYSEADAS 133
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLDGKTVKVAGFGLAKSL 133
           + +      V                  + RDLKP N+L+     G  VK+A FGLA  +
Sbjct: 134 HCIHQILESVNHIHQHDI----------VHRDLKPENLLLASKCKGAAVKLADFGLAIEV 183
Query: 134 YAYKGESSAE---VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
              +GE  A     GT  Y +PE+L     Y   VDIW  G I   ++ G P F   +  
Sbjct: 184 ---QGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDIWACGVILYILLVGYPPFWDEDQH 239
Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE 250
               +I          K    D  +  +  + P   +LI++ML ++P KRITA +AL+  
Sbjct: 240 KLYQQI----------KAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHP 289
Query: 251 Y 251
           +
Sbjct: 290 W 290

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+  DG+ VK++ FG    +          VGT Y+ APEL+   L Y  
Sbjct: 147 IHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 204
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE- 222
            VDIW +G +  EMV G+P +     L  +  I              RD+L      L  
Sbjct: 205 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHK 250
Query: 223 --PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
             P+    + ++L  DP +R TAAE L+  + 
Sbjct: 251 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 98/232 (42%), Gaps = 31/232 (13%)
Query: 26  NHPNIIRLMRVASQGIYLYPVFEYQVND--LAYLLKYPKDSMNGYSTKNFNSYSLFTTFL 83
            HPNII L  V   G ++Y V E       L  +L+        + ++   S+ L T   
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILR------QKFFSEREASFVLHTIGK 132
Query: 84  LVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL-VDLDG--KTVKVAGFGLAKSLYAYKGES 140
            VE                 + RDLKP NIL VD  G  + +++  FG AK L A  G  
Sbjct: 133 TVEYLHSQGV----------VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 141 SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKS 200
                T  + APE+L     Y    DIW +G +   M++G   F    S  T   I+ + 
Sbjct: 183 MTPCYTANFVAPEVL-KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS-DTPEEILTRI 240
Query: 201 RKPSFCKLSLRDHLTNG-FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
               F        L+ G +  +     DL+SKML +DP +R+TA + LQ  +
Sbjct: 241 GSGKFT-------LSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 98/232 (42%), Gaps = 31/232 (13%)
Query: 26  NHPNIIRLMRVASQGIYLYPVFEYQVND--LAYLLKYPKDSMNGYSTKNFNSYSLFTTFL 83
            HPNII L  V   G ++Y V E       L  +L+        + ++   S+ L T   
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILR------QKFFSEREASFVLHTIGK 132
Query: 84  LVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL-VDLDG--KTVKVAGFGLAKSLYAYKGES 140
            VE                 + RDLKP NIL VD  G  + +++  FG AK L A  G  
Sbjct: 133 TVEYLHSQGV----------VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 141 SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKS 200
                T  + APE+L     Y    DIW +G +   M++G   F    S  T   I+ + 
Sbjct: 183 MTPCYTANFVAPEVL-KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS-DTPEEILTRI 240
Query: 201 RKPSFCKLSLRDHLTNG-FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
               F        L+ G +  +     DL+SKML +DP +R+TA + LQ  +
Sbjct: 241 GSGKFT-------LSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+  DG+ VK++ FG    +          VGT Y+ APEL+   L Y  
Sbjct: 149 IHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 206
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE- 222
            VDIW +G +  EMV G+P +     L  +  I              RD+L      L  
Sbjct: 207 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHK 252
Query: 223 --PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
             P+    + ++L  DP +R TAAE L+  + 
Sbjct: 253 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+  DG+ VK++ FG    +          VGT Y+ APEL+   L Y  
Sbjct: 142 IHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 199
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE- 222
            VDIW +G +  EMV G+P +     L  +  I              RD+L      L  
Sbjct: 200 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHK 245
Query: 223 --PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
             P+    + ++L  DP +R TAAE L+  + 
Sbjct: 246 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 277

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+  DG+ VK++ FG    +          VGT Y+ APEL+   L Y  
Sbjct: 192 IHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 249
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE- 222
            VDIW +G +  EMV G+P +     L  +  I              RD+L      L  
Sbjct: 250 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHK 295
Query: 223 --PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
             P+    + ++L  DP +R TAAE L+  + 
Sbjct: 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 103/243 (42%), Gaps = 37/243 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGYSTKN 72
           +E+  +  L+HPNIIRL         +Y V E     ++ +     +  ++S      K+
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD 114
Query: 73  FNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL--VDLDGKTVKVAGFGLA 130
             S   +   L V                    RDLKP N L   D     +K+  FGLA
Sbjct: 115 VLSAVAYCHKLNV------------------AHRDLKPENFLFLTDSPDSPLKLIDFGLA 156
Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
                 K   + +VGT YY +P++L GL  Y    D W  G +   ++ G P F    S 
Sbjct: 157 ARFKPGKMMRT-KVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPF----SA 209
Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE 250
            T   ++ K R+ +F     +D L      + P    LI ++L   P +RIT+ +AL+ E
Sbjct: 210 PTDXEVMLKIREGTFT-FPEKDWL-----NVSPQAESLIRRLLTKSPKQRITSLQALEHE 263
Query: 251 YFK 253
           +F+
Sbjct: 264 WFE 266

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+  DG+ VK++ FG    +          VGT Y+ APEL+   L Y  
Sbjct: 138 IHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 195
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE- 222
            VDIW +G +  EMV G+P +     L  +  I              RD+L      L  
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHK 241
Query: 223 --PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
             P+    + ++L  DP +R TAAE L+  + 
Sbjct: 242 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RD+K  +IL+  DG+ VK++ FG    +          VGT Y+ APEL+   L Y  
Sbjct: 269 IHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP 326
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE- 222
            VDIW +G +  EMV G+P +     L  +  I              RD+L      L  
Sbjct: 327 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------RDNLPPRLKNLHK 372
Query: 223 --PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
             P+    + ++L  DP +R TAAE L+  + 
Sbjct: 373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D DG  V+++  GLA  L A + ++    GT  + APELLLG  EY  
Sbjct: 311 IYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDF 368
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           +VD + +G    EM++ +  F          R  G+  +    K  + +          P
Sbjct: 369 SVDYFALGVTLYEMIAARGPF----------RARGEKVENKELKQRVLEQAVTYPDKFSP 418
Query: 224 AGIDLISKMLGMDPDKRI 241
           A  D    +L  DP+KR+
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D DG  V+++  GLA  L A + ++    GT  + APELLLG  EY  
Sbjct: 311 IYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDF 368
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           +VD + +G    EM++ +  F          R  G+  +    K  + +          P
Sbjct: 369 SVDYFALGVTLYEMIAARGPF----------RARGEKVENKELKQRVLEQAVTYPDKFSP 418
Query: 224 AGIDLISKMLGMDPDKRI 241
           A  D    +L  DP+KR+
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D DG  V+++  GLA  L A + ++    GT  + APELLLG  EY  
Sbjct: 311 IYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDF 368
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           +VD + +G    EM++ +  F          R  G+  +    K  + +          P
Sbjct: 369 SVDYFALGVTLYEMIAARGPF----------RARGEKVENKELKQRVLEQAVTYPDKFSP 418
Query: 224 AGIDLISKMLGMDPDKRI 241
           A  D    +L  DP+KR+
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 103/243 (42%), Gaps = 37/243 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGYSTKN 72
           +E+  +  L+HPNIIRL         +Y V E     ++ +     +  ++S      K+
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD 131
Query: 73  FNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL--VDLDGKTVKVAGFGLA 130
             S   +   L V                    RDLKP N L   D     +K+  FGLA
Sbjct: 132 VLSAVAYCHKLNV------------------AHRDLKPENFLFLTDSPDSPLKLIDFGLA 173
Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
                 K   + +VGT YY +P++L GL  Y    D W  G +   ++ G P F    S 
Sbjct: 174 ARFKPGKMMRT-KVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPF----SA 226
Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE 250
            T   ++ K R+ +F     +D L      + P    LI ++L   P +RIT+ +AL+ E
Sbjct: 227 PTDXEVMLKIREGTFT-FPEKDWL-----NVSPQAESLIRRLLTKSPKQRITSLQALEHE 280
Query: 251 YFK 253
           +F+
Sbjct: 281 WFE 283

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 12/138 (8%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D DG  V+++  GLA  L A + ++    GT  + APELLLG  EY  
Sbjct: 311 IYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDF 368
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           +VD + +G    EM++ +  F          R  G+  +    K  + +          P
Sbjct: 369 SVDYFALGVTLYEMIAARGPF----------RARGEKVENKELKQRVLEQAVTYPDKFSP 418
Query: 224 AGIDLISKMLGMDPDKRI 241
           A  D    +L  DP+KR+
Sbjct: 419 ASKDFCEALLQKDPEKRL 436

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 70/148 (47%), Gaps = 20/148 (13%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  NIL+D DG  +K+A FG+ K       +++   GT  Y APE+LLG  +Y+ 
Sbjct: 141 VYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNH 198
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF--PGL 221
           +VD W  G +  EM+ G+  F G +       I                 + N F    L
Sbjct: 199 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----------------RMDNPFYPRWL 242
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQ 249
           E    DL+ K+   +P+KR+     ++Q
Sbjct: 243 EKEAKDLLVKLFVREPEKRLGVRGDIRQ 270

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 98/245 (40%), Gaps = 39/245 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVND--LAYLLKYPKDSMNGYSTKNFN 74
           RE+  L    HP+II+L +V S     + V EY        Y+ K+ +        +   
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR-------VEEME 112
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           +  LF   L   ++               + RDLKP N+L+D      K+A FGL+  + 
Sbjct: 113 ARRLFQQILSAVDYCHRHMV---------VHRDLKPENVLLDAH-MNAKIADFGLSNMMS 162
Query: 135 AYKGES-SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITL 193
              GE      G+  Y APE++ G L     VDIW  G I   ++ G   F   +     
Sbjct: 163 --DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF 220
Query: 194 GRIVGKS-RKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
            +I G     P +   S+                 L+  ML +DP KR T  +  + E+F
Sbjct: 221 KKIRGGVFYIPEYLNRSV---------------ATLLMHMLQVDPLKRATIKDIREHEWF 265
Query: 253 K-DVP 256
           K D+P
Sbjct: 266 KQDLP 270

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 70/148 (47%), Gaps = 20/148 (13%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  NIL+D DG  +K+A FG+ K       +++   GT  Y APE+LLG  +Y+ 
Sbjct: 140 VYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYNH 197
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF--PGL 221
           +VD W  G +  EM+ G+  F G +       I                 + N F    L
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----------------RMDNPFYPRWL 241
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQ 249
           E    DL+ K+   +P+KR+     ++Q
Sbjct: 242 EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 87/199 (43%), Gaps = 27/199 (13%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
             + REV  +  LNHPNI++L  V      LY V EY    +V D  YL+ + +      
Sbjct: 59  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD--YLVAHGR------ 110
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYI-RRDLKPVNILVDLDGKTVKVAGF 127
             K   + + F   +   ++             +YI  RDLK  N+L+D D   +K+A F
Sbjct: 111 -MKEKEARAKFRQIVSAVQYCH----------QKYIVHRDLKAENLLLDGD-MNIKIADF 158
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
           G +   +    +     G+  Y APEL  G       VD+W +G I   +VSG   F G 
Sbjct: 159 GFSNE-FTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217
Query: 188 NSLITLGRIV-GKSRKPSF 205
           N      R++ GK R P +
Sbjct: 218 NLKELRERVLRGKYRIPFY 236

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 26/230 (11%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTK 71
           +  I+E+  L +LNHPN+I+      +   L  V E     DL+ ++K+ K        +
Sbjct: 77  ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER 136
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
               Y           F             R + RD+KP N+ +   G  VK+   GL +
Sbjct: 137 TVWKY-----------FVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGR 184
Query: 132 SLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSL 190
              +    + + VGT YY +PE  +    Y+   DIW +GC+  EM +   P +    +L
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 243
Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
            +L + + +   P        DH +            L++  +  DP+KR
Sbjct: 244 YSLCKKIEQCDYPPL----PSDHYSEELR-------QLVNMCINPDPEKR 282

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 95/246 (38%), Gaps = 34/246 (13%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGV   + RE+     L HPNI+R+         +Y + E+              +  G 
Sbjct: 56  EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF--------------APRGE 101
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K    +  F                      + I RD+KP N+L+   G+ +K+A FG
Sbjct: 102 LYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE-LKIADFG 160
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
              S++A         GT  Y  PE++ G   +   VD+W  G +  E + G P F   +
Sbjct: 161 W--SVHAPSLRRRXMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPS 217
Query: 189 SLITLGRIVGKSRK-PSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
              T  RIV    K P F        L++G         DLISK+L   P +R+     +
Sbjct: 218 HTETHRRIVNVDLKFPPF--------LSDG-------SKDLISKLLRYHPPQRLPLKGVM 262
Query: 248 QQEYFK 253
           +  + K
Sbjct: 263 EHPWVK 268

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 95/246 (38%), Gaps = 34/246 (13%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGV   + RE+     L HPNI+R+         +Y + E+              +  G 
Sbjct: 55  EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF--------------APRGE 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K    +  F                      + I RD+KP N+L+   G+ +K+A FG
Sbjct: 101 LYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE-LKIADFG 159
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
              S++A         GT  Y  PE++ G   +   VD+W  G +  E + G P F   +
Sbjct: 160 W--SVHAPSLRRRXMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPS 216
Query: 189 SLITLGRIVGKSRK-PSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
              T  RIV    K P F        L++G         DLISK+L   P +R+     +
Sbjct: 217 HTETHRRIVNVDLKFPPF--------LSDG-------SKDLISKLLRYHPPQRLPLKGVM 261
Query: 248 QQEYFK 253
           +  + K
Sbjct: 262 EHPWVK 267

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 101/251 (40%), Gaps = 39/251 (15%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVND--LAYLLKYPKDSMNGY 68
           V   + RE+  L    HP+II+L +V S     + V EY        Y+ K+ +      
Sbjct: 54  VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR------ 107
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             +   +  LF   L   ++               + RDLKP N+L+D      K+A FG
Sbjct: 108 -VEEMEARRLFQQILSAVDYCHRHMV---------VHRDLKPENVLLDAH-MNAKIADFG 156
Query: 129 LAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
           L+  +    GE   +  G+  Y APE++ G L     VDIW  G I   ++ G   F   
Sbjct: 157 LSNMMS--DGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214
Query: 188 NSLITLGRIVGKS-RKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA 246
           +      +I G     P +   S+                 L+  ML +DP KR T  + 
Sbjct: 215 HVPTLFKKIRGGVFYIPEYLNRSV---------------ATLLMHMLQVDPLKRATIKDI 259
Query: 247 LQQEYFK-DVP 256
            + E+FK D+P
Sbjct: 260 REHEWFKQDLP 270

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 104/248 (41%), Gaps = 34/248 (13%)
Query: 13  SSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
            + ++EV  L +++ HPNII+L        + + VF+       +     K +++   T+
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                +L      + +                + RDLKP NIL+D D   +K+  FG + 
Sbjct: 128 KIMR-ALLEVICALHKL-------------NIVHRDLKPENILLD-DDMNIKLTDFGFSC 172
Query: 132 SLYAYKGESSAEV-GTHYYKAPELLLGLLE-----YSTAVDIWPVGCIFGEMVSGKPLFP 185
            L    GE    V GT  Y APE++   +      Y   VD+W  G I   +++G P F 
Sbjct: 173 QLDP--GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230
Query: 186 GANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE 245
               ++ L  I+  + +  F      D+             DL+S+ L + P KR TA E
Sbjct: 231 HRKQMLMLRMIMSGNYQ--FGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 246 ALQQEYFK 253
           AL   +F+
Sbjct: 281 ALAHPFFQ 288

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 104 IRRDLKPVNILV--DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + RDLKP N+L+     G  VK+A FGLA  +   +       GT  Y +PE+L     Y
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA-Y 183
Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
              VDIW  G I   ++ G P F   +      +I          K    D  +  +  +
Sbjct: 184 GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI----------KAGAYDFPSPEWDTV 233
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEY 251
            P   +LI++ML ++P KRITA EAL+  +
Sbjct: 234 TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 83/196 (42%), Gaps = 56/196 (28%)
Query: 107 DLKPVNILV---------DLDGK---------TVKVAGFGLAKSLYAYKGESSAEVGTHY 148
           DLKP NIL          +L+ K          V+V  FG A   + +    S  V T +
Sbjct: 162 DLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEH---HSTIVSTRH 218
Query: 149 YKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS---LITLGRIVG------- 198
           Y+APE++L L  +S   D+W +GCI  E   G  LF   ++   L  + RI+G       
Sbjct: 219 YRAPEVILEL-GWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMI 277
Query: 199 -KSRKPSF---------------------CKLSLRDHLTNGFPGLEPAGIDLISKMLGMD 236
            K+RK  +                     CK  LR +LT+          DLI  ML  +
Sbjct: 278 RKTRKQKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHHQL-FDLIESMLEYE 335
Query: 237 PDKRITAAEALQQEYF 252
           P KR+T  EALQ  +F
Sbjct: 336 PAKRLTLGEALQHPFF 351

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 66/146 (45%), Gaps = 16/146 (10%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  V +  FGL K    +   +S   GT  Y APE+L     Y  
Sbjct: 161 VYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDR 218
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VD W +G +  EM+ G P F   N+      I+ K        L L+ ++TN       
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------LQLKPNITN------- 264
Query: 224 AGIDLISKMLGMDPDKRITAAEALQQ 249
           +   L+  +L  D  KR+ A +   +
Sbjct: 265 SARHLLEGLLQKDRTKRLGAKDDFME 290

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 99/245 (40%), Gaps = 37/245 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPKDSMNGYSTKNFN 74
            E++    L H NI++ +   S+  ++  +F  QV    L+ LL+    S  G    N  
Sbjct: 54  EEIALHKHLKHKNIVQYLGSFSENGFI-KIFMEQVPGGSLSALLR----SKWGPLKDNEQ 108
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           +   +T  +L                 + + RD+K  N+L++     +K++ FG +K L 
Sbjct: 109 TIGFYTKQIL--------EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 160
Query: 135 AYKGESSAEVGTHYYKAPELL-LGLLEYSTAVDIWPVGCIFGEMVSGKPLF-----PGAN 188
                +    GT  Y APE++  G   Y  A DIW +GC   EM +GKP F     P A 
Sbjct: 161 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA- 219
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
           ++  +G        P       +  +   F   EP            DPDKR  A + L 
Sbjct: 220 AMFKVGMFKVHPEIPESMSAEAKAFILKCF---EP------------DPDKRACANDLLV 264
Query: 249 QEYFK 253
            E+ K
Sbjct: 265 DEFLK 269

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 99/245 (40%), Gaps = 37/245 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPKDSMNGYSTKNFN 74
            E++    L H NI++ +   S+  ++  +F  QV    L+ LL+    S  G    N  
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFI-KIFMEQVPGGSLSALLR----SKWGPLKDNEQ 122
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           +   +T  +L                 + + RD+K  N+L++     +K++ FG +K L 
Sbjct: 123 TIGFYTKQIL--------EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174
Query: 135 AYKGESSAEVGTHYYKAPELL-LGLLEYSTAVDIWPVGCIFGEMVSGKPLF-----PGAN 188
                +    GT  Y APE++  G   Y  A DIW +GC   EM +GKP F     P A 
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA- 233
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
           ++  +G        P       +  +   F   EP            DPDKR  A + L 
Sbjct: 234 AMFKVGMFKVHPEIPESMSAEAKAFILKCF---EP------------DPDKRACANDLLV 278
Query: 249 QEYFK 253
            E+ K
Sbjct: 279 DEFLK 283

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 95/237 (40%), Gaps = 34/237 (14%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           RE     +L HPNI+RL     +  + Y VF     DL            G   ++  + 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVF-----DLV---------TGGELFEDIVAR 99
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLDGKTVKVAGFGLAKSL- 133
             ++                       + R+LKP N+L+     G  VK+A FGLA  + 
Sbjct: 100 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159
Query: 134 --YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI 191
              A+ G +    GT  Y +PE+L     YS  VDIW  G I   ++ G P F   +   
Sbjct: 160 DSEAWHGFA----GTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214
Query: 192 TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              +I          K    D+ +  +  + P    LI  ML ++P KRITA +AL+
Sbjct: 215 LYAQI----------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 95/237 (40%), Gaps = 34/237 (14%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           RE     +L HPNI+RL     +  + Y VF     DL            G   ++  + 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVF-----DLV---------TGGELFEDIVAR 99
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLDGKTVKVAGFGLAKSL- 133
             ++                       + R+LKP N+L+     G  VK+A FGLA  + 
Sbjct: 100 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159
Query: 134 --YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI 191
              A+ G +    GT  Y +PE+L     YS  VDIW  G I   ++ G P F   +   
Sbjct: 160 DSEAWHGFA----GTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214
Query: 192 TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              +I          K    D+ +  +  + P    LI  ML ++P KRITA +AL+
Sbjct: 215 LYAQI----------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 95/237 (40%), Gaps = 34/237 (14%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           RE     +L HPNI+RL     +  + Y VF     DL            G   ++  + 
Sbjct: 53  REARICRKLQHPNIVRLHDSIQEESFHYLVF-----DLV---------TGGELFEDIVAR 98
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLDGKTVKVAGFGLAKSL- 133
             ++                       + R+LKP N+L+     G  VK+A FGLA  + 
Sbjct: 99  EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 158
Query: 134 --YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI 191
              A+ G +    GT  Y +PE+L     YS  VDIW  G I   ++ G P F   +   
Sbjct: 159 DSEAWHGFA----GTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHR 213
Query: 192 TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              +I          K    D+ +  +  + P    LI  ML ++P KRITA +AL+
Sbjct: 214 LYAQI----------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 260

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 35/247 (14%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRV--ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +++ +E+  L  L H N+I+L+ V    +   +Y V EY V  +  +L    DS+     
Sbjct: 51  ANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML----DSVPEKRF 106
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               ++  F   +   E+               + +D+KP N+L+   G T+K++  G+A
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHSQGI---------VHKDIKPGNLLLTTGG-TLKISALGVA 156
Query: 131 KSLYAYKGESSAEV--GTHYYKAPELLLGLLEYST-AVDIWPVGCIFGEMVSGKPLFPGA 187
           ++L+ +  + +     G+  ++ PE+  GL  +S   VDIW  G     + +G   F G 
Sbjct: 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG-LEPAGIDLISKMLGMDPDKRITAAEA 246
           N +  L   +GK               +   PG   P   DL+  ML  +P KR +  + 
Sbjct: 217 N-IYKLFENIGKG--------------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
Query: 247 LQQEYFK 253
            Q  +F+
Sbjct: 262 RQHSWFR 268

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 103 YIRRDLKPVNILVDLD-GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL-LE 160
           Y+  DLKP NI+        +K+  FGL   L   K       GT  + APE+  G  + 
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG 220
           Y T  D+W VG +   ++SG   F G N   TL       R    C  ++ D   + F G
Sbjct: 229 YYT--DMWSVGVLSYILLSGLSPFGGENDDETL-------RNVKSCDWNMDD---SAFSG 276
Query: 221 LEPAGIDLISKMLGMDPDKRITAAEALQQEYFK--DVPGRS 259
           +   G D I K+L  DP+ R+T  +AL+  +    + PGR 
Sbjct: 277 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 317

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 95/237 (40%), Gaps = 34/237 (14%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           RE     +L HPNI+RL     +  + Y VF     DL            G   ++  + 
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVF-----DLV---------TGGELFEDIVAR 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV--DLDGKTVKVAGFGLAKSL- 133
             ++                       + R+LKP N+L+     G  VK+A FGLA  + 
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 134 --YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI 191
              A+ G +    GT  Y +PE+L     YS  VDIW  G I   ++ G P F   +   
Sbjct: 183 DSEAWHGFA----GTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237
Query: 192 TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              +I          K    D+ +  +  + P    LI  ML ++P KRITA +AL+
Sbjct: 238 LYAQI----------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 103 YIRRDLKPVNILVDLD-GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL-LE 160
           Y+  DLKP NI+        +K+  FGL   L   K       GT  + APE+  G  + 
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG 220
           Y T  D+W VG +   ++SG   F G N   TL       R    C  ++ D   + F G
Sbjct: 335 YYT--DMWSVGVLSYILLSGLSPFGGENDDETL-------RNVKSCDWNMDD---SAFSG 382
Query: 221 LEPAGIDLISKMLGMDPDKRITAAEALQQEYFK--DVPGRS 259
           +   G D I K+L  DP+ R+T  +AL+  +    + PGR 
Sbjct: 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 423

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 169 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 222
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 223 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 250 EYFK 253
            + K
Sbjct: 273 PWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 169 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 222
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 223 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 250 EYFK 253
            + K
Sbjct: 273 PWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 121
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 122 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 168 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 221
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 222 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 250 EYFK 253
            + K
Sbjct: 272 PWIK 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 121
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 122 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 168 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 221
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 222 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 250 EYFK 253
            + K
Sbjct: 272 PWIK 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 169 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 222
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 223 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 250 EYFK 253
            + K
Sbjct: 273 PWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 169 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 222
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 223 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 250 EYFK 253
            + K
Sbjct: 273 PWIK 276

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS--MNGYSTKNFN 74
           REV    +L+H NI+ ++ V  +    Y V EY        ++ P  S  +  +   + +
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY--------IEGPTLSEYIESHGPLSVD 111
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           +   FT  +L                 R + RD+KP NIL+D   KT+K+  FG+AK+L 
Sbjct: 112 TAINFTNQIL--------DGIKHAHDMRIVHRDIKPQNILID-SNKTLKIFDFGIAKALS 162
Query: 135 AYK-GESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
                +++  +GT  Y +PE   G        DI+ +G +  EM+ G+P F G  ++
Sbjct: 163 ETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 169 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 222
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 223 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 250 EYFK 253
            + K
Sbjct: 273 PWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 93/245 (37%), Gaps = 39/245 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKT----VKVAGFGLAKS 132
            L   + L                 +    DLKP NI++ LD       +K+  FGLA  
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHK 167
Query: 133 LYAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           +  +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G  
Sbjct: 168 I-DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDT 221
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              TL  +       S       D     F        D I ++L  DP KR+T  ++LQ
Sbjct: 222 KQETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 249 QEYFK 253
             + K
Sbjct: 272 HPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 169 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 222
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 223 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 250 EYFK 253
            + K
Sbjct: 273 PWIK 276

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + + RD+KP NILV+  G+ +K+  FG++  L      S   VGT  Y +PE L G   Y
Sbjct: 125 KIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THY 180
Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
           S   DIW +G    EM  G+   P  ++         +  +P      L D++ N  P  
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDA--------KEDSRPPMAIFELLDYIVNEPPPK 232
Query: 222 EPAGI------DLISKMLGMDPDKRITAAEALQQEYFK 253
            P+G+      D ++K L  +P +R    + +   + K
Sbjct: 233 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 270

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 77/173 (44%), Gaps = 30/173 (17%)
Query: 105 RRDLKPVNILVDLDGKT--VKVAGFGLAKSLYAYKGESS--------AEVGTHYYKAPEL 154
            RDLKP NIL +   +   VK+  FGL   +    G+ S           G+  Y APE+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGI-KLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 155 LLGLLE----YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF--CKL 208
           +    E    Y    D+W +G I   ++SG P F G       G   G  R  +   C+ 
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG-----RCGSDCGWDRGEACPACQN 247
Query: 209 SLRDHLTNG---FPGLEPAGI-----DLISKMLGMDPDKRITAAEALQQEYFK 253
            L + +  G   FP  + A I     DLISK+L  D  +R++AA+ LQ  + +
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 169 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 222
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 223 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 250 EYFK 253
            + K
Sbjct: 273 PWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 169 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 222
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 223 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 250 EYFK 253
            + K
Sbjct: 273 PWIK 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 93/245 (37%), Gaps = 39/245 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKT----VKVAGFGLAKS 132
            L   + L                 +    DLKP NI++ LD       +K+  FGLA  
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHK 167
Query: 133 LYAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           +  +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G  
Sbjct: 168 I-DFGNEFKNIFGTPAFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDT 221
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              TL  +       S       D     F        D I ++L  DP KR+T  ++LQ
Sbjct: 222 KQETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 249 QEYFK 253
             + K
Sbjct: 272 HPWIK 276

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 32/233 (13%)
Query: 17  REVSCLMELNHPNIIRLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +E++ L +L+HPN+++L+ V       +LY VFE  VN    +++ P  ++   S     
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL-VNQ-GPVMEVP--TLKPLSEDQAR 140
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
            Y  F   +   E+             + I RD+KP N+LV  DG  +K+A FG++    
Sbjct: 141 FY--FQDLIKGIEYLHY---------QKIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFK 188
Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEY--STAVDIWPVGCIFGEMVSGKPLFPGANSLIT 192
                 S  VGT  + APE L    +     A+D+W +G      V G+  F     +  
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 193 LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE 245
             +I  ++       L   D      P +     DLI++ML  +P+ RI   E
Sbjct: 249 HSKIKSQA-------LEFPDQ-----PDIAEDLKDLITRMLDKNPESRIVVPE 289

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 169 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 222
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 223 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 250 EYFK 253
            + K
Sbjct: 273 PWIK 276

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 110/274 (40%), Gaps = 56/274 (20%)
Query: 13  SSMIREVSCLMELNHPNIIRL------------MRVASQGIYLYPVFEYQVNDLAYLLKY 60
             ++REV  L +L HP I+R             ++ +S  +YLY   + Q+     L   
Sbjct: 48  EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLY--IQMQLCRKENL--- 102
Query: 61  PKDSMNGYSTKNFNSYSL-FTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDG 119
            KD MNG  T      S+    FL + E                + RDLKP NI   +D 
Sbjct: 103 -KDWMNGRCTIEERERSVCLHIFLQIAE------AVEFLHSKGLMHRDLKPSNIFFTMDD 155
Query: 120 KTVKVAGFGLAKSLYAYKGESSA------------EVGTHYYKAPELLLGLLEYSTAVDI 167
             VKV  FGL  ++   + E +             +VGT  Y +PE + G   YS  VDI
Sbjct: 156 -VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDI 213
Query: 168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGID 227
           + +G I  E+     L+P +  +  + R +   R   F  L         F    P    
Sbjct: 214 FSLGLILFEL-----LYPFSTQMERV-RTLTDVRNLKFPPL---------FTQKYPCEYV 258
Query: 228 LISKMLGMDPDKRITAAEALQQEYFKDV--PGRS 259
           ++  ML   P +R  A   ++   F+D+  PG++
Sbjct: 259 MVQDMLSPSPMERPEAINIIENAVFEDLDFPGKT 292

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L E+ HPN+I L  V      +  + E       +     K+S+       F   
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSL 133
            L   + L                 +    DLKP NI++   ++    +K+  FGLA  +
Sbjct: 123 ILNGVYYL--------------HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 134 YAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
             +  E     GT  + APE++    LGL       D+W +G I   ++SG   F G   
Sbjct: 169 -DFGNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASPFLGDTK 222
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             TL  +       S       D     F        D I ++L  DP KR+T  ++LQ 
Sbjct: 223 QETLANV-------SAVNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 250 EYFK 253
            + K
Sbjct: 273 PWIK 276

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 101/262 (38%), Gaps = 38/262 (14%)
Query: 6   NTMEGVPSSMI-REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           ++  GV    I REV+ L E+ HPNII L  +      +  + E       +     K+S
Sbjct: 45  SSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES 104
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKT 121
           +       F    L     L                 R    DLKP NI++   ++    
Sbjct: 105 LTEDEATQFLKQILDGVHYL--------------HSKRIAHFDLKPENIMLLDKNVPNPR 150
Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEM 177
           +K+  FG+A  + A   E     GT  + APE++    LGL       D+W +G I   +
Sbjct: 151 IKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYIL 204
Query: 178 VSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
           +SG   F G     TL  I   +           D     F        D I ++L  DP
Sbjct: 205 LSGASPFLGETKQETLTNISAVNY----------DFDEEYFSNTSELAKDFIRRLLVKDP 254
Query: 238 DKRITAAEALQQEYFKDVPGRS 259
            +R+T A++L+  + K +  R+
Sbjct: 255 KRRMTIAQSLEHSWIKAIRRRN 276

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 99/255 (38%), Gaps = 33/255 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           E +  ++ RE+     L HPNI+R   V     +L  V EY              +  G 
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY--------------ASGGE 101
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVD-LDGKTVKVAGF 127
             +   +   F+       F             +   RDLK  N L+D      +K+A F
Sbjct: 102 LFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADF 161
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG- 186
           G +K+   +    SA VGT  Y APE+LL         D+W  G     M+ G   F   
Sbjct: 162 GYSKASVLHSQPKSA-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDP 220
Query: 187 ---ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA 243
               N   T+ RI+         + ++ D++      + P    LIS++   DP KRI+ 
Sbjct: 221 EEPKNFRKTIHRILN-------VQYAIPDYV-----HISPECRHLISRIFVADPAKRISI 268
Query: 244 AEALQQEYF-KDVPG 257
            E    E+F K++P 
Sbjct: 269 PEIRNHEWFLKNLPA 283

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P S + E   + +L H  +++L  V S+   +Y V EY   +   LL + KD   G + K
Sbjct: 48  PESFLEEAQIMKKLKHDKLVQLYAVVSEEP-IYIVTEYM--NKGSLLDFLKDG-EGRALK 103
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
             N         LV+                YI RDL+  NILV  +G   K+A FGLA+
Sbjct: 104 LPN---------LVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-NGLICKIADFGLAR 153
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+V+ G+  +PG 
Sbjct: 154 LI--EDNEXTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGM 210
Query: 188 NSLITLGRIVGKSRK--PSFCKLSLRDHLTNGF 218
           N+   L ++    R   P  C +SL + + + +
Sbjct: 211 NNREVLEQVERGYRMPCPQDCPISLHELMIHCW 243

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/81 (38%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  V+++  GLA      K +  A VGTH Y APE+L   + Y +
Sbjct: 314 VYRDLKPANILLDEHGH-VRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 164 AVDIWPVGCIFGEMVSGKPLF 184
           + D + +GC+  +++ G   F
Sbjct: 371 SADWFSLGCMLFKLLRGHSPF 391

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 76/173 (43%), Gaps = 30/173 (17%)
Query: 105 RRDLKPVNILVDLDGKT--VKVAGFGLAKSLYAYKGESS--------AEVGTHYYKAPEL 154
            RDLKP NIL +   +   VK+  F L   +    G+ S           G+  Y APE+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGI-KLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 155 LLGLLE----YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF--CKL 208
           +    E    Y    D+W +G I   ++SG P F G       G   G  R  +   C+ 
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG-----RCGSDCGWDRGEACPACQN 247
Query: 209 SLRDHLTNG---FPGLEPAGI-----DLISKMLGMDPDKRITAAEALQQEYFK 253
            L + +  G   FP  + A I     DLISK+L  D  +R++AA+ LQ  + +
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/81 (38%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  V+++  GLA      K +  A VGTH Y APE+L   + Y +
Sbjct: 313 VYRDLKPANILLDEHGH-VRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDS 369
Query: 164 AVDIWPVGCIFGEMVSGKPLF 184
           + D + +GC+  +++ G   F
Sbjct: 370 SADWFSLGCMLFKLLRGHSPF 390

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 97/246 (39%), Gaps = 35/246 (14%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYS 69
           G+   +  EV    +L HP+I+ L        Y+Y V E   N    + +Y K+ +  +S
Sbjct: 53  GMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN--GEMNRYLKNRVKPFS 110
Query: 70  TKNFNSY--SLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
                 +   + T  L +                  + RDL   N+L+  +   +K+A F
Sbjct: 111 ENEARHFMHQIITGMLYLHSHGI-------------LHRDLTLSNLLLTRN-MNIKIADF 156
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
           GLA  L     +     GT  Y +PE+      +    D+W +GC+F  ++ G+P F   
Sbjct: 157 GLATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTD 215
Query: 188 NSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA 246
               TL ++V      PSF  +  +               DLI ++L  +P  R++ +  
Sbjct: 216 TVKNTLNKVVLADYEMPSFLSIEAK---------------DLIHQLLRRNPADRLSLSSV 260
Query: 247 LQQEYF 252
           L   + 
Sbjct: 261 LDHPFM 266

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 26/159 (16%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + + RD+KP NILV+  G+ +K+  FG++  L      S   VGT  Y +PE L G   Y
Sbjct: 144 KIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THY 199
Query: 162 STAVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG 220
           S   DIW +G    EM  G+ P+  G+ S+                   L D++ N  P 
Sbjct: 200 SVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAI---------------FELLDYIVNEPPP 244
Query: 221 LEPAGI------DLISKMLGMDPDKRITAAEALQQEYFK 253
             P+G+      D ++K L  +P +R    + +   + K
Sbjct: 245 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 283

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/81 (38%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  V+++  GLA      K +  A VGTH Y APE+L   + Y +
Sbjct: 314 VYRDLKPANILLDEHGH-VRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 164 AVDIWPVGCIFGEMVSGKPLF 184
           + D + +GC+  +++ G   F
Sbjct: 371 SADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/81 (38%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  V+++  GLA      K +  A VGTH Y APE+L   + Y +
Sbjct: 314 VYRDLKPANILLDEHGH-VRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 164 AVDIWPVGCIFGEMVSGKPLF 184
           + D + +GC+  +++ G   F
Sbjct: 371 SADWFSLGCMLFKLLRGHSPF 391

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 6/113 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NIL+D +G  +K+  FG AK +      +    GT  Y APE++     Y+ 
Sbjct: 128 IYRDLKPENILLDKNGH-IKITDFGFAKYV---PDVTYXLCGTPDYIAPEVV-STKPYNK 182
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKS-RKPSFCKLSLRDHLT 215
           ++D W  G +  EM++G   F  +N++ T  +I+    R P F    ++D L+
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 235

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 16/155 (10%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE 160
            + I RDLK  NIL  LDG  +K+A FG++           + +GT Y+ APE+++    
Sbjct: 154 NKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 161 ----YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
               Y    D+W +G    EM   +P     N +  L +I  KS  P+  + S     ++
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-AKSEPPTLAQPS---RWSS 268
Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
            F        D + K L  + D R T ++ LQ  +
Sbjct: 269 NFK-------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 58/197 (29%)
Query: 107 DLKPVNILV------------------DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHY 148
           DLKP NIL                    +   +++VA FG A   + +    +  V T +
Sbjct: 157 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRH 213
Query: 149 YKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF---PGANSLITLGRIVG------- 198
           Y+ PE++L L  ++   D+W +GCI  E   G  LF        L+ + +I+G       
Sbjct: 214 YRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMI 272
Query: 199 -KSRKPSF---------------------CKLSLRDHLTNGFPGLEPAGI-DLISKMLGM 235
            ++RK  +                     CK  L+ ++      LE   + DL+ +ML  
Sbjct: 273 HRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQD--SLEHVQLFDLMRRMLEF 329
Query: 236 DPDKRITAAEALQQEYF 252
           DP +RIT AEAL   +F
Sbjct: 330 DPAQRITLAEALLHPFF 346

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 6/109 (5%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLA-KSLYAYKGESSAEVGTHYYKAPELLLGLL- 159
            Y+ RD+KP NIL+D++G  +++A FG   K +     +SS  VGT  Y +PE+L  +  
Sbjct: 195 HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 160 ---EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF 205
               Y    D W +G    EM+ G+  F   + + T G+I+    +  F
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 6/153 (3%)
Query: 104 IRRDLKPVNILV--DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + RDLKP N+L   + D   +K+  FG A+              T +Y APELL     Y
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGY 186
Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
             + D+W +G I   M+SG+  F   +  +T    V   +K      S        +  +
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE---GEAWKNV 243
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
                DLI  +L +DP+KR+  +     E+ +D
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 16/155 (10%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE 160
            + I RDLK  NIL  LDG  +K+A FG++           + +GT Y+ APE+++    
Sbjct: 154 NKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 161 ----YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
               Y    D+W +G    EM   +P     N +  L +I  KS  P+  + S     ++
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-AKSEPPTLAQPS---RWSS 268
Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
            F        D + K L  + D R T ++ LQ  +
Sbjct: 269 NFK-------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 58/197 (29%)
Query: 107 DLKPVNILV------------------DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHY 148
           DLKP NIL                    +   +++VA FG A   + +    +  V T +
Sbjct: 148 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRH 204
Query: 149 YKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF---PGANSLITLGRIVG------- 198
           Y+ PE++L L  ++   D+W +GCI  E   G  LF        L+ + +I+G       
Sbjct: 205 YRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMI 263
Query: 199 -KSRKPSF---------------------CKLSLRDHLTNGFPGLEPAGI-DLISKMLGM 235
            ++RK  +                     CK  L+ ++      LE   + DL+ +ML  
Sbjct: 264 HRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQD--SLEHVQLFDLMRRMLEF 320
Query: 236 DPDKRITAAEALQQEYF 252
           DP +RIT AEAL   +F
Sbjct: 321 DPAQRITLAEALLHPFF 337

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 58/197 (29%)
Query: 107 DLKPVNILV------------------DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHY 148
           DLKP NIL                    +   +++VA FG A   + +    +  V T +
Sbjct: 180 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRH 236
Query: 149 YKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF---PGANSLITLGRIVG------- 198
           Y+ PE++L L  ++   D+W +GCI  E   G  LF        L+ + +I+G       
Sbjct: 237 YRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMI 295
Query: 199 -KSRKPSF---------------------CKLSLRDHLTNGFPGLEPAGI-DLISKMLGM 235
            ++RK  +                     CK  L+ ++      LE   + DL+ +ML  
Sbjct: 296 HRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQD--SLEHVQLFDLMRRMLEF 352
Query: 236 DPDKRITAAEALQQEYF 252
           DP +RIT AEAL   +F
Sbjct: 353 DPAQRITLAEALLHPFF 369

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           I E   +M L+H  +++L  V ++   ++ + EY  N    LL Y ++  + + T+    
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN--GCLLNYLREMRHRFQTQQ--- 121
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
                   L+E               +++ RDL   N LV+ D   VKV+ FGL++  Y 
Sbjct: 122 --------LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSR--YV 170
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              E ++ VG+ +   +  PE+L+   ++S+  DIW  G +  E+ S
Sbjct: 171 LDDEETSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 16/155 (10%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE 160
            + I RDLK  NIL  LDG  +K+A FG++             +GT Y+ APE+++    
Sbjct: 154 NKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETS 212
Query: 161 ----YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
               Y    D+W +G    EM   +P     N +  L +I  KS  P+  + S     ++
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-AKSEPPTLAQPS---RWSS 268
Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
            F        D + K L  + D R T ++ LQ  +
Sbjct: 269 NFK-------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 98/255 (38%), Gaps = 33/255 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           E + +++ RE+     L HPNI+R   V     +L  V EY              +  G 
Sbjct: 56  EKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY--------------ASGGE 101
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVD-LDGKTVKVAGF 127
             +   +   F+       F             +   RDLK  N L+D      +K+  F
Sbjct: 102 LFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 161
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG- 186
           G +KS   +    S  VGT  Y APE+LL         D+W  G     M+ G   F   
Sbjct: 162 GYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDP 220
Query: 187 ---ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA 243
               N   T+ RI+         + ++ D++      + P    LIS++   DP KRI+ 
Sbjct: 221 EEPKNFRKTIHRILN-------VQYAIPDYV-----HISPECRHLISRIFVADPAKRISI 268
Query: 244 AEALQQEYF-KDVPG 257
            E    E+F K++P 
Sbjct: 269 PEIRNHEWFLKNLPA 283

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 15/89 (16%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAK----SLYAYKGES----------SAEVGTHYY 149
           I RDLKP+NI +D + + VK+  FGLAK    SL   K +S          ++ +GT  Y
Sbjct: 138 IHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196
Query: 150 KAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
            A E+L G   Y+  +D++ +G IF EM+
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 15/89 (16%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAK----SLYAYKGES----------SAEVGTHYY 149
           I RDLKP+NI +D + + VK+  FGLAK    SL   K +S          ++ +GT  Y
Sbjct: 138 IHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196
Query: 150 KAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
            A E+L G   Y+  +D++ +G IF EM+
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLL---- 156
            Y+ RD+KP N+L+D++G  +++A FG    +      +SS  VGT  Y +PE+L     
Sbjct: 195 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF 205
           G+ +Y    D W +G    EM+ G+  F   + + T G+I+    +  F
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 302

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLL---- 156
            Y+ RD+KP N+L+D++G  +++A FG    +      +SS  VGT  Y +PE+L     
Sbjct: 211 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF 205
           G+ +Y    D W +G    EM+ G+  F   + + T G+I+    +  F
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 318

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 97/255 (38%), Gaps = 33/255 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           E +  ++ RE+     L HPNI+R   V     +L  V EY              +  G 
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY--------------ASGGE 101
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVD-LDGKTVKVAGF 127
             +   +   F+       F             +   RDLK  N L+D      +K+  F
Sbjct: 102 LFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAF 161
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG- 186
           G +KS   +    S  VGT  Y APE+LL         D+W  G     M+ G   F   
Sbjct: 162 GYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDP 220
Query: 187 ---ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA 243
               N   T+ RI+         + ++ D++      + P    LIS++   DP KRI+ 
Sbjct: 221 EEPKNFRKTIHRILN-------VQYAIPDYV-----HISPECRHLISRIFVADPAKRISI 268
Query: 244 AEALQQEYF-KDVPG 257
            E    E+F K++P 
Sbjct: 269 PEIRNHEWFLKNLPA 283

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 74/172 (43%), Gaps = 28/172 (16%)
Query: 105 RRDLKPVNILVDLDGKT--VKVAGFGLAKSLYAYKG-------ESSAEVGTHYYKAPELL 155
            RDLKP NIL +   K   VK+  F L   +            E +   G+  Y APE++
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 156 LGLLE----YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP--SFCKLS 209
               +    Y    D+W +G +   M+SG P F G       G   G  R      C+  
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVG-----HCGADCGWDRGEVCRVCQNK 248
Query: 210 LRDHLTNG---FPGLEPAGI-----DLISKMLGMDPDKRITAAEALQQEYFK 253
           L + +  G   FP  + A I     DLISK+L  D  +R++AA+ LQ  + +
Sbjct: 249 LFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 100/262 (38%), Gaps = 38/262 (14%)
Query: 6   NTMEGVPSSMI-REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           ++  GV    I REV+ L E+ HPNII L  +      +  + E       +     K+S
Sbjct: 66  SSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES 125
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKT 121
           +       F    L     L                 R    DLKP NI++   ++    
Sbjct: 126 LTEDEATQFLKQILDGVHYL--------------HSKRIAHFDLKPENIMLLDKNVPNPR 171
Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEM 177
           +K+  FG+A  + A   E     GT  + APE++    LGL       D+W +G I   +
Sbjct: 172 IKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYIL 225
Query: 178 VSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
           +SG   F G     TL  I   +           D     F        D I ++L  DP
Sbjct: 226 LSGASPFLGETKQETLTNISAVN----------YDFDEEYFSNTSELAKDFIRRLLVKDP 275
Query: 238 DKRITAAEALQQEYFKDVPGRS 259
            +R+  A++L+  + K +  R+
Sbjct: 276 KRRMXIAQSLEHSWIKAIRRRN 297

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 2/94 (2%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NIL+D +G  +K+  FGL+K    ++ ++ +  GT  Y APE ++    +S 
Sbjct: 152 IYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQGHSH 209
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV 197
           + D W  G +  EM++G   F G +   T+  I+
Sbjct: 210 SADWWSYGVLMFEMLTGSLPFQGKDRKETMTLIL 243

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           I E   +M L+H  +++L  V ++   ++ + EY  N    LL Y ++  + + T+    
Sbjct: 51  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN--GCLLNYLREMRHRFQTQQ--- 105
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
                   L+E               +++ RDL   N LV+ D   VKV+ FGL++  Y 
Sbjct: 106 --------LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSR--YV 154
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              E ++ VG+ +   +  PE+L+   ++S+  DIW  G +  E+ S
Sbjct: 155 LDDEYTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 20/167 (11%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
            +E   +M+L+HP +++   V S+   +Y V EY  N    LL Y +    G        
Sbjct: 51  FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC--LLNYLRSHGKGLEPSQ--- 105
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
                   L+E               ++I RDL   N LVD D   VKV+ FG+ +  Y 
Sbjct: 106 --------LLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTR--YV 154
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              +  + VGT +   + APE+     +YS+  D+W  G +  E+ S
Sbjct: 155 LDDQYVSSVGTKFPVKWSAPEVF-HYFKYSSKSDVWAFGILMWEVFS 200

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           I E   +M L+H  +++L  V ++   ++ + EY  N    LL Y ++  + + T+    
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN--GCLLNYLREMRHRFQTQQ--- 121
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
                   L+E               +++ RDL   N LV+ D   VKV+ FGL++  Y 
Sbjct: 122 --------LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSR--YV 170
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              E ++ VG+ +   +  PE+L+   ++S+  DIW  G +  E+ S
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           I E   +M L+H  +++L  V ++   ++ + EY  N    LL Y ++  + + T+    
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN--GCLLNYLREMRHRFQTQQ--- 106
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
                   L+E               +++ RDL   N LV+ D   VKV+ FGL++  Y 
Sbjct: 107 --------LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSR--YV 155
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              E ++ VG+ +   +  PE+L+   ++S+  DIW  G +  E+ S
Sbjct: 156 LDDEYTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           I E   +M L+H  +++L  V ++   ++ + EY  N    LL Y ++  + + T+    
Sbjct: 58  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN--GCLLNYLREMRHRFQTQQ--- 112
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
                   L+E               +++ RDL   N LV+ D   VKV+ FGL++  Y 
Sbjct: 113 --------LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSR--YV 161
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              E ++ VG+ +   +  PE+L+   ++S+  DIW  G +  E+ S
Sbjct: 162 LDDEYTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYS 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           I E   +M L+H  +++L  V ++   ++ + EY  N    LL Y ++  + + T+    
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN--GCLLNYLREMRHRFQTQQ--- 101
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
                   L+E               +++ RDL   N LV+ D   VKV+ FGL++  Y 
Sbjct: 102 --------LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSR--YV 150
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              E ++ VG+ +   +  PE+L+   ++S+  DIW  G +  E+ S
Sbjct: 151 LDDEYTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYS 196

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 36/248 (14%)
Query: 11  VPSSMIR-EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYS 69
           V   ++R E+  L+ L+HPNII+L  +      +  V E       +     +    GY 
Sbjct: 90  VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF----DRIVEKGYY 145
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDG--KTVKVAGF 127
           ++   + ++      V                  + RDLKP N+L         +K+A F
Sbjct: 146 SERDAADAVKQILEAVAYLHENGI----------VHRDLKPENLLYATPAPDAPLKIADF 195
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG-KPLFPG 186
           GL+K +  ++       GT  Y APE+L G   Y   VD+W VG I   ++ G +P +  
Sbjct: 196 GLSK-IVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDE 253
Query: 187 ANSLITLGRIVGKSR---KPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA 243
                   RI+        P + ++SL                DL+ K++ +DP KR+T 
Sbjct: 254 RGDQFMFRRILNCEYYFISPWWDEVSLN-------------AKDLVRKLIVLDPKKRLTT 300
Query: 244 AEALQQEY 251
            +ALQ  +
Sbjct: 301 FQALQHPW 308

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA- 164
           RD+KP NIL+D +G+ VK++ FG  +S Y    +     GT+ +  PE       Y+ A 
Sbjct: 176 RDVKPSNILMDKNGR-VKLSDFG--ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAK 232
Query: 165 VDIWPVG-CIFGEMVSGKPLFPGANSL-ITLGRIVGKSRKPSFCKLSLRDHL-------- 214
           VDIW +G C++    +  P      SL I+L  +    R  +      R+H         
Sbjct: 233 VDIWSLGICLYVMFYNVVPF-----SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKK 287
Query: 215 ---TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
              +N F  L    ID +   L  +P +RIT+ +AL+ E+  D 
Sbjct: 288 STCSNNF--LSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 2/94 (2%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NIL+D +G  +K+  FGL+K    ++ ++ +  GT  Y APE ++    ++ 
Sbjct: 148 IYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQ 205
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV 197
           + D W  G +  EM++G   F G +   T+  I+
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 97/255 (38%), Gaps = 33/255 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           E +  ++ RE+     L HPNI+R   V     +L  V EY              +  G 
Sbjct: 55  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY--------------ASGGE 100
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVD-LDGKTVKVAGF 127
             +   +   F+       F             +   RDLK  N L+D      +K+  F
Sbjct: 101 LFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 160
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG- 186
           G +KS   +    S  VGT  Y APE+LL         D+W  G     M+ G   F   
Sbjct: 161 GYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDP 219
Query: 187 ---ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA 243
               N   T+ RI+         + ++ D++      + P    LIS++   DP KRI+ 
Sbjct: 220 EEPKNFRKTIHRILN-------VQYAIPDYV-----HISPECRHLISRIFVADPAKRISI 267
Query: 244 AEALQQEYF-KDVPG 257
            E    E+F K++P 
Sbjct: 268 PEIRNHEWFLKNLPA 282

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 19/143 (13%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLE-Y 161
           I RD+K  NIL+D +G  V +  FGL+K   A + E + +  GT  Y AP+++ G    +
Sbjct: 181 IYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239
Query: 162 STAVDIWPVGCIFGEMVSGKPLFP---GANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
             AVD W +G +  E+++G   F      NS   + R + KS  P   ++S         
Sbjct: 240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS--------- 290
Query: 219 PGLEPAGIDLISKMLGMDPDKRI 241
                   DLI ++L  DP KR+
Sbjct: 291 ----ALAKDLIQRLLMKDPKKRL 309

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 30/165 (18%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLE 160
           R + RDLKP NIL+D D   ++++  GLA  ++  +G++    VGT  Y APE++     
Sbjct: 306 RIVYRDLKPENILLD-DHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNE-R 361
Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG 220
           Y+ + D W +GC+  EM++G+  F      I    +               + L    P 
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---------------ERLVKEVPE 406
Query: 221 -----LEPAGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
                  P    L S++L  DP +R+     +A E  +   FK +
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 2/94 (2%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NIL+D +G  +K+  FGL+K    ++ ++ +  GT  Y APE ++    ++ 
Sbjct: 148 IYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQ 205
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV 197
           + D W  G +  EM++G   F G +   T+  I+
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 30/165 (18%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLE 160
           R + RDLKP NIL+D D   ++++  GLA  ++  +G++    VGT  Y APE++     
Sbjct: 306 RIVYRDLKPENILLD-DHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNE-R 361
Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG 220
           Y+ + D W +GC+  EM++G+  F      I    +               + L    P 
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---------------ERLVKEVPE 406
Query: 221 -----LEPAGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
                  P    L S++L  DP +R+     +A E  +   FK +
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 2/94 (2%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NIL+D +G  +K+  FGL+K    ++ ++ +  GT  Y APE ++    ++ 
Sbjct: 149 IYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQ 206
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV 197
           + D W  G +  EM++G   F G +   T+  I+
Sbjct: 207 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 240

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 97/255 (38%), Gaps = 33/255 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           E +  ++ RE+     L HPNI+R   V     +L  V EY              +  G 
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY--------------ASGGE 101
Query: 69  STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVD-LDGKTVKVAGF 127
             +   +   F+       F             +   RDLK  N L+D      +K+  F
Sbjct: 102 LFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAF 161
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG- 186
           G +KS   +  +    VGT  Y APE+LL         D+W  G     M+ G   F   
Sbjct: 162 GYSKSSVLH-SQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDP 220
Query: 187 ---ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA 243
               N   T+ RI+         + ++ D++      + P    LIS++   DP KRI+ 
Sbjct: 221 EEPKNFRKTIHRILN-------VQYAIPDYV-----HISPECRHLISRIFVADPAKRISI 268
Query: 244 AEALQQEYF-KDVPG 257
            E    E+F K++P 
Sbjct: 269 PEIRNHEWFLKNLPA 283

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 95/252 (37%), Gaps = 46/252 (18%)
Query: 17  REVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           REV  L E + HPN+IR         + Y   E      A L +Y          K+F  
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA---ATLQEY-------VEQKDFAH 115
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVK----VAGFGLAK 131
             L    LL +                 + RDLKP NIL+ +     K    ++ FGL K
Sbjct: 116 LGLEPITLLQQ----TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 132 SLYAYK---GESSAEVGTHYYKAPELLLGLLEY--STAVDIWPVGCIFGEMVS------G 180
            L   +      S   GT  + APE+L    +   +  VDI+  GC+F  ++S      G
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 181 KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
           K L   AN  I LG        P                  +    +LI KM+ MDP KR
Sbjct: 232 KSLQRQAN--ILLGACSLDCLHPE--------------KHEDVIARELIEKMIAMDPQKR 275
Query: 241 ITAAEALQQEYF 252
            +A   L+  +F
Sbjct: 276 PSAKHVLKHPFF 287

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 48  CPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 107
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 108 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 152
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 153 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 209
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 210 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 248 QQEYF 252
           +  ++
Sbjct: 261 KDRWY 265

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 104/270 (38%), Gaps = 67/270 (24%)
Query: 18  EVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS-MNGYSTKNFNS 75
           E+  L E + HPN+IR     +   +LY   E    +L  L++    S  N    K +N 
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 135
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK------------TVK 123
            SL                       + I RDLKP NILV    +             + 
Sbjct: 136 ISLLRQI---------ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 186
Query: 124 VAGFGLAKSLYA----YKGESSAEVGTHYYKAPELLLGLLEYST------AVDIWPVGCI 173
           ++ FGL K L +    ++   +   GT  ++APELL    E ST      ++DI+ +GC+
Sbjct: 187 ISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELL----EESTKRRLTRSIDIFSMGCV 242
Query: 174 FGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE----------- 222
           F  ++S                   K + P   K S   ++  G   L+           
Sbjct: 243 FYYILS-------------------KGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLI 283
Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               DLIS+M+  DP KR TA + L+   F
Sbjct: 284 AEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 107
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 108 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 152
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 153 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 209
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 210 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 248 QQEYF 252
           +  ++
Sbjct: 261 KDRWY 265

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 104/270 (38%), Gaps = 67/270 (24%)
Query: 18  EVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS-MNGYSTKNFNS 75
           E+  L E + HPN+IR     +   +LY   E    +L  L++    S  N    K +N 
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 135
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK------------TVK 123
            SL                       + I RDLKP NILV    +             + 
Sbjct: 136 ISLLRQI---------ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 186
Query: 124 VAGFGLAKSLYA----YKGESSAEVGTHYYKAPELLLGLLEYST------AVDIWPVGCI 173
           ++ FGL K L +    ++   +   GT  ++APELL    E ST      ++DI+ +GC+
Sbjct: 187 ISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELL----EESTKRRLTRSIDIFSMGCV 242
Query: 174 FGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE----------- 222
           F  ++S                   K + P   K S   ++  G   L+           
Sbjct: 243 FYYILS-------------------KGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLI 283
Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               DLIS+M+  DP KR TA + L+   F
Sbjct: 284 AEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 106
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 107 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 151
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 152 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 208
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 209 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 259
Query: 248 QQEYF 252
           +  ++
Sbjct: 260 KDRWY 264

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 107
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 108 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 152
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 153 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 209
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 210 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 248 QQEYF 252
           +  ++
Sbjct: 261 KDRWY 265

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + I RD+K  N+L+   G  VK+A FG+A  L   + + +  VGT ++ APE ++    Y
Sbjct: 140 KKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAY 197
Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
            +  DIW +G    E+  G+P     + +  L  ++ K+  P     +L    T  F   
Sbjct: 198 DSKADIWSLGITAIELAKGEPPNSDMHPMRVL-FLIPKNNPP-----TLVGDFTKSFK-- 249
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEY 251
                + I   L  DP  R TA E L+ ++
Sbjct: 250 -----EFIDACLNKDPSFRPTAKELLKHKF 274

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 106
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 107 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 151
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 152 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 208
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 209 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 259
Query: 248 QQEYF 252
           +  ++
Sbjct: 260 KDRWY 264

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 106
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 107 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 151
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 152 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 208
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 209 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 259
Query: 248 QQEYF 252
           +  ++
Sbjct: 260 KDRWY 264

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 106
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 107 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 151
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 152 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 208
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 209 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 259
Query: 248 QQEYF 252
           +  ++
Sbjct: 260 KDRWY 264

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 106
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 107 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 151
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 152 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 208
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 209 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 259
Query: 248 QQEYF 252
           +  ++
Sbjct: 260 KDRWY 264

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 106
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 107 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 151
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 152 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 208
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 209 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 259
Query: 248 QQEYF 252
           +  ++
Sbjct: 260 KDRWY 264

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 46  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 105
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 106 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 150
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 151 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 207
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 208 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 258
Query: 248 QQEYF 252
           +  ++
Sbjct: 259 KDRWY 263

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 107
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 108 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 152
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 153 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 209
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 210 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 248 QQEYF 252
           +  ++
Sbjct: 261 KDRWY 265

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 107
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 108 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 152
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 153 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 209
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 210 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 248 QQEYF 252
           +  ++
Sbjct: 261 KDRWY 265

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 107
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 108 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 152
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 153 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 209
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 210 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 248 QQEYF 252
           +  ++
Sbjct: 261 KDRWY 265

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 19/175 (10%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF-NS 75
           RE      LNHP I+         +Y     E     L Y++    + ++G + ++  ++
Sbjct: 61  REAQNAAALNHPAIV--------AVYDTGEAETPAGPLPYIVM---EYVDGVTLRDIVHT 109
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
               T    +E                 I RD+KP NIL+      VKV  FG+A+++ A
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISA-TNAVKVVDFGIARAI-A 167
Query: 136 YKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
             G S    +A +GT  Y +PE   G        D++ +GC+  E+++G+P F G
Sbjct: 168 DSGNSVXQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 97/256 (37%), Gaps = 38/256 (14%)
Query: 6   NTMEGVPSSMI-REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           ++  GV    I REV+ L E+ HPNII L  +      +  + E       +     K+S
Sbjct: 52  SSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES 111
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILV---DLDGKT 121
           +       F    L     L                 R    DLKP NI++   ++    
Sbjct: 112 LTEDEATQFLKQILDGVHYL--------------HSKRIAHFDLKPENIMLLDKNVPNPR 157
Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEM 177
           +K+  FG+A  + A   E     GT  + APE++    LGL       D+W +G I   +
Sbjct: 158 IKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYIL 211
Query: 178 VSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
           +SG   F G     TL  I   +           D     F        D I ++L  DP
Sbjct: 212 LSGASPFLGETKQETLTNISAVN----------YDFDEEYFSNTSELAKDFIRRLLVKDP 261
Query: 238 DKRITAAEALQQEYFK 253
            +R+  A++L+  + K
Sbjct: 262 KRRMXIAQSLEHSWIK 277

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G   K+A FG+ K        ++   GT  Y APE+L  +L Y  
Sbjct: 146 IYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGP 203
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANS 189
           AVD W +G +  EM+ G   F   N 
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENE 229

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/244 (21%), Positives = 95/244 (38%), Gaps = 30/244 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     +
Sbjct: 48  PENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ 107
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
            F              F           G     RD+KP N+L+D +   +K++ FGLA 
Sbjct: 108 RF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA- 151
Query: 132 SLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P   
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQ 209
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  +
Sbjct: 210 PSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 260
Query: 249 QEYF 252
             ++
Sbjct: 261 DRWY 264

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 30/159 (18%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLE 160
           + + RD+KP NILV+  G+ +K+  FG++  L     E + E VGT  Y +PE L G   
Sbjct: 128 KIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLI---DEMANEFVGTRSYMSPERLQG-TH 182
Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG 220
           YS   DIW +G    EM                   VG+  +P      L D++ N  P 
Sbjct: 183 YSVQSDIWSMGLSLVEMA------------------VGRYPRPPMAIFELLDYIVNEPPP 224
Query: 221 LEPAGI------DLISKMLGMDPDKRITAAEALQQEYFK 253
             P+ +      D ++K L  +P +R    + +   + K
Sbjct: 225 KLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 263

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/244 (21%), Positives = 95/244 (38%), Gaps = 30/244 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     +
Sbjct: 49  PENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ 108
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
            F              F           G     RD+KP N+L+D +   +K++ FGLA 
Sbjct: 109 RF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA- 152
Query: 132 SLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P   
Sbjct: 153 TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQ 210
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  +
Sbjct: 211 PSDSCQEYSDWKEKKTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
Query: 249 QEYF 252
             ++
Sbjct: 262 DRWY 265

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 107
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 108 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 152
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 153 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 209
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 210 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 248 QQEYF 252
           +  ++
Sbjct: 261 KDRWY 265

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/244 (21%), Positives = 95/244 (38%), Gaps = 30/244 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     +
Sbjct: 48  PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ 107
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
            F              F           G     RD+KP N+L+D +   +K++ FGLA 
Sbjct: 108 RF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA- 151
Query: 132 SLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P   
Sbjct: 152 TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQ 209
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  +
Sbjct: 210 PSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 260
Query: 249 QEYF 252
             ++
Sbjct: 261 DRWY 264

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
            P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 106
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + F              F           G     RD+KP N+L+D +   +K++ FGLA
Sbjct: 107 QRF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 151
Query: 131 KSLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
            +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P  
Sbjct: 152 -TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWD 208
Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
               +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  
Sbjct: 209 QPSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIK 259
Query: 248 QQEYF 252
           +  ++
Sbjct: 260 KDRWY 264

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 50/87 (57%), Gaps = 4/87 (4%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYS 162
           I RDLK  N+++D +G  +K+A FG+ K  +   G ++ E  GT  Y APE++     Y 
Sbjct: 142 IYRDLKLDNVMLDSEGH-IKIADFGMCKE-HMMDGVTTREFCGTPDYIAPEII-AYQPYG 198
Query: 163 TAVDIWPVGCIFGEMVSGKPLFPGANS 189
            +VD W  G +  EM++G+P F G + 
Sbjct: 199 KSVDWWAYGVLLYEMLAGQPPFDGEDE 225

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/244 (21%), Positives = 95/244 (38%), Gaps = 30/244 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     +
Sbjct: 48  PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ 107
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
            F              F           G     RD+KP N+L+D +   +K++ FGLA 
Sbjct: 108 RF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA- 151
Query: 132 SLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P   
Sbjct: 152 TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQ 209
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  +
Sbjct: 210 PSDSCQEYSDWKEKKTY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 260
Query: 249 QEYF 252
             ++
Sbjct: 261 DRWY 264

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 103/272 (37%), Gaps = 67/272 (24%)
Query: 18  EVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS-MNGYSTKNFNS 75
           E+  L E + HPN+IR     +   +LY   E    +L  L++    S  N    K +N 
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK------------TVK 123
            SL                       + I RDLKP NILV    +             + 
Sbjct: 118 ISLLRQI---------ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 124 VAGFGLAKSLYAYKGESSAEV------GTHYYKAPELLLGLLEYST------AVDIWPVG 171
           ++ FGL K L +  G+SS         GT  ++APELL       T      ++DI+ +G
Sbjct: 169 ISDFGLCKKLDS--GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226
Query: 172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE--------- 222
           C+F  ++S                   K + P   K S   ++  G   L+         
Sbjct: 227 CVFYYILS-------------------KGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRS 267
Query: 223 --PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                 DLIS+M+  DP KR TA + L+   F
Sbjct: 268 LIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/244 (21%), Positives = 95/244 (38%), Gaps = 30/244 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     +
Sbjct: 48  PENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ 107
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
            F              F           G     RD+KP N+L+D +   +K++ FGLA 
Sbjct: 108 RF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA- 151
Query: 132 SLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P   
Sbjct: 152 TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQ 209
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  +
Sbjct: 210 PSDSCQEYSDWKEKKTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 260
Query: 249 QEYF 252
             ++
Sbjct: 261 DRWY 264

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 19/175 (10%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF-NS 75
           RE      LNHP I+         +Y     E     L Y++    + ++G + ++  ++
Sbjct: 61  REAQNAAALNHPAIV--------AVYATGEAETPAGPLPYIVM---EYVDGVTLRDIVHT 109
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
               T    +E                 I RD+KP NI++      VKV  FG+A+++ A
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAI-A 167
Query: 136 YKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
             G S    +A +GT  Y +PE   G        D++ +GC+  E+++G+P F G
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 79/192 (41%), Gaps = 31/192 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYL-----YPVFEYQVNDLAYLLKYPKDSMNG 67
             +I+EV  L +L HPN I+      +G YL     + V EY +   + LL+  K  +  
Sbjct: 99  QDIIKEVRFLQKLRHPNTIQY-----RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 153
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
                    +L     L                   I RD+K  NIL+   G  VK+  F
Sbjct: 154 VEIAAVTHGALQGLAYL--------------HSHNMIHRDVKAGNILLSEPG-LVKLGDF 198
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--YSTAVDIWPVGCIFGEMVSGKPLFP 185
           G A  +      ++  VGT Y+ APE++L + E  Y   VD+W +G    E+   KP   
Sbjct: 199 GSASIM----APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254
Query: 186 GANSLITLGRIV 197
             N++  L  I 
Sbjct: 255 NMNAMSALYHIA 266

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/244 (21%), Positives = 95/244 (38%), Gaps = 30/244 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P ++ +E+     LNH N+++      +G   Y   EY      +    P   M     +
Sbjct: 48  PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ 107
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
            F              F           G     RD+KP N+L+D +   +K++ FGLA 
Sbjct: 108 RF--------------FHQLMAGVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA- 151
Query: 132 SLYAYKGES---SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           +++ Y       +   GT  Y APELL     ++  VD+W  G +   M++G+   P   
Sbjct: 152 TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQ 209
Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
              +         K ++          N +  ++ A + L+ K+L  +P  RIT  +  +
Sbjct: 210 PSDSXQEYSDWKEKKTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 260
Query: 249 QEYF 252
             ++
Sbjct: 261 DRWY 264

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 79/192 (41%), Gaps = 31/192 (16%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYL-----YPVFEYQVNDLAYLLKYPKDSMNG 67
             +I+EV  L +L HPN I+      +G YL     + V EY +   + LL+  K  +  
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQY-----RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 114
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
                    +L     L                   I RD+K  NIL+   G  VK+  F
Sbjct: 115 VEIAAVTHGALQGLAYL--------------HSHNMIHRDVKAGNILLSEPG-LVKLGDF 159
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--YSTAVDIWPVGCIFGEMVSGKPLFP 185
           G A  +      ++  VGT Y+ APE++L + E  Y   VD+W +G    E+   KP   
Sbjct: 160 GSASIM----APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
Query: 186 GANSLITLGRIV 197
             N++  L  I 
Sbjct: 216 NMNAMSALYHIA 227

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 19/175 (10%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF-NS 75
           RE      LNHP I+         +Y     E     L Y++    + ++G + ++  ++
Sbjct: 61  REAQNAAALNHPAIV--------AVYDTGEAETPAGPLPYIVM---EYVDGVTLRDIVHT 109
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
               T    +E                 I RD+KP NI++      VKV  FG+A+++ A
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAI-A 167
Query: 136 YKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
             G S    +A +GT  Y +PE   G        D++ +GC+  E+++G+P F G
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 81/194 (41%), Gaps = 26/194 (13%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY- 76
           E+  + +LNHPN++    V      L P      NDL  L      +M      +   Y 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAP------NDLPLL------AMEYCEGGDLRKYL 109
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRY------IRRDLKPVNILVDLDGKTV--KVAGFG 128
           + F     ++E              RY      I RDLKP NI++    + +  K+   G
Sbjct: 110 NQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169
Query: 129 LAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG-KPLFPG 186
            AK L   +GE   E VGT  Y APE LL   +Y+  VD W  G +  E ++G +P  P 
Sbjct: 170 YAKEL--DQGELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226
Query: 187 ANSLITLGRIVGKS 200
              +   G++  KS
Sbjct: 227 WQPVQWHGKVREKS 240

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 102/270 (37%), Gaps = 63/270 (23%)
Query: 18  EVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS-MNGYSTKNFNS 75
           E+  L E + HPN+IR     +   +LY   E    +L  L++    S  N    K +N 
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGK------------TVK 123
            SL                       + I RDLKP NILV    +             + 
Sbjct: 118 ISLLRQI---------ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 124 VAGFGLAKSLYA----YKGESSAEVGTHYYKAPELLLGLLEYST------AVDIWPVGCI 173
           ++ FGL K L +    ++   +   GT  ++APELL       T      ++DI+ +GC+
Sbjct: 169 ISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 174 FGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE----------- 222
           F  ++S                   K + P   K S   ++  G   L+           
Sbjct: 229 FYYILS-------------------KGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLI 269
Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               DLIS+M+  DP KR TA + L+   F
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 20/167 (11%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           I E   +M L+H  +++L  V ++   ++ + EY  N    LL Y ++  + + T+    
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN--GCLLNYLREMRHRFQTQQ--- 106
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
                   L+E               +++ RDL   N LV+ D   VKV+ FGL++  Y 
Sbjct: 107 --------LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSR--YV 155
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              E ++  G+ +   +  PE+L+   ++S+  DIW  G +  E+ S
Sbjct: 156 LDDEYTSSRGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 81/194 (41%), Gaps = 26/194 (13%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY- 76
           E+  + +LNHPN++    V      L P      NDL  L      +M      +   Y 
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAP------NDLPLL------AMEYCEGGDLRKYL 110
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRY------IRRDLKPVNILVDLDGKTV--KVAGFG 128
           + F     ++E              RY      I RDLKP NI++    + +  K+   G
Sbjct: 111 NQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 170
Query: 129 LAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG-KPLFPG 186
            AK L   +GE   E VGT  Y APE LL   +Y+  VD W  G +  E ++G +P  P 
Sbjct: 171 YAKEL--DQGELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227
Query: 187 ANSLITLGRIVGKS 200
              +   G++  KS
Sbjct: 228 WQPVQWHGKVREKS 241

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 19/175 (10%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF-NS 75
           RE      LNHP I+         +Y     E     L Y++    + ++G + ++  ++
Sbjct: 61  REAQNAAALNHPAIV--------AVYDTGEAETPAGPLPYIVM---EYVDGVTLRDIVHT 109
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
               T    +E                 I RD+KP NI++      VKV  FG+A+++ A
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAI-A 167
Query: 136 YKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
             G S    +A +GT  Y +PE   G        D++ +GC+  E+++G+P F G
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL---LGL 158
           + I RD+KP NIL+D  G  +K+  FG++  L     ++  + G   Y APE +      
Sbjct: 146 KIIHRDIKPSNILLDRSG-NIKLCDFGISGQLVDSIAKTR-DAGCRPYMAPERIDPSASR 203
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
             Y    D+W +G    E+ +G+  +P  NS+      V K   P       R+      
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE------ 257
Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
               P+ I+ ++  L  D  KR    E L+  + 
Sbjct: 258 --FSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 19/175 (10%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF-NS 75
           RE      LNHP I+         +Y     E     L Y++    + ++G + ++  ++
Sbjct: 61  REAQNAAALNHPAIV--------AVYDTGEAETPAGPLPYIVM---EYVDGVTLRDIVHT 109
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
               T    +E                 I RD+KP NI++      VKV  FG+A+++ A
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAI-A 167
Query: 136 YKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
             G S    +A +GT  Y +PE   G        D++ +GC+  E+++G+P F G
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/84 (38%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS--LYAYKGESSAEVGTHYYKAPELLLGL 158
             +I RD+K  NIL+D +  T K++ FGLA++   +A     S  VGT  Y APE L G 
Sbjct: 143 NHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRG- 200
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKP 182
            E +   DI+  G +  E+++G P
Sbjct: 201 -EITPKSDIYSFGVVLLEIITGLP 223

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 69/221 (31%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE------SSAE-------------- 143
           + RD+KP N L +   K   +  FGLA+  +  K E      S A+              
Sbjct: 139 VHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLS 198
Query: 144 --------VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANSLITLG 194
                    GT  ++APE+L      +TA+D+W  G IF  ++SG+ P +  ++ L  L 
Sbjct: 199 RRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALA 258
Query: 195 RIV---------------GKS------------RK---------PSFCKLS--LRDHLTN 216
           +I+               GKS            RK          S  KL+  ++ H TN
Sbjct: 259 QIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATN 318
Query: 217 --GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
             G+  +     DL+ K+L ++P  RITA EAL   +FKD+
Sbjct: 319 LEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 68/155 (43%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  N+++D DG  +K+  FGL K             GT  Y APE+L    +Y  
Sbjct: 274 VYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGR 331
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           AVD W +G +  EM+ G+  F   +                  +L L + +   FP  L 
Sbjct: 332 AVDWWGLGVVMYEMMCGRLPFYNQDH-------------EKLFELILMEEIR--FPRTLG 376
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L+S +L  DP +R+      A E +Q  +F
Sbjct: 377 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 68/155 (43%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  N+++D DG  +K+  FGL K             GT  Y APE+L    +Y  
Sbjct: 271 VYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGR 328
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           AVD W +G +  EM+ G+  F   +                  +L L + +   FP  L 
Sbjct: 329 AVDWWGLGVVMYEMMCGRLPFYNQDH-------------EKLFELILMEEIR--FPRTLG 373
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L+S +L  DP +R+      A E +Q  +F
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 18/159 (11%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGL-AKSLYAYKGESSAEVGTHYYKAPELLLGL-- 158
           R I RDLK  N+L+ L+G  +++A FG+ AK+L   +   S  +GT Y+ APE+++    
Sbjct: 137 RIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVVMCETM 194
Query: 159 --LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
               Y    DIW +G    EM   +P     N +  L +I  KS  P+         LT 
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSDPPTL--------LTP 245
Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
               +E    D +   L  +P+ R +AA+ L+  +   +
Sbjct: 246 SKWSVE--FRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 19/175 (10%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF-NS 75
           RE      LNHP I+         +Y     E     L Y++    + ++G + ++  ++
Sbjct: 78  REAQNAAALNHPAIV--------AVYDTGEAETPAGPLPYIVM---EYVDGVTLRDIVHT 126
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
               T    +E                 I RD+KP NI++      VKV  FG+A+++ A
Sbjct: 127 EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAI-A 184
Query: 136 YKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
             G S    +A +GT  Y +PE   G        D++ +GC+  E+++G+P F G
Sbjct: 185 DSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 66/152 (43%), Gaps = 21/152 (13%)
Query: 107 DLKPVNILVDLD-GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL----LGLLEY 161
           D+KP NI+ +     +VK+  FGLA  L   +        T  + APE++    +G    
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTTATAEFAAPEIVDREPVGFY-- 230
Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
               D+W +G +   ++SG   F G + L TL  +         C     +   + F  +
Sbjct: 231 ---TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-------KRCDWEFDE---DAFSSV 277
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
            P   D I  +L  +P KR+T  +AL+  + K
Sbjct: 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + + RD+KP NILV+  G+ +K+  FG++  L      S   VGT  Y +PE L G   Y
Sbjct: 125 KIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THY 180
Query: 162 STAVDIWPVGCIFGEMVSGK-PL-FPGANSL-ITLGRIV--------------------- 197
           S   DIW +G    EM  G+ P+  P A  L +  G  V                     
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 198 GKSRKPSFCKLSLRDHLTNGFPGLEPAGI------DLISKMLGMDPDKRITAAEALQQEY 251
           G   +P      L D++ N  P   P+G+      D ++K L  +P +R    + +   +
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 252 FK 253
            K
Sbjct: 301 IK 302

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 68/155 (43%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  N+++D DG  +K+  FGL K             GT  Y APE+L    +Y  
Sbjct: 131 VYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN-DYGR 188
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           AVD W +G +  EM+ G+  F   +                  +L L + +   FP  L 
Sbjct: 189 AVDWWGLGVVMYEMMCGRLPFYNQDH-------------EKLFELILMEEIR--FPRTLG 233
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L+S +L  DP +R+      A E +Q  +F
Sbjct: 234 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + + RD+KP NILV+  G+ +K+  FG++  L      S   VGT  Y +PE L G   Y
Sbjct: 125 KIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THY 180
Query: 162 STAVDIWPVGCIFGEMVSGK-PL-FPGANSL-ITLGRIV--------------------- 197
           S   DIW +G    EM  G+ P+  P A  L +  G  V                     
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 198 GKSRKPSFCKLSLRDHLTNGFPGLEPAGI------DLISKMLGMDPDKRITAAEALQQEY 251
           G   +P      L D++ N  P   P+G+      D ++K L  +P +R    + +   +
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 252 FK 253
            K
Sbjct: 301 IK 302

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 68/155 (43%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  N+++D DG  +K+  FGL K             GT  Y APE+L    +Y  
Sbjct: 133 VYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN-DYGR 190
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           AVD W +G +  EM+ G+  F   +                  +L L + +   FP  L 
Sbjct: 191 AVDWWGLGVVMYEMMCGRLPFYNQDH-------------EKLFELILMEEIR--FPRTLG 235
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L+S +L  DP +R+      A E +Q  +F
Sbjct: 236 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 68/155 (43%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  N+++D DG  +K+  FGL K             GT  Y APE+L    +Y  
Sbjct: 132 VYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN-DYGR 189
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           AVD W +G +  EM+ G+  F   +                  +L L + +   FP  L 
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPFYNQDH-------------EKLFELILMEEIR--FPRTLG 234
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L+S +L  DP +R+      A E +Q  +F
Sbjct: 235 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 18/159 (11%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGL-AKSLYAYKGESSAEVGTHYYKAPELLLGL-- 158
           R I RDLK  N+L+ L+G  +++A FG+ AK+L   +   S  +GT Y+ APE+++    
Sbjct: 129 RIIHRDLKAGNVLMTLEGD-IRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVVMCETM 186
Query: 159 --LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
               Y    DIW +G    EM   +P     N +  L +I  KS  P+         LT 
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSDPPTL--------LTP 237
Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
               +E    D +   L  +P+ R +AA+ L+  +   +
Sbjct: 238 SKWSVE--FRDFLKIALDKNPETRPSAAQLLEHPFVSSI 274

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + + RD+KP NILV+  G+ +K+  FG++  L      S   VGT  Y +PE L G   Y
Sbjct: 125 KIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THY 180
Query: 162 STAVDIWPVGCIFGEMVSGK-PL-FPGANSL-ITLGRIV--------------------- 197
           S   DIW +G    EM  G+ P+  P A  L +  G  V                     
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 198 GKSRKPSFCKLSLRDHLTNGFPGLEPAGI------DLISKMLGMDPDKRITAAEALQQEY 251
           G   +P      L D++ N  P   P+G+      D ++K L  +P +R    + +   +
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 252 FK 253
            K
Sbjct: 301 IK 302

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + + RD+KP NILV+  G+ +K+  FG++  L      S   VGT  Y +PE L G   Y
Sbjct: 125 KIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THY 180
Query: 162 STAVDIWPVGCIFGEMVSGK-PL-FPGANSL-ITLGRIV--------------------- 197
           S   DIW +G    EM  G+ P+  P A  L +  G  V                     
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 198 GKSRKPSFCKLSLRDHLTNGFPGLEPAGI------DLISKMLGMDPDKRITAAEALQQEY 251
           G   +P      L D++ N  P   P+G+      D ++K L  +P +R    + +   +
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300
Query: 252 FK 253
            K
Sbjct: 301 IK 302

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/84 (38%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS--LYAYKGESSAEVGTHYYKAPELLLGL 158
             +I RD+K  NIL+D +  T K++ FGLA++   +A     S  VGT  Y APE L G 
Sbjct: 152 NHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRG- 209
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKP 182
            E +   DI+  G +  E+++G P
Sbjct: 210 -EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 75/174 (43%), Gaps = 38/174 (21%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE------VGTHYYKAPELLLG 157
           I RD+K  NIL+  DG +V++A FG++ +  A  G+ +        VGT  + APE++  
Sbjct: 143 IHRDVKAGNILLGEDG-SVQIADFGVS-AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200
Query: 158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG 217
           +  Y    DIW  G    E+ +G   +                + P    L L   L N 
Sbjct: 201 VRGYDFKADIWSFGITAIELATGAAPY---------------HKYPPMKVLMLT--LQND 243
Query: 218 FPGLEPAGID-------------LISKMLGMDPDKRITAAEALQQEYFKDVPGR 258
            P LE    D             +IS  L  DP+KR TAAE L+ ++F+    +
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G  +K+  +G+ K        +S   GT  Y APE+L G  +Y  
Sbjct: 175 IYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGF 232
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS 204
           +VD W +G +  EM++G+  F           IVG S  P 
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFD----------IVGSSDNPD 263

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + + RD+KP NILV+  G+ +K+  FG++  L      S   VGT  Y +PE L G   Y
Sbjct: 152 KIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THY 207
Query: 162 STAVDIWPVGCIFGEMVSGK-PL-FPGANSL-ITLGRIV--------------------- 197
           S   DIW +G    EM  G+ P+  P A  L +  G  V                     
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 198 GKSRKPSFCKLSLRDHLTNGFPGLEPAGI------DLISKMLGMDPDKRITAAEALQQEY 251
           G   +P      L D++ N  P   P+G+      D ++K L  +P +R    + +   +
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 252 FK 253
            K
Sbjct: 328 IK 329

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 74/169 (43%), Gaps = 38/169 (22%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE------VGTHYYKAPELLLG 157
           I RD+K  NIL+  DG +V++A FG++ +  A  G+ +        VGT  + APE++  
Sbjct: 138 IHRDVKAGNILLGEDG-SVQIADFGVS-AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 195
Query: 158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG 217
           +  Y    DIW  G    E+ +G   +                + P    L L   L N 
Sbjct: 196 VRGYDFKADIWSFGITAIELATGAAPY---------------HKYPPMKVLMLT--LQND 238
Query: 218 FPGLEPAGID-------------LISKMLGMDPDKRITAAEALQQEYFK 253
            P LE    D             +IS  L  DP+KR TAAE L+ ++F+
Sbjct: 239 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 287

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 110
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 111 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 156
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 157 RLI--EDAEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G  +K+  +G+ K        +S   GT  Y APE+L G  +Y  
Sbjct: 143 IYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE-DYGF 200
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS 204
           +VD W +G +  EM++G+  F           IVG S  P 
Sbjct: 201 SVDWWALGVLMFEMMAGRSPFD----------IVGSSDNPD 231

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G  +K+  +G+ K        +S   GT  Y APE+L G  +Y  
Sbjct: 128 IYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE-DYGF 185
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS 204
           +VD W +G +  EM++G+  F           IVG S  P 
Sbjct: 186 SVDWWALGVLMFEMMAGRSPFD----------IVGSSDNPD 216

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+K  N+++D DG  +K+  FGL K   +         GT  Y APE+L    +Y  
Sbjct: 127 VYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGR 184
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE 222
           AVD W +G +  EM+ G+ P +   +  +    ++ + R P                 L 
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---------------TLS 229
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L++ +L  DP +R+      A E ++  +F
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 53  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 111
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 112 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 157
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 158 RLI--EDNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 214

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 110
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 111 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 156
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 157 RLI--EDNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+K  N+++D DG  +K+  FGL K   +         GT  Y APE+L    +Y  
Sbjct: 130 VYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGR 187
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE 222
           AVD W +G +  EM+ G+ P +   +  +    ++ + R P                 L 
Sbjct: 188 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---------------TLS 232
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L++ +L  DP +R+      A E ++  +F
Sbjct: 233 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 54  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 112
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 113 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 158
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 159 RLI--EDNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 215

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G  +K+  +G+ K        +S   GT  Y APE+L G  +Y  
Sbjct: 132 IYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE-DYGF 189
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS 204
           +VD W +G +  EM++G+  F           IVG S  P 
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFD----------IVGSSDNPD 220

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+K  N+++D DG  +K+  FGL K   +         GT  Y APE+L    +Y  
Sbjct: 127 VYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGR 184
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           AVD W +G +  EM+ G+  F   +                  +L L + +   FP  L 
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDH-------------ERLFELILMEEIR--FPRTLS 229
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L++ +L  DP +R+      A E ++  +F
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 110
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 111 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 156
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 157 RLI--EDNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 61  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 119
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 120 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 165
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 166 RLI--EDNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 222

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 60  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 118
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 119 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 164
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 165 RLI--EDNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 221

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 116
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 117 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 162
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 163 RLI--EDNEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + I RD+K  N+L+   G+ VK+A FG+A  L   + + +  VGT ++ APE ++    Y
Sbjct: 144 KKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAY 201
Query: 162 STAVDIWPVGCIFGEMVSGKP 182
            +  DIW +G    E+  G+P
Sbjct: 202 DSKADIWSLGITAIELARGEP 222

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+K  N+++D DG  +K+  FGL K   +         GT  Y APE+L    +Y  
Sbjct: 127 VYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN-DYGR 184
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE 222
           AVD W +G +  EM+ G+ P +   +  +    ++ + R P                 L 
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---------------TLS 229
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L++ +L  DP +R+      A E ++  +F
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+K  N+++D DG  +K+  FGL K   +         GT  Y APE+L    +Y  
Sbjct: 127 VYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN-DYGR 184
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE 222
           AVD W +G +  EM+ G+ P +   +  +    ++ + R P                 L 
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---------------TLS 229
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L++ +L  DP +R+      A E ++  +F
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 40/249 (16%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K  M  Y   
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSK--GSLLDFLKGEMGKY--- 110
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 111 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 162
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 163 LI--EDNEXTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA- 244
            +   L ++    R P    C  SL                DL+ +    DP++R T   
Sbjct: 220 VNREVLDQVERGYRMPCPPECPESLH---------------DLMCQCWRKDPEERPTFEY 264
Query: 245 -EALQQEYF 252
            +A  ++YF
Sbjct: 265 LQAFLEDYF 273

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+K  N+++D DG  +K+  FGL K   +         GT  Y APE+L    +Y  
Sbjct: 127 VYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN-DYGR 184
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE 222
           AVD W +G +  EM+ G+ P +   +  +    ++ + R P                 L 
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---------------TLS 229
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L++ +L  DP +R+      A E ++  +F
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 63/150 (42%), Gaps = 15/150 (10%)
Query: 104 IRRDLKPVNI--LVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + RDLKP N+  L   +   + +  FGL+K      G  S   GT  Y APE +L    Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPE-VLAQKPY 184
Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
           S AVD W +G I   ++ G P F          +I          K    +  +  +  +
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI----------KEGYYEFESPFWDDI 234
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEY 251
             +  D I  +L  DP++R T  +AL   +
Sbjct: 235 SESAKDFICHLLEKDPNERYTCEKALSHPW 264

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+K  N+++D DG  +K+  FGL K   +         GT  Y APE+L    +Y  
Sbjct: 132 VYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDN-DYGR 189
Query: 164 AVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE 222
           AVD W +G +  EM+ G+ P +   +  +    ++ + R P                 L 
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---------------TLS 234
Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYF 252
           P    L++ +L  DP +R+      A E ++  +F
Sbjct: 235 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 15/150 (10%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           R I RD+K  N+L+   G  VK+A FG+A  L   + + +  VGT ++ APE ++    Y
Sbjct: 136 RKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAY 193
Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
               DIW +G    E+  G+P     + +  L  I      P     +L    +  F   
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI------PKNSPPTLEGQHSKPFK-- 245
Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEY 251
                + +   L  DP  R TA E L+ ++
Sbjct: 246 -----EFVEACLNKDPRFRPTAKELLKHKF 270

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + I RD+K  N+L+   G+ VK+A FG+A  L   + + +  VGT ++ APE ++    Y
Sbjct: 124 KKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAY 181
Query: 162 STAVDIWPVGCIFGEMVSGKP 182
            +  DIW +G    E+  G+P
Sbjct: 182 DSKADIWSLGITAIELARGEP 202

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 65/167 (38%), Gaps = 18/167 (10%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           + E S + + +HPNIIRL  V ++G     V EY  N          D            
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---------- 147
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              FT   LV                 Y+ RDL   N+LVD      KV+ FGL++ L  
Sbjct: 148 ---FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLED 203
Query: 136 YKGESSAEVGTH---YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
               +    G      + APE  +    +S+A D+W  G +  E+++
Sbjct: 204 DPDAAXTTTGGKIPIRWTAPE-AIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 47  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 105
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 106 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 151
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 152 RLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 208

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 57  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 115
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 116 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 161
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 162 RLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + I RD+K  N+L+   G+ VK+A FG+A  L   + + +  VGT ++ APE ++    Y
Sbjct: 139 KKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAY 196
Query: 162 STAVDIWPVGCIFGEMVSGKP 182
            +  DIW +G    E+  G+P
Sbjct: 197 DSKADIWSLGITAIELARGEP 217

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 116
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 117 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 162
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 163 RLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 103/254 (40%), Gaps = 26/254 (10%)
Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPKDSMNGYS 69
           S +I E+  +  +  H NII L+   +Q   LY + EY  + N   YL       +    
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCY 137
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
             + N     ++  LV                + I RDL   N+LV  D   +K+A FGL
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGL 196
Query: 130 AKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLF 184
           A+ ++    YK  ++  +   +  APE L   + Y+   D+W  G +  E+ +  G P +
Sbjct: 197 ARDIHHIDYYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP-Y 253
Query: 185 PG--ANSLITLGRIVGKSRKPSFCK----LSLRDHLTNGFPGLEPAGIDLISKMLGMDPD 238
           PG     L  L +   +  KPS C     + +RD   +  P   P    L+  +      
Sbjct: 254 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL------ 306
Query: 239 KRITAAEALQQEYF 252
            RI A  +  QEY 
Sbjct: 307 DRIVALTS-NQEYL 319

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + + RD+KP NILV+  G+ +K+  FG++  L      S   VGT  Y +PE L G   Y
Sbjct: 187 KIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQG-THY 242
Query: 162 STAVDIWPVGCIFGEMVSGK-PLFP 185
           S   DIW +G    EM  G+ P+ P
Sbjct: 243 SVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + I RD+K  N+L+   G+ VK+A FG+A  L   + + +  VGT ++ APE ++    Y
Sbjct: 124 KKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAY 181
Query: 162 STAVDIWPVGCIFGEMVSGKP 182
            +  DIW +G    E+  G+P
Sbjct: 182 DSKADIWSLGITAIELARGEP 202

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 110
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 111 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 156
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 157 RLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 62  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 120
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI RDL+  NILV  D  + K+A FGLA
Sbjct: 121 LLDMAAQIAEGMAFIEE-------------RNYIHRDLRAANILVS-DTLSCKIADFGLA 166
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 167 RLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 40/249 (16%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K  M  Y   
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSK--GSLLDFLKGEMGKY--- 110
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 111 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 162
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 163 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA- 244
            +   L ++    R P    C  SL                DL+ +    DP++R T   
Sbjct: 220 VNREVLDQVERGYRMPCPPECPESLH---------------DLMCQCWRKDPEERPTFEY 264
Query: 245 -EALQQEYF 252
            +A  ++YF
Sbjct: 265 LQAFLEDYF 273

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 40/249 (16%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K  M  Y   
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVMEYMSK--GCLLDFLKGEMGKY--- 110
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 111 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 162
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 163 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA- 244
            +   L ++    R P    C  SL                DL+ +    DP++R T   
Sbjct: 220 VNREVLDQVERGYRMPCPPECPESLH---------------DLMCQCWRKDPEERPTFEY 264
Query: 245 -EALQQEYF 252
            +A  ++YF
Sbjct: 265 LQAFLEDYF 273

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPKDSMNGYS 69
           S +I E+  +  +  H NII L+   +Q   LY + EY  + N   YL       +    
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSY 137
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
             + N     ++  LV                + I RDL   N+LV  D   +K+A FGL
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGL 196
Query: 130 AKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLF 184
           A+ ++    YK  ++  +   +  APE L   + Y+   D+W  G +  E+ +  G P +
Sbjct: 197 ARDIHHIDYYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP-Y 253
Query: 185 PG--ANSLITLGRIVGKSRKPSFC 206
           PG     L  L +   +  KPS C
Sbjct: 254 PGVPVEELFKLLKEGHRMDKPSNC 277

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 5/84 (5%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS--LYAYKGESSAEVGTHYYKAPELLLGL 158
             +I RD+K  NIL+D +  T K++ FGLA++   +A        VGT  Y APE L G 
Sbjct: 152 NHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG- 209
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKP 182
            E +   DI+  G +  E+++G P
Sbjct: 210 -EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 19/234 (8%)
Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPKDSMNGYS 69
           S +I E+  +  +  H NII L+   +Q   LY + EY  + N   YL       +    
Sbjct: 63  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCY 122
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
             + N     ++  LV                + I RDL   N+LV  D   +K+A FGL
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGL 181
Query: 130 AKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLF 184
           A+ ++    YK  ++  +   +  APE L   + Y+   D+W  G +  E+ +  G P +
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP-Y 238
Query: 185 PG--ANSLITLGRIVGKSRKPSFCK----LSLRDHLTNGFPGLEPAGIDLISKM 232
           PG     L  L +   +  KPS C     + +RD   +  P   P    L+  +
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 291

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 19/234 (8%)
Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPKDSMNGYS 69
           S +I E+  +  +  H NII L+   +Q   LY + EY  + N   YL       +    
Sbjct: 67  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 126
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
             + N     ++  LV                + I RDL   N+LV  D   +K+A FGL
Sbjct: 127 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGL 185
Query: 130 AKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLF 184
           A+ ++    YK  ++  +   +  APE L   + Y+   D+W  G +  E+ +  G P +
Sbjct: 186 ARDIHHIDYYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP-Y 242
Query: 185 PG--ANSLITLGRIVGKSRKPSFCK----LSLRDHLTNGFPGLEPAGIDLISKM 232
           PG     L  L +   +  KPS C     + +RD   +  P   P    L+  +
Sbjct: 243 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 295

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 5/84 (5%)
Query: 101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS--LYAYKGESSAEVGTHYYKAPELLLGL 158
             +I RD+K  NIL+D +  T K++ FGLA++   +A        VGT  Y APE L G 
Sbjct: 146 NHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG- 203
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKP 182
            E +   DI+  G +  E+++G P
Sbjct: 204 -EITPKSDIYSFGVVLLEIITGLP 226

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 19/234 (8%)
Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPKDSMNGYS 69
           S +I E+  +  +  H NII L+   +Q   LY + EY  + N   YL       +    
Sbjct: 71  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 130
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
             + N     ++  LV                + I RDL   N+LV  D   +K+A FGL
Sbjct: 131 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGL 189
Query: 130 AKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLF 184
           A+ ++    YK  ++  +   +  APE L   + Y+   D+W  G +  E+ +  G P +
Sbjct: 190 ARDIHHIDYYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP-Y 246
Query: 185 PG--ANSLITLGRIVGKSRKPSFCK----LSLRDHLTNGFPGLEPAGIDLISKM 232
           PG     L  L +   +  KPS C     + +RD   +  P   P    L+  +
Sbjct: 247 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 299

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPKDSMNGYS 69
           S +I E+  +  +  H NII L+   +Q   LY + EY  + N   YL       +    
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 137
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
             + N     ++  LV                + I RDL   N+LV  D   +K+A FGL
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGL 196
Query: 130 AKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLF 184
           A+ ++    YK  ++  +   +  APE L   + Y+   D+W  G +  E+ +  G P +
Sbjct: 197 ARDIHHIDYYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP-Y 253
Query: 185 PG--ANSLITLGRIVGKSRKPSFC 206
           PG     L  L +   +  KPS C
Sbjct: 254 PGVPVEELFKLLKEGHRMDKPSNC 277

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + + RD+KP NILV+  G+ +K+  FG++  L      S   VGT  Y APE L G   Y
Sbjct: 135 QIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF--VGTRSYMAPERLQG-THY 190
Query: 162 STAVDIWPVGCIFGEMVSGK-PLFP 185
           S   DIW +G    E+  G+ P+ P
Sbjct: 191 SVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 65/167 (38%), Gaps = 18/167 (10%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           + E S + + +HPNIIRL  V ++G     V EY  N          D            
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---------- 147
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              FT   LV                 Y+ RDL   N+LVD      KV+ FGL++ L  
Sbjct: 148 ---FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLED 203
Query: 136 YKGESSAEVGTH---YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
               +    G      + APE  +    +S+A D+W  G +  E+++
Sbjct: 204 DPDAAYTTTGGKIPIRWTAPE-AIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 40/249 (16%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K  M  Y   
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVCEYMSK--GSLLDFLKGEMGKY--- 110
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 111 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 162
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 163 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA- 244
            +   L ++    R P    C  SL                DL+ +    DP++R T   
Sbjct: 220 VNREVLDQVERGYRMPCPPECPESLH---------------DLMCQCWRKDPEERPTFEY 264
Query: 245 -EALQQEYF 252
            +A  ++YF
Sbjct: 265 LQAFLEDYF 273

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 18/153 (11%)
Query: 104 IRRDLKPVNILV---DLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLL 159
           + RDLKP N+L    D + K + ++ FGL+K     KG+  S   GT  Y APE+L    
Sbjct: 142 VHRDLKPENLLYYSQDEESK-IMISDFGLSK--MEGKGDVMSTACGTPGYVAPEVL-AQK 197
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            YS AVD W +G I   ++ G P F   N      +I+    K  +      +  +  + 
Sbjct: 198 PYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQIL----KAEY------EFDSPYWD 247
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
            +  +  D I  ++  DP+KR T  +A +  + 
Sbjct: 248 DISDSAKDFIRNLMEKDPNKRYTCEQAARHPWI 280

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPKDSMNGYS 69
           S +I E+  +  +  H NII L+   +Q   LY + EY  + N   YL       +    
Sbjct: 70  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 129
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
             + N     ++  LV                + I RDL   N+LV  D   +K+A FGL
Sbjct: 130 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGL 188
Query: 130 AKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLF 184
           A+ ++    YK  ++  +   +  APE L   + Y+   D+W  G +  E+ +  G P +
Sbjct: 189 ARDIHHIDYYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP-Y 245
Query: 185 PG--ANSLITLGRIVGKSRKPSFC 206
           PG     L  L +   +  KPS C
Sbjct: 246 PGVPVEELFKLLKEGHRMDKPSNC 269

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 102/251 (40%), Gaps = 25/251 (9%)
Query: 13  SSMIREVSCL-MELNHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPKDSMNGYS 69
           S +I E+  + M   H NII L+   +Q   LY + EY  + N   YL       +    
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
             + N     ++  LV                + I RDL   N+LV  D   +K+A FGL
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGL 237
Query: 130 AKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLF 184
           A+ ++    YK  ++  +   +  APE L   + Y+   D+W  G +  E+ +  G P +
Sbjct: 238 ARDIHHIDYYKKTTNGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP-Y 294
Query: 185 PG--ANSLITLGRIVGKSRKPSFCK----LSLRDHLTNGFPGLEPAGIDLISKMLGMDPD 238
           PG     L  L +   +  KPS C     + +RD   +  P   P    L+  +      
Sbjct: 295 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL------ 347
Query: 239 KRITAAEALQQ 249
            RI A  + Q+
Sbjct: 348 DRIVALTSNQE 358

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 40/249 (16%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K  M  Y   
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSK--GSLLDFLKGEMGKY--- 110
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 111 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 162
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 163 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA- 244
            +   L ++    R P    C  SL                DL+ +    DP++R T   
Sbjct: 220 VNREVLDQVERGYRMPCPPECPESLH---------------DLMCQCWRKDPEERPTFEY 264
Query: 245 -EALQQEYF 252
            +A  ++YF
Sbjct: 265 LQAFLEDYF 273

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 40/249 (16%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K  M  Y   
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSK--GCLLDFLKGEMGKY--- 110
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 111 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 162
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 163 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA- 244
            +   L ++    R P    C  SL                DL+ +    DP++R T   
Sbjct: 220 VNREVLDQVERGYRMPCPPECPESLH---------------DLMCQCWRKDPEERPTFEY 264
Query: 245 -EALQQEYF 252
            +A  ++YF
Sbjct: 265 LQAFLEDYF 273

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 40/249 (16%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K  M  Y   
Sbjct: 48  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSK--GSLLDFLKGEMGKY--- 101
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 102 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 153
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 154 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 210
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA- 244
            +   L ++    R P    C  SL                DL+ +    DP++R T   
Sbjct: 211 VNREVLDQVERGYRMPCPPECPESLH---------------DLMCQCWRKDPEERPTFEY 255
Query: 245 -EALQQEYF 252
            +A  ++YF
Sbjct: 256 LQAFLEDYF 264

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 21/210 (10%)
Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGY---- 68
            ++ E + L ++NHP++I+L    SQ   L  + EY +   L   L+  +    GY    
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 69  -----STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVK 123
                S+ +       T   L+                + + RDL   NILV  +G+ +K
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-AEGRKMK 190
Query: 124 VAGFGLAKSLY---AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS- 179
           ++ FGL++ +Y   +Y   S   +   +     L   +  Y+T  D+W  G +  E+V+ 
Sbjct: 191 ISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTL 248
Query: 180 -GKPLFPG--ANSLITLGRIVGKSRKPSFC 206
            G P +PG     L  L +   +  +P  C
Sbjct: 249 GGNP-YPGIPPERLFNLLKTGHRMERPDNC 277

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 47/89 (52%), Gaps = 15/89 (16%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAK----SLYAYKGES----------SAEVGTHYY 149
           I R+LKP NI +D + + VK+  FGLAK    SL   K +S          ++ +GT  Y
Sbjct: 138 IHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXY 196
Query: 150 KAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
            A E+L G   Y+  +D + +G IF E +
Sbjct: 197 VATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 14/171 (8%)
Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
           + I E+  L  +NHPNI++L       + L  V EY      Y + +  + +  Y+  + 
Sbjct: 48  AFIVELRQLSRVNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHA 105
Query: 74  NSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
            S+ L        +                I RDLKP N+L+   G  +K+  FG A  +
Sbjct: 106 MSWCL--------QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 157
Query: 134 YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
             +   +    G+  + APE+  G   YS   D++  G I  E+++ +  F
Sbjct: 158 QTHMTNNK---GSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 14/171 (8%)
Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
           + I E+  L  +NHPNI++L       + L  V EY      Y + +  + +  Y+  + 
Sbjct: 47  AFIVELRQLSRVNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHA 104
Query: 74  NSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
            S+ L        +                I RDLKP N+L+   G  +K+  FG A  +
Sbjct: 105 MSWCL--------QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156
Query: 134 YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
             +   +    G+  + APE+  G   YS   D++  G I  E+++ +  F
Sbjct: 157 QTHMTNNK---GSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 78/180 (43%), Gaps = 24/180 (13%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNS 75
           RE + + E ++PNI++L+ V + G  +  +FEY    DL   L+    SM+ ++  + + 
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR----SMSPHTVCSLSH 154
Query: 76  YSLFTT----------FLLVEEFXXXXXXXXXXF---GTRYIRRDLKPVNILVDLDGKTV 122
             L T               E+                 +++ RDL   N LV  +   V
Sbjct: 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVV 213
Query: 123 KVAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+A FGL++++Y+   YK + +  +   +     +      Y+T  D+W  G +  E+ S
Sbjct: 214 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 271

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+++D +G  +K+A FG+ K        +    GT  Y APE++     Y  
Sbjct: 143 IYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQPYGK 200
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANS 189
           +VD W  G +  EM++G+  F G + 
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDE 226

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 40/249 (16%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K  M  Y   
Sbjct: 46  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSK--GSLLDFLKGEMGKY--- 99
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 100 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 151
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 152 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 208
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA- 244
            +   L ++    R P    C  SL                DL+ +    DP++R T   
Sbjct: 209 VNREVLDQVERGYRMPCPPECPESLH---------------DLMCQCWRKDPEERPTFEY 253
Query: 245 -EALQQEYF 252
            +A  ++YF
Sbjct: 254 LQAFLEDYF 262

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 43/77 (55%), Gaps = 3/77 (3%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + I RDLKP NI + +D K VK+  FGL  SL    G+ +   GT  Y +PE  +   +Y
Sbjct: 156 KLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSL-KNDGKRTRSKGTLRYMSPE-QISSQDY 212
Query: 162 STAVDIWPVGCIFGEMV 178
              VD++ +G I  E++
Sbjct: 213 GKEVDLYALGLILAELL 229

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+++D +G  +K+A FG+ K        +    GT  Y APE++     Y  
Sbjct: 464 IYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQPYGK 521
Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANS 189
           +VD W  G +  EM++G+  F G + 
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDE 547

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 90/254 (35%), Gaps = 33/254 (12%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYS 69
            +  ++ RE+     L HPNI+R   V     +L  + EY      Y         +   
Sbjct: 58  AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDE 117
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVD-LDGKTVKVAGFG 128
            + F              F             +   RDLK  N L+D      +K+  FG
Sbjct: 118 ARFF--------------FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG 163
Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
            +KS   +    S  VGT  Y APE+LL         D+W  G     M+ G   F    
Sbjct: 164 YSKSSVLHSQPKST-VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222
Query: 189 S----LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                  T+ RI+         K S+ D +      + P    LIS++   DP  RI+  
Sbjct: 223 EPRDYRKTIQRILS-------VKYSIPDDIR-----ISPECCHLISRIFVADPATRISIP 270
Query: 245 EALQQEYF-KDVPG 257
           E     +F K++P 
Sbjct: 271 EIKTHSWFLKNLPA 284

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N  L   LK P       + 
Sbjct: 48  PDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINK 106
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
               +  +      +EE               YI R+L+  NILV  D  + K+A FGLA
Sbjct: 107 LLDMAAQIAEGMAFIEE-------------RNYIHRNLRAANILVS-DTLSCKIADFGLA 152
Query: 131 KSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
           + +     E +A  G  +   + APE  +    ++   D+W  G +  E+V+ G+  +PG
Sbjct: 153 RLI--EDNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 209

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 100/249 (40%), Gaps = 40/249 (16%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + ++ H  +++L  V S+   +Y V EY       LL + K  M  Y   
Sbjct: 57  PEAFLQEAQVMKKIRHEKLVQLYAVVSEEP-IYIVTEYMSK--GSLLDFLKGEMGKY--- 110
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 111 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 162
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 163 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA- 244
            +   L ++    R P    C  SL                DL+ +    DP++R T   
Sbjct: 220 VNREVLDQVERGYRMPCPPECPESLH---------------DLMCQCWRKDPEERPTFEY 264
Query: 245 -EALQQEYF 252
            +A  ++YF
Sbjct: 265 LQAFLEDYF 273

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 40/249 (16%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K  M  Y   
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSK--GSLLDFLKGEMGKY--- 110
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL   NILV  +    KVA FGLA+
Sbjct: 111 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVG-ENLVCKVADFGLAR 162
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 163 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA- 244
            +   L ++    R P    C  SL                DL+ +    DP++R T   
Sbjct: 220 VNREVLDQVERGYRMPCPPECPESLH---------------DLMCQCWRKDPEERPTFEY 264
Query: 245 -EALQQEYF 252
            +A  ++YF
Sbjct: 265 LQAFLEDYF 273

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLL 156
           +++ RDL   N ++D +  TVKVA FGLA+ +     Y+   ++ A++   +       L
Sbjct: 152 KFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--L 208
Query: 157 GLLEYSTAVDIWPVGCIFGE-MVSGKPLFPGANSL-ITLGRIVGKS-RKPSFC 206
              +++T  D+W  G +  E M  G P +P  N+  IT+  + G+   +P +C
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 261

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLL 156
           +++ RDL   N ++D +  TVKVA FGLA+ +     Y+   ++ A++   +       L
Sbjct: 153 KFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--L 209
Query: 157 GLLEYSTAVDIWPVGCIFGE-MVSGKPLFPGANSL-ITLGRIVGKS-RKPSFC 206
              +++T  D+W  G +  E M  G P +P  N+  IT+  + G+   +P +C
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 262

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLL 156
           +++ RDL   N ++D +  TVKVA FGLA+ +     Y+   ++ A++   +       L
Sbjct: 153 KFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--L 209
Query: 157 GLLEYSTAVDIWPVGCIFGE-MVSGKPLFPGANSL-ITLGRIVGKS-RKPSFC 206
              +++T  D+W  G +  E M  G P +P  N+  IT+  + G+   +P +C
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 262

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLL 156
           +++ RDL   N ++D +  TVKVA FGLA+ +     Y+   ++ A++   +       L
Sbjct: 172 KFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--L 228
Query: 157 GLLEYSTAVDIWPVGCIFGE-MVSGKPLFPGANSL-ITLGRIVGKS-RKPSFC 206
              +++T  D+W  G +  E M  G P +P  N+  IT+  + G+   +P +C
Sbjct: 229 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 281

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 82/203 (40%), Gaps = 12/203 (5%)
Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPKDSMNGYS 69
           S +I E+  +  +  H NII L+   +Q   LY + EY  + N   YL       +    
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSF 137
Query: 70  TKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
             + N     ++  LV                + I RDL   N+LV  D   +K+A FGL
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGL 196
Query: 130 AKSLYAYKGESSAEVGTHYYK--APELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLFP 185
           A+ ++          G    K  APE L   + Y+   D+W  G +  E+ +  G P +P
Sbjct: 197 ARDIHHIDXXKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP-YP 254
Query: 186 G--ANSLITLGRIVGKSRKPSFC 206
           G     L  L +   +  KPS C
Sbjct: 255 GVPVEELFKLLKEGHRMDKPSNC 277

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY-----AYKGESSAEVGTHYYKAPELLL 156
           +++ RDL   N ++D +  TVKVA FGLA+ +Y     +   ++ A++   +       L
Sbjct: 152 KFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES--L 208
Query: 157 GLLEYSTAVDIWPVGCIFGE-MVSGKPLFPGANSL-ITLGRIVGKS-RKPSFC 206
              +++T  D+W  G +  E M  G P +P  N+  IT+  + G+   +P +C
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 261

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLL 156
           +++ RDL   N ++D +  TVKVA FGLA+ +     Y+   ++ A++   +       L
Sbjct: 148 KFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--L 204
Query: 157 GLLEYSTAVDIWPVGCIFGE-MVSGKPLFPGANSL-ITLGRIVGKS-RKPSFC 206
              +++T  D+W  G +  E M  G P +P  N+  IT+  + G+   +P +C
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLL 156
           +++ RDL   N ++D +  TVKVA FGLA+ +     Y+   ++ A++   +       L
Sbjct: 150 KFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--L 206
Query: 157 GLLEYSTAVDIWPVGCIFGE-MVSGKPLFPGANSL-ITLGRIVGKS-RKPSFC 206
              +++T  D+W  G +  E M  G P +P  N+  IT+  + G+   +P +C
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 259

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 99/249 (39%), Gaps = 40/249 (16%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K  M  Y   
Sbjct: 224 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSK--GSLLDFLKGEMGKY--- 277
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGL +
Sbjct: 278 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLGR 329
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 330 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 386
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA- 244
            +   L ++    R P    C  SL                DL+ +    DP++R T   
Sbjct: 387 VNREVLDQVERGYRMPCPPECPESLH---------------DLMCQCWRKDPEERPTFEY 431
Query: 245 -EALQQEYF 252
            +A  ++YF
Sbjct: 432 LQAFLEDYF 440

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 28/201 (13%)
Query: 2   MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRV----ASQGI----YLYPVFEYQVND 53
           M + N+ +      + E +C+ + +HPN+IRL+ V    +SQGI     + P  +Y   D
Sbjct: 70  MKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY--GD 127
Query: 54  LAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTR-YIRRDLKPVN 112
           L   L Y +        +    +    T L   +F             R ++ RDL   N
Sbjct: 128 LHTYLLYSR-------LETGPKHIPLQTLL---KFMVDIALGMEYLSNRNFLHRDLAARN 177
Query: 113 ILVDLDGKTVKVAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP 169
            ++  D  TV VA FGL+K +Y+   Y+    A++   +     L   +  Y++  D+W 
Sbjct: 178 CMLR-DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWA 234
Query: 170 VGCIFGEMVS-GKPLFPGANS 189
            G    E+ + G   +PG  +
Sbjct: 235 FGVTMWEIATRGMTPYPGVQN 255

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 53  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR 110
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 111 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 155
Query: 123 KVAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           KVA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ 
Sbjct: 156 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 179 S-GKPLFPGAN 188
           + G   +PG +
Sbjct: 212 TYGMSPYPGID 222

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 24/168 (14%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNII L  V ++   +  V EY  N           S++ +  KN     
Sbjct: 73  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMEN----------GSLDTFLKKNDGQ-- 120
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGL++ L   +
Sbjct: 121 -FTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVL---E 175
Query: 138 GESSAEVGTH------YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
            +  A   T        + APE  +   ++++A D+W  G +  E+VS
Sbjct: 176 DDPEAAYTTRGGKIPIRWTAPE-AIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLL 156
           +++ RDL   N ++D +  TVKVA FGLA+ +     Y+   ++ A++   +       L
Sbjct: 171 KFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--L 227
Query: 157 GLLEYSTAVDIWPVGCIFGE-MVSGKPLFPGANSL-ITLGRIVGKS-RKPSFC 206
              +++T  D+W  G +  E M  G P +P  N+  IT+  + G+   +P +C
Sbjct: 228 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 280

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLL 156
           +++ RDL   N ++D +  TVKVA FGLA+ +     Y+   ++ A++   +       L
Sbjct: 151 KFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--L 207
Query: 157 GLLEYSTAVDIWPVGCIFGE-MVSGKPLFPGANSL-ITLGRIVGKS-RKPSFC 206
              +++T  D+W  G +  E M  G P +P  N+  IT+  + G+   +P +C
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 260

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLL 156
           +++ RDL   N ++D +  TVKVA FGLA+ +     Y+   ++ A++   +       L
Sbjct: 145 KFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES--L 201
Query: 157 GLLEYSTAVDIWPVGCIFGE-MVSGKPLFPGANSL-ITLGRIVGKS-RKPSFC 206
              +++T  D+W  G +  E M  G P +P  N+  IT+  + G+   +P +C
Sbjct: 202 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 254

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 81/190 (42%), Gaps = 26/190 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 49  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR 106
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 107 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 151
Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           KVA FGL++ +       +A  G  +   + APE  L   ++S   D+W  G +  E+ +
Sbjct: 152 KVADFGLSRLMTG--DTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIAT 208
Query: 180 -GKPLFPGAN 188
            G   +PG +
Sbjct: 209 YGMSPYPGID 218

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 3/77 (3%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           + I RDLKP NI + +D K VK+  FGL  SL    G+     GT  Y +PE  +   +Y
Sbjct: 142 KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSL-KNDGKRXRSKGTLRYMSPE-QISSQDY 198
Query: 162 STAVDIWPVGCIFGEMV 178
              VD++ +G I  E++
Sbjct: 199 GKEVDLYALGLILAELL 215

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 78/193 (40%), Gaps = 43/193 (22%)
Query: 104 IRRDLKPVNILVDLDGK-----TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL 158
           I  D+KP N+L+++         +K+A  G A     Y    +  + T  Y++PE+LLG 
Sbjct: 154 IHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQTREYRSPEVLLGA 210
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLF-PGANSLIT-----LGRIV-------------GK 199
             +    DIW   C+  E+++G  LF P      T     + +I+             GK
Sbjct: 211 -PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 269
Query: 200 SRKPSF---------CKLS---LRDHLTN--GFPGLEPAGI-DLISKMLGMDPDKRITAA 244
             +  F          KL    L D LT    F   E   I D +S ML +DP KR  A 
Sbjct: 270 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329
Query: 245 EALQQEYFKDVPG 257
             +   + KD  G
Sbjct: 330 GLVNHPWLKDTLG 342

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 78/193 (40%), Gaps = 43/193 (22%)
Query: 104 IRRDLKPVNILVDLDGK-----TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL 158
           I  D+KP N+L+++         +K+A  G A     Y    +  + T  Y++PE+LLG 
Sbjct: 154 IHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQTREYRSPEVLLGA 210
Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLF-PGANSLIT-----LGRIV-------------GK 199
             +    DIW   C+  E+++G  LF P      T     + +I+             GK
Sbjct: 211 -PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 269
Query: 200 SRKPSF---------CKLS---LRDHLTN--GFPGLEPAGI-DLISKMLGMDPDKRITAA 244
             +  F          KL    L D LT    F   E   I D +S ML +DP KR  A 
Sbjct: 270 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329
Query: 245 EALQQEYFKDVPG 257
             +   + KD  G
Sbjct: 330 GLVNHPWLKDTLG 342

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 43/84 (51%), Gaps = 4/84 (4%)
Query: 100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL- 158
             R I RD+KP NIL+D  G  V +  F +A ++   + + +   GT  Y APE+     
Sbjct: 133 NQRIIHRDMKPDNILLDEHGH-VHITDFNIA-AMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 159 -LEYSTAVDIWPVGCIFGEMVSGK 181
              YS AVD W +G    E++ G+
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGR 214

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 27/212 (12%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKDSM---NGYSTK 71
           RE   L  L H +I++   V   G  L  VFEY  + DL  +L  +  D+M   +G   +
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                 L     +  +               ++ RDL   N LV  +   VK+  FG+++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGAN-LLVKIGDFGMSR 181
Query: 132 SLYAYKGESSAEVGTH-----YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLF 184
            +Y+        VG H      +  PE ++   +++T  D+W  G I  E+ +   +P F
Sbjct: 182 DVYS---TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 185 PGANS----LITLGRIVGKSRKPSFCKLSLRD 212
             +N+     IT GR++    +P  C   + D
Sbjct: 238 QLSNTEVIECITQGRVL---ERPRVCPKEVYD 266

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 46/102 (45%), Gaps = 28/102 (27%)
Query: 107 DLKPVNILVD--------------LDGKTV----------KVAGFGLAKSLYAYKGESSA 142
           DLKP NIL+D               DGK +          K+  FG A     Y G   +
Sbjct: 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG---S 218
Query: 143 EVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
            + T  Y+APE++L L  +  + D+W  GC+  E+ +G  LF
Sbjct: 219 IINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLF 259

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 76/176 (43%), Gaps = 36/176 (20%)
Query: 111 VNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV 170
           VN L   + + +KV    L  + + +K   + ++ T  Y++ E+L+G   Y+T  DIW  
Sbjct: 206 VNPLEPKNAEKLKVKIADLGNACWVHK-HFTEDIQTRQYRSLEVLIGS-GYNTPADIWST 263
Query: 171 GCIFGEMVSGKPLF-PGANSLIT------------LGR------IVGKSRKPSFCKLSLR 211
            C+  E+ +G  LF P +    T            LG+      + GK  K  F K    
Sbjct: 264 ACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 323
Query: 212 DHLTNGFP-GL-------------EPAGI-DLISKMLGMDPDKRITAAEALQQEYF 252
            H+T   P GL             E AG  D +  ML + P+KR TAAE L+  + 
Sbjct: 324 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 379

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 76/176 (43%), Gaps = 36/176 (20%)
Query: 111 VNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV 170
           VN L   + + +KV    L  + + +K   + ++ T  Y++ E+L+G   Y+T  DIW  
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVHK-HFTEDIQTRQYRSLEVLIGS-GYNTPADIWST 279
Query: 171 GCIFGEMVSGKPLF-PGANSLIT------------LGR------IVGKSRKPSFCKLSLR 211
            C+  E+ +G  LF P +    T            LG+      + GK  K  F K    
Sbjct: 280 ACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339
Query: 212 DHLTNGFP-GL-------------EPAGI-DLISKMLGMDPDKRITAAEALQQEYF 252
            H+T   P GL             E AG  D +  ML + P+KR TAAE L+  + 
Sbjct: 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 53  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 110
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 111 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 155
Query: 123 KVAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           KVA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ 
Sbjct: 156 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 179 S-GKPLFPGAN 188
           + G   +PG +
Sbjct: 212 TYGMSPYPGID 222

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 53  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 110
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 111 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 155
Query: 123 KVAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           KVA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ 
Sbjct: 156 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 179 S-GKPLFPGAN 188
           + G   +PG +
Sbjct: 212 TYGMSPYPGID 222

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 52  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 109
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 110 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 154
Query: 123 KVAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           KVA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ 
Sbjct: 155 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIA 210
Query: 179 S-GKPLFPGAN 188
           + G   +PG +
Sbjct: 211 TYGMSPYPGID 221

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 48  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 105
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 106 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 150
Query: 123 KVAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           KVA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ 
Sbjct: 151 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIA 206
Query: 179 S-GKPLFPGAN 188
           + G   +PG +
Sbjct: 207 TYGMSPYPGID 217

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 61  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 118
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 119 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 163
Query: 123 KVAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           KVA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ 
Sbjct: 164 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIA 219
Query: 179 S-GKPLFPGAN 188
           + G   +PG +
Sbjct: 220 TYGMSPYPGID 230

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 81/190 (42%), Gaps = 26/190 (13%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 53  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 110
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 111 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 155
Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           KVA FGL++ +       +A  G  +   + APE  L   ++S   D+W  G +  E+ +
Sbjct: 156 KVADFGLSRLMTG--DTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIAT 212
Query: 180 -GKPLFPGAN 188
            G   +PG +
Sbjct: 213 YGMSPYPGID 222

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGY---- 68
            ++ E + L ++NHP++I+L    SQ   L  + EY +   L   L+  +    GY    
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 69  -----STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVK 123
                S+ +       T   L+                + + RDL   NILV  +G+ +K
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-AEGRKMK 190
Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE-----YSTAVDIWPVGCIFGEMV 178
           ++ FGL++ +Y    E  + V     + P   + +       Y+T  D+W  G +  E+V
Sbjct: 191 ISDFGLSRDVY----EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 179 S--GKPLFPG--ANSLITLGRIVGKSRKPSFC 206
           +  G P +PG     L  L +   +  +P  C
Sbjct: 247 TLGGNP-YPGIPPERLFNLLKTGHRMERPDNC 277

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 50  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 107
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 108 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 152
Query: 123 KVAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           KVA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ 
Sbjct: 153 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIA 208
Query: 179 S-GKPLFPGAN 188
           + G   +PG +
Sbjct: 209 TYGMSPYPGID 219

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 28/190 (14%)
Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPKD 63
           +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  + 
Sbjct: 51  DTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 108
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVK 123
            +N                +L+                 +I RDL   N LV  +   VK
Sbjct: 109 EVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVK 153
Query: 124 VAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           VA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ +
Sbjct: 154 VADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIAT 209
Query: 180 -GKPLFPGAN 188
            G   +PG +
Sbjct: 210 YGMSPYPGID 219

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 48  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 105
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 106 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 150
Query: 123 KVAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           KVA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ 
Sbjct: 151 KVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIA 206
Query: 179 S-GKPLFPGAN 188
           + G   +PG +
Sbjct: 207 TYGMSPYPGID 217

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V EY  N           S++ +  K+    +
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN----------GSLDSFLRKH---DA 142
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGLA+ L    
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLARVLEDDP 201
Query: 138 GESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +    G      + +PE  +   ++++A D+W  G +  E++S
Sbjct: 202 EAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 72/166 (43%), Gaps = 10/166 (6%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPK-DSMNGYSTKNFN 74
           EV C +  +HPNII L+       YLY   EY    N L +L K    ++   ++  N  
Sbjct: 77  EVLCKLG-HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTR-YIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
           + +L +  LL   F             + +I RDL   NILV  +    K+A FGL++  
Sbjct: 136 ASTLSSQQLL--HFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQ 192
Query: 134 YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             Y  ++   +   +     L   +  Y+T  D+W  G +  E+VS
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 10/167 (5%)
Query: 18  EVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPK-DSMNGYSTKNF 73
           E+  L +L +HPNII L+       YLY   EY    N L +L K    ++   ++  N 
Sbjct: 65  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 124
Query: 74  NSYSLFTTFLLVEEFXXXXXXXXXXFGTR-YIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
            + +L +  LL   F             + +I RDL   NILV  +    K+A FGL++ 
Sbjct: 125 TASTLSSQQLL--HFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRG 181
Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              Y  ++   +   +     L   +  Y+T  D+W  G +  E+VS
Sbjct: 182 QEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVS 226

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 95/252 (37%), Gaps = 49/252 (19%)
Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REVS L ++ HPNII L  V      +  + E       +     K+S++     +F   
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 77  SLFTTFLLVEEFXXXXXXXXXXFGTRYIRR-DLKPVNILVDLDGKT----VKVAGFGLAK 131
            L     L                T+ I   DLKP NI++ LD       +K+  FGLA 
Sbjct: 124 ILDGVNYL---------------HTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAH 167
Query: 132 SLYAYKGESSAEV----GTHYYKAPELL----LGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
            +     E   E     GT  + APE++    LGL       D+W +G I   ++SG   
Sbjct: 168 EI-----EDGVEFKNIFGTPEFVAPEIVNYEPLGL-----EADMWSIGVITYILLSGASP 217
Query: 184 FPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA 243
           F G     TL  I   S           D     F        D I K+L  +  KR+T 
Sbjct: 218 FLGDTKQETLANITAVSY----------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTI 267
Query: 244 AEALQQEYFKDV 255
            EAL+  +   V
Sbjct: 268 QEALRHPWITPV 279

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 49  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 106
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 107 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 151
Query: 123 KVAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           KVA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ 
Sbjct: 152 KVADFGLSRLM---TGDTYTAPAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIA 207
Query: 179 S-GKPLFPGAN 188
           + G   +PG +
Sbjct: 208 TYGMSPYPGID 218

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 24/189 (12%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+       LL Y ++ 
Sbjct: 48  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMT--YGNLLDYLREC 103
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                  N    S      +  +               +I RDL   N LV  +   VKV
Sbjct: 104 -------NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG-ENHLVKV 152
Query: 125 AGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS- 179
           A FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ + 
Sbjct: 153 ADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 180 GKPLFPGAN 188
           G   +PG +
Sbjct: 209 GMSPYPGID 217

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 22/188 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+       LL Y ++ 
Sbjct: 46  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMT--YGNLLDYLREC 101
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                  N    S      +  +               +I RDL   N LV  +   VKV
Sbjct: 102 -------NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG-ENHLVKV 150
Query: 125 AGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-G 180
           A FGL++ +       +A  G  +   + APE  L   ++S   D+W  G +  E+ + G
Sbjct: 151 ADFGLSRLMTG--DTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYG 207
Query: 181 KPLFPGAN 188
              +PG +
Sbjct: 208 MSPYPGID 215

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 28/190 (14%)
Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPKD 63
           +TME      ++E + + E+ HPN+++L+ V +     Y V EY    N L YL +  ++
Sbjct: 68  DTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE 125
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVK 123
            +              T  +L+                 +I RDL   N LV  +   VK
Sbjct: 126 EV--------------TAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHVVK 170
Query: 124 VAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           VA FGL++ +    G++ +A  G  +   + APE  L    +S   D+W  G +  E+ +
Sbjct: 171 VADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNTFSIKSDVWAFGVLLWEIAT 226
Query: 180 -GKPLFPGAN 188
            G   +PG +
Sbjct: 227 YGMSPYPGID 236

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 28/191 (14%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPK 62
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  +
Sbjct: 50  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 107
Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTV 122
             +N                +L+                 +I RDL   N LV  +   V
Sbjct: 108 QEVNA--------------VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLV 152
Query: 123 KVAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           KVA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ 
Sbjct: 153 KVADFGLSRLM---TGDTYTAPAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIA 208
Query: 179 S-GKPLFPGAN 188
           + G   +PG +
Sbjct: 209 TYGMSPYPGID 219

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 39/164 (23%)
Query: 105 RRDLKPVNILVDLDGK--TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS 162
            RD+KP N+L     K   +K+  FG AK     +        T YY APE+L G  +Y 
Sbjct: 132 HRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPCYTPYYVAPEVL-GPEKYD 188
Query: 163 TAVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDH 213
            + D+W +G I   ++ G P F         PG    I LG+                  
Sbjct: 189 KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY----------------- 231
Query: 214 LTNGFPGLEPAGI-----DLISKMLGMDPDKRITAAEALQQEYF 252
              GFP  E + +      LI  +L  DP +R+T  + +   + 
Sbjct: 232 ---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 24/189 (12%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+       LL Y ++ 
Sbjct: 48  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMT--YGNLLDYLREC 103
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                  N    S      +  +               +I RDL   N LV  +   VKV
Sbjct: 104 -------NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG-ENHLVKV 152
Query: 125 AGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS- 179
           A FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ + 
Sbjct: 153 ADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 180 GKPLFPGAN 188
           G   +PG +
Sbjct: 209 GMSPYPGID 217

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 42/237 (17%)
Query: 30  IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFX 89
           IIRL        Y+Y V E    DL   LK  K S++ +  K++    L     + +   
Sbjct: 74  IIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGI 132
Query: 90  XXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTH 147
                         +  DLKP N L+ +DG  +K+  FG+A  +          ++VGT 
Sbjct: 133 --------------VHSDLKPANFLI-VDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 148 YYKAPELLLGL----------LEYSTAVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRI 196
            Y  PE +  +           + S   D+W +GCI   M  GK P     N +  L  I
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 236
Query: 197 VGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           +  + +  F  +  +D        L+    D++   L  DP +RI+  E L   Y +
Sbjct: 237 IDPNHEIEFPDIPEKD--------LQ----DVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 23/213 (10%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY   +   LL + K     Y   
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYM--NKGSLLDFLKGETGKY--- 107
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 108 -------LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 159
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 160 LI--EDNEWTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 216
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGF 218
            +   L ++    R P    C  SL D +   +
Sbjct: 217 VNREVLDQVERGYRMPCPPECPESLHDLMCQCW 249

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVA--SQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
           G  S  + E   + + +HPN++ L+ +   S+G  L  +   +  DL     + ++  + 
Sbjct: 73  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR---NFIRNETHN 129
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            + K+   + L                       +++ RDL   N ++D +  TVKVA F
Sbjct: 130 PTVKDLIGFGL-----------QVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADF 177
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE---YSTAVDIWPVGCIFGE-MVSGKPL 183
           GLA+ +Y  + +S             + L  L+   ++T  D+W  G +  E M  G P 
Sbjct: 178 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 237
Query: 184 FPGANSL-ITLGRIVGKS-RKPSFC 206
           +P  N+  IT+  + G+   +P +C
Sbjct: 238 YPDVNTFDITVYLLQGRRLLQPEYC 262

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 39/164 (23%)
Query: 105 RRDLKPVNILVDLDGK--TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS 162
            RD+KP N+L     K   +K+  FG AK     +        T YY APE+L G  +Y 
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPCYTPYYVAPEVL-GPEKYD 207
Query: 163 TAVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDH 213
            + D+W +G I   ++ G P F         PG    I LG+                  
Sbjct: 208 KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY----------------- 250
Query: 214 LTNGFPGLEPAGI-----DLISKMLGMDPDKRITAAEALQQEYF 252
              GFP  E + +      LI  +L  DP +R+T  + +   + 
Sbjct: 251 ---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 22/188 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+       LL Y ++ 
Sbjct: 46  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT--YGNLLDYLREC 101
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                  N    S      +  +               +I RDL   N LV  +   VKV
Sbjct: 102 -------NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG-ENHLVKV 150
Query: 125 AGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-G 180
           A FGL++ +       +A  G  +   + APE  L   ++S   D+W  G +  E+ + G
Sbjct: 151 ADFGLSRLMTG--DTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYG 207
Query: 181 KPLFPGAN 188
              +PG +
Sbjct: 208 MSPYPGID 215

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVA--SQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
           G  S  + E   + + +HPN++ L+ +   S+G  L  +   +  DL     + ++  + 
Sbjct: 74  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR---NFIRNETHN 130
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            + K+   + L                       +++ RDL   N ++D +  TVKVA F
Sbjct: 131 PTVKDLIGFGL-----------QVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADF 178
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE---YSTAVDIWPVGCIFGE-MVSGKPL 183
           GLA+ +Y  + +S             + L  L+   ++T  D+W  G +  E M  G P 
Sbjct: 179 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 238
Query: 184 FPGANSL-ITLGRIVGKS-RKPSFC 206
           +P  N+  IT+  + G+   +P +C
Sbjct: 239 YPDVNTFDITVYLLQGRRLLQPEYC 263

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVA--SQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
           G  S  + E   + + +HPN++ L+ +   S+G  L  +   +  DL     + ++  + 
Sbjct: 71  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR---NFIRNETHN 127
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            + K+   + L                       +++ RDL   N ++D +  TVKVA F
Sbjct: 128 PTVKDLIGFGL-----------QVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADF 175
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE---YSTAVDIWPVGCIFGE-MVSGKPL 183
           GLA+ +Y  + +S             + L  L+   ++T  D+W  G +  E M  G P 
Sbjct: 176 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 235
Query: 184 FPGANSL-ITLGRIVGKS-RKPSFC 206
           +P  N+  IT+  + G+   +P +C
Sbjct: 236 YPDVNTFDITVYLLQGRRLLQPEYC 260

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 42/237 (17%)
Query: 30  IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFX 89
           IIRL        Y+Y V E    DL   LK  K S++ +  K++    L     + +   
Sbjct: 70  IIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGI 128
Query: 90  XXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTH 147
                         +  DLKP N L+ +DG  +K+  FG+A  +          ++VGT 
Sbjct: 129 --------------VHSDLKPANFLI-VDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 172
Query: 148 YYKAPELLLGL----------LEYSTAVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRI 196
            Y  PE +  +           + S   D+W +GCI   M  GK P     N +  L  I
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 232
Query: 197 VGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           +  + +  F  +  +D        L+    D++   L  DP +RI+  E L   Y +
Sbjct: 233 IDPNHEIEFPDIPEKD--------LQ----DVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V EY  N           S++ +  K+    +
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN----------GSLDSFLRKH---DA 142
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGL++ L    
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDP 201
Query: 138 GESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +    G      + +PE  +   ++++A D+W  G +  E++S
Sbjct: 202 EAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 25/212 (11%)
Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGY---- 68
            ++ E + L ++NHP++I+L    SQ   L  + EY +   L   L+  +    GY    
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 69  -----STKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVK 123
                S+ +       T   L+                  + RDL   NILV  +G+ +K
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILV-AEGRKMK 190
Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE-----YSTAVDIWPVGCIFGEMV 178
           ++ FGL++ +Y    E  + V     + P   + +       Y+T  D+W  G +  E+V
Sbjct: 191 ISDFGLSRDVY----EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 179 S--GKPLFPG--ANSLITLGRIVGKSRKPSFC 206
           +  G P +PG     L  L +   +  +P  C
Sbjct: 247 TLGGNP-YPGIPPERLFNLLKTGHRMERPDNC 277

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 31/212 (14%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNG 67
           E       RE   L  L H +I+R   V ++G  L  VFEY +  DL   L+        
Sbjct: 84  ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 143
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            +     +        L+              G  ++ RDL   N LV   G  VK+  F
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDF 202
Query: 128 GLAKSLYAYKGESSAEVGTHYYKA------------PELLLGLLEYSTAVDIWPVGCIFG 175
           G+++ +Y+          T YY+             PE +L   +++T  D+W  G +  
Sbjct: 203 GMSRDIYS----------TDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLW 251
Query: 176 EMVS--GKPLFPGANS----LITLGRIVGKSR 201
           E+ +   +P +  +N+     IT GR + + R
Sbjct: 252 EIFTYGKQPWYQLSNTEAIDCITQGRELERPR 283

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVA--SQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
           G  S  + E   + + +HPN++ L+ +   S+G  L  +   +  DL     + ++  + 
Sbjct: 73  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR---NFIRNETHN 129
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            + K+   + L                       +++ RDL   N ++D +  TVKVA F
Sbjct: 130 PTVKDLIGFGL-----------QVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADF 177
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE---YSTAVDIWPVGCIFGE-MVSGKPL 183
           GLA+ +Y  + +S             + L  L+   ++T  D+W  G +  E M  G P 
Sbjct: 178 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 237
Query: 184 FPGANSL-ITLGRIVGKS-RKPSFC 206
           +P  N+  IT+  + G+   +P +C
Sbjct: 238 YPDVNTFDITVYLLQGRRLLQPEYC 262

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 38/163 (23%)
Query: 106 RDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           RD+KP N+L         +K+  FG AK   ++   ++    T YY APE+L G  +Y  
Sbjct: 146 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVL-GPEKYDK 203
Query: 164 AVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
           + D+W +G I   ++ G P F         PG  + I +G+                   
Sbjct: 204 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------------ 245
Query: 215 TNGFPGLEPAGID-----LISKMLGMDPDKRITAAEALQQEYF 252
              FP  E + +      LI  +L  +P +R+T  E +   + 
Sbjct: 246 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 69/164 (42%), Gaps = 29/164 (17%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSA------------EVGTHYYKA 151
           + RDLKP NI   +D   VKV  FGL  ++   + E +             +VGT  Y +
Sbjct: 186 MHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 152 PELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLR 211
           PE + G   YS  VDI+ +G I  E++         ++ +   RI+   R   F  L   
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELLY------SFSTQMERVRIITDVRNLKFPLL--- 294
Query: 212 DHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                 F    P    ++  ML   P +R  A + ++   F+++
Sbjct: 295 ------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V EY  N           S++ +  K+    +
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN----------GSLDSFLRKH---DA 142
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGL++ L    
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDP 201
Query: 138 GESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +    G      + +PE  +   ++++A D+W  G +  E++S
Sbjct: 202 EAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V EY  N           S++ +  K+    +
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN----------GSLDSFLRKH---DA 142
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGL++ L    
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDP 201
Query: 138 GESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +    G      + +PE  +   ++++A D+W  G +  E++S
Sbjct: 202 EAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVA--SQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
           G  S  + E   + + +HPN++ L+ +   S+G  L  +   +  DL     + ++  + 
Sbjct: 78  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR---NFIRNETHN 134
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            + K+   + L                       +++ RDL   N ++D +  TVKVA F
Sbjct: 135 PTVKDLIGFGL-----------QVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADF 182
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE---YSTAVDIWPVGCIFGE-MVSGKPL 183
           GLA+ +Y  + +S             + L  L+   ++T  D+W  G +  E M  G P 
Sbjct: 183 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 242
Query: 184 FPGANSL-ITLGRIVGKS-RKPSFC 206
           +P  N+  IT+  + G+   +P +C
Sbjct: 243 YPDVNTFDITVYLLQGRRLLQPEYC 267

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 42/237 (17%)
Query: 30  IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFX 89
           IIRL        Y+Y V E    DL   LK  K S++ +  K++    L     + +   
Sbjct: 90  IIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 90  XXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTH 147
                         +  DLKP N L+ +DG  +K+  FG+A  +          ++VGT 
Sbjct: 149 --------------VHSDLKPANFLI-VDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 192
Query: 148 YYKAPELLLGL----------LEYSTAVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRI 196
            Y  PE +  +           + S   D+W +GCI   M  GK P     N +  L  I
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252
Query: 197 VGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           +  + +  F  +  +D        L+    D++   L  DP +RI+  E L   Y +
Sbjct: 253 IDPNHEIEFPDIPEKD--------LQ----DVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVA--SQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
           G  S  + E   + + +HPN++ L+ +   S+G  L  +   +  DL     + ++  + 
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR---NFIRNETHN 188
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            + K+   + L                       +++ RDL   N ++D +  TVKVA F
Sbjct: 189 PTVKDLIGFGL-----------QVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADF 236
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE---YSTAVDIWPVGCIFGE-MVSGKPL 183
           GLA+ +Y  + +S             + L  L+   ++T  D+W  G +  E M  G P 
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
Query: 184 FPGANSL-ITLGRIVGKS-RKPSFC 206
           +P  N+  IT+  + G+   +P +C
Sbjct: 297 YPDVNTFDITVYLLQGRRLLQPEYC 321

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 24/189 (12%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+       LL Y ++ 
Sbjct: 46  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT--YGNLLDYLREC 101
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                  N    S      +  +               +I RDL   N LV  +   VKV
Sbjct: 102 -------NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG-ENHLVKV 150
Query: 125 AGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS- 179
           A FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ + 
Sbjct: 151 ADFGLSRLM---TGDTFTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 206
Query: 180 GKPLFPGAN 188
           G   +PG +
Sbjct: 207 GMSPYPGID 215

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 24/168 (14%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V EY  N           S++ +  K+    +
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN----------GSLDSFLRKH---DA 142
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGL++ L   +
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVL---E 198
Query: 138 GESSAEVGTH------YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
            +  A   T        + +PE  +   ++++A D+W  G +  E++S
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 23/213 (10%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY   +   LL + K     Y   
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYM--NKGSLLDFLKGETGKY--- 107
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 108 -------LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 159
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 160 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 216
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGF 218
            +   L ++    R P    C  SL D +   +
Sbjct: 217 VNREVLDQVERGYRMPCPPECPESLHDLMCQCW 249

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V EY  N           S++ +  K+    +
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN----------GSLDSFLRKH---DA 130
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGL++ L    
Sbjct: 131 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDP 189
Query: 138 GESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +    G      + +PE  +   ++++A D+W  G +  E++S
Sbjct: 190 EAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 38/163 (23%)
Query: 106 RDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           RD+KP N+L         +K+  FG AK   ++   ++    T YY APE+L G  +Y  
Sbjct: 145 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVL-GPEKYDK 202
Query: 164 AVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
           + D+W +G I   ++ G P F         PG  + I +G+                   
Sbjct: 203 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------------ 244
Query: 215 TNGFPGLEPAGID-----LISKMLGMDPDKRITAAEALQQEYF 252
              FP  E + +      LI  +L  +P +R+T  E +   + 
Sbjct: 245 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 42/237 (17%)
Query: 30  IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFX 89
           IIRL        Y+Y V E    DL   LK  K S++ +  K++    L     + +   
Sbjct: 118 IIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 90  XXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTH 147
                         +  DLKP N L+ +DG  +K+  FG+A  +          ++VGT 
Sbjct: 177 --------------VHSDLKPANFLI-VDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 148 YYKAPELLLGL----------LEYSTAVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRI 196
            Y  PE +  +           + S   D+W +GCI   M  GK P     N +  L  I
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280
Query: 197 VGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           +  + +  F  +  +D        L+    D++   L  DP +RI+  E L   Y +
Sbjct: 281 IDPNHEIEFPDIPEKD--------LQ----DVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 38/163 (23%)
Query: 106 RDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           RD+KP N+L         +K+  FG AK   ++   ++    T YY APE+L G  +Y  
Sbjct: 140 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVL-GPEKYDK 197
Query: 164 AVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
           + D+W +G I   ++ G P F         PG  + I +G+                   
Sbjct: 198 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------------ 239
Query: 215 TNGFPGLEPAGID-----LISKMLGMDPDKRITAAEALQQEYF 252
              FP  E + +      LI  +L  +P +R+T  E +   + 
Sbjct: 240 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 24/168 (14%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V EY  N           S++ +  K+    +
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN----------GSLDSFLRKH---DA 140
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGL++ L   +
Sbjct: 141 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVL---E 196
Query: 138 GESSAEVGTH------YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
            +  A   T        + +PE  +   ++++A D+W  G +  E++S
Sbjct: 197 DDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 31/212 (14%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNG 67
           E       RE   L  L H +I+R   V ++G  L  VFEY  + DL   L+        
Sbjct: 55  ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 114
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            +     +        L+              G  ++ RDL   N LV   G  VK+  F
Sbjct: 115 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDF 173
Query: 128 GLAKSLYAYKGESSAEVGTHYYKA------------PELLLGLLEYSTAVDIWPVGCIFG 175
           G+++ +Y+          T YY+             PE +L   +++T  D+W  G +  
Sbjct: 174 GMSRDIYS----------TDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLW 222
Query: 176 EMVS--GKPLFPGANS----LITLGRIVGKSR 201
           E+ +   +P +  +N+     IT GR + + R
Sbjct: 223 EIFTYGKQPWYQLSNTEAIDCITQGRELERPR 254

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 49  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 98
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 99  SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 153
Query: 123 KVAGFGLAKSLYA----YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           K+  FGL K L      +K +   E    +Y APE L    ++S A D+W  G +  E+ 
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELF 211
Query: 179 S 179
           +
Sbjct: 212 T 212

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 24/168 (14%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V EY  N           S++ +  K+    +
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN----------GSLDSFLRKH---DA 113
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGL++ L   +
Sbjct: 114 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVL---E 169
Query: 138 GESSAEVGTH------YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
            +  A   T        + +PE  +   ++++A D+W  G +  E++S
Sbjct: 170 DDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 24/189 (12%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+       LL Y ++ 
Sbjct: 53  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT--YGNLLDYLREC 108
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                  N    S      +  +               +I RDL   N LV  +   VKV
Sbjct: 109 -------NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG-ENHLVKV 157
Query: 125 AGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS- 179
           A FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ + 
Sbjct: 158 ADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 213
Query: 180 GKPLFPGAN 188
           G   +PG +
Sbjct: 214 GMSPYPGID 222

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 24/189 (12%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+       LL Y ++ 
Sbjct: 48  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT--YGNLLDYLREC 103
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                  N    S      +  +               +I RDL   N LV  +   VKV
Sbjct: 104 -------NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG-ENHLVKV 152
Query: 125 AGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS- 179
           A FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ + 
Sbjct: 153 ADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 180 GKPLFPGAN 188
           G   +PG +
Sbjct: 209 GMSPYPGID 217

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 42/237 (17%)
Query: 30  IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFX 89
           IIRL        Y+Y V E    DL   LK  K S++ +  K++    L     + +   
Sbjct: 90  IIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 90  XXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTH 147
                         +  DLKP N L+ +DG  +K+  FG+A  +          ++VGT 
Sbjct: 149 --------------VHSDLKPANFLI-VDG-MLKLIDFGIANQMQPDXXXVVKDSQVGTV 192
Query: 148 YYKAPELLLGL----------LEYSTAVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRI 196
            Y  PE +  +           + S   D+W +GCI   M  GK P     N +  L  I
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252
Query: 197 VGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           +  + +  F  +  +D        L+    D++   L  DP +RI+  E L   Y +
Sbjct: 253 IDPNHEIEFPDIPEKD--------LQ----DVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 23/207 (11%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K     Y   
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSK--GSLLDFLKGETGKY--- 276
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 277 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 328
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 329 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRD 212
            +   L ++    R P    C  SL D
Sbjct: 386 VNREVLDQVERGYRMPCPPECPESLHD 412

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 38/163 (23%)
Query: 106 RDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           RD+KP N+L         +K+  FG AK   ++   ++    T YY APE+L G  +Y  
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVL-GPEKYDK 196
Query: 164 AVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
           + D+W +G I   ++ G P F         PG  + I +G+                   
Sbjct: 197 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------------ 238
Query: 215 TNGFPGLEPAGID-----LISKMLGMDPDKRITAAEALQQEYF 252
              FP  E + +      LI  +L  +P +R+T  E +   + 
Sbjct: 239 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 38/163 (23%)
Query: 106 RDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           RD+KP N+L         +K+  FG AK   ++   ++    T YY APE+L G  +Y  
Sbjct: 147 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVL-GPEKYDK 204
Query: 164 AVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
           + D+W +G I   ++ G P F         PG  + I +G+                   
Sbjct: 205 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------------ 246
Query: 215 TNGFPGLEPAGID-----LISKMLGMDPDKRITAAEALQQEYF 252
              FP  E + +      LI  +L  +P +R+T  E +   + 
Sbjct: 247 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 23/213 (10%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K     Y   
Sbjct: 50  PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSK--GSLLDFLKGETGKY--- 103
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 104 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 155
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 156 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 212
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRDHLTNGF 218
            +   L ++    R P    C  SL D +   +
Sbjct: 213 VNREVLDQVERGYRMPCPPECPESLHDLMCQCW 245

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 23/207 (11%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K     Y   
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSK--GSLLDFLKGETGKY--- 276
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 277 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 328
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 329 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRD 212
            +   L ++    R P    C  SL D
Sbjct: 386 VNREVLDQVERGYRMPCPPECPESLHD 412

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 31/212 (14%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNG 67
           E       RE   L  L H +I+R   V ++G  L  VFEY  + DL   L+        
Sbjct: 61  ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 120
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            +     +        L+              G  ++ RDL   N LV   G  VK+  F
Sbjct: 121 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDF 179
Query: 128 GLAKSLYAYKGESSAEVGTHYYKA------------PELLLGLLEYSTAVDIWPVGCIFG 175
           G+++ +Y+          T YY+             PE +L   +++T  D+W  G +  
Sbjct: 180 GMSRDIYS----------TDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLW 228
Query: 176 EMVS--GKPLFPGANS----LITLGRIVGKSR 201
           E+ +   +P +  +N+     IT GR + + R
Sbjct: 229 EIFTYGKQPWYQLSNTEAIDCITQGRELERPR 260

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 24/189 (12%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
            +TME      ++E + + E+ HPN+++L+ V ++    Y + E+       LL Y ++ 
Sbjct: 48  EDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT--YGNLLDYLREC 103
Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKV 124
                  N    S      +  +               +I RDL   N LV  +   VKV
Sbjct: 104 -------NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG-ENHLVKV 152
Query: 125 AGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS- 179
           A FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ + 
Sbjct: 153 ADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 180 GKPLFPGAN 188
           G   +PG +
Sbjct: 209 GMSPYPGID 217

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 38/163 (23%)
Query: 106 RDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           RD+KP N+L         +K+  FG AK   ++   ++    T YY APE+L G  +Y  
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVL-GPEKYDK 198
Query: 164 AVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
           + D+W +G I   ++ G P F         PG  + I +G+                   
Sbjct: 199 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------------ 240
Query: 215 TNGFPGLEPAGID-----LISKMLGMDPDKRITAAEALQQEYF 252
              FP  E + +      LI  +L  +P +R+T  E +   + 
Sbjct: 241 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 93/237 (39%), Gaps = 42/237 (17%)
Query: 30  IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFX 89
           IIRL        Y+Y V E    DL   LK  K S++ +  K++    L     + +   
Sbjct: 71  IIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQHGI 129
Query: 90  XXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTH 147
                         +  DLKP N L+ +DG  +K+  FG+A  +          ++VGT 
Sbjct: 130 --------------VHSDLKPANFLI-VDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 148 YYKAPELLLGL----------LEYSTAVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRI 196
            Y  PE +  +           + S   D+W +GCI   M  GK P     N +  L  I
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
Query: 197 VGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
           +  + +  F  +  +D        L+    D++   L  DP +RI+  E L   Y +
Sbjct: 234 IDPNHEIEFPDIPEKD--------LQ----DVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 38/163 (23%)
Query: 106 RDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           RD+KP N+L         +K+  FG AK   ++   ++    T YY APE+L G  +Y  
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVL-GPEKYDK 242
Query: 164 AVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
           + D+W +G I   ++ G P F         PG  + I +G+                   
Sbjct: 243 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------------ 284
Query: 215 TNGFPGLEPAGID-----LISKMLGMDPDKRITAAEALQQEYF 252
              FP  E + +      LI  +L  +P +R+T  E +   + 
Sbjct: 285 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V EY  N           S++ +  K+    +
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN----------GSLDSFLRKH---DA 142
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGL + L    
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDP 201
Query: 138 GESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +    G      + +PE  +   ++++A D+W  G +  E++S
Sbjct: 202 EAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 18/167 (10%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           + E S + + +HPNII L  V ++   +  + EY  N           S++ +  KN   
Sbjct: 57  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMEN----------GSLDAFLRKNDGR 106
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              FT   LV                 Y+ RDL   NILV+      KV+ FG+++ L  
Sbjct: 107 ---FTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVN-SNLVCKVSDFGMSRVLED 162
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
               +    G      + APE  +   ++++A D+W  G +  E++S
Sbjct: 163 DPEAAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 38/163 (23%)
Query: 106 RDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           RD+KP N+L         +K+  FG AK   ++   ++    T YY APE+L G  +Y  
Sbjct: 191 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVL-GPEKYDK 248
Query: 164 AVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
           + D+W +G I   ++ G P F         PG  + I +G+                   
Sbjct: 249 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------------ 290
Query: 215 TNGFPGLEPAGID-----LISKMLGMDPDKRITAAEALQQEYF 252
              FP  E + +      LI  +L  +P +R+T  E +   + 
Sbjct: 291 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 18/167 (10%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           + E S + + +HPNII L  V ++   +  + EY  N           S++ +  KN   
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMEN----------GSLDAFLRKNDGR 112
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              FT   LV                 Y+ RDL   NILV+      KV+ FG+++ L  
Sbjct: 113 ---FTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVN-SNLVCKVSDFGMSRVLED 168
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
               +    G      + APE  +   ++++A D+W  G +  E++S
Sbjct: 169 DPEAAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 52  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 101
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y      +++     + + ++           GT RYI RDL   NILV+ + + V
Sbjct: 102 SLRDY----LQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 156
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 38/163 (23%)
Query: 106 RDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           RD+KP N+L         +K+  FG AK   ++   ++    T YY APE+L G  +Y  
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVL-GPEKYDK 198
Query: 164 AVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
           + D+W +G I   ++ G P F         PG  + I +G+                   
Sbjct: 199 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------------ 240
Query: 215 TNGFPGLEPAGID-----LISKMLGMDPDKRITAAEALQQEYF 252
              FP  E + +      LI  +L  +P +R+T  E +   + 
Sbjct: 241 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 23/207 (11%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K     Y   
Sbjct: 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSK--GSLLDFLKGETGKY--- 359
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 360 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 411
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 412 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRD 212
            +   L ++    R P    C  SL D
Sbjct: 469 VNREVLDQVERGYRMPCPPECPESLHD 495

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 28/158 (17%)
Query: 106 RDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           RD+KP N+L         +K+  FG AK   ++   ++    T YY APE+L G  +Y  
Sbjct: 155 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVL-GPEKYDK 212
Query: 164 AVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
           + D+W +G I   ++ G P F         PG  + I +G+   +   P + ++S    +
Sbjct: 213 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY--EFPNPEWSEVSEEVKM 270
Query: 215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                        LI  +L  +P +R+T  E +   + 
Sbjct: 271 -------------LIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 54  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 103
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 104 SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 158
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 159 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 217

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 23/181 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQ---GIYLYPVFEYQVNDLAYLLKYPKDSM 65
           +    + + E S + +L H N+++L+ V  +   G+Y+   +  + + + YL    +  +
Sbjct: 55  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVA 125
            G     F S  +      +E             G  ++ RDL   N+LV  D    KV+
Sbjct: 115 GGDCLLKF-SLDVCEAMEYLE-------------GNNFVHRDLAARNVLVSED-NVAKVS 159
Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLF 184
            FGL K   + +      V    + APE L    ++ST  D+W  G +  E+ S G+  +
Sbjct: 160 DFGLTKEASSTQDTGKLPVK---WTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY 215
Query: 185 P 185
           P
Sbjct: 216 P 216

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 50  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 99
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI R+L   NILV+ + + V
Sbjct: 100 SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRNLATRNILVENENR-V 154
Query: 123 KVAGFGLAKSLYA----YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           K+  FGL K L      YK +   E    +Y APE L    ++S A D+W  G +  E+ 
Sbjct: 155 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELF 212
Query: 179 S 179
           +
Sbjct: 213 T 213

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 47  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 96
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 97  SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 151
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 152 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 210

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 10/122 (8%)
Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLL 159
           Y+ RDL+  NILV  +    KVA FGLA+ +     E +A  G  +   + APE  L   
Sbjct: 125 YVHRDLRAANILVG-ENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAAL-YG 180
Query: 160 EYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPS--FCKLSLRDHLTN 216
            ++   D+W  G +  E+ + G+  +PG  +   L ++    R P    C  SL D +  
Sbjct: 181 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 240
Query: 217 GF 218
            +
Sbjct: 241 CW 242

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 52  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 101
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 102 SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 156
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 70/169 (41%), Gaps = 38/169 (22%)
Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
           D   VK+A  G A  ++ +  E   ++ T  Y++ E+L+G   YST  DIW   C+  E+
Sbjct: 223 DKIRVKIADLGNACWVHKHFTE---DIQTRQYRSIEVLIGA-GYSTPADIWSTACMAFEL 278
Query: 178 VSGKPLFPG-------------ANSLITLGRI------VGKSRKPSFCKLSLRDHLTN-- 216
            +G  LF               A+ +  LG I       GK  +  F +     H+T   
Sbjct: 279 ATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLK 338
Query: 217 ------------GFPGLEPAGI-DLISKMLGMDPDKRITAAEALQQEYF 252
                       G+P  + A   D +  ML M P+KR +A E L+  + 
Sbjct: 339 PWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRHPWL 387

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 96/244 (39%), Gaps = 42/244 (17%)
Query: 23  MELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTF 82
           ++ +   IIRL        Y+Y V E    DL   LK  K S++ +  K++    L    
Sbjct: 111 LQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVH 169
Query: 83  LLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--S 140
            + +                 +  DLKP N L+ +DG  +K+  FG+A  +         
Sbjct: 170 TIHQHGI--------------VHSDLKPANFLI-VDG-MLKLIDFGIANQMQPDTTSVVK 213
Query: 141 SAEVGTHYYKAPELLLGL----------LEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS 189
            ++VGT  Y  PE +  +           + S   D+W +GCI   M  GK P     N 
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
           +  L  I+  + +  F  +  +D        L+    D++   L  DP +RI+  E L  
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKD--------LQ----DVLKCCLKRDPKQRISIPELLAH 321
Query: 250 EYFK 253
            Y +
Sbjct: 322 PYVQ 325

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 23/207 (11%)
Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY       LL + K     Y   
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVGEYMSK--GSLLDFLKGETGKY--- 276
Query: 72  NFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                       LV+                Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 277 -------LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLAR 328
Query: 132 SLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
            +     E +A  G  +   + APE  L    ++   D+W  G +  E+ + G+  +PG 
Sbjct: 329 LI--EDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 188 NSLITLGRIVGKSRKPS--FCKLSLRD 212
            +   L ++    R P    C  SL D
Sbjct: 386 VNREVLDQVERGYRMPCPPECPESLHD 412

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 49  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 98
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 99  SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 153
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 212

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 10/166 (6%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPK-DSMNGYSTKNFN 74
           EV C +  +HPNII L+       YLY   EY    N L +L K    ++   ++  N  
Sbjct: 74  EVLCKLG-HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 132
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTR-YIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
           + +L +  LL   F             + +I R+L   NILV  +    K+A FGL++  
Sbjct: 133 ASTLSSQQLL--HFAADVARGMDYLSQKQFIHRNLAARNILVG-ENYVAKIADFGLSRGQ 189
Query: 134 YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             Y  ++   +   +     L   +  Y+T  D+W  G +  E+VS
Sbjct: 190 EVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVS 233

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 80  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 129
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 130 SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 184
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 185 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 53  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 102
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 103 SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 157
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 158 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 216

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 67  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 116
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 117 SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 171
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 230

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 49  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 98
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 99  SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 153
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 212

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 8/102 (7%)
Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEY 161
           Y+ RD+KP NIL+D  G  +++A FG    L A     S   VGT  Y +PE+L  +   
Sbjct: 183 YVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 162 STA------VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV 197
                     D W +G    EM  G+  F   ++  T G+IV
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 56  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 105
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 106 SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 160
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 161 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 219

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 48  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 97
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 98  SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 152
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 153 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 55  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 104
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 105 SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 159
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 160 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 218

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 38/163 (23%)
Query: 106 RDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           RD+KP N+L         +K+  FG AK   ++   +     T YY APE+L G  +Y  
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEP-CYTPYYVAPEVL-GPEKYDK 196
Query: 164 AVDIWPVGCIFGEMVSGKPLF---------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
           + D+W +G I   ++ G P F         PG  + I +G+                   
Sbjct: 197 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------------------ 238
Query: 215 TNGFPGLEPAGID-----LISKMLGMDPDKRITAAEALQQEYF 252
              FP  E + +      LI  +L  +P +R+T  E +   + 
Sbjct: 239 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPKD 63
           +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    N L YL +  + 
Sbjct: 295 DTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 352
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVK 123
            +N                +L+                 +I R+L   N LV  +   VK
Sbjct: 353 EVNA--------------VVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHLVK 397
Query: 124 VAGFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           VA FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ +
Sbjct: 398 VADFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIAT 453
Query: 180 -GKPLFPG 186
            G   +PG
Sbjct: 454 YGMSPYPG 461

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 23/181 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQ---GIYLYPVFEYQVNDLAYLLKYPKDSM 65
           +    + + E S + +L H N+++L+ V  +   G+Y+   +  + + + YL    +  +
Sbjct: 40  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 99
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVA 125
            G     F S  +      +E             G  ++ RDL   N+LV  D    KV+
Sbjct: 100 GGDCLLKF-SLDVCEAMEYLE-------------GNNFVHRDLAARNVLVSEDN-VAKVS 144
Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLF 184
            FGL K   + +      V    + APE L    ++ST  D+W  G +  E+ S G+  +
Sbjct: 145 DFGLTKEASSTQDTGKLPVK---WTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY 200
Query: 185 P 185
           P
Sbjct: 201 P 201

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  +++Y P  
Sbjct: 67  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEYLPYG 116
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 117 SLRDYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 171
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 230

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQ---GIYLYPVFEYQVNDLAYLLKYPKDSM 65
           +    + + E S + +L H N+++L+ V  +   G+Y+   +  + + + YL    +  +
Sbjct: 46  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 105
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVA 125
            G     F S  +      +E             G  ++ RDL   N+LV  D    KV+
Sbjct: 106 GGDCLLKF-SLDVCEAMEYLE-------------GNNFVHRDLAARNVLVSED-NVAKVS 150
Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLF 184
            FGL K   + +      V    + APE L     +ST  D+W  G +  E+ S G+  +
Sbjct: 151 DFGLTKEASSTQDTGKLPVK---WTAPEALRE-AAFSTKSDVWSFGILLWEIYSFGRVPY 206
Query: 185 P 185
           P
Sbjct: 207 P 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 23/181 (12%)
Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQ---GIYLYPVFEYQVNDLAYLLKYPKDSM 65
           +    + + E S + +L H N+++L+ V  +   G+Y+   +  + + + YL    +  +
Sbjct: 227 DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 286
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVA 125
            G     F S  +      +E             G  ++ RDL   N+LV  D    KV+
Sbjct: 287 GGDCLLKF-SLDVCEAMEYLE-------------GNNFVHRDLAARNVLVSEDN-VAKVS 331
Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLF 184
            FGL K   + +      V    + APE L    ++ST  D+W  G +  E+ S G+  +
Sbjct: 332 DFGLTKEASSTQDTGKLPVK---WTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY 387
Query: 185 P 185
           P
Sbjct: 388 P 388

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 66/165 (40%), Gaps = 33/165 (20%)
Query: 107 DLKPVNILVDLDGKT----VKVAGFGLAKSLYAYKGESSAEV----GTHYYKAPELL--- 155
           DLKP NI++ LD       +K+  FGLA  +     E   E     GT  + APE++   
Sbjct: 140 DLKPENIML-LDKNIPIPHIKLIDFGLAHEI-----EDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 156 -LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
            LGL       D+W +G I   ++SG   F G     TL  I   S           D  
Sbjct: 194 PLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY----------DFD 238
Query: 215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPGRS 259
              F        D I K+L  +  KR+T  EAL+  +   V  + 
Sbjct: 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 72/186 (38%), Gaps = 24/186 (12%)
Query: 26  NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL 84
           N P +++L        YLY V EY    DL  L+             N++    +  F  
Sbjct: 132 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS------------NYDVPEKWARFYT 179
Query: 85  VEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSA 142
            E            F    I RD+KP N+L+D  G  +K+A FG    +   +G      
Sbjct: 180 AEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDT 233
Query: 143 EVGTHYYKAPELLL---GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGK 199
            VGT  Y +PE+L    G   Y    D W VG    EM+ G   F   + + T  +I+  
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 293
Query: 200 SRKPSF 205
               +F
Sbjct: 294 KNSLTF 299

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 72/186 (38%), Gaps = 24/186 (12%)
Query: 26  NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL 84
           N P +++L        YLY V EY    DL  L+             N++    +  F  
Sbjct: 132 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS------------NYDVPEKWARFYT 179
Query: 85  VEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSA 142
            E            F    I RD+KP N+L+D  G  +K+A FG    +   +G      
Sbjct: 180 AEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDT 233
Query: 143 EVGTHYYKAPELLL---GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGK 199
            VGT  Y +PE+L    G   Y    D W VG    EM+ G   F   + + T  +I+  
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 293
Query: 200 SRKPSF 205
               +F
Sbjct: 294 KNSLTF 299

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V EY  N           S++ +  K+    +
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN----------GSLDSFLRKH---DA 142
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 ++ RDL   NIL++      KV+ FGL++ L    
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDP 201
Query: 138 GESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +    G      + +PE  +   ++++A D+W  G +  E++S
Sbjct: 202 EAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 66/165 (40%), Gaps = 33/165 (20%)
Query: 107 DLKPVNILVDLDGKT----VKVAGFGLAKSLYAYKGESSAEV----GTHYYKAPELL--- 155
           DLKP NI++ LD       +K+  FGLA  +     E   E     GT  + APE++   
Sbjct: 140 DLKPENIML-LDKNIPIPHIKLIDFGLAHEI-----EDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 156 -LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
            LGL       D+W +G I   ++SG   F G     TL  I   S           D  
Sbjct: 194 PLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY----------DFD 238
Query: 215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPGRS 259
              F        D I K+L  +  KR+T  EAL+  +   V  + 
Sbjct: 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 179 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 232
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 279
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 280 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 135 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 188
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 189 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 235
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 236 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 264

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 132 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 185
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 232
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 233 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 72/186 (38%), Gaps = 24/186 (12%)
Query: 26  NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL 84
           N P +++L        YLY V EY    DL  L+             N++    +  F  
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS------------NYDVPEKWARFYT 174
Query: 85  VEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSA 142
            E            F    I RD+KP N+L+D  G  +K+A FG    +   +G      
Sbjct: 175 AEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDT 228
Query: 143 EVGTHYYKAPELLL---GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGK 199
            VGT  Y +PE+L    G   Y    D W VG    EM+ G   F   + + T  +I+  
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288
Query: 200 SRKPSF 205
               +F
Sbjct: 289 KNSLTF 294

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 7/81 (8%)
Query: 105 RRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYS 162
            RD+K  N+L+  +  T  +A FGLA    A K  G++  +VGT  Y APE+L G + + 
Sbjct: 154 HRDIKSKNVLLK-NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQ 212
Query: 163 T----AVDIWPVGCIFGEMVS 179
                 +D++ +G +  E+ S
Sbjct: 213 RDAFLRIDMYAMGLVLWELAS 233

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 66/165 (40%), Gaps = 33/165 (20%)
Query: 107 DLKPVNILVDLDGKT----VKVAGFGLAKSLYAYKGESSAEV----GTHYYKAPELL--- 155
           DLKP NI++ LD       +K+  FGLA  +     E   E     GT  + APE++   
Sbjct: 140 DLKPENIML-LDKNIPIPHIKLIDFGLAHEI-----EDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 156 -LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
            LGL       D+W +G I   ++SG   F G     TL  I   S           D  
Sbjct: 194 PLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY----------DFD 238
Query: 215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPGRS 259
              F        D I K+L  +  KR+T  EAL+  +   V  + 
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 62/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y      +   GT  Y  PE +    
Sbjct: 137 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHR 190
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 237
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 238 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 66/165 (40%), Gaps = 33/165 (20%)
Query: 107 DLKPVNILVDLDGKT----VKVAGFGLAKSLYAYKGESSAEV----GTHYYKAPELL--- 155
           DLKP NI++ LD       +K+  FGLA  +     E   E     GT  + APE++   
Sbjct: 140 DLKPENIML-LDKNIPIPHIKLIDFGLAHEI-----EDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 156 -LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
            LGL       D+W +G I   ++SG   F G     TL  I   S           D  
Sbjct: 194 PLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY----------DFD 238
Query: 215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPGRS 259
              F        D I K+L  +  KR+T  EAL+  +   V  + 
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 136 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 189
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 190 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 236
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 237 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 137 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 190
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 237
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 238 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 62/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y      +   GT  Y  PE +    
Sbjct: 179 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHR 232
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 279
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 280 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 43/216 (19%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYP------VFEYQVNDLAYLLKYPKDSMN 66
            + +RE   +  LNHPN++ L+     GI L P      +  Y  +    LL++ +    
Sbjct: 67  EAFLREGLLMRGLNHPNVLALI-----GIMLPPEGLPHVLLPYMCH--GDLLQFIRSPQR 119
Query: 67  GYSTKNFNSYSLFTTF---LLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVK 123
             + K+  S+ L        L E+              +++ RDL   N ++D +  TVK
Sbjct: 120 NPTVKDLISFGLQVARGMEYLAEQ--------------KFVHRDLAARNCMLD-ESFTVK 164
Query: 124 VAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
           VA FGLA+ +     Y+ +    A +   +       L    ++T  D+W  G +  E++
Sbjct: 165 VADFGLARDILDREYYSVQQHRHARLPVKWTALES--LQTYRFTTKSDVWSFGVLLWELL 222
Query: 179 S-GKPLFPGANSLITLGRIVGKSRK---PSFCKLSL 210
           + G P +   +    L   + + R+   P +C  SL
Sbjct: 223 TRGAPPYRHIDPF-DLTHFLAQGRRLPQPEYCPDSL 257

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 137 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 190
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 237
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 238 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 266

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 136 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 189
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 190 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 236
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 237 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 265

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 164 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 217
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 264
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 265 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 15/154 (9%)
Query: 107 DLKPVNILVDLD-GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV 165
           D++P NI+       T+K+  FG A+ L              YY APE+    +  STA 
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY-APEVHQHDV-VSTAT 184
Query: 166 DIWPVGCIFGEMVSG-KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPA 224
           D+W +G +   ++SG  P     N  I +  I+    + +F +          F  +   
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNA--EYTFDE--------EAFKEISIE 233
Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFKDVPGR 258
            +D + ++L  +   R+TA+EALQ  + K    R
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 62/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y      +   GT  Y  PE +    
Sbjct: 151 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHR 204
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 251
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 252 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 5/85 (5%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG---- 157
           + I RD+K  N+L+  +   VK+  FG++  L    G  +  +GT Y+ APE++      
Sbjct: 149 KVIHRDIKGQNVLL-TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 207
Query: 158 LLEYSTAVDIWPVGCIFGEMVSGKP 182
              Y    D+W +G    EM  G P
Sbjct: 208 DATYDFKSDLWSLGITAIEMAEGAP 232

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 62/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y      +   GT  Y  PE +    
Sbjct: 132 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHR 185
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG-GQVFFRQRVSSECQ------------ 232
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 233 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 62/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y      +   GT  Y  PE +    
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHR 224
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 225 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 271
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 272 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 62/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y      +   GT  Y  PE +    
Sbjct: 152 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHR 205
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSSECQ------------ 252
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 253 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 8/89 (8%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL----LGLL 159
           I RD+KP NIL+D  G+ +K+  FG++  L   K +  +  G   Y APE +        
Sbjct: 147 IHRDVKPSNILLDERGQ-IKLCDFGISGRLVDDKAKDRS-AGCAAYMAPERIDPPDPTKP 204
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           +Y    D+W +G    E+ +G+  FP  N
Sbjct: 205 DYDIRADVWSLGISLVELATGQ--FPYKN 231

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 20/169 (11%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           + E S + + +HPN+I L  V ++   +  + E+  N           S++ +  +N   
Sbjct: 82  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN----------GSLDSFLRQNDGQ 131
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              FT   LV                 Y+ RDL   NILV+      KV+ FGL++ L  
Sbjct: 132 ---FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLED 187
Query: 136 YKGE---SSAEVGT--HYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              +   +SA  G     + APE  +   ++++A D+W  G +  E++S
Sbjct: 188 DTSDPTYTSALGGKIPIRWTAPE-AIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 165 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 218
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG-GQVFFRQRVSSECQ------------ 265
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 266 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 165 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 218
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 219 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG-GQVFFRQRVSSECQ------------ 265
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 266 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 66/165 (40%), Gaps = 33/165 (20%)
Query: 107 DLKPVNILVDLDGKT----VKVAGFGLAKSLYAYKGESSAEV----GTHYYKAPELL--- 155
           DLKP NI++ LD       +K+  FGLA  +     E   E     GT  + APE++   
Sbjct: 140 DLKPENIML-LDKNIPIPHIKLIDFGLAHEI-----EDGVEFKNIFGTPEFVAPEIVNYE 193
Query: 156 -LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
            LGL       D+W +G I   ++SG   F G     TL  I   S           D  
Sbjct: 194 PLGL-----EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY----------DFD 238
Query: 215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPGRS 259
              F        D I K+L  +  KR+T  EAL+  +   V  + 
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 164 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 217
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG-GQVFFRQRVSSECQ------------ 264
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 265 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 164 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 217
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R  S C+            
Sbjct: 218 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIG-GQVFFRQRVSSECQ------------ 264
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 265 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
           +TME      ++E + + E+ HPN+++L+ V ++    Y + E+       LL Y ++  
Sbjct: 256 DTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT--YGNLLDYLREC- 310
Query: 66  NGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVA 125
                 N    S      +  +               +I R+L   N LV  +   VKVA
Sbjct: 311 ------NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVG-ENHLVKVA 360
Query: 126 GFGLAKSLYAYKGES-SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-G 180
            FGL++ +    G++ +A  G  +   + APE  L   ++S   D+W  G +  E+ + G
Sbjct: 361 DFGLSRLM---TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYG 416
Query: 181 KPLFPG 186
              +PG
Sbjct: 417 MSPYPG 422

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 16/96 (16%)
Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK----GESS----AEVGTHYYKAPELLLG 157
           RDL   N+LV  DG  V ++ FGL+  L   +    GE      +EVGT  Y APE+L G
Sbjct: 144 RDLNSRNVLVKNDGTCV-ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202
Query: 158 ---LLEYSTA---VDIWPVGCIFGEM-VSGKPLFPG 186
              L +  +A   VD++ +G I+ E+ +    LFPG
Sbjct: 203 AVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 43/80 (53%), Gaps = 7/80 (8%)
Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYST 163
           RD K  N+L+  D   V +A FGLA      K  G++  +VGT  Y APE+L G + +  
Sbjct: 147 RDFKSKNVLLKSDLTAV-LADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQR 205
Query: 164 ----AVDIWPVGCIFGEMVS 179
                +D++ +G +  E+VS
Sbjct: 206 DAFLRIDMYAMGLVLWELVS 225

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 11/167 (6%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
           +  +REV+ +  L HPNI+  M   +Q   L  V EY      Y L +     +G   + 
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH----KSGAREQL 134
Query: 73  FNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
                L   + + +                 + RDLK  N+LVD    TVKV  FGL++ 
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNR-----NPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRL 188
Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +    S    GT  + APE+L        + D++  G I  E+ +
Sbjct: 189 KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 68/167 (40%), Gaps = 22/167 (13%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDL--AYLLKYPKDSMNGYSTKNFNS 75
           E S + + +HPN++ L  V ++G  +  V E+  N    A+L K+               
Sbjct: 94  EASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHD-------------- 139
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              FT   LV                 Y+ RDL   NILV+      KV+ FGL++ +  
Sbjct: 140 -GQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVN-SNLVCKVSDFGLSRVIED 197
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
                    G      + APE  +   ++++A D+W  G +  E++S
Sbjct: 198 DPEAVYTTTGGKIPVRWTAPE-AIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 95/244 (38%), Gaps = 42/244 (17%)
Query: 23  MELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTF 82
           ++ +   IIRL        Y+Y V E    DL   LK  K S++ +  K++    L    
Sbjct: 111 LQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVH 169
Query: 83  LLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--S 140
            + +                 +  DLKP N L+ +DG  +K+  FG+A  +         
Sbjct: 170 TIHQHGI--------------VHSDLKPANFLI-VDG-MLKLIDFGIANQMQPDTTSVVK 213
Query: 141 SAEVGTHYYKAPELLLGL----------LEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS 189
            ++VG   Y  PE +  +           + S   D+W +GCI   M  GK P     N 
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
           +  L  I+  + +  F  +  +D        L+    D++   L  DP +RI+  E L  
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKD--------LQ----DVLKCCLKRDPKQRISIPELLAH 321
Query: 250 EYFK 253
            Y +
Sbjct: 322 PYVQ 325

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY-PKD 63
           H+T E +     RE+  L  L H NI++   V          +     +L  ++++ P  
Sbjct: 52  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVC---------YSAGRRNLKLIMEFLPYG 101
Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGT-RYIRRDLKPVNILVDLDGKTV 122
           S+  Y  K+              ++           GT RYI RDL   NILV+ + + V
Sbjct: 102 SLREYLQKHKERIDHIKLL----QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-V 156
Query: 123 KVAGFGLAKSLYAYKGESSA-EVGTH--YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           K+  FGL K L   K      E G    ++ APE L    ++S A D+W  G +  E+ +
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE--VGTHYYKAPEL--LLGLL 159
           I RDLK  NI +  D  TVK+  FGLA     + G    E   G+  + APE+  +    
Sbjct: 142 IHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGK-SRKPSFCKL 208
            YS   D++  G +  E+++G+  +   N+   +  +VG+ S  P   K+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE--VGTHYYKAPEL--LLGLL 159
           I RDLK  NI +  D  TVK+  FGLA     + G    E   G+  + APE+  +    
Sbjct: 142 IHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGK-SRKPSFCKL 208
            YS   D++  G +  E+++G+  +   N+   +  +VG+ S  P   K+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 10  GVPSSMIREVSCLMELNHPNIIRLMRVA--SQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
           G  S  + E   + + +HPN++ L+ +   S+G  L  +   +  DL     + ++  + 
Sbjct: 74  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR---NFIRNETHN 130
Query: 68  YSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            + K+   + L                       +++ RDL   N ++D +  TVKVA F
Sbjct: 131 PTVKDLIGFGL-----------QVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADF 178
Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE---YSTAVDIWPVGCIFGE-MVSGKPL 183
           GLA+ +   + +S             + L  L+   ++T  D+W  G +  E M  G P 
Sbjct: 179 GLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 238
Query: 184 FPGANSL-ITLGRIVGKS-RKPSFC 206
           +P  N+  IT+  + G+   +P +C
Sbjct: 239 YPDVNTFDITVYLLQGRRLLQPEYC 263

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V E   N           S++ +  K+    +
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMEN----------GSLDSFLRKH---DA 142
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGL++ L    
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDP 201
Query: 138 GESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +    G      + +PE  +   ++++A D+W  G +  E++S
Sbjct: 202 EAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 72/188 (38%), Gaps = 11/188 (5%)
Query: 27  HPNIIRLMRVASQGIYLYPVFEY--QVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL 84
           H NII L+   +Q   LY + EY  + N   YL       M      N       T   L
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 85  VEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV 144
           V                + I RDL   N+LV  +   +K+A FGLA+ +           
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 145 GTHYYK--APELLLGLLEYSTAVDIWPVGCIFGEMVS--GKPLFPG--ANSLITLGRIVG 198
           G    K  APE L   + Y+   D+W  G +  E+ +  G P +PG     L  L +   
Sbjct: 219 GRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKEGH 276
Query: 199 KSRKPSFC 206
           +  KP+ C
Sbjct: 277 RMDKPANC 284

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 20/169 (11%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           + E S + +  HPNIIRL  V +  + +  + E+  N           +++ +   N   
Sbjct: 65  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMEN----------GALDSFLRLNDGQ 114
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              FT   LV                 Y+ RDL   NILV+      KV+ FGL++ L  
Sbjct: 115 ---FTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEE 170
Query: 136 YKGE--SSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              +   ++ +G      + APE  +   ++++A D W  G +  E++S
Sbjct: 171 NSSDPTETSSLGGKIPIRWTAPE-AIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 58/136 (42%), Gaps = 14/136 (10%)
Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGLLEYSTA 164
           RD+KP NILV  D     V  FG+A +    K  +    VGT YY APE        +  
Sbjct: 158 RDVKPENILVSADDFAYLV-DFGIASATTDEKLTQLGNTVGTLYYXAPE-RFSESHATYR 215
Query: 165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPA 224
            DI+ + C+  E ++G P + G    +    I     +PS  +           PG+  A
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPRPSTVR-----------PGIPVA 264
Query: 225 GIDLISKMLGMDPDKR 240
              +I++    +P+ R
Sbjct: 265 FDAVIARGXAKNPEDR 280

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y      +   GT  Y  PE +    
Sbjct: 132 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHR 185
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R    C+            
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSXECQ------------ 232
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 233 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 13/94 (13%)
Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY-----AYKGESSAEVGTHYYKAPELLL 156
           + I RDL   NIL+  +   VK+  FGLA+ +Y       KG++   +    + APE + 
Sbjct: 219 KCIHRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKGDTRLPLK---WMAPESIF 274
Query: 157 GLLEYSTAVDIWPVGCIFGEMVS--GKPLFPGAN 188
             + YST  D+W  G +  E+ S  G P +PG  
Sbjct: 275 DKI-YSTKSDVWSYGVLLWEIFSLGGSP-YPGVQ 306

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 23/191 (12%)
Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLL----KYPKDSM 65
            +++ E+  + +L +H NI+ L+   +    +Y +FEY    + L YL     K+ +D +
Sbjct: 93  EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152
Query: 66  NGYSTKNFNSYSLFT--TF--LLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKT 121
              + K           TF  LL   +          F +  + RDL   N+LV   GK 
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-CVHRDLAARNVLV-THGKV 210
Query: 122 VKVAGFGLAKSL-----YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGE 176
           VK+  FGLA+ +     Y  +G +   V    + APE L   + Y+   D+W  G +  E
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVK---WMAPESLFEGI-YTIKSDVWSYGILLWE 266
Query: 177 MVS-GKPLFPG 186
           + S G   +PG
Sbjct: 267 IFSLGVNPYPG 277

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 18  EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS 77
           E S + + +HPNIIRL  V ++   +  V E   N           S++ +  K+    +
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMEN----------GSLDSFLRKH---DA 113
Query: 78  LFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK 137
            FT   LV                 Y+ RDL   NIL++      KV+ FGL++ L   +
Sbjct: 114 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVL---E 169
Query: 138 GESSAEVGTH------YYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
            +  A   T        + +PE  +   ++++A D+W  G +  E++S
Sbjct: 170 DDPEAAYTTRGGKIPIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 32/247 (12%)
Query: 2   MGIHNTMEGVPSS--MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLK 59
           + I    EG  S    I E   +M+L+HP +++L  V  +   +  VFE+   +   L  
Sbjct: 34  VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM--EHGCLSD 91
Query: 60  YPKDSMNGYSTKNFNSYSLFTT--FLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDL 117
           Y +     ++ +      L        +EE                I RDL   N LV  
Sbjct: 92  YLRTQRGLFAAETLLGMCLDVCEGMAYLEE-------------ASVIHRDLAARNCLVG- 137
Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIF 174
           + + +KV+ FG+ +  +    + ++  GT +   + +PE+      YS+  D+W  G + 
Sbjct: 138 ENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLM 194
Query: 175 GEMVS-GK-PLFPGANSL----ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDL 228
            E+ S GK P    +NS     I+ G  + K R  S     + +H     P   PA   L
Sbjct: 195 WEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL 254
Query: 229 ISKMLGM 235
           + ++  +
Sbjct: 255 LRQLAAI 261

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE--VGTHYYKAPEL--LLGLL 159
           I RDLK  NI +  D  TVK+  FGLA     + G    E   G+  + APE+  +    
Sbjct: 130 IHRDLKSNNIFLHEDN-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGK-SRKPSFCKL 208
            YS   D++  G +  E+++G+  +   N+   +  +VG+ S  P   K+
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 238

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 18/167 (10%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           + E S + + +HPNII L  V ++   +  + EY  N           S++ +  KN   
Sbjct: 78  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMEN----------GSLDAFLRKNDGR 127
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              FT   LV                  + RDL   NILV+      KV+ FG+++ L  
Sbjct: 128 ---FTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVN-SNLVCKVSDFGMSRVLED 183
Query: 136 YKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
               +    G      + APE  +   ++++A D+W  G +  E++S
Sbjct: 184 DPEAAYTTRGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y      +   GT  Y  PE +    
Sbjct: 159 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHR 212
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R    C+            
Sbjct: 213 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSXECQ------------ 259
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 260 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 288

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLL 159
           YI RDL+  NILV       K+A FGLA+ +     E +A  G  +   + APE  +   
Sbjct: 132 YIHRDLRAANILVSA-SLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPE-AINFG 187
Query: 160 EYSTAVDIWPVGCIFGEMVS-GKPLFPGANS 189
            ++   D+W  G +  E+V+ G+  +PG ++
Sbjct: 188 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 218

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 70/186 (37%), Gaps = 24/186 (12%)
Query: 26  NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL 84
           N P +++L        YLY V EY    DL  L+             N++    +  F  
Sbjct: 133 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS------------NYDVPEKWAKFYT 180
Query: 85  VEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAE 143
            E                 I RD+KP N+L+D  G  +K+A FG    +           
Sbjct: 181 AE----VVLALDAIHSMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTA 235
Query: 144 VGTHYYKAPELLL---GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKS 200
           VGT  Y +PE+L    G   Y    D W VG    EM+ G   F   + + T  +I+   
Sbjct: 236 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM--D 293
Query: 201 RKPSFC 206
            K S C
Sbjct: 294 HKNSLC 299

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 10/106 (9%)
Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELL-LGL 158
           YI RDL+  N+LV  +    K+A FGLA+ +     E +A  G  +   + APE +  G 
Sbjct: 131 YIHRDLRAANVLVS-ESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGC 187
Query: 159 LEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKP 203
             ++   D+W  G +  E+V+ GK  +PG  +   +  +    R P
Sbjct: 188 --FTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMP 231

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLL 159
           YI RDL+  NILV       K+A FGLA+ +     E +A  G  +   + APE  +   
Sbjct: 305 YIHRDLRAANILVSA-SLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPE-AINFG 360
Query: 160 EYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
            ++   D+W  G +  E+V+ G+  +PG
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPG 388

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 20/169 (11%)
Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           + E S + +  HPNIIRL  V +  + +  + E+  N           +++ +   N   
Sbjct: 63  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMEN----------GALDSFLRLNDGQ 112
Query: 76  YSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
              FT   LV                 Y+ RDL   NILV+      KV+ FGL++ L  
Sbjct: 113 ---FTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEE 168
Query: 136 YKGES--SAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
              +   ++ +G      + APE  +   ++++A D W  G +  E++S
Sbjct: 169 NSSDPTYTSSLGGKIPIRWTAPE-AIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 78/200 (39%), Gaps = 25/200 (12%)
Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
            +RE   L +LNH NI++L  +  +    + V   +      L    ++  N Y      
Sbjct: 54  QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE-- 111
Query: 75  SYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNIL--VDLDGKTV-KVAGFGLAK 131
                + FL+V              G   + R++KP NI+  +  DG++V K+  FG A+
Sbjct: 112 -----SEFLIVLRDVVGGMNHLRENGI--VHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164
Query: 132 SLYAYKGESSAEVGTHYYKAPELLLGLL-------EYSTAVDIWPVGCIFGEMVSGKPLF 184
            L   +   S   GT  Y  P++    +       +Y   VD+W +G  F    +G   F
Sbjct: 165 ELEDDEQFVSL-YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
Query: 185 -----PGANSLITLGRIVGK 199
                P  N  +    I GK
Sbjct: 224 RPFEGPRRNKEVMYKIITGK 243

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 101/242 (41%), Gaps = 28/242 (11%)
Query: 2   MGIHNTMEGVPSS--MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLK 59
           + I    EG  S    I E   +M+L+HP +++L  V  +   +  VFE+   +   L  
Sbjct: 34  VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM--EHGCLSD 91
Query: 60  YPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDG 119
           Y + +  G     F + +L    L V E                I RDL   N LV  + 
Sbjct: 92  YLR-TQRGL----FAAETLLGMCLDVCEGMAYLEEACV------IHRDLAARNCLVG-EN 139
Query: 120 KTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGE 176
           + +KV+ FG+ +  +    + ++  GT +   + +PE+      YS+  D+W  G +  E
Sbjct: 140 QVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWE 196
Query: 177 MVS-GK-PLFPGANSL----ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
           + S GK P    +NS     I+ G  + K R  S     + +H     P   PA   L+ 
Sbjct: 197 VFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR 256
Query: 231 KM 232
           ++
Sbjct: 257 QL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 101/242 (41%), Gaps = 28/242 (11%)
Query: 2   MGIHNTMEGVPSS--MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLK 59
           + I    EG  S    I E   +M+L+HP +++L  V  +   +  VFE+   +   L  
Sbjct: 32  VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM--EHGCLSD 89
Query: 60  YPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDG 119
           Y + +  G     F + +L    L V E                I RDL   N LV  + 
Sbjct: 90  YLR-TQRGL----FAAETLLGMCLDVCEGMAYLEEACV------IHRDLAARNCLVG-EN 137
Query: 120 KTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGE 176
           + +KV+ FG+ +  +    + ++  GT +   + +PE+      YS+  D+W  G +  E
Sbjct: 138 QVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWE 194
Query: 177 MVS-GK-PLFPGANSL----ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
           + S GK P    +NS     I+ G  + K R  S     + +H     P   PA   L+ 
Sbjct: 195 VFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
Query: 231 KM 232
           ++
Sbjct: 255 QL 256

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y      +   GT  Y  PE +    
Sbjct: 151 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHR 204
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R    C+            
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSXECQ------------ 251
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 252 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 280

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 60/156 (38%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y          GT  Y  PE +    
Sbjct: 179 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------GTRVYSPPEWIRYHR 232
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R    C+            
Sbjct: 233 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSXECQ------------ 279
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 280 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 308

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 14  SMIREVSCLMEL-NHPNIIRLMRVASQ-GIYLYPVFEY-QVNDLAYLLKYPKDSMNGYST 70
           +++ E+  L+ + +H N++ L+   ++ G  L  + E+ +  +L+  L+  ++    Y  
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTR-YIRRDLKPVNILVDLDGKTVKVAGFGL 129
              + Y  F T   +  +            +R  I RDL   NIL+  +   VK+  FGL
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGL 194
Query: 130 AKSLY-----AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPL 183
           A+ +Y       KG++   +    + APE +   + Y+   D+W  G +  E+ S G   
Sbjct: 195 ARDIYKDPDXVRKGDARLPLK---WMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP 250
Query: 184 FPGAN 188
           +PG  
Sbjct: 251 YPGVK 255

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 14  SMIREVSCLMEL-NHPNIIRLMRVASQ-GIYLYPVFEY-QVNDLAYLLKYPKDSMNGYST 70
           +++ E+  L+ + +H N++ L+   ++ G  L  + E+ +  +L+  L+  ++    Y  
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTR-YIRRDLKPVNILVDLDGKTVKVAGFGL 129
              + Y  F T   +  +            +R  I RDL   NIL+  +   VK+  FGL
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGL 194
Query: 130 AKSL-----YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPL 183
           A+ +     Y  KG++   +    + APE +   + Y+   D+W  G +  E+ S G   
Sbjct: 195 ARDIYKDPDYVRKGDARLPLK---WMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP 250
Query: 184 FPGAN 188
           +PG  
Sbjct: 251 YPGVK 255

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 14  SMIREVSCLMEL-NHPNIIRLMRVASQ-GIYLYPVFEY-QVNDLAYLLKYPKDSMNGYST 70
           +++ E+  L+ + +H N++ L+   ++ G  L  + E+ +  +L+  L+  ++    Y  
Sbjct: 113 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 172
Query: 71  KNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTR-YIRRDLKPVNILVDLDGKTVKVAGFGL 129
              + Y  F T   +  +            +R  I RDL   NIL+  +   VK+  FGL
Sbjct: 173 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGL 231
Query: 130 AKSL-----YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPL 183
           A+ +     Y  KG++   +    + APE +   + Y+   D+W  G +  E+ S G   
Sbjct: 232 ARDIYKDPDYVRKGDARLPLK---WMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP 287
Query: 184 FPGAN 188
           +PG  
Sbjct: 288 YPGVK 292

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y      +   GT  Y  PE +    
Sbjct: 184 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHR 237
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R    C+            
Sbjct: 238 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSXECQ------------ 284
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 285 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 313

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 101/242 (41%), Gaps = 28/242 (11%)
Query: 2   MGIHNTMEGVPSS--MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLK 59
           + I    EG  S    I E   +M+L+HP +++L  V  +   +  VFE+   +   L  
Sbjct: 37  VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM--EHGCLSD 94
Query: 60  YPKDSMNGYSTKNFNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDG 119
           Y + +  G     F + +L    L V E                I RDL   N LV  + 
Sbjct: 95  YLR-TQRGL----FAAETLLGMCLDVCEGMAYLEEACV------IHRDLAARNCLVG-EN 142
Query: 120 KTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFGE 176
           + +KV+ FG+ +  +    + ++  GT +   + +PE+      YS+  D+W  G +  E
Sbjct: 143 QVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWE 199
Query: 177 MVS-GK-PLFPGANSL----ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
           + S GK P    +NS     I+ G  + K R  S     + +H     P   PA   L+ 
Sbjct: 200 VFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR 259
Query: 231 KM 232
           ++
Sbjct: 260 QL 261

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 11/167 (6%)
Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
           +  +REV+ +  L HPNI+  M   +Q   L  V EY      Y L +     +G   + 
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH----KSGAREQL 134
Query: 73  FNSYSLFTTFLLVEEFXXXXXXXXXXFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
                L   + + +                 + R+LK  N+LVD    TVKV  FGL++ 
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNR-----NPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRL 188
Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +    S +  GT  + APE+L        + D++  G I  E+ +
Sbjct: 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 30/156 (19%)
Query: 104 IRRDLKPVNILVDLDGKTVKVAGFG----LAKSLYAYKGESSAEVGTHYYKAPELLLGLL 159
           + RD+K  NIL+DL+   +K+  FG    L  ++Y      +   GT  Y  PE +    
Sbjct: 152 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHR 205
Query: 160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            +  +  +W +G +  +MV G   F     +I  G++  + R    C+            
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFFRQRVSXECQ------------ 252
Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
                   LI   L + P  R T  E     + +DV
Sbjct: 253 -------HLIRWCLALRPSDRPTFEEIQNHPWMQDV 281

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	259
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-72
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-72
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-71
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-71
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-71
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-70
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-70
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-69
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-69
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-69
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-67
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-65
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-63
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-62
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-59
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-58
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-56
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-53
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-51
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-51
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-51
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-50
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-50
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-50
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-50
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-49
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-47
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-46
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-45
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-43
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-42
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-31
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-28
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-27
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-26
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-24
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-24
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-24
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-22
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-05
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-21
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-04
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-20
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-20
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-20
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-19
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-18
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-18
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-18
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-18
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-17
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-17
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-17
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-17
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-16
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-16
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-16
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-16
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-15
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-15
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-14
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-14
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-14
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-14
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-14
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-14
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-13
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-13
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-13
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-13
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-13
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-13
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-12
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-12
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-12
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-12
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-12
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-11
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-11
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-11
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-11
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-11
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-11
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-11
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-11
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-11
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-11
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-11
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-11
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-11
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-11
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-10
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-10
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-10
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-10
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-10
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-10
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-10
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-10
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-10
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-10
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-10
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-10
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-10
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-10
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-10
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-09
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-09
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-09
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-09
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-09
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-09
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-09
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-08
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-08
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-08
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-08
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-07
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-05
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-04

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  222 bits (567), Expect = 4e-72
 Identities = 96/266 (36%), Positives = 140/266 (52%), Gaps = 35/266 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG+PS+ IRE+S L EL+HPNI+ L+ V      L  VFE+   DL  +L   K  +   
Sbjct: 60  EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS 119

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
             K +  Y L                R ++     R + RDLKP N+L++ DG  +K+A 
Sbjct: 120 QIKIY-LYQLL---------------RGVAHCHQHRILHRDLKPQNLLINSDG-ALKLAD 162

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        + EV T +Y+AP++L+G  +YST+VDIW +GCIF EM++GKPLFPG
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222

Query: 187 ANSLITLGRIV------------GKSRKPSFCKLSL----RDHLTNGFPGLEPAGIDLIS 230
                 L +I                  P + + +     +   ++  PG    GIDL+S
Sbjct: 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLS 282

Query: 231 KMLGMDPDKRITAAEALQQEYFKDVP 256
            ML  DP+KRI+A +A+   YFKD+ 
Sbjct: 283 NMLCFDPNKRISARDAMNHPYFKDLD 308

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  219 bits (561), Expect = 2e-71
 Identities = 96/272 (35%), Positives = 141/272 (51%), Gaps = 50/272 (18%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG+PS+ IRE+S L EL H NI++L  V      L  VFE+   DL  LL   +  +   
Sbjct: 41  EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV 100

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           + K+F    L                  +++    R + RDLKP N+L++ +G  +K+A 
Sbjct: 101 TAKSF-LLQLL---------------NGIAYCHDRRVLHRDLKPQNLLINREG-ELKIAD 143

Query: 127 FGLAKS----LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           FGLA++    +  Y    + E+ T +Y+AP++L+G  +YST +DIW VGCIF EMV+G P
Sbjct: 144 FGLARAFGIPVRKY----THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199

Query: 183 LFPGANSLITLGRI---VG----------------KSRKPSFCKLSLRDHLTNGFPGLEP 223
           LFPG +    L RI   +G                      +  L           GL+ 
Sbjct: 200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESF----LKGLDE 255

Query: 224 AGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +GIDL+SKML +DP++RITA +AL+  YFK+ 
Sbjct: 256 SGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  220 bits (562), Expect = 5e-71
 Identities = 86/270 (31%), Positives = 130/270 (48%), Gaps = 43/270 (15%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG P + IREVS L +L H NI+ L  +      L  VFEY   DL   L    + +N +
Sbjct: 41  EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMH 100

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           + K F  + L                R L++    + + RDLKP N+L++  G  +K+A 
Sbjct: 101 NVKLF-LFQLL---------------RGLAYCHRQKVLHRDLKPQNLLINERG-ELKLAD 143

Query: 127 FGLAKS----LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           FGLA++       Y      EV T +Y+ P++LLG  +YST +D+W VGCIF EM +G+P
Sbjct: 144 FGLARAKSIPTKTY----DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199

Query: 183 LFPGANSLITLGRIV------------GKSRKPSFCKLSL----RDHLTNGFPGLEPAGI 226
           LFPG+     L  I             G      F   +      + L +  P L+  G 
Sbjct: 200 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA 259

Query: 227 DLISKMLGMDPDKRITAAEALQQEYFKDVP 256
           DL++K+L  +   RI+A +A++  +F  + 
Sbjct: 260 DLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  219 bits (560), Expect = 5e-71
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 36/267 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
             +    +RE+  L +L HPN++ L+ V  +   L+ VFEY  + + + L   +  +  +
Sbjct: 43  PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEH 102

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
             K+  ++                  ++++F      I RD+KP NIL+      +K+  
Sbjct: 103 LVKSI-TWQTL---------------QAVNFCHKHNCIHRDVKPENILITKHS-VIKLCD 145

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FG A+ L         EV T +Y++PELL+G  +Y   VD+W +GC+F E++SG PL+PG
Sbjct: 146 FGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG 205

Query: 187 ANSLITLGRIV------------GKSRKPSFCKLSL-----RDHLTNGFPGLEPAGIDLI 229
            + +  L  I               S    F  + +      + L   FP +    + L+
Sbjct: 206 KSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLL 265

Query: 230 SKMLGMDPDKRITAAEALQQEYFKDVP 256
              L MDP +R+T  + L   YF+++ 
Sbjct: 266 KGCLHMDPTERLTCEQLLHHPYFENIR 292

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  217 bits (556), Expect = 3e-70
 Identities = 89/277 (32%), Positives = 131/277 (47%), Gaps = 48/277 (17%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EG PS+ IRE+S + EL H NI+RL  V      L  VFE+  NDL   +    DS    
Sbjct: 44  EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYM----DSRTVG 99

Query: 69  STKNFNSYSLFTTF---LLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVK 123
           +T      +L   F   LL          + L+F    + + RDLKP N+L++  G  +K
Sbjct: 100 NTPRGLELNLVKYFQWQLL----------QGLAFCHENKILHRDLKPQNLLINKRG-QLK 148

Query: 124 VAGFGLAKS----LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           +  FGLA++    +  +    S+EV T +Y+AP++L+G   YST++DIW  GCI  EM++
Sbjct: 149 LGDFGLARAFGIPVNTF----SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

Query: 180 GKPLFPGANSLITLGRIV---G----------------KSRKPSFCKLSLRDHLTN-GFP 219
           GKPLFPG N    L  I    G                           LR  L      
Sbjct: 205 GKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKE 264

Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
            L+   +D +  +L ++PD R++A +AL   +F +  
Sbjct: 265 PLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  217 bits (555), Expect = 6e-70
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 36/267 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           + V    +RE+  L +L H N++ L+ V  +    Y VFE+  + +   L+   + ++  
Sbjct: 65  KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQ 124

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
             + +  + +                  + F      I RD+KP NILV   G  VK+  
Sbjct: 125 VVQKY-LFQII---------------NGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCD 167

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FG A++L A       EV T +Y+APELL+G ++Y  AVD+W +GC+  EM  G+PLFPG
Sbjct: 168 FGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227

Query: 187 ANSLITLGRIV------------GKSRKPSFCKLSL-----RDHLTNGFPGLEPAGIDLI 229
            + +  L  I+              ++ P F  + L     R+ L   +P L    IDL 
Sbjct: 228 DSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLA 287

Query: 230 SKMLGMDPDKRITAAEALQQEYFKDVP 256
            K L +DPDKR   AE L  ++F+   
Sbjct: 288 KKCLHIDPDKRPFCAELLHHDFFQMDG 314

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  215 bits (550), Expect = 1e-69
 Identities = 91/270 (33%), Positives = 130/270 (48%), Gaps = 43/270 (15%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPSS +RE+  L EL H NI+RL  V      L  VFE+   DL          ++  
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE 101

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
             K+F  + L                + L F      + RDLKP N+L++ +G  +K+A 
Sbjct: 102 IVKSF-LFQLL---------------KGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLAN 144

Query: 127 FGLAKS----LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GK 181
           FGLA++    +  Y    SAEV T +Y+ P++L G   YST++D+W  GCIF E+ + G+
Sbjct: 145 FGLARAFGIPVRCY----SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

Query: 182 PLFPGANSLITLGRIV------------GKSRKPSFCKLSLRDH---LTNGFPGLEPAGI 226
           PLFPG +    L RI               ++ P +    +      L N  P L   G 
Sbjct: 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260

Query: 227 DLISKMLGMDPDKRITAAEALQQEYFKDVP 256
           DL+  +L  +P +RI+A EALQ  YF D  
Sbjct: 261 DLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  214 bits (548), Expect = 6e-69
 Identities = 92/273 (33%), Positives = 132/273 (48%), Gaps = 45/273 (16%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVP + IREVS L EL H NII L  V      L+ +FEY  NDL   +    D     
Sbjct: 74  EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM----DKNPDV 129

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT----V 122
           S +   S+      L+            ++F    R + RDLKP N+L+ +   +    +
Sbjct: 130 SMRVIKSFLYQ---LI----------NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+  FGLA++      + + E+ T +Y+ PE+LLG   YST+VDIW + CI+ EM+   P
Sbjct: 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236

Query: 183 LFPGANSLITLGRI---VG----------------KSRKPSFCKLSLRDHLTNGFPGLEP 223
           LFPG + +  L +I   +G                K   P F   +L+  L      L+ 
Sbjct: 237 LFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL---GALLDD 293

Query: 224 AGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
            G+DL++ ML MDP KRI+A  AL+  YF    
Sbjct: 294 EGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  215 bits (549), Expect = 7e-69
 Identities = 79/268 (29%), Positives = 118/268 (44%), Gaps = 41/268 (15%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           +G+  + +RE+  L EL+HPNII L+        +  VF++   DL  ++K     +   
Sbjct: 53  DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS 112

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
             K +                     + L +      + RDLKP N+L+D +G  +K+A 
Sbjct: 113 HIKAY-MLMTL---------------QGLEYLHQHWILHRDLKPNNLLLDENG-VLKLAD 155

Query: 127 FGLAKS----LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           FGLAKS      AY    + +V T +Y+APELL G   Y   VD+W VGCI  E++   P
Sbjct: 156 FGLAKSFGSPNRAY----THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211

Query: 183 LFPGANSLITLGRIV------------GKSRKPSFCKLSL--RDHLTNGFPGLEPAGIDL 228
             PG + L  L RI                  P +          L + F       +DL
Sbjct: 212 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 271

Query: 229 ISKMLGMDPDKRITAAEALQQEYFKDVP 256
           I  +   +P  RITA +AL+ +YF + P
Sbjct: 272 IQGLFLFNPCARITATQALKMKYFSNRP 299

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  210 bits (537), Expect = 3e-67
 Identities = 94/278 (33%), Positives = 134/278 (48%), Gaps = 45/278 (16%)

Query: 4   IHNTMEGVPSSMIREVSCLMELN---HPNIIRLMRV-----ASQGIYLYPVFEYQVNDLA 55
           +    EG+P S IREV+ L  L    HPN++RL  V       +   L  VFE+   DL 
Sbjct: 47  VQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT 106

Query: 56  -YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVN 112
            YL K P+  +   + K+   + L                R L F    R + RDLKP N
Sbjct: 107 TYLDKVPEPGVPTETIKDM-MFQLL---------------RGLDFLHSHRVVHRDLKPQN 150

Query: 113 ILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGC 172
           ILV   G  +K+A FGLA+  Y+++   ++ V T +Y+APE+LL    Y+T VD+W VGC
Sbjct: 151 ILVTSSG-QIKLADFGLARI-YSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGC 207

Query: 173 IFGEMVSGKPLFPGANSLITLGRI--------------VGKSRKPSFCKLSLRDHLTNGF 218
           IF EM   KPLF G++ +  LG+I                   + +F   S    +    
Sbjct: 208 IFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS-AQPIEKFV 266

Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
             ++  G DL+ K L  +P KRI+A  AL   YF+D+ 
Sbjct: 267 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  204 bits (521), Expect = 4e-65
 Identities = 94/273 (34%), Positives = 128/273 (46%), Gaps = 45/273 (16%)

Query: 9   EGVPSSMIREVSCLMELN---HPNIIRLMRV-----ASQGIYLYPVFEYQVNDLA-YLLK 59
            G+P S +REV+ L  L    HPN++RLM V       + I +  VFE+   DL  YL K
Sbjct: 52  GGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK 111

Query: 60  YPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDL 117
            P   +   + K+                      R L F      + RDLKP NILV  
Sbjct: 112 APPPGLPAETIKDL-MRQFL---------------RGLDFLHANCIVHRDLKPENILVTS 155

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
            G TVK+A FGLA+  Y+Y+   +  V T +Y+APE+LL    Y+T VD+W VGCIF EM
Sbjct: 156 GG-TVKLADFGLARI-YSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEM 212

Query: 178 VSGKPLFPGANSLITLGRI--------------VGKSRKPSFCKLSLRDHLTNGFPGLEP 223
              KPLF G +    LG+I                   + +F     R  + +  P +E 
Sbjct: 213 FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRP-VQSVVPEMEE 271

Query: 224 AGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
           +G  L+ +ML  +P KRI+A  ALQ  Y     
Sbjct: 272 SGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  200 bits (510), Expect = 6e-63
 Identities = 74/285 (25%), Positives = 116/285 (40%), Gaps = 49/285 (17%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIY--------LYPVFEYQVNDLA 55
           + N  EG P + +RE+  L  L H N++ L+ +              +Y VF++  +DLA
Sbjct: 52  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 111

Query: 56  YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNI 113
            LL            K      L                  L +    + + RD+K  N+
Sbjct: 112 GLLSNVLVKFTLSEIKRV-MQMLL---------------NGLYYIHRNKILHRDMKAANV 155

Query: 114 LVDLDGKTVKVAGFGLAKSLYAYKGESSA----EVGTHYYKAPELLLGLLEYSTAVDIWP 169
           L+  DG  +K+A FGLA++    K          V T +Y+ PELLLG  +Y   +D+W 
Sbjct: 156 LITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 214

Query: 170 VGCIFGEMVSGKPLFPGANSLITLGRIV------------GKSRKPSFCKLSL----RDH 213
            GCI  EM +  P+  G      L  I                    + KL L    +  
Sbjct: 215 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 274

Query: 214 LTNGFPGL--EPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
           + +       +P  +DLI K+L +DP +RI + +AL  ++F   P
Sbjct: 275 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  200 bits (509), Expect = 2e-62
 Identities = 81/299 (27%), Positives = 128/299 (42%), Gaps = 67/299 (22%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
            G+  S  RE++ L EL HPN+I L +V    A + ++L  +F+Y  +DL +++K+ + S
Sbjct: 59  TGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL--LFDYAEHDLWHIIKFHRAS 116

Query: 65  MNGYSTKNFNSYSL--FTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGK 120
                        +      +L            + +      + RDLKP NILV  +G 
Sbjct: 117 KANKKPVQLPRGMVKSLLYQIL----------DGIHYLHANWVLHRDLKPANILVMGEGP 166

Query: 121 ---TVKVAGFGLA-------KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV 170
               VK+A  G A       K L          V T +Y+APELLLG   Y+ A+DIW +
Sbjct: 167 ERGRVKIADMGFARLFNSPLKPLADLDPV----VVTFWYRAPELLLGARHYTKAIDIWAI 222

Query: 171 GCIFGEMVSGKPLFPGANSLITLG------------RIVG-------------------- 198
           GCIF E+++ +P+F      I                ++G                    
Sbjct: 223 GCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLM 282

Query: 199 -KSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
              R+ ++   SL  ++       +     L+ K+L MDP KRIT+ +A+Q  YF + P
Sbjct: 283 KDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  191 bits (487), Expect = 4e-59
 Identities = 75/265 (28%), Positives = 119/265 (44%), Gaps = 45/265 (16%)

Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEYQVNDLAYLLKY---PKDSMNG 67
           RE+  +  + HPN++ L             ++L  V EY    +    ++    K +M  
Sbjct: 81  RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM 140

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVA 125
              K +  Y L                RSL++        RD+KP N+L+D     +K+ 
Sbjct: 141 LLIKLY-MYQLL---------------RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI 184

Query: 126 GFGLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
            FG AK L    GE + + + + YY+APEL+ G   Y+T +DIW  GC+  E++ G+PLF
Sbjct: 185 DFGSAKILI--AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242

Query: 185 PGANSLITLGRIVG----------KSRKPSFCKLSL----RDHLTNGF-PGLEPAGIDLI 229
           PG + +  L  I+           K+  P++ +           +  F P   P  IDLI
Sbjct: 243 PGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLI 302

Query: 230 SKMLGMDPDKRITAAEALQQEYFKD 254
           S++L   P  R+TA EAL   +F +
Sbjct: 303 SRLLEYTPSARLTAIEALCHPFFDE 327

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  189 bits (483), Expect = 3e-58
 Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 45/265 (16%)

Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           RE+  + +L+H NI+RL             +YL  V +Y    +  + ++   +      
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155

Query: 71  ---KNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVA 125
              K +  Y LF               RSL++        RD+KP N+L+D D   +K+ 
Sbjct: 156 IYVKLY-MYQLF---------------RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 199

Query: 126 GFGLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
            FG AK L   +GE + + + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+F
Sbjct: 200 DFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

Query: 185 PGANSLITLGRIVG----------KSRKPSFCKLSL----RDHLTNGF-PGLEPAGIDLI 229
           PG + +  L  I+           +   P++ +           T  F P   P  I L 
Sbjct: 258 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 317

Query: 230 SKMLGMDPDKRITAAEALQQEYFKD 254
           S++L   P  R+T  EA    +F +
Sbjct: 318 SRLLEYTPTARLTPLEACAHSFFDE 342

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  183 bits (467), Expect = 2e-56
 Identities = 77/275 (28%), Positives = 116/275 (42%), Gaps = 54/275 (19%)

Query: 16  IREVSCLMEL---NHPNIIRLMRV-------ASQGIYLYPVFEYQVNDLAYLLKY---PK 62
            RE+  + +L   +HPNI++L            + IYL  V EY  + L    +     +
Sbjct: 64  NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQ 123

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF----GTRYIRRDLKPVNILVDLD 118
            +      K F  + L                RS+            RD+KP N+LV+  
Sbjct: 124 VAPPPILIKVF-LFQLI---------------RSIGCLHLPSVNVCHRDIKPHNVLVNEA 167

Query: 119 GKTVKVAGFGLAKSLYAYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
             T+K+  FG AK L     E + A + + YY+APEL+ G   Y+TAVDIW VGCIF EM
Sbjct: 168 DGTLKLCDFGSAKKLS--PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM 225

Query: 178 VSGKPLFPGANSLITLGRIV----------------GKSRK--PSFCKLSLRDHLTNGFP 219
           + G+P+F G NS   L  IV                  +     +   +   +  ++   
Sbjct: 226 MLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSL 285

Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
                  DL+S +L   P++R+   EAL   YF +
Sbjct: 286 KDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  175 bits (447), Expect = 2e-53
 Identities = 67/269 (24%), Positives = 108/269 (40%), Gaps = 55/269 (20%)

Query: 17  REVSCLMELNHPNIIRLMRVAS-------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYS 69
           RE+  L   +HPNI+ L  +           +YL  V E    DLA ++   +  ++   
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIHDQRIVISPQH 135

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTVK 123
            + F  Y +                     G   +       RDL P NIL+  +   + 
Sbjct: 136 IQYF-MYHILL-------------------GLHVLHEAGVVHRDLHPGNILLADNND-IT 174

Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
           +  F LA+         +  V   +Y+APEL++    ++  VD+W  GC+  EM + K L
Sbjct: 175 ICDFNLARE-DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233

Query: 184 FPGANSLITLGRIVGKSRKPS--------------FCKLSL----RDHLTNGFPGLEPAG 225
           F G+     L +IV     P               + + SL        T   P  +P  
Sbjct: 234 FRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVA 293

Query: 226 IDLISKMLGMDPDKRITAAEALQQEYFKD 254
           +DLI+KML  +P +RI+  +AL+  YF+ 
Sbjct: 294 LDLIAKMLEFNPQRRISTEQALRHPYFES 322

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  168 bits (428), Expect = 4e-51
 Identities = 66/284 (23%), Positives = 109/284 (38%), Gaps = 75/284 (26%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           RE+  +  L+H NI+++  +      L P                        T +  S 
Sbjct: 57  REIKIIRRLDHDNIVKVFEI------LGPS-------------------GSQLTDDVGSL 91

Query: 77  SLFTTFLLVEEFSSSD-----SSRSLS------F------GTRYIR------RDLKPVNI 113
           +   +  +V+E+  +D         L       F      G +YI       RDLKP N+
Sbjct: 92  TELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANL 151

Query: 114 LVDLDGKTVKVAGFGLAKSLYAYKGESSA---EVGTHYYKAPELLLGLLEYSTAVDIWPV 170
            ++ +   +K+  FGLA+ +  +          + T +Y++P LLL    Y+ A+D+W  
Sbjct: 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211

Query: 171 GCIFGEMVSGKPLFPGAN-----SLIT----------LGRIVGKSRK-----PSFCKLSL 210
           GCIF EM++GK LF GA+      LI              ++           +     L
Sbjct: 212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL 271

Query: 211 RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
                   PG+    +D + ++L   P  R+TA EAL   Y   
Sbjct: 272 TQL----LPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  169 bits (430), Expect = 4e-51
 Identities = 78/269 (28%), Positives = 115/269 (42%), Gaps = 60/269 (22%)

Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  L  + H N+I L+ V +           YL  V  +   DL  ++          
Sbjct: 72  RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMGLKFSEEK-- 127

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTV 122
               +  Y +                     G +YI       RDLKP N+ V+ D + +
Sbjct: 128 --IQYLVYQMLK-------------------GLKYIHSAGVVHRDLKPGNLAVNEDCE-L 165

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+  FGLA+       E +  V T +Y+APE++L  + Y+  VDIW VGCI  EM++GK 
Sbjct: 166 KILDFGLARH---ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSL-----------------RDHLTNGFPGLEPAG 225
           LF G + L  L +I+  +  P    +                   R   T  FP   P  
Sbjct: 223 LFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA 282

Query: 226 IDLISKMLGMDPDKRITAAEALQQEYFKD 254
            DL+ KML +D DKR+TAA+AL   +F+ 
Sbjct: 283 ADLLEKMLELDVDKRLTAAQALTHPFFEP 311

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  168 bits (427), Expect = 7e-51
 Identities = 62/270 (22%), Positives = 107/270 (39%), Gaps = 51/270 (18%)

Query: 16  IREVSCLMEL-NHPNIIRLMRV--ASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTK 71
            RE+  L  L   PNII L  +           VFE+  N D   L      ++  Y  +
Sbjct: 78  KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIR 133

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
            +  Y +                ++L +      + RD+KP N+++D + + +++  +GL
Sbjct: 134 FY-MYEIL---------------KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGAN 188
           A+  Y    E +  V + Y+K PELL+    Y  ++D+W +GC+   M+  K P F G +
Sbjct: 178 AEF-YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236

Query: 189 SLITLGRIVG----------------------KSRKPSFCKLSLRDHLTNG-FPGLEPAG 225
           +   L RI                                +      + +     + P  
Sbjct: 237 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 296

Query: 226 IDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           +D + K+L  D   R+TA EA++  YF  V
Sbjct: 297 LDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  168 bits (428), Expect = 1e-50
 Identities = 74/269 (27%), Positives = 117/269 (43%), Gaps = 59/269 (21%)

Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  L  + H N+I L+ V +           YL  V  +   DL  L+K      +  
Sbjct: 73  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMK------HEK 124

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTV 122
             ++   + ++                    G RYI       RDLKP N+ V+ D + +
Sbjct: 125 LGEDRIQFLVYQMLK----------------GLRYIHAAGIIHRDLKPGNLAVNEDCE-L 167

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+  FGLA+       E +  V T +Y+APE++L  + Y+  VDIW VGCI  EM++GK 
Sbjct: 168 KILDFGLARQ---ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSL-----------------RDHLTNGFPGLEPAG 225
           LF G++ L  L  I+  +  P    +                   +    +      P  
Sbjct: 225 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA 284

Query: 226 IDLISKMLGMDPDKRITAAEALQQEYFKD 254
           ++L+ KML +D ++R+TA EAL   YF+ 
Sbjct: 285 VNLLEKMLVLDAEQRVTAGEALAHPYFES 313

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  167 bits (425), Expect = 3e-50
 Identities = 74/271 (27%), Positives = 114/271 (42%), Gaps = 58/271 (21%)

Query: 17  REVSCLMELNHPNIIRLMRVAS-------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYS 69
           RE+  L+   H NII +  +         + +Y+  V +    DL  LLK        + 
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLK------TQHL 125

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTVK 123
           + +   Y L+                    G +YI       RDLKP N+L++     +K
Sbjct: 126 SNDHICYFLYQILR----------------GLKYIHSANVLHRDLKPSNLLLNTTCD-LK 168

Query: 124 VAGFGLAKSLYAYKGESSA---EVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
           +  FGLA+        +      V T +Y+APE++L    Y+ ++DIW VGCI  EM+S 
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

Query: 181 KPLFPGANSLITLGRIVGKSRKPSFCKLSL-----------------RDHLTNGFPGLEP 223
           +P+FPG + L  L  I+G    PS   L+                  +      FP  + 
Sbjct: 229 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS 288

Query: 224 AGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
             +DL+ KML  +P KRI   +AL   Y + 
Sbjct: 289 KALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  167 bits (424), Expect = 6e-50
 Identities = 80/273 (29%), Positives = 117/273 (42%), Gaps = 67/273 (24%)

Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  L  + H N+I L+ V +          +YL  V      DL  ++K         
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK--------- 125

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF----GTRYIR------RDLKPVNILVDLD 118
                    L           + D  + L +    G +YI       RDLKP N+ V+ D
Sbjct: 126 ------CQKL-----------TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 168

Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
            + +K+  FGLA+            V T +Y+APE++L  + Y+  VDIW VGCI  E++
Sbjct: 169 CE-LKILDFGLARHTADEMTG---YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224

Query: 179 SGKPLFPGANSLITLGRIVGKSRKPSFCKLSL-----------------RDHLTNGFPGL 221
           +G+ LFPG + +  L  I+     P    L                   + +  N F G 
Sbjct: 225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 284

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
            P  +DL+ KML +D DKRITAA+AL   YF  
Sbjct: 285 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  166 bits (423), Expect = 9e-50
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 53/285 (18%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           RE+  +  L+H NII+L+       Y     E +               NG +  + +  
Sbjct: 49  RELDIMKVLDHVNIIKLVDY----FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVI 104

Query: 77  SLFTTFL---LVEEF----------SSSDSSRSLSF------------GTRYIR------ 105
              +      ++ E+          S   S RS+                 +I       
Sbjct: 105 VNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICH 164

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTA 164
           RD+KP N+LV+    T+K+  FG AK L     E S   + + +Y+APEL+LG  EY+ +
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRFYRAPELMLGATEYTPS 222

Query: 165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG----------KSRKPSFCKLSL---- 210
           +D+W +GC+FGE++ GKPLF G  S+  L RI+               P + ++      
Sbjct: 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282

Query: 211 RDHLTNGFPGLEPA-GIDLISKMLGMDPDKRITAAEALQQEYFKD 254
                   P   P+  IDL+ ++L  +PD RI   EA+   +F  
Sbjct: 283 AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  164 bits (417), Expect = 4e-49
 Identities = 73/283 (25%), Positives = 116/283 (40%), Gaps = 74/283 (26%)

Query: 17  REVSCLMELNHPNIIRLMRVAS-------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYS 69
           RE+  L    H NII +  +           +Y+  + E    DL  ++           
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIS------TQML 109

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTVK 123
           + +   Y ++ T                    + +       RDLKP N+L++ +   +K
Sbjct: 110 SDDHIQYFIYQTLR----------------AVKVLHGSNVIHRDLKPSNLLINSNCD-LK 152

Query: 124 VAGFGLAKSLYAYKGESSAE----------VGTHYYKAPELLLGLLEYSTAVDIWPVGCI 173
           V  FGLA+ +     ++S            V T +Y+APE++L   +YS A+D+W  GCI
Sbjct: 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI 212

Query: 174 FGEMVSGKPLFPGANSLITLGRIVG-----------------KSRK-----PSFCKLSLR 211
             E+   +P+FPG +    L  I G                 ++R+     P +    L 
Sbjct: 213 LAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE 272

Query: 212 DHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
                 FP + P GIDL+ +ML  DP KRITA EAL+  Y + 
Sbjct: 273 KM----FPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  161 bits (409), Expect = 5e-47
 Identities = 80/276 (28%), Positives = 115/276 (41%), Gaps = 62/276 (22%)

Query: 17  REVSCLMELNHPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V +        Q +YL  V E    +L  +++   D     
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQMELDH---- 163

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
              ++  Y +                  +        I RDLKP NI+V  D   +K+  
Sbjct: 164 ERMSYLLYQML---------------CGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILD 207

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGLA++        +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFPG
Sbjct: 208 FGLART-AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPG 265

Query: 187 ANSLITLGRIV-------------------------GKSRKPSFCKL---SLRDHLTNGF 218
            + +    +++                          K    +F KL   SL    +   
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 325

Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
                   DL+SKML +DP KRI+  +ALQ  Y   
Sbjct: 326 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  157 bits (400), Expect = 2e-46
 Identities = 79/280 (28%), Positives = 113/280 (40%), Gaps = 70/280 (25%)

Query: 17  REVSCLMELNHPNIIRLMRV--------ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           RE+  +  +NH NII L+ V          Q +Y+  V E    +L  +++   D     
Sbjct: 73  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHER-- 128

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYI------RRDLKPVNILVDLDGKTV 122
                   S     +L               G +++       RDLKP NI+V  D   +
Sbjct: 129 -------MSYLLYQMLC--------------GIKHLHSAGIIHRDLKPSNIVVKSDCT-L 166

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+  FGLA++        +  V T YY+APE++LG+  Y   VDIW VGCI GEM+ G  
Sbjct: 167 KILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGV 224

Query: 183 LFPGANSLITLGRIV-------------------------GKSRKPSFCKL---SLRDHL 214
           LFPG + +    +++                          K    SF KL    L    
Sbjct: 225 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPAD 284

Query: 215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
           +           DL+SKML +D  KRI+  EALQ  Y   
Sbjct: 285 SEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  156 bits (397), Expect = 3e-45
 Identities = 74/338 (21%), Positives = 121/338 (35%), Gaps = 118/338 (34%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVAS-------QGIYLYPVFEYQVNDLAYLLKYP 61
                 ++RE++ L  LNH ++++++ +           +Y+  V E   +D   L +  
Sbjct: 93  LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV--VLEIADSDFKKLFR-- 148

Query: 62  KDSMNGYSTKNFNSYSLFTTFL---LVEEFSSSDSSRSLSFGTRYIR------RDLKPVN 112
                   T  + +     T L   LV              G +Y+       RDLKP N
Sbjct: 149 --------TPVYLTELHIKTLLYNLLV--------------GVKYVHSAGILHRDLKPAN 186

Query: 113 ILVDLDGKTVKVAGFGLAKSLYAYKGESSA---------------------------EVG 145
            LV+ D  +VKV  FGLA+++   +  +S                             V 
Sbjct: 187 CLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245

Query: 146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-----------GKPLFPGANSLITLG 194
           T +Y+APEL+L    Y+ A+D+W +GCIF E+++             PLFPG++      
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSP 305

Query: 195 RIVGKSRKPSFCKLSL-------------------------------------RDHLTNG 217
                +      + +                                         L   
Sbjct: 306 DQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365

Query: 218 FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
           FP      I L+ +ML  +P+KRIT  E L   +FK+V
Sbjct: 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  150 bits (382), Expect = 1e-43
 Identities = 76/315 (24%), Positives = 125/315 (39%), Gaps = 114/315 (36%)

Query: 17  REVSCLMELN-HPNIIRLMRVAS----QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           RE+  L EL+ H NI+ L+ V      + +YL  VF+Y   DL  +++            
Sbjct: 57  REIMILTELSGHENIVNLLNVLRADNDRDVYL--VFDYMETDLHAVIR------------ 102

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLS------F------GTRYIR------RDLKPVNI 113
                                 +  L                +Y+       RD+KP NI
Sbjct: 103 ----------------------ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNI 140

Query: 114 LVDLDGKTVKVAGFGLAKSLYAYKGESSAE---------------------VGTHYYKAP 152
           L++ +   VKVA FGL++S    +  ++                       V T +Y+AP
Sbjct: 141 LLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP 199

Query: 153 ELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG-------------- 198
           E+LLG  +Y+  +D+W +GCI GE++ GKP+FPG++++  L RI+G              
Sbjct: 200 EILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQ 259

Query: 199 -------------KSRKPSFCKLSLRDHLTNGFPGLEPA------GIDLISKMLGMDPDK 239
                        K       K  +     N    + P        +DL+ K+L  +P+K
Sbjct: 260 SPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319

Query: 240 RITAAEALQQEYFKD 254
           RI+A +AL+  +   
Sbjct: 320 RISANDALKHPFVSI 334

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  147 bits (374), Expect = 4e-42
 Identities = 79/320 (24%), Positives = 117/320 (36%), Gaps = 104/320 (32%)

Query: 16  IREVSCLMELNHPNIIRLMRV-------ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           +RE++ L  L    IIRL  +           +Y+  V E   +DL  L K        +
Sbjct: 73  LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFK-----TPIF 125

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTV 122
            T+           LL+              G  +I       RDLKP N L++ D   V
Sbjct: 126 LTEEHIKT--ILYNLLL--------------GENFIHESGIIHRDLKPANCLLNQDCS-V 168

Query: 123 KVAGFGLAKSLYAYKGESSAE----------------------VGTHYYKAPELLLGLLE 160
           KV  FGLA+++ + K  +                         V T +Y+APEL+L    
Sbjct: 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN 228

Query: 161 YSTAVDIWPVGCIFGEMVSG-----------KPLFPGANSLITLGRIVGKSR-------- 201
           Y+ ++DIW  GCIF E+++             PLFPG++          K          
Sbjct: 229 YTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQ 288

Query: 202 ---------KPSFCKLSL-----------------RDHLTNGFPGLEPAGIDLISKMLGM 235
                     P+   L                     +L   +P +   GI+L+  ML  
Sbjct: 289 LNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKF 348

Query: 236 DPDKRITAAEALQQEYFKDV 255
           +P+KRIT  +AL   Y KDV
Sbjct: 349 NPNKRITIDQALDHPYLKDV 368

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  128 bits (323), Expect = 2e-35
 Identities = 63/273 (23%), Positives = 95/273 (34%), Gaps = 42/273 (15%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-----------------QVNDLAY 56
            +  EV  + +L+HPNI RL  V     Y+  V E                         
Sbjct: 74  RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133

Query: 57  LLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS---RSLSFGTRYIR------RD 107
           ++K         + +  N         L         S   R +     Y+       RD
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRD 193

Query: 108 LKPVNILVDLD-GKTVKVAGFGLAKSLYAYKGESSAE----VGTHYYKAPELLLGLLE-Y 161
           +KP N L   +    +K+  FGL+K  Y              GT Y+ APE+L    E Y
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
               D W  G +   ++ G   FPG N   T+ ++   ++K  F            +  L
Sbjct: 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV--LNKKLCF--------ENPNYNVL 303

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
            P   DL+S +L  + D+R  A  ALQ  +   
Sbjct: 304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  123 bits (312), Expect = 4e-34
 Identities = 61/275 (22%), Positives = 99/275 (36%), Gaps = 67/275 (24%)

Query: 13  SSMIREVSCLMELNHPNIIRL-------------MRVASQGIYLYPVFEY-QVNDLAYLL 58
           S+++ EV  L  LNH  ++R              M    +   L+   EY +   L  L+
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106

Query: 59  KYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVN 112
                S N    ++   + LF               R +     Y      I RDLKP+N
Sbjct: 107 H----SENLNQQRDE-YWRLF---------------RQILEALSYIHSQGIIHRDLKPMN 146

Query: 113 ILVDLDGKTVKVAGFGLAKSLYAYKGESSAE--------------VGTHYYKAPELLLGL 158
           I +D     VK+  FGLAK+++        +              +GT  Y A E+L G 
Sbjct: 147 IFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205

Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
             Y+  +D++ +G IF EM+   P   G   +  L ++   S +             +  
Sbjct: 206 GHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFP-------PDFDDNK 256

Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
                    +I  ++  DP+KR  A   L   +  
Sbjct: 257 M---KVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  124 bits (313), Expect = 4e-34
 Identities = 59/262 (22%), Positives = 91/262 (34%), Gaps = 58/262 (22%)

Query: 14  SMIREVSCLMELNHPN--IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           S   E++ L +L   +  IIRL        Y+Y V E    DL   LK           K
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLK---------KKK 122

Query: 72  NFNSYSLFTTFL-LVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTVKV 124
           + + +   + +  ++E                 I        DLKP N L  +    +K+
Sbjct: 123 SIDPWERKSYWKNMLE-------------AVHTIHQHGIVHSDLKPANFL--IVDGMLKL 167

Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGL----------LEYSTAVDIWPVGC 172
             FG+A  +         +  VGT  Y  PE +  +           + S   D+W +GC
Sbjct: 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227

Query: 173 IFGEMVSGKPLFPG-ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISK 231
           I   M  GK  F    N +  L  I+  + +  F                E    D++  
Sbjct: 228 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF------------PDIPEKDLQDVLKC 275

Query: 232 MLGMDPDKRITAAEALQQEYFK 253
            L  DP +RI+  E L   Y +
Sbjct: 276 CLKRDPKQRISIPELLAHPYVQ 297

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  124 bits (312), Expect = 2e-33
 Identities = 60/261 (22%), Positives = 90/261 (34%), Gaps = 56/261 (21%)

Query: 14  SMIREVSCLMELNHPN--IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           S   E++ L +L   +  IIRL        Y+Y V E    DL   LK  K S++ +  K
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERK 158

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTVKVA 125
           ++     +   L                    I        DLKP N L  +    +K+ 
Sbjct: 159 SY-----WKNMLE---------------AVHTIHQHGIVHSDLKPANFL--IVDGMLKLI 196

Query: 126 GFGLAKSLYAYKGESSAE--VGTHYYKAPELLLG----------LLEYSTAVDIWPVGCI 173
            FG+A  +         +  VG   Y  PE +              + S   D+W +GCI
Sbjct: 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256

Query: 174 FGEMVSGKPLFPG-ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
              M  GK  F    N +  L  I+  + +  F                E    D++   
Sbjct: 257 LYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF------------PDIPEKDLQDVLKCC 304

Query: 233 LGMDPDKRITAAEALQQEYFK 253
           L  DP +RI+  E L   Y +
Sbjct: 305 LKRDPKQRISIPELLAHPYVQ 325

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  121 bits (306), Expect = 6e-33
 Identities = 59/262 (22%), Positives = 90/262 (34%), Gaps = 58/262 (22%)

Query: 14  SMIREVSCLMELNHPN--IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           S   E++ L +L   +  IIRL        Y+Y V E    DL   LK           K
Sbjct: 53  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLK---------KKK 103

Query: 72  NFNSYSLFTTFL-LVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTVKV 124
           + + +   + +  ++E                 I        DLKP N L  +    +K+
Sbjct: 104 SIDPWERKSYWKNMLE-------------AVHTIHQHGIVHSDLKPANFL--IVDGMLKL 148

Query: 125 AGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLG----------LLEYSTAVDIWPVGC 172
             FG+A  +         +  VGT  Y  PE +              + S   D+W +GC
Sbjct: 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 208

Query: 173 IFGEMVSGKPLFPG-ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISK 231
           I   M  GK  F    N +  L  I+  + +  F                E    D++  
Sbjct: 209 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF------------PDIPEKDLQDVLKC 256

Query: 232 MLGMDPDKRITAAEALQQEYFK 253
            L  DP +RI+  E L   Y +
Sbjct: 257 CLKRDPKQRISIPELLAHPYVQ 278

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  118 bits (298), Expect = 3e-32
 Identities = 58/274 (21%), Positives = 95/274 (34%), Gaps = 66/274 (24%)

Query: 14  SMIREVSCLMELNHPNIIRL------------MRVASQGIYLYPVFEY-QVNDLAYLLKY 60
            ++REV  L +L HP I+R             ++ +S  +YLY   +  +  +L   +  
Sbjct: 49  KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG 108

Query: 61  PKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNIL 114
                               T    E          ++    +      + RDLKP NI 
Sbjct: 109 RC------------------TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIF 150

Query: 115 VDLDGKTVKVAGFGLAKSL------------YAYKGESSAEVGTHYYKAPELLLGLLEYS 162
             +D   VKV  FGL  ++                   + +VGT  Y +PE + G   YS
Sbjct: 151 FTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYS 208

Query: 163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE 222
             VDI+ +G I  E++   P       + TL  +      P F +               
Sbjct: 209 HKVDIFSLGLILFELLY--PFSTQMERVRTLTDVRNLKFPPLFTQKY------------- 253

Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
           P    ++  ML   P +R  A   ++   F+D+ 
Sbjct: 254 PCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  121 bits (304), Expect = 4e-32
 Identities = 59/255 (23%), Positives = 89/255 (34%), Gaps = 48/255 (18%)

Query: 17  REVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
           REV  L E + HPN+IR         + Y   E     L   ++    +  G        
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL-- 123

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKT----VKVA 125
                              +  + G  +      + RDLKP NIL+ +          ++
Sbjct: 124 ------------------LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMIS 165

Query: 126 GFGLAKSLYAYK---GESSAEVGTHYYKAPELLLGLLE--YSTAVDIWPVGCIFGEMVS- 179
            FGL K L   +      S   GT  + APE+L    +   +  VDI+  GC+F  ++S 
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

Query: 180 GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK 239
           G   F  +        +       S   L    H             +LI KM+ MDP K
Sbjct: 226 GSHPFGKSLQRQANILL----GACSLDCLHPEKHED-------VIARELIEKMIAMDPQK 274

Query: 240 RITAAEALQQEYFKD 254
           R +A   L+  +F  
Sbjct: 275 RPSAKHVLKHPFFWS 289

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  117 bits (295), Expect = 7e-32
 Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 24/244 (9%)

Query: 14  SMIREVSCLMELNHPNIIRLMR--VASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
            ++ EV+ L EL HPNI+R     +      LY V EY    DLA ++            
Sbjct: 51  MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           +        T   L  +     S      G   + RDLKP N+ +D     VK+  FGLA
Sbjct: 111 EFVLRV--MTQLTLALKECHRRSDG----GHTVLHRDLKPANVFLDGKQ-NVKLGDFGLA 163

Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
           + L      +   VGT YY +PE +  +  Y+   DIW +GC+  E+ +  P F   +  
Sbjct: 164 RILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222

Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE 250
              G+I     +       +    ++          ++I++ML +    R +  E L+  
Sbjct: 223 ELAGKIREGKFRR------IPYRYSDEL-------NEIITRMLNLKDYHRPSVEEILENP 269

Query: 251 YFKD 254
              +
Sbjct: 270 LILE 273

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  118 bits (298), Expect = 3e-31
 Identities = 67/272 (24%), Positives = 106/272 (38%), Gaps = 53/272 (19%)

Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
              + E+  L E  +HPN+IR     +   +LY   E    +L  L++    S       
Sbjct: 53  DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLK-- 110

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKT---- 121
                       L +E++     R ++ G  +      I RDLKP NILV    +     
Sbjct: 111 ------------LQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158

Query: 122 --------VKVAGFGLAKSL----YAYKGESSAEVGTHYYKAPELLLGLLE------YST 163
                   + ++ FGL K L     +++   +   GT  ++APELL            + 
Sbjct: 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTR 218

Query: 164 AVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE 222
           ++DI+ +GC+F  ++S GK  F    S      I+           SL +        L 
Sbjct: 219 SIDIFSMGCVFYYILSKGKHPFGDKYS--RESNIIRG-------IFSLDEMKCLHDRSLI 269

Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
               DLIS+M+  DP KR TA + L+   F  
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  115 bits (291), Expect = 5e-31
 Identities = 54/247 (21%), Positives = 77/247 (31%), Gaps = 46/247 (18%)

Query: 14  SMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
             + EV    ++  HP  +RL +   +G  LY   E     L    +    S+       
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASL------- 154

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAG 126
                         E       R       +      +  D+KP NI +   G   K+  
Sbjct: 155 -------------PEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGD 200

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGL   L    G    + G   Y APELL G   Y TA D++ +G    E+     L  G
Sbjct: 201 FGLLVEL-GTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHG 257

Query: 187 ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA 246
                   ++      P F              GL      ++  ML  DP  R TA   
Sbjct: 258 GEG---WQQLRQGYLPPEF------------TAGLSSELRSVLVMMLEPDPKLRATAEAL 302

Query: 247 LQQEYFK 253
           L     +
Sbjct: 303 LALPVLR 309

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  113 bits (286), Expect = 2e-30
 Identities = 50/264 (18%), Positives = 85/264 (32%), Gaps = 63/264 (23%)

Query: 14  SMIREVSCLMELNHPNIIRL----------------MRVASQGIYLYPVFEYQVN-DLAY 56
              REV  L +L+H NI+                      S+   L+   E+     L  
Sbjct: 50  KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109

Query: 57  LLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKP 110
            ++  +                      +++  + +    ++ G  Y      I RDLKP
Sbjct: 110 WIEKRRGE-------------------KLDKVLALELFEQITKGVDYIHSKKLINRDLKP 150

Query: 111 VNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV 170
            NI +      VK+  FGL  SL    G+ +   GT  Y +PE +    +Y   VD++ +
Sbjct: 151 SNIFLVDTK-QVKIGDFGLVTSL-KNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYAL 207

Query: 171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLIS 230
           G I  E++         +   T  R               +                L+ 
Sbjct: 208 GLILAELLHVCDTAFETSKFFTDLR---DGIISDIFDKKEK---------------TLLQ 249

Query: 231 KMLGMDPDKRITAAEALQQEYFKD 254
           K+L   P+ R   +E L+      
Sbjct: 250 KLLSKKPEDRPNTSEILRTLTVWK 273

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (288), Expect = 3e-30
 Identities = 35/262 (13%), Positives = 59/262 (22%), Gaps = 30/262 (11%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKD--SMNGYSTKN 72
           +         L   +           +    V        A L     D    N      
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR----------------RDLKPVNILVD 116
             S  L   F  ++          +                            P N+ + 
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM 228

Query: 117 LDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLG-LLEYSTAVDIWPVGCIF 174
            DG  + +        +    G    A      Y   E L      ++ A++ W +G   
Sbjct: 229 PDG-RLMLGDVSALWKV----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283

Query: 175 GEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLG 234
             +      F      I         R P    L+           L      LI + L 
Sbjct: 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS-----CTPLPDFVKTLIGRFLN 338

Query: 235 MDPDKRITAAEALQQEYFKDVP 256
            D  +R+   EA++   F  + 
Sbjct: 339 FDRRRRLLPLEAMETPEFLQLQ 360

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  114 bits (288), Expect = 3e-30
 Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 41/248 (16%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKN 72
              REV+ L  + HPNI++      +   LY V +Y +  DL   +   K          
Sbjct: 69  ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-------- 120

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAG 126
                LF    +++ F        +    ++      + RD+K  NI +  DG TV++  
Sbjct: 121 -----LFQEDQILDWFVQ------ICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGD 168

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FG+A+ L +    + A +GT YY +PE+      Y+   DIW +GC+  E+ + K  F  
Sbjct: 169 FGIARVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEA 227

Query: 187 ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA 246
            +    + +I+  S  P      +  H +            L+S++   +P  R +    
Sbjct: 228 GSMKNLVLKIISGSFPP------VSLHYSYDL-------RSLVSQLFKRNPRDRPSVNSI 274

Query: 247 LQQEYFKD 254
           L++ +   
Sbjct: 275 LEKGFIAK 282

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  110 bits (278), Expect = 6e-29
 Identities = 46/249 (18%), Positives = 76/249 (30%), Gaps = 43/249 (17%)

Query: 11  VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           +    + E+     L+ P I+ L     +G ++    E                + G S 
Sbjct: 93  LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL---------------LEGGSL 137

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKV 124
                  L      + E  +         G  Y      +  D+K  N+L+  DG    +
Sbjct: 138 G-----QLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAAL 192

Query: 125 AGFGLAKSLYAYKGESSAE-----VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             FG A  L       S        GT  + APE+++G       VDIW   C+   M++
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLN 251

Query: 180 GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK 239
           G   +          +I      P      +            P     I + L  +P  
Sbjct: 252 GCHPWTQYFRGPLCLKI-ASEPPP---IREIPPSCA-------PLTAQAIQEGLRKEPVH 300

Query: 240 RITAAEALQ 248
           R +A E  +
Sbjct: 301 RASAMELRR 309

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  110 bits (276), Expect = 1e-28
 Identities = 47/256 (18%), Positives = 90/256 (35%), Gaps = 44/256 (17%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDSMNGYSTKN 72
           +   ++  +   +  N +  ++ +S  +YLY   +  +  +L   +       +    ++
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED---REH 163

Query: 73  FNSYSLFTTFLL-VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                +F      VE   S             + RDLKP NI   +D   VKV  FGL  
Sbjct: 164 GVCLHIFIQIAEAVEFLHSK----------GLMHRDLKPSNIFFTMDD-VVKVGDFGLVT 212

Query: 132 SL------------YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
           ++                   + +VGT  Y +PE + G   YS  VDI+ +G I  E++ 
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLY 271

Query: 180 GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK 239
                     +  +  +        F +               P    ++  ML   P +
Sbjct: 272 --SFSTQMERVRIITDVRNLKFPLLFTQKY-------------PQEHMMVQDMLSPSPTE 316

Query: 240 RITAAEALQQEYFKDV 255
           R  A + ++   F+++
Sbjct: 317 RPEATDIIENAIFENL 332

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  108 bits (273), Expect = 2e-28
 Identities = 55/241 (22%), Positives = 93/241 (38%), Gaps = 38/241 (15%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFN 74
           I+E+  L +LNHPN+I+      +   L  V E     DL+ ++K+ K        +   
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGFG 128
            Y  F                       +      + RD+KP N+ +   G  VK+   G
Sbjct: 140 KY--FVQLCS---------------ALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLG 181

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG-A 187
           L +   +    + + VGT YY +PE +     Y+   DIW +GC+  EM + +  F G  
Sbjct: 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDK 240

Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
            +L +L + + +   P        DH +            L++  +  DP+KR       
Sbjct: 241 MNLYSLCKKIEQCDYPPL----PSDHYSEEL-------RQLVNMCINPDPEKRPDVTYVY 289

Query: 248 Q 248
            
Sbjct: 290 D 290

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  109 bits (274), Expect = 3e-28
 Identities = 67/257 (26%), Positives = 99/257 (38%), Gaps = 52/257 (20%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNG------ 67
            + RE S    L HP+I+ L+   S    LY VFE+               M+G      
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF---------------MDGADLCFE 116

Query: 68  --YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVD--L 117
                     YS         E  +S   R +    RY      I RD+KP  +L+    
Sbjct: 117 IVKRADAGFVYS---------EAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE 167

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
           +   VK+ GFG+A  L      +   VGT ++ APE++     Y   VD+W  G I   +
Sbjct: 168 NSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFIL 226

Query: 178 VSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
           +SG   F G    +    I     K               +  +  +  DL+ +ML +DP
Sbjct: 227 LSGCLPFYGTKERL-FEGI--IKGKYKM--------NPRQWSHISESAKDLVRRMLMLDP 275

Query: 238 DKRITAAEALQQEYFKD 254
            +RIT  EAL   + K+
Sbjct: 276 AERITVYEALNHPWLKE 292

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  109 bits (274), Expect = 3e-28
 Identities = 51/255 (20%), Positives = 92/255 (36%), Gaps = 33/255 (12%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKDSMNGYSTKNFN 74
            E+  + ++ +   +    + +    +Y ++EY  N  +  +   +    ++   T    
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV--LDKNYTCFIP 149

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRY-------IRRDLKPVNILVDLDGKTVKVAGF 127
              +                +S+     Y         RD+KP NIL+D +G  VK++ F
Sbjct: 150 IQVIKCII------------KSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDF 196

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS-TAVDIWPVGCIFGEMVSGKPLFPG 186
           G ++  Y    +     GT+ +  PE       Y+   VDIW +G     M      F  
Sbjct: 197 GESE--YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

Query: 187 ANSLITLGRIVGK------SRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
             SL+ L   +          +  F         T     L    ID +   L  +P +R
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314

Query: 241 ITAAEALQQEYFKDV 255
           IT+ +AL+ E+  D 
Sbjct: 315 ITSEDALKHEWLADT 329

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  111 bits (279), Expect = 3e-28
 Identities = 63/251 (25%), Positives = 109/251 (43%), Gaps = 47/251 (18%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           ++ EV+ L  L+HPNI++L          Y V E                  G       
Sbjct: 83  LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC---------------YKGGE----- 122

Query: 75  SYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILVDLDGK--TVK 123
              LF   +   +F+  D++   + +  G  Y      + RDLKP N+L++   K   +K
Sbjct: 123 ---LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIK 179

Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
           +  FGL+  ++  + +    +GT YY APE+L    +Y    D+W +G I   +++G P 
Sbjct: 180 IVDFGLSA-VFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPP 236

Query: 184 FPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA 243
           F G      L ++  +  K +F         +  +  +     DLI +ML  D  +RI+A
Sbjct: 237 FGGQTDQEILRKV--EKGKYTF--------DSPEWKNVSEGAKDLIKQMLQFDSQRRISA 286

Query: 244 AEALQQEYFKD 254
            +AL+  + K+
Sbjct: 287 QQALEHPWIKE 297

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  111 bits (278), Expect = 5e-28
 Identities = 59/269 (21%), Positives = 89/269 (33%), Gaps = 55/269 (20%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQ----VNDLAYL-LKYPKDSMNG---- 67
            E+  + +LNHPN++              V +       NDL  L ++Y      G    
Sbjct: 61  LEIQIMKKLNHPNVVSA----------REVPDGLQKLAPNDLPLLAMEY----CEGGDLR 106

Query: 68  -YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGK 120
            Y  +  N   L       +E         +S   RY+       RDLKP NI++    +
Sbjct: 107 KYLNQFENCCGL-------KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159

Query: 121 --TVKVAGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGE 176
               K+   G AK L            VGT  Y APELL    +Y+  VD W  G +  E
Sbjct: 160 RLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFE 215

Query: 177 MVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGI--------- 226
            ++G   F      +     V  KS +       L   +        P  +         
Sbjct: 216 CITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLE 275

Query: 227 DLISKMLGMDPDKRITAAEALQQEYFKDV 255
             +  ML     +R T  +      F+ +
Sbjct: 276 RWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  109 bits (274), Expect = 1e-27
 Identities = 72/252 (28%), Positives = 110/252 (43%), Gaps = 47/252 (18%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
           S++REV  L +L+HPNI++L        Y Y V E                  G      
Sbjct: 72  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV---------------YTGGE---- 112

Query: 74  NSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILVDLDGK--TV 122
               LF   +  + FS  D++   R +  G  Y      + RDLKP N+L++   K   +
Sbjct: 113 ----LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANI 168

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           ++  FGL+   +    +   ++GT YY APE+L G   Y    D+W  G I   ++SG P
Sbjct: 169 RIIDFGLST-HFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCP 225

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F GAN    L ++  +  K +F            +  +  +  DLI KML   P  RI+
Sbjct: 226 PFNGANEYDILKKV--EKGKYTF--------ELPQWKKVSESAKDLIRKMLTYVPSMRIS 275

Query: 243 AAEALQQEYFKD 254
           A +AL  E+ + 
Sbjct: 276 ARDALDHEWIQT 287

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  107 bits (270), Expect = 3e-27
 Identities = 46/198 (23%), Positives = 73/198 (36%), Gaps = 58/198 (29%)

Query: 107 DLKPVNIL-VDLDGKTVKVAGFGLA----KSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           DLKP NIL        +KV  FG +    + +Y Y       + + +Y+APE++LG   Y
Sbjct: 225 DLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY-------IQSRFYRAPEVILGA-RY 276

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-------------GKSRKPSFCKL 208
              +D+W +GCI  E+++G PL PG +    L  ++              K  K      
Sbjct: 277 GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSK 336

Query: 209 ----------------------SLRDHLTNGFPGLEPAG----------IDLISKMLGMD 236
                                 S R  L       E             +D + + L  D
Sbjct: 337 GYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396

Query: 237 PDKRITAAEALQQEYFKD 254
           P  R+T  +AL+  + + 
Sbjct: 397 PAVRMTPGQALRHPWLRR 414

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  104 bits (262), Expect = 6e-27
 Identities = 53/250 (21%), Positives = 90/250 (36%), Gaps = 41/250 (16%)

Query: 14  SMIREVSCLMELNHPNIIRLMR----VASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGY 68
               E   L  L HPNI+R              +  V E   +  L   LK  K  M   
Sbjct: 71  RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIK 129

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF----GTRYIRRDLKPVNILVDLDGKTVKV 124
             +++         +L          + L F        I RDLK  NI +     +VK+
Sbjct: 130 VLRSW------CRQIL----------KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173

Query: 125 AGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
              GLA    A   ++   +GT  + APE+     +Y  +VD++  G    EM + +  +
Sbjct: 174 GDLGLATLKRASFAKA--VIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPY 229

Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
               +   + R V    KP     +  D +        P   ++I   +  + D+R +  
Sbjct: 230 SECQNAAQIYRRVTSGVKP-----ASFDKVAI------PEVKEIIEGCIRQNKDERYSIK 278

Query: 245 EALQQEYFKD 254
           + L   +F++
Sbjct: 279 DLLNHAFFQE 288

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  106 bits (266), Expect = 6e-27
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 63/202 (31%)

Query: 107 DLKPVNILVDLDGKT-VKVAGFGLA----KSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           DLKP NIL+    ++ +K+  FG +    + +Y Y       + + +Y++PE+LLG+  Y
Sbjct: 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY-------IQSRFYRSPEVLLGM-PY 235

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV------------------------ 197
             A+D+W +GCI  EM +G+PLF GAN +  + +IV                        
Sbjct: 236 DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKL 295

Query: 198 --------------GKSRKPSFCKLSLRDHLTNGFPGLEPAG------------IDLISK 231
                          + + P   KL     +  G PG   AG             DLI +
Sbjct: 296 PDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355

Query: 232 MLGMDPDKRITAAEALQQEYFK 253
           ML  DP  RI    ALQ  +FK
Sbjct: 356 MLDYDPKTRIQPYYALQHSFFK 377

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  104 bits (262), Expect = 7e-27
 Identities = 50/273 (18%), Positives = 90/273 (32%), Gaps = 61/273 (22%)

Query: 14  SMIREVSCLMELNHPNIIRLMRV----ASQGIYLYPVFEYQVN--DLA-YLLKYPKDSMN 66
             +RE   L +LNH NI++L  +     ++   L  + E+      L   L +    +  
Sbjct: 53  VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL--IMEF-CPCGSLYTVLEE--PSNAY 107

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDG- 119
           G                   E       R +  G  ++R      R++KP NI+  +   
Sbjct: 108 GLP-----------------ESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED 150

Query: 120 --KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL-------EYSTAVDIWPV 170
                K+  FG A+ L   +   S   GT  Y  P++    +       +Y   VD+W +
Sbjct: 151 GQSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209

Query: 171 GCIFGEMVSGKPLFPGANSLITLGRIVGK--SRKPSFCKLSLRDHLTNGF---------- 218
           G  F    +G   F           ++ K  + KPS     ++                 
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269

Query: 219 ---PGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
               GL+     +++ +L  D +K     +   
Sbjct: 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  103 bits (260), Expect = 1e-26
 Identities = 58/247 (23%), Positives = 93/247 (37%), Gaps = 52/247 (21%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           REV     L HPNI+RL         +Y + EY              +  G         
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEY--------------APLG--------- 94

Query: 77  SLFTTFLLVEEFSSSDSSR---SLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGF 127
           +++     + +F    ++     L+    Y      I RD+KP N+L+   G  +K+A F
Sbjct: 95  TVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADF 153

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
           G +    + +       GT  Y  PE++ G   +   VD+W +G +  E + GKP F   
Sbjct: 154 GWSVHAPSSRRTDL--CGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

Query: 188 NSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA 246
               T  RI   +   P F               +     DLIS++L  +P +R    E 
Sbjct: 211 TYQETYKRISRVEFTFPDF---------------VTEGARDLISRLLKHNPSQRPMLREV 255

Query: 247 LQQEYFK 253
           L+  +  
Sbjct: 256 LEHPWIT 262

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  105 bits (263), Expect = 2e-26
 Identities = 50/273 (18%), Positives = 91/273 (33%), Gaps = 59/273 (21%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYL-LKYPKDSMNG----- 67
             +RE   L +LNH NI++L          + + E        L +++            
Sbjct: 53  VQMREFEVLKKLNHKNIVKL----------FAIEEETTTRHKVLIMEF----CPCGSLYT 98

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDG-- 119
              +  N+Y L        E       R +  G  ++R      R++KP NI+  +    
Sbjct: 99  VLEEPSNAYGL-------PESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDG 151

Query: 120 -KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL-------EYSTAVDIWPVG 171
               K+  FG A+ L   +   S   GT  Y  P++    +       +Y   VD+W +G
Sbjct: 152 QSVYKLTDFGAARELEDDEQFVSL-YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG 210

Query: 172 CIFGEMVSGKPLFPGANSLITLGRIVGK--SRKPSFCKLSLRDHLTNGF----------- 218
             F    +G   F           ++ K  + KPS     ++                  
Sbjct: 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270

Query: 219 --PGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
              GL+     +++ +L  D +K     +   +
Sbjct: 271 LSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  102 bits (257), Expect = 2e-26
 Identities = 67/247 (27%), Positives = 102/247 (41%), Gaps = 48/247 (19%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
            + RE     +L HPNI+RL     +  + Y VF+                + G      
Sbjct: 51  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL---------------VTGGE---- 91

Query: 74  NSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILVD--LDGKTV 122
               LF   +  E +S +D+S   + +     Y      + R+LKP N+L+     G  V
Sbjct: 92  ----LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV 147

Query: 123 KVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
           K+A FGLA  +     E+     GT  Y +PE+L     YS  VDIW  G I   ++ G 
Sbjct: 148 KLADFGLAIEVN--DSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGY 204

Query: 182 PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
           P F   +      +I  K+    +         +  +  + P    LI  ML ++P KRI
Sbjct: 205 PPFWDEDQHRLYAQI--KAGAYDY--------PSPEWDTVTPEAKSLIDSMLTVNPKKRI 254

Query: 242 TAAEALQ 248
           TA +AL+
Sbjct: 255 TADQALK 261

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (256), Expect = 4e-26
 Identities = 43/267 (16%), Positives = 79/267 (29%), Gaps = 65/267 (24%)

Query: 14  SMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN--DLAYLLKYPKDSMNGYST 70
           + +REV     L  H +++R     ++  ++    EY  N   LA  +            
Sbjct: 56  NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY-CNGGSLADAIS----------- 103

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGK---- 120
           +N+   S F    L +          +  G RY      +  D+KP NI +         
Sbjct: 104 ENYRIMSYFKEAELKDLL------LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAA 157

Query: 121 --------------TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD 166
                           K+   G    +         E G   + A E+L     +    D
Sbjct: 158 SEEGDEDDWASNKVMFKIGDLGHVTRI----SSPQVEEGDSRFLANEVLQENYTHLPKAD 213

Query: 167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGI 226
           I+ +          +PL    +        + + R P                 L     
Sbjct: 214 IFALALTVVCAAGAEPLPRNGDQW----HEIRQGRLPRI------------PQVLSQEFT 257

Query: 227 DLISKMLGMDPDKRITAAEALQQEYFK 253
           +L+  M+  DP++R +A   ++     
Sbjct: 258 ELLKVMIHPDPERRPSAMALVKHSVLL 284

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (259), Expect = 4e-26
 Identities = 67/247 (27%), Positives = 102/247 (41%), Gaps = 48/247 (19%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
            + RE     +L HPNI+RL     +  + Y VF+                + G      
Sbjct: 74  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL---------------VTGGE---- 114

Query: 74  NSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILVD--LDGKTV 122
               LF   +  E +S +D+S   + +     Y      + R+LKP N+L+     G  V
Sbjct: 115 ----LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV 170

Query: 123 KVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
           K+A FGLA  +     E+     GT  Y +PE+L     YS  VDIW  G I   ++ G 
Sbjct: 171 KLADFGLAIEVN--DSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGY 227

Query: 182 PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
           P F   +      +I  K+    +         +  +  + P    LI  ML ++P KRI
Sbjct: 228 PPFWDEDQHRLYAQI--KAGAYDY--------PSPEWDTVTPEAKSLIDSMLTVNPKKRI 277

Query: 242 TAAEALQ 248
           TA +AL+
Sbjct: 278 TADQALK 284

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  103 bits (259), Expect = 6e-26
 Identities = 44/196 (22%), Positives = 71/196 (36%), Gaps = 51/196 (26%)

Query: 107 DLKPVNILVDLDGK-----TVKVAGFGLA----KSLYAYKGESSAEVGTHYYKAPELLLG 157
           D+KP N+L+++         +K+A  G A    +            + T  Y++PE+LLG
Sbjct: 157 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS-------IQTREYRSPEVLLG 209

Query: 158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT------LGRIV-------------G 198
              +    DIW   C+  E+++G  LF              + +I+             G
Sbjct: 210 A-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG 268

Query: 199 KSRKPSFCKL------------SLRDHLTNGFPGLEPAG---IDLISKMLGMDPDKRITA 243
           K  +  F                L D LT  +   +       D +S ML +DP KR  A
Sbjct: 269 KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328

Query: 244 AEALQQEYFKDVPGRS 259
              +   + KD  G  
Sbjct: 329 GGLVNHPWLKDTLGME 344

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  101 bits (255), Expect = 6e-26
 Identities = 68/263 (25%), Positives = 106/263 (40%), Gaps = 52/263 (19%)

Query: 8   MEGVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMN 66
           ++ +  + ++EV  L +++ HPNII+L        + + VF+        L+K       
Sbjct: 63  VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD--------LMK------K 108

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILVDL 117
           G          LF         S  ++    R+L            + RDLKP NIL+D 
Sbjct: 109 G---------ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD- 158

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLE-----YSTAVDIWPVG 171
           D   +K+  FG +  L    GE   E  GT  Y APE++   +      Y   VD+W  G
Sbjct: 159 DDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216

Query: 172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISK 231
            I   +++G P F     ++ L  I   S    F         +  +        DL+S+
Sbjct: 217 VIMYTLLAGSPPFWHRKQMLMLRMI--MSGNYQF--------GSPEWDDYSDTVKDLVSR 266

Query: 232 MLGMDPDKRITAAEALQQEYFKD 254
            L + P KR TA EAL   +F+ 
Sbjct: 267 FLVVQPQKRYTAEEALAHPFFQQ 289

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  103 bits (259), Expect = 7e-26
 Identities = 65/263 (24%), Positives = 105/263 (39%), Gaps = 61/263 (23%)

Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE----YQVNDLAY---LLKYPKDS 64
             ++  E+  L +LNHP II+          +   F+    Y V +L     L      +
Sbjct: 184 ALNVETEIEILKKLNHPCIIK----------IKNFFDAEDYYIVLELMEGGELFDKVVGN 233

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDL- 117
                                 E +       +    +Y      I RDLKP N+L+   
Sbjct: 234 ---------KRLK---------EATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275

Query: 118 -DGKTVKVAGFGLAKSLYAYKGESSA---EVGTHYYKAPELLLGLLE--YSTAVDIWPVG 171
            +   +K+  FG +K L    GE+S      GT  Y APE+L+ +    Y+ AVD W +G
Sbjct: 276 EEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331

Query: 172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISK 231
            I    +SG P F    + ++L   +  S K +F        +   +  +    +DL+ K
Sbjct: 332 VILFICLSGYPPFSEHRTQVSLKDQI-TSGKYNF--------IPEVWAEVSEKALDLVKK 382

Query: 232 MLGMDPDKRITAAEALQQEYFKD 254
           +L +DP  R T  EAL+  + +D
Sbjct: 383 LLVVDPKARFTTEEALRHPWLQD 405

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  102 bits (255), Expect = 7e-26
 Identities = 49/255 (19%), Positives = 83/255 (32%), Gaps = 47/255 (18%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQ----GIYLYPVFEY-QVNDLAYLLKYPKDSMNGYS 69
             RE       NHPNI+RL+    +        + +  + +   L        + +    
Sbjct: 73  AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW-------NEIERLK 125

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            K     +  T   ++         R L       Y  RDLKP NIL+  +G    +   
Sbjct: 126 DKG----NFLTEDQILWLLL--GICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDL 178

Query: 128 GLAKSL---------YAYKGESSAEVGTHYYKAPELLLGL--LEYSTAVDIWPVGCIFGE 176
           G                   + +A+  T  Y+APEL             D+W +GC+   
Sbjct: 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238

Query: 177 MVSGKPLFPGAN-SLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLG 234
           M+ G+  +        ++   V  +   P   + S              A   L++ M+ 
Sbjct: 239 MMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS-------------SALWQLLNSMMT 285

Query: 235 MDPDKRITAAEALQQ 249
           +DP +R      L Q
Sbjct: 286 VDPHQRPHIPLLLSQ 300

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (255), Expect = 2e-25
 Identities = 23/162 (14%), Positives = 48/162 (29%), Gaps = 35/162 (21%)

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL---------- 155
             L+PV+I++D  G  V + GF          G       +  ++ PEL           
Sbjct: 230 TYLRPVDIVLDQRGG-VFLTGFEHLVRD----GARVVSSVSRGFEPPELEARRATISYHR 284

Query: 156 LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRK-PSFCKLSLRDHL 214
                 + + D W +G +   +           +L     I    +  P   +       
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVR------- 337

Query: 215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
                        L+   L    + R+   +A++   ++ + 
Sbjct: 338 ------------ALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  100 bits (251), Expect = 2e-25
 Identities = 62/258 (24%), Positives = 103/258 (39%), Gaps = 56/258 (21%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE-----YQVNDLAY---LLKYPKDSM 65
            +  E+  L  L+HPNII++          + VFE     Y V +      LL    + +
Sbjct: 66  QIEAEIEVLKSLDHPNIIKI----------FEVFEDYHNMYIVMETCEGGELL----ERI 111

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVD--L 117
                +   + S         E   ++  + +     Y      + +DLKP NIL     
Sbjct: 112 VSAQARG-KALS---------EGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS 161

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGE 176
               +K+  FGLA+       E S    GT  Y APE+     + +   DIW  G +   
Sbjct: 162 PHSPIKIIDFGLAE--LFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYF 217

Query: 177 MVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD 236
           +++G   F G +      +     ++P++        LT       P  +DL+ +ML  D
Sbjct: 218 LLTGCLPFTGTSLEEVQQKA--TYKEPNY--AVECRPLT-------PQAVDLLKQMLTKD 266

Query: 237 PDKRITAAEALQQEYFKD 254
           P++R +AA+ L  E+FK 
Sbjct: 267 PERRPSAAQVLHHEWFKQ 284

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  100 bits (251), Expect = 3e-25
 Identities = 53/244 (21%), Positives = 92/244 (37%), Gaps = 39/244 (15%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVND-LAYLLKYPKDSMNGYSTKN 72
            +  E++    L H NI++ +   S+  ++    E      L+ LL+             
Sbjct: 65  PLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR------------- 111

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAG 126
               S +      E+      ++ +  G +Y      + RD+K  N+L++     +K++ 
Sbjct: 112 ----SKWGPLKDNEQTIGF-YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISD 166

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE-YSTAVDIWPVGCIFGEMVSGKPLFP 185
           FG +K L      +    GT  Y APE++      Y  A DIW +GC   EM +GKP F 
Sbjct: 167 FGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226

Query: 186 G-ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
                   + ++      P      + + ++             I K    DPDKR  A 
Sbjct: 227 ELGEPQAAMFKVGMFKVHP-----EIPESMS-------AEAKAFILKCFEPDPDKRACAN 274

Query: 245 EALQ 248
           + L 
Sbjct: 275 DLLV 278

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =   99 bits (250), Expect = 3e-25
 Identities = 60/249 (24%), Positives = 92/249 (36%), Gaps = 56/249 (22%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY 76
           RE+     L HPNI+R+         +Y + E+              +  G         
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF--------------APRG--------- 99

Query: 77  SLFTTFLLVEE--FSSSDSSR---SLSFGTRY------IRRDLKPVNILVDLDGKTVKVA 125
            L+    L +   F    S+     L+    Y      I RD+KP N+L+   G  +K+A
Sbjct: 100 ELYK--ELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIA 156

Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
            FG +   +A         GT  Y  PE++ G   +   VD+W  G +  E + G P F 
Sbjct: 157 DFGWSV--HAPSLRRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFD 213

Query: 186 GANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
             +   T  RIV    + P F               L     DLISK+L   P +R+   
Sbjct: 214 SPSHTETHRRIVNVDLKFPPF---------------LSDGSKDLISKLLRYHPPQRLPLK 258

Query: 245 EALQQEYFK 253
             ++  + K
Sbjct: 259 GVMEHPWVK 267

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  102 bits (256), Expect = 4e-25
 Identities = 65/256 (25%), Positives = 103/256 (40%), Gaps = 57/256 (22%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE-----YQVNDLAY---LLKYPKDSMN 66
           +  E+S L  L+HPNII+          L+ VFE     Y V +      L     + + 
Sbjct: 93  IYNEISLLKSLDHPNIIK----------LFDVFEDKKYFYLVTEFYEGGELF----EQI- 137

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVD--LD 118
                N + +          E  +++  + +  G  Y      + RD+KP NIL++    
Sbjct: 138 ----INRHKFD---------ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS 184

Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
              +K+  FGL+             +GT YY APE+L    +Y+   D+W  G I   ++
Sbjct: 185 LLNIKIVDFGLSSFFSKDYKLRDR-LGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILL 241

Query: 179 SGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD 238
            G P F G N    + ++  +  K  F          N +  +     +LI  ML  D +
Sbjct: 242 CGYPPFGGQNDQDIIKKV--EKGKYYF--------DFNDWKNISDEAKELIKLMLTYDYN 291

Query: 239 KRITAAEALQQEYFKD 254
           KR TA EAL   + K 
Sbjct: 292 KRCTAEEALNSRWIKK 307

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  100 bits (251), Expect = 4e-25
 Identities = 57/246 (23%), Positives = 88/246 (35%), Gaps = 47/246 (19%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           + REVS L ++ H N+I L  V      +  + E                ++G       
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENRTDVVLILEL---------------VSGGE----- 101

Query: 75  SYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILV---DLDGKTV 122
              LF      E  S  +++   + +  G  Y         DLKP NI++   ++    +
Sbjct: 102 ---LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+  FGLA        E     GT  + APE++          D+W +G I   ++SG  
Sbjct: 159 KLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGAS 216

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F G     TL  I               +     F        D I K+L  +  KR+T
Sbjct: 217 PFLGDTKQETLANITS-------VSYDFDE---EFFSHTSELAKDFIRKLLVKETRKRLT 266

Query: 243 AAEALQ 248
             EAL+
Sbjct: 267 IQEALR 272

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  101 bits (255), Expect = 4e-25
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 45/246 (18%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
            + RE      L HPNI+RL    S+  + Y +F+                + G      
Sbjct: 56  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL---------------VTGGE---- 96

Query: 74  NSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILVD--LDGKTV 122
               LF   +  E +S +D+S   + +     +      + R+LKP N+L+   L G  V
Sbjct: 97  ----LFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV 152

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+A FGLA  +   +       GT  Y +PE+L     Y   VD+W  G I   ++ G P
Sbjct: 153 KLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYP 211

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F   +      +I  K+    F         +  +  + P   DLI+KML ++P KRIT
Sbjct: 212 PFWDEDQHRLYQQI--KAGAYDF--------PSPEWDTVTPEAKDLINKMLTINPSKRIT 261

Query: 243 AAEALQ 248
           AAEAL+
Sbjct: 262 AAEALK 267

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  100 bits (250), Expect = 5e-25
 Identities = 61/253 (24%), Positives = 98/253 (38%), Gaps = 49/253 (19%)

Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           ++  +E++ L     HPNI++L  V    ++ + V E                +NG    
Sbjct: 50  ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL---------------LNGGE-- 92

Query: 72  NFNSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILV--DLDGK 120
                 LF      + FS +++S   R L     +      + RDLKP N+L   + D  
Sbjct: 93  ------LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNL 146

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
            +K+  FG A+              T +Y APELL     Y  + D+W +G I   M+SG
Sbjct: 147 EIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSG 205

Query: 181 KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGI-----DLISKMLGM 235
           +  F   +  +T    V   +K      S        F G     +     DLI  +L +
Sbjct: 206 QVPFQSHDRSLTCTSAVEIMKKIKKGDFS--------FEGEAWKNVSQEAKDLIQGLLTV 257

Query: 236 DPDKRITAAEALQ 248
           DP+KR+  +    
Sbjct: 258 DPNKRLKMSGLRY 270

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 99.2 bits (248), Expect = 5e-25
 Identities = 71/259 (27%), Positives = 109/259 (42%), Gaps = 59/259 (22%)

Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE-----YQVNDLAYLLKYPKDSMNG 67
           S+++REV  L +L+HPNI++          L+ + E     Y V +L            G
Sbjct: 66  STILREVELLKKLDHPNIMK----------LFEILEDSSSFYIVGELY---------TGG 106

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILVD-- 116
                     LF   +  + FS  D++   + +  G  Y      + RDLKP NIL++  
Sbjct: 107 ---------ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157

Query: 117 LDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFG 175
                +K+  FGL+      +       +GT YY APE+L G   Y    D+W  G I  
Sbjct: 158 EKDCDIKIIDFGLST--CFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILY 213

Query: 176 EMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM 235
            ++SG P F G N    L R+  ++ K +F            +  +     DLI KML  
Sbjct: 214 ILLSGTPPFYGKNEYDILKRV--ETGKYAF--------DLPQWRTISDDAKDLIRKMLTF 263

Query: 236 DPDKRITAAEALQQEYFKD 254
            P  RITA + L+  + + 
Sbjct: 264 HPSLRITATQCLEHPWIQK 282

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  100 bits (250), Expect = 6e-25
 Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 61/268 (22%)

Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE----YQVNDLAYLLKYPKDSMNG 67
             ++  E+  L +LNHP II+          +   F+    Y V +L            G
Sbjct: 59  ALNVETEIEILKKLNHPCIIK----------IKNFFDAEDYYIVLELM---------EGG 99

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILVDL- 117
                     LF   +  +    +        +    +Y      I RDLKP N+L+   
Sbjct: 100 ---------ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150

Query: 118 -DGKTVKVAGFGLAKSLYAYKGESSA---EVGTHYYKAPELLLGLLE--YSTAVDIWPVG 171
            +   +K+  FG +K L    GE+S      GT  Y APE+L+ +    Y+ AVD W +G
Sbjct: 151 EEDCLIKITDFGHSKIL----GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206

Query: 172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISK 231
            I    +SG P F    + ++L   +  S K +F        +   +  +    +DL+ K
Sbjct: 207 VILFICLSGYPPFSEHRTQVSLKDQI-TSGKYNF--------IPEVWAEVSEKALDLVKK 257

Query: 232 MLGMDPDKRITAAEALQQEYFKDVPGRS 259
           +L +DP  R T  EAL+  + +D   + 
Sbjct: 258 LLVVDPKARFTTEEALRHPWLQDEDMKR 285

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  101 bits (254), Expect = 7e-25
 Identities = 72/258 (27%), Positives = 111/258 (43%), Gaps = 57/258 (22%)

Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE-----YQVNDLAYLLKYPKDSMNG 67
           S+++REV  L +L+HPNI++          L+ + E     Y V +L            G
Sbjct: 66  STILREVELLKKLDHPNIMK----------LFEILEDSSSFYIVGEL----------YTG 105

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILVDLD 118
                     LF   +  + FS  D++   + +  G  Y      + RDLKP NIL++  
Sbjct: 106 GE--------LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157

Query: 119 GK--TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGE 176
            K   +K+  FGL+   +    +    +GT YY APE+L G   Y    D+W  G I   
Sbjct: 158 EKDCDIKIIDFGLST-CFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYI 214

Query: 177 MVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD 236
           ++SG P F G N    L R+  ++ K +F            +  +     DLI KML   
Sbjct: 215 LLSGTPPFYGKNEYDILKRV--ETGKYAF--------DLPQWRTISDDAKDLIRKMLTFH 264

Query: 237 PDKRITAAEALQQEYFKD 254
           P  RITA + L+  + + 
Sbjct: 265 PSLRITATQCLEHPWIQK 282

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 99.3 bits (248), Expect = 9e-25
 Identities = 65/267 (24%), Positives = 100/267 (37%), Gaps = 57/267 (21%)

Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           S + REV  L +   H N++ L+    +    Y VFE                M G S  
Sbjct: 55  SRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK---------------MRGGS-- 97

Query: 72  NFNSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILVDL--DGK 120
                 + +       F+  ++S   + ++    +        RDLKP NIL +      
Sbjct: 98  ------ILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVS 151

Query: 121 TVKVAGFGLAKSLYAYKGESSAE-------VGTHYYKAPELLLGLLE----YSTAVDIWP 169
            VK+  F L   +      S           G+  Y APE++    E    Y    D+W 
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211

Query: 170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG---FPGLEPAGI 226
           +G I   ++SG P F G            +      C+  L + +  G   FP  + A I
Sbjct: 212 LGVILYILLSGYPPFVGRCGS---DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI 268

Query: 227 -----DLISKMLGMDPDKRITAAEALQ 248
                DLISK+L  D  +R++AA+ LQ
Sbjct: 269 SCAAKDLISKLLVRDAKQRLSAAQVLQ 295

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 98.4 bits (246), Expect = 1e-24
 Identities = 64/252 (25%), Positives = 92/252 (36%), Gaps = 56/252 (22%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           M  E+S    L H +++          +++ V E                          
Sbjct: 62  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL--------------CRRR------- 100

Query: 75  SYSLFTTFLLVEE--FSSSDSSR---SLSFGTRY------IRRDLKPVNILVDLDGKTVK 123
             SL    L       +  ++      +  G +Y      I RDLK  N+ ++ D   VK
Sbjct: 101 --SLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVK 155

Query: 124 VAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           +  FGLA +   Y GE    + GT  Y APE+L     +S  VD+W +GCI   ++ GKP
Sbjct: 156 IGDFGLA-TKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKP 213

Query: 183 LFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
            F  +    T  RI   +   P                 + P    LI KML  DP  R 
Sbjct: 214 PFETSCLKETYLRIKKNEYSIPKH---------------INPVAASLIQKMLQTDPTARP 258

Query: 242 TAAEALQQEYFK 253
           T  E L  E+F 
Sbjct: 259 TINELLNDEFFT 270

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 99.3 bits (248), Expect = 1e-24
 Identities = 54/205 (26%), Positives = 75/205 (36%), Gaps = 66/205 (32%)

Query: 107 DLKPVNILV------------------DLDGKTVKVAGFGLA----KSLYAYKGESSAEV 144
           DLKP NIL                    L    +KV  FG A    +            V
Sbjct: 143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL-------V 195

Query: 145 GTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV------- 197
            T +Y+APE++L L  +S   D+W +GCI  E   G  +FP  +S   L  +        
Sbjct: 196 STRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLP 254

Query: 198 --------------------------GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISK 231
                                     G+    + CK  L++ + +     E    DLI K
Sbjct: 255 KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA-CK-PLKEFMLSQDVEHE-RLFDLIQK 311

Query: 232 MLGMDPDKRITAAEALQQEYFKDVP 256
           ML  DP KRIT  EAL+  +F  + 
Sbjct: 312 MLEYDPAKRITLREALKHPFFDLLK 336

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 97.7 bits (244), Expect = 2e-24
 Identities = 64/258 (24%), Positives = 98/258 (37%), Gaps = 59/258 (22%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE-----YQVNDLAYLLKYPKDSMNGY 68
              +E+  +  L+HPNIIR          LY  FE     Y V +L            G 
Sbjct: 52  RFKQEIEIMKSLDHPNIIR----------LYETFEDNTDIYLVMELC---------TGG- 91

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILVD--L 117
                    LF   +    F  SD++   + +     Y        RDLKP N L     
Sbjct: 92  --------ELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS 143

Query: 118 DGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGE 176
               +K+  FGLA       G+    +VGT YY +P++L G   Y    D W  G +   
Sbjct: 144 PDSPLKLIDFGLAA--RFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYV 199

Query: 177 MVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD 236
           ++ G P F        + +I  +    +F            +  + P    LI ++L   
Sbjct: 200 LLCGYPPFSAPTDSEVMLKI--REGTFTF--------PEKDWLNVSPQAESLIRRLLTKS 249

Query: 237 PDKRITAAEALQQEYFKD 254
           P +RIT+ +AL+ E+F+ 
Sbjct: 250 PKQRITSLQALEHEWFEK 267

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 97.6 bits (244), Expect = 2e-24
 Identities = 55/257 (21%), Positives = 93/257 (36%), Gaps = 53/257 (20%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
            G+   +  EV    +L HP+I+ L        Y+Y V E                 NG 
Sbjct: 52  AGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM--------------CHNG- 96

Query: 69  STKNFNSYSLFTTFLLVEE---FSSSDSSR---SLSFGTRY------IRRDLKPVNILVD 116
                    +     L      FS +++      +  G  Y      + RDL   N+L+ 
Sbjct: 97  --------EMNR--YLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT 146

Query: 117 LDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGE 176
            +   +K+A FGLA  L     +     GT  Y +PE+      +    D+W +GC+F  
Sbjct: 147 RNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYT 204

Query: 177 MVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD 236
           ++ G+P F       TL ++V            +   L+           DLI ++L  +
Sbjct: 205 LLIGRPPFDTDTVKNTLNKVVL-------ADYEMPSFLS-------IEAKDLIHQLLRRN 250

Query: 237 PDKRITAAEALQQEYFK 253
           P  R++ +  L   +  
Sbjct: 251 PADRLSLSSVLDHPFMS 267

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  100 bits (251), Expect = 2e-24
 Identities = 57/249 (22%), Positives = 91/249 (36%), Gaps = 54/249 (21%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE-----YQVNDLAY---LLKYPKDSMN 66
           + +E+  +  L HP ++ L          +  FE       + +      L +   D  N
Sbjct: 201 VRKEIQTMSVLRHPTLVNL----------HDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNIL-VDLDG 119
             S                 E  + +  R +  G  +      +  DLKP NI+      
Sbjct: 251 KMS-----------------EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS 293

Query: 120 KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             +K+  FGL       K       GT  + APE+  G        D+W VG +   ++S
Sbjct: 294 NELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLS 351

Query: 180 GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK 239
           G   F G N   TL  +         C  ++ D   + F G+   G D I K+L  DP+ 
Sbjct: 352 GLSPFGGENDDETLRNVKS-------CDWNMDD---SAFSGISEDGKDFIRKLLLADPNT 401

Query: 240 RITAAEALQ 248
           R+T  +AL+
Sbjct: 402 RMTIHQALE 410

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 98.6 bits (246), Expect = 3e-24
 Identities = 48/202 (23%), Positives = 72/202 (35%), Gaps = 60/202 (29%)

Query: 107 DLKPVNILV------------------DLDGKTVKVAGFGLA----KSLYAYKGESSAEV 144
           DLKP NIL                    +   +++VA FG A    +            V
Sbjct: 148 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTI-------V 200

Query: 145 GTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV---GK-- 199
            T +Y+ PE++L L  ++   D+W +GCI  E   G  LF    +   L  +    G   
Sbjct: 201 ATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIP 259

Query: 200 -------SRKPSFCKLSLRDHLTN-----GFPGLEP-------------AGIDLISKMLG 234
                   ++  F K  L     +          +P                DL+ +ML 
Sbjct: 260 SHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319

Query: 235 MDPDKRITAAEALQQEYFKDVP 256
            DP +RIT AEAL   +F  + 
Sbjct: 320 FDPAQRITLAEALLHPFFAGLT 341

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 98.2 bits (245), Expect = 5e-24
 Identities = 60/248 (24%), Positives = 90/248 (36%), Gaps = 49/248 (19%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
            + REVS L ++ HPNII L  V      +  + E        L+        G      
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDVVLILE--------LVS------GG------ 100

Query: 74  NSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILV---DLDGKT 121
               LF      E  S  +++   + +  G  Y         DLKP NI++   ++    
Sbjct: 101 ---ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157

Query: 122 VKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
           +K+  FGLA  +    G       GT  + APE++          D+W +G I   ++SG
Sbjct: 158 IKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSG 214

Query: 181 KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
              F G     TL  I               +     F        D I K+L  +  KR
Sbjct: 215 ASPFLGDTKQETLANITA-------VSYDFDE---EFFSQTSELAKDFIRKLLVKETRKR 264

Query: 241 ITAAEALQ 248
           +T  EAL+
Sbjct: 265 LTIQEALR 272

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 97.4 bits (243), Expect = 5e-24
 Identities = 64/252 (25%), Positives = 92/252 (36%), Gaps = 56/252 (22%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           M  E+S    L H +++          +++ V E                          
Sbjct: 88  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL--------------CRRR------- 126

Query: 75  SYSLFTTFLLVEE--FSSSDSSR---SLSFGTRY------IRRDLKPVNILVDLDGKTVK 123
             SL    L       +  ++      +  G +Y      I RDLK  N+ ++ D   VK
Sbjct: 127 --SLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVK 181

Query: 124 VAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           +  FGLA +   Y GE    + GT  Y APE+L     +S  VD+W +GCI   ++ GKP
Sbjct: 182 IGDFGLA-TKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKP 239

Query: 183 LFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
            F  +    T  RI   +   P                 + P    LI KML  DP  R 
Sbjct: 240 PFETSCLKETYLRIKKNEYSIPKH---------------INPVAASLIQKMLQTDPTARP 284

Query: 242 TAAEALQQEYFK 253
           T  E L  E+F 
Sbjct: 285 TINELLNDEFFT 296

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 96.9 bits (242), Expect = 6e-24
 Identities = 57/251 (22%), Positives = 96/251 (38%), Gaps = 51/251 (20%)

Query: 17  REVSCLMELNHPNIIRL---MRVASQGIYLYPVFEYQVNDLAYLLKY-PKDSMNGYSTKN 72
           +E+  L  L H N+I+L   +    +   +Y V EY V  +  +L   P+          
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQ-KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG 113

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAG 126
           +              F        L  G  Y      + +D+KP N+L+   G T+K++ 
Sbjct: 114 Y--------------F------CQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISA 152

Query: 127 FGLAKSLYAYKGESSAEV--GTHYYKAPELLLGLLEYS-TAVDIWPVGCIFGEMVSGKPL 183
            G+A++L+ +  + +     G+  ++ PE+  GL  +S   VDIW  G     + +G   
Sbjct: 153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

Query: 184 FPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
           F G N       I  G    P                   P   DL+  ML  +P KR +
Sbjct: 213 FEGDNIYKLFENIGKGSYAIPGD---------------CGPPLSDLLKGMLEYEPAKRFS 257

Query: 243 AAEALQQEYFK 253
             +  Q  +F+
Sbjct: 258 IRQIRQHSWFR 268

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 98.6 bits (245), Expect = 6e-24
 Identities = 24/160 (15%), Positives = 46/160 (28%), Gaps = 32/160 (20%)

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL---------L 156
             L+PV+I++D  G  V + GF          G S+       +  PE            
Sbjct: 235 TYLRPVDIVLDQRG-GVFLTGFEHLVRD----GASAVSPIGRGFAPPETTAERMLPFGQH 289

Query: 157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
                + A D W +G     +           +L     I    +               
Sbjct: 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIP------------ 337

Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
                +P    L+   L    + R+   +A++   ++ + 
Sbjct: 338 -----QPVR-ALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 96.6 bits (241), Expect = 1e-23
 Identities = 39/213 (18%), Positives = 65/213 (30%), Gaps = 80/213 (37%)

Query: 107 DLKPVNILV------------------------DLDGKTVKVAGFGLA----KSLYAYKG 138
           DLKP NIL+                              +K+  FG A        +   
Sbjct: 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSI-- 219

Query: 139 ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV- 197
                + T  Y+APE++L L  +  + D+W  GC+  E+ +G  LF     +  L  +  
Sbjct: 220 -----INTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMES 273

Query: 198 -------------------------------------GKSRKPSFCKLSLRDHLTNGFPG 220
                                                  S K     L L   + +    
Sbjct: 274 IIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH---- 329

Query: 221 LEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
                 D +  +L +DP  R + AE L+ ++ +
Sbjct: 330 --ELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 95.8 bits (239), Expect = 3e-23
 Identities = 69/253 (27%), Positives = 98/253 (38%), Gaps = 60/253 (23%)

Query: 17  REVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
            E+  L+    HPNII L  V   G Y+Y V E                M G        
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL---------------MKGGE------ 102

Query: 76  YSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILV---DLDGKTVK 123
             L    L  + FS  ++S    +++    Y      + RDLKP NIL      + ++++
Sbjct: 103 --LLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIR 160

Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
           +  FG AK L A  G       T  + APE+L     Y  A DIW +G +   M++G   
Sbjct: 161 ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTP 219

Query: 184 F---PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGI-----DLISKMLGM 235
           F   P       L RI                  +    G     +     DL+SKML +
Sbjct: 220 FANGPDDTPEEILARI-------------GSGKFS--LSGGYWNSVSDTAKDLVSKMLHV 264

Query: 236 DPDKRITAAEALQ 248
           DP +R+TAA  L+
Sbjct: 265 DPHQRLTAALVLR 277

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 95.4 bits (238), Expect = 3e-23
 Identities = 63/245 (25%), Positives = 97/245 (39%), Gaps = 47/245 (19%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDL-AYLLKYPKDSMNGYSTKNFNS 75
           RE+S L  L HP+II+L  V +    +  V EY   +L  Y+++  K  M     + F  
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE--KKRMTEDEGRRF-- 113

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGFGL 129
                       F      + +     Y      + RDLKP N+L+D +   VK+A FGL
Sbjct: 114 ------------F------QQIICAIEYCHRHKIVHRDLKPENLLLDDNLN-VKIADFGL 154

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
           + ++           G+  Y APE++ G L     VD+W  G +   M+ G+  F     
Sbjct: 155 S-NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213

Query: 190 LITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
                ++       P F               L P    LI +M+  DP +RIT  E  +
Sbjct: 214 PNLFKKVNSCVYVMPDF---------------LSPGAQSLIRRMIVADPMQRITIQEIRR 258

Query: 249 QEYFK 253
             +F 
Sbjct: 259 DPWFN 263

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 95.2 bits (237), Expect = 5e-23
 Identities = 69/269 (25%), Positives = 104/269 (38%), Gaps = 62/269 (23%)

Query: 1   MMGIHNTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFE-----YQVNDL 54
                  +E V  +  RE   L ++  HP+II           L   +E     + V DL
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIIT----------LIDSYESSSFMFLVFDL 181

Query: 55  AYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IR 105
                       G          LF         S  ++    RSL     +      + 
Sbjct: 182 M---------RKG---------ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVH 223

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE-VGTHYYKAPELLLGLLE---- 160
           RDLKP NIL+D D   ++++ FG +  L    GE   E  GT  Y APE+L   ++    
Sbjct: 224 RDLKPENILLD-DNMQIRLSDFGFSCHLE--PGEKLRELCGTPGYLAPEILKCSMDETHP 280

Query: 161 -YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            Y   VD+W  G I   +++G P F     ++ L  I     +  F         +  + 
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEGQYQF--------SSPEWD 330

Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQ 248
                  DLIS++L +DP+ R+TA +ALQ
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQ 359

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 94.0 bits (234), Expect = 2e-22
 Identities = 37/144 (25%), Positives = 59/144 (40%), Gaps = 13/144 (9%)

Query: 106 RDLKPVNIL-VDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA 164
            D+KP NI+       +VK+  FGLA               T  + APE++         
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIVKVTTATAEFAAPEIVDRE-PVGFY 230

Query: 165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPA 224
            D+W +G +   ++SG   F G + L TL  +         C     +   + F  + P 
Sbjct: 231 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-------CDWEFDE---DAFSSVSPE 280

Query: 225 GIDLISKMLGMDPDKRITAAEALQ 248
             D I  +L  +P KR+T  +AL+
Sbjct: 281 AKDFIKNLLQKEPRKRLTVHDALE 304

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 94.0 bits (234), Expect = 2e-22
 Identities = 49/145 (33%), Positives = 68/145 (46%), Gaps = 15/145 (10%)

Query: 106 RDLKPVNIL-VDLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLEYST 163
            DLKP NIL V+ D K +K+  FGLA+       E      GT  + APE++      S 
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYK--PREKLKVNFGTPEFLAPEVVNYD-FVSF 267

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
             D+W VG I   ++SG   F G N   TL  I+        C+  L D     F  +  
Sbjct: 268 PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA-------CRWDLED---EEFQDISE 317

Query: 224 AGIDLISKMLGMDPDKRITAAEALQ 248
              + ISK+L  +   RI+A+EAL+
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALK 342

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.2 bits (232), Expect = 2e-22
 Identities = 50/256 (19%), Positives = 89/256 (34%), Gaps = 62/256 (24%)

Query: 17  REVSCLMEL-NHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNG---- 67
           +EV    +    P+I+ ++ V          L  + E                M G    
Sbjct: 70  QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC---------------MEGGELF 114

Query: 68  --YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDG 119
                +   +++         E  +++  R +    ++        RD+KP N+L     
Sbjct: 115 SRIQERGDQAFT---------EREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE 165

Query: 120 K--TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
           K   +K+  FG AK     +        T YY APE+L    +Y  + D+W +G I   +
Sbjct: 166 KDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYIL 222

Query: 178 VSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGI-----DLISKM 232
           + G P F           +  + R   +           GFP  E + +      LI  +
Sbjct: 223 LCGFPPFYSNTGQAISPGMKRRIRLGQY-----------GFPNPEWSEVSEDAKQLIRLL 271

Query: 233 LGMDPDKRITAAEALQ 248
           L  DP +R+T  + + 
Sbjct: 272 LKTDPTERLTITQFMN 287

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 92.7 bits (231), Expect = 3e-22
 Identities = 39/147 (26%), Positives = 59/147 (40%), Gaps = 17/147 (11%)

Query: 106 RDLKPVNILV---DLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLEY 161
            DLKP NI++   ++    +K+  FGLA  +    G       GT  + APE++      
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEFVAPEIVNYE-PL 194

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
               D+W +G I   ++SG   F G     TL  +               D     F   
Sbjct: 195 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-------VNYEFED---EYFSNT 244

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQ 248
                D I ++L  DP KR+T  ++LQ
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 91.9 bits (229), Expect = 3e-22
 Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 17/147 (11%)

Query: 106 RDLKPVNILV---DLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLEY 161
            DLKP NI++   ++    +K+  FG+A  +    G       GT  + APE++      
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AGNEFKNIFGTPEFVAPEIVNYE-PL 188

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
               D+W +G I   ++SG   F G     TL  I               +     F   
Sbjct: 189 GLEADMWSIGVITYILLSGASPFLGETKQETLTNISA-------VNYDFDE---EYFSNT 238

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQ 248
                D I ++L  DP +R+T A++L+
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLE 265

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 92.0 bits (229), Expect = 3e-22
 Identities = 53/251 (21%), Positives = 92/251 (36%), Gaps = 41/251 (16%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFN 74
           I E+  L  +NHPNI++L       + L  V EY     L  +L         +  +   
Sbjct: 49  IVELRQLSRVNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVL---------HGAEPLP 97

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSF-----GTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
            Y+                S+ +++         I RDLKP N+L+   G  +K+  FG 
Sbjct: 98  YYTAAHAMSW-----CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG-AN 188
           A  +   +   +   G+  + APE+  G   YS   D++  G I  E+++ +  F     
Sbjct: 153 ACDI---QTHMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208

Query: 189 SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
               +   V    +P          L    P        L+++    DP +R +  E ++
Sbjct: 209 PAFRIMWAVHNGTRPP---------LIKNLP---KPIESLMTRCWSKDPSQRPSMEEIVK 256

Query: 249 --QEYFKDVPG 257
                 +  PG
Sbjct: 257 IMTHLMRYFPG 267

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.9 bits (229), Expect = 4e-22
 Identities = 63/261 (24%), Positives = 97/261 (37%), Gaps = 57/261 (21%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFE-----YQVNDLAYLL 58
           I  +     SS+  E++ L ++ H NI+           L  ++E     Y V  L    
Sbjct: 42  IKKSPAFRDSSLENEIAVLKKIKHENIVT----------LEDIYESTTHYYLVMQLV--- 88

Query: 59  KYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLK 109
                   G          LF   L    ++  D+S   + +    +Y      + RDLK
Sbjct: 89  ------SGG---------ELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133

Query: 110 PVNILV--DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI 167
           P N+L     +   + +  FGL+K      G  S   GT  Y APE+L     YS AVD 
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQK-PYSKAVDC 190

Query: 168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGID 227
           W +G I   ++ G P F          +I  K     F         +  +  +  +  D
Sbjct: 191 WSIGVITYILLCGYPPFYEETESKLFEKI--KEGYYEF--------ESPFWDDISESAKD 240

Query: 228 LISKMLGMDPDKRITAAEALQ 248
            I  +L  DP++R T  +AL 
Sbjct: 241 FICHLLEKDPNERYTCEKALS 261

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.0 bits (229), Expect = 6e-22
 Identities = 62/248 (25%), Positives = 99/248 (39%), Gaps = 55/248 (22%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFE-----YQVNDLAYLLKYPKDSMNGYSTK 71
            E+  L+ L+HPNII+          L  +FE       V +L            G    
Sbjct: 97  TEIGVLLRLSHPNIIK----------LKEIFETPTEISLVLELV---------TGG---- 133

Query: 72  NFNSYSLFTTFLLVEEFSSSDSS---RSLSFGTRY------IRRDLKPVNILV--DLDGK 120
                 LF   +    +S  D++   + +     Y      + RDLKP N+L        
Sbjct: 134 -----ELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA 188

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
            +K+A FGL+K +       +   GT  Y APE+L G   Y   VD+W VG I   ++ G
Sbjct: 189 PLKIADFGLSKIVEHQVLMKTV-CGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCG 246

Query: 181 KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
              F        + R +  + +  F        ++  +  +     DL+ K++ +DP KR
Sbjct: 247 FEPFYDERGDQFMFRRI-LNCEYYF--------ISPWWDEVSLNAKDLVRKLIVLDPKKR 297

Query: 241 ITAAEALQ 248
           +T  +ALQ
Sbjct: 298 LTTFQALQ 305

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 91.5 bits (228), Expect = 6e-22
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 18/142 (12%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEY 161
           I RDLKP NIL++ D   +++  FG AK L     ++ A   VGT  Y +PELL      
Sbjct: 152 IHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SA 209

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
             + D+W +GCI  ++V+G P F   N  +   +I+         +    +         
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-------KLEYDFPEKFF------ 256

Query: 222 EPAGIDLISKMLGMDPDKRITA 243
            P   DL+ K+L +D  KR+  
Sbjct: 257 -PKARDLVEKLLVLDATKRLGC 277

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 91.1 bits (227), Expect = 8e-22
 Identities = 35/145 (24%), Positives = 63/145 (43%), Gaps = 15/145 (10%)

Query: 106 RDLKPVNIL-VDLDGKTVKVAGFGLAKSLYAYKGES-SAEVGTHYYKAPELLLGLLEYST 163
            D++P NI+       T+K+  FG A+ L    G++         Y APE+       ST
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVHQHD-VVST 182

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           A D+W +G +   ++SG   F    +   +  I+         + +  +     F  +  
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-------AEYTFDE---EAFKEISI 232

Query: 224 AGIDLISKMLGMDPDKRITAAEALQ 248
             +D + ++L  +   R+TA+EALQ
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQ 257

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 92.1 bits (229), Expect = 1e-21
 Identities = 53/256 (20%), Positives = 95/256 (37%), Gaps = 61/256 (23%)

Query: 17  REVSCLMEL-NHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNG---- 67
           REV         P+I+R++ V     +    L  V E                ++G    
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC---------------LDGGELF 147

Query: 68  --YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILV--DL 117
                +   +++         E  +S+  +S+    +Y        RD+KP N+L     
Sbjct: 148 SRIQDRGDQAFT---------EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 198

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
               +K+  FG AK   ++   ++    T YY APE+L    +Y  + D+W +G I   +
Sbjct: 199 PNAILKLTDFGFAKETTSHNSLTTP-CYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYIL 256

Query: 178 VSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGI-----DLISKM 232
           + G P F   + L     +  + R     +          FP  E + +      LI  +
Sbjct: 257 LCGYPPFYSNHGLAISPGMKTRIRM---GQYE--------FPNPEWSEVSEEVKMLIRNL 305

Query: 233 LGMDPDKRITAAEALQ 248
           L  +P +R+T  E + 
Sbjct: 306 LKTEPTQRMTITEFMN 321

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 91.4 bits (227), Expect = 3e-21
 Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 17/157 (10%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D DG  V+++  GLA  L A + ++    GT  + APELLLG  EY  
Sbjct: 311 IYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDF 368

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           +VD + +G    EM++ +  F      +    +    ++     ++  D  +       P
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKEL---KQRVLEQAVTYPDKFS-------P 418

Query: 224 AGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
           A  D    +L  DP+KR+     +         F+D+
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.1 bits (226), Expect = 4e-21
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 21/158 (13%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  V+++  GLA      K +  A VGTH Y APE+L   + Y +
Sbjct: 314 VYRDLKPANILLDEHGH-VRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           + D + +GC+  +++ G   F    +         K +     +++L   +    P    
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKT---------KDKHEID-RMTLTMAVE--LPDSFS 418

Query: 223 PAGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
           P    L+  +L  D ++R+      A E  +  +F+ +
Sbjct: 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 88.9 bits (221), Expect = 8e-21
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 18/149 (12%)

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV 165
           RDLK  N+L+D D   +K+A FG + + +   G+  A  G   Y APEL  G       V
Sbjct: 138 RDLKAENLLLDADMN-IKIADFGFS-NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEV 195

Query: 166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPA 224
           D+W +G I   +VSG   F G N      R++ GK R P +               +   
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY---------------MSTD 240

Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFK 253
             +L+ + L ++P KR T  + ++  +  
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQIMKDRWIN 269

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 43.1 bits (102), Expect = 5e-05
 Identities = 15/33 (45%), Positives = 19/33 (57%)

Query: 17 REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY 49
          REV  +  LNHPNI++L  V      LY + EY
Sbjct: 63 REVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 88.9 bits (221), Expect = 8e-21
 Identities = 39/145 (26%), Positives = 62/145 (42%), Gaps = 14/145 (9%)

Query: 106 RDLKPVNILVD--LDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
            DLKP NIL+        +K+  FG+++    +  E    +GT  Y APE+L      +T
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACELREIMGTPEYLAPEILNYD-PITT 212

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           A D+W +G I   +++    F G ++  T   I       S   +   +     F  +  
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI-------SQVNVDYSE---ETFSSVSQ 262

Query: 224 AGIDLISKMLGMDPDKRITAAEALQ 248
              D I  +L  +P+KR TA   L 
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLS 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 88.1 bits (219), Expect = 9e-21
 Identities = 48/231 (20%), Positives = 89/231 (38%), Gaps = 33/231 (14%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNS 75
            EV  L +  H NI+  M  ++    L  V ++     L + L   +         +   
Sbjct: 69  NEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDI-- 125

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLA--K 131
                         +  ++R + +      I RDLK  NI +  +  TVK+  FGLA  K
Sbjct: 126 --------------ARQTARGMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEK 170

Query: 132 SLYAYKGESSAEVGTHYYKAPELLLGLLE--YSTAVDIWPVGCIFGEMVSGKPLFPGANS 189
           S ++   +     G+  + APE++       YS   D++  G +  E+++G+  +   N+
Sbjct: 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230

Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
              +  +VG+         SL   L+            L+++ L    D+R
Sbjct: 231 RDQIIEMVGRG--------SLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 88.6 bits (220), Expect = 1e-20
 Identities = 49/247 (19%), Positives = 90/247 (36%), Gaps = 55/247 (22%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN--DL-AYLLKYPKDSMNGYSTKNF 73
            E++ L  + H NII+++ +     +   V E   +  DL A++ ++P+           
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR----------- 126

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIR------RDLKPVNILVDLDGKTVKVAGF 127
                      ++E  +S   R L     Y+R      RD+K  NI++  D  T+K+  F
Sbjct: 127 -----------LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDF 174

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
           G A +            GT  Y APE+L+G       +++W +G     +V  +  F   
Sbjct: 175 GSA-AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233

Query: 188 NSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA 246
                    V      P                 +    + L+S +L   P++R T  + 
Sbjct: 234 E------ETVEAAIHPPYL---------------VSKELMSLVSGLLQPVPERRTTLEKL 272

Query: 247 LQQEYFK 253
           +   +  
Sbjct: 273 VTDPWVT 279

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.7 bits (218), Expect = 1e-20
 Identities = 40/151 (26%), Positives = 61/151 (40%), Gaps = 17/151 (11%)

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL-EYS-T 163
           RD+KP N+LV  DG  +K+A FG++          S  VGT  + APE L      +S  
Sbjct: 161 RDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGK 219

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLE 222
           A+D+W +G      V G+  F     +    +I       P    ++             
Sbjct: 220 ALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIA------------- 266

Query: 223 PAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
               DLI++ML  +P+ RI   E     +  
Sbjct: 267 EDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 39.6 bits (93), Expect = 6e-04
 Identities = 13/44 (29%), Positives = 26/44 (59%), Gaps = 4/44 (9%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRL---MRVASQGIYLYPVFEY 49
            G    + +E++ L +L+HPN+++L   +   ++  +LY VFE 
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFEL 119

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 87.9 bits (218), Expect = 2e-20
 Identities = 57/263 (21%), Positives = 95/263 (36%), Gaps = 60/263 (22%)

Query: 15  MIREVSCLMEL-NHPNIIRL-------MRVASQGIYLYPVF-EYQVNDLAYLLKYPKDSM 65
           +I+EV  + +L  HPNI++           +  G   + +  E     L        + +
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLV-------EFL 124

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF----GTRYIRRDLKPVNILVDLDGKT 121
               ++        +   +++ F    + R++          I RDLK  N+L+   G T
Sbjct: 125 KKMESRG-----PLSCDTVLKIFY--QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-T 176

Query: 122 VKVAGFGLAKSLYAYKGESS------------AEVGTHYYKAPEL--LLGLLEYSTAVDI 167
           +K+  FG A ++  Y   S                 T  Y+ PE+  L          DI
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236

Query: 168 WPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGI 226
           W +GCI   +   +  F     L    RIV GK   P         H             
Sbjct: 237 WALGCILYLLCFRQHPFEDGAKL----RIVNGKYSIPPHDTQYTVFH------------- 279

Query: 227 DLISKMLGMDPDKRITAAEALQQ 249
            LI  ML ++P++R++ AE + Q
Sbjct: 280 SLIRAMLQVNPEERLSIAEVVHQ 302

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 86.6 bits (215), Expect = 3e-20
 Identities = 50/244 (20%), Positives = 90/244 (36%), Gaps = 43/244 (17%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNS 75
           REV  +  LNHPNI++L  +      +  V E+    DL + L      +          
Sbjct: 72  REVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPI---------K 120

Query: 76  YSLFTTFLLVEEFSSSDSSRSL----SFGTRYIRRDLKPVNILVDLDGK----TVKVAGF 127
           +S+    +L       D +  +    +     + RDL+  NI +    +      KVA F
Sbjct: 121 WSVKLRLML-------DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE-YSTAVDIWPVGCIFGEMVSGKPLFPG 186
           GL++         S  +G   + APE +    E Y+   D +    I   +++G+  F  
Sbjct: 174 GLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

Query: 187 ANSL-ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE 245
            +   I    ++ +          LR  +    P   P   ++I      DP KR   + 
Sbjct: 231 YSYGKIKFINMIREE--------GLRPTIPEDCP---PRLRNVIELCWSGDPKKRPHFSY 279

Query: 246 ALQQ 249
            +++
Sbjct: 280 IVKE 283

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 85.8 bits (213), Expect = 7e-20
 Identities = 55/254 (21%), Positives = 89/254 (35%), Gaps = 40/254 (15%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNS 75
           REV+ +  L HPNI+  M   +Q   L  V EY     L  LL            +    
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-------AREQLD 135

Query: 76  YSLFTTFLLVEEFSSSDSSRSL----SFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                +          D ++ +    +     + R+LK  N+LVD    TVKV  FGL++
Sbjct: 136 ERRRLSMAY-------DVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSR 187

Query: 132 SLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI 191
              +    S +  GT  + APE+L      +   D++  G I  E+ + +  +   N   
Sbjct: 188 LKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246

Query: 192 TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR-----ITAA-E 245
            +  +  K ++           +        P    +I      +P KR     I     
Sbjct: 247 VVAAVGFKCKRLE---------IPRNLN---PQVAAIIEGCWTNEPWKRPSFATIMDLLR 294

Query: 246 ALQQEYFKDVPGRS 259
            L +      P RS
Sbjct: 295 PLIKSAVPP-PNRS 307

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.3 bits (212), Expect = 8e-20
 Identities = 58/253 (22%), Positives = 90/253 (35%), Gaps = 62/253 (24%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPV---------FEYQVNDLAYLLKYPKDSMNG 67
           RE+  L    HP+II+L +V S     + V         F+Y               +  
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK---------HGRVEE 110

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKT 121
              +                F      + +     Y      + RDLKP N+L+D     
Sbjct: 111 MEARRL--------------F------QQILSAVDYCHRHMVVHRDLKPENVLLDAHMN- 149

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
            K+A FGL+ ++ +         G+  Y APE++ G L     VDIW  G I   ++ G 
Sbjct: 150 AKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

Query: 182 PLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
             F   +      +I  G    P +               L  +   L+  ML +DP KR
Sbjct: 209 LPFDDEHVPTLFKKIRGGVFYIPEY---------------LNRSVATLLMHMLQVDPLKR 253

Query: 241 ITAAEALQQEYFK 253
            T  +  + E+FK
Sbjct: 254 ATIKDIREHEWFK 266

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 85.6 bits (212), Expect = 3e-19
 Identities = 61/253 (24%), Positives = 96/253 (37%), Gaps = 62/253 (24%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPV---------FEYQVNDLAYLLKYPKDSMNG 67
           RE+  L    HP+II+L +V S    ++ V         F+Y               ++ 
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK---------NGRLDE 115

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKT 121
             ++                F      + +  G  Y      + RDLKP N+L+D     
Sbjct: 116 KESRRL--------------F------QQILSGVDYCHRHMVVHRDLKPENVLLDAHMN- 154

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
            K+A FGL+ ++ +         G+  Y APE++ G L     VDIW  G I   ++ G 
Sbjct: 155 AKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

Query: 182 PLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
             F   +      +I  G    P +               L P+ I L+  ML +DP KR
Sbjct: 214 LPFDDDHVPTLFKKICDGIFYTPQY---------------LNPSVISLLKHMLQVDPMKR 258

Query: 241 ITAAEALQQEYFK 253
            T  +  + E+FK
Sbjct: 259 ATIKDIREHEWFK 271

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 85.6 bits (212), Expect = 3e-19
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 18/157 (11%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  ++++  GLA  +          VGT  Y APE++     Y+ 
Sbjct: 308 VYRDLKPENILLDDHGH-IRISDLGLAVHV-PEGQTIKGRVGTVGYMAPEVVKNE-RYTF 364

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           + D W +GC+  EM++G+  F      I    +    R          +  +       P
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVPEEYSERFS-------P 414

Query: 224 AGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
               L S++L  DP +R+     +A E  +   FK +
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 83.4 bits (207), Expect = 7e-19
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NI+++  G  VK+  FGL K        +    GT  Y APE+L+    ++ 
Sbjct: 143 IYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNR 200

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           AVD W +G +  +M++G P F G N   T+ +I+        CKL+L  +LT        
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL-------KCKLNLPPYLT-------Q 246

Query: 224 AGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
              DL+ K+L  +   R+      A E     +F+ +
Sbjct: 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 83.9 bits (208), Expect = 7e-19
 Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 18/156 (11%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL--GLLEY 161
           I RD+KP NIL+D  G  V +  F +A  L   + + +   GT  Y APE+        Y
Sbjct: 137 IHRDMKPDNILLDEHGH-VHITDFNIAAML-PRETQITTMAGTKPYMAPEMFSSRKGAGY 194

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-G 220
           S AVD W +G    E++ G+  +   +S          +             +T  +P  
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSS----------TSSKEIVHTFETTVVT--YPSA 242

Query: 221 LEPAGIDLISKMLGMDPDKRITAAEALQQ-EYFKDV 255
                + L+ K+L  +PD+R +    +Q   Y  D+
Sbjct: 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.0 bits (208), Expect = 8e-19
 Identities = 43/157 (27%), Positives = 66/157 (42%), Gaps = 21/157 (13%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  N+++D DG  +K+  FGL K             GT  Y APE+L    +Y  
Sbjct: 271 VYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGR 328

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           AVD W +G +  EM+ G+  F   +       I+         ++     L        P
Sbjct: 329 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MEEIRFPRTLG-------P 374

Query: 224 AGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
               L+S +L  DP +R+      A E +Q  +F  +
Sbjct: 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 82.6 bits (205), Expect = 1e-18
 Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 21/157 (13%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NIL+D +G  +K+  FGL+K    ++ ++ +  GT  Y APE++     ++ 
Sbjct: 148 IYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQ 205

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           + D W  G +  EM++G   F G +   T+  I+         KL +   L+       P
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL-------KAKLGMPQFLS-------P 251

Query: 224 AGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
               L+  +   +P  R+        E  +  +F  +
Sbjct: 252 EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 82.4 bits (204), Expect = 1e-18
 Identities = 36/240 (15%), Positives = 84/240 (35%), Gaps = 46/240 (19%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNS 75
           REV    +  H N++  M       +L  +        L  +++  K  ++   T+    
Sbjct: 78  REVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQI-- 135

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK-- 131
                         + +  + + +      + +DLK  N+    D   V +  FGL    
Sbjct: 136 --------------AQEIVKGMGYLHAKGILHKDLKSKNVFY--DNGKVVITDFGLFSIS 179

Query: 132 ---SLYAYKGESSAEVGTHYYKAPELLLGL--------LEYSTAVDIWPVGCIFGEMVSG 180
                   + +   + G   + APE++  L        L +S   D++ +G I+ E+ + 
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239

Query: 181 KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
           +  F    +   +   +G   KP+  ++ +   ++           D++      + ++R
Sbjct: 240 EWPFKTQPAEAIIW-QMGTGMKPNLSQIGMGKEIS-----------DILLFCWAFEQEER 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 82.4 bits (204), Expect = 1e-18
 Identities = 42/193 (21%), Positives = 72/193 (37%), Gaps = 35/193 (18%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNF 73
            ++EV  +  L HPN+++ + V  +   L  + EY     L  ++K              
Sbjct: 54  FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--------- 104

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                +     V    + D +  +++      I RDL   N LV  + K V VA FGLA+
Sbjct: 105 -----YPWSQRVS--FAKDIASGMAYLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLAR 156

Query: 132 SL--------------YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
            +                 + +    VG  Y+ APE++ G   Y   VD++  G +  E+
Sbjct: 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEI 215

Query: 178 VSGKPLFPGANSL 190
           +      P     
Sbjct: 216 IGRVNADPDYLPR 228

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 81.5 bits (202), Expect = 1e-18
 Identities = 42/200 (21%), Positives = 74/200 (37%), Gaps = 32/200 (16%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
            +E      L HPNII L  V  +   L  V E+               +N   +     
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA----------RGGPLNRVLSGKRIP 103

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSF-----GTRYIRRDLKPVNILVD-------LDGKTVK 123
             +   + +         +R +++         I RDLK  NIL+        L  K +K
Sbjct: 104 PDILVNWAV-------QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156

Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
           +  FGLA+    ++    +  G + + APE++     +S   D+W  G +  E+++G+  
Sbjct: 157 ITDFGLAR--EWHRTTKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVP 213

Query: 184 FPGANSLITLGRIVGKSRKP 203
           F G + L     +       
Sbjct: 214 FRGIDGLAVAYGVAMNKLAL 233

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 82.3 bits (204), Expect = 2e-18
 Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 21/157 (13%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RD+K  N+++D DG  +K+  FGL K   +         GT  Y APE+L    +Y  
Sbjct: 127 VYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGR 184

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           AVD W +G +  EM+ G+  F   +       I+         ++     L+       P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-------MEEIRFPRTLS-------P 230

Query: 224 AGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
               L++ +L  DP +R+      A E ++  +F  +
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 83.1 bits (205), Expect = 2e-18
 Identities = 34/157 (21%), Positives = 65/157 (41%), Gaps = 21/157 (13%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+++D +G  +K+A FG+ K        +    GT  Y APE++     Y  
Sbjct: 464 IYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGK 521

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           +VD W  G +  EM++G+  F G +       I+          ++    ++        
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-------EHNVAYPKSMS-------K 567

Query: 224 AGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
             + +   ++   P KR+        +  +  +F+ +
Sbjct: 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.9 bits (203), Expect = 2e-18
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 17/153 (11%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLK  NIL+D DG  +K+A FG+ K       +++   GT  Y APE+LLG  +Y+ 
Sbjct: 140 VYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNH 197

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           +VD W  G +  EM+ G+  F G +       I                 L         
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-------MDNPFYPRWLE-------K 243

Query: 224 AGIDLISKMLGMDPDKRITAAEALQ-QEYFKDV 255
              DL+ K+   +P+KR+     ++    F+++
Sbjct: 244 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 81.2 bits (201), Expect = 3e-18
 Identities = 50/255 (19%), Positives = 80/255 (31%), Gaps = 67/255 (26%)

Query: 17  REVSCLMELN----HPNIIRLMRVASQGIYLYPVFEYQVN--DL-AYLLKYPKDSMNGYS 69
            EV+ L ++     HP +IRL+           V E  +   DL  Y+ +          
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP------- 135

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSF-----GTRYIRR------DLKPVNILVDLD 118
                         L E       SR   F       ++         D+K  NIL+DL 
Sbjct: 136 --------------LGE-----GPSRCF-FGQVVAAIQHCHSRGVVHRDIKDENILIDLR 175

Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
               K+  FG       +    +   GT  Y  PE +     ++    +W +G +  +MV
Sbjct: 176 RGCAKLIDFGS--GALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233

Query: 179 SGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD 238
            G   F           I+         +L    H++       P    LI + L   P 
Sbjct: 234 CGDIPFERDQ------EILE-------AELHFPAHVS-------PDCCALIRRCLAPKPS 273

Query: 239 KRITAAEALQQEYFK 253
            R +  E L   + +
Sbjct: 274 SRPSLEEILLDPWMQ 288

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.6 bits (202), Expect = 4e-18
 Identities = 47/139 (33%), Positives = 64/139 (46%), Gaps = 21/139 (15%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP N+L+D  G  ++V  FG AK +   KG +    GT    APE++L    Y+ 
Sbjct: 163 IYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWTLCGTPEALAPEIILS-KGYNK 217

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLE 222
           AVD W +G +  EM +G P F     +    +IV GK R PS                  
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH---------------FS 262

Query: 223 PAGIDLISKMLGMDPDKRI 241
               DL+  +L +D  KR 
Sbjct: 263 SDLKDLLRNLLQVDLTKRF 281

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 80.4 bits (199), Expect = 4e-18
 Identities = 38/243 (15%), Positives = 80/243 (32%), Gaps = 62/243 (25%)

Query: 17  REVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVNDLAYLLKYPKDSM-NGYSTKNF 73
            E   L   +HPN++ ++         +   +  +               M  G      
Sbjct: 56  EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW---------------MPYG------ 94

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSF------GTRY--------IRRDLKPVNILVDLDG 119
              SL+   L        D S+++ F      G  +         R  L   ++++D + 
Sbjct: 95  ---SLYN-VLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-ED 149

Query: 120 KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG--LLEYSTAVDIWPVGCIFGEM 177
            T +++   +  S      +S   +    + APE L          + D+W    +  E+
Sbjct: 150 MTARISMADVKFSF-----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWEL 204

Query: 178 VSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
           V+ +  F   +++    ++  +  +P+              PG+ P    L+   +  DP
Sbjct: 205 VTREVPFADLSNMEIGMKVALEGLRPTI------------PPGISPHVSKLMKICMNEDP 252

Query: 238 DKR 240
            KR
Sbjct: 253 AKR 255

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 80.8 bits (200), Expect = 6e-18
 Identities = 50/254 (19%), Positives = 82/254 (32%), Gaps = 61/254 (24%)

Query: 17  REVSCLMELNH--PNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
            EV  L +++     +IRL             FE   +    +L+ P+            
Sbjct: 95  MEVVLLKKVSSGFSGVIRL----------LDWFERP-DSFVLILERPEPVQ--------- 134

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSF-----GTRY------IRRDLKPVNILVDLDGKTVK 123
              LF  F+        + +RS  F       R+      + RD+K  NIL+DL+   +K
Sbjct: 135 --DLFD-FITERGALQEELARSF-FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 190

Query: 124 VAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
           +  FG            +   GT  Y  PE +     +  +  +W +G +  +MV G   
Sbjct: 191 LIDFGS--GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

Query: 184 FPGANSLITLGRIV-GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
           F           I+ G+                     +      LI   L + P  R T
Sbjct: 249 FEHDE------EIIRGQVFFRQR---------------VSSECQHLIRWCLALRPSDRPT 287

Query: 243 AAEALQQEYFKDVP 256
             E     + +DV 
Sbjct: 288 FEEIQNHPWMQDVL 301

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 79.9 bits (198), Expect = 6e-18
 Identities = 37/152 (24%), Positives = 63/152 (41%), Gaps = 18/152 (11%)

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYST 163
           RD+KP N+L+D     +K++ FGLA        E       GT  Y APELL     ++ 
Sbjct: 129 RDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITL--GRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
            VD+W  G +   M++G+  +   +            K+    + K+             
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID------------ 235

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
             A + L+ K+L  +P  RIT  +  +  ++ 
Sbjct: 236 -SAPLALLHKILVENPSARITIPDIKKDRWYN 266

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 81.7 bits (202), Expect = 6e-18
 Identities = 39/143 (27%), Positives = 64/143 (44%), Gaps = 16/143 (11%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY-KGESSAEVGTHYYKAPELLLGLLE- 160
           Y+ RD+KP NIL+D++G  +++A FG    L      +SS  VGT  Y +PE+L  +   
Sbjct: 196 YVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254

Query: 161 ---YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG 217
              Y    D W +G    EM+ G+  F   + + T G+I+    +  F            
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF---------PTQ 305

Query: 218 FPGLEPAGIDLISKMLGMDPDKR 240
              +     DLI +++    + R
Sbjct: 306 VTDVSENAKDLIRRLI-CSREHR 327

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 81.3 bits (201), Expect = 7e-18
 Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 21/163 (12%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGL--- 158
           Y+ RD+KP NIL+D  G  +++A FG    L A     S   VGT  Y +PE+L  +   
Sbjct: 183 YVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241

Query: 159 ---LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLT 215
                Y    D W +G    EM  G+  F   ++  T G+IV         K  L   L 
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV-------HYKEHLSLPLV 294

Query: 216 NGFPGLEPAGIDLISKMLGMDPDKRIT---AAEALQQEYFKDV 255
           +   G+     D I ++L   P+ R+    A +     +F  +
Sbjct: 295 D--EGVPEEARDFIQRLL-CPPETRLGRGGAGDFRTHPFFFGL 334

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 80.4 bits (199), Expect = 8e-18
 Identities = 34/157 (21%), Positives = 65/157 (41%), Gaps = 21/157 (13%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+++D +G  +K+A FG+ K        +    GT  Y APE++     Y  
Sbjct: 143 IYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGK 200

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           +VD W  G +  EM++G+  F G +       I+          ++    ++        
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-------EHNVAYPKSMS-------K 246

Query: 224 AGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
             + +   ++   P KR+        +  +  +F+ +
Sbjct: 247 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 80.8 bits (200), Expect = 9e-18
 Identities = 44/156 (28%), Positives = 65/156 (41%), Gaps = 20/156 (12%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           + RDLKP NIL+D  G  + +  FGL K    +   +S   GT  Y APE+L     Y  
Sbjct: 161 VYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDR 218

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
            VD W +G +  EM+ G P F   N+      I+          L L+ ++T        
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-------NKPLQLKPNIT-------N 264

Query: 224 AGIDLISKMLGMDPDKRI----TAAEALQQEYFKDV 255
           +   L+  +L  D  KR+       E     +F  +
Sbjct: 265 SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 80.0 bits (198), Expect = 1e-17
 Identities = 37/152 (24%), Positives = 63/152 (41%), Gaps = 18/152 (11%)

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYST 163
           RD+KP N+L+D     +K++ FGLA        E       GT  Y APELL     ++ 
Sbjct: 129 RDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITL--GRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
            VD+W  G +   M++G+  +   +            K+    + K+             
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID------------ 235

Query: 222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
             A + L+ K+L  +P  RIT  +  +  ++ 
Sbjct: 236 -SAPLALLHKILVENPSARITIPDIKKDRWYN 266

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 79.7 bits (197), Expect = 1e-17
 Identities = 58/264 (21%), Positives = 110/264 (41%), Gaps = 50/264 (18%)

Query: 8   MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKD 63
           +E     +I+E+S + + + P++++      +   L+ V EY     V+D+   ++    
Sbjct: 64  VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI---IRLRNK 120

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDL 117
           ++                     E   +   +S   G  Y      I RD+K  NIL++ 
Sbjct: 121 TLT--------------------EDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT 160

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG--CIFG 175
           +G   K+A FG+A  L     + +  +GT ++ APE++  +  Y+   DIW +G   I  
Sbjct: 161 EGH-AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAI-- 216

Query: 176 EMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM 235
           EM  GKP +   + +  +  I   +  P        +  ++ F        D + + L  
Sbjct: 217 EMAEGKPPYADIHPMRAIFMI-PTNPPP---TFRKPELWSDNF-------TDFVKQCLVK 265

Query: 236 DPDKRITAAEALQQEYFKDVPGRS 259
            P++R TA + LQ  + +   G S
Sbjct: 266 SPEQRATATQLLQHPFVRSAKGVS 289

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.5 bits (199), Expect = 1e-17
 Identities = 40/142 (28%), Positives = 57/142 (40%), Gaps = 16/142 (11%)

Query: 103 YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLL---GL 158
           +I RD+KP N+L+D  G  +K+A FG    +           VGT  Y +PE+L    G 
Sbjct: 189 FIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247

Query: 159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
             Y    D W VG    EM+ G   F   + + T  +I+         K SL        
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM-------NHKNSLTFP---DD 297

Query: 219 PGLEPAGIDLISKMLGMDPDKR 240
             +     +LI   L  D + R
Sbjct: 298 NDISKEAKNLICAFL-TDREVR 318

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 1e-17
 Identities = 39/158 (24%), Positives = 63/158 (39%), Gaps = 22/158 (13%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G   K+A FG+ K        ++   GT  Y APE+L   + Y  
Sbjct: 146 IYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE-MLYGP 203

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           AVD W +G +  EM+ G   F   N       I+         ++     L         
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------NDEVVYPTWLH-------E 249

Query: 224 AGIDLISKMLGMDPDKRI-----TAAEALQ-QEYFKDV 255
               ++   +  +P  R+         A+    +FK++
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 79.3 bits (196), Expect = 2e-17
 Identities = 56/259 (21%), Positives = 104/259 (40%), Gaps = 34/259 (13%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST---- 70
           +++E+  + + +HPNI+           L+ V +                ++G S     
Sbjct: 60  LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL---------------LSGGSVLDII 104

Query: 71  KNFNSYSLFTTFLLVEEFSSS---DSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVA 125
           K+  +     + +L E   ++   +    L +      I RD+K  NIL+  DG +V++A
Sbjct: 105 KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIA 163

Query: 126 GFGLAKSLYAYKGESSAE-----VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
            FG++  L      +  +     VGT  + APE++  +  Y    DIW  G    E+ +G
Sbjct: 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

Query: 181 KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
              +     +  L   + ++  P    L               +   +IS  L  DP+KR
Sbjct: 224 AAPYHKYPPMKVLMLTL-QNDPP---SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279

Query: 241 ITAAEALQQEYFKDVPGRS 259
            TAAE L+ ++F+    + 
Sbjct: 280 PTAAELLRHKFFQKAKNKE 298

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 78.9 bits (195), Expect = 2e-17
 Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 42/246 (17%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +I E+  + E  +PNI+  +     G  L+ V EY               + G S  +  
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY---------------LAGGSLTD-- 106

Query: 75  SYSLFTTFLLVEE---FSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
              + T   + E        +  ++L F    + I RD+K  NIL+ +DG  VK+  FG 
Sbjct: 107 ---VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGF 162

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG--CIFGEMVSGKPLFPGA 187
              +   + + S  VGT Y+ APE++     Y   VDIW +G   I  EM+ G+P +   
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAI--EMIEGEPPYLNE 219

Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
           N L  L  I   +  P   +L   + L+  F        D +++ L MD +KR +A E L
Sbjct: 220 NPLRALYLI-ATNGTP---ELQNPEKLSAIF-------RDFLNRCLEMDVEKRGSAKELL 268

Query: 248 QQEYFK 253
           Q ++ K
Sbjct: 269 QHQFLK 274

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 78.9 bits (195), Expect = 3e-17
 Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 42/246 (17%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +  EV  + +  H N++ + +    G  L+ + E+               + G +  +  
Sbjct: 89  LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF---------------LQGGALTD-- 131

Query: 75  SYSLFTTFLLVEE---FSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
              + +   L EE          ++L++      I RD+K  +IL+ LDG+ VK++ FG 
Sbjct: 132 ---IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGF 187

Query: 130 AKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG--CIFGEMVSGKPLFPGA 187
              +     +  + VGT Y+ APE++     Y+T VDIW +G   I  EMV G+P +   
Sbjct: 188 CAQISKDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVI--EMVDGEPPYFSD 244

Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
           + +  + R+   S  P   KL     ++           D + +ML  DP +R TA E L
Sbjct: 245 SPVQAMKRLR-DSPPP---KLKNSHKVSPVL-------RDFLERMLVRDPQERATAQELL 293

Query: 248 QQEYFK 253
              +  
Sbjct: 294 DHPFLL 299

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 78.2 bits (193), Expect = 5e-17
 Identities = 42/154 (27%), Positives = 59/154 (38%), Gaps = 20/154 (12%)

Query: 106 RDLKPVNILVDLDGKT-VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA 164
           RDLK  N L+D      +K+  FG +K       +  + VGT  Y APE+LL        
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI 198

Query: 165 VDIWPVGCIFGEMVSGKPLFPGANSLI----TLGRIV-GKSRKPSFCKLSLRDHLTNGFP 219
            D+W  G     M+ G   F           T+ RI+  K   P   ++S          
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS---------- 248

Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK 253
              P    LIS++   DP  RI+  E     +F 
Sbjct: 249 ---PECCHLISRIFVADPATRISIPEIKTHSWFL 279

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 39.3 bits (92), Expect = 7e-04
 Identities = 12/33 (36%), Positives = 16/33 (48%)

Query: 17 REVSCLMELNHPNIIRLMRVASQGIYLYPVFEY 49
          RE+     L HPNI+R   V     +L  + EY
Sbjct: 65 REIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 78.0 bits (193), Expect = 7e-17
 Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 15/159 (9%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G  +K+  +G+ K        +S   GT  Y APE+L G  +Y  
Sbjct: 132 IYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGF 189

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           +VD W +G +  EM++G+  F    S          +    F  + L   +    P  L 
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGS---SDNPDQNTEDYLFQVI-LEKQIR--IPRSLS 243

Query: 223 PAGIDLISKMLGMDPDKRI------TAAEALQQEYFKDV 255
                ++   L  DP +R+        A+     +F++V
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 77.6 bits (192), Expect = 7e-17
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 24/157 (15%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLKP NIL+D +G  +K+  FG AK +      +    GT  Y APE++     Y+ 
Sbjct: 128 IYRDLKPENILLDKNGH-IKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVST-KPYNK 182

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
           ++D W  G +  EM++G   F  +N++ T  +I+         +L               
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL-------NAELRFPPFFN-------E 228

Query: 224 AGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
              DL+S+++  D  +R+        +     +FK+V
Sbjct: 229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.9 bits (190), Expect = 9e-17
 Identities = 43/251 (17%), Positives = 81/251 (32%), Gaps = 72/251 (28%)

Query: 17  REVSCLMEL-NHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNG---- 67
           REV         P+I+R++ V     +    L  V E                ++G    
Sbjct: 59  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC---------------LDGGELF 103

Query: 68  --YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVD--L 117
                +   +++         E  +S+  +S+    +Y        RD+KP N+L     
Sbjct: 104 SRIQDRGDQAFT---------EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 154

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
               +K+  FG A                      E      +Y  + D+W +G I   +
Sbjct: 155 PNAILKLTDFGFA---------------------KETTGE--KYDKSCDMWSLGVIMYIL 191

Query: 178 VSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
           + G P F   + L     +  + R     +    +     +  +      LI  +L  +P
Sbjct: 192 LCGYPPFYSNHGLAISPGMKTRIRM---GQYEFPN---PEWSEVSEEVKMLIRNLLKTEP 245

Query: 238 DKRITAAEALQ 248
            +R+T  E + 
Sbjct: 246 TQRMTITEFMN 256

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 77.1 bits (190), Expect = 1e-16
 Identities = 52/270 (19%), Positives = 83/270 (30%), Gaps = 63/270 (23%)

Query: 17  REVSCLMELNHPNIIRLMRVASQGIYLYP----VFEYQVNDLAYLLKYPKDSMNGYSTKN 72
            E+   + + H NI+  +    +G   +     + +Y          +   S+  Y    
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY----------HENGSLYDYLKST 129

Query: 73  FNSYSLFTTFLLVEEFSSSDSSR------SLSFGTRY----IRRDLKPVNILVDLDGKTV 122
                               S        +  F T+       RDLK  NILV  +G T 
Sbjct: 130 TLDAKSMLKLAY-------SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TC 181

Query: 123 KVAGFGLAKSLYAYKGE----SSAEVGTHYYKAPELLLGLL-----EYSTAVDIWPVGCI 173
            +A  GLA    +   E     +  VGT  Y  PE+L   L     +     D++  G I
Sbjct: 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI 241

Query: 174 FGEMVSG--------------KPLFPGANSLITLGRIVGKSRK-PSFCKLSLRDHLTNGF 218
             E+                   L P   S   +  IV   +  PSF      D      
Sbjct: 242 LWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD---ECL 298

Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
             +      L+++    +P  R+TA    +
Sbjct: 299 RQM----GKLMTECWAHNPASRLTALRVKK 324

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 77.4 bits (191), Expect = 1e-16
 Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 15/159 (9%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST 163
           I RDLK  N+L+D +G  +K+  +G+ K        +S   GT  Y APE+L G  +Y  
Sbjct: 175 IYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGF 232

Query: 164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP-GLE 222
           +VD W +G +  EM++G+  F    S          +    F  + L   +    P  L 
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGS---SDNPDQNTEDYLFQVI-LEKQIR--IPRSLS 286

Query: 223 PAGIDLISKMLGMDPDKRI------TAAEALQQEYFKDV 255
                ++   L  DP +R+        A+     +F++V
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 77.3 bits (190), Expect = 2e-16
 Identities = 51/291 (17%), Positives = 86/291 (29%), Gaps = 65/291 (22%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +  E+      NHPNI+           L+ V  +               M   S K+  
Sbjct: 73  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF---------------MAYGSAKDLI 117

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGFG 128
                       E + +   + +     Y      + R +K  +IL+ +DGK V ++G  
Sbjct: 118 CTHFMDGM---NELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK-VYLSGLR 173

Query: 129 LAKSLYA-------YKGESSAEVGTHYYKAPELLL-GLLEYSTAVDIWPVGCIFGEMVSG 180
              S+ +               V    + +PE+L   L  Y    DI+ VG    E+ +G
Sbjct: 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

Query: 181 KP----------LF----------------PGANSLITLGRIVGKSRKPSFCKLSLRDHL 214
                       L                 P     ++  R V  S        S     
Sbjct: 234 HVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS 293

Query: 215 TNGFPGLEPAG------IDLISKMLGMDPDKRITAAEALQQEYFKDVPGRS 259
               P               + + L  +PD R +A+  L   +FK +  R+
Sbjct: 294 NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA 344

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 75.9 bits (187), Expect = 3e-16
 Identities = 50/263 (19%), Positives = 89/263 (33%), Gaps = 49/263 (18%)

Query: 17  REVSCLMELNHPNIIRLM----RVASQGIYLYPVFEYQVN------------DLAYLLKY 60
            EV  L  + H NI++ +    R  S  + L+ +  +                   L   
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHI 126

Query: 61  PKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK 120
            +    G +            +L  +     D  +          RD+K  N+L+  +  
Sbjct: 127 AETMARGLA------------YLHEDIPGLKDGHK-----PAISHRDIKSKNVLLKNNL- 168

Query: 121 TVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLL----EYSTAVDIWPVGCIF 174
           T  +A FGLA    A K  G++  +VGT  Y APE+L G +    +    +D++ +G + 
Sbjct: 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228

Query: 175 GEMVSGKPLFPGANSLITLGRIVGKSRKPSF-------CKLSLRDHLTNGFPGLEPAG-- 225
            E+ S      G      L       + PS             R  L + +         
Sbjct: 229 WELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288

Query: 226 IDLISKMLGMDPDKRITAAEALQ 248
            + I +    D + R++A    +
Sbjct: 289 CETIEECWDHDAEARLSAGCVGE 311

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.2 bits (188), Expect = 3e-16
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 18/159 (11%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAK-SLYAYKGESSAEVGTHYYKAPELLLGLLE-Y 161
           I RD+K  NIL+D +G  V +  FGL+K  +      +    GT  Y AP+++ G    +
Sbjct: 181 IYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
             AVD W +G +  E+++G   F       +   I   SR+    +      ++      
Sbjct: 240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRILKSEPPYPQEMS------ 290

Query: 222 EPAGIDLISKMLGMDPDKRI-----TAAEALQQEYFKDV 255
                DLI ++L  DP KR+      A E  +  +F+ +
Sbjct: 291 -ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 75.8 bits (186), Expect = 4e-16
 Identities = 28/252 (11%), Positives = 70/252 (27%), Gaps = 42/252 (16%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNF 73
             + +  L        ++             V E      L   +   K++      +  
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILV----------DLDGKTVK 123
                     ++E+    +           I  D+KP N ++          D     + 
Sbjct: 174 VISFAMRMLYMIEQVHDCE----------IIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223

Query: 124 VAGFGLAKSLYAYKGES--SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
           +   G +  +  +   +  +A+  T  ++  E+L     ++  +D + V      M+ G 
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGT 282

Query: 182 PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
            +             + + R P     +                 +    ML +     +
Sbjct: 283 YMKVKNEGGECKPEGLFR-RLPHLDMWN-----------------EFFHVMLNIPDCHHL 324

Query: 242 TAAEALQQEYFK 253
            + + L+Q+  K
Sbjct: 325 PSLDLLRQKLKK 336

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 74.3 bits (183), Expect = 1e-15
 Identities = 52/270 (19%), Positives = 84/270 (31%), Gaps = 63/270 (23%)

Query: 17  REVSCLMELNHPNIIRLM----RVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
            E+   + L H NI+  +            L+ +  Y          +   S+  Y    
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY----------HEMGSLYDYLQLT 100

Query: 73  FNSYSLFTTFLLVEEFSSSDSSR------SLSFGTRY----IRRDLKPVNILVDLDGKTV 122
                     +L         +          FGT+       RDLK  NILV  +G   
Sbjct: 101 TLDTVSCLRIVL-------SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QC 152

Query: 123 KVAGFGLAK----SLYAYKGESSAEVGTHYYKAPELL-----LGLLEYSTAVDIWPVGCI 173
            +A  GLA     S       ++  VGT  Y APE+L     +   +    VDIW  G +
Sbjct: 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLV 212

Query: 174 FGEMVSGKP--------------LFPGANSLITLGRIVGKSRK-PSFCKLSLRDHLTNGF 218
             E+                   + P   S   + ++V   ++ P+       D      
Sbjct: 213 LWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSD---PTL 269

Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
             L      L+ +    +P  R+TA    +
Sbjct: 270 TSL----AKLMKECWYQNPSARLTALRIKK 295

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 74.0 bits (182), Expect = 1e-15
 Identities = 48/272 (17%), Positives = 85/272 (31%), Gaps = 67/272 (24%)

Query: 17  REVSCLMELNHPNIIRLM----RVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
            E+   + L H NI+  +    +       L+ V +Y          +   S+  Y  + 
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY----------HEHGSLFDYLNRY 134

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSF------GTRY----IRRDLKPVNILVDLDGKTV 122
             +        L        ++  L+       GT+       RDLK  NILV  +G T 
Sbjct: 135 TVTVEGMIKLAL-------STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TC 186

Query: 123 KVAGFGLAKSLYAYKGE----SSAEVGTHYYKAPELLLGLL-----EYSTAVDIWPVGCI 173
            +A  GLA    +         +  VGT  Y APE+L   +     E     DI+ +G +
Sbjct: 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246

Query: 174 FGEMVSG-----------------KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN 216
           F E+                     P  P    +  +  +  +  +P+            
Sbjct: 247 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV--VCEQKLRPNIPNRWQSCEALR 304

Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
                      ++ +    +   R+TA    +
Sbjct: 305 VM-------AKIMRECWYANGAARLTALRIKK 329

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 73.9 bits (182), Expect = 1e-15
 Identities = 55/263 (20%), Positives = 96/263 (36%), Gaps = 53/263 (20%)

Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY----QVNDLAYLLKYPKDSMNGY 68
              I E+  L   +HP I++L+        L+ + E+     V+ +   L          
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG------- 113

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTV 122
                           + E       R +     +      I RDLK  N+L+ L+G  +
Sbjct: 114 ----------------LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD-I 156

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL----EYSTAVDIWPVG--CIFGE 176
           ++A FG++        +  + +GT Y+ APE+++        Y    DIW +G   I  E
Sbjct: 157 RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI--E 214

Query: 177 MVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD 236
           M   +P     N +  L +I  KS  P    L      +  F        D +   L  +
Sbjct: 215 MAQIEPPHHELNPMRVLLKI-AKSDPP---TLLTPSKWSVEF-------RDFLKIALDKN 263

Query: 237 PDKRITAAEALQQEYFKDVPGRS 259
           P+ R +AA+ L+  +   +    
Sbjct: 264 PETRPSAAQLLEHPFVSSITSNK 286

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 74.2 bits (182), Expect = 2e-15
 Identities = 44/172 (25%), Positives = 69/172 (40%), Gaps = 38/172 (22%)

Query: 116 DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFG 175
           + +   VK+A  G A  ++ +  E    + T  Y++ E+L+G   Y+T  DIW   C+  
Sbjct: 229 NAEKLKVKIADLGNACWVHKHFTED---IQTRQYRSLEVLIGS-GYNTPADIWSTACMAF 284

Query: 176 EMVSGKPLFPGANSLI-------------TLGRI------VGKSRKPSFCK--------- 207
           E+ +G  LF   +                 LG++       GK  K  F K         
Sbjct: 285 ELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344

Query: 208 ---LSLRDHL--TNGFPGLEPAGI-DLISKMLGMDPDKRITAAEALQQEYFK 253
                L + L     +   E AG  D +  ML + P+KR TAAE L+  +  
Sbjct: 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 74.5 bits (183), Expect = 2e-15
 Identities = 31/147 (21%), Positives = 51/147 (34%), Gaps = 32/147 (21%)

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV 165
            DLKP NI++  +   +K+   G    +           GT  ++APE++      + A 
Sbjct: 206 NDLKPENIMLTEEQ--LKLIDLGAVSRI----NSFGYLYGTPGFQAPEIVRT--GPTVAT 257

Query: 166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE-PA 224
           DI+ VG     +    P   G                         D L    P L+   
Sbjct: 258 DIYTVGRTLAALTLDLPTRNGRY----------------------VDGLPEDDPVLKTYD 295

Query: 225 GID-LISKMLGMDPDKRITAAEALQQE 250
               L+ + +  DP +R T AE +  +
Sbjct: 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQ 322

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 72.7 bits (179), Expect = 4e-15
 Identities = 52/252 (20%), Positives = 102/252 (40%), Gaps = 40/252 (15%)

Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
             + +E++ L + + P + +      +   L+ + EY               + G S  +
Sbjct: 65  EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY---------------LGGGSALD 109

Query: 73  FNSYSLFTTFLLVEEFSSS---DSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGF 127
                L     L E   ++   +  + L +    + I RD+K  N+L+   G+ VK+A F
Sbjct: 110 -----LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE-VKLADF 163

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
           G+A  L   + + +  VGT ++ APE++     Y +  DIW +G    E+  G+P     
Sbjct: 164 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSEL 222

Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
           + +  L  I  K+  P     +L  + +           + +   L  +P  R TA E L
Sbjct: 223 HPMKVLFLI-PKNNPP-----TLEGNYSKPL-------KEFVEACLNKEPSFRPTAKELL 269

Query: 248 QQEYFKDVPGRS 259
           + ++      ++
Sbjct: 270 KHKFILRNAKKT 281

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 71.1 bits (175), Expect = 1e-14
 Identities = 41/148 (27%), Positives = 65/148 (43%), Gaps = 18/148 (12%)

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGLLEYSTA 164
           RD+KP NILV  D     +  FG+A +    K  +    VGT YY APE       ++T 
Sbjct: 158 RDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE--SHATY 214

Query: 165 -VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEP 223
             DI+ + C+  E ++G P + G    +    I     +PS    ++R       PG+ P
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPS----TVR-------PGI-P 262

Query: 224 AGID-LISKMLGMDPDKRITAAEALQQE 250
              D +I++ +  +P+ R      L   
Sbjct: 263 VAFDAVIARGMAKNPEDRYVTCGDLSAA 290

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 71.1 bits (175), Expect = 1e-14
 Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 19/152 (12%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLE 160
           I RD+KP NI++      VKV  FG+A+++        +++A +GT  Y +PE   G  +
Sbjct: 138 IHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--D 194

Query: 161 YSTA-VDIWPVGCIFGEMVSGKPLFPGANSL-ITLGRIVGKSRKPSFCKLSLRDHLTNGF 218
              A  D++ +GC+  E+++G+P F G + + +    +      PS              
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-----------ARH 243

Query: 219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQE 250
            GL      ++ K L  +P+ R   A  ++ +
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 70.1 bits (172), Expect = 3e-14
 Identities = 60/261 (22%), Positives = 96/261 (36%), Gaps = 69/261 (26%)

Query: 13  SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
             +I+EV  L +L HPN I+      +    + V EY +   + LL+  K  +       
Sbjct: 99  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ------ 152

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAG 126
                         E   +  +     G  Y      I RD+K  NIL+   G  VK+  
Sbjct: 153 --------------EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGD 197

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--YSTAVDIWPVG--CIFGEMVSGKP 182
           FG A  +      +++ VGT Y+ APE++L + E  Y   VD+W +G  CI  E+   KP
Sbjct: 198 FGSASIM----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAERKP 251

Query: 183 ----------LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
                     L+      I       ++  P+        H +  F        + +   
Sbjct: 252 PLFNMNAMSALY-----HIA------QNESPALQS----GHWSEYF-------RNFVDSC 289

Query: 233 LGMDPDKRITAAEALQQEYFK 253
           L   P  R T+   L+  +  
Sbjct: 290 LQKIPQDRPTSEVLLKHRFVL 310

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 69.6 bits (171), Expect = 4e-14
 Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 32/170 (18%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKDSMNGYSTKNF 73
            RE   L  L H +I++   V   G  L  VFEY  + DL  +L  +  D+M     +  
Sbjct: 65  QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
            +        ++    +S  +  + +     ++ RDL   N LV      VK+  FG+++
Sbjct: 125 QAKGELGLSQMLH--IASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSR 181

Query: 132 SLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVDIW 168
            +Y+          T YY+             PE ++     ++T  D+W
Sbjct: 182 DVYS----------TDYYRVGGHTMLPIRWMPPESIMYRK--FTTESDVW 219

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 69.7 bits (171), Expect = 4e-14
 Identities = 49/265 (18%), Positives = 93/265 (35%), Gaps = 50/265 (18%)

Query: 13  SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
             + +E++ L +  +H NI         G ++        + L  ++++        S  
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYY-----GAFIKKNPPGMDDQLWLVMEF----CGAGSVT 115

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVA 125
           +    +   T    +E   +   R +  G  +      I RD+K  N+L+  + + VK+ 
Sbjct: 116 DLIKNTKGNTL---KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLV 171

Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE----YSTAVDIWPVG--CIFGEMVS 179
            FG++  L    G  +  +GT Y+ APE++         Y    D+W +G   I  EM  
Sbjct: 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI--EMAE 229

Query: 180 GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAG-----IDLISKMLG 234
           G P     + +  L  I                   N  P L+           I   L 
Sbjct: 230 GAPPLCDMHPMRALFLIP-----------------RNPAPRLKSKKWSKKFQSFIESCLV 272

Query: 235 MDPDKRITAAEALQQEYFKDVPGRS 259
            +  +R    + ++  + +D P   
Sbjct: 273 KNHSQRPATEQLMKHPFIRDQPNER 297

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 68.4 bits (168), Expect = 9e-14
 Identities = 37/150 (24%), Positives = 67/150 (44%), Gaps = 16/150 (10%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPELLLGLLEYS 162
           + RD+KP NIL+D +   +K+  FG+AK+L       +  V GT  Y +PE   G  E +
Sbjct: 133 VHRDIKPQNILIDSNKT-LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG--EAT 189

Query: 163 TA-VDIWPVGCIFGEMVSGKPLFPGANSL-ITLGRIVGKSRKPSFCKLSLRDHLTNGFPG 220
               DI+ +G +  EM+ G+P F G  ++ I +  I       +          T+    
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT----------TDVRKD 239

Query: 221 LEPAGIDLISKMLGMDPDKRITAAEALQQE 250
           +  +  ++I +    D   R    + ++ +
Sbjct: 240 IPQSLSNVILRATEKDKANRYKTIQEMKDD 269

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 68.7 bits (168), Expect = 1e-13
 Identities = 42/195 (21%), Positives = 70/195 (35%), Gaps = 48/195 (24%)

Query: 17  REVSCLMELNHPNIIRLM-----RVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           + +  +  + H NI R +       A   +    V EY          YP  S+  Y + 
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY----------YPNGSLXKYLSL 105

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSF-----------GTRYIRRDLKPVNILVDLDGK 120
           + + +                 +R L++                 RDL   N+LV  DG 
Sbjct: 106 HTSDWVSSCRLAH-------SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG- 157

Query: 121 TVKVAGFGLAKSLYAYK--------GESSAEVGTHYYKAPELLLGLL------EYSTAVD 166
           T  ++ FGL+  L   +          + +EVGT  Y APE+L G +           VD
Sbjct: 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVD 217

Query: 167 IWPVGCIFGEMVSGK 181
           ++ +G I+ E+    
Sbjct: 218 MYALGLIYWEIFMRC 232

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 41/198 (20%), Positives = 77/198 (38%), Gaps = 37/198 (18%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDS 64
                     + E S + E N  +++RL+ V SQG     + E     DL   L+  + +
Sbjct: 66  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 125

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTV 122
           M         S S            + + +  +++    +++ RDL   N +V  +  TV
Sbjct: 126 MANNPVLAPPSLSKMIQM-------AGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTV 177

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVDIWP 169
           K+  FG+ + +Y           T YY+            +PE L  G+  ++T  D+W 
Sbjct: 178 KIGDFGMTRDIYE----------TDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWS 225

Query: 170 VGCIFGEMVS-GKPLFPG 186
            G +  E+ +  +  + G
Sbjct: 226 FGVVLWEIATLAEQPYQG 243

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 67.3 bits (165), Expect = 3e-13
 Identities = 41/182 (22%), Positives = 70/182 (38%), Gaps = 48/182 (26%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFN 74
            RE + + E ++PNI++L+ V + G  +  +FEY    DL   L+          + +  
Sbjct: 98  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 75  SYSLFTTFLLVEEFSSSD---------------SSRSLSFGTRYIRRDLKPVNILVDLDG 119
           S     +       S ++               S R      +++ RDL   N LV  + 
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER------KFVHRDLATRNCLVG-EN 210

Query: 120 KTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVD 166
             VK+A FGL++++Y+            YYK             PE +      Y+T  D
Sbjct: 211 MVVKIADFGLSRNIYS----------ADYYKADGNDAIPIRWMPPESIFYNR--YTTESD 258

Query: 167 IW 168
           +W
Sbjct: 259 VW 260

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 66.5 bits (163), Expect = 5e-13
 Identities = 42/189 (22%), Positives = 69/189 (36%), Gaps = 42/189 (22%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDS 64
           N        ++ E + L ++NHP++I+L    SQ   L  + EY     L   L+  +  
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGT------------RYIRRDLKPVN 112
             GY     +  S           +  D    +SF              + + RDL   N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGD---LISFAWQISQGMQYLAEMKLVHRDLAARN 180

Query: 113 ILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLL 159
           ILV  +G+ +K++ FGL++ +Y              Y             A E L   + 
Sbjct: 181 ILVA-EGRKMKISDFGLSRDVYE----------EDSYVKRSQGRIPVKWMAIESLFDHI- 228

Query: 160 EYSTAVDIW 168
            Y+T  D+W
Sbjct: 229 -YTTQSDVW 236

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 66.2 bits (162), Expect = 7e-13
 Identities = 36/155 (23%), Positives = 59/155 (38%), Gaps = 16/155 (10%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--- 160
           I RD+KP NIL+D  G+ +K+  FG++  L   K +     G   Y APE +        
Sbjct: 147 IHRDVKPSNILLDERGQ-IKLCDFGISGRLVDDKAKDR-SAGCAAYMAPERIDPPDPTKP 204

Query: 161 -YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFP 219
            Y    D+W +G    E+ +G+  +    +   +   V +   P    L      +  F 
Sbjct: 205 DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP---LLPGHMGFSGDF- 260

Query: 220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
                    +   L  D  KR    + L+  + K 
Sbjct: 261 ------QSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 66.4 bits (162), Expect = 7e-13
 Identities = 62/276 (22%), Positives = 101/276 (36%), Gaps = 61/276 (22%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +IRE+  L E N P I+            Y  F Y   +++  +++    M+G S     
Sbjct: 78  IIRELQVLHECNSPYIVGF----------YGAF-YSDGEISICMEH----MDGGSLD--- 119

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRY-------IRRDLKPVNILVDLDGKTVKVAGF 127
              +      + E      S ++  G  Y       + RD+KP NILV+  G+ +K+  F
Sbjct: 120 --QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDF 176

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
           G++  L      S   VGT  Y +PE L G   YS   DIW +G    EM  G+   P  
Sbjct: 177 GVSGQLIDSMANSF--VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPP 233

Query: 188 NSLITLGRIVGKSRKPSFCK------------------------LSLRDHLTNGFPGLEP 223
           ++         +    +                             L D++ N  P   P
Sbjct: 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293

Query: 224 AG------IDLISKMLGMDPDKRITAAEALQQEYFK 253
           +G       D ++K L  +P +R    + +   + K
Sbjct: 294 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 65.8 bits (161), Expect = 9e-13
 Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 13/154 (8%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--- 160
           I RD+KP NIL+D  G  +K+  FG++  L     ++  + G   Y APE +        
Sbjct: 148 IHRDIKPSNILLDRSGN-IKLCDFGISGQLVDSIAKTR-DAGCRPYMAPERIDPSASRQG 205

Query: 161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPG 220
           Y    D+W +G    E+ +G+  +P  NS+      V K   P      L +     F  
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP-----QLSNSEEREFS- 259

Query: 221 LEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
             P+ I+ ++  L  D  KR    E L+  +   
Sbjct: 260 --PSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 65.8 bits (161), Expect = 1e-12
 Identities = 39/176 (22%), Positives = 63/176 (35%), Gaps = 45/176 (25%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFN 74
            RE   L  L H +I+R   V ++G  L  VFEY  + DL   L+         +     
Sbjct: 91  QREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150

Query: 75  SYSLFTTFLLVE---------EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVA 125
           +        L+           + +            ++ RDL   N LV   G  VK+ 
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAG---------LHFVHRDLATRNCLVG-QGLVVKIG 200

Query: 126 GFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVDIW 168
            FG+++ +Y+          T YY+             PE +L     ++T  D+W
Sbjct: 201 DFGMSRDIYS----------TDYYRVGGRTMLPIRWMPPESILYRK--FTTESDVW 244

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 64.2 bits (157), Expect = 3e-12
 Identities = 39/157 (24%), Positives = 64/157 (40%), Gaps = 22/157 (14%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAE---VGTHYYKAPELLLGLLE 160
           I RD+KP N+L++  G+ VK+  FG++  L     +  A+    G   Y APE +   L 
Sbjct: 132 IHRDVKPSNVLINALGQ-VKMCDFGISGYL----VDDVAKDIDAGCKPYMAPERINPELN 186

Query: 161 ---YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG 217
              YS   DIW +G    E+   +  +    +     + V +   P        D  +  
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA----DKFSAE 242

Query: 218 FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD 254
           F       +D  S+ L  +  +R T  E +Q  +F  
Sbjct: 243 F-------VDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 63.8 bits (156), Expect = 4e-12
 Identities = 43/187 (22%), Positives = 66/187 (35%), Gaps = 46/187 (24%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKD 63
                +      E      L HPN++ L+ V ++   L  +F Y  + DL  +L+     
Sbjct: 50  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 109

Query: 64  SMNGYSTKNFNSYSLFTTFLLVE---------EFSSSDSSRSLSFGTRYIRRDLKPVNIL 114
           S  G +  +    S       V          E+ SS            + +DL   N+L
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---------HHVVHKDLATRNVL 160

Query: 115 VDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEY 161
           V  D   VK++  GL + +YA            YYK            APE ++ G   +
Sbjct: 161 VY-DKLNVKISDLGLFREVYA----------ADYYKLLGNSLLPIRWMAPEAIMYGK--F 207

Query: 162 STAVDIW 168
           S   DIW
Sbjct: 208 SIDSDIW 214

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 63.5 bits (155), Expect = 6e-12
 Identities = 41/182 (22%), Positives = 69/182 (37%), Gaps = 38/182 (20%)

Query: 6   NTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPK 62
              +        E+  L +L +HPNII L+       YLY   EY  + +L  +L K   
Sbjct: 63  YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 122

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVE---------EFSSSDSSRSLSFGTRYIRRDLKPVNI 113
              +       ++ S  ++  L+          ++ S           ++I RDL   NI
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---------KQFIHRDLAARNI 173

Query: 114 LVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------APE-LLLGLLEYSTAVD 166
           LV  +    K+A FGL++    Y  ++         +      A E L   +  Y+T  D
Sbjct: 174 LVG-ENYVAKIADFGLSRGQEVYVKKTMG-------RLPVRWMAIESLNYSV--YTTNSD 223

Query: 167 IW 168
           +W
Sbjct: 224 VW 225

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 62.3 bits (152), Expect = 2e-11
 Identities = 41/196 (20%), Positives = 77/196 (39%), Gaps = 43/196 (21%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKD 63
            T       ++ E   +  +++P++ RL+ +     + L  + +      L   ++  KD
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKD 112

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
           +                +  L+        ++ +++    R + RDL   N+LV    + 
Sbjct: 113 N--------------IGSQYLLN--WCVQIAKGMNYLEDRRLVHRDLAARNVLVK-TPQH 155

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYK------APELLLGLLEYSTAVDIWPVGCIFG 175
           VK+  FGLAK L A + E  AE G    K      A E +L    Y+   D+W     +G
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGG----KVPIKWMALESIL-HRIYTHQSDVWS----YG 206

Query: 176 ----EMVS-GKPLFPG 186
               E+++ G   + G
Sbjct: 207 VTVWELMTFGSKPYDG 222

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 45/185 (24%), Positives = 70/185 (37%), Gaps = 43/185 (23%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGI-YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF- 73
           + E S + +L H N+++L+ V  +    LY V EY               M   S  ++ 
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY---------------MAKGSLVDYL 278

Query: 74  --NSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVA 125
                S+     L+        S  +     Y      + RDL   N+LV  +    KV+
Sbjct: 279 RSRGRSVLGGDCLL------KFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVS 331

Query: 126 GFGLAKSLYAYKGESSAEVGTHY-YK--APELLLGLLEYSTAVDIWPVGCIFGEMVS-GK 181
            FGL K         S +       K  APE L    ++ST  D+W  G +  E+ S G+
Sbjct: 332 DFGLTKEAS------STQDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGR 384

Query: 182 PLFPG 186
             +P 
Sbjct: 385 VPYPR 389

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 45/181 (24%), Positives = 69/181 (38%), Gaps = 33/181 (18%)

Query: 6   NTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPK 62
           +  E   S ++ E+  +  +  H NII L+   +Q   LY + EY    +L  YL     
Sbjct: 78  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 137

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGK 120
             M      N       T   LV    +   +R + +    + I RDL   N+LV  +  
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLV-SC-TYQLARGMEYLASQKCIHRDLAARNVLVT-ENN 194

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVDI 167
            +K+A FGLA+ +              YYK            APE L   +  Y+   D+
Sbjct: 195 VMKIADFGLARDIN----------NIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDV 242

Query: 168 W 168
           W
Sbjct: 243 W 243

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 62.0 bits (151), Expect = 2e-11
 Identities = 44/181 (24%), Positives = 72/181 (39%), Gaps = 33/181 (18%)

Query: 6   NTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPK 62
           +  E   S +I E+  +  +  H NII L+   +Q   LY + EY    +L  YL     
Sbjct: 112 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 171

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGK 120
             +      + N     ++  LV    +   +R + +    + I RDL   N+LV  +  
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVS--CAYQVARGMEYLASKKCIHRDLAARNVLVT-EDN 228

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVDI 167
            +K+A FGLA+ ++             YYK            APE L   +  Y+   D+
Sbjct: 229 VMKIADFGLARDIHH----------IDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDV 276

Query: 168 W 168
           W
Sbjct: 277 W 277

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 61.5 bits (150), Expect = 3e-11
 Identities = 37/180 (20%), Positives = 66/180 (36%), Gaps = 33/180 (18%)

Query: 6   NTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKD 63
                   +++ E+  +  L  H NI+ L+   + G  +  + EY    DL   L+    
Sbjct: 87  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
            +         + +  T  LL   F SS  ++ ++F      I RD+   N+L+  +G  
Sbjct: 147 VLETDPAFAIANSTASTRDLL--HF-SSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHV 202

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVDIW 168
            K+  FGLA+ +               Y             APE +   +  Y+   D+W
Sbjct: 203 AKIGDFGLARDIM----------NDSNYIVKGNARLPVKWMAPESIFDCV--YTVQSDVW 250

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 61.5 bits (150), Expect = 3e-11
 Identities = 47/192 (24%), Positives = 75/192 (39%), Gaps = 34/192 (17%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
                + +  ++E   L + +HPNI+RL+ V +Q   +Y V E                +
Sbjct: 150 TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL---------------V 194

Query: 66  NGYSTKNF---NSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGK 120
            G     F       L    LL  +    D++  + +      I RDL   N LV  +  
Sbjct: 195 QGGDFLTFLRTEGARLRVKTLL--QM-VGDAAAGMEYLESKCCIHRDLAARNCLVT-EKN 250

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHY--YK--APE-LLLGLLEYSTAVDIWPVGCIFG 175
            +K++ FG+++      G  +A  G      K  APE L  G   YS+  D+W  G +  
Sbjct: 251 VLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGR--YSSESDVWSFGILLW 306

Query: 176 EMVS-GKPLFPG 186
           E  S G   +P 
Sbjct: 307 ETFSLGASPYPN 318

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 61.2 bits (149), Expect = 4e-11
 Identities = 45/181 (24%), Positives = 69/181 (38%), Gaps = 33/181 (18%)

Query: 6   NTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPK 62
           +  E   S ++ E+  +  +  H NII L+   +Q   LY + EY    +L  YL     
Sbjct: 124 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGK 120
             M      N       T   LV    +   +R + +    + I RDL   N+LV  +  
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLV-SC-TYQLARGMEYLASQKCIHRDLAARNVLVT-ENN 240

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVDI 167
            +K+A FGLA+ +              YYK            APE L   +  Y+   D+
Sbjct: 241 VMKIADFGLARDIN----------NIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDV 288

Query: 168 W 168
           W
Sbjct: 289 W 289

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 61.7 bits (150), Expect = 4e-11
 Identities = 42/191 (21%), Positives = 82/191 (42%), Gaps = 30/191 (15%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPK 62
             +TME      ++E + + E+ HPN+++L+ V ++    Y + E+    +L   L+   
Sbjct: 254 KEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 311

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGK 120
                            +  +L+   ++   S ++ +     +I R+L   N LV  +  
Sbjct: 312 RQE-------------VSAVVLLY-MAT-QISSAMEYLEKKNFIHRNLAARNCLVG-ENH 355

Query: 121 TVKVAGFGLAKSL----YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGE 176
            VKVA FGL++ +    Y     +   +    + APE L    ++S   D+W  G +  E
Sbjct: 356 LVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLA-YNKFSIKSDVWAFGVLLWE 411

Query: 177 MVS-GKPLFPG 186
           + + G   +PG
Sbjct: 412 IATYGMSPYPG 422

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 60.7 bits (148), Expect = 4e-11
 Identities = 41/196 (20%), Positives = 75/196 (38%), Gaps = 42/196 (21%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRV-ASQGIYLYPVFEYQVN-DLAYLLKYPKD 63
            T +     M+RE   + +L++P I+RL+ V  ++ + L  V E      L   L   ++
Sbjct: 48  GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML--VMEMAGGGPLHKFLVGKRE 105

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFG------TRYIRRDLKPVNILVDL 117
                               +       +    +S G        ++ RDL   N+L+  
Sbjct: 106 E--------------IPVSNVA------ELLHQVSMGMKYLEEKNFVHRDLAARNVLLV- 144

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------APELLLGLLEYSTAVDIWPVG 171
           +    K++ FGL+K+L A     +A       K      APE +    ++S+  D+W  G
Sbjct: 145 NRHYAKISDFGLSKALGADDSYYTARSAG---KWPLKWYAPECIN-FRKFSSRSDVWSYG 200

Query: 172 CIFGEMVS-GKPLFPG 186
               E +S G+  +  
Sbjct: 201 VTMWEALSYGQKPYKK 216

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 61.5 bits (149), Expect = 5e-11
 Identities = 38/195 (19%), Positives = 75/195 (38%), Gaps = 40/195 (20%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRV-ASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
            T +     M+RE   + +L++P I+RL+ V  ++ + L  V E                
Sbjct: 374 GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML--VMEM----------AGGGP 421

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFG------TRYIRRDLKPVNILVDLD 118
           ++ +         +     +       +    +S G        ++ R+L   N+L+  +
Sbjct: 422 LHKFLVGKREEIPVSN---VA------ELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-N 471

Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------APELLLGLLEYSTAVDIWPVGC 172
               K++ FGL+K+L A     +A       K      APE +    ++S+  D+W  G 
Sbjct: 472 RHYAKISDFGLSKALGADDSYYTARSAG---KWPLKWYAPECIN-FRKFSSRSDVWSYGV 527

Query: 173 IFGEMVS-GKPLFPG 186
              E +S G+  +  
Sbjct: 528 TMWEALSYGQKPYKK 542

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 60.8 bits (148), Expect = 6e-11
 Identities = 50/196 (25%), Positives = 74/196 (37%), Gaps = 41/196 (20%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDS 64
              E      + E S + + +HPNIIRL  V ++G     V EY  N  L   L+     
Sbjct: 88  GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ 147

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFG------TRYIRRDLKPVNILVDLD 118
                         FT   LV         R +  G        Y+ RDL   N+LVD  
Sbjct: 148 --------------FTIMQLV------GMLRGVGAGMRYLSDLGYVHRDLAARNVLVD-S 186

Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------APE-LLLGLLEYSTAVDIWPVG 171
               KV+ FGL++ L      +    G    K      APE +      +S+A D+W  G
Sbjct: 187 NLVCKVSDFGLSRVLEDDPDAAYTTTGG---KIPIRWTAPEAIAFR--TFSSASDVWSFG 241

Query: 172 CIFGEMVS-GKPLFPG 186
            +  E+++ G+  +  
Sbjct: 242 VVMWEVLAYGERPYWN 257

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 60.8 bits (148), Expect = 6e-11
 Identities = 46/192 (23%), Positives = 76/192 (39%), Gaps = 33/192 (17%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDS 64
              E      + E S + + +HPNIIRL  V ++   +  V EY  N  L   L+     
Sbjct: 84  GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLD 118
                         FT   LV         R ++ G +Y      + RDL   NIL++  
Sbjct: 144 --------------FTVIQLV------GMLRGIASGMKYLSDMGYVHRDLAARNILIN-S 182

Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHY---YKAPELLLGLLEYSTAVDIWPVGCIFG 175
               KV+ FGL + L      +    G      + +PE +    ++++A D+W  G +  
Sbjct: 183 NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA-YRKFTSASDVWSYGIVLW 241

Query: 176 EMVS-GKPLFPG 186
           E++S G+  +  
Sbjct: 242 EVMSYGERPYWE 253

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 60.4 bits (147), Expect = 7e-11
 Identities = 45/237 (18%), Positives = 89/237 (37%), Gaps = 53/237 (22%)

Query: 1   MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVN-D 53
           M+             +RE +C+ E +HP++ +L+ V+ +            +  +  + D
Sbjct: 58  MLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117

Query: 54  L-AYLLKY-PKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLK 109
           L A+LL     ++      +    + +             D +  + +     +I RDL 
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMV-------------DIACGMEYLSSRNFIHRDLA 164

Query: 110 PVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLL 156
             N ++  +  TV VA FGL++ +Y             YY+            A E L  
Sbjct: 165 ARNCMLA-EDMTVCVADFGLSRKIY----------SGDYYRQGCASKLPVKWLALESLAD 213

Query: 157 GLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSR--KPSFCKLSL 210
            L  Y+   D+W  G    E+++ G+  + G  +      ++G +R  +P  C   +
Sbjct: 214 NL--YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEV 268

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 60.4 bits (147), Expect = 8e-11
 Identities = 37/193 (19%), Positives = 68/193 (35%), Gaps = 42/193 (21%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKD 63
              E      + E   + + NH NI+R + V+ Q +  + + E     DL ++L +    
Sbjct: 71  VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR 130

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGK- 120
                        S      L+    + D +    +     +I RD+   N L+   G  
Sbjct: 131 PSQP---------SSLAMLDLLH--VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179

Query: 121 -TVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVD 166
              K+  FG+A+ +Y             YY+             PE  + G+  +++  D
Sbjct: 180 RVAKIGDFGMARDIY----------RASYYRKGGCAMLPVKWMPPEAFMEGI--FTSKTD 227

Query: 167 IWPVGCIFGEMVS 179
            W  G +  E+ S
Sbjct: 228 TWSFGVLLWEIFS 240

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 60.0 bits (146), Expect = 9e-11
 Identities = 41/190 (21%), Positives = 69/190 (36%), Gaps = 44/190 (23%)

Query: 6   NTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKD 63
                   +++ E+  + +L +H NI+ L+   +    +Y +FEY    DL   L+  ++
Sbjct: 86  KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKRE 145

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGT------------RYIRRDLKPV 111
             +    +  N   L       E+ +       L F                + RDL   
Sbjct: 146 KFSEDEIEYENQKRLEEE----EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201

Query: 112 NILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APELLL-GL 158
           N+LV   GK VK+  FGLA+ + +             Y             APE L  G+
Sbjct: 202 NVLVT-HGKVVKICDFGLARDIMS----------DSNYVVRGNARLPVKWMAPESLFEGI 250

Query: 159 LEYSTAVDIW 168
             Y+   D+W
Sbjct: 251 --YTIKSDVW 258

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 59.6 bits (145), Expect = 1e-10
 Identities = 30/188 (15%), Positives = 58/188 (30%), Gaps = 43/188 (22%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFN 74
               S + +L+H +++    V   G     V E+     L   LK  K+ +N        
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCIN-------- 111

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDL-------DGKTVKVA 125
                   L V    +   + ++ F      I  ++   NIL+         +   +K++
Sbjct: 112 ----ILWKLEV----AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163

Query: 126 GFGLAKSLYAYKGESSAEVGTHYYK------APELLLGLLEYSTAVDIWPVGCIFGEMVS 179
             G++ ++                +       PE +      + A D W  G    E+ S
Sbjct: 164 DPGISITVL----------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

Query: 180 -GKPLFPG 186
            G      
Sbjct: 214 GGDKPLSA 221

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 44/184 (23%), Positives = 68/184 (36%), Gaps = 36/184 (19%)

Query: 15  MIREVSCLMELNHPNIIRLMRV-ASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKN 72
            IREV+ +  L+H N+IRL  V  +  + +  V E      L   L+  +          
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM--VTELAPLGSLLDRLRKHQGH-------- 117

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFG------TRYIRRDLKPVNILVDLDGKTVKVAG 126
                 F    L         +  ++ G       R+I RDL   N+L+      VK+  
Sbjct: 118 ------FLLGTLS------RYAVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGD 164

Query: 127 FGLAKSLYAYKGESSAEVGTHY-YK--APELLLGLLEYSTAVDIWPVGCIFGEMVS-GKP 182
           FGL ++L         +      +   APE L     +S A D W  G    EM + G+ 
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQE 223

Query: 183 LFPG 186
            + G
Sbjct: 224 PWIG 227

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 44/192 (22%), Positives = 70/192 (36%), Gaps = 31/192 (16%)

Query: 6   NTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKD 63
           +       +++ E+  L  L NH NI+ L+   + G     + EY    DL   L+  +D
Sbjct: 64  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFS-SSDSSRSLSF--GTRYIRRDLKPVNILVDLDGK 120
           S     T             L +  S S   ++ ++F      I RDL   NIL+   G+
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGR 182

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APELLL-GLLEYSTAVDI 167
             K+  FGLA+ +               Y             APE +   +  Y+   D+
Sbjct: 183 ITKICDFGLARDIK----------NDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDV 230

Query: 168 WPVGCIFGEMVS 179
           W  G    E+ S
Sbjct: 231 WSYGIFLWELFS 242

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 36/182 (19%), Positives = 68/182 (37%), Gaps = 34/182 (18%)

Query: 6   NTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQ-GIYLYPVFEYQVN-DL-AYLLKYP 61
                   +++ E+  L+ + +H N++ L+   ++ G  L  + E+    +L  YL    
Sbjct: 68  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127

Query: 62  KDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDG 119
            + +              T   L+  +S    ++ + F    + I RDL   NIL+  + 
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLIC-YSF-QVAKGMEFLASRKCIHRDLAARNILLS-EK 184

Query: 120 KTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVD 166
             VK+  FGLA+ +Y              Y             APE +   +  Y+   D
Sbjct: 185 NVVKICDFGLARDIYK----------DPDYVRKGDARLPLKWMAPETIFDRV--YTIQSD 232

Query: 167 IW 168
           +W
Sbjct: 233 VW 234

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 58.8 bits (143), Expect = 2e-10
 Identities = 40/180 (22%), Positives = 72/180 (40%), Gaps = 31/180 (17%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF-- 73
           I E   +M+L+HP +++L  V  +   +  V E+               M      ++  
Sbjct: 51  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF---------------MEHGCLSDYLR 95

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
               LF    L+      D    +++      I RDL   N LV  + + +KV+ FG+ +
Sbjct: 96  TQRGLFAAETLLG--MCLDVCEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTR 152

Query: 132 SLYAYKGESSAEVGTHY-YK--APE-LLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
             +    + ++  GT +  K  +PE        YS+  D+W  G +  E+ S GK  +  
Sbjct: 153 --FVLDDQYTSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 59.3 bits (144), Expect = 2e-10
 Identities = 37/193 (19%), Positives = 68/193 (35%), Gaps = 42/193 (21%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKD 63
              E      + E   + + NH NI+R + V+ Q +  + + E     DL ++L +    
Sbjct: 112 VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR 171

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGK- 120
                        S      L+    + D +    +     +I RD+   N L+   G  
Sbjct: 172 PSQP---------SSLAMLDLLH--VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220

Query: 121 -TVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVD 166
              K+  FG+A+ +Y             YY+             PE  + G+  +++  D
Sbjct: 221 RVAKIGDFGMARDIY----------RAGYYRKGGCAMLPVKWMPPEAFMEGI--FTSKTD 268

Query: 167 IWPVGCIFGEMVS 179
            W  G +  E+ S
Sbjct: 269 TWSFGVLLWEIFS 281

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 58.9 bits (143), Expect = 2e-10
 Identities = 54/220 (24%), Positives = 76/220 (34%), Gaps = 65/220 (29%)

Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIY--LYPVFEYQVNDLAYLLKYPK 62
           H+T E +     RE+  L  L H NI++   V        L  + EY           P 
Sbjct: 80  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY----------LPY 128

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGT------------RYIRRDLKP 110
            S+  Y               L +     D  + L + +            RYI RDL  
Sbjct: 129 GSLRDY---------------LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 173

Query: 111 VNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APELLLGL 158
            NILV+ +   VK+  FGL K L              YYK            APE L   
Sbjct: 174 RNILVE-NENRVKIGDFGLTKVL---------PQDKEYYKVKEPGESPIFWYAPESLT-E 222

Query: 159 LEYSTAVDIWPVGCIFGEMVS--GKPLFPGANSLITLGRI 196
            ++S A D+W  G +  E+ +   K   P A  +  +G  
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 52/220 (23%), Positives = 76/220 (34%), Gaps = 65/220 (29%)

Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIY--LYPVFEYQVNDLAYLLKYPK 62
           H+T E +     RE+  L  L H NI++   V        L  + EY           P 
Sbjct: 49  HSTEEHL-RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY----------LPY 97

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGT------------RYIRRDLKP 110
            S+  Y               L +     D  + L + +            RYI RDL  
Sbjct: 98  GSLRDY---------------LQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 142

Query: 111 VNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APELLLGL 158
            NILV+ +   VK+  FGL K L              ++K            APE L   
Sbjct: 143 RNILVE-NENRVKIGDFGLTKVL---------PQDKEFFKVKEPGESPIFWYAPESLT-E 191

Query: 159 LEYSTAVDIWPVGCIFGEMVS--GKPLFPGANSLITLGRI 196
            ++S A D+W  G +  E+ +   K   P A  +  +G  
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 58.4 bits (142), Expect = 2e-10
 Identities = 39/203 (19%), Positives = 76/203 (37%), Gaps = 58/203 (28%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVN-DL-AYLLKYPK 62
            T + V    ++E   + + +HP+I++L+ V ++  +++  + E     +L ++L     
Sbjct: 54  CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI--IMELCTLGELRSFLQVRKY 111

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFG------TRYIRRDLKPVNILVD 116
                                L+        +  LS         R++ RD+   N+LV 
Sbjct: 112 S---------------LDLASLI------LYAYQLSTALAYLESKRFVHRDIAARNVLVS 150

Query: 117 LDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK-----------APE-LLLGLLEYSTA 164
                VK+  FGL++ +            + YYK           APE +      +++A
Sbjct: 151 -SNDCVKLGDFGLSRYME----------DSTYYKASKGKLPIKWMAPESINFR--RFTSA 197

Query: 165 VDIWPVGCIFGEMVS-GKPLFPG 186
            D+W  G    E++  G   F G
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQG 220

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 58.4 bits (142), Expect = 3e-10
 Identities = 39/202 (19%), Positives = 71/202 (35%), Gaps = 56/202 (27%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKD 63
           +         + E   +  L+HP+I++L+ +  +   ++  + E     +L + L+  K+
Sbjct: 51  DCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI--IMELYPYGELGHYLERNKN 108

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFG------TRYIRRDLKPVNILVDL 117
           S                   LV        S  +            + RD+   NILV  
Sbjct: 109 S--------------LKVLTLV------LYSLQICKAMAYLESINCVHRDIAVRNILVA- 147

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK-----------APE-LLLGLLEYSTAV 165
             + VK+  FGL++ +              YYK           +PE +      ++TA 
Sbjct: 148 SPECVKLGDFGLSRYIE----------DEDYYKASVTRLPIKWMSPESINFR--RFTTAS 195

Query: 166 DIWPVGCIFGEMVS-GKPLFPG 186
           D+W       E++S GK  F  
Sbjct: 196 DVWMFAVCMWEILSFGKQPFFW 217

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 58.5 bits (142), Expect = 3e-10
 Identities = 44/193 (22%), Positives = 74/193 (38%), Gaps = 35/193 (18%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDS 64
              E      + E   + + +H NIIRL  V S+   +  + EY  N  L   L+     
Sbjct: 84  GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE 143

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFG------TRYIRRDLKPVNILVDLD 118
                         F+   LV         R ++ G        Y+ RDL   NILV+  
Sbjct: 144 --------------FSVLQLV------GMLRGIAAGMKYLANMNYVHRDLAARNILVN-S 182

Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHY-YK--APE-LLLGLLEYSTAVDIWPVGCIF 174
               KV+ FGL++ L      +    G     +  APE +     ++++A D+W  G + 
Sbjct: 183 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVM 240

Query: 175 GEMVS-GKPLFPG 186
            E+++ G+  +  
Sbjct: 241 WEVMTYGERPYWE 253

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 59.1 bits (143), Expect = 3e-10
 Identities = 39/200 (19%), Positives = 76/200 (38%), Gaps = 52/200 (26%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVNDLAYLLKYPKDS 64
            T + V    ++E   + + +HP+I++L+ V ++  +++  + E                
Sbjct: 429 CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI--IMEL----------CTLGE 476

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFG------TRYIRRDLKPVNILVDLD 118
           +  +      S  L +   L+        +  LS         R++ RD+   N+LV   
Sbjct: 477 LRSFLQVRKFSLDLAS---LI------LYAYQLSTALAYLESKRFVHRDIAARNVLVS-S 526

Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK-----------APELLLGLLEYSTAVDI 167
              VK+  FGL++ +            + YYK           APE +     +++A D+
Sbjct: 527 NDCVKLGDFGLSRYME----------DSTYYKASKGKLPIKWMAPESIN-FRRFTSASDV 575

Query: 168 WPVGCIFGEMVS-GKPLFPG 186
           W  G    E++  G   F G
Sbjct: 576 WMFGVCMWEILMHGVKPFQG 595

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 57.6 bits (140), Expect = 5e-10
 Identities = 44/192 (22%), Positives = 68/192 (35%), Gaps = 55/192 (28%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKDSMNGYSTKNF 73
            +E   +M+L+HP +++   V S+   +Y V EY  N  L  YL  + K           
Sbjct: 51  FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---------- 100

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGF 127
                     L+      +    +  G  +      I RDL   N LVD     VKV+ F
Sbjct: 101 -----LEPSQLL------EMCYDVCEGMAFLESHQFIHRDLAARNCLVD-RDLCVKVSDF 148

Query: 128 GLAKSLYAYKGESSAEVGTHYYK-----------APE-LLLGLLEYSTAVDIWPVGCIFG 175
           G+ + +              Y             APE       +YS+  D+W  G +  
Sbjct: 149 GMTRYVL----------DDQYVSSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMW 196

Query: 176 EMVS-GKPLFPG 186
           E+ S GK  +  
Sbjct: 197 EVFSLGKMPYDL 208

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 57.7 bits (140), Expect = 6e-10
 Identities = 46/221 (20%), Positives = 81/221 (36%), Gaps = 52/221 (23%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQG-----IYLYPVFEYQVN-DL-AYLLKY-PKDSMNG 67
           + E +C+ + +HPN+IRL+ V  +           +  +    DL  YLL    +     
Sbjct: 84  LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVA 125
              +    + +             D +  + +     ++ RDL   N ++  D  TV VA
Sbjct: 144 IPLQTLLKFMV-------------DIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVA 189

Query: 126 GFGLAKSLYAYKGESSAEVGTHYYK------------APE-LLLGLLEYSTAVDIWPVGC 172
            FGL+K +Y             YY+            A E L   +  Y++  D+W  G 
Sbjct: 190 DFGLSKKIY----------SGDYYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGV 237

Query: 173 IFGEMVS-GKPLFPGANSLITLGRIVGKSR--KPSFCKLSL 210
              E+ + G   +PG  +      ++   R  +P  C   L
Sbjct: 238 TMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDEL 278

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 57.2 bits (139), Expect = 7e-10
 Identities = 41/192 (21%), Positives = 69/192 (35%), Gaps = 55/192 (28%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF-- 73
           I E   +M L+H  +++L  V ++   ++ + EY               M      N+  
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY---------------MANGCLLNYLR 111

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGF 127
                F T  L+      +  + +     Y      + RDL   N LV+ D   VKV+ F
Sbjct: 112 EMRHRFQTQQLL------EMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDF 164

Query: 128 GLAKSLYAYKGESSAEVGTHYYK-----------APE-LLLGLLEYSTAVDIWPVGCIFG 175
           GL++ +              Y              PE L+    ++S+  DIW  G +  
Sbjct: 165 GLSRYVL----------DDEYTSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMW 212

Query: 176 EMVS-GKPLFPG 186
           E+ S GK  +  
Sbjct: 213 EIYSLGKMPYER 224

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 57.3 bits (139), Expect = 7e-10
 Identities = 41/192 (21%), Positives = 76/192 (39%), Gaps = 35/192 (18%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKD 63
            T       ++ E   +  +++P++ RL+ +     + L  + +      L   ++  KD
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKD 112

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
           +                +  L+        ++ +++    R + RDL   N+LV    + 
Sbjct: 113 N--------------IGSQYLLN--WCVQIAKGMNYLEDRRLVHRDLAARNVLVK-TPQH 155

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYK------APELLLGLLEYSTAVDIWPVGCIFG 175
           VK+  FGLAK L A + E  AE G    K      A E +L    Y+   D+W  G    
Sbjct: 156 VKITDFGLAKLLGAEEKEYHAEGG----KVPIKWMALESIL-HRIYTHQSDVWSYGVTVW 210

Query: 176 EMVS-GKPLFPG 186
           E+++ G   + G
Sbjct: 211 ELMTFGSKPYDG 222

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 56.9 bits (138), Expect = 9e-10
 Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 30/180 (16%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DL-AYLLKYPKDSMNGYSTKNF 73
           ++E + + E+ HPN+++L+ V ++    Y + E+    +L  YL +  +           
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------- 107

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                 +  +L+    ++  S ++ +     +I RDL   N LV  +   VKVA FGL++
Sbjct: 108 -----VSAVVLLY--MATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSR 159

Query: 132 SLYAYKGESSAEVGTHY-YK--APE-LLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPG 186
                    +A  G  +  K  APE L      +S   D+W  G +  E+ + G   +PG
Sbjct: 160 --LMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPG 215

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 56.8 bits (138), Expect = 9e-10
 Identities = 46/182 (25%), Positives = 74/182 (40%), Gaps = 37/182 (20%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGI-YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF- 73
           + E S + +L H N+++L+ V  +    LY V EY               M   S  ++ 
Sbjct: 62  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY---------------MAKGSLVDYL 106

Query: 74  --NSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
                S+     L++   S D   ++ +  G  ++ RDL   N+LV  +    KV+ FGL
Sbjct: 107 RSRGRSVLGGDCLLK--FSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGL 163

Query: 130 AKSLYAYKGESSAEVGTHY-YK--APE-LLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLF 184
            K         S +       K  APE L      +ST  D+W  G +  E+ S G+  +
Sbjct: 164 TKEAS------STQDTGKLPVKWTAPEALREKK--FSTKSDVWSFGILLWEIYSFGRVPY 215

Query: 185 PG 186
           P 
Sbjct: 216 PR 217

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 56.1 bits (136), Expect = 1e-09
 Identities = 38/186 (20%), Positives = 76/186 (40%), Gaps = 41/186 (22%)

Query: 15  MIREVSCLMELNHPNIIRLMRV-ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
           ++ E + + +L++P I+R++ +  ++   L  V E                +N Y  +N 
Sbjct: 65  LLAEANVMQQLDNPYIVRMIGICEAESWML--VMEM----------AELGPLNKYLQQN- 111

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFG------TRYIRRDLKPVNILVDLDGKTVKVAGF 127
                     ++      +    +S G      + ++ RDL   N+L+       K++ F
Sbjct: 112 ---RHVKDKNII------ELVHQVSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDF 161

Query: 128 GLAKSLYAYKGESSAEVGTHYYK------APELLLGLLEYSTAVDIWPVGCIFGEMVS-G 180
           GL+K+L A +    A+      K      APE +    ++S+  D+W  G +  E  S G
Sbjct: 162 GLSKALRADENYYKAQTHG---KWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYG 217

Query: 181 KPLFPG 186
           +  + G
Sbjct: 218 QKPYRG 223

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 39/190 (20%), Positives = 72/190 (37%), Gaps = 42/190 (22%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIY--LYPVFEYQVNDLAYLLKYPKD 63
            +     + + +E+  L  L H NI++   + ++     +  + E+           P  
Sbjct: 61  ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF----------LPSG 110

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
           S+  Y  KN N  +L    L      +    + + +    +Y+ RDL   N+LV+     
Sbjct: 111 SLKEYLPKNKNKINL-KQQLKY----AVQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQ 164

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APELLLGLLEYSTAVDIWP 169
           VK+  FGL K++              YY             APE L+   ++  A D+W 
Sbjct: 165 VKIGDFGLTKAIET---------DKEYYTVKDDRDSPVFWYAPECLM-QSKFYIASDVWS 214

Query: 170 VGCIFGEMVS 179
            G    E+++
Sbjct: 215 FGVTLHELLT 224

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 55.4 bits (134), Expect = 3e-09
 Identities = 42/190 (22%), Positives = 69/190 (36%), Gaps = 44/190 (23%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIY--LYPVFEYQVNDLAYLLKYPKD 63
           +      S   +E+  L  L H +II+            L  V EY           P  
Sbjct: 71  DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY----------VPLG 120

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
           S+  Y  ++    +    F       +      +++     YI RDL   N+L+D + + 
Sbjct: 121 SLRDYLPRHSIGLAQLLLF-------AQQICEGMAYLHAQHYIHRDLAARNVLLD-NDRL 172

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APELLLGLLEYSTAVDIWP 169
           VK+  FGLAK++           G  YY+            APE L    ++  A D+W 
Sbjct: 173 VKIGDFGLAKAVPE---------GHEYYRVREDGDSPVFWYAPECLK-EYKFYYASDVWS 222

Query: 170 VGCIFGEMVS 179
            G    E+++
Sbjct: 223 FGVTLYELLT 232

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 55.0 bits (133), Expect = 4e-09
 Identities = 44/221 (19%), Positives = 87/221 (39%), Gaps = 47/221 (21%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKD 63
            T  G  S  + E   + + +HPN++ L+ +  +       V  Y  + DL     + ++
Sbjct: 64  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL---RNFIRN 120

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
             +  + K+   + L               ++ + +    +++ RDL   N ++D +  T
Sbjct: 121 ETHNPTVKDLIGFGL-------------QVAKGMKYLASKKFVHRDLAARNCMLD-EKFT 166

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL-------------EYSTAVDIW 168
           VKVA FGLA+ +Y             YY         L             +++T  D+W
Sbjct: 167 VKVADFGLARDMYD----------KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 216

Query: 169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSR--KPSFC 206
             G +  E+++ G P +P  N+      ++   R  +P +C
Sbjct: 217 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 44/190 (23%), Positives = 69/190 (36%), Gaps = 51/190 (26%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFN 74
           ++E   + +L H  +++L  V S+   +Y V EY     L   LK               
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKY--------- 276

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGFG 128
                    LV      D +  ++ G  Y      + RDL+  NILV  +    KVA FG
Sbjct: 277 ----LRLPQLV------DMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFG 325

Query: 129 LAKSLYAYKGESSAEVGTHYYK-----------APELLLGLLEYSTAVDIWPVGCIFGEM 177
           LA+ +              Y             APE  L    ++   D+W  G +  E+
Sbjct: 326 LARLIE----------DNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTEL 374

Query: 178 VS-GKPLFPG 186
            + G+  +PG
Sbjct: 375 TTKGRVPYPG 384

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 55.0 bits (133), Expect = 4e-09
 Identities = 32/201 (15%), Positives = 66/201 (32%), Gaps = 53/201 (26%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKD 63
            +      ++   +  +  L+H +I+RL+ +     + L  V +Y     L   ++  + 
Sbjct: 53  KSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL--VTQYLPLGSLLDHVRQHRG 110

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFG------TRYIRRDLKPVNILVDL 117
           +                  LL+      +    ++ G         + R+L   N+L+  
Sbjct: 111 A--------------LGPQLLL------NWGVQIAKGMYYLEEHGMVHRNLAARNVLLK- 149

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK-----------APELLLGLLEYSTAVD 166
               V+VA FG+A  L                            A E +    +Y+   D
Sbjct: 150 SPSQVQVADFGVADLLPP---------DDKQLLYSEAKTPIKWMALESIH-FGKYTHQSD 199

Query: 167 IWPVGCIFGEMVS-GKPLFPG 186
           +W  G    E+++ G   + G
Sbjct: 200 VWSYGVTVWELMTFGAEPYAG 220

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 55.3 bits (133), Expect = 5e-09
 Identities = 46/182 (25%), Positives = 73/182 (40%), Gaps = 35/182 (19%)

Query: 16  IREVSCLMELNHPNIIRLMRVAS-QGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNF 73
           ++E   + +L H  +++L  V S + IY+  V EY     L   LK              
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAVVSEEPIYI--VTEYMSKGSLLDFLKGETGKY-------- 359

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRY------IRRDLKPVNILVDLDGKTVKVAGF 127
                     LV      D +  ++ G  Y      + RDL+  NILV  +    KVA F
Sbjct: 360 -----LRLPQLV------DMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADF 407

Query: 128 GLAKSLY--AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLF 184
           GLA+ +    Y     A+    +  APE  L    ++   D+W  G +  E+ + G+  +
Sbjct: 408 GLARLIEDNEYTARQGAKFPIKWT-APEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPY 465

Query: 185 PG 186
           PG
Sbjct: 466 PG 467

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 53.8 bits (130), Expect = 1e-08
 Identities = 43/201 (21%), Positives = 79/201 (39%), Gaps = 49/201 (24%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGI-YLYPVFEYQVN-DLAYLLKYPKD 63
            T      + +RE   +  LNHPN++ L+ +        + +  Y  + DL   ++ P+ 
Sbjct: 60  ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR 119

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
           +    + K+  S+ L               +R + +    +++ RDL   N ++D +  T
Sbjct: 120 NP---TVKDLISFGL-------------QVARGMEYLAEQKFVHRDLAARNCMLD-ESFT 162

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYK--------------APE-LLLGLLEYSTAVD 166
           VKVA FGLA+ +              YY               A E L      ++T  D
Sbjct: 163 VKVADFGLARDIL----------DREYYSVQQHRHARLPVKWTALESLQTYR--FTTKSD 210

Query: 167 IWPVGCIFGEMVS-GKPLFPG 186
           +W  G +  E+++ G P +  
Sbjct: 211 VWSFGVLLWELLTRGAPPYRH 231

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 53.8 bits (130), Expect = 1e-08
 Identities = 48/188 (25%), Positives = 78/188 (41%), Gaps = 47/188 (25%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNF 73
           + E + + +L H  ++RL  V +Q  IY+  + EY  N  L   LK P            
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQEPIYI--ITEYMENGSLVDFLKTPSGIK-------- 105

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                 T   L++   ++  +  ++F     YI RDL+  NILV  D  + K+A FGLA+
Sbjct: 106 -----LTINKLLD--MAAQIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLAR 157

Query: 132 SLYAYKGESSAEVGTHYYK-----------APE-LLLGLLEYSTAVDIWPVGCIFGEMVS 179
            +              Y             APE +  G   ++   D+W  G +  E+V+
Sbjct: 158 LIE----------DNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVT 205

Query: 180 -GKPLFPG 186
            G+  +PG
Sbjct: 206 HGRIPYPG 213

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 50/214 (23%), Positives = 66/214 (30%), Gaps = 62/214 (28%)

Query: 12  PSSMIREVSCLMELNHPNIIRLMRV--ASQGIYLYPVFEYQVNDLAY--LLKYPKDSMNG 67
                RE+  L  L+   I++   V        L  V EY    L    L  + +     
Sbjct: 68  QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY----LPSGCLRDFLQRHRAR 123

Query: 68  YSTKNFNSYS---------LFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLD 118
                   YS         L               SR      R + RDL   NILV+  
Sbjct: 124 LDASRLLLYSSQICKGMEYL--------------GSR------RCVHRDLAARNILVE-S 162

Query: 119 GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYK------------APELLLGLLEYSTAVD 166
              VK+A FGLAK L          +   YY             APE L     +S   D
Sbjct: 163 EAHVKIADFGLAKLL---------PLDKDYYVVREPGQSPIFWYAPESLS-DNIFSRQSD 212

Query: 167 IWPVGCIFGEMVS--GKPLFPGANSLITLGRIVG 198
           +W  G +  E+ +   K   P A  L  +G    
Sbjct: 213 VWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 35/182 (19%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQ-GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           + E + +  L H  +++L  V ++  IY+  + E+       LL + K           +
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVVTKEPIYI--ITEFMAK--GSLLDFLKS----------D 276

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFG------TRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             S      L+      D S  ++ G        YI RDL+  NILV       K+A FG
Sbjct: 277 EGSKQPLPKLI------DFSAQIAEGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFG 329

Query: 129 LAKSLYAYKGESSAEVGTHY-YK--APELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLF 184
           LA+       E +A  G  +  K  APE +     ++   D+W  G +  E+V+ G+  +
Sbjct: 330 LAR--VIEDNEYTAREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPY 386

Query: 185 PG 186
           PG
Sbjct: 387 PG 388

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 52.1 bits (125), Expect = 5e-08
 Identities = 45/220 (20%), Positives = 86/220 (39%), Gaps = 45/220 (20%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKD 63
            T  G  S  + E   + + +HPN++ L+ +  +       V  Y  + DL   ++    
Sbjct: 128 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 187

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
           +               T   L+        ++ + F    +++ RDL   N ++D +  T
Sbjct: 188 N--------------PTVKDLIG--FGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFT 230

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYK-----------APE-LLLGLLEYSTAVDIWP 169
           VKVA FGLA+ +Y    +   +     +            A E L      ++T  D+W 
Sbjct: 231 VKVADFGLARDMY----DKEFDS---VHNKTGAKLPVKWMALESLQTQK--FTTKSDVWS 281

Query: 170 VGCIFGEMVS-GKPLFPGANSLITLGRIVGKSR--KPSFC 206
            G +  E+++ G P +P  N+      ++   R  +P +C
Sbjct: 282 FGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 321

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 49.4 bits (118), Expect = 3e-07
 Identities = 16/145 (11%), Positives = 34/145 (23%), Gaps = 44/145 (30%)

Query: 106 RDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV 165
               P  + V +DG  V +A                                    +   
Sbjct: 153 SIDHPSRVRVSIDG-DVVLAYPA--------------------TMPDA--------NPQD 183

Query: 166 DIWPVGCIFGEMVSGKPLFPGANSLITLG----RIVGKSRKPSFCKLSLRDHLTNGFPGL 221
           DI  +G     ++  +   P A     L        G+  +P+     +          +
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA----DID-------RDI 232

Query: 222 EPAGIDLISKMLGMDPDKRITAAEA 246
                 + ++ +  D   R  +   
Sbjct: 233 PFQISAVAARSVQGDGGIRSASTLL 257

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 49.5 bits (119), Expect = 3e-07
 Identities = 31/82 (37%), Positives = 45/82 (54%), Gaps = 7/82 (8%)

Query: 104 IRRDLKPVNILVDLDGK-TVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLE 160
           I RD+K  NIL  LD   T K++ FGLA++   +     +S  VGT  Y APE L G + 
Sbjct: 155 IHRDIKSANIL--LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEI- 211

Query: 161 YSTAVDIWPVGCIFGEMVSGKP 182
            +   DI+  G +  E+++G P
Sbjct: 212 -TPKSDIYSFGVVLLEIITGLP 232

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 45/247 (18%), Positives = 83/247 (33%), Gaps = 77/247 (31%)

Query: 6   NTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQ-GIYLYPVFEY-QVNDLAYLLKYPK 62
                   +++ E+  L+ + +H N++ L+   ++ G  L  + E+ +  +L+  L+  +
Sbjct: 63  GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122

Query: 63  DSMNGYST-----KNFNSYSLFTTFLLVEEFSSSDSSRS--------------------- 96
           +    Y T     +    Y       L     S  SS+S                     
Sbjct: 123 NEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182

Query: 97  -------------LSFGT------------RYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                        + +              + I RDL   NIL+  +   VK+  FGLA+
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLAR 241

Query: 132 SLYAYKGESSAEVGTHYYK-----------APELLLGLLEYSTAVDIWPVGCIFGEMVS- 179
            +Y             Y +           APE +   + Y+   D+W  G +  E+ S 
Sbjct: 242 DIYK---------DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSL 291

Query: 180 GKPLFPG 186
           G   +PG
Sbjct: 292 GASPYPG 298

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 44.5 bits (106), Expect = 1e-05
 Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 5/80 (6%)

Query: 104 IRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEV-GTHYYKAPE-LLLGLLEY 161
           I RD+K  NIL+D +     V  FGLAK +       +  V GT  + APE L  G    
Sbjct: 156 IHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-- 212

Query: 162 STAVDIWPVGCIFGEMVSGK 181
           S   D++  G +  E+++G+
Sbjct: 213 SEKTDVFGYGVMLLELITGQ 232

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 40.3 bits (95), Expect = 3e-04
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 12/85 (14%)

Query: 104 IRRDLKPVNILVDLDGKTV-KVAGFGLAKSLYAYKGES--SAEV-GTHYYKAPELLLG-- 157
           I RD+K +NIL  LD   V K+  FG++K       ++  S  V GT  Y  PE  +   
Sbjct: 161 IHRDVKSINIL--LDENFVPKITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGR 217

Query: 158 LLEYSTAVDIWPVGCIFGEMVSGKP 182
           L E S   D++  G +  E++  + 
Sbjct: 218 LTEKS---DVYSFGVVLFEVLCARS 239

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 39.1 bits (90), Expect = 7e-04
 Identities = 14/85 (16%), Positives = 30/85 (35%), Gaps = 15/85 (17%)

Query: 102 RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY 161
           R+  RDL   N+L+       K+      KS           + +   +       +++Y
Sbjct: 182 RFEHRDLHWGNVLLK-KTSLKKLHYTLNGKSST---------IPSCGLQVS-----IIDY 226

Query: 162 STAVDIWPVGCIFGEMVSGKPLFPG 186
           + +        +F ++   + LF G
Sbjct: 227 TLSRLERDGIVVFCDVSMDEDLFTG 251

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	259
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.71
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.57
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.18
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.99
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.83
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.67
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.5
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.03
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.88
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.83
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.26
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.19
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.8
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.59
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.47
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.46
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.19
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	93.89
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	93.55
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	93.31
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	91.91
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	89.45
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	89.4
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.25
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	89.16
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	87.61
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	86.98
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	86.29
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.8
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	83.68
3mes_A	424	Choline kinase; malaria, structural genomics, stru	80.21

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-60  Score=389.63  Aligned_cols=225  Identities=24%  Similarity=0.373  Sum_probs=196.1

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |+|...+....+.+.+|+++|++++|||||+++++|.+++.+|+|||||.| +|.+++..                ..+.
T Consensus       105 K~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----------------~~l~  168 (346)
T 4fih_A          105 KKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH----------------TRMN  168 (346)
T ss_dssp             EEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH----------------SCCC
T ss_pred             EEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc----------------CCCC
Confidence            555555566678899999999999999999999999999999999999996 89998864                3356


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccC
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      ...+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.+........+.+||+.|+|||++.+ ..
T Consensus       169 e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~  246 (346)
T 4fih_A          169 EEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LP  246 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CC
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC-CC
Confidence            778899999999999999999999999999999999998 8999999999877655555667899999999999977 57


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      |+.++|||||||++|||++|++||.+.+.......+...... ..          ..+..+|+++++||.+||..||++|
T Consensus       247 y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~----------~~~~~~s~~~~dli~~~L~~dP~~R  315 (346)
T 4fih_A          247 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RL----------KNLHKVSPSLKGFLDRLLVRDPAQR  315 (346)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CC----------SCGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CC----------CccccCCHHHHHHHHHHcCCChhHC
Confidence            899999999999999999999999999888888777554221 11          1234689999999999999999999


Q ss_pred             cCHHHHhcCccccCC
Q 039159          241 ITAAEALQQEYFKDV  255 (259)
Q Consensus       241 p~~~~~l~h~~f~~~  255 (259)
                      ||++|+|+||||+..
T Consensus       316 ~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          316 ATAAELLKHPFLAKA  330 (346)
T ss_dssp             CCHHHHTTCGGGGGC
T ss_pred             cCHHHHhcCHhhcCC
Confidence            999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.3e-59  Score=391.36  Aligned_cols=226  Identities=24%  Similarity=0.369  Sum_probs=197.5

Q ss_pred             CCCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchh
Q 039159            1 MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLF   79 (259)
Q Consensus         1 ~~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~   79 (259)
                      ||+|...+....+.+.+|+.+|++|+|||||+++++|.+++.+|+|||||.| +|.+++..                ..+
T Consensus       181 iK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~----------------~~l  244 (423)
T 4fie_A          181 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH----------------TRM  244 (423)
T ss_dssp             EEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH----------------SCC
T ss_pred             EEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc----------------cCC
Confidence            3555556666778899999999999999999999999999999999999996 89998864                335


Q ss_pred             HHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCcc
Q 039159           80 TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        80 ~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      ...++..++.|++.||+|||++||+||||||+|||++.+| .+||+|||+|+.+........+.+||+.|+|||++.+ .
T Consensus       245 ~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~  322 (423)
T 4fie_A          245 NEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-L  322 (423)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCCccccccccCcCcCCHHHHCC-C
Confidence            6778899999999999999999999999999999999998 8999999999877655555667799999999999987 6


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      .|+.++|||||||++|||++|++||.+.+.......+...... .          ...+..+|+++++||.+||..||++
T Consensus       323 ~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~----------~~~~~~~s~~~~dli~~~L~~dP~~  391 (423)
T 4fie_A          323 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-R----------LKNLHKVSPSLKGFLDRLLVRDPAQ  391 (423)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-C----------CSCTTSSCHHHHHHHHHHSCSSTTT
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-C----------CcccccCCHHHHHHHHHHcCCChhH
Confidence            7899999999999999999999999999888888777554321 1          1223578999999999999999999


Q ss_pred             ccCHHHHhcCccccCC
Q 039159          240 RITAAEALQQEYFKDV  255 (259)
Q Consensus       240 Rp~~~~~l~h~~f~~~  255 (259)
                      |||++|+|+||||+..
T Consensus       392 R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          392 RATAAELLKHPFLAKA  407 (423)
T ss_dssp             SCCHHHHTTCGGGGGC
T ss_pred             CcCHHHHhcCHHhcCC
Confidence            9999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2e-58  Score=368.43  Aligned_cols=216  Identities=28%  Similarity=0.369  Sum_probs=177.8

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ++..+++.+|++++++++|||||++++++.+++.+|+||||+.|+|.+.+...               ..++...+..++
T Consensus        54 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~~---------------~~l~e~~~~~~~  118 (275)
T 3hyh_A           54 SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR---------------DKMSEQEARRFF  118 (275)
T ss_dssp             --CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCEEHHHHHHHS---------------CSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCCCCCHHHHHHHc---------------CCCCHHHHHHHH
Confidence            34567899999999999999999999999999999999999988999988642               346678889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.... .....+.+||+.|+|||++.+...++.++|||
T Consensus       119 ~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~-~~~~~~~~GT~~Y~APE~~~~~~y~~~~~Diw  196 (275)
T 3hyh_A          119 QQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTD-GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVW  196 (275)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHH
T ss_pred             HHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCC-CCccCCeeECcccCChhhhcCCCCCCChhhhH
Confidence            9999999999999999999999999999988 899999999986543 23345568999999999998854457899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |+||++|+|++|+.||.+.+.......+......              ....+|+++++||.+||..||++|||++|+++
T Consensus       197 SlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~--------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          197 SCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT--------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            9999999999999999998888777777554321              11358999999999999999999999999999


Q ss_pred             CccccCC
Q 039159          249 QEYFKDV  255 (259)
Q Consensus       249 h~~f~~~  255 (259)
                      ||||+..
T Consensus       263 hpw~k~~  269 (275)
T 3hyh_A          263 DDWFKVD  269 (275)
T ss_dssp             CHHHHTT
T ss_pred             CcccccC
Confidence            9999853

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.1e-59  Score=383.90  Aligned_cols=217  Identities=25%  Similarity=0.384  Sum_probs=188.9

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|+++|++|+|||||++++++++++.+|+|||||.| +|.+++...++             ..++...++.++
T Consensus        65 ~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~-------------~~~~e~~~~~~~  131 (350)
T 4b9d_A           65 KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG-------------VLFQEDQILDWF  131 (350)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTT-------------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCC-------------CCCCHHHHHHHH
Confidence            4457899999999999999999999999999999999999996 99999964322             335667788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.||+|||++||+||||||+|||++.++ .+||+|||+|+............+||+.|+|||++.+ ..++.++|||
T Consensus       132 ~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~Diw  209 (350)
T 4b9d_A          132 VQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIW  209 (350)
T ss_dssp             HHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHH
T ss_pred             HHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeecCCcccccccCCCccccCHHHHCC-CCCCcHHHHH
Confidence            9999999999999999999999999999998 8999999999876433223345579999999999988 6789999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||||++|||++|++||.+.+.......+......+             ....+|+++++||.+||..||++|||++++|+
T Consensus       210 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          210 ALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP-------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            99999999999999999999888888876654221             12468999999999999999999999999999


Q ss_pred             CccccC
Q 039159          249 QEYFKD  254 (259)
Q Consensus       249 h~~f~~  254 (259)
                      ||||+.
T Consensus       277 hp~~~~  282 (350)
T 4b9d_A          277 KGFIAK  282 (350)
T ss_dssp             SHHHHT
T ss_pred             CHHhhc
Confidence            999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.9e-58  Score=372.38  Aligned_cols=217  Identities=28%  Similarity=0.420  Sum_probs=189.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ++..+.+.+|+++|++|+|||||++++++++++.+|+|||||.| +|.+.++..               ..++...+..+
T Consensus        73 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~---------------~~l~e~~~~~~  137 (311)
T 4aw0_A           73 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---------------GSFDETCTRFY  137 (311)
T ss_dssp             TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH---------------SSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc---------------CCCCHHHHHHH
Confidence            44567899999999999999999999999999999999999996 999999642               34667788999


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.|++.||+|||+++|+||||||+|||++.++ .+||+|||+|+.+....  ....+.+||+.|+|||++.+ ..++.++
T Consensus       138 ~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~  215 (311)
T 4aw0_A          138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSS  215 (311)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH-SCBCHHH
T ss_pred             HHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC-CCCCcHH
Confidence            99999999999999999999999999999998 89999999998764332  23456789999999999987 5789999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||+||++|+|++|++||.+.+......++......  .            ...+|+++++||.+||..||++|||++|
T Consensus       216 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--~------------p~~~s~~~~dli~~lL~~dp~~R~t~~e  281 (311)
T 4aw0_A          216 DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD--F------------PEKFFPKARDLVEKLLVLDATKRLGCEE  281 (311)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--C------------CTTCCHHHHHHHHHHSCSSGGGSTTSGG
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--C------------CcccCHHHHHHHHHHccCCHhHCcChHH
Confidence            9999999999999999999999988888887654321  1            1358999999999999999999999887


Q ss_pred             ------HhcCccccCCC
Q 039159          246 ------ALQQEYFKDVP  256 (259)
Q Consensus       246 ------~l~h~~f~~~~  256 (259)
                            +++||||+++.
T Consensus       282 ~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          282 MEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             GTCHHHHHTSGGGTTCC
T ss_pred             HcCCHHHHCCCCcCCCC
Confidence                  68999999874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.6e-58  Score=370.57  Aligned_cols=215  Identities=25%  Similarity=0.341  Sum_probs=181.6

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++.+|+++|++++|||||++++++++++.+|+|||||.| +|.+.+...               ..++...+..++.
T Consensus        69 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~---------------~~l~e~~~~~~~~  133 (304)
T 3ubd_A           69 DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE---------------VMFTEEDVKFYLA  133 (304)
T ss_dssp             ECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH---------------CCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            345788999999999999999999999999999999999996 999998642               3466778899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||++||+||||||+|||++.++ .+||+|||+|+..........+.+||+.|+|||++.+ ..++.++||||
T Consensus       134 qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwS  211 (304)
T 3ubd_A          134 ELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWS  211 (304)
T ss_dssp             HHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHH
T ss_pred             HHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccceeccCCCccccccccCcccCCHHHhcc-CCCCCCCcccc
Confidence            999999999999999999999999999998 8999999999876554555667789999999999987 67899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HH
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AA  244 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~  244 (259)
                      +||++|||+||++||.+.+..+....+......  .            ...+|+++++||.+||+.||++|||     ++
T Consensus       212 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--~------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~  277 (304)
T 3ubd_A          212 FGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG--M------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVE  277 (304)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--C------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHH
T ss_pred             hHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC--C------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHH
Confidence            999999999999999999988888887654321  1            2358999999999999999999998     58


Q ss_pred             HHhcCccccCCC
Q 039159          245 EALQQEYFKDVP  256 (259)
Q Consensus       245 ~~l~h~~f~~~~  256 (259)
                      |+++||||+++.
T Consensus       278 eil~Hp~f~~id  289 (304)
T 3ubd_A          278 EIKRHSFFSTID  289 (304)
T ss_dssp             HHHTSGGGTTCC
T ss_pred             HHHcCccccCCC
Confidence            999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.2e-57  Score=362.70  Aligned_cols=215  Identities=23%  Similarity=0.282  Sum_probs=176.9

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEe----CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQ----GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ...++|.+|++++++|+|||||+++++|++    ++.+|+|||||.| +|.+++...               ..++...+
T Consensus        67 ~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~---------------~~l~~~~~  131 (290)
T 3fpq_A           67 SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---------------KVMKIKVL  131 (290)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH---------------SSCCHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc---------------CCCCHHHH
Confidence            345679999999999999999999999975    3568999999996 999998642               34566788


Q ss_pred             HHHHhhcccccccccCCC--ceeccCCCCcEEEcC-CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           85 VEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDL-DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~--i~H~dlkp~Nili~~-~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      ..++.|++.||+|||+++  |+||||||+|||++. ++ .+||+|||+|+...  .....+.+||+.|+|||++.+  .+
T Consensus       132 ~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~~~~--~~~~~~~~GTp~YmAPE~~~~--~y  206 (290)
T 3fpq_A          132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEMYEE--KY  206 (290)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGGGCC--TTSBEESCSSCCCCCGGGGGT--CC
T ss_pred             HHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC-CEEEEeCcCCEeCC--CCccCCcccCccccCHHHcCC--CC
Confidence            899999999999999988  999999999999985 56 89999999997532  233456689999999999865  58


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      +.++|||||||++|||+||++||.+................|...           ....++++++||.+||..||++||
T Consensus       207 ~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~-----------~~~~~~~~~~li~~~L~~dP~~R~  275 (290)
T 3fpq_A          207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF-----------DKVAIPEVKEIIEGCIRQNKDERY  275 (290)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG-----------GGCCCHHHHHHHHHHSCSSGGGSC
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCC-----------CccCCHHHHHHHHHHccCChhHCc
Confidence            999999999999999999999998766555444443333222211           135788999999999999999999


Q ss_pred             CHHHHhcCccccCC
Q 039159          242 TAAEALQQEYFKDV  255 (259)
Q Consensus       242 ~~~~~l~h~~f~~~  255 (259)
                      |++++|+||||+..
T Consensus       276 s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          276 SIKDLLNHAFFQEE  289 (290)
T ss_dssp             CHHHHHTSGGGC--
T ss_pred             CHHHHhcCccccCC
Confidence            99999999999863

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-55  Score=360.33  Aligned_cols=214  Identities=21%  Similarity=0.253  Sum_probs=180.1

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhccc
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDS   93 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (259)
                      ..+|+.++++|+|||||++++++.+++.+|+|||||.| +|.++++..               ..++...+..++.|++.
T Consensus        97 ~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~---------------~~l~e~~~~~~~~qi~~  161 (336)
T 4g3f_A           97 RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM---------------GCLPEDRALYYLGQALE  161 (336)
T ss_dssp             CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH---------------SSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc---------------CCCCHHHHHHHHHHHHH
Confidence            35899999999999999999999999999999999996 999999642               34667888999999999


Q ss_pred             ccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-----CCcCCccCccccCcccccCccCCCcccchH
Q 039159           94 SRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-----ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        94 ~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ||+|||+++|+||||||+|||++.++..+||+|||+|+.+.....     .....+||+.|+|||++.+ ..++.++|||
T Consensus       162 aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~Diw  240 (336)
T 4g3f_A          162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIW  240 (336)
T ss_dssp             HHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT-CCCCTHHHHH
T ss_pred             HHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC-CCCCcHHHHH
Confidence            999999999999999999999998874699999999987643221     1234579999999999988 6789999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH--
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA--  246 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~--  246 (259)
                      ||||++|||+||++||.+.+.......+......           .....+.+|+.+.+||.+||..||++|||+.|+  
T Consensus       241 SlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-----------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~  309 (336)
T 4g3f_A          241 SSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-----------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRR  309 (336)
T ss_dssp             HHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-----------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-----------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            9999999999999999987766666666544321           112345789999999999999999999999998  


Q ss_pred             -----------hcCccccCC
Q 039159          247 -----------LQQEYFKDV  255 (259)
Q Consensus       247 -----------l~h~~f~~~  255 (259)
                                 |+|||+...
T Consensus       310 ~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          310 KVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHhhhhhccCCCcCCC
Confidence                       579999865

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-55  Score=366.94  Aligned_cols=229  Identities=30%  Similarity=0.497  Sum_probs=187.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEe------CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQ------GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ..+++.+|+++|++|+|||||++++++..      .+.+|+|||||.|+|.+++...               ..++...+
T Consensus        96 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~---------------~~l~~~~~  160 (398)
T 4b99_A           96 NAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS---------------QPLTLEHV  160 (398)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSS---------------SCCCHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhc---------------CCCCHHHH
Confidence            34678899999999999999999999864      3578999999999999998542               44667788


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccccc----CCCCcCCccCccccCcccccCccC
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY----KGESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      ..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+...    .....+.+||+.|+|||++.+...
T Consensus       161 ~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~  239 (398)
T 4b99_A          161 RYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE  239 (398)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSC
T ss_pred             HHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCC
Confidence            99999999999999999999999999999999988 8999999999865332    223456689999999999988666


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccc-----------------ccccccCCCCCCCH
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLS-----------------LRDHLTNGFPGLEP  223 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~  223 (259)
                      ++.++||||+||++|||++|++||.+.+.......+......|......                 ....+...++++|+
T Consensus       240 ~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  319 (398)
T 4b99_A          240 YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADR  319 (398)
T ss_dssp             CCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCH
T ss_pred             CCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCH
Confidence            7999999999999999999999999998888877775432222211100                 00112223467899


Q ss_pred             HHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          224 AGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       224 ~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ++.+||.+||..||++|||++|+|+||||+..
T Consensus       320 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          320 QALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            99999999999999999999999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.6e-55  Score=358.06  Aligned_cols=233  Identities=20%  Similarity=0.274  Sum_probs=182.5

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |.++..++...++|.+|+++|++|+|||||+++|+|.+++.+|+|||||+| +|.++++...................++
T Consensus        77 K~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~  156 (329)
T 4aoj_A           77 KALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG  156 (329)
T ss_dssp             EEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCC
T ss_pred             EEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCC
Confidence            555555666678899999999999999999999999999999999999995 9999997643221111111111224578


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  158 (259)
                      +.+++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++.......  ......||+.|+|||.+.+ 
T Consensus       157 ~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-  234 (329)
T 4aoj_A          157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-  234 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC----------------CCCCGGGCCHHHHTT-
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcC-
Confidence            889999999999999999999999999999999999888 999999999986543322  2344579999999999987 


Q ss_pred             cCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      ..++.++|||||||++|||+| |+.||.+.+..+....+....+.+ .            ...+++++.+|+.+||+.||
T Consensus       235 ~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~-~------------p~~~~~~~~~li~~cl~~dP  301 (329)
T 4aoj_A          235 RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE-R------------PRACPPEVYAIMRGCWQREP  301 (329)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCC-C------------CTTCCHHHHHHHHHHCCSST
T ss_pred             CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-C------------cccccHHHHHHHHHHcCcCh
Confidence            678999999999999999999 899999988888877776543221 1            24688999999999999999


Q ss_pred             CCccCHHHHhcC
Q 039159          238 DKRITAAEALQQ  249 (259)
Q Consensus       238 ~~Rp~~~~~l~h  249 (259)
                      ++|||+++|+++
T Consensus       302 ~~RPs~~ei~~~  313 (329)
T 4aoj_A          302 QQRHSIKDVHAR  313 (329)
T ss_dssp             TTSCCHHHHHHH
T ss_pred             hHCcCHHHHHHH
Confidence            999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-54  Score=349.24  Aligned_cols=215  Identities=20%  Similarity=0.259  Sum_probs=171.9

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +.+..++|.+|++++++++|||||+++|++.+ +.+++|||||+| +|.+.+....              ..+++.+++.
T Consensus        72 ~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~--------------~~l~~~~~~~  136 (307)
T 3omv_A           72 TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQE--------------TKFQMFQLID  136 (307)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSC--------------CCCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcC--------------CCCCHHHHHH
Confidence            33445789999999999999999999998865 568999999995 9999986432              3356778899


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCc--cCCC
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGL--LEYS  162 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~--~~~~  162 (259)
                      ++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+|+......  .......||+.|+|||++.+.  ..++
T Consensus       137 i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~  215 (307)
T 3omv_A          137 IARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS  215 (307)
T ss_dssp             HHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCC
T ss_pred             HHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCC
Confidence            999999999999999999999999999999888 99999999998654322  234456899999999999642  3588


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhC-CCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG-KSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      .++|||||||++|||+||+.||.+.+.......+.. ....|..         .....++++++.+|+.+||+.||++||
T Consensus       216 ~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~---------~~~~~~~~~~l~~li~~cl~~dP~~RP  286 (307)
T 3omv_A          216 FQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL---------SKLYKNCPKAMKRLVADCVKKVKEERP  286 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS---------TTSCTTSCHHHHHHHHHHTCSSSTTSC
T ss_pred             cHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc---------ccccccchHHHHHHHHHHcCCCHhHCc
Confidence            999999999999999999999998766555544433 3333222         223357889999999999999999999


Q ss_pred             CHHHHh
Q 039159          242 TAAEAL  247 (259)
Q Consensus       242 ~~~~~l  247 (259)
                      |+.+++
T Consensus       287 s~~ei~  292 (307)
T 3omv_A          287 LFPQIL  292 (307)
T ss_dssp             CHHHHH
T ss_pred             CHHHHH
Confidence            999874

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.3e-54  Score=356.50  Aligned_cols=228  Identities=25%  Similarity=0.378  Sum_probs=175.8

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...++.+|+++|+.+ +||||+++++++.+++.+|+||||+.| +|.+++.                  .++...+..++
T Consensus        62 ~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~------------------~l~~~~~~~~~  123 (361)
T 4f9c_A           62 HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN------------------SLSFQEVREYM  123 (361)
T ss_dssp             CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT------------------TCCHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc------------------CCCHHHHHHHH
Confidence            356789999999999 699999999999999999999999995 8999883                  24556788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC----------------------------CCC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK----------------------------GES  140 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~----------------------------~~~  140 (259)
                      .|++.||+|||++||+||||||+|||++.+.+.+||+|||+|+......                            ...
T Consensus       124 ~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (361)
T 4f9c_A          124 LNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQV  203 (361)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC------------------------
T ss_pred             HHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999874499999999997543211                            112


Q ss_pred             cCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHhCCC-------------------
Q 039159          141 SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA-NSLITLGRIVGKS-------------------  200 (259)
Q Consensus       141 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~-~~~~~~~~i~~~~-------------------  200 (259)
                      ...+||+.|+|||++.+...++.++||||+||++|||++|+.||... +.......+....                   
T Consensus       204 ~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~  283 (361)
T 4f9c_A          204 APRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCS  283 (361)
T ss_dssp             --CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEES
T ss_pred             cccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcccccccc
Confidence            34579999999999988566899999999999999999999999654 4444443332100                   


Q ss_pred             -CCCc-------------------cc-cccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          201 -RKPS-------------------FC-KLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       201 -~~~~-------------------~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                       ..+.                   .. ...........+..+|++++|||.+||..||++|+|++|+|+||||+++.
T Consensus       284 ~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          284 KEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             SCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             ccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence             0000                   00 00000011223567899999999999999999999999999999999874

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-54  Score=351.59  Aligned_cols=229  Identities=18%  Similarity=0.242  Sum_probs=187.0

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |.++..++...++|.+|+++|++|+|||||+++|++.+++.+|+|||||+| +|.++++......  ...........++
T Consensus        49 K~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~--~~~~~~~~~~~l~  126 (299)
T 4asz_A           49 KTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDA--VLMAEGNPPTELT  126 (299)
T ss_dssp             EEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHH--HHC----CCCCCC
T ss_pred             EEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCccc--ccccccCCCCCCC
Confidence            455556666678899999999999999999999999999999999999995 9999996532000  0000001114577


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  158 (259)
                      +.+++.++.|+++||+|||+++|+||||||+|||++.++ .+||+|||+++.......  ......||+.|+|||.+.+ 
T Consensus       127 ~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-  204 (299)
T 4asz_A          127 QSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-  204 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-
Confidence            888999999999999999999999999999999999888 899999999986543322  1233468999999999987 


Q ss_pred             cCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      ..++.++|||||||++|||+| |+.||.+.+..+....+..+...+             ....+|+++.+|+.+||+.||
T Consensus       205 ~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~-------------~p~~~~~~~~~li~~cl~~dP  271 (299)
T 4asz_A          205 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ-------------RPRTCPQEVYELMLGCWQREP  271 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC-------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-------------CCccchHHHHHHHHHHcCCCh
Confidence            579999999999999999998 899999998888887776554321             124688999999999999999


Q ss_pred             CCccCHHHHh
Q 039159          238 DKRITAAEAL  247 (259)
Q Consensus       238 ~~Rp~~~~~l  247 (259)
                      ++|||+++++
T Consensus       272 ~~RPs~~~i~  281 (299)
T 4asz_A          272 HMRKNIKGIH  281 (299)
T ss_dssp             GGSCCHHHHH
T ss_pred             hHCcCHHHHH
Confidence            9999999995

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.5e-54  Score=350.13  Aligned_cols=215  Identities=27%  Similarity=0.403  Sum_probs=164.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCc------------eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcc
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGI------------YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYS   77 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------------~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~   77 (259)
                      ..+++.+|+++|++|+|||||++++++.+.+            .+|+|||||.| +|.+++......            .
T Consensus        46 ~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~------------~  113 (299)
T 4g31_A           46 AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI------------E  113 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSG------------G
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC------------C
Confidence            4567899999999999999999999997543            47999999996 999999643211            1


Q ss_pred             hhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC------------CcCCcc
Q 039159           78 LFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE------------SSAEVG  145 (259)
Q Consensus        78 ~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~------------~~~~~~  145 (259)
                      ......++.++.|+++||+|||++||+||||||+|||++.++ .+||+|||+|+........            ....+|
T Consensus       114 ~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~G  192 (299)
T 4g31_A          114 ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVG  192 (299)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCCCC--------------------------C
T ss_pred             hhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEccCccceecCCCccccccccccccccccCCccc
Confidence            223345678899999999999999999999999999999998 8999999999876433211            223479


Q ss_pred             CccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChH-HHHHHHhCCCCCCccccccccccccCCCCCCCHH
Q 039159          146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL-ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPA  224 (259)
Q Consensus       146 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (259)
                      |+.|+|||++.+ ..++.++|||||||++|||++   ||.+.... .....+... ..|..            ++..++.
T Consensus       193 T~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~-~~p~~------------~~~~~~~  255 (299)
T 4g31_A          193 TKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL-KFPPL------------FTQKYPC  255 (299)
T ss_dssp             CCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTT-CCCHH------------HHHHCHH
T ss_pred             CccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcC-CCCCC------------CcccCHH
Confidence            999999999987 678999999999999999996   77654322 223333322 22211            1235678


Q ss_pred             HHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          225 GIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       225 ~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ..+||.+||+.||++|||+.++|+||||+++
T Consensus       256 ~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          256 EYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            8899999999999999999999999999976

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-53  Score=345.98  Aligned_cols=233  Identities=19%  Similarity=0.205  Sum_probs=187.9

Q ss_pred             CCCCCC-CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc-cccCCCcch
Q 039159            2 MGIHNT-MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS-TKNFNSYSL   78 (259)
Q Consensus         2 ~~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~-~~~~~~~~~   78 (259)
                      |.++.. +....++|.+|+.++++|+|||||+++|+|.+++.+++|||||++ +|.+++........... .........
T Consensus        62 K~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~  141 (308)
T 4gt4_A           62 KTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA  141 (308)
T ss_dssp             EECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECC
T ss_pred             EEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccC
Confidence            444433 334567899999999999999999999999999999999999995 99999965322111000 011111245


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCccccc
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLL  156 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~  156 (259)
                      +++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++......  .......||+.|+|||.+.
T Consensus       142 l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~  220 (308)
T 4gt4_A          142 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM  220 (308)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHh
Confidence            77788999999999999999999999999999999999888 89999999998664432  2344567999999999998


Q ss_pred             CccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          157 GLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      + ..++.++|||||||++|||+| |..||.+.+..+....+......+             ....+++.+.+|+.+||+.
T Consensus       221 ~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------------~p~~~~~~~~~li~~C~~~  286 (308)
T 4gt4_A          221 Y-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP-------------CPDDCPAWVYALMIECWNE  286 (308)
T ss_dssp             H-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCS
T ss_pred             C-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------CcccchHHHHHHHHHHcCC
Confidence            7 579999999999999999998 899999998888887776554332             1246889999999999999


Q ss_pred             CCCCccCHHHHhcC
Q 039159          236 DPDKRITAAEALQQ  249 (259)
Q Consensus       236 dp~~Rp~~~~~l~h  249 (259)
                      ||++|||+.+|+++
T Consensus       287 dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          287 FPSRRPRFKDIHSR  300 (308)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhHCcCHHHHHHH
Confidence            99999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.1e-52  Score=364.01  Aligned_cols=226  Identities=23%  Similarity=0.346  Sum_probs=192.0

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159            3 GIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus         3 ~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      .|........+.+.+|+++|+.|+|||||+++++|.+++.+|+|||||.| +|.+.+....              ..++.
T Consensus       189 ~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--------------~~l~e  254 (573)
T 3uto_A          189 FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--------------NKMSE  254 (573)
T ss_dssp             EEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT--------------SCEEH
T ss_pred             EEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC--------------CCCCH
Confidence            34444444457789999999999999999999999999999999999996 8998885321              34677


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCC--CCeEEEeeccccccccccCCCCcCCccCccccCcccccCcc
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~--~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      ..+..++.|++.||+|||+++|+||||||+|||++.+  + .+||+|||+++.+.. .......+||+.|+|||++.+ .
T Consensus       255 ~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~-~vKl~DFG~a~~~~~-~~~~~~~~GT~~y~APEv~~~-~  331 (573)
T 3uto_A          255 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEG-K  331 (573)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC-CEEECCCSSCEECCT-TSEEEEECSSGGGCCHHHHTT-C
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCC-CEEEeeccceeEccC-CCceeeeEECccccCHHHhCC-C
Confidence            8889999999999999999999999999999999864  5 899999999987643 223445689999999999988 6


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      .++.++||||+||++|+|++|.+||.+.+..+....+......+.          ...+.++|+++++||.+||..||.+
T Consensus       332 ~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~s~~~~dli~~~L~~dp~~  401 (573)
T 3uto_A          332 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD----------DSAFSGISEDGKDFIRKLLLADPNT  401 (573)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC----------SGGGTTSCHHHHHHHHTTSCSSGGG
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC----------cccccCCCHHHHHHHHHHccCChhH
Confidence            789999999999999999999999999999888888866543221          1223578999999999999999999


Q ss_pred             ccCHHHHhcCccccCC
Q 039159          240 RITAAEALQQEYFKDV  255 (259)
Q Consensus       240 Rp~~~~~l~h~~f~~~  255 (259)
                      |||+.|+|+||||+..
T Consensus       402 R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          402 RMTIHQALEHPWLTPG  417 (573)
T ss_dssp             SCCHHHHHHSTTTSCC
T ss_pred             CcCHHHHhcCcCcCCC
Confidence            9999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.9e-51  Score=337.85  Aligned_cols=225  Identities=20%  Similarity=0.296  Sum_probs=177.4

Q ss_pred             CCchhHHHHHHHhhCCC-CCeeEEEEEEEe-CceEEEEeeeecC-CHHHHhhcCCCCCCCcc-cccCCCcchhHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNH-PNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS-TKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H-~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   86 (259)
                      ..++|.+|+++|++++| ||||+++|+|.+ ++.+++|||||++ +|.++++.......... .........+++..++.
T Consensus       110 ~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  189 (353)
T 4ase_A          110 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC  189 (353)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHH
Confidence            34679999999999975 999999999976 4578999999995 99999975432111100 00011124577788999


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+|+.+.....  ......||+.|+|||.+.+ ..++.+
T Consensus       190 ~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~k  267 (353)
T 4ase_A          190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQ  267 (353)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHhHhhCCeecCccCccceeeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCc
Confidence            999999999999999999999999999999888 899999999986644322  2344578999999999987 679999


Q ss_pred             cchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +|||||||++|||+| |+.||.+.........+......+..            ...+++++.++|.+||+.||++|||+
T Consensus       268 sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~------------p~~~~~~~~~li~~c~~~dP~~RPt~  335 (353)
T 4ase_A          268 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA------------PDYTTPEMYQTMLDCWHGEPSQRPTF  335 (353)
T ss_dssp             HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCC------------CccCCHHHHHHHHHHcCcChhHCcCH
Confidence            999999999999998 89999986654444443332222222            23578999999999999999999999


Q ss_pred             HHHhcC
Q 039159          244 AEALQQ  249 (259)
Q Consensus       244 ~~~l~h  249 (259)
                      .++++|
T Consensus       336 ~eil~~  341 (353)
T 4ase_A          336 SELVEH  341 (353)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.3e-50  Score=349.98  Aligned_cols=206  Identities=23%  Similarity=0.304  Sum_probs=174.1

Q ss_pred             HHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhccccccc
Q 039159           19 VSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSL   97 (259)
Q Consensus        19 i~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~   97 (259)
                      +.+++.++|||||+++++|.+++.+|+||||+.| +|...+...               ..++...+..++.|++.||+|
T Consensus       243 l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~---------------~~l~E~~a~~y~~qIl~aL~y  307 (689)
T 3v5w_A          243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---------------GVFSEADMRFYAAEIILGLEH  307 (689)
T ss_dssp             HHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH---------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHH
Confidence            5667778999999999999999999999999996 999998642               346677889999999999999


Q ss_pred             ccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHHHHHHHH
Q 039159           98 SFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM  177 (259)
Q Consensus        98 lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~  177 (259)
                      ||++||+||||||+|||++.+| .+||+|||+|+....  ....+.+||+.|+|||++.+...|+.++|+|||||++|||
T Consensus       308 LH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~~~--~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEm  384 (689)
T 3v5w_A          308 MHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL  384 (689)
T ss_dssp             HHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS--CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHH
T ss_pred             HHHCCccccCCchHHeEEeCCC-CEEecccceeeecCC--CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence            9999999999999999999998 899999999986543  3345678999999999997546789999999999999999


Q ss_pred             HhCCCCCCCCC---hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HHHHhcC
Q 039159          178 VSGKPLFPGAN---SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AAEALQQ  249 (259)
Q Consensus       178 ~tg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~~~l~h  249 (259)
                      ++|.+||.+..   .......+.....              ..+..+|+++++||.+||..||.+|++     ++++++|
T Consensus       385 LtG~~PF~~~~~~~~~~i~~~i~~~~~--------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          385 LRGHSPFRQHKTKDKHEIDRMTLTMAV--------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HHSSCTTCGGGCCCHHHHHHHHHHCCC--------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             HhCCCCCCCCChHHHHHHHHhhcCCCC--------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            99999997643   2233333332211              112468999999999999999999998     7999999


Q ss_pred             ccccCCC
Q 039159          250 EYFKDVP  256 (259)
Q Consensus       250 ~~f~~~~  256 (259)
                      |||+++.
T Consensus       451 pfF~~id  457 (689)
T 3v5w_A          451 PFFRSLD  457 (689)
T ss_dssp             GGGTTCC
T ss_pred             ccccCCC
Confidence            9999874

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.4e-49  Score=319.67  Aligned_cols=224  Identities=26%  Similarity=0.392  Sum_probs=188.9

Q ss_pred             CCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            4 IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         4 ~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      +........+.+.+|+.++++++||||+++++++..++..++||||+.| +|.+++..                ..+...
T Consensus        53 ~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~~~~~  116 (297)
T 3fxz_A           53 MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------------TCMDEG  116 (297)
T ss_dssp             EEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH----------------SCCCHH
T ss_pred             eecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh----------------cCCCHH
Confidence            3334445567789999999999999999999999999999999999985 99998864                234567


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .+..++.+++.||+|||++||+||||||+||+++.++ .+||+|||++..............||+.|+|||.+.+ ..++
T Consensus       117 ~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~  194 (297)
T 3fxz_A          117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYG  194 (297)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC-SCBC
T ss_pred             HHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCcccccCCccCCcCccChhhhcC-CCCC
Confidence            7888999999999999999999999999999999888 8999999999876554445566689999999999987 5789


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      .++|||||||++|+|++|..||.+.+.......+........           .....+++.+.++|.+||..||.+|||
T Consensus       195 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps  263 (297)
T 3fxz_A          195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-----------QNPEKLSAIFRDFLNRCLEMDVEKRGS  263 (297)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-----------SCGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----------CCccccCHHHHHHHHHHccCChhHCcC
Confidence            999999999999999999999998887766665543221111           111357899999999999999999999


Q ss_pred             HHHHhcCccccCCC
Q 039159          243 AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ~~~~l~h~~f~~~~  256 (259)
                      ++++++||||+...
T Consensus       264 ~~ell~h~~~~~~~  277 (297)
T 3fxz_A          264 AKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHTTCGGGGGCC
T ss_pred             HHHHhhChhhcccC
Confidence            99999999998764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.5e-49  Score=323.24  Aligned_cols=235  Identities=39%  Similarity=0.645  Sum_probs=187.2

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +...+.+.+|++++++++||||+++++++.+++..++||||+.|+|.+.+....              ..++...+..++
T Consensus        60 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~~~~~~~~~~~  125 (311)
T 3niz_A           60 EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK--------------TGLQDSQIKIYL  125 (311)
T ss_dssp             -CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCT--------------TCCCHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhcc--------------CCCCHHHHHHHH
Confidence            334567899999999999999999999999999999999999999988886432              235567788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.||+|||+.||+||||||+||+++.++ .+||+|||++..............||+.|+|||.+.+...++.++|||
T Consensus       126 ~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  204 (311)
T 3niz_A          126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIW  204 (311)
T ss_dssp             HHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHH
T ss_pred             HHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhH
Confidence            9999999999999999999999999999988 899999999987644434445567899999999998756689999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhC---CCCCCcccccc-------------ccccccCCCCCCCHHHHHHHHhh
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVG---KSRKPSFCKLS-------------LRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                      ||||++|+|++|+.||.+.........+..   .......+...             .........+.+++++.+||.+|
T Consensus       205 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  284 (311)
T 3niz_A          205 SIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNM  284 (311)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHH
Confidence            999999999999999987665555444422   22111111100             00111222356889999999999


Q ss_pred             cCcCCCCccCHHHHhcCccccCCCCC
Q 039159          233 LGMDPDKRITAAEALQQEYFKDVPGR  258 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~h~~f~~~~~~  258 (259)
                      |..||++|||++++|+||||+++..+
T Consensus       285 L~~dP~~Rpt~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          285 LCFDPNKRISARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             SCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred             cCCChhHCCCHHHHhcCcccccCCcc
Confidence            99999999999999999999998654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.3e-48  Score=313.42  Aligned_cols=233  Identities=39%  Similarity=0.614  Sum_probs=183.5

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+...+.+.+|++++++++||||+++++++..++..++||||+.++|.+++....              ..++...+..+
T Consensus        40 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~~~~~~~~~~  105 (288)
T 1ob3_A           40 DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--------------GGLESVTAKSF  105 (288)
T ss_dssp             GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST--------------TCCCHHHHHHH
T ss_pred             ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhcc--------------cCCCHHHHHHH
Confidence            3455678899999999999999999999999999999999999999999886532              23455677889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||++||+||||||+||+++.++ .+||+|||.+..............||+.|+|||.+.+...++.++||
T Consensus       106 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  184 (288)
T 1ob3_A          106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI  184 (288)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHH
T ss_pred             HHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHH
Confidence            99999999999999999999999999999888 89999999997654333334455789999999999775568999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhC---CCCCCcccccc------------ccccccCCCCCCCHHHHHHHHhh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVG---KSRKPSFCKLS------------LRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                      |||||++|+|++|.+||.+.........+..   .......+...            ...........+++++.+||.+|
T Consensus       185 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  264 (288)
T 1ob3_A          185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM  264 (288)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHH
Confidence            9999999999999999998877766655532   11111111000            00111223356899999999999


Q ss_pred             cCcCCCCccCHHHHhcCccccCC
Q 039159          233 LGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      |..||++|||++++++||||++.
T Consensus       265 L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          265 LKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cCCCcccCCCHHHHhcCcchhhc
Confidence            99999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.5e-47  Score=310.82  Aligned_cols=233  Identities=35%  Similarity=0.527  Sum_probs=185.5

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +...+.+.+|+.++++++||||+++++++.+++..++||||+.+++...+....              ..++...+..++
T Consensus        42 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~l~~~~~~~~~  107 (292)
T 3o0g_A           42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN--------------GDLDPEIVKSFL  107 (292)
T ss_dssp             TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTT--------------TCCCHHHHHHHH
T ss_pred             CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCC--------------CCCCHHHHHHHH
Confidence            344577889999999999999999999999999999999999998888775422              335667788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.||+|||++||+||||||+||+++.++ .+||+|||.+..............||+.|+|||.+.+...++.++|||
T Consensus       108 ~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  186 (292)
T 3o0g_A          108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW  186 (292)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred             HHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHH
Confidence            9999999999999999999999999999988 899999999987654444455668899999999998755589999999


Q ss_pred             hHHHHHHHHHhCCCC-CCCCChHHHHHHHhCCCCCCccc---------------cccccccccCCCCCCCHHHHHHHHhh
Q 039159          169 PVGCIFGEMVSGKPL-FPGANSLITLGRIVGKSRKPSFC---------------KLSLRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       169 slG~~l~e~~tg~~p-f~~~~~~~~~~~i~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                      ||||++|+|++|..| |.+.........+......+...               ............+.+++++++|+.+|
T Consensus       187 slG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  266 (292)
T 3o0g_A          187 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNL  266 (292)
T ss_dssp             HHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHH
Confidence            999999999988766 55555555555543211111100               00111122233456889999999999


Q ss_pred             cCcCCCCccCHHHHhcCccccCCC
Q 039159          233 LGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |..||++|||++++|+||||++..
T Consensus       267 L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          267 LKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             hccChhhCCCHHHHhcCcccccCC
Confidence            999999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.8e-47  Score=313.95  Aligned_cols=238  Identities=34%  Similarity=0.526  Sum_probs=188.3

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +...+.+.+|++++++++||||+++++++..++..++||||+.|+|.+++.......         ....+....+..++
T Consensus        44 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~~  114 (317)
T 2pmi_A           44 EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGN---------TPRGLELNLVKYFQ  114 (317)
T ss_dssp             TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSS---------CCCCCCHHHHHHHH
T ss_pred             cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccc---------cccCCCHHHHHHHH
Confidence            345678999999999999999999999999999999999999999999886432110         01235667788889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.||+|||++||+||||||+||+++.++ .+||+|||.+..............||+.|+|||.+.+...++.++|||
T Consensus       115 ~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  193 (317)
T 2pmi_A          115 WQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIW  193 (317)
T ss_dssp             HHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHH
T ss_pred             HHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHH
Confidence            9999999999999999999999999999988 899999999986644333445567899999999998755689999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC---cccccc----------------cccc-ccCCCCCCCHHHHHH
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP---SFCKLS----------------LRDH-LTNGFPGLEPAGIDL  228 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~----------------~~~~-~~~~~~~~~~~~~~l  228 (259)
                      ||||++|+|++|+.||.+.........+......+   ..+...                .... .......+++++.+|
T Consensus       194 slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  273 (317)
T 2pmi_A          194 SCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDF  273 (317)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHH
Confidence            99999999999999999988777666653211111   000000                0000 011123578999999


Q ss_pred             HHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          229 ISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |.+||+.||++|||++++|+||||++..
T Consensus       274 i~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          274 LHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             HHHHCCCCcccCCCHHHHhCChhhhccc
Confidence            9999999999999999999999998753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.1e-47  Score=314.54  Aligned_cols=214  Identities=27%  Similarity=0.386  Sum_probs=183.5

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|+++++.++||||+++++++..++..|+||||+.| +|.+.+...               ..++...+..++.
T Consensus        57 ~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~~  121 (328)
T 3fe3_A           57 SLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---------------GRMKEKEARSKFR  121 (328)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH---------------CCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            345688999999999999999999999999999999999985 899888542               2355677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||++||+||||||+||+++.++ .+||+|||++..... ........||+.|+|||.+.+....+.++||||
T Consensus       122 qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws  199 (328)
T 3fe3_A          122 QIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTV-GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWS  199 (328)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSS-SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHH
T ss_pred             HHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCC-CCccccccCCcceeCcccccCCCcCCchhhhhh
Confidence            999999999999999999999999999988 899999999976533 234456689999999999988444468999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      |||++|+|++|+.||.+.+.......+.......              ...+++++.+|+.+||..||.+|||++++++|
T Consensus       200 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          200 LGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI--------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             hHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            9999999999999999988887777765443211              13578999999999999999999999999999


Q ss_pred             ccccCC
Q 039159          250 EYFKDV  255 (259)
Q Consensus       250 ~~f~~~  255 (259)
                      |||+..
T Consensus       266 ~~~~~~  271 (328)
T 3fe3_A          266 RWINAG  271 (328)
T ss_dssp             TTTTTT
T ss_pred             HhhcCC
Confidence            999854

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.9e-47  Score=316.59  Aligned_cols=218  Identities=26%  Similarity=0.290  Sum_probs=186.2

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+.++++++||||+++++++.+++.+++||||+.| +|.+++...               ..++...+..++.|
T Consensus        59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~---------------~~l~~~~~~~i~~q  123 (361)
T 2yab_A           59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK---------------ESLSEEEATSFIKQ  123 (361)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTC---------------SCCBHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            46789999999999999999999999999999999999985 999988532               34567788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCC---eEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGK---TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~---~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      ++.||+|||+.||+||||||+||+++.++.   .+||+|||++..... ........||+.|+|||.+.+ ..++.++||
T Consensus       124 i~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  201 (361)
T 2yab_A          124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-GVEFKNIFGTPEFVAPEIVNY-EPLGLEADM  201 (361)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT-TCCCCCCCSCGGGCCHHHHTT-CCCCTHHHH
T ss_pred             HHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC-CCccccCCCCccEECchHHcC-CCCCccccH
Confidence            999999999999999999999999987653   699999999986543 223445679999999999977 578999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||||++|+|++|.+||.+.+.......+........          ...+..+++.+.+||.+||..||.+|||+++++
T Consensus       202 wslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  271 (361)
T 2yab_A          202 WSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD----------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL  271 (361)
T ss_dssp             HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC----------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC----------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            9999999999999999999888888877765432211          112346889999999999999999999999999


Q ss_pred             cCccccCCC
Q 039159          248 QQEYFKDVP  256 (259)
Q Consensus       248 ~h~~f~~~~  256 (259)
                      +||||+...
T Consensus       272 ~hp~~~~~~  280 (361)
T 2yab_A          272 RHPWITPVD  280 (361)
T ss_dssp             TSTTTSCSS
T ss_pred             cCcCcCCCc
Confidence            999998653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.1e-47  Score=312.77  Aligned_cols=216  Identities=25%  Similarity=0.349  Sum_probs=186.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+++++.++||||+++++++.+.+.+|+||||+.| +|...+...               ..++...+..++
T Consensus        47 ~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~~~~~~~~~  111 (337)
T 1o6l_A           47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---------------RVFTEERARFYG  111 (337)
T ss_dssp             TCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------SCCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc---------------CCCCHHHHHHHH
Confidence            4456788999999999999999999999999999999999996 898888542               235567788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.||+|||++||+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|+|
T Consensus       112 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw  189 (337)
T 1o6l_A          112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWW  189 (337)
T ss_dssp             HHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHH
T ss_pred             HHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccCCCcccccccChhhCChhhhcC-CCCCchhhcc
Confidence            9999999999999999999999999999998 8999999999865444444566789999999999987 5789999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CH
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TA  243 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~  243 (259)
                      ||||++|+|++|..||.+.+.......+......  .            ...+++++.++|.+||..||.+||     ++
T Consensus       190 slG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~  255 (337)
T 1o6l_A          190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--F------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA  255 (337)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--C------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTH
T ss_pred             cchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--C------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCH
Confidence            9999999999999999988877777776543211  1            135789999999999999999999     99


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      +++++||||+++.
T Consensus       256 ~ei~~h~~f~~~~  268 (337)
T 1o6l_A          256 KEVMEHRFFLSIN  268 (337)
T ss_dssp             HHHHTSGGGTTCC
T ss_pred             HHHHcCCCcCCCC
Confidence            9999999998763

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-47  Score=315.88  Aligned_cols=233  Identities=36%  Similarity=0.552  Sum_probs=176.8

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+...+.+.+|++++++++||||+++++++.+++..++||||+.|+|.+++...               ..+....+..+
T Consensus        73 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---------------~~~~~~~~~~i  137 (329)
T 3gbz_A           73 EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN---------------PDVSMRVIKSF  137 (329)
T ss_dssp             -------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHC---------------TTCCHHHHHHH
T ss_pred             ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCCCHHHHHhhc---------------CCCCHHHHHHH
Confidence            344567788999999999999999999999999999999999999999998642               23556788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEc-----CCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVD-----LDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~-----~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      +.|++.||+|||+++|+||||||+||+++     ..+ .+||+|||.+..............||+.|+|||.+.+...++
T Consensus       138 ~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  216 (329)
T 3gbz_A          138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP-VLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYS  216 (329)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CC-EEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCC
T ss_pred             HHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccc-eEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCC
Confidence            99999999999999999999999999995     333 699999999986644434445557899999999998755689


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc---ccccccccCCC-------------CCCCHHHH
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK---LSLRDHLTNGF-------------PGLEPAGI  226 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~~-------------~~~~~~~~  226 (259)
                      .++|||||||++|+|++|.+||.+.........+......+....   ..........+             ..+++++.
T Consensus       217 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (329)
T 3gbz_A          217 TSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGL  296 (329)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHH
T ss_pred             cHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHH
Confidence            999999999999999999999999888777766643222111111   00000001111             12688999


Q ss_pred             HHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          227 DLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       227 ~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      +||.+||..||.+|||++++|+||||++..
T Consensus       297 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          297 DLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             HHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            999999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5e-47  Score=311.71  Aligned_cols=225  Identities=23%  Similarity=0.369  Sum_probs=188.8

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159            3 GIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus         3 ~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      .+........+.+.+|+.++++++||||+++++++..++..++||||+.| +|.+++..                ..++.
T Consensus        77 ~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------~~l~~  140 (321)
T 2c30_A           77 MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----------------VRLNE  140 (321)
T ss_dssp             EEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----------------CCCCH
T ss_pred             EEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----------------cCCCH
Confidence            34444455567799999999999999999999999999999999999986 89888753                23556


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      ..+..++.+++.||+|||+.||+||||||+||+++.++ .+||+|||++..............||+.|+|||.+.+ ..+
T Consensus       141 ~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~  218 (321)
T 2c30_A          141 EQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLY  218 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCB
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCccccccccCCccccCHhhhcC-CCC
Confidence            78889999999999999999999999999999999888 8999999999876544444556689999999999977 578


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      +.++||||||+++|+|++|+.||.+.........+...... ..          .....+++.+.+++.+||..||.+||
T Consensus       219 ~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~l~~li~~~l~~dp~~Rp  287 (321)
T 2c30_A          219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KL----------KNSHKVSPVLRDFLERMLVRDPQERA  287 (321)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CC----------TTGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-Cc----------CccccCCHHHHHHHHHHccCChhhCc
Confidence            89999999999999999999999988877766665433211 10          11135789999999999999999999


Q ss_pred             CHHHHhcCccccCCC
Q 039159          242 TAAEALQQEYFKDVP  256 (259)
Q Consensus       242 ~~~~~l~h~~f~~~~  256 (259)
                      |++++++||||....
T Consensus       288 s~~ell~hp~~~~~~  302 (321)
T 2c30_A          288 TAQELLDHPFLLQTG  302 (321)
T ss_dssp             CHHHHHTSGGGGGCC
T ss_pred             CHHHHhcChhhccCC
Confidence            999999999998653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.9e-47  Score=322.13  Aligned_cols=216  Identities=27%  Similarity=0.357  Sum_probs=185.8

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|++++++++||||+++++++.+++..|+||||+.| +|.+.+...               ..++...+..++.|
T Consensus        54 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~---------------~~~~e~~~~~i~~q  118 (444)
T 3soa_A           54 HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR---------------EYYSEADASHCIQQ  118 (444)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC---------------SCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            45688999999999999999999999999999999999996 898888642               33566788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcC---CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDL---DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~---~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      ++.||+|||++||+||||||+||+++.   ++ .+||+|||++..............||+.|+|||.+.+ ..++.++||
T Consensus       119 il~aL~~lH~~givHrDlKp~NIll~~~~~~~-~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DI  196 (444)
T 3soa_A          119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGA-AVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDL  196 (444)
T ss_dssp             HHHHHHHHHHTTCBCCCCSSTTEEESBSSTTC-CEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHH
T ss_pred             HHHHHHHHHHCCccccCCCHHHEEEeccCCCC-cEEEccCceeEEecCCCceeecccCCcccCCHHHhcC-CCCCCcccc
Confidence            999999999999999999999999984   34 7999999999876544444455689999999999977 578999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||+||++|+|++|.+||.+.+.......+........          .+.+..+++++.+||.+||..||++|||+.++|
T Consensus       197 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L  266 (444)
T 3soa_A          197 WACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP----------SPEWDTVTPEAKDLINKMLTINPSKRITAAEAL  266 (444)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC----------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            9999999999999999999888888777765433221          123457899999999999999999999999999


Q ss_pred             cCccccC
Q 039159          248 QQEYFKD  254 (259)
Q Consensus       248 ~h~~f~~  254 (259)
                      +||||+.
T Consensus       267 ~hp~~~~  273 (444)
T 3soa_A          267 KHPWISH  273 (444)
T ss_dssp             HSCTTHH
T ss_pred             cCccccC
Confidence            9999964

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.1e-48  Score=315.60  Aligned_cols=209  Identities=22%  Similarity=0.189  Sum_probs=155.8

Q ss_pred             HHHHHHHhhCCCCCeeEEEEEEEeCc----eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           16 IREVSCLMELNHPNIIRLMRVASQGI----YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        16 ~~Ei~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..|+..+.+++|||||+++|++.+++    .+|+||||++| +|.++++.                ..+++...+.++.+
T Consensus        45 e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~----------------~~l~~~~~~~i~~~  108 (303)
T 3hmm_A           45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----------------YTVTVEGMIKLALS  108 (303)
T ss_dssp             HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH----------------CCBCHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh----------------CCCCHHHHHHHHHH
Confidence            45666677899999999999998653    68999999995 99999964                33556778889999


Q ss_pred             cccccccccCC--------CceeccCCCCcEEEcCCCCeEEEeeccccccccccCC----CCcCCccCccccCcccccCc
Q 039159           91 SDSSRSLSFGT--------RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG----ESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        91 ~~~~l~~lh~~--------~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~  158 (259)
                      ++.||+|||++        +|+||||||+|||++.++ .+||+|||+++.......    ......||+.|+|||.+.+.
T Consensus       109 ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~  187 (303)
T 3hmm_A          109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS  187 (303)
T ss_dssp             HHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhccc
Confidence            99999999976        999999999999999998 899999999986544322    12345799999999999752


Q ss_pred             c-----CCCcccchHhHHHHHHHHHhCCCCCCCCC---------------hHHHHHHHhCCCCCCccccccccccccCCC
Q 039159          159 L-----EYSTAVDIWPVGCIFGEMVSGKPLFPGAN---------------SLITLGRIVGKSRKPSFCKLSLRDHLTNGF  218 (259)
Q Consensus       159 ~-----~~~~~~DiwslG~~l~e~~tg~~pf~~~~---------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  218 (259)
                      .     .++.++|||||||++|||+||.+||....               .......+......|..+...     .  .
T Consensus       188 ~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~-----~--~  260 (303)
T 3hmm_A          188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-----Q--S  260 (303)
T ss_dssp             SCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-----G--S
T ss_pred             ccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccc-----c--c
Confidence            1     35678999999999999999987664211               122222233333233222100     0  0


Q ss_pred             CCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          219 PGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       219 ~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ...++.+.+|+.+||+.||++|||+.++++
T Consensus       261 ~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          261 CEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            113356789999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=315.77  Aligned_cols=233  Identities=33%  Similarity=0.538  Sum_probs=181.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .....+.+|++++++++||||+++++++..++..++||||+.|+|.+.+....              ..++...+..++.
T Consensus        42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~  107 (324)
T 3mtl_A           42 GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG--------------NIINMHNVKLFLF  107 (324)
T ss_dssp             --CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHHTT--------------TCCCHHHHHHHHH
T ss_pred             ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccccCHHHHHHhcC--------------CCCCHHHHHHHHH
Confidence            33446778999999999999999999999999999999999999999886532              2355677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.||+|||+.||+||||||+||+++.++ .+||+|||++..............||+.|+|||.+.+...++.++||||
T Consensus       108 qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  186 (324)
T 3mtl_A          108 QLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWG  186 (324)
T ss_dssp             HHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred             HHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHH
Confidence            999999999999999999999999999988 8999999999765444444455678999999999987567899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCC---cccccc-------------ccccccCCCCCCCHHHHHHHHhhc
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKP---SFCKLS-------------LRDHLTNGFPGLEPAGIDLISKML  233 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l  233 (259)
                      |||++|+|++|+.||.+.........+......+   ..+...             .........+.+++++.+||.+||
T Consensus       187 lG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  266 (324)
T 3mtl_A          187 VGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLL  266 (324)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHS
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHc
Confidence            9999999999999999988777666653321111   111000             000111223568899999999999


Q ss_pred             CcCCCCccCHHHHhcCccccCCCC
Q 039159          234 GMDPDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h~~f~~~~~  257 (259)
                      +.||.+|||++++|+||||.++..
T Consensus       267 ~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          267 QFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             CSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             CcCcccCCCHHHHhcChhhhhccc
Confidence            999999999999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.7e-47  Score=314.80  Aligned_cols=216  Identities=24%  Similarity=0.319  Sum_probs=181.8

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...+.+.+|+.+++.+ +||||+++++++.+++.+|+||||+.| +|...+...               ..++...+..+
T Consensus        65 ~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~~~~~~~~  129 (353)
T 3txo_A           65 DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS---------------RRFDEARARFY  129 (353)
T ss_dssp             TTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---------------SSCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHH
Confidence            3456688999999998 699999999999999999999999996 898888642               33566778889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.||+|||++||+||||||+||+++.++ .+||+|||+++............+||+.|+|||.+.+ ..++.++|+
T Consensus       130 ~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  207 (353)
T 3txo_A          130 AAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDW  207 (353)
T ss_dssp             HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC---------CCGGGCCHHHHHH-HHCTTHHHH
T ss_pred             HHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceeecccCCccccccCCCcCeEChhhcCC-CCcCCccCC
Confidence            99999999999999999999999999999998 8999999999865444445566789999999999987 568899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH----
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA----  243 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~----  243 (259)
                      |||||++|+|++|+.||.+.+.......+.......              ...+++++.++|.+||..||.+||++    
T Consensus       208 wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~  273 (353)
T 3txo_A          208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--------------PTWLHEDATGILKSFMTKNPTMRLGSLTQG  273 (353)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGT
T ss_pred             CcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------------CCCCCHHHHHHHHHHhhhCHHHccCCcccC
Confidence            999999999999999999998888888876543211              13478999999999999999999998    


Q ss_pred             --HHHhcCccccCCC
Q 039159          244 --AEALQQEYFKDVP  256 (259)
Q Consensus       244 --~~~l~h~~f~~~~  256 (259)
                        +++++||||+++.
T Consensus       274 ~~~~il~hp~f~~~~  288 (353)
T 3txo_A          274 GEHAILRHPFFKEID  288 (353)
T ss_dssp             CTHHHHTSGGGTTCC
T ss_pred             CHHHHhhCCcccCCC
Confidence              9999999999763

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-47  Score=313.83  Aligned_cols=218  Identities=22%  Similarity=0.263  Sum_probs=185.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+++++.++||||+++++++.+++.+++||||+.| +|.+.+....              ..++...+..++.
T Consensus        44 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~~i~~  109 (321)
T 1tki_A           44 DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--------------FELNEREIVSYVH  109 (321)
T ss_dssp             HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS--------------CCCCHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC--------------CCCCHHHHHHHHH
Confidence            346688999999999999999999999999999999999996 9999885421              2356678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcC--CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDL--DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~--~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      |++.||+|||++||+||||||+||+++.  ++ .+||+|||++..... ........||+.|+|||.+.+ ..++.++||
T Consensus       110 qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  186 (321)
T 1tki_A          110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQH-DVVSTATDM  186 (321)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEESSSSCC-CEEECCCTTCEECCT-TCEEEEEESCGGGSCHHHHTT-CEECHHHHH
T ss_pred             HHHHHHHHHHHCCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeECCC-CCccccccCChhhcCcHHhcC-CCCCchhhH
Confidence            9999999999999999999999999987  55 899999999976533 222344578999999999987 567899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||||++|+|++|..||.+.........+.........          ..++.+++++.+|+.+||..||.+|||+.++|
T Consensus       187 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l  256 (321)
T 1tki_A          187 WSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----------EAFKEISIEAMDFVDRLLVKERKSRMTASEAL  256 (321)
T ss_dssp             HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH----------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh----------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            99999999999999999998888877777654432221          11346899999999999999999999999999


Q ss_pred             cCccccCC
Q 039159          248 QQEYFKDV  255 (259)
Q Consensus       248 ~h~~f~~~  255 (259)
                      +||||+..
T Consensus       257 ~hp~~~~~  264 (321)
T 1tki_A          257 QHPWLKQK  264 (321)
T ss_dssp             HSHHHHSC
T ss_pred             cChhhccC
Confidence            99999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=311.26  Aligned_cols=232  Identities=33%  Similarity=0.532  Sum_probs=186.8

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .....+.+|++++++++||||+++++++.+++..++||||+.++|...+....              ..++...+..++.
T Consensus        54 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~  119 (346)
T 1ua2_A           54 GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--------------LVLTPSHIKAYML  119 (346)
T ss_dssp             --CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC--------------SSCCSSHHHHHHH
T ss_pred             hhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhcC--------------cCCCHHHHHHHHH
Confidence            34567899999999999999999999999999999999999999988886422              2244556788899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.||+|||+++|+||||||+||+++.++ .+||+|||++..............||+.|+|||.+.+...++.++||||
T Consensus       120 qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  198 (346)
T 1ua2_A          120 MTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA  198 (346)
T ss_dssp             HHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred             HHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHh
Confidence            999999999999999999999999999888 8999999999876544444555678999999999977556889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc---cccc-c----------cccccCCCCCCCHHHHHHHHhhcCc
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF---CKLS-L----------RDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~-~----------~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      |||++|+|++|.+||.+.........+......+..   +... .          ..+....+...++++.+||.+||..
T Consensus       199 lG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  278 (346)
T 1ua2_A          199 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF  278 (346)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhcc
Confidence            999999999999999998887777666432111110   0000 0          0011112356789999999999999


Q ss_pred             CCCCccCHHHHhcCccccCCC
Q 039159          236 DPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       236 dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ||.+|||++++|+||||.+.+
T Consensus       279 dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          279 NPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             STTTSCCHHHHHTSGGGTSSS
T ss_pred             ChhhCCCHHHHhcChhhhcCC
Confidence            999999999999999998754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-46  Score=305.07  Aligned_cols=213  Identities=26%  Similarity=0.383  Sum_probs=184.1

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+.+++.++||||+++++++.+++.+|+||||+.| +|.+++...               ..++...+..++
T Consensus        48 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~~  112 (318)
T 1fot_A           48 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---------------QRFPNPVAKFYA  112 (318)
T ss_dssp             TCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT---------------SSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHc---------------CCCCHHHHHHHH
Confidence            3456788999999999999999999999999999999999996 999998642               234556778889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.||+|||++||+||||||+||+++.++ .+||+|||+++....   ......||+.|+|||.+.+ ..++.++|+|
T Consensus       113 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw  187 (318)
T 1fot_A          113 AEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVST-KPYNKSIDWW  187 (318)
T ss_dssp             HHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTT-CCBCTTHHHH
T ss_pred             HHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCC---ccccccCCccccCHhHhcC-CCCCcccchh
Confidence            9999999999999999999999999999888 899999999976432   3345679999999999987 5788999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CH
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TA  243 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~  243 (259)
                      ||||++|+|++|..||.+.+.......+......  .            .+.+++++.++|.+||..||.+||     ++
T Consensus       188 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  253 (318)
T 1fot_A          188 SFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--F------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGT  253 (318)
T ss_dssp             HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC--C------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTT
T ss_pred             hhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--C------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCH
Confidence            9999999999999999998888777777654321  1            135789999999999999999999     99


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      +++++||||+++.
T Consensus       254 ~~i~~hp~f~~~~  266 (318)
T 1fot_A          254 EDVKNHPWFKEVV  266 (318)
T ss_dssp             HHHHTSGGGSSCC
T ss_pred             HHHhcCccccCCC
Confidence            9999999998763

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=305.52  Aligned_cols=214  Identities=25%  Similarity=0.357  Sum_probs=176.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEe--CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ..+++.+|++++++++||||+++++++.+  ++..++||||+.+ +|.+++..                ..++...+..+
T Consensus        79 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----------------~~~~~~~~~~~  142 (298)
T 2zv2_A           79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----------------KPLSEDQARFY  142 (298)
T ss_dssp             --CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----------------SCCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----------------CCCCHHHHHHH
Confidence            35789999999999999999999999986  5689999999986 66554321                34566788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccC--CCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE--YSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~  165 (259)
                      +.|++.||+|||+++|+||||||+||+++.++ .+||+|||++..............||+.|+|||.+.+...  ++.++
T Consensus       143 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  221 (298)
T 2zv2_A          143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKAL  221 (298)
T ss_dssp             HHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHH
T ss_pred             HHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchh
Confidence            99999999999999999999999999999888 8999999999876543333455679999999999976322  46789


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||||++|+|++|..||.+.........+.......            +..+.+++++.++|.+||..||++||++++
T Consensus       222 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e  289 (298)
T 2zv2_A          222 DVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF------------PDQPDIAEDLKDLITRMLDKNPESRIVVPE  289 (298)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             hhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCC------------CCccccCHHHHHHHHHHhhcChhhCCCHHH
Confidence            99999999999999999999887766655554332111            112468899999999999999999999999


Q ss_pred             HhcCcccc
Q 039159          246 ALQQEYFK  253 (259)
Q Consensus       246 ~l~h~~f~  253 (259)
                      +++||||.
T Consensus       290 ~l~hp~~~  297 (298)
T 2zv2_A          290 IKLHPWVT  297 (298)
T ss_dssp             HTTCHHHH
T ss_pred             HhcCcccc
Confidence            99999996

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2e-46  Score=308.91  Aligned_cols=215  Identities=28%  Similarity=0.402  Sum_probs=174.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|+.++++++||||+++++++..++..|+||||+.| +|.+.+...               ..+....+..++
T Consensus        63 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~  127 (327)
T 3a62_A           63 KDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE---------------GIFMEDTACFYL  127 (327)
T ss_dssp             --------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH---------------SSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC---------------CCCCHHHHHHHH
Confidence            3456688999999999999999999999999999999999986 898888542               234556778889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.||+|||++||+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|||
T Consensus       128 ~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw  205 (327)
T 3a62_A          128 AEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWW  205 (327)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC----------CTTSSCCTTSCHHHHTT-SCCCTHHHHH
T ss_pred             HHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCcccccccCCccccccCCCcCccCHhhCcC-CCCCCcccch
Confidence            9999999999999999999999999999888 8999999999765443334455679999999999987 5688999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CH
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TA  243 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~  243 (259)
                      ||||++|+|++|..||.+.+.......+......              ..+.+++++.++|.+||..||.+||     ++
T Consensus       206 slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~--------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~  271 (327)
T 3a62_A          206 SLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN--------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDA  271 (327)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTH
T ss_pred             hHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCH
Confidence            9999999999999999998887777766543211              1135789999999999999999999     89


Q ss_pred             HHHhcCccccCC
Q 039159          244 AEALQQEYFKDV  255 (259)
Q Consensus       244 ~~~l~h~~f~~~  255 (259)
                      +++++||||+++
T Consensus       272 ~e~l~hp~f~~~  283 (327)
T 3a62_A          272 GEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHSGGGSSC
T ss_pred             HHHHcCCcccCC
Confidence            999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.4e-47  Score=318.10  Aligned_cols=228  Identities=32%  Similarity=0.558  Sum_probs=180.7

Q ss_pred             CCchhHHHHHHHhhCC-CCCeeEEEEEEEeCc--eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELN-HPNIIRLMRVASQGI--YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...++.+|+.+++++. ||||+++++++..++  .+|+||||+.++|..+++.                ..+.......+
T Consensus        51 ~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----------------~~~~~~~~~~i  114 (388)
T 3oz6_A           51 DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA----------------NILEPVHKQYV  114 (388)
T ss_dssp             HHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHH----------------TCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHc----------------CCCCHHHHHHH
Confidence            3466889999999997 999999999997544  7899999999999998864                23455667788


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccccc---------------------CCCCcCCccC
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY---------------------KGESSAEVGT  146 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~---------------------~~~~~~~~~~  146 (259)
                      +.|++.||+|||+.||+||||||+||+++.++ .+||+|||+++.....                     ........||
T Consensus       115 ~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  193 (388)
T 3oz6_A          115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVAT  193 (388)
T ss_dssp             HHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCG
T ss_pred             HHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCcccccccccccccccccccccccccccccccccccCCccc
Confidence            89999999999999999999999999999988 8999999999764321                     1112345799


Q ss_pred             ccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccc----------------
Q 039159          147 HYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSL----------------  210 (259)
Q Consensus       147 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----------------  210 (259)
                      +.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+......|.......                
T Consensus       194 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  273 (388)
T 3oz6_A          194 RWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEK  273 (388)
T ss_dssp             GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHH
T ss_pred             CCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCccc
Confidence            9999999998756789999999999999999999999999888877777654322222111000                


Q ss_pred             ----ccccc-------------CCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          211 ----RDHLT-------------NGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       211 ----~~~~~-------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                          .....             ......++++.+||.+||..||++|||++++|+||||+..
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          274 VEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF  335 (388)
T ss_dssp             CC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred             ccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence                00000             0112678999999999999999999999999999999765

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-46  Score=307.08  Aligned_cols=218  Identities=26%  Similarity=0.315  Sum_probs=183.5

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+++.+|+.++++++||||+++++++.+++..++||||+.| +|.+++...               ..++...+..++.|
T Consensus        58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~q  122 (326)
T 2y0a_A           58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---------------ESLTEEEATEFLKQ  122 (326)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS---------------SCCBHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc---------------CCcCHHHHHHHHHH
Confidence            56789999999999999999999999999999999999986 999988532               33566788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCC---eEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGK---TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~---~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      ++.||+|||+.+|+||||||+||+++.++.   .+||+|||++...... .......||+.|+|||.+.+ ..++.++||
T Consensus       123 i~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  200 (326)
T 2y0a_A          123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADM  200 (326)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT-SCCCCCCSCTTTCCHHHHTT-CCCCTHHHH
T ss_pred             HHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC-CccccccCCcCcCCceeecC-CCCCcHHHH
Confidence            999999999999999999999999987652   6999999999865432 23345579999999999976 568899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||||++|+|++|..||.+.........+........          ...+..+++.+.+||.+||..||.+|||++++|
T Consensus       201 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  270 (326)
T 2y0a_A          201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE----------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL  270 (326)
T ss_dssp             HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC----------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC----------ccccccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            9999999999999999998887777666644322111          111246889999999999999999999999999


Q ss_pred             cCccccCCC
Q 039159          248 QQEYFKDVP  256 (259)
Q Consensus       248 ~h~~f~~~~  256 (259)
                      +||||+...
T Consensus       271 ~hp~~~~~~  279 (326)
T 2y0a_A          271 QHPWIKPKD  279 (326)
T ss_dssp             HSTTTSCCS
T ss_pred             cCCCccCCc
Confidence            999998653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.6e-46  Score=317.35  Aligned_cols=220  Identities=24%  Similarity=0.304  Sum_probs=184.8

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+.+++.++||||+++++++.+++.+|+||||+.| +|.+++..                ..++...+..++
T Consensus       111 ~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----------------~~~~e~~~~~~~  174 (410)
T 3v8s_A          111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN----------------YDVPEKWARFYT  174 (410)
T ss_dssp             CCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----------------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc----------------CCCCHHHHHHHH
Confidence            4456788999999999999999999999999999999999986 99998854                224556778889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCcc---CCCcc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLL---EYSTA  164 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~---~~~~~  164 (259)
                      .+++.||+|||++||+||||||+||+++.++ .+||+|||+++....... .....+||+.|+|||.+.+..   .++.+
T Consensus       175 ~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~  253 (410)
T 3v8s_A          175 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE  253 (410)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETH
T ss_pred             HHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCc
Confidence            9999999999999999999999999999998 899999999976543221 234668999999999997632   26789


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC--ccC
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK--RIT  242 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rp~  242 (259)
                      +|+|||||++|+|++|++||.+.+.......+.........          +....+|+++++||.+||..+|.+  ||+
T Consensus       254 ~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------p~~~~~s~~~~~li~~lL~~~~~rlgR~~  323 (410)
T 3v8s_A          254 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF----------PDDNDISKEAKNLICAFLTDREVRLGRNG  323 (410)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC----------CTTCCCCHHHHHHHHHHSSCGGGCTTSSC
T ss_pred             ceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC----------CCcccccHHHHHHHHHHccChhhhCCCCC
Confidence            99999999999999999999999888888777653211111          112468999999999999999988  999


Q ss_pred             HHHHhcCccccCCC
Q 039159          243 AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ~~~~l~h~~f~~~~  256 (259)
                      ++++++||||+++.
T Consensus       324 ~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          324 VEEIKRHLFFKNDQ  337 (410)
T ss_dssp             HHHHHTSGGGCCSS
T ss_pred             HHHHhcCccccCCC
Confidence            99999999999763

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.3e-46  Score=310.43  Aligned_cols=221  Identities=28%  Similarity=0.406  Sum_probs=179.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|++++++++||||+++++++.+++.+|+||||+.| +|.+.+......           ...++...+..++.
T Consensus        69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~-----------~~~~~~~~~~~i~~  137 (351)
T 3c0i_A           69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA-----------GFVYSEAVASHYMR  137 (351)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHT-----------TCCCCHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhccc-----------CCCCCHHHHHHHHH
Confidence            457789999999999999999999999999999999999995 888777532110           02356677889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      |++.||+|||+++|+||||||+||+++.++  ..+||+|||++..............||+.|+|||.+.+ ..++.++||
T Consensus       138 qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  216 (351)
T 3c0i_A          138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDV  216 (351)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHH
T ss_pred             HHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhh
Confidence            999999999999999999999999998654  24999999999876544333455689999999999987 568999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||||++|+|++|..||.+.. ......+........          ...+..+++++.+||.+||..||++|||+.++|
T Consensus       217 wslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l  285 (351)
T 3c0i_A          217 WGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN----------PRQWSHISESAKDLVRRMLMLDPAERITVYEAL  285 (351)
T ss_dssp             HHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC----------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC----------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            999999999999999998754 334444433221111          011246889999999999999999999999999


Q ss_pred             cCccccC
Q 039159          248 QQEYFKD  254 (259)
Q Consensus       248 ~h~~f~~  254 (259)
                      +||||+.
T Consensus       286 ~hp~~~~  292 (351)
T 3c0i_A          286 NHPWLKE  292 (351)
T ss_dssp             TSHHHHT
T ss_pred             cChhhcC
Confidence            9999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.3e-46  Score=313.22  Aligned_cols=217  Identities=24%  Similarity=0.324  Sum_probs=179.1

Q ss_pred             CCCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ....+.+.+|+.+++++ +||||+++++++.+++.+|+||||+.| +|...+...               ..++...+..
T Consensus        93 ~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---------------~~l~~~~~~~  157 (396)
T 4dc2_A           93 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ---------------RKLPEEHARF  157 (396)
T ss_dssp             ---CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------SSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc---------------CCCCHHHHHH
Confidence            34556788999999887 899999999999999999999999996 898888642               3356678888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.+++.||+|||++||+||||||+||+++.++ .+||+|||+++............+||+.|+|||.+.+ ..++.++|
T Consensus       158 ~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~D  235 (396)
T 4dc2_A          158 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVD  235 (396)
T ss_dssp             HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHH
T ss_pred             HHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeecccCCCccccccCCcccCCchhhcC-CCCChHHH
Confidence            999999999999999999999999999999998 8999999999864444455667789999999999987 67899999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCC---------hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          167 IWPVGCIFGEMVSGKPLFPGAN---------SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      +|||||++|+|++|++||....         .......+.....              .....+++++.+||.+||+.||
T Consensus       236 iwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------------~~p~~~s~~~~~li~~lL~~dP  301 (396)
T 4dc2_A          236 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------------RIPRSLSVKAASVLKSFLNKDP  301 (396)
T ss_dssp             HHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--------------CCCTTSCHHHHHHHHHHTCSCT
T ss_pred             HHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--------------CCCCcCCHHHHHHHHHHhcCCH
Confidence            9999999999999999996421         1222333332211              1123588999999999999999


Q ss_pred             CCccCH------HHHhcCccccCCC
Q 039159          238 DKRITA------AEALQQEYFKDVP  256 (259)
Q Consensus       238 ~~Rp~~------~~~l~h~~f~~~~  256 (259)
                      .+||++      +++++||||+++.
T Consensus       302 ~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          302 KERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             TTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             hHcCCCCCCCCHHHHhcCccccCCC
Confidence            999984      8999999999763

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.3e-46  Score=310.14  Aligned_cols=216  Identities=26%  Similarity=0.361  Sum_probs=185.7

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +..+.+.+|..+++.+ +||||+++++++.+++.+|+||||+.| +|.+.+...               ..++...+..+
T Consensus        59 ~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~~~~~~~~  123 (345)
T 1xjd_A           59 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---------------HKFDLSRATFY  123 (345)
T ss_dssp             TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------SSCCHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHH
Confidence            4456788999999987 899999999999999999999999986 999988642               23556777889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||++||+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|+
T Consensus       124 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  201 (345)
T 1xjd_A          124 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDW  201 (345)
T ss_dssp             HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHH
T ss_pred             HHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC-CCCCChhhh
Confidence            99999999999999999999999999999998 8999999999865443444566789999999999987 568999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH-HH
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA-EA  246 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~-~~  246 (259)
                      |||||++|+|++|..||.+.+.......+......  .            ...+++++.+||.+||..||.+||++. ++
T Consensus       202 wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i  267 (345)
T 1xjd_A          202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF--Y------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDI  267 (345)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--C------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC--C------------CcccCHHHHHHHHHHhcCCHhHcCCChHHH
Confidence            99999999999999999998888777777544211  1            135789999999999999999999998 99


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      ++||||+++.
T Consensus       268 ~~hp~f~~~~  277 (345)
T 1xjd_A          268 RQHPLFREIN  277 (345)
T ss_dssp             GGSGGGTTCC
T ss_pred             HcCccccCCC
Confidence            9999998764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.1e-47  Score=312.96  Aligned_cols=215  Identities=27%  Similarity=0.333  Sum_probs=177.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      +...++.+|+.+++.++||||+++++++..++..++||||+.|+|.+.+...               ..++...+..++.
T Consensus        51 ~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~~---------------~~l~~~~~~~i~~  115 (336)
T 3h4j_B           51 DMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK---------------KRMTEDEGRRFFQ  115 (336)
T ss_dssp             TCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCEEHHHHHHHH---------------CSCCHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            4456899999999999999999999999999999999999988998888542               3356678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.|++|||+.||+||||||+||+++.++ .+||+|||++..... ........||+.|+|||.+.+....+.++||||
T Consensus       116 qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws  193 (336)
T 3h4j_B          116 QIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTD-GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWS  193 (336)
T ss_dssp             HHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTT-SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHH
T ss_pred             HHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccC-CcccccccCCcCcCCHHHHcCCCCCCCccchhH
Confidence            999999999999999999999999999888 899999999976543 223455679999999999987444478999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      |||++|+|++|+.||.+.........+.              .........+++++.+||.+||..||.+|||++++++|
T Consensus       194 lG~il~~ll~g~~Pf~~~~~~~~~~~i~--------------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          194 CGIVLYVMLVGRLPFDDEFIPNLFKKVN--------------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             HHHHHHHHHHSSCSSBCSSSTTCBCCCC--------------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHhCCCCCCCccHHHHHHHHH--------------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            9999999999999997654221111110              01111224578999999999999999999999999999


Q ss_pred             ccccCC
Q 039159          250 EYFKDV  255 (259)
Q Consensus       250 ~~f~~~  255 (259)
                      |||+..
T Consensus       260 p~~~~~  265 (336)
T 3h4j_B          260 PWFNVN  265 (336)
T ss_dssp             HHHHTT
T ss_pred             hhhccC
Confidence            999753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=315.10  Aligned_cols=219  Identities=25%  Similarity=0.296  Sum_probs=184.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|++++++++||||+++++++.+++..++||||+.| +|.+.+....              ..++...+..++
T Consensus       128 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--------------~~l~~~~~~~i~  193 (373)
T 2x4f_A          128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES--------------YNLTELDTILFM  193 (373)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG--------------GGCCHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC--------------CCCCHHHHHHHH
Confidence            3456789999999999999999999999999999999999986 8888775321              335567788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEE--cCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILV--DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili--~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .|++.||+|||+.+|+||||||+||++  +.++ .+||+|||++..... ........||+.|+|||.+.+ ..++.++|
T Consensus       194 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D  270 (373)
T 2x4f_A          194 KQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKP-REKLKVNFGTPEFLAPEVVNY-DFVSFPTD  270 (373)
T ss_dssp             HHHHHHHHHHHHTTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECCT-TCBCCCCCSSCTTCCHHHHTT-CBCCHHHH
T ss_pred             HHHHHHHHHHHHCCcccccCCHHHEEEecCCCC-cEEEEeCCCceecCC-ccccccccCCCcEeChhhccC-CCCCcHHh
Confidence            999999999999999999999999999  4445 899999999986533 223345579999999999976 57889999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||||++|+|++|..||.+.+.......+........          ...+..+++++.+||.+||..||.+||+++++
T Consensus       271 iwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~  340 (373)
T 2x4f_A          271 MWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE----------DEEFQDISEEAKEFISKLLIKEKSWRISASEA  340 (373)
T ss_dssp             HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC----------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            99999999999999999999888877777765432211          11235689999999999999999999999999


Q ss_pred             hcCccccCC
Q 039159          247 LQQEYFKDV  255 (259)
Q Consensus       247 l~h~~f~~~  255 (259)
                      |+||||+..
T Consensus       341 l~hp~~~~~  349 (373)
T 2x4f_A          341 LKHPWLSDH  349 (373)
T ss_dssp             HHSHHHHCH
T ss_pred             hcCcCcCCC
Confidence            999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=304.50  Aligned_cols=229  Identities=31%  Similarity=0.521  Sum_probs=177.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|++++++++||||+++++++.+++..++||||+.+ +|..++...               ..++...+..++.+
T Consensus        46 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------------~~~~~~~~~~i~~~  110 (311)
T 4agu_A           46 KKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ---------------RGVPEHLVKSITWQ  110 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTS---------------SCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhh---------------cCCCHHHHHHHHHH
Confidence            46678999999999999999999999999999999999997 566665432               23556778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.|++|||+.|++||||||+||+++.++ .++|+|||.+..............||+.|+|||.+.+...++.++|||||
T Consensus       111 l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  189 (311)
T 4agu_A          111 TLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAI  189 (311)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHH
T ss_pred             HHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHH
Confidence            99999999999999999999999999888 89999999998765444444556789999999999875678999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCC--CC---------------ccccccccccccCCCCCCCHHHHHHHHhhc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSR--KP---------------SFCKLSLRDHLTNGFPGLEPAGIDLISKML  233 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~--~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  233 (259)
                      |+++|++++|..||.+.........+.....  .+               ..+...........++++++++.+|+.+||
T Consensus       190 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  269 (311)
T 4agu_A          190 GCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCL  269 (311)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHC
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHc
Confidence            9999999999999998877666554422100  00               000000111122223578999999999999


Q ss_pred             CcCCCCccCHHHHhcCccccCCC
Q 039159          234 GMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ..||.+|||++++++||||+++.
T Consensus       270 ~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          270 HMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cCChhhcCCHHHHhcChHHHhcc
Confidence            99999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.9e-46  Score=310.46  Aligned_cols=216  Identities=27%  Similarity=0.371  Sum_probs=182.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|++++++++||||+++++++.+++..|+||||+.| +|.+.+...               ..++...+..++.|
T Consensus        72 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~~~q  136 (362)
T 2bdw_A           72 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---------------EFYSEADASHCIQQ  136 (362)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC---------------SCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            45788999999999999999999999999999999999996 898888532               33566788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++.||+|||+++|+||||||+||+++.++  ..+||+|||++..... ........||+.|+|||.+.+ ..++.++|||
T Consensus       137 i~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw  214 (362)
T 2bdw_A          137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIW  214 (362)
T ss_dssp             HHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT-CCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHH
T ss_pred             HHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC-CcccccCCCCccccCHHHHcc-CCCCchhhHH
Confidence            99999999999999999999999998643  2699999999976543 223345679999999999987 5788999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||||++|+|++|.+||.+.+.......+.........          ..+..+++++.+||.+||..||++||++.++|+
T Consensus       215 slG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          215 ACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc----------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            9999999999999999998887777776554322111          123467899999999999999999999999999


Q ss_pred             CccccC
Q 039159          249 QEYFKD  254 (259)
Q Consensus       249 h~~f~~  254 (259)
                      ||||..
T Consensus       285 hp~~~~  290 (362)
T 2bdw_A          285 VPWICN  290 (362)
T ss_dssp             SHHHHT
T ss_pred             CcccCC
Confidence            999974

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-45  Score=306.97  Aligned_cols=216  Identities=22%  Similarity=0.309  Sum_probs=186.2

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...+.+.+|..+++.+ +||||+++++++.+.+.+|+||||+.| +|.+.+...               ..++...+..+
T Consensus        62 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~~~~~~~~  126 (353)
T 2i0e_A           62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV---------------GRFKEPHAVFY  126 (353)
T ss_dssp             TCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---------------SSCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc---------------CCCCHHHHHHH
Confidence            4456788999999998 799999999999999999999999986 999988642               23556778889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.||+|||++||+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|+
T Consensus       127 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  204 (353)
T 2i0e_A          127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDW  204 (353)
T ss_dssp             HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHH
T ss_pred             HHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCcccccccCCcccccccCCccccChhhhcC-CCcCCcccc
Confidence            99999999999999999999999999999998 8999999999864433444566789999999999987 568999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----C
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----T  242 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~  242 (259)
                      |||||++|||++|+.||.+.+.......+......  .            ...+++++.+||.+||..||.+||     +
T Consensus       205 wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--~------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~  270 (353)
T 2i0e_A          205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--Y------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEG  270 (353)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--C------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTH
T ss_pred             cchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC--C------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCC
Confidence            99999999999999999998888887777654321  1            136889999999999999999999     4


Q ss_pred             HHHHhcCccccCCC
Q 039159          243 AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ~~~~l~h~~f~~~~  256 (259)
                      ++++++||||+.+.
T Consensus       271 ~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          271 ERDIKEHAFFRYID  284 (353)
T ss_dssp             HHHHHTSGGGTTCC
T ss_pred             HHHHhcCccccCCC
Confidence            79999999998763

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.6e-46  Score=307.18  Aligned_cols=213  Identities=25%  Similarity=0.356  Sum_probs=184.8

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+++++.++||||+++++++.+++.+|+||||+.| +|.+.+...               ..++...+..++
T Consensus        83 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~~~  147 (350)
T 1rdq_E           83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---------------GRFSEPHARFYA  147 (350)
T ss_dssp             TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc---------------CCCCHHHHHHHH
Confidence            3456788999999999999999999999999999999999985 999988642               235567788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.||+|||++||+||||||+||+++.++ .+||+|||+++....   ......||+.|+|||.+.+ ..++.++|+|
T Consensus       148 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw  222 (350)
T 1rdq_E          148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILS-KGYNKAVDWW  222 (350)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTT-CCBCTHHHHH
T ss_pred             HHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccC---CcccccCCccccCHHHhcC-CCCCCcCCEe
Confidence            9999999999999999999999999999888 899999999986532   3345679999999999987 5788999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----H
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----A  243 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~  243 (259)
                      ||||++|+|++|..||.+.+.......+......  .            ...+++++.++|.+||..||.+||+     +
T Consensus       223 slG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  288 (350)
T 1rdq_E          223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--F------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGV  288 (350)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--C------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTT
T ss_pred             cccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC--C------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCH
Confidence            9999999999999999998888877777654321  1            1357899999999999999999998     9


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      +++++||||+++.
T Consensus       289 ~ei~~h~~f~~~~  301 (350)
T 1rdq_E          289 NDIKNHKWFATTD  301 (350)
T ss_dssp             HHHHTSGGGTTCC
T ss_pred             HHHHhCcCcCCCC
Confidence            9999999998753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.6e-46  Score=303.34  Aligned_cols=233  Identities=36%  Similarity=0.524  Sum_probs=183.4

Q ss_pred             CCCCchhHHHHHHHhhCC---CCCeeEEEEEEEeCc-----eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            9 EGVPSSMIREVSCLMELN---HPNIIRLMRVASQGI-----YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~---H~niv~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      ......+.+|+.++++++   ||||+++++++....     ..++||||+.++|.+++.....             ..++
T Consensus        52 ~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~-------------~~~~  118 (308)
T 3g33_A           52 GGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPP-------------PGLP  118 (308)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCT-------------TCSC
T ss_pred             cccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccC-------------CCCC
Confidence            344568889999988885   999999999998754     5899999999999999965321             2366


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccC
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      ...+..++.|++.||+|||+++|+||||||+||+++.++ .+||+|||.+..... ........||+.|+|||.+.+ ..
T Consensus       119 ~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~  195 (308)
T 3g33_A          119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSY-QMALTPVVVTLWYRAPEVLLQ-ST  195 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECSCSCTTTSTT-CCCSGGGGCCCSSCCHHHHHT-SC
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEeeCccccccCC-CcccCCccccccccCchHHcC-CC
Confidence            778899999999999999999999999999999999888 899999999976532 233445678999999999987 56


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc-------------cccccccCCCCCCCHHHHH
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL-------------SLRDHLTNGFPGLEPAGID  227 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~  227 (259)
                      ++.++|||||||++|+|++|.+||.+.........+......+.....             ..........+.+++.+.+
T Consensus       196 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (308)
T 3g33_A          196 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQ  275 (308)
T ss_dssp             CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHH
T ss_pred             CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHH
Confidence            899999999999999999999999998887777666432111111000             0001112223568899999


Q ss_pred             HHHhhcCcCCCCccCHHHHhcCccccCCCC
Q 039159          228 LISKMLGMDPDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       228 li~~~l~~dp~~Rp~~~~~l~h~~f~~~~~  257 (259)
                      ||.+||..||++|||+.++|+||||+...+
T Consensus       276 li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          276 LLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             HHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            999999999999999999999999997643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.6e-45  Score=305.09  Aligned_cols=234  Identities=30%  Similarity=0.501  Sum_probs=182.7

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEe--------CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchh
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQ--------GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLF   79 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~   79 (259)
                      .+.....+.+|++++++++||||+++++++..        ++..++||||+.|+|...+....              ..+
T Consensus        56 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--------------~~~  121 (351)
T 3mi9_A           56 KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--------------VKF  121 (351)
T ss_dssp             SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTT--------------SCC
T ss_pred             cccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhcc--------------CCC
Confidence            34556688999999999999999999999987        34689999999998888886432              235


Q ss_pred             HHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC----CCCcCCccCccccCcccc
Q 039159           80 TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK----GESSAEVGTHYYKAPELL  155 (259)
Q Consensus        80 ~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~----~~~~~~~~~~~~~aPE~~  155 (259)
                      +...+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.......    .......||+.|+|||.+
T Consensus       122 ~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  200 (351)
T 3mi9_A          122 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL  200 (351)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchhcccccccccccccccCCcccccCccCchhh
Confidence            6677889999999999999999999999999999999888 89999999997654221    123445789999999999


Q ss_pred             cCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCC---CCCCccccc---cccccccCCC---C-------
Q 039159          156 LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGK---SRKPSFCKL---SLRDHLTNGF---P-------  219 (259)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~---~~~~~~~~~---~~~~~~~~~~---~-------  219 (259)
                      .+...++.++|||||||++|+|++|.+||.+.........+...   ......+..   ..........   .       
T Consensus       201 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (351)
T 3mi9_A          201 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK  280 (351)
T ss_dssp             TTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHH
T ss_pred             cCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhh
Confidence            87566899999999999999999999999998877666655321   111111110   0000000000   0       


Q ss_pred             --CCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          220 --GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       220 --~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                        ..++.+.+||.+||..||.+|||++++|+||||++..
T Consensus       281 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          281 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             HHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             hccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence              0367899999999999999999999999999998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4e-46  Score=313.09  Aligned_cols=218  Identities=22%  Similarity=0.338  Sum_probs=183.2

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|++++++++||||+++++++.+++..++||||+.| +|.+.+....              ..++...+..++.|
T Consensus        92 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--------------~~l~~~~~~~i~~q  157 (387)
T 1kob_A           92 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--------------YKMSEAEVINYMRQ  157 (387)
T ss_dssp             HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT--------------CCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc--------------CCCCHHHHHHHHHH
Confidence            45788999999999999999999999999999999999986 8988885321              23567788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCC-CCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLD-GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~-~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      ++.||+|||++||+||||||+||+++.+ ...+||+|||++...... .......||+.|+|||.+.+ ..++.++||||
T Consensus       158 i~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS  235 (387)
T 1kob_A          158 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWA  235 (387)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHH
T ss_pred             HHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-cceeeeccCCCccCchhccC-CCCCCcccEee
Confidence            9999999999999999999999999743 237999999999865332 22334578999999999987 56889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      |||++|+|++|..||.+.+.......+.......          ....+..+++++.+||.+||..||.+|||++++|+|
T Consensus       236 lG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          236 IGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF----------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             HHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC----------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            9999999999999999988777776665433221          112345789999999999999999999999999999


Q ss_pred             ccccCC
Q 039159          250 EYFKDV  255 (259)
Q Consensus       250 ~~f~~~  255 (259)
                      |||++.
T Consensus       306 p~~~~~  311 (387)
T 1kob_A          306 PWLKGD  311 (387)
T ss_dssp             TTTSSC
T ss_pred             ccccCC
Confidence            999865

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-46  Score=322.20  Aligned_cols=229  Identities=32%  Similarity=0.539  Sum_probs=172.8

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeC-----ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQG-----IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .+++.+|+++|++++||||+++++++...     ..+|+||||+.++|..++...               ..++...+..
T Consensus        96 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---------------~~l~~~~~~~  160 (458)
T 3rp9_A           96 CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP---------------VYLTELHIKT  160 (458)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSS---------------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccC---------------CCCCHHHHHH
Confidence            46788999999999999999999999543     578999999999999998642               3356678889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---------------------------C
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---------------------------E  139 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---------------------------~  139 (259)
                      ++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.......                           .
T Consensus       161 ~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (458)
T 3rp9_A          161 LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ  239 (458)
T ss_dssp             HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCTTSCTTCCCCCC----------------------
T ss_pred             HHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccchhccCccccccccccCcccccccccccccccccccc
Confidence            999999999999999999999999999999998 899999999986532211                           1


Q ss_pred             CcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHh-----------CCCCCCCCCh-------------------
Q 039159          140 SSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-----------GKPLFPGANS-------------------  189 (259)
Q Consensus       140 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~t-----------g~~pf~~~~~-------------------  189 (259)
                      ....+||+.|+|||++.....++.++|||||||++|||++           |+++|.+...                   
T Consensus       240 ~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~  319 (458)
T 3rp9_A          240 LTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRG  319 (458)
T ss_dssp             -----CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHH
T ss_pred             ccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccC
Confidence            2344689999999987654678999999999999999998           6777766432                   


Q ss_pred             -HHHHHHHhCCCCCCccc-----------------cccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCcc
Q 039159          190 -LITLGRIVGKSRKPSFC-----------------KLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY  251 (259)
Q Consensus       190 -~~~~~~i~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~  251 (259)
                       ......+......+...                 ...........++..++++.+||.+||..||.+|||++++|+|||
T Consensus       320 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~  399 (458)
T 3rp9_A          320 NRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF  399 (458)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             CHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHh
Confidence             11111111100000000                 000111233345678999999999999999999999999999999


Q ss_pred             ccCCC
Q 039159          252 FKDVP  256 (259)
Q Consensus       252 f~~~~  256 (259)
                      |+++.
T Consensus       400 f~~~~  404 (458)
T 3rp9_A          400 FKEVR  404 (458)
T ss_dssp             GTTTC
T ss_pred             hhhcC
Confidence            99873

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-45  Score=311.47  Aligned_cols=233  Identities=18%  Similarity=0.190  Sum_probs=177.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +..+.+.+|+.++++++||||+++++++.+++.+|+||||+.| +|.+++.....             ..+....+..++
T Consensus        68 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~  134 (389)
T 3gni_B           68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM-------------DGMNELAIAYIL  134 (389)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCT-------------TCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcc-------------cCCCHHHHHHHH
Confidence            3456788899999999999999999999999999999999995 89998865321             235667788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-------CCCcCCccCccccCcccccCc-cC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-------GESSAEVGTHYYKAPELLLGL-LE  160 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~-~~  160 (259)
                      .|++.||+|||+++|+||||||+||+++.++ .+||+|||.+.......       .......||+.|+|||.+.+. ..
T Consensus       135 ~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  213 (389)
T 3gni_B          135 QGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQG  213 (389)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSC
T ss_pred             HHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCC
Confidence            9999999999999999999999999999888 89999999986542221       112334789999999999763 46


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc--------------------------------c
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK--------------------------------L  208 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~--------------------------------~  208 (259)
                      ++.++|||||||++|+|++|+.||.+.........+...........                                .
T Consensus       214 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (389)
T 3gni_B          214 YDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS  293 (389)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------
T ss_pred             CCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccc
Confidence            88999999999999999999999987665544444332211100000                                0


Q ss_pred             cccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          209 SLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .......+....+++++.+||.+||+.||.+|||++++|+||||+.+.
T Consensus       294 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          294 NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             ------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence            000011123356889999999999999999999999999999999764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.2e-46  Score=304.43  Aligned_cols=218  Identities=22%  Similarity=0.319  Sum_probs=176.7

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +..+.+.+|+.+++.++||||+++++++.+++..|+||||+.| +|.+.+...               ..++...+..++
T Consensus        47 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~  111 (323)
T 3tki_A           47 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---------------IGMPEPDAQRFF  111 (323)
T ss_dssp             ----CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTT---------------TBCCHHHHHHHH
T ss_pred             chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhc---------------CCCCHHHHHHHH
Confidence            3457789999999999999999999999999999999999986 888887532               345667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .|++.||+|||+.||+||||||+||+++.++ .+||+|||++.......  .......||+.|+|||.+.+...++.++|
T Consensus       112 ~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  190 (323)
T 3tki_A          112 HQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD  190 (323)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHH
T ss_pred             HHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCccc
Confidence            9999999999999999999999999999888 89999999997653222  22345679999999999987444577899


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHH-HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLI-TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||||++|+|++|+.||....... ............            ..+..+++.+.+|+.+||..||.+|||+++
T Consensus       191 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  258 (323)
T 3tki_A          191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------NPWKKIDSAPLALLHKILVENPSARITIPD  258 (323)
T ss_dssp             HHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC------------CccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999999999998755432 222222221111            112357899999999999999999999999


Q ss_pred             HhcCccccCC
Q 039159          246 ALQQEYFKDV  255 (259)
Q Consensus       246 ~l~h~~f~~~  255 (259)
                      +++||||+..
T Consensus       259 il~h~~~~~~  268 (323)
T 3tki_A          259 IKKDRWYNKP  268 (323)
T ss_dssp             HTTCTTTTCC
T ss_pred             HhhChhhccc
Confidence            9999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-45  Score=304.73  Aligned_cols=214  Identities=24%  Similarity=0.331  Sum_probs=177.7

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+.+|+.+++++ +||||+++++++.+++.+|+||||+.| +|...+...               ..++...+..++.
T Consensus        53 ~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~---------------~~l~~~~~~~~~~  117 (345)
T 3a8x_A           53 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ---------------RKLPEEHARFYSA  117 (345)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH---------------SSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            35578999999998 899999999999999999999999986 898888542               2355677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.||+|||++||+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|+||
T Consensus       118 qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws  195 (345)
T 3a8x_A          118 EISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWA  195 (345)
T ss_dssp             HHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHH
T ss_pred             HHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccccCCCCcccccCCCccccCccccCC-CCCChHHhHHH
Confidence            999999999999999999999999999988 8999999999864444444566789999999999987 57899999999


Q ss_pred             HHHHHHHHHhCCCCCCCC---------ChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          170 VGCIFGEMVSGKPLFPGA---------NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      |||++|+|++|+.||...         ........+.....              .....+++++.+||.+||..||.+|
T Consensus       196 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------------~~p~~~s~~~~~li~~lL~~dP~~R  261 (345)
T 3a8x_A          196 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------------RIPRSLSVKAASVLKSFLNKDPKER  261 (345)
T ss_dssp             HHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--------------CCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--------------CCCCCCCHHHHHHHHHHhcCCHhHC
Confidence            999999999999999752         22222333332211              1123688999999999999999999


Q ss_pred             cCH------HHHhcCccccCCC
Q 039159          241 ITA------AEALQQEYFKDVP  256 (259)
Q Consensus       241 p~~------~~~l~h~~f~~~~  256 (259)
                      |++      +++++||||+++.
T Consensus       262 ~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          262 LGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             TTCCTTTHHHHHHTSGGGTTCC
T ss_pred             CCCCCcCCHHHHhcCCccCCCC
Confidence            995      8999999998764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.6e-46  Score=317.54  Aligned_cols=217  Identities=26%  Similarity=0.326  Sum_probs=175.7

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ......+.+|+++++.++||||+++++++.+++.+++||||+.| +|...+...               ..++...+..+
T Consensus       189 ~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~  253 (446)
T 4ejn_A          189 KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE---------------RVFSEDRARFY  253 (446)
T ss_dssp             ------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH---------------SCCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc---------------CCCCHHHHHHH
Confidence            34456788999999999999999999999999999999999996 888888542               33556778889


Q ss_pred             HhhcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           88 FSSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        88 ~~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +.|++.||+|||+ +||+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|
T Consensus       254 ~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D  331 (446)
T 4ejn_A          254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVD  331 (446)
T ss_dssp             HHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT-SCCCTHHH
T ss_pred             HHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceeccCCCcccccccCCccccCHhhcCC-CCCCCccc
Confidence            9999999999998 9999999999999999988 8999999999865444444556789999999999987 57899999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----  241 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----  241 (259)
                      ||||||++|+|++|+.||.+.+.......+......              ....+++++.+||.+||..||.+||     
T Consensus       332 iwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~  397 (446)
T 4ejn_A          332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSE  397 (446)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTT
T ss_pred             hhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC--------------CCccCCHHHHHHHHHHcccCHHHhCCCCCC
Confidence            999999999999999999998887777776543321              1135789999999999999999999     


Q ss_pred             CHHHHhcCccccCCC
Q 039159          242 TAAEALQQEYFKDVP  256 (259)
Q Consensus       242 ~~~~~l~h~~f~~~~  256 (259)
                      +++++++||||.++.
T Consensus       398 t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          398 DAKEIMQHRFFAGIV  412 (446)
T ss_dssp             THHHHHTSGGGTTCC
T ss_pred             CHHHHHhCccccCCC
Confidence            999999999999763

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-46  Score=312.32  Aligned_cols=226  Identities=31%  Similarity=0.492  Sum_probs=184.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCc------eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGI------YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ..+++.+|+++++.++||||+++++++..+.      .+|+||||+.++|.+++..                ..++...+
T Consensus        67 ~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----------------~~l~~~~~  130 (367)
T 1cm8_A           67 FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----------------EKLGEDRI  130 (367)
T ss_dssp             HHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH----------------CCCCHHHH
T ss_pred             HHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc----------------CCCCHHHH
Confidence            3467889999999999999999999998653      4699999997799999864                22445677


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++....   ......+|+.|+|||.+.+...++.+
T Consensus       131 ~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~  206 (367)
T 1cm8_A          131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQT  206 (367)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTT
T ss_pred             HHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChh
Confidence            88999999999999999999999999999999988 899999999976432   33455789999999999875678999


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc-----------------ccccccccCCCCCCCHHHHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK-----------------LSLRDHLTNGFPGLEPAGID  227 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~  227 (259)
                      +||||+||++|+|++|++||.+.+.......+......+....                 ..........+++.++.+.+
T Consensus       207 ~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (367)
T 1cm8_A          207 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVN  286 (367)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence            9999999999999999999999887777666543221111000                 00011233445678999999


Q ss_pred             HHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          228 LISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       228 li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |+.+||..||.+|||++++|+||||.+..
T Consensus       287 ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          287 LLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            99999999999999999999999998763

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.7e-46  Score=298.80  Aligned_cols=224  Identities=25%  Similarity=0.385  Sum_probs=186.8

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159            3 GIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus         3 ~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      ++........+++.+|++++++++||||+++++++.+++..++||||+.| +|.+.+...               ..++.
T Consensus        41 ~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~  105 (277)
T 3f3z_A           41 KIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK---------------RVFRE  105 (277)
T ss_dssp             EEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---------------CSCCH
T ss_pred             eehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc---------------CCCCH
Confidence            34444445567899999999999999999999999999999999999986 898887542               33566


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEE---cCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili---~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (259)
                      ..+..++.+++.|++|||+++++||||||+||++   +.++ .++|+|||.+..... ........||+.|+|||.+.+ 
T Consensus       106 ~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-  182 (277)
T 3f3z_A          106 SDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLAARFKP-GKMMRTKVGTPYYVSPQVLEG-  182 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECCT-TSCBCCCCSCTTTCCHHHHTT-
T ss_pred             HHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC-cEEEEecccceeccC-ccchhccCCCCCccChHHhcc-
Confidence            7888999999999999999999999999999999   6666 899999999976543 223445579999999999876 


Q ss_pred             cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                       .++.++||||||+++|+|++|..||...........+.........          ..+..+++.+.+++.+||..||.
T Consensus       183 -~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~  251 (277)
T 3f3z_A          183 -LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE----------KDWLNVSPQAESLIRRLLTKSPK  251 (277)
T ss_dssp             -CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH----------HHHTTSCHHHHHHHHHHTCSSTT
T ss_pred             -cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc----------hhhhcCCHHHHHHHHHHccCChh
Confidence             3889999999999999999999999998887777776554332211          11236789999999999999999


Q ss_pred             CccCHHHHhcCccccCC
Q 039159          239 KRITAAEALQQEYFKDV  255 (259)
Q Consensus       239 ~Rp~~~~~l~h~~f~~~  255 (259)
                      +||++.++|+||||++.
T Consensus       252 ~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          252 QRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             TSCCHHHHTTSHHHHHH
T ss_pred             hCcCHHHHhcCHHHhcc
Confidence            99999999999999854

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.8e-46  Score=314.79  Aligned_cols=223  Identities=23%  Similarity=0.352  Sum_probs=186.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|+.+++.++||||+++++++.+++.+|+||||+.| +|.+++....              ..++...+..++
T Consensus       116 ~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~--------------~~l~e~~~~~~~  181 (437)
T 4aw2_A          116 AETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE--------------DRLPEEMARFYL  181 (437)
T ss_dssp             TTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT--------------TCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc--------------CCCCHHHHHHHH
Confidence            3445689999999999999999999999999999999999985 9999996421              335667788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCccccc----CccCCCc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLL----GLLEYST  163 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~----~~~~~~~  163 (259)
                      .+++.||+|||+.+|+||||||+||+++.++ .+||+|||+++....... ......||+.|+|||.+.    +...++.
T Consensus       182 ~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~  260 (437)
T 4aw2_A          182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP  260 (437)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECT
T ss_pred             HHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCC
Confidence            9999999999999999999999999999998 899999999976543322 233468999999999997    2356889


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC--cc
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK--RI  241 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rp  241 (259)
                      ++|||||||++|||++|++||.+.+..+....+.......         ..+.....+|+++++||.+||..+|++  |+
T Consensus       261 ~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~  331 (437)
T 4aw2_A          261 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF---------QFPTQVTDVSENAKDLIRRLICSREHRLGQN  331 (437)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTT
T ss_pred             cCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc---------cCCcccccCCHHHHHHHHHHhcccccccCCC
Confidence            9999999999999999999999998888887775432111         111223468999999999999998888  99


Q ss_pred             CHHHHhcCccccCCC
Q 039159          242 TAAEALQQEYFKDVP  256 (259)
Q Consensus       242 ~~~~~l~h~~f~~~~  256 (259)
                      +++++++||||+++.
T Consensus       332 ~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          332 GIEDFKKHPFFSGID  346 (437)
T ss_dssp             TTHHHHTSGGGTTCC
T ss_pred             CHHHHhCCCccCCCC
Confidence            999999999998764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.4e-46  Score=316.30  Aligned_cols=229  Identities=34%  Similarity=0.541  Sum_probs=173.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeC-----ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQG-----IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .+++.+|++++++++||||+++++++...     +.+|+||||+.++|.+++...               ..++...+..
T Consensus        69 ~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---------------~~l~~~~~~~  133 (432)
T 3n9x_A           69 CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP---------------IFLTEEHIKT  133 (432)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSS---------------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhcc---------------CCCCHHHHHH
Confidence            46788999999999999999999999876     578999999999999999642               3356778889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC----------------------CCcCCc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG----------------------ESSAEV  144 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~----------------------~~~~~~  144 (259)
                      ++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++.......                      ......
T Consensus       134 i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  212 (432)
T 3n9x_A          134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV  212 (432)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC-------------------------------CC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCcccccccccccccccccccccccccccchhccccCCC
Confidence            999999999999999999999999999999988 899999999986543221                      124567


Q ss_pred             cCccccCcccccCccCCCcccchHhHHHHHHHHHh-----------CCCCCCCCCh-----------------HHHHHHH
Q 039159          145 GTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-----------GKPLFPGANS-----------------LITLGRI  196 (259)
Q Consensus       145 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~t-----------g~~pf~~~~~-----------------~~~~~~i  196 (259)
                      ||+.|+|||.+.....++.++|||||||++|||++           |.++|.+.+.                 ......+
T Consensus       213 gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i  292 (432)
T 3n9x_A          213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNII  292 (432)
T ss_dssp             CCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHH
T ss_pred             CCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHH
Confidence            99999999998665678999999999999999998           4455544321                 1122222


Q ss_pred             hCCCCCCcccc-----------------ccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          197 VGKSRKPSFCK-----------------LSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       197 ~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ......|....                 ..........++.+++++.+||.+||..||.+|||++++|+||||+++.
T Consensus       293 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          293 FNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            11100110000                 0000111223357899999999999999999999999999999999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.7e-45  Score=304.43  Aligned_cols=214  Identities=24%  Similarity=0.312  Sum_probs=181.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .+++.+|++++++++||||+++++++.+++..++||||+.|+|.+.+....              ..++...+..++.++
T Consensus        98 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~--------------~~l~~~~~~~i~~qi  163 (348)
T 1u5q_A           98 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--------------KPLQEVEIAAVTHGA  163 (348)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT--------------SCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCCCHHHHHHHhc--------------CCCCHHHHHHHHHHH
Confidence            356889999999999999999999999999999999999999888885321              235567788899999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC--ccCCCcccchHh
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG--LLEYSTAVDIWP  169 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Diws  169 (259)
                      +.||+|||+++|+||||||+||+++.++ .+||+|||++.....    .....||+.|+|||.+.+  ...++.++||||
T Consensus       164 ~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diws  238 (348)
T 1u5q_A          164 LQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS  238 (348)
T ss_dssp             HHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHH
T ss_pred             HHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHH
Confidence            9999999999999999999999999888 999999999976432    234578999999999853  256788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      |||++|+|++|+.||.+.+.......+........            ....+++.+.++|.+||..||++|||++++++|
T Consensus       239 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          239 LGITCIELAERKPPLFNMNAMSALYHIAQNESPAL------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            99999999999999998887776666554332111            113578999999999999999999999999999


Q ss_pred             ccccCCC
Q 039159          250 EYFKDVP  256 (259)
Q Consensus       250 ~~f~~~~  256 (259)
                      |||....
T Consensus       307 ~~~~~~~  313 (348)
T 1u5q_A          307 RFVLRER  313 (348)
T ss_dssp             HHHHSCC
T ss_pred             hhhhccC
Confidence            9998654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-45  Score=302.79  Aligned_cols=239  Identities=26%  Similarity=0.362  Sum_probs=186.1

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccc----------------
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTK----------------   71 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~----------------   71 (259)
                      ....+++.+|++++++++||||+++++++.+++..++||||+.| +|.+.+.............                
T Consensus        69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (345)
T 3hko_A           69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE  148 (345)
T ss_dssp             -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccc
Confidence            34557889999999999999999999999999999999999986 9999885321111000000                


Q ss_pred             ---------cCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCC-eEEEeeccccccccccCC---
Q 039159           72 ---------NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK-TVKVAGFGLAKSLYAYKG---  138 (259)
Q Consensus        72 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~-~vkl~dfg~~~~~~~~~~---  138 (259)
                               .......+....+..++.|++.||+|||+.+|+||||||+||+++.++. .+||+|||.+........   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~  228 (345)
T 3hko_A          149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY  228 (345)
T ss_dssp             HHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--
T ss_pred             ccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc
Confidence                     0000134567778889999999999999999999999999999976542 699999999986543222   


Q ss_pred             -CCcCCccCccccCcccccCc-cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccC
Q 039159          139 -ESSAEVGTHYYKAPELLLGL-LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTN  216 (259)
Q Consensus       139 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  216 (259)
                       ......||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.........+.........+          
T Consensus       229 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------  298 (345)
T 3hko_A          229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP----------  298 (345)
T ss_dssp             ------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG----------
T ss_pred             ccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc----------
Confidence             13455799999999999642 467889999999999999999999999988887777776544332221          


Q ss_pred             CCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCCC
Q 039159          217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       217 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~~  257 (259)
                      .+..+++.+.++|.+||..||.+||++.++|+||||++...
T Consensus       299 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          299 NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            12357899999999999999999999999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.7e-45  Score=313.56  Aligned_cols=215  Identities=28%  Similarity=0.377  Sum_probs=184.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +..+.+.+|+++++.++||||+++++++..++.+|+||||+.| +|.+++...               ..++...+..++
T Consensus        58 ~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~l~~~~~~~i~  122 (476)
T 2y94_A           58 DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN---------------GRLDEKESRRLF  122 (476)
T ss_dssp             TTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSS---------------SSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhc---------------CCCCHHHHHHHH
Confidence            3456789999999999999999999999999999999999986 999988532               335667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.||+|||++||+||||||+||+++.++ .+||+|||++..... ........||+.|+|||.+.+....+.++|||
T Consensus       123 ~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  200 (476)
T 2y94_A          123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSD-GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW  200 (476)
T ss_dssp             HHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCT-TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhccc-cccccccCCCcCeEChhhccCCCCCCCcceeh
Confidence            9999999999999999999999999999888 899999999986543 23344568999999999998744457899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||||++|+|++|..||.+.+.......+......              ....+++++.+||.+||..||.+|||++++++
T Consensus       201 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          201 SSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY--------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC--------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC--------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            9999999999999999988877777777654321              11357899999999999999999999999999


Q ss_pred             CccccCC
Q 039159          249 QEYFKDV  255 (259)
Q Consensus       249 h~~f~~~  255 (259)
                      ||||+..
T Consensus       267 hp~~~~~  273 (476)
T 2y94_A          267 HEWFKQD  273 (476)
T ss_dssp             CHHHHTT
T ss_pred             CHHhhhc
Confidence            9999754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2e-46  Score=322.11  Aligned_cols=225  Identities=33%  Similarity=0.485  Sum_probs=173.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeC------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ...+++.+|+.+++.++||||+++++++...      ..+|+||||+.++|...+..                 .+....
T Consensus       103 ~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~-----------------~l~~~~  165 (464)
T 3ttj_A          103 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----------------ELDHER  165 (464)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS-----------------CCCHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh-----------------cCCHHH
Confidence            3456788999999999999999999999654      36799999999988888742                 244567


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCc
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      +..++.|++.||+|||+.||+||||||+||+++.++ .+||+|||+++.... ........||+.|+|||.+.+ ..++.
T Consensus       166 ~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~  242 (464)
T 3ttj_A          166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKE  242 (464)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCCC------CCCC----CCCTTCCHHHHTT-CCCCT
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEeeeecCC-CcccCCCcccccccCHHHHcC-CCCCH
Confidence            788999999999999999999999999999999988 899999999976533 223445689999999999988 57899


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccc-c-------c--------ccccCCCCC-------
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLS-L-------R--------DHLTNGFPG-------  220 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-~-------~--------~~~~~~~~~-------  220 (259)
                      ++|||||||++|+|++|++||.+.+.......+......|...... .       .        ......++.       
T Consensus       243 ~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (464)
T 3ttj_A          243 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS  322 (464)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSS
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccc
Confidence            9999999999999999999999988877777664322211100000 0       0        000000000       


Q ss_pred             -----CCHHHHHHHHhhcCcCCCCccCHHHHhcCccccC
Q 039159          221 -----LEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       221 -----~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                           .++++++||.+||..||++|||++++|+||||..
T Consensus       323 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          323 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             ccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                 1567899999999999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.6e-45  Score=309.38  Aligned_cols=229  Identities=30%  Similarity=0.475  Sum_probs=178.2

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCc------eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGI------YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+|+++++.++||||+++++++....      .+++||||+.+++...+.......           ..++...+..++
T Consensus        79 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~-----------~~~~~~~~~~~~  147 (394)
T 4e7w_A           79 KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK-----------QTMPMLLIKLYM  147 (394)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTT-----------SCCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhc-----------CCCCHHHHHHHH
Confidence            457999999999999999999996543      488999999998776664321110           345566788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEc-CCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVD-LDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~-~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .|++.||+|||++||+||||||+||+++ .++ .+||+|||+++..... .......||+.|+|||.+.+...++.++||
T Consensus       148 ~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (394)
T 4e7w_A          148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDI  225 (394)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHH
T ss_pred             HHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHH
Confidence            9999999999999999999999999999 566 9999999999865432 233455789999999999875668999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc---------------ccccccccCCCCCCCHHHHHHHHhh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK---------------LSLRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                      |||||++|+|++|++||.+.+.......+......|....               ...........+.+++++.+||.+|
T Consensus       226 wSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (394)
T 4e7w_A          226 WSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRL  305 (394)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHH
Confidence            9999999999999999999887766666543211111100               0000000111235889999999999


Q ss_pred             cCcCCCCccCHHHHhcCccccCCC
Q 039159          233 LGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |..||.+|||+.++++||||+.+.
T Consensus       306 L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          306 LEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             CCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             hCCChhhCCCHHHHhcChhhhhhc
Confidence            999999999999999999999763

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-45  Score=307.32  Aligned_cols=216  Identities=27%  Similarity=0.359  Sum_probs=176.9

Q ss_pred             CCCchhHHHHHH-HhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSC-LMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~-l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .....+.+|..+ ++.++||||+++++++.+++.+|+||||+.| +|...+...               ..+....+..+
T Consensus        80 ~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---------------~~~~~~~~~~~  144 (373)
T 2r5t_A           80 KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE---------------RCFLEPRARFY  144 (373)
T ss_dssp             -----------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---------------SSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc---------------CCCCHHHHHHH
Confidence            344567778876 5778999999999999999999999999996 898888642               23445677788


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.||+|||++||+||||||+||+++.++ .+||+|||+++............+||+.|+|||.+.+ ..++.++|+
T Consensus       145 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  222 (373)
T 2r5t_A          145 AAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDW  222 (373)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHH
T ss_pred             HHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCccccccccCCCccccccCCccccCHHHhCC-CCCCchhhh
Confidence            99999999999999999999999999999998 8999999999865444445666789999999999987 578999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH----
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA----  243 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~----  243 (259)
                      |||||++|||++|..||.+.+.......+......              ..+.+++.+.+||.+||..||.+||++    
T Consensus       223 wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ--------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             HHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC--------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC--------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            99999999999999999998888888777654211              124688999999999999999999986    


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      .++++||||+++.
T Consensus       289 ~~i~~h~~f~~~~  301 (373)
T 2r5t_A          289 MEIKSHVFFSLIN  301 (373)
T ss_dssp             HHHHTSGGGTTCC
T ss_pred             HHHhCCccccCCC
Confidence            7999999998763

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=304.45  Aligned_cols=217  Identities=26%  Similarity=0.364  Sum_probs=166.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|++++++++||||+++++++.+++..++||||+.| +|.+.+...               ..++...+..++.|
T Consensus        92 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~q  156 (349)
T 2w4o_A           92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK---------------GYYSERDAADAVKQ  156 (349)
T ss_dssp             -------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC---------------SSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            46788999999999999999999999999999999999986 998888532               33556788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcC---CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDL---DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~---~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      ++.||+|||+.+|+||||||+||+++.   ++ .+||+|||+++.... ........||+.|+|||.+.+ ..++.++||
T Consensus       157 i~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  233 (349)
T 2w4o_A          157 ILEAVAYLHENGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIVEH-QVLMKTVCGTPGYCAPEILRG-CAYGPEVDM  233 (349)
T ss_dssp             HHHHHHHHHHTTCCCCCCCGGGEEESSSSTTC-CEEECCCC-----------------CGGGSCHHHHTT-CCCCTHHHH
T ss_pred             HHHHHHHHHHCCeEecCCCcccEEEecCCCCC-CEEEccCccccccCc-ccccccccCCCCccCHHHhcC-CCCCcccch
Confidence            999999999999999999999999975   55 899999999976533 222345578999999999987 568999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHH-HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLI-TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++|+|++|..||.+..... ....+......          ...+.+..+++++.+||.+||..||++|||+.++
T Consensus       234 wslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  303 (349)
T 2w4o_A          234 WSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY----------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA  303 (349)
T ss_dssp             HHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC----------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc----------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            999999999999999998766554 44444433221          1122345789999999999999999999999999


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      |+||||.+..
T Consensus       304 l~hp~~~~~~  313 (349)
T 2w4o_A          304 LQHPWVTGKA  313 (349)
T ss_dssp             HHSTTTTSTT
T ss_pred             hcCcccCCCc
Confidence            9999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=302.57  Aligned_cols=216  Identities=23%  Similarity=0.331  Sum_probs=179.1

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|+++++.++||||+++++++.+.+.+|+||||+.| +|...+...               ..++...+..++
T Consensus        57 ~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~---------------~~l~~~~~~~~~  121 (384)
T 4fr4_A           57 NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN---------------VHFKEETVKLFI  121 (384)
T ss_dssp             TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT---------------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc---------------CCCCHHHHHHHH
Confidence            3456788999999999999999999999999999999999986 898888642               335667788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC--ccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG--LLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D  166 (259)
                      .+++.||+|||+.||+||||||+||+++.++ .+||+|||++..... ........||+.|+|||.+.+  ...++.++|
T Consensus       122 ~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~D  199 (384)
T 4fr4_A          122 CELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLPR-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVD  199 (384)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCT-TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHH
T ss_pred             HHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeeeccC-CCceeccCCCccccCCeeeccCCCCCCCccce
Confidence            9999999999999999999999999999998 899999999986533 334456689999999999974  235788999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-
Q 039159          167 IWPVGCIFGEMVSGKPLFPGAN---SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-  242 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-  242 (259)
                      +|||||++|+|++|+.||....   .......+....              ......+++.+.+||.+||..||.+||+ 
T Consensus       200 iwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~  265 (384)
T 4fr4_A          200 WWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQ  265 (384)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCS
T ss_pred             eechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--------------cCCCCcCCHHHHHHHHHHhcCCHhHhccc
Confidence            9999999999999999997532   223333322211              1112467899999999999999999998 


Q ss_pred             HHHHhcCccccCCC
Q 039159          243 AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ~~~~l~h~~f~~~~  256 (259)
                      ++++++||||.++.
T Consensus       266 ~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          266 LSDVQNFPYMNDIN  279 (384)
T ss_dssp             HHHHHTSGGGTTCC
T ss_pred             HHHHHcChhhhcCC
Confidence            99999999998764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.6e-45  Score=298.14  Aligned_cols=218  Identities=25%  Similarity=0.265  Sum_probs=184.8

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+.++++++||||+++++++.+++..++||||+.| +|.+++...               ..++...+..++.+
T Consensus        59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~q  123 (321)
T 2a2a_A           59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---------------ESLSEEEATSFIKQ  123 (321)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC---------------SCEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            46789999999999999999999999999999999999985 999998642               33566788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCC---eEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGK---TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~---~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      ++.||+|||+.|++||||||+||+++.++.   .++|+|||.+...... .......||+.|+|||.+.+ ..++.++||
T Consensus       124 i~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  201 (321)
T 2a2a_A          124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADM  201 (321)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHH
T ss_pred             HHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcc-ccccccCCCCCccCcccccC-CCCCCcccc
Confidence            999999999999999999999999987763   5999999999765432 23345578999999999977 568899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||+++|+|++|..||.+.........+.........          ..+..+++.+.++|.+||..||++|||+++++
T Consensus       202 ~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l  271 (321)
T 2a2a_A          202 WSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE----------EFFSHTSELAKDFIRKLLVKETRKRLTIQEAL  271 (321)
T ss_dssp             HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH----------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh----------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            99999999999999999998887777776544322110          11246889999999999999999999999999


Q ss_pred             cCccccCCC
Q 039159          248 QQEYFKDVP  256 (259)
Q Consensus       248 ~h~~f~~~~  256 (259)
                      +||||.++.
T Consensus       272 ~hp~~~~~~  280 (321)
T 2a2a_A          272 RHPWITPVD  280 (321)
T ss_dssp             HSTTTSCSS
T ss_pred             cCccccCCC
Confidence            999998764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.9e-45  Score=302.82  Aligned_cols=220  Identities=24%  Similarity=0.335  Sum_probs=161.0

Q ss_pred             CCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ....+.+|+.+++++. ||||+++++++.++...|+||||+.| +|.+.+...               ..++...+..++
T Consensus        48 ~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~  112 (325)
T 3kn6_A           48 MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK---------------KHFSETEASYIM  112 (325)
T ss_dssp             GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC---------------SCCCHHHHHHHH
T ss_pred             hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc---------------CCCCHHHHHHHH
Confidence            3467889999999997 99999999999999999999999986 999988642               335667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCC--eEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK--TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~--~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .+++.||+|||+++|+||||||+||+++.++.  .+||+|||++..............||+.|+|||.+.+ ..++.++|
T Consensus       113 ~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D  191 (325)
T 3kn6_A          113 RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCD  191 (325)
T ss_dssp             HHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------------CCCCHHHH
T ss_pred             HHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC-CCCCCccc
Confidence            99999999999999999999999999976542  6999999999865544444556678999999999977 57889999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANS-------LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      ||||||++|+|++|..||.+...       ......+.........          ..+.++++++.+||.+||..||.+
T Consensus       192 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dP~~  261 (325)
T 3kn6_A          192 LWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG----------EAWKNVSQEAKDLIQGLLTVDPNK  261 (325)
T ss_dssp             HHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS----------HHHHTSCHHHHHHHHHHHCCCTTT
T ss_pred             hHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc----------ccccCCCHHHHHHHHHHCCCChhH
Confidence            99999999999999999986432       3334444333221110          112358899999999999999999


Q ss_pred             ccCHHHHhcCccccCCC
Q 039159          240 RITAAEALQQEYFKDVP  256 (259)
Q Consensus       240 Rp~~~~~l~h~~f~~~~  256 (259)
                      |||++++++||||++..
T Consensus       262 Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          262 RLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             CCCTTTSTTCGGGCTTC
T ss_pred             CCCHHHHhcChhhccCc
Confidence            99999999999998754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.2e-45  Score=311.26  Aligned_cols=230  Identities=26%  Similarity=0.453  Sum_probs=177.7

Q ss_pred             hhHHHHHHHhhCCCCCeeEEEEEEEeC------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           14 SMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+.+|++++++++||||+++++++...      ..+++||||+.+++..++......           ...+....+..+
T Consensus        93 ~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~-----------~~~l~~~~~~~~  161 (420)
T 1j1b_A           93 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-----------KQTLPVIYVKLY  161 (420)
T ss_dssp             SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHT-----------TCCCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhc-----------cCCCCHHHHHHH
Confidence            355899999999999999999998542      247899999999888777532111           034556778889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||+++|+||||||+||+++.++..+||+|||+++..... .......||+.|+|||.+.+...++.++||
T Consensus       162 ~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  240 (420)
T 1j1b_A          162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDV  240 (420)
T ss_dssp             HHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHH
T ss_pred             HHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhh
Confidence            9999999999999999999999999999976558999999999865432 233445789999999999875578999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc---------------ccccccccccCCCCCCCHHHHHHHHhh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF---------------CKLSLRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                      |||||++|||++|++||.+.+.......+......+..               +............+..++++.+||.+|
T Consensus       241 wSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~  320 (420)
T 1j1b_A          241 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL  320 (420)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHh
Confidence            99999999999999999998877666655432111110               000000000001245789999999999


Q ss_pred             cCcCCCCccCHHHHhcCccccCC
Q 039159          233 LGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      |..||.+||++.++++||||...
T Consensus       321 L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          321 LEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             ccCChhHCCCHHHHhCCHhhccc
Confidence            99999999999999999999764

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.9e-45  Score=299.62  Aligned_cols=228  Identities=21%  Similarity=0.309  Sum_probs=180.9

Q ss_pred             CCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            4 IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         4 ~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      +...+....+++.+|++++++++||||+++++++..++..++||||+.+ +|..++....              ..++..
T Consensus        52 ~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--------------~~~~~~  117 (302)
T 2j7t_A           52 IETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD--------------RGLTEP  117 (302)
T ss_dssp             EC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT--------------SCCCHH
T ss_pred             ecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc--------------cCCCHH
Confidence            3344455667899999999999999999999999999999999999987 8888775421              235567


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCccccc----Cc
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL----GL  158 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~  158 (259)
                      .+..++.+++.||+|||+.|++||||||+||+++.++ .++|+|||++..............|++.|+|||.+.    ..
T Consensus       118 ~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  196 (302)
T 2j7t_A          118 QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD  196 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTS
T ss_pred             HHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCccccccccccccccCChhhcCCeeeccccCCC
Confidence            8889999999999999999999999999999999888 899999999764332222334457899999999984    22


Q ss_pred             cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      ..++.++||||||+++|+|++|..||...+.......+.........           ....+++.+.+++.+||..||.
T Consensus       197 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~  265 (302)
T 2j7t_A          197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL-----------TPSKWSVEFRDFLKIALDKNPE  265 (302)
T ss_dssp             TTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-----------SGGGSCHHHHHHHHHHSCSCTT
T ss_pred             CCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccC-----------CccccCHHHHHHHHHHcccChh
Confidence            56788999999999999999999999988877666665443221111           1135788999999999999999


Q ss_pred             CccCHHHHhcCccccCCCC
Q 039159          239 KRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       239 ~Rp~~~~~l~h~~f~~~~~  257 (259)
                      +|||++++++||||++...
T Consensus       266 ~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          266 TRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             TSCCHHHHTTSTTTTTCCC
T ss_pred             hCCCHHHHhcChHHhhhcc
Confidence            9999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.9e-45  Score=316.23  Aligned_cols=218  Identities=26%  Similarity=0.411  Sum_probs=183.9

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ......+.+|+.+++.++||||+++++++.++...|+||||+.| +|.+.+...               ..++...+..+
T Consensus        77 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~---------------~~~~~~~~~~i  141 (494)
T 3lij_A           77 TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR---------------MKFNEVDAAVI  141 (494)
T ss_dssp             -CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---------------SSCCHHHHHHH
T ss_pred             chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc---------------CCCCHHHHHHH
Confidence            34467899999999999999999999999999999999999996 888877532               23556778889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.|++.||+|||++||+||||||+||+++..+  ..+||+|||++...... .......||+.|+|||.+.+  .++.++
T Consensus       142 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~  218 (494)
T 3lij_A          142 IKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRK--KYDEKC  218 (494)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHHTT--CBCTHH
T ss_pred             HHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-ccccccCCCcCeeCHHHHcc--cCCCch
Confidence            99999999999999999999999999997643  25999999999765432 23445679999999999864  588999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||+||++|+|++|.+||.+.........+.........          +.+..+|+.+.+||.+||..||.+|||+.+
T Consensus       219 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e  288 (494)
T 3lij_A          219 DVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS----------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQ  288 (494)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS----------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----------hhcccCCHHHHHHHHHHCCCChhhCccHHH
Confidence            9999999999999999999999888887777654433221          223578999999999999999999999999


Q ss_pred             HhcCccccC
Q 039159          246 ALQQEYFKD  254 (259)
Q Consensus       246 ~l~h~~f~~  254 (259)
                      +|+||||+.
T Consensus       289 ~l~hp~~~~  297 (494)
T 3lij_A          289 ALEHPWIKE  297 (494)
T ss_dssp             HHTCHHHHH
T ss_pred             HhcCccccc
Confidence            999999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=309.66  Aligned_cols=221  Identities=27%  Similarity=0.326  Sum_probs=182.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+.++..++||||+++++++.+++.+|+||||+.| +|.+++....              ..++...+..++.
T Consensus       104 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~--------------~~l~~~~~~~~~~  169 (412)
T 2vd5_A          104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG--------------ERIPAEMARFYLA  169 (412)
T ss_dssp             GGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--------------SCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC--------------CCCCHHHHHHHHH
Confidence            346688999999999999999999999999999999999985 9999986421              2355667788899


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccC------ccCCC
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLG------LLEYS  162 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~------~~~~~  162 (259)
                      +++.||+|||+++|+||||||+||+++.++ .+||+|||+++....... ......||+.|+|||.+.+      ...++
T Consensus       170 qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~  248 (412)
T 2vd5_A          170 EIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYG  248 (412)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEEC
T ss_pred             HHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCC
Confidence            999999999999999999999999999988 899999999986543322 2334589999999999972      24578


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc--
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR--  240 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R--  240 (259)
                      .++|+|||||++|||++|+.||.+.+.......+.........         +.....+|+++++||.+||. +|.+|  
T Consensus       249 ~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------p~~~~~~s~~~~dli~~lL~-~p~~Rlg  318 (412)
T 2vd5_A          249 PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL---------PLVDEGVPEEARDFIQRLLC-PPETRLG  318 (412)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC---------C----CCCHHHHHHHHTTSS-CGGGCTT
T ss_pred             hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC---------CccccCCCHHHHHHHHHHcC-ChhhcCC
Confidence            9999999999999999999999998888877777542111111         11124689999999999999 99998  


Q ss_pred             -cCHHHHhcCccccCCC
Q 039159          241 -ITAAEALQQEYFKDVP  256 (259)
Q Consensus       241 -p~~~~~l~h~~f~~~~  256 (259)
                       |+++++++||||+++.
T Consensus       319 r~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          319 RGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             TTTHHHHHTSGGGTTCC
T ss_pred             CCCHHHHhcCCCcCCCC
Confidence             5999999999998763

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.2e-45  Score=305.47  Aligned_cols=218  Identities=26%  Similarity=0.321  Sum_probs=166.0

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ....+.+.+|+.++++++||||+++++++.+++.+++||||+.| +|.+.+...               ..++...+..+
T Consensus        57 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i  121 (361)
T 3uc3_A           57 AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA---------------GRFSEDEARFF  121 (361)
T ss_dssp             TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---------------SSCCHHHHHHH
T ss_pred             ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc---------------CCCCHHHHHHH
Confidence            44567899999999999999999999999999999999999986 998888542               33566788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCC-eEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK-TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~-~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +.|++.||+|||++||+||||||+||+++.++. .+||+|||+++.... ........||+.|+|||.+.+....+.++|
T Consensus       122 ~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  200 (361)
T 3uc3_A          122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRQEYDGKIAD  200 (361)
T ss_dssp             HHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHH
T ss_pred             HHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc-cCCCCCCcCCCCcCChhhhcCCCCCCCeee
Confidence            999999999999999999999999999987651 499999999974322 223344579999999999987433345599


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCCh----HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANS----LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ||||||++|+|++|+.||.+...    ......+.......            +....+++.+.+||.+||..||.+|||
T Consensus       201 iwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~s~~~~~li~~~L~~dP~~Rps  268 (361)
T 3uc3_A          201 VWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI------------PDDIRISPECCHLISRIFVADPATRIS  268 (361)
T ss_dssp             HHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC------------CTTSCCCHHHHHHHHHHSCSCTTTSCC
T ss_pred             eehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC------------CCcCCCCHHHHHHHHHHccCChhHCcC
Confidence            99999999999999999986433    22233333221110            112357899999999999999999999


Q ss_pred             HHHHhcCccccC
Q 039159          243 AAEALQQEYFKD  254 (259)
Q Consensus       243 ~~~~l~h~~f~~  254 (259)
                      +.++++||||..
T Consensus       269 ~~ell~hp~f~~  280 (361)
T 3uc3_A          269 IPEIKTHSWFLK  280 (361)
T ss_dssp             HHHHHTSHHHHT
T ss_pred             HHHHHhCcchhc
Confidence            999999999954

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.3e-45  Score=294.07  Aligned_cols=219  Identities=26%  Similarity=0.378  Sum_probs=175.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|++++++++||||+++++++.+.+..++||||+.| +|.+.+......           ...++...+..++
T Consensus        62 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~i~  130 (285)
T 3is5_A           62 VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR-----------GKALSEGYVAELM  130 (285)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHH-----------TCCCCHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhc-----------ccCCCHHHHHHHH
Confidence            3457889999999999999999999999999999999999996 898888532110           0335667788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcC---CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDL---DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~---~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .+++.||+|||+.+|+||||||+||+++.   ++ .+||+|||++...... .......||+.|+|||.+.+  .++.++
T Consensus       131 ~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~  206 (285)
T 3is5_A          131 KQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKR--DVTFKC  206 (285)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTC-CEEECCCCCCCC-----------CTTGGGCCHHHHTT--CCCHHH
T ss_pred             HHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCC-CEEEEeeecceecCCc-ccCcCcccccCcCChHHhcc--CCCccc
Confidence            99999999999999999999999999943   45 7999999999765332 23345578999999999864  578899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||||+++|+|++|..||.+.........+........           .....+++.+.+++.+||..||++|||+.+
T Consensus       207 Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  275 (285)
T 3is5_A          207 DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-----------VECRPLTPQAVDLLKQMLTKDPERRPSAAQ  275 (285)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------C--CCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             CeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-----------cccCcCCHHHHHHHHHHccCChhhCcCHHH
Confidence            999999999999999999998877766655543322111           112347899999999999999999999999


Q ss_pred             HhcCccccC
Q 039159          246 ALQQEYFKD  254 (259)
Q Consensus       246 ~l~h~~f~~  254 (259)
                      +|+||||+.
T Consensus       276 ~l~hp~f~~  284 (285)
T 3is5_A          276 VLHHEWFKQ  284 (285)
T ss_dssp             HHTSGGGGC
T ss_pred             HhcCHHhhc
Confidence            999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.2e-45  Score=314.67  Aligned_cols=218  Identities=29%  Similarity=0.459  Sum_probs=183.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|++++++++||||+++++++.++..+|+||||+.| +|.+.+...               ..++...+..++
T Consensus        63 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~i~  127 (486)
T 3mwu_A           63 KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---------------KRFSEHDAARII  127 (486)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH---------------SSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc---------------CCCCHHHHHHHH
Confidence            3456789999999999999999999999999999999999986 888877532               335667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcC---CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDL---DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~---~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .|++.||+|||++||+||||||+||+++.   ++ .+||+|||++..... ........||+.|+|||.+.+  .++.++
T Consensus       128 ~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~  203 (486)
T 3mwu_A          128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDC-DIKIIDFGLSTCFQQ-NTKMKDRIGTAYYIAPEVLRG--TYDEKC  203 (486)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTC-CEEECSCSCTTTBCC-C----CCTTGGGGCCGGGGGS--CCCHHH
T ss_pred             HHHHHHHHHHHHCCeEeccCchHHEEEecCCCCC-CEEEEECCcCeECCC-CCccCCCcCCCCCCCHHHhCC--CCCchh
Confidence            99999999999999999999999999953   34 799999999976533 223445579999999999976  488999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||+||++|+|++|.+||.+.........+.........+          .+..+|+++.+||.+||..||.+|||+.+
T Consensus       204 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~~  273 (486)
T 3mwu_A          204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP----------QWRTISDDAKDLIRKMLTFHPSLRITATQ  273 (486)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG----------GGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc----------ccCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            99999999999999999999998888877776554332221          23468899999999999999999999999


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +|+||||+...
T Consensus       274 ~l~hp~~~~~~  284 (486)
T 3mwu_A          274 CLEHPWIQKYS  284 (486)
T ss_dssp             HHHCHHHHHTC
T ss_pred             HhcCHhhccCc
Confidence            99999998654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.5e-45  Score=302.34  Aligned_cols=217  Identities=28%  Similarity=0.398  Sum_probs=178.5

Q ss_pred             chhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           13 SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        13 ~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+..+|++++.++ +||||+++++++.+++.+|+||||+.| +|.+.+...               ..++...+..++.+
T Consensus        60 ~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~---------------~~~~~~~~~~~~~q  124 (342)
T 2qr7_A           60 RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ---------------KFFSEREASAVLFT  124 (342)
T ss_dssp             CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC---------------TTCCHHHHHHHHHH
T ss_pred             CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc---------------CCCCHHHHHHHHHH
Confidence            3467899999988 799999999999999999999999986 898888542               33566788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCC---CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDG---KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~---~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      ++.||+|||++||+||||||+||++..+.   ..+||+|||+++.............||+.|+|||.+.+ ..++.++||
T Consensus       125 i~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  203 (342)
T 2qr7_A          125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER-QGYDAACDI  203 (342)
T ss_dssp             HHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHH
T ss_pred             HHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC-CCCCCccCe
Confidence            99999999999999999999999985432   14999999999876554445566789999999999976 457889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCC---ChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          168 WPVGCIFGEMVSGKPLFPGA---NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||++|+|++|..||.+.   ........+.......          ....+..+++++.+||.+||..||++||++.
T Consensus       204 wslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  273 (342)
T 2qr7_A          204 WSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL----------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA  273 (342)
T ss_dssp             HHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC----------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             eeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc----------CccccccCCHHHHHHHHHHCCCChhHCcCHH
Confidence            99999999999999999863   3444444444332211          1123457899999999999999999999999


Q ss_pred             HHhcCccccCC
Q 039159          245 EALQQEYFKDV  255 (259)
Q Consensus       245 ~~l~h~~f~~~  255 (259)
                      ++++||||.+.
T Consensus       274 ~il~hp~~~~~  284 (342)
T 2qr7_A          274 LVLRHPWIVHW  284 (342)
T ss_dssp             HHTTSHHHHTG
T ss_pred             HHhcCCeecCc
Confidence            99999999753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.2e-45  Score=300.21  Aligned_cols=230  Identities=25%  Similarity=0.350  Sum_probs=174.5

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchh
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLF   79 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~   79 (259)
                      |.+........+++.+|+++++++ +||||+++++++.+++.+++||||+.| +|.+.+...               ..+
T Consensus        44 K~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~  108 (316)
T 2ac3_A           44 KIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR---------------RHF  108 (316)
T ss_dssp             EEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH---------------SSC
T ss_pred             EEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc---------------CCC
Confidence            344444556678899999999995 799999999999999999999999985 999988642               234


Q ss_pred             HHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCC--eEEEeeccccccccccCC-------CCcCCccCcccc
Q 039159           80 TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK--TVKVAGFGLAKSLYAYKG-------ESSAEVGTHYYK  150 (259)
Q Consensus        80 ~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~--~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~~~  150 (259)
                      +...+..++.|++.||+|||+++|+||||||+||+++.++.  .+||+|||++........       ......||+.|+
T Consensus       109 ~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  188 (316)
T 2ac3_A          109 NELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM  188 (316)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGC
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCcc
Confidence            56678889999999999999999999999999999987762  399999999875432211       122346899999


Q ss_pred             CcccccC----ccCCCcccchHhHHHHHHHHHhCCCCCCCCCh---------------HHHHHHHhCCCCCCcccccccc
Q 039159          151 APELLLG----LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS---------------LITLGRIVGKSRKPSFCKLSLR  211 (259)
Q Consensus       151 aPE~~~~----~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~  211 (259)
                      |||.+.+    ...++.++|||||||++|+|++|+.||.+...               ......+........       
T Consensus       189 aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-------  261 (316)
T 2ac3_A          189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFP-------  261 (316)
T ss_dssp             CHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCC-------
T ss_pred             ChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccC-------
Confidence            9999864    13478899999999999999999999986532               122223322221111       


Q ss_pred             ccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          212 DHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       212 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                         ...+..+++++.+||.+||..||++|||++++++||||++..
T Consensus       262 ---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          262 ---DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             ---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             ---chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence               011245789999999999999999999999999999998753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.8e-45  Score=303.65  Aligned_cols=228  Identities=34%  Similarity=0.557  Sum_probs=176.3

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|++++++++||||+++++++.+++..++||||+.+ +|..+....               ..++...+..++.+
T Consensus        68 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~~q  132 (331)
T 4aaa_A           68 KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP---------------NGLDYQVVQKYLFQ  132 (331)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHST---------------TCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhc---------------cCCCHHHHHHHHHH
Confidence            45578999999999999999999999999999999999998 455544321               33556778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPV  170 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl  170 (259)
                      ++.||+|||+.|++||||||+||+++.++ .++|+|||.+..............|++.|+|||.+.+...++.++|||||
T Consensus       133 i~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl  211 (331)
T 4aaa_A          133 IINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAI  211 (331)
T ss_dssp             HHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHH
T ss_pred             HHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHH
Confidence            99999999999999999999999999888 89999999997655444444556789999999999875578899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHhCCCC--CC---------------ccccccccccccCCCCCCCHHHHHHHHhhc
Q 039159          171 GCIFGEMVSGKPLFPGANSLITLGRIVGKSR--KP---------------SFCKLSLRDHLTNGFPGLEPAGIDLISKML  233 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~--~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  233 (259)
                      ||++|+|++|++||.+.........+.....  .+               ..+............+.+++.+.+||.+||
T Consensus       212 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  291 (331)
T 4aaa_A          212 GCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCL  291 (331)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHh
Confidence            9999999999999998877666555432110  00               000011111222233568999999999999


Q ss_pred             CcCCCCccCHHHHhcCccccCC
Q 039159          234 GMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ..||++|||++++|+||||+..
T Consensus       292 ~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          292 HIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccCcccCCCHHHHhcCchhccC
Confidence            9999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.6e-46  Score=309.75  Aligned_cols=225  Identities=34%  Similarity=0.526  Sum_probs=169.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeC------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ..+++.+|+++++.++||||+++++++...      ...|+|+|++.++|.+++..                ..++...+
T Consensus        71 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----------------~~l~~~~~  134 (367)
T 2fst_X           71 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----------------QKLTDDHV  134 (367)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC---------------------CCCCHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc----------------CCCCHHHH
Confidence            346788999999999999999999999754      56799999997788887743                23556778


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ..++.|++.||+|||+.||+||||||+||+++.++ .+||+|||+++....   ......||+.|+|||.+.+...++.+
T Consensus       135 ~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~  210 (367)
T 2fst_X          135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQT  210 (367)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC------------------CCCTTCCHHHHTTCCSCCTT
T ss_pred             HHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeeccccccccc---cCCCcCcCcCccChHHHcCCcCCCch
Confidence            88999999999999999999999999999999888 899999999976432   23445789999999999875678999


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc-----------------cccccccCCCCCCCHHHHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL-----------------SLRDHLTNGFPGLEPAGID  227 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~  227 (259)
                      +|||||||++|+|++|++||.+.+.......+......|.....                 .........+++.++.+.+
T Consensus       211 ~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  290 (367)
T 2fst_X          211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD  290 (367)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHH
Confidence            99999999999999999999998877666665432111110000                 0001122234568899999


Q ss_pred             HHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          228 LISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       228 li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ||.+||..||++|||++++|+||||...
T Consensus       291 Ll~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          291 LLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence            9999999999999999999999999875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.1e-45  Score=292.63  Aligned_cols=217  Identities=24%  Similarity=0.354  Sum_probs=156.3

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|+.++++++||||+++++++.+++..++||||+.+ +|.+++....              ..++...+..++
T Consensus        53 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~  118 (278)
T 3cok_A           53 GMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--------------KPFSENEARHFM  118 (278)
T ss_dssp             TCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS--------------SCCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc--------------CCCCHHHHHHHH
Confidence            3456789999999999999999999999999999999999986 8999886421              235567788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.|++|||+.+++||||||+||+++.++ .++|+|||.+..............||+.|+|||.+.+ ..++.++|||
T Consensus       119 ~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  196 (278)
T 3cok_A          119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVW  196 (278)
T ss_dssp             HHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC-----------------------------CTHHH
T ss_pred             HHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHH
Confidence            9999999999999999999999999999888 8999999999865433333345578999999999977 5678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|+|++|..||...........+....              ......+++++.+++.+||..||.+||+++++++
T Consensus       197 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          197 SLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--------------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HHHHHHHHHHHSSCSSCCCSCC-----CCSSC--------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc--------------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            99999999999999998755433332221110              0112357899999999999999999999999999


Q ss_pred             CccccCCC
Q 039159          249 QEYFKDVP  256 (259)
Q Consensus       249 h~~f~~~~  256 (259)
                      ||||....
T Consensus       263 h~~~~~~~  270 (278)
T 3cok_A          263 HPFMSRNS  270 (278)
T ss_dssp             STTTC---
T ss_pred             CccccCCC
Confidence            99998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.2e-44  Score=290.83  Aligned_cols=218  Identities=27%  Similarity=0.370  Sum_probs=183.3

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+++.+|++++++++||||+++++++.+++..++||||+.| +|.+.+...               ..++...+..++.+
T Consensus        49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~~~  113 (284)
T 3kk8_A           49 FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---------------EFYSEADASHCIQQ  113 (284)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH---------------SSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            46688999999999999999999999999999999999986 888877532               33566778889999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++.|++|||+.+++||||||+||+++.++  ..+||+|||.+..... ........||+.|+|||.+.+ ..++.++|||
T Consensus       114 i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  191 (284)
T 3kk8_A          114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIW  191 (284)
T ss_dssp             HHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS-SCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHH
T ss_pred             HHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc-CccccCCCCCcCCcCchhhcC-CCCCcccchH
Confidence            99999999999999999999999997654  2499999999976533 223344678999999999987 5688999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|+|++|..||.+.........+........          .+.+..+++++.+++.+||+.||++|||++++++
T Consensus       192 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          192 ACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP----------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC----------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            999999999999999999888777777654432211          1223568899999999999999999999999999


Q ss_pred             CccccCCC
Q 039159          249 QEYFKDVP  256 (259)
Q Consensus       249 h~~f~~~~  256 (259)
                      ||||.+..
T Consensus       262 h~~~~~~~  269 (284)
T 3kk8_A          262 VPWICNRE  269 (284)
T ss_dssp             SHHHHSCC
T ss_pred             CccccCCh
Confidence            99998764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-45  Score=306.13  Aligned_cols=229  Identities=33%  Similarity=0.510  Sum_probs=179.1

Q ss_pred             hhHHHHHHHhhCCCCCeeEEEEEEEe--------------------------------------CceEEEEeeeecCCHH
Q 039159           14 SMIREVSCLMELNHPNIIRLMRVASQ--------------------------------------GIYLYPVFEYQVNDLA   55 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H~niv~~~~~~~~--------------------------------------~~~~~lv~e~~~~~l~   55 (259)
                      ...+|+++++.++||||+++++++..                                      +..+++||||+.|+|.
T Consensus        46 ~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~  125 (383)
T 3eb0_A           46 YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH  125 (383)
T ss_dssp             SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHH
T ss_pred             hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHH
Confidence            34589999999999999999999854                                      3358999999999988


Q ss_pred             HHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcC-CCCeEEEeecccccccc
Q 039159           56 YLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDL-DGKTVKVAGFGLAKSLY  134 (259)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~-~~~~vkl~dfg~~~~~~  134 (259)
                      +.+......           ...++...+..++.|++.||+|||++||+||||||+||+++. ++ .+||+|||.++...
T Consensus       126 ~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~  193 (383)
T 3eb0_A          126 KVLKSFIRS-----------GRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TLKLCDFGSAKKLI  193 (383)
T ss_dssp             HHHHHHHHT-----------TCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTT-EEEECCCTTCEECC
T ss_pred             HHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCC-cEEEEECCCCcccC
Confidence            887532111           134566778889999999999999999999999999999984 55 99999999998654


Q ss_pred             ccCCCCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc---------
Q 039159          135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF---------  205 (259)
Q Consensus       135 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~---------  205 (259)
                      .. .......||+.|+|||.+.+...++.++||||+||++|+|++|++||.+.........+......|..         
T Consensus       194 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~  272 (383)
T 3eb0_A          194 PS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH  272 (383)
T ss_dssp             TT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred             CC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcc
Confidence            32 23445578999999999987556899999999999999999999999998877777666432211111         


Q ss_pred             ------ccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          206 ------CKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       206 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                            +...............++++.+||.+||..||.+|||+.++|+||||+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          273 YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL  328 (383)
T ss_dssp             C--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred             cccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence                  00000000011124578999999999999999999999999999999753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=301.91  Aligned_cols=234  Identities=28%  Similarity=0.455  Sum_probs=182.0

Q ss_pred             CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEE--------------eCceEEEEeeeecCCHHHHhhcCCCCCCCccccc
Q 039159            7 TMEGVPSSMIREVSCLMELNHPNIIRLMRVAS--------------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN   72 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~--------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~   72 (259)
                      .+....+++.+|++++++++||||+++++++.              +.+..++||||+.|+|.+++..            
T Consensus        47 ~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~------------  114 (320)
T 2i6l_A           47 TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ------------  114 (320)
T ss_dssp             CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT------------
T ss_pred             CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhc------------
Confidence            33344567899999999999999999999874              3468899999999999998853            


Q ss_pred             CCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC---CCCcCCccCccc
Q 039159           73 FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK---GESSAEVGTHYY  149 (259)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~  149 (259)
                          ..+....+..++.|++.||+|||++|++||||||+||+++.++..+||+|||.+.......   .......+++.|
T Consensus       115 ----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y  190 (320)
T 2i6l_A          115 ----GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY  190 (320)
T ss_dssp             ----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTT
T ss_pred             ----CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccc
Confidence                2345567788999999999999999999999999999998554489999999998653221   123344678999


Q ss_pred             cCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc----------------ccccc
Q 039159          150 KAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL----------------SLRDH  213 (259)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------------~~~~~  213 (259)
                      +|||.+.+...++.++|||||||++|+|++|+.||.+.........+............                .....
T Consensus       191 ~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (320)
T 2i6l_A          191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKP  270 (320)
T ss_dssp             CCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCC
T ss_pred             cCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCC
Confidence            99999876567889999999999999999999999988877666665433221110000                00011


Q ss_pred             ccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          214 LTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       214 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .....+.+++++.++|.+||..||.+|||++++++||||+...
T Consensus       271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          271 LTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             hhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            1222356899999999999999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.2e-45  Score=294.88  Aligned_cols=229  Identities=23%  Similarity=0.288  Sum_probs=177.1

Q ss_pred             CCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            4 IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         4 ~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      +........+.+.+|+.+++.++||||+++++++..++..++||||+.+ +|.+++......            ......
T Consensus        55 ~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~  122 (295)
T 2clq_A           55 IPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP------------LKDNEQ  122 (295)
T ss_dssp             EECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCC------------CTTCHH
T ss_pred             ccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccC------------CCccHH
Confidence            4444455667899999999999999999999999999999999999985 999998653221            234456


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcC-CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc-cC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDL-DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL-LE  160 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~-~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~  160 (259)
                      .+..++.+++.||+|||+.+++||||||+||+++. ++ .++|+|||.+..............|++.|+|||.+.+. ..
T Consensus       123 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  201 (295)
T 2clq_A          123 TIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG-VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG  201 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC-CEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGG
T ss_pred             HHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC-CEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCC
Confidence            77788999999999999999999999999999998 55 89999999998764433344556789999999999753 23


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHH-HHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT-LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      ++.++||||||+++|+|++|+.||........ ..........+            .....+++++.+++.+||..||++
T Consensus       202 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~  269 (295)
T 2clq_A          202 YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP------------EIPESMSAEAKAFILKCFEPDPDK  269 (295)
T ss_dssp             CSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC------------CCCTTSCHHHHHHHHHTTCSSTTT
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc------------cccccCCHHHHHHHHHHccCChhh
Confidence            78899999999999999999999976433322 11111111111            122468899999999999999999


Q ss_pred             ccCHHHHhcCccccCCCC
Q 039159          240 RITAAEALQQEYFKDVPG  257 (259)
Q Consensus       240 Rp~~~~~l~h~~f~~~~~  257 (259)
                      ||+++++++||||+....
T Consensus       270 Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          270 RACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             SCCHHHHHTSGGGCC---
T ss_pred             CCCHHHHhcChhhhhccc
Confidence            999999999999997643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=309.74  Aligned_cols=240  Identities=32%  Similarity=0.496  Sum_probs=172.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEe--CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .....+.+|+.++++++||||+++++++..  +..+++||||+.|+|.+++........      ......++...+..+
T Consensus        60 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~------~~~~~~l~~~~~~~i  133 (405)
T 3rgf_A           60 GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKA------NKKPVQLPRGMVKSL  133 (405)
T ss_dssp             SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------------CCHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccc------cccccCCCHHHHHHH
Confidence            445689999999999999999999999954  678999999999999888864221100      000123667788999


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEE----cCCCCeEEEeeccccccccccC---CCCcCCccCccccCcccccCccC
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILV----DLDGKTVKVAGFGLAKSLYAYK---GESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili----~~~~~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      +.|++.||+|||+.+|+||||||+||++    +.++ .+||+|||++.......   .......||+.|+|||.+.+...
T Consensus       134 ~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  212 (405)
T 3rgf_A          134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH  212 (405)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT-CEEECCTTCCC----------------CCCTTCCHHHHTTCCS
T ss_pred             HHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC-cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCc
Confidence            9999999999999999999999999999    5556 89999999998654321   12344578999999999987556


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChH---------HHHHHHhCCCCCCcccccc----------------------
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSL---------ITLGRIVGKSRKPSFCKLS----------------------  209 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~----------------------  209 (259)
                      ++.++|||||||++|+|++|.+||.+....         .....+......|......                      
T Consensus       213 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (405)
T 3rgf_A          213 YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTN  292 (405)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTT
T ss_pred             ccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCc
Confidence            899999999999999999999999765431         2233322111111110000                      


Q ss_pred             --ccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          210 --LRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       210 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                        ............++.+.+||.+||..||.+|||++++|+||||...+
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~  341 (405)
T 3rgf_A          293 CSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP  341 (405)
T ss_dssp             CCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred             chhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence              00001111123478899999999999999999999999999998753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.3e-45  Score=304.21  Aligned_cols=227  Identities=30%  Similarity=0.506  Sum_probs=182.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeC-----ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQG-----IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ..++.+|++++++++||||+++++++...     ...++||||+.|+|.+++..                ..++...+..
T Consensus        69 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~----------------~~~~~~~~~~  132 (364)
T 3qyz_A           69 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT----------------QHLSNDHICY  132 (364)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH----------------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh----------------CCCCHHHHHH
Confidence            46788999999999999999999999765     36899999999999998864                2355677888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCCCc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      ++.|++.||+|||++||+||||||+||+++.++ .+||+|||.+.........   .....||+.|+|||.+.+...++.
T Consensus       133 i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  211 (364)
T 3qyz_A          133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK  211 (364)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCST
T ss_pred             HHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCc
Confidence            999999999999999999999999999999888 8999999999865433221   244579999999999876566899


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc-----------------cccccccCCCCCCCHHHH
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL-----------------SLRDHLTNGFPGLEPAGI  226 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~  226 (259)
                      ++|||||||++|+|++|++||.+.........+......+.....                 .........++++++++.
T Consensus       212 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (364)
T 3qyz_A          212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL  291 (364)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHH
T ss_pred             chhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHH
Confidence            999999999999999999999987766665555322111111000                 000111222356899999


Q ss_pred             HHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          227 DLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       227 ~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      +||.+||..||.+|||++++|+||||+..
T Consensus       292 ~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          292 DLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            99999999999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.5e-44  Score=311.71  Aligned_cols=219  Identities=25%  Similarity=0.314  Sum_probs=182.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|++++++++||||+++++++.+++.+|+||||+.| +|...+.......           ..++...+..++.
T Consensus       228 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~-----------~~l~e~~~~~~~~  296 (543)
T 3c4z_A          228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN-----------PGFQEPRAIFYTA  296 (543)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTS-----------CSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhccc-----------ccccHHHHHHHHH
Confidence            346788999999999999999999999999999999999996 8988886532111           3466778888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||++||+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|+||
T Consensus       297 qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwS  374 (543)
T 3c4z_A          297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFA  374 (543)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHH
T ss_pred             HHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCc
Confidence            999999999999999999999999999998 8999999999876544434455689999999999987 57899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC----hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC---
Q 039159          170 VGCIFGEMVSGKPLFPGAN----SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT---  242 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---  242 (259)
                      |||++|||++|++||.+..    .......+.....              .....+++.+.+||.+||..||.+||+   
T Consensus       375 lGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~  440 (543)
T 3c4z_A          375 LGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--------------TYPDKFSPASKDFCEALLQKDPEKRLGFRD  440 (543)
T ss_dssp             HHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBT
T ss_pred             chHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--------------CCCcccCHHHHHHHHHhccCCHhHCCCCcc
Confidence            9999999999999998753    2334444433211              112468899999999999999999995   


Q ss_pred             --HHHHhcCccccCCC
Q 039159          243 --AAEALQQEYFKDVP  256 (259)
Q Consensus       243 --~~~~l~h~~f~~~~  256 (259)
                        ++++++||||+++.
T Consensus       441 ~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          441 GSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             TBSHHHHTSGGGTTCC
T ss_pred             cCHHHHHcCccccCCC
Confidence              58999999999863

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.6e-44  Score=313.76  Aligned_cols=219  Identities=28%  Similarity=0.418  Sum_probs=186.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+.++++++||||+++++++.++..+|+||||+.| +|.+.+...               ..++...+..++
T Consensus        88 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~---------------~~~~~~~~~~i~  152 (504)
T 3q5i_A           88 KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR---------------HKFDECDAANIM  152 (504)
T ss_dssp             CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------SCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc---------------CCCCHHHHHHHH
Confidence            4457789999999999999999999999999999999999986 898888542               335667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCC--eEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK--TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~--~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .|++.||+|||+.||+||||||+||+++.++.  .+||+|||++...... .......||+.|+|||.+.+  .++.++|
T Consensus       153 ~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~D  229 (504)
T 3q5i_A          153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCD  229 (504)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHH
T ss_pred             HHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHH
Confidence            99999999999999999999999999987652  5999999999865432 23445679999999999875  5889999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||+||++|+|++|.+||.+.+.......+.........+          .+..+|+++.+||.+||..||.+|||++++
T Consensus       230 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~  299 (504)
T 3q5i_A          230 VWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN----------DWKNISDEAKELIKLMLTYDYNKRCTAEEA  299 (504)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH----------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc----------ccCCCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            9999999999999999999998888887776554322211          134689999999999999999999999999


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      |+||||+...
T Consensus       300 l~h~~~~~~~  309 (504)
T 3q5i_A          300 LNSRWIKKYA  309 (504)
T ss_dssp             HTSHHHHHTC
T ss_pred             hcCHhhhhch
Confidence            9999998653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=293.09  Aligned_cols=220  Identities=23%  Similarity=0.375  Sum_probs=184.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|+.++++++||||+++++++..++..++||||+.+ +|.+++....              ..++...+..++.
T Consensus        67 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~  132 (314)
T 3com_A           67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN--------------KTLTEDEIATILQ  132 (314)
T ss_dssp             CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT--------------CCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC--------------CCCCHHHHHHHHH
Confidence            457899999999999999999999999999999999999997 9999885321              3355678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|++|||+.|++||||||+||+++.++ .++|+|||.+..............|++.|+|||.+.+ ..++.++||||
T Consensus       133 ~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s  210 (314)
T 3com_A          133 STLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWS  210 (314)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHH
T ss_pred             HHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhhccccCccCCCCCccChhhcCC-CCCCccccHHH
Confidence            999999999999999999999999999888 8999999999766544344455678999999999987 56889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      ||+++|+|++|..||...........+...... ..          .....+++.+.++|.+||..||.+|||++++++|
T Consensus       211 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          211 LGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TF----------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             HHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CC----------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-cc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            999999999999999987766555444332211 11          1113468999999999999999999999999999


Q ss_pred             ccccCCCC
Q 039159          250 EYFKDVPG  257 (259)
Q Consensus       250 ~~f~~~~~  257 (259)
                      |||++..+
T Consensus       280 ~~~~~~~~  287 (314)
T 3com_A          280 PFVRSAKG  287 (314)
T ss_dssp             HHHHTCCC
T ss_pred             HHHhcCCc
Confidence            99998764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-44  Score=294.96  Aligned_cols=223  Identities=24%  Similarity=0.321  Sum_probs=181.5

Q ss_pred             CCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159            5 HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus         5 ~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ........+.+.+|+.++++++||||+++++++.+++..++||||+.| +|.+.+...               ..++...
T Consensus        43 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~  107 (304)
T 2jam_A           43 KKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER---------------GVYTEKD  107 (304)
T ss_dssp             ECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH---------------SCCCHHH
T ss_pred             ecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc---------------CCCCHHH
Confidence            333334456789999999999999999999999999999999999986 998888542               2345677


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEE---cCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccC
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili---~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      +..++.+++.||+|||+.|++||||||+||++   +.++ .++|+|||.+.....  .......|++.|+|||.+.+ ..
T Consensus       108 ~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~  183 (304)
T 2jam_A          108 ASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS-KIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQ-KP  183 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTTCCCCC--BTTHHHHSCCCBCCTTTBSS-CS
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC-CEEEccCCcceecCC--CccccccCCCCccChHHhcc-CC
Confidence            88899999999999999999999999999999   5566 899999999875422  12334468999999999987 57


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      ++.++||||||+++|+|++|..||.+.........+........          .+.+..+++++.+++.+||..||.+|
T Consensus       184 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~R  253 (304)
T 2jam_A          184 YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE----------SPFWDDISESAKDFICHLLEKDPNER  253 (304)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC----------TTTTTTSCHHHHHHHHHHHCSSTTTS
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----------ccccccCCHHHHHHHHHHcCCChhHC
Confidence            88999999999999999999999998887777666654432211          12235688999999999999999999


Q ss_pred             cCHHHHhcCccccCCC
Q 039159          241 ITAAEALQQEYFKDVP  256 (259)
Q Consensus       241 p~~~~~l~h~~f~~~~  256 (259)
                      |+++++++||||.+..
T Consensus       254 ps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          254 YTCEKALSHPWIDGNT  269 (304)
T ss_dssp             CCHHHHHTSHHHHSSC
T ss_pred             cCHHHHhcCccccCCC
Confidence            9999999999998653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.8e-45  Score=314.73  Aligned_cols=218  Identities=30%  Similarity=0.465  Sum_probs=184.7

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ....+.+.+|++++++++||||+++++++.+.+.+++||||+.| +|.+.+...               ..++...+..+
T Consensus        67 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~i  131 (484)
T 3nyv_A           67 KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR---------------KRFSEVDAARI  131 (484)
T ss_dssp             SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC---------------SCCBHHHHHHH
T ss_pred             chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc---------------CCCCHHHHHHH
Confidence            34567799999999999999999999999999999999999986 898888542               33566778899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEc---CCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVD---LDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~---~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      +.|++.||+|||++||+||||||+||+++   .++ .+||+|||++...... .......||+.|+|||.+.+  .++.+
T Consensus       132 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~  207 (484)
T 3nyv_A          132 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA-NIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG--TYDEK  207 (484)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC-CEEECCTTHHHHBCCC-CSHHHHTTGGGTCCHHHHHT--CCCTH
T ss_pred             HHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCC-cEEEEeeeeeEEcccc-cccccCCCCccccCceeecC--CCCCc
Confidence            99999999999999999999999999994   455 8999999999765332 23344579999999999976  58899


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      +||||+||++|+|++|.+||.+.+.......+.........+          .+..+|+.+.+||.+||..||.+|||++
T Consensus       208 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~  277 (484)
T 3nyv_A          208 CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP----------QWKKVSESAKDLIRKMLTYVPSMRISAR  277 (484)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG----------GGGGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             ceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc----------ccccCCHHHHHHHHHHCCCChhHCcCHH
Confidence            999999999999999999999998888887776554332221          2346889999999999999999999999


Q ss_pred             HHhcCccccCC
Q 039159          245 EALQQEYFKDV  255 (259)
Q Consensus       245 ~~l~h~~f~~~  255 (259)
                      ++|+||||+..
T Consensus       278 e~l~h~~~~~~  288 (484)
T 3nyv_A          278 DALDHEWIQTY  288 (484)
T ss_dssp             HHHTSHHHHHH
T ss_pred             HHhhChhhccc
Confidence            99999999753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.9e-44  Score=290.69  Aligned_cols=214  Identities=28%  Similarity=0.381  Sum_probs=178.8

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|+.++++++||||+++++++.+++..++||||+.+ +|.+.+...               ..++...+..++
T Consensus        51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~---------------~~~~~~~~~~~~  115 (279)
T 3fdn_A           51 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---------------SKFDEQRTATYI  115 (279)
T ss_dssp             TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH---------------SSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc---------------CCCCHHHHHHHH
Confidence            3456788999999999999999999999999999999999996 898888542               235567788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||+.||+||||||+||+++.++ .++|+|||++.....  .......|++.|+|||.+.+ ..++.++|||
T Consensus       116 ~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  191 (279)
T 3fdn_A          116 TELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLW  191 (279)
T ss_dssp             HHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC----------CCCCTTCCHHHHTT-CCCCTTHHHH
T ss_pred             HHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCc--ccccccCCCCCccCHhHhcc-CCCCccchhH
Confidence            9999999999999999999999999999888 899999999864322  22344578999999999987 5678899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|+|++|..||...........+......              ....+++.+.+|+.+||..||.+||+++++++
T Consensus       192 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          192 SLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC--------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            9999999999999999988877776665433211              11357899999999999999999999999999


Q ss_pred             CccccCCC
Q 039159          249 QEYFKDVP  256 (259)
Q Consensus       249 h~~f~~~~  256 (259)
                      ||||....
T Consensus       258 h~~~~~~~  265 (279)
T 3fdn_A          258 HPWITANS  265 (279)
T ss_dssp             CHHHHHHC
T ss_pred             CccccCCc
Confidence            99998653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.8e-45  Score=304.62  Aligned_cols=228  Identities=28%  Similarity=0.462  Sum_probs=175.4

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEe-----CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQ-----GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +++.+|++++++++||||+++++++..     ...+|+||||+.|+|.+.+....              ..++...+..+
T Consensus        74 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--------------~~~~~~~~~~~  139 (362)
T 3pg1_A           74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR--------------IVISPQHIQYF  139 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT--------------SCCCHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc--------------cCCCHHHHHHH
Confidence            678999999999999999999999854     33789999999999999886421              24566788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||++||+||||||+||+++.++ .+||+|||.+...... .......||+.|+|||.+.+...++.++||
T Consensus       140 ~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  217 (362)
T 3pg1_A          140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDM  217 (362)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHH
T ss_pred             HHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHH
Confidence            99999999999999999999999999999888 8999999999754322 233445789999999999875678999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc------------------cccccccCCCCCCCHHHHHHH
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL------------------SLRDHLTNGFPGLEPAGIDLI  229 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~li  229 (259)
                      |||||++|++++|+.||.+.........+......+.....                  ..........+..++.+.+||
T Consensus       218 wslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  297 (362)
T 3pg1_A          218 WSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI  297 (362)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHH
Confidence            99999999999999999988877666665432211111100                  000011122356789999999


Q ss_pred             HhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          230 SKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       230 ~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .+||..||.+|||++++++||||+++.
T Consensus       298 ~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          298 AKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHhcCChhhCCCHHHHHcCchhhhcc
Confidence            999999999999999999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.9e-45  Score=311.43  Aligned_cols=227  Identities=26%  Similarity=0.369  Sum_probs=178.4

Q ss_pred             CchhHHHHHHHhhC------CCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           12 PSSMIREVSCLMEL------NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l------~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ...+.+|+++++.+      +|+||+++++++...+..++||||+.++|.+++.....             ..++...+.
T Consensus       137 ~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-------------~~~~~~~~~  203 (429)
T 3kvw_A          137 HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF-------------QGFSLPLVR  203 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTT-------------CCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccC-------------CCCCHHHHH
Confidence            45678899998887      57799999999999999999999999999999865321             235667788


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCe--EEEeeccccccccccCCCCcCCccCccccCcccccCccCCCc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKT--VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~--vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      .++.|++.||+|||+.+|+||||||+||+++.++ .  +||+|||++....   .......||+.|+|||.+.+ ..++.
T Consensus       204 ~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~-~~~vkL~DFG~a~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~  278 (429)
T 3kvw_A          204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIKVIDFGSSCYEH---QRVYTYIQSRFYRAPEVILG-ARYGM  278 (429)
T ss_dssp             HHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-SCCEEECCCTTCEETT---CCCCSSCSCGGGCCHHHHHT-BCCCT
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-CcceEEeecccceecC---CcccccCCCCCccChHHHhC-CCCCc
Confidence            9999999999999999999999999999999887 5  9999999996542   23445689999999999988 56899


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccc----------------------------------
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLS----------------------------------  209 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----------------------------------  209 (259)
                      ++|||||||++|+|++|.+||.+.+.......+......+......                                  
T Consensus       279 ~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (429)
T 3kvw_A          279 PIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGR  358 (429)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEE
T ss_pred             hHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccc
Confidence            9999999999999999999999988776665553221111100000                                  


Q ss_pred             ----------cccc-ccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          210 ----------LRDH-LTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       210 ----------~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                                .... ........++.+.+||.+||..||++|||++++|+||||+...
T Consensus       359 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          359 SRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             CTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             cchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence                      0000 0000123478899999999999999999999999999999764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.3e-44  Score=319.78  Aligned_cols=217  Identities=22%  Similarity=0.300  Sum_probs=189.0

Q ss_pred             CCCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +...+.+.+|..++..+ +||||+++++++.+.+.+|+||||+.| +|...+...               ..+....+..
T Consensus       382 ~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---------------~~~~~~~~~~  446 (674)
T 3pfq_A          382 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV---------------GRFKEPHAVF  446 (674)
T ss_dssp             TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH---------------SSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc---------------CCCCHHHHHH
Confidence            34567788999999998 699999999999999999999999996 899888642               2355677888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.+++.||+|||+.+|+||||||+|||++.++ .+||+|||+++.............||+.|+|||++.+ ..++.++|
T Consensus       447 ~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~D  524 (674)
T 3pfq_A          447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVD  524 (674)
T ss_dssp             HHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHH
T ss_pred             HHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeeccccCCcccccccCCCcccCHhhhcC-CCCCccce
Confidence            999999999999999999999999999999998 8999999999865444445566789999999999987 57899999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH---
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA---  243 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~---  243 (259)
                      +|||||++|||++|++||.+.+..+....+.......              ...+++++.+||.+||..||.+||++   
T Consensus       525 vwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~  590 (674)
T 3pfq_A          525 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--------------PKSMSKEAVAICKGLMTKHPGKRLGCGPE  590 (674)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC--------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTT
T ss_pred             EechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--------------CccCCHHHHHHHHHHccCCHHHCCCCCCC
Confidence            9999999999999999999999888888887643211              13689999999999999999999997   


Q ss_pred             --HHHhcCccccCCC
Q 039159          244 --AEALQQEYFKDVP  256 (259)
Q Consensus       244 --~~~l~h~~f~~~~  256 (259)
                        +++++||||+++.
T Consensus       591 ~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          591 GERDIKEHAFFRYID  605 (674)
T ss_dssp             HHHHHHSSGGGSSCC
T ss_pred             cHHHHhcCccccCCC
Confidence              9999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.9e-44  Score=288.95  Aligned_cols=214  Identities=27%  Similarity=0.389  Sum_probs=182.6

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|++++++++||||+++++++.+++..++||||+.+ +|.+.+...               ..++...+..++
T Consensus        56 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~  120 (284)
T 2vgo_A           56 GVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH---------------GRFDEQRSATFM  120 (284)
T ss_dssp             TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH---------------SSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc---------------CCCCHHHHHHHH
Confidence            3456789999999999999999999999999999999999986 999888642               234567788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.|++|||++|++||||||+||+++.++ .++|+|||.+.....  .......|++.|+|||.+.+ ..++.++|||
T Consensus       121 ~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  196 (284)
T 2vgo_A          121 EELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEG-KTHDEKVDLW  196 (284)
T ss_dssp             HHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSS--SCBCCCCSCGGGCCHHHHTT-CCBCTTHHHH
T ss_pred             HHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCcc--cccccccCCCCcCCHHHhcc-CCCCcccchh
Confidence            9999999999999999999999999999888 899999999865432  22345578999999999987 5678999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|++++|..||...........+......              ....+++++.+++.+||..||.+||+++++++
T Consensus       197 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          197 CAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC--------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            9999999999999999988877766666543211              11357899999999999999999999999999


Q ss_pred             CccccCCC
Q 039159          249 QEYFKDVP  256 (259)
Q Consensus       249 h~~f~~~~  256 (259)
                      ||||+...
T Consensus       263 h~~~~~~~  270 (284)
T 2vgo_A          263 HPWVKANS  270 (284)
T ss_dssp             CHHHHHHC
T ss_pred             CHHHHhhc
Confidence            99998654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-44  Score=298.61  Aligned_cols=218  Identities=24%  Similarity=0.371  Sum_probs=170.4

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc-----------------------------------------------
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGI-----------------------------------------------   41 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----------------------------------------------   41 (259)
                      +...+.+.+|++++++++||||+++++++.+..                                               
T Consensus        45 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  124 (332)
T 3qd2_B           45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV  124 (332)
T ss_dssp             TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccc
Confidence            345578999999999999999999999986543                                               


Q ss_pred             ----------eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCC
Q 039159           42 ----------YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKP  110 (259)
Q Consensus        42 ----------~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp  110 (259)
                                ..++||||+.| +|.+++......            .......++.++.|++.||+|||++||+||||||
T Consensus       125 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  192 (332)
T 3qd2_B          125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL------------EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP  192 (332)
T ss_dssp             -------CCCEEEEEEECCCSSCHHHHHHTCCSG------------GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             ccccCCCCCceEEEEEEecCCCCHHHHHhcccCc------------cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCc
Confidence                      38999999996 999998653211            2233456788999999999999999999999999


Q ss_pred             CcEEEcCCCCeEEEeeccccccccccCC------------CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHH
Q 039159          111 VNILVDLDGKTVKVAGFGLAKSLYAYKG------------ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV  178 (259)
Q Consensus       111 ~Nili~~~~~~vkl~dfg~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~  178 (259)
                      +||+++.++ .+||+|||++........            ......||+.|+|||.+.+ ..++.++|||||||++|+|+
T Consensus       193 ~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~  270 (332)
T 3qd2_B          193 SNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL  270 (332)
T ss_dssp             GGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC-CCCCTHHHHHHHHHHHHHHH
T ss_pred             ccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC-CCCcchhhHHHHHHHHHHHH
Confidence            999999888 899999999986544321            2234469999999999987 57899999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          179 SGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       179 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      +|..|+...  ......+... ..+..            +...++.+.+++.+||..||++||+++++++||||+++
T Consensus       271 ~~~~~~~~~--~~~~~~~~~~-~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          271 YSFSTQMER--VRIITDVRNL-KFPLL------------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             SCCCCHHHH--HHHHHHHHTT-CCCHH------------HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             HcCCChhHH--HHHHHHhhcc-CCCcc------------cccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            987665321  1222222222 11111            12356788999999999999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.6e-44  Score=287.31  Aligned_cols=221  Identities=22%  Similarity=0.314  Sum_probs=179.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+.+++.++||||+++++++.+++..++||||+.+ +|.+.+...               ..++...+..++
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~  111 (276)
T 2yex_A           47 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---------------IGMPEPDAQRFF  111 (276)
T ss_dssp             THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT---------------TBCCHHHHHHHH
T ss_pred             hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc---------------cCCCHHHHHHHH
Confidence            3457789999999999999999999999999999999999986 888877431               335667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .+++.||+|||++|++||||||+||+++.++ .++|+|||.+.......  .......|++.|+|||.+.+....+.++|
T Consensus       112 ~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  190 (276)
T 2yex_A          112 HQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD  190 (276)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHH
T ss_pred             HHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcch
Confidence            9999999999999999999999999999888 89999999997653221  22345578999999999987444477899


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHH-HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLI-TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||+++|++++|..||....... ....+.......            ..+..+++.+.+++.+||..||.+|||+++
T Consensus       191 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  258 (276)
T 2yex_A          191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------NPWKKIDSAPLALLHKILVENPSARITIPD  258 (276)
T ss_dssp             HHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc------------CchhhcCHHHHHHHHHHCCCCchhCCCHHH
Confidence            9999999999999999998755432 222222221110            112357899999999999999999999999


Q ss_pred             HhcCccccCCCCC
Q 039159          246 ALQQEYFKDVPGR  258 (259)
Q Consensus       246 ~l~h~~f~~~~~~  258 (259)
                      +++||||+....+
T Consensus       259 il~~~~~~~~~~~  271 (276)
T 2yex_A          259 IKKDRWYNKPLKK  271 (276)
T ss_dssp             HTTCTTTTCCCC-
T ss_pred             HhcCccccChhhc
Confidence            9999999977543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.4e-44  Score=291.30  Aligned_cols=217  Identities=22%  Similarity=0.308  Sum_probs=184.6

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ....+++.+|+.++++++||||+++++++.+++..++||||+.| +|.+++..                ..++...+..+
T Consensus        61 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~~  124 (303)
T 3a7i_A           61 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP----------------GPLDETQIATI  124 (303)
T ss_dssp             STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT----------------SCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc----------------CCCCHHHHHHH
Confidence            34457899999999999999999999999999999999999997 89988853                23556778899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.||+|||+.|++||||||+||+++.++ .++|+|||.+..............|++.|+|||.+.+ ..++.++||
T Consensus       125 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  202 (303)
T 3a7i_A          125 LREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADI  202 (303)
T ss_dssp             HHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHH
T ss_pred             HHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCccccccCccCCCcCccCHHHHhc-CCCCchhhh
Confidence            99999999999999999999999999999888 8999999999876544444456679999999999987 568889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||+++|+|++|..||...........+..... +            .....+++.+.+++.+||..||.+|||+++++
T Consensus       203 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  269 (303)
T 3a7i_A          203 WSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-P------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELL  269 (303)
T ss_dssp             HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C------------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred             HHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC-C------------CCccccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            9999999999999999998777666555433221 1            11246789999999999999999999999999


Q ss_pred             cCccccCCC
Q 039159          248 QQEYFKDVP  256 (259)
Q Consensus       248 ~h~~f~~~~  256 (259)
                      +||||....
T Consensus       270 ~~~~~~~~~  278 (303)
T 3a7i_A          270 KHKFILRNA  278 (303)
T ss_dssp             TCHHHHHHC
T ss_pred             hChhhhcCC
Confidence            999997543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.5e-44  Score=293.59  Aligned_cols=232  Identities=37%  Similarity=0.549  Sum_probs=185.8

Q ss_pred             CCCCchhHHHHHHHhhC---CCCCeeEEEEEEE-----eCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            9 EGVPSSMIREVSCLMEL---NHPNIIRLMRVAS-----QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l---~H~niv~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      +.....+.+|+.+++.+   +||||+++++++.     .....++||||+.|+|.+++.....             ..++
T Consensus        52 ~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-------------~~~~  118 (326)
T 1blx_A           52 EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-------------PGVP  118 (326)
T ss_dssp             TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT-------------TCSC
T ss_pred             ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhccc-------------CCCC
Confidence            34456788999988887   8999999999987     4568899999999999999865321             2355


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccC
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      ...+..++.+++.||+|||+.|++||||||+||+++.++ .+||+|||.+...... .......|++.|+|||.+.+ ..
T Consensus       119 ~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~  195 (326)
T 1blx_A          119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQ-SS  195 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTT-CC
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecCcccccccCC-CCccccccccceeCHHHHhc-CC
Confidence            677889999999999999999999999999999999888 8999999999765322 22344578999999999987 56


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc-------------ccccccccCCCCCCCHHHHH
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK-------------LSLRDHLTNGFPGLEPAGID  227 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~  227 (259)
                      ++.++||||||+++|+|++|+.||.+.........+......+....             .............+++.+.+
T Consensus       196 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 1blx_A          196 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD  275 (326)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHH
T ss_pred             CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHH
Confidence            88999999999999999999999999887776666543211111000             00111233344678999999


Q ss_pred             HHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          228 LISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       228 li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |+.+||..||.+||++.++++||||++..
T Consensus       276 li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          276 LLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHcCCCcccCCCHHHHhcCccccccc
Confidence            99999999999999999999999999774

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.5e-44  Score=311.39  Aligned_cols=216  Identities=24%  Similarity=0.296  Sum_probs=179.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|++++++++||||+++++++.+++.+|+||||+.| +|...+.....             ..++...+..++
T Consensus       226 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~-------------~~l~e~~~~~i~  292 (576)
T 2acx_A          226 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ-------------AGFPEARAVFYA  292 (576)
T ss_dssp             TCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSS-------------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCC-------------CCCCHHHHHHHH
Confidence            3346688999999999999999999999999999999999986 89988864321             235667888899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.||+|||++||+||||||+||+++.++ .+||+|||+++..... .......||+.|+|||.+.+ ..++.++|+|
T Consensus       293 ~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APEvl~~-~~~~~~~Diw  369 (576)
T 2acx_A          293 AEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWW  369 (576)
T ss_dssp             HHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECCTT-CCEECCCSCGGGCCHHHHTT-CEESSHHHHH
T ss_pred             HHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceecccC-ccccccCCCccccCHHHHcC-CCCCccchHH
Confidence            9999999999999999999999999999988 8999999999865332 23344589999999999987 5689999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCC----hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc---
Q 039159          169 PVGCIFGEMVSGKPLFPGAN----SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI---  241 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---  241 (259)
                      ||||++|+|++|.+||.+..    .......+.....              .....+|+++.+||.+||..||.+||   
T Consensus       370 SLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~--------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~  435 (576)
T 2acx_A          370 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE--------------EYSERFSPQARSLCSQLLCKDPAERLGCR  435 (576)
T ss_dssp             HHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC--------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred             HHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc--------------cCCccCCHHHHHHHHHhccCCHHHcCCCC
Confidence            99999999999999998753    2233333322111              11246899999999999999999999   


Q ss_pred             --CHHHHhcCccccCC
Q 039159          242 --TAAEALQQEYFKDV  255 (259)
Q Consensus       242 --~~~~~l~h~~f~~~  255 (259)
                        +++++++||||+++
T Consensus       436 ~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          436 GGSAREVKEHPLFKKL  451 (576)
T ss_dssp             SSHHHHHHTSGGGTTC
T ss_pred             CCCHHHHHhChhhccC
Confidence              89999999999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.1e-44  Score=299.51  Aligned_cols=224  Identities=21%  Similarity=0.271  Sum_probs=176.1

Q ss_pred             CchhHHHHHHHhhCC-----CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELN-----HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-----H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ...+.+|+.+++.++     ||||+++++++...+..++||||+.++|.+++.....             ..+....+..
T Consensus        75 ~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~-------------~~~~~~~~~~  141 (360)
T 3llt_A           75 TRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNY-------------NGFHIEDIKL  141 (360)
T ss_dssp             HHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTT-------------CCCCHHHHHH
T ss_pred             hhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCC-------------CCCCHHHHHH
Confidence            456788999999996     9999999999999999999999997799999975321             2356677888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcC-------------------------CCCeEEEeeccccccccccCCCCc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDL-------------------------DGKTVKVAGFGLAKSLYAYKGESS  141 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~-------------------------~~~~vkl~dfg~~~~~~~~~~~~~  141 (259)
                      ++.|++.||+|||++||+||||||+||+++.                         ++ .+||+|||++....   ....
T Consensus       142 i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~---~~~~  217 (360)
T 3llt_A          142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST-GIKLIDFGCATFKS---DYHG  217 (360)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCC-CEEECCCTTCEETT---SCCC
T ss_pred             HHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCC-CEEEEeccCceecC---CCCc
Confidence            9999999999999999999999999999974                         55 79999999997542   2334


Q ss_pred             CCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCC-Ccccccc----------c
Q 039159          142 AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRK-PSFCKLS----------L  210 (259)
Q Consensus       142 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~----------~  210 (259)
                      ...||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+...... +......          .
T Consensus       218 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  296 (360)
T 3llt_A          218 SIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVN  296 (360)
T ss_dssp             SCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEE
T ss_pred             CccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccC
Confidence            5678999999999987 57899999999999999999999999988776665554322111 1000000          0


Q ss_pred             cccccCCC---------------------CCCCHHHHHHHHhhcCcCCCCccCHHHHhcCcccc
Q 039159          211 RDHLTNGF---------------------PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFK  253 (259)
Q Consensus       211 ~~~~~~~~---------------------~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~  253 (259)
                      .......+                     ...++.+.+||.+||+.||.+|||++++|+||||+
T Consensus       297 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          297 KDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             TTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            00000000                     12347788999999999999999999999999996

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-44  Score=302.14  Aligned_cols=225  Identities=33%  Similarity=0.522  Sum_probs=178.8

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceE------EEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYL------YPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~------~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ...++.+|+.+++.++||||+++++++...+..      ++||||+.++|.+.+.                 ..++...+
T Consensus        84 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-----------------~~~~~~~~  146 (371)
T 4exu_A           84 FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG-----------------MEFSEEKI  146 (371)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT-----------------SCCCHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh-----------------cCCCHHHH
Confidence            346788999999999999999999999877654      9999999999888873                 22556788


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ..++.+++.||+|||+.||+||||||+||+++.++ .+||+|||.+....   .......||+.|+|||.+.+...++.+
T Consensus       147 ~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~  222 (371)
T 4exu_A          147 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHAD---AEMTGYVVTRWYRAPEVILSWMHYNQT  222 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTT
T ss_pred             HHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCcccccc---cCcCCcccCccccCHHHhcCCCCCCcH
Confidence            88999999999999999999999999999999888 89999999997542   233455789999999999875678999


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc-----------------ccccccccCCCCCCCHHHHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK-----------------LSLRDHLTNGFPGLEPAGID  227 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~  227 (259)
                      +|||||||++|+|++|+.||.+.+.......+......+....                 ..........++.+++.+.+
T Consensus       223 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
T 4exu_A          223 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAAD  302 (371)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHH
T ss_pred             HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHH
Confidence            9999999999999999999999887776666533211111000                 00001111223567999999


Q ss_pred             HHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          228 LISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       228 li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ||.+||..||++|||++++|+||||+...
T Consensus       303 li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          303 LLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence            99999999999999999999999998753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3e-44  Score=299.53  Aligned_cols=236  Identities=32%  Similarity=0.429  Sum_probs=181.6

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc-------eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGI-------YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      +.....+..+|++.++.++||||+++++++...+       .+++||||+.++|...+......           .....
T Consensus        59 ~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~-----------~~~~~  127 (360)
T 3e3p_A           59 DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR-----------QVAPP  127 (360)
T ss_dssp             CTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTT-----------TCCCC
T ss_pred             CccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhc-----------ccCCC
Confidence            3445667888999999999999999999997533       38999999999887766432111           13455


Q ss_pred             HHHHHHHHhhccccccccc--CCCceeccCCCCcEEEcC-CCCeEEEeeccccccccccCCCCcCCccCccccCcccccC
Q 039159           81 TFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDL-DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG  157 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh--~~~i~H~dlkp~Nili~~-~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (259)
                      ...+..++.+++.|++|||  ++||+||||||+||+++. ++ .+||+|||++...... .......||+.|+|||.+.+
T Consensus       128 ~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~-~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~  205 (360)
T 3e3p_A          128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFG  205 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT-EEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC-cEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcC
Confidence            6677888999999999999  999999999999999997 56 9999999999865432 23345578999999999977


Q ss_pred             ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc------------------ccccccccCCCC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK------------------LSLRDHLTNGFP  219 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------~~~~~~~~~~~~  219 (259)
                      ...++.++|||||||++|+|++|+.||.+.+.......+......+....                  ............
T Consensus       206 ~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (360)
T 3e3p_A          206 NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSL  285 (360)
T ss_dssp             CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhc
Confidence            55689999999999999999999999999887776666543211111000                  000001111223


Q ss_pred             CCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          220 GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       220 ~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ..++++.+||.+||+.||.+|||+.++|+||||+++.
T Consensus       286 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          286 KDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             TTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             cccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            3678999999999999999999999999999998763

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.9e-44  Score=289.49  Aligned_cols=214  Identities=28%  Similarity=0.327  Sum_probs=183.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+.++++++||||+++++++.+++..++||||+.| +|.+++...               ..++...+..++.
T Consensus        58 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~i~~  122 (294)
T 2rku_A           58 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---------------KALTEPEARYYLR  122 (294)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------CSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            346788999999999999999999999999999999999995 888887542               2355677889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.|++|||++|++||||||+||+++.++ .++|+|||.+..............|++.|+|||.+.+ ..++.++||||
T Consensus       123 qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s  200 (294)
T 2rku_A          123 QIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWS  200 (294)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHH
T ss_pred             HHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHH
Confidence            999999999999999999999999999888 8999999999876544444555678999999999977 56788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      ||+++|+|++|..||...........+......              ....+++.+.+++.+||..||++||+++++++|
T Consensus       201 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          201 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--------------IPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             HHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC--------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            999999999999999988777666665443211              113578999999999999999999999999999


Q ss_pred             ccccCC
Q 039159          250 EYFKDV  255 (259)
Q Consensus       250 ~~f~~~  255 (259)
                      |||.+.
T Consensus       267 ~~~~~~  272 (294)
T 2rku_A          267 EFFTSG  272 (294)
T ss_dssp             HHHHTS
T ss_pred             hheecC
Confidence            999865

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.6e-44  Score=295.79  Aligned_cols=214  Identities=28%  Similarity=0.327  Sum_probs=183.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+.++++++||||+++++++.+++..++||||+.+ +|.+++...               ..+....+..++.
T Consensus        84 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~l~~~~~~~i~~  148 (335)
T 2owb_A           84 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---------------KALTEPEARYYLR  148 (335)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH---------------CSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc---------------CCCCHHHHHHHHH
Confidence            346788999999999999999999999999999999999996 888887542               2355678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||+++|+||||||+||+++.++ .++|+|||++..............|++.|+|||.+.+ ..++.++||||
T Consensus       149 qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s  226 (335)
T 2owb_A          149 QIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWS  226 (335)
T ss_dssp             HHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHH
T ss_pred             HHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCceecccCcccccccCCCccccCHHHhcc-CCCCchhhHHH
Confidence            999999999999999999999999999888 8999999999876544444555679999999999987 56789999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      ||+++|+|++|+.||...........+......              ....+++.+.++|.+||..||.+||+++++++|
T Consensus       227 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          227 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--------------IPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC--------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            999999999999999988776666555433211              113578999999999999999999999999999


Q ss_pred             ccccCC
Q 039159          250 EYFKDV  255 (259)
Q Consensus       250 ~~f~~~  255 (259)
                      |||.+.
T Consensus       293 ~~~~~~  298 (335)
T 2owb_A          293 EFFTSG  298 (335)
T ss_dssp             HHHHTS
T ss_pred             ccccCC
Confidence            999865

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.4e-44  Score=299.33  Aligned_cols=228  Identities=31%  Similarity=0.527  Sum_probs=179.5

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeC-----ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQG-----IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ..++.+|++++++++||||+++++++..+     ...++||||+.++|.+.+..                ..++...+..
T Consensus        53 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----------------~~~~~~~~~~  116 (353)
T 2b9h_A           53 ALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST----------------QMLSDDHIQY  116 (353)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH----------------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh----------------cCCCHHHHHH
Confidence            45678999999999999999999998764     67899999999999998864                2355677888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC----------CcCCccCccccCccccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE----------SSAEVGTHYYKAPELLL  156 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~  156 (259)
                      ++.|++.||+|||++||+||||||+||+++.++ .+||+|||.+.........          .....||+.|+|||.+.
T Consensus       117 ~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  195 (353)
T 2b9h_A          117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML  195 (353)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEecccccccccccccccCccccccchhhccccccccCCeeec
Confidence            999999999999999999999999999999888 8999999999765332111          12346899999999987


Q ss_pred             CccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc------------------ccccccccCCC
Q 039159          157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK------------------LSLRDHLTNGF  218 (259)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------~~~~~~~~~~~  218 (259)
                      +...++.++|||||||++|+|++|.+||.+.+.......+......+....                  ..........+
T Consensus       196 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (353)
T 2b9h_A          196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMF  275 (353)
T ss_dssp             SCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHS
T ss_pred             cCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhc
Confidence            656788999999999999999999999998876665554422111111000                  00001112223


Q ss_pred             CCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       219 ~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      +.+++++.+||.+||..||++|||++++++||||+...
T Consensus       276 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          276 PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             ccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            57899999999999999999999999999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-43  Score=286.51  Aligned_cols=214  Identities=23%  Similarity=0.290  Sum_probs=173.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEe----CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQ----GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ..+.+.+|+.++++++||||+++++++..    +..+++||||+.+ +|.+++...               ..++...+.
T Consensus        68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~  132 (290)
T 1t4h_A           68 ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---------------KVMKIKVLR  132 (290)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH---------------SSCCHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc---------------cCCCHHHHH
Confidence            34678899999999999999999999875    3578999999986 999998642               234567788


Q ss_pred             HHHhhcccccccccCCC--ceeccCCCCcEEEc-CCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           86 EEFSSSDSSRSLSFGTR--YIRRDLKPVNILVD-LDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~--i~H~dlkp~Nili~-~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .++.+++.||+|||+.+  ++||||||+||+++ .++ .++|+|||++.....  .......||+.|+|||.+.+  .++
T Consensus       133 ~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~  207 (290)
T 1t4h_A          133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE--KYD  207 (290)
T ss_dssp             HHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS-CEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT--CCC
T ss_pred             HHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC-CEEEeeCCCcccccc--cccccccCCcCcCCHHHHhc--cCC
Confidence            89999999999999999  99999999999998 556 899999999965322  23344578999999998875  488


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      .++||||||+++|+|++|..||..................+...           ....++++.++|.+||..||.+|||
T Consensus       208 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps  276 (290)
T 1t4h_A          208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF-----------DKVAIPEVKEIIEGCIRQNKDERYS  276 (290)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG-----------GGCCCHHHHHHHHHHSCSSGGGSCC
T ss_pred             CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcccc-----------CCCCCHHHHHHHHHHccCChhhCCC
Confidence            99999999999999999999998855554444443332222111           1346789999999999999999999


Q ss_pred             HHHHhcCccccCC
Q 039159          243 AAEALQQEYFKDV  255 (259)
Q Consensus       243 ~~~~l~h~~f~~~  255 (259)
                      ++++++||||++.
T Consensus       277 ~~ell~h~~f~~~  289 (290)
T 1t4h_A          277 IKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHTSGGGC--
T ss_pred             HHHHhhCcccccC
Confidence            9999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.9e-44  Score=294.64  Aligned_cols=221  Identities=22%  Similarity=0.296  Sum_probs=181.1

Q ss_pred             CCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .....+.+|+.++++++ ||||+++++++.+++..++||||+.| +|.+++.....             ..++...+..+
T Consensus        70 ~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~i  136 (327)
T 3lm5_A           70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA-------------EMVSENDVIRL  136 (327)
T ss_dssp             ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC--------------CCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcc-------------cCCCHHHHHHH
Confidence            34568899999999995 79999999999999999999999997 88888743211             33566788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcC---CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDL---DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~---~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      +.+++.||+|||++||+||||||+||+++.   ++ .+||+|||++...... .......||+.|+|||.+.+ ..++.+
T Consensus       137 ~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~  213 (327)
T 3lm5_A          137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG-DIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNY-DPITTA  213 (327)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC-CEEECCGGGCEEC----------CCCGGGCCHHHHTT-CCCCTH
T ss_pred             HHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC-cEEEeeCccccccCCc-cccccccCCcCccCCeeecC-CCCCch
Confidence            999999999999999999999999999987   55 8999999999865332 22344579999999999977 578899


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      +||||||+++|+|++|..||.+.........+.......          ....+..+++.+.++|.+||..||.+|||++
T Consensus       214 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  283 (327)
T 3lm5_A          214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY----------SEETFSSVSQLATDFIQSLLVKNPEKRPTAE  283 (327)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc----------CchhhcccCHHHHHHHHHHcCCChhhCcCHH
Confidence            999999999999999999999988877776664433221          1122356899999999999999999999999


Q ss_pred             HHhcCccccCCC
Q 039159          245 EALQQEYFKDVP  256 (259)
Q Consensus       245 ~~l~h~~f~~~~  256 (259)
                      ++|+||||++..
T Consensus       284 ~ll~h~~~~~~~  295 (327)
T 3lm5_A          284 ICLSHSWLQQWD  295 (327)
T ss_dssp             HHTTCGGGCCCC
T ss_pred             HHhCCHhhcccc
Confidence            999999998763

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=295.38  Aligned_cols=208  Identities=22%  Similarity=0.230  Sum_probs=174.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-C-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-N-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+++.+|+.++++++||||+++++++.+++.+++||||+. | +|..++...               ..++...+..++
T Consensus        72 ~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~---------------~~l~~~~~~~i~  136 (335)
T 3dls_A           72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH---------------PRLDEPLASYIF  136 (335)
T ss_dssp             TTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTC---------------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc---------------CCCCHHHHHHHH
Confidence            45678999999999999999999999999999999999986 5 888888642               235667788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.||+|||+.+|+||||||+||+++.++ .+||+|||++...... .......||+.|+|||.+.+....+.++|||
T Consensus       137 ~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  214 (335)
T 3dls_A          137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMW  214 (335)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHH
T ss_pred             HHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccch
Confidence            9999999999999999999999999999888 8999999999865432 2334457999999999998744448899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||||++|+|++|..||.....      ....              .......+++++.+||.+||..||++|||++++++
T Consensus       215 slG~il~el~~g~~pf~~~~~------~~~~--------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          215 SLGVTLYTLVFEENPFCELEE------TVEA--------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             HHHHHHHHHHHSSCSCSSGGG------GTTT--------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHhCCCchhhHHH------HHhh--------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            999999999999999975321      1111              01112347899999999999999999999999999


Q ss_pred             CccccCC
Q 039159          249 QEYFKDV  255 (259)
Q Consensus       249 h~~f~~~  255 (259)
                      ||||+..
T Consensus       275 hp~~~~~  281 (335)
T 3dls_A          275 DPWVTQP  281 (335)
T ss_dssp             CTTTTCC
T ss_pred             CccccCC
Confidence            9999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=295.01  Aligned_cols=222  Identities=20%  Similarity=0.264  Sum_probs=175.5

Q ss_pred             CCCCchhHHHHHHHhhC-CCCCeeEEEEEEEe------CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            9 EGVPSSMIREVSCLMEL-NHPNIIRLMRVASQ------GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~------~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      ....+.+.+|+.+++++ +||||+++++++..      ++.+++||||+.+ +|.+++.....             ..++
T Consensus        61 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~  127 (326)
T 2x7f_A           61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------------NTLK  127 (326)
T ss_dssp             SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG-------------GCCC
T ss_pred             cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc-------------CCCC
Confidence            34567899999999999 79999999999987      4689999999986 99999865321             3355


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC---
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG---  157 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---  157 (259)
                      ...+..++.+++.||+|||+.|++||||||+||+++.++ .++|+|||++..............|++.|+|||.+.+   
T Consensus       128 ~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  206 (326)
T 2x7f_A          128 EEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN  206 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCTTTC-------------CCGGGCCHHHHC----
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeCcCceecCcCccccccccCCccccChhhhccccc
Confidence            677888999999999999999999999999999999888 8999999999765443333445678999999999862   


Q ss_pred             -ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          158 -LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       158 -~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                       ...++.++|||||||++|+|++|..||.+.........+...... .           .....+++.+.++|.+||..|
T Consensus       207 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~-----------~~~~~~~~~l~~li~~~l~~d  274 (326)
T 2x7f_A          207 PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP-R-----------LKSKKWSKKFQSFIESCLVKN  274 (326)
T ss_dssp             ----CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-C-----------CSCSCSCHHHHHHHHHHCCSS
T ss_pred             cCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc-c-----------CCccccCHHHHHHHHHHhccC
Confidence             245788999999999999999999999988776666555433211 1           112457899999999999999


Q ss_pred             CCCccCHHHHhcCccccCCC
Q 039159          237 PDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       237 p~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |.+||+++++++||||++.+
T Consensus       275 p~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          275 HSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             GGGSCCHHHHHTSHHHHCCT
T ss_pred             hhhCCCHHHHhhChHHhhCc
Confidence            99999999999999998764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.9e-44  Score=302.07  Aligned_cols=217  Identities=24%  Similarity=0.327  Sum_probs=167.8

Q ss_pred             chhHHHHHHHhh-CCCCCeeEEEEEEEe----CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           13 SSMIREVSCLME-LNHPNIIRLMRVASQ----GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        13 ~~~~~Ei~~l~~-l~H~niv~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ..+.+|+.++.+ .+||||+++++++..    ++.+|+||||+.| +|.+.+.....             ..++...+..
T Consensus        99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-------------~~l~~~~~~~  165 (400)
T 1nxk_A           99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-------------QAFTEREASE  165 (400)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----------------CCBHHHHHH
T ss_pred             hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCC-------------CCCCHHHHHH
Confidence            567899998754 589999999999876    5679999999986 99999964211             2466788899


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcC---CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDL---DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~---~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      ++.+++.||+|||+++|+||||||+||+++.   ++ .+||+|||+++.... ........||+.|+|||.+.+ ..++.
T Consensus       166 i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~  242 (400)
T 1nxk_A          166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETTS-HNSLTTPCYTPYYVAPEVLGP-EKYDK  242 (400)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTC-CEEECCCTTCEECC------------CTTCCGGGSCC-CCSSS
T ss_pred             HHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCc-cEEEEecccccccCC-CCccccCCCCCCccCHhhcCC-CCCCC
Confidence            9999999999999999999999999999997   55 899999999986532 223445678999999999977 67899


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHH----HHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLI----TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      ++|||||||++|+|++|..||.+.....    ....+......          .....+..+++++.+||.+||..||.+
T Consensus       243 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~----------~~~~~~~~~s~~~~~li~~~L~~dP~~  312 (400)
T 1nxk_A          243 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE----------FPNPEWSEVSEEVKMLIRNLLKTEPTQ  312 (400)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC----------CCTTTTTTSCHHHHHHHHTTSCSSGGG
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc----------CCCcccccCCHHHHHHHHHHCCCChhH
Confidence            9999999999999999999997654321    12222211111          111224568999999999999999999


Q ss_pred             ccCHHHHhcCccccCC
Q 039159          240 RITAAEALQQEYFKDV  255 (259)
Q Consensus       240 Rp~~~~~l~h~~f~~~  255 (259)
                      |||++++++||||...
T Consensus       313 Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          313 RMTITEFMNHPWIMQS  328 (400)
T ss_dssp             SCCHHHHHHSHHHHTT
T ss_pred             CcCHHHHhcCccccCC
Confidence            9999999999999754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.2e-44  Score=300.58  Aligned_cols=225  Identities=33%  Similarity=0.487  Sum_probs=170.5

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCc------eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGI------YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ..+++.+|+.+++.++||||+++++++...+      ..|+||||+.++|.+.+..                 .++...+
T Consensus        67 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----------------~~~~~~~  129 (371)
T 2xrw_A           67 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----------------ELDHERM  129 (371)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS-----------------CCCHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHhh-----------------ccCHHHH
Confidence            3467889999999999999999999997654      7899999999999888852                 2445677


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++..... ........||+.|+|||.+.+ ..++.+
T Consensus       130 ~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~  206 (371)
T 2xrw_A          130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKEN  206 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC-----------------CTTCCHHHHTT-CCCCTT
T ss_pred             HHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeeccccccc-ccccCCceecCCccCHHHhcC-CCCCch
Confidence            88999999999999999999999999999999888 899999999976432 222344578999999999987 578899


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccc--------------------cccccccC-CCC----
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKL--------------------SLRDHLTN-GFP----  219 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------------------~~~~~~~~-~~~----  219 (259)
                      +|||||||++|+|++|..||.+.+.......+......+.....                    ........ .++    
T Consensus       207 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (371)
T 2xrw_A          207 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSE  286 (371)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSH
T ss_pred             HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCccccc
Confidence            99999999999999999999998888877777654332211000                    00000000 000    


Q ss_pred             ---CCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          220 ---GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       220 ---~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                         ..++.+++||.+||..||.+|||++++|+||||...
T Consensus       287 ~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          287 HNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence               015678999999999999999999999999999854

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.3e-44  Score=293.39  Aligned_cols=217  Identities=24%  Similarity=0.272  Sum_probs=171.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+++.+|++++++++||||+++++++.+++..++||||+.| +|.+++......            ..++...++.++.|
T Consensus        78 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~i~~q  145 (309)
T 3p86_A           78 VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR------------EQLDERRRLSMAYD  145 (309)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHH------------HHSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCC------------CCCCHHHHHHHHHH
Confidence            45788999999999999999999999999999999999986 999998642110            23667788899999


Q ss_pred             cccccccccCCC--ceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTR--YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~--i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++.||+|||+.+  |+||||||+||+++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|||
T Consensus       146 i~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw  223 (309)
T 3p86_A          146 VAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVY  223 (309)
T ss_dssp             HHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC-----------------CCTTSCHHHHTT-CCCCTTHHHH
T ss_pred             HHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCCCccccccccccccCCCCccccChhhhcC-CCCCchhhHH
Confidence            999999999999  99999999999999888 8999999999765443333455679999999999987 5678999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||||++|+|++|+.||.+.........+.........            ...+++.+.++|.+||..||.+|||++++++
T Consensus       224 slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          224 SFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC------------CccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999988877776665433322221            2468899999999999999999999999987


Q ss_pred             --CccccC
Q 039159          249 --QEYFKD  254 (259)
Q Consensus       249 --h~~f~~  254 (259)
                        .+++++
T Consensus       292 ~L~~~~~~  299 (309)
T 3p86_A          292 LLRPLIKS  299 (309)
T ss_dssp             HHHHHHC-
T ss_pred             HHHHHHHh
Confidence              455553

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.1e-44  Score=296.02  Aligned_cols=228  Identities=26%  Similarity=0.412  Sum_probs=175.5

Q ss_pred             CCCchhHHHHHHHhhCC-CCCeeEEEEEEEe--CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           10 GVPSSMIREVSCLMELN-HPNIIRLMRVASQ--GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ...+++.+|++++++++ ||||+++++++.+  ....++||||+.+ +|..++.                  .+....+.
T Consensus        72 ~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------------------~~~~~~~~  133 (330)
T 3nsz_A           72 VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------------------TLTDYDIR  133 (330)
T ss_dssp             CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG------------------GCCHHHHH
T ss_pred             cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH------------------hCCHHHHH
Confidence            34578999999999997 9999999999987  5688999999996 8888773                  24556778


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.|++.||+|||++||+||||||+||+++.++..+||+|||++..... ........|++.|+|||.+.+...++.++
T Consensus       134 ~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  212 (330)
T 3nsz_A          134 FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLVDYQMYDYSL  212 (330)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT-TCCCCSCCSCGGGCCHHHHTTCCCCCTHH
T ss_pred             HHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC-CCccccccccccccChhhhcCCCcCCchh
Confidence            89999999999999999999999999999997766899999999976533 23344567899999999998756789999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCC-ChHHHHHHHhCCC---------------CCCcccc-------ccccc-cccCCCCCC
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGA-NSLITLGRIVGKS---------------RKPSFCK-------LSLRD-HLTNGFPGL  221 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~-~~~~~~~~i~~~~---------------~~~~~~~-------~~~~~-~~~~~~~~~  221 (259)
                      |||||||++|+|++|..||... ........+....               ..+....       ..... ........+
T Consensus       213 DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (330)
T 3nsz_A          213 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV  292 (330)
T ss_dssp             HHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGC
T ss_pred             hHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccC
Confidence            9999999999999999999543 3322222221100               0000000       00000 000111237


Q ss_pred             CHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          222 EPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       222 ~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ++++.+||.+||..||.+|||++++|+||||+++.
T Consensus       293 ~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          293 SPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            89999999999999999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2e-44  Score=293.60  Aligned_cols=237  Identities=21%  Similarity=0.263  Sum_probs=169.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|++++++++||||+++++++..++..++||||+.| +|.+++.......       ......++...+..++
T Consensus        55 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~i~  127 (303)
T 2vwi_A           55 TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKG-------EHKSGVLDESTIATIL  127 (303)
T ss_dssp             -----------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTT-------TTTTCSSCHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhcc-------ccccCCCCHHHHHHHH
Confidence            4456788999999999999999999999999999999999985 9999886421100       0001346677889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-----CCcCCccCccccCcccccCccCCCc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-----ESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      .|++.||+|||++|++||||||+||+++.++ .++|+|||.+........     ......||+.|+|||.+.+...++.
T Consensus       128 ~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (303)
T 2vwi_A          128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDF  206 (303)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCT
T ss_pred             HHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCc
Confidence            9999999999999999999999999999888 899999999875532211     1234568999999999875445789


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      ++||||||+++|+|++|..||.................. ....   ..........+++++.+++.+||..||.+||++
T Consensus       207 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  282 (303)
T 2vwi_A          207 KADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP-SLET---GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA  282 (303)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC-CTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             hhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC-cccc---ccccchhhhhhhHHHHHHHHHHccCChhhCcCH
Confidence            999999999999999999999887665555444333221 1110   001122335688999999999999999999999


Q ss_pred             HHHhcCccccCCCCC
Q 039159          244 AEALQQEYFKDVPGR  258 (259)
Q Consensus       244 ~~~l~h~~f~~~~~~  258 (259)
                      .++++||||++...+
T Consensus       283 ~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          283 AELLRHKFFQKAKNK  297 (303)
T ss_dssp             HHHHTSTTC------
T ss_pred             HHHhhChhhhcCCCC
Confidence            999999999987543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-43  Score=296.06  Aligned_cols=215  Identities=27%  Similarity=0.400  Sum_probs=181.2

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+.+|+.+++++ +||||+++++++......++||||+.| +|.+++...               ..++...+..++.
T Consensus       143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---------------~~l~~~~~~~i~~  207 (365)
T 2y7j_A          143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---------------VALSEKETRSIMR  207 (365)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH---------------SSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            45688999999999 799999999999999999999999997 899988532               2355677889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC-----ccCCCcc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG-----LLEYSTA  164 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~  164 (259)
                      |++.||+|||+.|++||||||+||+++.++ .++|+|||++...... .......||+.|+|||.+.+     ...++.+
T Consensus       208 qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  285 (365)
T 2y7j_A          208 SLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKE  285 (365)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTT
T ss_pred             HHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCch
Confidence            999999999999999999999999999888 8999999999765432 23445679999999999863     1357889


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      +|||||||++|+|++|..||.+.........+.........+          .+...++.+.+++.+||..||.+||+++
T Consensus       286 ~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~  355 (365)
T 2y7j_A          286 VDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP----------EWDDRSSTVKDLISRLLQVDPEARLTAE  355 (365)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH----------HHSSSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             hhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc----------ccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            999999999999999999999888777766665443322211          1246789999999999999999999999


Q ss_pred             HHhcCcccc
Q 039159          245 EALQQEYFK  253 (259)
Q Consensus       245 ~~l~h~~f~  253 (259)
                      ++|+||||+
T Consensus       356 ell~hp~f~  364 (365)
T 2y7j_A          356 QALQHPFFE  364 (365)
T ss_dssp             HHHHSGGGC
T ss_pred             HHhcCcccC
Confidence            999999997

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=289.19  Aligned_cols=209  Identities=24%  Similarity=0.290  Sum_probs=168.3

Q ss_pred             chhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .++.+|+..+.++ +||||+++++++.+++.+++||||+.++|.+.+....              ..++...+..++.++
T Consensus       101 ~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~--------------~~l~~~~~~~i~~qi  166 (311)
T 3p1a_A          101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWG--------------ASLPEAQVWGYLRDT  166 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHC--------------SCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcC--------------CCCCHHHHHHHHHHH
Confidence            3556666666655 8999999999999999999999999889999886432              235677888999999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      +.||+|||+.+|+||||||+||+++.++ .+||+|||++..... ........||+.|+|||.+.+  .++.++||||||
T Consensus       167 ~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG  242 (311)
T 3p1a_A          167 LLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGT-AGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLG  242 (311)
T ss_dssp             HHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC-------CCCCCGGGCCGGGGGT--CCSTHHHHHHHH
T ss_pred             HHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeeeccc-CCCCcccCCCccccCHhHhcC--CCCchhhHHHHH
Confidence            9999999999999999999999999888 899999999876533 223445579999999999876  588999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCcc
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY  251 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~  251 (259)
                      |++|+|++|..|+.+...   ...+......+.            ....+++++.+++.+||..||++|||++++|+|||
T Consensus       243 ~il~el~~g~~~~~~~~~---~~~~~~~~~~~~------------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  307 (311)
T 3p1a_A          243 LTILEVACNMELPHGGEG---WQQLRQGYLPPE------------FTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV  307 (311)
T ss_dssp             HHHHHHHHTCCCCSSHHH---HHHHTTTCCCHH------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHhCCCCCCCccH---HHHHhccCCCcc------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence            999999999877665432   222322221111            11468899999999999999999999999999999


Q ss_pred             ccC
Q 039159          252 FKD  254 (259)
Q Consensus       252 f~~  254 (259)
                      |+.
T Consensus       308 ~~~  310 (311)
T 3p1a_A          308 LRQ  310 (311)
T ss_dssp             GSC
T ss_pred             ccC
Confidence            986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.6e-44  Score=296.14  Aligned_cols=224  Identities=33%  Similarity=0.528  Sum_probs=176.9

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCce------EEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIY------LYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~------~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      .+++.+|+.++++++||||+++++++.....      +++||||+.++|.+.+.                 ..++...+.
T Consensus        67 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-----------------~~~~~~~~~  129 (353)
T 3coi_A           67 AKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG-----------------LKFSEEKIQ  129 (353)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT-----------------SCCCHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhc-----------------CCCCHHHHH
Confidence            4678899999999999999999999987653      49999999998877663                 225567788


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.|++.||+|||++||+||||||+||+++.++ .+||+|||.+.....   ......||+.|+|||.+.+...++.++
T Consensus       130 ~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~  205 (353)
T 3coi_A          130 YLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTV  205 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTH
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccccCCCC---CccccccCcCcCCHHHHhCcCCCCchh
Confidence            8999999999999999999999999999999888 899999999975422   233457899999999998756788999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc-----------------cccccccccCCCCCCCHHHHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC-----------------KLSLRDHLTNGFPGLEPAGIDL  228 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l  228 (259)
                      |||||||++|+|++|..||.+.+.......+......+...                 ...........++.+++++.+|
T Consensus       206 Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  285 (353)
T 3coi_A          206 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADL  285 (353)
T ss_dssp             HHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHH
Confidence            99999999999999999999887766555543211110000                 0000112233445789999999


Q ss_pred             HHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          229 ISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |.+||..||++|||++++++||||....
T Consensus       286 i~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          286 LEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence            9999999999999999999999998763

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-43  Score=285.01  Aligned_cols=215  Identities=27%  Similarity=0.359  Sum_probs=173.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +..+++.+|+++++.++||||+++++++..++..++||||+.+ +|.+++...               ..++...+..++
T Consensus        53 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~  117 (276)
T 2h6d_A           53 DVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH---------------GRVEEMEARRLF  117 (276)
T ss_dssp             TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---------------CSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc---------------CCCCHHHHHHHH
Confidence            4456788999999999999999999999999999999999986 999988542               234566788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .+++.||+|||+++++||||||+||+++.++ .++|+|||.+...... .......|++.|+|||.+.+....+.++|||
T Consensus       118 ~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  195 (276)
T 2h6d_A          118 QQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIW  195 (276)
T ss_dssp             HHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccCCC-cceecccCCccccCHHHHcCCCCCCccchHH
Confidence            9999999999999999999999999999888 8999999999765332 2233456899999999998744446899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |||+++|+|++|..||...........+......              ....+++.+.+++.+||+.||.+|||++++++
T Consensus       196 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          196 SCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY--------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            9999999999999999988777666655433211              11357899999999999999999999999999


Q ss_pred             CccccCC
Q 039159          249 QEYFKDV  255 (259)
Q Consensus       249 h~~f~~~  255 (259)
                      ||||++.
T Consensus       262 h~~~~~~  268 (276)
T 2h6d_A          262 HEWFKQD  268 (276)
T ss_dssp             SHHHHTT
T ss_pred             ChhhccC
Confidence            9999865

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.4e-44  Score=304.13  Aligned_cols=218  Identities=27%  Similarity=0.365  Sum_probs=165.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|++++++++||||+++++++. .+..++||||+.+ +|.+.+...               ..+....+..++.
T Consensus       183 ~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~i~~  246 (419)
T 3i6u_A          183 PALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN---------------KRLKEATCKLYFY  246 (419)
T ss_dssp             --CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS---------------CCCCHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc---------------CCCCHHHHHHHHH
Confidence            3456889999999999999999999985 4568999999986 888777432               3456678888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccCCCCcCCccCccccCcccccC--ccCCCccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG--LLEYSTAV  165 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~  165 (259)
                      |++.||+|||+++|+||||||+||+++.++  ..+||+|||+++.... ........||+.|+|||.+.+  ...++.++
T Consensus       247 qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  325 (419)
T 3i6u_A          247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV  325 (419)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHH
T ss_pred             HHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCC-CccccccCCCCCccCceeeecCCCCCCCchh
Confidence            999999999999999999999999997543  1599999999986533 223345679999999999863  34577899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHH-HHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITL-GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|+|++|.+||.+....... ..+.... ...         ....+..+++.+.+||.+||..||.+||+++
T Consensus       326 DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~-~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~  395 (419)
T 3i6u_A          326 DCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-YNF---------IPEVWAEVSEKALDLVKKLLVVDPKARFTTE  395 (419)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC-CCC---------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             hhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC-CCC---------CchhhcccCHHHHHHHHHHccCChhHCcCHH
Confidence            9999999999999999999865433222 2222221 111         1112346889999999999999999999999


Q ss_pred             HHhcCccccCC
Q 039159          245 EALQQEYFKDV  255 (259)
Q Consensus       245 ~~l~h~~f~~~  255 (259)
                      ++|+||||+..
T Consensus       396 e~l~hp~~~~~  406 (419)
T 3i6u_A          396 EALRHPWLQDE  406 (419)
T ss_dssp             HHHHSGGGCCH
T ss_pred             HHhCCcccCCh
Confidence            99999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.5e-44  Score=299.44  Aligned_cols=216  Identities=26%  Similarity=0.359  Sum_probs=171.2

Q ss_pred             CCchhHHHHHHHhhCC--CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELN--HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+.+|++++++++  ||||+++++++..++.+|+|||+..++|.+++...               ..+....+..++
T Consensus        97 ~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~---------------~~~~~~~~~~i~  161 (390)
T 2zmd_A           97 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK---------------KSIDPWERKSYW  161 (390)
T ss_dssp             HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHC---------------SSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHhc---------------CCCCHHHHHHHH
Confidence            3467899999999996  59999999999999999999997667999998642               223455677889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCc--------
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGL--------  158 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~--------  158 (259)
                      .|++.||+|||+.+|+||||||+||+++ ++ .+||+|||+++.......  ......||+.|+|||.+.+.        
T Consensus       162 ~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  239 (390)
T 2zmd_A          162 KNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK  239 (390)
T ss_dssp             HHHHHHHHHHHTTTCCCCCCCGGGEEES-SS-CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC--------
T ss_pred             HHHHHHHHHHHHCCeeecCCCHHHEEEE-CC-eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccc
Confidence            9999999999999999999999999996 45 799999999986543222  23455799999999998641        


Q ss_pred             --cCCCcccchHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          159 --LEYSTAVDIWPVGCIFGEMVSGKPLFPGANS-LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       159 --~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                        ..++.++|||||||++|+|++|+.||..... ......+.........            ....++++.+||.+||..
T Consensus       240 ~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~  307 (390)
T 2zmd_A          240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF------------PDIPEKDLQDVLKCCLKR  307 (390)
T ss_dssp             ----CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC------------CCCSCHHHHHHHHHHTCS
T ss_pred             cccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC------------CccchHHHHHHHHHHccc
Confidence              3578899999999999999999999987533 3444444433222111            123578999999999999


Q ss_pred             CCCCccCHHHHhcCccccCC
Q 039159          236 DPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       236 dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ||++||++.++|+||||+..
T Consensus       308 dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          308 DPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             STTTSCCHHHHHTSHHHHSC
T ss_pred             ChhhCCCHHHHhhCcCcccc
Confidence            99999999999999999753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=295.99  Aligned_cols=214  Identities=27%  Similarity=0.362  Sum_probs=169.0

Q ss_pred             CchhHHHHHHHhhCCC--CCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELNH--PNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H--~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+.+|+.++++++|  |||+++++++.+++.+++|||+..++|.+++...               ..++...+..++.
T Consensus        51 ~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------------~~~~~~~~~~i~~  115 (343)
T 3dbq_A           51 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK---------------KSIDPWERKSYWK  115 (343)
T ss_dssp             HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHS---------------CCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            4678899999999986  9999999999999999999997777999999642               2345567788999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccC----------
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLG----------  157 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~----------  157 (259)
                      |++.||+|||+.+|+||||||+||+++ ++ .+||+|||++........  ......||+.|+|||.+.+          
T Consensus       116 qi~~al~~lH~~~iiHrDikp~NIll~-~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  193 (343)
T 3dbq_A          116 NMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS  193 (343)
T ss_dssp             HHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC--------
T ss_pred             HHHHHHHHHHhCCeecCCCCcceEEEE-CC-cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcccccccccc
Confidence            999999999999999999999999997 55 899999999986543322  2335579999999999853          


Q ss_pred             ccCCCcccchHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS-LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                      ...++.++|||||||++|+|++|+.||..... ......+.........            ....++++.+++.+||..|
T Consensus       194 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~L~~d  261 (343)
T 3dbq_A          194 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF------------PDIPEKDLQDVLKCCLKRD  261 (343)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC------------CCCSCHHHHHHHHHHTCSS
T ss_pred             ccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC------------cccCCHHHHHHHHHHcCCC
Confidence            14578899999999999999999999987433 3333344332222111            1345688999999999999


Q ss_pred             CCCccCHHHHhcCccccC
Q 039159          237 PDKRITAAEALQQEYFKD  254 (259)
Q Consensus       237 p~~Rp~~~~~l~h~~f~~  254 (259)
                      |.+|||+.++|+||||+.
T Consensus       262 p~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          262 PKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             TTTSCCHHHHHTSHHHHS
T ss_pred             hhHCCCHHHHHhCccccc
Confidence            999999999999999974

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.6e-43  Score=285.67  Aligned_cols=218  Identities=26%  Similarity=0.390  Sum_probs=182.7

Q ss_pred             CchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           12 PSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+.+|+++++++. ||||+++++++..++..++||||+.+ +|.+++...               ..++...+..++.
T Consensus        67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~  131 (298)
T 1phk_A           67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---------------VTLSEKETRKIMR  131 (298)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------SSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc---------------CCCCHHHHHHHHH
Confidence            467889999999995 99999999999999999999999985 999988642               2355678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC-----ccCCCcc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG-----LLEYSTA  164 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~  164 (259)
                      +++.||+|||++|++||||||+||+++.++ .++|+|||.+..... ........|++.|+|||.+.+     ...++.+
T Consensus       132 qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~  209 (298)
T 1phk_A          132 ALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE  209 (298)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCT-TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH
T ss_pred             HHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccchhhcCC-CcccccccCCccccCHHHhccccccccccCCcc
Confidence            999999999999999999999999999888 899999999976543 223345578999999999852     2457889


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      +||||||+++|+|++|..||...........+.........          +.+..+++.+.+++.+||..||.+||+++
T Consensus       210 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~  279 (298)
T 1phk_A          210 VDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS----------PEWDDYSDTVKDLVSRFLVVQPQKRYTAE  279 (298)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------TTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             cccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc----------ccccccCHHHHHHHHHHccCCcccCCCHH
Confidence            99999999999999999999988877766666544322111          11235789999999999999999999999


Q ss_pred             HHhcCccccCCC
Q 039159          245 EALQQEYFKDVP  256 (259)
Q Consensus       245 ~~l~h~~f~~~~  256 (259)
                      ++++||||++..
T Consensus       280 ~ll~h~~~~~~~  291 (298)
T 1phk_A          280 EALAHPFFQQYV  291 (298)
T ss_dssp             HHTTSGGGCTTC
T ss_pred             HHHhChHhhhcc
Confidence            999999999764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.6e-44  Score=287.94  Aligned_cols=218  Identities=17%  Similarity=0.191  Sum_probs=171.1

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ....++.+|+..+.++ +||||+++++++.+++..++||||++| +|.+++......           ...++...+..+
T Consensus        52 ~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~i  120 (289)
T 1x8b_A           52 VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRI-----------MSYFKEAELKDL  120 (289)
T ss_dssp             HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHH-----------TCCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhccc-----------ccCCCHHHHHHH
Confidence            3456788999999999 899999999999999999999999986 999998642110           023566788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCC------------------CeEEEeeccccccccccCCCCcCCccCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG------------------KTVKVAGFGLAKSLYAYKGESSAEVGTHYY  149 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~------------------~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~  149 (259)
                      +.|++.||+|||+++|+||||||+||+++.++                  ..++|+|||.+.....    .....||+.|
T Consensus       121 ~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~gt~~y  196 (289)
T 1x8b_A          121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS----PQVEEGDSRF  196 (289)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC----SCCCCCCGGG
T ss_pred             HHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC----ccccCCCccc
Confidence            99999999999999999999999999998432                  2689999999976532    2234689999


Q ss_pred             cCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHH
Q 039159          150 KAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLI  229 (259)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  229 (259)
                      +|||.+.+...++.++|||||||++|++++|.+++.......   .+.... .+            .....+++.+.+++
T Consensus       197 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~-~~------------~~~~~~~~~~~~li  260 (289)
T 1x8b_A          197 LANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIRQGR-LP------------RIPQVLSQEFTELL  260 (289)
T ss_dssp             CCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHHTTC-CC------------CCSSCCCHHHHHHH
T ss_pred             cChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHHcCC-CC------------CCCcccCHHHHHHH
Confidence            999999874466789999999999999999998776554322   222221 11            11246889999999


Q ss_pred             HhhcCcCCCCccCHHHHhcCccccCCCCC
Q 039159          230 SKMLGMDPDKRITAAEALQQEYFKDVPGR  258 (259)
Q Consensus       230 ~~~l~~dp~~Rp~~~~~l~h~~f~~~~~~  258 (259)
                      .+||..||.+|||+.++++||||.+...|
T Consensus       261 ~~~l~~dp~~Rps~~~ll~h~~~~~~~~k  289 (289)
T 1x8b_A          261 KVMIHPDPERRPSAMALVKHSVLLSASRK  289 (289)
T ss_dssp             HHHTCSSGGGSCCHHHHHTCTTC------
T ss_pred             HHHhCCCcccCCCHHHHhhChHhhhhccC
Confidence            99999999999999999999999987654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=286.91  Aligned_cols=218  Identities=24%  Similarity=0.364  Sum_probs=178.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEE--eCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVAS--QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~--~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+.+|++++++++||||+++++++.  +++..++||||+.++|.+.+.....             ..++...+..++
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~  115 (305)
T 2wtk_C           49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-------------KRFPVCQAHGYF  115 (305)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTT-------------CSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcc-------------cccCHHHHHHHH
Confidence            3567899999999999999999999984  4458899999999888887764321             335567788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCc-cCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGL-LEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~~  165 (259)
                      .|++.||+|||+++++||||||+||+++.++ .++|+|||.+.......  .......|++.|+|||.+.+. ...+.++
T Consensus       116 ~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~  194 (305)
T 2wtk_C          116 CQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKV  194 (305)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHH
T ss_pred             HHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchh
Confidence            9999999999999999999999999999888 89999999997653221  123345689999999999762 2346789


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||||+++|+|++|..||.+.........+......              ....+++.+.+++.+||..||.+||++++
T Consensus       195 Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~--------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~  260 (305)
T 2wtk_C          195 DIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA--------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQ  260 (305)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC--------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC--------------CCCccCHHHHHHHHHHccCChhhCCCHHH
Confidence            9999999999999999999988877766665443211              12357899999999999999999999999


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +++||||++..
T Consensus       261 ll~~~~~~~~~  271 (305)
T 2wtk_C          261 IRQHSWFRKKH  271 (305)
T ss_dssp             HHHSHHHHSCC
T ss_pred             HhcCcccccCC
Confidence            99999998653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.6e-43  Score=284.44  Aligned_cols=218  Identities=25%  Similarity=0.325  Sum_probs=179.8

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|++++++++||||+++++++.+++..++||||+.+ +|.+++...               ..++...+..++.
T Consensus        51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~  115 (283)
T 3bhy_A           51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK---------------ESLTEDEATQFLK  115 (283)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---------------SSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc---------------CCCCHHHHHHHHH
Confidence            356789999999999999999999999999999999999985 999988532               2356678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCC---eEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGK---TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~---~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +++.||+|||+++++||||||+||+++.++.   .++|+|||.+...... .......|++.|+|||.+.+ ..++.++|
T Consensus       116 ~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  193 (283)
T 3bhy_A          116 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVNY-EPLGLEAD  193 (283)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTT-CCCCTHHH
T ss_pred             HHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCC-CcccccCCCcCccCcceecC-CCCCcchh
Confidence            9999999999999999999999999987652   6999999999765332 22334568999999999977 56889999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||+++|++++|..||.+.........+........          ...+..+++.+.+++.+||..||.+||++.++
T Consensus       194 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~  263 (283)
T 3bhy_A          194 MWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD----------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS  263 (283)
T ss_dssp             HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             hhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc----------chhcccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            99999999999999999998887777666654332211          11124678999999999999999999999999


Q ss_pred             hcCccccCC
Q 039159          247 LQQEYFKDV  255 (259)
Q Consensus       247 l~h~~f~~~  255 (259)
                      ++||||+.+
T Consensus       264 l~h~~~~~~  272 (283)
T 3bhy_A          264 LEHSWIKAI  272 (283)
T ss_dssp             HHCHHHHHH
T ss_pred             HhCHHHHHH
Confidence            999999865

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-43  Score=292.11  Aligned_cols=234  Identities=22%  Similarity=0.276  Sum_probs=181.5

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      +.+.+|++++++++||||+++++++.+++..++||||+.| +|.+++........       .....++...+..++.++
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-------~~~~~~~~~~~~~i~~qi  160 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-------NYTCFIPIQVIKCIIKSV  160 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-------SSCCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-------ccccCCCHHHHHHHHHHH
Confidence            7899999999999999999999999999999999999997 88887432110000       001456678889999999


Q ss_pred             ccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCc-ccchHh
Q 039159           92 DSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST-AVDIWP  169 (259)
Q Consensus        92 ~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Diws  169 (259)
                      +.|++|||+ +|++||||||+||+++.++ .++|+|||.+......  ......|++.|+|||.+.+...++. ++||||
T Consensus       161 ~~~l~~lH~~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s  237 (348)
T 2pml_X          161 LNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS  237 (348)
T ss_dssp             HHHHHHHHHTSCEECCCCCGGGEEECTTS-CEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHH
T ss_pred             HHHHHHHhccCCEeecCCChHhEEEcCCC-cEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHH
Confidence            999999998 9999999999999999888 8999999999765332  3445578999999999987435555 999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCh-HHHHHHHhCCCCCCcccccccc-----ccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          170 VGCIFGEMVSGKPLFPGANS-LITLGRIVGKSRKPSFCKLSLR-----DHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      ||+++|+|++|..||..... ......+...............     .........+++++.+|+.+||..||.+||++
T Consensus       238 lG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~  317 (348)
T 2pml_X          238 LGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS  317 (348)
T ss_dssp             HHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH
Confidence            99999999999999998766 5555555443221111000000     00011125689999999999999999999999


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      +++++||||.+..
T Consensus       318 ~e~l~hp~f~~~~  330 (348)
T 2pml_X          318 EDALKHEWLADTN  330 (348)
T ss_dssp             HHHHTSGGGTTCC
T ss_pred             HHHhcCccccCCC
Confidence            9999999999764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-45  Score=308.55  Aligned_cols=216  Identities=12%  Similarity=0.123  Sum_probs=168.5

Q ss_pred             CCCCchhHHHH---HHHhhCCCCCeeEEE-------EEEEeCc-----------------eEEEEeeeecCCHHHHhhcC
Q 039159            9 EGVPSSMIREV---SCLMELNHPNIIRLM-------RVASQGI-----------------YLYPVFEYQVNDLAYLLKYP   61 (259)
Q Consensus         9 ~~~~~~~~~Ei---~~l~~l~H~niv~~~-------~~~~~~~-----------------~~~lv~e~~~~~l~~~~~~~   61 (259)
                      ....+.+.+|+   +++++++||||++++       +++.+++                 ..|+||||+.|+|.+++...
T Consensus       114 ~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~  193 (377)
T 3byv_A          114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL  193 (377)
T ss_dssp             TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhc
Confidence            34457788999   555556899999998       7666553                 27899999988999999753


Q ss_pred             CCCCCCcccccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCc
Q 039159           62 KDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESS  141 (259)
Q Consensus        62 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~  141 (259)
                      ...        ......++...+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++..   .....
T Consensus       194 ~~~--------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a~~~---~~~~~  261 (377)
T 3byv_A          194 LSH--------SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRD---GARVV  261 (377)
T ss_dssp             HHT--------TTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGCEET---TCEEE
T ss_pred             ccc--------ccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEechhheec---CCccc
Confidence            111        01114456677888999999999999999999999999999999888 8999999999753   22334


Q ss_pred             CCccCccccCcccccCc----------cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccccc
Q 039159          142 AEVGTHYYKAPELLLGL----------LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLR  211 (259)
Q Consensus       142 ~~~~~~~~~aPE~~~~~----------~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  211 (259)
                      ...| +.|+|||.+.+.          ..++.++|||||||++|+|++|+.||.+........                 
T Consensus       262 ~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~-----------------  323 (377)
T 3byv_A          262 SSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE-----------------  323 (377)
T ss_dssp             CCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG-----------------
T ss_pred             CCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh-----------------
Confidence            5567 999999999873          268999999999999999999999997543221111                 


Q ss_pred             ccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          212 DHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       212 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                       .+......+++++.+||.+||..||.+||++.++++||||+++
T Consensus       324 -~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          324 -WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             -GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             -hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence             1222335789999999999999999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=302.16  Aligned_cols=221  Identities=26%  Similarity=0.345  Sum_probs=166.3

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +....+.+|+++++++ +||||+++++++.+++..|+||||+.|+|.+++.......              .......++
T Consensus        59 ~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~--------------~~~~~~~i~  124 (432)
T 3p23_A           59 ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAH--------------LGLEPITLL  124 (432)
T ss_dssp             TTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCC--------------CSSCHHHHH
T ss_pred             HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCc--------------cchhHHHHH
Confidence            3446688999999999 7999999999999999999999999999999997543221              112235778


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCC---C-CeEEEeeccccccccccC---CCCcCCccCccccCcccccC--cc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLD---G-KTVKVAGFGLAKSLYAYK---GESSAEVGTHYYKAPELLLG--LL  159 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~---~-~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~--~~  159 (259)
                      .|++.||+|||+++|+||||||+||+++.+   + ..++|+|||+++......   .......||+.|+|||.+.+  ..
T Consensus       125 ~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~  204 (432)
T 3p23_A          125 QQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE  204 (432)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---
T ss_pred             HHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhccccc
Confidence            899999999999999999999999999532   2 258899999998654322   12344579999999999974  24


Q ss_pred             CCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      .++.++|||||||++|+|++ |..||.......... +..........          .....+..+.+||.+||..||.
T Consensus       205 ~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~  273 (432)
T 3p23_A          205 NPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLGACSLDCLH----------PEKHEDVIARELIEKMIAMDPQ  273 (432)
T ss_dssp             CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTCCCCTTSC----------TTCHHHHHHHHHHHHHSCSSGG
T ss_pred             CCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-HhccCCccccC----------ccccccHHHHHHHHHHHhCCHh
Confidence            56779999999999999999 899997655443332 22221111100          0112456688999999999999


Q ss_pred             CccCHHHHhcCccccCC
Q 039159          239 KRITAAEALQQEYFKDV  255 (259)
Q Consensus       239 ~Rp~~~~~l~h~~f~~~  255 (259)
                      +|||++++++||||+++
T Consensus       274 ~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          274 KRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             GSCCHHHHHTSTTTCCH
T ss_pred             hCCCHHHHHhCccccCh
Confidence            99999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.6e-44  Score=288.17  Aligned_cols=215  Identities=20%  Similarity=0.236  Sum_probs=162.5

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccc
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS   94 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (259)
                      +.++...++.++||||+++++++.+++..++||||+.|+|.+++......           ...++...+..++.|++.|
T Consensus        53 ~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~-----------~~~~~~~~~~~i~~qi~~~  121 (290)
T 3fme_A           53 LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDK-----------GQTIPEDILGKIAVSIVKA  121 (290)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHT-----------TCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHH
Confidence            34455568888999999999999999999999999999988877542111           1346677888999999999


Q ss_pred             cccccCC-CceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCccccc---CccCCCcccchHhH
Q 039159           95 RSLSFGT-RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL---GLLEYSTAVDIWPV  170 (259)
Q Consensus        95 l~~lh~~-~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Diwsl  170 (259)
                      ++|||++ |++||||||+||+++.++ .+||+|||.+...... .......||+.|+|||.+.   ....++.++|||||
T Consensus       122 l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~sl  199 (290)
T 3fme_A          122 LEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSL  199 (290)
T ss_dssp             HHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHH
T ss_pred             HHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCccccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHH
Confidence            9999998 999999999999999888 8999999999765332 2333447899999999973   33567889999999


Q ss_pred             HHHHHHHHhCCCCCCCC-ChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          171 GCIFGEMVSGKPLFPGA-NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       171 G~~l~e~~tg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      |+++|++++|..||... ............... ..           ....+++++.+++.+||..||++|||++++++|
T Consensus       200 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          200 GITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-QL-----------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC-CC-----------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHCCCCccccCchHHHHHHHhccCCC-Cc-----------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            99999999999999863 333444333332211 11           113578999999999999999999999999999


Q ss_pred             ccccC
Q 039159          250 EYFKD  254 (259)
Q Consensus       250 ~~f~~  254 (259)
                      |||+.
T Consensus       268 p~f~~  272 (290)
T 3fme_A          268 PFFTL  272 (290)
T ss_dssp             HHHHH
T ss_pred             ccccc
Confidence            99974

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-43  Score=298.44  Aligned_cols=226  Identities=31%  Similarity=0.402  Sum_probs=174.7

Q ss_pred             CchhHHHHHHHhhCC-CCC-----eeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           12 PSSMIREVSCLMELN-HPN-----IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-H~n-----iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ...+.+|+++++.++ |+|     |+++++++..++..++||||+.|+|.+++.....             ..++...+.
T Consensus        94 ~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-------------~~~~~~~~~  160 (382)
T 2vx3_A           94 LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNF-------------RGVSLNLTR  160 (382)
T ss_dssp             HHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTT-------------SCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCc-------------CCCCHHHHH
Confidence            456778999999885 554     9999999999999999999999999999975321             235567788


Q ss_pred             HHHhhccccccccc--CCCceeccCCCCcEEEcC--CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           86 EEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDL--DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        86 ~~~~~~~~~l~~lh--~~~i~H~dlkp~Nili~~--~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      .++.|++.||+|||  +.+|+||||||+||+++.  ++ .+||+|||++....   .......||+.|+|||.+.+ ..+
T Consensus       161 ~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~DFG~a~~~~---~~~~~~~~t~~y~aPE~~~~-~~~  235 (382)
T 2vx3_A          161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVDFGSSCQLG---QRIYQYIQSRFYRSPEVLLG-MPY  235 (382)
T ss_dssp             HHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECCCTTCEETT---CCCCSSCSCGGGCCHHHHTT-CCC
T ss_pred             HHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEeccCceecc---cccccccCCccccChHHHcC-CCC
Confidence            99999999999999  479999999999999954  45 79999999997653   23345678999999999988 568


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccc-------cccc------------------cC
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSL-------RDHL------------------TN  216 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-------~~~~------------------~~  216 (259)
                      +.++|||||||++|+|++|++||.+.+.......+......+.......       ...+                  .+
T Consensus       236 ~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (382)
T 2vx3_A          236 DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP  315 (382)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCT
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCc
Confidence            9999999999999999999999999887777666543221111000000       0000                  00


Q ss_pred             C---------------------CCC----CCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          217 G---------------------FPG----LEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       217 ~---------------------~~~----~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      .                     ...    .++++.+||.+||..||++|||++++|+||||+..
T Consensus       316 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          316 GTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             chhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence            0                     000    01378899999999999999999999999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.3e-44  Score=292.47  Aligned_cols=216  Identities=24%  Similarity=0.393  Sum_probs=173.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCc----eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGI----YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ..++.+|++++++++||||+++++++....    ..|+||||+.| +|.+++...               ..+....+..
T Consensus        56 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---------------~~~~~~~~~~  120 (311)
T 3ork_A           56 YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---------------GPMTPKRAIE  120 (311)
T ss_dssp             HHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH---------------CSCCHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc---------------CCCCHHHHHH
Confidence            347889999999999999999999987654    35999999985 999988642               2356677889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      ++.|++.||+|||+++|+||||||+||+++.++ .+||+|||++........   ......||+.|+|||.+.+ ..++.
T Consensus       121 ~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  198 (311)
T 3ork_A          121 VIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDA  198 (311)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC------------------CCTTCCHHHHHT-CCCCH
T ss_pred             HHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCcccccccccccccccccCcCcccCCHHHhcC-CCCCc
Confidence            999999999999999999999999999999888 899999999976543221   2234468999999999987 57889


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      ++||||||+++|+|++|+.||.+................+...          ...++++++.++|.+||..||.+||++
T Consensus       199 ~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~R~~~  268 (311)
T 3ork_A          199 RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----------RHEGLSADLDAVVLKALAKNPENRYQT  268 (311)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH----------HSTTCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred             hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc----------ccCCCCHHHHHHHHHHHhcCHhhChhh
Confidence            9999999999999999999999988877766665544332211          124689999999999999999999999


Q ss_pred             HHHhcCccccC
Q 039159          244 AEALQQEYFKD  254 (259)
Q Consensus       244 ~~~l~h~~f~~  254 (259)
                      .++++|+|++.
T Consensus       269 ~~~l~~~l~~~  279 (311)
T 3ork_A          269 AAEMRADLVRV  279 (311)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999999873

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.6e-43  Score=293.11  Aligned_cols=226  Identities=22%  Similarity=0.267  Sum_probs=175.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|++++++++||||+++++++.+++..++||||+.| +|.+++...               ..++...+..++.
T Consensus        74 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~  138 (360)
T 3eqc_A           74 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---------------GRIPEQILGKVSI  138 (360)
T ss_dssp             HHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH---------------SSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc---------------CCCCHHHHHHHHH
Confidence            346789999999999999999999999999999999999986 999998642               2345677888999


Q ss_pred             hcccccccccCC-CceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGT-RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~-~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.||+|||+. +|+||||||+||+++.++ .++|+|||++......  ......||+.|+|||.+.+ ..++.++|||
T Consensus       139 ~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~  214 (360)
T 3eqc_A          139 AVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THYSVQSDIW  214 (360)
T ss_dssp             HHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTT-CCCSHHHHHH
T ss_pred             HHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcccccc--cccCCCCCCCeECHHHHcC-CCCCchhhHH
Confidence            999999999985 999999999999999988 8999999998754322  2334578999999999987 5789999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCC---Ccc---------------------c-----cccccc-cccCCC
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRK---PSF---------------------C-----KLSLRD-HLTNGF  218 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~---~~~---------------------~-----~~~~~~-~~~~~~  218 (259)
                      ||||++|+|++|..||...........+......   ...                     .     ...... ......
T Consensus       215 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (360)
T 3eqc_A          215 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS  294 (360)
T ss_dssp             HHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCT
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCc
Confidence            9999999999999999876655443222100000   000                     0     000000 000111


Q ss_pred             CCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          219 PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       219 ~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ..+++++.+||.+||..||.+|||++++|+||||+..
T Consensus       295 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          295 GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence            3478899999999999999999999999999999853

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-43  Score=292.26  Aligned_cols=229  Identities=26%  Similarity=0.297  Sum_probs=177.2

Q ss_pred             CCchhHHHHHHHhhCCCCC------eeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPN------IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~n------iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ..+.+.+|+++++.++|+|      ++++++++..++..++||||+.++|.+++.....             ..++...+
T Consensus        54 ~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-------------~~~~~~~~  120 (339)
T 1z57_A           54 YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF-------------LPFRLDHI  120 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTT-------------CCCCHHHH
T ss_pred             hhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCC-------------CCCcHHHH
Confidence            3467889999999997665      9999999999999999999997799999865321             23556778


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcC-------------------CCCeEEEeeccccccccccCCCCcCCcc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDL-------------------DGKTVKVAGFGLAKSLYAYKGESSAEVG  145 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~-------------------~~~~vkl~dfg~~~~~~~~~~~~~~~~~  145 (259)
                      ..++.|++.||+|||+++|+||||||+||+++.                   ++ .+||+|||.+....   .......|
T Consensus       121 ~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Dfg~~~~~~---~~~~~~~g  196 (339)
T 1z57_A          121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP-DIKVVDFGSATYDD---EHHSTLVS  196 (339)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCC-CEEECCCSSCEETT---SCCCSSCS
T ss_pred             HHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCC-CceEeeCcccccCc---cccccccC
Confidence            899999999999999999999999999999987                   44 69999999997542   23345678


Q ss_pred             CccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCC-CCCccc-c-c--------------
Q 039159          146 THYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKS-RKPSFC-K-L--------------  208 (259)
Q Consensus       146 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~-~~~~~~-~-~--------------  208 (259)
                      |+.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+.... ..|... . .              
T Consensus       197 t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  275 (339)
T 1z57_A          197 TRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWD  275 (339)
T ss_dssp             CGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCC
T ss_pred             CccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhcccccc
Confidence            999999999987 578999999999999999999999999877665444332110 000000 0 0              


Q ss_pred             -------------cccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCCC
Q 039159          209 -------------SLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPG  257 (259)
Q Consensus       209 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~~  257 (259)
                                   .............++++.+||.+||..||.+|||++++++||||+.+..
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          276 EHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             TTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred             ccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence                         0000000111223567889999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.2e-43  Score=288.82  Aligned_cols=210  Identities=25%  Similarity=0.329  Sum_probs=175.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|+.++++++||||+++++++.+++..++||||+.| +|.+++....              ..++...+..++
T Consensus        92 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~  157 (325)
T 3kul_A           92 RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD--------------GQFTIMQLVGML  157 (325)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTT--------------TCSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcc--------------cCCCHHHHHHHH
Confidence            3346789999999999999999999999999999999999986 9999986421              235667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .+++.||+|||+.+|+||||||+||+++.++ .+||+|||++.........   .....+|+.|+|||.+.+ ..++.++
T Consensus       158 ~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~  235 (325)
T 3kul_A          158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSAS  235 (325)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH-CEECHHH
T ss_pred             HHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHH
Confidence            9999999999999999999999999999888 8999999999865433221   222345778999999976 5688999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      ||||||+++|+|++ |..||.+.........+......+.             ...+++.+.+++..||..||.+||++.
T Consensus       236 Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~  302 (325)
T 3kul_A          236 DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-------------PMGCPHALHQLMLDCWHKDRAQRPRFS  302 (325)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC-------------CCCcCHHHHHHHHHHccCChhhCcCHH
Confidence            99999999999999 9999999888887777765533221             246889999999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++++
T Consensus       303 eil~  306 (325)
T 3kul_A          303 QIVS  306 (325)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1e-42  Score=281.67  Aligned_cols=220  Identities=29%  Similarity=0.448  Sum_probs=182.1

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ....+++.+|++++++++||||+++++++.+++..++||||+.+ +|.+.+...               ..++...+..+
T Consensus        62 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i  126 (287)
T 2wei_A           62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---------------KRFSEHDAARI  126 (287)
T ss_dssp             SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH---------------SSCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc---------------CCCCHHHHHHH
Confidence            34567889999999999999999999999999999999999986 888877532               23456778899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.+++.||+|||++|++||||||+||+++.++  ..+||+|||.+...... .......|++.|+|||.+.+  .++.++
T Consensus       127 ~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~  203 (287)
T 2wei_A          127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG--TYDEKC  203 (287)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-SSCSCHHHHHTTCCHHHHTT--CCCTHH
T ss_pred             HHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-CccccccCcccccChHHhcC--CCCCch
Confidence            99999999999999999999999999997643  26999999999765332 22334468999999999876  478899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||||+++|++++|..||.+.........+.........          +.+..+++++.+++.+||..||.+|||+++
T Consensus       204 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  273 (287)
T 2wei_A          204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----------PQWRTISDDAKDLIRKMLTFHPSLRITATQ  273 (287)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS----------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----------hhhhhcCHHHHHHHHHHcccChhhCcCHHH
Confidence            9999999999999999999998877776666544322211          112468899999999999999999999999


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +++||||+...
T Consensus       274 ll~hp~~~~~~  284 (287)
T 2wei_A          274 CLEHPWIQKYS  284 (287)
T ss_dssp             HHHSHHHHHHC
T ss_pred             HhcCHHHhccc
Confidence            99999998653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=289.28  Aligned_cols=216  Identities=24%  Similarity=0.302  Sum_probs=174.8

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...+.+.+|+++++++ +||||+++++++..++.+++||||+.| +|.+++...               ..++...+..+
T Consensus       100 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~  164 (355)
T 1vzo_A          100 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---------------ERFTEHEVQIY  164 (355)
T ss_dssp             SSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH---------------SCCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc---------------CCCCHHHHHHH
Confidence            4456788999999999 699999999999999999999999986 999988642               23456778888


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-CCCcCCccCccccCcccccCc-cCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGL-LEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~  165 (259)
                      +.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++...... .......||+.|+|||.+.+. ..++.++
T Consensus       165 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  243 (355)
T 1vzo_A          165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV  243 (355)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHH
T ss_pred             HHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchh
Confidence            99999999999999999999999999999888 89999999997653322 123345799999999999752 3468899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCC----hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGAN----SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      |||||||++|+|++|+.||....    .......+....              ......+++.+.+||.+||..||.+||
T Consensus       244 DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~li~~~L~~dP~~R~  309 (355)
T 1vzo_A          244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--------------PPYPQEMSALAKDLIQRLLMKDPKKRL  309 (355)
T ss_dssp             HHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--------------CCCCTTSCHHHHHHHHHHTCSSGGGST
T ss_pred             hHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--------------CCCCcccCHHHHHHHHHHhhhCHHHhc
Confidence            99999999999999999997432    222222222211              112246889999999999999999999


Q ss_pred             -----CHHHHhcCccccCC
Q 039159          242 -----TAAEALQQEYFKDV  255 (259)
Q Consensus       242 -----~~~~~l~h~~f~~~  255 (259)
                           +++++++||||..+
T Consensus       310 ~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          310 GCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             TSSTTTHHHHHTSGGGTTC
T ss_pred             CCCCCCHHHHHcCcchhcC
Confidence                 99999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.6e-43  Score=288.88  Aligned_cols=218  Identities=27%  Similarity=0.360  Sum_probs=169.7

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|++++++++||||+++++++..++ .++||||+.+ +|.+.+...               ..+....+..++.
T Consensus        58 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~  121 (322)
T 2ycf_A           58 PALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN---------------KRLKEATCKLYFY  121 (322)
T ss_dssp             ---CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTT---------------CCCCHHHHHHHHH
T ss_pred             hhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc---------------CCCCHHHHHHHHH
Confidence            3456899999999999999999999997655 8999999986 898887532               3355677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCC--eEEEeeccccccccccCCCCcCCccCccccCccccc--CccCCCccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGK--TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL--GLLEYSTAV  165 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~--~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~  165 (259)
                      |++.||+|||+++++||||||+||+++.++.  .+||+|||.+...... .......||+.|+|||.+.  +...++.++
T Consensus       122 qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  200 (322)
T 2ycf_A          122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAV  200 (322)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHH
T ss_pred             HHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchh
Confidence            9999999999999999999999999987551  4999999999764321 1122346899999999974  235678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChH-HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSL-ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|+|++|..||...... .....+...... .         ....+..+++.+.+++.+||..||++||+++
T Consensus       201 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~---------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~  270 (322)
T 2ycf_A          201 DCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-F---------IPEVWAEVSEKALDLVKKLLVVDPKARFTTE  270 (322)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC-C---------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             hHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc-c---------CchhhhhcCHHHHHHHHHHcccCHhhCCCHH
Confidence            9999999999999999999765432 122222221111 0         1111246889999999999999999999999


Q ss_pred             HHhcCccccCC
Q 039159          245 EALQQEYFKDV  255 (259)
Q Consensus       245 ~~l~h~~f~~~  255 (259)
                      ++++||||+..
T Consensus       271 ~~l~h~~~~~~  281 (322)
T 2ycf_A          271 EALRHPWLQDE  281 (322)
T ss_dssp             HHHTSGGGCCH
T ss_pred             HHhhCcCcCCH
Confidence            99999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=295.36  Aligned_cols=220  Identities=18%  Similarity=0.286  Sum_probs=181.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++.+|+.++++++||||+++++++.++...++||||+.| +|.+++.......        .....+....++.++.
T Consensus       117 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------~~~~~~~~~~~~~i~~  188 (367)
T 3l9p_A          117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP--------SQPSSLAMLDLLHVAR  188 (367)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCS--------SSCCCCCHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhcccc--------CccccccHHHHHHHHH
Confidence            345688999999999999999999999999999999999986 9999997543211        1113466778889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      |++.||+|||++||+||||||+||+++.++  ..+||+|||+++......  .......||+.|+|||.+.+ ..++.++
T Consensus       189 qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~  267 (367)
T 3l9p_A          189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKT  267 (367)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHH
T ss_pred             HHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHH
Confidence            999999999999999999999999998544  259999999997553322  23344568999999999977 5789999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|+|++ |..||.+.........+........             ...+++.+.+++.+||+.||.+||+++
T Consensus       268 DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~  334 (367)
T 3l9p_A          268 DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP-------------PKNCPGPVYRIMTQCWQHQPEDRPNFA  334 (367)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            99999999999998 9999999888877777765442211             245789999999999999999999999


Q ss_pred             HHhcCccc
Q 039159          245 EALQQEYF  252 (259)
Q Consensus       245 ~~l~h~~f  252 (259)
                      +++++.++
T Consensus       335 eil~~l~~  342 (367)
T 3l9p_A          335 IILERIEY  342 (367)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99987654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.8e-43  Score=279.78  Aligned_cols=210  Identities=21%  Similarity=0.285  Sum_probs=176.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++.+++..++||||+.+ +|.+++....              ..++...+..++.
T Consensus        48 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~  113 (269)
T 4hcu_A           48 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--------------GLFAAETLLGMCL  113 (269)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT--------------TCCCHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC--------------cccCHHHHHHHHH
Confidence            457799999999999999999999999999999999999986 8999886422              2355677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-CCCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.|++|||+.+++||||||+||+++.++ .++|+|||.+....... .......+++.|+|||.+.+ ..++.++|||
T Consensus       114 ~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  191 (269)
T 4hcu_A          114 DVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVW  191 (269)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEeccccccccccccccccccCcccccccCCHHHhcC-CCCCchhhhH
Confidence            999999999999999999999999999888 89999999997553321 12334456788999999976 5688999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|+|++ |..||.+.........+........             ....++.+.+++.+||..||.+||++.+++
T Consensus       192 slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll  258 (269)
T 4hcu_A          192 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-------------PRLASTHVYQIMNHCWRERPEDRPAFSRLL  258 (269)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC-------------CCcCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence            99999999999 9999999888877777655432211             134789999999999999999999999999


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      ++
T Consensus       259 ~~  260 (269)
T 4hcu_A          259 RQ  260 (269)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-42  Score=282.21  Aligned_cols=217  Identities=23%  Similarity=0.312  Sum_probs=172.5

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|+.++++++||||+++++++.+++..++||||+.| +|.+++...               ..++...+..++
T Consensus        53 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---------------~~~~~~~~~~~~  117 (294)
T 4eqm_A           53 ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH---------------GPLSVDTAINFT  117 (294)
T ss_dssp             HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---------------CSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc---------------CCCCHHHHHHHH
Confidence            3346789999999999999999999999999999999999986 999988642               235667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.||+|||++||+||||||+||+++.++ .+||+|||++........ ......||+.|+|||.+.+ ..++.++||
T Consensus       118 ~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di  195 (294)
T 4eqm_A          118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDI  195 (294)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC-------------CCSSCCHHHHHT-CCCCTTHHH
T ss_pred             HHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCccccccccccccCccccCccccCHhHhcC-CCCCchHhH
Confidence            9999999999999999999999999999888 899999999976543221 2334578999999999987 567899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||+++|+|++|+.||.+...................         ....+.+++.+.+++.+||..||.+||+..+.+
T Consensus       196 ~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l  266 (294)
T 4eqm_A          196 YSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT---------TDVRKDIPQSLSNVILRATEKDKANRYKTIQEM  266 (294)
T ss_dssp             HHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHH---------HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcc---------hhcccCCCHHHHHHHHHHhcCCHhHccccHHHH
Confidence            99999999999999999998877766665544322111         112356889999999999999999999544444


Q ss_pred             cCccc
Q 039159          248 QQEYF  252 (259)
Q Consensus       248 ~h~~f  252 (259)
                      .+.|.
T Consensus       267 ~~~l~  271 (294)
T 4eqm_A          267 KDDLS  271 (294)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            44543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.5e-43  Score=287.79  Aligned_cols=223  Identities=22%  Similarity=0.298  Sum_probs=168.6

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceE------EEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYL------YPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~------~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      ...+++.+|++++++++||||+++++++......      ++||||+.+ +|.+++........         ...++..
T Consensus        67 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~---------~~~~~~~  137 (323)
T 3qup_A           67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN---------PFNLPLQ  137 (323)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC------------CCCCCHH
T ss_pred             HHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcccc---------ccccCHH
Confidence            3456789999999999999999999999877654      999999996 99998864321110         0246677


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      .+..++.|++.||+|||+.||+||||||+||+++.++ .+||+|||.+........  ......+++.|+|||.+.+ ..
T Consensus       138 ~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  215 (323)
T 3qup_A          138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NL  215 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------------CCGGGCCHHHHHH-CC
T ss_pred             HHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-CEEEeeccccccccccccccccccccCcccccCchhhcC-CC
Confidence            8899999999999999999999999999999999888 899999999976533221  1223356788999999977 56


Q ss_pred             CCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          161 YSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      ++.++|||||||++|++++ |..||.+.........+......+.             .+.+++++.+++.+||..||.+
T Consensus       216 ~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~  282 (323)
T 3qup_A          216 YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ-------------PPECMEEVYDLMYQCWSADPKQ  282 (323)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHTTCSSGGG
T ss_pred             CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCC-------------CCccCHHHHHHHHHHccCChhh
Confidence            8899999999999999999 8999998877777766655432211             2468899999999999999999


Q ss_pred             ccC-------HHHHhcCccccCCC
Q 039159          240 RIT-------AAEALQQEYFKDVP  256 (259)
Q Consensus       240 Rp~-------~~~~l~h~~f~~~~  256 (259)
                      |||       ++++++|||+.+..
T Consensus       283 Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          283 RPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             SCCHHHHHHHHHHHHHC-------
T ss_pred             CcCHHHHHHHHHHHHHHhhhcCCC
Confidence            999       88888999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4e-43  Score=282.82  Aligned_cols=219  Identities=26%  Similarity=0.381  Sum_probs=178.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEe--CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ..+.+.+|++++++++||||+++++++..  +...++||||+.| +|.+++......           ...++...+..+
T Consensus        48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~i  116 (279)
T 2w5a_A           48 EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-----------RQYLDEEFVLRV  116 (279)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHT-----------TCCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhccc-----------CCCCCHHHHHHH
Confidence            35678899999999999999999998854  5689999999986 999998642111           023567788999


Q ss_pred             HhhcccccccccCCC-----ceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           88 FSSSDSSRSLSFGTR-----YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~-----i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      +.+++.||+|||+.+     ++||||||+||+++.++ .+||+|||.+..............|++.|+|||.+.+ ..++
T Consensus       117 ~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~  194 (279)
T 2w5a_A          117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYN  194 (279)
T ss_dssp             HHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC-C-CC
T ss_pred             HHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEecCchheeeccccccccccCCCccccChHHhcc-CCCC
Confidence            999999999999998     99999999999999888 8999999999765332222233468999999999987 5688


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      .++||||||+++|+|++|..||...........+......             .....+++++.+++.+||..||.+||+
T Consensus       195 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps  261 (279)
T 2w5a_A          195 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-------------RIPYRYSDELNEIITRMLNLKDYHRPS  261 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------------CCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-------------cCCcccCHHHHHHHHHHcCCCcccCCC
Confidence            9999999999999999999999988777666665443221             112357899999999999999999999


Q ss_pred             HHHHhcCccccCC
Q 039159          243 AAEALQQEYFKDV  255 (259)
Q Consensus       243 ~~~~l~h~~f~~~  255 (259)
                      ++++++|+|+...
T Consensus       262 ~~~ll~~~~~~~~  274 (279)
T 2w5a_A          262 VEEILENPLILEH  274 (279)
T ss_dssp             HHHHHTSTTCCGG
T ss_pred             HHHHHhChhhhhh
Confidence            9999999999754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=284.20  Aligned_cols=218  Identities=23%  Similarity=0.272  Sum_probs=171.6

Q ss_pred             CCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            4 IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         4 ~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      +...+....+.+.+|++++++++||||+++++++.+++..++||||+.| +|.+++....              ..++..
T Consensus        43 ~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~  108 (310)
T 3s95_A           43 LIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD--------------SQYPWS  108 (310)
T ss_dssp             ESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC--------------TTSCHH
T ss_pred             eccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc--------------CCCCHH
Confidence            4444455667899999999999999999999999999999999999986 9999996532              335667


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCC--------------cCCccCcc
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGES--------------SAEVGTHY  148 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~--------------~~~~~~~~  148 (259)
                      ....++.|++.||+|||+++|+||||||+||+++.++ .+||+|||.+..........              ....||+.
T Consensus       109 ~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  187 (310)
T 3s95_A          109 QRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY  187 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEECC--------------------CCCCSCGG
T ss_pred             HHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccceecccccccccccccccccccccccccCCCcc
Confidence            7889999999999999999999999999999999888 89999999997653322211              14579999


Q ss_pred             ccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHH
Q 039159          149 YKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDL  228 (259)
Q Consensus       149 ~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  228 (259)
                      |+|||.+.+ ..++.++||||||+++|++++|..||.........        ...... .  .......+.+++.+.++
T Consensus       188 y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~--------~~~~~~-~--~~~~~~~~~~~~~l~~l  255 (310)
T 3s95_A          188 WMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD--------FGLNVR-G--FLDRYCPPNCPPSFFPI  255 (310)
T ss_dssp             GCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT--------SSBCHH-H--HHHHTCCTTCCTTHHHH
T ss_pred             eeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH--------Hhhhhh-c--cccccCCCCCCHHHHHH
Confidence            999999987 67889999999999999999999988653211000        000000 0  00011125678999999


Q ss_pred             HHhhcCcCCCCccCHHHHhc
Q 039159          229 ISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       229 i~~~l~~dp~~Rp~~~~~l~  248 (259)
                      +.+||..||.+|||++++++
T Consensus       256 i~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          256 TVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHH
Confidence            99999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.5e-42  Score=288.97  Aligned_cols=224  Identities=22%  Similarity=0.272  Sum_probs=177.7

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccc-cCCCcchhHHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTK-NFNSYSLFTTFLLVEE   87 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   87 (259)
                      ..+++.+|+++++++ +||||+++++++.+++.+|+||||+.| +|.+++............. .......+....++.+
T Consensus       129 ~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  208 (370)
T 2psq_A          129 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC  208 (370)
T ss_dssp             HHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHH
Confidence            345789999999999 899999999999999999999999986 9999997643211100000 0001134667788999


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++.......  ......+|+.|+|||.+.+ ..++.++
T Consensus       209 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~  286 (370)
T 2psq_A          209 TYQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQS  286 (370)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHH
T ss_pred             HHHHHHHHHHHHhCCeeccccchhhEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHH
Confidence            99999999999999999999999999999888 899999999986543221  2233457889999999987 5789999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|||++ |..||.+.........+...... .            ....+++.+.++|.+||..||.+||++.
T Consensus       287 DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~  353 (370)
T 2psq_A          287 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM-D------------KPANCTNELYMMMRDCWHAVPSQRPTFK  353 (370)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-C------------CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC-C------------CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            99999999999999 99999987766666555443321 1            1246789999999999999999999999


Q ss_pred             HHhcC
Q 039159          245 EALQQ  249 (259)
Q Consensus       245 ~~l~h  249 (259)
                      +++++
T Consensus       354 ell~~  358 (370)
T 2psq_A          354 QLVED  358 (370)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3e-43  Score=296.90  Aligned_cols=228  Identities=24%  Similarity=0.324  Sum_probs=170.5

Q ss_pred             CCCchhHHHHHHHhhCC--------CCCeeEEEEEEE----eCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcc
Q 039159           10 GVPSSMIREVSCLMELN--------HPNIIRLMRVAS----QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYS   77 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~--------H~niv~~~~~~~----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~   77 (259)
                      ...+.+.+|++++++++        ||||+++++++.    .+...++||||+.+++.+.+.....             .
T Consensus        75 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-------------~  141 (397)
T 1wak_A           75 HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNY-------------Q  141 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTT-------------S
T ss_pred             cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhccc-------------C
Confidence            34567889999999996        788999999998    4568999999998888887754211             2


Q ss_pred             hhHHHHHHHHHhhcccccccccCC-CceeccCCCCcEEEcCCC-------------------------------------
Q 039159           78 LFTTFLLVEEFSSSDSSRSLSFGT-RYIRRDLKPVNILVDLDG-------------------------------------  119 (259)
Q Consensus        78 ~~~~~~~~~~~~~~~~~l~~lh~~-~i~H~dlkp~Nili~~~~-------------------------------------  119 (259)
                      .++...+..++.|++.||+|||++ ||+||||||+||+++.++                                     
T Consensus       142 ~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (397)
T 1wak_A          142 GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL  221 (397)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccc
Confidence            356678889999999999999998 999999999999998664                                     


Q ss_pred             -----------CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCC
Q 039159          120 -----------KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN  188 (259)
Q Consensus       120 -----------~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~  188 (259)
                                 ..+||+|||.+.....   ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||....
T Consensus       222 ~~~~~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          222 VNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             CCTTSGGGGGGCCEEECCGGGCEETTB---CSCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             ccccccccccccceEeccccccccccc---cCccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence                       2699999999976532   2344578999999999988 568899999999999999999999997543


Q ss_pred             ------hHHHHHHH---hCCCCCCc----------ccccccccccc---------------CCCCCCCHHHHHHHHhhcC
Q 039159          189 ------SLITLGRI---VGKSRKPS----------FCKLSLRDHLT---------------NGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       189 ------~~~~~~~i---~~~~~~~~----------~~~~~~~~~~~---------------~~~~~~~~~~~~li~~~l~  234 (259)
                            .......+   ........          .........+.               ......++.+.+||.+||.
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  377 (397)
T 1wak_A          298 GEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLE  377 (397)
T ss_dssp             CSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGC
T ss_pred             ccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhc
Confidence                  12222222   11110000          00000000000               0011234678899999999


Q ss_pred             cCCCCccCHHHHhcCccccC
Q 039159          235 MDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      .||++|||++++|+||||++
T Consensus       378 ~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          378 LIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             SSGGGSCCHHHHHTSGGGGC
T ss_pred             cChhhcCCHHHHhhCccccC
Confidence            99999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.4e-43  Score=294.45  Aligned_cols=227  Identities=14%  Similarity=0.081  Sum_probs=154.8

Q ss_pred             CchhHHHHHHHhhC--CCCCeeEEE-------EEEEeC-----------------ceEEEEeeeecCCHHHHhhcCCCCC
Q 039159           12 PSSMIREVSCLMEL--NHPNIIRLM-------RVASQG-----------------IYLYPVFEYQVNDLAYLLKYPKDSM   65 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l--~H~niv~~~-------~~~~~~-----------------~~~~lv~e~~~~~l~~~~~~~~~~~   65 (259)
                      .+.+.+|+.+++.|  +||||++++       +++...                 ..+|+||||+.|+|.+++...... 
T Consensus       106 ~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~-  184 (371)
T 3q60_A          106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV-  184 (371)
T ss_dssp             HHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHS-
T ss_pred             HHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccc-
Confidence            45667885555555  699988866       444432                 348999999999999999753111 


Q ss_pred             CCcccccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCcc
Q 039159           66 NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVG  145 (259)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~  145 (259)
                             ..............++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++....   ......+
T Consensus       185 -------~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~~---~~~~~~~  253 (371)
T 3q60_A          185 -------YVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGDVSALWKVGT---RGPASSV  253 (371)
T ss_dssp             -------CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTS-CEEECCGGGEEETTC---EEEGGGS
T ss_pred             -------cchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCC-CEEEEecceeeecCC---CccCccC
Confidence                   00101111112245668999999999999999999999999999988 899999999986422   2224467


Q ss_pred             CccccCcccccC-ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHH
Q 039159          146 THYYKAPELLLG-LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPA  224 (259)
Q Consensus       146 ~~~~~aPE~~~~-~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (259)
                      |+.|+|||.+.+ ...++.++|||||||++|+|++|+.||.+.......     .................+....+++.
T Consensus       254 t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (371)
T 3q60_A          254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-----SWKRPSLRVPGTDSLAFGSCTPLPDF  328 (371)
T ss_dssp             CGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-----CCCBCCTTSCCCCSCCCTTSSCCCHH
T ss_pred             CcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc-----chhhhhhhhccccccchhhccCCCHH
Confidence            799999999975 246789999999999999999999999875322100     00000000000011112223578999


Q ss_pred             HHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          225 GIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       225 ~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      +.+||.+||..||++|||+.++|+||||+++
T Consensus       329 ~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          329 VKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             HHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            9999999999999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=285.87  Aligned_cols=228  Identities=18%  Similarity=0.239  Sum_probs=172.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc--eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGI--YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ...+.+.+|++++++++||||+++++++...+  ..++||||+.| +|.+++......            ..++...+..
T Consensus        49 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~  116 (319)
T 4euu_A           49 RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA------------YGLPESEFLI  116 (319)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGT------------TCCCHHHHHH
T ss_pred             chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccc------------cCCCHHHHHH
Confidence            34567889999999999999999999998765  78999999985 999999753211            2266778899


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEE----cCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC-----
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILV----DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG-----  157 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili----~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----  157 (259)
                      ++.|++.||+|||+.+|+||||||+||++    +.++ .+||+|||++...... .......||+.|+|||.+..     
T Consensus       117 i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~  194 (319)
T 4euu_A          117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRK  194 (319)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE-EEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCC
T ss_pred             HHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc-eEEEccCCCceecCCC-CceeecccCCCccCHHHhhhccccc
Confidence            99999999999999999999999999998    6666 7999999999865432 23344579999999999862     


Q ss_pred             --ccCCCcccchHhHHHHHHHHHhCCCCCCCC----ChHHHHHHHhCCCCCCccccccc--------c---ccccCCCCC
Q 039159          158 --LLEYSTAVDIWPVGCIFGEMVSGKPLFPGA----NSLITLGRIVGKSRKPSFCKLSL--------R---DHLTNGFPG  220 (259)
Q Consensus       158 --~~~~~~~~DiwslG~~l~e~~tg~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~--------~---~~~~~~~~~  220 (259)
                        ...++.++|||||||++|+|++|+.||...    ........+..............        .   .........
T Consensus       195 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (319)
T 4euu_A          195 DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRG  274 (319)
T ss_dssp             CCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHH
T ss_pred             cccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchh
Confidence              256889999999999999999999999642    23344444443322111110000        0   000011123


Q ss_pred             CCHHHHHHHHhhcCcCCCCccCHHHHhcCcc
Q 039159          221 LEPAGIDLISKMLGMDPDKRITAAEALQQEY  251 (259)
Q Consensus       221 ~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~  251 (259)
                      +++.+.+++.+||..||.+|||++++|+||-
T Consensus       275 ~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          275 LQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             HHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            4567889999999999999999999999873

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2e-42  Score=277.23  Aligned_cols=210  Identities=23%  Similarity=0.278  Sum_probs=176.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++.+++..++||||+.| +|.+++....              ..++...+..++.
T Consensus        46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~  111 (268)
T 3sxs_A           46 SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--------------KGLEPSQLLEMCY  111 (268)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG--------------GGCCHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC--------------CCCCHHHHHHHHH
Confidence            456799999999999999999999999999999999999986 8999886421              3366778889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.|++|||+.+++||||||+||+++.++ .++|+|||.+........ ......+++.|+|||.+.+ ..++.++|||
T Consensus       112 qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  189 (268)
T 3sxs_A          112 DVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVW  189 (268)
T ss_dssp             HHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHH
T ss_pred             HHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc-cCCchhhhhH
Confidence            999999999999999999999999999888 899999999976533221 1223356778999999976 5688999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|++++ |..||...........+........             ....++.+.+++.+||..||.+|||+.+++
T Consensus       190 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll  256 (268)
T 3sxs_A          190 AFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-------------PHLASDTIYQIMYSCWHELPEKRPTFQQLL  256 (268)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC-------------CCcChHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            99999999999 9999998887777766654432211             134688999999999999999999999999


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      ++
T Consensus       257 ~~  258 (268)
T 3sxs_A          257 SS  258 (268)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.9e-43  Score=289.75  Aligned_cols=229  Identities=22%  Similarity=0.251  Sum_probs=176.3

Q ss_pred             CCCchhHHHHHHHhhCCCCC------eeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPN------IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~n------iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ...+.+.+|+.++++++|+|      ++.+++++...+..++||||+.+++.+.+.....             ..++...
T Consensus        58 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-------------~~~~~~~  124 (355)
T 2eu9_A           58 KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF-------------QPYPLPH  124 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTT-------------CCCCHHH
T ss_pred             cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccC-------------CCCCHHH
Confidence            34567889999999998766      9999999999999999999998888888764221             2356678


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEE-------------------cCCCCeEEEeeccccccccccCCCCcCCc
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILV-------------------DLDGKTVKVAGFGLAKSLYAYKGESSAEV  144 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili-------------------~~~~~~vkl~dfg~~~~~~~~~~~~~~~~  144 (259)
                      +..++.|++.||+|||+++|+||||||+||++                   +.++ .+||+|||++....   .......
T Consensus       125 ~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Dfg~~~~~~---~~~~~~~  200 (355)
T 2eu9_A          125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT-SIRVADFGSATFDH---EHHTTIV  200 (355)
T ss_dssp             HHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCC-CEEECCCTTCEETT---SCCCSSC
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCC-cEEEeecCcccccc---ccccCCc
Confidence            88999999999999999999999999999999                   4555 89999999997542   2334567


Q ss_pred             cCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCC-CCCcccc--c---cc--------
Q 039159          145 GTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKS-RKPSFCK--L---SL--------  210 (259)
Q Consensus       145 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~-~~~~~~~--~---~~--------  210 (259)
                      ||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+.... ..|....  .   ..        
T Consensus       201 gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  279 (355)
T 2eu9_A          201 ATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVW  279 (355)
T ss_dssp             SCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECC
T ss_pred             CCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhccccccc
Confidence            9999999999987 578999999999999999999999999877665444332111 1110000  0   00        


Q ss_pred             ----------------cccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          211 ----------------RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       211 ----------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                                      ...........++.+.+||.+||..||.+|||++++|+||||..+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          280 DENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             CTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             ccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence                            0000000112345788999999999999999999999999999764

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.5e-42  Score=277.83  Aligned_cols=216  Identities=26%  Similarity=0.319  Sum_probs=165.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEe-------------CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcc
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQ-------------GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYS   77 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~-------------~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~   77 (259)
                      .+.+.+|+.++++++||||+++++++.+             ++..++||||+.| +|.+++....              .
T Consensus        46 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~  111 (303)
T 1zy4_A           46 LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--------------L  111 (303)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC--------------G
T ss_pred             HHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc--------------c
Confidence            4678899999999999999999999865             3578999999986 9999996421              3


Q ss_pred             hhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--------------CCCcCC
Q 039159           78 LFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--------------GESSAE  143 (259)
Q Consensus        78 ~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--------------~~~~~~  143 (259)
                      ......+..++.|++.||+|||+++++||||||+||+++.++ .++|+|||.+.......              ......
T Consensus       112 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (303)
T 1zy4_A          112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA  190 (303)
T ss_dssp             GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCCCSCTTC----------------------
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEEeeCcchhhcccccchhccccccccccccccccC
Confidence            345567788999999999999999999999999999999888 89999999997653211              122344


Q ss_pred             ccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhCCCCCCccccccccccccCCCCCCC
Q 039159          144 VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN-SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE  222 (259)
Q Consensus       144 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (259)
                      .|++.|+|||.+.+...++.++|||||||++|+|++   ||.... .......+......  .+        .......+
T Consensus       191 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~--~~--------~~~~~~~~  257 (303)
T 1zy4_A          191 IGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIE--FP--------PDFDDNKM  257 (303)
T ss_dssp             ---CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCC--CC--------TTCCTTTS
T ss_pred             CCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccc--cC--------ccccccch
Confidence            689999999999875568899999999999999998   555432 22333333322111  00        11224567


Q ss_pred             HHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          223 PAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       223 ~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      +.+.+++.+||..||.+|||++++++||||+..
T Consensus       258 ~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          258 KVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            889999999999999999999999999999854

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3e-42  Score=294.15  Aligned_cols=225  Identities=28%  Similarity=0.354  Sum_probs=164.9

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+++++++ +||||+++++++.+++.+|+||||+.|+|.+++.........        ........++.++.|
T Consensus        52 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~--------~~~~~~~~~~~i~~q  123 (434)
T 2rio_A           52 CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDEN--------LKLQKEYNPISLLRQ  123 (434)
T ss_dssp             HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC--------------------CCHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchh--------hhhccchhHHHHHHH
Confidence            35678999999986 899999999999999999999999999999999753221100        011122345678999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCC------------CCeEEEeeccccccccccCCC----CcCCccCccccCccc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLD------------GKTVKVAGFGLAKSLYAYKGE----SSAEVGTHYYKAPEL  154 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~------------~~~vkl~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~  154 (259)
                      ++.||+|||+++|+||||||+||+++.+            ...+||+|||+++........    .....||+.|+|||.
T Consensus       124 i~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  203 (434)
T 2rio_A          124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL  203 (434)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHH
T ss_pred             HHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHH
Confidence            9999999999999999999999999753            237999999999876433221    234579999999999


Q ss_pred             ccC------ccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCC-CCCccccccccccccCCCCCCCHHHH
Q 039159          155 LLG------LLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKS-RKPSFCKLSLRDHLTNGFPGLEPAGI  226 (259)
Q Consensus       155 ~~~------~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (259)
                      +.+      ...++.++|||||||++|+|++ |..||.+......  .+.... ..+....        .....+++++.
T Consensus       204 ~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~i~~~~~~~~~~~~--------~~~~~~~~~~~  273 (434)
T 2rio_A          204 LEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDEMKC--------LHDRSLIAEAT  273 (434)
T ss_dssp             HSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--HHHHTCCCCCCCTT--------CCCHHHHHHHH
T ss_pred             hccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--HHhcCCCCcccccc--------cccccchHHHH
Confidence            965      2457889999999999999999 8999976554432  222211 1111000        00123567899


Q ss_pred             HHHHhhcCcCCCCccCHHHHhcCccccC
Q 039159          227 DLISKMLGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       227 ~li~~~l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      ++|.+||..||.+|||+.++++||||++
T Consensus       274 ~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          274 DLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            9999999999999999999999999975

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.6e-42  Score=275.00  Aligned_cols=208  Identities=23%  Similarity=0.295  Sum_probs=166.6

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+++++.++||||+++++++.+++..++||||+.| +|.+++..                ..++...+..++
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~i~  111 (271)
T 3dtc_A           48 QTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----------------KRIPPDILVNWA  111 (271)
T ss_dssp             -CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS----------------SCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc----------------CCCCHHHHHHHH
Confidence            3356789999999999999999999999999999999999986 88888843                335567788999


Q ss_pred             hhcccccccccCCC---ceeccCCCCcEEEcC--------CCCeEEEeeccccccccccCCCCcCCccCccccCcccccC
Q 039159           89 SSSDSSRSLSFGTR---YIRRDLKPVNILVDL--------DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG  157 (259)
Q Consensus        89 ~~~~~~l~~lh~~~---i~H~dlkp~Nili~~--------~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  157 (259)
                      .+++.|++|||+++   ++||||||+||+++.        ++ .++|+|||.+......  ......||+.|+|||.+.+
T Consensus       112 ~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~-~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~  188 (271)
T 3dtc_A          112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK-ILKITDFGLAREWHRT--TKMSAAGAYAWMAPEVIRA  188 (271)
T ss_dssp             HHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC-CEEECCCCC---------------CCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc-ceEEccCCcccccccc--cccCCCCccceeCHHHhcc
Confidence            99999999999998   899999999999986        44 7999999999765332  2234578999999999977


Q ss_pred             ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                       ..++.++||||||+++|++++|+.||.+.........+.........            ...+++.+.+++.+||..||
T Consensus       189 -~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p  255 (271)
T 3dtc_A          189 -SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI------------PSTCPEPFAKLMEDCWNPDP  255 (271)
T ss_dssp             -CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC------------CTTCCHHHHHHHHHHTCSSG
T ss_pred             -CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC------------CcccCHHHHHHHHHHhcCCc
Confidence             56889999999999999999999999988877776666544332221            24678999999999999999


Q ss_pred             CCccCHHHHhcC
Q 039159          238 DKRITAAEALQQ  249 (259)
Q Consensus       238 ~~Rp~~~~~l~h  249 (259)
                      .+|||+.+++++
T Consensus       256 ~~Rps~~e~l~~  267 (271)
T 3dtc_A          256 HSRPSFTNILDQ  267 (271)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             ccCcCHHHHHHH
Confidence            999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.2e-42  Score=277.42  Aligned_cols=210  Identities=23%  Similarity=0.288  Sum_probs=176.7

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++.+++..++||||+.+ +|.+++....              ..++...+..++.
T Consensus        62 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~  127 (283)
T 3gen_A           62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--------------HRFQTQQLLEMCK  127 (283)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG--------------GCCCHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc--------------cCCCHHHHHHHHH
Confidence            457799999999999999999999999999999999999985 8999986421              3356678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-CCCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.||+|||+++++||||||+||+++.++ .++|+|||.+....... .......+|+.|+|||.+.+ ..++.++|||
T Consensus       128 qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~  205 (283)
T 3gen_A          128 DVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIW  205 (283)
T ss_dssp             HHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHH
T ss_pred             HHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEccccccccccccccccccCCccCcccCCHHHhcc-CCCCchhhHH
Confidence            999999999999999999999999999888 89999999997653321 12233456788999999986 5688999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|++++ |..||...........+........             ....++.+.+++.+||..||.+|||+++++
T Consensus       206 slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll  272 (283)
T 3gen_A          206 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-------------PHLASEKVYTIMYSCWHEKADERPTFKILL  272 (283)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC-------------CCcCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            99999999998 9999998888777777665432211             135689999999999999999999999999


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      +|
T Consensus       273 ~~  274 (283)
T 3gen_A          273 SN  274 (283)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.4e-42  Score=288.21  Aligned_cols=209  Identities=22%  Similarity=0.307  Sum_probs=173.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++.+++..++||||+.| +|.++++...              ..++...++.++.
T Consensus       155 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~~~  220 (377)
T 3cbl_A          155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--------------ARLRVKTLLQMVG  220 (377)
T ss_dssp             HHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG--------------GGCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC--------------CCCCHHHHHHHHH
Confidence            346789999999999999999999999998999999999985 9999886421              2356678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCcccch
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      |++.|++|||+++++||||||+||+++.++ .+||+|||+++......  .......+++.|+|||.+.+ ..++.++||
T Consensus       221 qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  298 (377)
T 3cbl_A          221 DAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDV  298 (377)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHH
T ss_pred             HHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhH
Confidence            999999999999999999999999999888 89999999997543211  11222345778999999976 568899999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++|||++ |..||.+.........+......+.             ...+++.+.++|.+||..||++|||++++
T Consensus       299 wslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i  365 (377)
T 3cbl_A          299 WSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC-------------PELCPDAVFRLMEQCWAYEPGQRPSFSTI  365 (377)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            999999999998 9999998887776665554432211             23578999999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       366 ~~  367 (377)
T 3cbl_A          366 YQ  367 (377)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-42  Score=281.28  Aligned_cols=211  Identities=17%  Similarity=0.177  Sum_probs=170.9

Q ss_pred             CCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159            5 HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus         5 ~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ........+++.+|++++++++||||+++++++.+++..++||||+.| +|.+++....              ..++...
T Consensus        49 ~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~  114 (289)
T 4fvq_A           49 DKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK--------------NCINILW  114 (289)
T ss_dssp             CGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTG--------------GGCCHHH
T ss_pred             ccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC--------------CCCCHHH
Confidence            334445567899999999999999999999999999999999999995 9999996421              2356677


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCe--------EEEeeccccccccccCCCCcCCccCccccCcccc
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKT--------VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL  155 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~--------vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~  155 (259)
                      +..++.|++.||+|||+++|+||||||+||+++.++ .        +||+|||.+.....    .....|++.|+|||.+
T Consensus       115 ~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~  189 (289)
T 4fvq_A          115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREE-DRKTGNPPFIKLSDPGISITVLP----KDILQERIPWVPPECI  189 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECC-BGGGTBCCEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHH
T ss_pred             HHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCC-cccccccceeeeccCcccccccC----ccccCCcCcccCHHHh
Confidence            889999999999999999999999999999998877 5        99999999865422    2234578899999999


Q ss_pred             cCccCCCcccchHhHHHHHHHHHhC-CCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcC
Q 039159          156 LGLLEYSTAVDIWPVGCIFGEMVSG-KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~e~~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                      .+...++.++||||||+++|+|++| .+||..................               ....++++.+++.+||.
T Consensus       190 ~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~~l~  254 (289)
T 4fvq_A          190 ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL---------------PAPKAAELANLINNCMD  254 (289)
T ss_dssp             HCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------------CCCSSCTTHHHHHHHSC
T ss_pred             CCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC---------------CCCCCHHHHHHHHHHcC
Confidence            8755689999999999999999995 4556555544444333322111               13457889999999999


Q ss_pred             cCCCCccCHHHHhcC
Q 039159          235 MDPDKRITAAEALQQ  249 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~h  249 (259)
                      .||++|||+++++++
T Consensus       255 ~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          255 YEPDHRPSFRAIIRD  269 (289)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhHCcCHHHHHHH
Confidence            999999999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1e-41  Score=292.12  Aligned_cols=207  Identities=25%  Similarity=0.335  Sum_probs=171.5

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCc-eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGI-YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..++|.+|++++++++||||+++++++.+.+ .+++||||+.+ +|.++++....             ..++...++.++
T Consensus       229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~  295 (450)
T 1k9a_A          229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------------SVLGGDCLLKFS  295 (450)
T ss_dssp             TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCT-------------TTCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCC-------------CCCCHHHHHHHH
Confidence            5678999999999999999999999987665 79999999986 99999975321             234567788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.||+|||+++++||||||+||+++.++ .+||+|||+++....   ......+++.|+|||.+.+ ..++.++|||
T Consensus       296 ~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~sDvw  370 (450)
T 1k9a_A          296 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALRE-KKFSTKSDVW  370 (450)
T ss_dssp             HHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCEECC---------CCCTTTSCHHHHHS-SCCCHHHHHH
T ss_pred             HHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCcccccc---cccCCCCCcceeCHHHhcC-CCCCcHHHHH
Confidence            9999999999999999999999999999888 899999999975422   1223356889999999987 5789999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++|||++ |..||.+....+....+....+.+             ....+++.+.++|.+||..||.+|||+.+++
T Consensus       371 slG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~  437 (450)
T 1k9a_A          371 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLR  437 (450)
T ss_dssp             HHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            99999999998 999999877666665555443221             1246889999999999999999999999997


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       438 ~  438 (450)
T 1k9a_A          438 E  438 (450)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.7e-42  Score=288.96  Aligned_cols=209  Identities=23%  Similarity=0.302  Sum_probs=163.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++.+++..++||||++| +|.+++....              ..++...++.++.
T Consensus        89 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~i~~  154 (373)
T 2qol_A           89 QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------------AQFTVIQLVGMLR  154 (373)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT--------------TCSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCC--------------CCCCHHHHHHHHH
Confidence            346789999999999999999999999999999999999985 9999996421              2356677889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +++.||+|||+++|+||||||+||+++.++ .+||+|||+++........   .....+++.|+|||.+.+ ..++.++|
T Consensus       155 qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  232 (373)
T 2qol_A          155 GIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD  232 (373)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC----------------------CTTSCHHHHHH-CCCCHHHH
T ss_pred             HHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCccccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhc
Confidence            999999999999999999999999999888 8999999999865432211   112235678999999976 57889999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||+++||+++ |..||.+.........+......+             ....+++.+.+++.+||+.||.+||++++
T Consensus       233 v~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~  299 (373)
T 2qol_A          233 VWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP-------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQ  299 (373)
T ss_dssp             HHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC-------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------CCccccHHHHHHHHHHhCcChhhCcCHHH
Confidence            9999999999998 999999888777666665432211             12357899999999999999999999999


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +++
T Consensus       300 i~~  302 (373)
T 2qol_A          300 IVS  302 (373)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            885

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.8e-42  Score=273.59  Aligned_cols=208  Identities=16%  Similarity=0.196  Sum_probs=173.1

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ...+++.+|+.++++++||||+++++++.+.  +..++||||+.| +|.+++.....             ..++...+..
T Consensus        49 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~  115 (271)
T 3kmu_A           49 RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------------FVVDQSQAVK  115 (271)
T ss_dssp             HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSS-------------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhccc-------------CCCCHHHHHH
Confidence            3446789999999999999999999999877  788999999996 99999975321             2466778899


Q ss_pred             HHhhcccccccccCCC--ceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCcc--CCC
Q 039159           87 EFSSSDSSRSLSFGTR--YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL--EYS  162 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~--i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~  162 (259)
                      ++.|++.||+|||+++  ++||||||+||+++.++ .++++|||++...     ......||+.|+|||.+.+..  .++
T Consensus       116 i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~  189 (271)
T 3kmu_A          116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVKFSF-----QSPGRMYAPAWVAPEALQKKPEDTNR  189 (271)
T ss_dssp             HHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGSCCTT-----SCTTCBSCGGGSCHHHHHSCGGGSCH
T ss_pred             HHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccceeee-----cccCccCCccccChhhhccCCCCCCC
Confidence            9999999999999999  99999999999999888 8999999887542     223457899999999998632  223


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      .++||||||+++|+|++|+.||.+.........+......+..            ...+++++.+++.+||..||++|||
T Consensus       190 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps  257 (271)
T 3kmu_A          190 RSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI------------PPGISPHVSKLMKICMNEDPAKRPK  257 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             chhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC------------CCCCCHHHHHHHHHHcCCChhhCcC
Confidence            3799999999999999999999988877776666544433322            2468899999999999999999999


Q ss_pred             HHHHhc
Q 039159          243 AAEALQ  248 (259)
Q Consensus       243 ~~~~l~  248 (259)
                      ++++++
T Consensus       258 ~~~il~  263 (271)
T 3kmu_A          258 FDMIVP  263 (271)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-42  Score=283.45  Aligned_cols=228  Identities=19%  Similarity=0.234  Sum_probs=176.5

Q ss_pred             CCCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc--------cccCCCcch
Q 039159            9 EGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS--------TKNFNSYSL   78 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~--------~~~~~~~~~   78 (259)
                      ....+.+.+|+.+++++ +||||+++++++..++..++||||++| +|.+++...........        .........
T Consensus        89 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (344)
T 1rjb_A           89 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV  168 (344)
T ss_dssp             ---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred             HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhccccccccccc
Confidence            44567899999999999 899999999999999999999999986 99999976432211000        000011134


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCccccc
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLL  156 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~  156 (259)
                      ++...++.++.+++.||+|||++||+||||||+||+++.++ .++|+|||++.........  .....||+.|+|||.+.
T Consensus       169 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  247 (344)
T 1rjb_A          169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF  247 (344)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhc
Confidence            67788899999999999999999999999999999999888 9999999999765433221  23345788999999997


Q ss_pred             CccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          157 GLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      + ..++.++||||||+++|+|+| |..||.+.........+......+..            ....++++.+++.+||..
T Consensus       248 ~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~  314 (344)
T 1rjb_A          248 E-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ------------PFYATEEIYIIMQSCWAF  314 (344)
T ss_dssp             H-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC------------CTTCCHHHHHHHHHHTCS
T ss_pred             c-CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCC------------CCCCCHHHHHHHHHHcCC
Confidence            7 568899999999999999998 99999887655444444333222111            235789999999999999


Q ss_pred             CCCCccCHHHHhcCc
Q 039159          236 DPDKRITAAEALQQE  250 (259)
Q Consensus       236 dp~~Rp~~~~~l~h~  250 (259)
                      ||.+||++.+++++.
T Consensus       315 dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          315 DSRKRPSFPNLTSFL  329 (344)
T ss_dssp             SGGGSCCHHHHHHHH
T ss_pred             CchhCcCHHHHHHHH
Confidence            999999999999763

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.9e-42  Score=283.24  Aligned_cols=224  Identities=20%  Similarity=0.299  Sum_probs=154.4

Q ss_pred             CchhHHHHH-HHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVS-CLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~-~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|+. +++.++||||+++++++.+++..++||||+.|+|.+++........          ..+....+..++.+
T Consensus        64 ~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~----------~~~~~~~~~~i~~~  133 (327)
T 3aln_A           64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLD----------DVIPEEILGKITLA  133 (327)
T ss_dssp             HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTC----------CCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhc----------ccCcHHHHHHHHHH
Confidence            345666776 7777899999999999999999999999999998888764211100          34556778889999


Q ss_pred             cccccccccCC-CceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC---ccCCCcccc
Q 039159           91 SDSSRSLSFGT-RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG---LLEYSTAVD  166 (259)
Q Consensus        91 ~~~~l~~lh~~-~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~D  166 (259)
                      ++.|+.|||+. |++||||||+||+++.++ .+||+|||++...... .......||+.|+|||.+..   ...++.++|
T Consensus       134 i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~D  211 (327)
T 3aln_A          134 TVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSD  211 (327)
T ss_dssp             HHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSSCC-------------------------------CCSHHH
T ss_pred             HHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCceecccc-cccccCCCCccccCceeeccccCcCCCCchhh
Confidence            99999999998 999999999999999888 9999999999765332 22333478999999999842   245788999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||+++|+|++|..||.+................+.        ........+++.+.+++.+||..||.+||++.++
T Consensus       212 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  283 (327)
T 3aln_A          212 VWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ--------LSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL  283 (327)
T ss_dssp             HHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC--------CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC--------CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence            99999999999999999986542211111011111111        1111234689999999999999999999999999


Q ss_pred             hcCccccCC
Q 039159          247 LQQEYFKDV  255 (259)
Q Consensus       247 l~h~~f~~~  255 (259)
                      ++||||...
T Consensus       284 l~hp~~~~~  292 (327)
T 3aln_A          284 LKHPFILMY  292 (327)
T ss_dssp             TTSHHHHHH
T ss_pred             HhChHHHHh
Confidence            999999753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-41  Score=278.36  Aligned_cols=224  Identities=23%  Similarity=0.298  Sum_probs=177.8

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc---------cccCCCcchhH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS---------TKNFNSYSLFT   80 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~---------~~~~~~~~~~~   80 (259)
                      ..+++.+|++++++++||||+++++++.+++..++||||+.| +|.+++...........         .........++
T Consensus        69 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (314)
T 2ivs_A           69 ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT  148 (314)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEEC
T ss_pred             HHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcC
Confidence            346788999999999999999999999999999999999995 99999976432111000         00001113467


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  158 (259)
                      ...+..++.+++.||+|||+++|+||||||+||+++.++ .+||+|||++........  ......+++.|+|||.+.+ 
T Consensus       149 ~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  226 (314)
T 2ivs_A          149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-  226 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcC-
Confidence            788899999999999999999999999999999999888 899999999976533222  2233457888999999977 


Q ss_pred             cCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      ..++.++||||||+++|+|++ |..||.+.........+......             .....+++.+.+++.+||..||
T Consensus       227 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~dp  293 (314)
T 2ivs_A          227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM-------------ERPDNCSEEMYRLMLQCWKQEP  293 (314)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-------------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred             CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC-------------CCCccCCHHHHHHHHHHccCCh
Confidence            568899999999999999999 99999987766666555443221             1124688999999999999999


Q ss_pred             CCccCHHHHhcC
Q 039159          238 DKRITAAEALQQ  249 (259)
Q Consensus       238 ~~Rp~~~~~l~h  249 (259)
                      .+||++++++++
T Consensus       294 ~~Rps~~~l~~~  305 (314)
T 2ivs_A          294 DKRPVFADISKD  305 (314)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCcCHHHHHHH
Confidence            999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-42  Score=284.86  Aligned_cols=223  Identities=19%  Similarity=0.249  Sum_probs=177.1

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCccc---------ccCCCcchhH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST---------KNFNSYSLFT   80 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~---------~~~~~~~~~~   80 (259)
                      ..+++.+|++++++++||||+++++++.+++..++||||+.+ +|.+++............         ........+.
T Consensus        93 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  172 (343)
T 1luf_A           93 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS  172 (343)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCC
Confidence            356789999999999999999999999999999999999996 999999763221100000         0000113466


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  158 (259)
                      ...++.++.|++.||+|||+++|+||||||+||+++.++ .+||+|||++.......  .......+|+.|+|||.+.+ 
T Consensus       173 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-  250 (343)
T 1luf_A          173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-  250 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhcc-
Confidence            788899999999999999999999999999999999888 89999999997653322  22334567899999999976 


Q ss_pred             cCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      ..++.++||||||+++|+|++ |..||.+.........+...... .            ....+++.+.+++.+||..||
T Consensus       251 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~l~~li~~~l~~~p  317 (343)
T 1luf_A          251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL-A------------CPENCPLELYNLMRLCWSKLP  317 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-C------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred             CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC-C------------CCCCCCHHHHHHHHHHcccCc
Confidence            568899999999999999999 99999988877777666544321 1            124678999999999999999


Q ss_pred             CCccCHHHHhc
Q 039159          238 DKRITAAEALQ  248 (259)
Q Consensus       238 ~~Rp~~~~~l~  248 (259)
                      .+||++.++++
T Consensus       318 ~~Rps~~~~~~  328 (343)
T 1luf_A          318 ADRPSFCSIHR  328 (343)
T ss_dssp             GGSCCHHHHHH
T ss_pred             ccCCCHHHHHH
Confidence            99999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=285.19  Aligned_cols=223  Identities=22%  Similarity=0.300  Sum_probs=180.7

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc-cccCCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS-TKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~   88 (259)
                      .+++.+|+++++++ +||||+++++++.+++..++||||+.| +|.+++........... .........++...++.++
T Consensus       118 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  197 (382)
T 3tt0_A          118 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA  197 (382)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHH
Confidence            36788999999999 899999999999999999999999986 99999976432111000 0011112457788899999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .+++.||+|||+.+|+||||||+||+++.++ .+||+|||++.......  .......+|+.|+|||.+.+ ..++.++|
T Consensus       198 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D  275 (382)
T 3tt0_A          198 YQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSD  275 (382)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHH
T ss_pred             HHHHHHHHHHHhCCEecCCCCcceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhH
Confidence            9999999999999999999999999999888 89999999998654322  12334457889999999987 67899999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||||++|+|++ |..||.+.........+........             ...+++++.+++.+||..||++||++++
T Consensus       276 iwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~e  342 (382)
T 3tt0_A          276 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK-------------PSNCTNELYMMMRDCWHAVPSQRPTFKQ  342 (382)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-------------CSSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            9999999999999 9999998887777766654432211             2467899999999999999999999999


Q ss_pred             HhcC
Q 039159          246 ALQQ  249 (259)
Q Consensus       246 ~l~h  249 (259)
                      ++++
T Consensus       343 ll~~  346 (382)
T 3tt0_A          343 LVED  346 (382)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9974

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-42  Score=285.10  Aligned_cols=232  Identities=16%  Similarity=0.138  Sum_probs=174.4

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHH
Q 039159            3 GIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTT   81 (259)
Q Consensus         3 ~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (259)
                      ++........+++.+|++++++++||||+++++++.+++..++||||+.| +|.+.+......           ...+..
T Consensus        70 ~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~  138 (321)
T 2qkw_B           70 RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP-----------TMSMSW  138 (321)
T ss_dssp             ECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCC-----------SCCCCH
T ss_pred             EecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCC-----------ccccCH
Confidence            34444445567899999999999999999999999999999999999986 898888542211           134667


Q ss_pred             HHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCcc
Q 039159           82 FLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        82 ~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      ..++.++.+++.||+|||++|++||||||+||+++.++ .+||+|||++........  ......||+.|+|||.+.+ .
T Consensus       139 ~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~  216 (321)
T 2qkw_B          139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-G  216 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH-C
T ss_pred             HHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeecccccccccccccccccccCCCccccCHHHhcC-C
Confidence            78889999999999999999999999999999999888 899999999976432221  2234468999999999977 5


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCChHHH------HHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhc
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT------LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKML  233 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  233 (259)
                      .++.++|||||||++|+|++|+.||.+......      .................   ......+..++.+.+++.+||
T Consensus       217 ~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l  293 (321)
T 2qkw_B          217 RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN---LADKIRPESLRKFGDTAVKCL  293 (321)
T ss_dssp             BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS---CTTCSCHHHHHHHHHHHHHHT
T ss_pred             CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh---hccccCHHHHHHHHHHHHHHc
Confidence            688999999999999999999999976432111      00111111111111000   011111234568889999999


Q ss_pred             CcCCCCccCHHHHhcCc
Q 039159          234 GMDPDKRITAAEALQQE  250 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h~  250 (259)
                      ..||++|||+++++++.
T Consensus       294 ~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          294 ALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CSSGGGSCCHHHHHHHH
T ss_pred             CCCcccCcCHHHHHHHH
Confidence            99999999999999763

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-41  Score=274.89  Aligned_cols=210  Identities=23%  Similarity=0.342  Sum_probs=163.6

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|+.++++++||||+++++++. ++..++||||+.+ +|.+++....              ..++...+..++
T Consensus        58 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~  122 (281)
T 1mp8_A           58 SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK--------------YSLDLASLILYA  122 (281)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT--------------TTSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcC--------------CCCCHHHHHHHH
Confidence            34567889999999999999999999984 5678899999996 9999986421              235567788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.||+|||++|++||||||+||+++.++ .+||+|||++........ ......+++.|+|||.+.+ ..++.++||
T Consensus       123 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  200 (281)
T 1mp8_A          123 YQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDV  200 (281)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC-------------------CCGGGCCHHHHHH-CCCSHHHHH
T ss_pred             HHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccccccCcccccccccCCCcccccChhhccc-CCCCCccCc
Confidence            9999999999999999999999999999888 999999999976543221 1233356788999999976 568899999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|++++ |..||.+.........+......+             ..+.+++.+.+++.+||..||++||++.++
T Consensus       201 ~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  267 (281)
T 1mp8_A          201 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL  267 (281)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            999999999997 999999877666666665443221             124688999999999999999999999999


Q ss_pred             hcC
Q 039159          247 LQQ  249 (259)
Q Consensus       247 l~h  249 (259)
                      +++
T Consensus       268 ~~~  270 (281)
T 1mp8_A          268 KAQ  270 (281)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1e-41  Score=280.82  Aligned_cols=211  Identities=20%  Similarity=0.227  Sum_probs=170.8

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ....+++.+|+.++++++||||+++++++.++. .++|+||+.+ +|.+.+....              ..+....++.+
T Consensus        58 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~  122 (327)
T 3poz_A           58 PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK--------------DNIGSQYLLNW  122 (327)
T ss_dssp             --CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHST--------------TSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcC--------------CCCCHHHHHHH
Confidence            345578999999999999999999999998765 6788899885 9999886532              23556678889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.+++.||+|||+++|+||||||+||+++.++ .+||+|||+++........  .....+|+.|+|||.+.+ ..++.++
T Consensus       123 ~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~  200 (327)
T 3poz_A          123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQS  200 (327)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHH
T ss_pred             HHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCcceeEccCCcccccccCCCccccccChHHhcc-CCCCchh
Confidence            99999999999999999999999999999888 8999999999865433222  223356889999999987 5789999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|++++ |+.||.+.........+......+.             ....+.++.+++.+||..||.+||++.
T Consensus       201 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~  267 (327)
T 3poz_A          201 DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-------------PPICTIDVYMIMVKCWMIDADSRPKFR  267 (327)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-------------CTTBCHHHHHHHHHHTCSCGGGSCCHH
T ss_pred             hhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCCChhhCCCHH
Confidence            99999999999999 9999988776655555544332211             245788999999999999999999999


Q ss_pred             HHhcC
Q 039159          245 EALQQ  249 (259)
Q Consensus       245 ~~l~h  249 (259)
                      +++++
T Consensus       268 ell~~  272 (327)
T 3poz_A          268 ELIIE  272 (327)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.3e-42  Score=283.49  Aligned_cols=228  Identities=22%  Similarity=0.182  Sum_probs=170.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ....++.+|++++++++||||+++++++..++..++||||+.| +|.+++.......           ..+....+..++
T Consensus        69 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~i~  137 (326)
T 3uim_A           69 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----------PPLDWPKRQRIA  137 (326)
T ss_dssp             -CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTC-----------CCCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccC-----------CCCCHHHHHHHH
Confidence            3445799999999999999999999999999999999999986 9999997533211           346677888999


Q ss_pred             hhcccccccccCC---CceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcc
Q 039159           89 SSSDSSRSLSFGT---RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        89 ~~~~~~l~~lh~~---~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      .+++.||+|||+.   +|+||||||+||+++.++ .+||+|||++........ ......||+.|+|||.+.+ ..++.+
T Consensus       138 ~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  215 (326)
T 3uim_A          138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEK  215 (326)
T ss_dssp             HHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHH
T ss_pred             HHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCccccccCcccccccccccCCcCccCHHHhcc-CCCCcc
Confidence            9999999999999   999999999999999888 899999999986543322 2334469999999999976 568899


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCC
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGA-----NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK  239 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  239 (259)
                      +|||||||++|+|++|..||...     ........+.........................++.+.+++.+||..||.+
T Consensus       216 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  295 (326)
T 3uim_A          216 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPME  295 (326)
T ss_dssp             HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGG
T ss_pred             ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCcc
Confidence            99999999999999999999521     1111111111111000000000000001111223468889999999999999


Q ss_pred             ccCHHHHhcCc
Q 039159          240 RITAAEALQQE  250 (259)
Q Consensus       240 Rp~~~~~l~h~  250 (259)
                      |||+.++++|-
T Consensus       296 Rps~~ell~~L  306 (326)
T 3uim_A          296 RPKMSEVVRML  306 (326)
T ss_dssp             SCCHHHHHHHH
T ss_pred             CCCHHHHHHHh
Confidence            99999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.2e-42  Score=295.81  Aligned_cols=211  Identities=22%  Similarity=0.301  Sum_probs=174.9

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...++|.+|++++++++||||+++++++.+++.+++||||+.+ +|.++++....             ..+....++.++
T Consensus       258 ~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~~~~~~~~i~  324 (495)
T 1opk_A          258 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------------QEVSAVVLLYMA  324 (495)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT-------------TTSCHHHHHHHH
T ss_pred             cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCc-------------CCCCHHHHHHHH
Confidence            3467899999999999999999999999999999999999995 99999965321             235567788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .|++.||+|||+++|+||||||+||+++.++ .+||+|||+++....... ......+++.|+|||.+.+ ..++.++||
T Consensus       325 ~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv  402 (495)
T 1opk_A          325 TQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDV  402 (495)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHH
T ss_pred             HHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhH
Confidence            9999999999999999999999999999888 899999999986533211 1223346778999999976 568899999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++|||++ |..||.+.........+......+             ....+++.+.+||.+||..||.+|||+.++
T Consensus       403 wSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~RPs~~el  469 (495)
T 1opk_A          403 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-------------RPEGCPEKVYELMRACWQWNPSDRPSFAEI  469 (495)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence            999999999999 999999877666655554332211             124688999999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       470 ~~  471 (495)
T 1opk_A          470 HQ  471 (495)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-41  Score=279.49  Aligned_cols=211  Identities=18%  Similarity=0.162  Sum_probs=170.8

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .....++.+|+.++++++||||+++++++. ++..++||||+.+ +|.+.+....              ..+....+..+
T Consensus        56 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~  120 (325)
T 3kex_A           56 RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR--------------GALGPQLLLNW  120 (325)
T ss_dssp             CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSG--------------GGSCTTHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHcc--------------ccCCHHHHHHH
Confidence            345577889999999999999999999986 4578899999995 9999886431              33555678889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.|++.||+|||+.||+||||||+||+++.++ .+||+|||+++.......  ......|++.|+|||.+.+ ..++.++
T Consensus       121 ~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~  198 (325)
T 3kex_A          121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQS  198 (325)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCcccccCcccccccccCCCCcccccChHHhcc-CCCChhh
Confidence            99999999999999999999999999999888 899999999987543322  2234467889999999986 5688999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|++++ |..||.+.........+......+.             ....++++.+++.+||..||.+||++.
T Consensus       199 Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~dp~~Rps~~  265 (325)
T 3kex_A          199 DVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ-------------PQICTIDVYMVMVKCWMIDENIRPTFK  265 (325)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC-------------CTTBCTTTTHHHHHHTCSCTTTSCCHH
T ss_pred             HhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC-------------CCcCcHHHHHHHHHHcCCChhhCcCHH
Confidence            99999999999999 9999998776666655544322111             134677889999999999999999999


Q ss_pred             HHhcC
Q 039159          245 EALQQ  249 (259)
Q Consensus       245 ~~l~h  249 (259)
                      +++++
T Consensus       266 el~~~  270 (325)
T 3kex_A          266 ELANE  270 (325)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.7e-42  Score=278.81  Aligned_cols=229  Identities=22%  Similarity=0.260  Sum_probs=168.2

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcch
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      |++...++...+++.+|++++++++||||+++++++...  ..+++||||+.+ +|.+++....              ..
T Consensus        45 K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~  110 (295)
T 3ugc_A           45 KKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--------------ER  110 (295)
T ss_dssp             EEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCG--------------GG
T ss_pred             EEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcc--------------cc
Confidence            334444444456889999999999999999999998654  468999999986 9999986431              23


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccc
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELL  155 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~  155 (259)
                      ++...+..++.+++.||+|||+.+|+||||||+||+++.++ .+||+|||++........   ......+++.|+|||.+
T Consensus       111 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  189 (295)
T 3ugc_A          111 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL  189 (295)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCSCC-------------CTTCGGGGCCHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCcccccccCCcceeeeccCCCCccceeCcHHh
Confidence            56677889999999999999999999999999999999888 999999999986543221   12334577789999999


Q ss_pred             cCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc-----ccccccccCCCCCCCHHHHHHHH
Q 039159          156 LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK-----LSLRDHLTNGFPGLEPAGIDLIS  230 (259)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~  230 (259)
                      .+ ..++.++||||||+++|++++|..||......  ...............     ........+....+++++.+++.
T Consensus       190 ~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  266 (295)
T 3ugc_A          190 TE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMT  266 (295)
T ss_dssp             HH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHH
Confidence            87 56899999999999999999999988653221  111111111000000     00000111223468899999999


Q ss_pred             hhcCcCCCCccCHHHHhc
Q 039159          231 KMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       231 ~~l~~dp~~Rp~~~~~l~  248 (259)
                      +||..||++|||+.++++
T Consensus       267 ~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          267 ECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHSCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhhCCCHHHHHH
Confidence            999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.4e-41  Score=278.24  Aligned_cols=217  Identities=26%  Similarity=0.360  Sum_probs=169.2

Q ss_pred             CCchhHHHHHHHhhCC--CCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELN--HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+++.+|++++++++  ||||+++++++..++..++|||+..++|.+++...               ..+....+..++
T Consensus        69 ~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------------~~~~~~~~~~i~  133 (313)
T 3cek_A           69 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK---------------KSIDPWERKSYW  133 (313)
T ss_dssp             HHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHC---------------SSCCHHHHHHHH
T ss_pred             chHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEecCCCcHHHHHHhc---------------CCCCHHHHHHHH
Confidence            4467899999999997  59999999999999999999997667999998642               234556778889


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCc--------
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGL--------  158 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~--------  158 (259)
                      .+++.||+|||+.+++||||||+||+++ ++ .+||+|||.+........  ......|++.|+|||.+.+.        
T Consensus       134 ~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  211 (313)
T 3cek_A          134 KNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK  211 (313)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCC--------------CCGGGCCHHHHTTCC-------
T ss_pred             HHHHHHHHHHHHCCceecCCCcccEEEE-CC-eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccccccccc
Confidence            9999999999999999999999999997 45 899999999976543222  12345689999999998651        


Q ss_pred             --cCCCcccchHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          159 --LEYSTAVDIWPVGCIFGEMVSGKPLFPGANS-LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       159 --~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                        ..++.++||||||+++|+|++|..||..... ......+.........            ....++++.+++.+||..
T Consensus       212 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~  279 (313)
T 3cek_A          212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF------------PDIPEKDLQDVLKCCLKR  279 (313)
T ss_dssp             ---CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC------------CCCSCHHHHHHHHHHTCS
T ss_pred             ccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC------------cccchHHHHHHHHHHccC
Confidence              3577899999999999999999999987533 3333334332222111            134578999999999999


Q ss_pred             CCCCccCHHHHhcCccccCCC
Q 039159          236 DPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       236 dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ||.+||+++++++||||+...
T Consensus       280 dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          280 DPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             STTTSCCHHHHHTSHHHHCC-
T ss_pred             CcccCcCHHHHhcCccccCCC
Confidence            999999999999999998653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-41  Score=275.13  Aligned_cols=214  Identities=22%  Similarity=0.268  Sum_probs=162.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|++++++++||||++++++. .....++||||+.| +|.+.+....              ..++...+..++.
T Consensus        63 ~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~  127 (289)
T 3og7_A           63 QLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE--------------TKFEMKKLIDIAR  127 (289)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC-----------------CCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhcc--------------CCCCHHHHHHHHH
Confidence            346789999999999999999999965 55678999999996 8988885321              3456677889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccC--ccCCCccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLG--LLEYSTAV  165 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~--~~~~~~~~  165 (259)
                      +++.||+|||+.+++||||||+||+++.++ .++|+|||++.......  .......||+.|+|||.+..  ...++.++
T Consensus       128 qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  206 (289)
T 3og7_A          128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS  206 (289)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC------------------CCCTTCCHHHHC----CCSCHHH
T ss_pred             HHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCccc
Confidence            999999999999999999999999999988 99999999997543221  12334568999999999862  24578899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||||+++|+|++|+.||.+..................        ........+++.+.+++.+||..||.+||++++
T Consensus       207 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e  278 (289)
T 3og7_A          207 DVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP--------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPR  278 (289)
T ss_dssp             HHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC--------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             chHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc--------chhhccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence            999999999999999999988665555544432221111        112223568899999999999999999999999


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +++
T Consensus       279 ll~  281 (289)
T 3og7_A          279 ILA  281 (289)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.7e-42  Score=285.20  Aligned_cols=224  Identities=20%  Similarity=0.292  Sum_probs=173.3

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCc-eEEEEeeeecC-CHHHHhhcCCCCCCCccc------------------
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGI-YLYPVFEYQVN-DLAYLLKYPKDSMNGYST------------------   70 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~-~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~------------------   70 (259)
                      .+++.+|+++++++ +||||+++++++.+.+ .+++||||+.| +|.+++............                  
T Consensus        69 ~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (359)
T 3vhe_A           69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD  148 (359)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------
T ss_pred             HHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchh
Confidence            35689999999999 7999999999998754 58999999996 999999765431100000                  


Q ss_pred             ---------------------------------ccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcC
Q 039159           71 ---------------------------------KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDL  117 (259)
Q Consensus        71 ---------------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~  117 (259)
                                                       ........++...+..++.|++.||+|||+.+|+||||||+||+++.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~  228 (359)
T 3vhe_A          149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  228 (359)
T ss_dssp             -----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             hhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC
Confidence                                             00000122677888999999999999999999999999999999998


Q ss_pred             CCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 039159          118 DGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLG  194 (259)
Q Consensus       118 ~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~  194 (259)
                      ++ .+||+|||++........  ......||+.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+........
T Consensus       229 ~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  306 (359)
T 3vhe_A          229 KN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  306 (359)
T ss_dssp             GG-CEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred             CC-cEEEEeccceeeecccccchhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH
Confidence            88 899999999976533222  2334568899999999987 578899999999999999998 999998766444443


Q ss_pred             HHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          195 RIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       195 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      ........+..            ...+++++.+++.+||..||.+|||+.++++|
T Consensus       307 ~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          307 RRLKEGTRMRA------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCC------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            33222211111            23578999999999999999999999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-41  Score=272.16  Aligned_cols=210  Identities=21%  Similarity=0.269  Sum_probs=175.5

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++.+++..++||||+.| +|.+++....              ..++...+..++.
T Consensus        46 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~  111 (267)
T 3t9t_A           46 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR--------------GLFAAETLLGMCL  111 (267)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT--------------TCCCHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc--------------ccCCHHHHHHHHH
Confidence            347899999999999999999999999999999999999986 9999886432              2345677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-CCCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.||+|||+++++||||||+||+++.++ .++|+|||.+....... .......+++.|+|||.+.+ ..++.++|||
T Consensus       112 ~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  189 (267)
T 3t9t_A          112 DVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVW  189 (267)
T ss_dssp             HHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEcccccccccccccccccccccccccccChhhhcC-CCccchhchh
Confidence            999999999999999999999999999888 89999999997653221 12233457788999999976 5678999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|+|++ |..||...........+.......             .....++.+.+++.+||..||.+||++.+++
T Consensus       190 slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll  256 (267)
T 3t9t_A          190 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLL  256 (267)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC-------------CCccCcHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999 899999888777776665543211             1135789999999999999999999999998


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      ++
T Consensus       257 ~~  258 (267)
T 3t9t_A          257 RQ  258 (267)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.6e-42  Score=292.95  Aligned_cols=210  Identities=20%  Similarity=0.284  Sum_probs=174.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...++|.+|++++++++||||+++++++. ++..++||||+.+ +|.++++....             ...+...++.++
T Consensus       225 ~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~  290 (454)
T 1qcf_A          225 MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEG-------------SKQPLPKLIDFS  290 (454)
T ss_dssp             BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHH-------------HTCCHHHHHHHH
T ss_pred             ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccC-------------CCCCHHHHHHHH
Confidence            34678999999999999999999999986 5678999999985 99999964211             234556788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-CCCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .|++.||+|||+++|+||||||+||+++.++ .+||+|||+++...... .......+++.|+|||.+.+ ..++.++||
T Consensus       291 ~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  368 (454)
T 1qcf_A          291 AQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDV  368 (454)
T ss_dssp             HHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHH
T ss_pred             HHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHH
Confidence            9999999999999999999999999999888 89999999998653221 11223346788999999976 568999999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++|||++ |+.||.+....+....+......+.             ...+++++.++|.+||..||++|||++++
T Consensus       369 wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i  435 (454)
T 1qcf_A          369 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------------PENCPEELYNIMMRCWKNRPEERPTFEYI  435 (454)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            999999999999 9999999888777766654433221             24678999999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       436 ~~  437 (454)
T 1qcf_A          436 QS  437 (454)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.2e-42  Score=280.82  Aligned_cols=213  Identities=22%  Similarity=0.253  Sum_probs=162.9

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCc----eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGI----YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ...+.+|+.++++++||||+++++++..+.    .+++||||+.+ +|.++++.                ..++...+..
T Consensus        62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----------------~~~~~~~~~~  125 (322)
T 3soc_A           62 SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----------------NVVSWNELCH  125 (322)
T ss_dssp             HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH----------------CCBCHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh----------------cCCCHHHHHH
Confidence            445677999999999999999999998743    47999999986 99999964                2356677889


Q ss_pred             HHhhcccccccccCC----------CceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCccc
Q 039159           87 EFSSSDSSRSLSFGT----------RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPEL  154 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~----------~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~  154 (259)
                      ++.|++.||+|||+.          +|+||||||+||+++.++ .+||+|||+++.......  ......||+.|+|||.
T Consensus       126 i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  204 (322)
T 3soc_A          126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV  204 (322)
T ss_dssp             HHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEEccCCcccccccccCccccccCccCccccCHhh
Confidence            999999999999999          999999999999999888 899999999976544322  2334579999999999


Q ss_pred             ccCc----cCCCcccchHhHHHHHHHHHhCCCCCCCCCh----------------HHHHHHHhCCCCCCccccccccccc
Q 039159          155 LLGL----LEYSTAVDIWPVGCIFGEMVSGKPLFPGANS----------------LITLGRIVGKSRKPSFCKLSLRDHL  214 (259)
Q Consensus       155 ~~~~----~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~  214 (259)
                      +.+.    ..++.++|||||||++|+|++|+.||.+...                ......+......+.....     .
T Consensus       205 ~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~  279 (322)
T 3soc_A          205 LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDY-----W  279 (322)
T ss_dssp             HTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGG-----G
T ss_pred             cccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCcccc-----c
Confidence            9762    2455688999999999999999999975321                1111122222222111110     0


Q ss_pred             cCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          215 TNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       215 ~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      .  ....++++.++|.+||+.||++|||++++++
T Consensus       280 ~--~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          280 Q--KHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             G--SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c--ccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            0  0112456899999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.3e-41  Score=277.00  Aligned_cols=208  Identities=21%  Similarity=0.232  Sum_probs=172.2

Q ss_pred             CCchhHHHHHHHhhCC--CCCeeEEEEEEEeCceEEEEeeeec--CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           11 VPSSMIREVSCLMELN--HPNIIRLMRVASQGIYLYPVFEYQV--NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ..+++.+|+.++++++  ||||+++++++..++..++|||++.  ++|.+++...               ..+....+..
T Consensus        89 ~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~---------------~~l~~~~~~~  153 (320)
T 3a99_A           89 NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---------------GALQEELARS  153 (320)
T ss_dssp             TCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH---------------CSCCHHHHHH
T ss_pred             hhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc---------------CCCCHHHHHH
Confidence            4467889999999996  5999999999999999999999987  5899888642               2345677888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEc-CCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVD-LDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~-~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      ++.|++.||+|||+.+|+||||||+||+++ .++ .+||+|||++.....  .......||+.|+|||.+.+....+.++
T Consensus       154 i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~~kL~Dfg~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~  230 (320)
T 3a99_A          154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSA  230 (320)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHH
T ss_pred             HHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC-CEEEeeCcccccccc--ccccCCCCCccCCChHHhccCCCCCccc
Confidence            999999999999999999999999999999 455 899999999976542  2233457899999999997644457889


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||||+++|+|++|+.||.....      +.....              .....+++++.++|.+||..||++||++++
T Consensus       231 Di~slG~il~el~~g~~pf~~~~~------~~~~~~--------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  290 (320)
T 3a99_A          231 AVWSLGILLYDMVCGDIPFEHDEE------IIRGQV--------------FFRQRVSSECQHLIRWCLALRPSDRPTFEE  290 (320)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCSHHH------HHHCCC--------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hHHhHHHHHHHHHHCCCCCCChhh------hhcccc--------------cccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            999999999999999999975421      111110              011468899999999999999999999999


Q ss_pred             HhcCccccCCC
Q 039159          246 ALQQEYFKDVP  256 (259)
Q Consensus       246 ~l~h~~f~~~~  256 (259)
                      +++||||++..
T Consensus       291 ll~hp~~~~~~  301 (320)
T 3a99_A          291 IQNHPWMQDVL  301 (320)
T ss_dssp             HHTSGGGSSCC
T ss_pred             HhcCHhhcCcc
Confidence            99999999764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.2e-42  Score=287.78  Aligned_cols=227  Identities=22%  Similarity=0.306  Sum_probs=168.0

Q ss_pred             CchhHHHHHHHhhCC-----------CCCeeEEEEEEEeCc----eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCc
Q 039159           12 PSSMIREVSCLMELN-----------HPNIIRLMRVASQGI----YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY   76 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-----------H~niv~~~~~~~~~~----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~   76 (259)
                      .+.+.+|+.++++++           ||||+++++++...+    .+++|||++.++|.+++.....             
T Consensus        59 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~-------------  125 (373)
T 1q8y_A           59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH-------------  125 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTT-------------
T ss_pred             hhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhc-------------
Confidence            466889999999987           899999999998654    7899999997799999865321             


Q ss_pred             chhHHHHHHHHHhhcccccccccCC-CceeccCCCCcEEEcC------CCCeEEEeeccccccccccCCCCcCCccCccc
Q 039159           77 SLFTTFLLVEEFSSSDSSRSLSFGT-RYIRRDLKPVNILVDL------DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYY  149 (259)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~l~~lh~~-~i~H~dlkp~Nili~~------~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~  149 (259)
                      ..++...+..++.|++.||+|||++ ||+||||||+||+++.      .+ .+||+|||++.....   ......||+.|
T Consensus       126 ~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~-~~kl~Dfg~a~~~~~---~~~~~~~t~~y  201 (373)
T 1q8y_A          126 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI-QIKIADLGNACWYDE---HYTNSIQTREY  201 (373)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE-EEEECCCTTCEETTB---CCCSCCSCGGG
T ss_pred             cCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc-eEEEcccccccccCC---CCCCCCCCccc
Confidence            2355677888999999999999998 9999999999999953      33 799999999976532   23345789999


Q ss_pred             cCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCCh------HHHHHHHhCC-CCCCccc------------cc--
Q 039159          150 KAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANS------LITLGRIVGK-SRKPSFC------------KL--  208 (259)
Q Consensus       150 ~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~------~~~~~~i~~~-~~~~~~~------------~~--  208 (259)
                      +|||.+.+ ..++.++|||||||++|+|++|..||.+...      ......+... ...|...            ..  
T Consensus       202 ~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  280 (373)
T 1q8y_A          202 RSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL  280 (373)
T ss_dssp             CCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--C
T ss_pred             cCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcch
Confidence            99999987 5689999999999999999999999986541      1222222110 0000000            00  


Q ss_pred             ----------ccc---ccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          209 ----------SLR---DHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       209 ----------~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                                ...   ..........++++.+||.+||+.||++|||++++|+||||++..
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          281 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             BSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             hcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence                      000   000001123457888999999999999999999999999999764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-41  Score=271.25  Aligned_cols=210  Identities=23%  Similarity=0.240  Sum_probs=174.6

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++ ..+..++||||+.+ +|.+++....              ..++...+..++.
T Consensus        53 ~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~  117 (287)
T 1u59_A           53 DTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--------------EEIPVSNVAELLH  117 (287)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCT--------------TTSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCC--------------ccCCHHHHHHHHH
Confidence            456788999999999999999999999 55678999999996 8999885321              3356678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +++.||+|||+.+++||||||+||+++.++ .++|+|||.+........   ......+|+.|+|||.+.+ ..++.++|
T Consensus       118 qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  195 (287)
T 1u59_A          118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSD  195 (287)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHH
T ss_pred             HHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccceeeeccCcceeeccccccccccccCHHHhcc-CCCCchhh
Confidence            999999999999999999999999999888 999999999976533221   1233456889999999976 56888999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||+++|+|++ |..||.+.........+......             ...+.+++.+.+++.+||..||.+||++.+
T Consensus       196 i~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  262 (287)
T 1u59_A          196 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------------ECPPECPPELYALMSDCWIYKWEDRPDFLT  262 (287)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC-------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHH
Confidence            9999999999998 99999988777766666543321             112468899999999999999999999999


Q ss_pred             HhcCc
Q 039159          246 ALQQE  250 (259)
Q Consensus       246 ~l~h~  250 (259)
                      ++++.
T Consensus       263 l~~~l  267 (287)
T 1u59_A          263 VEQRM  267 (287)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99763

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.4e-41  Score=276.43  Aligned_cols=225  Identities=23%  Similarity=0.273  Sum_probs=174.5

Q ss_pred             CCCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCccc-ccCCCcchhHHHHHH
Q 039159            9 EGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST-KNFNSYSLFTTFLLV   85 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   85 (259)
                      ....+++.+|+++++++ +||||+++++++.+++..++||||+++ +|.+++............ -.......++...++
T Consensus        66 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (327)
T 1fvr_A           66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  145 (327)
T ss_dssp             ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHH
Confidence            44567899999999999 899999999999999999999999986 999999653200000000 000001346678889


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.+++.||+|||++||+||||||+||+++.++ .+||+|||++...... .......+++.|+|||.+.+ ..++.++
T Consensus       146 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~  222 (327)
T 1fvr_A          146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNS  222 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHHH
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC-eEEEcccCcCcccccc-ccccCCCCCccccChhhhcc-ccCCchh
Confidence            9999999999999999999999999999999888 8999999998743221 22233456889999999976 5678999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|+|++ |..||.+.........+.......             ....+++.+.+++.+||..||.+||+++
T Consensus       223 Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~  289 (327)
T 1fvr_A          223 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE-------------KPLNCDDEVYDLMRQCWREKPYERPSFA  289 (327)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCC-------------CCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCC-------------CCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence            99999999999998 999999888777666654432211             1235789999999999999999999999


Q ss_pred             HHhcC
Q 039159          245 EALQQ  249 (259)
Q Consensus       245 ~~l~h  249 (259)
                      +++++
T Consensus       290 ell~~  294 (327)
T 1fvr_A          290 QILVS  294 (327)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99974

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-41  Score=274.51  Aligned_cols=213  Identities=22%  Similarity=0.298  Sum_probs=175.9

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +....+++.+|++++++++||||+++++++.+++..++||||+.| +|.+++.....             ..++...+..
T Consensus        49 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~  115 (288)
T 3kfa_A           49 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------------QEVSAVVLLY  115 (288)
T ss_dssp             CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCT-------------TTSCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhccc-------------CCccHhHHHH
Confidence            334457799999999999999999999999999999999999995 99999864321             3356677889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      ++.+++.||+|||+.+++||||||+||+++.++ .++|+|||.+........ ......+++.|+|||.+.+ ..++.++
T Consensus       116 i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~  193 (288)
T 3kfa_A          116 MATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKS  193 (288)
T ss_dssp             HHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHH
T ss_pred             HHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccceeccCCccccccCCccccCcCChhhhcc-CCCCchh
Confidence            999999999999999999999999999999888 899999999976543221 1223356788999999977 5688999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      ||||||+++|+|++ |..||.+.........+......+             ....+++.+.+++.+||..||.+||+++
T Consensus       194 Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~  260 (288)
T 3kfa_A          194 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-------------RPEGCPEKVYELMRACWQWNPSDRPSFA  260 (288)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC-------------CCCCCCHHHHHHHHHHhCCChhhCcCHH
Confidence            99999999999999 999998877666555554332211             1246789999999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++++
T Consensus       261 ~~~~  264 (288)
T 3kfa_A          261 EIHQ  264 (288)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9985

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.1e-41  Score=270.15  Aligned_cols=205  Identities=21%  Similarity=0.232  Sum_probs=164.7

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      +++.+|++++++++||||+++++++.+..  ++||||+.+ +|.+.+....              ..+....+..++.++
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~l  131 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA--------------HPIKWSVKLRLMLDI  131 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTT--------------SCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhccc--------------CCccHHHHHHHHHHH
Confidence            67899999999999999999999997655  689999995 9988885422              345667788999999


Q ss_pred             ccccccccCCC--ceeccCCCCcEEEcCCCC----eEEEeeccccccccccCCCCcCCccCccccCcccccC-ccCCCcc
Q 039159           92 DSSRSLSFGTR--YIRRDLKPVNILVDLDGK----TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG-LLEYSTA  164 (259)
Q Consensus        92 ~~~l~~lh~~~--i~H~dlkp~Nili~~~~~----~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~  164 (259)
                      +.|++|||+++  ++||||||+||+++.++.    .+||+|||+++...   .......||+.|+|||.+.+ ...++.+
T Consensus       132 ~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~  208 (287)
T 4f0f_A          132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEK  208 (287)
T ss_dssp             HHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS---SCEECCCCCCTTSCGGGSSCSSCEECHH
T ss_pred             HHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccc---ccccccCCCccccCchhhccCCCCcCch
Confidence            99999999999  999999999999987661    29999999997432   23445678999999999843 2456889


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHH--HHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLIT--LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      +|||||||++|+|++|+.||........  ...+......+.            ....+++.+.+++.+||..||.+||+
T Consensus       209 ~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps  276 (287)
T 4f0f_A          209 ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT------------IPEDCPPRLRNVIELCWSGDPKKRPH  276 (287)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC------------CCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC------------CCcccCHHHHHHHHHHhcCChhhCcC
Confidence            9999999999999999999986543322  333322222221            12467899999999999999999999


Q ss_pred             HHHHhc
Q 039159          243 AAEALQ  248 (259)
Q Consensus       243 ~~~~l~  248 (259)
                      ++++++
T Consensus       277 ~~~ll~  282 (287)
T 4f0f_A          277 FSYIVK  282 (287)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999985

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8e-41  Score=271.75  Aligned_cols=214  Identities=18%  Similarity=0.136  Sum_probs=172.1

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+++++++ +|+|++++++++.++...++||||+.++|.+++....              ..++...+..++.
T Consensus        48 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~  113 (298)
T 1csn_A           48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG--------------RKFSVKTVAMAAK  113 (298)
T ss_dssp             TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT--------------TCCCHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecCCCHHHHHHHhc--------------cCCCHHHHHHHHH
Confidence            456799999999999 7999999999999999999999999669999996431              2356678899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCC----eEEEeeccccccccccCC-------CCcCCccCccccCcccccCc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGK----TVKVAGFGLAKSLYAYKG-------ESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~----~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~  158 (259)
                      |++.||+|||+++|+||||||+||+++.++.    .++|+|||.+........       ......||+.|+|||.+.+ 
T Consensus       114 qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  192 (298)
T 1csn_A          114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-  192 (298)
T ss_dssp             HHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-
T ss_pred             HHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC-
Confidence            9999999999999999999999999986651    399999999986544322       1344579999999999987 


Q ss_pred             cCCCcccchHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGAN---SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~tg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      ..++.++||||||+++|+|++|+.||.+..   .......+......+         ......+.+++++.+++.+||..
T Consensus       193 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~  263 (298)
T 1csn_A          193 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---------PLRELCAGFPEEFYKYMHYARNL  263 (298)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS---------CHHHHTTTSCHHHHHHHHHHHHC
T ss_pred             CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc---------cHHHHHhhCcHHHHHHHHHHhcC
Confidence            568999999999999999999999998742   333333332111101         11112346889999999999999


Q ss_pred             CCCCccCHHHHhc
Q 039159          236 DPDKRITAAEALQ  248 (259)
Q Consensus       236 dp~~Rp~~~~~l~  248 (259)
                      ||++||+++++++
T Consensus       264 dp~~RP~~~~l~~  276 (298)
T 1csn_A          264 AFDATPDYDYLQG  276 (298)
T ss_dssp             CTTCCCCHHHHHH
T ss_pred             CcccCCCHHHHHH
Confidence            9999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.3e-41  Score=276.78  Aligned_cols=224  Identities=22%  Similarity=0.256  Sum_probs=175.1

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccc---cCCCcchhHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTK---NFNSYSLFTTFLLVE   86 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~   86 (259)
                      .+.+.+|+++++++ +||||+++++++.+++..++||||+.+ +|.+++.............   .......++...+..
T Consensus        70 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (313)
T 1t46_A           70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS  149 (313)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHH
Confidence            46789999999999 899999999999999999999999986 9999997643221100000   000112467788899


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ++.+++.||+|||+++++||||||+||+++.++ .+||+|||.+.........  .....+++.|+|||.+.+ ..++.+
T Consensus       150 ~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  227 (313)
T 1t46_A          150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFE  227 (313)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHHCCeecCCCccceEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChH
Confidence            999999999999999999999999999999888 9999999999765433221  234457889999999977 578899


Q ss_pred             cchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +||||||+++|+|++ |..||.+................+.            ....+++.+.+++.+||..||.+|||+
T Consensus       228 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~  295 (313)
T 1t46_A          228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML------------SPEHAPAEMYDIMKTCWDADPLKRPTF  295 (313)
T ss_dssp             HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC------------CcccCCHHHHHHHHHHcCCCchhCcCH
Confidence            999999999999999 9999987665444444332221111            124578999999999999999999999


Q ss_pred             HHHhcC
Q 039159          244 AEALQQ  249 (259)
Q Consensus       244 ~~~l~h  249 (259)
                      ++++++
T Consensus       296 ~ell~~  301 (313)
T 1t46_A          296 KQIVQL  301 (313)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-41  Score=279.88  Aligned_cols=221  Identities=18%  Similarity=0.281  Sum_probs=178.7

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ....++.+|+.++++++||||+++++++.+++..++||||+.| +|.+++.......        .....+....++.++
T Consensus        75 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--------~~~~~~~~~~~~~i~  146 (327)
T 2yfx_A           75 QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP--------SQPSSLAMLDLLHVA  146 (327)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCS--------SSTTSCCHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccc--------cccccccHHHHHHHH
Confidence            3446788999999999999999999999999999999999975 9999997543211        011346667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCcc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      .+++.||+|||+.+++||||||+||+++.++  ..++|+|||.+.......  .......|++.|+|||.+.+ ..++.+
T Consensus       147 ~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  225 (327)
T 2yfx_A          147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSK  225 (327)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCch
Confidence            9999999999999999999999999998432  269999999997543322  12334567899999999976 568899


Q ss_pred             cchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +||||||+++|+|++ |..||...........+.......             ....+++.+.+++.+||..||.+||++
T Consensus       226 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~  292 (327)
T 2yfx_A          226 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD-------------PPKNCPGPVYRIMTQCWQHQPEDRPNF  292 (327)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC-------------CCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence            999999999999998 999999887777666665443221             124678999999999999999999999


Q ss_pred             HHHhcCccc
Q 039159          244 AEALQQEYF  252 (259)
Q Consensus       244 ~~~l~h~~f  252 (259)
                      .+++++.++
T Consensus       293 ~~ll~~l~~  301 (327)
T 2yfx_A          293 AIILERIEY  301 (327)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999998764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-41  Score=290.81  Aligned_cols=216  Identities=25%  Similarity=0.369  Sum_probs=173.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..++|.+|++++++++||||+++++++.+ +..++||||+.+ +|.+++....+             ..++...++.++.
T Consensus       222 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~  287 (452)
T 1fmk_A          222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-------------KYLRLPQLVDMAA  287 (452)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHH-------------TTCCHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCC-------------CCCCHHHHHHHHH
Confidence            45789999999999999999999999876 678999999985 99999853211             2355678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      |++.||+|||+++|+||||||+||+++.++ .+||+|||+++....... ......+++.|+|||.+.+ ..++.++|||
T Consensus       288 qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvw  365 (452)
T 1fmk_A          288 QIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVW  365 (452)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCccceecCCCceecccCCcccccccCHhHHhc-CCCCccccHH
Confidence            999999999999999999999999999888 899999999976543211 1223346788999999976 5789999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|||++ |+.||.+....+....+......+.             ...+++.+.++|.+||..||++|||+++++
T Consensus       366 slG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~  432 (452)
T 1fmk_A          366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------------PPECPESLHDLMCQCWRKEPEERPTFEYLQ  432 (452)
T ss_dssp             HHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999 9999999888777776655433221             246789999999999999999999999998


Q ss_pred             c--CccccCC
Q 039159          248 Q--QEYFKDV  255 (259)
Q Consensus       248 ~--h~~f~~~  255 (259)
                      +  ..++.+.
T Consensus       433 ~~L~~~~~~~  442 (452)
T 1fmk_A          433 AFLEDYFTST  442 (452)
T ss_dssp             HHHHTTTSCS
T ss_pred             HHHHHHhccC
Confidence            6  3565544

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.8e-41  Score=296.15  Aligned_cols=209  Identities=22%  Similarity=0.227  Sum_probs=171.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|++++++++||||+++++++.. +.+++||||+.| +|.+++....              ..++...+..++
T Consensus       378 ~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~  442 (613)
T 2ozo_A          378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR--------------EEIPVSNVAELL  442 (613)
T ss_dssp             TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCT--------------TTSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhcc--------------CCCCHHHHHHHH
Confidence            456789999999999999999999999976 568999999996 8999885421              335667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .|++.||+|||+++|+||||||+||+++.++ .+||+|||+++........   .....+++.|+|||.+.+ ..++.++
T Consensus       443 ~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~s  520 (613)
T 2ozo_A          443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRS  520 (613)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTCC--------------CCTTSCHHHHHH-CCCCHHH
T ss_pred             HHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHH
Confidence            9999999999999999999999999999888 9999999999865332211   122245688999999976 5789999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|||++ |+.||.+....+....+......+             ....+++++.++|.+||..||++||+++
T Consensus       521 DvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~-------------~p~~~~~~l~~li~~cl~~dP~~RPs~~  587 (613)
T 2ozo_A          521 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME-------------CPPECPPELYALMSDCWIYKWEDRPDFL  587 (613)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHTTCSSTTTSCCHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-------------CCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence            99999999999998 999999988877777665543221             1246889999999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++++
T Consensus       588 ~l~~  591 (613)
T 2ozo_A          588 TVEQ  591 (613)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-41  Score=273.08  Aligned_cols=208  Identities=23%  Similarity=0.353  Sum_probs=161.8

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|++++++++||||+++++++.+  ..++||||+.| +|.+++......            ..+....++.++
T Consensus        43 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~  108 (307)
T 2eva_A           43 SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPL------------PYYTAAHAMSWC  108 (307)
T ss_dssp             THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSE------------ECCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCC------------CccCHHHHHHHH
Confidence            345789999999999999999999999874  47899999986 999999653211            235567788889


Q ss_pred             hhcccccccccC---CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFG---TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~---~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .+++.||+|||+   ++|+||||||+||+++.++..+||+|||.+.....   ......||+.|+|||.+.+ ..++.++
T Consensus       109 ~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~  184 (307)
T 2eva_A          109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEVFEG-SNYSEKC  184 (307)
T ss_dssp             HHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTC-CCCCTHH
T ss_pred             HHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc---ccccCCCCCceEChhhhCC-CCCCcHH
Confidence            999999999999   89999999999999998875589999999975432   2233468999999999987 5788999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCC--hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGAN--SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      ||||||+++|+|++|+.||....  .......+..... +            .....+++.+.+++.+||..||.+|||+
T Consensus       185 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~  251 (307)
T 2eva_A          185 DVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-P------------PLIKNLPKPIESLMTRCWSKDPSQRPSM  251 (307)
T ss_dssp             HHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-C------------CCBTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-C------------CcccccCHHHHHHHHHHhcCChhhCcCH
Confidence            99999999999999999997532  2222223322221 1            1124688999999999999999999999


Q ss_pred             HHHhc
Q 039159          244 AEALQ  248 (259)
Q Consensus       244 ~~~l~  248 (259)
                      +++++
T Consensus       252 ~ell~  256 (307)
T 2eva_A          252 EEIVK  256 (307)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99987

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.8e-41  Score=277.74  Aligned_cols=212  Identities=18%  Similarity=0.152  Sum_probs=169.7

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|+++++++ +||||+++++++..++..++||||+.++|.+++....              ..++...++.++.
T Consensus        47 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~  112 (330)
T 2izr_A           47 RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD--------------RTFSLKTVLMIAI  112 (330)
T ss_dssp             SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT--------------TCCCHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCCCHHHHHHHcC--------------CCCCHHHHHHHHH
Confidence            346799999999999 8999999999999999999999999669999997531              3456678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCe-----EEEeeccccccccccCCC-------CcCCccCccccCcccccC
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKT-----VKVAGFGLAKSLYAYKGE-------SSAEVGTHYYKAPELLLG  157 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~-----vkl~dfg~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~  157 (259)
                      |++.||+|||+.+|+||||||+||+++.++ .     +||+|||+++........       .....||+.|+|||.+.+
T Consensus       113 qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  191 (330)
T 2izr_A          113 QLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG  191 (330)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             HHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC
Confidence            999999999999999999999999999876 5     999999999865433221       245679999999999988


Q ss_pred             ccCCCcccchHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN---SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                       ..++.++|||||||++|+|++|+.||.+..   .......+.......         .........+ ++.+++..||.
T Consensus       192 -~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~---------~~~~~~~~~p-~~~~li~~~l~  260 (330)
T 2izr_A          192 -KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT---------PIEVLCENFP-EMATYLRYVRR  260 (330)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS---------CHHHHTTTCH-HHHHHHHHHHH
T ss_pred             -CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC---------CHHHHhccCh-HHHHHHHHHHh
Confidence             678999999999999999999999998743   333333332111000         0000112234 99999999999


Q ss_pred             cCCCCccCHHHHhc
Q 039159          235 MDPDKRITAAEALQ  248 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~  248 (259)
                      .||.+||+++++++
T Consensus       261 ~~p~~RP~~~~l~~  274 (330)
T 2izr_A          261 LDFFEKPDYDYLRK  274 (330)
T ss_dssp             CCTTCCCCHHHHHH
T ss_pred             CCCCCCCCHHHHHH
Confidence            99999999998875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-40  Score=271.24  Aligned_cols=209  Identities=24%  Similarity=0.331  Sum_probs=164.0

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+.+.+|+.++++++||||+++++++..++..++||||+.| +|.+++...               ..++...+..++.+
T Consensus        78 ~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~q  142 (309)
T 2h34_A           78 RTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ---------------GPLAPPRAVAIVRQ  142 (309)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH---------------CSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            46788999999999999999999999999999999999997 999988642               23556778899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-CCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      ++.|++|||+.+|+||||||+||+++.++ .++|+|||++....... .......|++.|+|||.+.+ ..++.++||||
T Consensus       143 i~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s  220 (309)
T 2h34_A          143 IGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYA  220 (309)
T ss_dssp             HHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHH
T ss_pred             HHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHH
Confidence            99999999999999999999999999888 89999999987653322 12334578999999999987 57889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-CHHHHhc
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-TAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-~~~~~l~  248 (259)
                      ||+++|++++|+.||.+.........+......+           ....+++++.+.+++.+||..||++|| +++++++
T Consensus       221 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          221 LTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRP-----------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCG-----------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCc-----------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            9999999999999999876654444443332211           122357889999999999999999999 8888875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-40  Score=275.37  Aligned_cols=210  Identities=23%  Similarity=0.287  Sum_probs=170.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++.+|++++++++||||+++++++.+++..++||||+.| +|.+++....              ..++...++.++.
T Consensus        89 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~  154 (333)
T 1mqb_A           89 QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--------------GEFSVLQLVGMLR  154 (333)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT--------------TCSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC--------------CCCCHHHHHHHHH
Confidence            345688999999999999999999999999999999999997 9999986421              2355678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +++.||+|||+.||+||||||+||+++.++ .+||+|||.+.........   .....+++.|+|||.+.+ ..++.++|
T Consensus       155 qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  232 (333)
T 1mqb_A          155 GIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASD  232 (333)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHH
T ss_pred             HHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCCcchhhccccccccccCCCCccccccCchhccc-CCCCchhh
Confidence            999999999999999999999999999888 8999999999765432211   122345788999999987 56889999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||+++|++++ |..||.+.........+......+.             ...+++.+.+++.+||..||.+||++.+
T Consensus       233 i~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~  299 (333)
T 1mqb_A          233 VWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-------------PMDCPSAIYQLMMQCWQQERARRPKFAD  299 (333)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------------CTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC-------------cccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            9999999999999 9999998887777766655433221             2357899999999999999999999999


Q ss_pred             HhcC
Q 039159          246 ALQQ  249 (259)
Q Consensus       246 ~l~h  249 (259)
                      ++++
T Consensus       300 l~~~  303 (333)
T 1mqb_A          300 IVSI  303 (333)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2e-41  Score=273.30  Aligned_cols=209  Identities=21%  Similarity=0.252  Sum_probs=168.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|+.++++++||||+++++++.+ +..++||||+.+ +|.+++....              ..++...+..++.
T Consensus        56 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~  120 (281)
T 3cc6_A           56 NKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNK--------------NSLKVLTLVLYSL  120 (281)
T ss_dssp             HHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHT--------------TTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhcc--------------ccCCHHHHHHHHH
Confidence            45778999999999999999999999865 456899999995 9999986421              2355677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++.||+|||+++++||||||+||+++.++ .++|+|||.+........ ......+++.|+|||.+.+ ..++.++|||
T Consensus       121 ~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  198 (281)
T 3cc6_A          121 QICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVW  198 (281)
T ss_dssp             HHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHH
T ss_pred             HHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCcccccccccccccCCCCcceeCchhhcc-CCCCchhccH
Confidence            999999999999999999999999999888 999999999976543221 2234457889999999976 5688999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|+|++ |+.||...........+......+             ....+++.+.+++.+||..||++||++.+++
T Consensus       199 slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell  265 (281)
T 3cc6_A          199 MFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP-------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELV  265 (281)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC-------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            99999999998 999998766555554444332211             1235789999999999999999999999998


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      ++
T Consensus       266 ~~  267 (281)
T 3cc6_A          266 CS  267 (281)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.9e-41  Score=279.08  Aligned_cols=219  Identities=21%  Similarity=0.302  Sum_probs=147.7

Q ss_pred             hHHHHH-HHhhCCCCCeeEEEEEEEe----CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           15 MIREVS-CLMELNHPNIIRLMRVASQ----GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        15 ~~~Ei~-~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+|+. .++.++||||+++++++..    +..+++||||+.| +|.+++.....             ..++...+..++
T Consensus        68 ~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~-------------~~l~~~~~~~i~  134 (336)
T 3fhr_A           68 ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD-------------QAFTEREAAEIM  134 (336)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-C-------------CCCBHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCC-------------CCCCHHHHHHHH
Confidence            444544 4667799999999999976    4568999999997 99999975321             246677889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .|++.||+|||++||+||||||+||+++.++  ..+||+|||++.....  .......||+.|+|||.+.+ ..++.++|
T Consensus       135 ~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~D  211 (336)
T 3fhr_A          135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGP-EKYDKSCD  211 (336)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------------CHHHHHHH
T ss_pred             HHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc--cccccCCCCcCccChhhhCC-CCCCchhh
Confidence            9999999999999999999999999997632  2599999999975432  23345578999999999976 56788999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||||++|+|++|..||....................      .....+.+..+++++.+||.+||..||.+|||++++
T Consensus       212 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  285 (336)
T 3fhr_A          212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF  285 (336)
T ss_dssp             HHHHHHHHHHHHHSSCCC---------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            99999999999999999976554332211111100000      001112335789999999999999999999999999


Q ss_pred             hcCccccCC
Q 039159          247 LQQEYFKDV  255 (259)
Q Consensus       247 l~h~~f~~~  255 (259)
                      ++||||+..
T Consensus       286 l~hp~~~~~  294 (336)
T 3fhr_A          286 MNHPWINQS  294 (336)
T ss_dssp             HHSHHHHTG
T ss_pred             hcCcccccc
Confidence            999999853

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.9e-41  Score=274.77  Aligned_cols=218  Identities=19%  Similarity=0.273  Sum_probs=176.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|++++++++||||+++++++.+++..++||||+.| +|.+++.......     ........+....+..++.+
T Consensus        72 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~~~i~~q  146 (322)
T 1p4o_A           72 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM-----ANNPVLAPPSLSKMIQMAGE  146 (322)
T ss_dssp             HHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHH-----HHCTTCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhh-----ccCCCCCCcCHHHHHHHHHH
Confidence            34688999999999999999999999999999999999986 9999986421100     00000123456788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      ++.||+|||++||+||||||+||+++.++ .+||+|||++........  ......+|+.|+|||.+.+ ..++.++|||
T Consensus       147 i~~~l~~lH~~~i~H~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  224 (322)
T 1p4o_A          147 IADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVW  224 (322)
T ss_dssp             HHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHH
T ss_pred             HHHHHHHHHHCCCccCCCccceEEEcCCC-eEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHH
Confidence            99999999999999999999999999888 899999999976543221  2234457889999999976 5688999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||+++|+|++ |..||.+.........+......+             ....+++.+.+++.+||..||.+||++.+++
T Consensus       225 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l  291 (322)
T 1p4o_A          225 SFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD-------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEII  291 (322)
T ss_dssp             HHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            99999999999 899999888777776665443211             1246889999999999999999999999999


Q ss_pred             cC
Q 039159          248 QQ  249 (259)
Q Consensus       248 ~h  249 (259)
                      ++
T Consensus       292 ~~  293 (322)
T 1p4o_A          292 SS  293 (322)
T ss_dssp             HH
T ss_pred             HH
Confidence            76

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7e-41  Score=274.47  Aligned_cols=214  Identities=20%  Similarity=0.274  Sum_probs=161.2

Q ss_pred             hHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccc
Q 039159           15 MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSS   94 (259)
Q Consensus        15 ~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (259)
                      +.++..+++.++||||+++++++.+++..++||||+.+.+..+.....              ..++...+..++.+++.|
T Consensus        71 ~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~  136 (318)
T 2dyl_A           71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ--------------GPIPERILGKMTVAIVKA  136 (318)
T ss_dssp             HHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHT--------------SCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEeccCCcHHHHHHHhc--------------cCCCHHHHHHHHHHHHHH
Confidence            344555788889999999999999999999999999656665554211              235567788999999999


Q ss_pred             cccccCC-CceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC----ccCCCcccchHh
Q 039159           95 RSLSFGT-RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG----LLEYSTAVDIWP  169 (259)
Q Consensus        95 l~~lh~~-~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Diws  169 (259)
                      |+|||+. |++||||||+||+++.++ .+||+|||.+...... .......|++.|+|||.+.+    ...++.++||||
T Consensus       137 l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s  214 (318)
T 2dyl_A          137 LYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS  214 (318)
T ss_dssp             HHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHH
T ss_pred             HHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCchhccCC-ccccccCCCccccChhhcccccccccCCccccchhh
Confidence            9999995 999999999999999888 8999999999765332 22334578999999999952    245788999999


Q ss_pred             HHHHHHHHHhCCCCCCCC-ChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          170 VGCIFGEMVSGKPLFPGA-NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ||+++|+|++|+.||... ........+..... +..          +....+++++.+++.+||..||.+||+++++++
T Consensus       215 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          215 LGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-PLL----------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-CCC----------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-CCC----------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            999999999999999874 44444444433321 111          112358899999999999999999999999999


Q ss_pred             CccccCC
Q 039159          249 QEYFKDV  255 (259)
Q Consensus       249 h~~f~~~  255 (259)
                      ||||+..
T Consensus       284 h~~~~~~  290 (318)
T 2dyl_A          284 HSFIKRY  290 (318)
T ss_dssp             SHHHHHH
T ss_pred             CHHHHhc
Confidence            9999753

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.7e-41  Score=275.91  Aligned_cols=211  Identities=19%  Similarity=0.219  Sum_probs=167.3

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      .....+.+.+|+.++++++||||+++++++..+. .++|+||+.+ +|.+.+....              ..+....++.
T Consensus        57 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~--------------~~~~~~~~~~  121 (327)
T 3lzb_A           57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK--------------DNIGSQYLLN  121 (327)
T ss_dssp             SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTT--------------TCCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcC--------------CCCCHHHHHH
Confidence            3455678999999999999999999999998765 7788888885 9999886532              2355667888


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ++.|++.||+|||+++|+||||||+||+++.++ .+||+|||++........  ......+|+.|+|||.+.+ ..++.+
T Consensus       122 i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~  199 (327)
T 3lzb_A          122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ  199 (327)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC----------------CCCGGGSCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcceeEccCccccccccCCCccccccCHHHHcC-CCCChH
Confidence            999999999999999999999999999999888 899999999986533222  1223356788999999987 578899


Q ss_pred             cchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +|||||||++|++++ |..||.+.........+......+.             ...+++++.+++.+||..||.+||++
T Consensus       200 ~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~  266 (327)
T 3lzb_A          200 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-------------PPICTIDVYMIMRKCWMIDADSRPKF  266 (327)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-------------CTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCCChhHCcCH
Confidence            999999999999999 9999998776666555544332221             24578999999999999999999999


Q ss_pred             HHHhc
Q 039159          244 AEALQ  248 (259)
Q Consensus       244 ~~~l~  248 (259)
                      .++++
T Consensus       267 ~ell~  271 (327)
T 3lzb_A          267 RELII  271 (327)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.9e-41  Score=279.12  Aligned_cols=229  Identities=21%  Similarity=0.201  Sum_probs=171.5

Q ss_pred             CCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEE--eCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            4 IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVAS--QGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         4 ~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~--~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      +........+++.+|++++++++||||+++++++.  +....++||||+.| +|.+++....              ..++
T Consensus        60 ~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~  125 (327)
T 3lxl_A           60 LQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--------------ARLD  125 (327)
T ss_dssp             ESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG--------------GGCC
T ss_pred             eccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc--------------cCCC
Confidence            34444444567899999999999999999999987  45678999999975 9999986421              3366


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccC
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLG  157 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~  157 (259)
                      ...++.++.+++.||+|||+.+++||||||+||+++.++ .+||+|||.+........   ......|++.|+|||.+.+
T Consensus       126 ~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  204 (327)
T 3lxl_A          126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD  204 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEcccccceecccCCccceeeccCCccccccCHHHhcc
Confidence            778899999999999999999999999999999999888 899999999986533222   2234467888999999977


Q ss_pred             ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc---ccccccccCCCCCCCHHHHHHHHhhcC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK---LSLRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                       ..++.++||||||+++|+|++|..||............. ....+....   .............+++.+.+++.+||.
T Consensus       205 -~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  282 (327)
T 3lxl_A          205 -NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC-ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWA  282 (327)
T ss_dssp             -CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             -CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc-ccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcC
Confidence             567899999999999999999999987543321110000 000000000   000001112235688999999999999


Q ss_pred             cCCCCccCHHHHhcC
Q 039159          235 MDPDKRITAAEALQQ  249 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~h  249 (259)
                      .||.+|||+++++++
T Consensus       283 ~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          283 PSPQDRPSFSALGPQ  297 (327)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.9e-41  Score=270.53  Aligned_cols=206  Identities=19%  Similarity=0.254  Sum_probs=170.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+++.+|++++++++||||+++++++ ..+..++||||+.+ +|.+++...               ..++...+..++.+
T Consensus        62 ~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~q  125 (291)
T 1xbb_A           62 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN---------------RHVKDKNIIELVHQ  125 (291)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHC---------------TTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC---------------cCCCHHHHHHHHHH
Confidence            56789999999999999999999999 56778999999995 999998642               23556778899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCCCcccch
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      ++.||+|||+.+++||||||+||+++.++ .++|+|||++.........   .....+++.|+|||.+.+ ..++.++||
T Consensus       126 i~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  203 (291)
T 1xbb_A          126 VSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDV  203 (291)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHH
T ss_pred             HHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhH
Confidence            99999999999999999999999999888 9999999999765332221   122346788999999976 567889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|+|++ |..||.+.........+...... .            ....+++.+.+++.+||..||++||++.++
T Consensus       204 ~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  270 (291)
T 1xbb_A          204 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-G------------CPAGCPREMYDLMNLCWTYDVENRPGFAAV  270 (291)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-C------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-C------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            999999999999 99999988877666665543221 1            124688999999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       271 ~~  272 (291)
T 1xbb_A          271 EL  272 (291)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.3e-41  Score=272.21  Aligned_cols=211  Identities=18%  Similarity=0.264  Sum_probs=167.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ...+++.+|++++++++||||+++++++...  +.+++||||+.+ +|.+++....              ..++...+..
T Consensus        65 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~  130 (302)
T 4e5w_A           65 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--------------NKINLKQQLK  130 (302)
T ss_dssp             CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT--------------TTCCHHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc--------------ccCCHHHHHH
Confidence            4457889999999999999999999999876  678999999986 9999985421              2356678889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      ++.+++.||+|||+++|+||||||+||+++.++ .++|+|||.+........   ......||+.|+|||.+.+ ..++.
T Consensus       131 ~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  208 (302)
T 4e5w_A          131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYI  208 (302)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEH
T ss_pred             HHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECcccccccccCCCcceeccCCCCCCccccCCeeecC-CCCCc
Confidence            999999999999999999999999999999888 999999999986544322   2334568888999999977 56788


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCC--------------hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHH
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGAN--------------SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLI  229 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~--------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  229 (259)
                      ++||||||+++|+|++|..|+....              .............            .......+++.+.+++
T Consensus       209 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li  276 (302)
T 4e5w_A          209 ASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK------------RLPCPPNCPDEVYQLM  276 (302)
T ss_dssp             HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC------------CCCCCTTCCHHHHHHH
T ss_pred             chhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccC------------CCCCCCCCCHHHHHHH
Confidence            9999999999999999998764321              1111111111111            1112356889999999


Q ss_pred             HhhcCcCCCCccCHHHHhc
Q 039159          230 SKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       230 ~~~l~~dp~~Rp~~~~~l~  248 (259)
                      .+||..||.+|||+.++++
T Consensus       277 ~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          277 RKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHTTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCCCCCCCHHHHHH
Confidence            9999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-41  Score=280.65  Aligned_cols=223  Identities=19%  Similarity=0.244  Sum_probs=173.3

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+.+|+++++++ +||||+++++++.+++..++||||+.+ +|.+++........... ........++...+..++
T Consensus        92 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  170 (333)
T 2i1m_A           92 EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP-AFAIANSTASTRDLLHFS  170 (333)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC--------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccc-cccccccccCHHHHHHHH
Confidence            346788999999999 899999999999999999999999986 99999865321100000 000001335677889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .+++.||+|||+.+|+||||||+||+++.++ .+||+|||++.........  .....+|+.|+|||.+.+ ..++.++|
T Consensus       171 ~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  248 (333)
T 2i1m_A          171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSD  248 (333)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGCEEEGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHH
T ss_pred             HHHHHHHHHHhcCCcccCCcccceEEECCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHH
Confidence            9999999999999999999999999999888 8999999999865433221  234457889999999977 56889999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||||++|+|++ |..||.+.........+......+.            .....++.+.+++.+||..||.+|||+.+
T Consensus       249 i~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~  316 (333)
T 2i1m_A          249 VWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA------------QPAFAPKNIYSIMQACWALEPTHRPTFQQ  316 (333)
T ss_dssp             HHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC------------CCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence            9999999999998 9999987655444444332221111            12346899999999999999999999999


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +++
T Consensus       317 l~~  319 (333)
T 2i1m_A          317 ICS  319 (333)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=275.73  Aligned_cols=208  Identities=22%  Similarity=0.250  Sum_probs=165.1

Q ss_pred             CCchhHHHHHHHhhC----CCCCeeEEEEEEEeCceEEEEeee-ecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           11 VPSSMIREVSCLMEL----NHPNIIRLMRVASQGIYLYPVFEY-QVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l----~H~niv~~~~~~~~~~~~~lv~e~-~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ....+.+|+.+++++    +||||+++++++..++..++|||+ +.+ +|.+++...               ..+....+
T Consensus        77 ~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~---------------~~~~~~~~  141 (312)
T 2iwi_A           77 DSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK---------------GPLGEGPS  141 (312)
T ss_dssp             --CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH---------------CSCCHHHH
T ss_pred             hhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc---------------CCCCHHHH
Confidence            456678899999999    899999999999999999999999 554 999988642               23566788


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEc-CCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVD-LDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~-~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      ..++.+++.||+|||+++++||||||+||+++ .++ .++|+|||.+.....  .......|++.|+|||.+.+....+.
T Consensus       142 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~kl~dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  218 (312)
T 2iwi_A          142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHD--EPYTDFDGTRVYSPPEWISRHQYHAL  218 (312)
T ss_dssp             HHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT-EEEECCCSSCEECCS--SCBCCCCSCTTTSCHHHHHHSCBCHH
T ss_pred             HHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC-eEEEEEcchhhhccc--CcccccCCcccccCceeeecCCCCCc
Confidence            89999999999999999999999999999999 566 899999999976543  23344568999999999876444456


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      ++||||||+++|++++|+.||.....      +.....              .....+++.+.++|.+||..||++||++
T Consensus       219 ~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~  278 (312)
T 2iwi_A          219 PATVWSLGILLYDMVCGDIPFERDQE------ILEAEL--------------HFPAHVSPDCCALIRRCLAPKPSSRPSL  278 (312)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCC--------------CCCTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cchHHHHHHHHHHHHHCCCCCCChHH------Hhhhcc--------------CCcccCCHHHHHHHHHHccCChhhCcCH
Confidence            89999999999999999999975321      111110              1124678999999999999999999999


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      +++++||||+...
T Consensus       279 ~e~l~~~~~~~~~  291 (312)
T 2iwi_A          279 EEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHSTTTCC--
T ss_pred             HHHhcChhhcCch
Confidence            9999999999754

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.1e-41  Score=271.16  Aligned_cols=209  Identities=23%  Similarity=0.260  Sum_probs=171.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++..++ .++||||+.+ +|.+.+....              ..+....+..++.
T Consensus        64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~  128 (291)
T 1u46_A           64 AMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ--------------GHFLLGTLSRYAV  128 (291)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG--------------GGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhcc--------------CCcCHHHHHHHHH
Confidence            4567889999999999999999999998765 8899999985 9999886421              3355678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +++.||+|||+++++||||||+||+++.++ .++|+|||.+........   ......+++.|+|||.+.+ ..++.++|
T Consensus       129 ~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  206 (291)
T 1u46_A          129 QVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASD  206 (291)
T ss_dssp             HHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHH
T ss_pred             HHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEccccccccccccccchhhhccCCCCceeeCchhhcC-CCCCchhh
Confidence            999999999999999999999999999888 899999999976543222   1223457788999999976 56788999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||+++|+|++ |..||.+.........+......+.            ....+++++.+++.+||..||.+||++.+
T Consensus       207 i~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~  274 (291)
T 1u46_A          207 TWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVA  274 (291)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC------------CCcCcCHHHHHHHHHHccCCcccCcCHHH
Confidence            9999999999999 9999998887777776654432221            12468899999999999999999999999


Q ss_pred             Hhc
Q 039159          246 ALQ  248 (259)
Q Consensus       246 ~l~  248 (259)
                      +++
T Consensus       275 l~~  277 (291)
T 1u46_A          275 LRD  277 (291)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.2e-41  Score=273.39  Aligned_cols=214  Identities=21%  Similarity=0.273  Sum_probs=167.8

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCc-----eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGI-----YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      .+.+.+|+.++++++||||+++++++.+..     ..++||||+.+ +|.+++.......         ....++...++
T Consensus        80 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~  150 (313)
T 3brb_A           80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET---------GPKHIPLQTLL  150 (313)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTT---------SCCCCCHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhc---------CCccCCHHHHH
Confidence            466889999999999999999999998654     35999999996 9999885432110         01446678889


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      .++.+++.||+|||+++|+||||||+||+++.++ .+||+|||++.......  .......+++.|+|||.+.+ ..++.
T Consensus       151 ~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~  228 (313)
T 3brb_A          151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTS  228 (313)
T ss_dssp             HHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS-CEEECSCSCC----------------CCGGGSCHHHHHS-SCCCH
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccc
Confidence            9999999999999999999999999999999888 89999999997653322  12233457889999999987 57889


Q ss_pred             ccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          164 AVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       164 ~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ++||||||+++|+|++ |..||.+.........+.......             ....+++.+.+++.+||..||.+||+
T Consensus       229 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps  295 (313)
T 3brb_A          229 KSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK-------------QPEDCLDELYEIMYSCWRTDPLDRPT  295 (313)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-------------CBTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred             hhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC-------------CCccccHHHHHHHHHHcCCChhhCcC
Confidence            9999999999999999 899998877766666655443221             12468899999999999999999999


Q ss_pred             HHHHhcC
Q 039159          243 AAEALQQ  249 (259)
Q Consensus       243 ~~~~l~h  249 (259)
                      +.+++++
T Consensus       296 ~~~l~~~  302 (313)
T 3brb_A          296 FSVLRLQ  302 (313)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.7e-41  Score=281.41  Aligned_cols=214  Identities=11%  Similarity=0.062  Sum_probs=162.1

Q ss_pred             hhHHHHHHHhhCCCCCeeEEEEEEEeC----ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           14 SMIREVSCLMELNHPNIIRLMRVASQG----IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H~niv~~~~~~~~~----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      .+.+|+..++.++||||+++++++...    ...++||||+.++|.+++....              ..++...++.++.
T Consensus        94 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~--------------~~l~~~~~~~i~~  159 (364)
T 3op5_A           94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA--------------KRFSRKTVLQLSL  159 (364)
T ss_dssp             HHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT--------------SCCCHHHHHHHHH
T ss_pred             HHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc--------------CCCCHHHHHHHHH
Confidence            344566667778899999999998765    4689999999559999986521              3356778899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEc--CCCCeEEEeeccccccccccCCC-------CcCCccCccccCcccccCccC
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVD--LDGKTVKVAGFGLAKSLYAYKGE-------SSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~--~~~~~vkl~dfg~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      |++.||+|||+.+|+||||||+||+++  .++ .+||+|||+++........       .....||+.|+|||.+.+ ..
T Consensus       160 qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  237 (364)
T 3op5_A          160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VA  237 (364)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEEESSCTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CC
T ss_pred             HHHHHHHHHHHCCeEEecCCHHHEEEecCCCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CC
Confidence            999999999999999999999999998  666 8999999999765433211       133459999999999987 56


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCC--CCCCCHHHHHHHHhhcCcCCC
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNG--FPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~  238 (259)
                      ++.++|||||||++|+|++|+.||.+................+...     ......  ..++++++.+++..||..||.
T Consensus       238 ~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~cl~~~p~  312 (364)
T 3op5_A          238 PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIA-----SLMDKCFPAANAPGEIAKYMETVKLLDYT  312 (364)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHH-----HHHHHHSCTTCCCHHHHHHHHHHHTCCTT
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHH-----HHHHHhcccccCHHHHHHHHHHHhcCCCC
Confidence            8999999999999999999999998633222211111000000000     000001  146789999999999999999


Q ss_pred             CccCHHHHhc
Q 039159          239 KRITAAEALQ  248 (259)
Q Consensus       239 ~Rp~~~~~l~  248 (259)
                      +||+++++++
T Consensus       313 ~RP~~~~l~~  322 (364)
T 3op5_A          313 EKPLYENLRD  322 (364)
T ss_dssp             CCCCHHHHHH
T ss_pred             CCCCHHHHHH
Confidence            9999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.7e-41  Score=275.79  Aligned_cols=223  Identities=23%  Similarity=0.300  Sum_probs=170.4

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +...+.+.+|++++++++||||+++++++.+++..++||||+.+ +|.+.+......            ..++...+..+
T Consensus        71 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~i  138 (307)
T 2nru_A           71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------------PPLSWHMRCKI  138 (307)
T ss_dssp             TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC------------CCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC------------CCCCHHHHHHH
Confidence            34567899999999999999999999999999999999999985 999988643211            33566788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.+++.||+|||+.+++||||||+||+++.++ .++|+|||.+.........  .....||+.|+|||.+.+  .++.++
T Consensus       139 ~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~  215 (307)
T 2nru_A          139 AQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKS  215 (307)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHH
T ss_pred             HHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccc
Confidence            99999999999999999999999999999888 8999999999765432221  334578999999999876  478899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHH----HHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLIT----LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      ||||||+++|+|++|.+||........    ...+......  ... .............++.+.+++.+||..||.+||
T Consensus       216 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp  292 (307)
T 2nru_A          216 DIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT--IED-YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP  292 (307)
T ss_dssp             HHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC--HHH-HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             hhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh--hhh-hccccccccchHHHHHHHHHHHHHcCCCcccCc
Confidence            999999999999999999986543221    1111111110  000 000011111223456788999999999999999


Q ss_pred             CHHHHhcC
Q 039159          242 TAAEALQQ  249 (259)
Q Consensus       242 ~~~~~l~h  249 (259)
                      ++++++++
T Consensus       293 s~~~l~~~  300 (307)
T 2nru_A          293 DIKKVQQL  300 (307)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            99999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=272.81  Aligned_cols=214  Identities=16%  Similarity=0.169  Sum_probs=172.2

Q ss_pred             CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159            7 TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ..+...+.+.+|+.++++++||||+++++++.+++..++||||+.| +|.+++....              ..++...+.
T Consensus        68 ~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~  133 (319)
T 2y4i_B           68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--------------IVLDVNKTR  133 (319)
T ss_dssp             CCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC--------------CCCCSHHHH
T ss_pred             CCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC--------------CCCCHHHHH
Confidence            3455567899999999999999999999999999999999999986 9999986421              234567788


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccccc-----CCCCcCCccCccccCcccccC---
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY-----KGESSAEVGTHYYKAPELLLG---  157 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~---  157 (259)
                      .++.+++.||+|||+++++||||||+||+++ ++ .++|+|||++......     ........|++.|+|||.+.+   
T Consensus       134 ~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  211 (319)
T 2y4i_B          134 QIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP  211 (319)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSC
T ss_pred             HHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccc
Confidence            9999999999999999999999999999998 55 7999999998654211     122334468999999999874   


Q ss_pred             -----ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhh
Q 039159          158 -----LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       158 -----~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                           ...++.++||||||+++|+|++|..||...........+........ .           ...+++++.+++.+|
T Consensus       212 ~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~-----------~~~~~~~l~~li~~~  279 (319)
T 2y4i_B          212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL-S-----------QIGMGKEISDILLFC  279 (319)
T ss_dssp             C--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC-C-----------CSSCCTTHHHHHHHH
T ss_pred             cccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC-C-----------cCCCCHHHHHHHHHH
Confidence                 23468899999999999999999999998887776666654432211 1           135788999999999


Q ss_pred             cCcCCCCccCHHHHhc
Q 039159          233 LGMDPDKRITAAEALQ  248 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~  248 (259)
                      |..||.+|||++++++
T Consensus       280 l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          280 WAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HCSSTTTSCCHHHHHH
T ss_pred             hcCChhhCcCHHHHHH
Confidence            9999999999999995

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-40  Score=267.85  Aligned_cols=209  Identities=21%  Similarity=0.253  Sum_probs=169.0

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceE-EEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYL-YPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+++.+|++++++++||||+++++++.+.+.. ++||||+.+ +|.+++....              ..++...+..++
T Consensus        65 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~i~  130 (298)
T 3pls_A           65 QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--------------RNPTVKDLISFG  130 (298)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTT--------------CCCBHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccc--------------cCCCHHHHHHHH
Confidence            346788999999999999999999999876654 999999975 9999986522              234566788899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeecccccccccc----CCCCcCCccCccccCcccccCccCCCcc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAY----KGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      .+++.||+|||+.|++||||||+||+++.++ .+||+|||.+......    ........+++.|+|||.+.+ ..++.+
T Consensus       131 ~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  208 (298)
T 3pls_A          131 LQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTK  208 (298)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHH
T ss_pred             HHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChh
Confidence            9999999999999999999999999999888 8999999999754332    122334467889999999987 578899


Q ss_pred             cchHhHHHHHHHHHhC-CCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVSG-KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +||||||+++|+|++| .+||...........+......+.             ...+++.+.+++.+||..||.+|||+
T Consensus       209 ~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~  275 (298)
T 3pls_A          209 SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-------------PEYCPDSLYQVMQQCWEADPAVRPTF  275 (298)
T ss_dssp             HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC-------------CccchHHHHHHHHHHccCChhhCcCH
Confidence            9999999999999995 566666555555555444332211             24578999999999999999999999


Q ss_pred             HHHhc
Q 039159          244 AEALQ  248 (259)
Q Consensus       244 ~~~l~  248 (259)
                      +++++
T Consensus       276 ~~ll~  280 (298)
T 3pls_A          276 RVLVG  280 (298)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-40  Score=268.03  Aligned_cols=210  Identities=23%  Similarity=0.304  Sum_probs=172.9

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|++++++++||||+++++++. ++..++||||+.| +|.+++....+             ..++...+..++
T Consensus        50 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~i~  115 (279)
T 1qpc_A           50 MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSG-------------IKLTINKLLDMA  115 (279)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHH-------------HTCCHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCC-------------CCCCHHHHHHHH
Confidence            34678999999999999999999999986 4568999999985 99998853210             245667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .+++.||+|||++|++||||||+||+++.++ .++|+|||.+........ ......+++.|+|||.+.+ ..++.++||
T Consensus       116 ~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  193 (279)
T 1qpc_A          116 AQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDV  193 (279)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHH
T ss_pred             HHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCcccccccCcccccccCCCCccCccChhhhcc-CCCCchhhh
Confidence            9999999999999999999999999999888 899999999976543221 1233456788999999976 567889999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|+|++ |..||.+.........+.......             ....+++.+.+++.+||..||.+|||++++
T Consensus       194 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  260 (279)
T 1qpc_A          194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-------------RPDNCPEELYQLMRLCWKERPEDRPTFDYL  260 (279)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC-------------CcccccHHHHHHHHHHhccChhhCCCHHHH
Confidence            999999999999 899999888777666665442211             124678999999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       261 ~~  262 (279)
T 1qpc_A          261 RS  262 (279)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-41  Score=281.71  Aligned_cols=210  Identities=20%  Similarity=0.264  Sum_probs=162.3

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEe-CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+++.+|+.++++++||||+++++++.+ ++..++||||+.+ +|.++++...              ...+...+..++
T Consensus       133 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~  198 (373)
T 3c1x_A          133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--------------HNPTVKDLIGFG  198 (373)
T ss_dssp             HHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTT--------------CCCBHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcc--------------cCCCHHHHHHHH
Confidence            45678999999999999999999998754 4688999999996 9999996432              234556778899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC----CCcCCccCccccCcccccCccCCCcc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG----ESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      .|++.||+|||+++|+||||||+||+++.++ .+||+|||+++.......    ......+++.|+|||.+.+ ..++.+
T Consensus       199 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  276 (373)
T 3c1x_A          199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTK  276 (373)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---------------------CCGGGSCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeeccccccccccccccccccCCCCCcccccChHHhcC-CCCCcH
Confidence            9999999999999999999999999999888 899999999976533211    1223357788999999987 578899


Q ss_pred             cchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +|||||||++|+|++ |.+||.+.........+......+             ....+++.+.+++.+||..||++||++
T Consensus       277 ~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~-------------~p~~~~~~l~~li~~cl~~dp~~RPs~  343 (373)
T 3c1x_A          277 SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-------------QPEYCPDPLYEVMLKCWHPKAEMRPSF  343 (373)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            999999999999999 678888766555554544432211             123578999999999999999999999


Q ss_pred             HHHhcC
Q 039159          244 AEALQQ  249 (259)
Q Consensus       244 ~~~l~h  249 (259)
                      ++++++
T Consensus       344 ~ell~~  349 (373)
T 3c1x_A          344 SELVSR  349 (373)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-40  Score=274.06  Aligned_cols=223  Identities=22%  Similarity=0.266  Sum_probs=176.8

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCccccc-CCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKN-FNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~   88 (259)
                      .+++.+|+++++++ +||||+++++++.+++..++||||+.+ +|.+++.............. ......++...++.++
T Consensus        84 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  163 (334)
T 2pvf_A           84 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT  163 (334)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHH
Confidence            45688999999999 899999999999999999999999986 99999976432111110000 0011346677889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      .+++.||+|||+.+|+||||||+||+++.++ .+||+|||++........  ......+++.|+|||.+.+ ..++.++|
T Consensus       164 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  241 (334)
T 2pvf_A          164 YQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSD  241 (334)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHH
T ss_pred             HHHHHHHHHHHhCCeeCCCCccceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHH
Confidence            9999999999999999999999999999888 899999999976543221  1233356788999999976 56889999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||+++|+|++ |..||.+.........+......+             ....+++.+.+++.+||..||.+||++++
T Consensus       242 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e  308 (334)
T 2pvf_A          242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD-------------KPANCTNELYMMMRDCWHAVPSQRPTFKQ  308 (334)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC-------------CCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999999 999999887776666554432211             12467899999999999999999999999


Q ss_pred             HhcC
Q 039159          246 ALQQ  249 (259)
Q Consensus       246 ~l~h  249 (259)
                      ++++
T Consensus       309 ll~~  312 (334)
T 2pvf_A          309 LVED  312 (334)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-40  Score=294.93  Aligned_cols=208  Identities=19%  Similarity=0.252  Sum_probs=170.9

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+++.+|++++++++||||+++++++.. +..++||||+.+ +|.+++...               ..+....++.++
T Consensus       412 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~---------------~~l~~~~~~~i~  475 (635)
T 4fl3_A          412 ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN---------------RHVKDKNIIELV  475 (635)
T ss_dssp             GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHC---------------TTCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhC---------------CCCCHHHHHHHH
Confidence            345789999999999999999999999964 568899999996 899998642               335567788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .|++.||+|||+++|+||||||+||+++.++ .+||+|||+++.......   ......+|+.|+|||.+.+ ..++.++
T Consensus       476 ~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~s  553 (635)
T 4fl3_A          476 HQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKS  553 (635)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC-------------CGGGSCHHHHHH-CCCCHHH
T ss_pred             HHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC-CCCCcHH
Confidence            9999999999999999999999999999888 999999999986543221   1223346788999999976 5789999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|||++ |+.||.+.........+......+             ....+++++.++|..||..||++||+++
T Consensus       554 DvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~-------------~p~~~~~~l~~li~~cl~~dP~~RPs~~  620 (635)
T 4fl3_A          554 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-------------CPAGCPREMYDLMNLCWTYDVENRPGFA  620 (635)
T ss_dssp             HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            99999999999998 999999988877776665543221             1246889999999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++++
T Consensus       621 ~l~~  624 (635)
T 4fl3_A          621 AVEL  624 (635)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.4e-40  Score=270.54  Aligned_cols=213  Identities=25%  Similarity=0.366  Sum_probs=160.6

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|++++++++||||+++++++..++..++||||+.+ +|.+++......           ...++...+..++.
T Consensus        75 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~i~~  143 (310)
T 2wqm_A           75 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ-----------KRLIPERTVWKYFV  143 (310)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHT-----------TCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhccc-----------ccCCCHHHHHHHHH
Confidence            446788999999999999999999999999999999999996 999988642111           03355677889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      +++.||+|||+.+++||||||+||+++.++ .++|+|||++..............|++.|+|||.+.+ ..++.++||||
T Consensus       144 qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s  221 (310)
T 2wqm_A          144 QLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWS  221 (310)
T ss_dssp             HHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC------------------CCSSCCHHHHTT-CCCCHHHHHHH
T ss_pred             HHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEeccceeeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHH
Confidence            999999999999999999999999999888 8999999999765443333445578999999999987 56889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC--hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          170 VGCIFGEMVSGKPLFPGAN--SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||+++|+|++|..||.+..  .......+.... .+..+           ...+++++.+++.+||..||.+||++++++
T Consensus       222 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~il  289 (310)
T 2wqm_A          222 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLP-----------SDHYSEELRQLVNMCINPDPEKRPDVTYVY  289 (310)
T ss_dssp             HHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-SCCCC-----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-CCCCc-----------ccccCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            9999999999999997643  223333332221 11111           135789999999999999999999999998


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       290 ~  290 (310)
T 2wqm_A          290 D  290 (310)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.1e-41  Score=278.11  Aligned_cols=214  Identities=13%  Similarity=0.084  Sum_probs=165.5

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEe----CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQ----GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+.+|+..++.++||||+++++++..    +...|+||||+.++|.+++...               ..++...++.++
T Consensus        93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~---------------~~~~~~~~~~i~  157 (345)
T 2v62_A           93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN---------------GTFKKSTVLQLG  157 (345)
T ss_dssp             HHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGG---------------GBCCHHHHHHHH
T ss_pred             hHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhc---------------CCCCHHHHHHHH
Confidence            457788899999999999999999988    6789999999955999988542               245678889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCC-CeEEEeeccccccccccCC-------CCcCCccCccccCcccccCccC
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDG-KTVKVAGFGLAKSLYAYKG-------ESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~-~~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      .|++.||+|||+++|+||||||+||+++.++ ..+||+|||+++.......       ......||+.|+|||.+.+ ..
T Consensus       158 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  236 (345)
T 2v62_A          158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VA  236 (345)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CC
T ss_pred             HHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CC
Confidence            9999999999999999999999999998654 2699999999976543221       1134578999999999987 57


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCC--ChHHHHHHHhC-CCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGA--NSLITLGRIVG-KSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~--~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      ++.++|||||||++|+|++|+.||.+.  ........... ....+....    ..  .....+++++.+++.+||..||
T Consensus       237 ~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~~~l~~li~~~l~~dp  310 (345)
T 2v62_A          237 LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVL----KW--APSGSSCCEIAQFLVCAHSLAY  310 (345)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHH----HH--SCTTSCCHHHHHHHHHHHTCCT
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHH----hh--ccccccHHHHHHHHHHHhhcCc
Confidence            899999999999999999999999652  22211111100 000111000    00  0012688999999999999999


Q ss_pred             CCccCHHHHhc
Q 039159          238 DKRITAAEALQ  248 (259)
Q Consensus       238 ~~Rp~~~~~l~  248 (259)
                      ++||+++++++
T Consensus       311 ~~Rps~~~l~~  321 (345)
T 2v62_A          311 DEKPNYQALKK  321 (345)
T ss_dssp             TCCCCHHHHHH
T ss_pred             ccCCCHHHHHH
Confidence            99999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1e-40  Score=268.74  Aligned_cols=208  Identities=24%  Similarity=0.327  Sum_probs=164.3

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeC-ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...+++.+|++++++++||||+++++++.+. +..++||||+.+ +|.+++.....             ..++...+..+
T Consensus        56 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~  122 (278)
T 1byg_A           56 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------------SVLGGDCLLKF  122 (278)
T ss_dssp             C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH-------------HHCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc-------------ccCCHHHHHHH
Confidence            3567899999999999999999999997654 478999999997 99999864210             22556778899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.+++.|++|||+++++||||||+||+++.++ .++|+|||.+.....   ......+++.|+|||.+.+ ..++.++||
T Consensus       123 ~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di  197 (278)
T 1byg_A          123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALRE-KKFSTKSDV  197 (278)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC---------------CCTTTSCHHHHHH-CCCCHHHHH
T ss_pred             HHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeeccccccccc---cccCCCccccccCHHHhCC-CCCCchhcH
Confidence            99999999999999999999999999999888 899999999875432   2233457889999999976 568899999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||+++|+|++ |..||...........+......             .....+++.+.+++.+||..||.+||++.++
T Consensus       198 ~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  264 (278)
T 1byg_A          198 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL  264 (278)
T ss_dssp             HHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-------------CCcccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            999999999998 99999887666555555433211             1124688999999999999999999999999


Q ss_pred             hc
Q 039159          247 LQ  248 (259)
Q Consensus       247 l~  248 (259)
                      ++
T Consensus       265 ~~  266 (278)
T 1byg_A          265 RE  266 (278)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3e-40  Score=268.45  Aligned_cols=209  Identities=21%  Similarity=0.266  Sum_probs=168.6

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEE-eCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVAS-QGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~-~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..+++.+|+.++++++||||+++++++. .++..++||||+.+ +|.+++....              ...+...+..++
T Consensus        69 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~  134 (298)
T 3f66_A           69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--------------HNPTVKDLIGFG  134 (298)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTT--------------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcc--------------cCCCHHHHHHHH
Confidence            3467889999999999999999999865 45688999999997 9999996422              234566778899


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC----CCCcCCccCccccCcccccCccCCCcc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK----GESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      .|++.||+|||+++++||||||+||+++.++ .+||+|||.+.......    .......+|+.|+|||.+.+ ..++.+
T Consensus       135 ~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~  212 (298)
T 3f66_A          135 LQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTK  212 (298)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECcccccccccccchhccccccCCCCCccccChHHhcC-CCCChH
Confidence            9999999999999999999999999999888 89999999997653321    12233457889999999977 568899


Q ss_pred             cchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +||||||+++|++++ |.+||.+.........+........             ...+++.+.+++.+||..||.+||++
T Consensus       213 ~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~  279 (298)
T 3f66_A          213 SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-------------PEYCPDPLYEVMLKCWHPKAEMRPSF  279 (298)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC-------------CccCCHHHHHHHHHHcCCChhhCcCH
Confidence            999999999999999 6678877666555555544332211             23578999999999999999999999


Q ss_pred             HHHhc
Q 039159          244 AEALQ  248 (259)
Q Consensus       244 ~~~l~  248 (259)
                      .++++
T Consensus       280 ~ell~  284 (298)
T 3f66_A          280 SELVS  284 (298)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7e-41  Score=292.46  Aligned_cols=216  Identities=25%  Similarity=0.364  Sum_probs=177.2

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..++|.+|++++++|+||||+++++++.+ +..++||||+.+ +|.+++....+             ..+....++.++.
T Consensus       305 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~  370 (535)
T 2h8h_A          305 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-------------KYLRLPQLVDMAA  370 (535)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHH-------------TTCCHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCC-------------CCCCHHHHHHHHH
Confidence            45789999999999999999999999876 678999999986 99999953211             2355678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-CCCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      |++.||+|||+++|+||||||+|||++.++ .+||+|||+++...... .......++..|+|||.+.+ ..++.++|||
T Consensus       371 qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvw  448 (535)
T 2h8h_A          371 QIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVW  448 (535)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccceecCCCceecccCCcCcccccCHHHhcc-CCCCchhhHH
Confidence            999999999999999999999999999888 89999999997653211 11223346788999999976 5689999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++|||++ |+.||.+....+....+....+.+             ....+++.+.+||.+||..||++|||+++++
T Consensus       449 SlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~  515 (535)
T 2h8h_A          449 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQ  515 (535)
T ss_dssp             HHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            99999999999 899999988877777665543322             1246789999999999999999999999998


Q ss_pred             cC--ccccCC
Q 039159          248 QQ--EYFKDV  255 (259)
Q Consensus       248 ~h--~~f~~~  255 (259)
                      +.  .+|.+.
T Consensus       516 ~~L~~~~~~~  525 (535)
T 2h8h_A          516 AFLEDYFTST  525 (535)
T ss_dssp             HHHHTSSCCC
T ss_pred             HHHHHHhhcc
Confidence            63  555544

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-40  Score=272.60  Aligned_cols=224  Identities=20%  Similarity=0.288  Sum_probs=171.9

Q ss_pred             CchhHHHHHHHhhC-CCCCeeEEEEEEEeCc-eEEEEeeeecC-CHHHHhhcCCCCCCCccc-ccCCCcchhHHHHHHHH
Q 039159           12 PSSMIREVSCLMEL-NHPNIIRLMRVASQGI-YLYPVFEYQVN-DLAYLLKYPKDSMNGYST-KNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~-~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   87 (259)
                      .+++.+|+++++++ +||||+++++++...+ .+++||||+.| +|.+++............ ........++...+..+
T Consensus        74 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (316)
T 2xir_A           74 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY  153 (316)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHH
T ss_pred             HHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHH
Confidence            45788999999999 6999999999987654 58999999996 999999754321100000 00000123677888999


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.+++.||+|||+.+|+||||||+||+++.++ .+||+|||.+.........  .....||+.|+|||.+.+ ..++.++
T Consensus       154 ~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~  231 (316)
T 2xir_A          154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQS  231 (316)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHH
T ss_pred             HHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchh
Confidence            99999999999999999999999999999888 8999999999765432221  233457889999999977 5688999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      ||||||+++|+|++ |..||.+................+.            ....+++.+.+++.+||..||.+|||+.
T Consensus       232 Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~  299 (316)
T 2xir_A          232 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------------APDYTTPEMYQTMLDCWHGEPSQRPTFS  299 (316)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            99999999999998 9999987654333333222211111            1235789999999999999999999999


Q ss_pred             HHhcC
Q 039159          245 EALQQ  249 (259)
Q Consensus       245 ~~l~h  249 (259)
                      ++++|
T Consensus       300 ell~~  304 (316)
T 2xir_A          300 ELVEH  304 (316)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.8e-41  Score=295.03  Aligned_cols=231  Identities=23%  Similarity=0.221  Sum_probs=171.6

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEe------CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQ------GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~------~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ..+++.+|++++++++||||+++++++..      ++..++||||+.| +|.+++......            ..++...
T Consensus        55 ~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~------------~~lse~~  122 (676)
T 3qa8_A           55 NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC------------CGLKEGP  122 (676)
T ss_dssp             HHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT------------TCCCSSH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccC------------CCCCHHH
Confidence            35678899999999999999999999765      6678999999986 999998753221            2345567


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCCC--eEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK--TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~--~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      +..++.+++.||+|||+.||+||||||+||+++.++.  .++|+|||.+...... .......||+.|+|||.+.+ ..+
T Consensus       123 i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~  200 (676)
T 3qa8_A          123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQ-KKY  200 (676)
T ss_dssp             HHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCC-SCC
T ss_pred             HHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccc-cccccccCCcccCChHHhcc-CCC
Confidence            7889999999999999999999999999999987652  4899999999865432 23345678999999999987 678


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCc---------cccc-cccccccCCCCCCCHHHHHHHHh
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS---------FCKL-SLRDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~---------~~~~-~~~~~~~~~~~~~~~~~~~li~~  231 (259)
                      +.++|||||||++|++++|..||.+..................         .... ............+++.+.+++.+
T Consensus       201 s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~  280 (676)
T 3qa8_A          201 TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQC  280 (676)
T ss_dssp             STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHH
Confidence            9999999999999999999999987644332211110000000         0000 00001111223467889999999


Q ss_pred             hcCcCCCCccCHHHHhcCccccCC
Q 039159          232 MLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ||..||.+|||+.++++||||..+
T Consensus       281 mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          281 MLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             HSCSSCC---CCTTCCCCTTHHHH
T ss_pred             HccCCHhhCcCHHHHhcCHHHHHH
Confidence            999999999999999999999753

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=276.84  Aligned_cols=214  Identities=24%  Similarity=0.334  Sum_probs=150.8

Q ss_pred             CCCCCchhHHHHHHHhhCC-CCCeeEEEEEEE--------eCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcch
Q 039159            8 MEGVPSSMIREVSCLMELN-HPNIIRLMRVAS--------QGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~--------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      .....+.+.+|+.+++++. ||||+++++++.        ....++++|||+.|+|.+++......            ..
T Consensus        65 ~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~------------~~  132 (337)
T 3ll6_A           65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR------------GP  132 (337)
T ss_dssp             SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTT------------CS
T ss_pred             chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhcc------------CC
Confidence            3344567889999999996 999999999994        34468999999999999988642111            34


Q ss_pred             hHHHHHHHHHhhcccccccccCCC--ceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC------------CcCCc
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE------------SSAEV  144 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~--i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~------------~~~~~  144 (259)
                      ++...+..++.+++.||+|||+.+  |+||||||+||+++.++ .+||+|||++.........            .....
T Consensus       133 ~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (337)
T 3ll6_A          133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN  211 (337)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-CEEBCCCTTCBCCSSCC-------------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-CEEEecCccceeccccCcccccccccccchhhcccc
Confidence            667788999999999999999999  99999999999999888 8999999999765332111            11345


Q ss_pred             cCccccCccccc--CccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCC
Q 039159          145 GTHYYKAPELLL--GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE  222 (259)
Q Consensus       145 ~~~~~~aPE~~~--~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (259)
                      ||+.|+|||.+.  ....++.++|||||||++|+|++|..||.+............                .......+
T Consensus       212 ~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~  275 (337)
T 3ll6_A          212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS----------------IPPHDTQY  275 (337)
T ss_dssp             ------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------CC----------------CCTTCCSS
T ss_pred             CCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCccc----------------CCcccccc
Confidence            899999999984  225678899999999999999999999976543322221110                01123567


Q ss_pred             HHHHHHHHhhcCcCCCCccCHHHHhcCc
Q 039159          223 PAGIDLISKMLGMDPDKRITAAEALQQE  250 (259)
Q Consensus       223 ~~~~~li~~~l~~dp~~Rp~~~~~l~h~  250 (259)
                      +.+.+++.+||..||.+||++++++++-
T Consensus       276 ~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          276 TVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             GGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             hHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            8899999999999999999999999763

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.8e-40  Score=265.91  Aligned_cols=207  Identities=23%  Similarity=0.295  Sum_probs=168.7

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEe----------------CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCC
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQ----------------GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNS   75 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~----------------~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~   75 (259)
                      +.+.+|++++++++||||+++++++..                ....++||||+.+ +|.+++.....            
T Consensus        49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------  116 (284)
T 2a19_B           49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG------------  116 (284)
T ss_dssp             GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG------------
T ss_pred             HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC------------
Confidence            578899999999999999999999864                4468999999996 99999964211            


Q ss_pred             cchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccc
Q 039159           76 YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELL  155 (259)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~  155 (259)
                       ..++...+..++.+++.||+|||+++|+||||||+||+++.++ .++|+|||.+....... ......|++.|+|||.+
T Consensus       117 -~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~  193 (284)
T 2a19_B          117 -EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQI  193 (284)
T ss_dssp             -SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHH
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-CEEECcchhheeccccc-cccccCCcccccChhhh
Confidence             2355677889999999999999999999999999999999888 89999999997654322 23445689999999999


Q ss_pred             cCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          156 LGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      .+ ..++.++||||||+++|+|++|..|+....  .....+....                ....+++.+.+++.+||..
T Consensus       194 ~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~~----------------~~~~~~~~~~~li~~~l~~  254 (284)
T 2a19_B          194 SS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGI----------------ISDIFDKKEKTLLQKLLSK  254 (284)
T ss_dssp             HC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHTTC----------------CCTTSCHHHHHHHHHHTCS
T ss_pred             cc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhccc----------------ccccCCHHHHHHHHHHccC
Confidence            87 568899999999999999999998875321  1122222111                1135789999999999999


Q ss_pred             CCCCccCHHHHhcCcccc
Q 039159          236 DPDKRITAAEALQQEYFK  253 (259)
Q Consensus       236 dp~~Rp~~~~~l~h~~f~  253 (259)
                      ||.+||++.+++++.+..
T Consensus       255 dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          255 KPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             SGGGSCCHHHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHHHH
Confidence            999999999999987654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.4e-40  Score=267.19  Aligned_cols=213  Identities=24%  Similarity=0.289  Sum_probs=161.9

Q ss_pred             CchhHHHHHHHhh--CCCCCeeEEEEEEEeC----ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           12 PSSMIREVSCLME--LNHPNIIRLMRVASQG----IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        12 ~~~~~~Ei~~l~~--l~H~niv~~~~~~~~~----~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ...+.+|.+++..  ++||||+++++++...    ..+++||||+.+ +|.++++.                ..++...+
T Consensus        44 ~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----------------~~~~~~~~  107 (301)
T 3q4u_A           44 EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----------------TTLDTVSC  107 (301)
T ss_dssp             HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT----------------CCBCHHHH
T ss_pred             chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh----------------cccCHHHH
Confidence            4566778887777  7999999999997543    468999999996 99999953                33566778


Q ss_pred             HHHHhhccccccccc--------CCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC----CcCCccCccccCc
Q 039159           85 VEEFSSSDSSRSLSF--------GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE----SSAEVGTHYYKAP  152 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh--------~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~----~~~~~~~~~~~aP  152 (259)
                      ..++.+++.||+|||        +++|+||||||+||+++.++ .+||+|||++.........    .....||+.|+||
T Consensus       108 ~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  186 (301)
T 3q4u_A          108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP  186 (301)
T ss_dssp             HHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCH
T ss_pred             HHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEeeCCCeeecccccccccccccccccccceeCh
Confidence            899999999999999        99999999999999999888 8999999999765433221    2344799999999


Q ss_pred             ccccCcc-----CCCcccchHhHHHHHHHHHhC----------CCCCCCC----ChHHHHHHH-hCCCCCCccccccccc
Q 039159          153 ELLLGLL-----EYSTAVDIWPVGCIFGEMVSG----------KPLFPGA----NSLITLGRI-VGKSRKPSFCKLSLRD  212 (259)
Q Consensus       153 E~~~~~~-----~~~~~~DiwslG~~l~e~~tg----------~~pf~~~----~~~~~~~~i-~~~~~~~~~~~~~~~~  212 (259)
                      |.+.+..     .++.++|||||||++|+|++|          ..||...    ......... ......+..+...   
T Consensus       187 E~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  263 (301)
T 3q4u_A          187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRW---  263 (301)
T ss_dssp             HHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG---
T ss_pred             hhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhh---
Confidence            9997632     344689999999999999999          8888643    222222232 2222222221100   


Q ss_pred             cccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          213 HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                          .....++.+.+++.+||..||.+|||++++++
T Consensus       264 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          264 ----FSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             ----GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----ccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                01224578999999999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.9e-40  Score=268.22  Aligned_cols=207  Identities=21%  Similarity=0.222  Sum_probs=165.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeC--ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQG--IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .+.+.+|++++++++||||+++++++.+.  ..+++||||+.+ +|.+++..                ..++...+..++
T Consensus        77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------~~~~~~~~~~i~  140 (318)
T 3lxp_A           77 RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----------------HSIGLAQLLLFA  140 (318)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG----------------SCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh----------------CCCCHHHHHHHH
Confidence            46689999999999999999999999874  688999999986 99999854                225567788999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .+++.||+|||+.+|+||||||+||+++.++ .+||+|||.+........   ......+++.|+|||.+.+ ..++.++
T Consensus       141 ~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~  218 (318)
T 3lxp_A          141 QQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYAS  218 (318)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHH
T ss_pred             HHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEECCccccccccccccccccccCCCCCceeeChHHhcC-CCCCcHH
Confidence            9999999999999999999999999999888 899999999986543221   1234457888999999987 5678899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHH--------------HHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHh
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLIT--------------LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~--------------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  231 (259)
                      ||||||+++|+|++|..||........              .........            .......+++++.++|.+
T Consensus       219 Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~  286 (318)
T 3lxp_A          219 DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE------------RLPRPDKCPAEVYHLMKN  286 (318)
T ss_dssp             HHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC------------CCCCCTTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc------------CCCCCccccHHHHHHHHH
Confidence            999999999999999999975432211              111111111            111234688999999999


Q ss_pred             hcCcCCCCccCHHHHhc
Q 039159          232 MLGMDPDKRITAAEALQ  248 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~  248 (259)
                      ||..||.+|||++++++
T Consensus       287 ~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          287 CWETEASFRPTFENLIP  303 (318)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HcCCCcccCcCHHHHHH
Confidence            99999999999999984

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=278.88  Aligned_cols=225  Identities=19%  Similarity=0.243  Sum_probs=169.1

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc--eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGI--YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ...+.+.+|++++++++||||+++++++...+  ..++||||+.| +|.+++......            ..++...+..
T Consensus        49 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~l~~~~~~~  116 (396)
T 4eut_A           49 RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA------------YGLPESEFLI  116 (396)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGT------------TCCCHHHHHH
T ss_pred             chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcc------------cCCCHHHHHH
Confidence            33567889999999999999999999998765  78999999986 999998643211            2266778899


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEE----cCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc----
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILV----DLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL----  158 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili----~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----  158 (259)
                      ++.+++.||+|||+++|+||||||+||++    +.++ .+||+|||.++..... .......||+.|+|||.+.+.    
T Consensus       117 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~  194 (396)
T 4eut_A          117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRK  194 (396)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE-EEEECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--
T ss_pred             HHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce-eEEEecCCCceEccCC-CccccccCCccccCHHHhhcccccc
Confidence            99999999999999999999999999998    6565 7999999999865432 223345799999999998641    


Q ss_pred             ---cCCCcccchHhHHHHHHHHHhCCCCCCC----CChHHHHHHHhCCCCCCccccccc-----------cccccCCCCC
Q 039159          159 ---LEYSTAVDIWPVGCIFGEMVSGKPLFPG----ANSLITLGRIVGKSRKPSFCKLSL-----------RDHLTNGFPG  220 (259)
Q Consensus       159 ---~~~~~~~DiwslG~~l~e~~tg~~pf~~----~~~~~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~~~  220 (259)
                         ..++.++|||||||++|+|++|+.||..    .........+..............           ..........
T Consensus       195 ~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  274 (396)
T 4eut_A          195 DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRG  274 (396)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHH
T ss_pred             ccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchH
Confidence               3567899999999999999999999964    233444555544432211111000           0000011123


Q ss_pred             CCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          221 LEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       221 ~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      +++.+.+++.+||..||++||+++++++
T Consensus       275 ~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          275 LQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             HHhhchHHHHHhhccChhhhccHHHHHH
Confidence            4567789999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.1e-40  Score=270.07  Aligned_cols=228  Identities=21%  Similarity=0.264  Sum_probs=169.1

Q ss_pred             CCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc--eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchh
Q 039159            3 GIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGI--YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLF   79 (259)
Q Consensus         3 ~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~   79 (259)
                      .+...++...+++.+|++++++++||||+++++++...+  ..++||||+.+ +|.+++....              ..+
T Consensus        77 ~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~  142 (326)
T 2w1i_A           77 KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--------------ERI  142 (326)
T ss_dssp             EESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST--------------TSS
T ss_pred             EeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc--------------cCC
Confidence            344444455568999999999999999999999987654  78999999986 9999996532              225


Q ss_pred             HHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCccccc
Q 039159           80 TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLL  156 (259)
Q Consensus        80 ~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~  156 (259)
                      +...++.++.+++.||+|||+.+++||||||+||+++.++ .++|+|||.+........   ......++..|+|||.+.
T Consensus       143 ~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  221 (326)
T 2w1i_A          143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT  221 (326)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCcchhhccccccccccccCCCCceeEECchhhc
Confidence            5667888999999999999999999999999999999888 999999999986543322   122345678899999997


Q ss_pred             CccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccc-----ccccccCCCCCCCHHHHHHHHh
Q 039159          157 GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLS-----LRDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       157 ~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~  231 (259)
                      + ..++.++||||||+++|+|++|..||.....  ..................     ......+....+++++.++|.+
T Consensus       222 ~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  298 (326)
T 2w1i_A          222 E-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE  298 (326)
T ss_dssp             H-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             C-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Confidence            7 5678899999999999999999988864311  111111111000000000     0000111234688999999999


Q ss_pred             hcCcCCCCccCHHHHhc
Q 039159          232 MLGMDPDKRITAAEALQ  248 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~  248 (259)
                      ||..||++||++.++++
T Consensus       299 cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          299 CWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HSCSSGGGSCCHHHHHH
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-39  Score=263.67  Aligned_cols=213  Identities=20%  Similarity=0.169  Sum_probs=165.6

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEE-EeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVA-SQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++.+|+.+++.++|++++..++.+ ..++..++||||+.++|.+++....              ..++...+..++.
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~  112 (296)
T 3uzp_A           47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS--------------RKFSLKTVLLLAD  112 (296)
T ss_dssp             SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT--------------TCCCHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEecCCCHHHHHHhhc--------------cCCCHHHHHHHHH
Confidence            346799999999999988866666655 5677889999999779999996422              2356678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEc---CCCCeEEEeeccccccccccCC-------CCcCCccCccccCcccccCcc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVD---LDGKTVKVAGFGLAKSLYAYKG-------ESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~---~~~~~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      |++.||+|||+++|+||||||+||+++   .++ .+||+|||.+........       ......||+.|+|||.+.+ .
T Consensus       113 qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~  190 (296)
T 3uzp_A          113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-I  190 (296)
T ss_dssp             HHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-C
T ss_pred             HHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccccccccccccccccccccccccccCChhhhcC-C
Confidence            999999999999999999999999994   566 899999999986544322       1245579999999999987 5


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANS---LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                      .++.++|||||||++|+|++|+.||.+...   ......+.....         ..+.......+++++.+++.+||+.|
T Consensus       191 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~d  261 (296)
T 3uzp_A          191 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM---------STPIEVLCKGYPSEFATYLNFCRSLR  261 (296)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH---------HSCHHHHTTTSCHHHHHHHHHHHTSC
T ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc---------CCchHHHHhhCCHHHHHHHHHHHhcC
Confidence            688999999999999999999999986321   111212111000         00111122468899999999999999


Q ss_pred             CCCccCHHHHhc
Q 039159          237 PDKRITAAEALQ  248 (259)
Q Consensus       237 p~~Rp~~~~~l~  248 (259)
                      |++||+++++++
T Consensus       262 p~~Rps~~~l~~  273 (296)
T 3uzp_A          262 FDDKPDYSYLRQ  273 (296)
T ss_dssp             TTCCCCHHHHHH
T ss_pred             cCcCCCHHHHHH
Confidence            999999999885

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=273.19  Aligned_cols=217  Identities=21%  Similarity=0.231  Sum_probs=166.4

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEe----CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQ----GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      +....+.+.+|++++++++||||+++++++..    ....++||||+.+ +|.+++......           ...++..
T Consensus        66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~  134 (317)
T 2buj_A           66 EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK-----------GNFLTED  134 (317)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTT-----------TCCCCHH
T ss_pred             CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhc-----------CCCCCHH
Confidence            34455678999999999999999999999873    3478999999996 999988653211           1345677


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---------CcCCccCccccCcc
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---------SSAEVGTHYYKAPE  153 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---------~~~~~~~~~~~aPE  153 (259)
                      .+..++.|++.||+|||+++|+||||||+||+++.++ .++|+|||.+.........         .....||+.|+|||
T Consensus       135 ~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  213 (317)
T 2buj_A          135 QILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE  213 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGG
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEEEecCcchhcccccccccccccccccccccCCcccCCHh
Confidence            8889999999999999999999999999999999888 8999999998654221110         01234789999999


Q ss_pred             cccCcc--CCCcccchHhHHHHHHHHHhCCCCCCCCCh--HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHH
Q 039159          154 LLLGLL--EYSTAVDIWPVGCIFGEMVSGKPLFPGANS--LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLI  229 (259)
Q Consensus       154 ~~~~~~--~~~~~~DiwslG~~l~e~~tg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  229 (259)
                      .+.+..  .++.++||||||+++|+|++|+.||.....  ......+......             +....+++.+.+++
T Consensus       214 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~l~~li  280 (317)
T 2buj_A          214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI-------------PQSPRHSSALWQLL  280 (317)
T ss_dssp             GSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C-------------CCCTTSCHHHHHHH
T ss_pred             HhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC-------------CccccCCHHHHHHH
Confidence            987522  368899999999999999999999953110  0111111111111             11246789999999


Q ss_pred             HhhcCcCCCCccCHHHHhcC
Q 039159          230 SKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       230 ~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      .+||..||.+||++++++++
T Consensus       281 ~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          281 NSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcChhhCCCHHHHHHH
Confidence            99999999999999999975

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.5e-40  Score=265.69  Aligned_cols=213  Identities=20%  Similarity=0.178  Sum_probs=165.6

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEE-EeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVA-SQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...++.+|+++++.++|+|++..++.+ ..++..++||||+.++|.+++....              ..++...+..++.
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~  112 (296)
T 4hgt_A           47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS--------------RKFSLKTVLLLAD  112 (296)
T ss_dssp             -CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT--------------SCCCHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEccCCCHHHHHHHhc--------------CCCCHHHHHHHHH
Confidence            345789999999999988777766655 5677899999999779999986422              2356678889999


Q ss_pred             hcccccccccCCCceeccCCCCcEEE---cCCCCeEEEeeccccccccccCC-------CCcCCccCccccCcccccCcc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSLYAYKG-------ESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili---~~~~~~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      |++.||+|||+++|+||||||+||++   +.++ .+||+|||.+........       ......||+.|+|||.+.+ .
T Consensus       113 qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~  190 (296)
T 4hgt_A          113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-I  190 (296)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-C
T ss_pred             HHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC-C
Confidence            99999999999999999999999999   6676 899999999986544322       1234578999999999987 5


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCCCCCChH---HHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLFPGANSL---ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                      .++.++|||||||++|++++|+.||.+....   .....+....         ...........+++++.+++..||..|
T Consensus       191 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~  261 (296)
T 4hgt_A          191 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK---------MSTPIEVLCKGYPSEFATYLNFCRSLR  261 (296)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH---------HHSCHHHHTTTSCHHHHHHHHHHHTSC
T ss_pred             CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc---------ccchhhhhhccCCHHHHHHHHHHHhcC
Confidence            6889999999999999999999999764321   1111111000         000111122467899999999999999


Q ss_pred             CCCccCHHHHhc
Q 039159          237 PDKRITAAEALQ  248 (259)
Q Consensus       237 p~~Rp~~~~~l~  248 (259)
                      |++||+++++++
T Consensus       262 p~~Rpt~~~l~~  273 (296)
T 4hgt_A          262 FDDKPDYSYLRQ  273 (296)
T ss_dssp             TTCCCCHHHHHH
T ss_pred             CCCCCCHHHHHH
Confidence            999999999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.6e-39  Score=264.47  Aligned_cols=201  Identities=22%  Similarity=0.325  Sum_probs=155.1

Q ss_pred             CchhHHHHHHH-hhCCCCCeeEEEEEEEe----CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           12 PSSMIREVSCL-MELNHPNIIRLMRVASQ----GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        12 ~~~~~~Ei~~l-~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ...+.+|+.++ +.++||||+++++++..    +...++||||+.| +|.+++.....             ..++...+.
T Consensus        54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~  120 (299)
T 3m2w_A           54 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-------------QAFTEREAS  120 (299)
T ss_dssp             SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTT-------------CCCBHHHHH
T ss_pred             cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccC-------------CCCCHHHHH
Confidence            35688999988 66689999999999987    6789999999986 99999975321             246677889


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcC---CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCC
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDL---DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~---~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .++.+++.||+|||+.+++||||||+||+++.   ++ .++|+|||++....                      + ..++
T Consensus       121 ~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~~----------------------~-~~~~  176 (299)
T 3m2w_A          121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETT----------------------G-EKYD  176 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECT----------------------T-CGGG
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCC-cEEEeccccccccc----------------------c-ccCC
Confidence            99999999999999999999999999999998   55 89999999986431                      1 3467


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      .++|||||||++|+|++|..||.+...................      ......+..+++++.+++.+||..||.+|||
T Consensus       177 ~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps  250 (299)
T 3m2w_A          177 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT  250 (299)
T ss_dssp             GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC------SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc------cCCchhcccCCHHHHHHHHHHcccChhhCCC
Confidence            8899999999999999999999875543322111111100000      0011112468899999999999999999999


Q ss_pred             HHHHhcCccccCC
Q 039159          243 AAEALQQEYFKDV  255 (259)
Q Consensus       243 ~~~~l~h~~f~~~  255 (259)
                      ++++++||||.+.
T Consensus       251 ~~e~l~hp~~~~~  263 (299)
T 3m2w_A          251 ITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHHHTSHHHHTG
T ss_pred             HHHHhcChhhccc
Confidence            9999999999865

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.6e-39  Score=287.25  Aligned_cols=208  Identities=23%  Similarity=0.339  Sum_probs=170.4

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+++.+|+.++++++||||+++++++. ++..++||||+.+ +|.+++....              ..++...++.++.
T Consensus       434 ~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~  498 (656)
T 2j0j_A          434 VREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK--------------FSLDLASLILYAY  498 (656)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTT--------------TTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhcc--------------CCCCHHHHHHHHH
Confidence            3477899999999999999999999985 4578999999995 9999986421              2355677888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccchH
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      |++.||+|||+++|+||||||+||+++.++ .+||+|||++........ ......+++.|+|||.+.+ ..++.++|||
T Consensus       499 qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Diw  576 (656)
T 2j0j_A          499 QLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVW  576 (656)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCCCSCCC----------CCGGGCCHHHHHH-CCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHH
Confidence            999999999999999999999999999888 999999999986533221 1223356789999999976 5788999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++|||++ |..||.+.........+......+             ..+.+++.+.++|.+||..||.+||++.+++
T Consensus       577 SlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~  643 (656)
T 2j0j_A          577 MFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELK  643 (656)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC-------------CCccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            99999999997 999999888777776665443221             1246889999999999999999999999998


Q ss_pred             c
Q 039159          248 Q  248 (259)
Q Consensus       248 ~  248 (259)
                      +
T Consensus       644 ~  644 (656)
T 2j0j_A          644 A  644 (656)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=271.30  Aligned_cols=216  Identities=13%  Similarity=0.142  Sum_probs=167.6

Q ss_pred             chhHHHHHHHhhCCCCCeeE---------------EEEEEEe-CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCc
Q 039159           13 SSMIREVSCLMELNHPNIIR---------------LMRVASQ-GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSY   76 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~---------------~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~   76 (259)
                      +++.+|++++++++||||++               +++++.. +...++||||+.++|.+++.....             
T Consensus        87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-------------  153 (352)
T 2jii_A           87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPK-------------  153 (352)
T ss_dssp             STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGG-------------
T ss_pred             chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCc-------------
Confidence            57899999999999999988               6777776 678999999995599999964311             


Q ss_pred             chhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCC-CeEEEeeccccccccccCC-------CCcCCccCcc
Q 039159           77 SLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG-KTVKVAGFGLAKSLYAYKG-------ESSAEVGTHY  148 (259)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~-~~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~  148 (259)
                      ..++...++.++.|++.||+|||+++|+||||||+||+++.++ ..+||+|||+++.......       ......||+.
T Consensus       154 ~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~  233 (352)
T 2jii_A          154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLE  233 (352)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCcc
Confidence            3466788899999999999999999999999999999999765 2699999999976543221       1234479999


Q ss_pred             ccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhCC--CCCCccccccccccccCCCCCCCHHH
Q 039159          149 YKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN-SLITLGRIVGK--SRKPSFCKLSLRDHLTNGFPGLEPAG  225 (259)
Q Consensus       149 ~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~-~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (259)
                      |+|||.+.+ ..++.++|||||||++|+|++|+.||.... ...........  ...+...      .....+..+++++
T Consensus       234 y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l  306 (352)
T 2jii_A          234 FISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFV------GPCGHWIRPSETL  306 (352)
T ss_dssp             TCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEE------CTTSCEECCCHHH
T ss_pred             ccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhh------hhccccCCCcHHH
Confidence            999999987 578899999999999999999999998753 22222221110  0001100      0011123578999


Q ss_pred             HHHHHhhcCcCCCCccCHHHHhc
Q 039159          226 IDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       226 ~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      .+++.+||..||.+||+++++++
T Consensus       307 ~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          307 QKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhCChhhCCCHHHHHH
Confidence            99999999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-38  Score=262.64  Aligned_cols=212  Identities=26%  Similarity=0.299  Sum_probs=158.7

Q ss_pred             chhHHHHHHHhhC--CCCCeeEEEEEEEeC----ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           13 SSMIREVSCLMEL--NHPNIIRLMRVASQG----IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        13 ~~~~~Ei~~l~~l--~H~niv~~~~~~~~~----~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ..+.+|.+++..+  +||||+++++++...    ..+++||||+.+ +|.+++..                ..+....+.
T Consensus        74 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----------------~~~~~~~~~  137 (337)
T 3mdy_A           74 ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS----------------TTLDAKSML  137 (337)
T ss_dssp             HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH----------------CCBCHHHHH
T ss_pred             chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc----------------cCCCHHHHH
Confidence            4556666666665  899999999999887    689999999986 99999954                235567788


Q ss_pred             HHHhhcccccccccCC--------CceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC----CcCCccCccccCcc
Q 039159           86 EEFSSSDSSRSLSFGT--------RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE----SSAEVGTHYYKAPE  153 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~--------~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE  153 (259)
                      .++.+++.||+|||+.        +|+||||||+||+++.++ .+||+|||++.........    .....||+.|+|||
T Consensus       138 ~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  216 (337)
T 3mdy_A          138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE  216 (337)
T ss_dssp             HHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEECC---------CCSSCSCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeCCCceeeccccccccCCCCCCccCcceeChh
Confidence            9999999999999998        999999999999999888 8999999999765433222    23457999999999


Q ss_pred             cccCccCCCc------ccchHhHHHHHHHHHhC----------CCCCCCCC----hHHHHHHHh-CCCCCCccccccccc
Q 039159          154 LLLGLLEYST------AVDIWPVGCIFGEMVSG----------KPLFPGAN----SLITLGRIV-GKSRKPSFCKLSLRD  212 (259)
Q Consensus       154 ~~~~~~~~~~------~~DiwslG~~l~e~~tg----------~~pf~~~~----~~~~~~~i~-~~~~~~~~~~~~~~~  212 (259)
                      .+.+. ....      ++|||||||++|||++|          ..||....    ......... .....+..+...   
T Consensus       217 ~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  292 (337)
T 3mdy_A          217 VLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW---  292 (337)
T ss_dssp             HHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG---
T ss_pred             hcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccc---
Confidence            99763 3333      38999999999999999          66775421    122222222 121122211100   


Q ss_pred             cccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          213 HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                          ....+++++.+++.+||..||.+|||+++++++
T Consensus       293 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          293 ----SSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             ----GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                012356789999999999999999999999975

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-38  Score=263.36  Aligned_cols=214  Identities=21%  Similarity=0.209  Sum_probs=165.5

Q ss_pred             CchhHHHHHHHhh--CCCCCeeEEEEEEEeCc----eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           12 PSSMIREVSCLME--LNHPNIIRLMRVASQGI----YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        12 ~~~~~~Ei~~l~~--l~H~niv~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ...+.+|+++++.  ++||||+++++++..+.    ..++||||+.+ +|.+++..                ..++...+
T Consensus        78 ~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----------------~~~~~~~~  141 (342)
T 1b6c_B           78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----------------YTVTVEGM  141 (342)
T ss_dssp             HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH----------------CCBCHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc----------------cCccHHHH
Confidence            4678899999988  78999999999998775    78999999996 99999964                23556778


Q ss_pred             HHHHhhccccccccc--------CCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC----CCcCCccCccccCc
Q 039159           85 VEEFSSSDSSRSLSF--------GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG----ESSAEVGTHYYKAP  152 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh--------~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~aP  152 (259)
                      +.++.+++.||+|||        +.+|+||||||+||+++.++ .+||+|||++........    ......||+.|+||
T Consensus       142 ~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aP  220 (342)
T 1b6c_B          142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP  220 (342)
T ss_dssp             HHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCH
T ss_pred             HHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECCCceeccccccccccccccCCcCcccCCH
Confidence            899999999999999        89999999999999999888 899999999976543322    23445799999999


Q ss_pred             ccccCccC-----CCcccchHhHHHHHHHHHhC----------CCCCCCCC-----hHHHHHHHhCCCCCCccccccccc
Q 039159          153 ELLLGLLE-----YSTAVDIWPVGCIFGEMVSG----------KPLFPGAN-----SLITLGRIVGKSRKPSFCKLSLRD  212 (259)
Q Consensus       153 E~~~~~~~-----~~~~~DiwslG~~l~e~~tg----------~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~  212 (259)
                      |.+.+...     ++.++|||||||++|+|++|          ..||....     .......+......+..+...   
T Consensus       221 E~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  297 (342)
T 1b6c_B          221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW---  297 (342)
T ss_dssp             HHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG---
T ss_pred             hhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc---
Confidence            99976322     23689999999999999999          77886542     222233333332222221100   


Q ss_pred             cccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          213 HLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                          .....++.+.+++.+||..||++|||+.+++++
T Consensus       298 ----~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          298 ----QSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             ----GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ----cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                011344678899999999999999999999975

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4e-39  Score=273.15  Aligned_cols=215  Identities=14%  Similarity=0.124  Sum_probs=162.2

Q ss_pred             CCCchhHHHHHHHhhCCC-CCe---------------------eEEEEEEEe-----CceEEEEeeeecCCHHHHhhcCC
Q 039159           10 GVPSSMIREVSCLMELNH-PNI---------------------IRLMRVASQ-----GIYLYPVFEYQVNDLAYLLKYPK   62 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H-~ni---------------------v~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~~   62 (259)
                      ...+.+.+|+.+++.++| +|.                     ..+..++..     ....+++|+++.++|.++++...
T Consensus       120 ~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~  199 (413)
T 3dzo_A          120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL  199 (413)
T ss_dssp             -CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhh
Confidence            446789999999999987 221                     111122221     12468888888889999985321


Q ss_pred             CCCCCcccccCCCcchhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcC
Q 039159           63 DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSA  142 (259)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~  142 (259)
                      ...        .....++...++.++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++.....   ...
T Consensus       200 ~~~--------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~-~~kL~DFG~a~~~~~~---~~~  267 (413)
T 3dzo_A          200 SHS--------STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGAS---AVS  267 (413)
T ss_dssp             HHT--------TTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGCEETTEE---ECC
T ss_pred             ccc--------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCC-eEEEEeccceeecCCc---ccc
Confidence            100        0115677788889999999999999999999999999999999998 7999999998764322   345


Q ss_pred             CccCccccCccccc---------CccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccccccc
Q 039159          143 EVGTHYYKAPELLL---------GLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDH  213 (259)
Q Consensus       143 ~~~~~~~~aPE~~~---------~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  213 (259)
                      ..| +.|+|||.+.         ....++.++|||||||++|+|++|+.||.+........                  .
T Consensus       268 ~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~------------------~  328 (413)
T 3dzo_A          268 PIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE------------------W  328 (413)
T ss_dssp             CCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG------------------G
T ss_pred             CCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH------------------H
Confidence            567 9999999993         22457889999999999999999999998654321111                  1


Q ss_pred             ccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          214 LTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       214 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      .......+++.+.+||.+||..||++||++.++++||||+.+
T Consensus       329 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          329 IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            122334688999999999999999999999999999999754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.1e-38  Score=271.72  Aligned_cols=212  Identities=17%  Similarity=0.175  Sum_probs=167.3

Q ss_pred             CchhHHHHHHHhhCCC-CCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNH-PNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|+++++.|+| +++..+..++..++..++||||+.++|.+++....              ..+....++.++.|
T Consensus        46 ~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~--------------~~l~~~~~~~i~~q  111 (483)
T 3sv0_A           46 HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS--------------RKLSLKTVLMLADQ  111 (483)
T ss_dssp             SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT--------------TCCCHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECCCCCHHHHHHhhc--------------CCCCHHHHHHHHHH
Confidence            4568999999999986 66667777777888999999999779999997432              23567788999999


Q ss_pred             cccccccccCCCceeccCCCCcEEE---cCCCCeEEEeeccccccccccCCC-------CcCCccCccccCcccccCccC
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILV---DLDGKTVKVAGFGLAKSLYAYKGE-------SSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili---~~~~~~vkl~dfg~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      ++.||+|||+++|+||||||+|||+   +.++ .+||+|||+++........       .....||+.|+|||.+.+ ..
T Consensus       112 i~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~  189 (483)
T 3sv0_A          112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-IE  189 (483)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CC
T ss_pred             HHHHHHHHHHCCEeecccCcceEEEecCCCCC-eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC-CC
Confidence            9999999999999999999999999   4566 8999999999876443221       225579999999999987 57


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCCh---HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANS---LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      ++.++|||||||++|+|++|+.||.+...   ...+..+.....         .........++++++.+++..||..||
T Consensus       190 ~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---------~~~~~~l~~~~p~~l~~li~~cl~~dP  260 (483)
T 3sv0_A          190 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---------ATSIEALCRGYPTEFASYFHYCRSLRF  260 (483)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH---------HSCHHHHHTTSCHHHHHHHHHHHTCCT
T ss_pred             CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc---------cccHHHHhcCCcHHHHHHHHHHhcCCh
Confidence            89999999999999999999999987432   222322221110         011111224678999999999999999


Q ss_pred             CCccCHHHHhc
Q 039159          238 DKRITAAEALQ  248 (259)
Q Consensus       238 ~~Rp~~~~~l~  248 (259)
                      ++||+++++++
T Consensus       261 ~~RPs~~el~~  271 (483)
T 3sv0_A          261 DDKPDYSYLKR  271 (483)
T ss_dssp             TCCCCHHHHHH
T ss_pred             hhCcCHHHHHH
Confidence            99999998874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=266.86  Aligned_cols=219  Identities=23%  Similarity=0.255  Sum_probs=154.4

Q ss_pred             chhHHHHHH--HhhCCCCCeeEEEEEEEe-----CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           13 SSMIREVSC--LMELNHPNIIRLMRVASQ-----GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        13 ~~~~~Ei~~--l~~l~H~niv~~~~~~~~-----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ..+..|.++  ++.++||||+++++.+..     ...+++||||+++ +|.+++...                .......
T Consensus        50 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~  113 (336)
T 3g2f_A           50 QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----------------TSDWVSS  113 (336)
T ss_dssp             HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC----------------CBCHHHH
T ss_pred             hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc----------------ccchhHH
Confidence            344555555  445899999999986542     2367999999985 999999642                2245667


Q ss_pred             HHHHhhcccccccccCC---------CceeccCCCCcEEEcCCCCeEEEeeccccccccccC--------CCCcCCccCc
Q 039159           85 VEEFSSSDSSRSLSFGT---------RYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--------GESSAEVGTH  147 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~---------~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--------~~~~~~~~~~  147 (259)
                      ..++.|++.||+|||+.         +|+||||||+||+++.++ .+||+|||++.......        .......||+
T Consensus       114 ~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~  192 (336)
T 3g2f_A          114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI  192 (336)
T ss_dssp             HHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEECCCTTCEECSSSSCC---------CCTTSCG
T ss_pred             HHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEEeeccceeecccccccCccccccccccCCCcc
Confidence            78899999999999999         999999999999999888 89999999997654321        1122446999


Q ss_pred             cccCcccccCc------cCCCcccchHhHHHHHHHHHhCCCCCCCCCh-----------------HHHHHH-HhCCCCCC
Q 039159          148 YYKAPELLLGL------LEYSTAVDIWPVGCIFGEMVSGKPLFPGANS-----------------LITLGR-IVGKSRKP  203 (259)
Q Consensus       148 ~~~aPE~~~~~------~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~-----------------~~~~~~-i~~~~~~~  203 (259)
                      .|+|||.+.+.      ..++.++|||||||++|||++|..||.....                 ...... +......+
T Consensus       193 ~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (336)
T 3g2f_A          193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP  272 (336)
T ss_dssp             GGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCC
T ss_pred             ceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCC
Confidence            99999999762      2355789999999999999999766543211                 111111 11111111


Q ss_pred             ccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc------CccccC
Q 039159          204 SFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ------QEYFKD  254 (259)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~------h~~f~~  254 (259)
                      ..+.      ........++.+.++|.+||..||.+|||++++++      ++|-++
T Consensus       273 ~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          273 KFPE------AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CCCT------TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             CCCc------ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence            1110      00001124557999999999999999999999954      566554

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=265.03  Aligned_cols=209  Identities=11%  Similarity=0.051  Sum_probs=163.8

Q ss_pred             CCCCchhHHHHHHHhhCC---CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159            9 EGVPSSMIREVSCLMELN---HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ......+.+|+++++.++   |+||+++++++..++..|+||||+.| +|.+++.......          ...++...+
T Consensus       105 ~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~l~~~~~  174 (365)
T 3e7e_A          105 PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTP----------EKVMPQGLV  174 (365)
T ss_dssp             SCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTST----------TCSCCHHHH
T ss_pred             CCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhccc----------ccCCCHHHH
Confidence            345567889999999997   99999999999999999999999985 9999996432211          144677889


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcC-----------CCCeEEEeecccccccccc--CCCCcCCccCccccC
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDL-----------DGKTVKVAGFGLAKSLYAY--KGESSAEVGTHYYKA  151 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~-----------~~~~vkl~dfg~~~~~~~~--~~~~~~~~~~~~~~a  151 (259)
                      +.++.|++.||+|||+++|+||||||+||+++.           ++ .+||+|||+++.....  ........||+.|+|
T Consensus       175 ~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a  253 (365)
T 3e7e_A          175 ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC  253 (365)
T ss_dssp             HHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCC
T ss_pred             HHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCC
Confidence            999999999999999999999999999999987           66 8999999999754322  222345579999999


Q ss_pred             cccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHh
Q 039159          152 PELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       152 PE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  231 (259)
                      ||++.+ ..++.++|||||||++|+|++|+.||.......            .    ........  ...++.+.+++..
T Consensus       254 PE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------------~----~~~~~~~~--~~~~~~~~~~~~~  314 (365)
T 3e7e_A          254 VEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------------C----KPEGLFRR--LPHLDMWNEFFHV  314 (365)
T ss_dssp             HHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE------------E----EECSCCTT--CSSHHHHHHHHHH
T ss_pred             hHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCc------------e----eechhccc--cCcHHHHHHHHHH
Confidence            999988 568999999999999999999999996532210            0    00000111  1246678899999


Q ss_pred             hcCcCCCCccCHHHHh
Q 039159          232 MLGMDPDKRITAAEAL  247 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l  247 (259)
                      ||+.+|.+|++..+.+
T Consensus       315 ~l~~~p~~r~~~~~~l  330 (365)
T 3e7e_A          315 MLNIPDCHHLPSLDLL  330 (365)
T ss_dssp             HHCCCCTTCCCCHHHH
T ss_pred             HcCCCCCCcchHHHHH
Confidence            9999999996543333

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.7e-39  Score=264.92  Aligned_cols=208  Identities=16%  Similarity=0.136  Sum_probs=155.2

Q ss_pred             CCchhHHHHHHHhhCC---------CCCeeEEEEEEE------------------------------eCceEEEEeeeec
Q 039159           11 VPSSMIREVSCLMELN---------HPNIIRLMRVAS------------------------------QGIYLYPVFEYQV   51 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~---------H~niv~~~~~~~------------------------------~~~~~~lv~e~~~   51 (259)
                      ..+.+.+|+.+++.++         ||||+++.+++.                              +++.+|+||||+.
T Consensus        66 ~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~  145 (336)
T 2vuw_A           66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF  145 (336)
T ss_dssp             CHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEEC
T ss_pred             hHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecC
Confidence            3478899999999986         888887777643                              2678999999998


Q ss_pred             C-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhccccccccc-CCCceeccCCCCcEEEcCCC----------
Q 039159           52 N-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF-GTRYIRRDLKPVNILVDLDG----------  119 (259)
Q Consensus        52 ~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh-~~~i~H~dlkp~Nili~~~~----------  119 (259)
                      + ++.+.+..                ..++...+..++.|++.||+||| +++|+||||||+|||++.++          
T Consensus       146 ~g~ll~~~~~----------------~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~  209 (336)
T 2vuw_A          146 GGIDLEQMRT----------------KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNG  209 (336)
T ss_dssp             CCEETGGGTT----------------TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETT
T ss_pred             CCccHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccC
Confidence            5 55555522                22456788999999999999999 99999999999999999774          


Q ss_pred             ---------CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHHHH-HHHHHhCCCCCCCCCh
Q 039159          120 ---------KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCI-FGEMVSGKPLFPGANS  189 (259)
Q Consensus       120 ---------~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~-l~e~~tg~~pf~~~~~  189 (259)
                               ..+||+|||+++....     ....||+.|+|||.+.+. . +.++||||+|++ .+++++|..||.+...
T Consensus       210 ~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~  282 (336)
T 2vuw_A          210 KSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDEDLFTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLW  282 (336)
T ss_dssp             EEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSGGGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH
T ss_pred             ccccccCCCceEEEeeccccEecCC-----CcEEEeecccChhhhcCC-C-ccceehhhhhCCCCcccccccCCCcchhh
Confidence                     2799999999986532     244799999999999873 3 789999998776 7778889999854211


Q ss_pred             -HHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh-cCcccc
Q 039159          190 -LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL-QQEYFK  253 (259)
Q Consensus       190 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l-~h~~f~  253 (259)
                       ......+..........       ....++.+++++.+||.+||..|     |++++| +||||+
T Consensus       283 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          283 LHYLTDKMLKQMTFKTKC-------NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHTCCCSSCC-------CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhHHHHhhhhhhccCccc-------chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence             11122222111111110       00112347789999999999986     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-37  Score=278.19  Aligned_cols=199  Identities=20%  Similarity=0.219  Sum_probs=158.1

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCce-----EEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIY-----LYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-----~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      +..+.+.+|++++++++||||+++++++...+.     .|+||||+.| +|.+.+.                 ..++...
T Consensus       121 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~-----------------~~l~~~~  183 (681)
T 2pzi_A          121 EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-----------------QKLPVAE  183 (681)
T ss_dssp             HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC---------------------CCCCHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh-----------------CCCCHHH
Confidence            344578899999999999999999999987654     7999999997 7766543                 2355678


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCc
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      ++.++.+++.||+|||++||+||||||+||+++.+  .+||+|||+++....    .....||+.|+|||.+.+.  ++.
T Consensus       184 ~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~----~~~~~gt~~y~aPE~~~~~--~~~  255 (681)
T 2pzi_A          184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINS----FGYLYGTPGFQAPEIVRTG--PTV  255 (681)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTC----CSCCCCCTTTSCTTHHHHC--SCH
T ss_pred             HHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhccc----CCccCCCccccCHHHHcCC--CCC
Confidence            88999999999999999999999999999999864  699999999986533    2455799999999998762  488


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      ++|||||||++|+|++|.+||.+....        .  .+...      .    ....++.+.++|.+||..||.+||+.
T Consensus       256 ~sDi~slG~~l~~l~~g~~~~~~~~~~--------~--~~~~~------~----~~~~~~~l~~li~~~l~~dP~~R~~~  315 (681)
T 2pzi_A          256 ATDIYTVGRTLAALTLDLPTRNGRYVD--------G--LPEDD------P----VLKTYDSYGRLLRRAIDPDPRQRFTT  315 (681)
T ss_dssp             HHHHHHHHHHHHHHHSCCCEETTEECS--------S--CCTTC------H----HHHHCHHHHHHHHHHTCSSGGGSCSS
T ss_pred             ceehhhhHHHHHHHHhCCCCCcccccc--------c--ccccc------c----ccccCHHHHHHHhhhccCChhhCCCH
Confidence            999999999999999999888652110        0  00000      0    01245788999999999999999998


Q ss_pred             HHHhcCcccc
Q 039159          244 AEALQQEYFK  253 (259)
Q Consensus       244 ~~~l~h~~f~  253 (259)
                      .+.+.|+|+.
T Consensus       316 ~~~l~~~l~~  325 (681)
T 2pzi_A          316 AEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            8888887763

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3e-36  Score=243.57  Aligned_cols=182  Identities=13%  Similarity=0.076  Sum_probs=142.6

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      +++.+|++++++++||||+++++++..++..|+||||+.| +|.++++..                . .......++.|+
T Consensus        76 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----------------~-~~~~~~~i~~ql  138 (286)
T 3uqc_A           76 QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----------------P-SPVGAIRAMQSL  138 (286)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC----------------C-CHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC----------------C-ChHHHHHHHHHH
Confidence            6799999999999999999999999999999999999986 999998431                1 123467789999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHH
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVG  171 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG  171 (259)
                      +.||+|||++||+||||||+||+++.++ .++|++++                    |++        .++.++||||||
T Consensus       139 ~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~--------------------~~~--------~~~~~~Di~slG  189 (286)
T 3uqc_A          139 AAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPA--------------------TMP--------DANPQDDIRGIG  189 (286)
T ss_dssp             HHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCC--------------------CCT--------TCCHHHHHHHHH
T ss_pred             HHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecc--------------------ccC--------CCCchhHHHHHH
Confidence            9999999999999999999999999888 89987432                    222        367889999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          172 CIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       172 ~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      |++|+|++|+.||.+.+..............       .........+++++++.+++.+||..||++| |+.++++
T Consensus       190 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          190 ASLYALLVNRWPLPEAGVRSGLAPAERDTAG-------QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHHHHSEECSCCCSBCCCSEECCBCTTS-------CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHHHHCCCCCCcCCcchhhHHHHHHhcc-------CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            9999999999999875432111000000000       0001112235689999999999999999999 9999985

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.7e-34  Score=253.13  Aligned_cols=149  Identities=13%  Similarity=0.009  Sum_probs=111.0

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ..++|.+|+++|+++ .|+||+++++++++++.+||||||++| +|.+.+....               .+..   ..++
T Consensus       284 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~---------------~l~~---~~I~  345 (569)
T 4azs_A          284 NKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE---------------EIDR---EKIL  345 (569)
T ss_dssp             HHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC---------------CCCH---HHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC---------------CCCH---HHHH
Confidence            345799999999999 699999999999999999999999998 9999996531               1122   2467


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.||+|+|++||+||||||+|||++.+| .+||+|||+++..........+.+||+.|+|||++.+  .+...+|+|
T Consensus       346 ~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~  422 (569)
T 4azs_A          346 GSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWR  422 (569)
T ss_dssp             HHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------
T ss_pred             HHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCCccccCceechhhccHHHhCC--CCCCccccc
Confidence            8999999999999999999999999999998 8999999999876554444556689999999999976  356789999


Q ss_pred             hHHHHHHHHHhC
Q 039159          169 PVGCIFGEMVSG  180 (259)
Q Consensus       169 slG~~l~e~~tg  180 (259)
                      |+|++++++.++
T Consensus       423 s~g~~~~~l~~~  434 (569)
T 4azs_A          423 SAPVHPFNLPQP  434 (569)
T ss_dssp             ------CCCCTT
T ss_pred             ccccchhhhccc
Confidence            999987766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=6.6e-26  Score=197.65  Aligned_cols=147  Identities=17%  Similarity=0.103  Sum_probs=119.4

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      +++.+|++++++++||||+++..++...+..|+||||++| +|.+++..                       ...++.|+
T Consensus       384 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----------------------~~~i~~qi  440 (540)
T 3en9_A          384 SRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----------------------NLDIAYKI  440 (540)
T ss_dssp             HHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----------------------CTHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----------------------HHHHHHHH
Confidence            4589999999999999999555555566778999999985 99998852                       34778899


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-------CcCCccCccccCcccccC-ccCCCc
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-------SSAEVGTHYYKAPELLLG-LLEYST  163 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~-~~~~~~  163 (259)
                      ++||+|||+++|+||||||+||+++.   .+||+|||+++........       .....||+.|+|||.+.. ...|+.
T Consensus       441 ~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~  517 (540)
T 3en9_A          441 GEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKS  517 (540)
T ss_dssp             HHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHH
Confidence            99999999999999999999999987   5999999999875432111       124579999999999975 124677


Q ss_pred             ccchHhHHHHHHHHHhCCCCCC
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFP  185 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~  185 (259)
                      .+|+|+..+-..+...++.+|.
T Consensus       518 ~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          518 VYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HCTTHHHHHHHHHHHHTCSCCC
T ss_pred             HHhHHHHHHHHHHHHHhccccC
Confidence            8899999988888877776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.71  E-value=1.6e-18  Score=139.32  Aligned_cols=104  Identities=15%  Similarity=0.053  Sum_probs=82.6

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..++.+|++++++++  | +++++++.. +..|+||||++| +|.+ +..                     .....++.+
T Consensus       148 ~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------------------~~~~~i~~q  201 (282)
T 1zar_A          148 IRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------------------ENPDEVLDM  201 (282)
T ss_dssp             HHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------------------SCHHHHHHH
T ss_pred             HHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------------------hhHHHHHHH
Confidence            356889999999999  4 566665533 567999999987 8877 421                     112357889


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCccccc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL  156 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~  156 (259)
                      ++.|++|||++||+||||||+||+++ ++ .++|+|||.+..             +..+.|||.+.
T Consensus       202 i~~~l~~lH~~giiHrDlkp~NILl~-~~-~vkl~DFG~a~~-------------~~~~~a~e~l~  252 (282)
T 1zar_A          202 ILEEVAKFYHRGIVHGDLSQYNVLVS-EE-GIWIIDFPQSVE-------------VGEEGWREILE  252 (282)
T ss_dssp             HHHHHHHHHHTTEECSCCSTTSEEEE-TT-EEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred             HHHHHHHHHHCCCEeCCCCHHHEEEE-CC-cEEEEECCCCeE-------------CCCCCHHHHHH
Confidence            99999999999999999999999999 77 999999999963             23467888774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.57  E-value=9.4e-16  Score=121.56  Aligned_cols=95  Identities=15%  Similarity=0.103  Sum_probs=73.1

Q ss_pred             hhHHHHHHHhhCCCCCe--eEEEEEEEeCceEEEEeeeecC------CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           14 SMIREVSCLMELNHPNI--IRLMRVASQGIYLYPVFEYQVN------DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H~ni--v~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      .+.+|++++++++|+|+  +.+++.    +..++||||+.+      +|.+....                  .......
T Consensus       116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------------~~~~~~~  173 (258)
T 1zth_A          116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------------LKELDVE  173 (258)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------------GGGSCHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------------cChHHHH
Confidence            68899999999988754  444432    356899999952      44444311                  1123456


Q ss_pred             HHHhhccccccccc-CCCceeccCCCCcEEEcCCCCeEEEeeccccccc
Q 039159           86 EEFSSSDSSRSLSF-GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL  133 (259)
Q Consensus        86 ~~~~~~~~~l~~lh-~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~  133 (259)
                      .++.+++.++.||| ++||+||||||+|||++.   .++|+|||++...
T Consensus       174 ~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          174 GIFNDVVENVKRLYQEAELVHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             HHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            78889999999999 999999999999999986   5999999999653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.18  E-value=4.5e-12  Score=105.02  Aligned_cols=92  Identities=13%  Similarity=0.020  Sum_probs=64.0

Q ss_pred             HHHHHHHhhCCCCCee--EEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcc
Q 039159           16 IREVSCLMELNHPNII--RLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSD   92 (259)
Q Consensus        16 ~~Ei~~l~~l~H~niv--~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (259)
                      .+|...|.++.+.++.  ..++.  .  ..++||||+.| +|..+...                     .....++.|++
T Consensus       161 ~kE~~nL~rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~---------------------~~~~~l~~qll  215 (397)
T 4gyi_A          161 IKEFAFMKALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV---------------------PDPASLYADLI  215 (397)
T ss_dssp             HHHHHHHHHHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCCC---------------------SCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhccc---------------------HHHHHHHHHHH
Confidence            4577777777554432  22221  1  23799999998 55443311                     11245678899


Q ss_pred             cccccccCCCceeccCCCCcEEEcCCCC---------eEEEeecccccc
Q 039159           93 SSRSLSFGTRYIRRDLKPVNILVDLDGK---------TVKVAGFGLAKS  132 (259)
Q Consensus        93 ~~l~~lh~~~i~H~dlkp~Nili~~~~~---------~vkl~dfg~~~~  132 (259)
                      .++.+||++|||||||||.|||++.++.         .+.|+||+-+..
T Consensus       216 ~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          216 ALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             HHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999999999999999999999987651         388999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.99  E-value=2.8e-10  Score=90.08  Aligned_cols=46  Identities=7%  Similarity=-0.004  Sum_probs=40.3

Q ss_pred             CchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHH
Q 039159           12 PSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYL   57 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~   57 (259)
                      ..++.+|+++++.|. +..+.++++++..++..|+|||+++| ++...
T Consensus        53 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~  100 (263)
T 3tm0_A           53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhc
Confidence            457999999999995 77889999999988899999999999 77665

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.83  E-value=2.1e-09  Score=84.64  Aligned_cols=43  Identities=14%  Similarity=0.086  Sum_probs=35.3

Q ss_pred             CchhHHHHHHHhhCCCCC--eeEEEEEEEeCceEEEEeeeecC-CH
Q 039159           12 PSSMIREVSCLMELNHPN--IIRLMRVASQGIYLYPVFEYQVN-DL   54 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~n--iv~~~~~~~~~~~~~lv~e~~~~-~l   54 (259)
                      ...+.+|+.+++.+.+.+  +.+++++...++..++||||++| ++
T Consensus        57 ~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l  102 (264)
T 1nd4_A           57 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL  102 (264)
T ss_dssp             TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence            367889999999996444  56689988887889999999998 55

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.67  E-value=1.1e-08  Score=84.60  Aligned_cols=41  Identities=10%  Similarity=0.202  Sum_probs=33.2

Q ss_pred             CchhHHHHHHHhhCC--CCCeeEEEEEEEeC---ceEEEEeeeecC
Q 039159           12 PSSMIREVSCLMELN--HPNIIRLMRVASQG---IYLYPVFEYQVN   52 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~--H~niv~~~~~~~~~---~~~~lv~e~~~~   52 (259)
                      ..++.+|+.+++.|.  +..+.+++.++.+.   +..|+||||++|
T Consensus        80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G  125 (359)
T 3dxp_A           80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSG  125 (359)
T ss_dssp             --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCC
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCC
Confidence            457899999999997  45688999988766   357899999998

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.50  E-value=2.1e-08  Score=81.00  Aligned_cols=83  Identities=16%  Similarity=0.111  Sum_probs=49.1

Q ss_pred             CCceeccCCCCcEEEcCC-CCeEEEeeccccccccccCCCCcCCccCccccCccccc----CccC---------CCcccc
Q 039159          101 TRYIRRDLKPVNILVDLD-GKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLL----GLLE---------YSTAVD  166 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~-~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~---------~~~~~D  166 (259)
                      ..++|+|++|.||+++.+ +..+.++||+.+........ .........-..|+...    .+..         .....+
T Consensus       191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~  269 (304)
T 3sg8_A          191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEK  269 (304)
T ss_dssp             CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHH
T ss_pred             ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHH
Confidence            478999999999999974 43688999999865311100 00000000001222111    1000         122358


Q ss_pred             hHhHHHHHHHHHhCCCCC
Q 039159          167 IWPVGCIFGEMVSGKPLF  184 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf  184 (259)
                      .|++|.++|.+.+|..+|
T Consensus       270 ~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          270 YWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHcCCHHH
Confidence            999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.88  E-value=2.5e-05  Score=63.00  Aligned_cols=45  Identities=13%  Similarity=0.049  Sum_probs=33.1

Q ss_pred             CchhHHHHHHHhhCCCC---CeeEEEEEEE-eCceEEEEeeeecC-CHHH
Q 039159           12 PSSMIREVSCLMELNHP---NIIRLMRVAS-QGIYLYPVFEYQVN-DLAY   56 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~---niv~~~~~~~-~~~~~~lv~e~~~~-~l~~   56 (259)
                      ..++.+|+++|+.|.+.   .|.+++.+.. .++..++|||+.+| ++..
T Consensus        53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~  102 (306)
T 3tdw_A           53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE  102 (306)
T ss_dssp             HHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence            45788999999999753   3566666664 34567899999998 6554

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.83  E-value=4.1e-05  Score=60.37  Aligned_cols=45  Identities=7%  Similarity=-0.095  Sum_probs=36.1

Q ss_pred             chhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHH
Q 039159           13 SSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYL   57 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~   57 (259)
                      ..+.+|...|+.|. +--|.++++++.+++..++|||+++| ++...
T Consensus        64 ~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~  110 (272)
T 4gkh_A           64 NDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV  110 (272)
T ss_dssp             HHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred             hHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence            45788999999885 43478888999888999999999998 65543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.26  E-value=0.00012  Score=60.22  Aligned_cols=43  Identities=7%  Similarity=0.071  Sum_probs=32.8

Q ss_pred             chhHHHHHHHhhCC-C--CCeeEEEEEEEeC---ceEEEEeeeecC-CHH
Q 039159           13 SSMIREVSCLMELN-H--PNIIRLMRVASQG---IYLYPVFEYQVN-DLA   55 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~-H--~niv~~~~~~~~~---~~~~lv~e~~~~-~l~   55 (259)
                      .++.+|+.+++.|. +  -.+.+++.+..++   +..++|||+++| ++.
T Consensus        72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            67899999999995 3  3577888887655   356899999998 543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.80  E-value=0.0028  Score=51.38  Aligned_cols=32  Identities=13%  Similarity=0.111  Sum_probs=27.5

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ...++|||+.+.||+++.++ .+.++||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENE-QIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGG-CEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCC-cEEEEehhhccc
Confidence            46899999999999997666 799999998753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.47  E-value=0.001  Score=53.21  Aligned_cols=30  Identities=10%  Similarity=-0.053  Sum_probs=24.8

Q ss_pred             CCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ..++|+|+.+.||+. .++ .+.++||..+..
T Consensus       173 ~~l~HgDl~~~Nil~-~~~-~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFLD-TGE-RMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEEE-CSS-CEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEEE-CCC-CEEEEecccccC
Confidence            468999999999994 455 689999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.46  E-value=0.013  Score=44.24  Aligned_cols=135  Identities=16%  Similarity=0.016  Sum_probs=79.7

Q ss_pred             CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhccccccccc-CCCceeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159           53 DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF-GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus        53 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh-~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      +|.++++...              .+++..++..++.|.+.+|.-+- ...-..+=+.|..|++..+| .|-..+ ..+.
T Consensus        34 SL~eIL~~~~--------------~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~   97 (229)
T 2yle_A           34 SLEEILRLYN--------------QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD   97 (229)
T ss_dssp             EHHHHHHHHT--------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C---
T ss_pred             cHHHHHHHcC--------------CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc
Confidence            6777776543              45667778888888877765541 11111223456889999888 566543 1110


Q ss_pred             cccccCCCCcCCccCccccCcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccccccc
Q 039159          132 SLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLR  211 (259)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  211 (259)
                                  .....+.|||...  ...+.+.=|||||+++|.-+--..|=                           
T Consensus        98 ------------~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e---------------------------  136 (229)
T 2yle_A           98 ------------AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE---------------------------  136 (229)
T ss_dssp             ---------------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT---------------------------
T ss_pred             ------------ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc---------------------------
Confidence                        1122356787763  23457788999999999876522111                           


Q ss_pred             ccccCCCCCCCHHHHHHHHhhcCc-------------------------CCCCccCHHHHhc
Q 039159          212 DHLTNGFPGLEPAGIDLISKMLGM-------------------------DPDKRITAAEALQ  248 (259)
Q Consensus       212 ~~~~~~~~~~~~~~~~li~~~l~~-------------------------dp~~Rp~~~~~l~  248 (259)
                          .....+|+.+..||..|..-                         .+..|++.++|++
T Consensus       137 ----~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          137 ----NEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ----TEEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             ----ccchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence                00135889999999988755                         2467888888885

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.19  E-value=0.0031  Score=52.28  Aligned_cols=31  Identities=16%  Similarity=0.300  Sum_probs=26.7

Q ss_pred             CCceeccCCCCcEEEcCC----CCeEEEeecccccc
Q 039159          101 TRYIRRDLKPVNILVDLD----GKTVKVAGFGLAKS  132 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~----~~~vkl~dfg~~~~  132 (259)
                      ..++|+|+.+.||+++.+    + .+.++||..+..
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~-~~~~IDwE~a~~  254 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENAD-SLMLVDFEYSSY  254 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---C-CEEECCCTTCEE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccC-cEEEEecccCCc
Confidence            478999999999999876    4 799999998863

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=93.89  E-value=0.1  Score=41.84  Aligned_cols=41  Identities=15%  Similarity=0.037  Sum_probs=34.2

Q ss_pred             CchhHHHHHHHhhCC---CCCeeEEEEEEEeCceEEEEeeeecC
Q 039159           12 PSSMIREVSCLMELN---HPNIIRLMRVASQGIYLYPVFEYQVN   52 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~---H~niv~~~~~~~~~~~~~lv~e~~~~   52 (259)
                      ...+.+|+..|+.|.   ...+.+++.+...++..++|||+.+|
T Consensus        72 ~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           72 RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            456889999999984   36788899888877889999999987

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=93.55  E-value=0.036  Score=46.48  Aligned_cols=33  Identities=18%  Similarity=0.135  Sum_probs=28.2

Q ss_pred             cCCCceeccCCCCcEEEcCCCCeEEEeeccccccc
Q 039159           99 FGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL  133 (259)
Q Consensus        99 h~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~  133 (259)
                      +...++|||+.|.||+++.++  +.++||+.+...
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC--EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC--CEEEeCcccccC
Confidence            567899999999999998664  899999998643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=93.31  E-value=0.032  Score=44.74  Aligned_cols=32  Identities=22%  Similarity=0.116  Sum_probs=26.4

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ..+++|+|+.+.||+++.++ .+.++||+.+..
T Consensus       186 ~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~  217 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  217 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             CcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence            35799999999999998664 558999988753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=91.91  E-value=0.065  Score=43.22  Aligned_cols=32  Identities=28%  Similarity=0.338  Sum_probs=27.4

Q ss_pred             CCCceeccCCCCcEEEcCC----CCeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLD----GKTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~----~~~vkl~dfg~~~~  132 (259)
                      ...++|||+.+.||+++.+    + .+.++||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~-~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLA-RVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGG-GEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCC-CeEEEeCCCcCc
Confidence            4589999999999999864    4 689999999864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=89.45  E-value=0.19  Score=41.60  Aligned_cols=31  Identities=23%  Similarity=0.168  Sum_probs=26.2

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ...++|||+.+.||+++.+  .++++||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~--~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH--ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS--CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC--CeEEEeCccccc
Confidence            4689999999999999865  489999988754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=89.40  E-value=0.15  Score=40.94  Aligned_cols=30  Identities=20%  Similarity=0.133  Sum_probs=25.5

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ...++|||+++.||+++ +  .+.++||+.+..
T Consensus       194 ~~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~  223 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D--GPMFVDLDDARN  223 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred             CeeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence            45789999999999998 3  589999988754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.25  E-value=0.17  Score=41.50  Aligned_cols=30  Identities=17%  Similarity=0.270  Sum_probs=24.8

Q ss_pred             CCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ..++|+|+.+.||+++.+  .+.++||..+..
T Consensus       212 ~~l~HgDl~~~Nil~~~~--~~~lID~e~a~~  241 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNK--CLRLIDFEYSGF  241 (369)
T ss_dssp             EEEECSCCCGGGEEECC---CEEECCCTTCEE
T ss_pred             eEEEeCCCCcccEEecCC--cEEEEEecCCCC
Confidence            478999999999999754  489999988753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=89.16  E-value=0.13  Score=41.77  Aligned_cols=32  Identities=13%  Similarity=0.161  Sum_probs=27.4

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ...++|+|+.+.||+++.++ .+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            34789999999999998766 799999988764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=87.61  E-value=0.18  Score=42.45  Aligned_cols=36  Identities=19%  Similarity=0.093  Sum_probs=26.4

Q ss_pred             chhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC
Q 039159           13 SSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN   52 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~   52 (259)
                      +.+.+|..+++.|. +.-..++++.+.+    .+|+||++|
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G  156 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPS  156 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCE
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCC
Confidence            56778999999985 4334677776643    278999886

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=86.98  E-value=0.3  Score=41.39  Aligned_cols=33  Identities=18%  Similarity=0.089  Sum_probs=24.3

Q ss_pred             HHHHHHHhhCCCCCe-eEEEEEEEeCceEEEEeeeecC
Q 039159           16 IREVSCLMELNHPNI-IRLMRVASQGIYLYPVFEYQVN   52 (259)
Q Consensus        16 ~~Ei~~l~~l~H~ni-v~~~~~~~~~~~~~lv~e~~~~   52 (259)
                      .+|..+++.|...++ .++++++. +   .+|+||++|
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G  185 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDG  185 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCS
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCC
Confidence            689999999964344 67777773 2   249999887

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.80  E-value=4.1  Score=30.50  Aligned_cols=83  Identities=12%  Similarity=0.093  Sum_probs=57.3

Q ss_pred             CCCCeeEEEEEEEeCceEEEEeeeec-C-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccccccccCCCc
Q 039159           26 NHPNIIRLMRVASQGIYLYPVFEYQV-N-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRY  103 (259)
Q Consensus        26 ~H~niv~~~~~~~~~~~~~lv~e~~~-~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~i  103 (259)
                      .||+.++. .+-++++.+.+.++.-. + +... +                  ........+..+..++....+++  .-
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------------------k~~~~~eKlr~l~ni~~l~~~~~--~r  100 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------------------KSFTKNEKLRYLLNIKNLEEVNR--TR  100 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------------------GGSCHHHHHHHHHHGGGGGGGGG--SS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------------------HhcCHHHHHHHHHHHHHHHHHhc--Cc
Confidence            58999877 56667777766666544 2 2222 2                  44555677777878877665543  34


Q ss_pred             eeccCCCCcEEEcCCCCeEEEeeccccc
Q 039159          104 IRRDLKPVNILVDLDGKTVKVAGFGLAK  131 (259)
Q Consensus       104 ~H~dlkp~Nili~~~~~~vkl~dfg~~~  131 (259)
                      +|--+.|+|++++.++ .+++.-.|+..
T Consensus       101 ~tf~L~P~NL~f~~~~-~p~i~~RGik~  127 (215)
T 4ann_A          101 YTFVLAPDELFFTRDG-LPIAKTRGLQN  127 (215)
T ss_dssp             EECCCSGGGEEECTTS-CEEESCCEETT
T ss_pred             eEEEEecceEEEcCCC-CEEEEEccCcc
Confidence            6777999999999998 89998777653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=83.68  E-value=0.54  Score=39.02  Aligned_cols=31  Identities=16%  Similarity=0.225  Sum_probs=24.5

Q ss_pred             CceeccCCCCcEEEcC-----CCCeEEEeecccccc
Q 039159          102 RYIRRDLKPVNILVDL-----DGKTVKVAGFGLAKS  132 (259)
Q Consensus       102 ~i~H~dlkp~Nili~~-----~~~~vkl~dfg~~~~  132 (259)
                      .++|+|+.+.||++..     ....+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            4679999999999932     233799999999864

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=80.21  E-value=0.75  Score=38.53  Aligned_cols=30  Identities=13%  Similarity=0.349  Sum_probs=25.5

Q ss_pred             CCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ..++|+|+.+.|++ +.++ .+.++||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~-~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQN-NIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSS-CEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCC-cEEEEecccCCc
Confidence            47899999999999 5565 799999999864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	259
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-45
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-41
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-41
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-40
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-40
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-39
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-38
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-37
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-37
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-36
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-36
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-34
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-33
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-32
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-29
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-29
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-29
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-29
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-29
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-28
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-27
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-27
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-27
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-27
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-27
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-26
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-26
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-26
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-26
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-25
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-25
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-25
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-25
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-24
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-23
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-23
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-22
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-22
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-22
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-22
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-21

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 8e-45
 Identities = 79/262 (30%), Positives = 119/262 (45%), Gaps = 29/262 (11%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           +G+  + +RE+  L EL+HPNII L+        +  VF++   DL  ++K     +   
Sbjct: 41  DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS 100

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
             K +    +  T   +E                 + RDLKP N+L+D +G  +K+A FG
Sbjct: 101 HIKAY----MLMTLQGLEYLHQH----------WILHRDLKPNNLLLDENG-VLKLADFG 145

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LAKS  +     + +V T +Y+APELL G   Y   VD+W VGCI  E++   P  PG +
Sbjct: 146 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205

Query: 189 SLITLGRIVGKSRKPS--------------FCKLSLRDHLTNGFPGLEPAGIDLISKMLG 234
            L  L RI      P+                K      L + F       +DLI  +  
Sbjct: 206 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFL 265

Query: 235 MDPDKRITAAEALQQEYFKDVP 256
            +P  RITA +AL+ +YF + P
Sbjct: 266 FNPCARITATQALKMKYFSNRP 287

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-43
 Identities = 102/264 (38%), Positives = 138/264 (52%), Gaps = 31/264 (11%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           EGVPS+ IRE+S L ELNHPNI++L+ V      LY VFE+   DL   +     ++ G 
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGI 99

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY       L    S            R + RDLKP N+L++ +G  +K+A FG
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSH-----------RVLHRDLKPQNLLINTEG-AIKLADFG 147

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        + EV T +Y+APE+LLG   YSTAVDIW +GCIF EMV+ + LFPG +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

Query: 189 SLITLGRIV----------------GKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
            +  L RI                     KPSF K + R   +   P L+  G  L+S+M
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA-RQDFSKVVPPLDEDGRSLLSQM 266

Query: 233 LGMDPDKRITAAEALQQEYFKDVP 256
           L  DP+KRI+A  AL   +F+DV 
Sbjct: 267 LHYDPNKRISAKAALAHPFFQDVT 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  143 bits (360), Expect = 5e-42
 Identities = 94/269 (34%), Positives = 140/269 (52%), Gaps = 30/269 (11%)

Query: 1   MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY 60
            + +    EG+PS+ IRE+S L EL H NI++L  V      L  VFE+   DL  LL  
Sbjct: 33  KIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV 92

Query: 61  PKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK 120
            +  +   + K+F    L      +                R + RDLKP N+L++ +G 
Sbjct: 93  CEGGLESVTAKSF----LLQLLNGIAYCHDR----------RVLHRDLKPQNLLINREG- 137

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
            +K+A FGLA++      + + E+ T +Y+AP++L+G  +YST +DIW VGCIF EMV+G
Sbjct: 138 ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

Query: 181 KPLFPGANSLITLGRIVGKSRKPSF---------------CKLSLRDHLTNGFPGLEPAG 225
            PLFPG +    L RI      P+                  +       +   GL+ +G
Sbjct: 198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESG 257

Query: 226 IDLISKMLGMDPDKRITAAEALQQEYFKD 254
           IDL+SKML +DP++RITA +AL+  YFK+
Sbjct: 258 IDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-41
 Identities = 54/256 (21%), Positives = 97/256 (37%), Gaps = 33/256 (12%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKD 63
           I    E      + E+  L   +HPNI++L+        L+ + E+              
Sbjct: 45  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF----------CAGG 94

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
           +++    +     +     ++        +  +L++    + I RDLK  NIL  LDG  
Sbjct: 95  AVDAVMLELERPLTESQIQVVC-----KQTLDALNYLHDNKIIHRDLKAGNILFTLDG-D 148

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL----EYSTAVDIWPVGCIFGEM 177
           +K+A FG++           + +GT Y+ APE+++        Y    D+W +G    EM
Sbjct: 149 IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208

Query: 178 VSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
              +P     N +  L +I  KS  P+  +                   D + K L  + 
Sbjct: 209 AEIEPPHHELNPMRVLLKIA-KSEPPTLAQ----------PSRWSSNFKDFLKKCLEKNV 257

Query: 238 DKRITAAEALQQEYFK 253
           D R T ++ LQ  +  
Sbjct: 258 DARWTTSQLLQHPFVT 273

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 8e-41
 Identities = 63/253 (24%), Positives = 103/253 (40%), Gaps = 32/253 (12%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKD 63
           ++   +     +I E+  + E  +PNI+  +     G  L+ V EY              
Sbjct: 53  MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG---------- 102

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
           S+    T+                    +  ++L F    + I RD+K  NIL+ +DG +
Sbjct: 103 SLTDVVTETCMDEGQIAAVCR-------ECLQALEFLHSNQVIHRDIKSDNILLGMDG-S 154

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
           VK+  FG    +   + + S  VGT Y+ APE++     Y   VDIW +G +  EM+ G+
Sbjct: 155 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGE 213

Query: 182 PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
           P +   N L  L  I   +  P                 L     D +++ L MD +KR 
Sbjct: 214 PPYLNENPLRALYLIA-TNGTPEL----------QNPEKLSAIFRDFLNRCLDMDVEKRG 262

Query: 242 TAAEALQQEYFKD 254
           +A E LQ ++ K 
Sbjct: 263 SAKELLQHQFLKI 275

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  140 bits (354), Expect = 2e-40
 Identities = 53/256 (20%), Positives = 87/256 (33%), Gaps = 30/256 (11%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKD 63
           +    E    ++ +E+  +  L HP ++ L         +  ++E+              
Sbjct: 59  VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF----------MSGG 108

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDLDGK- 120
            +        N  S       + +         L       Y+  DLKP NI+       
Sbjct: 109 ELFEKVADEHNKMSEDEAVEYMRQVCKG-----LCHMHENNYVHLDLKPENIMFTTKRSN 163

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
            +K+  FGL   L   K       GT  + APE+  G        D+W VG +   ++SG
Sbjct: 164 ELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSG 221

Query: 181 KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
              F G N   TL  +                   + F G+   G D I K+L  DP+ R
Sbjct: 222 LSPFGGENDDETLRNVKSCDWNMDD----------SAFSGISEDGKDFIRKLLLADPNTR 271

Query: 241 ITAAEALQQEYFKDVP 256
           +T  +AL+  +     
Sbjct: 272 MTIHQALEHPWLTPGN 287

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-40
 Identities = 56/280 (20%), Positives = 95/280 (33%), Gaps = 53/280 (18%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
             + + +IRE+  L E N P I+           +    E+        +      +   
Sbjct: 45  PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 104

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF---GTRYIRRDLKPVNILVDLDGKTVKVA 125
                                S    + L++     + + RD+KP NILV+  G  +K+ 
Sbjct: 105 ILGKV----------------SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLC 147

Query: 126 GFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFP 185
            FG++  L      +++ VGT  Y +PE L G   YS   DIW +G    EM  G+   P
Sbjct: 148 DFGVSGQLI--DSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIP 204

Query: 186 GANS------------------------LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGL 221
             ++                                G   +P      L D++ N  P  
Sbjct: 205 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264

Query: 222 EPAG------IDLISKMLGMDPDKRITAAEALQQEYFKDV 255
            P+G       D ++K L  +P +R    + +   + K  
Sbjct: 265 LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-39
 Identities = 49/250 (19%), Positives = 91/250 (36%), Gaps = 32/250 (12%)

Query: 8   MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
               P ++ +E+     LNH N+++      +G   Y   EY      +    P   M  
Sbjct: 43  AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE 102

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVA 125
              + F                       + +  G     RD+KP N+L+D     +K++
Sbjct: 103 PDAQRF----------------FHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKIS 145

Query: 126 GFGLAKSLYA--YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPL 183
            FGLA        +   +   GT  Y APELL     ++  VD+W  G +   M++G+  
Sbjct: 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205

Query: 184 FPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA 243
           +   +          + +              N +  ++ A + L+ K+L  +P  RIT 
Sbjct: 206 WDQPSDSCQEYSDWKEKKTYL-----------NPWKKIDSAPLALLHKILVENPSARITI 254

Query: 244 AEALQQEYFK 253
            +  +  ++ 
Sbjct: 255 PDIKKDRWYN 264

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-39
 Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 37/263 (14%)

Query: 17  REVSCLMELNHPNIIRLMRV------ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
           RE+  + +L+H NI+RL             +YL  V +Y    +  + ++   +      
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                Y                  RSL++        RD+KP N+L+D D   +K+  FG
Sbjct: 122 IYVKLYMY-------------QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
            AK L   +   S  + + YY+APEL+ G  +Y++++D+W  GC+  E++ G+P+FPG +
Sbjct: 169 SAKQLVRGEPNVS-YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227

Query: 189 SLITLGRIVGKSRKPS---------------FCKLSLRDHLTNGFPGLEPAGIDLISKML 233
            +  L  I+     P+               F ++          P   P  I L S++L
Sbjct: 228 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 287

Query: 234 GMDPDKRITAAEALQQEYFKDVP 256
              P  R+T  EA    +F ++ 
Sbjct: 288 EYTPTARLTPLEACAHSFFDELR 310

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 5e-39
 Identities = 73/286 (25%), Positives = 115/286 (40%), Gaps = 45/286 (15%)

Query: 1   MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGI--------YLYPVFEYQVN 52
            + + N  EG P + +RE+  L  L H N++ L+ +              +Y VF++  +
Sbjct: 42  KVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 101

Query: 53  DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVN 112
           DLA LL            K      L   + +                 + + RD+K  N
Sbjct: 102 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR--------------NKILHRDMKAAN 147

Query: 113 ILVDLDGKTVKVAGFGLAKSLYAYKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIW 168
           +L+  DG  +K+A FGLA++    K       +  V T +Y+ PELLLG  +Y   +D+W
Sbjct: 148 VLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 206

Query: 169 PVGCIFGEMVSGKPLFPGANSLITLGRIV------------GKSRKPSFCKLSLRDHLTN 216
             GCI  EM +  P+  G      L  I                    + KL L      
Sbjct: 207 GAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKR 266

Query: 217 GFP------GLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
                      +P  +DLI K+L +DP +RI + +AL  ++F   P
Sbjct: 267 KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 3e-38
 Identities = 48/243 (19%), Positives = 82/243 (33%), Gaps = 31/243 (12%)

Query: 15  MIREVSCLMELNHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYST 70
              E   L  L HPNI+R              +  V E   +            M     
Sbjct: 55  FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 114

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           +++         L   +F  +            I RDLK  NI +     +VK+   GLA
Sbjct: 115 RSW-----CRQILKGLQFLHTR-------TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162

Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
               A    + A +GT  + APE+     +Y  +VD++  G    EM + +  +    + 
Sbjct: 163 TLKRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA 218

Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE 250
             + R V    KP+                  P   ++I   +  + D+R +  + L   
Sbjct: 219 AQIYRRVTSGVKPASFD-----------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 267

Query: 251 YFK 253
           +F+
Sbjct: 268 FFQ 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 5e-38
 Identities = 58/245 (23%), Positives = 87/245 (35%), Gaps = 29/245 (11%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           + REVS L E+ HPN+I L  V      +  + E       +     K+S+       F 
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG---KTVKVAGFGLAK 131
              L   + L                      DLKP NI++         +K+  FGLA 
Sbjct: 120 KQILNGVYYLHSLQ--------------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165

Query: 132 SLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLI 191
            +  +  E     GT  + APE++          D+W +G I   ++SG   F G     
Sbjct: 166 KI-DFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQE 223

Query: 192 TLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEY 251
           TL  +               D     F        D I ++L  DP KR+T  ++LQ  +
Sbjct: 224 TLANVSA-------VNYEFEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

Query: 252 FKDVP 256
            K   
Sbjct: 274 IKPKD 278

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 5e-38
 Identities = 89/270 (32%), Positives = 126/270 (46%), Gaps = 31/270 (11%)

Query: 1   MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKY 60
            + + +  EGVPSS +RE+  L EL H NI+RL  V      L  VFE+   DL      
Sbjct: 34  RVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS 93

Query: 61  PKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK 120
               ++    K+F    LF     +    S             + RDLKP N+L++ +G 
Sbjct: 94  CNGDLDPEIVKSF----LFQLLKGLGFCHS----------RNVLHRDLKPQNLLINRNG- 138

Query: 121 TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
            +K+A FGLA++        SAEV T +Y+ P++L G   YST++D+W  GCIF E+ + 
Sbjct: 139 ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198

Query: 181 K-PLFPGANSLITLGRIVGKSRKPS---------------FCKLSLRDHLTNGFPGLEPA 224
             PLFPG +    L RI      P+               +        L N  P L   
Sbjct: 199 GRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNAT 258

Query: 225 GIDLISKMLGMDPDKRITAAEALQQEYFKD 254
           G DL+  +L  +P +RI+A EALQ  YF D
Sbjct: 259 GRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (332), Expect = 1e-37
 Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 37/243 (15%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
           +I+EV  L +L HPN I+      +    + V EY +   + LL+  K  +         
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV- 120

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
                          +  + + L++      I RD+K  NIL+   G  VK+  FG A  
Sbjct: 121 ---------------THGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASI 164

Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLE--YSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
           +      +++ VGT Y+ APE++L + E  Y   VD+W +G    E+   KP     N++
Sbjct: 165 MA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220

Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQE 250
             L  I  ++  P+                      + +   L   P  R T+   L+  
Sbjct: 221 SALYHIA-QNESPALQS-----------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268

Query: 251 YFK 253
           +  
Sbjct: 269 FVL 271

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 1e-37
 Identities = 64/254 (25%), Positives = 98/254 (38%), Gaps = 24/254 (9%)

Query: 1   MMGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRV--ASQGIYLYPVFEYQVN-DLAYL 57
            +   +  E     ++ EV+ L EL HPNI+R            LY V EY    DLA +
Sbjct: 36  ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASV 95

Query: 58  LKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDL 117
           +            +         T  L E    SD           + RDLKP N+ +D 
Sbjct: 96  ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH------TVLHRDLKPANVFLDG 149

Query: 118 DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
               VK+  FGLA+ L      + A VGT YY +PE +  +  Y+   DIW +GC+  E+
Sbjct: 150 KQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYEL 207

Query: 178 VSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
            +  P F   +     G+I     +    + S                 ++I++ML +  
Sbjct: 208 CALMPPFTAFSQKELAGKIREGKFRRIPYRYS-------------DELNEIITRMLNLKD 254

Query: 238 DKRITAAEALQQEY 251
             R +  E L+   
Sbjct: 255 YHRPSVEEILENPL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-37
 Identities = 46/241 (19%), Positives = 80/241 (33%), Gaps = 28/241 (11%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNF 73
           + +E+S L    H NI+ L         L  +FE+    D+   +      +N     ++
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY 107

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG-KTVKVAGFGLAKS 132
                     L                      D++P NI+       T+K+  FG A+ 
Sbjct: 108 VHQVCEALQFLHSH--------------NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153

Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT 192
           L              YY            STA D+W +G +   ++SG   F    +   
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211

Query: 193 LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
           +  I+                    F  +    +D + ++L  +   R+TA+EALQ  + 
Sbjct: 212 IENIMNAEYTFDE----------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

Query: 253 K 253
           K
Sbjct: 262 K 262

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 4e-37
 Identities = 63/247 (25%), Positives = 98/247 (39%), Gaps = 36/247 (14%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
            GV   + REV     L HPNI+RL         +Y + EY      Y         +  
Sbjct: 47  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ 106

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
            T  +                 ++ + +LS+    R I RD+KP N+L+   G  +K+A 
Sbjct: 107 RTATY----------------ITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIAD 149

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FG +   +A     +   GT  Y  PE++ G   +   VD+W +G +  E + GKP F  
Sbjct: 150 FGWSV--HAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEA 206

Query: 187 ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA 246
                T  RI       S  + +  D +T           DLIS++L  +P +R    E 
Sbjct: 207 NTYQETYKRI-------SRVEFTFPDFVT-------EGARDLISRLLKHNPSQRPMLREV 252

Query: 247 LQQEYFK 253
           L+  +  
Sbjct: 253 LEHPWIT 259

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-37
 Identities = 69/269 (25%), Positives = 106/269 (39%), Gaps = 32/269 (11%)

Query: 8   MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNG 67
            +      +RE+  L+   H NII +  +            Y V  L     Y       
Sbjct: 46  HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH 105

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
            S  +   +       L    S+             + RDLKP N+L++     +K+  F
Sbjct: 106 LSNDHICYFLYQILRGLKYIHSA-----------NVLHRDLKPSNLLLNTTC-DLKICDF 153

Query: 128 GLAKSLY---AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
           GLA+       + G  +  V T +Y+APE++L    Y+ ++DIW VGCI  EM+S +P+F
Sbjct: 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213

Query: 185 PGANSLITLGRIVGKSRKPS-----------------FCKLSLRDHLTNGFPGLEPAGID 227
           PG + L  L  I+G    PS                       +      FP  +   +D
Sbjct: 214 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 273

Query: 228 LISKMLGMDPDKRITAAEALQQEYFKDVP 256
           L+ KML  +P KRI   +AL   Y +   
Sbjct: 274 LLDKMLTFNPHKRIEVEQALAHPYLEQYY 302

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 3e-36
 Identities = 92/279 (32%), Positives = 127/279 (45%), Gaps = 43/279 (15%)

Query: 1   MMGIHNTMEGVPSSMIREVSCLMEL---NHPNIIRLMRVASQG-----IYLYPVFEYQVN 52
            + +    EG+P S IREV+ L  L    HPN++RL  V +         L  VFE+   
Sbjct: 40  RVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ 99

Query: 53  D-LAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLK 109
           D   YL K P+  +   + K+     L                R L F    R + RDLK
Sbjct: 100 DLTTYLDKVPEPGVPTETIKDMMFQLL----------------RGLDFLHSHRVVHRDLK 143

Query: 110 PVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP 169
           P NILV   G  +K+A FGLA+        +S  V T +Y+APE+LL    Y+T VD+W 
Sbjct: 144 PQNILVTSSG-QIKLADFGLARIYSFQMALTSV-VVTLWYRAPEVLLQS-SYATPVDLWS 200

Query: 170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS-------------FCKLSLRDHLTN 216
           VGCIF EM   KPLF G++ +  LG+I+     P                       +  
Sbjct: 201 VGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260

Query: 217 GFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV 255
               ++  G DL+ K L  +P KRI+A  AL   YF+D+
Sbjct: 261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  128 bits (323), Expect = 7e-36
 Identities = 50/253 (19%), Positives = 93/253 (36%), Gaps = 28/253 (11%)

Query: 4   IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPK 62
           I+        ++  E+S + +L+HP +I L         +  + E+    +L   +    
Sbjct: 62  INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDL-DGKT 121
             M+     N+    +      ++                 +  D+KP NI+ +     +
Sbjct: 122 YKMSEAEVINY----MRQACEGLKHMHEH----------SIVHLDIKPENIMCETKKASS 167

Query: 122 VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
           VK+  FGLA  L            T  + APE++          D+W +G +   ++SG 
Sbjct: 168 VKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGL 225

Query: 182 PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
             F G + L TL  +     +             + F  + P   D I  +L  +P KR+
Sbjct: 226 SPFAGEDDLETLQNVKRCDWEFDE----------DAFSSVSPEAKDFIKNLLQKEPRKRL 275

Query: 242 TAAEALQQEYFKD 254
           T  +AL+  + K 
Sbjct: 276 TVHDALEHPWLKG 288

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  127 bits (320), Expect = 8e-36
 Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 30/251 (11%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEY-QVNDLAYLLKYPKDS 64
             +EG   SM  E++ L ++ HPNI+ L  +   G +LY + +     +L   +      
Sbjct: 45  KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----- 99

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK--TV 122
             G+ T+   S  +F     V+                 + RDLKP N+L     +   +
Sbjct: 100 EKGFYTERDASRLIFQVLDAVKYLHD----------LGIVHRDLKPENLLYYSLDEDSKI 149

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
            ++ FGL+K +       S   GT  Y APE+L     YS AVD W +G I   ++ G P
Sbjct: 150 MISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYP 207

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F   N      +I+    +               +  +  +  D I  ++  DP+KR T
Sbjct: 208 PFYDENDAKLFEQILKAEYEFDSPY----------WDDISDSAKDFIRHLMEKDPEKRFT 257

Query: 243 AAEALQQEYFK 253
             +ALQ  +  
Sbjct: 258 CEQALQHPWIA 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 7e-35
 Identities = 59/250 (23%), Positives = 96/250 (38%), Gaps = 32/250 (12%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           E     + RE   +  L+HP  ++L         LY    Y  N           S +  
Sbjct: 49  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 108

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
            T+ + +  +     L  +                I RDLKP NIL++ D   +++  FG
Sbjct: 109 CTRFYTAEIVSALEYLHGKG--------------IIHRDLKPENILLNEDM-HIQITDFG 153

Query: 129 LAK--SLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
            AK  S  + +  +++ VGT  Y +PELL        + D+W +GCI  ++V+G P F  
Sbjct: 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRA 212

Query: 187 ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA 246
            N  +   +I+         +    +          P   DL+ K+L +D  KR+   E 
Sbjct: 213 GNEYLIFQKIIK-------LEYDFPEKFF-------PKARDLVEKLLVLDATKRLGCEEM 258

Query: 247 LQQEYFKDVP 256
                 K  P
Sbjct: 259 EGYGPLKAHP 268

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  122 bits (306), Expect = 4e-34
 Identities = 60/252 (23%), Positives = 103/252 (40%), Gaps = 32/252 (12%)

Query: 8   MEGVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMN 66
           ++ +  + ++EV  L +++ HPNII+L        + + VF+             K  + 
Sbjct: 49  VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL----------MKKGELF 98

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAG 126
            Y T+        T  ++        +   L      + RDLKP NIL+D D   +K+  
Sbjct: 99  DYLTEKVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDM-NIKLTD 153

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE-----YSTAVDIWPVGCIFGEMVSGK 181
           FG +  L     +     GT  Y APE++   +      Y   VD+W  G I   +++G 
Sbjct: 154 FGFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

Query: 182 PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
           P F     ++ L  I+  + +    +          +        DL+S+ L + P KR 
Sbjct: 213 PPFWHRKQMLMLRMIMSGNYQFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRY 262

Query: 242 TAAEALQQEYFK 253
           TA EAL   +F+
Sbjct: 263 TAEEALAHPFFQ 274

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 5e-34
 Identities = 49/243 (20%), Positives = 90/243 (37%), Gaps = 33/243 (13%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKN 72
           +   EV  L +  H NI+  M  ++    L  V ++     L + L   +         +
Sbjct: 50  AFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID 108

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
                            +  +++ + +      I RDLK  NI +  D  TVK+  FGLA
Sbjct: 109 I----------------ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLA 151

Query: 131 KSLYAYKGESSAE--VGTHYYKAPELLLGL--LEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
                + G    E   G+  + APE++       YS   D++  G +  E+++G+  +  
Sbjct: 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211

Query: 187 ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA 246
            N+   +  +VG+          L   L+        A   L+++ L    D+R    + 
Sbjct: 212 INNRDQIIFMVGRGY--------LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263

Query: 247 LQQ 249
           L  
Sbjct: 264 LAS 266

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (307), Expect = 9e-34
 Identities = 61/270 (22%), Positives = 108/270 (40%), Gaps = 47/270 (17%)

Query: 15  MIREVSCLMELN-HPNIIRLMRV--ASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST 70
           + RE+  L  L   PNII L  +           VFE+  N D   L +    ++  Y  
Sbjct: 76  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDI 131

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
           + +         L   ++  S            + RD+KP N+++D + + +++  +GLA
Sbjct: 132 RFY-----MYEILKALDYCHS---------MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177

Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK-PLFPGANS 189
           +  +    E +  V + Y+K PELL+    Y  ++D+W +GC+   M+  K P F G ++
Sbjct: 178 EFYHP-GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236

Query: 190 LITLGRIVGKSRKPSFCKLSLRDHL-----------------------TNGFPGLEPAGI 226
              L RI              + ++                       +     + P  +
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296

Query: 227 DLISKMLGMDPDKRITAAEALQQEYFKDVP 256
           D + K+L  D   R+TA EA++  YF  V 
Sbjct: 297 DFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  121 bits (304), Expect = 2e-33
 Identities = 56/246 (22%), Positives = 95/246 (38%), Gaps = 38/246 (15%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
              E   L  + HP IIR+         ++ + +Y      + L            K + 
Sbjct: 51  TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY- 109

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
                   L +E   S             I RDLKP NIL+D +G  +K+  FG AK + 
Sbjct: 110 ---AAEVCLALEYLHSK----------DIIYRDLKPENILLDKNG-HIKITDFGFAKYV- 154

Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
                +    GT  Y APE++     Y+ ++D W  G +  EM++G   F  +N++ T  
Sbjct: 155 --PDVTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211

Query: 195 RIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAEALQQ 249
           +I+  + +  F             P       DL+S+++  D  +R+        +    
Sbjct: 212 KIL--NAELRF------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257

Query: 250 EYFKDV 255
            +FK+V
Sbjct: 258 PWFKEV 263

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 6e-33
 Identities = 61/249 (24%), Positives = 101/249 (40%), Gaps = 33/249 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNG 67
           + V  +M+ +    +   HP +  +         L+ V EY    DL Y ++    S + 
Sbjct: 44  DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHK 99

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGF 127
           +       Y+      L    S              + RDLK  NIL+D DG   K+A F
Sbjct: 100 FDLSRATFYAAEIILGLQFLHS-----------KGIVYRDLKLDNILLDKDGHI-KIADF 147

Query: 128 GLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGA 187
           G+ K       +++   GT  Y APE+LLG  +Y+ +VD W  G +  EM+ G+  F G 
Sbjct: 148 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206

Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA-EA 246
           +       I  +   P + +             LE    DL+ K+   +P+KR+    + 
Sbjct: 207 DEEELFHSI--RMDNPFYPR------------WLEKEAKDLLVKLFVREPEKRLGVRGDI 252

Query: 247 LQQEYFKDV 255
            Q   F+++
Sbjct: 253 RQHPLFREI 261

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-32
 Identities = 53/246 (21%), Positives = 86/246 (34%), Gaps = 35/246 (14%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
            + E   L    HP +  L         L  V EY        L +       ++ +   
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE---LFFHLSRERVFTEERAR 108

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
            Y       L    S              + RD+K  N+++D DG  +K+  FGL K   
Sbjct: 109 FYGAEIVSALEYLHSR-----------DVVYRDIKLENLMLDKDG-HIKITDFGLCKEGI 156

Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
           +         GT  Y APE+L    +Y  AVD W +G +  EM+ G+  F   +      
Sbjct: 157 SDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

Query: 195 RIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAEALQQ 249
            I+ +  +                  L P    L++ +L  DP +R+      A E ++ 
Sbjct: 216 LILMEEIRFP--------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261

Query: 250 EYFKDV 255
            +F  +
Sbjct: 262 RFFLSI 267

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 2e-32
 Identities = 43/244 (17%), Positives = 78/244 (31%), Gaps = 37/244 (15%)

Query: 15  MIREVSCLMELN--HPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
           +  EV  L +++     +IRL+    +      + E           +   +  G   + 
Sbjct: 54  VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ---DLFDFITERGALQEE 110

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
                 +     V    +             + RD+K  NIL+DL+   +K+  FG    
Sbjct: 111 LARSFFWQVLEAVRHCHNC----------GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160

Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT 192
           L       +   GT  Y  PE +     +  +  +W +G +  +MV G   F     +I 
Sbjct: 161 LK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 218

Query: 193 LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYF 252
                         ++  R  ++            LI   L + P  R T  E     + 
Sbjct: 219 -------------GQVFFRQRVS-------SECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

Query: 253 KDVP 256
           +DV 
Sbjct: 259 QDVL 262

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 4e-32
 Identities = 74/271 (27%), Positives = 116/271 (42%), Gaps = 43/271 (15%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVNDLAYLLKYPK 62
           E       RE+  L  + H N+I L+ V +           Y V  +   DL  L+K+ K
Sbjct: 58  ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 117

Query: 63  DSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTV 122
              +               FL+ +         +       I RDLKP N+ V+ D +  
Sbjct: 118 LGED------------RIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCEL- 160

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+  FGLA+       E +  V T +Y+APE++L  + Y+  VDIW VGCI  EM++GK 
Sbjct: 161 KILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSL-----------------RDHLTNGFPGLEPAG 225
           LF G++ L  L  I+  +  P    +                   +    +      P  
Sbjct: 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA 277

Query: 226 IDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
           ++L+ KML +D ++R+TA EAL   YF+ + 
Sbjct: 278 VNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 6e-32
 Identities = 77/258 (29%), Positives = 112/258 (43%), Gaps = 31/258 (12%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
            RE+  L  + H N+I L+ V +    L    +       YL+ +   +      K    
Sbjct: 65  YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV------YLVTHLMGADLNNIVKCQKL 118

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
                 FL+ +         S       I RDLKP N+ V+ D +  K+  FGLA     
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCEL-KILDFGLA---RH 170

Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGR 195
              E +  V T +Y+APE++L  + Y+  VDIW VGCI  E+++G+ LFPG + +  L  
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

Query: 196 IVGKSRKPSFCKLSL-----------------RDHLTNGFPGLEPAGIDLISKMLGMDPD 238
           I+     P    L                   + +  N F G  P  +DL+ KML +D D
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290

Query: 239 KRITAAEALQQEYFKDVP 256
           KRITAA+AL   YF    
Sbjct: 291 KRITAAQALAHAYFAQYH 308

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-29
 Identities = 46/252 (18%), Positives = 92/252 (36%), Gaps = 33/252 (13%)

Query: 13  SSMIREVSCLMEL-NHPNIIRLMRV----ASQGIYLYPVFEYQVN-DLAYLLKYPKDSMN 66
               REV         P+I+R++ V     +    L  V E     +L   ++       
Sbjct: 49  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ------- 101

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVD--LDGKTV 122
               +   +++      +++         ++ +        RD+KP N+L         +
Sbjct: 102 ---DRGDQAFTEREASEIMKSIG-----EAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 153

Query: 123 KVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
           K+  FG AK   ++   ++    T YY APE+L    +Y  + D+W +G I   ++ G P
Sbjct: 154 KLTDFGFAKETTSHNSLTTPCY-TPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYP 211

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F   + L     +  + R   +      +     +  +      LI  +L  +P +R+T
Sbjct: 212 PFYSNHGLAISPGMKTRIRMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 265

Query: 243 AAEALQQEYFKD 254
             E +   +   
Sbjct: 266 ITEFMNHPWIMQ 277

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 3e-29
 Identities = 50/238 (21%), Positives = 89/238 (37%), Gaps = 32/238 (13%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
            I E   +M L+H  +++L  V ++   ++ + EY  N    LL Y ++  + + T+   
Sbjct: 46  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLL 103

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
                    +                 +++ RDL   N LV+  G  VKV+ FGL++ + 
Sbjct: 104 EMCKDVCEAM-----------EYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVL 151

Query: 135 AYKGESS-AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLIT 192
             +  SS        +  PE+L+   ++S+  DIW  G +  E+ S GK  +    +  T
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210

Query: 193 LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGI-DLISKMLGMDPDKRITAAEALQQ 249
              I    R                 P L    +  ++        D+R T    L  
Sbjct: 211 AEHIAQGLRLY--------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  110 bits (277), Expect = 3e-29
 Identities = 48/246 (19%), Positives = 91/246 (36%), Gaps = 33/246 (13%)

Query: 16  IREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNS 75
              +S +   + P I+ +         L  + +                ++ + +++   
Sbjct: 55  RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL----------MNGGDLHYHLSQHGVF 104

Query: 76  YSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYA 135
                 F   E     +   +       + RDLKP NIL+D  G  V+++  GLA     
Sbjct: 105 SEADMRFYAAEIILGLEHMHNRFV----VYRDLKPANILLDEHG-HVRISDLGLACDFS- 158

Query: 136 YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGR 195
            K +  A VGTH Y APE+L   + Y ++ D + +GC+  +++ G   F    +      
Sbjct: 159 -KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217

Query: 196 IVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AAEALQQE 250
                R      + L D  +       P    L+  +L  D ++R+      A E  +  
Sbjct: 218 D----RMTLTMAVELPDSFS-------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266

Query: 251 YFKDVP 256
           +F+ + 
Sbjct: 267 FFRSLD 272

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  108 bits (271), Expect = 6e-29
 Identities = 52/249 (20%), Positives = 90/249 (36%), Gaps = 33/249 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRV----ASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
                   RE      LNHP I+ +          G   Y V EY        L+    +
Sbjct: 48  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT---LRDIVHT 104

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKV 124
               + K            L     +             I RD+KP NI++      VKV
Sbjct: 105 EGPMTPKRAIEVIADACQALNFSHQN-----------GIIHRDVKPANIMIS-ATNAVKV 152

Query: 125 AGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
             FG+A+++        +++A +GT  Y +PE   G        D++ +GC+  E+++G+
Sbjct: 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGE 211

Query: 182 PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI 241
           P F G + +    + V +   P   +            GL      ++ K L  +P+ R 
Sbjct: 212 PPFTGDSPVSVAYQHVREDPIPPSAR----------HEGLSADLDAVVLKALAKNPENRY 261

Query: 242 TAAEALQQE 250
             A  ++ +
Sbjct: 262 QTAAEMRAD 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 9e-29
 Identities = 46/257 (17%), Positives = 86/257 (33%), Gaps = 27/257 (10%)

Query: 5   HNTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPK 62
                    +++ E+  + +L +H NI+ L+   +    +Y +FEY    DL   L+  +
Sbjct: 77  EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 136

Query: 63  DSMNGYSTKNFNSYSLFTTFLL--VEEFSSSDSSRSLSFGTRY------IRRDLKPVNIL 114
           +  +    +  N   L     L  +        +  ++ G  +      + RDL   N+L
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196

Query: 115 VDLDGKTVKVAGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGC 172
           V      VK+  FGLA+ + +               + APE L     Y+   D+W  G 
Sbjct: 197 VTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGI 254

Query: 173 IFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISK 231
           +  E+ S G   +PG        +++    K                         ++  
Sbjct: 255 LLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP------------FYATEEIYIIMQS 302

Query: 232 MLGMDPDKRITAAEALQ 248
               D  KR +      
Sbjct: 303 CWAFDSRKRPSFPNLTS 319

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-28
 Identities = 41/237 (17%), Positives = 83/237 (35%), Gaps = 28/237 (11%)

Query: 14  SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
             I E   +M+L+HP +++L  V  +   +  VFE+  +    L  Y +     ++ +  
Sbjct: 46  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC--LSDYLRTQRGLFAAETL 103

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
               L     +     +             I RDL   N LV  +   +KV+ FG+ + +
Sbjct: 104 LGMCLDVCEGMAYLEEA-----------CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV 151

Query: 134 YAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT 192
              +   S+       + +PE+      YS+  D+W  G +  E+ S   +     S   
Sbjct: 152 LDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210

Query: 193 LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
           +   +    +    +L                   +++      P+ R   +  L+Q
Sbjct: 211 VVEDISTGFRLYKPRL------------ASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-28
 Identities = 49/249 (19%), Positives = 92/249 (36%), Gaps = 32/249 (12%)

Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTK 71
           P + ++E   + +L H  +++L  V S+   +Y V EY            +        +
Sbjct: 56  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 114

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
             +  +   + +   E               Y+ RDL+  NILV  +    KVA FGLA+
Sbjct: 115 LVDMAAQIASGMAYVERM------------NYVHRDLRAANILVGENL-VCKVADFGLAR 161

Query: 132 SLYAYKGES-SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANS 189
            +   +  +         + APE  L    ++   D+W  G +  E+ + G+  +PG  +
Sbjct: 162 LIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN 220

Query: 190 LITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ- 248
              L ++    R P               P    +  DL+ +    +P++R T       
Sbjct: 221 REVLDQVERGYRMPC-------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAF 267

Query: 249 -QEYFKDVP 256
            ++YF    
Sbjct: 268 LEDYFTSTE 276

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (269), Expect = 3e-28
 Identities = 51/291 (17%), Positives = 98/291 (33%), Gaps = 46/291 (15%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIY-LYPVFEYQVNDLAYLLKYPKDSMNG 67
           +    +   E+  L  +N  +  +   + +  I  L   F ++  +  +++   +     
Sbjct: 50  KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN 109

Query: 68  YSTKNFNSYSLFTTFLLVEEFSSS--DSSRSLSFGTRYIRRDLKPVNILVDLDGKT---- 121
                          + V++ S         +      I  D+KP N+L+++        
Sbjct: 110 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169

Query: 122 -VKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
            +K+A  G A     +   S   + T  Y++PE+LLG   +    DIW   C+  E+++G
Sbjct: 170 QIKIADLGNACWYDEHYTNS---IQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITG 225

Query: 181 KPLFPG------ANSLITLGRIV-------------GKSRKPSFCKLSLRDHLTNG---- 217
             LF              + +I+             GK  +  F    L  +++      
Sbjct: 226 DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 285

Query: 218 -----------FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVPG 257
                               D +S ML +DP KR  A   +   + KD  G
Sbjct: 286 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 336

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 4e-27
 Identities = 75/276 (27%), Positives = 109/276 (39%), Gaps = 42/276 (15%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
           +       RE+  +  +NH NII L+ V +    L    +  +  +  +       +   
Sbjct: 57  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV-MELMDANLCQVIQME 115

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFG 128
                 SY L+     ++   S             I RDLKP NI+V  D  T+K+  FG
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHS----------AGIIHRDLKPSNIVVKSDC-TLKILDFG 164

Query: 129 LAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN 188
           LA++        +  V T YY+APE++LG+  Y   VDIW VGCI GEMV  K LFPG +
Sbjct: 165 LART-AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRD 222

Query: 189 SLITLGRIV----------------------------GKSRKPSFCKLSLRDHLTNGFPG 220
            +    +++                                 P     SL    +     
Sbjct: 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 282

Query: 221 LEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP 256
                 DL+SKML +DP KRI+  +ALQ  Y     
Sbjct: 283 KASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  104 bits (259), Expect = 4e-27
 Identities = 45/256 (17%), Positives = 89/256 (34%), Gaps = 28/256 (10%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDS 64
                + +   RE + + E ++PNI++L+ V + G  +  +FEY    DL   L+     
Sbjct: 54  EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSR---------SLSFGTRYIRRDLKPVNILV 115
                + +  S     +       S ++            +     +++ RDL   N LV
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV 173

Query: 116 DLDGKTVKVAGFGLAKSLYA--YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCI 173
             +   VK+A FGL++++Y+  Y      +     +  PE +     Y+T  D+W  G +
Sbjct: 174 GENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVV 231

Query: 174 FGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKM 232
             E+ S G   + G      +  +   +                          +L+   
Sbjct: 232 LWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC-------------PENCPLELYNLMRLC 278

Query: 233 LGMDPDKRITAAEALQ 248
               P  R +     +
Sbjct: 279 WSKLPADRPSFCSIHR 294

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 8e-27
 Identities = 49/238 (20%), Positives = 79/238 (33%), Gaps = 32/238 (13%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
            IREV+ +  L+H N+IRL  V      +  V E        LL   +     +     +
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGS--LLDRLRKHQGHFLLGTLS 114

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
            Y++     +    S            R+I RDL   N+L+      VK+  FGL ++L 
Sbjct: 115 RYAVQVAEGMGYLESK-----------RFIHRDLAARNLLLATRD-LVKIGDFGLMRALP 162

Query: 135 AYKGE---SSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSL 190
                            + APE L     +S A D W  G    EM + G+  + G N  
Sbjct: 163 QNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221

Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ 248
             L +I  +  +                        +++ +     P+ R T      
Sbjct: 222 QILHKIDKEGERLPR------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 9e-27
 Identities = 51/243 (20%), Positives = 87/243 (35%), Gaps = 32/243 (13%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKDSMN 66
           +    + + E S + +L H N+++L+ V  +    LY V EY     L   L+       
Sbjct: 41  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS------ 94

Query: 67  GYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAG 126
                     S+     L++       +     G  ++ RDL   N+LV  D    KV+ 
Sbjct: 95  -------RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSD 146

Query: 127 FGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG 186
           FGL K   + +           + APE L    ++ST  D+W  G +  E+ S   +   
Sbjct: 147 FGLTKEASSTQ---DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYP 202

Query: 187 ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA 246
              L  +   V K  K                 G  PA  +++     +D   R +  + 
Sbjct: 203 RIPLKDVVPRVEKGYKMDA------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQL 250

Query: 247 LQQ 249
            +Q
Sbjct: 251 REQ 253

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  103 bits (257), Expect = 9e-27
 Identities = 43/250 (17%), Positives = 91/250 (36%), Gaps = 34/250 (13%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
              E      + E S + + +HPN+I L  V ++   +  + E+              S+
Sbjct: 65  GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEF----------MENGSL 114

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVA 125
           + +  +N   +++     ++   ++     +      Y+ RDL   NILV+ +    KV+
Sbjct: 115 DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNL-VCKVS 170

Query: 126 GFGLAKSLYAYKGESS-----AEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS- 179
            FGL++ L     + +            + APE +    ++++A D+W  G +  E++S 
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSY 229

Query: 180 GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDK 239
           G+  +    +   +  I    R P                    A   L+      D + 
Sbjct: 230 GERPYWDMTNQDVINAIEQDYRLPPPMDCP-------------SALHQLMLDCWQKDRNH 276

Query: 240 RITAAEALQQ 249
           R    + +  
Sbjct: 277 RPKFGQIVNT 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 2e-26
 Identities = 50/247 (20%), Positives = 95/247 (38%), Gaps = 31/247 (12%)

Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
           + T + V    ++E   + + +HP+I++L+ V ++   ++ + E        L  + +  
Sbjct: 45  NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGE--LRSFLQVR 101

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKV 124
                  +   Y+   +  L    S            R++ RD+   N+LV  +   VK+
Sbjct: 102 KYSLDLASLILYAYQLSTALAYLES-----------KRFVHRDIAARNVLVSSND-CVKL 149

Query: 125 AGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM-VSGKP 182
             FGL++ +      ++S       + APE +     +++A D+W  G    E+ + G  
Sbjct: 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVK 208

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            F G  +   +GRI    R P               P   P    L++K    DP +R  
Sbjct: 209 PFQGVKNNDVIGRIENGERLPM-------------PPNCPPTLYSLMTKCWAYDPSRRPR 255

Query: 243 AAEALQQ 249
             E   Q
Sbjct: 256 FTELKAQ 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 3e-26
 Identities = 51/239 (21%), Positives = 87/239 (36%), Gaps = 18/239 (7%)

Query: 14  SMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVND--LAYLLKYPKDSMNGYST 70
               E+  L +L +HPNII L+       YLY   EY  +   L +L K      +    
Sbjct: 56  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115

Query: 71  KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLA 130
              ++ S  ++  L+   +            ++I RDL   NILV  +    K+A FGL+
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLS 174

Query: 131 KSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
           +    Y  ++        + A E L     Y+T  D+W  G +  E+VS         + 
Sbjct: 175 RGQEVYVKKTMG-RLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232

Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
             L   + +  +                   +    DL+ +     P +R + A+ L  
Sbjct: 233 AELYEKLPQGYRLEK------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  101 bits (253), Expect = 3e-26
 Identities = 43/237 (18%), Positives = 83/237 (35%), Gaps = 29/237 (12%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN--DLAYLLKYPKDSMNGYSTKN 72
            ++E + + E+ HPN+++L+ V ++    Y + E+      L YL +  +  ++      
Sbjct: 60  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
             +        L ++               +I RDL   N LV  +   VKVA FGL++ 
Sbjct: 120 MATQISSAMEYLEKK--------------NFIHRDLAARNCLVGENH-LVKVADFGLSRL 164

Query: 133 LYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLIT 192
           +      + A             L   ++S   D+W  G +  E+ +          L  
Sbjct: 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224

Query: 193 LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ 249
           +  ++ K  +                 G      +L+      +P  R + AE  Q 
Sbjct: 225 VYELLEKDYRMERP------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQA 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 4e-26
 Identities = 48/255 (18%), Positives = 87/255 (34%), Gaps = 31/255 (12%)

Query: 17  REVSCLMELNHPNIIRLMRVASQG----IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTK 71
            E+   + L H NI+  +   ++       L+ V +Y  +  L   L   + ++      
Sbjct: 46  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMI 103

Query: 72  NFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAK 131
                +      L  E   +    +         RDLK  NILV  +G T  +A  GLA 
Sbjct: 104 KLALSTASGLAHLHMEIVGTQGKPA------IAHRDLKSKNILVKKNG-TCCIADLGLAV 156

Query: 132 SLYA----YKGESSAEVGTHYYKAPELLLGLL-----EYSTAVDIWPVGCIFGEMVSGKP 182
              +         +  VGT  Y APE+L   +     E     DI+ +G +F E+     
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216

Query: 183 LFPGANSL------ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLE--PAGIDLISKMLG 234
           +             +       +  +   C+  LR ++ N +   E       ++ +   
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276

Query: 235 MDPDKRITAAEALQQ 249
            +   R+TA    + 
Sbjct: 277 ANGAARLTALRIKKT 291

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 5e-26
 Identities = 48/251 (19%), Positives = 84/251 (33%), Gaps = 35/251 (13%)

Query: 15  MIREVSCLMELNH-PNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKN 72
              E   L  +   P ++ L         L+ + +Y    +L   L            + 
Sbjct: 75  TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---------QRER 125

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS 132
           F  + +      +                  I RD+K  NIL+D +G  V +  FGL+K 
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKL------GIIYRDIKLENILLDSNGH-VVLTDFGLSKE 178

Query: 133 LYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL 190
             A + E + +      Y     +  G   +  AVD W +G +  E+++G   F      
Sbjct: 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238

Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAE 245
            +   I  +  K                  +     DLI ++L  DP KR+      A E
Sbjct: 239 NSQAEISRRILKSEPPY----------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 288

Query: 246 ALQQEYFKDVP 256
             +  +F+ + 
Sbjct: 289 IKEHLFFQKIN 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 1e-25
 Identities = 45/246 (18%), Positives = 84/246 (34%), Gaps = 30/246 (12%)

Query: 6   NTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSM 65
              E      + E   + + +H NIIRL  V S+   +  + EY  N         KD  
Sbjct: 47  GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE 106

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVA 125
                  F+   L      +       ++        Y+ RDL   NILV+ +    KV+
Sbjct: 107 -------FSVLQLVGMLRGIAAGMKYLANM------NYVHRDLAARNILVNSNL-VCKVS 152

Query: 126 GFGLAKSLY---AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKP 182
            FGL++ L         +S       + APE +    ++++A D+W  G +  E+++   
Sbjct: 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGE 211

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
                 S   + + +    +                     A   L+ +    +  +R  
Sbjct: 212 RPYWELSNHEVMKAINDGFRLPT------------PMDCPSAIYQLMMQCWQQERARRPK 259

Query: 243 AAEALQ 248
            A+ + 
Sbjct: 260 FADIVS 265

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  101 bits (251), Expect = 1e-25
 Identities = 55/246 (22%), Positives = 86/246 (34%), Gaps = 38/246 (15%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFN 74
            + E   L  +N P +++L         LY V EY      +         +    + + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147

Query: 75  SYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLY 134
           +  + T   L                   I RDLKP N+L+D  G  ++V  FG AK   
Sbjct: 148 AQIVLTFEYLHSL--------------DLIYRDLKPENLLIDQQG-YIQVTDFGFAKR-- 190

Query: 135 AYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLG 194
             KG +    GT    APE++L    Y+ AVD W +G +  EM +G P F     +    
Sbjct: 191 -VKGRTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

Query: 195 RIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TAAEALQQ 249
           +IV    +                        DL+  +L +D  KR         +    
Sbjct: 249 KIVSGKVRF--------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294

Query: 250 EYFKDV 255
           ++F   
Sbjct: 295 KWFATT 300

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 4e-25
 Identities = 42/255 (16%), Positives = 85/255 (33%), Gaps = 40/255 (15%)

Query: 9   EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGY 68
             +   ++ E + + +L++P I+R++ +     +   V E                +   
Sbjct: 49  PALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK 107

Query: 69  STKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTVKVAG 126
           +                        S  + +   + ++ RDL   N+L+       K++ 
Sbjct: 108 NIIEL----------------VHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISD 150

Query: 127 FGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKP 182
           FGL+K+L A   Y    +       + APE +    ++S+  D+W  G +  E  S G+ 
Sbjct: 151 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQK 209

Query: 183 LFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT 242
            + G         +  K  +                 G      DL++     D + R  
Sbjct: 210 PYRGMKGSEVTAMLE-KGERMGCP------------AGCPREMYDLMNLCWTYDVENRPG 256

Query: 243 AAEALQ--QEYFKDV 255
            A      + Y+ DV
Sbjct: 257 FAAVELRLRNYYYDV 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 5e-25
 Identities = 49/252 (19%), Positives = 87/252 (34%), Gaps = 39/252 (15%)

Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKD 63
             T +     M+RE   + +L++P I+RL+ V  Q   L  V E      L   L   ++
Sbjct: 46  QGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKRE 104

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKT 121
            +   +                        S  + +     ++ RDL   N+L+      
Sbjct: 105 EIPVSNVAEL----------------LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY- 147

Query: 122 VKVAGFGLAKSLYA---YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
            K++ FGL+K+L A   Y    SA      + APE +    ++S+  D+W  G    E +
Sbjct: 148 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEAL 206

Query: 179 S-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
           S G+  +        +  I  + ++                P   P    L+S       
Sbjct: 207 SYGQKPYKKMKGPEVMAFIE-QGKRMECP------------PECPPELYALMSDCWIYKW 253

Query: 238 DKRITAAEALQQ 249
           + R       Q+
Sbjct: 254 EDRPDFLTVEQR 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 8e-25
 Identities = 49/251 (19%), Positives = 101/251 (40%), Gaps = 38/251 (15%)

Query: 7   TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG-IYLYPVFEYQVNDLAYLLKYPKDSM 65
           T  G  S  + E   + + +HPN++ L+ +  +       V  Y  +    L  + ++  
Sbjct: 67  TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD--LRNFIRNET 124

Query: 66  NGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVA 125
           +  + K+   + L     +    S            +++ RDL   N ++D +  TVKVA
Sbjct: 125 HNPTVKDLIGFGLQVAKGMKFLASK-----------KFVHRDLAARNCMLD-EKFTVKVA 172

Query: 126 GFGLAKSLYAYKGES----SAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-G 180
            FGLA+ +Y  + +S    +       + A E L    +++T  D+W  G +  E+++ G
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRG 231

Query: 181 KPLFPGANSLITLGRIVGKSR--KPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD 238
            P +P  N+      ++   R  +P +C   L                +++ K      +
Sbjct: 232 APPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY---------------EVMLKCWHPKAE 276

Query: 239 KRITAAEALQQ 249
            R + +E + +
Sbjct: 277 MRPSFSELVSR 287

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.5 bits (237), Expect = 5e-24
 Identities = 46/247 (18%), Positives = 85/247 (34%), Gaps = 36/247 (14%)

Query: 12  PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDL--AYLLKYPKDSMNGYS 69
           P + + E + + +L H  ++RL  V +Q   +Y + EY  N     +L       +    
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINK 110

Query: 70  TKNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGL 129
             +  +        + E                YI RDL+  NILV     + K+A FGL
Sbjct: 111 LLDMAAQIAEGMAFIEER--------------NYIHRDLRAANILVSDTL-SCKIADFGL 155

Query: 130 AKSLYAYK-GESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGA 187
           A+ +   +            + APE +     ++   D+W  G +  E+V+ G+  +PG 
Sbjct: 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGM 214

Query: 188 NSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL 247
            +   +  +    R                          L+       P+ R T     
Sbjct: 215 TNPEVIQNLERGYRMVRPDNCP-------------EELYQLMRLCWKERPEDRPTFDYLR 261

Query: 248 Q--QEYF 252
              +++F
Sbjct: 262 SVLEDFF 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.2 bits (236), Expect = 1e-23
 Identities = 43/249 (17%), Positives = 85/249 (34%), Gaps = 34/249 (13%)

Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDS 64
             T       ++ E   +  +++P++ RL+ +                    LL Y ++ 
Sbjct: 48  EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGC---LLDYVREH 104

Query: 65  MNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDGKTV 122
            +   ++   ++ +               ++ +++    R + RDL   N+LV      V
Sbjct: 105 KDNIGSQYLLNWCV-------------QIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HV 150

Query: 123 KVAGFGLAKSLYAYKGESSAE--VGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
           K+  FGLAK L A + E  AE       + A E +L    Y+   D+W  G    E+++ 
Sbjct: 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTF 209

Query: 181 KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
                       +  I+ K  +                P        ++ K   +D D R
Sbjct: 210 GSKPYDGIPASEISSILEKGERLPQ------------PPICTIDVYMIMVKCWMIDADSR 257

Query: 241 ITAAEALQQ 249
               E + +
Sbjct: 258 PKFRELIIE 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 1e-23
 Identities = 46/251 (18%), Positives = 89/251 (35%), Gaps = 30/251 (11%)

Query: 15  MIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNF 73
            + E S + E N  +++RL+ V SQG     + E     DL   L+  + +M        
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSL 133
            S S                  +     +++ RDL   N +V  D  TVK+  FG+ + +
Sbjct: 130 PSLSKMIQM-----AGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDI 183

Query: 134 YA--YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG-KPLFPGANSL 190
           Y   Y  +    +    + +PE L     ++T  D+W  G +  E+ +  +  + G ++ 
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242

Query: 191 ITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQ-- 248
             L  ++                             +L+      +P  R +  E +   
Sbjct: 243 QVLRFVMEGGLLDKPDNCP-------------DMLFELMRMCWQYNPKMRPSFLEIISSI 289

Query: 249 ----QEYFKDV 255
               +  F++V
Sbjct: 290 KEEMEPGFREV 300

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.5 bits (226), Expect = 2e-22
 Identities = 46/252 (18%), Positives = 88/252 (34%), Gaps = 23/252 (9%)

Query: 5   HNTMEGVPSSMIREVSCLMELNHPNIIRLMRVA--SQGIYLYPVFEYQVN-DLAYLLKYP 61
                    +++ E+  L+ + H   +  +  A    G  L  + E+    +L+  L+  
Sbjct: 53  EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 112

Query: 62  KDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRSLSF--GTRYIRRDLKPVNILVDLDG 119
           ++    Y     + Y  F T   +  +S    ++ + F    + I RDL   NIL+    
Sbjct: 113 RNEFVPYKVAPEDLYKDFLTLEHLICYSF-QVAKGMEFLASRKCIHRDLAARNILLSEKN 171

Query: 120 KTVKVAGFGLAKSLYA--YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEM 177
             VK+  FGLA+ +Y                + APE +     Y+   D+W  G +  E+
Sbjct: 172 -VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEI 229

Query: 178 VSG-KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD 236
            S     +PG        R + +  +                    P     +      +
Sbjct: 230 FSLGASPYPGVKIDEEFCRRLKEGTRMRA------------PDYTTPEMYQTMLDCWHGE 277

Query: 237 PDKRITAAEALQ 248
           P +R T +E ++
Sbjct: 278 PSQRPTFSELVE 289

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.5 bits (226), Expect = 2e-22
 Identities = 49/249 (19%), Positives = 91/249 (36%), Gaps = 19/249 (7%)

Query: 6   NTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKD 63
           +  E   S +I E+  +  +  H NII L+   +Q   LY + EY    +L   L+  + 
Sbjct: 56  DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 115

Query: 64  SMNGYST-KNFNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTV 122
               YS   + N     ++  LV                + I RDL   N+LV  D   +
Sbjct: 116 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VM 174

Query: 123 KVAGFGLAKSLYA--YKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSG 180
           K+A FGLA+ ++   Y  +++       + APE L     Y+   D+W  G +  E+ + 
Sbjct: 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTL 233

Query: 181 KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR 240
                    +  L +++ +  +                         ++       P +R
Sbjct: 234 GGSPYPGVPVEELFKLLKEGHRMDKP------------SNCTNELYMMMRDCWHAVPSQR 281

Query: 241 ITAAEALQQ 249
            T  + ++ 
Sbjct: 282 PTFKQLVED 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 90.7 bits (224), Expect = 4e-22
 Identities = 42/244 (17%), Positives = 72/244 (29%), Gaps = 31/244 (12%)

Query: 15  MIREVSCLMELNHPNIIRLMRVA-SQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNF 73
           +  E      +     I  +R   ++G Y   V E     L  L  +     +  +    
Sbjct: 49  LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLL 108

Query: 74  NSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAK 131
                      +E   S            +I RD+KP N L+ L      V +  FGLAK
Sbjct: 109 ----ADQMISRIEYIHSK----------NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

Query: 132 SL-------YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLF 184
                    +    E+    GT  Y +    LG+ E S   D+  +G +      G   +
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPW 213

Query: 185 PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA 244
            G  +     +    S K       +   +     G        ++    +  D +   +
Sbjct: 214 QGLKAATKRQKYERISEKK------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267

Query: 245 EALQ 248
              Q
Sbjct: 268 YLRQ 271

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.3 bits (223), Expect = 7e-22
 Identities = 52/251 (20%), Positives = 87/251 (34%), Gaps = 22/251 (8%)

Query: 6   NTMEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKD 63
           +       +++ E+  L  L NH NI+ L+   + G     + EY    DL   L+  +D
Sbjct: 64  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 64  SMNGYSTKNFNSYSLFTTFLLVEEFS-SSDSSRSLSF--GTRYIRRDLKPVNILVDLDGK 120
           S     T             L +  S S   ++ ++F      I RDL   NIL+     
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR- 182

Query: 121 TVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMV 178
             K+  FGLA+ +                 + APE +     Y+   D+W  G    E+ 
Sbjct: 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELF 241

Query: 179 S-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP 237
           S G   +PG        +++ +  +                        D++      DP
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSP------------EHAPAEMYDIMKTCWDADP 289

Query: 238 DKRITAAEALQ 248
            KR T  + +Q
Sbjct: 290 LKRPTFKQIVQ 300

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 88.7 bits (219), Expect = 2e-21
 Identities = 39/250 (15%), Positives = 65/250 (26%), Gaps = 39/250 (15%)

Query: 14  SMIREVSCLMELNHPNII-RLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKN 72
            +  E      L     I  +     +G++   V +     L  LL       +  +   
Sbjct: 46  QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM 105

Query: 73  FNSYSLFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGK----TVKVAGFG 128
                       V+                 + RD+KP N L+          + V  FG
Sbjct: 106 A----AKQMLARVQSIHEK----------SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151

Query: 129 LAKSL-------YAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGEMVSGK 181
           + K         +    E     GT  Y +    LG  E S   D+  +G +F   + G 
Sbjct: 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGS 210

Query: 182 PLFPG---ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD 238
             + G   A +     RI  K +     +L           G        +     +  D
Sbjct: 211 LPWQGLKAATNKQKYERIGEKKQSTPLREL---------CAGFPEEFYKYMHYARNLAFD 261

Query: 239 KRITAAEALQ 248
                     
Sbjct: 262 ATPDYDYLQG 271

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	259
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.68
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.78
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.27
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.19
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.87
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	89.99
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	88.11

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-57  Score=367.06  Aligned_cols=225  Identities=26%  Similarity=0.394  Sum_probs=191.7

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |.+........+.+.+|++++++++|||||++++++.+++.+|+||||+.| +|.+++..                ..++
T Consensus        51 K~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~----------------~~l~  114 (293)
T d1yhwa1          51 RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------------TCMD  114 (293)
T ss_dssp             EEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH----------------SCCC
T ss_pred             EEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc----------------cCCC
Confidence            344444455567899999999999999999999999999999999999996 88887753                3356


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccC
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      ...+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.............||+.|+|||.+.+ ..
T Consensus       115 ~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~  192 (293)
T d1yhwa1         115 EGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KA  192 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS-SC
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeeccccccccccccCCCccChhhhcC-CC
Confidence            678889999999999999999999999999999999988 8999999999877555555667789999999999988 57


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      ++.++|||||||++|+|++|.+||.+.+.......+....... .          .....+|+++++||.+||..||++|
T Consensus       193 ~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-~----------~~~~~~s~~~~~li~~~L~~dP~~R  261 (293)
T d1yhwa1         193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-L----------QNPEKLSAIFRDFLNRCLDMDVEKR  261 (293)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-C----------SSGGGSCHHHHHHHHHHTCSSTTTS
T ss_pred             CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-C----------CCcccCCHHHHHHHHHHccCChhHC
Confidence            8999999999999999999999999888777766654432211 1          1123588999999999999999999


Q ss_pred             cCHHHHhcCccccCC
Q 039159          241 ITAAEALQQEYFKDV  255 (259)
Q Consensus       241 p~~~~~l~h~~f~~~  255 (259)
                      ||++|+|+||||+..
T Consensus       262 ~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         262 GSAKELLQHQFLKIA  276 (293)
T ss_dssp             CCHHHHTTCGGGGGC
T ss_pred             cCHHHHhcCHhhCCC
Confidence            999999999999854

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-57  Score=363.65  Aligned_cols=229  Identities=22%  Similarity=0.293  Sum_probs=192.2

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |.+...+.+..+++.+|++++++++|||||++++++.+++.+|+||||+.| +|..++....              ..++
T Consensus        43 K~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~--------------~~l~  108 (288)
T d2jfla1          43 KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--------------RPLT  108 (288)
T ss_dssp             EEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT--------------SCCC
T ss_pred             EEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC--------------CCCC
Confidence            445555666678899999999999999999999999999999999999996 8888875421              3356


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC---
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG---  157 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---  157 (259)
                      ..++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.............||+.|+|||.+..   
T Consensus       109 e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~  187 (288)
T d2jfla1         109 ESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS  187 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCST
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCcccccccccccccCCHHHHhhccc
Confidence            778899999999999999999999999999999999998 8999999999765443333456689999999999853   


Q ss_pred             -ccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcC
Q 039159          158 -LLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMD  236 (259)
Q Consensus       158 -~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  236 (259)
                       ...++.++|||||||++|+|++|+.||.+.+..+....+....... .          .....+|+++.+||.+||+.|
T Consensus       188 ~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-~----------~~~~~~s~~~~~li~~~L~~d  256 (288)
T d2jfla1         188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-L----------AQPSRWSSNFKDFLKKCLEKN  256 (288)
T ss_dssp             TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-C----------SSGGGSCHHHHHHHHHHSCSS
T ss_pred             CCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-C----------CccccCCHHHHHHHHHHccCC
Confidence             2457889999999999999999999999988877777766543211 1          112468899999999999999


Q ss_pred             CCCccCHHHHhcCccccCCC
Q 039159          237 PDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       237 p~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |++|||++|+|+||||+...
T Consensus       257 p~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         257 VDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             TTTSCCHHHHTTSGGGCCCC
T ss_pred             hhHCcCHHHHhcCcccCCCC
Confidence            99999999999999998644

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=356.85  Aligned_cols=220  Identities=22%  Similarity=0.306  Sum_probs=179.3

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+..+++.+|++++++++||||+++++++.+++.+|+||||+.| +|.+.+...               ..++...+..+
T Consensus        44 ~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~---------------~~l~e~~~~~i  108 (271)
T d1nvra_          44 VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---------------IGMPEPDAQRF  108 (271)
T ss_dssp             -----CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT---------------TBCCHHHHHHH
T ss_pred             chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcC---------------CCCCHHHHHHH
Confidence            34567899999999999999999999999999999999999996 898888531               34667788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.|+++||+|||++||+||||||+|||++.++ .+||+|||+|+......  .......||+.|+|||++.+...++.++
T Consensus       109 ~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~  187 (271)
T d1nvra_         109 FHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV  187 (271)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHH
T ss_pred             HHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCce
Confidence            99999999999999999999999999999888 89999999998764332  2244568999999999998744456789


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHH-HHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITL-GRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      ||||+||++|+|++|++||......... ..+.......            ..+..+|+++.+||.+||+.||++|||++
T Consensus       188 DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~  255 (271)
T d1nvra_         188 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------------NPWKKIDSAPLALLHKILVENPSARITIP  255 (271)
T ss_dssp             HHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             eeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------------CccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            9999999999999999999875543332 2232222111            11245789999999999999999999999


Q ss_pred             HHhcCccccCCC
Q 039159          245 EALQQEYFKDVP  256 (259)
Q Consensus       245 ~~l~h~~f~~~~  256 (259)
                      ++|+||||+..-
T Consensus       256 eil~hpwf~~~l  267 (271)
T d1nvra_         256 DIKKDRWYNKPL  267 (271)
T ss_dssp             HHTTCTTTTCCC
T ss_pred             HHhcCHhhCcCC
Confidence            999999998653

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=352.86  Aligned_cols=214  Identities=28%  Similarity=0.400  Sum_probs=186.5

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +...+.+.+|++++++++||||+++++++.+++.+|+||||++| +|.+.+...               ..++...+..+
T Consensus        47 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~---------------~~l~e~~~~~i  111 (263)
T d2j4za1          47 AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---------------SKFDEQRTATY  111 (263)
T ss_dssp             TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------SSCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc---------------CCCCHHHHHHH
Confidence            45567889999999999999999999999999999999999995 999988642               34567788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||++||+||||||+||+++.++ .+||+|||+++....  .......||+.|+|||++.+ ..++.++||
T Consensus       112 ~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~--~~~~~~~Gt~~Y~APE~~~~-~~~~~~~Di  187 (263)
T d2j4za1         112 ITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIEG-RMHDEKVDL  187 (263)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCC--CCCEETTEEGGGCCHHHHTT-CCCCTTHHH
T ss_pred             HHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCC--CcccccCCCCcccCHHHHcC-CCCCchhhh
Confidence            99999999999999999999999999999988 899999999976533  23445679999999999988 568999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      |||||++|+|++|+.||.+.+.......+......  .            ...+|+++++||.+||+.||++|||++++|
T Consensus       188 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--~------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil  253 (263)
T d2j4za1         188 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--F------------PDFVTEGARDLISRLLKHNPSQRPMLREVL  253 (263)
T ss_dssp             HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--C------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--C------------CccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence            99999999999999999998888877777554321  1            135789999999999999999999999999


Q ss_pred             cCccccCC
Q 039159          248 QQEYFKDV  255 (259)
Q Consensus       248 ~h~~f~~~  255 (259)
                      +||||.+-
T Consensus       254 ~hp~~~~~  261 (263)
T d2j4za1         254 EHPWITAN  261 (263)
T ss_dssp             TCHHHHHH
T ss_pred             cCcCcCCc
Confidence            99999753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-55  Score=353.89  Aligned_cols=218  Identities=27%  Similarity=0.367  Sum_probs=173.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      .....+.+|+.+|++++||||+++++++.+++.+|+|||||+| +|.+++...               ..++...+..++
T Consensus        49 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~---------------~~l~e~~~~~~~  113 (307)
T d1a06a_          49 GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---------------GFYTERDASRLI  113 (307)
T ss_dssp             ------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC---------------SCCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcc---------------cCCCHHHHHHHH
Confidence            4456788999999999999999999999999999999999995 999998642               346678889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcC---CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDL---DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~---~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .|++.||+|||+++|+||||||+||++..   ++ .+||+|||+++.... ........||+.|+|||.+.+ ..++.++
T Consensus       114 ~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a~~~~~-~~~~~~~~GT~~y~APE~~~~-~~~~~~~  190 (307)
T d1a06a_         114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS-KIMISDFGLSKMEDP-GSVLSTACGTPGYVAPEVLAQ-KPYSKAV  190 (307)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC-CEEECCC-------------------CTTSCHHHHTT-CCCCTHH
T ss_pred             HHHHHHHHhhhhceeeeEEecccceeecccCCCc-eEEEeccceeEEccC-CCeeeeeeeCccccCcHHHcC-CCCCcHH
Confidence            99999999999999999999999999953   45 899999999976533 233445679999999999987 5789999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||||++|+|++|.+||.+.........+......+..          +.++.+|+++.+||.+||..||++|||++|
T Consensus       191 DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  260 (307)
T d1a06a_         191 DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS----------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQ  260 (307)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT----------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC----------ccccCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            9999999999999999999998888888887765433221          223578999999999999999999999999


Q ss_pred             HhcCccccCC
Q 039159          246 ALQQEYFKDV  255 (259)
Q Consensus       246 ~l~h~~f~~~  255 (259)
                      +++||||++.
T Consensus       261 il~hp~~~~~  270 (307)
T d1a06a_         261 ALQHPWIAGD  270 (307)
T ss_dssp             HHHSTTTTSS
T ss_pred             HhcCHhhCCC
Confidence            9999999854

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=344.52  Aligned_cols=213  Identities=23%  Similarity=0.287  Sum_probs=175.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEe----CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQ----GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ...+++.+|++++++++|||||++++++++    +..+|+||||++| +|.+++...               ..++...+
T Consensus        50 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~---------------~~~~~~~~  114 (270)
T d1t4ha_          50 SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---------------KVMKIKVL  114 (270)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH---------------SSCCHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc---------------ccccHHHH
Confidence            335678999999999999999999999875    3578999999996 999988642               34556778


Q ss_pred             HHHHhhcccccccccCCC--ceeccCCCCcEEEcC-CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           85 VEEFSSSDSSRSLSFGTR--YIRRDLKPVNILVDL-DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~--i~H~dlkp~Nili~~-~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      ..++.|+++||+|||+++  |+||||||+|||++. ++ .+||+|||+++....  .......||+.|+|||.+.+  .+
T Consensus       115 ~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~-~~Kl~DFGla~~~~~--~~~~~~~GT~~Y~aPE~~~~--~~  189 (270)
T d1t4ha_         115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE--KY  189 (270)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS-CEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT--CC
T ss_pred             HHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC-CEEEeecCcceeccC--CccCCcccCccccCHHHhCC--CC
Confidence            889999999999999988  999999999999975 55 899999999975422  23445689999999999876  48


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      +.++|||||||++|||++|+.||.+................+...           ....++++.+||.+||..||++||
T Consensus       190 ~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~-----------~~~~~~~~~~li~~~l~~dp~~R~  258 (270)
T d1t4ha_         190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF-----------DKVAIPEVKEIIEGCIRQNKDERY  258 (270)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG-----------GGCCCHHHHHHHHHHSCSSGGGSC
T ss_pred             CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCccc-----------CccCCHHHHHHHHHHccCCHhHCc
Confidence            999999999999999999999998765555444433332222111           135789999999999999999999


Q ss_pred             CHHHHhcCcccc
Q 039159          242 TAAEALQQEYFK  253 (259)
Q Consensus       242 ~~~~~l~h~~f~  253 (259)
                      |++|+|+||||+
T Consensus       259 s~~ell~Hp~fk  270 (270)
T d1t4ha_         259 SIKDLLNHAFFQ  270 (270)
T ss_dssp             CHHHHHTSGGGC
T ss_pred             CHHHHhCCcccC
Confidence            999999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=348.64  Aligned_cols=217  Identities=28%  Similarity=0.422  Sum_probs=184.8

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +...+.+.+|++++++++||||+++++++.+++.+|+||||++| +|.+++...               ..++...+..+
T Consensus        49 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~---------------~~l~e~~~~~~  113 (288)
T d1uu3a_          49 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---------------GSFDETCTRFY  113 (288)
T ss_dssp             TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH---------------SSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc---------------CCCCHHHHHHH
Confidence            44557799999999999999999999999999999999999996 898887642               34567788899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      +.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++.+.....  ......||+.|+|||++.+ ..++.++
T Consensus       114 ~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~  191 (288)
T d1uu3a_         114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSS  191 (288)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC----------CCCCGGGCCHHHHHT-CCCCHHH
T ss_pred             HHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccCCcccccccccCCccccCceeecc-CCCCccc
Confidence            99999999999999999999999999999998 899999999987643322  2345679999999999988 5789999


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      |||||||++|+|++|+.||.+.+.......+......  .            ...+|+++++||.+||+.||++|||++|
T Consensus       192 DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--~------------p~~~s~~~~~li~~~L~~dP~~R~t~~e  257 (288)
T d1uu3a_         192 DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--F------------PEKFFPKARDLVEKLLVLDATKRLGCEE  257 (288)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC--C------------CTTCCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred             ceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC--C------------CccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            9999999999999999999998888888777654321  1            1368999999999999999999999987


Q ss_pred             ------HhcCccccCCC
Q 039159          246 ------ALQQEYFKDVP  256 (259)
Q Consensus       246 ------~l~h~~f~~~~  256 (259)
                            +++||||+++.
T Consensus       258 ~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         258 MEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             GTCHHHHHTSGGGTTCC
T ss_pred             HcCCHHHHcCCccCCCC
Confidence                  68899999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=350.37  Aligned_cols=217  Identities=26%  Similarity=0.390  Sum_probs=171.3

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEe--CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQ--GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ...+.+.+|++++++++|||||++++++.+  ++.+|+||||++| +|.+++......           ...++...+..
T Consensus        45 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~-----------~~~l~e~~~~~  113 (269)
T d2java1          45 AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-----------RQYLDEEFVLR  113 (269)
T ss_dssp             HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHH-----------TCCCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhcccc-----------CCCCCHHHHHH
Confidence            345678999999999999999999999864  4578999999996 999988532111           03466788899


Q ss_pred             HHhhcccccccccCCC-----ceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCC
Q 039159           87 EFSSSDSSRSLSFGTR-----YIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~-----i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      ++.|++.||+|||+.+     |+||||||+|||++.++ .+||+|||+++.............||+.|+|||.+.+ ..+
T Consensus       114 i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~  191 (269)
T d2java1         114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSY  191 (269)
T ss_dssp             HHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCHHHHHHC-----------CCCSCCCHHHHTT-CCC
T ss_pred             HHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeeccceeecccCCCccccCCCCcccCCHHHHcC-CCC
Confidence            9999999999999865     99999999999999988 8999999999877554444556789999999999987 578


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      +.++|||||||++|||+||+.||.+.+..+....+......             .....+|+++.+||.+||+.||++||
T Consensus       192 ~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~-------------~~~~~~s~~l~~li~~~L~~dp~~Rp  258 (269)
T d2java1         192 NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-------------RIPYRYSDELNEIITRMLNLKDYHRP  258 (269)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-------------CCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-------------CCCcccCHHHHHHHHHHcCCChhHCc
Confidence            99999999999999999999999998888777776544321             11246899999999999999999999


Q ss_pred             CHHHHhcCccc
Q 039159          242 TAAEALQQEYF  252 (259)
Q Consensus       242 ~~~~~l~h~~f  252 (259)
                      |++|+|+|||+
T Consensus       259 s~~ell~hp~i  269 (269)
T d2java1         259 SVEEILENPLI  269 (269)
T ss_dssp             CHHHHHTSTTC
T ss_pred             CHHHHHhCCcC
Confidence            99999999996

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=349.18  Aligned_cols=232  Identities=33%  Similarity=0.527  Sum_probs=187.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ...+++.+|++++++++|||||++++++.+++.+|+||||+.|++...+....              ..++...+..++.
T Consensus        42 ~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~--------------~~l~~~~~~~~~~  107 (299)
T d1ua2a_          42 GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--------------LVLTPSHIKAYML  107 (299)
T ss_dssp             --CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC--------------SSCCSSHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcc--------------cCCCHHHHHHHHH
Confidence            44678999999999999999999999999999999999999986555554321              3344567888999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      |++.||+|||++||+||||||+||+++.++ .+||+|||.++.............||+.|+|||.+.+...++.++||||
T Consensus       108 qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  186 (299)
T d1ua2a_         108 MTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA  186 (299)
T ss_dssp             HHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred             HHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhh
Confidence            999999999999999999999999999888 8999999999876555455556689999999999976567899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc------cc--------ccccccCCCCCCCHHHHHHHHhhcCc
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK------LS--------LRDHLTNGFPGLEPAGIDLISKMLGM  235 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~------~~--------~~~~~~~~~~~~~~~~~~li~~~l~~  235 (259)
                      |||++|||++|.+||.+.+..+....+......+....      ..        ........++.+++++.+||.+||+.
T Consensus       187 lGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~  266 (299)
T d1ua2a_         187 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF  266 (299)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred             cchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccC
Confidence            99999999999999999888877776643211111000      00        00011222356789999999999999


Q ss_pred             CCCCccCHHHHhcCccccCCC
Q 039159          236 DPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       236 dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      ||++|||++|+|+||||++.+
T Consensus       267 dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         267 NPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             STTTSCCHHHHHTSGGGTSSS
T ss_pred             ChhhCcCHHHHhCCHhhCCCC
Confidence            999999999999999999764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-54  Score=348.41  Aligned_cols=214  Identities=24%  Similarity=0.318  Sum_probs=180.7

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhc
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSS   91 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (259)
                      .+++.+|++++++++|||||++++++.+++.+|+|||||.|++...+....              ..++...+..++.|+
T Consensus        59 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~--------------~~l~e~~~~~i~~qi  124 (309)
T d1u5ra_          59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--------------KPLQEVEIAAVTHGA  124 (309)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT--------------SCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC--------------CCCCHHHHHHHHHHH
Confidence            356889999999999999999999999999999999999974444332211              345677889999999


Q ss_pred             ccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc--cCCCcccchHh
Q 039159           92 DSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL--LEYSTAVDIWP  169 (259)
Q Consensus        92 ~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Diws  169 (259)
                      +.||+|||++||+||||||+|||++.++ .+||+|||++.....    .....||+.|+|||++.+.  ..++.++||||
T Consensus       125 ~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwS  199 (309)
T d1u5ra_         125 LQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWS  199 (309)
T ss_dssp             HHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHH
T ss_pred             HHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhh
Confidence            9999999999999999999999999888 999999999976432    3456799999999999642  45788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      |||++|||++|..||.+.+.......+......+..            ...+|+++.+||.+||+.||.+|||++++|+|
T Consensus       200 lGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         200 LGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             HHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            999999999999999998888777776554322111            13578999999999999999999999999999


Q ss_pred             ccccCCC
Q 039159          250 EYFKDVP  256 (259)
Q Consensus       250 ~~f~~~~  256 (259)
                      |||....
T Consensus       268 p~~~~~~  274 (309)
T d1u5ra_         268 RFVLRER  274 (309)
T ss_dssp             HHHHSCC
T ss_pred             HHhcCCC
Confidence            9998643

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.9e-54  Score=356.20  Aligned_cols=227  Identities=23%  Similarity=0.336  Sum_probs=191.1

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |.+........+.+.+|+++|++|+|||||++++++.+++.+|+||||+.| +|.+.+....              ..++
T Consensus        57 K~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~--------------~~l~  122 (350)
T d1koaa2          57 KFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--------------NKMS  122 (350)
T ss_dssp             EEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT--------------SCBC
T ss_pred             EEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc--------------CCCC
Confidence            445444445567789999999999999999999999999999999999996 9999885321              3467


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcC--CCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDL--DGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~--~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (259)
                      ...+..++.|++.||+|||++||+||||||+|||++.  ++ .+||+|||+++.... ........||+.|+|||++.+ 
T Consensus       123 e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~-~vkL~DFG~a~~~~~-~~~~~~~~gT~~Y~aPEv~~~-  199 (350)
T d1koaa2         123 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEG-  199 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSC-CEEECCCTTCEECCT-TSCEEEECSCTTTCCHHHHHT-
T ss_pred             HHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCC-eEEEeecchheeccc-ccccceecCcccccCHHHHcC-
Confidence            7888999999999999999999999999999999964  45 899999999986533 223445679999999999988 


Q ss_pred             cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      ..++.++|||||||++|+|++|..||.+.+..+....+......+..          ..++++|+++++||.+||..||+
T Consensus       200 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dP~  269 (350)
T d1koaa2         200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------SAFSGISEDGKDFIRKLLLADPN  269 (350)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC----------GGGGGCCHHHHHHHHHHCCSSGG
T ss_pred             CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----------ccccCCCHHHHHHHHHHccCChh
Confidence            57889999999999999999999999998888888777654432211          12246899999999999999999


Q ss_pred             CccCHHHHhcCccccCC
Q 039159          239 KRITAAEALQQEYFKDV  255 (259)
Q Consensus       239 ~Rp~~~~~l~h~~f~~~  255 (259)
                      +|||++++|+||||+..
T Consensus       270 ~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         270 TRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             GSCCHHHHHHSTTTSCT
T ss_pred             HCcCHHHHhcCcccCCC
Confidence            99999999999999865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=348.61  Aligned_cols=216  Identities=25%  Similarity=0.351  Sum_probs=189.4

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+..+.+.+|+.+|++++||||+++++++.+++.+|+||||+.| +|...+...               ..++...+..+
T Consensus        46 ~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~---------------~~~~e~~~~~~  110 (337)
T d1o6la_          46 KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---------------RVFTEERARFY  110 (337)
T ss_dssp             TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------SCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcc---------------cCCcHHHHHHH
Confidence            34567789999999999999999999999999999999999996 888888642               34556778889


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||++||+||||||+|||++.+| .+||+|||+++............+||+.|+|||++.+ ..++.++|+
T Consensus       111 ~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~Di  188 (337)
T d1o6la_         111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDW  188 (337)
T ss_dssp             HHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHH
T ss_pred             HHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccCCcccccceeCHHHhhhhhccC-CCCChhhcc
Confidence            99999999999999999999999999999998 8999999999876555555666789999999999988 578999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----  242 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----  242 (259)
                      |||||++|||++|++||.+.+.......+......  .            +..+|+++++||.+||+.||.+|++     
T Consensus       189 wSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~--~------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~  254 (337)
T d1o6la_         189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--F------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSD  254 (337)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--C------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred             cchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC--C------------CccCCHHHHHHHHhhccCCchhhccccccc
Confidence            99999999999999999999888877777654321  1            2468999999999999999999994     


Q ss_pred             HHHHhcCccccCC
Q 039159          243 AAEALQQEYFKDV  255 (259)
Q Consensus       243 ~~~~l~h~~f~~~  255 (259)
                      ++++++||||+++
T Consensus       255 ~~eil~Hp~f~~i  267 (337)
T d1o6la_         255 AKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHHTSGGGTTC
T ss_pred             HHHHHcCcccccC
Confidence            9999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3e-54  Score=355.34  Aligned_cols=225  Identities=21%  Similarity=0.333  Sum_probs=189.5

Q ss_pred             CCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHH
Q 039159            4 IHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTF   82 (259)
Q Consensus         4 ~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (259)
                      +........+.+.+|+++|++|+|||||++++++.+++.+|+|||||.| +|.+.+....              ..++..
T Consensus        62 i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~--------------~~l~e~  127 (352)
T d1koba_          62 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--------------YKMSEA  127 (352)
T ss_dssp             EECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT--------------CCBCHH
T ss_pred             ECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC--------------CCCCHH
Confidence            3333333456788999999999999999999999999999999999996 8888774321              346778


Q ss_pred             HHHHHHhhcccccccccCCCceeccCCCCcEEEc--CCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccC
Q 039159           83 LLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVD--LDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLE  160 (259)
Q Consensus        83 ~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~--~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  160 (259)
                      ++..++.|++.||+|||++||+||||||+|||++  .++ .+||+|||+++.... ........||+.|+|||.+.+ ..
T Consensus       128 ~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~  204 (352)
T d1koba_         128 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNP-DEIVKVTTATAEFAAPEIVDR-EP  204 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCC-CEEECCCTTCEECCT-TSCEEEECSSGGGCCHHHHTT-CC
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCC-eEEEeecccceecCC-CCceeeccCcccccCHHHHcC-CC
Confidence            8999999999999999999999999999999997  345 899999999987643 233445679999999999987 67


Q ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCc
Q 039159          161 YSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKR  240 (259)
Q Consensus       161 ~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (259)
                      ++.++|||||||++|+|+||..||.+.+.......+......+.          ...++++|+++.+||.+||..||.+|
T Consensus       205 ~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~s~~~~~li~~~L~~dp~~R  274 (352)
T d1koba_         205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD----------EDAFSSVSPEAKDFIKNLLQKEPRKR  274 (352)
T ss_dssp             BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC----------SSTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred             CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------cccccCCCHHHHHHHHHHccCChhHC
Confidence            89999999999999999999999999988888877765432211          12345789999999999999999999


Q ss_pred             cCHHHHhcCccccCC
Q 039159          241 ITAAEALQQEYFKDV  255 (259)
Q Consensus       241 p~~~~~l~h~~f~~~  255 (259)
                      ||++|+|+||||+..
T Consensus       275 ~s~~eil~Hp~~~~~  289 (352)
T d1koba_         275 LTVHDALEHPWLKGD  289 (352)
T ss_dssp             CCHHHHHTSTTTSSC
T ss_pred             cCHHHHhcCHhhCCC
Confidence            999999999999854

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=353.53  Aligned_cols=228  Identities=23%  Similarity=0.288  Sum_probs=176.3

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      +...+++.+|+++|++++|||||+++++|.+++.+|+||||+.| +|.+++...               ..++...+..+
T Consensus        45 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~---------------~~l~~~~~~~~  109 (322)
T d1s9ja_          45 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---------------GRIPEQILGKV  109 (322)
T ss_dssp             TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH---------------SSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc---------------CCCCHHHHHHH
Confidence            44457899999999999999999999999999999999999996 899988642               33566788899


Q ss_pred             HhhcccccccccC-CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           88 FSSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        88 ~~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      +.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+|+.....  ......||+.|+|||++.+ ..++.++|
T Consensus       110 ~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~-~~y~~~~D  185 (322)
T d1s9ja_         110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THYSVQSD  185 (322)
T ss_dssp             HHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHC-SCCCTTHH
T ss_pred             HHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccccCCC--ccccccCCccccCchHHcC-CCCCcHHH
Confidence            9999999999997 5999999999999999998 8999999999865432  2345689999999999998 67999999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCC--CCC----------------------Ccccccccc-----ccccCC
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGK--SRK----------------------PSFCKLSLR-----DHLTNG  217 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~--~~~----------------------~~~~~~~~~-----~~~~~~  217 (259)
                      |||+||++|||++|+.||.+.+...........  ...                      +........     ......
T Consensus       186 iWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (322)
T d1s9ja_         186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL  265 (322)
T ss_dssp             HHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCC
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccC
Confidence            999999999999999999875433221110000  000                      000000000     000000


Q ss_pred             -CCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          218 -FPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       218 -~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                       ...+|+++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       266 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         266 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence             12368899999999999999999999999999999753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=342.88  Aligned_cols=235  Identities=40%  Similarity=0.634  Sum_probs=190.2

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      .+...+++.+|++++++++|||||++++++.+++.+|+||||+.+++...+.....             ..++...+..+
T Consensus        41 ~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~-------------~~l~e~~~~~~  107 (298)
T d1gz8a_          41 TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL-------------TGIPLPLIKSY  107 (298)
T ss_dssp             ---CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTT-------------TCCCHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcc-------------cCCCHHHHHHH
Confidence            34567889999999999999999999999999999999999999877776643211             44677889999


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||+.||+||||||+||+++.++ .+||+|||.++.............||+.|+|||.+.....++.++||
T Consensus       108 ~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~Di  186 (298)
T d1gz8a_         108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI  186 (298)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHH
T ss_pred             HHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccc
Confidence            99999999999999999999999999999888 89999999998765545555666899999999998875667889999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcc---cccc------------ccccccCCCCCCCHHHHHHHHhh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSF---CKLS------------LRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~------------~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                      ||+||++|+|++|+.||.+.+.......+......+..   ....            .........+.+|+++.+|+.+|
T Consensus       187 wSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~m  266 (298)
T d1gz8a_         187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM  266 (298)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred             cccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHH
Confidence            99999999999999999998877776665321111110   0000            00011112346789999999999


Q ss_pred             cCcCCCCccCHHHHhcCccccCCC
Q 039159          233 LGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      |..||++|||++|+|+||||+++.
T Consensus       267 L~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         267 LHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             TCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccCChhHCcCHHHHhCCHhhccCC
Confidence            999999999999999999999874

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.7e-53  Score=342.75  Aligned_cols=214  Identities=25%  Similarity=0.358  Sum_probs=184.8

Q ss_pred             CCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            9 EGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ....+.+.+|+.++++++||||+++++++.+++.+|+||||+.| +|...+...               ..........+
T Consensus        45 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~---------------~~~~~~~~~~~  109 (316)
T d1fota_          45 LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---------------QRFPNPVAKFY  109 (316)
T ss_dssp             TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT---------------SSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccc---------------ccccccHHHHH
Confidence            34457789999999999999999999999999999999999997 777777543               23345566778


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....   ......||+.|+|||++.+ ..++.++||
T Consensus       110 ~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~l~~-~~y~~~~Di  184 (316)
T d1fota_         110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVST-KPYNKSIDW  184 (316)
T ss_dssp             HHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTT-CCBCTTHHH
T ss_pred             HHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEecc---ccccccCcccccCHHHHcC-CCCCchhhc
Confidence            89999999999999999999999999999988 899999999987533   3445689999999999987 578899999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----C
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----T  242 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~  242 (259)
                      |||||++|+|++|+.||.+.+..+....+......              ..+.+|+++.+++.+||..||.+|+     |
T Consensus       185 wSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~--------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t  250 (316)
T d1fota_         185 WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNG  250 (316)
T ss_dssp             HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC--------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTT
T ss_pred             cccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC--------------CCCCCCHHHHHHHHHHhhhCHHhccccchhh
Confidence            99999999999999999999888888877654321              1146889999999999999999996     9


Q ss_pred             HHHHhcCccccCCC
Q 039159          243 AAEALQQEYFKDVP  256 (259)
Q Consensus       243 ~~~~l~h~~f~~~~  256 (259)
                      ++++++||||+++.
T Consensus       251 ~~~il~Hp~f~~i~  264 (316)
T d1fota_         251 TEDVKNHPWFKEVV  264 (316)
T ss_dssp             THHHHTSGGGSSCC
T ss_pred             HHHHHcCcccccCC
Confidence            99999999999863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=342.00  Aligned_cols=219  Identities=26%  Similarity=0.309  Sum_probs=186.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..+.+.+|+++|++++|||||++++++.+++.+|+|||||.| +|.+++...               ..++...+..++.
T Consensus        56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~---------------~~l~~~~~~~~~~  120 (293)
T d1jksa_          56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---------------ESLTEEEATEFLK  120 (293)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---------------SSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc---------------cccchhHHHHHHH
Confidence            356789999999999999999999999999999999999996 999988642               3466778899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCC---eEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGK---TVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~---~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      |++.||+|||+.+|+||||||+||+++.++.   .+|++|||++..... ........||+.|+|||.+.+ ..++.++|
T Consensus       121 qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~-~~~~~~~~~t~~y~APE~~~~-~~~~~~~D  198 (293)
T d1jksa_         121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTPEFVAPEIVNY-EPLGLEAD  198 (293)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT-SCBCSCCCCCGGGCCHHHHTT-CCBCTHHH
T ss_pred             HHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC-CccccccCCCCcccCHHHHcC-CCCCCccc
Confidence            9999999999999999999999999987662   499999999987543 233455679999999999987 57899999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      ||||||++|+|++|+.||.+.+..+....+.........          ..++.+|+.+++||.+||..||++|||++++
T Consensus       199 iwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei  268 (293)
T d1jksa_         199 MWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED----------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS  268 (293)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH----------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             chhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc----------hhcCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            999999999999999999999888888777655432211          1124689999999999999999999999999


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      |+||||+...
T Consensus       269 l~hp~~~~~~  278 (293)
T d1jksa_         269 LQHPWIKPKD  278 (293)
T ss_dssp             HHSTTTCC--
T ss_pred             hcCcccCCCC
Confidence            9999998653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.9e-52  Score=334.10  Aligned_cols=215  Identities=27%  Similarity=0.397  Sum_probs=185.7

Q ss_pred             chhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           13 SSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      +++.+|+.++++++ ||||+++++++.+++.+|+||||++| +|.+++...               ..++..++..++.|
T Consensus        54 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~---------------~~l~e~~~~~~~~q  118 (277)
T d1phka_          54 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---------------VTLSEKETRKIMRA  118 (277)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------SSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc---------------CCCCHHHHHHHHHH
Confidence            46889999999997 99999999999999999999999996 999999642               44678899999999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccC-----ccCCCccc
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLG-----LLEYSTAV  165 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~  165 (259)
                      ++.||+|||++||+||||||+||+++.++ .+||+|||+++..... .......||+.|+|||.+.+     ...++.++
T Consensus       119 i~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~  196 (277)
T d1phka_         119 LLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV  196 (277)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHH
T ss_pred             HHHHHHHHHHcCCcccccccceEEEcCCC-CeEEccchheeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchh
Confidence            99999999999999999999999999888 8999999999876432 23445679999999999863     23468899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||+||++|+|++|+.||.+.+.......+......+..          +..+++|+++++|+.+||+.||.+|||+++
T Consensus       197 DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~~p~~R~s~~e  266 (277)
T d1phka_         197 DMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS----------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEE  266 (277)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             eEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC----------cccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            9999999999999999999999888877777655433221          123468999999999999999999999999


Q ss_pred             HhcCccccC
Q 039159          246 ALQQEYFKD  254 (259)
Q Consensus       246 ~l~h~~f~~  254 (259)
                      +|+||||+.
T Consensus       267 il~h~~~~~  275 (277)
T d1phka_         267 ALAHPFFQQ  275 (277)
T ss_dssp             HTTSGGGCT
T ss_pred             HHcCHHHHH
Confidence            999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-52  Score=342.57  Aligned_cols=213  Identities=25%  Similarity=0.339  Sum_probs=186.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.+.+|+++|+.++||||+++++++.+.+..++||||+.| +|...+...               ..++...+..++
T Consensus        83 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~---------------~~l~e~~~~~i~  147 (350)
T d1rdqe_          83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---------------GRFSEPHARFYA  147 (350)
T ss_dssp             TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhc---------------CCCCHHHHHHHH
Confidence            4456789999999999999999999999999999999999996 888887542               345667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchH
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      .|++.||.|||+++|+||||||+|||++.++ .+||+|||+++....   ......||+.|+|||++.+ ..++.++|||
T Consensus       148 ~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~~~~-~~~~~~~Diw  222 (350)
T d1rdqe_         148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILS-KGYNKAVDWW  222 (350)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTT-CCBCTHHHHH
T ss_pred             HHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeeccc---ccccccCccccCCHHHHcC-CCCCcccccc
Confidence            9999999999999999999999999999998 899999999987632   3445689999999999988 5789999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-----CH
Q 039159          169 PVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-----TA  243 (259)
Q Consensus       169 slG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~  243 (259)
                      ||||++|+|+||+.||.+.+.......+.......              ...+|+++.+||.+||..||.+|+     |+
T Consensus       223 SlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~--------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~  288 (350)
T d1rdqe_         223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGV  288 (350)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTT
T ss_pred             chhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC--------------CccCCHHHHHHHHHHhhhCHHhccccccccH
Confidence            99999999999999999998888887776543221              246899999999999999999995     99


Q ss_pred             HHHhcCccccCCC
Q 039159          244 AEALQQEYFKDVP  256 (259)
Q Consensus       244 ~~~l~h~~f~~~~  256 (259)
                      +++++||||+++.
T Consensus       289 ~ell~Hp~f~~~~  301 (350)
T d1rdqe_         289 NDIKNHKWFATTD  301 (350)
T ss_dssp             HHHHTSGGGTTCC
T ss_pred             HHHHcCccccCCC
Confidence            9999999998763

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.4e-51  Score=330.26  Aligned_cols=232  Identities=39%  Similarity=0.615  Sum_probs=185.0

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ++...+++.+|+.+|++++||||+++++++..++..+++||++.+++...+....              ..++...+..+
T Consensus        40 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~--------------~~l~~~~~~~i  105 (286)
T d1ob3a_          40 DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--------------GGLESVTAKSF  105 (286)
T ss_dssp             GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST--------------TCCCHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhc--------------CCcchhhhHHH
Confidence            4566789999999999999999999999999999999999999987666664322              45677888899


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccch
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      +.|++.||+|||+.+|+||||||+||+++.++ .+|++|||.+..............|++.|+|||.+.+...++.++||
T Consensus       106 ~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~Di  184 (286)
T d1ob3a_         106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI  184 (286)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHH
T ss_pred             HHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceee
Confidence            99999999999999999999999999999998 89999999998765444445556789999999999876678999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCChHHHHHHHhC---CCCCCccccc------------cccccccCCCCCCCHHHHHHHHhh
Q 039159          168 WPVGCIFGEMVSGKPLFPGANSLITLGRIVG---KSRKPSFCKL------------SLRDHLTNGFPGLEPAGIDLISKM  232 (259)
Q Consensus       168 wslG~~l~e~~tg~~pf~~~~~~~~~~~i~~---~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~~  232 (259)
                      ||+||++|||++|++||.+.+......++..   .......+..            ..........+.+++++.+||++|
T Consensus       185 wslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~  264 (286)
T d1ob3a_         185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM  264 (286)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHH
T ss_pred             hhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHH
Confidence            9999999999999999998887766665532   1111111100            011122233466899999999999


Q ss_pred             cCcCCCCccCHHHHhcCccccC
Q 039159          233 LGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       233 l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      |+.||++|||++|+|+||||+.
T Consensus       265 L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         265 LKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccCChhHCcCHHHHhcCcccCc
Confidence            9999999999999999999974

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=335.93  Aligned_cols=216  Identities=26%  Similarity=0.372  Sum_probs=186.5

Q ss_pred             CCCCchhHHHHHHHh-hCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            9 EGVPSSMIREVSCLM-ELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~-~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ++..+.+.+|+.++. .++||||+++++++.+++.+|+||||+.| +|.+++...               ..++...+..
T Consensus        43 ~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~---------------~~~~e~~~~~  107 (320)
T d1xjda_          43 DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---------------HKFDLSRATF  107 (320)
T ss_dssp             TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH---------------SSCCHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc---------------CCCCHHHHHH
Confidence            344567788888765 68999999999999999999999999996 999988643               3345677889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++.............||+.|+|||.+.+ ..++.++|
T Consensus       108 ~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D  185 (320)
T d1xjda_         108 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVD  185 (320)
T ss_dssp             HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHH
T ss_pred             HHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhcccccccccccCCCCCcCCHHHHcC-CCCCchhh
Confidence            999999999999999999999999999999888 8999999999876555555666789999999999988 57899999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH-H
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA-E  245 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~-~  245 (259)
                      ||||||++|+|++|+.||.+.+.......+.....  ..            ...+|+++.+||.+||..||++||++. +
T Consensus       186 iwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--~~------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~  251 (320)
T d1xjda_         186 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--FY------------PRWLEKEAKDLLVKLFVREPEKRLGVRGD  251 (320)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CC------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSC
T ss_pred             hhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--CC------------CccCCHHHHHHHHHhcccCCCCCcCHHHH
Confidence            99999999999999999999988888877754421  11            135899999999999999999999995 8


Q ss_pred             HhcCccccCC
Q 039159          246 ALQQEYFKDV  255 (259)
Q Consensus       246 ~l~h~~f~~~  255 (259)
                      +++||||+++
T Consensus       252 l~~hpff~~~  261 (320)
T d1xjda_         252 IRQHPLFREI  261 (320)
T ss_dssp             GGGSGGGTTC
T ss_pred             HHhCchhccC
Confidence            9999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.8e-51  Score=340.25  Aligned_cols=208  Identities=23%  Similarity=0.317  Sum_probs=172.1

Q ss_pred             HHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhcccccc
Q 039159           18 EVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDSSRS   96 (259)
Q Consensus        18 Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~   96 (259)
                      |+++++.++|||||++++++.+++.+|+||||+.| +|.+.+...               ..+....+..++.|++.||+
T Consensus        57 ~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~---------------~~~~e~~~~~~~~qi~~aL~  121 (364)
T d1omwa3          57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---------------GVFSEADMRFYAAEIILGLE  121 (364)
T ss_dssp             HHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH---------------CSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc---------------ccccHHHHHHHHHHHHHHHH
Confidence            46677788899999999999999999999999995 899988642               33456778889999999999


Q ss_pred             cccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHhHHHHHHH
Q 039159           97 LSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWPVGCIFGE  176 (259)
Q Consensus        97 ~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~e  176 (259)
                      |||++||+||||||+|||++.++ .+||+|||+++....  .......||+.|+|||++.+...++.++|||||||++|+
T Consensus       122 ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilye  198 (364)
T d1omwa3         122 HMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK  198 (364)
T ss_dssp             HHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECSS--SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHH
T ss_pred             HHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecCC--CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHH
Confidence            99999999999999999999988 899999999986543  234556899999999999764678999999999999999


Q ss_pred             HHhCCCCCCCCChHHH--HHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC-----HHHHhcC
Q 039159          177 MVSGKPLFPGANSLIT--LGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT-----AAEALQQ  249 (259)
Q Consensus       177 ~~tg~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~-----~~~~l~h  249 (259)
                      |+||+.||.+......  ........ .+            .....+|+++++||.+||..||.+|||     ++++++|
T Consensus       199 mltG~~Pf~~~~~~~~~~~~~~~~~~-~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         199 LLRGHSPFRQHKTKDKHEIDRMTLTM-AV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             HHHSSCSSCSSCSSCHHHHHHHSSSC-CC------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             HHhCCCCCCCCCHHHHHHHHHhcccC-CC------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            9999999987543222  21211111 11            112468999999999999999999999     7999999


Q ss_pred             ccccCCC
Q 039159          250 EYFKDVP  256 (259)
Q Consensus       250 ~~f~~~~  256 (259)
                      |||+++.
T Consensus       266 p~f~~i~  272 (364)
T d1omwa3         266 PFFRSLD  272 (364)
T ss_dssp             GGGTTCC
T ss_pred             ccccCCC
Confidence            9999863

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-51  Score=331.67  Aligned_cols=234  Identities=36%  Similarity=0.541  Sum_probs=185.9

Q ss_pred             CCCCCCchhHHHHHHHhhC---CCCCeeEEEEEEEe-----CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcch
Q 039159            7 TMEGVPSSMIREVSCLMEL---NHPNIIRLMRVASQ-----GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l---~H~niv~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      ..+.....+.+|+.+++.|   +||||++++++|..     +..++++|||+.+++..+......             ..
T Consensus        46 ~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~-------------~~  112 (305)
T d1blxa_          46 GEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-------------PG  112 (305)
T ss_dssp             CTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT-------------TC
T ss_pred             ccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccC-------------CC
Confidence            3445567788999988877   79999999999863     347899999999876655543221             34


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCc
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  158 (259)
                      ++...+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||.++.... ........||+.|+|||++.+ 
T Consensus       113 ~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~dfg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~-  189 (305)
T d1blxa_         113 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQ-  189 (305)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTT-
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecchhhhhhhcc-cccCCCcccChhhcCcchhcC-
Confidence            55677788999999999999999999999999999999888 899999999876433 233456689999999999987 


Q ss_pred             cCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc-------------cccccccccCCCCCCCHHH
Q 039159          159 LEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC-------------KLSLRDHLTNGFPGLEPAG  225 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~  225 (259)
                      ..++.++||||+||++|||++|++||.+.+.......+......+...             ..............+++.+
T Consensus       190 ~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  269 (305)
T d1blxa_         190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG  269 (305)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHH
T ss_pred             CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHH
Confidence            678999999999999999999999999988877776653321111100             0111122333456789999


Q ss_pred             HHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          226 IDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       226 ~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .+||.+||..||++|||++|+|+||||+++.
T Consensus       270 ~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         270 KDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence            9999999999999999999999999999884

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=339.38  Aligned_cols=217  Identities=22%  Similarity=0.268  Sum_probs=185.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...+.+|+++|++++||||+++++++++++.+|+|||||.| +|.+.+....              ..++..++..++.|
T Consensus        45 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~--------------~~l~e~~~~~i~~q  110 (321)
T d1tkia_          45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--------------FELNEREIVSYVHQ  110 (321)
T ss_dssp             HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS--------------CCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC--------------CCCCHHHHHHHHHH
Confidence            35688999999999999999999999999999999999996 8999885421              24677889999999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCC-CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccchHh
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDG-KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVDIWP  169 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~-~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws  169 (259)
                      ++.|++|||++||+||||||+||+++.++ ..+||+|||++..... ........||+.|+|||.+.+ ..++.++||||
T Consensus       111 i~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWS  188 (321)
T d1tkia_         111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWS  188 (321)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-TCEEEEEESCGGGSCHHHHTT-CEECHHHHHHH
T ss_pred             HHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc-CCcccccccccccccchhccC-CCCCchhhccc
Confidence            99999999999999999999999998542 2799999999976533 233445578999999999987 57889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcC
Q 039159          170 VGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQ  249 (259)
Q Consensus       170 lG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h  249 (259)
                      +||++|+|++|..||.+.+.......+......+..          ..++.+|+++++||.+||..||.+|||++|+|+|
T Consensus       189 lGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         189 LGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE----------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH----------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh----------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            999999999999999999988888887665433221          1134689999999999999999999999999999


Q ss_pred             ccccC
Q 039159          250 EYFKD  254 (259)
Q Consensus       250 ~~f~~  254 (259)
                      |||+.
T Consensus       259 p~~~~  263 (321)
T d1tkia_         259 PWLKQ  263 (321)
T ss_dssp             HHHHS
T ss_pred             Hhhcc
Confidence            99974

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=329.58  Aligned_cols=217  Identities=22%  Similarity=0.256  Sum_probs=173.2

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +....++|.+|++++++++|||||++++++. ++.+++||||++| +|.+++....              ..++...++.
T Consensus        44 ~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~--------------~~~~~~~~~~  108 (276)
T d1uwha_          44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIE--------------TKFEMIKLID  108 (276)
T ss_dssp             CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSC--------------CCCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhcc--------------CCCCHHHHHH
Confidence            4455678999999999999999999999875 4568999999995 9999886432              3356678889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC--CCCcCCccCccccCcccccCc--cCCC
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK--GESSAEVGTHYYKAPELLLGL--LEYS  162 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~--~~~~  162 (259)
                      ++.|+++||+|||+++|+||||||+|||++.++ .+||+|||+++......  .......||+.|+|||.+.+.  ..++
T Consensus       109 i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~  187 (276)
T d1uwha_         109 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS  187 (276)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCC
T ss_pred             HHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCC
Confidence            999999999999999999999999999999888 89999999997654322  223455799999999999752  3478


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhC-CCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVG-KSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      .++|||||||++|||+||+.||.+.........+.. ....|..         .....++++++.+|+.+||..||++||
T Consensus       188 ~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~---------~~~~~~~~~~l~~li~~cl~~dp~~RP  258 (276)
T d1uwha_         188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL---------SKVRSNCPKAMKRLMAECLKKKRDERP  258 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG---------GGSCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             chhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc---------hhccccchHHHHHHHHHHcCCCHhHCc
Confidence            899999999999999999999998766655544433 3222221         222356889999999999999999999


Q ss_pred             CHHHHhcC
Q 039159          242 TAAEALQQ  249 (259)
Q Consensus       242 ~~~~~l~h  249 (259)
                      |+++++++
T Consensus       259 t~~~il~~  266 (276)
T d1uwha_         259 LFPQILAS  266 (276)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            99999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-51  Score=330.65  Aligned_cols=211  Identities=22%  Similarity=0.303  Sum_probs=169.8

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...++|.+|+++|++++|||||+++|++.+++.+++||||+.| +|.+++....              ..+++.+++.++
T Consensus        69 ~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--------------~~l~~~~~~~i~  134 (299)
T d1jpaa_          69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--------------GQFTVIQLVGML  134 (299)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--------------TCSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc--------------CCCCHHHHHHHH
Confidence            3446799999999999999999999999999999999999996 8988876432              345667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-----CcCCccCccccCcccccCccCCCc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-----SSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      .|+++||+|||+++|+||||||+|||++.++ .+||+|||+++........     .....||+.|+|||.+.+ ..++.
T Consensus       135 ~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~  212 (299)
T d1jpaa_         135 RGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTS  212 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC-----------------------CGGGSCHHHHHS-CCCCH
T ss_pred             HHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCc
Confidence            9999999999999999999999999999888 8999999999865432221     112357899999999987 57899


Q ss_pred             ccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          164 AVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       164 ~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ++|||||||++|||+| |++||.+....+....+....+.+.             ..++++++.+|+.+||+.||++|||
T Consensus       213 ~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------~~~~~~~l~~li~~cl~~~P~~RPs  279 (299)
T d1jpaa_         213 ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-------------PMDCPSALHQLMLDCWQKDRNHRPK  279 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             ccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------CccchHHHHHHHHHHcCCCHhHCcC
Confidence            9999999999999998 8999999888887777765543321             2468899999999999999999999


Q ss_pred             HHHHhcC
Q 039159          243 AAEALQQ  249 (259)
Q Consensus       243 ~~~~l~h  249 (259)
                      +++++++
T Consensus       280 ~~ei~~~  286 (299)
T d1jpaa_         280 FGQIVNT  286 (299)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9998764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=328.37  Aligned_cols=212  Identities=19%  Similarity=0.275  Sum_probs=175.6

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ..++|.+|++++++++|||||+++|++.. +..++||||++| +|.++++..               ..++...++.++.
T Consensus        51 ~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~---------------~~l~~~~~~~i~~  114 (277)
T d1xbba_          51 LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN---------------RHVKDKNIIELVH  114 (277)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHC---------------TTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhc---------------cCCCHHHHHHHHH
Confidence            35679999999999999999999999965 467899999996 899988642               3456778899999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCcccc
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      |++.||+|||+++|+||||||+||+++.++ .+|++|||+++.......   ......||+.|+|||.+.+ ..++.++|
T Consensus       115 qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sD  192 (277)
T d1xbba_         115 QVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSD  192 (277)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHH
T ss_pred             HHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhccccccccccccccCCCceecCchhhcC-CCCCchhh
Confidence            999999999999999999999999999988 999999999986543322   1234468999999999987 56889999


Q ss_pred             hHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHH
Q 039159          167 IWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAE  245 (259)
Q Consensus       167 iwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  245 (259)
                      ||||||++|||+| |+.||.+.+..+....+..+.+. ..            ...+|+++.+||.+||+.||++|||+++
T Consensus       193 iwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-~~------------p~~~~~~~~~li~~cl~~dp~~RPs~~~  259 (277)
T d1xbba_         193 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-GC------------PAGCPREMYDLMNLCWTYDVENRPGFAA  259 (277)
T ss_dssp             HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-CC------------CTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC-CC------------CcccCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            9999999999998 89999998887777666554322 11            2468899999999999999999999999


Q ss_pred             Hh---cCcccc
Q 039159          246 AL---QQEYFK  253 (259)
Q Consensus       246 ~l---~h~~f~  253 (259)
                      ++   +|+|+.
T Consensus       260 i~~~L~~~~~~  270 (277)
T d1xbba_         260 VELRLRNYYYD  270 (277)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHhhCHHhh
Confidence            84   565553

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=327.66  Aligned_cols=214  Identities=22%  Similarity=0.253  Sum_probs=178.8

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...++|.+|++++++++|||||+++|++.+ +.+|+||||++| +|.+++...+              ..++...++.++
T Consensus        51 ~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~  115 (285)
T d1u59a_          51 ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR--------------EEIPVSNVAELL  115 (285)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCT--------------TTSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccc--------------cCCCHHHHHHHH
Confidence            345679999999999999999999999965 568999999996 8988875422              335667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .|++.||+|||+++|+||||||+||+++.++ .+||+|||+++.......   ......||+.|+|||.+.+ ..++.++
T Consensus       116 ~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ks  193 (285)
T d1u59a_         116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRS  193 (285)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHH
T ss_pred             HHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhhhcccccccccccccccccCccccChHHHhC-CCCCccc
Confidence            9999999999999999999999999999988 999999999987643322   2334568999999999987 5789999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|||+| |+.||.+.+..+....+..+.+. .            ..+++++++.+||.+||..||++|||+.
T Consensus       194 DVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~-~------------~p~~~~~~l~~li~~cl~~~p~~RPs~~  260 (285)
T d1u59a_         194 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-E------------CPPECPPELYALMSDCWIYKWEDRPDFL  260 (285)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-C------------CCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             hhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C------------CCCcCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            99999999999998 89999988877777766654322 1            1246889999999999999999999998


Q ss_pred             HH---hcCcccc
Q 039159          245 EA---LQQEYFK  253 (259)
Q Consensus       245 ~~---l~h~~f~  253 (259)
                      ++   |+|+|+.
T Consensus       261 ~i~~~L~~~~~~  272 (285)
T d1u59a_         261 TVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHH
Confidence            88   5677764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-51  Score=332.89  Aligned_cols=228  Identities=19%  Similarity=0.234  Sum_probs=180.0

Q ss_pred             CCCCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc--------cccCCCcc
Q 039159            8 MEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS--------TKNFNSYS   77 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~--------~~~~~~~~   77 (259)
                      .+.....+.+|+.+++++ +|||||+++|++.+.+.+|+|||||+| +|.++++..........        ........
T Consensus        80 ~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (325)
T d1rjba_          80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN  159 (325)
T ss_dssp             ----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred             CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccC
Confidence            345567899999999998 899999999999999999999999995 99999976543211110        00111124


Q ss_pred             hhHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccc
Q 039159           78 LFTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELL  155 (259)
Q Consensus        78 ~~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~  155 (259)
                      .++...++.++.|+++||+|||+++|+||||||+||+++.++ .+||+|||+|+........  .....||+.|+|||.+
T Consensus       160 ~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l  238 (325)
T d1rjba_         160 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL  238 (325)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence            567788999999999999999999999999999999999888 9999999999865443322  2345689999999999


Q ss_pred             cCccCCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcC
Q 039159          156 LGLLEYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       156 ~~~~~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                      .+ ..++.++|||||||++|||+| |.+||.+.+.......+......+..            ...+|+++.+||.+||+
T Consensus       239 ~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~------------p~~~~~~l~~li~~cl~  305 (325)
T d1rjba_         239 FE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ------------PFYATEEIYIIMQSCWA  305 (325)
T ss_dssp             HH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC------------CTTCCHHHHHHHHHHTC
T ss_pred             cC-CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC------------CCcCCHHHHHHHHHHcC
Confidence            87 578999999999999999998 89999987666665565544333222            24688999999999999


Q ss_pred             cCCCCccCHHHHhcC
Q 039159          235 MDPDKRITAAEALQQ  249 (259)
Q Consensus       235 ~dp~~Rp~~~~~l~h  249 (259)
                      .||++|||+++|++|
T Consensus       306 ~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         306 FDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhHCcCHHHHHHH
Confidence            999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-51  Score=322.91  Aligned_cols=218  Identities=21%  Similarity=0.259  Sum_probs=170.8

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |++.. +....++|.+|++++++++||||++++|++.+++.+++||||+.+ +|.+++....              ..++
T Consensus        35 K~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~~   99 (263)
T d1sm2a_          35 KTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--------------GLFA   99 (263)
T ss_dssp             EECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT--------------TCCC
T ss_pred             EEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc--------------cCCC
Confidence            44443 334457899999999999999999999999999999999999995 8999876422              3355


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCcc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      ....+.++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++....... ......||+.|+|||.+.+ .
T Consensus       100 ~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~  177 (263)
T d1sm2a_         100 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-S  177 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC------------------CTTSCCHHHHTT-C
T ss_pred             HHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccCCCceeecceecCcccCChHHhcC-C
Confidence            677788999999999999999999999999999999988 899999999986644322 2334578999999999987 5


Q ss_pred             CCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      .++.++|||||||++|||+| |.+||...+..+....+......+ .            ....++++.+++.+||+.||+
T Consensus       178 ~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~------------p~~~~~~l~~li~~cl~~~p~  244 (263)
T d1sm2a_         178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-K------------PRLASTHVYQIMNHCWKERPE  244 (263)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-C------------CTTSCHHHHHHHHHHTCSSGG
T ss_pred             CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-C------------ccccCHHHHHHHHHHccCCHh
Confidence            78999999999999999999 567777777776666665543221 1            135789999999999999999


Q ss_pred             CccCHHHHhcC
Q 039159          239 KRITAAEALQQ  249 (259)
Q Consensus       239 ~Rp~~~~~l~h  249 (259)
                      +|||++++++|
T Consensus       245 ~Rps~~~il~~  255 (263)
T d1sm2a_         245 DRPAFSRLLRQ  255 (263)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=332.30  Aligned_cols=231  Identities=26%  Similarity=0.448  Sum_probs=181.8

Q ss_pred             chhHHHHHHHhhCCCCCeeEEEEEEEeC------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           13 SSMIREVSCLMELNHPNIIRLMRVASQG------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        13 ~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ..+.+|+++|++++||||++++++|...      .++|+||||+.+++...+......           ...++...+..
T Consensus        58 ~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~-----------~~~l~~~~~~~  126 (350)
T d1q5ka_          58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-----------KQTLPVIYVKL  126 (350)
T ss_dssp             SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHT-----------TCCCCHHHHHH
T ss_pred             hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhc-----------cCCCCHHHHHH
Confidence            3456899999999999999999998643      358999999998776666431111           14567788899


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.|++.||+|||++||+||||||+|||++.++..+||+|||++...... .......||+.|+|||.+.+...++.++|
T Consensus       127 i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  205 (350)
T d1q5ka_         127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSID  205 (350)
T ss_dssp             HHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHH
T ss_pred             HHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC-cccccccccccccChHHhhcccCCCccee
Confidence            99999999999999999999999999999987658999999999865432 33445689999999999887567899999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCC---------------CCccccccccccccCCCCCCCHHHHHHHHh
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSR---------------KPSFCKLSLRDHLTNGFPGLEPAGIDLISK  231 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  231 (259)
                      |||+||++|||++|.+||...+.......+.....               ....+............+..++++.+||.+
T Consensus       206 IwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~  285 (350)
T d1q5ka_         206 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR  285 (350)
T ss_dssp             HHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHH
T ss_pred             ecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHH
Confidence            99999999999999999998887766665532110               011111111111222335689999999999


Q ss_pred             hcCcCCCCccCHHHHhcCccccCC
Q 039159          232 MLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       232 ~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ||..||++|||+.|+|+||||+.+
T Consensus       286 mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         286 LLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HccCChhHCcCHHHHhcCHhhccc
Confidence            999999999999999999999865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-51  Score=333.36  Aligned_cols=223  Identities=23%  Similarity=0.310  Sum_probs=174.8

Q ss_pred             CchhHHHHHHHhh-CCCCCeeEEEEEEEe----CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           12 PSSMIREVSCLME-LNHPNIIRLMRVASQ----GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        12 ~~~~~~Ei~~l~~-l~H~niv~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ...+.+|+.++.+ ++|||||+++++|++    +..+|+|||||+| +|.+++.....             ..++..++.
T Consensus        48 ~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~-------------~~l~e~~~~  114 (335)
T d2ozaa1          48 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-------------QAFTEREAS  114 (335)
T ss_dssp             SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSC-------------CCEEHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCC-------------CCcCHHHHH
Confidence            3578899998765 589999999999976    4678999999996 99999964211             357788899


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCC--CeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDG--KTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~--~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      .++.|++.||+|||+.||+||||||+||+++.++  +.+||+|||+++.... ........||+.|+|||.+.+ ..++.
T Consensus       115 ~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~y~~  192 (335)
T d2ozaa1         115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-HNSLTTPCYTPYYVAPEVLGP-EKYDK  192 (335)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC-CCCCCCCSCCCSSCCCCCCCG-GGGSH
T ss_pred             HHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccC-CCccccccCCcccCCcHHHcC-CCCCH
Confidence            9999999999999999999999999999998632  2799999999986544 334456689999999999987 57899


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      ++|||||||++|+|+||++||.+.+.......+..........      ...+.+..+|+++.+||.+||..||++|||+
T Consensus       193 ~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~  266 (335)
T d2ozaa1         193 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI  266 (335)
T ss_dssp             HHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCH
Confidence            9999999999999999999998765544433332221111100      0011123578999999999999999999999


Q ss_pred             HHHhcCccccCC
Q 039159          244 AEALQQEYFKDV  255 (259)
Q Consensus       244 ~~~l~h~~f~~~  255 (259)
                      .++++||||...
T Consensus       267 ~eil~hp~~~~~  278 (335)
T d2ozaa1         267 TEFMNHPWIMQS  278 (335)
T ss_dssp             HHHHHSHHHHTT
T ss_pred             HHHHcCHHhhCC
Confidence            999999999754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=322.20  Aligned_cols=209  Identities=21%  Similarity=0.230  Sum_probs=173.6

Q ss_pred             CCchhHHHHHHHhhCC--CCCeeEEEEEEEeCceEEEEeeeecC--CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           11 VPSSMIREVSCLMELN--HPNIIRLMRVASQGIYLYPVFEYQVN--DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ...++.+|+.++++++  ||||+++++++.+++..++||||+.+  ++..++...               ..++...+..
T Consensus        50 ~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~---------------~~l~e~~~~~  114 (273)
T d1xwsa_          50 NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---------------GALQEELARS  114 (273)
T ss_dssp             TCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH---------------CSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc---------------CCCCHHHHHH
Confidence            3456889999999997  99999999999999999999999974  666766532               3456678889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.|++.||+|||+++|+||||||+||+++.+++.+||+|||+++....  .......||+.|+|||.+.+...++.++|
T Consensus       115 ~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~D  192 (273)
T d1xwsa_         115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAA  192 (273)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc--ccccccccCCCcCCHHHHcCCCCCCcccc
Confidence            9999999999999999999999999999987644899999999976432  23445689999999999987445577899


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||+||++|+|++|+.||.+.+      .+.....              .....+|+++++||.+||..||++|||++|+
T Consensus       193 iwSlGvilyell~g~~Pf~~~~------~i~~~~~--------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei  252 (273)
T d1xwsa_         193 VWSLGILLYDMVCGDIPFEHDE------EIIRGQV--------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEI  252 (273)
T ss_dssp             HHHHHHHHHHHHHSSCSCCSHH------HHHHCCC--------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cccceeeehhHhhCCCCCCCch------HHhhccc--------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence            9999999999999999997632      1221111              1124689999999999999999999999999


Q ss_pred             hcCccccCCC
Q 039159          247 LQQEYFKDVP  256 (259)
Q Consensus       247 l~h~~f~~~~  256 (259)
                      |+||||+++.
T Consensus       253 l~hp~~~~~~  262 (273)
T d1xwsa_         253 QNHPWMQDVL  262 (273)
T ss_dssp             HTSGGGSSCC
T ss_pred             hcCHhhCCCC
Confidence            9999999863

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-50  Score=325.16  Aligned_cols=218  Identities=21%  Similarity=0.261  Sum_probs=175.4

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |.++.. ....++|.+|++++++++|||||+++|++.+++.+++||||+.+ +|...+.....             ..++
T Consensus        48 K~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~-------------~~~~  113 (287)
T d1opja_          48 KTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------------QEVS  113 (287)
T ss_dssp             EECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT-------------TTSC
T ss_pred             EEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccc-------------cchH
Confidence            444433 34467899999999999999999999999999999999999995 89888854221             4466


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccCcc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~  159 (259)
                      ...++.++.|+++||+|||+++|+||||||+|||++.++ .+||+|||+++........ .....|++.|+|||.+.+ .
T Consensus       114 ~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~  191 (287)
T d1opja_         114 AVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-N  191 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH-C
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEccccceeecCCCCceeeccccccccccChHHHcC-C
Confidence            678889999999999999999999999999999999988 8999999999865433222 233458899999999987 5


Q ss_pred             CCCcccchHhHHHHHHHHHhCCCCC-CCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSGKPLF-PGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      .++.++|||||||++|||++|..|| .+.+.......+... ..+.            ....+++++.+||.+||+.||+
T Consensus       192 ~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~~------------~~~~~~~~l~~li~~cl~~dP~  258 (287)
T d1opja_         192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME------------RPEGCPEKVYELMRACWQWNPS  258 (287)
T ss_dssp             CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCC------------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCCC------------CCccchHHHHHHHHHHcCCCHh
Confidence            7899999999999999999976555 444544444444332 2222            1246889999999999999999


Q ss_pred             CccCHHHHhc
Q 039159          239 KRITAAEALQ  248 (259)
Q Consensus       239 ~Rp~~~~~l~  248 (259)
                      +|||++++++
T Consensus       259 ~Rps~~ei~~  268 (287)
T d1opja_         259 DRPSFAEIHQ  268 (287)
T ss_dssp             GSCCHHHHHH
T ss_pred             HCcCHHHHHH
Confidence            9999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=332.24  Aligned_cols=227  Identities=31%  Similarity=0.487  Sum_probs=184.7

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCc------eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGI------YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ...+++.+|+++|++++|||||+++++|...+      .+|+||||+.++|..+.+.                ..++...
T Consensus        59 ~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----------------~~l~~~~  122 (346)
T d1cm8a_          59 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----------------EKLGEDR  122 (346)
T ss_dssp             HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH----------------CCCCHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh----------------ccccHHH
Confidence            34567899999999999999999999997654      5799999997788888754                3467788


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCc
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      +..++.|++.||+|||++||+||||||+|||++.++ .+|++|||.++...   .......||+.|+|||.+.+...++.
T Consensus       123 ~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~  198 (346)
T d1cm8a_         123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQAD---SEMTGYVVTRWYRAPEVILNWMRYTQ  198 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC---SSCCSSCSCGGGCCTHHHHTTTCCCT
T ss_pred             HHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccceeccC---CccccccccccccCHHHHcCCCCCCc
Confidence            899999999999999999999999999999999998 89999999998653   33455689999999999987566789


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccc-----------------cccccccccCCCCCCCHHHH
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFC-----------------KLSLRDHLTNGFPGLEPAGI  226 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~  226 (259)
                      ++||||+||++|+|++|.+||.+.+.......+......+...                 .............+.++.+.
T Consensus       199 ~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  278 (346)
T d1cm8a_         199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV  278 (346)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHH
T ss_pred             cchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHH
Confidence            9999999999999999999999887766655543211111000                 00011123334467899999


Q ss_pred             HHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          227 DLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       227 ~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      +||.+||..||++|||++++|+||||+.+.
T Consensus       279 dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         279 NLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            999999999999999999999999998753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-51  Score=324.23  Aligned_cols=223  Identities=22%  Similarity=0.301  Sum_probs=180.4

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |+++. +....+.|.+|++++++++|||||+++|++.+ +.+++||||+++ +|.+.+.....             ..++
T Consensus        43 K~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~-------------~~l~  107 (272)
T d1qpca_          43 KSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-------------IKLT  107 (272)
T ss_dssp             EEECT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHH-------------HTCC
T ss_pred             EEEcc-CcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCC-------------CCCC
Confidence            44443 33446789999999999999999999998854 567899999995 88887743211             2367


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCcc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      ...++.++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++....... ......||+.|+|||.+.+ .
T Consensus       108 ~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~  185 (272)
T d1qpca_         108 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-G  185 (272)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-C
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccceEEccCCccccccccCCcccccChHHHhC-C
Confidence            788899999999999999999999999999999999888 899999999987643322 2344578999999999986 5


Q ss_pred             CCCcccchHhHHHHHHHHHhC-CCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSG-KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      .++.++|||||||++|||+|| .+||......+....+....+.+ .            ...+++++.+|+.+||+.||+
T Consensus       186 ~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~------------p~~~~~~l~~li~~cl~~~P~  252 (272)
T d1qpca_         186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-R------------PDNCPEELYQLMRLCWKERPE  252 (272)
T ss_dssp             EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-C------------CTTCCHHHHHHHHHHTCSSGG
T ss_pred             CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-C------------cccChHHHHHHHHHHcCCCHh
Confidence            688999999999999999995 56666666666666665443221 1            246889999999999999999


Q ss_pred             CccCHHHHhc--CccccC
Q 039159          239 KRITAAEALQ--QEYFKD  254 (259)
Q Consensus       239 ~Rp~~~~~l~--h~~f~~  254 (259)
                      +|||++++++  ++||.+
T Consensus       253 ~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         253 DRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             GSCCHHHHHHHHHHHHHH
T ss_pred             HCcCHHHHHHHhhhhhhc
Confidence            9999999998  788864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=313.47  Aligned_cols=218  Identities=23%  Similarity=0.259  Sum_probs=182.2

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |.++. +....++|.+|+.++++++||||++++|++.+++.+++||||+.+ +|..++....              ..+.
T Consensus        34 K~l~~-~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~--------------~~~~   98 (258)
T d1k2pa_          34 KMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--------------HRFQ   98 (258)
T ss_dssp             EEEES-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGG--------------GCCC
T ss_pred             EEECc-CcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccc--------------cCCc
Confidence            33443 334467899999999999999999999999999999999999985 7888865422              3345


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC-CcCCccCccccCcccccCcc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE-SSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~  159 (259)
                      ...+..++.|+++||+|||++||+||||||+||+++.++ .+||+|||+++........ .....||+.|+|||.+.+ .
T Consensus        99 ~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~  176 (258)
T d1k2pa_          99 TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-S  176 (258)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-C
T ss_pred             HHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC-C
Confidence            567789999999999999999999999999999999888 8999999999865443322 334568999999999987 5


Q ss_pred             CCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      .++.++|||||||++|||+| |+.||.+.+..+....+....+.+ .            ....++++.+||.+||+.||+
T Consensus       177 ~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-~------------p~~~~~~l~~li~~cl~~dP~  243 (258)
T d1k2pa_         177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-R------------PHLASEKVYTIMYSCWHEKAD  243 (258)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-C------------CTTCCHHHHHHHHHTTCSSGG
T ss_pred             CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC-C------------cccccHHHHHHHHHHccCCHh
Confidence            78999999999999999998 899999998888887776543321 1            135789999999999999999


Q ss_pred             CccCHHHHhcC
Q 039159          239 KRITAAEALQQ  249 (259)
Q Consensus       239 ~Rp~~~~~l~h  249 (259)
                      +|||++++++|
T Consensus       244 ~RPt~~eil~~  254 (258)
T d1k2pa_         244 ERPTFKILLSN  254 (258)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=318.62  Aligned_cols=234  Identities=30%  Similarity=0.487  Sum_probs=178.7

Q ss_pred             CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeC--------ceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcch
Q 039159            7 TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQG--------IYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      ..+....++.+|+++|++++||||+++++++...        +.+|+||||+.+++........              ..
T Consensus        48 ~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~--------------~~  113 (318)
T d3blha1          48 EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--------------VK  113 (318)
T ss_dssp             CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTT--------------CC
T ss_pred             cchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcc--------------cc
Confidence            4556778899999999999999999999998653        4589999999987666554322              33


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC----CCCcCCccCccccCccc
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK----GESSAEVGTHYYKAPEL  154 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~----~~~~~~~~~~~~~aPE~  154 (259)
                      +....+..++.|++.|++|||++||+||||||+||+++.++ .+|++|||+++......    .......||+.|+|||.
T Consensus       114 ~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~  192 (318)
T d3blha1         114 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL  192 (318)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHH
T ss_pred             cccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecceeeecccccccccccccceecCHHHhhHHH
Confidence            55567788999999999999999999999999999999998 89999999997654322    12334579999999999


Q ss_pred             ccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCc---ccc---ccccccccCCC----------
Q 039159          155 LLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS---FCK---LSLRDHLTNGF----------  218 (259)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~---~~~---~~~~~~~~~~~----------  218 (259)
                      +.+...++.++||||+||++|||++|++||.+.+.......+......+.   ...   ...........          
T Consensus       193 ~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (318)
T d3blha1         193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL  272 (318)
T ss_dssp             HTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHH
T ss_pred             HcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhh
Confidence            98756789999999999999999999999998877766655422111110   000   00000000000          


Q ss_pred             --CCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          219 --PGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       219 --~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                        ...++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus       273 ~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         273 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             HHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             ccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence              0136788999999999999999999999999999964

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=316.62  Aligned_cols=210  Identities=22%  Similarity=0.263  Sum_probs=166.4

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ....+|.+|++++++++|||||+++|++.+++.+++||||+.+ ++.+.+....              ..+.+.+++.++
T Consensus        51 ~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~--------------~~~~~~~~~~i~  116 (283)
T d1mqba_          51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--------------GEFSVLQLVGML  116 (283)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT--------------TCSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhccc--------------ccccHHHHHHHH
Confidence            3345789999999999999999999999999999999999996 7777665422              345667888999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .|++.|++|||+++|+||||||+|||++.++ .+||+|||+++.......   ......||+.|+|||.+.+ ..++.++
T Consensus       117 ~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~s  194 (283)
T d1mqba_         117 RGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSAS  194 (283)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHH
T ss_pred             HHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcc
Confidence            9999999999999999999999999999988 899999999987543322   1233468999999999987 6789999


Q ss_pred             chHhHHHHHHHHHhCC-CCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVSGK-PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~tg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|||++|. +|+...+..+....+....+.+             ...++++.+.+|+.+||+.||++|||+.
T Consensus       195 DI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~cl~~~p~~RPt~~  261 (283)
T d1mqba_         195 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-------------TPMDCPSAIYQLMMQCWQQERARRPKFA  261 (283)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------------CCTTCBHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             cccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-------------CchhhHHHHHHHHHHHCcCCHhHCcCHH
Confidence            9999999999999964 5565566666665555443221             1235789999999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++++
T Consensus       262 eil~  265 (283)
T d1mqba_         262 DIVS  265 (283)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9976

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=312.99  Aligned_cols=233  Identities=34%  Similarity=0.507  Sum_probs=183.3

Q ss_pred             CCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159            7 TMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus         7 ~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ..+...+++.+|+.+++.++||||+++++++.+....+++++++.| ++..++...               ..+....+.
T Consensus        40 ~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~---------------~~~~~~~~~  104 (292)
T d1unla_          40 DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN---------------GDLDPEIVK  104 (292)
T ss_dssp             SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTT---------------TCCCHHHHH
T ss_pred             CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccc---------------cccchhHHH
Confidence            3445678899999999999999999999999999999999999997 555555321               334566788


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCccc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .++.|++.||+|||++||+||||||+||+++.++ .+|++|||.++.............+++.|+|||.+.+...++.++
T Consensus       105 ~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~  183 (292)
T d1unla_         105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI  183 (292)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHH
T ss_pred             HHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchh
Confidence            9999999999999999999999999999999888 899999999987655444455556788999999998755678999


Q ss_pred             chHhHHHHHHHHHhCCCCCC-CCChHHHHHHHhCCCCCCc---------------cccccccccccCCCCCCCHHHHHHH
Q 039159          166 DIWPVGCIFGEMVSGKPLFP-GANSLITLGRIVGKSRKPS---------------FCKLSLRDHLTNGFPGLEPAGIDLI  229 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~-~~~~~~~~~~i~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li  229 (259)
                      ||||+||++|||++|+.||. +.+..+....+......+.               ..............+.+++.+.+||
T Consensus       184 DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll  263 (292)
T d1unla_         184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL  263 (292)
T ss_dssp             HHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHH
T ss_pred             hccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHH
Confidence            99999999999999988765 4444444444321111100               0001111233334467899999999


Q ss_pred             HhhcCcCCCCccCHHHHhcCccccCC
Q 039159          230 SKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       230 ~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      .+||+.||++|||++|+|+||||+..
T Consensus       264 ~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         264 QNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             HHHccCChhHCcCHHHHhcChhhcCC
Confidence            99999999999999999999999865

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=315.92  Aligned_cols=210  Identities=23%  Similarity=0.342  Sum_probs=167.0

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      ...+.|.+|++++++++||||++++|++. ++.+|+||||+.+ +|..++....              ..++...++.++
T Consensus        50 ~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~--------------~~l~~~~~~~~~  114 (273)
T d1mp8a_          50 SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK--------------YSLDLASLILYA  114 (273)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT--------------TTSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccC--------------CCCCHHHHHHHH
Confidence            34567999999999999999999999996 4678999999996 7887765322              345677889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCccCCCcccch
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLLEYSTAVDI  167 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  167 (259)
                      .|+++||+|||+++|+||||||+||+++.++ .+||+|||+++....... ......||+.|+|||.+.+ ..++.++||
T Consensus       115 ~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~Di  192 (273)
T d1mp8a_         115 YQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDV  192 (273)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC-------------------CCGGGCCHHHHHH-CCCSHHHHH
T ss_pred             HHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhheeccCCcceeccceecCcccchhhHhcc-CCCCCcccc
Confidence            9999999999999999999999999999988 999999999987644322 2334468999999999987 578999999


Q ss_pred             HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHH
Q 039159          168 WPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEA  246 (259)
Q Consensus       168 wslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~  246 (259)
                      |||||++|||++ |.+||.+.+..+....+......+             ..+++|+++.+||.+||..||++|||++++
T Consensus       193 wSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~-------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei  259 (273)
T d1mp8a_         193 WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTEL  259 (273)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            999999999998 899999888887777776554322             235689999999999999999999999999


Q ss_pred             hcC
Q 039159          247 LQQ  249 (259)
Q Consensus       247 l~h  249 (259)
                      +++
T Consensus       260 ~~~  262 (273)
T d1mp8a_         260 KAQ  262 (273)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-49  Score=314.81  Aligned_cols=226  Identities=23%  Similarity=0.328  Sum_probs=177.3

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhH
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFT   80 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (259)
                      |.++.. ....+.|.+|+.++++++|||||+++|++.+ +..++||||+.+ +|..++.....             ..++
T Consensus        47 K~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~-------------~~l~  111 (285)
T d1fmka3          47 KTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-------------KYLR  111 (285)
T ss_dssp             EECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHH-------------TTCC
T ss_pred             EEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhccc-------------ccch
Confidence            444433 3345789999999999999999999999854 568899999996 78877753210             3467


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC-CCcCCccCccccCcccccCcc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG-ESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      +.+++.++.+++.||+|||+.+|+||||||+||+++.++ .+||+|||+++....... ......||+.|+|||.+.+ .
T Consensus       112 ~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~  189 (285)
T d1fmka3         112 LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-G  189 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC--------------CCGGGSCHHHHHH-C
T ss_pred             HHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchhhhccCCCceeeccccccccccChHHHhC-C
Confidence            788999999999999999999999999999999999888 899999999976543322 2334568999999999987 5


Q ss_pred             CCCcccchHhHHHHHHHHHhC-CCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVSG-KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      .++.++|||||||++|||++| .+|+.+....+....+......+             ..+.+++++.++|.+||+.||+
T Consensus       190 ~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~  256 (285)
T d1fmka3         190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-------------CPPECPESLHDLMCQCWRKEPE  256 (285)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------CCTTSCHHHHHHHHHHTCSSGG
T ss_pred             CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-------------CCcccCHHHHHHHHHHcccCHh
Confidence            789999999999999999996 55666666666666665543322             1246889999999999999999


Q ss_pred             CccCHHHHhc--CccccCCCC
Q 039159          239 KRITAAEALQ--QEYFKDVPG  257 (259)
Q Consensus       239 ~Rp~~~~~l~--h~~f~~~~~  257 (259)
                      +||++++|++  ++||.+...
T Consensus       257 ~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         257 ERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             GSCCHHHHHHHHHTTTSCSCC
T ss_pred             HCcCHHHHHHHHhhhhcCCCC
Confidence            9999999987  889987643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=322.10  Aligned_cols=229  Identities=30%  Similarity=0.477  Sum_probs=179.7

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCc-----eEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGI-----YLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ..+++.+|+++|++|+||||+++++++..+.     .+|++++++.|+|.+++..                ..++...+.
T Consensus        49 ~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~----------------~~l~~~~i~  112 (345)
T d1pmea_          49 YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----------------QHLSNDHIC  112 (345)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH----------------CCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc----------------CCCCHHHHH
Confidence            3567889999999999999999999997653     3566666555699999864                345678889


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC---CCcCCccCccccCcccccCccCCC
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG---ESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .++.|++.||+|||++||+||||||+|||++.++ .+||+|||++........   ......||+.|+|||.+.....++
T Consensus       113 ~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~  191 (345)
T d1pmea_         113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT  191 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCS
T ss_pred             HHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCC
Confidence            9999999999999999999999999999999888 899999999976543322   245567999999999997656788


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc-----------------ccccccccCCCCCCCHHH
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK-----------------LSLRDHLTNGFPGLEPAG  225 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~  225 (259)
                      .++||||+||++|+|++|++||.+.+..............+....                 ..........++++|+++
T Consensus       192 ~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  271 (345)
T d1pmea_         192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA  271 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHH
T ss_pred             chhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHH
Confidence            999999999999999999999998776555544322111111000                 000011222346788999


Q ss_pred             HHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          226 IDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       226 ~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      .+|+.+||..||++|||++++|+||||+...
T Consensus       272 ~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         272 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence            9999999999999999999999999998653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.2e-48  Score=317.03  Aligned_cols=227  Identities=26%  Similarity=0.411  Sum_probs=174.6

Q ss_pred             CCchhHHHHHHHhhCC-CCCeeEEEEEEEeC--ceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159           11 VPSSMIREVSCLMELN-HPNIIRLMRVASQG--IYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      ..+++.+|+++|++++ ||||+++++++...  ..+++||||+.+ +|....                  ..++...+..
T Consensus        72 ~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~------------------~~l~e~~i~~  133 (328)
T d3bqca1          72 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------------QTLTDYDIRF  133 (328)
T ss_dssp             CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT------------------TSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh------------------cCCCHHHHHH
Confidence            3568899999999995 99999999999743  579999999997 665443                  2356677889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcccc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTAVD  166 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D  166 (259)
                      ++.|++.||+|||++||+||||||+|||++.++..+||+|||+++.... ........+|+.|+|||.+.+...++.++|
T Consensus       134 i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  212 (328)
T d3bqca1         134 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLVDYQMYDYSLD  212 (328)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-TCCCCSCCSCGGGCCHHHHTTCCCCCTHHH
T ss_pred             HHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-CCcccccccCccccCcccccCCCCCCcccc
Confidence            9999999999999999999999999999997765799999999986543 234456678999999999987666899999


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCChH-HHHHHHh---------------CCCCCCcccccc-------cc-ccccCCCCCCC
Q 039159          167 IWPVGCIFGEMVSGKPLFPGANSL-ITLGRIV---------------GKSRKPSFCKLS-------LR-DHLTNGFPGLE  222 (259)
Q Consensus       167 iwslG~~l~e~~tg~~pf~~~~~~-~~~~~i~---------------~~~~~~~~~~~~-------~~-~~~~~~~~~~~  222 (259)
                      |||+||++|++++|..||...... .....+.               .....+......       .. .........+|
T Consensus       213 iwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  292 (328)
T d3bqca1         213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS  292 (328)
T ss_dssp             HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCC
T ss_pred             hhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCC
Confidence            999999999999999999765432 2221111               000001100000       00 01111223478


Q ss_pred             HHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          223 PAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       223 ~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                      +++.+||.+||..||.+|||++|+|+||||+++.
T Consensus       293 ~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         293 PEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999999863

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=310.17  Aligned_cols=210  Identities=23%  Similarity=0.255  Sum_probs=175.2

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEF   88 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   88 (259)
                      +..++|.+|+.++++++||||++++|++.+ +.+++||||+.+ ++.+.+....              ..++...++.++
T Consensus        53 ~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~--------------~~l~~~~~~~~~  117 (273)
T d1u46a_          53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ--------------GHFLLGTLSRYA  117 (273)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHG--------------GGSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhccc--------------CCCCHHHHHHHH
Confidence            345689999999999999999999999965 577899999995 8887765321              446778889999


Q ss_pred             hhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC---CcCCccCccccCcccccCccCCCccc
Q 039159           89 SSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE---SSAEVGTHYYKAPELLLGLLEYSTAV  165 (259)
Q Consensus        89 ~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~  165 (259)
                      .|++.||+|||+++|+||||||+||+++.++ .+||+|||+++........   .....|++.|+|||.+.+ ..++.++
T Consensus       118 ~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~  195 (273)
T d1u46a_         118 VQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHAS  195 (273)
T ss_dssp             HHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHH
T ss_pred             HHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcch
Confidence            9999999999999999999999999999988 9999999999876443221   223357889999999987 5788999


Q ss_pred             chHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHH
Q 039159          166 DIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAA  244 (259)
Q Consensus       166 DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  244 (259)
                      |||||||++|||+| |++||.+.+..+....+......+..            .+++|+++.+||.+||+.||++|||+.
T Consensus       196 Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~------------~~~~~~~l~~li~~cl~~dp~~RPt~~  263 (273)
T d1u46a_         196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR------------PEDCPQDIYNVMVQCWAHKPEDRPTFV  263 (273)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC------------cccccHHHHHHHHHHcCCChhHCcCHH
Confidence            99999999999998 89999999988888887665443322            246889999999999999999999999


Q ss_pred             HHhc
Q 039159          245 EALQ  248 (259)
Q Consensus       245 ~~l~  248 (259)
                      ++++
T Consensus       264 ei~~  267 (273)
T d1u46a_         264 ALRD  267 (273)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9873

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.9e-48  Score=311.74  Aligned_cols=215  Identities=26%  Similarity=0.403  Sum_probs=170.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCc----eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGI----YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLV   85 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (259)
                      ..+++.+|++++++++||||+++++++...+    .+|+||||+.| +|...+...               ..++...+.
T Consensus        50 ~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~---------------~~l~~~~~~  114 (277)
T d1o6ya_          50 FYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---------------GPMTPKRAI  114 (277)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH---------------CSCCHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhccc---------------CCCCHHHHH
Confidence            3457899999999999999999999997643    48999999996 888777542               346677889


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC---CCCcCCccCccccCcccccCccCCC
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK---GESSAEVGTHYYKAPELLLGLLEYS  162 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~  162 (259)
                      .++.|++.||+|||++||+||||||+||+++.++ .++++|||.+.......   .......||+.|+|||.+.+ ..++
T Consensus       115 ~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~  192 (277)
T d1o6ya_         115 EVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVD  192 (277)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTTCEECC----------------TTCCHHHHTT-CCCC
T ss_pred             HHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhhhhhhccccccccccccccCcccccCHHHHcC-CCCC
Confidence            9999999999999999999999999999999888 89999999987553322   23445579999999999987 5789


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc-
Q 039159          163 TAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI-  241 (259)
Q Consensus       163 ~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-  241 (259)
                      .++|||||||++|+|+||++||.+.+..+....+......+..          ...+++|+++.++|.+||..||++|| 
T Consensus       193 ~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~s~~l~~li~~~L~~dp~~R~~  262 (277)
T d1o6ya_         193 ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS----------ARHEGLSADLDAVVLKALAKNPENRYQ  262 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG----------GTSSSCCHHHHHHHHHHTCSSGGGSCS
T ss_pred             cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc----------hhccCCCHHHHHHHHHHccCCHhHCHh
Confidence            9999999999999999999999998888877776655433321          12357899999999999999999999 


Q ss_pred             CHHHHhcCcccc
Q 039159          242 TAAEALQQEYFK  253 (259)
Q Consensus       242 ~~~~~l~h~~f~  253 (259)
                      |++++ .|+|.+
T Consensus       263 sa~~l-~~~l~r  273 (277)
T d1o6ya_         263 TAAEM-RADLVR  273 (277)
T ss_dssp             SHHHH-HHHHHH
T ss_pred             HHHHH-HHHHHH
Confidence            55555 566654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=315.77  Aligned_cols=212  Identities=20%  Similarity=0.228  Sum_probs=171.3

Q ss_pred             CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHH
Q 039159            8 MEGVPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVE   86 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   86 (259)
                      +....++|.+|++++++++|||||+++|++.+++ .++++|++. |+|.+.+....              ..++...++.
T Consensus        51 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~--------------~~~~~~~~~~  115 (317)
T d1xkka_          51 SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK--------------DNIGSQYLLN  115 (317)
T ss_dssp             --CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTS--------------SSCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccc--------------cCCCHHHHHH
Confidence            3455678999999999999999999999998754 566777776 58888776432              3456677889


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCC--CcCCccCccccCcccccCccCCCcc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGE--SSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ++.|++.||+|||+++|+||||||+||+++.++ .+||+|||+++........  .....||+.|+|||.+.+ ..++.+
T Consensus       116 i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~  193 (317)
T d1xkka_         116 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQ  193 (317)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccceecccccccccccccccCccccChHHHhc-CCCChh
Confidence            999999999999999999999999999999988 9999999999876443222  233468999999999987 578999


Q ss_pred             cchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +|||||||++|||+| |.+||.+.+..+....+..+.+.+             ..+.+++++.+|+.+||..||.+|||+
T Consensus       194 sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-------------~p~~~~~~~~~li~~cl~~dP~~RPs~  260 (317)
T d1xkka_         194 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-------------QPPICTIDVYMIMVKCWMIDADSRPKF  260 (317)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC-------------CCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-------------CCcccCHHHHHHHHHhCCCChhhCcCH
Confidence            999999999999998 789998877666665554433221             124678999999999999999999999


Q ss_pred             HHHhcC
Q 039159          244 AEALQQ  249 (259)
Q Consensus       244 ~~~l~h  249 (259)
                      .++++|
T Consensus       261 ~eil~~  266 (317)
T d1xkka_         261 RELIIE  266 (317)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999976

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=308.30  Aligned_cols=215  Identities=24%  Similarity=0.323  Sum_probs=170.2

Q ss_pred             CCCCCCCCCCCchhHHHHHHHhhCCCCCeeEEEEEEEe-CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchh
Q 039159            2 MGIHNTMEGVPSSMIREVSCLMELNHPNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLF   79 (259)
Q Consensus         2 ~~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~   79 (259)
                      |.+++  +...++|.+|++++++++||||++++|++.+ ++.+++||||+++ +|.+++....             ...+
T Consensus        36 K~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-------------~~~l  100 (262)
T d1byga_          36 KCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-------------RSVL  100 (262)
T ss_dssp             EECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH-------------HHHC
T ss_pred             EEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcC-------------CCCC
Confidence            44443  4456889999999999999999999999865 4568999999996 8999985321             0346


Q ss_pred             HHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCcc
Q 039159           80 TTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLL  159 (259)
Q Consensus        80 ~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  159 (259)
                      +...++.++.|++.|++|||+.+|+||||||+||+++.++ .+|++|||+++....   ......+++.|+|||.+.+ .
T Consensus       101 ~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~---~~~~~~~~~~y~aPE~l~~-~  175 (262)
T d1byga_         101 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALRE-K  175 (262)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC---------------CCTTTSCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccceecCC---CCccccccccCCChHHHhC-C
Confidence            6788899999999999999999999999999999999998 899999999986532   2334467889999999987 5


Q ss_pred             CCCcccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCC
Q 039159          160 EYSTAVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPD  238 (259)
Q Consensus       160 ~~~~~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (259)
                      .++.++|||||||++|||+| |.+||......+....+....+. ..            ...+++++.+||.+||+.||+
T Consensus       176 ~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~-~~------------~~~~~~~~~~li~~cl~~dP~  242 (262)
T d1byga_         176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-DA------------PDGCPPAVYEVMKNCWHLDAA  242 (262)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-CC------------CTTCCHHHHHHHHHHTCSSGG
T ss_pred             CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CC------------CccCCHHHHHHHHHHcccCHh
Confidence            78999999999999999998 78899888777777776544322 21            246789999999999999999


Q ss_pred             CccCHHHHhcC
Q 039159          239 KRITAAEALQQ  249 (259)
Q Consensus       239 ~Rp~~~~~l~h  249 (259)
                      +|||+.+++++
T Consensus       243 ~Rps~~~l~~~  253 (262)
T d1byga_         243 MRPSFLQLREQ  253 (262)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=315.95  Aligned_cols=221  Identities=23%  Similarity=0.284  Sum_probs=176.7

Q ss_pred             CCCchhHHHHHHHhhCCC-CCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHH
Q 039159           10 GVPSSMIREVSCLMELNH-PNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEE   87 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (259)
                      ...+.+.+|++++++++| |||+++++++.+...++++|||+.| +|...+...               .......+..+
T Consensus        70 ~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~---------------~~~~e~~~~~~  134 (322)
T d1vzoa_          70 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---------------ERFTEHEVQIY  134 (322)
T ss_dssp             SSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH---------------SCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc---------------ccccHHHHHHH
Confidence            456788999999999976 8999999999999999999999996 899888653               23345667788


Q ss_pred             HhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccC-CCCcCCccCccccCcccccCc-cCCCccc
Q 039159           88 FSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYK-GESSAEVGTHYYKAPELLLGL-LEYSTAV  165 (259)
Q Consensus        88 ~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~  165 (259)
                      +.|++.|++|+|+.+|+||||||+||+++.++ .+||+|||+++.+.... .......|++.|+|||.+.+. ..++.++
T Consensus       135 ~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ks  213 (322)
T d1vzoa_         135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV  213 (322)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHH
T ss_pred             HHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchh
Confidence            89999999999999999999999999999998 89999999997654332 234456799999999999763 2467899


Q ss_pred             chHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc----
Q 039159          166 DIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI----  241 (259)
Q Consensus       166 DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp----  241 (259)
                      |||||||++|+|++|+.||.+.........+.....          ....+....+|+++.+||.+||+.||++||    
T Consensus       214 DIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~----------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~  283 (322)
T d1vzoa_         214 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL----------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP  283 (322)
T ss_dssp             HHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH----------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSST
T ss_pred             hhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc----------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCc
Confidence            999999999999999999987543333222211100          011112346899999999999999999999    


Q ss_pred             -CHHHHhcCccccCCC
Q 039159          242 -TAAEALQQEYFKDVP  256 (259)
Q Consensus       242 -~~~~~l~h~~f~~~~  256 (259)
                       |++|+++||||+.+.
T Consensus       284 ~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         284 RDADEIKEHLFFQKIN  299 (322)
T ss_dssp             TTHHHHHTSGGGTTCC
T ss_pred             ccHHHHHcCHhhcCCC
Confidence             589999999998753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=309.29  Aligned_cols=226  Identities=23%  Similarity=0.258  Sum_probs=177.2

Q ss_pred             CCCCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc-cccCCCcchhHHHHH
Q 039159            8 MEGVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS-TKNFNSYSLFTTFLL   84 (259)
Q Consensus         8 ~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~   84 (259)
                      +++..++|.+|+++|+++ +|||||+++|++.+++.+++||||++| +|.++++.......... .........++..+.
T Consensus        50 ~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~  129 (309)
T d1fvra_          50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL  129 (309)
T ss_dssp             -----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred             ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHH
Confidence            345677899999999999 799999999999999999999999995 99999865311000000 000111245677889


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ..++.|++.|+.|||+++|+||||||+|||++.++ .+||+|||+++..... .......||+.|+|||.+.+ ..++.+
T Consensus       130 ~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~-~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~  206 (309)
T d1fvra_         130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTN  206 (309)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHH
T ss_pred             HHHHHHHHHHHHhhhcCCccccccccceEEEcCCC-ceEEcccccccccccc-ccccceecCCcccchHHhcc-CCCCcc
Confidence            99999999999999999999999999999999988 8999999999754332 22334468999999999987 578999


Q ss_pred             cchHhHHHHHHHHHhCC-CCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVSGK-PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +|||||||++|||++|. +||.+.+..+....+....+. .            ....+++++.+||.+||..||++|||+
T Consensus       207 sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~-~------------~~~~~~~~~~~li~~cl~~dP~~RPs~  273 (309)
T d1fvra_         207 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-E------------KPLNCDDEVYDLMRQCWREKPYERPSF  273 (309)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC-C------------CCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC-C------------CCccCCHHHHHHHHHHcCCChhHCcCH
Confidence            99999999999999965 678888877777776554322 1            124688999999999999999999999


Q ss_pred             HHHhcC
Q 039159          244 AEALQQ  249 (259)
Q Consensus       244 ~~~l~h  249 (259)
                      ++++++
T Consensus       274 ~eil~~  279 (309)
T d1fvra_         274 AQILVS  279 (309)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-47  Score=308.42  Aligned_cols=223  Identities=18%  Similarity=0.228  Sum_probs=178.5

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcc---------cccCCCcchhH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYS---------TKNFNSYSLFT   80 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~---------~~~~~~~~~~~   80 (259)
                      ..++|.+|++++++++||||+++++++..++..+++|||+.+ +|.+++...........         .........++
T Consensus        59 ~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  138 (301)
T d1lufa_          59 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS  138 (301)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCC
T ss_pred             HHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCC
Confidence            356799999999999999999999999999999999999985 99999865432211100         00111123467


Q ss_pred             HHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCc
Q 039159           81 TFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        81 ~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  158 (259)
                      ....+.++.|++.||+|||+++++||||||+||+++.++ .+||+|||+++.......  ......|++.|+|||.+.+ 
T Consensus       139 ~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  216 (301)
T d1lufa_         139 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-  216 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-
T ss_pred             HHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-
Confidence            788999999999999999999999999999999999988 899999999976543322  2345578999999999987 


Q ss_pred             cCCCcccchHhHHHHHHHHHhCC-CCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCC
Q 039159          159 LEYSTAVDIWPVGCIFGEMVSGK-PLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDP  237 (259)
Q Consensus       159 ~~~~~~~DiwslG~~l~e~~tg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  237 (259)
                      ..++.++|||||||++|||++|. +||.+.+..+....+...... .            ....+++++.+|+.+||+.||
T Consensus       217 ~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~-~------------~p~~~~~~~~~li~~cl~~~P  283 (301)
T d1lufa_         217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL-A------------CPENCPLELYNLMRLCWSKLP  283 (301)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-C------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred             CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-C------------CCccchHHHHHHHHHHcCCCh
Confidence            67899999999999999999985 789888888887777655422 1            124688999999999999999


Q ss_pred             CCccCHHHHhc
Q 039159          238 DKRITAAEALQ  248 (259)
Q Consensus       238 ~~Rp~~~~~l~  248 (259)
                      ++|||+.+|++
T Consensus       284 ~~RPt~~ev~~  294 (301)
T d1lufa_         284 ADRPSFCSIHR  294 (301)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=315.37  Aligned_cols=225  Identities=32%  Similarity=0.505  Sum_probs=173.9

Q ss_pred             CCchhHHHHHHHhhCCCCCeeEEEEEEEeC-----ceEEEEeeeec-CCHHHHhhcCCCCCCCcccccCCCcchhHHHHH
Q 039159           11 VPSSMIREVSCLMELNHPNIIRLMRVASQG-----IYLYPVFEYQV-NDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLL   84 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-----~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (259)
                      ..+++.+|+++|++++||||+++++++...     ...+++++|+. |+|.+++..                ..++...+
T Consensus        60 ~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~----------------~~l~e~~~  123 (348)
T d2gfsa1          60 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----------------QKLTDDHV  123 (348)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT----------------CCCCHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc----------------ccccHHHH
Confidence            345788999999999999999999998643     23344455555 599998853                33566788


Q ss_pred             HHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCcc
Q 039159           85 VEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        85 ~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ..++.|++.||+|||++||+||||||+||+++.++ .+|++|||.+....   .......|++.|+|||.+.+...++.+
T Consensus       124 ~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~  199 (348)
T d2gfsa1         124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQT  199 (348)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTT
T ss_pred             HHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhcccC---cccccccccccccCchhhcCCccCCcc
Confidence            89999999999999999999999999999999998 89999999997542   234556789999999998875667899


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCcccc-----------------ccccccccCCCCCCCHHHHH
Q 039159          165 VDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCK-----------------LSLRDHLTNGFPGLEPAGID  227 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~  227 (259)
                      +|||||||++|+|++|.+||.+.+.......+......+....                 ..........+.+.++++++
T Consensus       200 ~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  279 (348)
T d2gfsa1         200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD  279 (348)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHH
T ss_pred             cchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHH
Confidence            9999999999999999999999887766666533221111000                 00001112223568999999


Q ss_pred             HHHhhcCcCCCCccCHHHHhcCccccCC
Q 039159          228 LISKMLGMDPDKRITAAEALQQEYFKDV  255 (259)
Q Consensus       228 li~~~l~~dp~~Rp~~~~~l~h~~f~~~  255 (259)
                      ||.+||..||.+|||++|+|+||||+..
T Consensus       280 li~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         280 LLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999865

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-47  Score=307.97  Aligned_cols=219  Identities=19%  Similarity=0.200  Sum_probs=171.4

Q ss_pred             CCCCCC-CCCCCchhHHHHHHHhhCCCCCeeEEEEEEEe-CceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcch
Q 039159            2 MGIHNT-MEGVPSSMIREVSCLMELNHPNIIRLMRVASQ-GIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSL   78 (259)
Q Consensus         2 ~~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~   78 (259)
                      |++... +....++|.+|++++++++||||++++|++.+ ++..++|||||.+ +|.+++....              ..
T Consensus        61 K~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~--------------~~  126 (311)
T d1r0pa_          61 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--------------HN  126 (311)
T ss_dssp             EEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTT--------------CC
T ss_pred             EEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcccc--------------cc
Confidence            344432 33445789999999999999999999999875 4689999999996 8888876432              23


Q ss_pred             hHHHHHHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC----CCcCCccCccccCccc
Q 039159           79 FTTFLLVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG----ESSAEVGTHYYKAPEL  154 (259)
Q Consensus        79 ~~~~~~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~  154 (259)
                      .....++.++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||+++.......    ......||+.|+|||.
T Consensus       127 ~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  205 (311)
T d1r0pa_         127 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES  205 (311)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHH
T ss_pred             chHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEecccchhhccccccccceecccccccccccChHH
Confidence            34566788999999999999999999999999999999888 899999999986543322    1223468999999999


Q ss_pred             ccCccCCCcccchHhHHHHHHHHHhCCCCCCC-CChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhc
Q 039159          155 LLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPG-ANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKML  233 (259)
Q Consensus       155 ~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  233 (259)
                      +.+ ..++.++||||||+++|||+||..||.. .+.......+..+.+ +..            ...+++++.+||.+||
T Consensus       206 ~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-~~~------------p~~~~~~l~~li~~cl  271 (311)
T d1r0pa_         206 LQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQ------------PEYCPDPLYEVMLKCW  271 (311)
T ss_dssp             HHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-CCC------------CTTCCHHHHHHHHHHT
T ss_pred             Hhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CCC------------cccCcHHHHHHHHHHc
Confidence            987 5789999999999999999997766654 333344444444332 221            1357899999999999


Q ss_pred             CcCCCCccCHHHHhcC
Q 039159          234 GMDPDKRITAAEALQQ  249 (259)
Q Consensus       234 ~~dp~~Rp~~~~~l~h  249 (259)
                      +.||++||++.++++|
T Consensus       272 ~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         272 HPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHH
Confidence            9999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-48  Score=318.41  Aligned_cols=225  Identities=33%  Similarity=0.470  Sum_probs=168.6

Q ss_pred             CCCchhHHHHHHHhhCCCCCeeEEEEEEEe------CceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHH
Q 039159           10 GVPSSMIREVSCLMELNHPNIIRLMRVASQ------GIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFL   83 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (259)
                      ....++.+|+.++++++||||++++++|..      ...+|+||||+.|++...+.                 ..++...
T Consensus        58 ~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~-----------------~~~~~~~  120 (355)
T d2b1pa1          58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----------------MELDHER  120 (355)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT-----------------SCCCHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh-----------------cCCCHHH
Confidence            334578899999999999999999999963      36889999999998877773                 2345677


Q ss_pred             HHHHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccCcccccCccCCCc
Q 039159           84 LVEEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        84 ~~~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      +..++.|++.||+|||+.||+||||||+||+++.++ .++++|||.++.... ........||+.|+|||.+.+ ..++.
T Consensus       121 i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~~~-~~~~~~~~~t~~y~aPE~l~~-~~~~~  197 (355)
T d2b1pa1         121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKE  197 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC----------------CCTTCCHHHHTT-CCCCT
T ss_pred             HHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhhhcccc-ccccccccccccccChhhhcC-CCCCC
Confidence            889999999999999999999999999999999988 899999999876533 233455578999999999988 67899


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCc--------------------cccc--------ccccccc
Q 039159          164 AVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPS--------------------FCKL--------SLRDHLT  215 (259)
Q Consensus       164 ~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~--------------------~~~~--------~~~~~~~  215 (259)
                      ++||||+||++|+|++|++||.+.+.......+......+.                    ....        .......
T Consensus       198 ~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (355)
T d2b1pa1         198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS  277 (355)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSS
T ss_pred             CcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccc
Confidence            99999999999999999999998876665555432111100                    0000        0000000


Q ss_pred             CCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccC
Q 039159          216 NGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKD  254 (259)
Q Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~  254 (259)
                      ......|+++++||++||..||++|||++|+|+||||+.
T Consensus       278 ~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         278 EHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             cccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            000124678899999999999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=302.34  Aligned_cols=224  Identities=22%  Similarity=0.277  Sum_probs=180.3

Q ss_pred             CCCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCc-ccccCCCcchhHHHHHHH
Q 039159           10 GVPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGY-STKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        10 ~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~   86 (259)
                      .....+.+|+..++++ +|||||++++++.+++.+++||||+.+ +|.+++.......... ..........++...++.
T Consensus        60 ~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  139 (299)
T d1fgka_          60 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS  139 (299)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHH
Confidence            3447788999999888 899999999999999999999999995 8999997543211100 001111224577889999


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++.......  ......|++.|+|||.+.+ ..++.+
T Consensus       140 ~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k  217 (299)
T d1fgka_         140 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQ  217 (299)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHhhhCCEEeeeecccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCch
Confidence            999999999999999999999999999999998 899999999987654322  2344578999999999987 678999


Q ss_pred             cchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +|||||||++|||++ |.+||.+.........+..... +..            ...+++++.+||.+||+.||.+|||+
T Consensus       218 ~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~-~~~------------p~~~~~~l~~li~~cl~~dP~~Rps~  284 (299)
T d1fgka_         218 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR-MDK------------PSNCTNELYMMMRDCWHAVPSQRPTF  284 (299)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-CCC------------CSSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCC-CCC------------CccchHHHHHHHHHHccCCHhHCcCH
Confidence            999999999999998 6899988887777666654432 222            24688999999999999999999999


Q ss_pred             HHHhc
Q 039159          244 AEALQ  248 (259)
Q Consensus       244 ~~~l~  248 (259)
                      .++++
T Consensus       285 ~eil~  289 (299)
T d1fgka_         285 KQLVE  289 (299)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=303.79  Aligned_cols=225  Identities=19%  Similarity=0.269  Sum_probs=168.5

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeC-ceEEEEeeeecC-CHHHHhhcCCCCCCCcc-cccCCCcchhHHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQG-IYLYPVFEYQVN-DLAYLLKYPKDSMNGYS-TKNFNSYSLFTTFLLVE   86 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~   86 (259)
                      ..+.+.+|+.++.++ +|+||+++++++.++ +.+++|||||+| +|.++++.......... .........+++.+++.
T Consensus        59 ~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  138 (299)
T d1ywna1          59 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC  138 (299)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHH
Confidence            345688888888887 699999999998754 578999999995 99999975432111100 00111124577789999


Q ss_pred             HHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcc
Q 039159           87 EFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTA  164 (259)
Q Consensus        87 ~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~  164 (259)
                      ++.|+++||+|||+++|+||||||+|||++.++ .+||+|||+++.......  ......||+.|+|||.+.+ ..++.+
T Consensus       139 ~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~  216 (299)
T d1ywna1         139 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQ  216 (299)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHH
T ss_pred             HHHHHHHHHHHHHhCCCcCCcCCccceeECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcc
Confidence            999999999999999999999999999999888 899999999986543322  2345579999999999987 678999


Q ss_pred             cchHhHHHHHHHHHhC-CCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCH
Q 039159          165 VDIWPVGCIFGEMVSG-KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITA  243 (259)
Q Consensus       165 ~DiwslG~~l~e~~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  243 (259)
                      +|||||||++|||+|| .+||.+.........+......+..            ...+++++.+++.+||+.||++|||+
T Consensus       217 sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~~Rpt~  284 (299)
T d1ywna1         217 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA------------PDYTTPEMYQTMLDCWHGEPSQRPTF  284 (299)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC------------CccCCHHHHHHHHHHcCCChhHCcCH
Confidence            9999999999999986 5788876655555444333322222            24578999999999999999999999


Q ss_pred             HHHhcC
Q 039159          244 AEALQQ  249 (259)
Q Consensus       244 ~~~l~h  249 (259)
                      +++++|
T Consensus       285 ~eil~~  290 (299)
T d1ywna1         285 SELVEH  290 (299)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=305.51  Aligned_cols=223  Identities=19%  Similarity=0.273  Sum_probs=182.4

Q ss_pred             CchhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ...|.+|++++++++||||++++|++..++..++||||+.+ +|.+++.......     .........+...+..++.+
T Consensus        67 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~  141 (308)
T d1p4oa_          67 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM-----ANNPVLAPPSLSKMIQMAGE  141 (308)
T ss_dssp             HHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHH-----HHCTTCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhccccc-----ccccccCCCCHHHHHHHHHH
Confidence            34688999999999999999999999999999999999995 8988886421100     00011123466788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCcccchH
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYSTAVDIW  168 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Diw  168 (259)
                      +++||+|||+++|+||||||+|||++.++ .+||+|||+++.......  ......||+.|+|||.+.+ ..++.++|||
T Consensus       142 ia~gl~~LH~~~ivHrDlk~~NiLld~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~  219 (308)
T d1p4oa_         142 IADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVW  219 (308)
T ss_dssp             HHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHH
T ss_pred             HHHHHHHHhhCCeeeceEcCCceeecCCc-eEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccc
Confidence            99999999999999999999999999888 899999999986644322  2344468999999999987 5788999999


Q ss_pred             hHHHHHHHHHhC-CCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHh
Q 039159          169 PVGCIFGEMVSG-KPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEAL  247 (259)
Q Consensus       169 slG~~l~e~~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l  247 (259)
                      ||||++|||+|| .+||.+.+..+....+......+             ....+++.+.++|.+||+.||++|||+++++
T Consensus       220 S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~-------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il  286 (308)
T d1p4oa_         220 SFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD-------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEII  286 (308)
T ss_dssp             HHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC-------------CcccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            999999999998 58898888888887776544321             1246789999999999999999999999999


Q ss_pred             c------CccccC
Q 039159          248 Q------QEYFKD  254 (259)
Q Consensus       248 ~------h~~f~~  254 (259)
                      +      +|+|++
T Consensus       287 ~~L~~~~~~~~~~  299 (308)
T d1p4oa_         287 SSIKEEMEPGFRE  299 (308)
T ss_dssp             HHHGGGSCTTHHH
T ss_pred             HHHHHhcCCCCcC
Confidence            7      677764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=303.98  Aligned_cols=224  Identities=22%  Similarity=0.249  Sum_probs=177.3

Q ss_pred             CCchhHHHHHHHhhC-CCCCeeEEEEEEEeCceEEEEeeeecC-CHHHHhhcCCCCCCCccc---ccCCCcchhHHHHHH
Q 039159           11 VPSSMIREVSCLMEL-NHPNIIRLMRVASQGIYLYPVFEYQVN-DLAYLLKYPKDSMNGYST---KNFNSYSLFTTFLLV   85 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~   85 (259)
                      ....|.+|+.+++++ +|||||+++|++.+++..++||||+.| +|.++++...........   ........++...++
T Consensus        69 ~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  148 (311)
T d1t46a_          69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL  148 (311)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHH
Confidence            345788999999999 699999999999999999999999996 899998764432111000   011112457778899


Q ss_pred             HHHhhcccccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC--CCcCCccCccccCcccccCccCCCc
Q 039159           86 EEFSSSDSSRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG--ESSAEVGTHYYKAPELLLGLLEYST  163 (259)
Q Consensus        86 ~~~~~~~~~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  163 (259)
                      .++.|++.|++|||+++++||||||+||+++.++ .++++|||.++.......  ......||+.|+|||.+.+ ..++.
T Consensus       149 ~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  226 (311)
T d1t46a_         149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTF  226 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCH
T ss_pred             HHHHHHHHHHHHHHhCCeeecccccccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCC
Confidence            9999999999999999999999999999999888 999999999987644322  2344578999999999987 57899


Q ss_pred             ccchHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCccC
Q 039159          164 AVDIWPVGCIFGEMVS-GKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRIT  242 (259)
Q Consensus       164 ~~DiwslG~~l~e~~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~  242 (259)
                      ++|||||||++|||+| |.+||.+.+.......+......+..            ....++++.+||.+||+.||++|||
T Consensus       227 ~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~------------~~~~~~~l~~Li~~cl~~dP~~RPs  294 (311)
T d1t46a_         227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS------------PEHAPAEMYDIMKTCWDADPLKRPT  294 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             cccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC------------cccccHHHHHHHHHHcCCChhHCcC
Confidence            9999999999999998 66777776665555555433322221            1357899999999999999999999


Q ss_pred             HHHHhc
Q 039159          243 AAEALQ  248 (259)
Q Consensus       243 ~~~~l~  248 (259)
                      ++++++
T Consensus       295 ~~~il~  300 (311)
T d1t46a_         295 FKQIVQ  300 (311)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999985

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-44  Score=287.94  Aligned_cols=209  Identities=22%  Similarity=0.189  Sum_probs=153.4

Q ss_pred             HHHHHHHhhCCCCCeeEEEEEEEeCc----eEEEEeeeecC-CHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           16 IREVSCLMELNHPNIIRLMRVASQGI----YLYPVFEYQVN-DLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        16 ~~Ei~~l~~l~H~niv~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      ..|+..+++++||||+++++++.+.+    .+|+||||+.+ +|..+++.                ..+++.+.+.++.+
T Consensus        45 e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----------------~~l~~~~~~~~~~~  108 (303)
T d1vjya_          45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----------------YTVTVEGMIKLALS  108 (303)
T ss_dssp             HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH----------------CCBCHHHHHHHHHH
T ss_pred             HHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc----------------CCCCHHHHHHHHHH
Confidence            34555566789999999999997653    68999999985 99999964                23556777888999


Q ss_pred             cccccccccC--------CCceeccCCCCcEEEcCCCCeEEEeeccccccccccCC----CCcCCccCccccCcccccCc
Q 039159           91 SDSSRSLSFG--------TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKG----ESSAEVGTHYYKAPELLLGL  158 (259)
Q Consensus        91 ~~~~l~~lh~--------~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~  158 (259)
                      ++.|++|+|+        ++|+||||||+|||++.++ .+||+|||+++.......    ......||+.|+|||.+.+.
T Consensus       109 ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  187 (303)
T d1vjya_         109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS  187 (303)
T ss_dssp             HHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCccccccCCCcceeccccceecccCcCChhhcccc
Confidence            9999999996        5999999999999999998 899999999987644332    23455799999999998752


Q ss_pred             c-----CCCcccchHhHHHHHHHHHhCCCCCCCCC---------------hHHHHHHHhCCCCCCccccccccccccCCC
Q 039159          159 L-----EYSTAVDIWPVGCIFGEMVSGKPLFPGAN---------------SLITLGRIVGKSRKPSFCKLSLRDHLTNGF  218 (259)
Q Consensus       159 ~-----~~~~~~DiwslG~~l~e~~tg~~pf~~~~---------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  218 (259)
                      .     .++.++|||||||++|||+||.+||....               ..............|..+...     .  .
T Consensus       188 ~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-----~--~  260 (303)
T d1vjya_         188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-----Q--S  260 (303)
T ss_dssp             SCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-----G--G
T ss_pred             ccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCccc-----C--C
Confidence            1     25678999999999999999988764211               112222222222222221100     0  0


Q ss_pred             CCCCHHHHHHHHhhcCcCCCCccCHHHHhc
Q 039159          219 PGLEPAGIDLISKMLGMDPDKRITAAEALQ  248 (259)
Q Consensus       219 ~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~  248 (259)
                      ......+.+|+.+||+.||.+|||+.|+++
T Consensus       261 ~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         261 CEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             CHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            112346889999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-42  Score=277.28  Aligned_cols=221  Identities=18%  Similarity=0.184  Sum_probs=165.6

Q ss_pred             CchhHHHHHHHhhCCCCC-eeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhh
Q 039159           12 PSSMIREVSCLMELNHPN-IIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSS   90 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~H~n-iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (259)
                      .+++.+|++++++++|+| |+.+.+++.+++..++||||+.+++...+....              ..++...+..++.|
T Consensus        46 ~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~q  111 (299)
T d1ckia_          46 HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS--------------RKFSLKTVLLLADQ  111 (299)
T ss_dssp             SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT--------------TCCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCCchhhhhhhcc--------------CCCcHHHHHHHHHH
Confidence            456899999999998665 555566667888999999999988888775432              34566788899999


Q ss_pred             cccccccccCCCceeccCCCCcEEEcCC--CCeEEEeeccccccccccCC-------CCcCCccCccccCcccccCccCC
Q 039159           91 SDSSRSLSFGTRYIRRDLKPVNILVDLD--GKTVKVAGFGLAKSLYAYKG-------ESSAEVGTHYYKAPELLLGLLEY  161 (259)
Q Consensus        91 ~~~~l~~lh~~~i~H~dlkp~Nili~~~--~~~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~  161 (259)
                      ++.||+|||++||+||||||+||+++..  +..++++|||+++.......       ......||+.|+|||.+.+ ..+
T Consensus       112 i~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~  190 (299)
T d1ckia_         112 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQ  190 (299)
T ss_dssp             HHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCC
T ss_pred             HHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC-CCC
Confidence            9999999999999999999999998642  23699999999987644322       1234579999999999988 568


Q ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCChHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcCcCCCCcc
Q 039159          162 STAVDIWPVGCIFGEMVSGKPLFPGANSLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLGMDPDKRI  241 (259)
Q Consensus       162 ~~~~DiwslG~~l~e~~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  241 (259)
                      +.++|||||||++|||++|+.||...........+.....      .....+.+....++|+++.+++..||..||++||
T Consensus       191 ~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP  264 (299)
T d1ckia_         191 SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP  264 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH------HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCC
T ss_pred             CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc------ccCCCChhHhccCCCHHHHHHHHHHccCChhHCc
Confidence            9999999999999999999999987554433222211000      0000111222357889999999999999999999


Q ss_pred             CHHH---HhcCcccc
Q 039159          242 TAAE---ALQQEYFK  253 (259)
Q Consensus       242 ~~~~---~l~h~~f~  253 (259)
                      ++++   +|+|+|.+
T Consensus       265 ~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         265 DYSYLRQLFRNLFHR  279 (299)
T ss_dssp             CHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHH
Confidence            9874   46676654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.7e-41  Score=270.47  Aligned_cols=212  Identities=18%  Similarity=0.138  Sum_probs=168.2

Q ss_pred             CCchhHHHHHHHhhCCC-CCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHh
Q 039159           11 VPSSMIREVSCLMELNH-PNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFS   89 (259)
Q Consensus        11 ~~~~~~~Ei~~l~~l~H-~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   89 (259)
                      ....+.+|+++++.|+| +|++.+++++..+...++||||+.++|.+++....              ..++......++.
T Consensus        43 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~--------------~~~~~~~~~~i~~  108 (293)
T d1csna_          43 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG--------------RKFSVKTVAMAAK  108 (293)
T ss_dssp             TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTT--------------TCCCHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecCCCHHHHHHhhc--------------cchhhHHHHHHHH
Confidence            34668999999999975 99999999999999999999999889999886532              2355677788999


Q ss_pred             hcccccccccCCCceeccCCCCcEEEcC-----CCCeEEEeeccccccccccCC-------CCcCCccCccccCcccccC
Q 039159           90 SSDSSRSLSFGTRYIRRDLKPVNILVDL-----DGKTVKVAGFGLAKSLYAYKG-------ESSAEVGTHYYKAPELLLG  157 (259)
Q Consensus        90 ~~~~~l~~lh~~~i~H~dlkp~Nili~~-----~~~~vkl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~  157 (259)
                      |++.||+|||++||+||||||+||+++.     ++ .++|+|||+++.......       ......||+.|+|||.+.+
T Consensus       109 q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~-~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~  187 (293)
T d1csna_         109 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG  187 (293)
T ss_dssp             HHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTT-CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             HHHHHHHHHHHCCceeccCCccceeecCcccccCC-ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC
Confidence            9999999999999999999999999975     34 799999999987543221       2334579999999999988


Q ss_pred             ccCCCcccchHhHHHHHHHHHhCCCCCCCCC---hHHHHHHHhCCCCCCccccccccccccCCCCCCCHHHHHHHHhhcC
Q 039159          158 LLEYSTAVDIWPVGCIFGEMVSGKPLFPGAN---SLITLGRIVGKSRKPSFCKLSLRDHLTNGFPGLEPAGIDLISKMLG  234 (259)
Q Consensus       158 ~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (259)
                       ..++.++|||||||++|||+||..||.+..   .......+......+         ......+++++++.+++..|+.
T Consensus       188 -~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~---------~~~~l~~~~p~~l~~ii~~~~~  257 (293)
T d1csna_         188 -REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---------PLRELCAGFPEEFYKYMHYARN  257 (293)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS---------CHHHHTTTSCHHHHHHHHHHHH
T ss_pred             -CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC---------ChHHhcCCCCHHHHHHHHHHhc
Confidence             678999999999999999999999997543   222232322111100         1112235688999999999999


Q ss_pred             cCCCCccCHHHHh
Q 039159          235 MDPDKRITAAEAL  247 (259)
Q Consensus       235 ~dp~~Rp~~~~~l  247 (259)
                      .+|++||+.+.+.
T Consensus       258 ~~~~~rP~y~~l~  270 (293)
T d1csna_         258 LAFDATPDYDYLQ  270 (293)
T ss_dssp             CCTTCCCCHHHHH
T ss_pred             CCcccCcCHHHHH
Confidence            9999999877664

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-40  Score=273.58  Aligned_cols=228  Identities=21%  Similarity=0.297  Sum_probs=159.6

Q ss_pred             CchhHHHHHHHhhCC-----------CCCeeEEEEEEEeC--ceEEEEeeeecC--CHHHHhhcCCCCCCCcccccCCCc
Q 039159           12 PSSMIREVSCLMELN-----------HPNIIRLMRVASQG--IYLYPVFEYQVN--DLAYLLKYPKDSMNGYSTKNFNSY   76 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-----------H~niv~~~~~~~~~--~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~   76 (259)
                      .+.+.+|+++++.++           |+||+++++++...  ...+++++++.+  +..........             
T Consensus        53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------  119 (362)
T d1q8ya_          53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH-------------  119 (362)
T ss_dssp             HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTT-------------
T ss_pred             hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccc-------------
Confidence            467789999999885           57899999988643  466667776653  33333322111             


Q ss_pred             chhHHHHHHHHHhhcccccccccC-CCceeccCCCCcEEEcCCCC-----eEEEeeccccccccccCCCCcCCccCcccc
Q 039159           77 SLFTTFLLVEEFSSSDSSRSLSFG-TRYIRRDLKPVNILVDLDGK-----TVKVAGFGLAKSLYAYKGESSAEVGTHYYK  150 (259)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~l~~lh~-~~i~H~dlkp~Nili~~~~~-----~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~  150 (259)
                      ..+....+..++.|++.|++|||+ .||+||||||+|||++.++.     .++++|||.+....   .......||+.|+
T Consensus       120 ~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~---~~~~~~~gt~~y~  196 (362)
T d1q8ya_         120 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQTREYR  196 (362)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT---BCCCSCCSCGGGC
T ss_pred             cCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccc---ccccccccccccc
Confidence            445667788999999999999997 89999999999999986542     48999999997543   2345567999999


Q ss_pred             CcccccCccCCCcccchHhHHHHHHHHHhCCCCCCCCChH------HHHH---HHhCCCCC-------------------
Q 039159          151 APELLLGLLEYSTAVDIWPVGCIFGEMVSGKPLFPGANSL------ITLG---RIVGKSRK-------------------  202 (259)
Q Consensus       151 aPE~~~~~~~~~~~~DiwslG~~l~e~~tg~~pf~~~~~~------~~~~---~i~~~~~~-------------------  202 (259)
                      |||.+.+ ..++.++|+||+||++++|++|+.||......      ....   .+......                   
T Consensus       197 aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~  275 (362)
T d1q8ya_         197 SPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL  275 (362)
T ss_dssp             CHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CB
T ss_pred             Chhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhh
Confidence            9999987 56889999999999999999999999754321      1111   11111000                   


Q ss_pred             ---Cccccccc---cccccCCCCCCCHHHHHHHHhhcCcCCCCccCHHHHhcCccccCCC
Q 039159          203 ---PSFCKLSL---RDHLTNGFPGLEPAGIDLISKMLGMDPDKRITAAEALQQEYFKDVP  256 (259)
Q Consensus       203 ---~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~~l~h~~f~~~~  256 (259)
                         ........   ...........++++.+||.+||..||.+|||++|+|+||||+...
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             SSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             hccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence               00000000   0000011123467899999999999999999999999999999663

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.68  E-value=2.6e-18  Score=128.43  Aligned_cols=122  Identities=14%  Similarity=0.018  Sum_probs=85.5

Q ss_pred             hhHHHHHHHhhCCCCCeeEEEEEEEeCceEEEEeeeecCCHHHHhhcCCCCCCCcccccCCCcchhHHHHHHHHHhhccc
Q 039159           14 SMIREVSCLMELNHPNIIRLMRVASQGIYLYPVFEYQVNDLAYLLKYPKDSMNGYSTKNFNSYSLFTTFLLVEEFSSSDS   93 (259)
Q Consensus        14 ~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (259)
                      .+.+|...+.++.|.+++..+++..    .+++|||+.+....-+                     .......++.+++.
T Consensus        60 ~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~l---------------------~~~~~~~i~~ql~~  114 (191)
T d1zara2          60 SARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYRV---------------------RVENPDEVLDMILE  114 (191)
T ss_dssp             HHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGGC---------------------CCSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccch---------------------hhHHHHHHHHHHHH
Confidence            3457899999999999999887642    3789999987322111                     11223456788999


Q ss_pred             ccccccCCCceeccCCCCcEEEcCCCCeEEEeeccccccccccCCCCcCCccCccccC------cccccCccCCCcccch
Q 039159           94 SRSLSFGTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKSLYAYKGESSAEVGTHYYKA------PELLLGLLEYSTAVDI  167 (259)
Q Consensus        94 ~l~~lh~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~~~~~~~~~~~~~~~~~~~a------PE~~~~~~~~~~~~Di  167 (259)
                      +++|||++||+||||||+|||++.+  .++|+|||.+........        ..|..      .+.+.  ..++..+|+
T Consensus       115 ~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG~a~~~~~~~~--------~~~l~rd~~~~~~~f~--r~y~~~~d~  182 (191)
T d1zara2         115 EVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEEGW--------REILERDVRNIITYFS--RTYRTEKDI  182 (191)
T ss_dssp             HHHHHHHTTEECSCCSTTSEEEETT--EEEECCCTTCEETTSTTH--------HHHHHHHHHHHHHHHH--HHHCCCCCH
T ss_pred             HHHHHhhCCEEEccCChhheeeeCC--CEEEEECCCcccCCCCCc--------HHHHHHHHHHHHHHHc--CCCCCcccH
Confidence            9999999999999999999999955  589999999865421110        01111      11221  357889999


Q ss_pred             HhHHH
Q 039159          168 WPVGC  172 (259)
Q Consensus       168 wslG~  172 (259)
                      ||..-
T Consensus       183 ~s~~~  187 (191)
T d1zara2         183 NSAID  187 (191)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.78  E-value=1.4e-05  Score=60.88  Aligned_cols=49  Identities=8%  Similarity=0.049  Sum_probs=37.7

Q ss_pred             CCCCchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC-CHHHH
Q 039159            9 EGVPSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN-DLAYL   57 (259)
Q Consensus         9 ~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~   57 (259)
                      ......+.+|+..++.|. +--+.+++.+..+++..++||++.+| ++...
T Consensus        50 ~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          50 KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred             ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence            344557889999998884 44467888888888899999999998 55443

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.27  E-value=0.00012  Score=55.11  Aligned_cols=41  Identities=10%  Similarity=-0.015  Sum_probs=32.6

Q ss_pred             CchhHHHHHHHhhCC--CCCeeEEEEEEEeCceEEEEeeeecC
Q 039159           12 PSSMIREVSCLMELN--HPNIIRLMRVASQGIYLYPVFEYQVN   52 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~--H~niv~~~~~~~~~~~~~lv~e~~~~   52 (259)
                      ...+.+|+..++.|.  .-.+.+++.+..+++..++||++++|
T Consensus        48 ~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          48 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            456889999999884  33367778888888889999999987

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.19  E-value=0.0032  Score=48.68  Aligned_cols=32  Identities=22%  Similarity=0.116  Sum_probs=27.2

Q ss_pred             CCCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          100 GTRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       100 ~~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ..|++|+|+.++|++++.+. ..-++||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhccccc-ceeEeccccccc
Confidence            35899999999999999775 568999999853

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.87  E-value=0.0037  Score=50.07  Aligned_cols=37  Identities=19%  Similarity=0.086  Sum_probs=27.7

Q ss_pred             CchhHHHHHHHhhCC-CCCeeEEEEEEEeCceEEEEeeeecC
Q 039159           12 PSSMIREVSCLMELN-HPNIIRLMRVASQGIYLYPVFEYQVN   52 (259)
Q Consensus        12 ~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~lv~e~~~~   52 (259)
                      .-+..+|..+++.+. +.-..++++++.+    .+|+||..|
T Consensus        88 ~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g  125 (395)
T d1nw1a_          88 ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPS  125 (395)
T ss_dssp             HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCE
T ss_pred             hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEecc
Confidence            345779999999985 5555688888753    478999876

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=89.99  E-value=0.07  Score=42.30  Aligned_cols=30  Identities=23%  Similarity=0.160  Sum_probs=25.6

Q ss_pred             CCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      ..++|||+.+.|||++.++  ++++||..+..
T Consensus       223 ~~LiHGDl~~gNIlv~~~~--~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE--TKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC--EEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCCc--eEEechhhccc
Confidence            3689999999999998664  89999988864

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=88.11  E-value=0.1  Score=40.03  Aligned_cols=29  Identities=24%  Similarity=0.239  Sum_probs=23.7

Q ss_pred             CCceeccCCCCcEEEcCCCCeEEEeecccccc
Q 039159          101 TRYIRRDLKPVNILVDLDGKTVKVAGFGLAKS  132 (259)
Q Consensus       101 ~~i~H~dlkp~Nili~~~~~~vkl~dfg~~~~  132 (259)
                      .+++|+|+.+.||+++ ++  ..++||+.+..
T Consensus       192 ~~liHgDlh~~NvL~~-~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWR-DG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEES-SS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEe-CC--ceEEechhccc
Confidence            4789999999999996 44  35789998853